PDF_Name;Match;Sample Size;Distance T-Test
Doc16; data from 1970;1970;-1
Doc19;32 saleswomen;32;-1
Doc19;22 women;22;-1
Doc26;1199  participants;1199;-1
Doc3; data from  3;3;-1
Doc3; data from the 2000;2000;-1
Doc3; data  from the 2000;2000;-1
Doc3; data from 2000;2000;-1
Doc4;6,283 NLSY  women;6283;-1
Doc4;11Although women;11;-1
Doc5;1006  servative Protestant women;1006;-1
Doc5;23,000 individuals;23000;-1
Doc5;12,594 individuals;12594;-1
Doc5;1,000 individuals;1000;-1
Doc5;3 A fourth category represents individuals;3;-1
Doc5;24 enrolled;24;-1
Doc5; data on most of the 3,143;3143;-1
Doc7;100,000 persons;100000;-1
Doc7;100  protest participants;100;-1
Doc7;50 participants;50;-1
Doc7;150 participants;150;-1
Doc7;100 participants;100;-1
Doc7;25,000 people;25000;-1
Doc7;12 people;12;-1
Doc7; data from the 2000;2000;-1
Doc3;50 women;50;-1
Doc3;50 cis women;50;-1
Doc3;17Some participants;17;-1
Doc4;0 identify individuals;0;-1
Doc4;total of 43;43;-1
Doc4; data from1996;1996;-1
Doc5;450 people;450;-1
Doc6;100,000 individuals;100000;-1
Doc6;97,000 individuals;97000;-1
Doc6;5 individuals;5;-1
Doc6;20 individuals;20;-1
Doc6;total of  12;12;-1
Doc7;total of 533;533;-1
Doc12;24 women;24;-1
Doc3;3,000 people;3000;-1
Doc3;  data from the 100;100;-1
Doc3; data from the 1980;1980;-1
Doc34;140 women;140;-1
Doc5;1364  nesspeople;1364;-1
Doc6;62 subjects;62;-1
Doc6;total of 32;32;-1
Doc7;858,774 446,942 705,943 394,434 340,208 186,086  N individuals;8,58774E+35;-1
Doc9;50 undergraduate women;50;-1
Doc23;16 laypeople;16;-1
Doc25;2,000 young  adults;2000;-1
Doc33;300 individuals;300;-1
Doc34;300 individuals;300;-1
Doc4;89 and they were knee patients;89;-1
Doc4;12 patients;12;-1
Doc5;28,429 unique actors and include individuals;28429;-1
Doc5;total of 25,136;25136;-1
Doc5; data consist of 44,528;44528;-1
Doc6;7,000 participants;7000;-1
Doc6;7,490 participants;7490;-1
Doc6;100  people;100;-1
Doc6;100 people;100;-1
Doc6;222 people;222;-1
Doc6;621 people;621;-1
Doc7;1,000 women;1000;-1
Doc7;2,000 people;2000;-1
Doc7;total of 31;31;-1
Doc7;total of 68;68;-1
Doc11;40  individuals;40;-1
Doc13;958  men and women;958;-1
Doc18;5 million additional individuals;5;-1
Doc19;5 million additional individuals;5;-1
Doc3;4 Although persons;4;-1
Doc3;12,686 young  people;12686;-1
Doc3;640  cohort of individuals;640;-1
Doc3;total of 133,121;133121;-1
Doc3; data from 12;12;-1
Doc5;total of  10,902;10902;-1
Doc6;18 participants;18;-1
Doc6;838  ciation participants;838;-1
Doc6;824  people;824;-1
Doc7;23These persons;23;-1
Doc7;894  paring persons;894;-1
Doc7; data from the 2010;2010;-1
Doc11;26 women;26;-1
Doc11;69 women;69;-1
Doc3;335  of participants;335;-1
Doc3;14,000 participants;14000;-1
Doc4;119,000 people;119000;-1
Doc4;24Some of the people;24;-1
Doc4; data from 2006;2006;-1
Doc5;11 women;11;-1
Doc5;200 persons;200;-1
Doc5;5,000 people;5000;-1
Doc5;1,000 people;1000;-1
Doc5;total of 55;55;-1
Doc6;1925 Mussolini  granted women;1925;-1
Doc6;100 people;100;-1
Doc6;1,000 people;1000;-1
Doc6;1,000  people;1000;-1
Doc6;50,000 people;50000;-1
Doc6;271,139 people;271139;-1
Doc6;total of 100,000;100000;-1
Doc7;56 potential subjects;56;-1
Doc7;60 subjects;60;-1
Doc8;1960s describes  women;1960;-1
Doc11 3;40  individuals;40;-1
Doc11;26 women;26;-1
Doc11;69 women;69;-1
Doc12 5;24 women;24;-1
Doc13 2;958  men and women;958;-1
Doc16 3; data from 1970;1970;-1
Doc18 2;5 million additional individuals;5;-1
Doc19 3;32 saleswomen;32;-1
Doc19 3;22 women;22;-1
Doc19;5 million additional individuals;5;-1
Doc23 4;16 laypeople;16;-1
Doc25 3;2,000 young  adults;2000;-1
Doc26 4;1199  participants;1199;-1
Doc3 2;335  of participants;335;-1
Doc3 2;14,000 participants;14000;-1
Doc3 4;3,000 people;3000;-1
Doc3 4;  data from the 100;100;-1
Doc3 4; data from the 1980;1980;-1
Doc3 5; data from  3;3;-1
Doc3 5; data from the 2000;2000;-1
Doc3 5; data  from the 2000;2000;-1
Doc3 5; data from 2000;2000;-1
Doc3 6;50 women;50;-1
Doc3 6;50 cis women;50;-1
Doc3 6;17Some participants;17;-1
Doc3;4 Although persons;4;-1
Doc3;12,686 young  people;12686;-1
Doc3;640  cohort of individuals;640;-1
Doc3;total of 133,121;133121;-1
Doc3; data from 12;12;-1
Doc33;300 individuals;300;-1
Doc34 2;140 women;140;-1
Doc34;300 individuals;300;-1
Doc4 2;119,000 people;119000;-1
Doc4 2;24Some of the people;24;-1
Doc4 2; data from 2006;2006;-1
Doc4 3;89 and they were knee patients;89;-1
Doc4 3;12 patients;12;-1
Doc4 5;6,283 NLSY  women;6283;-1
Doc4 5;11Although women;11;-1
Doc4 6;0 identify individuals;0;-1
Doc4 6;total of 43;43;-1
Doc4 6; data from1996;1996;-1
Doc5 2;11 women;11;-1
Doc5 2;200 persons;200;-1
Doc5 2;5,000 people;5000;-1
Doc5 2;1,000 people;1000;-1
Doc5 2;total of 55;55;-1
Doc5 3;28,429 unique actors and include individuals;28429;-1
Doc5 3;total of 25,136;25136;-1
Doc5 3; data consist of 44,528;44528;-1
Doc5 4;1364  nesspeople;1364;-1
Doc5 5;1006  servative Protestant women;1006;-1
Doc5 5;23,000 individuals;23000;-1
Doc5 5;12,594 individuals;12594;-1
Doc5 5;1,000 individuals;1000;-1
Doc5 5;3 A fourth category represents individuals;3;-1
Doc5 5;24 enrolled;24;-1
Doc5 5; data on most of the 3,143;3143;-1
Doc5 6;450 people;450;-1
Doc5;total of  10,902;10902;-1
Doc6 2;1925 Mussolini  granted women;1925;-1
Doc6 2;100 people;100;-1
Doc6 2;1,000 people;1000;-1
Doc6 2;1,000  people;1000;-1
Doc6 2;50,000 people;50000;-1
Doc6 2;271,139 people;271139;-1
Doc6 2;total of 100,000;100000;-1
Doc6 3;7,000 participants;7000;-1
Doc6 3;7,490 participants;7490;-1
Doc6 3;100  people;100;-1
Doc6 3;100 people;100;-1
Doc6 3;222 people;222;-1
Doc6 3;621 people;621;-1
Doc6 4;100,000 individuals;100000;-1
Doc6 4;97,000 individuals;97000;-1
Doc6 4;5 individuals;5;-1
Doc6 4;20 individuals;20;-1
Doc6 4;total of  12;12;-1
Doc6 6;62 subjects;62;-1
Doc6 6;total of 32;32;-1
Doc6;18 participants;18;-1
Doc6;838  ciation participants;838;-1
Doc6;824  people;824;-1
Doc7 2;56 potential subjects;56;-1
Doc7 2;60 subjects;60;-1
Doc7 3;1,000 women;1000;-1
Doc7 3;2,000 people;2000;-1
Doc7 3;total of 31;31;-1
Doc7 3;total of 68;68;-1
Doc7 4;total of 533;533;-1
Doc7 5;858,774 446,942 705,943 394,434 340,208 186,086  N individuals;8,58774E+35;-1
Doc7 6;100,000 persons;100000;-1
Doc7 6;100  protest participants;100;-1
Doc7 6;50 participants;50;-1
Doc7 6;150 participants;150;-1
Doc7 6;100 participants;100;-1
Doc7 6;25,000 people;25000;-1
Doc7 6;12 people;12;-1
Doc7 6; data from the 2000;2000;-1
Doc7;23These persons;23;-1
Doc7;894  paring persons;894;-1
Doc7; data from the 2010;2010;-1
Doc8 2;1960s describes  women;1960;-1
Doc9 6;50 undergraduate women;50;-1
2003_1268660628251083_manuscript;316 patients;316;-1
2003_1268660628251083_manuscript;5 923 patients;5923;-1
2003_1268660628251083_manuscript;6 816 patients;6816;-1
2003_1268660628251083_manuscript;8507 patients;8507;-1
2003_1268660628251083_manuscript;0 indicates per cent of patients;0;-1
2003_3790290742779899_manuscript;2982 subjects;2982;-1
2003_3790290742779899_manuscript;170 patients;170;-1
2003_3790290742779899_manuscript;n=52;52;-1
2003_3790290742779899_manuscript;n=145;145;-1
2003_3790290742779899_manuscript;n=9;9;-1
2003_3790290742779899_manuscript;n=0;0;-1
2003_3790290742779899_manuscript;n=57;57;-1
2003_3790290742779899_manuscript;n=42;42;-1
2003_3790290742779899_manuscript;n=31;31;-1
2003_3790290742779899_manuscript;n=11;11;-1
2003_3790290742779899_manuscript;n=15;15;-1
2003_3790290742779899_manuscript;n= 24;24;-1
2003_3790290742779899_manuscript;n=8;8;-1
2003_3790290742779899_manuscript;n=7;7;-1
2003_3790290742779899_manuscript;n=16;16;-1
2003_3790290742779899_manuscript;n  =8;8;-1
2003_3790290742779899_manuscript;n  =7;7;-1
2003_3790290742779899_manuscript;n  =1;1;-1
2003_5605307752504297_manuscript;n=17;17;-1
2004_1049386905365439_manuscript;n=9;9;-1
2004_1049386905365439_manuscript;n=11;11;-1
2004_1049386905365439_manuscript;n=12;12;-1
2004_1068872322341841_manuscript;39   subjects;39;-1
2004_1068872322341841_manuscript;41 subjects;41;-1
2004_1068872322341841_manuscript;21 subjects;21;-1
2004_1068872322341841_manuscript;19 subjects;19;-1
2004_1068872322341841_manuscript;100 patients;100;-1
2004_1068872322341841_manuscript;n =   21;21;-1
2004_1068872322341841_manuscript;n = 19;19;-1
2004_1068872322341841_manuscript;n = 21;21;-1
2004_1068872322341841_manuscript;n = 39;39;-1
2004_1068872322341841_manuscript;n = 38;38;-1
2004_1068872322341841_manuscript;41 subjects enrolled;41;-1
2004_1084132846461833_manuscript;11 patients;11;-1
2004_1084132846461833_manuscript;14 patients;14;-1
2004_1084132846461833_manuscript;11   patients;11;-1
2004_1084132846461833_manuscript;3 patients;3;-1
2004_1084132846461833_manuscript;n= 3;3;-1
2004_1084132846461833_manuscript;n= 11;11;-1
2004_1084132846461833_manuscript;n= 6;6;-1
2004_1084132846461833_manuscript;n= 2;2;-1
2004_1084132846461833_manuscript;n=264;264;-1
2004_1084132846461833_manuscript;n= 34;34;-1
2004_1178678495339983_manuscript;12 participants;12;-1
2004_1178678495339983_manuscript;1156 participants;1156;-1
2004_1178678495339983_manuscript;400 participants;400;-1
2004_1178678495339983_manuscript;n = 410;410;-1
2004_1178678495339983_manuscript;n = 416;416;-1
2004_1178678495339983_manuscript;841 men had been   enrolled;841;-1
2004_1178678495339983_manuscript; data from 46;46;-1
2004_1240436566304127_manuscript;312 Native American women;312;-1
2004_1240436566304127_manuscript;273 women;273;-1
2004_1240436566304127_manuscript;8,000 women;8000;-1
2004_1240436566304127_manuscript;312 women;312;-1
2004_1240436566304127_manuscript;9 women;9;-1
2004_1240436566304127_manuscript;3,130 Georgia women;3130;-1
2004_1240436566304127_manuscript;1,600 women;1600;-1
2004_1240436566304127_manuscript;30 Native American women;30;-1
2004_1240436566304127_manuscript;588   Native American women;588;-1
2004_1240436566304127_manuscript;5 million Native women;5;-1
2004_1240436566304127_manuscript;5 women;5;-1
2004_1240436566304127_manuscript;n=9;9;-1
2004_1240436566304127_manuscript;n=312;312;-1
2004_1240436566304127_manuscript;n=273;273;-1
2004_1240436566304127_manuscript;N=268;268;-1
2004_1240436566304127_manuscript;total of 273;273;-1
2004_1240436566304127_manuscript;total of 312;312;-1
2004_1240436566304127_manuscript;total of 58;58;-1
2004_1240436566304127_manuscript;total of 62;62;-1
2004_1240436566304127_manuscript;total   of 40;40;-1
2004_1240436566304127_manuscript;total of 13;13;-1
2004_1378558713021999_manuscript;n = 52;52;-1
2004_1679402705491088_manuscript;1,600 women;1600;14834
2004_1679402705491088_manuscript;5 women;5;15993
2004_1679402705491088_manuscript;3 women;3;17415
2004_1679402705491088_manuscript;1 women;1;22172
2004_1679402705491088_manuscript;4,854 randomly selected persons;4854;439
2004_1679402705491088_manuscript;240 medicated schizophrenic patients;240;16165
2004_1679402705491088_manuscript;12 patients;12;17021
2004_1679402705491088_manuscript;N = 38;38;15959
2004_1679402705491088_manuscript;N = 5;5;15989
2004_1679402705491088_manuscript;N = 34;34;19871
2004_1679402705491088_manuscript;N = 30;30;20197
2004_1679402705491088_manuscript;N = 4,854;4854;40828
2004_1771485029291097_manuscript;total of   342;342;-1
2004_1801904336440924_manuscript;5 million individuals;5;-1
2004_1801904336440924_manuscript;total of 67;67;-1
2004_1801904336440924_manuscript;total of 70;70;-1
2004_1890920133310893_manuscript;154 women;154;-1
2004_1890920133310893_manuscript;8 women;8;-1
2004_1890920133310893_manuscript;19 additional women;19;-1
2004_1890920133310893_manuscript;553 women;553;-1
2004_1890920133310893_manuscript;14 women;14;-1
2004_1890920133310893_manuscript;77 additional women;77;-1
2004_1890920133310893_manuscript;total of 15;15;-1
2004_1890920133310893_manuscript;total of 7070;7070;-1
2004_1890920133310893_manuscript;total of 138;138;-1
2004_1890920133310893_manuscript;total of 915;915;-1
2004_1912019953288053_manuscript;620 patients;620;-1
2004_1912019953288053_manuscript;217 patients;217;-1
2004_1912019953288053_manuscript;35 patients;35;-1
2004_1912019953288053_manuscript;33 patients;33;-1
2004_1912019953288053_manuscript;171 patients;171;-1
2004_1912019953288053_manuscript;total of 114;114;-1
2004_1912019953288053_manuscript;total of 77;77;-1
2004_1924062381437026_manuscript;9341 persons;9341;-1
2004_1924062381437026_manuscript;2,030 persons;2030;-1
2004_1924062381437026_manuscript;9341 asymptomatic study participants;9341;-1
2004_1924062381437026_manuscript;9341 patients;9341;-1
2004_1924062381437026_manuscript;n=130;130;-1
2004_1924062381437026_manuscript;n=127;127;-1
2004_2000556821316480_manuscript;436 patients;436;-1
2004_2000556821316480_manuscript;577 patients;577;-1
2004_2000556821316480_manuscript;281 patients;281;-1
2004_2000556821316480_manuscript;433 patients;433;-1
2004_2000556821316480_manuscript;41 patients;41;-1
2004_2000556821316480_manuscript;393 patients;393;-1
2004_2000556821316480_manuscript;338 patients;338;-1
2004_2000556821316480_manuscript;4444 patients;4444;-1
2004_2000556821316480_manuscript;95 patients;95;-1
2004_2000556821316480_manuscript;338   patients;338;-1
2004_2000556821316480_manuscript;450,000 people;450000;-1
2004_2000556821316480_manuscript;n=393;393;-1
2004_2000556821316480_manuscript;n=433;433;-1
2004_2000556821316480_manuscript;n=95;95;-1
2004_2000556821316480_manuscript;n=338;338;-1
2004_2000556821316480_manuscript;n=161;161;-1
2004_2000556821316480_manuscript;n=232;232;-1
2004_2000556821316480_manuscript;total of 95;95;-1
2004_2000556821316480_manuscript;total of 577;577;-1
2004_2000556821316480_manuscript;total of 76;76;-1
2004_2044449494314728_manuscript;100,000 in   persons;100000;-1
2004_2044449494314728_manuscript;n = 94;94;-1
2004_2044449494314728_manuscript;n=1;1;-1
2004_2044449494314728_manuscript;n= 3;3;-1
2004_2044449494314728_manuscript;n=18;18;-1
2004_2044449494314728_manuscript;n=2;2;-1
2004_2044449494314728_manuscript;n=3;3;-1
2004_2044449494314728_manuscript;n=5;5;-1
2004_2044449494314728_manuscript;total of 1,458;1458;-1
2004_2301012855285169_manuscript;5082   women;5082;-1
2004_2301012855285169_manuscript;5082   participating women;5082;-1
2004_2301012855285169_manuscript;4072 randomised participants;4072;-1
2004_2301012855285169_manuscript;4072 participants;4072;-1
2004_2301012855285169_manuscript;1000 participants;1000;-1
2004_2301012855285169_manuscript;5806 participants;5806;-1
2004_2301012855285169_manuscript;1263 participants;1263;-1
2004_2301012855285169_manuscript;20,000   participants;20000;-1
2004_2301012855285169_manuscript;674 HPS participants;674;-1
2004_2301012855285169_manuscript;444 patients;444;-1
2004_2301012855285169_manuscript;4162 patients;4162;-1
2004_2301012855285169_manuscript;4444 patients;4444;-1
2004_2301012855285169_manuscript;5963 people;5963;-1
2004_2301012855285169_manuscript;20 536 people;20536;-1
2004_2301012855285169_manuscript;20,536 individuals;20536;-1
2004_2301012855285169_manuscript;20,536 UK adults;20536;-1
2004_2301012855285169_manuscript;total of 20,536;20536;-1
2004_4548538023666260_manuscript;562 participants;562;-1
2004_4548538023666260_manuscript;671 eligible patients;671;-1
2004_4548538023666260_manuscript;n=518;518;-1
2004_4548538023666260_manuscript;N=562;562;-1
2004_4548538023666260_manuscript;total of 671;671;-1
2004_5348884694145367_manuscript;2,912 individuals;2912;-1
2004_5348884694145367_manuscript;2,823 individuals;2823;-1
2004_5348884694145367_manuscript;n=3;3;-1
2004_5348884694145367_manuscript;n=4;4;-1
2004_5348884694145367_manuscript;n=5;5;-1
2004_5348884694145367_manuscript;N=1644;1644;-1
2004_5348884694145367_manuscript;N=1642;1642;-1
2004_5348884694145367_manuscript;N=1638;1638;-1
2004_5348884694145367_manuscript;N=1636;1636;-1
2004_5348884694145367_manuscript;N=1633;1633;-1
2004_5348884694145367_manuscript;N=1630;1630;-1
2004_5348884694145367_manuscript;N=1647;1647;-1
2004_5348884694145367_manuscript;N=1645;1645;-1
2004_5348884694145367_manuscript;N=1641;1641;-1
2004_5348884694145367_manuscript;N=1591;1591;-1
2004_5348884694145367_manuscript;N=1589;1589;-1
2004_5348884694145367_manuscript;N=1584;1584;-1
2004_5348884694145367_manuscript;N=999;999;-1
2004_5348884694145367_manuscript;N=1001;1001;-1
2004_5348884694145367_manuscript;N=996;996;-1
2004_5348884694145367_manuscript;N=974;974;-1
2004_5348884694145367_manuscript;N=972;972;-1
2004_5348884694145367_manuscript;N=1611;1611;-1
2004_5348884694145367_manuscript;N=1608;1608;-1
2004_5348884694145367_manuscript;N=1604;1604;-1
2004_5348884694145367_manuscript;N=705;705;-1
2004_5348884694145367_manuscript;N=704;704;-1
2004_5348884694145367_manuscript;N=1609;1609;-1
2004_5348884694145367_manuscript;N=1607;1607;-1
2004_5348884694145367_manuscript;N=1602;1602;-1
2004_5348884694145367_manuscript;N=661;661;-1
2004_5348884694145367_manuscript;N=658;658;-1
2004_5348884694145367_manuscript;N=659;659;-1
2004_5348884694145367_manuscript;N=1598;1598;-1
2004_5348884694145367_manuscript;N=1596;1596;-1
2004_5348884694145367_manuscript;N=1590;1590;-1
2004_5348884694145367_manuscript;N=938;938;-1
2004_5348884694145367_manuscript;N=937;937;-1
2004_5348884694145367_manuscript;N=936;936;-1
2004_5348884694145367_manuscript;N=1620;1620;-1
2004_5348884694145367_manuscript;N=1617;1617;-1
2004_5348884694145367_manuscript;N=1612;1612;-1
2004_5348884694145367_manuscript;N=1587;1587;-1
2004_5348884694145367_manuscript;N=1578;1578;-1
2004_5348884694145367_manuscript;N=998;998;-1
2004_5348884694145367_manuscript;N=1000;1000;-1
2004_5348884694145367_manuscript;N=973;973;-1
2004_5348884694145367_manuscript;N=970;970;-1
2004_5348884694145367_manuscript;N=1606;1606;-1
2004_5348884694145367_manuscript;N=1597;1597;-1
2004_5348884694145367_manuscript;N=703;703;-1
2004_5348884694145367_manuscript;N=701;701;-1
2004_5348884694145367_manuscript;N=656;656;-1
2004_5348884694145367_manuscript;N=1595;1595;-1
2004_5348884694145367_manuscript;N=1594;1594;-1
2004_5348884694145367_manuscript;N=933;933;-1
2004_5348884694145367_manuscript;N=1601;1601;-1
2004_5348884694145367_manuscript;N=1600;1600;-1
2004_5348884694145367_manuscript;N=1603;1603;-1
2004_5348884694145367_manuscript;N=1616;1616;-1
2004_5348884694145367_manuscript;N  =9;9;-1
2004_5348884694145367_manuscript;N  =1;1;-1
2004_5348884694145367_manuscript;N=1555;1555;-1
2004_5348884694145367_manuscript;N=1552;1552;-1
2004_5348884694145367_manuscript;N=1542;1542;-1
2004_5348884694145367_manuscript;N=1546;1546;-1
2004_5348884694145367_manuscript;N=1563;1563;-1
2004_5348884694145367_manuscript;N=984;984;-1
2004_5348884694145367_manuscript;N=983;983;-1
2004_5348884694145367_manuscript;N=976;976;-1
2004_5348884694145367_manuscript;N=980;980;-1
2004_5348884694145367_manuscript;N=989;989;-1
2004_5348884694145367_manuscript;N=975;975;-1
2004_5348884694145367_manuscript;N=981;981;-1
2004_5348884694145367_manuscript;N=1610;1610;-1
2004_5348884694145367_manuscript;N=1618;1618;-1
2004_5348884694145367_manuscript;N=969;969;-1
2004_5348884694145367_manuscript;N=979;979;-1
2004_5348884694145367_manuscript;N=1614;1614;-1
2004_5348884694145367_manuscript;N=1599;1599;-1
2004_5348884694145367_manuscript;N=1621;1621;-1
2004_5348884694145367_manuscript;N=956;956;-1
2004_5348884694145367_manuscript;N=955;955;-1
2004_5348884694145367_manuscript;N=954;954;-1
2004_5348884694145367_manuscript;N=957;957;-1
2004_5348884694145367_manuscript;N=964;964;-1
2004_5348884694145367_manuscript;N=1615;1615;-1
2004_5348884694145367_manuscript;N=1622;1622;-1
2004_5348884694145367_manuscript;N=971;971;-1
2004_6385678742913366_manuscript;n=115;115;-1
2004_6385678742913366_manuscript;total of 480;480;-1
2004_6457917963361349_manuscript;n = 4;4;13980
2004_6457917963361349_manuscript;n = 40;40;12418
2004_6457917963361349_manuscript;n = 3;3;11024
2004_6457917963361349_manuscript;n = 8;8;43380
2004_6457917963361349_manuscript;n = 7;7;43398
2004_6457917963361349_manuscript;n = 5;5;43420
2004_6497233172874328_manuscript;17 MDD subjects;17;-1
2004_6497233172874328_manuscript;n = 14;14;-1
2004_6497233172874328_manuscript;   data from 124;124;-1
2005_1076060939878252_manuscript;80women;80;-1
2005_1076060939878252_manuscript;120women;120;-1
2005_1076060939878252_manuscript;255women;255;-1
2005_1076060939878252_manuscript;7  whenallbutthreeofthewomen;7;-1
2005_1076060939878252_manuscript;40women;40;-1
2005_1076060939878252_manuscript;60women;60;-1
2005_1076060939878252_manuscript;103  women;103;-1
2005_1076060939878252_manuscript;1ofwomen;1;-1
2005_1076060939878252_manuscript;70  individuals;70;-1
2005_1076060939878252_manuscript;N=40;40;-1
2005_1076060939878252_manuscript;N=80;80;-1
2005_1076060939878252_manuscript;N=2879;2879;-1
2005_1142198306654406_manuscript;13 patients;13;-1
2005_1142198306654406_manuscript;total of 1000;1000;-1
2005_1308358959585487_manuscript;1537 subjects;1537;33957
2005_1308358959585487_manuscript;105 subjects;105;33909
2005_1308358959585487_manuscript;1428 subjects;1428;33746
2005_1308358959585487_manuscript;141 subjects;141;31536
2005_1308358959585487_manuscript;97 SSF subjects;97;31440
2005_1308358959585487_manuscript;3   Proportion of subjects;3;2854
2005_1308358959585487_manuscript;n=141;141;39841
2005_1308358959585487_manuscript;n=97;97;39771
2005_1308358959585487_manuscript;n=1537;1537;34396
2005_1308358959585487_manuscript;n=86;86;34052
2005_1308358959585487_manuscript;n=244;244;33075
2005_1308358959585487_manuscript;n=219;219;32975
2005_1308358959585487_manuscript;n=271;271;32771
2005_1308358959585487_manuscript;n=177;177;32585
2005_1308358959585487_manuscript;n=12;12;32071
2005_1308358959585487_manuscript;n=105;105;32056
2005_1308358959585487_manuscript;n=265;265;28667
2005_1308358959585487_manuscript;n=238;238;2564
2005_1308358959585487_manuscript;n=1384;1384;931
2005_1308358959585487_manuscript;n=232;232;3108
2005_1308358959585487_manuscript;total of 21 545;21545;34979
2005_1308358959585487_manuscript; data from 141;141;31547
2005_1417353633609310_manuscript;940 patients;940;-1
2005_1417353633609310_manuscript;37 patients;37;-1
2005_1417353633609310_manuscript;954 patients;954;-1
2005_1417353633609310_manuscript;312 MI patients;312;-1
2005_1417353633609310_manuscript;860 patients;860;-1
2005_1417353633609310_manuscript;38 patients;38;-1
2005_1417353633609310_manuscript;42 patients;42;-1
2005_1417353633609310_manuscript;923 patients;923;-1
2005_1417353633609310_manuscript;470 patients;470;-1
2005_1417353633609310_manuscript;462 control patients;462;-1
2005_1417353633609310_manuscript;111 patients;111;-1
2005_1417353633609310_manuscript;121 patients;121;-1
2005_1417353633609310_manuscript;419 patients;419;-1
2005_1417353633609310_manuscript;404   patients;404;-1
2005_1417353633609310_manuscript;823 patients;823;-1
2005_1417353633609310_manuscript;51 patients;51;-1
2005_1417353633609310_manuscript;74   patients;74;-1
2005_1417353633609310_manuscript;1 patients;1;-1
2005_1417353633609310_manuscript;45 patients;45;-1
2005_1417353633609310_manuscript;65 patients;65;-1
2005_1417353633609310_manuscript;32 MI patients;32;-1
2005_1417353633609310_manuscript;32 anterior MI patients;32;-1
2005_1417353633609310_manuscript;1   patients;1;-1
2005_1417353633609310_manuscript;N=20201;20201;-1
2005_1417353633609310_manuscript;N=8361;8361;-1
2005_1417353633609310_manuscript;N=1838;1838;-1
2005_1417353633609310_manuscript;N=232;232;-1
2005_1417353633609310_manuscript;N=708;708;-1
2005_1417353633609310_manuscript;N=125;125;-1
2005_1417353633609310_manuscript;N=698;698;-1
2005_1417353633609310_manuscript;total of 125;125;-1
2005_1478460433839480_manuscript;total of 20,000;20000;-1
2005_1508230745889837_manuscript;4 persons;4;-1
2005_1508230745889837_manuscript;2003 and enrolled participants;2003;-1
2005_1508230745889837_manuscript;158 Surveillance Study   participants;158;-1
2005_1508230745889837_manuscript;41 surveillance   participants;41;-1
2005_1508230745889837_manuscript;190 participants;190;-1
2005_1508230745889837_manuscript;164 participants;164;-1
2005_1508230745889837_manuscript;37 participants;37;-1
2005_1508230745889837_manuscript;164studyparticipants;164;-1
2005_1508230745889837_manuscript;43 subjects;43;-1
2005_1508230745889837_manuscript;5 subjects;5;-1
2005_1508230745889837_manuscript;46 subjects;46;-1
2005_1508230745889837_manuscript;49 subjects;49;-1
2005_1508230745889837_manuscript;26 190      Columns show number of subjects;26190;-1
2005_1508230745889837_manuscript;164subjects;164;-1
2005_1508230745889837_manuscript;60 164      Columns show number of subjects;60164;-1
2005_1508230745889837_manuscript;227 people;227;-1
2005_1508230745889837_manuscript;70 people;70;-1
2005_1508230745889837_manuscript;29 people;29;-1
2005_1508230745889837_manuscript;37 people;37;-1
2005_1508230745889837_manuscript;10 of the not fatigued people;10;-1
2005_1508230745889837_manuscript;227 adults;227;-1
2005_1508230745889837_manuscript;900,000 adults;900000;-1
2005_1508230745889837_manuscript;7,162 fatigued and non-fatigued adults;7162;-1
2005_1508230745889837_manuscript;24 recruited;24;-1
2005_1508230745889837_manuscript;n=58;58;-1
2005_1508230745889837_manuscript;n=55;55;-1
2005_1508230745889837_manuscript;n=59;59;-1
2005_1508230745889837_manuscript;n=27;27;-1
2005_1508230745889837_manuscript;n=28;28;-1
2005_1508230745889837_manuscript;n = 6;6;-1
2005_1508230745889837_manuscript;n = 4;4;-1
2005_1508230745889837_manuscript;n = 3;3;-1
2005_1508230745889837_manuscript;n = 2;2;-1
2005_1508230745889837_manuscript;n =   2;2;-1
2005_1508230745889837_manuscript;n = 1;1;-1
2005_1508230745889837_manuscript;N=227;227;-1
2005_1508230745889837_manuscript;n=30;30;-1
2005_1508230745889837_manuscript;n=67;67;-1
2005_1508230745889837_manuscript;2003 and enrolled;2003;-1
2005_1508230745889837_manuscript;46 subjects enrolled;46;-1
2005_1766620715888330_manuscript;350participants;350;-1
2005_1766620715888330_manuscript;10subjects;10;-1
2005_1766620715888330_manuscript;5subjects;5;-1
2005_1766620715888330_manuscript;4subjects;4;-1
2005_1766620715888330_manuscript;8  femalesubjects;8;-1
2005_1766620715888330_manuscript;6subjects;6;-1
2005_1766620715888330_manuscript;6additional  subjects;6;-1
2005_1766620715888330_manuscript;3subjects;3;-1
2005_1766620715888330_manuscript;40subjects;40;-1
2005_1766620715888330_manuscript;22  subjects;22;-1
2005_1766620715888330_manuscript;27  patients;27;-1
2005_1766620715888330_manuscript;28  suggestingthatindividuals;28;-1
2005_1766620715888330_manuscript;4alleleinindividuals;4;-1
2005_1766620715888330_manuscript;datafrom6;6;-1
2005_3105314136215875_manuscript;n = 97;97;-1
2005_3105314136215875_manuscript;n = 27672;27672;-1
2005_3105314136215875_manuscript;n = 27769;27769;-1
2005_3105314136215875_manuscript; data from 161;161;-1
2005_4607440707090639_manuscript;N=852;852;-1
2005_4607440707090639_manuscript;total of  300;300;-1
2005_6833616298779306_manuscript;1627patients;1627;-1
2005_6833616298779306_manuscript;3  mayimprovepatients;3;-1
2005_6833616298779306_manuscript;6patients;6;-1
2005_6833616298779306_manuscript;3patients;3;-1
2005_6833616298779306_manuscript;20  highnumberofpatients;20;-1
2005_6833616298779306_manuscript;n=172;172;-1
2005_6833616298779306_manuscript;n=167;167;-1
2005_6833616298779306_manuscript;n=171;171;-1
2005_6833616298779306_manuscript;n=175;175;-1
2005_6833616298779306_manuscript;n=277;277;-1
2005_6833616298779306_manuscript;n=271;271;-1
2005_6833616298779306_manuscript;n=202;202;-1
2005_6833616298779306_manuscript;n=192;192;-1
2005_6833616298779306_manuscript;n=35;35;-1
2005_6833616298779306_manuscript;n=18;18;-1
2005_6833616298779306_manuscript;n=17;17;-1
2005_6833616298779306_manuscript;n=12;12;-1
2005_6833616298779306_manuscript;n=7;7;-1
2005_6833616298779306_manuscript;n=6;6;-1
2005_6833616298779306_manuscript;n=5;5;-1
2005_6833616298779306_manuscript;n=4;4;-1
2005_6833616298779306_manuscript;n=3;3;-1
2005_6833616298779306_manuscript;n=339;339;-1
2005_6833616298779306_manuscript;n=346;346;-1
2005_6833616298779306_manuscript;n=548;548;-1
2005_6833616298779306_manuscript;n=394;394;-1
2005_6833616298779306_manuscript;N=1627;1627;-1
2005_6833616298779306_manuscript;n=67;67;-1
2005_6833616298779306_manuscript;n=78;78;-1
2005_6833616298779306_manuscript;n=99;99;-1
2005_6833616298779306_manuscript;n=71;71;-1
2005_6833616298779306_manuscript;N=315;315;-1
2006_1017672256110695_manuscript;259women;259;-1
2006_1017672256110695_manuscript;56participants;56;-1
2006_1017672256110695_manuscript;147participants;147;-1
2006_1017672256110695_manuscript;252  participants;252;-1
2006_1017672256110695_manuscript;70participants;70;-1
2006_1017672256110695_manuscript;45participants;45;-1
2006_1017672256110695_manuscript;501  people;501;-1
2006_1017672256110695_manuscript;1030people;1030;-1
2006_1017672256110695_manuscript;295,000people;295000;-1
2006_1017672256110695_manuscript;702people;702;-1
2006_1017672256110695_manuscript;30  people;30;-1
2006_1017672256110695_manuscript;175people;175;-1
2006_1017672256110695_manuscript;n=201;201;-1
2006_1017672256110695_manuscript;n=501;501;-1
2006_1017672256110695_manuscript;n=119;119;-1
2006_1017672256110695_manuscript;n=390;390;-1
2006_1017672256110695_manuscript;n=30;30;-1
2006_1017672256110695_manuscript;n=129;129;-1
2006_1017672256110695_manuscript;n=372;372;-1
2006_1017672256110695_manuscript;n=34;34;-1
2006_1017672256110695_manuscript;n=430;430;-1
2006_1017672256110695_manuscript;n=71;71;-1
2006_1017672256110695_manuscript;n=426;426;-1
2006_1017672256110695_manuscript;n=512;512;-1
2006_1017672256110695_manuscript;n=45;45;-1
2006_1017672256110695_manuscript;n=48;48;-1
2006_1017672256110695_manuscript;n=72;72;-1
2006_1017672256110695_manuscript;n=121;121;-1
2006_1104226936124723_manuscript;29,424individuals;29424;-1
2006_1104226936124723_manuscript;409adults;409;-1
2006_1104226936124723_manuscript;N=199;199;-1
2006_1104226936124723_manuscript;N=213;213;-1
2006_1116441375955764_manuscript;90 subjects;90;-1
2006_1116441375955764_manuscript;70 subjects;70;-1
2006_1116441375955764_manuscript;N=70;70;-1
2006_1116441375955764_manuscript;N=37;37;-1
2006_1116441375955764_manuscript;N=33;33;-1
2006_1116441375955764_manuscript;N = 36;36;-1
2006_1116441375955764_manuscript;N = 33;33;-1
2006_1116441375955764_manuscript;N=10;10;-1
2006_1116441375955764_manuscript;N=126;126;-1
2006_1116441375955764_manuscript;N=56;56;-1
2006_1116441375955764_manuscript;N= 33;33;-1
2006_1116441375955764_manuscript;N=143;143;-1
2006_1116441375955764_manuscript;N=136;136;-1
2006_1116441375955764_manuscript;N= 37;37;-1
2006_1116441375955764_manuscript;N=7;7;-1
2006_1358309871253348_manuscript;23,534menand  women;23534;-1
2006_1358309871253348_manuscript;N=312;312;-1
2006_1458240240117805_manuscript;100patients;100;-1
2006_1458240240117805_manuscript;1000in  patients;1000;-1
2006_1458240240117805_manuscript;500patients;500;-1
2006_1458240240117805_manuscript;2457patients;2457;-1
2006_1458240240117805_manuscript;9212patients;9212;-1
2006_1458240240117805_manuscript;1200troponin-positive  NSTEMIpatients;1200;-1
2006_1458240240117805_manuscript;28,825patients;28825;-1
2006_1458240240117805_manuscript;158,831elderlyMedicarepatients;158831;-1
2006_1458240240117805_manuscript;1000patients;1000;-1
2006_1458240240117805_manuscript;45,852patients;45852;-1
2006_1462282749122518_manuscript;60patients;60;-1
2006_1462282749122518_manuscript;60 inpatients;60;-1
2006_1462282749122518_manuscript;60 patients;60;-1
2006_1465351748957220_manuscript;104 patients;104;-1
2006_1465351748957220_manuscript;4 probable JE patients;4;-1
2006_1465351748957220_manuscript;135 patients;135;-1
2006_1465351748957220_manuscript;n = 86;86;-1
2006_1465351748957220_manuscript;n = 4;4;-1
2006_1465351748957220_manuscript;n = 90;90;-1
2006_1478970554101845_manuscript;36 participants;36;907
2006_1478970554101845_manuscript;200 participants;200;397
2006_1478970554101845_manuscript;72 patients;72;6480
2006_1478970554101845_manuscript;3 patients;3;6451
2006_1478970554101845_manuscript;34 patients;34;6409
2006_1478970554101845_manuscript;108 patients;108;925
2006_1478970554101845_manuscript;54 patients;54;674
2006_1478970554101845_manuscript;90 patients;90;526
2006_1478970554101845_manuscript;34   patients;34;1174
2006_1478970554101845_manuscript;total of 36;36;779
2006_1582309028116032_manuscript;1,000 persons;1000;-1
2006_1582309028116032_manuscript;1,000 patients;1000;-1
2006_1582309028116032_manuscript;3 million patients;3;-1
2006_1582309028116032_manuscript;1   million patients;1;-1
2006_1582309028116032_manuscript;1,000 aspirin users per year for patients;1000;-1
2006_1582309028116032_manuscript;N=   16,598;16598;-1
2006_1582309028116032_manuscript;N=9,129;9129;-1
2006_1582309028116032_manuscript;2000 who had been enrolled;2000;-1
2006_1622309239982555_manuscript;54 participants;54;-1
2006_1622309239982555_manuscript;48 patients;48;-1
2006_1622309239982555_manuscript;54 participants were recruited;54;-1
2006_1622309239982555_manuscript;n=35;35;-1
2006_1622309239982555_manuscript;n=13;13;-1
2006_1622309239982555_manuscript;n = 16;16;-1
2006_1622309239982555_manuscript;n = 53;53;-1
2006_1622309239982555_manuscript;n = 26;26;-1
2006_1622309239982555_manuscript;n =   27;27;-1
2006_1622309239982555_manuscript;n=79;79;-1
2006_1622309239982555_manuscript;n=54;54;-1
2006_1622309239982555_manuscript;n=25;25;-1
2006_1622309239982555_manuscript;n=9;9;-1
2006_1622309239982555_manuscript;n=1;1;-1
2006_1622309239982555_manuscript;n=2;2;-1
2006_1622309239982555_manuscript;n=27;27;-1
2006_1622309239982555_manuscript;n=26;26;-1
2006_1622309239982555_manuscript;n=23;23;-1
2006_1622309239982555_manuscript;n = 1;1;-1
2006_1622309239982555_manuscript;n=3;3;-1
2006_1622309239982555_manuscript;total of 4;4;-1
2006_1632194749107220_manuscript;72 postmenopausal women;72;47074
2006_1632194749107220_manuscript;131 postmenopausal women;131;42201
2006_1632194749107220_manuscript;52,705 women;52705;14839
2006_1632194749107220_manuscript;108,411 women;108411;14801
2006_1632194749107220_manuscript;18 patients;18;43275
2006_1632194749107220_manuscript;159   remaining patients;159;43131
2006_1632194749107220_manuscript;88 patients;88;42751
2006_1632194749107220_manuscript;72 patients;72;36131
2006_1632194749107220_manuscript;14 patients;14;31930
2006_1632194749107220_manuscript;13 patients;13;30669
2006_1632194749107220_manuscript;142 patients;142;22096
2006_1632194749107220_manuscript;284 age- matched patients;284;22026
2006_1632194749107220_manuscript;984 breast cancer patients;984;5950
2006_1632194749107220_manuscript;n=72;72;46964
2006_1632194749107220_manuscript;n=524;524;43619
2006_1632194749107220_manuscript;n=231;231;43397
2006_1632194749107220_manuscript;n=103;103;43347
2006_1632194749107220_manuscript;n=6;6;43312
2006_1632194749107220_manuscript;n=7;7;46964
2006_1632194749107220_manuscript;n=50;50;36364
2006_1632194749107220_manuscript;n=51;51;29115
2006_1632194749107220_manuscript;n=80;80;28696
2006_1632194749107220_manuscript;n=54;54;27199
2006_1632194749107220_manuscript;n=30;30;27175
2006_1632194749107220_manuscript;n=88;88;1246
2006_1632194749107220_manuscript;n=56;56;1086
2006_1632194749107220_manuscript;n=32;32;1068
2006_1632194749107220_manuscript;n=22;22;1059
2006_1632194749107220_manuscript; data from   51;51;14882
2006_1681105951116964_manuscript;759postmenopausalwomen;759;-1
2006_1681105951116964_manuscript;4203postmenopausalwomen;4203;-1
2006_1681105951116964_manuscript;1686postmenopausalwomen;1686;-1
2006_1681105951116964_manuscript;1686women;1686;-1
2006_1681105951116964_manuscript;95women;95;-1
2006_1681105951116964_manuscript;45women;45;-1
2006_1681105951116964_manuscript;973menandwomen;973;-1
2006_1681105951116964_manuscript;45participants;45;-1
2006_1681105951116964_manuscript;n=759;759;-1
2006_1762901676125551_manuscript;9millionpeople;9;-1
2006_1762901676125551_manuscript;000 people;0;-1
2006_1762901676125551_manuscript;000 individuals;0;-1
2006_1814513697106646_manuscript;21 patients;21;-1
2006_1814513697106646_manuscript;10,263 individuals;10263;-1
2006_1814513697106646_manuscript;1,255   individuals;1255;-1
2006_1814513697106646_manuscript;2,914 individuals;2914;-1
2006_1814513697106646_manuscript;10 individuals;10;-1
2006_1814513697106646_manuscript;21 non-  demented individuals;21;-1
2006_1814513697106646_manuscript;21 individuals;21;-1
2006_1814513697106646_manuscript;17 individuals;17;-1
2006_1814513697106646_manuscript;16 individuals;16;-1
2006_1814513697106646_manuscript;199 older adults;199;-1
2006_1814513697106646_manuscript;810 adults;810;-1
2006_1814513697106646_manuscript;N = 21;21;-1
2006_1814513697106646_manuscript;N = 921;921;-1
2006_1814513697106646_manuscript;N = 851;851;-1
2006_1814513697106646_manuscript;N = 253;253;-1
2006_1814513697106646_manuscript;N = 441;441;-1
2006_1814513697106646_manuscript;N = 421;421;-1
2006_1826043451951482_manuscript;3 positive subjects;3;-1
2006_1826043451951482_manuscript;748 stage IV melanoma patients;748;-1
2006_1826043451951482_manuscript;748 AJCC stage IV melanoma   patients;748;-1
2006_1826043451951482_manuscript;267 patients;267;-1
2006_1826043451951482_manuscript;217   patients;217;-1
2006_1826043451951482_manuscript;141 patients;141;-1
2006_1826043451951482_manuscript;82 patients;82;-1
2006_1826043451951482_manuscript;26 patients;26;-1
2006_1826043451951482_manuscript;15 patients;15;-1
2006_1826043451951482_manuscript;302 stage I-III patients;302;-1
2006_1826043451951482_manuscript;709 stage IV melanoma patients;709;-1
2006_1826043451951482_manuscript;391 stage IV melanoma patients;391;-1
2006_1826043451951482_manuscript;n=11;11;-1
2006_1826043451951482_manuscript;n = 302;302;-1
2006_1826043451951482_manuscript;n = 301;301;-1
2006_1826043451951482_manuscript;n = 214;214;-1
2006_1826043451951482_manuscript;n =   215;215;-1
2006_1826043451951482_manuscript;n = 739;739;-1
2006_1826043451951482_manuscript;n = 709;709;-1
2006_1826043451951482_manuscript;n = 391;391;-1
2006_1831561735107128_manuscript;332 patients;332;14126
2006_1831561735107128_manuscript;2166 patients;2166;8840
2006_1831561735107128_manuscript;19   patients;19;7981
2006_1831561735107128_manuscript;357 patients;357;2890
2006_1831561735107128_manuscript;82 patients;82;3047
2006_1831561735107128_manuscript;324 patients;324;4202
2006_1831561735107128_manuscript;8 patients;8;4292
2006_1831561735107128_manuscript;12 patients;12;4364
2006_1831561735107128_manuscript;277 patients;277;4964
2006_1831561735107128_manuscript;107 patients;107;13436
2006_1831561735107128_manuscript;105 patients;105;13483
2006_1831561735107128_manuscript;69 patients;69;13536
2006_1831561735107128_manuscript;3 patients;3;14716
2006_1831561735107128_manuscript;105 mildly depressed   patients;105;28799
2006_1831561735107128_manuscript;N=119;119;33169
2006_1831561735107128_manuscript;N=124;124;33202
2006_1831561735107128_manuscript;N=81;81;33226
2006_1831561735107128_manuscript;N=123;123;38969
2006_1831561735107128_manuscript;N=127;127;38975
2006_1831561735107128_manuscript;N=82;82;38981
2006_1831561735107128_manuscript;n=124;124;41866
2006_1831561735107128_manuscript;n=119;119;41894
2006_1831561735107128_manuscript;n=81;81;41911
2006_1885794812461673_manuscript;8870women;8870;-1
2006_1885794812461673_manuscript;6200women;6200;-1
2006_1885794812461673_manuscript;6382women;6382;-1
2006_1885794812461673_manuscript;4  timesthatinwomen;4;-1
2006_1885794812461673_manuscript;777women;777;-1
2006_1885794812461673_manuscript;8timestheprevalenceinwomen;8;-1
2006_1885794812461673_manuscript;31women;31;-1
2006_1885794812461673_manuscript;838women;838;-1
2006_1885794812461673_manuscript;504women;504;-1
2006_1885794812461673_manuscript;145  Urbanwomen;145;-1
2006_1885794812461673_manuscript;150  Ruralwomen;150;-1
2006_1885794812461673_manuscript;226  Urbanwomen;226;-1
2006_1885794812461673_manuscript;739  Ruralwomen;739;-1
2006_1885794812461673_manuscript;14women;14;-1
2006_1885794812461673_manuscript;852  Urbanwomen;852;-1
2006_1885794812461673_manuscript;720  Ruralwomen;720;-1
2006_1885794812461673_manuscript;364     Urbanwomen;364;-1
2006_1885794812461673_manuscript;955     Ruralwomen;955;-1
2006_1885794812461673_manuscript;5000women;5000;-1
2006_1885794812461673_manuscript;838people;838;-1
2006_1885794812461673_manuscript;617people;617;-1
2006_1885794812461673_manuscript;3  people;3;-1
2006_1885794812461673_manuscript;600people;600;-1
2006_1885794812461673_manuscript;45millionpeople;45;-1
2006_1885794812461673_manuscript;1981people;1981;-1
2006_1885794812461673_manuscript;2870people;2870;-1
2006_1885794812461673_manuscript;230eligiblepeople;230;-1
2006_1885794812461673_manuscript;800people;800;-1
2006_1885794812461673_manuscript;400people;400;-1
2006_1885794812461673_manuscript;585samplesbelongingtopeople;585;-1
2006_1885794812461673_manuscript;225people;225;-1
2006_1885794812461673_manuscript;241people;241;-1
2006_1885794812461673_manuscript;14  people;14;-1
2006_1885794812461673_manuscript;6  millionpeople;6;-1
2006_1885794812461673_manuscript;25adults;25;-1
2006_1885794812461673_manuscript;N = 221;221;-1
2006_1885794812461673_manuscript;N = 14;14;-1
2006_1885794812461673_manuscript;N = 3;3;-1
2006_1885794812461673_manuscript;N = 2;2;-1
2006_1885794812461673_manuscript;N = 238;238;-1
2006_1885794812461673_manuscript;N = 585;585;-1
2006_1885794812461673_manuscript;N = 584;584;-1
2006_1885794812461673_manuscript;N = 12,375;12375;-1
2006_1885794812461673_manuscript;N = 1,238;1238;-1
2006_1885794812461673_manuscript;N = 0;0;-1
2006_1885794812461673_manuscript;N = 4;4;-1
2006_1885794812461673_manuscript;N = 242;242;-1
2006_1885794812461673_manuscript;N =12,617;12617;-1
2006_1885794812461673_manuscript;N = 1;1;-1
2006_1885794812461673_manuscript;datafromthe2005;2005;-1
2006_1903922570125013_manuscript;944subjects;944;-1
2006_1903922570125013_manuscript;6,736U.K.subjects;6736;-1
2006_1903922570125013_manuscript;2minorallele  carrierpatients;2;-1
2006_1903922570125013_manuscript;1155people;1155;-1
2006_2017874261106548_manuscript;20 patients;20;-1
2006_2017874261106548_manuscript;17 patients;17;-1
2006_2017874261106548_manuscript;2 influenza patients;2;-1
2006_2017874261106548_manuscript;n = 202;202;-1
2006_2017874261106548_manuscript;n = 150;150;-1
2006_2017874261106548_manuscript;n=140;140;-1
2006_2017874261106548_manuscript;n=100;100;-1
2006_2017874261106548_manuscript;n=40;40;-1
2006_2017874261106548_manuscript;n=96;96;-1
2006_2017874261106548_manuscript;n=122;122;-1
2006_2017874261106548_manuscript;n=77;77;-1
2006_2017874261106548_manuscript;n=45;45;-1
2006_2017874261106548_manuscript;n=66;66;-1
2006_2017874261106548_manuscript;n=35;35;-1
2006_2017874261106548_manuscript;total of 122;122;-1
2006_2252427711232538_manuscript;5000participants;5000;-1
2006_2252427711232538_manuscript;429subjects;429;-1
2006_2252427711232538_manuscript;195 Korean subjects;195;-1
2006_2252427711232538_manuscript;429patients;429;-1
2006_2252427711232538_manuscript;40patients;40;-1
2006_2252427711232538_manuscript;360patients;360;-1
2006_2252427711232538_manuscript;278patients;278;-1
2006_2252427711232538_manuscript;4 patients;4;-1
2006_2252427711232538_manuscript;360 patients;360;-1
2006_2252427711232538_manuscript;278 patients;278;-1
2006_2252427711232538_manuscript;19 healthy  individuals;19;-1
2006_2252427711232538_manuscript;638 individuals;638;-1
2006_2252427711232538_manuscript;n=429;429;-1
2006_2252427711232538_manuscript;n=113;113;-1
2006_2252427711232538_manuscript;n=316;316;-1
2006_2678182811003311_manuscript;34 patients;34;3867
2006_2678182811003311_manuscript;n=204;204;41619
2006_2678182811003311_manuscript;n=27;27;41634
2006_2678182811003311_manuscript;n=2;2;41619
2006_2678182811003311_manuscript;n=19;19;41671
2006_2678182811003311_manuscript;n=32;32;41685
2006_2678182811003311_manuscript;n=6;6;41699
2006_2678182811003311_manuscript;n=118;118;42385
2006_2678182811003311_manuscript;n=88;88;42400
2006_2678182811003311_manuscript;n=13;13;42424
2006_2678182811003311_manuscript;n=25;25;42438
2006_2678182811003311_manuscript;n=109;109;43140
2006_2678182811003311_manuscript;n=101;101;43155
2006_2678182811003311_manuscript;n=23;23;43170
2006_2678182811003311_manuscript;n=24;24;43208
2006_2678182811003311_manuscript;n=10;10;43140
2006_2678182811003311_manuscript;n=31;31;43933
2006_2678182811003311_manuscript;n=9;9;43979
2006_2678182811003311_manuscript;n=195;195;44025
2006_2678182811003311_manuscript;n=58;58;44073
2006_4339211931195803_manuscript;1000subjects;1000;-1
2006_4339211931195803_manuscript;45elderlypeople;45;-1
2006_4339211931195803_manuscript;10,000individuals;10000;-1
2006_4339211931195803_manuscript;100individuals;100;-1
2006_4339211931195803_manuscript;1000 infected individuals;1000;-1
2006_4339211931195803_manuscript;2adults;2;-1
2006_4339211931195803_manuscript;100workingadults;100;-1
2006_5720106109294150_manuscript;148patients;148;-1
2006_5720106109294150_manuscript;120patients;120;-1
2006_5720106109294150_manuscript;n=1;1;-1
2006_5720106109294150_manuscript;n=0;0;-1
2006_5720106109294150_manuscript;n=7;7;-1
2006_8463957271184067_manuscript;543eligiblesubjects;543;-1
2006_8463957271184067_manuscript;650subjects;650;-1
2006_8463957271184067_manuscript;176  interventionsubjects;176;-1
2006_8463957271184067_manuscript;57controlsubjects;57;-1
2006_8463957271184067_manuscript;124controlsubjects;124;-1
2006_8463957271184067_manuscript;29foruniversity-qualified  subjects;29;-1
2006_8463957271184067_manuscript;23tasksforcontrolsubjects;23;-1
2006_8463957271184067_manuscript;34tasksfor  interventionsubjects;34;-1
2006_8463957271184067_manuscript;20people;20;-1
2006_8463957271184067_manuscript;N=176;176;-1
2006_8463957271184067_manuscript;N=187;187;-1
2006_8463957271184067_manuscript;N=56;56;-1
2006_8463957271184067_manuscript;N=57;57;-1
2006_8463957271184067_manuscript;N=116;116;-1
2006_8463957271184067_manuscript;N=124;124;-1
2006_8463957271184067_manuscript;databasesof16,188;16188;-1
2006_8851356191250532_manuscript;n=120;120;-1
2006_8851356191250532_manuscript;n=30;30;-1
2006_8851356191250532_manuscript;n=4;4;-1
2006_8851356191250532_manuscript;n=6;6;-1
2006_8851356191250532_manuscript;n=3;3;-1
2006_8851356191250532_manuscript;n=90;90;-1
2006_8851356191250532_manuscript;total of 6;6;-1
2007_1037630317139316_manuscript;30forthefirst  eightparticipants;30;-1
2007_1037630317139316_manuscript;00fortheremaining  participants;0;-1
2007_1037630317139316_manuscript;10participants;10;-1
2007_1037630317139316_manuscript;443participants;443;-1
2007_1037630317139316_manuscript;32participants;32;-1
2007_1037630317139316_manuscript;156participants;156;-1
2007_1037630317139316_manuscript;79consecutiveparticipants;79;-1
2007_1037630317139316_manuscript;443subjects;443;-1
2007_1037630317139316_manuscript;135subjects;135;-1
2007_1037630317139316_manuscript;509subjects;509;-1
2007_1037630317139316_manuscript;66excludedsubjects;66;-1
2007_1037630317139316_manuscript;308subjects;308;-1
2007_1037630317139316_manuscript;50subjects;50;-1
2007_1037630317139316_manuscript;11subjects;11;-1
2007_1037630317139316_manuscript;44  subjects;44;-1
2007_1037630317139316_manuscript;44subjects;44;-1
2007_1037630317139316_manuscript;132subjects;132;-1
2007_1037630317139316_manuscript;16,000patients;16000;-1
2007_1037630317139316_manuscript;50millionadults;50;-1
2007_1037630317139316_manuscript;n=2;2;-1
2007_1037630317139316_manuscript;N=50;50;-1
2007_1037630317139316_manuscript;N=21;21;-1
2007_1037630317139316_manuscript;443subjectsenrolled;443;-1
2007_1285451265146489_manuscript;8,855 adults;8855;-1
2007_1285451265146489_manuscript;1,003 adults;1003;-1
2007_1285451265146489_manuscript;N=983;983;-1
2007_1285451265146489_manuscript;N=535;535;-1
2007_1285451265146489_manuscript;N=448;448;-1
2007_1289585644157727_manuscript;n=5;5;-1
2007_1345233844176134_manuscript;52 female participants;52;-1
2007_1345233844176134_manuscript;73 participants;73;-1
2007_1345233844176134_manuscript;137 participants;137;-1
2007_1345233844176134_manuscript;95 participants;95;-1
2007_1345233844176134_manuscript;137 included subjects;137;-1
2007_1345233844176134_manuscript;90 subjects;90;-1
2007_1345233844176134_manuscript;95 subjects;95;-1
2007_1345233844176134_manuscript;n = 72;72;-1
2007_1345233844176134_manuscript;n = 90;90;-1
2007_1345233844176134_manuscript;n = 95;95;-1
2007_1345233844176134_manuscript;total of 137;137;-1
2007_1513362635167638_manuscript;181 adult patients;181;-1
2007_1513362635167638_manuscript;84 patients;84;-1
2007_1513362635167638_manuscript;293 contacting patients;293;-1
2007_1513362635167638_manuscript;181 patients;181;-1
2007_1513362635167638_manuscript;160 patients;160;-1
2007_1513362635167638_manuscript;21 patients;21;-1
2007_1513362635167638_manuscript;127 patients;127;-1
2007_1513362635167638_manuscript;85 patients;85;-1
2007_1513362635167638_manuscript;96   patients;96;-1
2007_1513362635167638_manuscript;42 patients;42;-1
2007_1513362635167638_manuscript;173 patients;173;-1
2007_1513362635167638_manuscript;82 patients;82;-1
2007_1513362635167638_manuscript;91 patients;91;-1
2007_1513362635167638_manuscript;26 patients;26;-1
2007_1513362635167638_manuscript;15 patients;15;-1
2007_1513362635167638_manuscript;n=85;85;-1
2007_1513362635167638_manuscript;n=96;96;-1
2007_1513362635167638_manuscript;N=181;181;-1
2007_1513362635167638_manuscript;N=133;133;-1
2007_1513362635167638_manuscript;n= 96;96;-1
2007_1513362635167638_manuscript;n=181;181;-1
2007_1513362635167638_manuscript;n=133;133;-1
2007_1513362635167638_manuscript;n=55;55;-1
2007_1513362635167638_manuscript;n=78;78;-1
2007_1513362635167638_manuscript;N=293;293;-1
2007_1513362635167638_manuscript;N=96;96;-1
2007_1513362635167638_manuscript;N=89;89;-1
2007_1513362635167638_manuscript;N=83;83;-1
2007_1513362635167638_manuscript;N=79;79;-1
2007_1513362635167638_manuscript;N=72;72;-1
2007_1513362635167638_manuscript;N=1;1;-1
2007_1513362635167638_manuscript;N=5;5;-1
2007_1513362635167638_manuscript;N=4;4;-1
2007_1513362635167638_manuscript;N=3;3;-1
2007_1513362635167638_manuscript;N=18;18;-1
2007_1513362635167638_manuscript;N=85;85;-1
2007_1513362635167638_manuscript;N=80;80;-1
2007_1513362635167638_manuscript;N=77;77;-1
2007_1513362635167638_manuscript;N=76;76;-1
2007_1513362635167638_manuscript;N=67;67;-1
2007_1513362635167638_manuscript;N=2;2;-1
2007_1513362635167638_manuscript;N=9;9;-1
2007_1513362635167638_manuscript;N=112;112;-1
2007_1513362635167638_manuscript;N=45;45;-1
2007_1513362635167638_manuscript;N=42;42;-1
2007_1513362635167638_manuscript;N=25;25;-1
2007_1513362635167638_manuscript;N=78;78;-1
2007_1513362635167638_manuscript;N=55;55;-1
2007_1513362635167638_manuscript;N=30;30;-1
2007_1625580750154941_manuscript;113,494 participants;113494;-1
2007_1625580750154941_manuscript;N = 113,494;113494;-1
2007_1625580750154941_manuscript;n=21;21;-1
2007_1625580750154941_manuscript;n=8;8;-1
2007_1625580750154941_manuscript;n=4;4;-1
2007_1625580750154941_manuscript;n=3;3;-1
2007_1625580750154941_manuscript;n=2;2;-1
2007_1625580750154941_manuscript;n=612;612;-1
2007_1625580750154941_manuscript;n=61;61;-1
2007_1625580750154941_manuscript;N=23;23;-1
2007_1625580750154941_manuscript;n=15;15;-1
2007_1625580750154941_manuscript;n=17;17;-1
2007_1625580750154941_manuscript;N=673;673;-1
2007_1625580750154941_manuscript;n=673;673;-1
2007_1647995166134693_manuscript;total of 26,166;26166;-1
2007_1716807665147321_manuscript;25  women;25;-1
2007_1716807665147321_manuscript;1631pregnantwomen;1631;-1
2007_1716807665147321_manuscript;278women;278;-1
2007_1716807665147321_manuscript;41women;41;-1
2007_1716807665147321_manuscript;1631women;1631;-1
2007_1716807665147321_manuscript;8  pregnantwomen;8;-1
2007_1716807665147321_manuscript;41pregnantwomen;41;-1
2007_1716807665147321_manuscript;41patients;41;-1
2007_1716807665147321_manuscript;33MApatients;33;-1
2007_1716807665147321_manuscript;10patients;10;-1
2007_1716807665147321_manuscript;16patients;16;-1
2007_1716807665147321_manuscript;15  patients;15;-1
2007_1716807665147321_manuscript;20patients;20;-1
2007_1716807665147321_manuscript;18patients;18;-1
2007_1716807665147321_manuscript;12patients;12;-1
2007_1716807665147321_manuscript;4patients;4;-1
2007_1716807665147321_manuscript;26patients;26;-1
2007_1716807665147321_manuscript;7patients;7;-1
2007_1716807665147321_manuscript;2patients;2;-1
2007_1716807665147321_manuscript;9patients;9;-1
2007_1716807665147321_manuscript;3Questionnairedatainpatients;3;-1
2007_1716807665147321_manuscript;4Variousmeasurementsinpatients;4;-1
2007_1716807665147321_manuscript;n=1631;1631;-1
2007_1716807665147321_manuscript;n=41;41;-1
2007_1716807665147321_manuscript;n=34;34;-1
2007_1716807665147321_manuscript;n=7;7;-1
2007_1786659302168805_manuscript;680participantswere  women;680;-1
2007_1786659302168805_manuscript;680participants;680;-1
2007_1786659302168805_manuscript;680patients;680;-1
2007_1786659302168805_manuscript;680  patients;680;-1
2007_1786659302168805_manuscript;2  Proportionofpatients;2;-1
2007_1786659302168805_manuscript;N=370;370;-1
2007_1786659302168805_manuscript;n=37;37;-1
2007_1786659302168805_manuscript;N=51;51;-1
2007_1786659302168805_manuscript;N=621;621;-1
2007_1786659302168805_manuscript;N=15;15;-1
2007_1786659302168805_manuscript;N=10;10;-1
2007_1786659302168805_manuscript;N=89;89;-1
2007_1786659302168805_manuscript;N=115;115;-1
2007_1786659302168805_manuscript;N=159;159;-1
2007_1786659302168805_manuscript;N=170;170;-1
2007_1786659302168805_manuscript;N=151;151;-1
2007_1786659302168805_manuscript;N=141;141;-1
2007_1786659302168805_manuscript;N=204;204;-1
2007_1786659302168805_manuscript;N=106;106;-1
2007_1786659302168805_manuscript;N=163;163;-1
2007_1786659302168805_manuscript;N=148;148;-1
2007_1786659302168805_manuscript;N=135;135;-1
2007_1786659302168805_manuscript;N=199;199;-1
2007_1786659302168805_manuscript;N=540;540;-1
2007_1786659302168805_manuscript;N=43;43;-1
2007_1913544416500749_manuscript;2 746   patients;2746;-1
2007_1913544416500749_manuscript;2 445 patients;2445;-1
2007_1913544416500749_manuscript;301 patients;301;-1
2007_1913544416500749_manuscript;2 445   patients;2445;-1
2007_1913544416500749_manuscript;2   patients;2;-1
2007_1913544416500749_manuscript;32 200 patients;32200;-1
2007_1913544416500749_manuscript;13 patients;13;-1
2007_1913544416500749_manuscript;1151 patients;1151;-1
2007_1913544416500749_manuscript;3 268 patients;3268;-1
2007_1913544416500749_manuscript;2 746 patients;2746;-1
2007_1913544416500749_manuscript;2,445   patients;2445;-1
2007_1913544416500749_manuscript;1620 patients;1620;-1
2007_1913544416500749_manuscript;N = 18;18;-1
2007_1913544416500749_manuscript;N = 4;4;-1
2007_1913544416500749_manuscript;n = 2 746;2746;-1
2007_1913544416500749_manuscript;n = 5;5;-1
2007_1913544416500749_manuscript;n = 8;8;-1
2007_1913544416500749_manuscript;n = 4;4;-1
2007_1913544416500749_manuscript;n = 1;1;-1
2007_1913544416500749_manuscript;n = 0;0;-1
2007_1913544416500749_manuscript;n = 45;45;-1
2007_1913544416500749_manuscript;n = 10;10;-1
2007_1913544416500749_manuscript;n = 3;3;-1
2007_1913544416500749_manuscript;n = 27;27;-1
2007_1913544416500749_manuscript;total of 13;13;-1
2007_1929649261151453_manuscript;n=121;121;-1
2007_1929649261151453_manuscript;n=123;123;-1
2007_1929649261151453_manuscript;n = 61;61;-1
2007_1929649261151453_manuscript;n=60;60;-1
2007_1929649261151453_manuscript;n=79;79;-1
2007_1929649261151453_manuscript;n=24;24;-1
2007_1929649261151453_manuscript;n=68;68;-1
2007_1929649261151453_manuscript;n=33;33;-1
2007_1929649261151453_manuscript;n=31;31;-1
2007_1929649261151453_manuscript;n=28;28;-1
2007_1929649261151453_manuscript;n=89;89;-1
2007_1929649261151453_manuscript;n=29;29;-1
2007_1929649261151453_manuscript;n=27;27;-1
2007_1929649261151453_manuscript;n=21;21;-1
2007_1929649261151453_manuscript;n=3;3;-1
2007_1929649261151453_manuscript;n=22;22;-1
2007_1929649261151453_manuscript;n=11;11;-1
2007_1929649261151453_manuscript;n=15;15;-1
2007_1929649261151453_manuscript;n=7;7;-1
2007_1929649261151453_manuscript;n=58;58;-1
2007_1929649261151453_manuscript;n=12;12;-1
2007_1929649261151453_manuscript;n=19;19;-1
2007_1929649261151453_manuscript;n=72;72;-1
2007_1929649261151453_manuscript;n=114;114;-1
2007_1929649261151453_manuscript;n=93;93;-1
2007_1929649261151453_manuscript;n=87;87;-1
2007_1929649261151453_manuscript;n=97;97;-1
2007_1929649261151453_manuscript;n=36;36;-1
2007_1929649261151453_manuscript;n = 14;14;-1
2007_1929649261151453_manuscript;n = 65;65;-1
2007_1929649261151453_manuscript;n=6;6;-1
2007_1929649261151453_manuscript;n=9;9;-1
2007_1929649261151453_manuscript;n=95;95;-1
2007_1929649261151453_manuscript;n=59;59;-1
2007_1929649261151453_manuscript;n=16;16;-1
2007_1929649261151453_manuscript;n=13;13;-1
2007_1929649261151453_manuscript;n=65;65;-1
2007_1929649261151453_manuscript;n = 34;34;-1
2007_1929649261151453_manuscript;N=112;112;-1
2007_1929649261151453_manuscript;n=115;115;-1
2007_1929649261151453_manuscript;n=108;108;-1
2007_1929649261151453_manuscript;n=118;118;-1
2007_1929649261151453_manuscript;n= 121;121;-1
2007_1929649261151453_manuscript;n=112;112;-1
2007_1936797349135117_manuscript;9 patients;9;-1
2007_1936797349135117_manuscript;2 patients;2;-1
2007_1936797349135117_manuscript;122X   patients;122;-1
2007_1936797349135117_manuscript;18 study patients;18;-1
2007_1936797349135117_manuscript;122X homozygous patients;122;-1
2007_1936797349135117_manuscript;122X patients;122;-1
2007_1936797349135117_manuscript;n=9;9;-1
2007_1936797349135117_manuscript;n=4;4;-1
2007_1936797349135117_manuscript;n=5;5;-1
2007_1936797349135117_manuscript;122X patients enrolled;122;-1
2007_1961830001166500_manuscript;n=2492;2492;-1
2007_1961830001166500_manuscript;n=1250;1250;-1
2007_1961830001166500_manuscript;n=2074;2074;-1
2007_1961830001166500_manuscript;n=19;19;-1
2007_1961830001166500_manuscript;n=17;17;-1
2007_1961830001166500_manuscript;N=19;19;-1
2007_1961830001166500_manuscript;N=14;14;-1
2007_1961830001166500_manuscript;datafrom2003;2003;-1
2007_2011672673133096_manuscript;5 million people;5;-1
2007_2011672673133096_manuscript;20 000 people;20000;-1
2007_2025533633147387_manuscript;676 women;676;-1
2007_2025533633147387_manuscript;2688 eligible individuals;2688;-1
2007_2025533633147387_manuscript;n= 2580;2580;-1
2007_2025533633147387_manuscript;n=1601;1601;-1
2007_2025533633147387_manuscript;n=4;4;-1
2007_2025533633147387_manuscript;n=2;2;-1
2007_2025533633147387_manuscript;n=3;3;-1
2007_2025533633147387_manuscript;n=1000;1000;-1
2007_2025533633147387_manuscript;total of 21;21;-1
2007_2025533633147387_manuscript;total of 7;7;-1
2007_2064630364160607_manuscript;200 million women;200;-1
2007_2064630364160607_manuscript;n=6,217;6217;-1
2007_2064630364160607_manuscript;n=3,618;3618;-1
2007_2064630364160607_manuscript;n=4,066;4066;-1
2007_2064630364160607_manuscript;n=3618;3618;-1
2007_2064630364160607_manuscript;total of 11,904;11904;-1
2007_2189433921338360_manuscript;n=2846;2846;-1
2007_2189433921338360_manuscript;n=203;203;-1
2007_2189433921338360_manuscript;n=68;68;-1
2007_2189433921338360_manuscript;n=50;50;-1
2007_2189433921338360_manuscript;n=12;12;-1
2007_2189433921338360_manuscript;n=6;6;-1
2007_2189433921338360_manuscript;n=135;135;-1
2007_2189433921338360_manuscript;n=2643;2643;-1
2007_2189433921338360_manuscript;n=1;1;-1
2007_2189433921338360_manuscript;n=23;23;-1
2007_2189433921338360_manuscript;n=7;7;-1
2007_2189433921338360_manuscript;n=13;13;-1
2007_2189433921338360_manuscript;n=2;2;-1
2007_2189433921338360_manuscript;n=4;4;-1
2007_2189433921338360_manuscript;n=3;3;-1
2007_2189433921338360_manuscript;n=39;39;-1
2007_2189433921338360_manuscript;n=29;29;-1
2007_2189433921338360_manuscript;total of 39;39;-1
2007_2698962831708369_manuscript;301 participants;301;-1
2007_2698962831708369_manuscript;21,270 participants;21270;-1
2007_2698962831708369_manuscript;161 patients;161;-1
2007_2698962831708369_manuscript;73 patients;73;-1
2007_2698962831708369_manuscript;69 patients;69;-1
2007_2698962831708369_manuscript;7 patients;7;-1
2007_2698962831708369_manuscript;149 patients;149;-1
2007_2698962831708369_manuscript;92 patients;92;-1
2007_2698962831708369_manuscript;n=161;161;-1
2007_2698962831708369_manuscript;n=436;436;-1
2007_2698962831708369_manuscript;n=213;213;-1
2007_3064546791416923_manuscript;2000 women;2000;-1
2007_3705195691605849_manuscript;518patients;518;-1
2007_3705195691605849_manuscript;3501patients;3501;-1
2007_3705195691605849_manuscript;834patients;834;-1
2007_3705195691605849_manuscript;76  ovariancancerpatients;76;-1
2007_4812458761346832_manuscript;1000 persons;1000;-1
2007_4812458761346832_manuscript;1000   persons;1000;-1
2007_4812458761346832_manuscript;1000 patients;1000;-1
2007_4812458761346832_manuscript;total of 56;56;-1
2007_9177414841327857_manuscript;10inpatients;10;-1
2007_9259246781334488_manuscript;N=5830458;5830458;-1
2008_1070938692203135_manuscript;1 patients;1;11873
2008_1070938692203135_manuscript;n=3;3;5491
2008_1070938692203135_manuscript;n=6;6;24205
2008_1197357751241433_manuscript;456 individuals;456;278
2008_1197357751241433_manuscript;n=396;396;6197
2008_1197357751241433_manuscript;n=208;208;6178
2008_1197357751241433_manuscript;n=201;201;6160
2008_1197357751241433_manuscript;n=191;191;6139
2008_1197357751241433_manuscript;n=220;220;6120
2008_1197357751241433_manuscript;n=88;88;6101
2008_1197357751241433_manuscript;n=61;61;6083
2008_1197357751241433_manuscript;n=236;236;6061
2008_1197357751241433_manuscript;n=101;101;112
2008_1197357751241433_manuscript;n=144;144;9
2008_1197357751241433_manuscript;n=456;456;276
2008_1197357751241433_manuscript;n =0;0;33275
2008_1320165722176305_manuscript;5terminalpatients;5;-1
2008_1320165722176305_manuscript;5terminal  patients;5;-1
2008_1320165722176305_manuscript;n=1478;1478;-1
2008_1320165722176305_manuscript;n=1750;1750;-1
2008_1320165722176305_manuscript;n=1217;1217;-1
2008_1320165722176305_manuscript;n=1508;1508;-1
2008_1320165722176305_manuscript;n=1275;1275;-1
2008_1320165722176305_manuscript;n=1514;1514;-1
2008_1320165722176305_manuscript;n=1397;1397;-1
2008_1320165722176305_manuscript;N=1478;1478;-1
2008_1320165722176305_manuscript;N=1750;1750;-1
2008_1320165722176305_manuscript;N=1397;1397;-1
2008_1320165722176305_manuscript;N=1217;1217;-1
2008_1320165722176305_manuscript;N=1508;1508;-1
2008_1320165722176305_manuscript;N=1275;1275;-1
2008_1320165722176305_manuscript;N=1514;1514;-1
2008_1320165722176305_manuscript;n=6587;6587;-1
2008_1320165722176305_manuscript;n=6348;6348;-1
2008_1498911845235235_manuscript;n=3;3;-1
2008_1559645878224483_manuscript;4825 women;4825;678
2008_1559645878224483_manuscript;5473 persons;5473;6207
2008_1559645878224483_manuscript;4686 persons;4686;11049
2008_1559645878224483_manuscript;150 subjects;150;5778
2008_1559645878224483_manuscript;112 subjects;112;18329
2008_1559645878224483_manuscript;38 patients;38;8561
2008_1559645878224483_manuscript;27 patients;27;1078
2008_1559645878224483_manuscript;4519 patients;4519;6761
2008_1559645878224483_manuscript;7 patients;7;1077
2008_1559645878224483_manuscript;753 patients;753;30192
2008_1559645878224483_manuscript;64 patients;64;31512
2008_1559645878224483_manuscript;5743 individuals;5743;10548
2008_1559645878224483_manuscript;4519 individuals;4519;1322
2008_1559645878224483_manuscript;1020 individuals;1020;3586
2008_1559645878224483_manuscript;38   individuals;38;7333
2008_1559645878224483_manuscript;27   individuals;27;7903
2008_1559645878224483_manuscript;11 individuals;11;9299
2008_1559645878224483_manuscript;25 individuals;25;9730
2008_1559645878224483_manuscript;122,310 individuals;122310;24161
2008_1559645878224483_manuscript;N = 1890;1890;38322
2008_1559645878224483_manuscript;N = 3853;3853;38381
2008_1559645878224483_manuscript;n=25;25;38614
2008_1559645878224483_manuscript;n=386;386;38631
2008_1559645878224483_manuscript;n=900;900;38649
2008_1559645878224483_manuscript;n=1442;1442;38667
2008_1559645878224483_manuscript;n=1279;1279;38686
2008_1559645878224483_manuscript;n=610;610;38705
2008_1559645878224483_manuscript;n=183;183;38721
2008_1559645878224483_manuscript;n=4824;4824;38742
2008_1559645878224483_manuscript;n=12;12;38686
2008_1559645878224483_manuscript;n=31;31;39789
2008_1559645878224483_manuscript;n=125;125;39806
2008_1559645878224483_manuscript;n=249;249;39824
2008_1559645878224483_manuscript;n=281;281;39842
2008_1559645878224483_manuscript;n=166;166;39860
2008_1559645878224483_manuscript;n=54;54;39876
2008_1559645878224483_manuscript;n=918;918;39896
2008_1559645878224483_manuscript;n = 25;25;42995
2008_1559645878224483_manuscript;n = 13;13;43034
2008_1559645878224483_manuscript;n = 36;36;43292
2008_1559645878224483_manuscript;n = 17;17;43338
2008_1559645878224483_manuscript;n=503;503;43602
2008_1559645878224483_manuscript;n=1136;1136;43618
2008_1559645878224483_manuscript;n=1059;1059;43635
2008_1559645878224483_manuscript;n=336;336;43653
2008_1559645878224483_manuscript;n=1485;1485;43667
2008_1559645878224483_manuscript;total of 38;38;1224
2008_1559645878224483_manuscript; data from 5;5;21503
2008_1610010055192474_manuscript;n=450;450;-1
2008_1617897589203257_manuscript;1000 consecutive patients;1000;-1
2008_1617897589203257_manuscript;n=32,298;32298;-1
2008_1617897589203257_manuscript;n=102;102;-1
2008_1617897589203257_manuscript;n=16;16;-1
2008_1617897589203257_manuscript;N=548;548;-1
2008_1617897589203257_manuscript;N=192;192;-1
2008_1617897589203257_manuscript;total of 9972;9972;-1
2008_1778887901196715_manuscript;402 potential participants;402;887
2008_1778887901196715_manuscript;n = 6;6;4646
2008_1778887901196715_manuscript;N = 342;342;32945
2008_1778887901196715_manuscript;N = 150;150;34042
2008_1778887901196715_manuscript;N = 192;192;34992
2008_1778887901196715_manuscript;N  =  6;6;40927
2008_1778887901196715_manuscript;N  =  19;19;40954
2008_1778887901196715_manuscript;N  =  17;17;40985
2008_1778887901196715_manuscript;N  =  18;18;41016
2008_1778887901196715_manuscript;N  =  15;15;41047
2008_1778887901196715_manuscript;N  =  27;27;41078
2008_1778887901196715_manuscript;N  =  10;10;41145
2008_1778887901196715_manuscript;N  =  11;11;41179
2008_1827866415186879_manuscript;n=4;4;-1
2008_1827866415186879_manuscript;n = 3;3;-1
2008_1827866415186879_manuscript;n = 4;4;-1
2008_1827866415186879_manuscript;n = 14;14;-1
2008_1891807038245356_manuscript;26,786COPDpatients;26786;-1
2008_1891807038245356_manuscript;1dataforindividualpatients;1;-1
2008_1891807038245356_manuscript;6000patients;6000;-1
2008_1891807038245356_manuscript;156patients;156;-1
2008_1891807038245356_manuscript;244patients;244;-1
2008_1891807038245356_manuscript;400patients;400;-1
2008_1891807038245356_manuscript;26,786patients;26786;-1
2008_1891807038245356_manuscript;23,245patients;23245;-1
2008_1891807038245356_manuscript;3541patients;3541;-1
2008_1891807038245356_manuscript;7201 patients;7201;-1
2008_1891807038245356_manuscript;8312patients;8312;-1
2008_1891807038245356_manuscript;3861patients;3861;-1
2008_1891807038245356_manuscript;1NotonlyCOPDpatients;1;-1
2008_1891807038245356_manuscript;n=9,434;9434;-1
2008_1891807038245356_manuscript;n=17,352;17352;-1
2008_1891807038245356_manuscript;n=433;433;-1
2008_1891807038245356_manuscript;n=79;79;-1
2008_1891807038245356_manuscript;n=445;445;-1
2008_1891807038245356_manuscript;n=653;653;-1
2008_1891807038245356_manuscript;n=1207;1207;-1
2008_1891807038245356_manuscript;n=742;742;-1
2008_1891807038245356_manuscript;n=1465;1465;-1
2008_1891807038245356_manuscript;n=1022;1022;-1
2008_1891807038245356_manuscript;n=78;78;-1
2008_1891807038245356_manuscript;n=6112;6112;-1
2008_1891807038245356_manuscript;n=432;432;-1
2008_1891807038245356_manuscript;n=921;921;-1
2008_1891807038245356_manuscript;n=824;824;-1
2008_1891807038245356_manuscript;n=408;408;-1
2008_1891807038245356_manuscript;n=196;196;-1
2008_1891807038245356_manuscript;n=392;392;-1
2008_1891807038245356_manuscript;n=1010;1010;-1
2008_1891807038245356_manuscript;n=540;540;-1
2008_1891807038245356_manuscript;n=994;994;-1
2008_1891807038245356_manuscript;n=68;68;-1
2008_1891807038245356_manuscript;n=278;278;-1
2008_1891807038245356_manuscript;n=671;671;-1
2008_1891807038245356_manuscript;n=1829;1829;-1
2008_1891807038245356_manuscript;n=281;281;-1
2008_1891807038245356_manuscript;n=114;114;-1
2008_1891807038245356_manuscript;n=434;434;-1
2008_1891807038245356_manuscript;n=634;634;-1
2008_1891807038245356_manuscript;n=812;812;-1
2008_1891807038245356_manuscript;n=244;244;-1
2008_1891807038245356_manuscript;n=92;92;-1
2008_1891807038245356_manuscript;n=121;121;-1
2008_1891807038245356_manuscript;n=1323;1323;-1
2008_1891807038245356_manuscript;n=98;98;-1
2008_2016711686187994_manuscript;96unrelatedFAP  patients;96;-1
2008_2016711686187994_manuscript;96patients;96;-1
2008_2016711686187994_manuscript;315disease-  affectedlivingpatients;315;-1
2008_2016711686187994_manuscript;6ofthesepatients;6;-1
2008_2016711686187994_manuscript;29patients;29;-1
2008_2016711686187994_manuscript;81patients;81;-1
2008_2016711686187994_manuscript;95patients;95;-1
2008_2016711686187994_manuscript;4patients;4;-1
2008_2016711686187994_manuscript;2patients;2;-1
2008_2016711686187994_manuscript;61newpatients;61;-1
2008_2016711686187994_manuscript;150unrelatedpatients;150;-1
2008_2016711686187994_manuscript;150  individuals;150;-1
2008_2016711686187994_manuscript;150individuals;150;-1
2008_2016711686187994_manuscript;1inindividuals;1;-1
2008_2032416569241104_manuscript;39082 participants;39082;-1
2008_2032416569241104_manuscript;1 Sociodemographics of all participants;1;-1
2008_2032416569241104_manuscript;N=39082;39082;-1
2008_2032416569241104_manuscript;n=12080;12080;-1
2008_2032416569241104_manuscript;n=26808;26808;-1
2008_2032416569241104_manuscript;total of 39082;39082;-1
2008_2032416569241104_manuscript;total of 6;6;-1
2008_2146251396186604_manuscript;n=7,915;7915;-1
2008_2146251396186604_manuscript;n=1,081;1081;-1
2008_2146251396186604_manuscript;n=180;180;-1
2008_2146251396186604_manuscript;n=12,761;12761;-1
2008_2146251396186604_manuscript;n=19,491;19491;-1
2008_2146251396186604_manuscript;n=6,151;6151;-1
2008_2146251396186604_manuscript;n=297;297;-1
2008_2146251396186604_manuscript;n=178;178;-1
2008_2146251396186604_manuscript;n=3,106;3106;-1
2008_2146251396186604_manuscript;n=27,234;27234;-1
2008_2146251396186604_manuscript;n=4,835;4835;-1
2008_4064400032236747_manuscript;96women;96;-1
2008_4064400032236747_manuscript;7983participants;7983;-1
2008_4064400032236747_manuscript;7129participants;7129;-1
2008_4064400032236747_manuscript;588participants;588;-1
2008_4064400032236747_manuscript;22056subjects;22056;-1
2008_4064400032236747_manuscript;10275eligible  individuals;10275;-1
2008_5882906962006706_manuscript;123 patients;123;-1
2008_5882906962006706_manuscript;19 outpatients;19;-1
2008_5882906962006706_manuscript;19 patients;19;-1
2008_5882906962006706_manuscript;4 additional patients;4;-1
2008_5882906962006706_manuscript;20 outpatients;20;-1
2008_5882906962006706_manuscript;71 patients;71;-1
2008_5882906962006706_manuscript;N = 51;51;-1
2008_5882906962006706_manuscript;N = 58;58;-1
2008_5882906962006706_manuscript;n = 34;34;-1
2008_5882906962006706_manuscript;n = 37;37;-1
2008_5882906962006706_manuscript;n = 39;39;-1
2008_5882906962006706_manuscript;n = 40;40;-1
2008_5882906962006706_manuscript;n = 29;29;-1
2008_5882906962006706_manuscript;n = 31;31;-1
2008_5882906962006706_manuscript;n = 94;94;-1
2008_5882906962006706_manuscript;n = 42;42;-1
2008_5882906962006706_manuscript;n = 121;121;-1
2008_5882906962006706_manuscript;n=29;29;-1
2008_5882906962006706_manuscript;n=34;34;-1
2008_5882906962006706_manuscript;n=31;31;-1
2008_5882906962006706_manuscript;n=94;94;-1
2008_5882906962006706_manuscript;total of 123;123;-1
2008_6477168022345993_manuscript;100patients;100;-1
2008_6477168022345993_manuscript;5  Commentaryfromotherpeople;5;-1
2008_6477168022345993_manuscript;N=57;57;-1
2008_6477168022345993_manuscript;N=48;48;-1
2008_6477168022345993_manuscript;N=352;352;-1
2008_6477168022345993_manuscript;N=201;201;-1
2008_6477168022345993_manuscript;N=47;47;-1
2008_6477168022345993_manuscript;N=58;58;-1
2008_6477168022345993_manuscript;N=357;357;-1
2008_7055635152144161_manuscript;143 subjects;143;12259
2008_7055635152144161_manuscript;143 myeloma patients;143;17571
2008_7055635152144161_manuscript;9486 patients;9486;17389
2008_7055635152144161_manuscript;9321 patients;9321;16953
2008_7055635152144161_manuscript;143   patients;143;13036
2008_7055635152144161_manuscript;142 patients;142;12919
2008_7055635152144161_manuscript;142   patients;142;12862
2008_7055635152144161_manuscript;n=70;70;23389
2008_7055635152144161_manuscript;n=73;73;23314
2008_7055635152144161_manuscript;n=52;52;17502
2008_7055635152144161_manuscript;n=91;91;17480
2008_7055635152144161_manuscript;n= 70;70;16736
2008_7055635152144161_manuscript;n=10;10;7280
2008_7055635152144161_manuscript;n=92;92;6425
2008_7055635152144161_manuscript;n= 27;27;6390
2008_7055635152144161_manuscript;total of 279;279;8583
2008_7055635152144161_manuscript;total of 10,000;10000;1605
2008_7055635152144161_manuscript;143 myeloma patients enrolled;143;17571
2008_7055635152144161_manuscript; data set of 143;143;13049
2008_7535528662412461_manuscript;85for  women;85;-1
2008_7535528662412461_manuscript;3ofthe  participants;3;-1
2008_7535528662412461_manuscript;N=253;253;-1
2008_7535528662412461_manuscript;N=139;139;-1
2008_7535528662412461_manuscript;N=114;114;-1
2008_7535528662412461_manuscript;datafrom253;253;-1
2008_7931076312138626_manuscript;11   pregnant women;11;-1
2008_7931076312138626_manuscript;286 participants;286;-1
2008_7931076312138626_manuscript;14 patients;14;-1
2008_7931076312138626_manuscript;1 million adults;1;-1
2009_1011958087269863_manuscript;115patients;115;-1
2009_1011958087269863_manuscript;24,789patients;24789;-1
2009_1011958087269863_manuscript;1070     fewerpatients;1070;-1
2009_1011958087269863_manuscript;13,152hospitalizedpatients;13152;-1
2009_1011958087269863_manuscript;26fortraumapatients;26;-1
2009_1011958087269863_manuscript;n=24,789;24789;-1
2009_1011958087269863_manuscript;n=115;115;-1
2009_1011958087269863_manuscript;n=40;40;-1
2009_1011958087269863_manuscript;n=4007;4007;-1
2009_1011958087269863_manuscript;n=20,789;20789;-1
2009_1011958087269863_manuscript;n=308;308;-1
2009_1011958087269863_manuscript;datafrom32;32;-1
2009_1048862627295513_manuscript;282 persons;282;-1
2009_1048862627295513_manuscript;108 persons;108;-1
2009_1048862627295513_manuscript;n=4,469;4469;-1
2009_1048862627295513_manuscript;n=191,109;191109;-1
2009_1048862627295513_manuscript;n=3,437,837;3437837;-1
2009_1048862627295513_manuscript;n=108;108;-1
2009_1048862627295513_manuscript;n=282;282;-1
2009_1048862627295513_manuscript;n=15;15;-1
2009_1048862627295513_manuscript;n=135;135;-1
2009_1048862627295513_manuscript;n=34;34;-1
2009_1048862627295513_manuscript;n=184;184;-1
2009_1048862627295513_manuscript;n=3;3;-1
2009_1048862627295513_manuscript;n=55;55;-1
2009_1048862627295513_manuscript;n=19;19;-1
2009_1048862627295513_manuscript;n=77;77;-1
2009_1048862627295513_manuscript;n=0;0;-1
2009_1048862627295513_manuscript;n=8;8;-1
2009_1048862627295513_manuscript;n=2;2;-1
2009_1048862627295513_manuscript;n=5;5;-1
2009_1048862627295513_manuscript;n=433;433;-1
2009_1048862627295513_manuscript;n=1,776;1776;-1
2009_1048862627295513_manuscript;n= 261;261;-1
2009_1048862627295513_manuscript;n=2470;2470;-1
2009_1048862627295513_manuscript;n=132;132;-1
2009_1048862627295513_manuscript;n=341;341;-1
2009_1048862627295513_manuscript;n=58;58;-1
2009_1048862627295513_manuscript;n=531;531;-1
2009_1048862627295513_manuscript;n=121;121;-1
2009_1048862627295513_manuscript;n=558;558;-1
2009_1048862627295513_manuscript;n=756;756;-1
2009_1048862627295513_manuscript;n=38;38;-1
2009_1048862627295513_manuscript;n=94;94;-1
2009_1048862627295513_manuscript;n=7;7;-1
2009_1048862627295513_manuscript;n=139;139;-1
2009_1048862627295513_manuscript; data from 1990;1990;-1
2009_1131648596294845_manuscript;26persons;26;-1
2009_1131648596294845_manuscript;5623subjects;5623;-1
2009_1131648596294845_manuscript;781clinicallyevaluatedsubjects;781;-1
2009_1131648596294845_manuscript;5,623subjects;5623;-1
2009_1131648596294845_manuscript;781subjects;781;-1
2009_1131648596294845_manuscript;100subjects;100;-1
2009_1131648596294845_manuscript;210subjects;210;-1
2009_1131648596294845_manuscript;98subjects;98;-1
2009_1131648596294845_manuscript;n=469;469;-1
2009_1131648596294845_manuscript;n=505;505;-1
2009_1131648596294845_manuscript;n=641;641;-1
2009_1131648596294845_manuscript;n=781;781;-1
2009_1131648596294845_manuscript;n=280;280;-1
2009_1131648596294845_manuscript;n=501;501;-1
2009_1131648596294845_manuscript;n=1609;1609;-1
2009_1131648596294845_manuscript;n=282;282;-1
2009_1131648596294845_manuscript;n=5558;5558;-1
2009_1131648596294845_manuscript;n=213;213;-1
2009_1131648596294845_manuscript;n=421;421;-1
2009_1131648596294845_manuscript;n=147;147;-1
2009_1131648596294845_manuscript;n=133;133;-1
2009_1131648596294845_manuscript;n=114;114;-1
2009_1131648596294845_manuscript;n=33;33;-1
2009_1131648596294845_manuscript;n=210;210;-1
2009_1131648596294845_manuscript;n=100;100;-1
2009_1131648596294845_manuscript;n=110;110;-1
2009_1246299958288786_manuscript;139patients;139;-1
2009_1246299958288786_manuscript;3timeshigherinpatients;3;-1
2009_1246299958288786_manuscript;1diabeticpatients;1;-1
2009_1246299958288786_manuscript;38patients;38;-1
2009_1246299958288786_manuscript;3patients;3;-1
2009_1246299958288786_manuscript;8patients;8;-1
2009_1246299958288786_manuscript;462patients;462;-1
2009_1246299958288786_manuscript;n=44;44;-1
2009_1246299958288786_manuscript;n=31;31;-1
2009_1246299958288786_manuscript;n=13;13;-1
2009_1246299958288786_manuscript;n=46;46;-1
2009_1246299958288786_manuscript;n=24;24;-1
2009_1246299958288786_manuscript;n=22;22;-1
2009_1246299958288786_manuscript;n=49;49;-1
2009_1246299958288786_manuscript;n=16;16;-1
2009_1246299958288786_manuscript;n=33;33;-1
2009_1246299958288786_manuscript;dataofthe139;139;-1
2009_1274052602278306_manuscript;6,316 patients;6316;-1
2009_1274052602278306_manuscript;6,316patients;6316;-1
2009_1274052602278306_manuscript;2,872 patients;2872;-1
2009_1274052602278306_manuscript;163patients;163;-1
2009_1274052602278306_manuscript;2,107patients;2107;-1
2009_1274052602278306_manuscript;2,553patients;2553;-1
2009_1274052602278306_manuscript;934patients;934;-1
2009_1377677989297772_manuscript;1displaystheflowof  participants;1;-1
2009_1377677989297772_manuscript;n=430;430;-1
2009_1377677989297772_manuscript;n=446;446;-1
2009_1377677989297772_manuscript;n=423;423;-1
2009_1377677989297772_manuscript;N=685;685;-1
2009_1377677989297772_manuscript;N=301;301;-1
2009_1377677989297772_manuscript;N=383;383;-1
2009_1377677989297772_manuscript;N=674;674;-1
2009_1377677989297772_manuscript;N=337;337;-1
2009_1377677989297772_manuscript;N=336;336;-1
2009_1422089111265449_manuscript;88  adulttuberculosispatients;88;-1
2009_1422089111265449_manuscript;36Inimmunocompetentpatients;36;-1
2009_1422089111265449_manuscript;95individuals;95;-1
2009_1422089111265449_manuscript;2hRMPconcentrationsinadults;2;-1
2009_1422089111265449_manuscript;17Incomparisontoadults;17;-1
2009_1422089111265449_manuscript;N=21;21;-1
2009_1422089111265449_manuscript;N=33;33;-1
2009_1491260264258889_manuscript;6700 patients;6700;-1
2009_1561046423320571_manuscript;13participants;13;-1
2009_1561046423320571_manuscript;1Apatients;1;-1
2009_1561046423320571_manuscript;1A  patients;1;-1
2009_1561046423320571_manuscript;29patients;29;-1
2009_1561046423320571_manuscript;13patients;13;-1
2009_1561046423320571_manuscript;12adultpatients;12;-1
2009_1561046423320571_manuscript;10age-  matcheduntreatedpatients;10;-1
2009_1561046423320571_manuscript;12treatedpatients;12;-1
2009_1561046423320571_manuscript;12patients;12;-1
2009_1561046423320571_manuscript;5000people;5000;-1
2009_1561046423320571_manuscript;1Ainadults;1;-1
2009_1561046423320571_manuscript;1Apatientswererecruited;1;-1
2009_1561046423320571_manuscript;n=4;4;-1
2009_1590367906289074_manuscript;67 of the patients;67;-1
2009_1590367906289074_manuscript;31 patients;31;-1
2009_1590367906289074_manuscript;3 major subclasses of patients;3;-1
2009_1590367906289074_manuscript;6,934 genes and the   individual patients;6934;-1
2009_1590367906289074_manuscript;16  subclass A patients;16;-1
2009_1590367906289074_manuscript;98 patients;98;-1
2009_1590367906289074_manuscript;n = 11;11;-1
2009_1590367906289074_manuscript;n = 32;32;-1
2009_1590367906289074_manuscript;n = 98;98;-1
2009_1616447148266042_manuscript;13 Flow of participants;13;-1
2009_1616447148266042_manuscript;234 subjects;234;-1
2009_1616447148266042_manuscript;n = 1,368;1368;-1
2009_1616447148266042_manuscript;n = 931;931;-1
2009_1616447148266042_manuscript;n = 101;101;-1
2009_1616447148266042_manuscript;N=271;271;-1
2009_1616447148266042_manuscript;N=264;264;-1
2009_1616447148266042_manuscript;N=273;273;-1
2009_1616447148266042_manuscript;n=392;392;-1
2009_1616447148266042_manuscript;n=332;332;-1
2009_1616447148266042_manuscript;n=38;38;-1
2009_1616447148266042_manuscript;n=22;22;-1
2009_1616447148266042_manuscript;n=1200;1200;-1
2009_1616447148266042_manuscript;n=808;808;-1
2009_1616447148266042_manuscript;n=264;264;-1
2009_1616447148266042_manuscript;n=271;271;-1
2009_1616447148266042_manuscript;n=273;273;-1
2009_1616447148266042_manuscript;n=24;24;-1
2009_1616447148266042_manuscript;n=10;10;-1
2009_1616447148266042_manuscript;n=14;14;-1
2009_1616447148266042_manuscript;n=247;247;-1
2009_1616447148266042_manuscript;n=5;5;-1
2009_1616447148266042_manuscript;n=1;1;-1
2009_1616447148266042_manuscript;n=8;8;-1
2009_1616447148266042_manuscript;n=259;259;-1
2009_1616447148266042_manuscript;n=16;16;-1
2009_1616447148266042_manuscript;n=248;248;-1
2009_1616447148266042_manuscript;n=239;239;-1
2009_1616447148266042_manuscript;n=3;3;-1
2009_1616447148266042_manuscript;n=224;224;-1
2009_1616447148266042_manuscript;n=7;7;-1
2009_1616447148266042_manuscript;n=253;253;-1
2009_1616447148266042_manuscript;total of 1200;1200;-1
2009_1616468965288590_manuscript;7,383 patients;7383;-1
2009_1616468965288590_manuscript;2,219caseswererecruited;2219;-1
2009_1616468965288590_manuscript;n=2,219;2219;-1
2009_1616468965288590_manuscript;n=887;887;-1
2009_1616468965288590_manuscript;274wereenrolled;274;-1
2009_1616468965288590_manuscript;datafrom2007;2007;-1
2009_1663055956308716_manuscript;1subjects;1;-1
2009_1663055956308716_manuscript;2subjects;2;-1
2009_1663055956308716_manuscript;2andAD-FDRsubjects;2;-1
2009_1663055956308716_manuscript;1subjects;1;-1
2009_1663055956308716_manuscript;4  subjects;4;-1
2009_1663055956308716_manuscript;2andAD-FDR  subjects;2;-1
2009_1663055956308716_manuscript;93patients;93;-1
2009_1663055956308716_manuscript;93AD patients;93;-1
2009_1663055956308716_manuscript;1subjectsandADpatients;1;-1
2009_1663055956308716_manuscript;1subjectsandAD  patients;1;-1
2009_1663055956308716_manuscript;1subjectsandADpatients;1;-1
2009_1663055956308716_manuscript;20ADpatients;20;-1
2009_1663055956308716_manuscript;170individuals;170;-1
2009_1681641971270083_manuscript;n=265;265;-1
2009_1687316482541434_manuscript;6749women;6749;-1
2009_1687316482541434_manuscript;3260patients;3260;-1
2009_1687316482541434_manuscript;n=3;3;-1
2009_1687316482541434_manuscript;n=1;1;-1
2009_1687316482541434_manuscript;n=173;173;-1
2009_1687316482541434_manuscript;n=16;16;-1
2009_1687316482541434_manuscript;n=47;47;-1
2009_1687316482541434_manuscript;n=48;48;-1
2009_1687316482541434_manuscript;n=10;10;-1
2009_1687316482541434_manuscript;n=9;9;-1
2009_1687316482541434_manuscript;n=33;33;-1
2009_1687316482541434_manuscript;n=157;157;-1
2009_1702867713333365_manuscript;3 patients;3;-1
2009_1702867713333365_manuscript;295 patients;295;-1
2009_1702867713333365_manuscript;56 patients;56;-1
2009_1702867713333365_manuscript;24   of these patients;24;-1
2009_1702867713333365_manuscript;24 patients;24;-1
2009_1702867713333365_manuscript;126   patients;126;-1
2009_1702867713333365_manuscript;n = 24;24;-1
2009_1732424011263084_manuscript;471 patients;471;-1
2009_1732424011263084_manuscript;5 patients;5;-1
2009_1732424011263084_manuscript;394 patients;394;-1
2009_1732424011263084_manuscript;5   Outpatients;5;-1
2009_1745844106339390_manuscript;n=774;774;-1
2009_1745844106339390_manuscript;n=661;661;-1
2009_1745844106339390_manuscript;n = 85;85;-1
2009_1745844106339390_manuscript;n = 576;576;-1
2009_1745844106339390_manuscript;n =435;435;-1
2009_1745844106339390_manuscript;n = 413;413;-1
2009_1745844106339390_manuscript;n = 161;161;-1
2009_1745844106339390_manuscript;n = 87;87;-1
2009_1745844106339390_manuscript;N=774;774;-1
2009_1745844106339390_manuscript;N=672;672;-1
2009_1745844106339390_manuscript;N=744;744;-1
2009_1749555083308920_manuscript;200subjects;200;-1
2009_1749555083308920_manuscript;n=276;276;-1
2009_1749555083308920_manuscript;n=18;18;-1
2009_1749555083308920_manuscript;n=128;128;-1
2009_1749555083308920_manuscript;n=148;148;-1
2009_1749555083308920_manuscript;n=316;316;-1
2009_1749555083308920_manuscript;n=339;339;-1
2009_1749555083308920_manuscript;n=164;164;-1
2009_1749555083308920_manuscript;n=175;175;-1
2009_1749555083308920_manuscript;n=91;91;-1
2009_1749555083308920_manuscript;n=84;84;-1
2009_1749555083308920_manuscript;n=80;80;-1
2009_1749555083308920_manuscript;n=9;9;-1
2009_1749555083308920_manuscript;n=0;0;-1
2009_1749555083308920_manuscript;n=7;7;-1
2009_1749555083308920_manuscript;n=2;2;-1
2009_1749555083308920_manuscript;n=6;6;-1
2009_1749555083308920_manuscript;n=3;3;-1
2009_1749555083308920_manuscript;n=1;1;-1
2009_1749555083308920_manuscript;n=16;16;-1
2009_1749555083308920_manuscript;n=5;5;-1
2009_1749555083308920_manuscript;n=14;14;-1
2009_1749555083308920_manuscript;n=4;4;-1
2009_1749555083308920_manuscript;n=10;10;-1
2009_1749555083308920_manuscript;339childrenwereenrolled;339;-1
2009_1785228233295686_manuscript;6500individuals;6500;-1
2009_1785228233295686_manuscript;7588 individuals;7588;-1
2009_1785228233295686_manuscript;5566individuals;5566;-1
2009_1785228233295686_manuscript;863individuals;863;-1
2009_1785228233295686_manuscript;2168 individuals;2168;-1
2009_1785228233295686_manuscript;111 individuals;111;-1
2009_1785228233295686_manuscript;196 individuals;196;-1
2009_1785228233295686_manuscript;4  individuals;4;-1
2009_1785228233295686_manuscript;n=7588;7588;-1
2009_1785228233295686_manuscript;n=3709;3709;-1
2009_1785228233295686_manuscript;n=3879;3879;-1
2009_1818099850257014_manuscript;146 patients;146;-1
2009_1818099850257014_manuscript;1   were patients;1;-1
2009_1818099850257014_manuscript;2 were patients;2;-1
2009_1818099850257014_manuscript;3 were patients;3;-1
2009_1818099850257014_manuscript;295 patients;295;-1
2009_1818099850257014_manuscript;146 different   patients;146;-1
2009_1818099850257014_manuscript;3 Basal-like patients;3;-1
2009_1818099850257014_manuscript;295 breast cancer patients;295;-1
2009_1818099850257014_manuscript;412 patients;412;-1
2009_1818099850257014_manuscript;N=0;0;-1
2009_1818099850257014_manuscript;N=1;1;-1
2009_1818099850257014_manuscript;N=136;136;-1
2009_1818099850257014_manuscript;N=295;295;-1
2009_1818099850257014_manuscript;N=111;111;-1
2009_1818099850257014_manuscript;N=50;50;-1
2009_1884916126261103_manuscript;2subjects;2;-1
2009_1884916126261103_manuscript;3subjects;3;-1
2009_1884916126261103_manuscript;1150subjects;1150;-1
2009_1884916126261103_manuscript;40insubjects;40;-1
2009_1884916126261103_manuscript;344subjects;344;-1
2009_1884916126261103_manuscript;1146subjects;1146;-1
2009_1884916126261103_manuscript;1includedallsubjects;1;-1
2009_1884916126261103_manuscript;98othersubjects;98;-1
2009_1884916126261103_manuscript;30subjects;30;-1
2009_1884916126261103_manuscript;383  Inclusionofsubjects;383;-1
2009_1884916126261103_manuscript;N=181;181;-1
2009_1884916126261103_manuscript;N=180;180;-1
2009_1884916126261103_manuscript;N=385;385;-1
2009_1884916126261103_manuscript;N=383;383;-1
2009_1884916126261103_manuscript;N=1150;1150;-1
2009_1884916126261103_manuscript;N=382;382;-1
2009_1884916126261103_manuscript;N=65;65;-1
2009_1884916126261103_manuscript;N=66;66;-1
2009_1884916126261103_manuscript;N=183;183;-1
2009_1884916126261103_manuscript;N=186;186;-1
2009_1884916126261103_manuscript;N=67;67;-1
2009_1884916126261103_manuscript;N=71;71;-1
2009_1884916126261103_manuscript;N=68;68;-1
2009_1884916126261103_manuscript;N=72;72;-1
2009_1884916126261103_manuscript;N=73;73;-1
2009_1884916126261103_manuscript;N=13;13;-1
2009_1884916126261103_manuscript;N=14;14;-1
2009_1884916126261103_manuscript;N=15;15;-1
2009_1884916126261103_manuscript;N=27;27;-1
2009_1884916126261103_manuscript;N=26;26;-1
2009_1884916126261103_manuscript;1150subjectsenrolled;1150;-1
2009_1890805975277731_manuscript;17MRSApositivepatients;17;-1
2009_1890805975277731_manuscript;9patients;9;-1
2009_1890805975277731_manuscript;6B  patients;6;-1
2009_1905462595300340_manuscript;2 participants;2;1224
2009_1905462595300340_manuscript;600 consecutive   patients;600;11064
2009_1905462595300340_manuscript;645 eligible stroke patients;645;6177
2009_1905462595300340_manuscript;29 patients;29;1399
2009_1905462595300340_manuscript;n=328;328;4635
2009_1905462595300340_manuscript;n=70;70;1807
2009_1905462595300340_manuscript;n=120;120;1824
2009_1905462595300340_manuscript;n=90;90;1843
2009_1905462595300340_manuscript;n=154;154;1875
2009_1905462595300340_manuscript;n=48;48;1917
2009_1905462595300340_manuscript;n=84;84;1953
2009_1905462595300340_manuscript;n=184;184;3945
2009_1905462595300340_manuscript;n=260;260;4393
2009_1905462595300340_manuscript;n=203;203;4411
2009_1905462595300340_manuscript;n=122;122;4527
2009_1905462595300340_manuscript;n=396;396;4547
2009_1905462595300340_manuscript;n=82;82;4652
2009_1905462595300340_manuscript;n=246;246;4671
2009_1905462595300340_manuscript;n=13;13;8331
2009_1905462595300340_manuscript;n=8;8;1953
2009_1905462595300340_manuscript;n=987;987;24929
2009_1905462595300340_manuscript;n=172;172;24954
2009_1963449396280924_manuscript;2004weremore  pronouncedforwomen;2004;-1
2009_1963449396280924_manuscript;2000Censuspopulationsofwhitewomen;2000;-1
2009_1971764791284613_manuscript;100,000   subjects;100000;-1
2009_1971764791284613_manuscript;3,847 subjects;3847;-1
2009_1971764791284613_manuscript;6,805 subjects;6805;-1
2009_1971764791284613_manuscript;369 patients;369;-1
2009_1971764791284613_manuscript;14,407 adults;14407;-1
2009_1971764791284613_manuscript;2000 335,612 adults;2000335612;-1
2009_1971764791284613_manuscript;n = 19;19;-1
2009_1971764791284613_manuscript;n = 4;4;-1
2009_1971764791284613_manuscript;n = 14;14;-1
2009_1971764791284613_manuscript;n = 7;7;-1
2009_1971764791284613_manuscript;n = 10;10;-1
2009_1971764791284613_manuscript;n = 9;9;-1
2009_1971764791284613_manuscript;n =   7;7;-1
2009_1971764791284613_manuscript;n = 5;5;-1
2009_1971764791284613_manuscript;n   = 7;7;-1
2009_1971764791284613_manuscript;n = 6;6;-1
2009_1971764791284613_manuscript;n = 2;2;-1
2009_1971764791284613_manuscript;n =   19;19;-1
2009_1971764791284613_manuscript;n = 8;8;-1
2009_1971764791284613_manuscript;n = 41;41;-1
2009_1971764791284613_manuscript;n = 3;3;-1
2009_1971764791284613_manuscript;n = 31;31;-1
2009_1971764791284613_manuscript;n = 12;12;-1
2009_1971764791284613_manuscript;n = 18;18;-1
2009_1971764791284613_manuscript;n =19;19;-1
2009_1971764791284613_manuscript;total of 104;104;-1
2009_1971764791284613_manuscript;total of 11;11;-1
2009_1971764791284613_manuscript;total of 17;17;-1
2009_1971764791284613_manuscript;total of 24;24;-1
2009_1971764791284613_manuscript;total of 83;83;-1
2009_1971764791284613_manuscript;total of 142,205;142205;-1
2009_2024723134285762_manuscript;137patients;137;-1
2009_2024723134285762_manuscript;n=6;6;-1
2009_2024723134285762_manuscript;n=4;4;-1
2009_2024723134285762_manuscript;n=12;12;-1
2009_2136394579336854_manuscript;173,234subjects;173234;-1
2009_2136394579336854_manuscript;N=46,895;46895;-1
2009_2136394579336854_manuscript;N=5,075;5075;-1
2009_2136394579336854_manuscript;N=44,628;44628;-1
2009_2136394579336854_manuscript;N=4,741;4741;-1
2009_2136394579336854_manuscript;N=181,790;181790;-1
2009_2136394579336854_manuscript;2003  filewereenrolled;2003;-1
2009_2815619753261164_manuscript;189 eligible patients;189;-1
2009_2815619753261164_manuscript;802 patients;802;-1
2009_2815619753261164_manuscript;356 relapsed OC patients;356;-1
2009_2815619753261164_manuscript;201 patients;201;-1
2009_2815619753261164_manuscript;204 patients;204;-1
2009_2815619753261164_manuscript;5 patients;5;-1
2009_2815619753261164_manuscript;2 patients;2;-1
2009_2815619753261164_manuscript;189 eligible   patients;189;-1
2009_2815619753261164_manuscript;4 patients;4;-1
2009_2815619753261164_manuscript;29 patients;29;-1
2009_2815619753261164_manuscript;177 patients;177;-1
2009_2815619753261164_manuscript;9 patients;9;-1
2009_2815619753261164_manuscript;6 patients;6;-1
2009_2815619753261164_manuscript;122   patients;122;-1
2009_2815619753261164_manuscript;8 patients;8;-1
2009_2815619753261164_manuscript;26 patients;26;-1
2009_2815619753261164_manuscript;704 patients;704;-1
2009_2815619753261164_manuscript;n=204;204;-1
2009_2815619753261164_manuscript;n=189;189;-1
2009_2815619753261164_manuscript;n=96;96;-1
2009_2815619753261164_manuscript;n=89;89;-1
2009_2815619753261164_manuscript;n=7;7;-1
2009_2815619753261164_manuscript;n=2;2;-1
2009_2815619753261164_manuscript;n=5;5;-1
2009_2815619753261164_manuscript;n=24;24;-1
2009_2815619753261164_manuscript;n=13;13;-1
2009_2815619753261164_manuscript;n=8;8;-1
2009_2815619753261164_manuscript;n=3;3;-1
2009_2815619753261164_manuscript;n=93;93;-1
2009_2815619753261164_manuscript;n=85;85;-1
2009_2815619753261164_manuscript;n=1;1;-1
2009_2815619753261164_manuscript;n=6;6;-1
2009_2815619753261164_manuscript;n=90;90;-1
2009_2815619753261164_manuscript;n=87;87;-1
2009_2815619753261164_manuscript;n=20;20;-1
2009_2815619753261164_manuscript;n=10;10;-1
2009_2815619753261164_manuscript;n=4;4;-1
2009_2815619753261164_manuscript;n=58;58;-1
2009_2815619753261164_manuscript;n=37;37;-1
2009_2815619753261164_manuscript;n=64;64;-1
2009_2815619753261164_manuscript;n=32;32;-1
2009_2815619753261164_manuscript;total of 189;189;-1
2009_2815619753261164_manuscript;total of 503;503;-1
2009_2815619753261164_manuscript;total of 475;475;-1
2009_2815619753261164_manuscript;total of 159;159;-1
2009_2815619753261164_manuscript;total of 26;26;-1
2009_2891896782624232_manuscript;2,633 subjects;2633;-1
2009_2891896782624232_manuscript;1,306 subjects;1306;-1
2009_2891896782624232_manuscript;109 patients;109;-1
2009_2891896782624232_manuscript;1,327 patients;1327;-1
2009_2891896782624232_manuscript;934 patients;934;-1
2009_2891896782624232_manuscript;927 patients;927;-1
2009_2891896782624232_manuscript;886 patients;886;-1
2009_2891896782624232_manuscript;666 patients;666;-1
2009_2891896782624232_manuscript;2,633 patients;2633;-1
2009_2891896782624232_manuscript;7,911   patients;7911;-1
2009_2891896782624232_manuscript;n=2,011;2011;-1
2009_2891896782624232_manuscript;n=1,334;1334;-1
2009_2891896782624232_manuscript;total of 17;17;-1
2009_2891896782624232_manuscript;total of 184;184;-1
2009_2891896782624232_manuscript;total of 2,633;2633;-1
2009_3857211983310098_manuscript;2699 persons;2699;-1
2009_3857211983310098_manuscript;2699 individuals;2699;-1
2009_3857211983310098_manuscript;2870 individuals;2870;-1
2009_3857211983310098_manuscript;total of 41;41;-1
2009_3911684002565292_manuscript;69 women;69;-1
2009_3911684002565292_manuscript;n=335;335;-1
2009_3911684002565292_manuscript;N = 69;69;-1
2009_3911684002565292_manuscript;N = 358;358;-1
2009_3911684002565292_manuscript;total of 4091;4091;-1
2009_4438170233164515_manuscript;1450women;1450;-1
2009_4438170233164515_manuscript;420women;420;-1
2009_4438170233164515_manuscript;100,000women;100000;-1
2009_4462684903391320_manuscript;208 GC patients;208;10819
2009_4462684903391320_manuscript;96 EC patients;96;10685
2009_4462684903391320_manuscript;56   patients;56;852
2009_4462684903391320_manuscript;n=346;346;21524
2009_4462684903391320_manuscript;n=208;208;21542
2009_4462684903391320_manuscript;n=241;241;23890
2009_4462684903391320_manuscript;n=96;96;23906
2009_4462684903391320_manuscript;n=6;6;26011
2009_4462684903391320_manuscript;total of 25;25;2297
2009_4794419163068760_manuscript;100,000 men and women;100000;-1
2009_4794419163068760_manuscript;473 participants;473;-1
2009_4794419163068760_manuscript;1displaystheflowofparticipants;1;-1
2009_4794419163068760_manuscript;811subjects;811;-1
2009_4794419163068760_manuscript;323 non-suicidal subjects;323;-1
2009_4794419163068760_manuscript;473 suicidal subjects;473;-1
2009_4794419163068760_manuscript;473subjects;473;-1
2009_4794419163068760_manuscript;811 adult patients;811;-1
2009_4794419163068760_manuscript;N=42;42;-1
2009_4794419163068760_manuscript;N=41;41;-1
2009_4794419163068760_manuscript;N=57;57;-1
2009_4794419163068760_manuscript;N=9;9;-1
2009_4794419163068760_manuscript;N=8;8;-1
2009_4794419163068760_manuscript;N=33;33;-1
2009_4794419163068760_manuscript;N=196;196;-1
2009_4794419163068760_manuscript;N=127;127;-1
2009_4794419163068760_manuscript;N=254;254;-1
2009_4794419163068760_manuscript;N=219;219;-1
2009_4953934023314451_manuscript;694   participants;694;-1
2009_4953934023314451_manuscript;694   participants were recruited;694;-1
2009_4953934023314451_manuscript;total of 9,010;9010;-1
2009_4953934023314451_manuscript;total of 694;694;-1
2009_4968950692847959_manuscript;4000 diabetic patients;4000;1679
2009_4968950692847959_manuscript;4404 patients;4404;74
2009_4968950692847959_manuscript;2 diabetic patients;2;11306
2009_4968950692847959_manuscript;4404 diabetic patients;4404;12656
2009_4968950692847959_manuscript;3953 diabetic patients;3953;15227
2009_4968950692847959_manuscript;255 000 people;255000;2582
2009_4968950692847959_manuscript;n=950;950;35306
2009_4968950692847959_manuscript;n=4337;4337;35535
2009_4968950692847959_manuscript;n=3953;3953;36206
2009_4968950692847959_manuscript;N=3952;3952;36511
2009_4968950692847959_manuscript;n=3952;3952;37069
2009_4968950692847959_manuscript;n=3901;3901;37391
2009_4968950692847959_manuscript;n=3659;3659;37597
2009_4968950692847959_manuscript;n=3927;3927;37783
2009_4968950692847959_manuscript;N=2725;2725;38666
2009_4968950692847959_manuscript;N=824;824;38717
2009_4968950692847959_manuscript;n=801;801;38762
2009_4968950692847959_manuscript;n=688;688;38810
2009_4968950692847959_manuscript;n=1364;1364;38859
2009_4968950692847959_manuscript;N=249;249;39390
2009_4968950692847959_manuscript;N=135;135;39416
2009_4968950692847959_manuscript;N=24;24;39390
2009_4968950692847959_manuscript;N=869;869;39464
2009_4968950692847959_manuscript;N=1508;1508;39492
2009_4968950692847959_manuscript;N=390;390;39529
2009_4968950692847959_manuscript;N=2737;2737;39559
2009_4968950692847959_manuscript;N=4404;4404;39605
2009_4968950692847959_manuscript;total of 4404;4404;12647
2009_4968950692847959_manuscript;total of 3953;3953;15218
2009_4968950692847959_manuscript;4404 patients enrolled;4404;74
2009_4968950692847959_manuscript; data from 1998;1998;29382
2009_5072040882600028_manuscript;2   million active patients;2;-1
2009_5072040882600028_manuscript;7 million patients;7;-1
2009_5072040882600028_manuscript;n=1;1;-1
2009_5072040882600028_manuscript;n=5,477;5477;-1
2009_5072040882600028_manuscript;n=38,314;38314;-1
2009_5314890003318130_manuscript;1208 patients;1208;13182
2009_5314890003318130_manuscript;205 patients;205;1173
2009_5314890003318130_manuscript;1208 new patients;1208;3006
2009_5314890003318130_manuscript;216 patients;216;8975
2009_5314890003318130_manuscript;0              All patients;0;26797
2009_5314890003318130_manuscript;1577  TB patients;1577;29208
2009_5314890003318130_manuscript;N=1417;1417;25763
2009_5314890003318130_manuscript;n=1208;1208;25770
2009_5314890003318130_manuscript;n=548;548;26388
2009_5314890003318130_manuscript;n=484;484;26394
2009_5314890003318130_manuscript;n=1417;1417;26825
2009_5314890003318130_manuscript;n=440;440;28192
2009_5314890003318130_manuscript;n=1066;1066;29140
2009_5314890003318130_manuscript;N=1577;1577;29206
2009_5314890003318130_manuscript;N=1343;1343;29238
2009_5314890003318130_manuscript;N=160;160;29288
2009_5314890003318130_manuscript;N=342;342;29310
2009_5314890003318130_manuscript;N=440;440;29331
2009_5314890003318130_manuscript;N=548;548;29354
2009_5314890003318130_manuscript;N=869;869;29381
2009_5314890003318130_manuscript;N=44;44;29331
2009_5314890003318130_manuscript;N=35;35;29429
2009_5314890003318130_manuscript;N=1208;1208;29449
2009_5314890003318130_manuscript;N=135;135;29478
2009_5314890003318130_manuscript;N=484;484;29501
2009_5314890003318130_manuscript;N=724;724;29528
2009_5314890003318130_manuscript;N=626;626;29547
2009_5314890003318130_manuscript;N=98;98;29570
2009_5314890003318130_manuscript;N=469;469;29591
2009_5314890003318130_manuscript;N=15;15;29206
2009_5380522743361956_manuscript;3 breast  cancer patients;3;-1
2009_6333447932671206_manuscript;203subjects;203;-1
2009_6333447932671206_manuscript;203  subjects;203;-1
2009_6464309233364312_manuscript;4itisunlikelythatRCTpatients;4;-1
2009_6464309233364312_manuscript;11individuals;11;-1
2009_6464309233364312_manuscript;449,269individuals;449269;-1
2009_6464309233364312_manuscript;64individuals;64;-1
2009_6464309233364312_manuscript;832individuals;832;-1
2009_6464309233364312_manuscript;1Giventhesmallnumberofindividuals;1;-1
2009_6464309233364312_manuscript;2625and  individuals;2625;-1
2009_6464309233364312_manuscript;N=64;64;-1
2009_6464309233364312_manuscript;N=768;768;-1
2009_6464309233364312_manuscript;N=12;12;-1
2009_6464309233364312_manuscript;N=811;811;-1
2009_6464309233364312_manuscript;N=719;719;-1
2009_6464309233364312_manuscript;N=413;413;-1
2009_6464309233364312_manuscript;N=713;713;-1
2009_6464309233364312_manuscript;N=639;639;-1
2009_6464309233364312_manuscript;N=58;58;-1
2009_6464309233364312_manuscript;N=55;55;-1
2009_6464309233364312_manuscript;N=49;49;-1
2009_6464309233364312_manuscript;N=24;24;-1
2009_6464309233364312_manuscript;N=7;7;-1
2009_6464309233364312_manuscript;N=113;113;-1
2009_6980369203279067_manuscript;total of 2040;2040;-1
2009_6980369203279067_manuscript;total of 13;13;-1
2009_6980369203279067_manuscript; data at each of the 17;17;-1
2009_8709035603052008_manuscript;200million people;200;-1
2009_8709035603052008_manuscript;500,000 people;500000;-1
2009_8709035603052008_manuscript;n=840;840;-1
2009_8709035603052008_manuscript;n=120;120;-1
2009_8709035603052008_manuscript;n=240;240;-1
2009_8784070743055067_manuscript;54 phenotypically normal individuals;54;-1
2009_8784070743055067_manuscript;111 autistic individuals;111;-1
2009_8784070743055067_manuscript;20 individuals;20;-1
2009_8784070743055067_manuscript;119 unrelated autistic individuals;119;-1
2009_8784070743055067_manuscript;119 autistic individuals;119;-1
2009_8784070743055067_manuscript;n=2;2;-1
2009_8784070743055067_manuscript;n=3;3;-1
2009_8784070743055067_manuscript;n=20;20;-1
2009_8784070743055067_manuscript;n=10;10;-1
2009_8784070743055067_manuscript;n=6;6;-1
2009_8784070743055067_manuscript; dataset of 119;119;-1
2009_9079150122484710_manuscript;86patients;86;-1
2009_9079150122484710_manuscript;363patients;363;-1
2009_9079150122484710_manuscript;134patients;134;-1
2010_1102934377394390_manuscript;N=1195;1195;-1
2010_1102934377394390_manuscript;N=1269;1269;-1
2010_1102934377394390_manuscript;N=812;812;-1
2010_1102934377394390_manuscript;N=863;863;-1
2010_1102934377394390_manuscript;N=2789;2789;-1
2010_1110699226455162_manuscript;n=31;31;-1
2010_1110699226455162_manuscript;n=62;62;-1
2010_1117103377360156_manuscript;403 patients;403;-1
2010_1117103377360156_manuscript;1,296 patients;1296;-1
2010_1117103377360156_manuscript;171 consecutive patients;171;-1
2010_1117103377360156_manuscript;2010 Taiwanese patients;2010;-1
2010_1117103377360156_manuscript;n=47;47;-1
2010_1117103377360156_manuscript;n=42;42;-1
2010_1117103377360156_manuscript;n=36;36;-1
2010_1117103377360156_manuscript;n=6;6;-1
2010_1117103377360156_manuscript;n=16;16;-1
2010_1156576698365762_manuscript;211   participants;211;-1
2010_1156576698365762_manuscript;n=50;50;-1
2010_1156576698365762_manuscript;n=70;70;-1
2010_1156576698365762_manuscript;n=114;114;-1
2010_1156576698365762_manuscript;n=73;73;-1
2010_1156576698365762_manuscript;n=61;61;-1
2010_1156576698365762_manuscript;n=121;121;-1
2010_1156576698365762_manuscript;n=131;131;-1
2010_1156576698365762_manuscript;n=201;201;-1
2010_1156576698365762_manuscript;n=123;123;-1
2010_1156576698365762_manuscript;n=235;235;-1
2010_1156576698365762_manuscript;n = 1;1;-1
2010_1192549388479320_manuscript;100 rheumatoid arthritis subjects;100;-1
2010_1192549388479320_manuscript;99 subjects;99;-1
2010_1192549388479320_manuscript;88 patients;88;-1
2010_1192549388479320_manuscript;84   patients;84;-1
2010_1192549388479320_manuscript;79 patients;79;-1
2010_1192549388479320_manuscript;n=67;67;-1
2010_1192549388479320_manuscript;n=32;32;-1
2010_1192549388479320_manuscript;n=17;17;-1
2010_1192549388479320_manuscript;n=15;15;-1
2010_1192549388479320_manuscript;n=99;99;-1
2010_1192549388479320_manuscript;n =32;32;-1
2010_1192549388479320_manuscript;n =99;99;-1
2010_1280705199445370_manuscript;63 subjects;63;-1
2010_1280705199445370_manuscript;519 patients;519;-1
2010_1280705199445370_manuscript;35 patients;35;-1
2010_1280705199445370_manuscript;441 patients;441;-1
2010_1280705199445370_manuscript;278 evaluable patients;278;-1
2010_1280705199445370_manuscript;433 patients;433;-1
2010_1280705199445370_manuscript;406 patients;406;-1
2010_1280705199445370_manuscript;37 patients;37;-1
2010_1280705199445370_manuscript;163 patients;163;-1
2010_1280705199445370_manuscript;n=43;43;-1
2010_1280705199445370_manuscript;n=33;33;-1
2010_1280705199445370_manuscript;n=6;6;-1
2010_1280705199445370_manuscript;n=9;9;-1
2010_1280705199445370_manuscript;n=28;28;-1
2010_1280705199445370_manuscript;n=148;148;-1
2010_1280705199445370_manuscript;n=47;47;-1
2010_1280705199445370_manuscript;n=63;63;-1
2010_1280705199445370_manuscript;n=111;111;-1
2010_1280705199445370_manuscript;n=226;226;-1
2010_1280705199445370_manuscript;n=130;130;-1
2010_1280705199445370_manuscript;519 patients were enrolled;519;-1
2010_1280705199445370_manuscript; data from 6;6;-1
2010_1359643285416538_manuscript;9   subjects;9;-1
2010_1359643285416538_manuscript;500 patients;500;-1
2010_1359643285416538_manuscript;8   individuals;8;-1
2010_1359643285416538_manuscript;21   individuals;21;-1
2010_1359643285416538_manuscript;16   individuals;16;-1
2010_1359643285416538_manuscript;6   individuals;6;-1
2010_1359643285416538_manuscript;N=54;54;-1
2010_1359643285416538_manuscript;N=3;3;-1
2010_1435803773402834_manuscript;n=6;6;-1
2010_1435803773402834_manuscript;n=3;3;-1
2010_1435803773402834_manuscript;total of 18;18;-1
2010_1499816764498920_manuscript;10,000   subjects;10000;-1
2010_1499816764498920_manuscript;2 study recruited;2;-1
2010_1528687410476664_manuscript;504 patients;504;50936
2010_1528687410476664_manuscript;400 patients;400;38726
2010_1528687410476664_manuscript;500 patients;500;38636
2010_1528687410476664_manuscript;13 definite CLR patients;13;36655
2010_1528687410476664_manuscript;403 patients;403;36113
2010_1528687410476664_manuscript;78 patients;78;36051
2010_1528687410476664_manuscript;22 patients;22;36011
2010_1528687410476664_manuscript;43 patients;43;33583
2010_1528687410476664_manuscript;700 patients;700;24074
2010_1528687410476664_manuscript;n = 155;155;37347
2010_1528687410476664_manuscript;n=53;53;35685
2010_1528687410476664_manuscript;total of 504;504;38424
2010_1537428253379036_manuscript;80 otherwise healthy women;80;-1
2010_1537428253379036_manuscript;79 patients;79;-1
2010_1537428253379036_manuscript;195 patients;195;-1
2010_1537428253379036_manuscript;80 patients;80;-1
2010_1537428253379036_manuscript;4 patients;4;-1
2010_1537428253379036_manuscript;5 patients;5;-1
2010_1537428253379036_manuscript;2 ibuprofen patients;2;-1
2010_1537428253379036_manuscript;78   UTI patients;78;-1
2010_1537428253379036_manuscript;n=40;40;-1
2010_1537428253379036_manuscript;n=39;39;-1
2010_1537428253379036_manuscript;n=9;9;-1
2010_1537428253379036_manuscript;n=3;3;-1
2010_1537428253379036_manuscript;n=36;36;-1
2010_1537428253379036_manuscript;n=33;33;-1
2010_1537428253379036_manuscript;total of 58;58;-1
2010_1537428253379036_manuscript;total of 195;195;-1
2010_1617774304499446_manuscript;1000 patients;1000;-1
2010_1617774304499446_manuscript;174 patients;174;-1
2010_1617774304499446_manuscript;n = 10;10;-1
2010_1686482573466476_manuscript;1,701 women;1701;-1
2010_1686482573466476_manuscript;17,017 women;17017;-1
2010_1686482573466476_manuscript;1,702 women;1702;-1
2010_1686482573466476_manuscript;1 million people;1;-1
2010_1686482573466476_manuscript;N=1701;1701;-1
2010_1686482573466476_manuscript;N=17017;17017;-1
2010_1686482573466476_manuscript;n = 1701;1701;-1
2010_1686482573466476_manuscript;n = 17017;17017;-1
2010_1715229527465619_manuscript;total of 30;30;8247
2010_1734716091481500_manuscript;658 primary care patients;658;-1
2010_1746257052411585_manuscript;n=2,342;2342;-1
2010_1746257052411585_manuscript;n  =  2;2;-1
2010_1746257052411585_manuscript;n  =  1;1;-1
2010_1920047176442376_manuscript;191 patients;191;-1
2010_1920047176442376_manuscript;36 patients;36;-1
2010_1920047176442376_manuscript;51 patients;51;-1
2010_1920047176442376_manuscript;36   patients;36;-1
2010_1920047176442376_manuscript;180 patients;180;-1
2010_1920047176442376_manuscript;131   patients;131;-1
2010_1920047176442376_manuscript;20 patients;20;-1
2010_1920047176442376_manuscript;25 patients;25;-1
2010_1920047176442376_manuscript;17 diabetic patients;17;-1
2010_1920047176442376_manuscript;6 nondiabetic patients;6;-1
2010_1920047176442376_manuscript;72 patients;72;-1
2010_1920047176442376_manuscript;231 patients;231;-1
2010_1920047176442376_manuscript;111   patients;111;-1
2010_1920047176442376_manuscript;n=29;29;-1
2010_1920047176442376_manuscript;n=51;51;-1
2010_1920047176442376_manuscript;n=20;20;-1
2010_1920047176442376_manuscript;n=13;13;-1
2010_1920047176442376_manuscript;n=9;9;-1
2010_1920047176442376_manuscript;n=5;5;-1
2010_1920047176442376_manuscript;n=4;4;-1
2010_1920047176442376_manuscript;n=56;56;-1
2010_1920047176442376_manuscript;n=28;28;-1
2010_1920047176442376_manuscript;n=15;15;-1
2010_1920047176442376_manuscript;n=10;10;-1
2010_1920047176442376_manuscript;n=38;38;-1
2010_1920047176442376_manuscript;n=17;17;-1
2010_1920047176442376_manuscript;n=6;6;-1
2010_1920047176442376_manuscript;n= 231;231;-1
2010_1920047176442376_manuscript;n= 111;111;-1
2010_1920047176442376_manuscript;n= 180;180;-1
2010_1920047176442376_manuscript;191 patients   were enrolled;191;-1
2010_1920047176442376_manuscript; data set of 108;108;-1
2010_1956147576498468_manuscript;90 patients;90;-1
2010_1956147576498468_manuscript;64 patients;64;-1
2010_1956147576498468_manuscript;26 patients;26;-1
2010_1956147576498468_manuscript;90   patients;90;-1
2010_2040888470478109_manuscript;276 participants;276;-1
2010_2040888470478109_manuscript;276 st udy participants;276;-1
2010_2040888470478109_manuscript;6   participants;6;-1
2010_2040888470478109_manuscript;39,429 for all participants;39429;-1
2010_2040888470478109_manuscript;276 study participants;276;-1
2010_2040888470478109_manuscript;15   infected patients;15;-1
2010_2040888470478109_manuscript;10   patients;10;-1
2010_2040888470478109_manuscript;3   number of patients;3;-1
2010_2040888470478109_manuscript;20   Two hundred seventy-six patients;20;-1
2010_2040888470478109_manuscript;31 patients;31;-1
2010_2040888470478109_manuscript;32 patients;32;-1
2010_2040888470478109_manuscript;113 patients;113;-1
2010_2040888470478109_manuscript;1   age of the patients;1;-1
2010_2040888470478109_manuscript;276 patients;276;-1
2010_2040888470478109_manuscript;22   patients;22;-1
2010_2040888470478109_manuscript;12   patients;12;-1
2010_2040888470478109_manuscript;11   patients;11;-1
2010_2040888470478109_manuscript;17   HIV-infected patients;17;-1
2010_2040888470478109_manuscript;19   patients;19;-1
2010_2040888470478109_manuscript;13   rural AIDS patients;13;-1
2010_2040888470478109_manuscript;10   immunodeficiency syndrome patients;10;-1
2010_2040888470478109_manuscript;13   infected patients;13;-1
2010_2040888470478109_manuscript;920,000 people;920000;-1
2010_2040888470478109_manuscript;112,000 people;112000;-1
2010_2040888470478109_manuscript;N=276;276;-1
2010_2040888470478109_manuscript;total of 320,000;320000;-1
2010_2040888470478109_manuscript; data from the 20;20;-1
2010_2059310386362730_manuscript;n  =  1;1;-1
2010_2059310386362730_manuscript;n=142;142;-1
2010_2059310386362730_manuscript;n=1,430;1430;-1
2010_2059310386362730_manuscript;total of 24,935;24935;-1
2010_2099259381350773_manuscript;220 subjects;220;58945
2010_2099259381350773_manuscript;50   control subjects;50;46336
2010_2099259381350773_manuscript;26 CRC   subjects;26;46238
2010_2099259381350773_manuscript;70 treatment-naive CRC subjects;70;34497
2010_2099259381350773_manuscript;40 pre-treatment CRC subjects;40;33398
2010_2099259381350773_manuscript;40 pre-treatment CRC patients;40;57617
2010_2099259381350773_manuscript;46 pre-surgery CRC   patients;46;57332
2010_2099259381350773_manuscript;40 pre-surgery CRC patients;40;56942
2010_2099259381350773_manuscript;40 CRC patients;40;46356
2010_2099259381350773_manuscript;n=222;222;65932
2010_2099259381350773_manuscript;n=220;220;65542
2010_2099259381350773_manuscript;n=5000;5000;20882
2010_2099259381350773_manuscript;n=1500;1500;20818
2010_2099259381350773_manuscript; data from all 90;90;53089
2010_2107505164424858_manuscript;177   participants;177;764
2010_2107505164424858_manuscript;185 participants;185;847
2010_2107505164424858_manuscript;362   patients;362;16168
2010_2107505164424858_manuscript;185   patients;185;16080
2010_2107505164424858_manuscript;177 patients;177;16032
2010_2107505164424858_manuscript;2 patients;2;15038
2010_2107505164424858_manuscript;5 patients;5;14953
2010_2107505164424858_manuscript;755 general medical and surgical patients;755;11174
2010_2107505164424858_manuscript;316 patients;316;10179
2010_2107505164424858_manuscript;1,954 patients;1954;245
2010_2107505164424858_manuscript;362 patients;362;695
2010_2107505164424858_manuscript;n=47;47;11793
2010_2107505164424858_manuscript;n= 378;378;7572
2010_2107505164424858_manuscript;n=606;606;7492
2010_2107505164424858_manuscript;n=282;282;7333
2010_2107505164424858_manuscript;n=177;177;762
2010_2107505164424858_manuscript;n=185;185;845
2010_2107505164424858_manuscript;n=251;251;3390
2010_2107505164424858_manuscript;n=3,455;3455;7649
2010_2107505164424858_manuscript;n=323;323;20672
2010_2107505164424858_manuscript;n=280;280;20729
2010_2107505164424858_manuscript;n=1954;1954;23442
2010_2107505164424858_manuscript;n=1592;1592;23486
2010_2107505164424858_manuscript;n=1166;1166;23527
2010_2107505164424858_manuscript;n=788;788;23560
2010_2107505164424858_manuscript;n=69;69;23592
2010_2107505164424858_manuscript;n=200;200;23621
2010_2107505164424858_manuscript;n=67;67;23647
2010_2107505164424858_manuscript;n=90;90;23675
2010_2107505164424858_manuscript;n=362;362;23696
2010_2107505164424858_manuscript;n=280,100;280100;23803
2010_2107505164424858_manuscript;n=0;0;23837
2010_2107505164424858_manuscript;n= 72;72;23953
2010_2107505164424858_manuscript;total of 22;22;4873
2010_2107505164424858_manuscript;total of 82;82;5005
2010_2145837425469873_manuscript;5754 patients;5754;-1
2010_2145837425469873_manuscript;100 patients;100;-1
2010_2145837425469873_manuscript;3369 patients;3369;-1
2010_2145837425469873_manuscript;522   patients;522;-1
2010_2145837425469873_manuscript;1863 patients;1863;-1
2010_2145837425469873_manuscript;800 patients;800;-1
2010_2145837425469873_manuscript;1000 patients;1000;-1
2010_2145837425469873_manuscript;25 patients;25;-1
2010_2145837425469873_manuscript;total of 5754;5754;-1
2010_2145837425469873_manuscript;total of 234;234;-1
2010_2145837425469873_manuscript;total of 1854;1854;-1
2010_2145837425469873_manuscript;total of 37;37;-1
2010_2192396803443941_manuscript;376,257 women;376257;-1
2010_2192396803443941_manuscript;495,294 women;495294;-1
2010_2192396803443941_manuscript;1000 women;1000;-1
2010_2192396803443941_manuscript;n = 550,000;550000;-1
2010_2192396803443941_manuscript;n = 13;13;-1
2010_2192396803443941_manuscript;n = 8;8;-1
2010_2192396803443941_manuscript; dataset of 647,876;647876;-1
2010_2192396803443941_manuscript;   databases of the 13;13;-1
2010_2577079424869693_manuscript;14 subjects;14;7093
2010_2577079424869693_manuscript;7 lean subjects;7;13234
2010_2577079424869693_manuscript;3 studies   were also recruited;3;5557
2010_2577079424869693_manuscript;n=534;534;7042
2010_2577079424869693_manuscript;n=603;603;6245
2010_2577079424869693_manuscript;n=1183;1183;6191
2010_2577079424869693_manuscript;n=262;262;6101
2010_2577079424869693_manuscript;n=298;298;4960
2010_2577079424869693_manuscript;n=3;3;13987
2010_2661366924404582_manuscript;1,503 subjects;1503;-1
2010_2661366924404582_manuscript;886   patients;886;-1
2010_2661366924404582_manuscript;3 Survival of enrolled patients;3;-1
2010_2661366924404582_manuscript;total of 4;4;-1
2010_2661366924404582_manuscript;total of 245;245;-1
2010_2661366924404582_manuscript;3 Survival of enrolled;3;-1
2010_2676256564750872_manuscript;9317 men and women;9317;-1
2010_2676256564750872_manuscript;632 white men and women;632;-1
2010_2676256564750872_manuscript;117 men and women;117;-1
2010_2676256564750872_manuscript;6654 men   and women;6654;-1
2010_2676256564750872_manuscript;42 men and women;42;-1
2010_2676256564750872_manuscript;5242 men and women;5242;-1
2010_2676256564750872_manuscript;1037 men and women;1037;-1
2010_2676256564750872_manuscript;1596 men and women;1596;-1
2010_2676256564750872_manuscript;7764 men   and women;7764;-1
2010_2676256564750872_manuscript;63 men and women;63;-1
2010_2676256564750872_manuscript;8191 men   and women;8191;-1
2010_2676256564750872_manuscript;83 men and women;83;-1
2010_2676256564750872_manuscript;2401 men and women;2401;-1
2010_2676256564750872_manuscript;4692 men and women;4692;-1
2010_2676256564750872_manuscript;198 men and women;198;-1
2010_2676256564750872_manuscript;48 men   and women;48;-1
2010_2676256564750872_manuscript;128 men and women;128;-1
2010_2676256564750872_manuscript;4391 men and women;4391;-1
2010_2676256564750872_manuscript;95 men and women;95;-1
2010_2676256564750872_manuscript;144 men and women;144;-1
2010_2676256564750872_manuscript;81 non allergic men and   women;81;-1
2010_2676256564750872_manuscript;5887 men and women;5887;-1
2010_2676256564750872_manuscript;1901 men and women;1901;-1
2010_2676256564750872_manuscript;869 men and women;869;-1
2010_2676256564750872_manuscript;13 subjects;13;-1
2010_2676256564750872_manuscript;1000 subjects;1000;-1
2010_2676256564750872_manuscript;100 subjects;100;-1
2010_2676256564750872_manuscript;13 male patients;13;-1
2010_2676256564750872_manuscript;54 recruited;54;-1
2010_2676256564750872_manuscript;n=12;12;-1
2010_2676256564750872_manuscript;n=23;23;-1
2010_2676256564750872_manuscript;n=6;6;-1
2010_2676256564750872_manuscript;n=8;8;-1
2010_2676256564750872_manuscript;n=10;10;-1
2010_2676256564750872_manuscript;n=17;17;-1
2010_2676256564750872_manuscript;n=25;25;-1
2010_2676256564750872_manuscript;n =9;9;-1
2010_2676256564750872_manuscript;n=61;61;-1
2010_2676256564750872_manuscript;n=53;53;-1
2010_2676256564750872_manuscript;n=58;58;-1
2010_2676256564750872_manuscript;n=49;49;-1
2010_2676256564750872_manuscript;total of 260;260;-1
2010_2676256564750872_manuscript;total of 303;303;-1
2010_2676256564750872_manuscript; data from the 1994;1994;-1
2010_2676256564750872_manuscript; data   from 7;7;-1
2010_2858257884819205_manuscript;2 diabetic patients;2;-1
2010_2858257884819205_manuscript;2,000 individuals;2000;-1
2010_2858257884819205_manuscript;1,500 individuals;1500;-1
2010_2858257884819205_manuscript;10 individuals;10;-1
2010_2858257884819205_manuscript;N = 21;21;-1
2010_2952671455007453_manuscript;4,334   women;4334;-1
2010_2952671455007453_manuscript;142 control   subjects;142;-1
2010_2952671455007453_manuscript;140 patients;140;-1
2010_2952671455007453_manuscript;140 individuals;140;-1
2010_2952671455007453_manuscript;total of 140;140;-1
2010_2952671455007453_manuscript;total of 142;142;-1
2010_2952671455007453_manuscript;2008 and enrolled;2008;-1
2010_3103480613702380_manuscript;543  consecutivelyCOPDpatients;543;-1
2010_3103480613702380_manuscript;808consecutiveCOPDpatients;808;-1
2010_3103480613702380_manuscript;543eligiblepatients;543;-1
2010_3103480613702380_manuscript;543patients;543;-1
2010_3103480613702380_manuscript;3126patients;3126;-1
2010_3103480613702380_manuscript;n=543;543;-1
2010_3103480613702380_manuscript;n=472;472;-1
2010_3103480613702380_manuscript;n=71;71;-1
2010_3103480613702380_manuscript;n=32;32;-1
2010_3103480613702380_manuscript;n=36;36;-1
2010_3103480613702380_manuscript;n=12;12;-1
2010_3103480613702380_manuscript;n=35;35;-1
2010_3103480613702380_manuscript;n=20;20;-1
2010_3176803243846228_manuscript;n = 161;161;-1
2010_3176803243846228_manuscript;n = 300;300;-1
2010_3176803243846228_manuscript;n = 271;271;-1
2010_3176803243846228_manuscript;n=271;271;-1
2010_3176803243846228_manuscript;n=161;161;-1
2010_3176803243846228_manuscript;n =11;11;-1
2010_3176803243846228_manuscript;n =150;150;-1
2010_3176803243846228_manuscript;n =58;58;-1
2010_3176803243846228_manuscript;n =103;103;-1
2010_3176803243846228_manuscript;n = 122;122;-1
2010_3176803243846228_manuscript;n =39;39;-1
2010_3176803243846228_manuscript;n=65;65;-1
2010_3176803243846228_manuscript;n=96;96;-1
2010_3176803243846228_manuscript;total of 300;300;-1
2010_3176803243846228_manuscript;total of 271;271;-1
2010_3176803243846228_manuscript;total of 161;161;-1
2010_4818806764727330_manuscript;N=9;9;-1
2010_4818806764727330_manuscript;N= 43;43;-1
2010_4818806764727330_manuscript;n=1;1;-1
2010_4818806764727330_manuscript;n=3;3;-1
2010_5242787853825908_manuscript;80 GIST patients;80;-1
2010_5242787853825908_manuscript;80   patients;80;-1
2010_5242787853825908_manuscript;29 patients;29;-1
2010_5242787853825908_manuscript;80 patients;80;-1
2010_5242787853825908_manuscript;26 patients;26;-1
2010_5242787853825908_manuscript;48 patients;48;-1
2010_5242787853825908_manuscript;n=36;36;-1
2010_5242787853825908_manuscript;n=2;2;-1
2010_5242787853825908_manuscript;n=27;27;-1
2010_5242787853825908_manuscript;n=8;8;-1
2010_5242787853825908_manuscript;n=52;52;-1
2010_5242787853825908_manuscript;n=7;7;-1
2010_5242787853825908_manuscript;n=19;19;-1
2010_5242787853825908_manuscript;n=6;6;-1
2010_5242787853825908_manuscript;n=1;1;-1
2010_5242787853825908_manuscript;n=3;3;-1
2010_5242787853825908_manuscript;n=13;13;-1
2010_5242787853825908_manuscript;n=21;21;-1
2010_5242787853825908_manuscript;n=28;28;-1
2010_5242787853825908_manuscript;n=4;4;-1
2010_5242787853825908_manuscript;n=25;25;-1
2010_5242787853825908_manuscript;n=33;33;-1
2010_5242787853825908_manuscript;total of 80;80;-1
2010_5242787853825908_manuscript;total of 70;70;-1
2010_5242787853825908_manuscript;80 patients   enrolled;80;-1
2010_5242787853825908_manuscript; data from 10;10;-1
2010_5297164947340872_manuscript;45 subjects;45;4834
2010_5297164947340872_manuscript;38 subjects;38;4652
2010_5297164947340872_manuscript;7 subjects;7;2515
2010_5297164947340872_manuscript;18 female subjects;18;1387
2010_5297164947340872_manuscript;20 subjects;20;36244
2010_5297164947340872_manuscript;7 million people;7;15349
2010_5297164947340872_manuscript;2 individuals;2;4488
2010_5297164947340872_manuscript;4 individuals;4;27183
2010_5297164947340872_manuscript;n=21;21;19322
2010_5297164947340872_manuscript;n=17;17;19308
2010_5297164947340872_manuscript;n=18;18;36925
2010_5297164947340872_manuscript;n=9;9;36942
2010_5297164947340872_manuscript;n= 21;21;64528
2010_5297164947340872_manuscript;n= 200;200;64695
2010_5297164947340872_manuscript; data from 27;27;2128
2010_5964562763753735_manuscript;1676 patients;1676;-1
2010_5964562763753735_manuscript;15 improves   patients;15;-1
2010_5964562763753735_manuscript;1455 unselected AMI patients;1455;-1
2010_5964562763753735_manuscript;9461 patients;9461;-1
2010_6095268844394017_manuscript;102 included participants;102;6905
2010_6095268844394017_manuscript;100 participants;100;6167
2010_6095268844394017_manuscript;n = 34;34;6127
2010_6095268844394017_manuscript;n = 33;33;6094
2010_6095268844394017_manuscript;n=30;30;2838
2010_6095268844394017_manuscript;n=10;10;3391
2010_6095268844394017_manuscript;n=9;9;3409
2010_6095268844394017_manuscript;n=137;137;44886
2010_6095268844394017_manuscript;n=35;35;44904
2010_6095268844394017_manuscript;n=102;102;44962
2010_6095268844394017_manuscript;n=34;34;44985
2010_6095268844394017_manuscript;n=1;1;3391
2010_6095268844394017_manuscript;n=24;24;45506
2010_6095268844394017_manuscript;n=23;23;45604
2010_6095268844394017_manuscript;n=33;33;45768
2010_6388706014917286_manuscript;873 eligible patients;873;-1
2010_6388706014917286_manuscript;7      All eligible patients;7;-1
2010_6388706014917286_manuscript;10   Eligible and registered patients;10;-1
2010_6388706014917286_manuscript;6   of patients;6;-1
2010_6388706014917286_manuscript;8   patients;8;-1
2010_6388706014917286_manuscript;900 patients;900;-1
2010_6388706014917286_manuscript;170 patients;170;-1
2010_6388706014917286_manuscript;15   eligible patients;15;-1
2010_6388706014917286_manuscript;909 patients;909;-1
2010_6388706014917286_manuscript;12      patients;12;-1
2010_6388706014917286_manuscript;30 patients;30;-1
2010_6388706014917286_manuscript;11   patients;11;-1
2010_6388706014917286_manuscript;12   patients;12;-1
2010_6388706014917286_manuscript;10 patients;10;-1
2010_6388706014917286_manuscript;13      patients;13;-1
2010_6388706014917286_manuscript;2   When patients;2;-1
2010_6388706014917286_manuscript;16   patients;16;-1
2010_6388706014917286_manuscript;116 patients;116;-1
2010_6388706014917286_manuscript;76 patients;76;-1
2010_6388706014917286_manuscript;135 patients;135;-1
2010_6388706014917286_manuscript;4   patients;4;-1
2010_6388706014917286_manuscript;1264 patients;1264;-1
2010_6388706014917286_manuscript;2,094 treated patients;2094;-1
2010_6388706014917286_manuscript;14   patients;14;-1
2010_6388706014917286_manuscript;17   patients;17;-1
2010_6388706014917286_manuscript;2   patients;2;-1
2010_6388706014917286_manuscript;55 patients;55;-1
2010_6388706014917286_manuscript;7 patients;7;-1
2010_6388706014917286_manuscript;48 patients;48;-1
2010_6388706014917286_manuscript;295 patients;295;-1
2010_6388706014917286_manuscript;24   patients;24;-1
2010_6388706014917286_manuscript;9   patients;9;-1
2010_6388706014917286_manuscript;n=909;909;-1
2010_6388706014917286_manuscript;n=873;873;-1
2010_6388706014917286_manuscript;n=441;441;-1
2010_6388706014917286_manuscript;n=423;423;-1
2010_6388706014917286_manuscript;n=18;18;-1
2010_6388706014917286_manuscript;n=8;8;-1
2010_6388706014917286_manuscript;n=6;6;-1
2010_6388706014917286_manuscript;n=4;4;-1
2010_6388706014917286_manuscript;n=432;432;-1
2010_6388706014917286_manuscript;n=414;414;-1
2010_6388706014917286_manuscript;n=350;350;-1
2010_6388706014917286_manuscript;n=77;77;-1
2010_6388706014917286_manuscript;n=3;3;-1
2010_6388706014917286_manuscript;n=14;14;-1
2010_6388706014917286_manuscript;n=5;5;-1
2010_6388706014917286_manuscript;n=30;30;-1
2010_6388706014917286_manuscript;n=16;16;-1
2010_6388706014917286_manuscript;n=347;347;-1
2010_6388706014917286_manuscript;n=71;71;-1
2010_6388706014917286_manuscript;n=10;10;-1
2010_6388706014917286_manuscript;n=2;2;-1
2010_6388706014917286_manuscript;n=31;31;-1
2010_6388706014917286_manuscript;n=9;9;-1
2010_6388706014917286_manuscript;n=118;118;-1
2010_6388706014917286_manuscript;n=311;311;-1
2010_6388706014917286_manuscript;n=12;12;-1
2010_6388706014917286_manuscript;n=128;128;-1
2010_6388706014917286_manuscript;n=297;297;-1
2010_6388706014917286_manuscript;n=7;7;-1
2010_6388706014917286_manuscript;total of 16;16;-1
2010_6654544583618148_manuscript;10patients;10;-1
2010_6654544583618148_manuscript;1  millionpeople;1;-1
2010_6654544583618148_manuscript;n=128,511;128511;-1
2010_6654544583618148_manuscript;n=30,836;30836;-1
2010_6654544583618148_manuscript;n=32,277;32277;-1
2010_6749441363889495_manuscript;3 patients;3;-1
2010_6749441363889495_manuscript;40,000 White American   patients;40000;-1
2010_6749441363889495_manuscript;7 patients;7;-1
2010_6749441363889495_manuscript;n=26;26;-1
2010_6749441363889495_manuscript;n=9;9;-1
2010_6749441363889495_manuscript;n= 9;9;-1
2010_6749441363889495_manuscript;n=12;12;-1
2010_6749441363889495_manuscript;n=14;14;-1
2010_6749441363889495_manuscript;n=10;10;-1
2010_6749441363889495_manuscript;n   =18;18;-1
2010_6749441363889495_manuscript;n=19;19;-1
2010_6749441363889495_manuscript;n=18;18;-1
2010_6749441363889495_manuscript;total of 19;19;-1
2010_6749441363889495_manuscript;total of 30;30;-1
2010_6749441363889495_manuscript;total of 8;8;-1
2010_6749441363889495_manuscript;total of 50;50;-1
2010_6774682064814284_manuscript;500,000   persons;500000;-1
2010_6774682064814284_manuscript;500,000 persons;500000;-1
2010_6774682064814284_manuscript;3000 treated patients;3000;-1
2010_6774682064814284_manuscript;3000   patients;3000;-1
2010_6774682064814284_manuscript;13 patients;13;-1
2010_6796286784995704_manuscript;405 patients;405;-1
2010_6796286784995704_manuscript;870 patients;870;-1
2010_7207300854796676_manuscript;50 million individuals;50;-1
2010_7207300854796676_manuscript;N =   5,831;5831;-1
2010_7207300854796676_manuscript;n = 52;52;-1
2010_7207300854796676_manuscript;n = 28;28;-1
2010_7207300854796676_manuscript;n = 16;16;-1
2010_7207300854796676_manuscript;N     =     1;1;-1
2010_7207300854796676_manuscript;N = 1,015;1015;-1
2010_7207300854796676_manuscript;n = 659;659;-1
2010_7207300854796676_manuscript;n = 459;459;-1
2010_7207300854796676_manuscript;N = 1208;1208;-1
2010_7207300854796676_manuscript;n = 871;871;-1
2010_7207300854796676_manuscript;n = 572;572;-1
2010_7395737473601917_manuscript;403 patients;403;-1
2010_7395737473601917_manuscript;n=45;45;-1
2010_7395737473601917_manuscript;n=33;33;-1
2010_7395737473601917_manuscript;n=46;46;-1
2010_7395737473601917_manuscript;n=44;44;-1
2010_7395737473601917_manuscript;n=2029;2029;-1
2010_7395737473601917_manuscript;n=47;47;-1
2010_7395737473601917_manuscript;n=35;35;-1
2010_7395737473601917_manuscript;n=20;20;-1
2010_7395737473601917_manuscript;n=28;28;-1
2010_7395737473601917_manuscript;n=31;31;-1
2010_7395737473601917_manuscript;n=16;16;-1
2010_7395737473601917_manuscript;n=43;43;-1
2010_8036401613518686_manuscript;33askedparticipants;33;-1
2010_8036401613518686_manuscript;36suggestthatpatients;36;-1
2010_8036401613518686_manuscript;83patients;83;-1
2010_8036401613518686_manuscript;300rheumatologyinpatients;300;-1
2010_8036401613518686_manuscript;29samplesofindividuals;29;-1
2010_9130881714856293_manuscript;80   million individuals;80;-1
2010_9185573394818021_manuscript;288 patients;288;19642
2010_9185573394818021_manuscript;2 diabetic and hypertensive patients;2;13127
2010_9185573394818021_manuscript;288 consecutive patients;288;12566
2010_9185573394818021_manuscript;64 diabetic patients;64;12410
2010_9185573394818021_manuscript;7  patients;7;11848
2010_9185573394818021_manuscript;2 diabetic patients;2;4645
2010_9185573394818021_manuscript;1 patients;1;6754
2010_9360998904960249_manuscript;104 subjects;104;13647
2010_9360998904960249_manuscript;52 patients;52;8103
2010_9360998904960249_manuscript;72 patients;72;2356
2010_9360998904960249_manuscript;n=34;34;19549
2010_9360998904960249_manuscript;n=31;31;19576
2010_9673510741548879_manuscript;497 women;497;-1
2010_9673510741548879_manuscript;120   participants;120;-1
2010_9673510741548879_manuscript;80 patients;80;-1
2010_9673510741548879_manuscript;56 patients;56;-1
2010_9673510741548879_manuscript;480 patients;480;-1
2010_9673510741548879_manuscript;540 patients;540;-1
2010_9673510741548879_manuscript;179 patients;179;-1
2010_9673510741548879_manuscript;400 patients;400;-1
2010_9673510741548879_manuscript;150 patients;150;-1
2010_9673510741548879_manuscript;930 patients;930;-1
2010_9673510741548879_manuscript;139 of these patients;139;-1
2010_9673510741548879_manuscript;791 patients;791;-1
2010_9673510741548879_manuscript;789 patients;789;-1
2010_9673510741548879_manuscript;746 patients;746;-1
2010_9673510741548879_manuscript;722 patients;722;-1
2010_9673510741548879_manuscript;31 patients;31;-1
2010_9673510741548879_manuscript;59 patients;59;-1
2010_9673510741548879_manuscript;791 randomised patients;791;-1
2010_9673510741548879_manuscript;3 people;3;-1
2010_9673510741548879_manuscript;n=12;12;-1
2010_9673510741548879_manuscript;N=86;86;-1
2010_9673510741548879_manuscript;N=137;137;-1
2010_9673510741548879_manuscript;n=394;394;-1
2010_9673510741548879_manuscript;n=395;395;-1
2010_9673510741548879_manuscript;n=534;534;-1
2010_9673510741548879_manuscript;n=177;177;-1
2010_9673510741548879_manuscript;n= 139;139;-1
2010_9673510741548879_manuscript;n= 358;358;-1
2010_9673510741548879_manuscript;n= 15;15;-1
2010_9673510741548879_manuscript;n= 373;373;-1
2010_9673510741548879_manuscript;n= 21;21;-1
2010_9673510741548879_manuscript;n= 395;395;-1
2010_9673510741548879_manuscript;n=1;1;-1
2010_9673510741548879_manuscript;n= 22;22;-1
2010_9673510741548879_manuscript;n=396;396;-1
2010_9673510741548879_manuscript;n= 1;1;-1
2010_9673510741548879_manuscript;n= 353;353;-1
2010_9673510741548879_manuscript;n= 20;20;-1
2010_9673510741548879_manuscript;n= 176;176;-1
2010_9673510741548879_manuscript;n= 177;177;-1
2010_9673510741548879_manuscript;n= 534;534;-1
2010_9673510741548879_manuscript;n= 421;421;-1
2010_9673510741548879_manuscript;n=102;102;-1
2010_9673510741548879_manuscript;n=167;167;-1
2010_9673510741548879_manuscript;n= 113;113;-1
2010_9673510741548879_manuscript;n= 134;134;-1
2010_9673510741548879_manuscript;n=32;32;-1
2010_9673510741548879_manuscript;n=64;64;-1
2010_9673510741548879_manuscript;n= 43;43;-1
2010_9673510741548879_manuscript;n= 415;415;-1
2010_9673510741548879_manuscript;n=6;6;-1
2010_9673510741548879_manuscript;n= 412;412;-1
2010_9673510741548879_manuscript;n=3;3;-1
2010_9673510741548879_manuscript;total of 930;930;-1
2010_9673510741548879_manuscript;total of 31;31;-1
2010_9673510741548879_manuscript;total of 59;59;-1
2010_9673510741548879_manuscript;total   of 722;722;-1
2010_9673510741548879_manuscript;930 patients were enrolled;930;-1
2011_1006720333554813_manuscript;262 consecutive subjects;262;-1
2011_1006720333554813_manuscript;2 diabetic   patients;2;-1
2011_1006720333554813_manuscript;n=162;162;-1
2011_1006720333554813_manuscript;n=70;70;-1
2011_1058506343561862_manuscript;219 patients;219;8188
2011_1058506343561862_manuscript;18 patients;18;8022
2011_1058506343561862_manuscript;2932 patients;2932;525
2011_1058506343561862_manuscript;737 patients;737;595
2011_1058506343561862_manuscript;139 patients;139;708
2011_1058506343561862_manuscript;313 patients;313;839
2011_1058506343561862_manuscript;21   patients;21;3153
2011_1058506343561862_manuscript;76 patients;76;3569
2011_1058506343561862_manuscript;25   patients;25;18564
2011_1058506343561862_manuscript;94 were   recruited;94;870
2011_1058506343561862_manuscript;n=94;94;17523
2011_1058506343561862_manuscript;n=219;219;17554
2011_1058506343561862_manuscript;313 patients finally enrolled;313;839
2011_1070379483507634_manuscript;285 trauma   patients;285;-1
2011_1070379483507634_manuscript;79 different individuals;79;-1
2011_1070379483507634_manuscript;total of 143;143;-1
2011_1072187996360978_manuscript;487 consecutive patients;487;-1
2011_1072187996360978_manuscript;81 patients;81;-1
2011_1072187996360978_manuscript;2000 patients;2000;-1
2011_1072187996360978_manuscript;980 patients;980;-1
2011_1114403053548554_manuscript;60 patients;60;-1
2011_1114403053548554_manuscript;9 million people;9;-1
2011_1114403053548554_manuscript;n=3,623;3623;-1
2011_1114403053548554_manuscript;n=2,881;2881;-1
2011_1114403053548554_manuscript;n=20;20;-1
2011_1114403053548554_manuscript;n=171;171;-1
2011_1114403053548554_manuscript;n=232;232;-1
2011_1114403053548554_manuscript;n=190;190;-1
2011_1114403053548554_manuscript;n=1,515;1515;-1
2011_1114403053548554_manuscript;n=55;55;-1
2011_1114403053548554_manuscript;n=526;526;-1
2011_1114403053548554_manuscript;n=107;107;-1
2011_1114403053548554_manuscript;n=40;40;-1
2011_1114403053548554_manuscript;n=16;16;-1
2011_1114403053548554_manuscript;n=9;9;-1
2011_1114403053548554_manuscript;n=742;742;-1
2011_1114403053548554_manuscript;n=709;709;-1
2011_1114403053548554_manuscript;n=74;74;-1
2011_1114403053548554_manuscript;n=378;378;-1
2011_1114403053548554_manuscript;n=142;142;-1
2011_1114403053548554_manuscript;n=18;18;-1
2011_1114403053548554_manuscript;n=4;4;-1
2011_1114403053548554_manuscript;n=49;49;-1
2011_1114403053548554_manuscript;n=26;26;-1
2011_1114403053548554_manuscript;n=2;2;-1
2011_1114403053548554_manuscript;n=6;6;-1
2011_1114403053548554_manuscript;n=5;5;-1
2011_1114403053548554_manuscript;n=3;3;-1
2011_1114403053548554_manuscript;n=33;33;-1
2011_1114403053548554_manuscript;n=12;12;-1
2011_1114403053548554_manuscript;n=23;23;-1
2011_1114403053548554_manuscript; data from 7;7;-1
2011_1125424013642149_manuscript;6   participants;6;-1
2011_1125424013642149_manuscript;140 participants;140;-1
2011_1125424013642149_manuscript;69 patients;69;-1
2011_1125424013642149_manuscript;n = 0;0;-1
2011_1125424013642149_manuscript;n = 33;33;-1
2011_1125424013642149_manuscript;n = 3;3;-1
2011_1125424013642149_manuscript;n = 2;2;-1
2011_1125424013642149_manuscript;n = 1;1;-1
2011_1125424013642149_manuscript;n = 74;74;-1
2011_1125424013642149_manuscript;n = 71;71;-1
2011_1125424013642149_manuscript;n   =   7;7;-1
2011_1130758332506731_manuscript;1000 individuals;1000;-1
2011_1134314910638682_manuscript;1333 patients;1333;-1
2011_1134314910638682_manuscript;n=28;28;-1
2011_1134314910638682_manuscript;n=5;5;-1
2011_1134314910638682_manuscript;n=9;9;-1
2011_1134314910638682_manuscript;n=29;29;-1
2011_1134314910638682_manuscript;n=6;6;-1
2011_1134314910638682_manuscript;n=7;7;-1
2011_1134314910638682_manuscript;N=3407;3407;-1
2011_1134314910638682_manuscript;N=91;91;-1
2011_1134314910638682_manuscript;N=37;37;-1
2011_1134314910638682_manuscript;N=42;42;-1
2011_1134314910638682_manuscript;N=5;5;-1
2011_1134314910638682_manuscript;N=6;6;-1
2011_1134314910638682_manuscript;N=3;3;-1
2011_1134314910638682_manuscript;N=11;11;-1
2011_1134314910638682_manuscript;N=13;13;-1
2011_1134314910638682_manuscript;N=4;4;-1
2011_1134314910638682_manuscript;N=10;10;-1
2011_1134314910638682_manuscript;N=4549;4549;-1
2011_1134314910638682_manuscript;N=3316;3316;-1
2011_1134314910638682_manuscript;N= 2316;2316;-1
2011_1134314910638682_manuscript;N=1809;1809;-1
2011_1134314910638682_manuscript;N=0;0;-1
2011_1134314910638682_manuscript;total of 42;42;-1
2011_1174761967627974_manuscript;20 pregnant women;20;-1
2011_1174761967627974_manuscript;3000   subjects;3000;-1
2011_1174761967627974_manuscript;94 CRC-free subjects;94;-1
2011_1174761967627974_manuscript;98 younger subjects;98;-1
2011_1174761967627974_manuscript;300 of the subjects;300;-1
2011_1174761967627974_manuscript;300 evaluable subjects;300;-1
2011_1174761967627974_manuscript;104 subjects;104;-1
2011_1174761967627974_manuscript;10,000 subjects;10000;-1
2011_1174761967627974_manuscript;50 untreated CRC patients;50;-1
2011_1174761967627974_manuscript;300 colonoscopy patients;300;-1
2011_1174761967627974_manuscript;8000 asymptomatic patients;8000;-1
2011_1174761967627974_manuscript;306 patients;306;-1
2011_1174761967627974_manuscript;306 colonoscopy patients;306;-1
2011_1174761967627974_manuscript;40 million individuals;40;-1
2011_1174761967627974_manuscript;8000 asymptomatic individuals;8000;-1
2011_1272792415543001_manuscript;8 adults;8;-1
2011_1272792415543001_manuscript;3  Adolescents and young   adults;3;-1
2011_1272792415543001_manuscript;2,513 adults;2513;-1
2011_1272792415543001_manuscript;N=448;448;-1
2011_1272792415543001_manuscript;N=313;313;-1
2011_1272792415543001_manuscript;N=49;49;-1
2011_1272792415543001_manuscript;N=303;303;-1
2011_1272792415543001_manuscript;N=1630;1630;-1
2011_1272792415543001_manuscript;N=216;216;-1
2011_1272792415543001_manuscript;N=8;8;-1
2011_1272792415543001_manuscript;total of 224;224;-1
2011_1272792415543001_manuscript;total of 307;307;-1
2011_1293284313568303_manuscript;1036   control subjects;1036;-1
2011_1293284313568303_manuscript;7   control subjects;7;-1
2011_1293284313568303_manuscript;1036 control subjects;1036;-1
2011_1293284313568303_manuscript;855   patients;855;-1
2011_1293284313568303_manuscript;855 incident patients;855;-1
2011_1293284313568303_manuscript;41 patients;41;-1
2011_1293284313568303_manuscript;855   incident patients;855;-1
2011_1293284313568303_manuscript;798 NPC patients;798;-1
2011_1293284313568303_manuscript;13 individuals;13;-1
2011_1293284313568303_manuscript;n = 41;41;-1
2011_1293284313568303_manuscript;n = 13;13;-1
2011_1293284313568303_manuscript;n = 773;773;-1
2011_1293284313568303_manuscript;n   =   7;7;-1
2011_1293284313568303_manuscript;n   =   1;1;-1
2011_1293284313568303_manuscript;total of 5;5;-1
2011_1364778132647734_manuscript;2089 patients;2089;-1
2011_1364778132647734_manuscript;n = 368;368;-1
2011_1364778132647734_manuscript;n = 296;296;-1
2011_1364778132647734_manuscript;n = 19;19;-1
2011_1364778132647734_manuscript;n = 2;2;-1
2011_1364778132647734_manuscript;n = 72;72;-1
2011_1364778132647734_manuscript;n = 52;52;-1
2011_1364778132647734_manuscript;n = 7;7;-1
2011_1364778132647734_manuscript;n = 1;1;-1
2011_1364778132647734_manuscript;n = 27;27;-1
2011_1364778132647734_manuscript;n = 25;25;-1
2011_1364778132647734_manuscript;n = 13;13;-1
2011_1364778132647734_manuscript;n= 2;2;-1
2011_1400294324578538_manuscript;10 participants;10;-1
2011_1400294324578538_manuscript;703 participants;703;-1
2011_1400294324578538_manuscript;610 participants;610;-1
2011_1400294324578538_manuscript;31 trials enrolling participants;31;-1
2011_1400294324578538_manuscript;446 participants;446;-1
2011_1400294324578538_manuscript;10 trials enrolling participants;10;-1
2011_1400294324578538_manuscript;152 participants;152;-1
2011_1400294324578538_manuscript;52 participants;52;-1
2011_1400294324578538_manuscript;12 participants;12;-1
2011_1400294324578538_manuscript;20 participants;20;-1
2011_1400294324578538_manuscript;412 participants;412;-1
2011_1400294324578538_manuscript;133 participants;133;-1
2011_1400294324578538_manuscript;41 participants;41;-1
2011_1400294324578538_manuscript;1 diabetic participants;1;-1
2011_1400294324578538_manuscript;133   participants;133;-1
2011_1400294324578538_manuscript;41 overweight participants;41;-1
2011_1400294324578538_manuscript;20 diabetic participants;20;-1
2011_1400294324578538_manuscript;22 participants;22;-1
2011_1400294324578538_manuscript;85   participants;85;-1
2011_1400294324578538_manuscript;41   participants;41;-1
2011_1400294324578538_manuscript;52 diabetic participants;52;-1
2011_1400294324578538_manuscript;41   overweight participants;41;-1
2011_1400294324578538_manuscript;2 diabetic participants;2;-1
2011_1400294324578538_manuscript;2 diabetic subjects;2;-1
2011_1400294324578538_manuscript;7 people;7;-1
2011_1400294324578538_manuscript;n=1;1;-1
2011_1400294324578538_manuscript;n=2;2;-1
2011_1400294324578538_manuscript;n=7;7;-1
2011_1400294324578538_manuscript;n=9;9;-1
2011_1400294324578538_manuscript;n=3;3;-1
2011_1400294324578538_manuscript;n=23;23;-1
2011_1400294324578538_manuscript;n=15;15;-1
2011_1400294324578538_manuscript;n=3666;3666;-1
2011_1400294324578538_manuscript;n=3175;3175;-1
2011_1400294324578538_manuscript;n=3114;3114;-1
2011_1400294324578538_manuscript;n=58;58;-1
2011_1400294324578538_manuscript;n=491;491;-1
2011_1400294324578538_manuscript;n=440;440;-1
2011_1400294324578538_manuscript;n=114;114;-1
2011_1400294324578538_manuscript;n=77;77;-1
2011_1400294324578538_manuscript;n=79;79;-1
2011_1400294324578538_manuscript;n=46;46;-1
2011_1400294324578538_manuscript;n=44;44;-1
2011_1400294324578538_manuscript;n=13;13;-1
2011_1400294324578538_manuscript;n=1292;1292;-1
2011_1400294324578538_manuscript;n=4958;4958;-1
2011_1400294324578538_manuscript;n=0;0;-1
2011_1400294324578538_manuscript;total of 41;41;-1
2011_1400294324578538_manuscript;total of 12;12;-1
2011_1445387870508044_manuscript;16 CCSVI-MS patients;16;13210
2011_1445387870508044_manuscript;16 MS patients;16;1383
2011_1445387870508044_manuscript;56 MS patients;56;7904
2011_1445387870508044_manuscript;n=8;8;20672
2011_1525943131524961_manuscript;868 patients;868;8269
2011_1525943131524961_manuscript;868   consecutive patients;868;4423
2011_1525943131524961_manuscript;17 we   classified patients;17;3188
2011_1525943131524961_manuscript;17 patients;17;2669
2011_1525943131524961_manuscript;100 patients;100;2054
2011_1525943131524961_manuscript;5000 patients;5000;426
2011_1525943131524961_manuscript;17000 patients;17000;865
2011_1525943131524961_manuscript;448 patients;448;1863
2011_1525943131524961_manuscript;105 patients;105;2072
2011_1525943131524961_manuscript;470 patients;470;2792
2011_1525943131524961_manuscript;354 patients;354;3263
2011_1525943131524961_manuscript;647 patients;647;4678
2011_1525943131524961_manuscript;323 patients;323;5333
2011_1525943131524961_manuscript;N = 1283;1283;18878
2011_1525943131524961_manuscript;N = 5511;5511;18916
2011_1525943131524961_manuscript;N = 10311;10311;18950
2011_1525943131524961_manuscript;N = 1144;1144;20194
2011_1525943131524961_manuscript;N = 62;62;20221
2011_1525943131524961_manuscript;N = 4373;4373;20249
2011_1525943131524961_manuscript;N = 871;871;20276
2011_1525943131524961_manuscript;N = 5697;5697;20305
2011_1525943131524961_manuscript;N = 4323;4323;20332
2011_1525943131524961_manuscript;N=17105;17105;21743
2011_1525943131524961_manuscript;total of 1;1;4652
2011_1525943131524961_manuscript;total of 60;60;4435
2011_1534218058528965_manuscript;n  =  3;3;-1
2011_1535880786612513_manuscript;100 patients;100;-1
2011_1535880786612513_manuscript;156 patients;156;-1
2011_1535880786612513_manuscript;183 patients;183;-1
2011_1535880786612513_manuscript;12 patients;12;-1
2011_1535880786612513_manuscript;1 infected   patients;1;-1
2011_1535880786612513_manuscript;151 patients;151;-1
2011_1535880786612513_manuscript;141 adult patients;141;-1
2011_1535880786612513_manuscript;132 patients;132;-1
2011_1535880786612513_manuscript;18 patients;18;-1
2011_1535880786612513_manuscript;59 patients;59;-1
2011_1535880786612513_manuscript;19 patients;19;-1
2011_1535880786612513_manuscript;197 septic   patients;197;-1
2011_1535880786612513_manuscript;55 septic   patients;55;-1
2011_1535880786612513_manuscript;101   patients;101;-1
2011_1535880786612513_manuscript;99 HIV   patients;99;-1
2011_1535880786612513_manuscript;183 adults;183;-1
2011_1535880786612513_manuscript;273 adults;273;-1
2011_1535880786612513_manuscript;152 adults;152;-1
2011_1535880786612513_manuscript;314 adults;314;-1
2011_1535880786612513_manuscript;262 adults;262;-1
2011_1535880786612513_manuscript;293 adults;293;-1
2011_1535880786612513_manuscript;100 adults;100;-1
2011_1535880786612513_manuscript;151 adults;151;-1
2011_1535880786612513_manuscript;141 adults;141;-1
2011_1535880786612513_manuscript;N=44;44;-1
2011_1535880786612513_manuscript;N=31;31;-1
2011_1535880786612513_manuscript;n=273;273;-1
2011_1618676916459119_manuscript;15,000 patients;15000;14993
2011_1618676916459119_manuscript;322 patients;322;12996
2011_1618676916459119_manuscript;303 patients;303;12933
2011_1622094537537840_manuscript;405   voluntary individuals;405;-1
2011_1622094537537840_manuscript;25 individuals;25;-1
2011_1624565686543097_manuscript;262,700 Medicare patients;262700;-1
2011_1624565686543097_manuscript;4444 patients;4444;-1
2011_1624565686543097_manuscript;2 million   individuals;2;-1
2011_1624565686543097_manuscript;n = 4126;4126;-1
2011_1624565686543097_manuscript;total of 35,438;35438;-1
2011_1649212546573413_manuscript;85 women;85;-1
2011_1649212546573413_manuscript;88   women;88;-1
2011_1649212546573413_manuscript;n=133;133;-1
2011_1649212546573413_manuscript;n=151;151;-1
2011_1649212546573413_manuscript;n=11;11;-1
2011_1649212546573413_manuscript;n=30;30;-1
2011_1649212546573413_manuscript;n=15;15;-1
2011_1649212546573413_manuscript;n=10;10;-1
2011_1649212546573413_manuscript;n=3;3;-1
2011_1649212546573413_manuscript;n=5;5;-1
2011_1649212546573413_manuscript;n=2;2;-1
2011_1649212546573413_manuscript;n=36;36;-1
2011_1649212546573413_manuscript;n = 46;46;-1
2011_1649212546573413_manuscript;n = 7;7;-1
2011_1649212546573413_manuscript;n = 13;13;-1
2011_1649212546573413_manuscript;n = 16;16;-1
2011_1649212546573413_manuscript;n = 3;3;-1
2011_1649212546573413_manuscript;n = 2;2;-1
2011_1649212546573413_manuscript;n = 11;11;-1
2011_1649212546573413_manuscript;n = 0;0;-1
2011_1649212546573413_manuscript;n = 5;5;-1
2011_1649212546573413_manuscript;n = 6;6;-1
2011_1649212546573413_manuscript;n = 79;79;-1
2011_1649212546573413_manuscript;n = 22;22;-1
2011_1649212546573413_manuscript;n = 204;204;-1
2011_1649212546573413_manuscript;n = 173;173;-1
2011_1649212546573413_manuscript;n = 31;31;-1
2011_1649212546573413_manuscript;n = 88;88;-1
2011_1649212546573413_manuscript;n = 85;85;-1
2011_1649212546573413_manuscript;total of 173;173;-1
2011_1649212546573413_manuscript;total of 204;204;-1
2011_1649212546573413_manuscript;total of 2123;2123;-1
2011_1649612812560755_manuscript;573 patients;573;-1
2011_1649612812560755_manuscript;270   patients;270;-1
2011_1649612812560755_manuscript;143,000 people;143000;-1
2011_1649612812560755_manuscript;143,000 individuals;143000;-1
2011_1649612812560755_manuscript;n = 6;6;-1
2011_1649612812560755_manuscript;n= 573;573;-1
2011_1649612812560755_manuscript;n= 63;63;-1
2011_1649612812560755_manuscript;n= 510;510;-1
2011_1649612812560755_manuscript;n=387;387;-1
2011_1649612812560755_manuscript;n=123;123;-1
2011_1649612812560755_manuscript;n= 122;122;-1
2011_1649612812560755_manuscript;n= 265;265;-1
2011_1649612812560755_manuscript;n = 265;265;-1
2011_1649612812560755_manuscript;n=258;258;-1
2011_1649612812560755_manuscript;n=142;142;-1
2011_1649612812560755_manuscript;n=43;43;-1
2011_1649612812560755_manuscript;n=97;97;-1
2011_1649612812560755_manuscript;n=125;125;-1
2011_1649612812560755_manuscript;n=122;122;-1
2011_1708052122522336_manuscript;1i=participants;1;-1
2011_1708052122522336_manuscript;2i=participants;2;-1
2011_1708052122522336_manuscript;5259 patients;5259;-1
2011_1708052122522336_manuscript;400 patients;400;-1
2011_1708052122522336_manuscript;8 RCTs enrolled patients;8;-1
2011_1708052122522336_manuscript;total of 5259;5259;-1
2011_1708052122522336_manuscript;8 RCTs enrolled;8;-1
2011_1715105952536720_manuscript;233 patients;233;8786
2011_1715105952536720_manuscript;7 million of patients;7;6887
2011_1715105952536720_manuscript;958 consecutive elderly patients;958;3602
2011_1715105952536720_manuscript;958 patients;958;747
2011_1715105952536720_manuscript;725 patients;725;947
2011_1715105952536720_manuscript;N = 958;958;9251
2011_1799826755537063_manuscript;1 patients;1;23146
2011_1799826755537063_manuscript;1   patients;1;22356
2011_1799826755537063_manuscript;42 patients;42;17588
2011_1799826755537063_manuscript;27 patients;27;11857
2011_1799826755537063_manuscript;35   patients;35;11641
2011_1799826755537063_manuscript;7 patients;7;11856
2011_1799826755537063_manuscript;30   patients;30;264
2011_1799826755537063_manuscript;n=36;36;12623
2011_1799826755537063_manuscript;n=40;40;12557
2011_1799826755537063_manuscript;n=16;16;11213
2011_1799826755537063_manuscript;n=5;5;11191
2011_1799826755537063_manuscript;n=4;4;12557
2011_1799826755537063_manuscript;total of   16;16;16246
2011_1872818306537730_manuscript;2   were defined as case subjects;2;-1
2011_1872818306537730_manuscript;2 were   considered control subjects;2;-1
2011_1872818306537730_manuscript;240 subjects;240;-1
2011_1872818306537730_manuscript;312 million obese individuals;312;-1
2011_1872818306537730_manuscript;4923 adults;4923;-1
2011_1872818306537730_manuscript;total of   810;810;-1
2011_1872818306537730_manuscript;total   of 27;27;-1
2011_1872818306537730_manuscript;total of 21;21;-1
2011_1872818306537730_manuscript;total of 59;59;-1
2011_1872818306537730_manuscript;total of 41,734;41734;-1
2011_1872818306537730_manuscript;total of 11;11;-1
2011_1888736422562147_manuscript;102 critically ill patients;102;-1
2011_1888736422562147_manuscript;600 patients;600;-1
2011_1888736422562147_manuscript;759   patients;759;-1
2011_1888736422562147_manuscript;42 patients;42;-1
2011_1897320765513900_manuscript;28 women;28;-1
2011_1897320765513900_manuscript;500 persons;500;-1
2011_1897320765513900_manuscript;61   participants;61;-1
2011_1897320765513900_manuscript;n=508;508;-1
2011_1897320765513900_manuscript;n=501;501;-1
2011_1897320765513900_manuscript;n=333;333;-1
2011_1897320765513900_manuscript;n=315;315;-1
2011_1897320765513900_manuscript;n=166;166;-1
2011_1897320765513900_manuscript;n=174;174;-1
2011_1897320765513900_manuscript;n=338;338;-1
2011_1897320765513900_manuscript;n=132;132;-1
2011_1897320765513900_manuscript;n=206;206;-1
2011_1897320765513900_manuscript;n=300;300;-1
2011_1897320765513900_manuscript;n=184;184;-1
2011_1897320765513900_manuscript;n=116;116;-1
2011_1897320765513900_manuscript;n=240;240;-1
2011_1897320765513900_manuscript;n=296;296;-1
2011_1897320765513900_manuscript;n=283;283;-1
2011_1897320765513900_manuscript;n=218;218;-1
2011_1897320765513900_manuscript;n=35;35;-1
2011_1897320765513900_manuscript;n=34;34;-1
2011_1921289597504177_manuscript;363 women;363;-1
2011_1921289597504177_manuscript;382   women;382;-1
2011_1921289597504177_manuscript;16    active women;16;-1
2011_1921289597504177_manuscript;877 controls subjects;877;-1
2011_1921289597504177_manuscript;19 subjects;19;-1
2011_1921289597504177_manuscript;17 subjects;17;-1
2011_1921289597504177_manuscript;22 patients;22;-1
2011_1921289597504177_manuscript;n =38;38;-1
2011_1921289597504177_manuscript;n = 12;12;-1
2011_1921289597504177_manuscript;n = 10;10;-1
2011_1921289597504177_manuscript;n = 8;8;-1
2011_1921289597504177_manuscript;n = 9;9;-1
2011_1921289597504177_manuscript;n = 20;20;-1
2011_1921289597504177_manuscript;n = 44;44;-1
2011_1921289597504177_manuscript;total of 363;363;-1
2011_1921289597504177_manuscript;total of 405;405;-1
2011_1921289597504177_manuscript;total of 877;877;-1
2011_1921289597504177_manuscript;total of 382;382;-1
2011_1921289597504177_manuscript;total of 19;19;-1
2011_1921289597504177_manuscript; data from 13;13;-1
2011_1951246534537000_manuscript;n= 85;85;-1
2011_1951246534537000_manuscript;n=14011;14011;-1
2011_1951246534537000_manuscript;n= 16271;16271;-1
2011_1951246534537000_manuscript;n= 13628;13628;-1
2011_1951246534537000_manuscript;n= 95;95;-1
2011_1951246534537000_manuscript;n= 89;89;-1
2011_1951246534537000_manuscript;n= 16;16;-1
2011_1951246534537000_manuscript;n= 21;21;-1
2011_1951246534537000_manuscript;n= 5468;5468;-1
2011_1951246534537000_manuscript;n= 2260;2260;-1
2011_1951246534537000_manuscript;n= 383;383;-1
2011_1951246534537000_manuscript;n=13543;13543;-1
2011_1951246534537000_manuscript;n=51;51;-1
2011_1951246534537000_manuscript;n= 4;4;-1
2011_1951246534537000_manuscript;n= 6;6;-1
2011_1951246534537000_manuscript;total of 20;20;-1
2011_1951246534537000_manuscript;total   of 21739;21739;-1
2011_1951246534537000_manuscript;total of 21;21;-1
2011_1951246534537000_manuscript; data of 17;17;-1
2011_1951246534537000_manuscript; database from 22;22;-1
2011_1972659029608078_manuscript;57 women;57;8293
2011_1972659029608078_manuscript;2D subjects;2;12858
2011_1972659029608078_manuscript;300,000 IU vitamin D to the subjects;300000;13202
2011_1972659029608078_manuscript;n=41;41;17841
2011_1972659029608078_manuscript;n=50;50;2714
2011_1972659029608078_manuscript;total of 100;100;8326
2011_1973376178560680_manuscript;N  =  1;1;-1
2011_1973376178560680_manuscript;N  =  5;5;-1
2011_1973376178560680_manuscript;N  =  3;3;-1
2011_1973376178560680_manuscript;N  =  2;2;-1
2011_1973376178560680_manuscript;n = 5,615;5615;-1
2011_1973376178560680_manuscript;n = 5,612;5612;-1
2011_1973376178560680_manuscript;n = 84;84;-1
2011_1973376178560680_manuscript;n = 5,528;5528;-1
2011_1973376178560680_manuscript;n = 3,365;3365;-1
2011_1973376178560680_manuscript;n = 48;48;-1
2011_1973376178560680_manuscript;n = 3,317;3317;-1
2011_1973376178560680_manuscript;n = 2,930;2930;-1
2011_1973376178560680_manuscript;n = 2,928;2928;-1
2011_1973376178560680_manuscript;n = 45;45;-1
2011_1973376178560680_manuscript;n = 2,883;2883;-1
2011_1973376178560680_manuscript;n = 1,916;1916;-1
2011_1973376178560680_manuscript;n = 1,893;1893;-1
2011_1973376178560680_manuscript;n = 26;26;-1
2011_1973376178560680_manuscript;n = 1,867;1867;-1
2011_1980438095518953_manuscript;12 SLE patients;12;7064
2011_1986823473554649_manuscript;n = 3;3;28
2011_1992876551563828_manuscript;n=10;10;-1
2011_2213154475275667_manuscript;322 women;322;-1
2011_2213154475275667_manuscript;479 persons;479;-1
2011_2213154475275667_manuscript;479 participants;479;-1
2011_2213154475275667_manuscript;705 participants;705;-1
2011_2213154475275667_manuscript;14 participants;14;-1
2011_2213154475275667_manuscript;599 participants;599;-1
2011_2213154475275667_manuscript;72 participants;72;-1
2011_2213154475275667_manuscript;48 participants;48;-1
2011_2213154475275667_manuscript;92   participants;92;-1
2011_2213154475275667_manuscript;246 participants;246;-1
2011_2213154475275667_manuscript;7 participants;7;-1
2011_2213154475275667_manuscript;n=393;393;-1
2011_2213154475275667_manuscript;n=479;479;-1
2011_2213154475275667_manuscript;n  =  4;4;-1
2011_2213154475275667_manuscript;n  =  3;3;-1
2011_2213154475275667_manuscript;n  =  1;1;-1
2011_2213154475275667_manuscript;N=372;372;-1
2011_2213154475275667_manuscript;N=107;107;-1
2011_2213154475275667_manuscript;n=72;72;-1
2011_2213154475275667_manuscript;n=407;407;-1
2011_2260566535233720_manuscript;42   patients;42;-1
2011_2260566535233720_manuscript;406 patients;406;-1
2011_2260566535233720_manuscript;43   patients;43;-1
2011_2260566535233720_manuscript;80   adult patients;80;-1
2011_2260566535233720_manuscript;118   management of all patients;118;-1
2011_2260566535233720_manuscript;126   all patients;126;-1
2011_2260566535233720_manuscript;200 patients;200;-1
2011_2260566535233720_manuscript;167   two groups of patients;167;-1
2011_2260566535233720_manuscript;202 patients;202;-1
2011_2260566535233720_manuscript;204 patients;204;-1
2011_2260566535233720_manuscript;34 patients;34;-1
2011_2260566535233720_manuscript;28 patients;28;-1
2011_2260566535233720_manuscript;35 patients;35;-1
2011_2260566535233720_manuscript;19 patients;19;-1
2011_2260566535233720_manuscript;9 patients;9;-1
2011_2260566535233720_manuscript;191 patients;191;-1
2011_2260566535233720_manuscript;12 patients;12;-1
2011_2260566535233720_manuscript;193   In three of these patients;193;-1
2011_2260566535233720_manuscript;39 patients;39;-1
2011_2260566535233720_manuscript;15 patients;15;-1
2011_2260566535233720_manuscript;24 patients;24;-1
2011_2260566535233720_manuscript;7 patients;7;-1
2011_2260566535233720_manuscript;201 patients;201;-1
2011_2260566535233720_manuscript;229   patients;229;-1
2011_2260566535233720_manuscript;267   population consisted of patients;267;-1
2011_2260566535233720_manuscript;279   selection of patients;279;-1
2011_2260566535233720_manuscript;289   care patients;289;-1
2011_2260566535233720_manuscript;351   well as patients;351;-1
2011_2260566535233720_manuscript;432   patients;432;-1
2011_2260566535233720_manuscript;500   a No of patients;500;-1
2011_2260566535233720_manuscript;91 patients;91;-1
2011_2260566535233720_manuscript;97 patients;97;-1
2011_2260566535233720_manuscript;517   Detected Pathogens All patients;517;-1
2011_2260566535233720_manuscript;442   adults;442;-1
2011_2260566535233720_manuscript;37   Patients were recruited;37;-1
2011_2260566535233720_manuscript;n=9;9;-1
2011_2260566535233720_manuscript;n=25;25;-1
2011_2260566535233720_manuscript;n=34;34;-1
2011_2260566535233720_manuscript;n=243;243;-1
2011_2260566535233720_manuscript;n=92;92;-1
2011_2260566535233720_manuscript;n=12;12;-1
2011_2260566535233720_manuscript;n=6 220;6220;-1
2011_2260566535233720_manuscript;n=202;202;-1
2011_2260566535233720_manuscript;n= 204;204;-1
2011_2260566535233720_manuscript;n=204;204;-1
2011_2260566535233720_manuscript;total of 335;335;-1
2011_2260566535233720_manuscript;94   Patients were enrolled;94;-1
2011_2281043275577816_manuscript;123   participants;123;-1
2011_2281043275577816_manuscript;5 participants;5;-1
2011_2281043275577816_manuscript;10 participants;10;-1
2011_2281043275577816_manuscript;21 structured questions participants;21;-1
2011_2281043275577816_manuscript;20 participants;20;-1
2011_2281043275577816_manuscript;10   participants;10;-1
2011_2281043275577816_manuscript;116 participants;116;-1
2011_2281043275577816_manuscript;7 participants;7;-1
2011_2281043275577816_manuscript;116   interviewed participants;116;-1
2011_2281043275577816_manuscript;40 participants;40;-1
2011_2281043275577816_manuscript;48   participants;48;-1
2011_2281043275577816_manuscript;15 participants;15;-1
2011_2281043275577816_manuscript;101 participants;101;-1
2011_2281043275577816_manuscript;50 people;50;-1
2011_2281043275577816_manuscript;123 people;123;-1
2011_2281043275577816_manuscript;7 people;7;-1
2011_2281043275577816_manuscript;123   participants were recruited;123;-1
2011_2281043275577816_manuscript;1 recruited;1;-1
2011_2281043275577816_manuscript;n= 123;123;-1
2011_2281043275577816_manuscript;n= 62;62;-1
2011_2281043275577816_manuscript;n = 60;60;-1
2011_2281043275577816_manuscript;n= 2;2;-1
2011_2281043275577816_manuscript;n= 1;1;-1
2011_2281043275577816_manuscript;n= 61;61;-1
2011_2281043275577816_manuscript;n= 55;55;-1
2011_2281043275577816_manuscript;n= 5;5;-1
2011_2281043275577816_manuscript;n= 3;3;-1
2011_2281043275577816_manuscript;n= 0;0;-1
2011_2281043275577816_manuscript;n=55;55;-1
2011_2281043275577816_manuscript;n=61;61;-1
2011_2281043275577816_manuscript;n= 116;116;-1
2011_2281043275577816_manuscript;n=62;62;-1
2011_2414291885139068_manuscript;4281 people subjects;4281;-1
2011_2414291885139068_manuscript;108 subjects;108;-1
2011_2414291885139068_manuscript;4281 people;4281;-1
2011_2414291885139068_manuscript;2500 adults;2500;-1
2011_2414291885139068_manuscript;n=837;837;-1
2011_2414291885139068_manuscript;n=733;733;-1
2011_2414291885139068_manuscript;n=694;694;-1
2011_2414291885139068_manuscript;n=650;650;-1
2011_2414291885139068_manuscript;n=643;643;-1
2011_2414291885139068_manuscript;n=724;724;-1
2011_2414291885139068_manuscript;N=108;108;-1
2011_2414291885139068_manuscript;N=881;881;-1
2011_2416081555348925_manuscript;4839 patients;4839;-1
2011_2416081555348925_manuscript;11 patients;11;-1
2011_2416081555348925_manuscript;2900 patients;2900;-1
2011_2416081555348925_manuscript;17 included both adults;17;-1
2011_2416081555348925_manuscript;n=7;7;-1
2011_2416081555348925_manuscript;n=9;9;-1
2011_2416081555348925_manuscript;n=5;5;-1
2011_2416081555348925_manuscript;n=6;6;-1
2011_2416081555348925_manuscript;N=405;405;-1
2011_2416081555348925_manuscript;N=232;232;-1
2011_2416081555348925_manuscript;N=115;115;-1
2011_2416081555348925_manuscript;N=58;58;-1
2011_2416081555348925_manuscript;N=18;18;-1
2011_2416081555348925_manuscript;N=2;2;-1
2011_2416081555348925_manuscript;N=21;21;-1
2011_2416081555348925_manuscript;N=0;0;-1
2011_2416081555348925_manuscript;N=271;271;-1
2011_2416081555348925_manuscript;N=40;40;-1
2011_2416081555348925_manuscript;N=6;6;-1
2011_2416081555348925_manuscript;N=8;8;-1
2011_2416081555348925_manuscript;N=5;5;-1
2011_2416081555348925_manuscript;N=3;3;-1
2011_2416081555348925_manuscript;N=4;4;-1
2011_2416081555348925_manuscript;N=1;1;-1
2011_2416081555348925_manuscript;N=236;236;-1
2011_2557247915611096_manuscript;2010 Hong Kong   All subjects;2010;-1
2011_2557247915611096_manuscript;54   million general practice patients;54;-1
2011_2557247915611096_manuscript;2DM patients;2;-1
2011_2557247915611096_manuscript;21 studies explicitly excluded individuals;21;-1
2011_2557247915611096_manuscript;n=38;38;-1
2011_2557247915611096_manuscript;n=28;28;-1
2011_2557247915611096_manuscript;n=24;24;-1
2011_2557247915611096_manuscript;n=21;21;-1
2011_2557247915611096_manuscript;n=17;17;-1
2011_2557247915611096_manuscript;n=10;10;-1
2011_2557247915611096_manuscript;n=8;8;-1
2011_2557247915611096_manuscript;n = 2;2;-1
2011_2557247915611096_manuscript;n = 3;3;-1
2011_2557247915611096_manuscript;n = 4;4;-1
2011_2557247915611096_manuscript;n = 6;6;-1
2011_2557247915611096_manuscript;n = 8;8;-1
2011_2736297585400374_manuscript;n=28;28;-1
2011_2736297585400374_manuscript;n=14;14;-1
2011_2736297585400374_manuscript;n=8;8;-1
2011_2736297585400374_manuscript;n=4;4;-1
2011_2736297585400374_manuscript;n=3;3;-1
2011_2736297585400374_manuscript;n=10;10;-1
2011_2736297585400374_manuscript;n=49;49;-1
2011_2736297585400374_manuscript;n=31;31;-1
2011_2736297585400374_manuscript;n=48;48;-1
2011_2736297585400374_manuscript;n=33;33;-1
2011_2736297585400374_manuscript;n=70;70;-1
2011_2736297585400374_manuscript;n=21;21;-1
2011_2736297585400374_manuscript;n=7;7;-1
2011_2736297585400374_manuscript;n=26;26;-1
2011_2736297585400374_manuscript;n=12;12;-1
2011_2736297585400374_manuscript;n=91;91;-1
2011_2736297585400374_manuscript;n=69;69;-1
2011_2736297585400374_manuscript;n=22;22;-1
2011_2736297585400374_manuscript;n=110;110;-1
2011_2736297585400374_manuscript;n=20;20;-1
2011_2736297585400374_manuscript;n=145;145;-1
2011_2736297585400374_manuscript;n=40;40;-1
2011_2736297585400374_manuscript;n=53;53;-1
2011_2736297585400374_manuscript;n=34;34;-1
2011_2736297585400374_manuscript;n=43;43;-1
2011_2736297585400374_manuscript;n=35;35;-1
2011_2736297585400374_manuscript;n=19;19;-1
2011_2736297585400374_manuscript;n=5;5;-1
2011_5081683635810203_manuscript;2006 529,935 150,401        - Mental health outpatients;2,00653E+15;-1
2011_5081683635810203_manuscript;400,000 people;400000;-1
2011_5081683635810203_manuscript;n=17,045;17045;-1
2011_5081683635810203_manuscript;n=26,626;26626;-1
2011_5081683635810203_manuscript;n  =  1;1;-1
2011_5081683635810203_manuscript;n  =  2;2;-1
2011_5081683635810203_manuscript;n  =  8;8;-1
2011_5081683635810203_manuscript;n  =  4;4;-1
2011_5222227475157965_manuscript;949 persons;949;-1
2011_5222227475157965_manuscript;1237 persons;1237;-1
2011_5222227475157965_manuscript;95 persons;95;-1
2011_5222227475157965_manuscript;128 persons;128;-1
2011_5222227475157965_manuscript;15 persons;15;-1
2011_5222227475157965_manuscript;35 persons;35;-1
2011_5222227475157965_manuscript;949 older persons;949;-1
2011_5222227475157965_manuscript;70 million persons;70;-1
2011_5222227475157965_manuscript;1000 community-dwelling older persons;1000;-1
2011_5222227475157965_manuscript;2 participants;2;-1
2011_5222227475157965_manuscript;964   participants;964;-1
2011_5222227475157965_manuscript;253 participants;253;-1
2011_5222227475157965_manuscript;155 participants;155;-1
2011_5222227475157965_manuscript;64 patients;64;-1
2011_5222227475157965_manuscript;n=8;8;-1
2011_5222227475157965_manuscript;n=1;1;-1
2011_5222227475157965_manuscript;N=704;704;-1
2011_5222227475157965_manuscript;N=837;837;-1
2011_5222227475157965_manuscript; data from 949;949;-1
2011_6169578495648976_manuscript;2152 women;2152;-1
2011_6169578495648976_manuscript;45 women;45;-1
2011_6169578495648976_manuscript;38 women;38;-1
2011_6169578495648976_manuscript;1   million women;1;-1
2011_6169578495648976_manuscript;2152 participants;2152;-1
2011_6169578495648976_manuscript;2 participants;2;-1
2011_6169578495648976_manuscript;8 Indigenous participants;8;-1
2011_6169578495648976_manuscript;9 Indigenous participants;9;-1
2011_6169578495648976_manuscript;6 Indigenous participants;6;-1
2011_6169578495648976_manuscript;26 Indigenous participants;26;-1
2011_6169578495648976_manuscript;38 women recruited;38;-1
2011_6169578495648976_manuscript;n=1494;1494;-1
2011_6169578495648976_manuscript;n=655;655;-1
2011_6169578495648976_manuscript;n = 1494;1494;-1
2011_6169578495648976_manuscript;n = 655;655;-1
2011_6169578495648976_manuscript;n=3;3;-1
2011_6169578495648976_manuscript;n=1;1;-1
2011_6169578495648976_manuscript;n=2152;2152;-1
2011_6169578495648976_manuscript;total of 2156;2156;-1
2011_6298700725192697_manuscript;n=32;32;-1
2011_6298700725192697_manuscript;n=9;9;-1
2011_6298700725192697_manuscript;total of 65;65;-1
2011_6298700725192697_manuscript;total of 9;9;-1
2011_6493358555837068_manuscript;100 CML patients;100;-1
2011_6493358555837068_manuscript;54   patients;54;-1
2011_6554325075637158_manuscript;713   women;713;-1
2011_6554325075637158_manuscript;total of 31;31;-1
2011_6579107896157484_manuscript;258   identify subjects;258;-1
2011_6579107896157484_manuscript;420   treatment of patients;420;-1
2011_6579107896157484_manuscript;570   patients;570;-1
2011_6579107896157484_manuscript;50   recruited;50;-1
2011_6579107896157484_manuscript;n = 7616;7616;-1
2011_6579107896157484_manuscript;n=4325;4325;-1
2011_6579107896157484_manuscript;n=1216;1216;-1
2011_6579107896157484_manuscript;n=952;952;-1
2011_6579107896157484_manuscript;n=1096;1096;-1
2011_6579107896157484_manuscript;n=1061;1061;-1
2011_6579107896157484_manuscript;n=7616;7616;-1
2011_6579107896157484_manuscript;n=5875;5875;-1
2011_6579107896157484_manuscript;n=1741;1741;-1
2011_6579107896157484_manuscript;n=1550;1550;-1
2011_6579107896157484_manuscript;n=468;468;-1
2011_6579107896157484_manuscript;n=942;942;-1
2011_6579107896157484_manuscript;n=110;110;-1
2011_6579107896157484_manuscript;n=81;81;-1
2011_6579107896157484_manuscript;n=78;78;-1
2011_6579107896157484_manuscript;n=2;2;-1
2011_6579107896157484_manuscript;n=39;39;-1
2011_6579107896157484_manuscript;n=21;21;-1
2011_6579107896157484_manuscript;n=1161;1161;-1
2011_6579107896157484_manuscript;n=909;909;-1
2011_6579107896157484_manuscript;n=1041;1041;-1
2011_6579107896157484_manuscript;n=1036;1036;-1
2011_6579107896157484_manuscript;n=1212;1212;-1
2011_6579107896157484_manuscript;n=4;4;-1
2011_6579107896157484_manuscript;n=945;945;-1
2011_6579107896157484_manuscript;n=7;7;-1
2011_6579107896157484_manuscript;n=1089;1089;-1
2011_6579107896157484_manuscript;n=1050;1050;-1
2011_6579107896157484_manuscript;n=11;11;-1
2011_6579107896157484_manuscript;53   enrolled;53;-1
2011_6579107896157484_manuscript; data from the 300;300;-1
2011_7359287915356338_manuscript;12 patients;12;-1
2011_7388954336534303_manuscript;92 women;92;-1
2011_7388954336534303_manuscript;2810 patients;2810;-1
2011_7388954336534303_manuscript;4 tumours and patients;4;-1
2011_7388954336534303_manuscript;80 patients;80;-1
2011_7388954336534303_manuscript;400 patients;400;-1
2011_7388954336534303_manuscript;750 patients;750;-1
2011_7388954336534303_manuscript;100 patients;100;-1
2011_7388954336534303_manuscript;375 patients;375;-1
2011_7388954336534303_manuscript;325 patients;325;-1
2011_7388954336534303_manuscript;50 patients;50;-1
2011_7388954336534303_manuscript;97 patients;97;-1
2011_7388954336534303_manuscript;99 patients;99;-1
2011_7388954336534303_manuscript;3        NSCLC patients;3;-1
2011_7388954336534303_manuscript;284 patients;284;-1
2011_7388954336534303_manuscript;253 patients;253;-1
2011_7388954336534303_manuscript;255 patients;255;-1
2011_7388954336534303_manuscript;106 patients;106;-1
2011_7388954336534303_manuscript;103 patients;103;-1
2011_7388954336534303_manuscript;175 patients;175;-1
2011_7388954336534303_manuscript;128 patients;128;-1
2011_7388954336534303_manuscript;770 patients;770;-1
2011_7388954336534303_manuscript;2299 patients;2299;-1
2011_7388954336534303_manuscript;196 adults;196;-1
2011_7388954336534303_manuscript;n = 584;584;-1
2011_7388954336534303_manuscript;n=241;241;-1
2011_7388954336534303_manuscript;n=229;229;-1
2011_7388954336534303_manuscript;n=217;217;-1
2011_7388954336534303_manuscript;n = 106;106;-1
2011_7388954336534303_manuscript;n = 103;103;-1
2011_7388954336534303_manuscript;N = 175;175;-1
2011_7388954336534303_manuscript;total of 10;10;-1
2011_7422344526223783_manuscript;6 persons;6;39261
2011_7422344526223783_manuscript;9 persons;9;39324
2011_7422344526223783_manuscript;2 persons;2;39542
2011_7422344526223783_manuscript;8 persons;8;39606
2011_7422344526223783_manuscript;20 persons;20;40003
2011_7422344526223783_manuscript;98 patients;98;20653
2011_7422344526223783_manuscript;10 patients;10;20396
2011_7422344526223783_manuscript;58 patients;58;13728
2011_7422344526223783_manuscript;119 patients;119;11951
2011_7422344526223783_manuscript;27 patients;27;11887
2011_7422344526223783_manuscript;18 eligible patients;18;11545
2011_7422344526223783_manuscript;10   dementia patients;10;9429
2011_7422344526223783_manuscript;13   patients;13;2867
2011_7422344526223783_manuscript;13 patients;13;6270
2011_7422344526223783_manuscript;61 dementia patients;61;10421
2011_7422344526223783_manuscript;553 individuals;553;19968
2011_7422344526223783_manuscript;n=61;61;20627
2011_7422344526223783_manuscript;n=50;50;19353
2011_7422344526223783_manuscript;N=553;553;13528
2011_7422344526223783_manuscript;n=434;434;2762
2011_7422344526223783_manuscript;n=79;79;840
2011_7422344526223783_manuscript;n=35;35;2366
2011_7422344526223783_manuscript;n=63;63;5174
2011_7422344526223783_manuscript;n=96;96;5486
2011_7422344526223783_manuscript;n=32;32;7765
2011_7422344526223783_manuscript;n=84;84;8159
2011_7422344526223783_manuscript;n= 102;102;8840
2011_7422344526223783_manuscript;n=107;107;9324
2011_7422344526223783_manuscript;n  =  9;9;26345
2011_7422344526223783_manuscript;n  =  5;5;26443
2011_7422344526223783_manuscript;n  =  4;4;26496
2011_7422344526223783_manuscript;n  =  6;6;33935
2011_7422344526223783_manuscript;total of 67;67;5427
2011_7792417295285172_manuscript;12 participants;12;-1
2011_7792417295285172_manuscript;621 consenting eligible patients;621;-1
2011_7792417295285172_manuscript;642 patients;642;-1
2011_7792417295285172_manuscript;598 patients;598;-1
2011_7792417295285172_manuscript;87 patients;87;-1
2011_7792417295285172_manuscript;609 patients;609;-1
2011_7792417295285172_manuscript;23 patients;23;-1
2011_7792417295285172_manuscript;86 physicians enrolled;86;-1
2011_8084154951976293_manuscript;n=10;10;-1
2011_8084154951976293_manuscript;n=8;8;-1
2011_8335034415835119_manuscript;232 patients;232;-1
2011_8335034415835119_manuscript;70 patients;70;-1
2011_8335034415835119_manuscript;68 patients;68;-1
2011_8335034415835119_manuscript;   data from a 6;6;-1
2011_8588518559431849_manuscript;3 cohorts of KD and FC subjects;3;-1
2011_8588518559431849_manuscript;30 FC subjects;30;-1
2011_8588518559431849_manuscript;441 KD   patients;441;-1
2011_8588518559431849_manuscript;53 FC patients;53;-1
2011_8588518559431849_manuscript;783 patients;783;-1
2011_8588518559431849_manuscript;596   patients;596;-1
2011_8588518559431849_manuscript;12   KD blood group patients;12;-1
2011_8588518559431849_manuscript;25 KD urine group patients;25;-1
2011_8588518559431849_manuscript;5 million people;5;-1
2011_8588518559431849_manuscript;n=68;68;-1
2011_8588518559431849_manuscript;n=271;271;-1
2011_8588518559431849_manuscript;n=55;55;-1
2011_8588518559431849_manuscript;n=16;16;-1
2011_8588518559431849_manuscript;n=10;10;-1
2011_8588518559431849_manuscript;n=21;21;-1
2011_8588518559431849_manuscript;n=323;323;-1
2011_8588518559431849_manuscript;n=34;34;-1
2011_8588518559431849_manuscript;n=83;83;-1
2011_8588518559431849_manuscript;n=1;1;-1
2011_8588518559431849_manuscript;n=23;23;-1
2011_8588518559431849_manuscript;n=113;113;-1
2011_8588518559431849_manuscript;n=74;74;-1
2011_8588518559431849_manuscript;n=30;30;-1
2011_8588518559431849_manuscript;n = 441;441;-1
2011_8588518559431849_manuscript;n = 342;342;-1
2011_8588518559431849_manuscript;n = 53;53;-1
2011_8588518559431849_manuscript;n = 23;23;-1
2011_8588518559431849_manuscript;n = 16;16;-1
2011_8588518559431849_manuscript; data set of 783;783;-1
2011_9022520456248421_manuscript;1   diabetic patients;1;-1
2011_9022520456248421_manuscript;30  CSII young  CSII adults;30;-1
2011_9739352405619004_manuscript;n = 89,037;89037;-1
2011_9739352405619004_manuscript;total of 89,037;89037;-1
2011_9739352405619004_manuscript; data on MDE from 10;10;-1
2012_1001499325856017_manuscript;6 million   patients;6;26277
2012_1001499325856017_manuscript;n =   324;324;11110
2012_1001499325856017_manuscript;n = 405;405;11085
2012_1001499325856017_manuscript;n= 4;4;42400
2012_1001499325856017_manuscript;n=4;4;43143
2012_1001499325856017_manuscript;n=   4;4;44159
2012_1001499325856017_manuscript;n=6;6;45183
2012_1001499325856017_manuscript;n=5;5;45898
2012_1022332445827345_manuscript;359 symptomatic subjects;359;-1
2012_1022332445827345_manuscript;359 subjects;359;-1
2012_1022332445827345_manuscript;150 patients;150;-1
2012_1022332445827345_manuscript;359 patients;359;-1
2012_1022332445827345_manuscript;239 patients;239;-1
2012_1022332445827345_manuscript;209 of the patients;209;-1
2012_1022332445827345_manuscript;71 patients;71;-1
2012_1022332445827345_manuscript;91 patients;91;-1
2012_1022332445827345_manuscript;63 patients;63;-1
2012_1022332445827345_manuscript;101 normal patients;101;-1
2012_1022332445827345_manuscript;n=150;150;-1
2012_1022332445827345_manuscript;n=209;209;-1
2012_1022332445827345_manuscript;n=120;120;-1
2012_1022332445827345_manuscript;n=239;239;-1
2012_1022332445827345_manuscript;N=209;209;-1
2012_1044933637230104_manuscript;1304 subjects;1304;35848
2012_1044933637230104_manuscript;554 C-group subjects;554;35403
2012_1044933637230104_manuscript;17 subjects;17;24650
2012_1044933637230104_manuscript;11 control subjects;11;17105
2012_1044933637230104_manuscript;984 subjects;984;968
2012_1044933637230104_manuscript;301 subjects;301;464
2012_1044933637230104_manuscript;137   subjects;137;1179
2012_1044933637230104_manuscript;546 subjects;546;1866
2012_1044933637230104_manuscript;463 patients;463;20526
2012_1044933637230104_manuscript;571 patients;571;18779
2012_1044933637230104_manuscript;18 adults;18;26807
2012_1044933637230104_manuscript;10 adults;10;24520
2012_1044933637230104_manuscript;n=984;984;35381
2012_1044933637230104_manuscript;n = 430;430;3237
2012_1044933637230104_manuscript;n = 554;554;3219
2012_1044933637230104_manuscript;n = 984;984;3196
2012_1044933637230104_manuscript;n = 85;85;487
2012_1044933637230104_manuscript;n = 216;216;506
2012_1044933637230104_manuscript;n = 22;22;1204
2012_1044933637230104_manuscript;n = 115;115;1223
2012_1044933637230104_manuscript;n = 447;447;1891
2012_1044933637230104_manuscript;n = 99;99;1911
2012_1044933637230104_manuscript;total of 463;463;20535
2012_1044933637230104_manuscript;total of 571;571;18788
2012_1046272223815786_manuscript;2max women;2;-1
2012_1046272223815786_manuscript;total of 4454;4454;-1
2012_1046272223815786_manuscript; data of 6;6;-1
2012_1049566980842811_manuscript;29   women;29;-1
2012_1049566980842811_manuscript;2 million women;2;-1
2012_1049566980842811_manuscript;32,465 women;32465;-1
2012_1049566980842811_manuscript;64   women;64;-1
2012_1049566980842811_manuscript;74   women;74;-1
2012_1049566980842811_manuscript;541 women;541;-1
2012_1049566980842811_manuscript;3,745 women;3745;-1
2012_1049566980842811_manuscript;796 women;796;-1
2012_1049566980842811_manuscript;111   these women;111;-1
2012_1049566980842811_manuscript;864 women;864;-1
2012_1049566980842811_manuscript;3 million women;3;-1
2012_1049566980842811_manuscript;1,178,939 women;1178939;-1
2012_1049566980842811_manuscript;131   women;131;-1
2012_1049566980842811_manuscript;164   of women;164;-1
2012_1049566980842811_manuscript;2,431 women;2431;-1
2012_1049566980842811_manuscript;8 women;8;-1
2012_1049566980842811_manuscript;4 such women;4;-1
2012_1049566980842811_manuscript;11 women;11;-1
2012_1049566980842811_manuscript;239   women;239;-1
2012_1049566980842811_manuscript;4 of UK women;4;-1
2012_1049566980842811_manuscript;314   non-obese women;314;-1
2012_1049566980842811_manuscript;21,828 British men and women;21828;-1
2012_1049566980842811_manuscript;5,992   No. of women;5992;-1
2012_1049566980842811_manuscript;32,465   No. of women;32465;-1
2012_1049566980842811_manuscript;81   participants;81;-1
2012_1049566980842811_manuscript;83   participants;83;-1
2012_1049566980842811_manuscript;84   participants;84;-1
2012_1049566980842811_manuscript;95   were also participants;95;-1
2012_1049566980842811_manuscript;310 000 participants;310000;-1
2012_1049566980842811_manuscript;378579 individuals;378579;-1
2012_1049566980842811_manuscript;900 000 adults;900000;-1
2012_1049566980842811_manuscript;46 million white   adults;46;-1
2012_1049566980842811_manuscript;3 million women recruited;3;-1
2012_1049566980842811_manuscript;307   cohort was recruited;307;-1
2012_1049566980842811_manuscript;N=2,431;2431;-1
2012_1049566980842811_manuscript;N=28,866;28866;-1
2012_1049566980842811_manuscript;N=44,787;44787;-1
2012_1049566980842811_manuscript;N=509,874;509874;-1
2012_1049566980842811_manuscript;N=420,712;420712;-1
2012_1049566980842811_manuscript;N=145,551;145551;-1
2012_1049566980842811_manuscript;N=58,015;58015;-1
2012_1049566980842811_manuscript;N=1,178,939;1178939;-1
2012_1158975230731671_manuscript;476 patients;476;-1
2012_1158975230731671_manuscript;34   patients;34;-1
2012_1158975230731671_manuscript;2   cohorts of people;2;-1
2012_1158975230731671_manuscript;n  =2;2;-1
2012_1158975230731671_manuscript;n  =7;7;-1
2012_1161985098773480_manuscript;120 liver cirrhosis patients;120;-1
2012_1161985098773480_manuscript;120 patients;120;-1
2012_1161985098773480_manuscript;22 ELISA were unaware of patients;22;-1
2012_1161985098773480_manuscript;159 patients;159;-1
2012_1161985098773480_manuscript;14   patients;14;-1
2012_1161985098773480_manuscript;29 patients;29;-1
2012_1161985098773480_manuscript;13 patients;13;-1
2012_1161985098773480_manuscript;16 patients;16;-1
2012_1161985098773480_manuscript;22 significantly discriminated patients;22;-1
2012_1161985098773480_manuscript;n=57;57;-1
2012_1161985098773480_manuscript;n=40;40;-1
2012_1161985098773480_manuscript;n=120;120;-1
2012_1173488141754412_manuscript;29 patients;29;38477
2012_1173488141754412_manuscript;9   analyzed patients;9;2945
2012_1173488141754412_manuscript;9 analyzed patients;9;2578
2012_1173488141754412_manuscript;n = 9;9;2949
2012_1173488141754412_manuscript;n   = 9;9;2584
2012_1173488141754412_manuscript;n=12;12;696
2012_1173488141754412_manuscript;n=17;17;680
2012_1173488141754412_manuscript;n=29;29;663
2012_1188078910659340_manuscript;352 participants;352;2231
2012_1188078910659340_manuscript;352 were recruited;352;2082
2012_1188078910659340_manuscript;n = 5;5;2908
2012_1216224540738942_manuscript;3 individuals;3;-1
2012_1216224540738942_manuscript;2 excluded all individuals;2;-1
2012_1216224540738942_manuscript;40 individuals;40;-1
2012_1216224540738942_manuscript;n=175;175;-1
2012_1216224540738942_manuscript;n=32;32;-1
2012_1216224540738942_manuscript;n=67;67;-1
2012_1216224540738942_manuscript;n=51;51;-1
2012_1216224540738942_manuscript;n=127;127;-1
2012_1216224540738942_manuscript;n=108;108;-1
2012_1216224540738942_manuscript;n=35;35;-1
2012_1216224540738942_manuscript;n=40;40;-1
2012_1216224540738942_manuscript;n=106;106;-1
2012_1216224540738942_manuscript;n=79;79;-1
2012_1216224540738942_manuscript;n=126;126;-1
2012_1216224540738942_manuscript;n=20;20;-1
2012_1235877497873229_manuscript;1435 patients;1435;-1
2012_1235877497873229_manuscript;873 patients;873;-1
2012_1235877497873229_manuscript;411 patients;411;-1
2012_1235877497873229_manuscript;265   patients;265;-1
2012_1235877497873229_manuscript;124 Japanese patients;124;-1
2012_1235877497873229_manuscript;50 consecutive established   RA patients;50;-1
2012_1235877497873229_manuscript;14 early RA patients;14;-1
2012_1235877497873229_manuscript;92 RA and UA   patients;92;-1
2012_1235877497873229_manuscript;309 patients;309;-1
2012_1235877497873229_manuscript;25   patients;25;-1
2012_1235877497873229_manuscript;91 RA patients;91;-1
2012_1235877497873229_manuscript;3435TT patients;3435;-1
2012_1235877497873229_manuscript;2R patients;2;-1
2012_1235877497873229_manuscript;829TT patients;829;-1
2012_1235877497873229_manuscript;347CC   patients;347;-1
2012_1235877497873229_manuscript;1298AA-positive patients;1298;-1
2012_1235877497873229_manuscript;876   patients;876;-1
2012_1235877497873229_manuscript;210 patients;210;-1
2012_1235877497873229_manuscript;18,572 patients;18572;-1
2012_1235877497873229_manuscript;n = 205;205;-1
2012_1235877497873229_manuscript;n =   484;484;-1
2012_1235877497873229_manuscript;n=496;496;-1
2012_1235877497873229_manuscript;n = 38;38;-1
2012_1235877497873229_manuscript;n = 8;8;-1
2012_1235877497873229_manuscript;n = 25;25;-1
2012_1235877497873229_manuscript;n = 84;84;-1
2012_1235877497873229_manuscript;n = 174;174;-1
2012_1235877497873229_manuscript;n = 92;92;-1
2012_1235877497873229_manuscript;n = 48;48;-1
2012_1235877497873229_manuscript;n = 2614;2614;-1
2012_1252263068734107_manuscript;7 million   participants;7;-1
2012_1329416829860198_manuscript;55 VS and MCS patients;55;-1
2012_1329416829860198_manuscript;6 MCS   patients;6;-1
2012_1329416829860198_manuscript;5 VS patients;5;-1
2012_1329416829860198_manuscript;12 VS patients;12;-1
2012_1329416829860198_manuscript;55   patients;55;-1
2012_1329416829860198_manuscript;18 VS patients;18;-1
2012_1329416829860198_manuscript;37 MCS   patients;37;-1
2012_1329416829860198_manuscript;55 patients;55;-1
2012_1329416829860198_manuscript;37 MCS patients;37;-1
2012_1329416829860198_manuscript;31 TBI patients;31;-1
2012_1329416829860198_manuscript;24 non-TBI patients;24;-1
2012_1358087974848130_manuscript;11 women;11;21171
2012_1358087974848130_manuscript;09 participants;9;18089
2012_1358087974848130_manuscript;15 participants;15;17343
2012_1358087974848130_manuscript;10   participants;10;9849
2012_1358087974848130_manuscript;09   participants;9;780
2012_1358087974848130_manuscript;10 subjects;10;9694
2012_1358087974848130_manuscript;7 subjects;7;9587
2012_1358087974848130_manuscript;N=10;10;9235
2012_1358087974848130_manuscript;N=7;7;9192
2012_1361927036850496_manuscript;37 individuals;37;-1
2012_1361927036850496_manuscript;total of 23;23;-1
2012_1370005947874793_manuscript;n=148;148;-1
2012_1370005947874793_manuscript;total of 31;31;-1
2012_1390013453838937_manuscript;n = 12;12;-1
2012_1390013453838937_manuscript;n = 6;6;-1
2012_1390013453838937_manuscript;n = 8;8;-1
2012_1390013453838937_manuscript;n = 3;3;-1
2012_1390013453838937_manuscript;n =   12;12;-1
2012_1393354560773764_manuscript;19 subjects;19;-1
2012_1393354560773764_manuscript;24 patients;24;-1
2012_1393354560773764_manuscript;12   CF patients;12;-1
2012_1398825556666863_manuscript;n = 10;10;46808
2012_1398825556666863_manuscript;n = 8;8;46842
2012_1398825556666863_manuscript;n = 9;9;46875
2012_1398825556666863_manuscript;n = 16;16;46910
2012_1398825556666863_manuscript;n = 7;7;46947
2012_1398825556666863_manuscript;n = 3;3;48096
2012_1398825556666863_manuscript;n = 6;6;48844
2012_1398825556666863_manuscript;n = 4;4;49787
2012_1398825556666863_manuscript;n =   3;3;52463
2012_1398825556666863_manuscript;n =   16;16;54477
2012_1398825556666863_manuscript;n   = 10;10;54572
2012_1419686132867967_manuscript;N=11314364;11314364;-1
2012_1426229142875579_manuscript;1 diabetes subjects;1;-1
2012_1426229142875579_manuscript;16 subjects;16;-1
2012_1426229142875579_manuscript;16   subjects;16;-1
2012_1426229142875579_manuscript;n=52;52;-1
2012_1426229142875579_manuscript;n=50;50;-1
2012_1426229142875579_manuscript;N= 16;16;-1
2012_1455019915788183_manuscript;18 POLY individual patients;18;6523
2012_1455019915788183_manuscript;14 SJIA patients;14;9497
2012_1455019915788183_manuscript;31 unique SJIA patients;31;45155
2012_1455019915788183_manuscript;18 unique PolyJIA patients;18;45184
2012_1455019915788183_manuscript;15 SJIA patients;15;45212
2012_1455019915788183_manuscript;7 PolyJIA patients;7;45233
2012_1455019915788183_manuscript;n=15;15;6742
2012_1455019915788183_manuscript;n=7;7;6753
2012_1455019915788183_manuscript;n= 131;131;10119
2012_1455019915788183_manuscript;n= 50;50;10285
2012_1455019915788183_manuscript;n=75;75;12043
2012_1455019915788183_manuscript;n=189;189;20099
2012_1455019915788183_manuscript;n=119;119;24839
2012_1455019915788183_manuscript;total of 46;46;6583
2012_1474681647763596_manuscript;N = 4;4;-1
2012_1474681647763596_manuscript;n = 6;6;-1
2012_1474681647763596_manuscript;N = 3;3;-1
2012_1474681647763596_manuscript;N = 7;7;-1
2012_1474681647763596_manuscript;n = 3;3;-1
2012_1474681647763596_manuscript;N = 6;6;-1
2012_1476391701806359_manuscript;250,000,000 women;250000000;-1
2012_1476391701806359_manuscript;N=10;10;-1
2012_1476391701806359_manuscript;N=5;5;-1
2012_1476391701806359_manuscript;n=5;5;-1
2012_1476391701806359_manuscript;N = 6;6;-1
2012_1476391701806359_manuscript;N = 3;3;-1
2012_1476391701806359_manuscript;n=4;4;-1
2012_1477252077791450_manuscript;1 influenza patients;1;-1
2012_1477252077791450_manuscript;230 patients;230;-1
2012_1477252077791450_manuscript;1013 patients;1013;-1
2012_1477252077791450_manuscript;1520 patients;1520;-1
2012_1477252077791450_manuscript;197 patients;197;-1
2012_1477252077791450_manuscript;3043 adults;3043;-1
2012_1477252077791450_manuscript;   database of 3043;3043;-1
2012_1477252077791450_manuscript; data from 61;61;-1
2012_1515107698524935_manuscript;70 women;70;18080
2012_1515107698524935_manuscript;n = 24;24;11009
2012_1515107698524935_manuscript;n = 12;12;8132
2012_1515107698524935_manuscript;n=384;384;2738
2012_1515107698524935_manuscript;n=288;288;7975
2012_1515107698524935_manuscript;n=48;48;41664
2012_1515107698524935_manuscript;n=32;32;41723
2012_1515107698524935_manuscript;n=16;16;41787
2012_1515107698524935_manuscript;n=36;36;42594
2012_1515107698524935_manuscript;n=24;24;48433
2012_1515107698524935_manuscript;n=12;12;49636
2012_1515107698524935_manuscript; data of 8;8;50114
2012_1587032086738351_manuscript;216 participants;216;-1
2012_1587032086738351_manuscript;127!  Potential participants;127;-1
2012_1587032086738351_manuscript;153!  participants;153;-1
2012_1587032086738351_manuscript;240 participants;240;-1
2012_1587032086738351_manuscript;284!  participants;284;-1
2012_1587032086738351_manuscript;293!  participants;293;-1
2012_1587032086738351_manuscript;220 305!  participants;220305;-1
2012_1587032086738351_manuscript;61 participants;61;-1
2012_1587032086738351_manuscript;316!  Two intervention group participants;316;-1
2012_1587032086738351_manuscript;325!  participants;325;-1
2012_1587032086738351_manuscript;352!  less frail participants;352;-1
2012_1587032086738351_manuscript;355!  participants;355;-1
2012_1587032086738351_manuscript;20!  participants;20;-1
2012_1587032086738351_manuscript;35!  people;35;-1
2012_1587032086738351_manuscript;79!  frail older people;79;-1
2012_1587032086738351_manuscript;111!  frail older people;111;-1
2012_1587032086738351_manuscript;139!  Community-dwelling older people;139;-1
2012_1587032086738351_manuscript;208!  people;208;-1
2012_1587032086738351_manuscript;241 people;241;-1
2012_1587032086738351_manuscript;17!  Our sample of frail older people;17;-1
2012_1587032086738351_manuscript;376!  people;376;-1
2012_1587032086738351_manuscript;392!  frail older people;392;-1
2012_1587032086738351_manuscript;406!  older people;406;-1
2012_1587032086738351_manuscript;462!  For frail older people;462;-1
2012_1587032086738351_manuscript;493!  frail older people;493;-1
2012_1587032086738351_manuscript;49!  those recruited;49;-1
2012_1587032086738351_manuscript;285!  were recruited;285;-1
2012_1587032086738351_manuscript;n=149;149;-1
2012_1587032086738351_manuscript;n=79;79;-1
2012_1587032086738351_manuscript;n=76;76;-1
2012_1587032086738351_manuscript;n=140;140;-1
2012_1587032086738351_manuscript;n=120;120;-1
2012_1587032086738351_manuscript;n=121;121;-1
2012_1587032086738351_manuscript;n=1;1;-1
2012_1587032086738351_manuscript;n= 111;111;-1
2012_1587032086738351_manuscript;n=107;107;-1
2012_1587032086738351_manuscript;n=117;117;-1
2012_1587032086738351_manuscript;n=109;109;-1
2012_1587032086738351_manuscript;n=111;111;-1
2012_1587032086738351_manuscript;n=42;42;-1
2012_1587032086738351_manuscript;n=17;17;-1
2012_1587032086738351_manuscript;n=23;23;-1
2012_1587032086738351_manuscript;n=24;24;-1
2012_1601979844712271_manuscript;41 women;41;16409
2012_1601979844712271_manuscript;1,292 idiopathic infertility patients;1292;41051
2012_1601979844712271_manuscript;1,292   idiopathic infertility patients;1292;40931
2012_1601979844712271_manuscript;1,657   infertile patients;1657;36865
2012_1601979844712271_manuscript;268 infertility patients;268;36069
2012_1601979844712271_manuscript;256   infertility patients;256;36010
2012_1601979844712271_manuscript;768   infertility patients;768;35932
2012_1601979844712271_manuscript;768 patients;768;22628
2012_1601979844712271_manuscript;524 infertility patients;524;19335
2012_1601979844712271_manuscript;768   patients;768;18715
2012_1601979844712271_manuscript;1,633 patients;1633;9822
2012_1601979844712271_manuscript;1,772 Han Chinese individuals;1772;26164
2012_1601979844712271_manuscript;n = 2;2;34122
2012_1601979844712271_manuscript;n = 12;12;20819
2012_1601979844712271_manuscript;n = 480;480;1131
2012_1601979844712271_manuscript;n = 524;524;1108
2012_1601979844712271_manuscript;n = 768;768;1085
2012_1601979844712271_manuscript;n   =   4;4;2002
2012_1601979844712271_manuscript;n   =   5;5;2046
2012_1601979844712271_manuscript;n   =   7;7;2091
2012_1601979844712271_manuscript;total of 1,292;1292;40940
2012_1601979844712271_manuscript;total of 1,657;1657;36874
2012_1601979844712271_manuscript;total of 450;450;22586
2012_1624597712681754_manuscript;n=142;142;4720
2012_1624597712681754_manuscript;n=16;16;438
2012_1624597712681754_manuscript;n=10;10;1693
2012_1624597712681754_manuscript;n=18;18;20703
2012_1626766677357256_manuscript;5000   patients;5000;-1
2012_1626766677357256_manuscript;70,616 patients;70616;-1
2012_1626766677357256_manuscript;2114 adult patients;2114;-1
2012_1626766677357256_manuscript;197   Outcome of patients;197;-1
2012_1626766677357256_manuscript;198   patients;198;-1
2012_1626766677357256_manuscript;110 consecutive patients;110;-1
2012_1626766677357256_manuscript;272   patients;272;-1
2012_1626766677357256_manuscript;total of   97;97;-1
2012_1674437099816346_manuscript;6   subjects;6;-1
2012_1674437099816346_manuscript;7 patients;7;-1
2012_1674437099816346_manuscript;n=38;38;-1
2012_1674437099816346_manuscript;n=20;20;-1
2012_1693757420664135_manuscript;5 neurologically normal patients;5;-1
2012_1693757420664135_manuscript;95 epilepsy patients;95;-1
2012_1693757420664135_manuscript;3 patients;3;-1
2012_1693757420664135_manuscript;4 patients;4;-1
2012_1693757420664135_manuscript;4 genotype patients;4;-1
2012_1693757420664135_manuscript;59 epilepsy patients;59;-1
2012_1693757420664135_manuscript;3   patients;3;-1
2012_1693757420664135_manuscript;4   patients;4;-1
2012_1693757420664135_manuscript;n = 6;6;-1
2012_1693757420664135_manuscript;n = 4;4;-1
2012_1758203110793054_manuscript;2 diabetes patients;2;-1
2012_1758203110793054_manuscript;714 patients;714;-1
2012_1758203110793054_manuscript;12,000 patients;12000;-1
2012_1758203110793054_manuscript;2 diabetes   patients;2;-1
2012_1758203110793054_manuscript;25 patients;25;-1
2012_1760215772800444_manuscript;n=57;57;-1
2012_1760215772800444_manuscript;n=35;35;-1
2012_1760215772800444_manuscript;n=7;7;-1
2012_1760215772800444_manuscript;n=2;2;-1
2012_1760215772800444_manuscript;n=94;94;-1
2012_1760215772800444_manuscript;n=43;43;-1
2012_1760215772800444_manuscript;n=13;13;-1
2012_1760215772800444_manuscript;n=29;29;-1
2012_1760215772800444_manuscript;n=17;17;-1
2012_1760215772800444_manuscript;n=6;6;-1
2012_1760215772800444_manuscript;n=34;34;-1
2012_1760215772800444_manuscript;n=45;45;-1
2012_1760215772800444_manuscript;n=76;76;-1
2012_1760215772800444_manuscript;n=19;19;-1
2012_1760215772800444_manuscript;n=8;8;-1
2012_1760215772800444_manuscript;n=26;26;-1
2012_1760215772800444_manuscript;n=14;14;-1
2012_1760215772800444_manuscript;n=10;10;-1
2012_1760215772800444_manuscript;n=32;32;-1
2012_1760215772800444_manuscript;n=12;12;-1
2012_1760215772800444_manuscript;n=9;9;-1
2012_1760215772800444_manuscript;n=5;5;-1
2012_1760215772800444_manuscript;n=23;23;-1
2012_1760215772800444_manuscript;n=24;24;-1
2012_1760215772800444_manuscript;n=3;3;-1
2012_1760215772800444_manuscript;n=4;4;-1
2012_1760215772800444_manuscript;n=48;48;-1
2012_1760215772800444_manuscript;n=41;41;-1
2012_1853568711803988_manuscript;100,000 women;100000;-1
2012_1853568711803988_manuscript;5 million women;5;-1
2012_1853568711803988_manuscript;4 thousand women;4;-1
2012_1853568711803988_manuscript;60 thousand VIA-positive women;60;-1
2012_1853568711803988_manuscript;510   people;510;-1
2012_1864587566830998_manuscript;59,123 women;59123;-1
2012_1864587566830998_manuscript;103,835 women;103835;-1
2012_1864587566830998_manuscript;81,301 of these women;81301;-1
2012_1864587566830998_manuscript;7,406 women;7406;-1
2012_1864587566830998_manuscript;14,012 women;14012;-1
2012_1864587566830998_manuscript;9,792 women;9792;-1
2012_1864587566830998_manuscript;24   and smoking women;24;-1
2012_1864587566830998_manuscript;49,102 women;49102;-1
2012_1864587566830998_manuscript;17,491 women;17491;-1
2012_1864587566830998_manuscript;24   women;24;-1
2012_1864587566830998_manuscript;4   women;4;-1
2012_1864587566830998_manuscript;11   women;11;-1
2012_1864587566830998_manuscript;119 women;119;-1
2012_1864587566830998_manuscript;1   participants;1;-1
2012_1864587566830998_manuscript;n=1,451;1451;-1
2012_1864587566830998_manuscript;n=856;856;-1
2012_1864587566830998_manuscript;n=4,503;4503;-1
2012_1864587566830998_manuscript;n=4,733;4733;-1
2012_1864587566830998_manuscript;n=119;119;-1
2012_1864587566830998_manuscript;n=45,053;45053;-1
2012_1864587566830998_manuscript;n=54,136;54136;-1
2012_1864587566830998_manuscript;n=59,123;59123;-1
2012_1864587566830998_manuscript;n=49,102;49102;-1
2012_1864587566830998_manuscript;n=240;240;-1
2012_1864587566830998_manuscript;n=1,211;1211;-1
2012_1864587566830998_manuscript;n=28,949;28949;-1
2012_1864587566830998_manuscript;total of 59,123;59123;-1
2012_1864587566830998_manuscript;total of 49,102;49102;-1
2012_1864587566830998_manuscript;data from Q1;1;-1
2012_1873081497860954_manuscript;406 participants;406;-1
2012_1873081497860954_manuscript;29 subjects;29;-1
2012_1873081497860954_manuscript;406 subjects;406;-1
2012_1873081497860954_manuscript;31 patients;31;-1
2012_1873081497860954_manuscript;84 individuals;84;-1
2012_1873081497860954_manuscript;total of 29;29;-1
2012_1873081497860954_manuscript;total of 31;31;-1
2012_1873081497860954_manuscript;total of 97;97;-1
2012_1873081497860954_manuscript;total of   91;91;-1
2012_1888740752685152_manuscript;n = 21;21;-1
2012_1888740752685152_manuscript;n = 5;5;-1
2012_1888740752685152_manuscript;n = 4;4;-1
2012_1888740752685152_manuscript;n = 12;12;-1
2012_1888740752685152_manuscript;n = 101;101;-1
2012_1888740752685152_manuscript;n = 76;76;-1
2012_1888740752685152_manuscript;n = 400;400;-1
2012_1888740752685152_manuscript;n =   12;12;-1
2012_1888740752685152_manuscript;n = 6;6;-1
2012_1888740752685152_manuscript; data from VO2;2;-1
2012_1894044408738686_manuscript;77 women;77;-1
2012_1894044408738686_manuscript;53   adults;53;-1
2012_1894044408738686_manuscript;158   adults;158;-1
2012_1894044408738686_manuscript;n = 123;123;-1
2012_1894044408738686_manuscript;n = 151;151;-1
2012_1894044408738686_manuscript;n = 90;90;-1
2012_1894044408738686_manuscript;n = 119;119;-1
2012_1894044408738686_manuscript;n = 93;93;-1
2012_1894044408738686_manuscript;n = 901;901;-1
2012_1894044408738686_manuscript;n =   100;100;-1
2012_1894044408738686_manuscript;n = 618;618;-1
2012_1894044408738686_manuscript;n = 110;110;-1
2012_1894044408738686_manuscript;n = 228;228;-1
2012_1894044408738686_manuscript;n = 34;34;-1
2012_1894044408738686_manuscript;n = 322;322;-1
2012_1894044408738686_manuscript;n = 53;53;-1
2012_1894044408738686_manuscript;n = 382;382;-1
2012_1894044408738686_manuscript;n = 37;37;-1
2012_1894044408738686_manuscript;n = 158;158;-1
2012_1894044408738686_manuscript;n = 111;111;-1
2012_1894044408738686_manuscript;n = 65;65;-1
2012_1894044408738686_manuscript;n = 165;165;-1
2012_1894044408738686_manuscript;n = 598;598;-1
2012_1894044408738686_manuscript;n = 442;442;-1
2012_1894044408738686_manuscript;n = 36;36;-1
2012_1894044408738686_manuscript;n = 99;99;-1
2012_1894044408738686_manuscript;n = 44;44;-1
2012_1894044408738686_manuscript;n = 42 481;42481;-1
2012_1894044408738686_manuscript;n = 2054;2054;-1
2012_1900079847755291_manuscript;24 active AOSD   patients;24;-1
2012_1900079847755291_manuscript;20   patients;20;-1
2012_1900079847755291_manuscript;18 patients;18;-1
2012_1900079847755291_manuscript;8 patients;8;-1
2012_1900079847755291_manuscript;3 patients;3;-1
2012_1900079847755291_manuscript;24 patients;24;-1
2012_1900079847755291_manuscript;15   AOSD patients;15;-1
2012_1900079847755291_manuscript;62 patients;62;-1
2012_1900079847755291_manuscript;24 active AOSD patients;24;-1
2012_1900079847755291_manuscript;12 AOSD patients;12;-1
2012_1900079847755291_manuscript;n=31;31;-1
2012_1900079847755291_manuscript;n=8;8;-1
2012_1900079847755291_manuscript;n=2;2;-1
2012_1900079847755291_manuscript;n=0;0;-1
2012_1900079847755291_manuscript;n=1;1;-1
2012_1900079847755291_manuscript;n=474;474;-1
2012_1900079847755291_manuscript;n=306;306;-1
2012_1900079847755291_manuscript;n=51;51;-1
2012_1900079847755291_manuscript;n=85;85;-1
2012_1900079847755291_manuscript;n=70;70;-1
2012_1900079847755291_manuscript;n=24;24;-1
2012_1900079847755291_manuscript;n = 24;24;-1
2012_1900079847755291_manuscript;n=12;12;-1
2012_1909059719850911_manuscript;33 individuals;33;-1
2012_1909059719850911_manuscript;n = 33;33;-1
2012_1909059719850911_manuscript;n = 4,201;4201;-1
2012_1909059719850911_manuscript;n = 5,622;5622;-1
2012_1949506648705369_manuscript;8371 women;8371;7787
2012_1949506648705369_manuscript;132   women;132;7897
2012_1949506648705369_manuscript;207 women;207;8016
2012_1949506648705369_manuscript;19864   participants;19864;31971
2012_1949506648705369_manuscript;20773 subjects;20773;5287
2012_1949506648705369_manuscript;19864   subjects;19864;7743
2012_1949506648705369_manuscript;19864 subjects;19864;8520
2012_1949506648705369_manuscript;19864 study subjects;19864;8553
2012_1949506648705369_manuscript;902 subjects;902;30889
2012_1949506648705369_manuscript;19864 adults;19864;2764
2012_1949506648705369_manuscript;n=3;3;30472
2012_1979167138011003_manuscript;1 million participants;1;-1
2012_1979167138011003_manuscript;1,600 subjects;1600;-1
2012_1979167138011003_manuscript;1,468 subjects;1468;-1
2012_1979167138011003_manuscript;1468 subjects;1468;-1
2012_1979167138011003_manuscript;1 disease patients;1;-1
2012_1979167138011003_manuscript;2D patients;2;-1
2012_1979167138011003_manuscript;179 individuals;179;-1
2012_1979167138011003_manuscript;820 obese   individuals;820;-1
2012_1979167138011003_manuscript;1443 individuals;1443;-1
2012_1979167138011003_manuscript;n= 0;0;-1
2012_1979167138011003_manuscript; data of 179;179;-1
2012_1979167138011003_manuscript; data from the 1000;1000;-1
2012_1996644488784456_manuscript;n=12;12;-1
2012_1996644488784456_manuscript;n=4;4;-1
2012_1996644488784456_manuscript;n=5;5;-1
2012_1996644488784456_manuscript;n=6;6;-1
2012_2097681897833288_manuscript;217 women;217;-1
2012_2097681897833288_manuscript;48 women;48;-1
2012_2097681897833288_manuscript;217 PCOS patients;217;-1
2012_2097681897833288_manuscript;72 patients;72;-1
2012_2097681897833288_manuscript;74 patients;74;-1
2012_2097681897833288_manuscript;33 patients;33;-1
2012_2097681897833288_manuscript;38 patients;38;-1
2012_2097681897833288_manuscript;total of 217;217;-1
2012_2097681897833288_manuscript;total of 128;128;-1
2012_2097681897833288_manuscript;total of 45;45;-1
2012_2101184150859655_manuscript;10 participants;10;-1
2012_2101184150859655_manuscript;973 participants;973;-1
2012_2101184150859655_manuscript;2891 participants;2891;-1
2012_2101184150859655_manuscript;448 participants;448;-1
2012_2101184150859655_manuscript;24 patients;24;-1
2012_2101184150859655_manuscript;N=2891;2891;-1
2012_2101184150859655_manuscript;n = 2891;2891;-1
2012_2101184150859655_manuscript;n = 973;973;-1
2012_2101184150859655_manuscript;total of 16;16;-1
2012_2289764947857764_manuscript;18 patients;18;-1
2012_2289764947857764_manuscript;3 patients;3;-1
2012_2466603387213034_manuscript;n = 6;6;-1
2012_2466603387213034_manuscript;n = 4;4;-1
2012_2466603387213034_manuscript;total of 2890;2890;-1
2012_3688279807247876_manuscript;64 patients;64;-1
2012_3688279807247876_manuscript;2 diabetic patients;2;-1
2012_3688279807247876_manuscript;113 patients;113;-1
2012_3688279807247876_manuscript;25 patients;25;-1
2012_3688279807247876_manuscript;8 of the patients;8;-1
2012_3688279807247876_manuscript;4 patients;4;-1
2012_3688279807247876_manuscript;3 patients;3;-1
2012_3688279807247876_manuscript;12 renal transplanted patients;12;-1
2012_3688279807247876_manuscript;n=33;33;-1
2012_3688279807247876_manuscript;n=64;64;-1
2012_3688279807247876_manuscript;n=130;130;-1
2012_3688279807247876_manuscript;n= 64;64;-1
2012_3688279807247876_manuscript;n=31;31;-1
2012_3688279807247876_manuscript;n=29;29;-1
2012_3688279807247876_manuscript;n=28;28;-1
2012_3688279807247876_manuscript;n=121;121;-1
2012_3688279807247876_manuscript;n=57;57;-1
2012_3688279807247876_manuscript;n=50;50;-1
2012_3688279807247876_manuscript;n=5;5;-1
2012_3688279807247876_manuscript;n=2;2;-1
2012_3688279807247876_manuscript;total of 20;20;-1
2012_3688279807247876_manuscript;total of 113;113;-1
2012_3688279807247876_manuscript;total of 64;64;-1
2012_3777607008730945_manuscript;1,746 participants;1746;2185
2012_3777607008730945_manuscript;3,647 subjects;3647;1499
2012_3777607008730945_manuscript;1,650 people;1650;208
2012_3777607008730945_manuscript;840 individuals;840;2081
2012_3777607008730945_manuscript;723 individuals;723;2556
2012_3777607008730945_manuscript;n=3,120;3120;8731
2012_3777607008730945_manuscript;n=1,712;1712;8621
2012_3777607008730945_manuscript;n=723;723;3813
2012_3777607008730945_manuscript;n=989;989;4196
2012_3777607008730945_manuscript;n=3120;3120;28823
2012_3777607008730945_manuscript;n=1712;1712;30340
2012_3777607008730945_manuscript;total of 1,746;1746;2176
2012_4235968167487789_manuscript;n=9;9;15825
2012_4235968167487789_manuscript;n=30;30;7718
2012_4235968167487789_manuscript;n=15;15;6720
2012_4235968167487789_manuscript;n=3;3;7718
2012_4235968167487789_manuscript;n=5;5;115
2012_4245252498785927_manuscript;7 million participants;7;-1
2012_4245252498785927_manuscript;20,822   people;20822;-1
2012_4548777477398210_manuscript;4493 adult patients;4493;10917
2012_4548777477398210_manuscript;9      patients;9;314
2012_4548777477398210_manuscript;1912 RA patients;1912;502
2012_4548777477398210_manuscript;131 patients;131;3022
2012_4548777477398210_manuscript;2450 patients;2450;4504
2012_4548777477398210_manuscript;589   patients;589;4589
2012_4548777477398210_manuscript;600 patients;600;4822
2012_4548777477398210_manuscript;2450 patients were enrolled;2450;4504
2012_4943319047463225_manuscript;106 HCC patients;106;5900
2012_4943319047463225_manuscript;n = 64;64;7532
2012_4943319047463225_manuscript;n = 42;42;7566
2012_4943319047463225_manuscript;n = 10;10;28083
2012_4943319047463225_manuscript;total of 101;101;7058
2012_5678434318197292_manuscript;n=0;0;-1
2012_5678434318197292_manuscript;n = 0;0;-1
2012_5678434318197292_manuscript;n =   2,000;2000;-1
2012_5678434318197292_manuscript;n =   0;0;-1
2012_5678434318197292_manuscript; data of 30;30;-1
2012_5678434318197292_manuscript; dataset of 93;93;-1
2012_5678434318197292_manuscript; database of 2000;2000;-1
2012_5893531067469282_manuscript;149 participants;149;20239
2012_5893531067469282_manuscript;121 participants;121;20125
2012_5893531067469282_manuscript;75 subjects;75;22966
2012_5893531067469282_manuscript;n=149;149;35982
2012_5893531067469282_manuscript;n=59;59;20095
2012_5893531067469282_manuscript;n=62;62;20070
2012_5893531067469282_manuscript;n=90;90;19819
2012_5893531067469282_manuscript;n=13;13;19761
2012_5893531067469282_manuscript;n=101;101;19499
2012_5893531067469282_manuscript;n=47;47;19212
2012_5893531067469282_manuscript;n=54;54;19188
2012_5893531067469282_manuscript;N=75;75;15666
2012_5893531067469282_manuscript;n = 149;149;78
2012_5893531067469282_manuscript;n = 76;76;70
2012_5893531067469282_manuscript;n=73;73;61
2012_5893531067469282_manuscript;n=76;76;2086
2012_5923026528153540_manuscript;77,669 persons;77669;-1
2012_5923026528153540_manuscript;17,007 persons;17007;-1
2012_5923026528153540_manuscript;900 persons;900;-1
2012_5923026528153540_manuscript;3,557 subjects;3557;-1
2012_5923026528153540_manuscript;217 bipolar patients;217;-1
2012_5923026528153540_manuscript;n = 2,929,065;2929065;-1
2012_5923026528153540_manuscript;n = 1,480,648;1480648;-1
2012_5923026528153540_manuscript;n = 1,448,417;1448417;-1
2012_5923026528153540_manuscript;n= 25;25;-1
2012_5923026528153540_manuscript;n = 18;18;-1
2012_5923026528153540_manuscript;total of 77,669;77669;-1
2012_5923026528153540_manuscript;total of 10,001;10001;-1
2012_5923026528153540_manuscript;total of 900;900;-1
2012_6178254786081384_manuscript;3 status of the   persons;3;-1
2012_6178254786081384_manuscript;65229 participants;65229;-1
2012_6178254786081384_manuscript;20,485 patients;20485;-1
2012_6178254786081384_manuscript;3 status of the patients;3;-1
2012_6178254786081384_manuscript;3 index of patients;3;-1
2012_6178254786081384_manuscript;2501 CHD patients;2501;-1
2012_6178254786081384_manuscript;4837 patients;4837;-1
2012_6178254786081384_manuscript;7046 eligible patients;7046;-1
2012_6178254786081384_manuscript;778 patients;778;-1
2012_6178254786081384_manuscript;3 deficient   patients;3;-1
2012_6178254786081384_manuscript;100 patients;100;-1
2012_6178254786081384_manuscript;354 patients;354;-1
2012_6178254786081384_manuscript;4444 patients;4444;-1
2012_6178254786081384_manuscript;18,686 people;18686;-1
2012_6178254786081384_manuscript;n=102;102;-1
2012_6178254786081384_manuscript;n=100;100;-1
2012_6178254786081384_manuscript;n=333;333;-1
2012_6178254786081384_manuscript;n=4848;4848;-1
2012_6178254786081384_manuscript;   data from 27;27;-1
2012_6605521318230832_manuscript;67 participants;67;43223
2012_6605521318230832_manuscript;12   recruited;12;36146
2012_6605521318230832_manuscript;121 Parents recruited;121;48056
2012_6605521318230832_manuscript;n=50;50;3047
2012_6605521318230832_manuscript;n=12;12;3106
2012_6762960828107386_manuscript;64 enrolled;64;-1
2012_6847781157699184_manuscript;04   Lean subjects;4;45657
2012_6847781157699184_manuscript;18 study patients;18;8294
2012_6847781157699184_manuscript;n=6;6;40666
2012_6953448448380201_manuscript;426   women;426;-1
2012_6953448448380201_manuscript;762,753 participants;762753;-1
2012_6953448448380201_manuscript;222   Although subjects;222;-1
2012_6953448448380201_manuscript;267   referent subjects;267;-1
2012_6953448448380201_manuscript;52   matched AD-free diabetes patients;52;-1
2012_6953448448380201_manuscript;2DM patients;2;-1
2012_6953448448380201_manuscript;9,810 patients;9810;-1
2012_6953448448380201_manuscript;439   care patients;439;-1
2012_6953448448380201_manuscript;2DM affected people;2;-1
2012_6953448448380201_manuscript;343   tracked individuals;343;-1
2012_6953448448380201_manuscript;435   individuals;435;-1
2012_6953448448380201_manuscript;800,000 individuals;800000;-1
2012_6953448448380201_manuscript;n=762,753;762753;-1
2012_6953448448380201_manuscript;n=62,988;62988;-1
2012_6953448448380201_manuscript;n=699,795;699795;-1
2012_6953448448380201_manuscript;n=40,232;40232;-1
2012_6953448448380201_manuscript;n=22,756;22756;-1
2012_6953448448380201_manuscript;n=800,000;800000;-1
2012_6953448448380201_manuscript;n=37,247;37247;-1
2012_6953448448380201_manuscript;n=699,765;699765;-1
2012_6953448448380201_manuscript;n=60,646;60646;-1
2012_6953448448380201_manuscript;n=21,487;21487;-1
2012_6953448448380201_manuscript;n=39,159;39159;-1
2012_6953448448380201_manuscript;n=723,451;723451;-1
2012_6953448448380201_manuscript;n=39,302;39302;-1
2012_6953448448380201_manuscript;n=12,898;12898;-1
2012_6953448448380201_manuscript;n=9,810;9810;-1
2012_6953448448380201_manuscript;n=1,509;1509;-1
2012_6953448448380201_manuscript;n=2,904;2904;-1
2012_6953448448380201_manuscript;n=5,397;5397;-1
2012_6953448448380201_manuscript;n=1,945;1945;-1
2012_6953448448380201_manuscript;n=4,094;4094;-1
2012_6953448448380201_manuscript;n=11,103;11103;-1
2012_6953448448380201_manuscript;n=9,262;9262;-1
2012_6953448448380201_manuscript; data of 800,000;800000;-1
2012_6953448448380201_manuscript;   data of 762,753;762753;-1
2012_6953448448380201_manuscript; data from 1;1;-1
2012_7018401778602143_manuscript;3 cohorts of US adults;3;-1
2012_7020223928582689_manuscript;N=8;8;-1
2012_7020223928582689_manuscript;N=13;13;-1
2012_7020223928582689_manuscript;N=7;7;-1
2012_7020223928582689_manuscript;N=36;36;-1
2012_7020223928582689_manuscript;total of 40;40;-1
2012_7081839627365973_manuscript;2 positive patients;2;-1
2012_7081839627365973_manuscript;n = 10;10;-1
2012_7081839627365973_manuscript;n=3;3;-1
2012_7158536517739292_manuscript;5 Treated participants;5;-1
2012_7158536517739292_manuscript;n=76;76;-1
2012_7158536517739292_manuscript;total of 58;58;-1
2012_7461386558318382_manuscript;4000   participants;4000;-1
2012_7461386558318382_manuscript;1,441   participants;1441;-1
2012_7461386558318382_manuscript;815 participants;815;-1
2012_7461386558318382_manuscript;539   participants;539;-1
2012_7461386558318382_manuscript;24,059 patients;24059;-1
2012_7461386558318382_manuscript;183   patients;183;-1
2012_7461386558318382_manuscript;253 patients;253;-1
2012_7461386558318382_manuscript;21 patients;21;-1
2012_7461386558318382_manuscript;204 patients;204;-1
2012_7461386558318382_manuscript;3,600 patients;3600;-1
2012_7461386558318382_manuscript;74 patients;74;-1
2012_7461386558318382_manuscript;50 patients;50;-1
2012_7461386558318382_manuscript;56 patients;56;-1
2012_7461386558318382_manuscript;66 patients;66;-1
2012_7461386558318382_manuscript;155 patients;155;-1
2012_7461386558318382_manuscript;150 patients;150;-1
2012_7461386558318382_manuscript;total of 224;224;-1
2012_7488605567359266_manuscript;1,425 subjects;1425;-1
2012_7488605567359266_manuscript;1,425 patients;1425;-1
2012_7488605567359266_manuscript;450 patients;450;-1
2012_7488605567359266_manuscript;total of 7;7;-1
2012_7488605567359266_manuscript;total of 123;123;-1
2012_7526283078004111_manuscript;0 CN individuals;0;-1
2012_7569498227441683_manuscript;266 women;266;-1
2012_7569498227441683_manuscript;502 patients;502;-1
2012_7569498227441683_manuscript;211 patients;211;-1
2012_7569498227441683_manuscript;22 patients;22;-1
2012_7569498227441683_manuscript;2 settings involved patients;2;-1
2012_7569498227441683_manuscript;100 patients;100;-1
2012_7569498227441683_manuscript;257 were inpatients;257;-1
2012_7569498227441683_manuscript;396 patients;396;-1
2012_7569498227441683_manuscript;502   patients;502;-1
2012_7569498227441683_manuscript;n=396;396;-1
2012_7569498227441683_manuscript;n=211;211;-1
2012_7569498227441683_manuscript;n=209;209;-1
2012_7569498227441683_manuscript;n=187;187;-1
2012_7569498227441683_manuscript;n=182;182;-1
2012_7569498227441683_manuscript;n=29;29;-1
2012_7569498227441683_manuscript;n=502;502;-1
2012_7569498227441683_manuscript;n=22;22;-1
2012_7569498227441683_manuscript;n=39;39;-1
2012_7569498227441683_manuscript;n=240;240;-1
2012_7569498227441683_manuscript;n=140;140;-1
2012_7569498227441683_manuscript;n=122;122;-1
2012_7622811256683382_manuscript;n=6;6;-1
2012_7958158987885264_manuscript;1 of patients;1;-1
2012_7958158987885264_manuscript;3 Symptomatic individuals;3;-1
2012_7958158987885264_manuscript;2 Swabbed individuals;2;-1
2012_8192080798426585_manuscript;40 subjects;40;-1
2012_8192080798426585_manuscript;20163   patients;20163;-1
2012_8192080798426585_manuscript;4 infected patients;4;-1
2012_8192080798426585_manuscript;12184 patients;12184;-1
2012_8192080798426585_manuscript;11839 patients;11839;-1
2012_8192080798426585_manuscript;2786 patients;2786;-1
2012_8192080798426585_manuscript;2340 patients;2340;-1
2012_8192080798426585_manuscript;3 patients;3;-1
2012_8192080798426585_manuscript;1 coinfected and monoinfected patients;1;-1
2012_8192080798426585_manuscript;1 infected patients;1;-1
2012_8192080798426585_manuscript;1 coinfected patients;1;-1
2012_8192080798426585_manuscript;1 patients;1;-1
2012_8192080798426585_manuscript;1,518 patients;1518;-1
2012_8192080798426585_manuscript;200 million people;200;-1
2012_8192080798426585_manuscript;n= 1;1;-1
2012_8192080798426585_manuscript;n= 82;82;-1
2012_8192080798426585_manuscript;n= 125;125;-1
2012_8192080798426585_manuscript;n= 67;67;-1
2012_8192080798426585_manuscript;n= 10;10;-1
2012_8192080798426585_manuscript;n=1;1;-1
2012_8192080798426585_manuscript;n=2;2;-1
2012_8192080798426585_manuscript;n=3;3;-1
2012_8280322078364744_manuscript;2 diabetic patients;2;-1
2012_8280322078364744_manuscript;2D adult patients;2;-1
2012_8280322078364744_manuscript;2 diabetes   patients;2;-1
2012_8280322078364744_manuscript;2 diabetes patients;2;-1
2012_8486180208019127_manuscript;2   patients;2;-1
2012_8486180208019127_manuscript;n= 8;8;-1
2012_8486180208019127_manuscript;n   = 100;100;-1
2012_8486180208019127_manuscript;n = 60;60;-1
2012_8486180208019127_manuscript;n = 3;3;-1
2012_8486180208019127_manuscript;n = 6;6;-1
2012_8486180208019127_manuscript;n = 4;4;-1
2012_8486180208019127_manuscript; data of O2;2;-1
2012_8584162147423059_manuscript;26,994 MS patients;26994;-1
2012_8584162147423059_manuscript;115,172 ID   patients;115172;-1
2012_8584162147423059_manuscript;1D patients;1;-1
2012_8584162147423059_manuscript;n=115,172;115172;-1
2012_8584162147423059_manuscript;n= 15,492;15492;-1
2012_8584162147423059_manuscript;n=39,666;39666;-1
2012_8584162147423059_manuscript;n= 4,046;4046;-1
2012_8584162147423059_manuscript;n= 20,574;20574;-1
2012_8584162147423059_manuscript;n= 23,892;23892;-1
2012_8584162147423059_manuscript;n=11,502;11502;-1
2012_8584162147423059_manuscript;n=3,787;3787;-1
2012_8584162147423059_manuscript;n=1,524;1524;-1
2012_8584162147423059_manuscript;total of 26,994;26994;-1
2012_8756349396873998_manuscript;30 individuals;30;-1
2012_8781542338771614_manuscript;n = 3;3;10199
2012_8781542338771614_manuscript;n = 30;30;20477
2012_8781542338771614_manuscript;n = 36;36;20704
2012_8781542338771614_manuscript;n = 25;25;20751
2012_8781542338771614_manuscript;n = 10;10;22627
2012_8781542338771614_manuscript;n = 15;15;22658
2012_8781542338771614_manuscript;n = 17;17;22837
2012_8781542338771614_manuscript;n = 4;4;26053
2012_8781542338771614_manuscript;n =   36;36;61022
2012_8894527278425914_manuscript;6   patients;6;-1
2012_8894527278425914_manuscript;38   Control patients;38;-1
2012_8894527278425914_manuscript;61 patients;61;-1
2012_8894527278425914_manuscript;62 control patients;62;-1
2012_8894527278425914_manuscript;1411   patients;1411;-1
2012_8894527278425914_manuscript;139 lithium patients;139;-1
2012_8894527278425914_manuscript;N = 139;139;-1
2012_8894527278425914_manuscript;N = 70;70;-1
2012_9254872176585161_manuscript;100 patients;100;-1
2012_9254872176585161_manuscript;87 patients;87;-1
2012_9254872176585161_manuscript;96 patients;96;-1
2012_9254872176585161_manuscript;38 patients;38;-1
2012_9254872176585161_manuscript;244 patients;244;-1
2012_9254872176585161_manuscript;78 patients;78;-1
2012_9254872176585161_manuscript;76 patients;76;-1
2012_9254872176585161_manuscript;8 patients;8;-1
2012_9254872176585161_manuscript;2 patients;2;-1
2012_9254872176585161_manuscript;5 patients;5;-1
2012_9254872176585161_manuscript;12 patients;12;-1
2012_9254872176585161_manuscript;10 people;10;-1
2012_9254872176585161_manuscript;34,902 individuals;34902;-1
2012_9834992738610073_manuscript;368   young women;368;-1
2012_9834992738610073_manuscript;7 women;7;-1
2012_9834992738610073_manuscript;368 young   women;368;-1
2012_9834992738610073_manuscript;170,255 patients;170255;-1
2013_1008540923950444_manuscript;9258 women;9258;-1
2013_1008540923950444_manuscript;146 538 participants;146538;-1
2013_1008540923950444_manuscript;369 patients;369;-1
2013_1008540923950444_manuscript;2,481 patients;2481;-1
2013_1008540923950444_manuscript;2,481 patients were   recruited;2481;-1
2013_1008540923950444_manuscript;n=978;978;-1
2013_1008540923950444_manuscript;n=647;647;-1
2013_1008540923950444_manuscript;n=856;856;-1
2013_1008540923950444_manuscript;total of 369;369;-1
2013_1008540923950444_manuscript;total of 2,481;2481;-1
2013_1013573369891955_manuscript;35 G > A KRAS mutant patients;35;-1
2013_1013573369891955_manuscript;12   KRAS mutant patients;12;-1
2013_1013573369891955_manuscript;35 G > T   KRAS mutant patients;35;-1
2013_1064080660989326_manuscript;16 patients;16;-1
2013_1064080660989326_manuscript;16 breast cancer   patients;16;-1
2013_1064080660989326_manuscript;n=5;5;-1
2013_1064080660989326_manuscript;n=3;3;-1
2013_1064080660989326_manuscript;n=2;2;-1
2013_1064080660989326_manuscript;n=10;10;-1
2013_1064080660989326_manuscript;n=9;9;-1
2013_1064080660989326_manuscript;n=13;13;-1
2013_1064080660989326_manuscript;n=7;7;-1
2013_1064080660989326_manuscript;n=12;12;-1
2013_1068593196105476_manuscript;total of   12064;12064;-1
2013_1068593196105476_manuscript;total of   2342;2342;-1
2013_1100249201114788_manuscript;4   participants;4;5004
2013_1100249201114788_manuscript;13   patients;13;9269
2013_1100249201114788_manuscript;6   untreated patients;6;7581
2013_1100249201114788_manuscript;19   patients;19;3804
2013_1100249201114788_manuscript;8   patients;8;2883
2013_1100249201114788_manuscript;28 patients;28;784
2013_1100249201114788_manuscript;56 patients;56;601
2013_1100249201114788_manuscript;17 patients;17;1346
2013_1100249201114788_manuscript;16 patients;16;1394
2013_1100249201114788_manuscript;18   patients;18;1912
2013_1100249201114788_manuscript;4 patients;4;2399
2013_1100249201114788_manuscript;14 patients;14;2658
2013_1100249201114788_manuscript;7   patients;7;2701
2013_1100249201114788_manuscript;23 patients;23;3637
2013_1100249201114788_manuscript;15 patients;15;4291
2013_1100249201114788_manuscript;11 patients;11;4395
2013_1100249201114788_manuscript;2 patients;2;4688
2013_1100249201114788_manuscript;11   patients;11;4744
2013_1100249201114788_manuscript;2   patients;2;5727
2013_1100249201114788_manuscript;6 patients;6;602
2013_1100249201114788_manuscript;6   patients;6;6071
2013_1100249201114788_manuscript;1 of these patients;1;6328
2013_1100249201114788_manuscript;14   PFS of patients;14;6724
2013_1100249201114788_manuscript;18 patients;18;10235
2013_1100249201114788_manuscript;17   patients;17;11444
2013_1100249201114788_manuscript;9   patients;9;3803
2013_1100249201114788_manuscript;5 patients;5;4292
2013_1100249201114788_manuscript;10   patients;10;14531
2013_1100249201114788_manuscript;16   PFS rate of the patients;16;15003
2013_1100249201114788_manuscript;21   enroll more patients;21;15443
2013_1100249201114788_manuscript;30 patients;30;17925
2013_1100249201114788_manuscript;100 patients;100;18611
2013_1100249201114788_manuscript;21 patients;21;20925
2013_1100249201114788_manuscript;37   patients;37;23376
2013_1100249201114788_manuscript;29   newly diagnosed patients;29;29739
2013_1100249201114788_manuscript;n = 15;15;4896
2013_1100249201114788_manuscript;n = 9;9;4960
2013_1100249201114788_manuscript;n = 8;8;8086
2013_1100249201114788_manuscript;n = 5;5;8154
2013_1100249201114788_manuscript;n =   28;28;30163
2013_1100249201114788_manuscript;N   =   2;2;32446
2013_1100249201114788_manuscript;n = 28;28;34784
2013_1100249201114788_manuscript;total of 28;28;766
2013_1100249201114788_manuscript;total of 17;17;1337
2013_1100249201114788_manuscript;total of 14;14;2649
2013_1100249201114788_manuscript;total of 15;15;4282
2013_1100249201114788_manuscript;total of 65;65;4880
2013_1117706832104552_manuscript;7,447 participants;7447;-1
2013_1117706832104552_manuscript;3,923 participants;3923;-1
2013_1117706832104552_manuscript;20 participants;20;-1
2013_1117706832104552_manuscript;2,513 participants;2513;-1
2013_1117706832104552_manuscript;59 participants;59;-1
2013_1117706832104552_manuscript;22 participants;22;-1
2013_1117706832104552_manuscript;18 participants;18;-1
2013_1117706832104552_manuscript;1,618 subjects;1618;-1
2013_1117706832104552_manuscript;151 million people;151;-1
2013_1117706832104552_manuscript;n=1,870;1870;-1
2013_1117706832104552_manuscript;n=33;33;-1
2013_1117706832104552_manuscript;n=3;3;-1
2013_1117706832104552_manuscript;n=1446;1446;-1
2013_1117706832104552_manuscript;n=1293;1293;-1
2013_1117706832104552_manuscript;n=1184;1184;-1
2013_1117706832104552_manuscript; data from 2,513;2513;-1
2013_1130757499102520_manuscript;14,772 individuals;14772;-1
2013_1130757499102520_manuscript;14,772   adults;14772;-1
2013_1130757499102520_manuscript;n=9,379;9379;-1
2013_1130757499102520_manuscript; data from the 1998;1998;-1
2013_1139455565111585_manuscript;386 subjects;386;-1
2013_1139455565111585_manuscript;1   patients;1;-1
2013_1139455565111585_manuscript;13,792 patients;13792;-1
2013_1139455565111585_manuscript;600 patients;600;-1
2013_1139455565111585_manuscript;200 million people;200;-1
2013_1139455565111585_manuscript;20,000 individuals;20000;-1
2013_1144695393107830_manuscript;22   people;22;-1
2013_1165358659102646_manuscript;1291 men and   women;1291;-1
2013_1165358659102646_manuscript;1,470 participants;1470;-1
2013_1165358659102646_manuscript;179 subjects;179;-1
2013_1165358659102646_manuscript;1291 subjects;1291;-1
2013_1165358659102646_manuscript;1291 people;1291;-1
2013_1165358659102646_manuscript;N = 103;103;-1
2013_1165358659102646_manuscript;N = 403;403;-1
2013_1165358659102646_manuscript;N = 404;404;-1
2013_1165358659102646_manuscript;N = 381;381;-1
2013_1216272351105468_manuscript;37   subjects;37;-1
2013_1216272351105468_manuscript;3   patients;3;-1
2013_1236925614112983_manuscript;1000 people;1000;-1
2013_1236925614112983_manuscript;99,598 individuals;99598;-1
2013_1236925614112983_manuscript;total of 1811;1811;-1
2013_1242391073111421_manuscript;53 persons;53;-1
2013_1242391073111421_manuscript;194   participants;194;-1
2013_1242391073111421_manuscript;191 participants;191;-1
2013_1242391073111421_manuscript;195 participants;195;-1
2013_1242391073111421_manuscript;46 participants;46;-1
2013_1242391073111421_manuscript;19 participants;19;-1
2013_1242391073111421_manuscript;194 participants;194;-1
2013_1242391073111421_manuscript;7 people;7;-1
2013_1242391073111421_manuscript;200 individuals;200;-1
2013_1242391073111421_manuscript;14 individuals;14;-1
2013_1242391073111421_manuscript;190 individuals;190;-1
2013_1242391073111421_manuscript;166 individuals;166;-1
2013_1242391073111421_manuscript;n=541;541;-1
2013_1242391073111421_manuscript;N=185;185;-1
2013_1242391073111421_manuscript;n=82;82;-1
2013_1242391073111421_manuscript;n = 48;48;-1
2013_1242391073111421_manuscript;n=17;17;-1
2013_1242391073111421_manuscript;n=12;12;-1
2013_1242391073111421_manuscript;n=8;8;-1
2013_1242391073111421_manuscript;n=5;5;-1
2013_1242391073111421_manuscript;n=2;2;-1
2013_1242391073111421_manuscript;n=46;46;-1
2013_1250750213952256_manuscript;62 schizophrenic subjects;62;-1
2013_1262645790116251_manuscript;19   women;19;-1
2013_1262645790116251_manuscript;2   women;2;-1
2013_1262645790116251_manuscript;98862 participants;98862;-1
2013_1262645790116251_manuscript;116,147 participants;116147;-1
2013_1262645790116251_manuscript;59,125 participants;59125;-1
2013_1262645790116251_manuscript;271,357 participants;271357;-1
2013_1262645790116251_manuscript;274,135 participants;274135;-1
2013_1262645790116251_manuscript;2   participants;2;-1
2013_1262645790116251_manuscript;n = 0;0;-1
2013_1262645790116251_manuscript; data from 274,135;274135;-1
2013_1287198274103357_manuscript;356 men and women;356;-1
2013_1287198274103357_manuscript;30 patients;30;-1
2013_1287198274103357_manuscript;7,000 mostly Bemba people;7000;-1
2013_1287198274103357_manuscript;3,729 people;3729;-1
2013_1287198274103357_manuscript;11,000 people;11000;-1
2013_1287198274103357_manuscript;8,000 people;8000;-1
2013_1287198274103357_manuscript;n=379;379;-1
2013_1287198274103357_manuscript;n=360;360;-1
2013_1287198274103357_manuscript;n=356;356;-1
2013_1287198274103357_manuscript;n=354;354;-1
2013_1287198274103357_manuscript;total      of 48;48;-1
2013_1375059934926644_manuscript;61 participants;61;-1
2013_1375059934926644_manuscript;113,000 participants;113000;-1
2013_1375059934926644_manuscript;N=   1105;1105;-1
2013_1375059934926644_manuscript;N= 1099;1099;-1
2013_1375059934926644_manuscript;n = 49;49;-1
2013_1375059934926644_manuscript;n= 1,105;1105;-1
2013_1375059934926644_manuscript;n= 1,099;1099;-1
2013_1375059934926644_manuscript;N = 1,145;1145;-1
2013_1375059934926644_manuscript;n= 957;957;-1
2013_1375059934926644_manuscript;n= 1,102;1102;-1
2013_1375059934926644_manuscript;n= 85;85;-1
2013_1375059934926644_manuscript;n= 24;24;-1
2013_1375059934926644_manuscript;n= 25;25;-1
2013_1375059934926644_manuscript;n= 9;9;-1
2013_1375059934926644_manuscript;n= 21;21;-1
2013_1375059934926644_manuscript;n= 6;6;-1
2013_1375059934926644_manuscript;n= 15;15;-1
2013_1375059934926644_manuscript;n= 11;11;-1
2013_1375059934926644_manuscript;n= 3;3;-1
2013_1375059934926644_manuscript;n= 23;23;-1
2013_1375059934926644_manuscript; data of 1,145;1145;-1
2013_1429192506100319_manuscript;109 MS   patients;109;-1
2013_1429192506100319_manuscript;109 patients;109;-1
2013_1429192506100319_manuscript;26 patients;26;-1
2013_1429192506100319_manuscript;109 MS patients;109;-1
2013_1429192506100319_manuscript;109 MS multiple   sclerosis patients;109;-1
2013_1429192506100319_manuscript;n = 64;64;-1
2013_1429192506100319_manuscript;n=109;109;-1
2013_1429192506100319_manuscript;n=45;45;-1
2013_1429192506100319_manuscript;n=64;64;-1
2013_1429192506100319_manuscript;109 patients enrolled;109;-1
2013_1449782201103120_manuscript;11 control subjects;11;-1
2013_1449782201103120_manuscript;26 new ASP subjects;26;-1
2013_1449782201103120_manuscript;26 ASP   subjects;26;-1
2013_1449782201103120_manuscript;430 ASD subjects;430;-1
2013_1449782201103120_manuscript;26 subjects;26;-1
2013_1449782201103120_manuscript;430 subjects;430;-1
2013_1449782201103120_manuscript;26 ASD subjects;26;-1
2013_1449782201103120_manuscript;26 ASP subject subjects;26;-1
2013_1449782201103120_manuscript;26 ASP-subjects;26;-1
2013_1449782201103120_manuscript;26 ASP subjects;26;-1
2013_1449782201103120_manuscript;26 randomly   referred ASP subjects;26;-1
2013_1449782201103120_manuscript;430 ASD patients;430;-1
2013_1449782201103120_manuscript;26 patients;26;-1
2013_1449782201103120_manuscript;554 patients;554;-1
2013_1449782201103120_manuscript;26 ASP   patients;26;-1
2013_1449782201103120_manuscript;n = 26;26;-1
2013_1449782201103120_manuscript;n   = 430;430;-1
2013_1449782201103120_manuscript;n=430;430;-1
2013_1449782201103120_manuscript;n=26;26;-1
2013_1449782201103120_manuscript;total of 430;430;-1
2013_1449782201103120_manuscript;total of 26;26;-1
2013_1449782201103120_manuscript;total of   554;554;-1
2013_1480399919104640_manuscript;7 million people;7;-1
2013_1480399919104640_manuscript;17   these individuals;17;-1
2013_1480399919104640_manuscript;n =3382;3382;-1
2013_1480399919104640_manuscript;n =2606;2606;-1
2013_1480399919104640_manuscript;total of 966;966;-1
2013_1481401549884852_manuscript;1000   women;1000;-1
2013_1481401549884852_manuscript;n=7;7;-1
2013_1481401549884852_manuscript;n=8;8;-1
2013_1481401549884852_manuscript;n=9;9;-1
2013_1481401549884852_manuscript;n=10;10;-1
2013_1481401549884852_manuscript;n=11;11;-1
2013_1481401549884852_manuscript;n=15;15;-1
2013_1497658756994238_manuscript;94,821 participants;94821;-1
2013_1497658756994238_manuscript;210   participants;210;-1
2013_1497658756994238_manuscript;1,578 participants;1578;-1
2013_1497658756994238_manuscript;15,592 participants;15592;-1
2013_1497658756994238_manuscript;350   patients;350;-1
2013_1497658756994238_manuscript;83   individuals;83;-1
2013_1497658756994238_manuscript;205   included adults;205;-1
2013_1497658756994238_manuscript;257    In adults;257;-1
2013_1497658756994238_manuscript;478   adults;478;-1
2013_1497658756994238_manuscript;548   Australian adults;548;-1
2013_1497658756994238_manuscript;total of 1,356;1356;-1
2013_1497658756994238_manuscript;total of 35 182;35182;-1
2013_1497658756994238_manuscript;total of 94,821;94821;-1
2013_1497658756994238_manuscript; data are of 65;65;-1
2013_1497658756994238_manuscript; data from 33;33;-1
2013_1541274846934947_manuscript;41 matched control subjects;41;-1
2013_1541274846934947_manuscript;1 patients;1;-1
2013_1541274846934947_manuscript;1   patients;1;-1
2013_1541274846934947_manuscript;104 patients;104;-1
2013_1541274846934947_manuscript;1 control   individuals;1;-1
2013_1541274846934947_manuscript;n=5;5;-1
2013_1541274846934947_manuscript;n=27;27;-1
2013_1541274846934947_manuscript;n=74;74;-1
2013_1541274846934947_manuscript;n=42;42;-1
2013_1541274846934947_manuscript;n=104;104;-1
2013_1541274846934947_manuscript;n=79;79;-1
2013_1541274846934947_manuscript;n=36;36;-1
2013_1541274846934947_manuscript; data of NF1;1;-1
2013_1631202407904855_manuscript;159 participants;159;-1
2013_1631202407904855_manuscript;39    participants;39;-1
2013_1631202407904855_manuscript;692 participants;692;-1
2013_1631202407904855_manuscript;363 participants;363;-1
2013_1631202407904855_manuscript;212 participants;212;-1
2013_1631202407904855_manuscript;215   participants;215;-1
2013_1631202407904855_manuscript;329 participants;329;-1
2013_1631202407904855_manuscript;335 subjects;335;-1
2013_1631202407904855_manuscript;391 subjects;391;-1
2013_1631202407904855_manuscript;67 subjects;67;-1
2013_1631202407904855_manuscript;165 subjects;165;-1
2013_1631202407904855_manuscript;83 patients;83;-1
2013_1631202407904855_manuscript;61 patients;61;-1
2013_1631202407904855_manuscript;29 patients;29;-1
2013_1631202407904855_manuscript;418 patients;418;-1
2013_1631202407904855_manuscript;n=42;42;-1
2013_1631202407904855_manuscript;n=92;92;-1
2013_1631202407904855_manuscript;n=537;537;-1
2013_1631202407904855_manuscript;n=159;159;-1
2013_1631202407904855_manuscript;n=108;108;-1
2013_1631202407904855_manuscript;n=24;24;-1
2013_1631202407904855_manuscript;n=26;26;-1
2013_1631202407904855_manuscript;n=197;197;-1
2013_1631202407904855_manuscript;n=190;190;-1
2013_1631202407904855_manuscript;n=36,913;36913;-1
2013_1631202407904855_manuscript;n=194;194;-1
2013_1631202407904855_manuscript;n=195;195;-1
2013_1631202407904855_manuscript;n=13,070;13070;-1
2013_1631202407904855_manuscript;n=347;347;-1
2013_1631202407904855_manuscript;n=77;77;-1
2013_1631202407904855_manuscript;n=22;22;-1
2013_1631202407904855_manuscript;n=6;6;-1
2013_1631202407904855_manuscript;n=2644;2644;-1
2013_1631202407904855_manuscript;n=1119;1119;-1
2013_1631202407904855_manuscript;n=982;982;-1
2013_1631202407904855_manuscript;n=3763;3763;-1
2013_1631202407904855_manuscript;n=55;55;-1
2013_1631202407904855_manuscript;n=17;17;-1
2013_1631202407904855_manuscript;n = 3763;3763;-1
2013_1631202407904855_manuscript;n = 73;73;-1
2013_1631202407904855_manuscript;n = 3690;3690;-1
2013_1631202407904855_manuscript;n = 2644;2644;-1
2013_1631202407904855_manuscript;n = 982;982;-1
2013_1631202407904855_manuscript;n = 63;63;-1
2013_1631202407904855_manuscript;n = 1;1;-1
2013_1631202407904855_manuscript;n = 55;55;-1
2013_1631202407904855_manuscript;n = 18;18;-1
2013_1631202407904855_manuscript;n = 2;2;-1
2013_1631202407904855_manuscript;n = 5;5;-1
2013_1631202407904855_manuscript;n = 10;10;-1
2013_1631202407904855_manuscript;n = 72;72;-1
2013_1631202407904855_manuscript;n = 17;17;-1
2013_1631202407904855_manuscript;total of 3759;3759;-1
2013_1631202407904855_manuscript;total of 3763;3763;-1
2013_1647844203109843_manuscript;32 PE patients;32;2018
2013_1647844203109843_manuscript;n=32;32;10644
2013_1647844203109843_manuscript;n=111;111;4712
2013_1647844203109843_manuscript;n=152;152;4699
2013_1647844203109843_manuscript;n=5;5;4621
2013_1647844203109843_manuscript;n=15;15;4699
2013_1647844203109843_manuscript;n=16;16;1445
2013_1647844203109843_manuscript;n=17;17;1465
2013_1647844203109843_manuscript;n = 15;15;31957
2013_1647844203109843_manuscript;n = 16;16;31972
2013_1647844203109843_manuscript;n = 17;17;31987
2013_1647844203109843_manuscript;n = 32;32;32577
2013_1647844203109843_manuscript;n=0;0;34392
2013_1647844203109843_manuscript;n=1;1;4712
2013_1647844203109843_manuscript;n=2;2;34433
2013_1647844203109843_manuscript;n=3;3;11523
2013_1647844203109843_manuscript;n=4;4;34471
2013_1647844203109843_manuscript;n=6;6;34507
2013_1647844203109843_manuscript;n=7;7;35003
2013_1647844203109843_manuscript;n=8;8;35020
2013_1647844203109843_manuscript;n=9;9;35037
2013_1647844203109843_manuscript;n=10;10;35054
2013_1647844203109843_manuscript;n=11;11;4712
2013_1647844203109843_manuscript;total of 11;11;3749
2013_1647844203109843_manuscript; dataset of 3020;3020;26665
2013_1667573359110295_manuscript;30 patients;30;-1
2013_1667573359110295_manuscript;6 million patients;6;-1
2013_1667573359110295_manuscript;150   patients;150;-1
2013_1667573359110295_manuscript;90   patients;90;-1
2013_1667573359110295_manuscript;n=  12;12;-1
2013_1667573359110295_manuscript;n=  23;23;-1
2013_1667573359110295_manuscript;n=  7;7;-1
2013_1667573359110295_manuscript;n=  25;25;-1
2013_1667573359110295_manuscript;n  =7;7;-1
2013_1667573359110295_manuscript;n=  11;11;-1
2013_1667573359110295_manuscript;n=1992;1992;-1
2013_1687672486961534_manuscript;1706 patients;1706;-1
2013_1687672486961534_manuscript;1706   patients;1706;-1
2013_1687672486961534_manuscript;5834 patients;5834;-1
2013_1687672486961534_manuscript;total of 1706;1706;-1
2013_1687672486961534_manuscript;total of 90;90;-1
2013_1688540881905106_manuscript;17   and women;17;-1
2013_1688540881905106_manuscript;12   In women;12;-1
2013_1688540881905106_manuscript;28   of women;28;-1
2013_1688540881905106_manuscript;2   men and women;2;-1
2013_1688540881905106_manuscript;314 women;314;-1
2013_1688540881905106_manuscript;1614 persons;1614;-1
2013_1688540881905106_manuscript;145 persons;145;-1
2013_1688540881905106_manuscript;116 persons;116;-1
2013_1688540881905106_manuscript;283 men participants;283;-1
2013_1688540881905106_manuscript;18 079 participants;18079;-1
2013_1688540881905106_manuscript;3080 participants;3080;-1
2013_1688540881905106_manuscript;1036 participants;1036;-1
2013_1688540881905106_manuscript;17   remarkable benefits people;17;-1
2013_1688540881905106_manuscript;4261 individuals;4261;-1
2013_1688540881905106_manuscript;20   young adults;20;-1
2013_1688540881905106_manuscript;18 079 participants recruited;18079;-1
2013_1688540881905106_manuscript;N = 216;216;-1
2013_1688540881905106_manuscript;N = 22;22;-1
2013_1688540881905106_manuscript;N = 10;10;-1
2013_1688540881905106_manuscript;N=646;646;-1
2013_1688540881905106_manuscript;N=595;595;-1
2013_1688540881905106_manuscript;N=207;207;-1
2013_1688540881905106_manuscript;N=314;314;-1
2013_1743121680109660_manuscript;24,871 vaccinated women;24871;-1
2013_1743121680109660_manuscript;7 million women;7;-1
2013_1743121680109660_manuscript;24,871 women;24871;-1
2013_1743121680109660_manuscript;3,690 women;3690;-1
2013_1743121680109660_manuscript;14,085 unvaccinated women;14085;-1
2013_1743121680109660_manuscript;3 doses and these women;3;-1
2013_1743121680109660_manuscript;115,789 HPV-positive women;115789;-1
2013_1743121680109660_manuscript;n=30;30;-1
2013_1769298207936314_manuscript;2 million individuals;2;-1
2013_1848546120969724_manuscript;70 distribution of patients;70;-1
2013_1856564693107711_manuscript;2399 individuals;2399;-1
2013_1856564693107711_manuscript;1361 individuals;1361;-1
2013_1856564693107711_manuscript;n=0;0;-1
2013_1856564693107711_manuscript;n=383;383;-1
2013_1856564693107711_manuscript;n=346;346;-1
2013_1856564693107711_manuscript;n=5;5;-1
2013_1856564693107711_manuscript;n=10;10;-1
2013_1856564693107711_manuscript;n=9;9;-1
2013_1856564693107711_manuscript;n=3;3;-1
2013_1856564693107711_manuscript;n=4;4;-1
2013_1856564693107711_manuscript;n=1;1;-1
2013_1856564693107711_manuscript;n=7;7;-1
2013_1856564693107711_manuscript;n=2;2;-1
2013_1856564693107711_manuscript;n=8;8;-1
2013_1856564693107711_manuscript;n=12;12;-1
2013_1856564693107711_manuscript;n=11;11;-1
2013_1856564693107711_manuscript;n=6;6;-1
2013_1856564693107711_manuscript;n=22;22;-1
2013_1856564693107711_manuscript;n=20;20;-1
2013_1864522908937096_manuscript;216 participants;216;-1
2013_1864522908937096_manuscript;230 participants;230;-1
2013_1864522908937096_manuscript;16 participants;16;-1
2013_1864522908937096_manuscript;5 ABOUT HERE      A number of participants;5;-1
2013_1864522908937096_manuscript;1 diagnoses people;1;-1
2013_1864522908937096_manuscript;3 people;3;-1
2013_1864522908937096_manuscript;1 Care of frail individuals;1;-1
2013_1864522908937096_manuscript;n=385;385;-1
2013_1864522908937096_manuscript;n=144;144;-1
2013_1864522908937096_manuscript;n=63;63;-1
2013_1864522908937096_manuscript;n=81;81;-1
2013_1864522908937096_manuscript;n=109;109;-1
2013_1864522908937096_manuscript;n=107;107;-1
2013_1864522908937096_manuscript;n=11;11;-1
2013_1864522908937096_manuscript;n=13;13;-1
2013_1864522908937096_manuscript;n=120;120;-1
2013_1864522908937096_manuscript;n=116;116;-1
2013_1864522908937096_manuscript;n=4;4;-1
2013_1864522908937096_manuscript;n=12;12;-1
2013_1864522908937096_manuscript;n=121;121;-1
2013_1864522908937096_manuscript;n=0;0;-1
2013_1864522908937096_manuscript;n=117;117;-1
2013_1864522908937096_manuscript;n=241;241;-1
2013_1864522908937096_manuscript;n=1;1;-1
2013_1864522908937096_manuscript;n=2;2;-1
2013_1864522908937096_manuscript;n=42;42;-1
2013_1864522908937096_manuscript;n=17;17;-1
2013_1864522908937096_manuscript;n=23;23;-1
2013_1864522908937096_manuscript;n=24;24;-1
2013_1864522908937096_manuscript;total of 216;216;-1
2013_1864522908937096_manuscript; data from 109;109;-1
2013_1875573548922330_manuscript;127 SLE patients;127;-1
2013_1875573548922330_manuscript;2 RA patients;2;-1
2013_1875573548922330_manuscript;total of 127;127;-1
2013_1876502742996670_manuscript;n=3,823;3823;1797
2013_1876502742996670_manuscript;n=4,701;4701;1959
2013_1876502742996670_manuscript;n=1,218;1218;2107
2013_1876502742996670_manuscript;n=725;725;2262
2013_1876502742996670_manuscript;n=2,374;2374;15841
2013_1876502742996670_manuscript;n=2,935;2935;15885
2013_1876502742996670_manuscript;n=727;727;17579
2013_1876502742996670_manuscript;n=393;393;17619
2013_1887588551107721_manuscript;76 patients;76;-1
2013_1887588551107721_manuscript;50 patients;50;-1
2013_1898849212108120_manuscript;70,351 pregnant women;70351;-1
2013_1898849212108120_manuscript;n=1,309;1309;-1
2013_1898849212108120_manuscript;n=26,623;26623;-1
2013_1898849212108120_manuscript;n=21,060;21060;-1
2013_1898849212108120_manuscript;n=1,441;1441;-1
2013_1898849212108120_manuscript;total of 70,351;70351;-1
2013_1898849212108120_manuscript;total of 304;304;-1
2013_1906389369102927_manuscript;20,296 patients;20296;-1
2013_1906389369102927_manuscript;242 patients;242;-1
2013_1906389369102927_manuscript;2,289 patients;2289;-1
2013_1906389369102927_manuscript;100 patients;100;-1
2013_1911271896107659_manuscript;n=3432;3432;-1
2013_1911271896107659_manuscript;n=715;715;-1
2013_1911271896107659_manuscript;n=2717;2717;-1
2013_1911271896107659_manuscript;n =   2717;2717;-1
2013_1911271896107659_manuscript;n=2645;2645;-1
2013_1911271896107659_manuscript;n=4811;4811;-1
2013_1911271896107659_manuscript;N=690;690;-1
2013_1911271896107659_manuscript;n=4076;4076;-1
2013_1911271896107659_manuscript;n   =   33;33;-1
2013_1911271896107659_manuscript;n=  40;40;-1
2013_1911271896107659_manuscript;n=  18;18;-1
2013_1911271896107659_manuscript;n=   2;2;-1
2013_1911271896107659_manuscript;n   =   19;19;-1
2013_1911271896107659_manuscript;n=  3;3;-1
2013_1911271896107659_manuscript;n=  1;1;-1
2013_1911271896107659_manuscript; data from 12;12;-1
2013_1921712640938380_manuscript;16,781 participants;16781;2072
2013_1921712640938380_manuscript;16,781 subjects;16781;2342
2013_1921712640938380_manuscript;4047 adult patients;4047;3836
2013_1921712640938380_manuscript;404 people;404;2456
2013_1921712640938380_manuscript;404 individuals;404;2370
2013_1921712640938380_manuscript;n=16,781;16781;10606
2013_1921712640938380_manuscript;n=4047;4047;10297
2013_1921712640938380_manuscript;n=37;37;2885
2013_1921712640938380_manuscript;n=3;3;2885
2013_1921712640938380_manuscript;n=28;28;2840
2013_1921712640938380_manuscript;n=30;30;2816
2013_1921712640938380_manuscript;n=91;91;2788
2013_1921712640938380_manuscript;n=406;406;1270
2013_1921712640938380_manuscript;n=949;949;1325
2013_1921712640938380_manuscript;n=468;468;33105
2013_1921712640938380_manuscript;n=3579;3579;33122
2013_1942306889979095_manuscript;835 participants;835;-1
2013_1942306889979095_manuscript;n=223;223;-1
2013_1942306889979095_manuscript;n=435;435;-1
2013_1942306889979095_manuscript;n = 3,019;3019;-1
2013_1942306889979095_manuscript;n=994;994;-1
2013_1942306889979095_manuscript;n=2025;2025;-1
2013_1942306889979095_manuscript;n=835;835;-1
2013_1942306889979095_manuscript;n=524;524;-1
2013_1942306889979095_manuscript;n=470;470;-1
2013_1942306889979095_manuscript;n=1038;1038;-1
2013_1942306889979095_manuscript;n=987;987;-1
2013_1942306889979095_manuscript;n=  52;52;-1
2013_1942306889979095_manuscript;n=  47;47;-1
2013_1942306889979095_manuscript;n=  10;10;-1
2013_1942306889979095_manuscript;n=  98;98;-1
2013_1942306889979095_manuscript;n=  41;41;-1
2013_1942306889979095_manuscript;n=  42;42;-1
2013_1942306889979095_manuscript;total of 16,224;16224;-1
2013_1943093447113345_manuscript;n=15,056,095;15056095;-1
2013_1943093447113345_manuscript;n=17,470,479;17470479;-1
2013_1943093447113345_manuscript;n=912,167;912167;-1
2013_1943093447113345_manuscript;n=191,262;191262;-1
2013_1943093447113345_manuscript;n=9,901;9901;-1
2013_1943093447113345_manuscript;n=171,427;171427;-1
2013_1943093447113345_manuscript;n=2,727;2727;-1
2013_1943093447113345_manuscript;n=1,969;1969;-1
2013_1943093447113345_manuscript;n=650,848;650848;-1
2013_1943093447113345_manuscript;n= 13,294,819;13294819;-1
2013_1943093447113345_manuscript;n= 1,761,276;1761276;-1
2013_1984335693937198_manuscript;252 patients;252;22231
2013_1984335693937198_manuscript;n=3;3;7126
2013_1984335693937198_manuscript;n=31;31;1218
2013_1984335693937198_manuscript;n=73;73;1227
2013_1984335693937198_manuscript;n=7;7;1227
2013_1984335693937198_manuscript;n=10;10;38609
2013_2010430640926585_manuscript;70 subjects;70;-1
2013_2010430640926585_manuscript;61 subjects;61;-1
2013_2010430640926585_manuscript;total of 82;82;-1
2013_2036752537995913_manuscript;n = 33;33;53452
2013_2036752537995913_manuscript;n = 30;30;53254
2013_2036752537995913_manuscript;n = 27;27;52504
2013_2036752537995913_manuscript;n = 34;34;52488
2013_2036752537995913_manuscript;n   = 30;30;52456
2013_2036752537995913_manuscript;n = 24;24;52433
2013_2036752537995913_manuscript;n = 36;36;52412
2013_2036752537995913_manuscript;n = 32;32;51807
2013_2036752537995913_manuscript;n   = 32;32;51792
2013_2036752537995913_manuscript;n = 29;29;51774
2013_2036752537995913_manuscript;n = 37;37;51758
2013_2036752537995913_manuscript;n   = 26;26;51705
2013_2036752537995913_manuscript;n = 39;39;51682
2013_2036752537995913_manuscript;n = 31;31;51277
2013_2036752537995913_manuscript;n = 11;11;50595
2013_2036752537995913_manuscript;n = 16;16;50552
2013_2036752537995913_manuscript;n = 17;17;50463
2013_2036752537995913_manuscript;n = 19;19;50357
2013_2036752537995913_manuscript;n = 14;14;50269
2013_2036752537995913_manuscript;n = 25;25;50073
2013_2036752537995913_manuscript;n =   52;52;49625
2013_2036752537995913_manuscript;n = 22;22;49120
2013_2036752537995913_manuscript;n = 21;21;48557
2013_2036752537995913_manuscript;n = 50;50;47937
2013_2036752537995913_manuscript;n = 26;26;47714
2013_2036752537995913_manuscript;n = 13;13;47661
2013_2036752537995913_manuscript;n = 23;23;47537
2013_2036752537995913_manuscript;n = 42;42;47143
2013_2036752537995913_manuscript;n = 18;18;45105
2013_2036752537995913_manuscript;n = 8;8;43990
2013_2036752537995913_manuscript;n = 44;44;43093
2013_2036752537995913_manuscript;n = 48;48;43074
2013_2036752537995913_manuscript;n = 41;41;43025
2013_2036752537995913_manuscript;n = 47;47;42993
2013_2036752537995913_manuscript;n = 9;9;41805
2013_2036752537995913_manuscript;n = 28;28;40489
2013_2036752537995913_manuscript;n = 52;52;641
2013_2036752537995913_manuscript;n =   50;50;1508
2013_2036752537995913_manuscript;n =   22;22;4619
2013_2036752537995913_manuscript;n = 40;40;5114
2013_2036752537995913_manuscript;n =   28;28;6326
2013_2037542200112068_manuscript; dataset of 12,000;12000;-1
2013_2041206312104022_manuscript;N=421;421;-1
2013_2041206312104022_manuscript;N=189;189;-1
2013_2041206312104022_manuscript;N=210;210;-1
2013_2041206312104022_manuscript;N=81;81;-1
2013_2041206312104022_manuscript;total of 511;511;-1
2013_2041206312104022_manuscript;total of 667;667;-1
2013_2066340164955159_manuscript;500 patients;500;20428
2013_2179067941020894_manuscript;10 women;10;-1
2013_2179067941020894_manuscript;96 women;96;-1
2013_2179067941020894_manuscript;1232 women;1232;-1
2013_2179067941020894_manuscript;357 women;357;-1
2013_2179067941020894_manuscript;109 women;109;-1
2013_2179067941020894_manuscript;120   women;120;-1
2013_2179067941020894_manuscript;34 women;34;-1
2013_2179067941020894_manuscript;133 ADA-exposed women;133;-1
2013_2179067941020894_manuscript;7 women;7;-1
2013_2179067941020894_manuscript;94   ADA-exposed women;94;-1
2013_2179067941020894_manuscript;58 women;58;-1
2013_2179067941020894_manuscript;87 women;87;-1
2013_2179067941020894_manuscript;3907 women;3907;-1
2013_2179067941020894_manuscript;6,273 patients;6273;-1
2013_2179067941020894_manuscript;n=  10;10;-1
2013_2179067941020894_manuscript;n  =5;5;-1
2013_2179067941020894_manuscript;n=552;552;-1
2013_2179067941020894_manuscript;n=49;49;-1
2013_2179067941020894_manuscript;n=74;74;-1
2013_2179067941020894_manuscript;n=335;335;-1
2013_2179067941020894_manuscript;n=36;36;-1
2013_2179067941020894_manuscript;n=429;429;-1
2013_2179067941020894_manuscript;n=58;58;-1
2013_2179067941020894_manuscript;n=94;94;-1
2013_2179067941020894_manuscript;n=478;478;-1
2013_2179067941020894_manuscript;total of 58;58;-1
2013_2179067941020894_manuscript;total of 1232;1232;-1
2013_2179067941020894_manuscript; data analysis of 127;127;-1
2013_2378407071073559_manuscript;1307 persons;1307;-1
2013_2378407071073559_manuscript;6696 participants;6696;-1
2013_2378407071073559_manuscript;3496 participants;3496;-1
2013_2378407071073559_manuscript;6696 subjects;6696;-1
2013_2378407071073559_manuscript;9294 subjects;9294;-1
2013_2378407071073559_manuscript;2382 subjects;2382;-1
2013_2378407071073559_manuscript;n=1454;1454;-1
2013_2378407071073559_manuscript;n=464;464;-1
2013_2378407071073559_manuscript;n=260;260;-1
2013_2378407071073559_manuscript;n=212;212;-1
2013_2378407071073559_manuscript;n=1070;1070;-1
2013_2378407071073559_manuscript;n=321;321;-1
2013_2378407071073559_manuscript;n=204;204;-1
2013_2378407071073559_manuscript;n=304;304;-1
2013_2378407071073559_manuscript;n=244;244;-1
2013_2378407071073559_manuscript;n=127;127;-1
2013_2378407071073559_manuscript;n=378;378;-1
2013_2378407071073559_manuscript;n=133;133;-1
2013_2378407071073559_manuscript;n= 134;134;-1
2013_2378407071073559_manuscript;N=5242;5242;-1
2013_2378407071073559_manuscript;N=1454;1454;-1
2013_2378407071073559_manuscript;n=5972;5972;-1
2013_2378407071073559_manuscript;N=5389;5389;-1
2013_2378407071073559_manuscript;N=1307;1307;-1
2013_2378407071073559_manuscript;N  =5;5;-1
2013_2378407071073559_manuscript;N  =1;1;-1
2013_2378407071073559_manuscript;n=  63;63;-1
2013_2378407071073559_manuscript;N  =3;3;-1
2013_2378407071073559_manuscript;n=  61;61;-1
2013_2378407071073559_manuscript;total of 3496;3496;-1
2013_2415709808892172_manuscript;n = 307;307;-1
2013_2415709808892172_manuscript;n = 108;108;-1
2013_2415709808892172_manuscript;n = 29;29;-1
2013_2415709808892172_manuscript;n = 519;519;-1
2013_2415709808892172_manuscript;n = 478;478;-1
2013_2415709808892172_manuscript;n = 457;457;-1
2013_2415709808892172_manuscript;n = 204;204;-1
2013_2415709808892172_manuscript;n = 296;296;-1
2013_2415709808892172_manuscript;n = 369;369;-1
2013_2415709808892172_manuscript;n = 328;328;-1
2013_2415709808892172_manuscript;n = 280;280;-1
2013_2415709808892172_manuscript;total of 534;534;-1
2013_2527281481127819_manuscript;36   pregnant women;36;9858
2013_2527281481127819_manuscript;30 women;30;3665
2013_2527281481127819_manuscript;20 117   women;20117;3261
2013_2527281481127819_manuscript;213   recruiting women;213;4186
2013_2527281481127819_manuscript;503   preeclamptic women;503;26989
2013_2527281481127819_manuscript;100   Study participants;100;4769
2013_2527281481127819_manuscript;101   Participants were recruited;101;4730
2013_2527281481127819_manuscript;n=30;30;2751
2013_2527281481127819_manuscript;n=8;8;2516
2013_2527281481127819_manuscript;n=20;20;8798
2013_2527281481127819_manuscript;n=12;12;10188
2013_2527281481127819_manuscript;n=4;4;29502
2013_2527281481127819_manuscript;n=14;14;30162
2013_2527281481127819_manuscript;n=16;16;30181
2013_2527281481127819_manuscript;n= 20;20;33836
2013_2665104831005136_manuscript;560 RM women;560;-1
2013_2665104831005136_manuscript;89861 women;89861;-1
2013_2665104831005136_manuscript;3805 women;3805;-1
2013_2665104831005136_manuscript;100,000 pregnant women;100000;-1
2013_2665104831005136_manuscript;000 women;0;-1
2013_2710251429417042_manuscript;978 participants;978;-1
2013_2710251429417042_manuscript;60 participants;60;-1
2013_2710251429417042_manuscript;60,000 participants;60000;-1
2013_2710251429417042_manuscript;10,641 adults;10641;-1
2013_2710251429417042_manuscript;n=1,540;1540;-1
2013_2710251429417042_manuscript;n=1540;1540;-1
2013_2710251429417042_manuscript;n=17;17;-1
2013_2710251429417042_manuscript;n=19;19;-1
2013_2710251429417042_manuscript;n  =9;9;-1
2013_2710251429417042_manuscript;n  =1;1;-1
2013_2710251429417042_manuscript;n  =7;7;-1
2013_2710251429417042_manuscript;n  =6;6;-1
2013_2710251429417042_manuscript;n  =8;8;-1
2013_2710251429417042_manuscript;n  =2;2;-1
2013_2710251429417042_manuscript;n=  4;4;-1
2013_2710251429417042_manuscript;n  =5;5;-1
2013_2710251429417042_manuscript;n=  25;25;-1
2013_2710251429417042_manuscript;n  =4;4;-1
2013_2710251429417042_manuscript;n=  69;69;-1
2013_2710251429417042_manuscript;n=  61;61;-1
2013_2710251429417042_manuscript;total of 160;160;-1
2013_2710251429417042_manuscript; data pooled from 18;18;-1
2013_2778368088947599_manuscript;n=7,139;7139;-1
2013_2778368088947599_manuscript;n=4,234;4234;-1
2013_2779580071009883_manuscript;N=536;536;17212
2013_2779580071009883_manuscript;N=121;121;17060
2013_2779580071009883_manuscript;n=143;143;10388
2013_2779580071009883_manuscript;n=10;10;2880
2013_2779580071009883_manuscript;n=520;520;3738
2013_2779580071009883_manuscript;n=304;304;3875
2013_2779580071009883_manuscript;n=216;216;3904
2013_2779580071009883_manuscript;n=15;15;3976
2013_2779580071009883_manuscript;n=94;94;4942
2013_2779580071009883_manuscript;n=113;113;5259
2013_2779580071009883_manuscript;n=75;75;5343
2013_2779580071009883_manuscript;n=37;37;5370
2013_2779580071009883_manuscript;n=8;8;5452
2013_2779580071009883_manuscript;n=1;1;10388
2013_2779580071009883_manuscript;n=481;481;5579
2013_2779580071009883_manuscript;n=48;48;5579
2013_2779580071009883_manuscript;n=7;7;5343
2013_2779580071009883_manuscript;n=116;116;5838
2013_2779580071009883_manuscript;n=42;42;6116
2013_2779580071009883_manuscript;n=110;110;6335
2013_2779580071009883_manuscript;n=11;11;5259
2013_2779580071009883_manuscript;n=88;88;6534
2013_2779580071009883_manuscript;n=32;32;6563
2013_2779580071009883_manuscript;n=96;96;6907
2013_2779580071009883_manuscript;n=24;24;6936
2013_2779580071009883_manuscript;N=108;108;7063
2013_2779580071009883_manuscript;n=77;77;7579
2013_2779580071009883_manuscript;n=2;2;3904
2013_2779580071009883_manuscript;n=36;36;9188
2013_2779580071009883_manuscript;n=30;30;3875
2013_2779580071009883_manuscript;n=17;17;9866
2013_2779580071009883_manuscript;n=34;34;10166
2013_2779580071009883_manuscript;n=20;20;10731
2013_2779580071009883_manuscript;n=22;22;11020
2013_2779580071009883_manuscript;n=5;5;3738
2013_2779580071009883_manuscript;n=3;3;3875
2013_2779580071009883_manuscript;n=9;9;4942
2013_2779580071009883_manuscript;n=4;4;5579
2013_2779580071009883_manuscript;n=533;533;50972
2013_2779580071009883_manuscript;N=106;106;51136
2013_2779580071009883_manuscript;N=107;107;51285
2013_2779580071009883_manuscript; data from a 2006;2006;49636
2013_2917643961026771_manuscript;9,974 patients;9974;-1
2013_2917643961026771_manuscript;5,513 patients;5513;-1
2013_2917643961026771_manuscript;7,261 patients;7261;-1
2013_2917643961026771_manuscript;8 million patients;8;-1
2013_2917643961026771_manuscript;5,513   patients;5513;-1
2013_2917643961026771_manuscript;10K patients;10;-1
2013_2917643961026771_manuscript;15K patients;15;-1
2013_3091146941103400_manuscript;81 participants;81;-1
2013_3091146941103400_manuscript;1 Flow of participants;1;-1
2013_3091146941103400_manuscript;81 families were recruited;81;-1
2013_3091146941103400_manuscript;N=67;67;-1
2013_3091146941103400_manuscript;n=47;47;-1
2013_3091146941103400_manuscript;n=46;46;-1
2013_3091146941103400_manuscript;n=67;67;-1
2013_3091146941103400_manuscript;n  =6;6;-1
2013_3091146941103400_manuscript;n=821;821;-1
2013_3091146941103400_manuscript;n=729;729;-1
2013_3091146941103400_manuscript;n=316;316;-1
2013_3091146941103400_manuscript;n=403;403;-1
2013_3091146941103400_manuscript;n=10;10;-1
2013_3091146941103400_manuscript;n=32;32;-1
2013_3091146941103400_manuscript;n=27;27;-1
2013_3091146941103400_manuscript;n=30;30;-1
2013_3091146941103400_manuscript;n=34;34;-1
2013_3091146941103400_manuscript;n=42;42;-1
2013_3091146941103400_manuscript;n=4;4;-1
2013_3091146941103400_manuscript;n=1;1;-1
2013_3091146941103400_manuscript;n=39;39;-1
2013_3091146941103400_manuscript;n=7;7;-1
2013_3091146941103400_manuscript;n=33;33;-1
2013_3091146941103400_manuscript;n=93;93;-1
2013_3099417091036106_manuscript;35,078 women;35078;-1
2013_3099417091036106_manuscript;6,989 women;6989;-1
2013_3099417091036106_manuscript;59,467 individuals;59467;-1
2013_3099417091036106_manuscript;60,000   individuals;60000;-1
2013_3099417091036106_manuscript;5,033 individuals;5033;-1
2013_3099417091036106_manuscript;n = 21;21;-1
2013_3099417091036106_manuscript;n = 2,044;2044;-1
2013_3099417091036106_manuscript;n =   2,202;2202;-1
2013_3099417091036106_manuscript;n=   2;2;-1
2013_3099417091036106_manuscript;n=   3;3;-1
2013_3099417091036106_manuscript;total of 59,467;59467;-1
2013_3225528099392026_manuscript;117 participants;117;-1
2013_3225528099392026_manuscript;45 participants;45;-1
2013_3225528099392026_manuscript;120 participants;120;-1
2013_3225528099392026_manuscript;85 participants;85;-1
2013_3225528099392026_manuscript;43 participants;43;-1
2013_3225528099392026_manuscript;42 participants;42;-1
2013_3225528099392026_manuscript;18 participants;18;-1
2013_3225528099392026_manuscript;N=35;35;-1
2013_3225528099392026_manuscript;n=514;514;-1
2013_3225528099392026_manuscript;n=234;234;-1
2013_3225528099392026_manuscript;n=72;72;-1
2013_3225528099392026_manuscript;n=162;162;-1
2013_3225528099392026_manuscript;n=280;280;-1
2013_3225528099392026_manuscript;n=144;144;-1
2013_3225528099392026_manuscript;n=10;10;-1
2013_3225528099392026_manuscript;n=6;6;-1
2013_3225528099392026_manuscript;n=1;1;-1
2013_3225528099392026_manuscript;n=2;2;-1
2013_3225528099392026_manuscript;n=117;117;-1
2013_3225528099392026_manuscript;n=17;17;-1
2013_3225528099392026_manuscript;n=59;59;-1
2013_3225528099392026_manuscript;n=58;58;-1
2013_3225528099392026_manuscript;n=31;31;-1
2013_3225528099392026_manuscript;n=33;33;-1
2013_3225528099392026_manuscript;n=28;28;-1
2013_3225528099392026_manuscript;n=25;25;-1
2013_3225528099392026_manuscript;N=53;53;-1
2013_3225528099392026_manuscript;N=56;56;-1
2013_3225528099392026_manuscript;N=59;59;-1
2013_3225528099392026_manuscript;N=58;58;-1
2013_3225528099392026_manuscript;total of 117;117;-1
2013_3225528099392026_manuscript;total of 85;85;-1
2013_3225528099392026_manuscript;117 volunteers were enrolled;117;-1
2013_3319187931044789_manuscript;1390 women;1390;-1
2013_3319187931044789_manuscript;2 IgA seronegative women;2;-1
2013_3319187931044789_manuscript;31 seropositive subjects;31;-1
2013_3319187931044789_manuscript;1390 subjects;1390;-1
2013_3319187931044789_manuscript;73 subjects;73;-1
2013_3319187931044789_manuscript;1065 subjects;1065;-1
2013_3319187931044789_manuscript;921 subjects;921;-1
2013_3319187931044789_manuscript;16 subjects;16;-1
2013_3319187931044789_manuscript;23 subjects;23;-1
2013_3319187931044789_manuscript;2 subjects;2;-1
2013_3319187931044789_manuscript;356 patients;356;-1
2013_3319187931044789_manuscript;2 IgA false positive patients;2;-1
2013_3319187931044789_manuscript;2000 patients;2000;-1
2013_3319187931044789_manuscript;259,013 people;259013;-1
2013_3319187931044789_manuscript;2 IgA seropositive individuals;2;-1
2013_3319187931044789_manuscript;3011 adults;3011;-1
2013_3319187931044789_manuscript;1000 randomly selected Swedish adults;1000;-1
2013_3319187931044789_manuscript;n=1494;1494;-1
2013_3319187931044789_manuscript;n=1540;1540;-1
2013_3319187931044789_manuscript;n=13;13;-1
2013_3319187931044789_manuscript;n=11;11;-1
2013_3373478051068601_manuscript;86 patients;86;-1
2013_3373478051068601_manuscript;604 consecutive patients;604;-1
2013_3373478051068601_manuscript;523 patients;523;-1
2013_3373478051068601_manuscript;89 patients;89;-1
2013_3373478051068601_manuscript;81 patients;81;-1
2013_3373478051068601_manuscript;83 patients;83;-1
2013_3373478051068601_manuscript;1      linkage of patients;1;-1
2013_3373478051068601_manuscript;n=86;86;-1
2013_3373478051068601_manuscript;n=15;15;-1
2013_3373478051068601_manuscript;n=49;49;-1
2013_3373478051068601_manuscript;n=22;22;-1
2013_3373478051068601_manuscript;n=81;81;-1
2013_3373478051068601_manuscript;n=  86;86;-1
2013_3373478051068601_manuscript;n  =2;2;-1
2013_3373478051068601_manuscript;n  =3;3;-1
2013_3373478051068601_manuscript;n=  15;15;-1
2013_3373478051068601_manuscript;n  =4;4;-1
2013_3373478051068601_manuscript;n  =1;1;-1
2013_3373478051068601_manuscript;n  =8;8;-1
2013_3373478051068601_manuscript;n  =6;6;-1
2013_3373478051068601_manuscript; data from 86;86;-1
2013_3405449578837590_manuscript;43 subjects;43;489
2013_3405449578837590_manuscript;46   age-matched control subjects;46;401
2013_3405449578837590_manuscript;14 TSC   subjects;14;317
2013_3405449578837590_manuscript;16 subjects;16;160
2013_3405449578837590_manuscript;16 patients;16;8504
2013_3405449578837590_manuscript;18 autistic adults;18;8433
2013_3405449578837590_manuscript;10 autistic adults;10;8981
2013_3405449578837590_manuscript;n=14;14;23669
2013_3405449578837590_manuscript;n=29;29;23644
2013_3405449578837590_manuscript;n=16;16;23599
2013_3405449578837590_manuscript;n=46;46;23573
2013_3405449578837590_manuscript;n = 46;46;45279
2013_3405449578837590_manuscript;n = 29;29;45292
2013_3405449578837590_manuscript;n = 14;14;45310
2013_3405449578837590_manuscript;n = 16;16;45323
2013_3896415751047979_manuscript;150 participants;150;-1
2013_3896415751047979_manuscript;200 participants;200;-1
2013_3896415751047979_manuscript;10 patients;10;-1
2013_3896415751047979_manuscript;12 patients;12;-1
2013_3896415751047979_manuscript;81 consecutive patients;81;-1
2013_3896415751047979_manuscript;10   Age of patients;10;-1
2013_3896415751047979_manuscript;83   Gender of patients;83;-1
2013_3896415751047979_manuscript;n=88;88;-1
2013_3896415751047979_manuscript;n=42;42;-1
2013_3896415751047979_manuscript;N=22;22;-1
2013_3896415751047979_manuscript;n=1;1;-1
2013_3896415751047979_manuscript;N=67;67;-1
2013_4441227481069361_manuscript;381 patients;381;-1
2013_4441227481069361_manuscript;89 patients;89;-1
2013_4441227481069361_manuscript;5,707   patients;5707;-1
2013_4441227481069361_manuscript;97 patients;97;-1
2013_4441227481069361_manuscript;106 RA patients;106;-1
2013_4441227481069361_manuscript;293 patients;293;-1
2013_4441227481069361_manuscript;233 patients;233;-1
2013_4441227481069361_manuscript;1,600 patients;1600;-1
2013_4441227481069361_manuscript;n=162;162;-1
2013_4441227481069361_manuscript;n = 5,339;5339;-1
2013_4441227481069361_manuscript;n = 456;456;-1
2013_4441227481069361_manuscript;n=211;211;-1
2013_4691888601040579_manuscript;7447 participants;7447;-1
2013_4691888601040579_manuscript;153 participants;153;-1
2013_4691888601040579_manuscript;210 participants;210;-1
2013_4691888601040579_manuscript;5,505 participants;5505;-1
2013_4691888601040579_manuscript;1,350 participants;1350;-1
2013_4691888601040579_manuscript;1,579 subjects;1579;-1
2013_4691888601040579_manuscript;n=7,447;7447;-1
2013_4691888601040579_manuscript;total of 443;443;-1
2013_4792155095093535_manuscript;1206 acute   and rehabilitation inpatients;1206;-1
2013_4792155095093535_manuscript;67 patients;67;-1
2013_4792155095093535_manuscript;100 patients;100;-1
2013_4792155095093535_manuscript;2 patients;2;-1
2013_4792155095093535_manuscript;500 patients;500;-1
2013_4792155095093535_manuscript;100 cognitively intact patients;100;-1
2013_4792155095093535_manuscript;n=1206;1206;-1
2013_4792155095093535_manuscript;n=0;0;-1
2013_5051009589258434_manuscript;71   patients;71;-1
2013_5051009589258434_manuscript;122   of patients;122;-1
2013_5051009589258434_manuscript;144   dyskinetic PD patients;144;-1
2013_5051009589258434_manuscript;235   increased monitoring of patients;235;-1
2013_5051009589258434_manuscript;257   patients;257;-1
2013_5051009589258434_manuscript;277   quality of life of patients;277;-1
2013_5051009589258434_manuscript;312   of the care patients;312;-1
2013_5051009589258434_manuscript;344   patients;344;-1
2013_5051009589258434_manuscript;364   repertoire of patients;364;-1
2013_5051009589258434_manuscript;372   patients;372;-1
2013_5051009589258434_manuscript;459   patients;459;-1
2013_5051009589258434_manuscript;492   systematic across patients;492;-1
2013_5051009589258434_manuscript;507   progression within patients;507;-1
2013_5051009589258434_manuscript;520   patients;520;-1
2013_5051009589258434_manuscript;89 patients;89;-1
2013_5051009589258434_manuscript;64 patients;64;-1
2013_5629470839998185_manuscript;69253 subjects;69253;-1
2013_5629470839998185_manuscript;38,947 patients;38947;-1
2013_5629470839998185_manuscript;38,947 pulmonary TB patients;38947;-1
2013_5629470839998185_manuscript;23,917 TB patients;23917;-1
2013_5629470839998185_manuscript;100,000 people;100000;-1
2013_5657025801007763_manuscript;6094 subjects;6094;-1
2013_5657025801007763_manuscript;619 subjects;619;-1
2013_5657025801007763_manuscript;3322   subjects;3322;-1
2013_5657025801007763_manuscript;3322 individuals;3322;-1
2013_5657025801007763_manuscript;28 449 individuals;28449;-1
2013_5657025801007763_manuscript;89 individuals;89;-1
2013_5657025801007763_manuscript;14 individuals;14;-1
2013_5657025801007763_manuscript;3322 individuals   recruited;3322;-1
2013_5657025801007763_manuscript;28 449 individuals   enrolled;28449;-1
2013_5796462771077112_manuscript;2823 participants;2823;-1
2013_5796462771077112_manuscript;1077 participants;1077;-1
2013_5796462771077112_manuscript;1308 participants;1308;-1
2013_5796462771077112_manuscript;335 participants;335;-1
2013_5796462771077112_manuscript;505   participants;505;-1
2013_5796462771077112_manuscript;505 original participants;505;-1
2013_5796462771077112_manuscript;501 participants;501;-1
2013_5796462771077112_manuscript;106 participants;106;-1
2013_5796462771077112_manuscript;2399 individuals;2399;-1
2013_5796462771077112_manuscript;1361 individuals;1361;-1
2013_5796462771077112_manuscript;1362   individuals;1362;-1
2013_5796462771077112_manuscript;n=383;383;-1
2013_5796462771077112_manuscript;n=346;346;-1
2013_5796462771077112_manuscript;n=10;10;-1
2013_5796462771077112_manuscript;n=245;245;-1
2013_5796462771077112_manuscript;n=352;352;-1
2013_5796462771077112_manuscript;n=122;122;-1
2013_5796462771077112_manuscript;n=270;270;-1
2013_5796462771077112_manuscript;n=367;367;-1
2013_5796462771077112_manuscript;n=71;71;-1
2013_5796462771077112_manuscript;n=6;6;-1
2013_5796462771077112_manuscript;n=3;3;-1
2013_5796462771077112_manuscript;n= 0;0;-1
2013_5796462771077112_manuscript;n=30;30;-1
2013_5796462771077112_manuscript;n=726;726;-1
2013_5796462771077112_manuscript;n=618;618;-1
2013_5796462771077112_manuscript;n=22;22;-1
2013_5796462771077112_manuscript;n=26;26;-1
2013_5796462771077112_manuscript;n = 20;20;-1
2013_5796462771077112_manuscript;n=20;20;-1
2013_5796462771077112_manuscript;n=24;24;-1
2013_5796462771077112_manuscript;N  =  5;5;-1
2013_5796462771077112_manuscript;N  =  2;2;-1
2013_5796462771077112_manuscript;N  =  1;1;-1
2013_5796462771077112_manuscript;N  =5;5;-1
2013_5796462771077112_manuscript;N  =  6;6;-1
2013_5796462771077112_manuscript;N  =  9;9;-1
2013_5796462771077112_manuscript;N  =4;4;-1
2013_5796462771077112_manuscript;N  =  7;7;-1
2013_5796462771077112_manuscript;N = 600;600;-1
2013_5796462771077112_manuscript;N=605;605;-1
2013_5796462771077112_manuscript;N=552;552;-1
2013_5796462771077112_manuscript;N=604;604;-1
2013_5796462771077112_manuscript;N=599;599;-1
2013_5796462771077112_manuscript;N=548;548;-1
2013_5796462771077112_manuscript;N=598;598;-1
2013_5796462771077112_manuscript;N=597;597;-1
2013_5796462771077112_manuscript;N=546;546;-1
2013_5796462771077112_manuscript;N=596;596;-1
2013_5796462771077112_manuscript;N=667;667;-1
2013_5796462771077112_manuscript;N=570;570;-1
2013_5796462771077112_manuscript;N=668;668;-1
2013_5796462771077112_manuscript;N=571;571;-1
2013_5796462771077112_manuscript;N=252;252;-1
2013_5796462771077112_manuscript;N=204;204;-1
2013_5796462771077112_manuscript;N=122;122;-1
2013_5796462771077112_manuscript;N=94;94;-1
2013_5796462771077112_manuscript;N=59;59;-1
2013_5796462771077112_manuscript;N=45;45;-1
2013_5796462771077112_manuscript;N  =7;7;-1
2013_5796462771077112_manuscript;N  =2;2;-1
2013_5796462771077112_manuscript;N  =6;6;-1
2013_5796462771077112_manuscript;N  =  8;8;-1
2013_5796462771077112_manuscript;N  =  3;3;-1
2013_5796462771077112_manuscript;N=848;848;-1
2013_5796462771077112_manuscript;N=843;843;-1
2013_5796462771077112_manuscript;N=348;348;-1
2013_5796462771077112_manuscript;N=731;731;-1
2013_5796462771077112_manuscript;N=347;347;-1
2013_5796462771077112_manuscript;N=733;733;-1
2013_5796462771077112_manuscript;N=361;361;-1
2013_5796462771077112_manuscript;N=742;742;-1
2013_5796462771077112_manuscript;N=334;334;-1
2013_5796462771077112_manuscript;N=562;562;-1
2013_5796462771077112_manuscript;N=542;542;-1
2013_5796462771077112_manuscript;N=528;528;-1
2013_5796462771077112_manuscript;N=313;313;-1
2013_5796462771077112_manuscript;N=391;391;-1
2013_5796462771077112_manuscript;N=328;328;-1
2013_5796462771077112_manuscript;N=403;403;-1
2013_5796462771077112_manuscript;N=329;329;-1
2013_5796462771077112_manuscript;N=397;397;-1
2013_5796462771077112_manuscript;N=399;399;-1
2013_5796462771077112_manuscript;N=261;261;-1
2013_5796462771077112_manuscript;N  =  4;4;-1
2013_5796462771077112_manuscript;N  =1;1;-1
2013_5796462771077112_manuscript;N  =8;8;-1
2013_5796462771077112_manuscript;N  =3;3;-1
2013_5796462771077112_manuscript;total of 6901;6901;-1
2013_5796462771077112_manuscript;total of 3333;3333;-1
2013_5854496989514502_manuscript;19 patients;19;-1
2013_6127956929268343_manuscript;22,239 patients;22239;-1
2013_6127956929268343_manuscript;19,725 patients;19725;-1
2013_6127956929268343_manuscript;1,196 patients;1196;-1
2013_6127956929268343_manuscript;845 patients;845;-1
2013_6127956929268343_manuscript;20 thousand patients;20;-1
2013_6156354131077677_manuscript;15,000 kJ for women;15000;-1
2013_6156354131077677_manuscript;85   All participants;85;-1
2013_6156354131077677_manuscript;135   Categorization of the participants;135;-1
2013_6156354131077677_manuscript;189   participants;189;-1
2013_6156354131077677_manuscript;2378 participants;2378;-1
2013_6156354131077677_manuscript;208 participants;208;-1
2013_6156354131077677_manuscript;34 subjects;34;-1
2013_6156354131077677_manuscript;2378 CAD patients;2378;-1
2013_6156354131077677_manuscript;14   diabetes patients;14;-1
2013_6156354131077677_manuscript;21   patients;21;-1
2013_6156354131077677_manuscript;22   patients;22;-1
2013_6156354131077677_manuscript;23   patients;23;-1
2013_6156354131077677_manuscript;12,536 patients;12536;-1
2013_6156354131077677_manuscript;62   patients;62;-1
2013_6156354131077677_manuscript;3090 patients;3090;-1
2013_6156354131077677_manuscript;2484 patients;2484;-1
2013_6156354131077677_manuscript;2412 patients;2412;-1
2013_6156354131077677_manuscript;2378 patients;2378;-1
2013_6156354131077677_manuscript;723 patients;723;-1
2013_6156354131077677_manuscript;183   patients;183;-1
2013_6156354131077677_manuscript;202   diabetic patients;202;-1
2013_6156354131077677_manuscript;212   patients;212;-1
2013_6156354131077677_manuscript;226   diabetic patients;226;-1
2013_6156354131077677_manuscript;59 patients;59;-1
2013_6156354131077677_manuscript;258 246   patients;258246;-1
2013_6156354131077677_manuscript;256   patients;256;-1
2013_6156354131077677_manuscript;265   patients;265;-1
2013_6156354131077677_manuscript;302   majority of patients;302;-1
2013_6156354131077677_manuscript;318   dysglycemic patients;318;-1
2013_6156354131077677_manuscript;319   diabetic patients;319;-1
2013_6156354131077677_manuscript;361   In this cohort of patients;361;-1
2013_6156354131077677_manuscript;363   non-diabetic patients;363;-1
2013_6156354131077677_manuscript;n=53;53;-1
2013_6156354131077677_manuscript;n=380;380;-1
2013_6156354131077677_manuscript;n=259;259;-1
2013_6156354131077677_manuscript;n=84;84;-1
2013_6156354131077677_manuscript;n=423;423;-1
2013_6156354131077677_manuscript;n=0;0;-1
2013_6156354131077677_manuscript;n  =2;2;-1
2013_6156354131077677_manuscript;n=  10;10;-1
2013_6156354131077677_manuscript;n=  31;31;-1
2013_6156354131077677_manuscript;n=  38;38;-1
2013_6156354131077677_manuscript;n=  25;25;-1
2013_6156354131077677_manuscript;n=  84;84;-1
2013_6156354131077677_manuscript;n  =1;1;-1
2013_6156354131077677_manuscript;n  =3;3;-1
2013_6156354131077677_manuscript;total of 46;46;-1
2013_6156354131077677_manuscript;total of 1577;1577;-1
2013_6156354131077677_manuscript;total of 208;208;-1
2013_6163546301030630_manuscript;1 patients;1;-1
2013_6163546301030630_manuscript;18 820 patients;18820;-1
2013_6163546301030630_manuscript;2 million people;2;-1
2013_6248532709552941_manuscript;5   a group of patients;5;-1
2013_6248532709552941_manuscript;936 patients;936;-1
2013_6248532709552941_manuscript;134 patients;134;-1
2013_6248532709552941_manuscript;17   otherwise healthy patients;17;-1
2013_6248532709552941_manuscript;7 patients;7;-1
2013_6248532709552941_manuscript;10   these patients;10;-1
2013_6248532709552941_manuscript;23   unvaccinated individuals;23;-1
2013_6248532709552941_manuscript;n=83;83;-1
2013_6248532709552941_manuscript;n=104;104;-1
2013_6248532709552941_manuscript;n=219;219;-1
2013_6248532709552941_manuscript;n=116;116;-1
2013_6248532709552941_manuscript;N  =6;6;-1
2013_6248532709552941_manuscript;N  =  83;83;-1
2013_6248532709552941_manuscript;N  =  10;10;-1
2013_6248532709552941_manuscript;N  =  11;11;-1
2013_6248532709552941_manuscript;total of 257;257;-1
2013_6248532709552941_manuscript;total of 3,500;3500;-1
2013_6248532709552941_manuscript;total of 137;137;-1
2013_6288921761142096_manuscript;1,751,841 registered patients;1751841;-1
2013_6288921761142096_manuscript;270 patients;270;-1
2013_6288921761142096_manuscript;215 patients;215;-1
2013_6288921761142096_manuscript;001   Hypertension patients;1;-1
2013_6288921761142096_manuscript;2,582 people;2582;-1
2013_6288921761142096_manuscript;8 million individuals;8;-1
2013_6288921761142096_manuscript;n=170;170;-1
2013_6288921761142096_manuscript;n=80,985;80985;-1
2013_6288921761142096_manuscript;n=147;147;-1
2013_6288921761142096_manuscript;n=73,508;73508;-1
2013_6288921761142096_manuscript;n=80,863;80863;-1
2013_6288921761142096_manuscript;n=81,297;81297;-1
2013_6288921761142096_manuscript;n=462;462;-1
2013_6288921761142096_manuscript;n=232,986;232986;-1
2013_6288921761142096_manuscript;n=232;232;-1
2013_6288921761142096_manuscript;n=233,852;233852;-1
2013_6288921761142096_manuscript; dataset of 1,751,841;1751841;-1
2013_6288921761142096_manuscript; data from 314;314;-1
2013_6592104329046237_manuscript;100 women;100;-1
2013_6592104329046237_manuscript;1597   subjects;1597;-1
2013_6592104329046237_manuscript;114 patients;114;-1
2013_6592104329046237_manuscript;410 SS patients;410;-1
2013_6592104329046237_manuscript;2489 SLE patients;2489;-1
2013_6592104329046237_manuscript;100   pSS patients;100;-1
2013_6592104329046237_manuscript;445   pSS patients;445;-1
2013_6592104329046237_manuscript;133 patients;133;-1
2013_6592104329046237_manuscript;27 patients;27;-1
2013_6592104329046237_manuscript;202 SSc patients;202;-1
2013_6592104329046237_manuscript;176   primary SS patients;176;-1
2013_6592104329046237_manuscript;20 patients;20;-1
2013_6592104329046237_manuscript;10 patients;10;-1
2013_6592104329046237_manuscript;16 patients;16;-1
2013_6592104329046237_manuscript;400 patients;400;-1
2013_6592104329046237_manuscript;65 patients;65;-1
2013_6592104329046237_manuscript;1010 patients;1010;-1
2013_6592104329046237_manuscript;188 patients;188;-1
2013_6592104329046237_manuscript;35 patients;35;-1
2013_6592104329046237_manuscript;133 consecutive patients;133;-1
2013_6592104329046237_manuscript;43 patients;43;-1
2013_6592104329046237_manuscript;196   patients;196;-1
2013_7491653051066404_manuscript;3,849 women;3849;-1
2013_7491653051066404_manuscript;7,786 eligible women;7786;-1
2013_7491653051066404_manuscript;3,243 women;3243;-1
2013_7491653051066404_manuscript;44,546 individuals;44546;-1
2013_7491653051066404_manuscript;152   individuals;152;-1
2013_7491653051066404_manuscript;N=3,243;3243;-1
2013_7491653051066404_manuscript;N = 2,546;2546;-1
2013_7491653051066404_manuscript; data from the 2009;2009;-1
2013_7491653051066404_manuscript; data from 15;15;-1
2013_7657394131028684_manuscript;3 women;3;-1
2013_7657394131028684_manuscript;2 women;2;-1
2013_7657394131028684_manuscript;5 women;5;-1
2013_7657394131028684_manuscript;7 patients;7;-1
2013_7657394131028684_manuscript;23      patients;23;-1
2013_7657394131028684_manuscript;n=5;5;-1
2013_7657394131028684_manuscript;n= 3;3;-1
2013_7657394131028684_manuscript;n= 5;5;-1
2013_8002437321148335_manuscript;16 patients;16;15866
2013_8002437321148335_manuscript;13 patients;13;15060
2013_8002437321148335_manuscript;248 patients;248;10077
2013_8002437321148335_manuscript;68 patients;68;9038
2013_8002437321148335_manuscript;33 patients;33;8817
2013_8002437321148335_manuscript;12   patients;12;8768
2013_8002437321148335_manuscript;17 patients;17;8713
2013_8002437321148335_manuscript;19   patients;19;8673
2013_8002437321148335_manuscript;99 patients;99;617
2013_8002437321148335_manuscript;7 patients;7;8712
2013_8002437321148335_manuscript;29 patients;29;1677
2013_8002437321148335_manuscript;92 patients;92;1809
2013_8002437321148335_manuscript;23 patients;23;2402
2013_8002437321148335_manuscript;3   patients;3;3059
2013_8002437321148335_manuscript;30 patients;30;7132
2013_8002437321148335_manuscript;19 patients;19;7267
2013_8002437321148335_manuscript;30   patients;30;7434
2013_8002437321148335_manuscript;20 patients;20;7552
2013_8002437321148335_manuscript;2 patients;2;1810
2013_8002437321148335_manuscript;33 group I patients;33;13968
2013_8002437321148335_manuscript;30 of group II patients;30;14096
2013_8002437321148335_manuscript;n=35;35;16199
2013_8002437321148335_manuscript;n=33;33;16126
2013_8002437321148335_manuscript;n=31;31;16041
2013_8002437321148335_manuscript;n=10;10;8418
2013_8002437321148335_manuscript;n=7;7;8442
2013_8002437321148335_manuscript;n=92;92;32607
2013_8002437321148335_manuscript;n=30;30;32667
2013_8002437321148335_manuscript;n=29;29;32688
2013_8087848089432098_manuscript;372 nursing home patients;372;-1
2013_8087848089432098_manuscript;161 patients;161;-1
2013_8087848089432098_manuscript;3 patients;3;-1
2013_8087848089432098_manuscript;135 patients;135;-1
2013_8087848089432098_manuscript;372 patients;372;-1
2013_8087848089432098_manuscript;2 Selection of patients;2;-1
2013_8087848089432098_manuscript;n   =   1;1;-1
2013_8087848089432098_manuscript;n = 161;161;-1
2013_8087848089432098_manuscript;n  =1;1;-1
2013_8087848089432098_manuscript;491 residents enrolled;491;-1
2013_8087848089432098_manuscript;119 residents enrolled;119;-1
2013_8087848089432098_manuscript;372 residents enrolled;372;-1
2013_8200422931065119_manuscript;67 women;67;3170
2013_8200422931065119_manuscript;3681 women;3681;2249
2013_8200422931065119_manuscript;2211 women;2211;2291
2013_8200422931065119_manuscript;85 women;85;2653
2013_8200422931065119_manuscript;400,000 women;400000;15834
2013_8200422931065119_manuscript;3681 women were recruited;3681;2249
2013_8200422931065119_manuscript;n=3681;3681;15753
2013_8200422931065119_manuscript;N=532;532;18693
2013_8200422931065119_manuscript;N= 922;922;18714
2013_8200422931065119_manuscript;total of 3681;3681;2240
2013_8200422931065119_manuscript;total   of 85;85;2642
2013_8783739971032055_manuscript;30 women;30;-1
2013_8783739971032055_manuscript;12257 participants;12257;-1
2013_8783739971032055_manuscript;2006 NHANES participants;2006;-1
2013_8783739971032055_manuscript;23 magnesium deficient patients;23;-1
2013_8783739971032055_manuscript;5 magnesium deficient patients;5;-1
2013_8783739971032055_manuscript;11 magnesium deficient patients;11;-1
2013_8783739971032055_manuscript;n=16819;16819;-1
2013_8783739971032055_manuscript;n=  69;69;-1
2013_8783739971032055_manuscript;n=  36;36;-1
2013_8783739971032055_manuscript;N  =1;1;-1
2013_8892888972000397_manuscript;22 participants;22;86931
2013_8892888972000397_manuscript;09 participants;9;81645
2013_8892888972000397_manuscript;09 all subjects;9;79000
2013_8892888972000397_manuscript;09 and all subjects;9;45961
2013_8892888972000397_manuscript;22 subjects;22;38684
2013_8892888972000397_manuscript;n=22;22;79574
2013_8892888972000397_manuscript;n=12;12;69323
2013_8892888972000397_manuscript;n=40;40;52028
2013_8901326529596596_manuscript;1527 subjects;1527;-1
2013_8901326529596596_manuscript;1159 subjects;1159;-1
2013_8901326529596596_manuscript;6,666 SZ subjects;6666;-1
2013_8901326529596596_manuscript;1,782 Chinese and Japanese SZ   subjects;1782;-1
2013_8901326529596596_manuscript;1021 Irish subjects;1021;-1
2013_8901326529596596_manuscript;626 Irish control   subjects;626;-1
2013_8901326529596596_manuscript;50,000 subjects;50000;-1
2013_8901326529596596_manuscript;2,496 SZ subjects;2496;-1
2013_8901326529596596_manuscript;1000 subjects;1000;-1
2013_8901326529596596_manuscript;184 MDD and BD subjects;184;-1
2013_8901326529596596_manuscript;738 SZ subjects;738;-1
2013_8901326529596596_manuscript;466 German MDD patients;466;-1
2013_8901326529596596_manuscript;228   MDD patients;228;-1
2013_8901326529596596_manuscript;300 Caucasian MDD patients;300;-1
2013_8901326529596596_manuscript;87 patients;87;-1
2013_8901326529596596_manuscript;206 Han Chinese patients;206;-1
2013_8901326529596596_manuscript;159 Spanish MDD   outpatients;159;-1
2013_8901326529596596_manuscript;1809 MDD   outpatients;1809;-1
2013_8901326529596596_manuscript;89 Swedish patients;89;-1
2013_8901326529596596_manuscript;317 MDD patients;317;-1
2013_8901326529596596_manuscript;35 SZ patients;35;-1
2013_8901326529596596_manuscript;31 BD patients;31;-1
2013_8901326529596596_manuscript;548 BD patients;548;-1
2013_8901326529596596_manuscript;246 elderly MDD patients;246;-1
2013_8901326529596596_manuscript;113   Korean patients;113;-1
2013_8901326529596596_manuscript;364 patients;364;-1
2013_8901326529596596_manuscript;780 patients;780;-1
2013_8901326529596596_manuscript;635 patients;635;-1
2013_8901326529596596_manuscript;234 Caucasian individuals;234;-1
2013_8901326529596596_manuscript;1054 Scottish individuals;1054;-1
2013_8901326529596596_manuscript;34 control individuals;34;-1
2013_8901326529596596_manuscript;49 individuals;49;-1
2013_8901326529596596_manuscript;13 unmedicated recovered MDD individuals;13;-1
2013_8901326529596596_manuscript;847 Caucasian non-Maori individuals;847;-1
2013_8901326529596596_manuscript;n =10;10;-1
2013_8901326529596596_manuscript;n=422;422;-1
2013_8901326529596596_manuscript;n=299;299;-1
2013_8901326529596596_manuscript;n=30;30;-1
2013_8901326529596596_manuscript;n=15;15;-1
2013_8901326529596596_manuscript;n=61;61;-1
2013_8901326529596596_manuscript;49 individuals   enrolled;49;-1
2013_8901326529596596_manuscript; data from 1809;1809;-1
2013_8901326529596596_manuscript; data from 49;49;-1
2013_8901326529596596_manuscript; data from 37;37;-1
2013_9007206979968216_manuscript;7,216 men and women;7216;-1
2013_9007206979968216_manuscript;80 y and women;80;-1
2013_9007206979968216_manuscript;4145 women;4145;-1
2013_9007206979968216_manuscript;7,447 elderly   participants;7447;-1
2013_9007206979968216_manuscript;7,216   individuals;7216;-1
2013_9007206979968216_manuscript;n=153;153;-1
2013_9007206979968216_manuscript;n=78;78;-1
2013_9007206979968216_manuscript;n=2118;2118;-1
2013_9007206979968216_manuscript;n=2803;2803;-1
2013_9007206979968216_manuscript;n=2295;2295;-1
2013_9007206979968216_manuscript;n=2916;2916;-1
2013_9007206979968216_manuscript;n=2547;2547;-1
2013_9007206979968216_manuscript;n=1753;1753;-1
2013_9007206979968216_manuscript;n=3308;3308;-1
2013_9007206979968216_manuscript;n=2643;2643;-1
2013_9007206979968216_manuscript;n=1265;1265;-1
2013_9007206979968216_manuscript;total of 3071;3071;-1
2013_9219062009996637_manuscript;3,700 patients;3700;-1
2013_9219062009996637_manuscript;1 infected individuals;1;-1
2013_9219062009996637_manuscript;total of   53;53;-1
2013_9219062009996637_manuscript;4,600 is projected to be enrolled;4600;-1
2013_9219062009996637_manuscript; data from 3;3;-1
2013_9219062009996637_manuscript; data from the 3;3;-1
2013_9236524159109862_manuscript;n=346;346;-1
2013_9236524159109862_manuscript;n=154;154;-1
2013_9236524159109862_manuscript;n=104;104;-1
2013_9236524159109862_manuscript;n=442;442;-1
2013_9236524159109862_manuscript;n=439;439;-1
2013_9236524159109862_manuscript;total of 1641;1641;-1
2013_9299586741078930_manuscript;102 subjects;102;12119
2013_9299586741078930_manuscript;95 subjects;95;3561
2013_9299586741078930_manuscript;8 subjects;8;3875
2013_9299586741078930_manuscript;2 diabetes patients;2;14593
2013_9299586741078930_manuscript;n=8;8;12477
2013_9299586741078930_manuscript;n=24;24;503
2013_9299586741078930_manuscript;n=43;43;553
2013_9299586741078930_manuscript;n=10;10;671
2013_9299586741078930_manuscript;n=39;39;16967
2013_9299586741078930_manuscript;n=23;23;16981
2013_9299586741078930_manuscript;n=40;40;16995
2013_9299586741078930_manuscript; data from 8;8;3864
2013_9438601361118018_manuscript;4 patients;4;-1
2013_9438601361118018_manuscript;90 patients;90;-1
2013_9438601361118018_manuscript;25 patients;25;-1
2013_9438601361118018_manuscript;64 patients;64;-1
2013_9456857331005329_manuscript;468,561 participants;468561;-1
2013_9456857331005329_manuscript;346,570 participants;346570;-1
2013_9456857331005329_manuscript;n =   372,927;372927;-1
2013_9456857331005329_manuscript;n = 292,026;292026;-1
2013_9456857331005329_manuscript;n = 406,539;406539;-1
2013_9456857331005329_manuscript;total of 468,561;468561;-1
2014_1012322617121041_manuscript;75  Healthy subjects;75;-1
2014_1048577691257559_manuscript;2D patients;2;-1
2014_1048577691257559_manuscript;389   patients;389;-1
2014_1048577691257559_manuscript;2 608   diabetic patients;2608;-1
2014_1048577691257559_manuscript;71   individuals;71;-1
2014_1048577691257559_manuscript;2D patients and obese individuals;2;-1
2014_1048577691257559_manuscript;n=13;13;-1
2014_1048577691257559_manuscript;n=9;9;-1
2014_1048577691257559_manuscript;n=4;4;-1
2014_1048577691257559_manuscript;total of 262;262;-1
2014_1091447673130540_manuscript;200 participants;200;-1
2014_1091447673130540_manuscript;200,000 voluntary participants;200000;-1
2014_1091447673130540_manuscript;800 participants;800;-1
2014_1091447673130540_manuscript;200 patients;200;-1
2014_1091447673130540_manuscript;610 patients;610;-1
2014_1091447673130540_manuscript;10 patients;10;-1
2014_1091447673130540_manuscript;15 patients;15;-1
2014_1091447673130540_manuscript;3,000 patients;3000;-1
2014_1091447673130540_manuscript;282 patients;282;-1
2014_1091447673130540_manuscript;n=282;282;-1
2014_1091447673130540_manuscript;n=610;610;-1
2014_1091447673130540_manuscript;n=529;529;-1
2014_1091447673130540_manuscript;n=280;280;-1
2014_1091447673130540_manuscript;n=200;200;-1
2014_1091447673130540_manuscript;n=351;351;-1
2014_1091447673130540_manuscript;n=53;53;-1
2014_1091447673130540_manuscript;n=51;51;-1
2014_1091447673130540_manuscript;n=21;21;-1
2014_1091447673130540_manuscript;n=81;81;-1
2014_1091447673130540_manuscript;total of 3,000;3000;-1
2014_1095087934124611_manuscript;826,352 individuals;826352;-1
2014_1095087934124611_manuscript;n=3,885;3885;-1
2014_1095087934124611_manuscript;n=3,852;3852;-1
2014_1095087934124611_manuscript;n=158;158;-1
2014_1095087934124611_manuscript;n=10;10;-1
2014_1095087934124611_manuscript;n=200;200;-1
2014_1095087934124611_manuscript;n=2,084;2084;-1
2014_1095087934124611_manuscript;n=881;881;-1
2014_1095087934124611_manuscript;n=597;597;-1
2014_1095087934124611_manuscript;n=323;323;-1
2014_1095087934124611_manuscript;n=3,248;3248;-1
2014_1095087934124611_manuscript;n=7,353;7353;-1
2014_1095087934124611_manuscript;total of 9,852;9852;-1
2014_1115081331451613_manuscript;26   studies covering men and women;26;-1
2014_1115081331451613_manuscript;490,288 participants;490288;-1
2014_1115081331451613_manuscript;1170 adults;1170;-1
2014_1115081331451613_manuscript;13   adults;13;-1
2014_1115081331451613_manuscript;1170   adults;1170;-1
2014_1115081331451613_manuscript; data from 4;4;-1
2014_1115081331451613_manuscript; data   from the 490,288;490288;-1
2014_1130660771153340_manuscript;n = 28;28;-1
2014_1130660771153340_manuscript;n = 21;21;-1
2014_1130660771153340_manuscript;n = 18;18;-1
2014_1130660771153340_manuscript;n = 25;25;-1
2014_1130660771153340_manuscript;n = 10;10;-1
2014_1130660771153340_manuscript; data from 1950;1950;-1
2014_1167905310126530_manuscript;n=2217;2217;-1
2014_1167905310126530_manuscript;N=1728;1728;-1
2014_1167905310126530_manuscript;N=350;350;-1
2014_1167905310126530_manuscript;N=1378;1378;-1
2014_1180692969126439_manuscript;20   participants;20;4817
2014_1180692969126439_manuscript;996 participants;996;15380
2014_1180692969126439_manuscript;3   inpatients;3;14247
2014_1180692969126439_manuscript;996 patients;996;13281
2014_1180692969126439_manuscript;25   flow of the patients;25;3119
2014_1180692969126439_manuscript;27   patients;27;19217
2014_1180692969126439_manuscript;n=496;496;13196
2014_1180692969126439_manuscript;n=500;500;13162
2014_1180692969126439_manuscript;n=54;54;3803
2014_1180692969126439_manuscript;n=94;94;3831
2014_1180692969126439_manuscript;n=1;1;4017
2014_1180692969126439_manuscript;n=4;4;13196
2014_1180692969126439_manuscript;n=92;92;5348
2014_1180692969126439_manuscript;n=95;95;5406
2014_1180692969126439_manuscript;n = 996;996;31995
2014_1180692969126439_manuscript;n = 496;496;32023
2014_1180692969126439_manuscript;n = 500;500;32045
2014_1180692969126439_manuscript;total of 996;996;3009
2014_1182087688137415_manuscript;63 women;63;-1
2014_1182087688137415_manuscript;28,354 participants;28354;-1
2014_1182087688137415_manuscript;31,689 subjects;31689;-1
2014_1182087688137415_manuscript;2 diabetic patients;2;-1
2014_1182087688137415_manuscript;2 diabetes patients;2;-1
2014_1182087688137415_manuscript;2 diabetic   patients;2;-1
2014_1182087688137415_manuscript;63,084 individuals;63084;-1
2014_1182087688137415_manuscript;n=28,354;28354;-1
2014_1182087688137415_manuscript;n=355;355;-1
2014_1182087688137415_manuscript;n=216;216;-1
2014_1182087688137415_manuscript;n=653;653;-1
2014_1182087688137415_manuscript;n=115;115;-1
2014_1182087688137415_manuscript;n=80;80;-1
2014_1182087688137415_manuscript;n=1,346;1346;-1
2014_1182087688137415_manuscript;n  =2;2;-1
2014_1182087688137415_manuscript;N  =7;7;-1
2014_1182087688137415_manuscript;N  =8;8;-1
2014_1182087688137415_manuscript;N  =2;2;-1
2014_1182087688137415_manuscript;n  =5;5;-1
2014_1182087688137415_manuscript;N=2,250;2250;-1
2014_1182087688137415_manuscript;N=355;355;-1
2014_1182087688137415_manuscript;N=216;216;-1
2014_1182087688137415_manuscript;N=653;653;-1
2014_1182087688137415_manuscript;N=115;115;-1
2014_1182087688137415_manuscript;2 diabetic patients enrolled;2;-1
2014_1182087688137415_manuscript;63,084 individuals enrolled;63084;-1
2014_1189937422145320_manuscript;3703 subjects;3703;-1
2014_1189937422145320_manuscript;55,000 patients;55000;-1
2014_1189937422145320_manuscript;3700 patients;3700;-1
2014_1189937422145320_manuscript;n   =   29;29;-1
2014_1189937422145320_manuscript;n =   197;197;-1
2014_1189937422145320_manuscript;n = 146;146;-1
2014_1189937422145320_manuscript;n = 1;1;-1
2014_1189937422145320_manuscript;n =4;4;-1
2014_1189937422145320_manuscript;n = 21;21;-1
2014_1189937422145320_manuscript;n = 35;35;-1
2014_1189937422145320_manuscript;n =2313;2313;-1
2014_1189937422145320_manuscript;n = 2116;2116;-1
2014_1189937422145320_manuscript;n = 56;56;-1
2014_1189937422145320_manuscript;n = 23;23;-1
2014_1189937422145320_manuscript;n = 0;0;-1
2014_1189937422145320_manuscript;n = 2;2;-1
2014_1189937422145320_manuscript;n = 31;31;-1
2014_1189937422145320_manuscript;n = 419;419;-1
2014_1189937422145320_manuscript;n = 363;363;-1
2014_1194026025120427_manuscript;300,000   people;300000;18591
2014_1194026025120427_manuscript;2 million people;2;18558
2014_1194026025120427_manuscript;5 people;5;4175
2014_1194026025120427_manuscript;n=153;153;23871
2014_1194026025120427_manuscript;n=15;15;23871
2014_1194026025120427_manuscript;n=13;13;21737
2014_1194026025120427_manuscript;n=6;6;21702
2014_1194026025120427_manuscript;n=40;40;550
2014_1194026025120427_manuscript;n=14;14;528
2014_1194026025120427_manuscript;n=361;361;27791
2014_1194026025120427_manuscript;N=46;46;27937
2014_1194026025120427_manuscript;n=270;270;27960
2014_1194026025120427_manuscript;N=153;153;28374
2014_1194026025120427_manuscript;N=176;176;28453
2014_1196145443123733_manuscript;N  =6;6;-1
2014_1196145443123733_manuscript;N  =1;1;-1
2014_1196145443123733_manuscript;N  =9;9;-1
2014_1196145443123733_manuscript;total of 750;750;-1
2014_1236453591140770_manuscript;291,169 registered patients;291169;-1
2014_1236453591140770_manuscript;22   patients;22;-1
2014_1236453591140770_manuscript;296 visually impaired patients;296;-1
2014_1236453591140770_manuscript;1,751,841 registered patients;1751841;-1
2014_1236453591140770_manuscript;21   patients;21;-1
2014_1236453591140770_manuscript;2   patients;2;-1
2014_1236453591140770_manuscript;23   patients;23;-1
2014_1236453591140770_manuscript;9   stroke patients;9;-1
2014_1236453591140770_manuscript;42   older people;42;-1
2014_1236453591140770_manuscript;19   people;19;-1
2014_1236453591140770_manuscript;15   individuals;15;-1
2014_1236453591140770_manuscript; dataset of 291,169;291169;-1
2014_1266910088151260_manuscript;2519 subjects;2519;-1
2014_1266910088151260_manuscript;1872 non-institutionalized individuals;1872;-1
2014_1266910088151260_manuscript;2614 non-  institutionalized individuals;2614;-1
2014_1266910088151260_manuscript;2085 individuals;2085;-1
2014_1266910088151260_manuscript;1872 individuals;1872;-1
2014_1266910088151260_manuscript;N=1872;1872;-1
2014_1266910088151260_manuscript;N  =1;1;-1
2014_1285742342144544_manuscript;41,504 subjects;41504;-1
2014_1285742342144544_manuscript;261 patients;261;-1
2014_1285742342144544_manuscript;1   patients;1;-1
2014_1285742342144544_manuscript;4 patients;4;-1
2014_1285742342144544_manuscript;3 patients;3;-1
2014_1285742342144544_manuscript;293 patients;293;-1
2014_1285742342144544_manuscript;11 patients;11;-1
2014_1285742342144544_manuscript;21 patients;21;-1
2014_1285742342144544_manuscript;210 patients;210;-1
2014_1285742342144544_manuscript;178 patients;178;-1
2014_1285742342144544_manuscript;10 patients;10;-1
2014_1285742342144544_manuscript;1 patients;1;-1
2014_1285742342144544_manuscript;162 patients;162;-1
2014_1285742342144544_manuscript;56 patients;56;-1
2014_1285742342144544_manuscript;10   patients;10;-1
2014_1285742342144544_manuscript;n= 261;261;-1
2014_1285742342144544_manuscript;n=101;101;-1
2014_1285742342144544_manuscript;n=123;123;-1
2014_1285742342144544_manuscript;n= 37;37;-1
2014_1285742342144544_manuscript;total of 495;495;-1
2014_1285742342144544_manuscript; data from 96,551;96551;-1
2014_1298377597119791_manuscript;300 patients;300;-1
2014_1298377597119791_manuscript;3 of patients;3;-1
2014_1298377597119791_manuscript;50 patients;50;-1
2014_1298377597119791_manuscript;90 patients;90;-1
2014_1298377597119791_manuscript;6 patients;6;-1
2014_1298377597119791_manuscript;136 patients;136;-1
2014_1298377597119791_manuscript;164 patients;164;-1
2014_1298377597119791_manuscript;196 patients;196;-1
2014_1305615660152398_manuscript;1815 participants;1815;-1
2014_1305615660152398_manuscript;4 count of participants;4;-1
2014_1305615660152398_manuscript;2Included only participants;2;-1
2014_1305615660152398_manuscript;1150 patients;1150;-1
2014_1305615660152398_manuscript;196 patients;196;-1
2014_1305615660152398_manuscript;175 patients;175;-1
2014_1305615660152398_manuscript;175 people;175;-1
2014_1305615660152398_manuscript;n=2608;2608;-1
2014_1305615660152398_manuscript;n=1876;1876;-1
2014_1305615660152398_manuscript;n=937;937;-1
2014_1305615660152398_manuscript;n=939;939;-1
2014_1305615660152398_manuscript;n=901;901;-1
2014_1305615660152398_manuscript;n=354;354;-1
2014_1305615660152398_manuscript;n=392;392;-1
2014_1305615660152398_manuscript;n=181;181;-1
2014_1305615660152398_manuscript;n=232;232;-1
2014_1305615660152398_manuscript;n=96;96;-1
2014_1305615660152398_manuscript;n=90;90;-1
2014_1305615660152398_manuscript;n=6;6;-1
2014_1305615660152398_manuscript;n=11;11;-1
2014_1305615660152398_manuscript;n=10;10;-1
2014_1305615660152398_manuscript;n=75;75;-1
2014_1305615660152398_manuscript;n=173;173;-1
2014_1305615660152398_manuscript;n=8;8;-1
2014_1305615660152398_manuscript;n=624;624;-1
2014_1305615660152398_manuscript;n=2697;2697;-1
2014_1305615660152398_manuscript;n=89;89;-1
2014_1305615660152398_manuscript;n=4573;4573;-1
2014_1305615660152398_manuscript;n=87;87;-1
2014_1305615660152398_manuscript;n=80;80;-1
2014_1305615660152398_manuscript;n=7;7;-1
2014_1305615660152398_manuscript;n=12;12;-1
2014_1305615660152398_manuscript;n=13;13;-1
2014_1305615660152398_manuscript;n=62;62;-1
2014_1305615660152398_manuscript;n=184;184;-1
2014_1305615660152398_manuscript;n=180;180;-1
2014_1305615660152398_manuscript;n=4;4;-1
2014_1305615660152398_manuscript;n=643;643;-1
2014_1305615660152398_manuscript;n=914;914;-1
2014_1305615660152398_manuscript;n=356;356;-1
2014_1305615660152398_manuscript;n=423;423;-1
2014_1305615660152398_manuscript;n=220;220;-1
2014_1305615660152398_manuscript;n=25;25;-1
2014_1305615660152398_manuscript;n=36;36;-1
2014_1305615660152398_manuscript;total of 1815;1815;-1
2014_1305615660152398_manuscript;4 enrolled;4;-1
2014_1380302162145533_manuscript;n = 5;5;-1
2014_1380328414135991_manuscript;200,000 people;200000;-1
2014_1390750370141658_manuscript;243   women;243;-1
2014_1390750370141658_manuscript;311   pregnant women;311;-1
2014_1390750370141658_manuscript;90,747 participants;90747;-1
2014_1390750370141658_manuscript;10,015 participants;10015;-1
2014_1390750370141658_manuscript;n=7;7;-1
2014_1390750370141658_manuscript;n=12;12;-1
2014_1390750370141658_manuscript; data from an 86;86;-1
2014_1441205069148138_manuscript;N=24;24;-1
2014_1448105514149263_manuscript;100,000 well people;100000;-1
2014_1448105514149263_manuscript;100,000 individuals;100000;-1
2014_1497363434125178_manuscript;26 normal subjects;26;3029
2014_1497363434125178_manuscript;62   patients;62;10520
2014_1497363434125178_manuscript;62 patients;62;10056
2014_1497363434125178_manuscript;16 patients;16;9682
2014_1497363434125178_manuscript;13 patients;13;8304
2014_1497363434125178_manuscript;22 patients;22;8263
2014_1497363434125178_manuscript;59 patients;59;2876
2014_1497363434125178_manuscript;13   patients;13;2907
2014_1497363434125178_manuscript;8 patients;8;6008
2014_1497363434125178_manuscript;3 patients;3;8303
2014_1497363434125178_manuscript;5 patients;5;6094
2014_1497363434125178_manuscript;n=62;62;33140
2014_1503884928145220_manuscript;96 patients;96;-1
2014_1503884928145220_manuscript;13,600 patients;13600;-1
2014_1503884928145220_manuscript;96 RCC patients;96;-1
2014_1503884928145220_manuscript;63 patients;63;-1
2014_1503884928145220_manuscript;n=410;410;-1
2014_1503884928145220_manuscript;n=509;509;-1
2014_1503884928145220_manuscript;n=157;157;-1
2014_1503884928145220_manuscript;n=66;66;-1
2014_1503884928145220_manuscript;n=11;11;-1
2014_1503884928145220_manuscript;n=38;38;-1
2014_1503884928145220_manuscript;n=2;2;-1
2014_1503884928145220_manuscript;n=51;51;-1
2014_1503884928145220_manuscript;n=125;125;-1
2014_1503884928145220_manuscript;n=37;37;-1
2014_1503884928145220_manuscript;n=5;5;-1
2014_1503884928145220_manuscript;n=167;167;-1
2014_1503884928145220_manuscript;n=50;50;-1
2014_1518752318144407_manuscript;112,049 women;112049;-1
2014_1518752318144407_manuscript;70,000 women;70000;-1
2014_1518752318144407_manuscript;7610 women;7610;-1
2014_1518752318144407_manuscript;000 women;0;-1
2014_1518752318144407_manuscript; data from >70,000;70000;-1
2014_1543427399129055_manuscript;274,135 women;274135;-1
2014_1543427399129055_manuscript;576 women;576;-1
2014_1543427399129055_manuscript;286 women;286;-1
2014_1543427399129055_manuscript;577,000   participants;577000;-1
2014_1543427399129055_manuscript;534,906 individuals;534906;-1
2014_1543427399129055_manuscript;27,886 adults;27886;-1
2014_1543427399129055_manuscript;n=249;249;-1
2014_1543427399129055_manuscript;n=1900;1900;-1
2014_1543427399129055_manuscript;n=128;128;-1
2014_1543427399129055_manuscript; data from   21;21;-1
2014_1562083350122722_manuscript;2,487 patients;2487;-1
2014_1562083350122722_manuscript;3,276 episodes were recruited;3276;-1
2014_1562083350122722_manuscript;n=1081;1081;-1
2014_1562083350122722_manuscript;n=97;97;-1
2014_1562083350122722_manuscript;n=865;865;-1
2014_1562083350122722_manuscript;n=441;441;-1
2014_1562083350122722_manuscript;total of 3,276;3276;-1
2014_1562083350122722_manuscript; data analysis of 10;10;-1
2014_1574197104149856_manuscript;953 patients;953;-1
2014_1574197104149856_manuscript;139 patients;139;-1
2014_1574197104149856_manuscript;70 patients;70;-1
2014_1574197104149856_manuscript;139   lithium patients;139;-1
2014_1574197104149856_manuscript;1862 patients;1862;-1
2014_1574197104149856_manuscript;1,172 patients;1172;-1
2014_1574197104149856_manuscript;24 patients;24;-1
2014_1574197104149856_manuscript;74 patients;74;-1
2014_1574197104149856_manuscript;695 outpatients;695;-1
2014_1574197104149856_manuscript;6,360   patients;6360;-1
2014_1574197104149856_manuscript;N=1862;1862;-1
2014_1574197104149856_manuscript; data from 74;74;-1
2014_1582201407138360_manuscript;75 participants;75;-1
2014_1582201407138360_manuscript;862 participants;862;-1
2014_1582201407138360_manuscript;n=452;452;-1
2014_1582201407138360_manuscript;n=231;231;-1
2014_1582201407138360_manuscript;n=273;273;-1
2014_1582201407138360_manuscript;n=956;956;-1
2014_1582201407138360_manuscript;n=15;15;-1
2014_1582201407138360_manuscript;n=43;43;-1
2014_1582201407138360_manuscript;n=5;5;-1
2014_1582201407138360_manuscript;n=862;862;-1
2014_1582201407138360_manuscript;n=405;405;-1
2014_1582201407138360_manuscript;n=156;156;-1
2014_1582201407138360_manuscript;n=48;48;-1
2014_1582201407138360_manuscript;n=253;253;-1
2014_1582201407138360_manuscript;n=848;848;-1
2014_1582201407138360_manuscript;n=849;849;-1
2014_1586423495128609_manuscript;1,317 women;1317;-1
2014_1586423495128609_manuscript;438 women;438;-1
2014_1586423495128609_manuscript;401 women;401;-1
2014_1586423495128609_manuscript;227 fasting pregnant women;227;-1
2014_1586423495128609_manuscript;369 women;369;-1
2014_1586423495128609_manuscript;338 participants;338;-1
2014_1586423495128609_manuscript;n=438;438;-1
2014_1586423495128609_manuscript;n=464;464;-1
2014_1586423495128609_manuscript;n=88;88;-1
2014_1586423495128609_manuscript;n=26;26;-1
2014_1586423495128609_manuscript;N=28;28;-1
2014_1586423495128609_manuscript;n=1,279;1279;-1
2014_1586423495128609_manuscript;n  =  8;8;-1
2014_1586423495128609_manuscript;n  =  2;2;-1
2014_1586423495128609_manuscript;n  =  3;3;-1
2014_1586423495128609_manuscript;n  =  1;1;-1
2014_1586423495128609_manuscript;n=  22;22;-1
2014_1586423495128609_manuscript;n  =2;2;-1
2014_1586423495128609_manuscript;n  =3;3;-1
2014_1586423495128609_manuscript;n=114;114;-1
2014_1586423495128609_manuscript;n=36;36;-1
2014_1586423495128609_manuscript;n=19;19;-1
2014_1614353177142227_manuscript;118 individuals;118;-1
2014_1614353177142227_manuscript;49 adults;49;-1
2014_1614353177142227_manuscript;n=31;31;-1
2014_1614353177142227_manuscript;n=42;42;-1
2014_1614353177142227_manuscript;n = 2;2;-1
2014_1614353177142227_manuscript;n = 8;8;-1
2014_1614353177142227_manuscript;total of 75;75;-1
2014_1614353177142227_manuscript;total of 64;64;-1
2014_1614353177142227_manuscript;total of 88;88;-1
2014_1616411517130207_manuscript;3921 control participants;3921;-1
2014_1616411517130207_manuscript;295 subjects;295;-1
2014_1616411517130207_manuscript;372 subjects;372;-1
2014_1616411517130207_manuscript;6814 subjects;6814;-1
2014_1616411517130207_manuscript;2023 consecutive patients;2023;-1
2014_1616411517130207_manuscript;2047 patients;2047;-1
2014_1616411517130207_manuscript;37,485 individuals;37485;-1
2014_1616411517130207_manuscript;45,828 individuals;45828;-1
2014_1616411517130207_manuscript;58 434 individuals;58434;-1
2014_1616411517130207_manuscript;37 485 individuals;37485;-1
2014_1616411517130207_manuscript;95,783 individuals;95783;-1
2014_1616411517130207_manuscript;n = 18 569;18569;-1
2014_1616411517130207_manuscript;total   of 37,485;37485;-1
2014_1616411517130207_manuscript; data from 20;20;-1
2014_1635292196149739_manuscript;25 meeting participants;25;-1
2014_1635292196149739_manuscript;25 invited participants;25;-1
2014_1663964731225706_manuscript;1000 participants;1000;-1
2014_1663964731225706_manuscript;2,762,899 participants;2762899;-1
2014_1663964731225706_manuscript;108,449 participants;108449;-1
2014_1663964731225706_manuscript;735,143 participants;735143;-1
2014_1663964731225706_manuscript;2,737,152 participants;2737152;-1
2014_1663964731225706_manuscript;10,000 participants;10000;-1
2014_1663964731225706_manuscript;90,056 participants;90056;-1
2014_1663964731225706_manuscript;170,000 participants;170000;-1
2014_1663964731225706_manuscript;246 955 participants;246955;-1
2014_1663964731225706_manuscript;44 patients;44;-1
2014_1663964731225706_manuscript;8 million general population   patients;8;-1
2014_1663964731225706_manuscript;170,255 patients;170255;-1
2014_1663964731225706_manuscript;32,225 diabetic and nondiabetic patients;32225;-1
2014_1663964731225706_manuscript;175,000   people;175000;-1
2014_1663964731225706_manuscript;n=110;110;-1
2014_1663964731225706_manuscript;N=12010;12010;-1
2014_1663964731225706_manuscript;n = 95;95;-1
2014_1663964731225706_manuscript;n = 200;200;-1
2014_1663964731225706_manuscript;n=137;137;-1
2014_1663964731225706_manuscript;n=20;20;-1
2014_1663964731225706_manuscript;n=86;86;-1
2014_1663964731225706_manuscript; data from 90,056;90056;-1
2014_1663964731225706_manuscript; data from 170,000;170000;-1
2014_1663964731225706_manuscript; data from 27;27;-1
2014_1663964731225706_manuscript; data from 175,000;175000;-1
2014_1669045221123958_manuscript;16 studies including men and women;16;-1
2014_1669045221123958_manuscript;63,189 participants;63189;-1
2014_1669045221123958_manuscript;53987 participants;53987;-1
2014_1669045221123958_manuscript;13,945   participants;13945;-1
2014_1669045221123958_manuscript;534,906 individuals;534906;-1
2014_1669045221123958_manuscript;n=22;22;-1
2014_1669045221123958_manuscript;n=5;5;-1
2014_1669045221123958_manuscript;n=4;4;-1
2014_1669045221123958_manuscript;n=23;23;-1
2014_1669045221123958_manuscript;n=14;14;-1
2014_1669045221123958_manuscript;n=9;9;-1
2014_1669045221123958_manuscript;n=3;3;-1
2014_1669045221123958_manuscript;n=7;7;-1
2014_1669045221123958_manuscript;n=16;16;-1
2014_1669045221123958_manuscript;n=15;15;-1
2014_1669045221123958_manuscript;n=11;11;-1
2014_1669045221123958_manuscript;n=10;10;-1
2014_1726642341140994_manuscript;768 patients;768;-1
2014_1726642341140994_manuscript;11   patients;11;-1
2014_1726642341140994_manuscript;n=768;768;-1
2014_1726642341140994_manuscript;n=402;402;-1
2014_1726642341140994_manuscript;n=269;269;-1
2014_1726642341140994_manuscript;n=293;293;-1
2014_1726642341140994_manuscript;n=206;206;-1
2014_1726642341140994_manuscript;n=155;155;-1
2014_1726642341140994_manuscript;n=355;355;-1
2014_1726642341140994_manuscript;n=353;353;-1
2014_1726642341140994_manuscript;n=455;455;-1
2014_1726642341140994_manuscript;n=55;55;-1
2014_1727337713453178_manuscript;59   Violence against women;59;20874
2014_1727337713453178_manuscript;64   Underlying both women;64;20383
2014_1727337713453178_manuscript;68   women;68;19920
2014_1727337713453178_manuscript;92   violence against women;92;17404
2014_1727337713453178_manuscript;171   against women;171;9451
2014_1727337713453178_manuscript;100 women;100;4409
2014_1727337713453178_manuscript;150 women;150;4198
2014_1727337713453178_manuscript;800 women;800;3650
2014_1727337713453178_manuscript;374 women;374;3854
2014_1727337713453178_manuscript;343 women;343;3951
2014_1727337713453178_manuscript;600 women;600;4023
2014_1727337713453178_manuscript;530 women;530;4107
2014_1727337713453178_manuscript;334   Approximately a third of women;334;4795
2014_1727337713453178_manuscript;337   women;337;5136
2014_1727337713453178_manuscript;351   women;351;6344
2014_1727337713453178_manuscript;365   Both women;365;7330
2014_1727337713453178_manuscript;372   women;372;8033
2014_1727337713453178_manuscript;517   women;517;21380
2014_1727337713453178_manuscript;676   Domestic Violence against women;676;35743
2014_1727337713453178_manuscript;644   participants;644;33112
2014_1727337713453178_manuscript;273   people;273;550
2014_1727337713453178_manuscript;5 317   people;5317;3253
2014_1727337713453178_manuscript;87   towards enrolled individuals;87;17872
2014_1727337713453178_manuscript;439   selecting individuals;439;13835
2014_1727337713453178_manuscript;119   were recruited;119;14838
2014_1727337713453178_manuscript;n=1583;1583;22624
2014_1727337713453178_manuscript;n=2532;2532;22565
2014_1727337713453178_manuscript;87   towards enrolled;87;17872
2014_1736239302152501_manuscript;n=13;13;-1
2014_1736239302152501_manuscript;n=15;15;-1
2014_1736239302152501_manuscript;n=812;812;-1
2014_1736239302152501_manuscript;n=890;890;-1
2014_1742324906136299_manuscript;100,000 people;100000;-1
2014_1742324906136299_manuscript;N =   12;12;-1
2014_1742324906136299_manuscript;N = 10;10;-1
2014_1742324906136299_manuscript;N =23;23;-1
2014_1742324906136299_manuscript;N = 25;25;-1
2014_1742324906136299_manuscript;N = 450;450;-1
2014_1742324906136299_manuscript;total of 48;48;-1
2014_1742324906136299_manuscript; data ran from 3;3;-1
2014_1746342339134803_manuscript;454 study participants;454;-1
2014_1746342339134803_manuscript;4 million participants;4;-1
2014_1746342339134803_manuscript;454 Tanzanian adult study participants;454;-1
2014_1746342339134803_manuscript;454 Tanzanian adult   study participants;454;-1
2014_1746342339134803_manuscript;301 study subjects;301;-1
2014_1746342339134803_manuscript;3,500 patients;3500;-1
2014_1746342339134803_manuscript;150 patients;150;-1
2014_1746342339134803_manuscript;721 patients;721;-1
2014_1746342339134803_manuscript;20 adults;20;-1
2014_1746342339134803_manuscript;2 groups of HIV-infected adults;2;-1
2014_1746342339134803_manuscript;2 groups of HIV-infected   adults;2;-1
2014_1746342339134803_manuscript;488 consecutive adults;488;-1
2014_1746342339134803_manuscript;481 eligible adults;481;-1
2014_1746342339134803_manuscript;153 HIV-negative adults;153;-1
2014_1746342339134803_manuscript;151 HIV-infected ART-naive   adults;151;-1
2014_1746342339134803_manuscript;150 HIV-infected adults;150;-1
2014_1746342339134803_manuscript;150 HIV-infected   adults;150;-1
2014_1746342339134803_manuscript;76 total adults;76;-1
2014_1746342339134803_manuscript;454 Tanzanian adults;454;-1
2014_1746342339134803_manuscript;n=153;153;-1
2014_1746342339134803_manuscript;n=151;151;-1
2014_1746342339134803_manuscript;n=150;150;-1
2014_1746342339134803_manuscript;n=378;378;-1
2014_1746342339134803_manuscript;n=76;76;-1
2014_1746342339134803_manuscript;n  =1;1;-1
2014_1746342339134803_manuscript;N  =1;1;-1
2014_1746342339134803_manuscript;n=184;184;-1
2014_1746342339134803_manuscript;n=194;194;-1
2014_1746342339134803_manuscript;n=60;60;-1
2014_1746342339134803_manuscript;n=16;16;-1
2014_1746342339134803_manuscript;n=66;66;-1
2014_1746342339134803_manuscript;n=62;62;-1
2014_1746342339134803_manuscript;n=20;20;-1
2014_1746342339134803_manuscript;n=5;5;-1
2014_1746342339134803_manuscript;n=69;69;-1
2014_1746342339134803_manuscript;n=74;74;-1
2014_1746342339134803_manuscript;n=7;7;-1
2014_1746342339134803_manuscript;n=1;1;-1
2014_1746342339134803_manuscript;n=49;49;-1
2014_1746342339134803_manuscript;n=58;58;-1
2014_1746342339134803_manuscript;n=33;33;-1
2014_1746342339134803_manuscript;n=10;10;-1
2014_1746342339134803_manuscript;total of 454;454;-1
2014_1761268867126331_manuscript;5 patients;5;-1
2014_1761268867126331_manuscript;n=62;62;-1
2014_1772116883139519_manuscript;622   participants;622;362
2014_1772116883139519_manuscript;622 participants;622;4823
2014_1772116883139519_manuscript;4492 EPIC-Oxford participants;4492;16426
2014_1772116883139519_manuscript;150 people;150;4694
2014_1772116883139519_manuscript;772 individuals;772;4238
2014_1772116883139519_manuscript;5 individuals;5;9261
2014_1772116883139519_manuscript;n=8,193;8193;3872
2014_1772116883139519_manuscript;n=617;617;9491
2014_1783571502127676_manuscript;7,216 men and women;7216;-1
2014_1783571502127676_manuscript;30000 Italian women;30000;-1
2014_1783571502127676_manuscript;7,447 participants;7447;-1
2014_1783571502127676_manuscript;7,216 participants;7216;-1
2014_1783571502127676_manuscript;n = 153;153;-1
2014_1783571502127676_manuscript;n = 78;78;-1
2014_1783571502127676_manuscript;n  =2;2;-1
2014_1783571502127676_manuscript;total of 7,216;7216;-1
2014_1798379921141582_manuscript;170 subjects;170;-1
2014_1798379921141582_manuscript;N=170;170;-1
2014_1798379921141582_manuscript;N=171;171;-1
2014_1798379921141582_manuscript;N  =1;1;-1
2014_1798379921141582_manuscript;total of 170;170;-1
2014_1798379921141582_manuscript;total of 243;243;-1
2014_1824446279121307_manuscript;120   Study subjects;120;-1
2014_1824446279121307_manuscript;154   subjects;154;-1
2014_1824446279121307_manuscript;175   All subjects;175;-1
2014_1824446279121307_manuscript;193   subjects;193;-1
2014_1824446279121307_manuscript;49   Cancer patients;49;-1
2014_1824446279121307_manuscript;54   Ovarian cancer patients;54;-1
2014_1824446279121307_manuscript;60   cancer patients;60;-1
2014_1824446279121307_manuscript;75   Ovarian cancer patients;75;-1
2014_1824446279121307_manuscript;95   patients;95;-1
2014_1824446279121307_manuscript;99   In ovarian cancer patients;99;-1
2014_1824446279121307_manuscript;10,182 patients;10182;-1
2014_1824446279121307_manuscript;6,160 patients;6160;-1
2014_1824446279121307_manuscript;6,590 180   patients;6590180;-1
2014_1824446279121307_manuscript;16 patients;16;-1
2014_1824446279121307_manuscript;228   patients;228;-1
2014_1824446279121307_manuscript;235   making these patients;235;-1
2014_1824446279121307_manuscript;291   cancer patients;291;-1
2014_1824446279121307_manuscript;377   patients;377;-1
2014_1824446279121307_manuscript;396   patients;396;-1
2014_1824446279121307_manuscript;10,963 patients;10963;-1
2014_1824446279121307_manuscript;423   patients;423;-1
2014_1824446279121307_manuscript;273   people;273;-1
2014_1824446279121307_manuscript;8,810 individuals;8810;-1
2014_1824446279121307_manuscript;2011 were recruited;2011;-1
2014_1824446279121307_manuscript;n = 171;171;-1
2014_1824446279121307_manuscript;n = 172;172;-1
2014_1824446279121307_manuscript;n = 4;4;-1
2014_1824446279121307_manuscript;n = 8,810;8810;-1
2014_1824446279121307_manuscript;total of 10,182;10182;-1
2014_1824446279121307_manuscript; data from the 112;112;-1
2014_1837283962118278_manuscript;539 persons;539;-1
2014_1837283962118278_manuscript;124 participants;124;-1
2014_1837283962118278_manuscript;567 participants;567;-1
2014_1837283962118278_manuscript;124 of the participants;124;-1
2014_1837283962118278_manuscript;271 participants;271;-1
2014_1837283962118278_manuscript;539 individuals;539;-1
2014_1837283962118278_manuscript;n=539;539;-1
2014_1837283962118278_manuscript;n=237;237;-1
2014_1837283962118278_manuscript;n=244;244;-1
2014_1837283962118278_manuscript;n=405;405;-1
2014_1837283962118278_manuscript;n=247;247;-1
2014_1837283962118278_manuscript;n=431;431;-1
2014_1848220736144442_manuscript;33 subjects;33;-1
2014_1848220736144442_manuscript;16 and patients;16;-1
2014_1848220736144442_manuscript;4 patients;4;-1
2014_1848220736144442_manuscript;6 patients;6;-1
2014_1848220736144442_manuscript;6   patients;6;-1
2014_1848220736144442_manuscript;10 Individual   patients;10;-1
2014_1848220736144442_manuscript;33 subjects were recruited;33;-1
2014_1848220736144442_manuscript;n=8;8;-1
2014_1848220736144442_manuscript;n=7;7;-1
2014_1848220736144442_manuscript;n=9;9;-1
2014_1848220736144442_manuscript;n=10;10;-1
2014_1848220736144442_manuscript;n=33;33;-1
2014_1848220736144442_manuscript;n=18;18;-1
2014_1851046561130611_manuscript;152   All participants;152;-1
2014_1851046561130611_manuscript;151 participants;151;-1
2014_1851046561130611_manuscript;202   TB participants;202;-1
2014_1851046561130611_manuscript;151 consecutive patients;151;-1
2014_1851046561130611_manuscript;68   pulmonary TB patients;68;-1
2014_1851046561130611_manuscript;175 patients;175;-1
2014_1851046561130611_manuscript;24 patients;24;-1
2014_1851046561130611_manuscript;151 patients;151;-1
2014_1851046561130611_manuscript;197   TB patients;197;-1
2014_1851046561130611_manuscript;508   initial management of patients;508;-1
2014_1851046561130611_manuscript;9 patients;9;-1
2014_1851046561130611_manuscript;4 HIV-infected patients;4;-1
2014_1851046561130611_manuscript;27 non-TB patients;27;-1
2014_1851046561130611_manuscript;n= 5;5;-1
2014_1851046561130611_manuscript;n=16;16;-1
2014_1851046561130611_manuscript;n=4;4;-1
2014_1851046561130611_manuscript;n=3;3;-1
2014_1851046561130611_manuscript;n=1;1;-1
2014_1851046561130611_manuscript;N=151;151;-1
2014_1851046561130611_manuscript;n=74;74;-1
2014_1851046561130611_manuscript;n=50;50;-1
2014_1851046561130611_manuscript;n=27;27;-1
2014_1851046561130611_manuscript;n=145;145;-1
2014_1851046561130611_manuscript;n=146;146;-1
2014_1851046561130611_manuscript;n=126;126;-1
2014_1851046561130611_manuscript;n=141;141;-1
2014_1851046561130611_manuscript;n=142;142;-1
2014_1851046561130611_manuscript;n=148;148;-1
2014_1851046561130611_manuscript;n=135;135;-1
2014_1851046561130611_manuscript;n=136;136;-1
2014_1851046561130611_manuscript;151 patients enrolled;151;-1
2014_1858406008139055_manuscript;40   persons;40;-1
2014_1858406008139055_manuscript;13   majority of people;13;-1
2014_1858406008139055_manuscript;28   infected individuals;28;-1
2014_1858406008139055_manuscript;1   adults;1;-1
2014_1871686381125981_manuscript;total of 144;144;-1
2014_1871686381125981_manuscript;total of 39;39;-1
2014_1871686381125981_manuscript;total of 8;8;-1
2014_1871686381125981_manuscript;total of 26;26;-1
2014_1871686381125981_manuscript;total of 350;350;-1
2014_1871686381125981_manuscript;total of 347;347;-1
2014_1871686381125981_manuscript;total   of 1228;1228;-1
2014_1871686381125981_manuscript;total of   350;350;-1
2014_1871686381125981_manuscript;total of 65;65;-1
2014_1871686381125981_manuscript;total of 52;52;-1
2014_1871686381125981_manuscript;total of 21;21;-1
2014_1871686381125981_manuscript;total of 15;15;-1
2014_1871686381125981_manuscript; data from 144;144;-1
2014_1886417665123090_manuscript;924,502 male subjects;924502;-1
2014_1886417665123090_manuscript;n = 2087;2087;-1
2014_1886417665123090_manuscript;n = 1092;1092;-1
2014_1886417665123090_manuscript;n = 1090;1090;-1
2014_1886417665123090_manuscript;n = 62;62;-1
2014_1886417665123090_manuscript;n = 3433;3433;-1
2014_1886417665123090_manuscript;n = 902;902;-1
2014_1886417665123090_manuscript;n = 3382;3382;-1
2014_1886417665123090_manuscript;n = 51;51;-1
2014_1886417665123090_manuscript;n = 8;8;-1
2014_1886417665123090_manuscript;n = 1;1;-1
2014_1886417665123090_manuscript;n = 2;2;-1
2014_1886417665123090_manuscript;n = 4;4;-1
2014_1886417665123090_manuscript;total of 23;23;-1
2014_1886417665123090_manuscript;total of 108,136;108136;-1
2014_1892265850152137_manuscript;169   subjects;169;-1
2014_1892265850152137_manuscript;180   Thus we ordered individuals;180;-1
2014_1892265850152137_manuscript;271   individuals;271;-1
2014_1892265850152137_manuscript;n=375;375;-1
2014_1892265850152137_manuscript;n=105;105;-1
2014_1895968861152174_manuscript;100 patients;100;-1
2014_1899643538141030_manuscript;187   participants;187;3546
2014_1899643538141030_manuscript;154,504 subjects;154504;29419
2014_1899643538141030_manuscript;254   multimorbid patients;254;22871
2014_1899643538141030_manuscript;262   giving insured patients;262;10410
2014_1899643538141030_manuscript;308   clinical management of patients;308;14811
2014_1899643538141030_manuscript;169   people;169;2024
2014_1899643538141030_manuscript;185   people;185;3338
2014_1899643538141030_manuscript;195   majority of people;195;4196
2014_1899643538141030_manuscript;9 working-age adults;9;6810
2014_1899643538141030_manuscript;225   adults;225;6953
2014_1899643538141030_manuscript;N = 162,464;162464;11913
2014_1899643538141030_manuscript;N   =   1;1;2849
2014_1899643538141030_manuscript;N=177,501;177501;9913
2014_1899643538141030_manuscript;n = 162,464;162464;10460
2014_1899643538141030_manuscript;N=120;120;17741
2014_1899643538141030_manuscript;n=4;4;50530
2014_1899643538141030_manuscript;n=2;2;18097
2014_1899643538141030_manuscript;total of 40;40;534
2014_1899643538141030_manuscript;total of 162,464;162464;31160
2014_1926227847138205_manuscript;188 DNRCC-Arrest patients;188;12711
2014_1926227847138205_manuscript;88 DNRCC patients;88;12684
2014_1926227847138205_manuscript;2,051 Non-DNR patients;2051;12659
2014_1926227847138205_manuscript;2,440 patients;2440;559
2014_1926227847138205_manuscript;389 patients;389;692
2014_1926227847138205_manuscript;188 patients;188;706
2014_1926227847138205_manuscript;88 patients;88;707
2014_1926227847138205_manuscript;104 patients;104;842
2014_1926227847138205_manuscript;88 Non-DNR patients;88;1950
2014_1926227847138205_manuscript;188 Non-DNR patients;188;3759
2014_1926227847138205_manuscript;35   patients;35;29816
2014_1926227847138205_manuscript;41   Non-DNR patients;41;35685
2014_1926227847138205_manuscript;57   and Non-DNR patients;57;53008
2014_1926227847138205_manuscript;60   DNRCC-Arrest and Non-DNR patients;60;55784
2014_1926227847138205_manuscript;N   =   8;8;23688
2014_1926227847138205_manuscript;N   =   2;2;23743
2014_1926227847138205_manuscript;N   =   1;1;23804
2014_1926227847138205_manuscript;N = 88;88;29857
2014_1926227847138205_manuscript;N = 188;188;35741
2014_1926227847138205_manuscript;total of 104;104;833
2014_1926227847138205_manuscript;total of 88;88;1751
2014_1926227847138205_manuscript;total of 39;39;5281
2014_1926227847138205_manuscript;total of 41;41;5977
2014_1939864099137810_manuscript;141 patients;141;-1
2014_1939864099137810_manuscript;423 patients;423;-1
2014_1939864099137810_manuscript;43 patients;43;-1
2014_1939864099137810_manuscript;400 breast cancer patients;400;-1
2014_1939864099137810_manuscript;1,000 patients;1000;-1
2014_1939864099137810_manuscript;2 positive patients;2;-1
2014_1939864099137810_manuscript;14,002 people;14002;-1
2014_1939864099137810_manuscript;423 patients enrolled;423;-1
2014_1953524522146145_manuscript;67,138 women;67138;-1
2014_1953524522146145_manuscript;85,884 women;85884;-1
2014_1953524522146145_manuscript;459,790 participants;459790;-1
2014_1953524522146145_manuscript;41,479 HPFS participants;41479;-1
2014_1953524522146145_manuscript;67,138   NHS participants;67138;-1
2014_1953524522146145_manuscript;85,884 NHS II participants;85884;-1
2014_1953524522146145_manuscript;2 diabetic patients;2;-1
2014_1953524522146145_manuscript;2 diabetic   patients;2;-1
2014_1953524522146145_manuscript;26 million people;26;-1
2014_1953524522146145_manuscript;366 million people;366;-1
2014_1953524522146145_manuscript;3 cohorts of US adults;3;-1
2014_1953524522146145_manuscript;n  =8;8;-1
2014_1953524522146145_manuscript;n  =1;1;-1
2014_1953524522146145_manuscript;total of 15,156;15156;-1
2014_1953524522146145_manuscript;total of 11;11;-1
2014_1953524522146145_manuscript; data from 3;3;-1
2014_1953524522146145_manuscript; data from 41,479;41479;-1
2014_1954770101151670_manuscript;n=1962;1962;-1
2014_1954770101151670_manuscript;n=1387;1387;-1
2014_1954770101151670_manuscript;3170 children enrolled;3170;-1
2014_1976326548118498_manuscript;324,168 participants;324168;-1
2014_1976326548118498_manuscript;6,339 prostate   cancer patients;6339;-1
2014_1976326548118498_manuscript;20,000 cancer patients;20000;-1
2014_1976326548118498_manuscript;62 prostate cancer patients;62;-1
2014_1976326548118498_manuscript;2 colorectal cancer patients;2;-1
2014_1976326548118498_manuscript;4 cancer patients;4;-1
2014_1976326548118498_manuscript;1,779 breast cancer patients;1779;-1
2014_1976326548118498_manuscript;3 breast cancer   patients;3;-1
2014_1976326548118498_manuscript;11,863 breast cancer patients;11863;-1
2014_1976326548118498_manuscript;7,081 colorectal cancer patients;7081;-1
2014_1976326548118498_manuscript;8,128 prostate cancer patients;8128;-1
2014_1976326548118498_manuscript;10,969 breast cancer patients;10969;-1
2014_1976326548118498_manuscript;6,666 colorectal cancer patients;6666;-1
2014_1976326548118498_manuscript;7,495 prostate cancer patients;7495;-1
2014_1976326548118498_manuscript;10,853 breast cancer patients;10853;-1
2014_1976326548118498_manuscript;6,540 colorectal cancer patients;6540;-1
2014_1976326548118498_manuscript;7,388 prostate cancer patients;7388;-1
2014_1976326548118498_manuscript;9,971 breast cancer patients;9971;-1
2014_1976326548118498_manuscript;4,762 colorectal cancer patients;4762;-1
2014_1976326548118498_manuscript;6,513 prostate cancer patients;6513;-1
2014_1976326548118498_manuscript;9,814 breast cancer patients;9814;-1
2014_1976326548118498_manuscript;6,339 prostate cancer patients;6339;-1
2014_1976326548118498_manuscript;n=0;0;-1
2014_1983866476129914_manuscript;n=56;56;7843
2014_1983866476129914_manuscript;n=10;10;7044
2014_1983866476129914_manuscript;n=7;7;6970
2014_1983866476129914_manuscript;n=5;5;7843
2014_1983866476129914_manuscript;n=9;9;6835
2014_1983866476129914_manuscript;n=8;8;6712
2014_1983866476129914_manuscript;n=3;3;6379
2014_1983866476129914_manuscript;n=17;17;5830
2014_1983866476129914_manuscript;n=48;48;5799
2014_1983866476129914_manuscript;n=33;33;5769
2014_1983866476129914_manuscript;n=36;36;5754
2014_1983866476129914_manuscript;n=31;31;5720
2014_1983866476129914_manuscript;n=79;79;5704
2014_1983866476129914_manuscript;n=88;88;5685
2014_1983866476129914_manuscript;n=44;44;7571
2014_2000393905123160_manuscript;1320 patients;1320;6857
2014_2000393905123160_manuscript;3644 patients;3644;3377
2014_2000393905123160_manuscript;2294 patients;2294;1231
2014_2000393905123160_manuscript;2324   not included patients;2324;28099
2014_2000393905123160_manuscript;n = 2230;2230;3177
2014_2000393905123160_manuscript;n = 10;10;2422
2014_2000393905123160_manuscript;n = 5;5;2399
2014_2000393905123160_manuscript;n = 42;42;2376
2014_2000393905123160_manuscript;n = 974;974;1430
2014_2000393905123160_manuscript;n = 693;693;22967
2014_2000393905123160_manuscript;n = 627;627;23005
2014_2000393905123160_manuscript;n = 1320;1320;26917
2014_2000393905123160_manuscript;n = 2309;2309;26956
2014_2001130879141792_manuscript;67 patients;67;-1
2014_2001130879141792_manuscript;60 randomised patients;60;-1
2014_2001130879141792_manuscript;n=35;35;-1
2014_2001130879141792_manuscript;n=32;32;-1
2014_2001130879141792_manuscript;n=53;53;-1
2014_2001130879141792_manuscript;n=36;36;-1
2014_2001130879141792_manuscript;n=15;15;-1
2014_2001130879141792_manuscript;n=2;2;-1
2014_2001130879141792_manuscript;n=28;28;-1
2014_2001130879141792_manuscript;n=26;26;-1
2014_2039851280141780_manuscript;13  women;13;-1
2014_2039851280141780_manuscript;14,434 patients;14434;-1
2014_2039851280141780_manuscript;3The denominator is AMI patients;3;-1
2014_2039851280141780_manuscript;100,000 people;100000;-1
2014_2041908099127059_manuscript;1,000 persons;1000;-1
2014_2041908099127059_manuscript;1000 persons;1000;-1
2014_2047950899125049_manuscript;271 subjects;271;-1
2014_2047950899125049_manuscript;2 diabetic patients;2;-1
2014_2047950899125049_manuscript;6,103 patients;6103;-1
2014_2047950899125049_manuscript;50 ambulatory patients;50;-1
2014_2047950899125049_manuscript;7,387 diabetic patients;7387;-1
2014_2047950899125049_manuscript;323 patients;323;-1
2014_2047950899125049_manuscript;6,103   patients;6103;-1
2014_2047950899125049_manuscript;4,657 patients;4657;-1
2014_2047950899125049_manuscript;7 million people;7;-1
2014_2047950899125049_manuscript;n=2,808;2808;-1
2014_2047950899125049_manuscript;n=271;271;-1
2014_2047950899125049_manuscript;n=106;106;-1
2014_2047950899125049_manuscript;n=5,832;5832;-1
2014_2047950899125049_manuscript;total of 6,103;6103;-1
2014_2052715861447611_manuscript;6 million people;6;-1
2014_2052715861447611_manuscript;10 adults;10;-1
2014_2057095301146410_manuscript;1   pregnant women;1;-1
2014_2057095301146410_manuscript;53   individual pregnant women;53;-1
2014_2057095301146410_manuscript;61   women;61;-1
2014_2057095301146410_manuscript;95   women;95;-1
2014_2057095301146410_manuscript;129   We studied pregnant women;129;-1
2014_2057095301146410_manuscript;140   pregnant women;140;-1
2014_2057095301146410_manuscript;144   all participating women;144;-1
2014_2057095301146410_manuscript;181   system captured women;181;-1
2014_2057095301146410_manuscript;222   recruited women;222;-1
2014_2057095301146410_manuscript;651   and iron-replete women;651;-1
2014_2057095301146410_manuscript;675   Characteristic All women;675;-1
2014_2057095301146410_manuscript;457   thalassemia status of all participants;457;-1
2014_2057095301146410_manuscript;82   individuals;82;-1
2014_2057095301146410_manuscript;222   recruited;222;-1
2014_2057095301146410_manuscript;n=468;468;-1
2014_2057095301146410_manuscript;n=174;174;-1
2014_2057095301146410_manuscript;n=466;466;-1
2014_2057095301146410_manuscript;n=213;213;-1
2014_2057095301146410_manuscript;n=91;91;-1
2014_2091777649139057_manuscript;724,949 women;724949;-1
2014_2091777649139057_manuscript;1,424,378 participants;1424378;-1
2014_2091777649139057_manuscript;35,690 people;35690;-1
2014_2091777649139057_manuscript;1,424,378 individuals;1424378;-1
2014_2091777649139057_manuscript;total of 35,690;35690;-1
2014_2125225148130318_manuscript;1 also contains details of patients;1;-1
2014_2132953376127266_manuscript; data from  2004;2004;-1
2014_2137088001371897_manuscript;77 women;77;1668
2014_2137088001371897_manuscript;129 consecutive adult   patients;129;13030
2014_2137088001371897_manuscript;31 additional   patients;31;12355
2014_2137088001371897_manuscript;2009 all consecutive patients;2009;7831
2014_2137088001371897_manuscript;2013 all consecutive obese   patients;2013;7565
2014_2137088001371897_manuscript;31 additional patients;31;6405
2014_2137088001371897_manuscript;129 patients;129;3798
2014_2137088001371897_manuscript;31 additional adult patients;31;6614
2014_2137088001371897_manuscript;97 obese patients;97;8184
2014_2137088001371897_manuscript;30 patients;30;8475
2014_2137088001371897_manuscript;129 adult patients;129;9536
2014_2137088001371897_manuscript;32 were non-  obese patients;32;14259
2014_2137088001371897_manuscript;18 adult patients;18;16176
2014_2137088001371897_manuscript;n=1;1;2153
2014_2137088001371897_manuscript;n=32;32;1896
2014_2137088001371897_manuscript;n=97;97;1929
2014_2137088001371897_manuscript;n=11;11;8233
2014_2137088001371897_manuscript;n=56;56;8309
2014_2137088001371897_manuscript;n=40;40;15970
2014_2137088001371897_manuscript;n=10;10;15991
2014_2137088001371897_manuscript;n =129;129;30606
2014_2137088001371897_manuscript;n=129;129;34470
2014_2137088001371897_manuscript; data from   129;129;9531
2014_2140435614930856_manuscript;337 subjects;337;-1
2014_2140435614930856_manuscript;6423   subjects;6423;-1
2014_2140435614930856_manuscript;10,512 patients;10512;-1
2014_2140435614930856_manuscript;377 patients;377;-1
2014_2140435614930856_manuscript;n=8,410;8410;-1
2014_2140435614930856_manuscript;n=2,102;2102;-1
2014_2140435614930856_manuscript;n=6,728;6728;-1
2014_2140435614930856_manuscript;n=10,512;10512;-1
2014_2140435614930856_manuscript;n=283;283;-1
2014_2140435614930856_manuscript;n=155;155;-1
2014_2140435614930856_manuscript;n=6423;6423;-1
2014_2140435614930856_manuscript;n=1,475;1475;-1
2014_2140435614930856_manuscript;n=627;627;-1
2014_2186451301488541_manuscript;2 levels of women;2;9757
2014_2186451301488541_manuscript;530 women;530;1962
2014_2186451301488541_manuscript;200 women;200;2047
2014_2186451301488541_manuscript;206 patients;206;1979
2014_2186451301488541_manuscript;124 patients;124;2014
2014_2186451301488541_manuscript;256   these patients;256;8053
2014_2186451301488541_manuscript;n = 357;357;10158
2014_2186451301488541_manuscript;n = 212;212;10137
2014_2186451301488541_manuscript;n = 380;380;10099
2014_2186451301488541_manuscript;n = 206;206;31397
2014_2186451301488541_manuscript;n = 124;124;31493
2014_2186451301488541_manuscript;n = 528;528;31537
2014_2186451301488541_manuscript;n = 534;534;32066
2014_2186451301488541_manuscript;n = 55;55;32103
2014_2186451301488541_manuscript;n  =3;3;32388
2014_2186451301488541_manuscript;n  =   35;35;32423
2014_2186451301488541_manuscript;n  =   21;21;32462
2014_2186451301488541_manuscript;n  =8;8;36200
2014_2186451301488541_manuscript;n  =   55;55;36234
2014_2186451301488541_manuscript;n  =   48;48;36270
2014_2186451301488541_manuscript;n   =   3;3;38173
2014_2186451301488541_manuscript;n   =   2;2;38252
2014_2186451301488541_manuscript;n   =   8;8;41239
2014_2186451301488541_manuscript;n   =   5;5;41277
2014_2186451301488541_manuscript;n   =   4;4;41316
2014_2186451301488541_manuscript;total of 949;949;10226
2014_2186451301488541_manuscript;total of 106;106;13348
2014_2186451301488541_manuscript; databases of the 155;155;436
2014_2220750171343165_manuscript;490,288 UK Biobank   participants;490288;-1
2014_2220750171343165_manuscript;11 patients;11;-1
2014_2427160912139930_manuscript;30 000 participants;30000;-1
2014_2427160912139930_manuscript;N=17;17;-1
2014_2427160912139930_manuscript;n=5;5;-1
2014_2427160912139930_manuscript;n  =7;7;-1
2014_2427160912139930_manuscript;n=  73;73;-1
2014_2427160912139930_manuscript;n=  90;90;-1
2014_2427160912139930_manuscript;n=  30;30;-1
2014_2427160912139930_manuscript;n  =1;1;-1
2014_2427160912139930_manuscript;n  =5;5;-1
2014_2427160912139930_manuscript;n  =4;4;-1
2014_2427160912139930_manuscript;n  =2;2;-1
2014_2427160912139930_manuscript;n  =9;9;-1
2014_2427160912139930_manuscript;total of 1023;1023;-1
2014_2435566814022793_manuscript;7   of older women;7;-1
2014_2435566814022793_manuscript;4   and eight of both men and women;4;-1
2014_2435566814022793_manuscript;25   women;25;-1
2014_2435566814022793_manuscript;12   participants;12;-1
2014_2435566814022793_manuscript;709,499 subjects;709499;-1
2014_2435566814022793_manuscript;225,189 subjects;225189;-1
2014_2435566814022793_manuscript;17   enrolled elderly people;17;-1
2014_2435566814022793_manuscript;n = 10;10;-1
2014_2435566814022793_manuscript;n = 9;9;-1
2014_2435566814022793_manuscript;n = 8;8;-1
2014_2435566814022793_manuscript;n = 7;7;-1
2014_2435566814022793_manuscript;17   enrolled;17;-1
2014_2435566814022793_manuscript; data from two 21;21;-1
2014_2865257011470128_manuscript;75 NCWS patients;75;-1
2014_2865257011470128_manuscript;35 NCWS patients;35;-1
2014_2865257011470128_manuscript;80 patients;80;-1
2014_2865257011470128_manuscript;75 patients;75;-1
2014_2865257011470128_manuscript;30 patients;30;-1
2014_2865257011470128_manuscript;39 NCWS patients;39;-1
2014_2865257011470128_manuscript;36 NCWS patients;36;-1
2014_2865257011470128_manuscript;42 NCWS patients;42;-1
2014_2865257011470128_manuscript;N=75;75;-1
2014_2865257011470128_manuscript;N=65;65;-1
2014_2865257011470128_manuscript;N=50;50;-1
2014_2865257011470128_manuscript;n=40;40;-1
2014_2865257011470128_manuscript;n=29;29;-1
2014_2865257011470128_manuscript;n=6;6;-1
2014_3009930681177296_manuscript;total of 684;684;-1
2014_3011415013146269_manuscript;222 patients;222;-1
2014_3011415013146269_manuscript;1 were patients;1;-1
2014_3011415013146269_manuscript;2 were patients;2;-1
2014_3011415013146269_manuscript;3 patients;3;-1
2014_3011415013146269_manuscript;9,629 patients;9629;-1
2014_3011415013146269_manuscript;4140 patients;4140;-1
2014_3011415013146269_manuscript;5,489 patients;5489;-1
2014_3011415013146269_manuscript;1 patients;1;-1
2014_3011415013146269_manuscript;2 patients;2;-1
2014_3011415013146269_manuscript;12 diabetic patients;12;-1
2014_3011415013146269_manuscript;4,140 patients;4140;-1
2014_3011415013146269_manuscript;2 diabetic patients;2;-1
2014_3011415013146269_manuscript;112 traumatic brain injured patients;112;-1
2014_3011415013146269_manuscript;n= 222;222;-1
2014_3011415013146269_manuscript;n = 143;143;-1
2014_3011415013146269_manuscript;n=79;79;-1
2014_3011415013146269_manuscript;n=2,709;2709;-1
2014_3011415013146269_manuscript;n=2,558;2558;-1
2014_3011415013146269_manuscript; data set of 9,629;9629;-1
2014_3099439126330232_manuscript;N = 5;5;-1
2014_3099439126330232_manuscript;n=7;7;-1
2014_3099439126330232_manuscript;n=10;10;-1
2014_3099439126330232_manuscript;n=5;5;-1
2014_3099439126330232_manuscript;n=8;8;-1
2014_3099439126330232_manuscript;N=3;3;-1
2014_3099439126330232_manuscript;N=5;5;-1
2014_3099439126330232_manuscript;n=39;39;-1
2014_3099439126330232_manuscript;N=2;2;-1
2014_3099439126330232_manuscript;n=42;42;-1
2014_3099439126330232_manuscript;N=11;11;-1
2014_3099439126330232_manuscript;n=17;17;-1
2014_3099439126330232_manuscript;n=16;16;-1
2014_3099439126330232_manuscript;N=6;6;-1
2014_3099439126330232_manuscript;n=12;12;-1
2014_3099439126330232_manuscript;N=4;4;-1
2014_3099439126330232_manuscript;n=9;9;-1
2014_3099439126330232_manuscript;N=8;8;-1
2014_3099439126330232_manuscript;n=6;6;-1
2014_3099439126330232_manuscript;n=20;20;-1
2014_3099439126330232_manuscript;n=14;14;-1
2014_3099439126330232_manuscript;n=4;4;-1
2014_3099439126330232_manuscript;N=1;1;-1
2014_3099439126330232_manuscript;n=15;15;-1
2014_3099439126330232_manuscript;n=43;43;-1
2014_3218452981400402_manuscript;n=14;14;-1
2014_3231281051489339_manuscript;n=65439;65439;-1
2014_3231281051489339_manuscript;n=4680;4680;-1
2014_3231281051489339_manuscript;n=4394;4394;-1
2014_3231281051489339_manuscript;n=69946;69946;-1
2014_3231281051489339_manuscript;n=57143;57143;-1
2014_3231281051489339_manuscript;n=19778;19778;-1
2014_3231281051489339_manuscript;n=62119;62119;-1
2014_3231281051489339_manuscript;n=50223;50223;-1
2014_3231281051489339_manuscript;n=19155;19155;-1
2014_3231281051489339_manuscript;total of 107379;107379;-1
2014_3231281051489339_manuscript;90040 mother-child pairs enrolled;90040;-1
2014_3612559315375787_manuscript;50   patients;50;-1
2014_3740325231240393_manuscript;100   Study participants;100;15818
2014_3740325231240393_manuscript;7   patients;7;22431
2014_3740325231240393_manuscript;329 patients;329;21487
2014_3740325231240393_manuscript;58   patients;58;18712
2014_3740325231240393_manuscript;80   patients;80;17369
2014_3740325231240393_manuscript;101   All patients;101;15793
2014_3740325231240393_manuscript;113   fracture patients;113;14720
2014_3740325231240393_manuscript;133   All patients;133;13096
2014_3740325231240393_manuscript;148   All patients;148;11855
2014_3740325231240393_manuscript;300 patients;300;6968
2014_3740325231240393_manuscript;370 patients;370;6768
2014_3740325231240393_manuscript;332 patients;332;6706
2014_3740325231240393_manuscript;221   patients;221;6349
2014_3740325231240393_manuscript;224   patients;224;6074
2014_3740325231240393_manuscript;10 patients;10;3752
2014_3740325231240393_manuscript;255   missing patients;255;3485
2014_3740325231240393_manuscript;446 patients;446;2923
2014_3740325231240393_manuscript;269   included patients;269;2800
2014_3740325231240393_manuscript;35 273   patients;35273;2415
2014_3740325231240393_manuscript;285   patients;285;1441
2014_3740325231240393_manuscript;46 patients;46;2922
2014_3740325231240393_manuscript;228 patients;228;491
2014_3740325231240393_manuscript;370   patients;370;4809
2014_3740325231240393_manuscript;388   fracture patients;388;6453
2014_3740325231240393_manuscript;450   include patients;450;11323
2014_3740325231240393_manuscript;30 patients;30;25925
2014_3740325231240393_manuscript;69 patients;69;25974
2014_3740325231240393_manuscript;23   patients;23;28213
2014_3740325231240393_manuscript;17 patients;17;28641
2014_3740325231240393_manuscript;22 patients;22;28710
2014_3740325231240393_manuscript;24 patients;24;28759
2014_3740325231240393_manuscript;11 patients;11;31227
2014_3740325231240393_manuscript;23 patients;23;31450
2014_3740325231240393_manuscript;16   patients;16;31499
2014_3740325231240393_manuscript;14 patients;14;31577
2014_3740325231240393_manuscript;33 patients;33;32620
2014_3740325231240393_manuscript;29 patients;29;21486
2014_3740325231240393_manuscript;225   recruited;225;5985
2014_3740325231240393_manuscript;n=163;163;24398
2014_3740325231240393_manuscript;n=166;166;24423
2014_3740325231240393_manuscript;n=121;121;29074
2014_3740325231240393_manuscript;n=98;98;29154
2014_3740325231240393_manuscript;n=95;95;29185
2014_3740325231240393_manuscript;n=228;228;33383
2014_3740325231240393_manuscript;n=226;226;34218
2014_3740325231240393_manuscript;n=203;203;34228
2014_3740325231240393_manuscript;n= 222;222;34276
2014_3740325231240393_manuscript;n=466;466;35055
2014_3740325231240393_manuscript;n=134;134;35075
2014_3740325231240393_manuscript;n=53;53;35120
2014_3740325231240393_manuscript;n=22;22;33383
2014_3740325231240393_manuscript;n=59;59;35355
2014_3740325231240393_manuscript;n=14;14;35806
2014_3740325231240393_manuscript;n=162;162;36003
2014_3740325231240393_manuscript;n=1;1;24398
2014_3740325231240393_manuscript;n=21;21;36310
2014_3740325231240393_manuscript;n=165;165;36503
2014_3740325231240393_manuscript;n=332;332;36724
2014_3740325231240393_manuscript;n=3;3;36724
2014_3740325231240393_manuscript;n=19;19;36954
2014_3740325231240393_manuscript;n=28;28;37232
2014_4447371991258809_manuscript;769 patients;769;-1
2014_4447371991258809_manuscript;100 patients;100;-1
2014_4530068871500563_manuscript;2013 involving men and women;2013;-1
2014_4530068871500563_manuscript;N=169500;169500;-1
2014_4530068871500563_manuscript;N=354927;354927;-1
2014_4530068871500563_manuscript; data set of 30;30;-1
2014_4530068871500563_manuscript; data from all 30;30;-1
2014_4864343401190976_manuscript;1542 patients;1542;-1
2014_4864343401190976_manuscript;4498 patients;4498;-1
2014_4864343401190976_manuscript;251   patients;251;-1
2014_4864343401190976_manuscript;205   patients;205;-1
2014_4864343401190976_manuscript;168 patients;168;-1
2014_4864343401190976_manuscript;205 patients;205;-1
2014_4864343401190976_manuscript;247   patients;247;-1
2014_4864343401190976_manuscript;195 patients;195;-1
2014_4864343401190976_manuscript;247 patients;247;-1
2014_4864343401190976_manuscript;117 patients;117;-1
2014_4864343401190976_manuscript;151 patients;151;-1
2014_4864343401190976_manuscript;1000 patients;1000;-1
2014_4864343401190976_manuscript;125 consecutive patients;125;-1
2014_4864343401190976_manuscript;total of 1542;1542;-1
2014_4864343401190976_manuscript;total of 79;79;-1
2014_4968149821413695_manuscript;9   study subjects;9;-1
2014_4968149821413695_manuscript;8,341 patients;8341;-1
2014_4968149821413695_manuscript;14   patients;14;-1
2014_4968149821413695_manuscript;1   Elderly patients;1;-1
2014_4968149821413695_manuscript;5   patients;5;-1
2014_4968149821413695_manuscript;12   patients;12;-1
2014_4968149821413695_manuscript;15   urbanization level of patients;15;-1
2014_4968149821413695_manuscript;18   patients;18;-1
2014_4968149821413695_manuscript;11   models allowed patients;11;-1
2014_4968149821413695_manuscript;8,341 elderly patients;8341;-1
2014_4968149821413695_manuscript;7   patients;7;-1
2014_4968149821413695_manuscript;5,807 deaths occurred in elderly patients;5807;-1
2014_4968149821413695_manuscript;8   patients;8;-1
2014_4968149821413695_manuscript;6,292 patients;6292;-1
2014_4968149821413695_manuscript;2,049 patients;2049;-1
2014_4968149821413695_manuscript;1,984 matched patients;1984;-1
2014_4968149821413695_manuscript;1   patients;1;-1
2014_4968149821413695_manuscript;9   elderly patients;9;-1
2014_4968149821413695_manuscript;17   patients;17;-1
2014_4968149821413695_manuscript;9   patients;9;-1
2014_4968149821413695_manuscript;6   bias because patients;6;-1
2014_4968149821413695_manuscript;8   of end-stage renal disease patients;8;-1
2014_4968149821413695_manuscript;2   incident haemodialysis patients;2;-1
2014_4968149821413695_manuscript;4   patients;4;-1
2014_4968149821413695_manuscript;n=6,292;6292;-1
2014_4968149821413695_manuscript;n=2,049;2049;-1
2014_4968149821413695_manuscript;total of 8,341;8341;-1
2014_4968149821413695_manuscript;total of 5,807;5807;-1
2014_5029727191333040_manuscript;200 participants;200;-1
2014_5029727191333040_manuscript;1737 participants;1737;-1
2014_5029727191333040_manuscript;1,588   neurologically-healthy subjects;1588;-1
2014_5029727191333040_manuscript;33,671 patients;33671;-1
2014_5029727191333040_manuscript;3660 elderly people;3660;-1
2014_5029727191333040_manuscript;746 individuals;746;-1
2014_5029727191333040_manuscript;1,254 individuals;1254;-1
2014_5029727191333040_manuscript;994 neurologically-healthy adults;994;-1
2014_5029727191333040_manuscript;3660 elderly adults;3660;-1
2014_5029727191333040_manuscript;n = 6;6;-1
2014_5029727191333040_manuscript;n = 4;4;-1
2014_5029727191333040_manuscript; databases from 1946;1946;-1
2014_5344622091417380_manuscript;500 participants;500;-1
2014_5344622091417380_manuscript;150   surgically treated patients;150;-1
2014_5344622091417380_manuscript;500 patients;500;-1
2014_5344622091417380_manuscript;500   severely obese patients;500;-1
2014_5344622091417380_manuscript;200 patients;200;-1
2014_5344622091417380_manuscript;150 patients;150;-1
2014_5344622091417380_manuscript;308 surgical patients;308;-1
2014_5344622091417380_manuscript;253 patients;253;-1
2014_5344622091417380_manuscript;500 severely obese patients;500;-1
2014_5344622091417380_manuscript;n  =1;1;-1
2014_5344622091417380_manuscript;n=  20;20;-1
2014_5344622091417380_manuscript;n=  15;15;-1
2014_5344622091417380_manuscript;n  =2;2;-1
2014_5344622091417380_manuscript;500 patients enrolled;500;-1
2014_5344622091417380_manuscript; data from 500;500;-1
2014_5458910971207155_manuscript;575 patients;575;-1
2014_5458910971207155_manuscript;total of 31;31;-1
2014_5458910971207155_manuscript; databases from 1980;1980;-1
2014_5514766381435424_manuscript;108   Study setting and participants;108;-1
2014_5514766381435424_manuscript;262   of participants;262;-1
2014_5514766381435424_manuscript;497   young people;497;-1
2014_5514766381435424_manuscript;224   Eligible individuals;224;-1
2014_5514766381435424_manuscript;499   adults;499;-1
2014_5514766381435424_manuscript;n=111;111;-1
2014_5514766381435424_manuscript;n=98;98;-1
2014_5514766381435424_manuscript;n=105;105;-1
2014_5514766381435424_manuscript;n=96;96;-1
2014_5514766381435424_manuscript;n=209;209;-1
2014_5514766381435424_manuscript;n=1027;1027;-1
2014_5514766381435424_manuscript;n=69;69;-1
2014_5514766381435424_manuscript;n=537;537;-1
2014_5514766381435424_manuscript;n=273;273;-1
2014_5514766381435424_manuscript;n=64;64;-1
2014_5514766381435424_manuscript;n=57;57;-1
2014_5514766381435424_manuscript;n=54;54;-1
2014_5514766381435424_manuscript;n= 98;98;-1
2014_5514766381435424_manuscript;n=55;55;-1
2014_5514766381435424_manuscript;n=47;47;-1
2014_5514766381435424_manuscript;n=45;45;-1
2014_5514766381435424_manuscript;n= 56;56;-1
2014_5514766381435424_manuscript;n=49;49;-1
2014_5514766381435424_manuscript;n=94;94;-1
2014_5514766381435424_manuscript;n=91;91;-1
2014_5514766381435424_manuscript;total of 49;49;-1
2014_5514766381435424_manuscript;total of 1027;1027;-1
2014_5532965181283850_manuscript;n=109;109;-1
2014_5532965181283850_manuscript;n=287;287;-1
2014_5532965181283850_manuscript;n = 536;536;-1
2014_5532965181283850_manuscript;n=295;295;-1
2014_5532965181283850_manuscript;n =109;109;-1
2014_5532965181283850_manuscript;n=33;33;-1
2014_5532965181283850_manuscript;n = 20;20;-1
2014_5532965181283850_manuscript;n = 109;109;-1
2014_5532965181283850_manuscript;n =   109;109;-1
2014_5532965181283850_manuscript;n=81;81;-1
2014_5532965181283850_manuscript;n=40;40;-1
2014_5532965181283850_manuscript;n = 33;33;-1
2014_5532965181283850_manuscript;n = 287;287;-1
2014_5642592151248965_manuscript;424   women;424;-1
2014_5642592151248965_manuscript;461   postmenopausal women;461;-1
2014_5642592151248965_manuscript;124   eligible participants;124;-1
2014_5642592151248965_manuscript;7172 participants;7172;-1
2014_5642592151248965_manuscript;187   participants;187;-1
2014_5642592151248965_manuscript;236   excluding participants;236;-1
2014_5642592151248965_manuscript;247 individuals;247;-1
2014_5642592151248965_manuscript;n=28;28;-1
2014_5642592151248965_manuscript;n=0;0;-1
2014_5642592151248965_manuscript;n=1434;1434;-1
2014_5642592151248965_manuscript;n=1435;1435;-1
2014_5642592151248965_manuscript;n=4311;4311;-1
2014_5642592151248965_manuscript;n=4286;4286;-1
2014_5642592151248965_manuscript;n=4236;4236;-1
2014_5642592151248965_manuscript;n=4291;4291;-1
2014_5642592151248965_manuscript; data from 7172;7172;-1
2014_5754541531402337_manuscript;2,180 women;2180;-1
2014_5754541531402337_manuscript;2,212 women;2212;-1
2014_5754541531402337_manuscript;5,474 Eligible women;5474;-1
2014_5754541531402337_manuscript;3 women;3;-1
2014_5754541531402337_manuscript;25 women;25;-1
2014_5754541531402337_manuscript;5 women;5;-1
2014_5754541531402337_manuscript;7 women;7;-1
2014_5754541531402337_manuscript;643,902   persons;643902;-1
2014_5754541531402337_manuscript;N=1105;1105;-1
2014_5754541531402337_manuscript;N=1097;1097;-1
2014_5754541531402337_manuscript;N=2202;2202;-1
2014_5754541531402337_manuscript;N=1075;1075;-1
2014_5754541531402337_manuscript;N=1067;1067;-1
2014_5754541531402337_manuscript;total of 2,142;2142;-1
2014_5754541531402337_manuscript; data from 7,738;7738;-1
2014_6101195211236542_manuscript;15 000 Swedish men and women;15000;-1
2014_6101195211236542_manuscript;n=1,271;1271;-1
2014_6101195211236542_manuscript;n=4,324;4324;-1
2014_6101195211236542_manuscript;n= 38,588;38588;-1
2014_6101195211236542_manuscript;n =9,647;9647;-1
2014_6101195211236542_manuscript;n = 19,294;19294;-1
2014_6101195211236542_manuscript;n = 9,647;9647;-1
2014_6101195211236542_manuscript;n= 37,620;37620;-1
2014_6101195211236542_manuscript;n = 9,401;9401;-1
2014_6101195211236542_manuscript;n = 18,799;18799;-1
2014_6101195211236542_manuscript;n = 9,420;9420;-1
2014_6101195211236542_manuscript;n=30,941;30941;-1
2014_6101195211236542_manuscript;n=7,174;7174;-1
2014_6101195211236542_manuscript;n=15,694;15694;-1
2014_6101195211236542_manuscript;n=8,073;8073;-1
2014_6101195211236542_manuscript;n=35,332;35332;-1
2014_6101195211236542_manuscript;n=8,815;8815;-1
2014_6101195211236542_manuscript;n=1,767;1767;-1
2014_6101195211236542_manuscript;n=8,839;8839;-1
2014_6101195211236542_manuscript;n=38,581;38581;-1
2014_6101195211236542_manuscript;n=9,645;9645;-1
2014_6101195211236542_manuscript;n=19,290;19290;-1
2014_6101195211236542_manuscript;n=9,646;9646;-1
2014_6101195211236542_manuscript;n = 27,766;27766;-1
2014_6101195211236542_manuscript;n = 30,186;30186;-1
2014_6200422321420470_manuscript;63,189 participants;63189;-1
2014_6200422321420470_manuscript;n =6;6;-1
2014_6200422321420470_manuscript;n=5;5;-1
2014_6200422321420470_manuscript;n=4;4;-1
2014_6200422321420470_manuscript;n=2;2;-1
2014_6200422321420470_manuscript;n=1;1;-1
2014_6200422321420470_manuscript;n=14;14;-1
2014_6200422321420470_manuscript;n=6;6;-1
2014_6200422321420470_manuscript;n=8;8;-1
2014_6200422321420470_manuscript;n=22;22;-1
2014_7157668941430065_manuscript;6,763 women;6763;-1
2014_7157668941430065_manuscript;1 When women;1;-1
2014_7157668941430065_manuscript;64 participants;64;-1
2014_7157668941430065_manuscript;1,919 participants;1919;-1
2014_7157668941430065_manuscript;113 participants;113;-1
2014_7157668941430065_manuscript;1,919 female patients;1919;-1
2014_7157668941430065_manuscript;5 people;5;-1
2014_7157668941430065_manuscript;1 million   people;1;-1
2014_7157668941430065_manuscript;n= 483;483;-1
2014_7157668941430065_manuscript;n=480;480;-1
2014_7157668941430065_manuscript;n=481;481;-1
2014_7157668941430065_manuscript;n=475;475;-1
2014_7157668941430065_manuscript;n=116;116;-1
2014_7157668941430065_manuscript;n=42;42;-1
2014_7157668941430065_manuscript;N=1919;1919;-1
2014_7157668941430065_manuscript;n=1919;1919;-1
2014_7157668941430065_manuscript;n=483;483;-1
2014_7157668941430065_manuscript;total of 6,763;6763;-1
2014_7157668941430065_manuscript; data   from 113;113;-1
2014_7468167691525095_manuscript;2,793 women;2793;22445
2014_7468167691525095_manuscript;2 million pregnant women;2;19933
2014_7468167691525095_manuscript;94   pregnant women;94;18472
2014_7468167691525095_manuscript;336 women;336;16734
2014_7468167691525095_manuscript;144   of women;144;14675
2014_7468167691525095_manuscript;161   Pregnant women;161;13201
2014_7468167691525095_manuscript;171   pregnant women;171;12268
2014_7468167691525095_manuscript;201   For women;201;9485
2014_7468167691525095_manuscript;216   up of women;216;8050
2014_7468167691525095_manuscript;265   Following enrolment women;265;3901
2014_7468167691525095_manuscript;1396 women;1396;2088
2014_7468167691525095_manuscript;294   analysis only included women;294;1366
2014_7468167691525095_manuscript;300   women;300;767
2014_7468167691525095_manuscript;342   Of women;342;2777
2014_7468167691525095_manuscript;18 women;18;2933
2014_7468167691525095_manuscript;2,775 women;2775;3003
2014_7468167691525095_manuscript;351   Of women;351;3515
2014_7468167691525095_manuscript;1,013 women;1013;3857
2014_7468167691525095_manuscript;152 women;152;5616
2014_7468167691525095_manuscript;393   women;393;7184
2014_7468167691525095_manuscript;475   women;475;13923
2014_7468167691525095_manuscript;485   and women;485;14783
2014_7468167691525095_manuscript;474 women;474;18528
2014_7468167691525095_manuscript;534   those women;534;19104
2014_7468167691525095_manuscript;628   treatment of pregnant women;628;26320
2014_7468167691525095_manuscript;645   women;645;27573
2014_7468167691525095_manuscript;689   pregnant women;689;30993
2014_7468167691525095_manuscript;740   women;740;34797
2014_7468167691525095_manuscript;19 women;19;48069
2014_7468167691525095_manuscript;457   Few participants;457;12271
2014_7468167691525095_manuscript;400 study participants;400;15041
2014_7468167691525095_manuscript;2,793 trial participants;2793;35361
2014_7468167691525095_manuscript;572   patients;572;22224
2014_7468167691525095_manuscript;n = 279;279;11303
2014_7468167691525095_manuscript;n = 2,752;2752;6698
2014_7468167691525095_manuscript;n=754;754;4085
2014_7468167691525095_manuscript;n = 75;75;14084
2014_7468167691525095_manuscript;n = 1,382;1382;35649
2014_7468167691525095_manuscript;n = 1,393;1393;35690
2014_7468167691525095_manuscript;n = 2,729;2729;35751
2014_7468167691525095_manuscript;n = 2,721;2721;35813
2014_7468167691525095_manuscript;n = 2,714;2714;35883
2014_7468167691525095_manuscript;n = 2,771;2771;35939
2014_7468167691525095_manuscript;n = 2,650;2650;35997
2014_7468167691525095_manuscript;n = 1,374;1374;43716
2014_7468167691525095_manuscript;n = 1,378;1378;43753
2014_7468167691525095_manuscript;n = 754;754;48914
2014_7468167691525095_manuscript;total of 293;293;8952
2014_7468167691525095_manuscript;183   enrolled;183;11221
2014_7468167691525095_manuscript;2,793 were enrolled;2793;2823
2014_7468167691525095_manuscript;531   ultimately enrolled;531;18797
2014_7494840114146866_manuscript;1,013 participants;1013;-1
2014_7494840114146866_manuscript;2914 participants;2914;-1
2014_7494840114146866_manuscript;1,375 clinical interview participants;1375;-1
2014_7494840114146866_manuscript;1,013   subjects;1013;-1
2014_7494840114146866_manuscript;158 subjects;158;-1
2014_7494840114146866_manuscript;1,375 subjects;1375;-1
2014_7494840114146866_manuscript;1,375 people;1375;-1
2014_7494840114146866_manuscript;15   people;15;-1
2014_7494840114146866_manuscript;362 people;362;-1
2014_7494840114146866_manuscript;1,013 people;1013;-1
2014_7494840114146866_manuscript;1,375 individuals;1375;-1
2014_7494840114146866_manuscript;17 individuals;17;-1
2014_7494840114146866_manuscript;n=1,013;1013;-1
2014_7494840114146866_manuscript;n=1,614;1614;-1
2014_7494840114146866_manuscript;n=731;731;-1
2014_7494840114146866_manuscript;n=1,255;1255;-1
2014_7494840114146866_manuscript;n=683;683;-1
2014_7494840114146866_manuscript;n=330;330;-1
2014_7494840114146866_manuscript;n=57;57;-1
2014_7494840114146866_manuscript;n=39;39;-1
2014_7494840114146866_manuscript;N=78;78;-1
2014_7494840114146866_manuscript;N=346;346;-1
2014_7494840114146866_manuscript;N=556;556;-1
2014_7494840114146866_manuscript;N=49;49;-1
2014_7494840114146866_manuscript;N=56;56;-1
2014_7494840114146866_manuscript;N=255;255;-1
2014_7494840114146866_manuscript;N=645;645;-1
2014_7494840114146866_manuscript;N=57;57;-1
2014_7494840114146866_manuscript;N=15;15;-1
2014_7494840114146866_manuscript;N=635;635;-1
2014_7494840114146866_manuscript;N=17;17;-1
2014_7562220751375822_manuscript;28 subjects;28;-1
2014_7562220751375822_manuscript;50 patients;50;-1
2014_7562220751375822_manuscript;45 patients;45;-1
2014_7562220751375822_manuscript;10 patients;10;-1
2014_7562220751375822_manuscript;19 patients;19;-1
2014_7562220751375822_manuscript;5 patients;5;-1
2014_7562220751375822_manuscript;12 patients;12;-1
2014_7562220751375822_manuscript;total of 44;44;-1
2014_7665432151407805_manuscript;15 million people;15;-1
2014_7665432151407805_manuscript;3 billion individuals;3;-1
2014_7822102761258448_manuscript;24 subjects;24;33943
2014_7822102761258448_manuscript;20 subjects;20;44306
2014_7822102761258448_manuscript;17   subjects;17;44662
2014_7822102761258448_manuscript;24 ASD control patients;24;907
2014_7822102761258448_manuscript;n = 471;471;742
2014_7822102761258448_manuscript; database of 3;3;12527
2014_8132473101472212_manuscript;100,000 persons;100000;11141
2014_8132473101472212_manuscript;10   participants;10;1718
2014_8132473101472212_manuscript;120 participants;120;1000
2014_8132473101472212_manuscript;62 patients;62;12803
2014_8132473101472212_manuscript;58 patients;58;12729
2014_8132473101472212_manuscript;20 patients;20;11157
2014_8132473101472212_manuscript;35,000 patients;35000;11304
2014_8132473101472212_manuscript;16 patients;16;2117
2014_8132473101472212_manuscript;120 patients;120;612
2014_8132473101472212_manuscript;2 patients;2;12802
2014_8132473101472212_manuscript;118 patients;118;896
2014_8132473101472212_manuscript;4 patients;4;928
2014_8132473101472212_manuscript;25 patients;25;9148
2014_8132473101472212_manuscript;N=58;58;18939
2014_8132473101472212_manuscript;N=60;60;18962
2014_8358292731472400_manuscript;69   of pregnant women;69;-1
2014_8358292731472400_manuscript;338   proportion of women;338;-1
2014_8358292731472400_manuscript;12 status of pregnant Indian women;12;-1
2014_8375060441396624_manuscript;5,184 participants;5184;-1
2014_8375060441396624_manuscript;7,864 participants;7864;-1
2014_8375060441396624_manuscript;5,892 participants;5892;-1
2014_8375060441396624_manuscript;13,983 participants;13983;-1
2014_8375060441396624_manuscript;17   participants;17;-1
2014_8375060441396624_manuscript;2,652 participants;2652;-1
2014_8375060441396624_manuscript;40 nondiabetics patients;40;-1
2014_8375060441396624_manuscript;N=14,797;14797;-1
2014_8375060441396624_manuscript;N=9,268;9268;-1
2014_8375060441396624_manuscript;N=1,089;1089;-1
2014_8375060441396624_manuscript;N=315;315;-1
2014_8375060441396624_manuscript;N=4117;4117;-1
2014_8375060441396624_manuscript;N=1067;1067;-1
2014_8375060441396624_manuscript;N  =5;5;-1
2014_8375060441396624_manuscript;N  =1;1;-1
2014_8375060441396624_manuscript;N  =2;2;-1
2014_8375060441396624_manuscript;N  =3;3;-1
2014_8375060441396624_manuscript;N  =4;4;-1
2014_8405791871329523_manuscript;16 patients;16;-1
2014_8405791871329523_manuscript;160 patients;160;-1
2014_8405791871329523_manuscript;120 patients;120;-1
2014_8405791871329523_manuscript;348 patients;348;-1
2014_8405791871329523_manuscript;   data points from 43,000;43000;-1
2014_8648090431424261_manuscript;33 severe edema subjects;33;-1
2014_8648090431424261_manuscript;10  B CA  Delayed edematous subjects;10;-1
2014_8648090431424261_manuscript;70 pediatric patients;70;-1
2014_8648090431424261_manuscript;70 pediatric TBI patients;70;-1
2014_8648090431424261_manuscript;70 TBI patients;70;-1
2014_8648090431424261_manuscript;n = 37;37;-1
2014_8648090431424261_manuscript;n = 33;33;-1
2014_8648090431424261_manuscript;n = 36;36;-1
2014_8648090431424261_manuscript;n = 22;22;-1
2014_8648090431424261_manuscript;n = 48;48;-1
2014_8648090431424261_manuscript;n = 6;6;-1
2014_8648090431424261_manuscript;total of 70;70;-1
2014_8712063661188940_manuscript;1,577   participants;1577;-1
2014_8712063661188940_manuscript;n=1,577;1577;-1
2014_8712063661188940_manuscript;n=1,197;1197;-1
2014_8712063661188940_manuscript;n=1,167;1167;-1
2014_8875779431283094_manuscript;258 subjects;258;-1
2014_8875779431283094_manuscript;138 Taiwanese BD subjects;138;-1
2014_8875779431283094_manuscript;1256 SCZ subjects;1256;-1
2014_8875779431283094_manuscript;139 pediatric subjects;139;-1
2014_8875779431283094_manuscript;1,816 of these SSRI-treated subjects;1816;-1
2014_8875779431283094_manuscript;294 Taiwanese subjects;294;-1
2014_8875779431283094_manuscript;24 subjects;24;-1
2014_8875779431283094_manuscript;6 EM subjects;6;-1
2014_8875779431283094_manuscript;97 subjects;97;-1
2014_8875779431283094_manuscript;359 BD patients;359;-1
2014_8875779431283094_manuscript;88 BD   patients;88;-1
2014_8875779431283094_manuscript;687 SCZ patients;687;-1
2014_8875779431283094_manuscript;1435 MDD and BD patients;1435;-1
2014_8875779431283094_manuscript;1,953 patients;1953;-1
2014_8875779431283094_manuscript;2,199 patients;2199;-1
2014_8875779431283094_manuscript;2,200 MDD patients;2200;-1
2014_8875779431283094_manuscript;44 MDD patients;44;-1
2014_8875779431283094_manuscript;227 MDD patients;227;-1
2014_8875779431283094_manuscript;2000 survey   of individuals;2000;-1
2014_9444004221218029_manuscript;1 patients;1;-1
2014_9444004221218029_manuscript;n=78;78;-1
2014_9444004221218029_manuscript;n=82;82;-1
2014_9444004221218029_manuscript;N=82;82;-1
2014_9444004221218029_manuscript;N=78;78;-1
2014_9444004221218029_manuscript;N=160;160;-1
2014_9522499101476999_manuscript;1,049 patients;1049;11061
2014_9522499101476999_manuscript;1,368 patients;1368;10215
2014_9522499101476999_manuscript;319 individuals;319;10921
2014_9522499101476999_manuscript;15 long-lived-individuals;15;5572
2014_9522499101476999_manuscript;total of 848;848;7487
2014_9522499101476999_manuscript;total of 282;282;2863
2014_9522499101476999_manuscript;total of 190;190;4590
2014_9522499101476999_manuscript;total of 172;172;6594
2014_9522499101476999_manuscript;total of 110;110;6799
2014_9522499101476999_manuscript;total of 319;319;8178
2014_9567924191389653_manuscript;2000   patients;2000;-1
2014_9567924191389653_manuscript;1 infected patients;1;-1
2014_9782479931326062_manuscript;5,144 participants;5144;-1
2014_9782479931326062_manuscript;5,144 trial participants;5144;-1
2014_9782479931326062_manuscript;2   trial participants;2;-1
2014_9782479931326062_manuscript;11   adults;11;-1
2014_9782479931326062_manuscript;N=2659;2659;-1
2014_9782479931326062_manuscript;N=1515;1515;-1
2014_9782479931326062_manuscript; data from 5,144;5144;-1
bmj4_10_e004641.full;2 exists because some people;2;-1
bmj4_10_e004641.full;227 individuals;227;-1
bmj4_10_e004641.full;208 individuals;208;-1
bmj4_10_e004641.full;19 individuals;19;-1
bmj4_10_e004641.full;n=208;208;-1
bmj4_10_e004641.full;n=416;416;-1
bmj4_10_e004641.full;n=153;153;-1
bmj4_10_e004641.full;n=263;263;-1
bmj4_10_e004641.full;n=176;176;-1
bmj4_10_e004641.full;n=110;110;-1
bmj4_10_e004641.full;n=130;130;-1
bmj4_10_e005096.full;2092 subjects;2092;-1
bmj4_10_e005096.full;88 subjects;88;-1
bmj4_10_e005096.full;3012 subjects;3012;-1
bmj4_10_e005096.full;80 subjects;80;-1
bmj4_10_e005096.full;21 subjects;21;-1
bmj4_10_e005096.full;35 subjects;35;-1
bmj4_10_e005096.full;33 subjects;33;-1
bmj4_10_e005096.full;465 subjects;465;-1
bmj4_10_e005096.full;88 individuals;88;-1
bmj4_10_e005096.full;2000 individuals;2000;-1
bmj4_10_e005096.full;11 Participants were recruited;11;-1
bmj4_10_e005096.full;N=0;0;-1
bmj4_10_e005096.full;total of 3012;3012;-1
bmj4_10_e005096.full;total of  371;371;-1
bmj4_10_e005119.full;30 patients;30;-1
bmj4_10_e005119.full;120  patients;120;-1
bmj4_10_e005119.full;480 patients;480;-1
bmj4_10_e005119.full;104  patients;104;-1
bmj4_10_e005119.full;40 patients;40;-1
bmj4_10_e005119.full;116 patients;116;-1
bmj4_10_e005119.full;28 116 individuals;28116;-1
bmj4_10_e005119.full;40 patients shall be recruited;40;-1
bmj4_10_e005119.full;28 116 individuals will be recruited;28116;-1
bmj4_10_e005119.full;total of 480;480;-1
bmj4_10_e005150.full;120 patients;120;-1
bmj4_10_e005150.full;47 patients;47;-1
bmj4_10_e005150.full;116 randomised patients;116;-1
bmj4_10_e005150.full;83 patients;83;-1
bmj4_10_e005150.full;33 patients;33;-1
bmj4_10_e005150.full;150 patients;150;-1
bmj4_10_e005150.full;101 patients;101;-1
bmj4_10_e005150.full;516 de novo CD patients;516;-1
bmj4_10_e005150.full;n=55;55;-1
bmj4_10_e005150.full;n=61;61;-1
bmj4_10_e005150.full;n=16;16;-1
bmj4_10_e005150.full;n=4;4;-1
bmj4_10_e005150.full;n=45;45;-1
bmj4_10_e005150.full;n=38;38;-1
bmj4_10_e005150.full;n=116;116;-1
bmj4_10_e005150.full;n=150;150;-1
bmj4_10_e005150.full;n=300;300;-1
bmj4_10_e005150.full;n=10;10;-1
bmj4_10_e005150.full;n=23;23;-1
bmj4_10_e005150.full;n=47;47;-1
bmj4_10_e005150.full;n=36;36;-1
bmj4_10_e005150.full;total of 120;120;-1
bmj4_10_e005150.full;total of 33;33;-1
bmj4_10_e005173.full;1462 women;1462;-1
bmj4_10_e005173.full;1460 women;1460;-1
bmj4_10_e005173.full;27 In women;27;-1
bmj4_10_e005173.full;n=372;372;-1
bmj4_10_e005173.full;n=431;431;-1
bmj4_10_e005173.full;n=398;398;-1
bmj4_10_e005173.full;n=180;180;-1
bmj4_10_e005173.full;n=79;79;-1
bmj4_10_e005173.full;n=1460;1460;-1
bmj4_10_e005173.full;total of 1462;1462;-1
bmj4_10_e005173.full; data from  32;32;-1
bmj4_10_e005182.full;3  and patients;3;5368
bmj4_10_e005182.full;2 middle-aged adults;2;5405
bmj4_10_e005182.full;4 older adults;4;5382
bmj4_10_e005182.full;N=720;720;2390
bmj4_10_e005182.full;N=708;708;14071
bmj4_10_e005249.full;331 004 patients;331004;-1
bmj4_10_e005249.full;19 889 patients;19889;-1
bmj4_10_e005249.full;n=124;124;-1
bmj4_10_e005249.full;n=14;14;-1
bmj4_10_e005249.full;total of  19 889;19889;-1
bmj4_10_e005249.full;total of 19 889;19889;-1
bmj4_10_e005341.full;1260 self-swabbing participants;1260;-1
bmj4_10_e005341.full;314 HCP swabbing  participants;314;-1
bmj4_10_e005341.full;10 448 individuals;10448;-1
bmj4_10_e005341.full;2405 individuals;2405;-1
bmj4_10_e005341.full;3349 individuals;3349;-1
bmj4_10_e005341.full;1908 individuals;1908;-1
bmj4_10_e005341.full;3146  individuals;3146;-1
bmj4_10_e005341.full;202 individuals;202;-1
bmj4_10_e005341.full;320 individuals;320;-1
bmj4_10_e005341.full;101 individuals;101;-1
bmj4_10_e005341.full;160  individuals;160;-1
bmj4_10_e005341.full;3200 older children and adults;3200;-1
bmj4_10_e005341.full;n=1260;1260;-1
bmj4_10_e005341.full;N=5395;5395;-1
bmj4_10_e005341.full;n=314;314;-1
bmj4_10_e005341.full;N=5054;5054;-1
bmj4_10_e005341.full;n=27;27;-1
bmj4_10_e005341.full;N=290;290;-1
bmj4_10_e005341.full;n=96;96;-1
bmj4_10_e005341.full;n=3;3;-1
bmj4_10_e005341.full;n=34;34;-1
bmj4_10_e005341.full;N=277;277;-1
bmj4_10_e005341.full;n=931;931;-1
bmj4_10_e005341.full;N=3349;3349;-1
bmj4_10_e005341.full;n=258;258;-1
bmj4_10_e005341.full;N=3146;3146;-1
bmj4_10_e005341.full;n=329;329;-1
bmj4_10_e005341.full;N=2045;2045;-1
bmj4_10_e005341.full;n=56;56;-1
bmj4_10_e005341.full;n=656;656;-1
bmj4_10_e005341.full;N=1574;1574;-1
bmj4_10_e005341.full;n=439;439;-1
bmj4_10_e005341.full;N=1254;1254;-1
bmj4_10_e005341.full;n=239;239;-1
bmj4_10_e005341.full;n=79;79;-1
bmj4_10_e005341.full;N=309;309;-1
bmj4_10_e005341.full;n=105;105;-1
bmj4_10_e005341.full;n=49;49;-1
bmj4_10_e005341.full;N=1219;1219;-1
bmj4_10_e005341.full;n=13;13;-1
bmj4_10_e005341.full;n=7;7;-1
bmj4_10_e005341.full;N=307;307;-1
bmj4_10_e005341.full;n=5;5;-1
bmj4_10_e005341.full;n=30;30;-1
bmj4_10_e005341.full;N=329;329;-1
bmj4_10_e005341.full;N=56;56;-1
bmj4_10_e005341.full;n=19;19;-1
bmj4_10_e005341.full;N=907;907;-1
bmj4_10_e005341.full;n=2;2;-1
bmj4_10_e005341.full;N=253;253;-1
bmj4_10_e005341.full;n=11;11;-1
bmj4_10_e005341.full;N=137;137;-1
bmj4_10_e005341.full;N=464;464;-1
bmj4_10_e005341.full;N=306;306;-1
bmj4_10_e005341.full;n=15;15;-1
bmj4_10_e005341.full;N=30;30;-1
bmj4_10_e005341.full;N=19;19;-1
bmj4_10_e005341.full;n=29;29;-1
bmj4_10_e005341.full;total of 10 448;10448;-1
bmj4_10_e005413.full;912 Japanese men and women;912;-1
bmj4_10_e005413.full;548 women;548;-1
bmj4_10_e005413.full;149 women;149;-1
bmj4_10_e005413.full;10 women;10;-1
bmj4_10_e005413.full;66  women;66;-1
bmj4_10_e005413.full;320 women;320;-1
bmj4_10_e005413.full;24 When participants;24;-1
bmj4_10_e005413.full;1445 participants;1445;-1
bmj4_10_e005413.full;433 participants;433;-1
bmj4_10_e005413.full;6 participants;6;-1
bmj4_10_e005413.full;912 participants;912;-1
bmj4_10_e005413.full;912  participants;912;-1
bmj4_10_e005413.full;163,944 Austrian adults;163944;-1
bmj4_10_e005413.full;total of 912;912;-1
bmj4_10_e005491.full;128  participants;128;-1
bmj4_10_e005491.full;128 participants;128;-1
bmj4_10_e005491.full;64 participants;64;-1
bmj4_10_e005491.full;128  patients;128;-1
bmj4_10_e005502.full;4 362 624 patients;4362624;-1
bmj4_10_e005502.full;1000 patients;1000;-1
bmj4_10_e005502.full;25 Although patients;25;-1
bmj4_10_e005502.full;8451 patients;8451;-1
bmj4_10_e005502.full;1000 surgical patients;1000;-1
bmj4_10_e005502.full;1000  patients;1000;-1
bmj4_10_e005502.full;1000  surgical patients;1000;-1
bmj4_10_e005502.full;1000 elective surgical patients;1000;-1
bmj4_10_e005502.full;1000  elective surgical patients;1000;-1
bmj4_10_e005502.full;5,451 patients;5451;-1
bmj4_10_e005529.full; data from 2006;2006;-1
bmj4_10_e005530.full;12 765 participants;12765;-1
bmj4_10_e005530.full;35 Older people;35;-1
bmj4_10_e005530.full;n=3186;3186;-1
bmj4_10_e005530.full;n=12 765;12765;-1
bmj4_10_e005530.full;n=5050;5050;-1
bmj4_10_e005536.full;100 participants;100;8024
bmj4_10_e005536.full;3 patients;3;14041
bmj4_10_e005536.full;10 patients;10;13965
bmj4_10_e005536.full;39 If patients;39;11195
bmj4_10_e005536.full;20 patients;20;4311
bmj4_10_e005536.full;n=0;0;932
bmj4_10_e005536.full;total of 10;10;13974
bmj4_10_e005550.full;70 participants;70;-1
bmj4_10_e005550.full;70  participants;70;-1
bmj4_10_e005550.full;70  patients;70;-1
bmj4_10_e005550.full;n=5;5;-1
bmj4_10_e005578.full;31 making  those people;31;-1
bmj4_10_e005578.full;160 000 adults;160000;-1
bmj4_10_e005578.full;118,000 working adults;118000;-1
bmj4_10_e005578.full;n=2;2;-1
bmj4_10_e005578.full;n=145;145;-1
bmj4_10_e005578.full;n=151;151;-1
bmj4_10_e005578.full;n=171;171;-1
bmj4_10_e005578.full;n=144;144;-1
bmj4_10_e005578.full;n=4;4;-1
bmj4_10_e005578.full;n=216;216;-1
bmj4_10_e005578.full;n=232;232;-1
bmj4_10_e005578.full;n=40;40;-1
bmj4_10_e005578.full;n=901;901;-1
bmj4_10_e005578.full;n=584;584;-1
bmj4_10_e005578.full;n=  14;14;-1
bmj4_10_e005578.full;n=1485;1485;-1
bmj4_10_e005578.full;n=655;655;-1
bmj4_10_e005578.full;total of 20;20;-1
bmj4_10_e005586.full;159 078 women;159078;-1
bmj4_10_e005586.full;496 438 women;496438;-1
bmj4_10_e005586.full;62 626 women;62626;-1
bmj4_10_e005627.full;251 confirmed cases  of participants;251;-1
bmj4_10_e005627.full;n=251;251;-1
bmj4_10_e005627.full;n=260;260;-1
bmj4_10_e005627.full;n=512;512;-1
bmj4_10_e005627.full;n=252;252;-1
bmj4_10_e005627.full;212 were enrolled;212;-1
bmj4_10_e005652.full;30 Although participants;30;-1
bmj4_10_e005652.full;n=23;23;-1
bmj4_10_e005652.full;n=10;10;-1
bmj4_10_e005652.full;n=108;108;-1
bmj4_10_e005652.full;n=57;57;-1
bmj4_10_e005652.full;total of 943;943;-1
bmj4_10_e005652.full;total of 20 091;20091;-1
bmj4_10_e005652.full;total of 717;717;-1
bmj4_10_e005652.full;total of 512;512;-1
bmj4_10_e005694.full;65 903 persons;65903;-1
bmj4_10_e005694.full;52 082 participants;52082;-1
bmj4_10_e005694.full;6065  prison participants;6065;-1
bmj4_10_e005694.full;9954  participants;9954;-1
bmj4_10_e005694.full;53 062 individuals;53062;-1
bmj4_10_e005694.full;n=46 125;46125;-1
bmj4_10_e005694.full;n=5957;5957;-1
bmj4_10_e005694.full;n=52 082;52082;-1
bmj4_10_e005694.full;n=4977;4977;-1
bmj4_10_e005694.full;n=46125;46125;-1
bmj4_10_e005694.full;n=9954;9954;-1
bmj4_10_e005694.full;n= 4977;4977;-1
bmj4_10_e005704.full;n=4;4;-1
bmj4_10_e005704.full;n=670;670;-1
bmj4_10_e005704.full;N=628;628;-1
bmj4_10_e005704.full;  data from 2006;2006;-1
bmj4_10_e005704.full; data from 2010;2010;-1
bmj4_10_e005704.full;  data from 2012;2012;-1
bmj4_10_e005704.full; data from 1994;1994;-1
bmj4_10_e005704.full; data from 2012;2012;-1
bmj4_10_e005704.full; data from 1999;1999;-1
bmj4_10_e005742.full;30 participants;30;-1
bmj4_10_e005742.full;12 participants;12;-1
bmj4_10_e005742.full;20 participants;20;-1
bmj4_10_e005742.full;80 patients;80;-1
bmj4_10_e005742.full;15 patients;15;-1
bmj4_10_e005742.full;30 partici-  pants will be recruited;30;-1
bmj4_10_e005762.full;1  This also benefits patients;1;-1
bmj4_10_e005762.full;1 Flow chart of patients;1;-1
bmj4_10_e005762.full;N=585;585;-1
bmj4_10_e005762.full;N=345;345;-1
bmj4_10_e005762.full;n=390;390;-1
bmj4_10_e005762.full;n=195;195;-1
bmj4_10_e005762.full;n=230;230;-1
bmj4_10_e005762.full;n=115;115;-1
bmj4_10_e005781.full;1008 participants;1008;1490
bmj4_10_e005781.full;1008 consecutive PCI patients;1008;13486
bmj4_10_e005781.full;11 000 patients;11000;9454
bmj4_10_e005781.full;13 predisposes  patients;13;8361
bmj4_10_e005781.full;1008 patients;1008;655
bmj4_10_e005781.full;1043 consecutive PCI patients;1043;1318
bmj4_10_e005781.full;2 Flow chart of study patients;2;4365
bmj4_10_e005781.full;24 and STEMI patients;24;16530
bmj4_10_e005781.full;5,833 consecutive patients;5833;30121
bmj4_10_e005781.full;n=1;1;12133
bmj4_10_e005781.full;n=2;2;12040
bmj4_10_e005781.full;n=18;18;12012
bmj4_10_e005781.full;n=35;35;1474
bmj4_10_e005781.full;n=37;37;4295
bmj4_10_e005781.full;n=5;5;4340
bmj4_10_e005781.full;n=1008;1008;4459
bmj4_10_e005781.full;n=665;665;4478
bmj4_10_e005781.full;n=343;343;4508
bmj4_10_e005781.full;n=57;57;8889
bmj4_10_e005781.full;n=52;52;8966
bmj4_10_e005781.full;n=3;3;1474
bmj4_10_e005781.full;n=47;47;9772
bmj4_10_e005781.full;n=34;34;4508
bmj4_10_e005781.full;n=13;13;9898
bmj4_10_e005781.full;n=1007;1007;11783
bmj4_10_e005781.full;n=664;664;11802
bmj4_10_e005781.full;n=14;14;12805
bmj4_10_e005781.full;n=8;8;13048
bmj4_10_e005787.full;1649 postmenopausal women;1649;-1
bmj4_10_e005787.full;5091 postmenopausal women;5091;-1
bmj4_10_e005787.full;17 Subgroups of participants;17;-1
bmj4_10_e005787.full;1649 postmenopausal women recruited;1649;-1
bmj4_10_e005787.full;5091 postmenopausal women recruited;5091;-1
bmj4_10_e005834.full;n=10;10;-1
bmj4_10_e005859.full;7 million  participants;7;-1
bmj4_10_e005859.full; data from 10;10;-1
bmj4_10_e005859.full;  data from 22;22;-1
bmj4_10_e005860.full;10 participants;10;-1
bmj4_10_e005860.full;62 and get people;62;-1
bmj4_10_e005860.full;20 individuals;20;-1
bmj4_10_e005860.full;33 A Sri Lankan study of  individuals;33;-1
bmj4_10_e005886.full;278 000 patients;278000;-1
bmj4_10_e005886.full;10 IDUs were  defined as patients;10;-1
bmj4_10_e005886.full;8556 patients;8556;-1
bmj4_10_e005886.full;193 patients;193;-1
bmj4_10_e005886.full;13  Since three patients;13;-1
bmj4_10_e005886.full;306 patients;306;-1
bmj4_10_e005886.full;120 patients;120;-1
bmj4_10_e005886.full;8556 individuals;8556;-1
bmj4_10_e005886.full; data from 49;49;-1
bmj4_10_e005920.full;3 For some  patients;3;-1
bmj4_10_e005920.full;43 In  patients;43;-1
bmj4_10_e005920.full;n=20;20;-1
bmj4_10_e005920.full;n=120;120;-1
bmj4_10_e005920.full;n=39;39;-1
bmj4_10_e005920.full;n=117;117;-1
bmj4_10_e005935.full;76 870 pregnant women;76870;-1
bmj4_10_e005935.full;76 870 women;76870;-1
bmj4_10_e005935.full;4  Violence against women;4;-1
bmj4_10_e005935.full;22 All pregnant women;22;-1
bmj4_10_e005935.full;79 363 women;79363;-1
bmj4_10_e005935.full;13 475 pregnancies of women;13475;-1
bmj4_10_e005935.full;703 women;703;-1
bmj4_10_e005935.full;1700 women;1700;-1
bmj4_10_e005935.full;6421 pregnant women;6421;-1
bmj4_10_e005935.full;1555 women;1555;-1
bmj4_10_e005935.full;n=297;297;-1
bmj4_10_e005935.full;n=41;41;-1
bmj4_10_e005935.full;N=76 870;76870;-1
bmj4_10_e005935.full;N=3620;3620;-1
bmj4_10_e005935.full;N=2107;2107;-1
bmj4_10_e005935.full;N=6257;6257;-1
bmj4_10_e005935.full;total of 76 870;76870;-1
bmj4_10_e005935.full;total of 4;4;-1
bmj4_10_e005935.full;76 870 women enrolled;76870;-1
bmj4_10_e005947.full;2192 patients;2192;7315
bmj4_10_e005947.full;13 233 patients;13233;7254
bmj4_10_e005947.full;496  patients;496;6474
bmj4_10_e005947.full;891 patients;891;6351
bmj4_10_e005947.full;13 233 registered patients;13233;1821
bmj4_10_e005947.full;793 patients;793;556
bmj4_10_e005947.full;1,399  patients;1399;644
bmj4_10_e005947.full;1 Demographics of patients;1;4255
bmj4_10_e005947.full;108 929 patients;108929;11181
bmj4_10_e005947.full;n=793;793;7018
bmj4_10_e005947.full;n=1399;1399;6943
bmj4_10_e005947.full;n=2192;2192;351
bmj4_10_e005947.full;n=11 041;11041;281
bmj4_10_e005947.full;n=698;698;593
bmj4_10_e005947.full;n=95;95;619
bmj4_10_e005947.full;n=996;996;686
bmj4_10_e005947.full;n=403;403;714
bmj4_10_e005947.full;n=329;329;878
bmj4_10_e005947.full;n=636;636;964
bmj4_10_e005947.full;n=510;510;1080
bmj4_10_e005947.full;n=925;925;1125
bmj4_10_e005947.full;n=44;44;1665
bmj4_10_e005947.full;n=50;50;1712
bmj4_10_e005947.full;N=1399;1399;4337
bmj4_10_e005947.full;N=793;793;4358
bmj4_10_e005947.full;N=11 041;11041;6622
bmj4_10_e005947.full;N=2192;2192;6642
bmj4_10_e005947.full;N=823;823;7669
bmj4_10_e005947.full;N=418;418;7682
bmj4_10_e005947.full;N=891;891;14709
bmj4_10_e005947.full;N=496;496;14729
bmj4_10_e005947.full;N=389;389;15052
bmj4_10_e005947.full;N=164;164;15072
bmj4_10_e005950.full;2505 patients;2505;19250
bmj4_10_e005950.full;53 patients;53;18460
bmj4_10_e005950.full;80 patients;80;18426
bmj4_10_e005950.full;100 patients;100;17977
bmj4_10_e005950.full;102 HIV patients;102;17926
bmj4_10_e005950.full;32 In patients;32;8527
bmj4_10_e005950.full;254 patients;254;6600
bmj4_10_e005950.full;254 patients have  been recruited;254;6600
bmj4_10_e005950.full;n=309;309;18140
bmj4_10_e005950.full;total of 254;254;6591
bmj4_10_e005961.full;13 of  the patients;13;-1
bmj4_10_e005961.full;10 female patients;10;-1
bmj4_10_e005961.full;n=33;33;-1
bmj4_10_e005961.full;n=26;26;-1
bmj4_10_e005961.full;n=16;16;-1
bmj4_10_e005961.full;n=10;10;-1
bmj4_10_e005961.full;n=5;5;-1
bmj4_10_e005961.full;n=52;52;-1
bmj4_10_e005961.full;n=35;35;-1
bmj4_10_e005961.full;n=3;3;-1
bmj4_10_e005961.full;n=2;2;-1
bmj4_10_e005961.full;n=49;49;-1
bmj4_10_e005961.full;n=13;13;-1
bmj4_10_e005961.full;total of 52;52;-1
bmj4_10_e005963.full;8,218 men and women;8218;-1
bmj4_10_e005963.full;n=2581;2581;-1
bmj4_10_e005963.full;n=7984;7984;-1
bmj4_10_e005963.full;n=4027;4027;-1
bmj4_10_e005963.full;n=277;277;-1
bmj4_10_e005963.full;n=1090;1090;-1
bmj4_10_e005963.full;n=14;14;-1
bmj4_10_e005963.full;n=65;65;-1
bmj4_10_e005963.full;n=86;86;-1
bmj4_10_e005963.full;n=6;6;-1
bmj4_10_e005963.full;n=1535;1535;-1
bmj4_10_e005963.full;n=521;521;-1
bmj4_10_e005963.full;n=198;198;-1
bmj4_10_e005963.full;n=150;150;-1
bmj4_10_e005963.full;n=177;177;-1
bmj4_10_e005963.full; data from 2003;2003;-1
bmj4_10_e005974.full;n=2712;2712;-1
bmj4_10_e005974.full;total of 443;443;-1
bmj4_10_e005980.full;110 participants;110;-1
bmj4_10_e005980.full;40 trainers were recruited;40;-1
bmj4_10_e005980.full;N=70;70;-1
bmj4_10_e005980.full;N=40;40;-1
bmj4_10_e005980.full;n=253;253;-1
bmj4_10_e005980.full;n=185;185;-1
bmj4_10_e005980.full;n=262;262;-1
bmj4_10_e005980.full;n=15;15;-1
bmj4_10_e005980.full;n=276;276;-1
bmj4_10_e005983.full;2397  patients;2397;-1
bmj4_10_e005983.full;544  patients;544;-1
bmj4_10_e005983.full;61 patients;61;-1
bmj4_10_e005983.full;10 000 people;10000;-1
bmj4_10_e005983.full;30 million adults;30;-1
bmj4_10_e005983.full;total of 14;14;-1
bmj4_10_e005991.full;85 women;85;-1
bmj4_10_e005991.full;605 consecutive  patients;605;-1
bmj4_10_e005991.full;247 patients;247;-1
bmj4_10_e005991.full;2012 ESC  Ranking patients;2012;-1
bmj4_10_e005991.full;23  In patients;23;-1
bmj4_10_e005991.full;8901 placebo patients;8901;-1
bmj4_10_e005991.full;181 patients;181;-1
bmj4_10_e005991.full;4  In older people;4;-1
bmj4_10_e005991.full;n=48;48;-1
bmj4_10_e005991.full;n=92;92;-1
bmj4_10_e005991.full;n=32;32;-1
bmj4_10_e005991.full;n=40;40;-1
bmj4_10_e005991.full;n=247;247;-1
bmj4_10_e005991.full;n=103;103;-1
bmj4_10_e005991.full;n=293;293;-1
bmj4_10_e005991.full;n=26;26;-1
bmj4_10_e005999.full;300 000 people;300000;-1
bmj4_10_e005999.full;100 000 people;100000;-1
bmj4_10_e005999.full; data capture of 90;90;-1
bmj4_10_e006006.full;51 participants;51;-1
bmj4_10_e006006.full;48 Our participants;48;-1
bmj4_10_e006006.full;15 Screening and treating people;15;-1
bmj4_10_e006006.full;35  RESULTS  Fifty-one individuals;35;-1
bmj4_10_e006006.full;n=41;41;-1
bmj4_10_e006006.full;n=51;51;-1
bmj4_10_e006012.full;n=3023;3023;-1
bmj4_10_e006012.full;n=2556;2556;-1
bmj4_10_e006012.full;n=2904;2904;-1
bmj4_10_e006012.full;n  =8;8;-1
bmj4_10_e006012.full;n  =6;6;-1
bmj4_10_e006012.full;n  =5;5;-1
bmj4_10_e006012.full;n  =7;7;-1
bmj4_10_e006012.full;n  =9;9;-1
bmj4_10_e006012.full;n=865;865;-1
bmj4_10_e006012.full;n=575;575;-1
bmj4_10_e006012.full;n=686;686;-1
bmj4_10_e006012.full;n=715;715;-1
bmj4_10_e006012.full;n=881;881;-1
bmj4_10_e006012.full;n=709;709;-1
bmj4_10_e006012.full;n=589;589;-1
bmj4_10_e006012.full;n=944;944;-1
bmj4_10_e006025.full;167 women;167;11210
bmj4_10_e006025.full;74 participants;74;4838
bmj4_10_e006025.full;141 participants;141;2885
bmj4_10_e006025.full;n=92;92;3347
bmj4_10_e006025.full;n=91;91;3364
bmj4_10_e006025.full;n=85;85;7886
bmj4_10_e006025.full;n=76;76;7891
bmj4_10_e006025.full;n=7;7;7891
bmj4_10_e006025.full;n=15;15;8159
bmj4_10_e006025.full;n=183;183;11777
bmj4_10_e006082.full;N=30;30;-1
bmj4_10_e006082.full;total of 30;30;-1
bmj4_10_e006082.full;total of 420;420;-1
bmj4_10_e006082.full; data from 6;6;-1
bmj4_10_e006094.full;29 adult  patients;29;-1
bmj4_10_e006094.full;55  paediatric oncology patients;55;-1
bmj4_10_e006094.full;1023 consecutive  outpatients;1023;-1
bmj4_10_e006094.full;3 T MRI and experienced  adults;3;-1
bmj4_10_e006094.full;3 T MRI and  experienced adults;3;-1
bmj4_10_e006094.full;58 adults;58;-1
bmj4_10_e006094.full;26 adults;26;-1
bmj4_10_e006094.full;3 T clinical MRI and of  adults;3;-1
bmj4_10_e006094.full;7  T MRI and experienced adults;7;-1
bmj4_10_e006094.full;n=58;58;-1
bmj4_10_e006094.full;n=31;31;-1
bmj4_10_e006094.full;n=26;26;-1
bmj4_10_e006094.full;n=10;10;-1
bmj4_10_e006094.full;n=21;21;-1
bmj4_10_e006108.full;321 patients;321;-1
bmj4_10_e006108.full;93 While some  patients;93;-1
bmj4_10_e006108.full;70  and patients;70;-1
bmj4_10_e006108.full;n=42;42;-1
bmj4_10_e006108.full;n=32;32;-1
bmj4_10_e006108.full;n=23;23;-1
bmj4_10_e006108.full;n=33;33;-1
bmj4_10_e006108.full;n=6;6;-1
bmj4_10_e006108.full;n=3;3;-1
bmj4_10_e006108.full;total of 43;43;-1
bmj4_10_e006108.full; data of 588;588;-1
bmj4_10_e006120.full;10 000 women;10000;-1
bmj4_10_e006120.full;100 000 in men and women;100000;-1
bmj4_10_e006120.full;65 million people;65;-1
bmj4_10_e006141.full;127 632 individuals;127632;-1
bmj4_10_e006141.full;125 000 individuals;125000;-1
bmj4_10_e006141.full;N=127 632;127632;-1
bmj4_10_e006141.full;n=127 632;127632;-1
bmj4_10_e006141.full; data from 25;25;-1
bmj4_10_e006142.full;24 participants;24;-1
bmj4_10_e006142.full;24 normoalbuminuric  patients;24;-1
bmj4_10_e006142.full;24 fulfilled patients;24;-1
bmj4_10_e006142.full;24 patients;24;-1
bmj4_10_e006142.full;1 diabetic patients;1;-1
bmj4_10_e006142.full;2 diabetic patients;2;-1
bmj4_10_e006168.full;150  patients;150;-1
bmj4_10_e006168.full;150 patients;150;-1
bmj4_10_e006168.full;88 patients;88;-1
bmj4_10_e006168.full;88 patients per month of  people;88;-1
bmj4_10_e006168.full;150  patients will be recruited;150;-1
bmj4_10_e006168.full;150 patients will be recruited;150;-1
bmj4_10_e006226.full;184 participants;184;-1
bmj4_10_e006226.full;n=364;364;-1
bmj4_10_e006226.full;total of 31;31;-1
bmj4_10_e006239.full;1400  patients;1400;-1
bmj4_10_e006242.full;204 668 individuals;204668;463
bmj4_10_e006242.full;14373 individuals;14373;1131
bmj4_10_e006242.full;n=5892;5892;1751
bmj4_10_e006242.full;n=198 776;198776;1796
bmj4_10_e006242.full;n=221;221;1851
bmj4_10_e006242.full;n=14 152;14152;1898
bmj4_10_e006242.full;total of 629 024;629024;425
bmj4_10_e006242.full;total of 14373;14373;1122
bmj4_10_e006242.full;total of 4477;4477;3087
bmj4_10_e006252.full;494 women;494;-1
bmj4_10_e006252.full;3157 women;3157;-1
bmj4_10_e006252.full;26 and receive women;26;-1
bmj4_10_e006252.full;3651 eligible women;3651;-1
bmj4_10_e006252.full;494  women;494;-1
bmj4_10_e006252.full;238 women;238;-1
bmj4_10_e006252.full;244 women;244;-1
bmj4_10_e006252.full;28 women;28;-1
bmj4_10_e006252.full;27 women;27;-1
bmj4_10_e006252.full;3156 women;3156;-1
bmj4_10_e006252.full;n=494;494;-1
bmj4_10_e006252.full;n=3157;3157;-1
bmj4_10_e006252.full;n=3156;3156;-1
bmj4_10_e006252.full;n=490;490;-1
bmj4_10_e006252.full;n=3145;3145;-1
bmj4_10_e006252.full;total of 6072;6072;-1
bmj4_10_e006252.full;total of 31;31;-1
bmj4_10_e006291.full;597 women;597;-1
bmj4_10_e006291.full;597 nulliparous women;597;-1
bmj4_10_e006291.full;9 women;9;-1
bmj4_10_e006291.full;n=301;301;-1
bmj4_10_e006291.full;n=296;296;-1
bmj4_10_e006301.full;500 women;500;-1
bmj4_10_e006301.full;200 women;200;-1
bmj4_10_e006301.full;506  participants;506;-1
bmj4_10_e006301.full;500 participants;500;-1
bmj4_10_e006301.full;500 patients;500;-1
bmj4_10_e006301.full;506 patients;506;-1
bmj4_10_e006301.full;n=961;961;-1
bmj4_10_e006301.full;total of 506;506;-1
bmj4_10_e006326.full;120 eligible patients;120;-1
bmj4_10_e006326.full;n=40;40;-1
bmj4_10_e006326.full;total of 28;28;-1
bmj4_10_e006337.full;19 014 patients;19014;-1
bmj4_10_e006337.full;19 000 patients;19000;-1
bmj4_10_e006337.full;n=15 429;15429;-1
bmj4_10_e006344.full;64 exposure participants;64;616
bmj4_10_e006344.full;64  control participants;64;587
bmj4_10_e006344.full;300 000 patients;300000;9687
bmj4_10_e006356.full;200 study participants;200;-1
bmj4_10_e006356.full;100 participants;100;-1
bmj4_10_e006359.full;14 When patients;14;30088
bmj4_10_e006359.full;44 outpatients;44;27620
bmj4_10_e006359.full;n=2;2;18200
bmj4_10_e006359.full;n=1;1;13833
bmj4_10_e006359.full;n=40;40;2602
bmj4_10_e006374.full;2894 participants;2894;-1
bmj4_10_e006374.full;1447 participants;1447;-1
bmj4_10_e006374.full;1034 participants;1034;-1
bmj4_10_e006374.full;37 All adults;37;-1
bmj4_10_e006374.full;2894 participants recruited;2894;-1
bmj4_10_e006374.full;total of 2894;2894;-1
bmj4_10_e006382.full;16 patients;16;-1
bmj4_10_e006382.full;45 patients;45;-1
bmj4_10_e006382.full;14 patients;14;-1
bmj4_10_e006382.full;11 patients;11;-1
bmj4_10_e006382.full;n=14;14;-1
bmj4_10_e006382.full;n=8;8;-1
bmj4_10_e006382.full;n=7;7;-1
bmj4_10_e006384.full;2700 people;2700;-1
bmj4_10_e006416.full;37 participants;37;-1
bmj4_10_e006416.full;293  patients;293;-1
bmj4_10_e006416.full;n=18;18;-1
bmj4_10_e006416.full;n=19;19;-1
bmj4_10_e006416.full;n=37;37;-1
bmj4_10_e006416.full;total of 37;37;-1
bmj4_10_e006530.full;4426 participants;4426;-1
bmj4_10_e006530.full;2653 participants;2653;-1
bmj4_10_e006530.full;9551 participants;9551;-1
bmj4_10_e006530.full;4426 eligible survey participants;4426;-1
bmj4_10_e006530.full;22 236 individuals;22236;-1
bmj4_10_e006530.full; data from 9;9;-1
bmj4_10_e006531.full;1234 women;1234;-1
bmj4_10_e006536.full;180 participants;180;-1
bmj4_10_e006536.full;300 participants;300;-1
bmj4_10_e006536.full;60 participants;60;-1
bmj4_10_e006536.full;150 participants;150;-1
bmj4_10_e006536.full;300 par-  ticipants recruited;300;-1
bmj4_10_e006536.full;45 will  be recruited;45;-1
bmj4_10_e006536.full;150 participants will be recruited;150;-1
bmj4_10_e006536.full;total  of 180;180;-1
bmj4_10_e006543.full;275 patients;275;-1
bmj4_10_e006547.full;39 This  pregnant women;39;-1
bmj4_10_e006547.full;15 000 Swedish men and women;15000;-1
bmj4_10_e006547.full;780 people;780;-1
bmj4_10_e006571.full;9  Infants of women;9;-1
bmj4_10_e006571.full;24 as do women;24;-1
bmj4_10_e006571.full;28 and obese women;28;-1
bmj4_10_e006571.full;32  Since infants of women;32;-1
bmj4_10_e006571.full;94  women;94;-1
bmj4_10_e006571.full;43 women;43;-1
bmj4_10_e006571.full;658 women;658;-1
bmj4_10_e006571.full;625 women;625;-1
bmj4_10_e006571.full;100 women;100;-1
bmj4_10_e006571.full;200 women;200;-1
bmj4_10_e006571.full;933 women;933;-1
bmj4_10_e006571.full;43 We recruited;43;-1
bmj4_10_e006571.full;n=254;254;-1
bmj4_10_e006571.full;n=184;184;-1
bmj4_10_e006571.full; data from 43;43;-1
bmj4_10_e006599.full;265 000 participants;265000;-1
bmj4_10_e006599.full;38 Our study participants;38;-1
bmj4_10_e006599.full;20 000 participants;20000;-1
bmj4_10_e006599.full;45 and Up Study participants;45;-1
bmj4_10_e006599.full;45  and Up participants;45;-1
bmj4_10_e006599.full;45 and Up participants;45;-1
bmj4_10_e006599.full;30 individuals;30;-1
bmj4_10_e006599.full;265 000 adults;265000;-1
bmj4_10_e006599.full;N=979 834;979834;-1
bmj4_10_e006599.full;N=1177;1177;-1
bmj4_10_e006618.full;600 eligible patients;600;-1
bmj4_10_e006618.full;600 patients;600;-1
bmj4_10_e006618.full;total of 600;600;-1
bmj4_10_e006629.full;12 participants;12;-1
bmj4_10_e006629.full;61 potential participants;61;-1
bmj4_10_e006629.full;140 million  people;140;-1
bmj4_10_e006629.full;1200  adults;1200;-1
bmj4_10_e006701.full;total of 22;22;-1
bmj4_10_e006701.full;total of 61;61;-1
bmj4_11_e004838.full;622 women;622;-1
bmj4_11_e004838.full;1 In  women;1;-1
bmj4_11_e004838.full;10 women;10;-1
bmj4_11_e004838.full;10 eligible women;10;-1
bmj4_11_e004838.full;131 800  women;131800;-1
bmj4_11_e004838.full;280  women;280;-1
bmj4_11_e004838.full;308 women;308;-1
bmj4_11_e004838.full;617 women;617;-1
bmj4_11_e004838.full;461 women;461;-1
bmj4_11_e004838.full;n=140;140;-1
bmj4_11_e004838.full;N=617;617;-1
bmj4_11_e004838.full;n=428;428;-1
bmj4_11_e004838.full;total of 622;622;-1
bmj4_11_e004838.full;total of 131 800;131800;-1
bmj4_11_e004883.full;511 938 women;511938;-1
bmj4_11_e004883.full;2 million women;2;-1
bmj4_11_e004883.full;34 and women;34;-1
bmj4_11_e004883.full;n=511 938;511938;-1
bmj4_11_e004883.full;n=15 767;15767;-1
bmj4_11_e004883.full;n=132 391;132391;-1
bmj4_11_e004883.full;n=89 041;89041;-1
bmj4_11_e004883.full;n=4120;4120;-1
bmj4_11_e004883.full;n=  49;49;-1
bmj4_11_e004883.full;n=  14;14;-1
bmj4_11_e004883.full;n=  21;21;-1
bmj4_11_e004883.full;n=  19;19;-1
bmj4_11_e004974.full;128 HIV-positive women;128;-1
bmj4_11_e004974.full;1  For women;1;-1
bmj4_11_e004974.full;8  Menopausal women;8;-1
bmj4_11_e004974.full;537 women;537;-1
bmj4_11_e004974.full;178  HIV-negative women;178;-1
bmj4_11_e004974.full;188 women;188;-1
bmj4_11_e004974.full;n=53;53;-1
bmj4_11_e004974.full;n=62;62;-1
bmj4_11_e004974.full;n=306;306;-1
bmj4_11_e004974.full;n=128;128;-1
bmj4_11_e004974.full;n=178;178;-1
bmj4_11_e004974.full;n=125;125;-1
bmj4_11_e004974.full;n=93;93;-1
bmj4_11_e004974.full;n=124;124;-1
bmj4_11_e005041.full;419 patients;419;-1
bmj4_11_e005041.full;430 known patients;430;-1
bmj4_11_e005041.full;27 patients;27;-1
bmj4_11_e005041.full;14 patients;14;-1
bmj4_11_e005041.full;2 patients;2;-1
bmj4_11_e005041.full;11 patients;11;-1
bmj4_11_e005041.full;366 patients;366;-1
bmj4_11_e005041.full;46 patients;46;-1
bmj4_11_e005041.full;6 patients;6;-1
bmj4_11_e005041.full;46 deceased patients;46;-1
bmj4_11_e005041.full;40 deceased patients;40;-1
bmj4_11_e005041.full;22 patients;22;-1
bmj4_11_e005041.full;75 patients;75;-1
bmj4_11_e005041.full;48 patients;48;-1
bmj4_11_e005041.full;11DS patients;11;-1
bmj4_11_e005041.full;11DS  patients;11;-1
bmj4_11_e005041.full;11Ds patients;11;-1
bmj4_11_e005041.full;n=46;46;-1
bmj4_11_e005041.full;n=19;19;-1
bmj4_11_e005166.full;n=2016;2016;-1
bmj4_11_e005166.full;n=1217;1217;-1
bmj4_11_e005166.full;n=1570;1570;-1
bmj4_11_e005166.full;n=397;397;-1
bmj4_11_e005166.full;n=280;280;-1
bmj4_11_e005205.full;N=70;70;8683
bmj4_11_e005205.full;N=43;43;8648
bmj4_11_e005205.full;N=182;182;5868
bmj4_11_e005205.full;N=197;197;5891
bmj4_11_e005205.full;N=113;113;8978
bmj4_11_e005205.full;N=266;266;9002
bmj4_11_e005205.full;N=214;214;12272
bmj4_11_e005205.full;N=165;165;12318
bmj4_11_e005276.full;5023 acute patients;5023;-1
bmj4_11_e005276.full;4535 patients;4535;-1
bmj4_11_e005276.full;5023 patients;5023;-1
bmj4_11_e005276.full;271 patients;271;-1
bmj4_11_e005276.full;217 patients;217;-1
bmj4_11_e005276.full;1537 patients;1537;-1
bmj4_11_e005276.full;2999 patients;2999;-1
bmj4_11_e005276.full;1 Inclusion criteria of patients;1;-1
bmj4_11_e005276.full;5024 patients;5024;-1
bmj4_11_e005276.full;1419 patients;1419;-1
bmj4_11_e005276.full;252 patients;252;-1
bmj4_11_e005276.full;5,024 young stroke  patients;5024;-1
bmj4_11_e005276.full;n=1071;1071;-1
bmj4_11_e005276.full;n=3396;3396;-1
bmj4_11_e005276.full;n=68;68;-1
bmj4_11_e005276.full;n=4535;4535;-1
bmj4_11_e005276.full;n=2675;2675;-1
bmj4_11_e005276.full;n=1860;1860;-1
bmj4_11_e005276.full;n=136;136;-1
bmj4_11_e005276.full;n=443;443;-1
bmj4_11_e005276.full;n=1250;1250;-1
bmj4_11_e005276.full;n=2706;2706;-1
bmj4_11_e005276.full;n=3469;3469;-1
bmj4_11_e005276.full;n=2865;2865;-1
bmj4_11_e005276.full;n=4496;4496;-1
bmj4_11_e005276.full;n=4502;4502;-1
bmj4_11_e005276.full;n=4499;4499;-1
bmj4_11_e005276.full;n=4516;4516;-1
bmj4_11_e005276.full;n=4505;4505;-1
bmj4_11_e005276.full;n=4147;4147;-1
bmj4_11_e005276.full;n=4534;4534;-1
bmj4_11_e005276.full;n=  10;10;-1
bmj4_11_e005276.full;n=  33;33;-1
bmj4_11_e005276.full;n=  34;34;-1
bmj4_11_e005276.full;n=  92;92;-1
bmj4_11_e005276.full;n=  20;20;-1
bmj4_11_e005276.full;n=  13;13;-1
bmj4_11_e005276.full;total of 5023;5023;-1
bmj4_11_e005276.full;total of 5024;5024;-1
bmj4_11_e005276.full;total of 4535;4535;-1
bmj4_11_e005276.full;total of 1419;1419;-1
bmj4_11_e005276.full;5024 patients were enrolled;5024;-1
bmj4_11_e005294.full;29 participants;29;-1
bmj4_11_e005294.full;75 million  adults;75;-1
bmj4_11_e005294.full; data from the 2009;2009;-1
bmj4_11_e005321.full;3339 participants;3339;-1
bmj4_11_e005321.full;4030 participants;4030;-1
bmj4_11_e005321.full;n=4030;4030;-1
bmj4_11_e005321.full;n=63;63;-1
bmj4_11_e005321.full;N=3339;3339;-1
bmj4_11_e005321.full;n  =3;3;-1
bmj4_11_e005340.full;N=1187;1187;-1
bmj4_11_e005394.full;31 excluded women;31;-1
bmj4_11_e005394.full;n=632 805;632805;-1
bmj4_11_e005496.full;18 354 participants;18354;-1
bmj4_11_e005496.full;2 Flow of participants;2;-1
bmj4_11_e005496.full;n=690;690;-1
bmj4_11_e005496.full;n  =1;1;-1
bmj4_11_e005496.full;n=  32;32;-1
bmj4_11_e005496.full;n=  37;37;-1
bmj4_11_e005497.full;434 342 participants;434342;-1
bmj4_11_e005497.full;2D cases and number of  participants;2;-1
bmj4_11_e005497.full;424 677 participants;424677;-1
bmj4_11_e005497.full;290 927 participants;290927;-1
bmj4_11_e005497.full;232 097  participants;232097;-1
bmj4_11_e005497.full;251 235 participants;251235;-1
bmj4_11_e005497.full;439 million  adults;439;-1
bmj4_11_e005497.full;total of 10;10;-1
bmj4_11_e005497.full; data from  11;11;-1
bmj4_11_e005553.full;706  patients;706;-1
bmj4_11_e005553.full;706 patients;706;-1
bmj4_11_e005553.full;480 patients;480;-1
bmj4_11_e005553.full;197  patients;197;-1
bmj4_11_e005553.full;178 patients;178;-1
bmj4_11_e005553.full;N=706;706;-1
bmj4_11_e005553.full;n=491;491;-1
bmj4_11_e005553.full;n=215;215;-1
bmj4_11_e005561.full;1103 women;1103;-1
bmj4_11_e005561.full;1054 women;1054;-1
bmj4_11_e005561.full;N=657;657;-1
bmj4_11_e005561.full;N=164;164;-1
bmj4_11_e005561.full;N=143;143;-1
bmj4_11_e005561.full;N=178;178;-1
bmj4_11_e005561.full;N=172;172;-1
bmj4_11_e005561.full;n=307;307;-1
bmj4_11_e005561.full;n=350;350;-1
bmj4_11_e005569.full;n=7;7;-1
bmj4_11_e005569.full;n=9;9;-1
bmj4_11_e005569.full;total of 23;23;-1
bmj4_11_e005602.full;203 962 women;203962;714
bmj4_11_e005602.full;10 000 women;10000;13750
bmj4_11_e005602.full;3 million individuals;3;6630
bmj4_11_e005602.full;N=203 962;203962;2733
bmj4_11_e005602.full;N=208 161;208161;1501
bmj4_11_e005602.full;N=45;45;2493
bmj4_11_e005602.full;N=47;47;5398
bmj4_11_e005602.full;N=53;53;8071
bmj4_11_e005602.full;N=35;35;8149
bmj4_11_e005602.full;total of 203 962;203962;377
bmj4_11_e005602.full;total of 416;416;661
bmj4_11_e005617.full;n=6;6;-1
bmj4_11_e005617.full;n=4;4;-1
bmj4_11_e005617.full;n=2;2;-1
bmj4_11_e005617.full;n=1;1;-1
bmj4_11_e005671.full;12 participants;12;-1
bmj4_11_e005671.full;2109 participants;2109;-1
bmj4_11_e005671.full;1841 participants;1841;-1
bmj4_11_e005671.full;2607 NHANES participants;2607;-1
bmj4_11_e005671.full;668 participants;668;-1
bmj4_11_e005671.full;8970  participants;8970;-1
bmj4_11_e005671.full;4740 diabetic participants;4740;-1
bmj4_11_e005671.full;16 Our study similarly excluded participants;16;-1
bmj4_11_e005671.full;2625 participants;2625;-1
bmj4_11_e005671.full;2 diabetic patients;2;-1
bmj4_11_e005671.full;13,087  patients;13087;-1
bmj4_11_e005671.full;8334 people;8334;-1
bmj4_11_e005671.full;89 000 Ukrainian people;89000;-1
bmj4_11_e005671.full;13 087 people;13087;-1
bmj4_11_e005671.full;2625 people;2625;-1
bmj4_11_e005671.full;19 people;19;-1
bmj4_11_e005671.full;2607 adults;2607;-1
bmj4_11_e005671.full;46 million white adults;46;-1
bmj4_11_e005671.full;n=668;668;-1
bmj4_11_e005671.full;n=846;846;-1
bmj4_11_e005671.full;n=235;235;-1
bmj4_11_e005671.full;n=22;22;-1
bmj4_11_e005671.full;n=38;38;-1
bmj4_11_e005671.full;n=15;15;-1
bmj4_11_e005671.full;n=129;129;-1
bmj4_11_e005671.full;n=58;58;-1
bmj4_11_e005671.full;N=394;394;-1
bmj4_11_e005671.full;N=925;925;-1
bmj4_11_e005671.full;N=659;659;-1
bmj4_11_e005671.full;N=565;565;-1
bmj4_11_e005671.full;total of  2607;2607;-1
bmj4_11_e005720.full;2773 patients;2773;-1
bmj4_11_e005720.full;848 patients;848;-1
bmj4_11_e005720.full;296 patients;296;-1
bmj4_11_e005720.full;100 randomly selected patients;100;-1
bmj4_11_e005720.full;192  patients;192;-1
bmj4_11_e005720.full;118 patients;118;-1
bmj4_11_e005720.full;195 patients;195;-1
bmj4_11_e005720.full;n=296;296;-1
bmj4_11_e005720.full;N=296;296;-1
bmj4_11_e005720.full;N=345;345;-1
bmj4_11_e005720.full;N=188;188;-1
bmj4_11_e005720.full;N=335;335;-1
bmj4_11_e005720.full;n=848;848;-1
bmj4_11_e005720.full;n=2773;2773;-1
bmj4_11_e005720.full;n=15 395;15395;-1
bmj4_11_e005720.full;n=  82;82;-1
bmj4_11_e005720.full;n=  27;27;-1
bmj4_11_e005720.full;n=  17;17;-1
bmj4_11_e005792.full;300  people;300;-1
bmj4_11_e005792.full;20 000 individuals;20000;-1
bmj4_11_e005792.full;3700 adults;3700;-1
bmj4_11_e005792.full;3700  adults;3700;-1
bmj4_11_e005798.full;100 000 persons;100000;-1
bmj4_11_e005798.full;111 patients;111;-1
bmj4_11_e005798.full;111 young patients;111;-1
bmj4_11_e005798.full;873 consecu-  tive patients;873;-1
bmj4_11_e005798.full;14 All patients;14;-1
bmj4_11_e005798.full;111 patients constitute all patients;111;-1
bmj4_11_e005798.full;873  patients;873;-1
bmj4_11_e005798.full;92 patients;92;-1
bmj4_11_e005798.full;12 patients;12;-1
bmj4_11_e005798.full;70 patients;70;-1
bmj4_11_e005798.full;7 patients;7;-1
bmj4_11_e005798.full;8 patients;8;-1
bmj4_11_e005798.full;15 patients;15;-1
bmj4_11_e005798.full;6 patients;6;-1
bmj4_11_e005798.full;3 patients;3;-1
bmj4_11_e005798.full;1 Employment status of patients;1;-1
bmj4_11_e005798.full;26 patients;26;-1
bmj4_11_e005798.full;38 patients;38;-1
bmj4_11_e005798.full;39 patients;39;-1
bmj4_11_e005798.full;33 patients;33;-1
bmj4_11_e005798.full;246  patients;246;-1
bmj4_11_e005798.full;71  patients;71;-1
bmj4_11_e005798.full;50 patients;50;-1
bmj4_11_e005798.full;35 patients;35;-1
bmj4_11_e005798.full;25 patients;25;-1
bmj4_11_e005798.full;28 patients;28;-1
bmj4_11_e005798.full;74 patients;74;-1
bmj4_11_e005798.full;177 patients;177;-1
bmj4_11_e005798.full;7  A small proportion of people;7;-1
bmj4_11_e005798.full;n=3;3;-1
bmj4_11_e005798.full;n=10;10;-1
bmj4_11_e005798.full;total of 68;68;-1
bmj4_11_e005840.full;798 732 women;798732;-1
bmj4_11_e005840.full;798 674 women;798674;-1
bmj4_11_e005840.full;N=798 674;798674;-1
bmj4_11_e005840.full;n  =2;2;-1
bmj4_11_e005840.full;n  =1;1;-1
bmj4_11_e005840.full;n  =3;3;-1
bmj4_11_e005840.full;n  =6;6;-1
bmj4_11_e005858.full;8268 women;8268;-1
bmj4_11_e005858.full;113 participants;113;-1
bmj4_11_e005858.full;93 550 enlisted patients;93550;-1
bmj4_11_e005858.full;N=6561;6561;-1
bmj4_11_e005858.full;N=8268;8268;-1
bmj4_11_e005858.full;n=  14;14;-1
bmj4_11_e005858.full;N  =1;1;-1
bmj4_11_e005858.full;total of 93 550;93550;-1
bmj4_11_e005862.full;4336 women;4336;-1
bmj4_11_e005862.full;8028 persons;8028;-1
bmj4_11_e005862.full;6986 patients;6986;-1
bmj4_11_e005862.full;6354 patients;6354;-1
bmj4_11_e005862.full;416 patients;416;-1
bmj4_11_e005862.full;8028 individuals;8028;-1
bmj4_11_e005862.full;103 individuals;103;-1
bmj4_11_e005862.full;N=460;460;-1
bmj4_11_e005889.full;402 pregnant women;402;-1
bmj4_11_e005889.full;397 pregnant women;397;-1
bmj4_11_e005889.full;80 preg-  nant women;80;-1
bmj4_11_e005889.full;60 pregnant women;60;-1
bmj4_11_e005889.full;47 HBsAg positive women;47;-1
bmj4_11_e005889.full;20 pregnant women;20;-1
bmj4_11_e005889.full;397 participants;397;-1
bmj4_11_e005889.full;402  participants;402;-1
bmj4_11_e005889.full;402 participants;402;-1
bmj4_11_e005889.full;397  antenatal hepatitis B study participants;397;-1
bmj4_11_e005889.full;7 million people;7;-1
bmj4_11_e005889.full;24 In northern Uganda where people;24;-1
bmj4_11_e005889.full;402  participants were recruited;402;-1
bmj4_11_e005889.full;n=356;356;-1
bmj4_11_e005889.full;n=382;382;-1
bmj4_11_e005889.full;n=285;285;-1
bmj4_11_e005889.full;n=37;37;-1
bmj4_11_e005889.full;N=397;397;-1
bmj4_11_e005903.full;30 patients;30;-1
bmj4_11_e005903.full;18  involved patients;18;-1
bmj4_11_e005922.full;78 168 pregnant women;78168;-1
bmj4_11_e005922.full;1000 women;1000;-1
bmj4_11_e005922.full;100 000 women;100000;-1
bmj4_11_e005922.full;4606 low-risk women;4606;-1
bmj4_11_e005922.full;n=398;398;-1
bmj4_11_e005922.full;n=1814;1814;-1
bmj4_11_e005922.full;n=1000;1000;-1
bmj4_11_e005922.full;n=215;215;-1
bmj4_11_e005922.full;n=2;2;-1
bmj4_11_e005922.full;n=8;8;-1
bmj4_11_e005922.full;total of 122 739;122739;-1
bmj4_11_e005938.full;57 participants;57;-1
bmj4_11_e005938.full;1035 participants;1035;-1
bmj4_11_e005938.full;1 Flow chart of participants;1;-1
bmj4_11_e005938.full;45 patients;45;-1
bmj4_11_e005938.full;39 people;39;-1
bmj4_11_e005938.full;1035 individuals;1035;-1
bmj4_11_e005938.full;218 individuals;218;-1
bmj4_11_e005938.full;4931 individuals;4931;-1
bmj4_11_e005938.full;1924 individuals;1924;-1
bmj4_11_e005938.full;4931 individuals were recruited;4931;-1
bmj4_11_e005938.full;n=817;817;-1
bmj4_11_e005938.full;n=218;218;-1
bmj4_11_e005938.full;total of 4931;4931;-1
bmj4_11_e005938.full;total of 1035;1035;-1
bmj4_11_e006020.full;699 patients;699;-1
bmj4_11_e006020.full;346 patients;346;-1
bmj4_11_e006020.full;2712 patients;2712;-1
bmj4_11_e006020.full;699  patients;699;-1
bmj4_11_e006020.full; data from 1990;1990;-1
bmj4_11_e006034.full;2008 participants;2008;-1
bmj4_11_e006034.full;628 participants;628;-1
bmj4_11_e006034.full;2289 adults;2289;-1
bmj4_11_e006034.full;15 102 adults;15102;-1
bmj4_11_e006034.full;4507 adults;4507;-1
bmj4_11_e006034.full;28  Previous studies of adults;28;-1
bmj4_11_e006034.full;222 497 Australian adults;222497;-1
bmj4_11_e006034.full;N=1651;1651;-1
bmj4_11_e006034.full;N=521;521;-1
bmj4_11_e006034.full;N=355;355;-1
bmj4_11_e006034.full;N=775;775;-1
bmj4_11_e006034.full;N=152;152;-1
bmj4_11_e006034.full;N=214;214;-1
bmj4_11_e006034.full;N=549;549;-1
bmj4_11_e006034.full;total of 2289;2289;-1
bmj4_11_e006046.full;19 targeted women;19;-1
bmj4_11_e006046.full;17 000 participants;17000;-1
bmj4_11_e006046.full;8 recruited participants;8;-1
bmj4_11_e006046.full;2549 participants;2549;-1
bmj4_11_e006046.full;34 studies specifying participants;34;-1
bmj4_11_e006046.full;8 recruited;8;-1
bmj4_11_e006046.full;n=257;257;-1
bmj4_11_e006046.full;n=12;12;-1
bmj4_11_e006058.full;100 participants;100;531
bmj4_11_e006058.full;100 patients;100;19191
bmj4_11_e006058.full;4 some patients;4;18418
bmj4_11_e006058.full;3057 patients;3057;13917
bmj4_11_e006058.full;200 chronic pain patients;200;15201
bmj4_11_e006058.full;100 patients will be enrolled;100;19191
bmj4_11_e006071.full;5018 men and women;5018;-1
bmj4_11_e006071.full;9 women;9;-1
bmj4_11_e006071.full;25 639 men and  women;25639;-1
bmj4_11_e006071.full;2751  women;2751;-1
bmj4_11_e006071.full;5018 participants;5018;-1
bmj4_11_e006071.full;131 individuals;131;-1
bmj4_11_e006071.full;25 639 men and  women were recruited;25639;-1
bmj4_11_e006071.full;N=4712;4712;-1
bmj4_11_e006071.full;N=4476;4476;-1
bmj4_11_e006071.full;N=4795;4795;-1
bmj4_11_e006071.full;n=0;0;-1
bmj4_11_e006071.full;N=25 639;25639;-1
bmj4_11_e006071.full;n  =3;3;-1
bmj4_11_e006071.full;n  =1;1;-1
bmj4_11_e006071.full;n  =4;4;-1
bmj4_11_e006071.full;n=  0;0;-1
bmj4_11_e006071.full;total of 5018;5018;-1
bmj4_11_e006071.full;total of  38;38;-1
bmj4_11_e006098.full;192 patients;192;-1
bmj4_11_e006098.full;171 patients;171;-1
bmj4_11_e006098.full;38 patients;38;-1
bmj4_11_e006098.full;192  patients;192;-1
bmj4_11_e006098.full;total of 171;171;-1
bmj4_11_e006140.full;11 participants;11;-1
bmj4_11_e006140.full;total of 304;304;-1
bmj4_11_e006161.full;1500 persons;1500;-1
bmj4_11_e006161.full;4 million people;4;-1
bmj4_11_e006177.full;5  million patients;5;-1
bmj4_11_e006177.full;total of 16;16;-1
bmj4_11_e006177.full;total of 494 628;494628;-1
bmj4_11_e006177.full; data from 2008;2008;-1
bmj4_11_e006179.full;712 postcardiac surgery  participants;712;-1
bmj4_11_e006179.full;712 participants;712;-1
bmj4_11_e006179.full;22 patients;22;-1
bmj4_11_e006179.full;10,811  patients;10811;-1
bmj4_11_e006179.full;100 individuals;100;-1
bmj4_11_e006179.full;n=350;350;-1
bmj4_11_e006179.full;n=152;152;-1
bmj4_11_e006179.full;n=410;410;-1
bmj4_11_e006179.full;n=356;356;-1
bmj4_11_e006179.full;total of  712;712;-1
bmj4_11_e006195.full;310 111 persons;310111;-1
bmj4_11_e006195.full;1216 persons;1216;-1
bmj4_11_e006255.full;859 patients;859;-1
bmj4_11_e006255.full;937  consecutive patients;937;-1
bmj4_11_e006255.full;937 patients;937;-1
bmj4_11_e006255.full;349 patients;349;-1
bmj4_11_e006255.full;857 included patients;857;-1
bmj4_11_e006255.full;71 patients;71;-1
bmj4_11_e006255.full;3 patients;3;-1
bmj4_11_e006255.full;3  chronic HCV because these individuals;3;-1
bmj4_11_e006255.full;n=10;10;-1
bmj4_11_e006255.full;n=9;9;-1
bmj4_11_e006255.full;n=3;3;-1
bmj4_11_e006255.full;n=43;43;-1
bmj4_11_e006255.full;n=1;1;-1
bmj4_11_e006255.full;n=4;4;-1
bmj4_11_e006255.full;n=6;6;-1
bmj4_11_e006255.full;n=859;859;-1
bmj4_11_e006255.full;n=533;533;-1
bmj4_11_e006255.full;n=326;326;-1
bmj4_11_e006255.full;total of 937;937;-1
bmj4_11_e006255.full;859 patients  were enrolled;859;-1
bmj4_11_e006275.full;516  patients;516;-1
bmj4_11_e006275.full;516 patients;516;-1
bmj4_11_e006275.full;n=291;291;-1
bmj4_11_e006275.full;n=225;225;-1
bmj4_11_e006286.full;42 women;42;-1
bmj4_11_e006286.full;80 patients;80;-1
bmj4_11_e006286.full;11 patients;11;-1
bmj4_11_e006286.full;69 patients;69;-1
bmj4_11_e006286.full;n=11;11;-1
bmj4_11_e006286.full;n=69;69;-1
bmj4_11_e006286.full;n=48;48;-1
bmj4_11_e006286.full;n=21;21;-1
bmj4_11_e006286.full;total of 38;38;-1
bmj4_11_e006286.full;total of  86;86;-1
bmj4_11_e006316.full;125 million girls  and women;125;-1
bmj4_11_e006316.full;17 million women;17;-1
bmj4_11_e006316.full;38 390 women;38390;-1
bmj4_11_e006316.full;97 million  women;97;-1
bmj4_11_e006316.full;32 088 women;32088;-1
bmj4_11_e006316.full;66 A  third study compared women;66;-1
bmj4_11_e006316.full;125 million girls and women;125;-1
bmj4_11_e006316.full;17 million female participants;17;-1
bmj4_11_e006316.full;N=57;57;-1
bmj4_11_e006316.full;n=3657;3657;-1
bmj4_11_e006316.full;n=3611;3611;-1
bmj4_11_e006316.full;n=6564;6564;-1
bmj4_11_e006316.full;n=28 940;28940;-1
bmj4_11_e006316.full;n=6204;6204;-1
bmj4_11_e006316.full;n=12 540;12540;-1
bmj4_11_e006316.full;n=12 912;12912;-1
bmj4_11_e006316.full;n=36 473;36473;-1
bmj4_11_e006316.full;n=32 088;32088;-1
bmj4_11_e006316.full;total of 75;75;-1
bmj4_11_e006442.full;3 List of participants;3;-1
bmj4_11_e006442.full;12 patients;12;-1
bmj4_11_e006442.full;14 patients;14;-1
bmj4_11_e006442.full;15 patients;15;-1
bmj4_11_e006442.full;20 patients;20;-1
bmj4_11_e006442.full;10 patients;10;-1
bmj4_11_e006476.full;1322 participants;1322;667
bmj4_11_e006476.full;960 participants;960;933
bmj4_11_e006476.full;432 patients;432;3755
bmj4_11_e006476.full;461  patients;461;3320
bmj4_11_e006476.full;3295 patients;3295;2866
bmj4_11_e006476.full;443 patients;443;5149
bmj4_11_e006476.full;32  patients;32;8141
bmj4_11_e006476.full;6 Some  patients;6;14450
bmj4_11_e006476.full;12 patients;12;16476
bmj4_11_e006476.full;N  =4;4;9449
bmj4_11_e006476.full;N  =2;2;12261
bmj4_11_e006476.full;total of 1322;1322;658
bmj4_11_e006476.full;total of 443;443;5140
bmj4_11_e006486.full;88 315 patients;88315;-1
bmj4_11_e006486.full;88 315 consecutive  patients;88315;-1
bmj4_11_e006486.full;12  Identification of patients;12;-1
bmj4_11_e006486.full;1007 patients;1007;-1
bmj4_11_e006486.full;29,900 patients;29900;-1
bmj4_11_e006486.full;149 individuals;149;-1
bmj4_11_e006525.full;645 449 participants;645449;-1
bmj4_11_e006525.full;645 449 patients;645449;-1
bmj4_11_e006525.full;N=645 449;645449;-1
bmj4_11_e006525.full;total of 645 449;645449;-1
bmj4_11_e006525.full; data of 823;823;-1
bmj4_11_e006551.full;2037 women;2037;787
bmj4_11_e006551.full;n=1842;1842;8682
bmj4_11_e006551.full;n=1819;1819;8707
bmj4_11_e006551.full;n=1050;1050;8729
bmj4_11_e006551.full;n=925;925;11671
bmj4_11_e006551.full;n=894;894;11709
bmj4_11_e006551.full;2013 were enrolled;2013;7751
bmj4_11_e006554.full; data from 16;16;-1
bmj4_11_e006554.full; data  from 39;39;-1
bmj4_11_e006554.full; data from 11;11;-1
bmj4_11_e006604.full;13 million patients;13;-1
bmj4_11_e006604.full;100 000 patients;100000;-1
bmj4_11_e006604.full;38 Of patients;38;-1
bmj4_11_e006604.full;20 comparison patients;20;-1
bmj4_11_e006604.full;530 000 people;530000;-1
bmj4_11_e006604.full;13 million people;13;-1
bmj4_11_e006604.full; database of 13;13;-1
bmj4_11_e006622.full;9 million  patients;9;-1
bmj4_11_e006622.full;33 To document patients;33;-1
bmj4_11_e006622.full;450,000 people;450000;-1
bmj4_11_e006647.full;800 000 people;800000;-1
bmj4_11_e006647.full;n=6383;6383;-1
bmj4_11_e006647.full;n=6987;6987;-1
bmj4_11_e006647.full;n=7417;7417;-1
bmj4_11_e006647.full; data from 42;42;-1
bmj4_11_e006710.full;2170  participants;2170;-1
bmj4_11_e006710.full;4644 patients;4644;-1
bmj4_11_e006710.full;6 Stroke patients;6;-1
bmj4_11_e006710.full;3982 patients;3982;-1
bmj4_11_e006710.full;4 Dose effect analysis of patients;4;-1
bmj4_11_e006710.full;2 million people;2;-1
bmj4_11_e006710.full;23 million Taiwanese people;23;-1
bmj4_11_e006710.full;N=89;89;-1
bmj4_11_e006710.full;N=573;573;-1
bmj4_11_e006710.full;N=3982;3982;-1
bmj4_11_e006710.full;N=2170;2170;-1
bmj4_11_e006710.full;N=434;434;-1
bmj4_11_e006710.full;N=3548;3548;-1
bmj4_11_e006710.full;N=1736;1736;-1
bmj4_11_e006710.full;total of 2170;2170;-1
bmj4_11_e006710.full; datasets from 2010;2010;-1
bmj4_11_e006753.full;144 subjects;144;16703
bmj4_11_e006753.full;144 SAP subjects;144;3183
bmj4_11_e006753.full;27  Compliance of subjects;27;6292
bmj4_11_e006753.full;144 patients;144;5948
bmj4_11_e006753.full;7 of all patients;7;1151
bmj4_11_e006753.full;total of 144;144;5957
bmj4_11_e006757.full;482 patients;482;-1
bmj4_11_e006757.full;419 evaluable patients;419;-1
bmj4_11_e006757.full;106 patients;106;-1
bmj4_11_e006757.full;144  patients;144;-1
bmj4_11_e006757.full;65 patients;65;-1
bmj4_11_e006757.full;146 patients;146;-1
bmj4_11_e006757.full;73  patients;73;-1
bmj4_11_e006757.full;23  Standard care  All patients;23;-1
bmj4_11_e006757.full;146 adults;146;-1
bmj4_11_e006757.full;n=34;34;-1
bmj4_11_e006757.full;n=31;31;-1
bmj4_11_e006780.full;800 000 people;800000;-1
bmj4_11_e006780.full;1500 people;1500;-1
bmj4_11_e006782.full;N=80;80;-1
bmj4_11_e006945.full;n=3;3;-1
bmj4_11_e007032.full;35 people;35;-1
bmj4_11_e007032.full;n=110;110;-1
bmj4_11_e007045.full;330 patients;330;-1
bmj4_11_e007045.full;325 patients;325;-1
bmj4_11_e007045.full;330 patients have been recruited;330;-1
bmj4_12_e004983.full;1600 participants;1600;-1
bmj4_12_e004983.full;18 We proscribed all participants;18;-1
bmj4_12_e004983.full;1678 participants;1678;-1
bmj4_12_e004983.full;12 million patients;12;-1
bmj4_12_e004983.full;n=287;287;-1
bmj4_12_e004983.full;n=204;204;-1
bmj4_12_e004983.full;n=825;825;-1
bmj4_12_e004983.full;n=853;853;-1
bmj4_12_e004983.full;n=1678;1678;-1
bmj4_12_e005040.full;500 consenting participants;500;-1
bmj4_12_e005040.full;375 participants;375;-1
bmj4_12_e005040.full;52 participants;52;-1
bmj4_12_e005040.full;323 participants;323;-1
bmj4_12_e005040.full;155 participants;155;-1
bmj4_12_e005040.full;118 participants;118;-1
bmj4_12_e005040.full;109 participants;109;-1
bmj4_12_e005040.full;N=375;375;-1
bmj4_12_e005040.full;N=109;109;-1
bmj4_12_e005040.full;total of 170;170;-1
bmj4_12_e005040.full;375 participants were  enrolled;375;-1
bmj4_12_e005232.full;N=2154;2154;-1
bmj4_12_e005232.full;n=78;78;-1
bmj4_12_e005232.full;n=42;42;-1
bmj4_12_e005232.full;n=8;8;-1
bmj4_12_e005232.full;N=1107;1107;-1
bmj4_12_e005232.full;N=750;750;-1
bmj4_12_e005232.full;N=297;297;-1
bmj4_12_e005232.full;n=2154;2154;-1
bmj4_12_e005232.full;total of 2154;2154;-1
bmj4_12_e005232.full;total of 10;10;-1
bmj4_12_e005232.full;total of 14;14;-1
bmj4_12_e005232.full;total of 120;120;-1
bmj4_12_e005325.full;14 patients;14;-1
bmj4_12_e005325.full;7 A large proportion of patients;7;-1
bmj4_12_e005325.full;1070 patients;1070;-1
bmj4_12_e005325.full;2 diabetic patients;2;-1
bmj4_12_e005360.full;20 study participants;20;-1
bmj4_12_e005360.full;10  participants;10;-1
bmj4_12_e005360.full;1520  patients;1520;-1
bmj4_12_e005360.full;total of 49;49;-1
bmj4_12_e005370.full;1316 patients;1316;-1
bmj4_12_e005370.full;1395 patients;1395;-1
bmj4_12_e005370.full;471  patients;471;-1
bmj4_12_e005370.full;n=328;328;-1
bmj4_12_e005370.full;n=311;311;-1
bmj4_12_e005370.full;n=384;384;-1
bmj4_12_e005370.full;N=293;293;-1
bmj4_12_e005370.full;N=328;328;-1
bmj4_12_e005370.full;N=311;311;-1
bmj4_12_e005370.full;N=384;384;-1
bmj4_12_e005370.full;total of 12 965;12965;-1
bmj4_12_e005370.full;total of 1395;1395;-1
bmj4_12_e005468.full;726 women;726;-1
bmj4_12_e005468.full;291 women;291;-1
bmj4_12_e005468.full;18 201 women;18201;-1
bmj4_12_e005468.full;n=291;291;-1
bmj4_12_e005468.full;n=18 201;18201;-1
bmj4_12_e005468.full;n=18 485;18485;-1
bmj4_12_e005468.full;n=16 902;16902;-1
bmj4_12_e005468.full;n=18 471;18471;-1
bmj4_12_e005468.full;n=18 238;18238;-1
bmj4_12_e005468.full;n=18 488;18488;-1
bmj4_12_e005468.full;n=16 905;16905;-1
bmj4_12_e005468.full;n=17 766;17766;-1
bmj4_12_e005468.full;n=16 351;16351;-1
bmj4_12_e005468.full;study population included 18 492;18492;-1
bmj4_12_e005498.full;9  Total participants;9;-1
bmj4_12_e005498.full;38 patients;38;-1
bmj4_12_e005498.full;38  patients;38;-1
bmj4_12_e005498.full;314  million people;314;-1
bmj4_12_e005527.full;763 Dutch patients;763;-1
bmj4_12_e005527.full;576 ethnic  minority patients;576;-1
bmj4_12_e005527.full;17 Non-Dutch  patients;17;-1
bmj4_12_e005527.full;1474 patients;1474;-1
bmj4_12_e005527.full;1376 patients;1376;-1
bmj4_12_e005527.full;591 ethnic minority patients;591;-1
bmj4_12_e005527.full;20 patients;20;-1
bmj4_12_e005527.full;37  patients;37;-1
bmj4_12_e005527.full;576 ethnic minority patients;576;-1
bmj4_12_e005527.full;60 patients;60;-1
bmj4_12_e005527.full;600 ethnic minority patients;600;-1
bmj4_12_e005527.full;N=763;763;-1
bmj4_12_e005527.full;N=576;576;-1
bmj4_12_e005527.full;N=284;284;-1
bmj4_12_e005527.full;N=525;525;-1
bmj4_12_e005527.full;N=1339;1339;-1
bmj4_12_e005527.full;total of  1376;1376;-1
bmj4_12_e005527.full; data varied from  18;18;-1
bmj4_12_e005663.full;502 712 men and women;502712;-1
bmj4_12_e005663.full;2 Mean women;2;-1
bmj4_12_e005663.full;306,620 participants;306620;-1
bmj4_12_e005663.full;3 billion  individuals;3;-1
bmj4_12_e005663.full;n=168;168;-1
bmj4_12_e005664.full;23 syphil-  itic patients;23;-1
bmj4_12_e005664.full;59 patients;59;-1
bmj4_12_e005664.full;n=32;32;-1
bmj4_12_e005664.full;n=56;56;-1
bmj4_12_e005664.full;n=59;59;-1
bmj4_12_e005664.full;n=53;53;-1
bmj4_12_e005664.full;total of 112;112;-1
bmj4_12_e005691.full;1 Consort flow-chart of participants;1;-1
bmj4_12_e005691.full;8 Although individuals;8;-1
bmj4_12_e005691.full;n=14;14;-1
bmj4_12_e005691.full;n=12;12;-1
bmj4_12_e005691.full;n=13;13;-1
bmj4_12_e005691.full;N=26;26;-1
bmj4_12_e005691.full;N=25;25;-1
bmj4_12_e005696.full;total of 31;31;-1
bmj4_12_e005713.full;5056 women;5056;-1
bmj4_12_e005713.full;25 167 participants;25167;-1
bmj4_12_e005713.full;4 million individuals;4;-1
bmj4_12_e005713.full;56 634 individuals;56634;-1
bmj4_12_e005713.full;n=8994;8994;-1
bmj4_12_e005713.full;n=4552;4552;-1
bmj4_12_e005713.full;n  =8;8;-1
bmj4_12_e005713.full;n  =3;3;-1
bmj4_12_e005713.full;n  =1;1;-1
bmj4_12_e005713.full;n  =9;9;-1
bmj4_12_e005713.full;n  =5;5;-1
bmj4_12_e005713.full;n  =2;2;-1
bmj4_12_e005713.full;n  =4;4;-1
bmj4_12_e005713.full;n=  29;29;-1
bmj4_12_e005713.full;n=  39;39;-1
bmj4_12_e005713.full;n=3646;3646;-1
bmj4_12_e005713.full;n=4658;4658;-1
bmj4_12_e005713.full;total of 56 634;56634;-1
bmj4_12_e005713.full;total of 4;4;-1
bmj4_12_e005752.full;2967 patients;2967;-1
bmj4_12_e005752.full;2967  patients;2967;-1
bmj4_12_e005752.full;2967 adult patients;2967;-1
bmj4_12_e005752.full;3  Some patients;3;-1
bmj4_12_e005752.full;4 These patients;4;-1
bmj4_12_e005752.full;0 patients;0;-1
bmj4_12_e005752.full;2DM patients;2;-1
bmj4_12_e005752.full;2967 adults;2967;-1
bmj4_12_e005752.full;total of 2967;2967;-1
bmj4_12_e005752.full;total of 5831;5831;-1
bmj4_12_e005777.full;496 patients;496;-1
bmj4_12_e005777.full;2321 patients;2321;-1
bmj4_12_e005777.full;2146 patients;2146;-1
bmj4_12_e005777.full;n=496;496;-1
bmj4_12_e005777.full;n=2321;2321;-1
bmj4_12_e005777.full;N=2817;2817;-1
bmj4_12_e005777.full;total of 84;84;-1
bmj4_12_e005777.full;total of 361;361;-1
bmj4_12_e005791.full;N=1206;1206;-1
bmj4_12_e005791.full;N=381;381;-1
bmj4_12_e005791.full;N=257;257;-1
bmj4_12_e005791.full;N=193;193;-1
bmj4_12_e005791.full;N=94;94;-1
bmj4_12_e005791.full;N=88;88;-1
bmj4_12_e005795.full;30 This age range represents women;30;-1
bmj4_12_e005795.full;57 247 individuals;57247;-1
bmj4_12_e005795.full;12 280 individuals;12280;-1
bmj4_12_e005795.full;1 Proportion of individuals;1;-1
bmj4_12_e005795.full;total of 57 247;57247;-1
bmj4_12_e005805.full;314 migrant patients;314;-1
bmj4_12_e005805.full;418 migrant TB patients;418;-1
bmj4_12_e005805.full;314 patients;314;-1
bmj4_12_e005805.full;20 individuals;20;-1
bmj4_12_e005805.full;16 individuals;16;-1
bmj4_12_e005805.full;11  individuals;11;-1
bmj4_12_e005805.full;314 patients successfully recruited;314;-1
bmj4_12_e005805.full;total of 314;314;-1
bmj4_12_e005805.full;total of 12;12;-1
bmj4_12_e005805.full;total of 418;418;-1
bmj4_12_e005805.full;total of 64;64;-1
bmj4_12_e005811.full;222 participants;222;-1
bmj4_12_e005811.full;200 participants;200;-1
bmj4_12_e005811.full;208 participants;208;-1
bmj4_12_e005811.full;97 participants;97;-1
bmj4_12_e005811.full;207 participants;207;-1
bmj4_12_e005811.full;20  people;20;-1
bmj4_12_e005811.full;222 participants recruited;222;-1
bmj4_12_e005811.full;total of 208;208;-1
bmj4_12_e005820.full;749 123 people;749123;7505
bmj4_12_e005820.full;180 Nigerian adults;180;13612
bmj4_12_e005820.full;180 adults;180;7789
bmj4_12_e005820.full;n=11;11;6966
bmj4_12_e005820.full;n=106;106;826
bmj4_12_e005820.full;n=111;111;886
bmj4_12_e005820.full;n=117;117;918
bmj4_12_e005820.full;N=180;180;2424
bmj4_12_e005820.full;n=90;90;2468
bmj4_12_e005820.full;N  =1;1;7968
bmj4_12_e005820.full;n  =1;1;8259
bmj4_12_e005820.full;n  =3;3;8512
bmj4_12_e005820.full;n  =2;2;8777
bmj4_12_e005836.full;n=15 745;15745;-1
bmj4_12_e005836.full;n=15 375;15375;-1
bmj4_12_e005887.full;115 patients;115;14391
bmj4_12_e005887.full;121  patients;121;14196
bmj4_12_e005887.full;62 patients;62;1033
bmj4_12_e005887.full;136 patients;136;843
bmj4_12_e005887.full;310 patients;310;13131
bmj4_12_e005887.full;total of 62;62;1042
bmj4_12_e005919.full;10 participants;10;-1
bmj4_12_e005919.full;5 participants;5;-1
bmj4_12_e005919.full;3  participants;3;-1
bmj4_12_e005919.full;n=10;10;-1
bmj4_12_e005919.full;N=10;10;-1
bmj4_12_e005919.full;n=2;2;-1
bmj4_12_e005919.full;n=3;3;-1
bmj4_12_e005919.full;n=5;5;-1
bmj4_12_e005965.full;204 participants;204;-1
bmj4_12_e005965.full;144 participants;144;-1
bmj4_12_e005965.full;366 patients;366;-1
bmj4_12_e005965.full;12 patients;12;-1
bmj4_12_e005965.full;4 Summary of patients;4;-1
bmj4_12_e005965.full;77 patients;77;-1
bmj4_12_e005965.full;397 patients;397;-1
bmj4_12_e005965.full;n=359;359;-1
bmj4_12_e005965.full;N=366;366;-1
bmj4_12_e005965.full;N=42;42;-1
bmj4_12_e005965.full;N=229;229;-1
bmj4_12_e005965.full;total of 366;366;-1
bmj4_12_e005965.full;total of 3099;3099;-1
bmj4_12_e005982.full;20 women;20;-1
bmj4_12_e005982.full;14 women;14;-1
bmj4_12_e005982.full;4 million people;4;-1
bmj4_12_e005982.full; data from 284;284;-1
bmj4_12_e005984.full;6 outpatient participants;6;-1
bmj4_12_e005984.full;11 young normal participants;11;-1
bmj4_12_e005984.full;6 patients;6;-1
bmj4_12_e005984.full;19 patients;19;-1
bmj4_12_e005984.full;12 patients;12;-1
bmj4_12_e005984.full;10 patients;10;-1
bmj4_12_e005984.full;37 patients;37;-1
bmj4_12_e005984.full;N=12;12;-1
bmj4_12_e005984.full;N=6;6;-1
bmj4_12_e005984.full;total of 28;28;-1
bmj4_12_e005984.full;total of 24;24;-1
bmj4_12_e005988.full;38 668 patients;38668;-1
bmj4_12_e005988.full;4842 patients;4842;-1
bmj4_12_e005988.full;1110 patients;1110;-1
bmj4_12_e005988.full;2675 patients;2675;-1
bmj4_12_e005988.full;6 and analysed patients;6;-1
bmj4_12_e005988.full;20 patients;20;-1
bmj4_12_e005988.full;343 patients;343;-1
bmj4_12_e005988.full;2 patients;2;-1
bmj4_12_e005988.full;n=  10;10;-1
bmj4_12_e005988.full;n=  46;46;-1
bmj4_12_e005988.full;n=  26;26;-1
bmj4_12_e005988.full;n=  16;16;-1
bmj4_12_e005988.full;n=  11;11;-1
bmj4_12_e005988.full;n=  48;48;-1
bmj4_12_e005988.full;n=  65;65;-1
bmj4_12_e005988.full;n=  15;15;-1
bmj4_12_e005988.full;n=  95;95;-1
bmj4_12_e005988.full;n=  38;38;-1
bmj4_12_e005988.full;n  =4;4;-1
bmj4_12_e005988.full;n=6509;6509;-1
bmj4_12_e005988.full;n=15 337;15337;-1
bmj4_12_e005988.full;n=15 867;15867;-1
bmj4_12_e005988.full;n=955;955;-1
bmj4_12_e005988.full;total of 57 353;57353;-1
bmj4_12_e006032.full;10 000 adults;10000;-1
bmj4_12_e006032.full;10 000  adults;10000;-1
bmj4_12_e006076.full;10 476 participants;10476;-1
bmj4_12_e006076.full;10 476  participants;10476;-1
bmj4_12_e006076.full;11 032 people;11032;-1
bmj4_12_e006076.full;244 people;244;-1
bmj4_12_e006076.full;10 476 individuals;10476;-1
bmj4_12_e006076.full;900 000 adults;900000;-1
bmj4_12_e006076.full;N=3541;3541;-1
bmj4_12_e006093.full;217 persons;217;-1
bmj4_12_e006093.full;1252 participants;1252;-1
bmj4_12_e006093.full;40 000 clinic patients;40000;-1
bmj4_12_e006093.full;19 million people;19;-1
bmj4_12_e006093.full;n=38 635;38635;-1
bmj4_12_e006097.full;64  Sample of persons;64;-1
bmj4_12_e006097.full;40  Cohort of persons;40;-1
bmj4_12_e006097.full;24  Cohort of persons;24;-1
bmj4_12_e006097.full;60 partners of persons;60;-1
bmj4_12_e006097.full;n=166;166;-1
bmj4_12_e006097.full;n=64;64;-1
bmj4_12_e006097.full;n=40;40;-1
bmj4_12_e006097.full;n=24;24;-1
bmj4_12_e006097.full;n=21;21;-1
bmj4_12_e006097.full;n=63;63;-1
bmj4_12_e006097.full;n=23;23;-1
bmj4_12_e006097.full;n=39;39;-1
bmj4_12_e006097.full;n=60;60;-1
bmj4_12_e006097.full;n=31;31;-1
bmj4_12_e006097.full;n=19;19;-1
bmj4_12_e006097.full;n=37;37;-1
bmj4_12_e006097.full;n=35;35;-1
bmj4_12_e006097.full;total of 40;40;-1
bmj4_12_e006128.full;28 patients;28;-1
bmj4_12_e006128.full;137 patients;137;-1
bmj4_12_e006128.full;274 patients;274;-1
bmj4_12_e006128.full;43  patients;43;-1
bmj4_12_e006128.full;total of 274;274;-1
bmj4_12_e006128.full;274 patients enrolled;274;-1
bmj4_12_e006135.full;10 million patients;10;-1
bmj4_12_e006135.full;47 724 individuals;47724;-1
bmj4_12_e006135.full;47 724 eligible individuals;47724;-1
bmj4_12_e006135.full;1 Flow of individuals;1;-1
bmj4_12_e006135.full;n=1331;1331;-1
bmj4_12_e006135.full;n=1545;1545;-1
bmj4_12_e006135.full;n=4824;4824;-1
bmj4_12_e006135.full;n=4597;4597;-1
bmj4_12_e006135.full;n=7094;7094;-1
bmj4_12_e006135.full;N  =4;4;-1
bmj4_12_e006135.full;N  =2;2;-1
bmj4_12_e006135.full;N  =1;1;-1
bmj4_12_e006135.full;N  =9;9;-1
bmj4_12_e006144.full;386 participants;386;27757
bmj4_12_e006144.full;50 ethnic minority participants;50;18803
bmj4_12_e006144.full;20 participants;20;12345
bmj4_12_e006144.full;386  patients;386;18427
bmj4_12_e006144.full;50 patients;50;2358
bmj4_12_e006144.full;total of 386;386;18436
bmj4_12_e006144.full;total of 6;6;12887
bmj4_12_e006171.full;58 589 patients;58589;-1
bmj4_12_e006171.full;6 if  patients;6;-1
bmj4_12_e006171.full;58 589  patients;58589;-1
bmj4_12_e006171.full;2138 patients;2138;-1
bmj4_12_e006171.full;n=31 049;31049;-1
bmj4_12_e006171.full;n=14 189;14189;-1
bmj4_12_e006171.full;n=13 351;13351;-1
bmj4_12_e006171.full;2138 patients enrolled;2138;-1
bmj4_12_e006174.full;713 women;713;-1
bmj4_12_e006174.full;19  Study participants;19;-1
bmj4_12_e006174.full;24  All participants;24;-1
bmj4_12_e006174.full;n=713;713;-1
bmj4_12_e006199.full;n=6;6;-1
bmj4_12_e006199.full;n=25;25;-1
bmj4_12_e006236.full;36 subjects;36;1333
bmj4_12_e006236.full;21 Patients will be recruited;21;3474
bmj4_12_e006236.full;n=18;18;1030
bmj4_12_e006250.full;50 persons;50;-1
bmj4_12_e006250.full;27 Potential subjects;27;-1
bmj4_12_e006250.full;3 million people;3;-1
bmj4_12_e006250.full;N=307;307;-1
bmj4_12_e006325.full;13 129 women;13129;-1
bmj4_12_e006325.full;11 included women;11;-1
bmj4_12_e006325.full;7 studies including fertile  women;7;-1
bmj4_12_e006325.full;7 studies including  infertile women;7;-1
bmj4_12_e006325.full;411  women;411;-1
bmj4_12_e006325.full;567 unaffected  women;567;-1
bmj4_12_e006325.full;total of 13 129;13129;-1
bmj4_12_e006325.full; data from 38;38;-1
bmj4_12_e006327.full;50 056 women;50056;-1
bmj4_12_e006327.full;15 women;15;-1
bmj4_12_e006327.full;107 237  patients;107237;-1
bmj4_12_e006327.full;1210 patients;1210;-1
bmj4_12_e006327.full;106 027  patients;106027;-1
bmj4_12_e006327.full;72 patients;72;-1
bmj4_12_e006327.full;106 027 patients;106027;-1
bmj4_12_e006327.full;62 patients;62;-1
bmj4_12_e006327.full;107 237 individuals;107237;-1
bmj4_12_e006327.full;n=1210;1210;-1
bmj4_12_e006327.full;total of 107 237;107237;-1
bmj4_12_e006327.full; data from 23;23;-1
bmj4_12_e006350.full;822 persons;822;-1
bmj4_12_e006350.full;436 persons;436;-1
bmj4_12_e006350.full;n=215;215;-1
bmj4_12_e006350.full;n=221;221;-1
bmj4_12_e006350.full;n=6;6;-1
bmj4_12_e006350.full;n=681;681;-1
bmj4_12_e006350.full;n=141;141;-1
bmj4_12_e006350.full;n=35;35;-1
bmj4_12_e006350.full;n=436;436;-1
bmj4_12_e006350.full;n=1;1;-1
bmj4_12_e006350.full;total of  822;822;-1
bmj4_12_e006378.full;802 participants;802;-1
bmj4_12_e006378.full;29 participants;29;-1
bmj4_12_e006378.full;34 participants;34;-1
bmj4_12_e006378.full;14 participants;14;-1
bmj4_12_e006378.full;802 participants were recruited;802;-1
bmj4_12_e006378.full;N=696;696;-1
bmj4_12_e006378.full;n=404;404;-1
bmj4_12_e006378.full;n=130;130;-1
bmj4_12_e006378.full;n=106;106;-1
bmj4_12_e006378.full;n=291;291;-1
bmj4_12_e006378.full;n=129;129;-1
bmj4_12_e006378.full;n=28;28;-1
bmj4_12_e006378.full;n=226;226;-1
bmj4_12_e006378.full;n=117;117;-1
bmj4_12_e006378.full;n=47;47;-1
bmj4_12_e006378.full;n=19;19;-1
bmj4_12_e006378.full;n=20;20;-1
bmj4_12_e006378.full;n=133;133;-1
bmj4_12_e006378.full;n=346;346;-1
bmj4_12_e006378.full;n=199;199;-1
bmj4_12_e006378.full;n=91;91;-1
bmj4_12_e006378.full;n=93;93;-1
bmj4_12_e006378.full;n=88;88;-1
bmj4_12_e006378.full;n=34;34;-1
bmj4_12_e006378.full;n=32;32;-1
bmj4_12_e006378.full;n=14;14;-1
bmj4_12_e006378.full;n=7;7;-1
bmj4_12_e006378.full;n=679;679;-1
bmj4_12_e006378.full;n=549;549;-1
bmj4_12_e006378.full;n=526;526;-1
bmj4_12_e006378.full;total of 19;19;-1
bmj4_12_e006378.full;total of 802;802;-1
bmj4_12_e006378.full;total of 70;70;-1
bmj4_12_e006380.full;100 persons;100;-1
bmj4_12_e006380.full;1092 participants;1092;-1
bmj4_12_e006380.full;1800 participants;1800;-1
bmj4_12_e006380.full;100 individuals;100;-1
bmj4_12_e006380.full; data are  from 2012;2012;-1
bmj4_12_e006391.full;2 million people;2;-1
bmj4_12_e006391.full;n=1386;1386;-1
bmj4_12_e006391.full;n=1;1;-1
bmj4_12_e006391.full;N=1386;1386;-1
bmj4_12_e006395.full;100 000 patients;100000;-1
bmj4_12_e006411.full;12 participants;12;-1
bmj4_12_e006411.full;N=50;50;-1
bmj4_12_e006411.full;total of 57;57;-1
bmj4_12_e006411.full;total of 40;40;-1
bmj4_12_e006411.full;total of 150;150;-1
bmj4_12_e006411.full;total of 176;176;-1
bmj4_12_e006414.full;32 and  pregnant women;32;-1
bmj4_12_e006414.full;12 Homeless persons;12;-1
bmj4_12_e006414.full;26 Mentally Ill persons;26;-1
bmj4_12_e006414.full;103 included younger people as participants;103;-1
bmj4_12_e006414.full;500 participants;500;-1
bmj4_12_e006414.full;79 participants;79;-1
bmj4_12_e006414.full;98 103 Twenty-three per cent of  participants;98103;-1
bmj4_12_e006414.full;100 000 participants;100000;-1
bmj4_12_e006414.full;18 involving people;18;-1
bmj4_12_e006414.full;5 people;5;-1
bmj4_12_e006414.full;43 At-risk young people;43;-1
bmj4_12_e006414.full;47 Indigenous people;47;-1
bmj4_12_e006414.full;87 and people;87;-1
bmj4_12_e006414.full;86  and people;86;-1
bmj4_12_e006414.full;103 included younger people;103;-1
bmj4_12_e006414.full;109 Studies involving people;109;-1
bmj4_12_e006414.full;n=2133;2133;-1
bmj4_12_e006414.full;n=24;24;-1
bmj4_12_e006414.full;n=16;16;-1
bmj4_12_e006414.full;n=18;18;-1
bmj4_12_e006414.full;n=38;38;-1
bmj4_12_e006414.full;n  =2;2;-1
bmj4_12_e006414.full;n  =1;1;-1
bmj4_12_e006414.full;n  =3;3;-1
bmj4_12_e006414.full;n  =5;5;-1
bmj4_12_e006414.full;n=2;2;-1
bmj4_12_e006414.full;n=3;3;-1
bmj4_12_e006421.full;44  were women;44;-1
bmj4_12_e006423.full;36 participants;36;750
bmj4_12_e006423.full;30 eligible patients;30;11706
bmj4_12_e006423.full;n=18;18;1995
bmj4_12_e006434.full;1000 participants;1000;-1
bmj4_12_e006434.full;475  participants;475;-1
bmj4_12_e006434.full;475 participants;475;-1
bmj4_12_e006434.full;27 participants;27;-1
bmj4_12_e006434.full;1000 people;1000;-1
bmj4_12_e006434.full;35 000 people;35000;-1
bmj4_12_e006434.full;n=8;8;-1
bmj4_12_e006434.full;n=1;1;-1
bmj4_12_e006434.full;n=2;2;-1
bmj4_12_e006434.full;n=5;5;-1
bmj4_12_e006434.full;n=397;397;-1
bmj4_12_e006434.full;n=140;140;-1
bmj4_12_e006434.full; dataset of the 4100;4100;-1
bmj4_12_e006447.full;145 women;145;7521
bmj4_12_e006447.full;71 women;71;617
bmj4_12_e006447.full;37 women;37;15595
bmj4_12_e006447.full;27 participants;27;672
bmj4_12_e006447.full;8 were recruited;8;3187
bmj4_12_e006447.full;n=71;71;7528
bmj4_12_e006447.full;n=77;77;2482
bmj4_12_e006447.full;n=155;155;2471
bmj4_12_e006447.full;n=156;156;2455
bmj4_12_e006451.full;15 patients;15;-1
bmj4_12_e006451.full;3 billion people;3;-1
bmj4_12_e006451.full;n=272;272;-1
bmj4_12_e006451.full;n=151;151;-1
bmj4_12_e006451.full;n=121;121;-1
bmj4_12_e006451.full;total of 304;304;-1
bmj4_12_e006451.full;total of 117;117;-1
bmj4_12_e006451.full;total of 88;88;-1
bmj4_12_e006460.full;44 participants;44;-1
bmj4_12_e006460.full;19 million  people;19;-1
bmj4_12_e006460.full;44 participants recruited;44;-1
bmj4_12_e006460.full;n=44;44;-1
bmj4_12_e006460.full;total of 425;425;-1
bmj4_12_e006471.full;n=107;107;-1
bmj4_12_e006471.full;n=189;189;-1
bmj4_12_e006475.full;293 patients;293;-1
bmj4_12_e006475.full;total of 293;293;-1
bmj4_12_e006491.full;30 818 persons;30818;-1
bmj4_12_e006491.full;39 695 individuals;39695;-1
bmj4_12_e006491.full;19 We excluded individuals;19;-1
bmj4_12_e006491.full;80 653 788 individuals;80653788;-1
bmj4_12_e006491.full;31 These individuals;31;-1
bmj4_12_e006491.full;total  of 30 818;30818;-1
bmj4_12_e006491.full;total of 8003;8003;-1
bmj4_12_e006542.full;33 patients;33;11023
bmj4_12_e006542.full;23 patients;23;10988
bmj4_12_e006542.full;266 patients;266;1163
bmj4_12_e006542.full;22 patients;22;1276
bmj4_12_e006542.full;8  million people;8;9281
bmj4_12_e006542.full;N=32;32;11600
bmj4_12_e006542.full;N=30;30;11697
bmj4_12_e006542.full;N=20;20;16783
bmj4_12_e006542.full;N=33;33;16969
bmj4_12_e006542.full;N=23;23;16974
bmj4_12_e006542.full;total of 20;20;4122
bmj4_12_e006542.full;33 patients were enrolled;33;11023
bmj4_12_e006542.full;33 patients who were enrolled;33;1924
bmj4_12_e006544.full;46  Presence of non-participants;46;-1
bmj4_12_e006544.full;10 For adults;10;-1
bmj4_12_e006544.full;n=7;7;-1
bmj4_12_e006609.full;49 participants;49;-1
bmj4_12_e006609.full;2 Examples of participants;2;-1
bmj4_12_e006609.full;3 Examples of participants;3;-1
bmj4_12_e006609.full;4 Examples of participants;4;-1
bmj4_12_e006609.full;5 Examples of participants;5;-1
bmj4_12_e006609.full;n=16;16;-1
bmj4_12_e006609.full;n=22;22;-1
bmj4_12_e006609.full;n=27;27;-1
bmj4_12_e006634.full;4315 male patients;4315;-1
bmj4_12_e006634.full;2679 male patients;2679;-1
bmj4_12_e006634.full;2649 female patients;2649;-1
bmj4_12_e006634.full;25 000 patients;25000;-1
bmj4_12_e006634.full;30 A higher  proportion of male patients;30;-1
bmj4_12_e006634.full;27 positive individuals;27;-1
bmj4_12_e006645.full;4001 women;4001;-1
bmj4_12_e006645.full;3325  women;3325;-1
bmj4_12_e006645.full;3325 women;3325;-1
bmj4_12_e006645.full;2402 women;2402;-1
bmj4_12_e006645.full;2 women;2;-1
bmj4_12_e006645.full;1537 women;1537;-1
bmj4_12_e006645.full;26 For both women;26;-1
bmj4_12_e006645.full;2 participants;2;-1
bmj4_12_e006645.full;7 These patients;7;-1
bmj4_12_e006645.full;N=31 115;31115;-1
bmj4_12_e006645.full;N=1205;1205;-1
bmj4_12_e006645.full;N=1539;1539;-1
bmj4_12_e006645.full;N=581;581;-1
bmj4_12_e006645.full;N=4001;4001;-1
bmj4_12_e006645.full;N=3057;3057;-1
bmj4_12_e006645.full;N=1213;1213;-1
bmj4_12_e006645.full;N=1058;1058;-1
bmj4_12_e006645.full;N=316;316;-1
bmj4_12_e006645.full;N  =3;3;-1
bmj4_12_e006645.full;N  =2;2;-1
bmj4_12_e006645.full;N  =1;1;-1
bmj4_12_e006645.full;N  =5;5;-1
bmj4_12_e006645.full;N=2402;2402;-1
bmj4_12_e006645.full;N=923;923;-1
bmj4_12_e006645.full;N=1907;1907;-1
bmj4_12_e006645.full;N=680;680;-1
bmj4_12_e006645.full; data of <5;5;-1
bmj4_12_e006657.full;5 million people;5;-1
bmj4_12_e006657.full;2500 people;2500;-1
bmj4_12_e006657.full;1 A large number of these individuals;1;-1
bmj4_12_e006657.full;011  Self-identifying individuals;11;-1
bmj4_12_e006657.full;253 Self-identifying individuals;253;-1
bmj4_12_e006657.full;2500 multiracial individuals;2500;-1
bmj4_12_e006657.full;n=29 757;29757;-1
bmj4_12_e006657.full;n=871;871;-1
bmj4_12_e006657.full;n=128;128;-1
bmj4_12_e006657.full;n=743;743;-1
bmj4_12_e006657.full; data, a list of 791;791;-1
bmj4_12_e006657.full; data from 44;44;-1
bmj4_12_e006671.full;390 participants;390;-1
bmj4_12_e006671.full;412 randomised participants;412;-1
bmj4_12_e006671.full;204 participants;204;-1
bmj4_12_e006671.full;208 participants;208;-1
bmj4_12_e006671.full;2673 patients;2673;-1
bmj4_12_e006671.full;412 adults;412;-1
bmj4_12_e006671.full;200 adults;200;-1
bmj4_12_e006671.full;n=192;192;-1
bmj4_12_e006671.full;n=198;198;-1
bmj4_12_e006671.full;n=390;390;-1
bmj4_12_e006685.full;1738 persons;1738;-1
bmj4_12_e006685.full;56 754 persons;56754;-1
bmj4_12_e006685.full;1738 participants;1738;-1
bmj4_12_e006685.full;56 754 participants;56754;-1
bmj4_12_e006685.full;1660  matched pairs of participants;1660;-1
bmj4_12_e006685.full;n=1838;1838;-1
bmj4_12_e006685.full;n=67 086;67086;-1
bmj4_12_e006685.full;n=2;2;-1
bmj4_12_e006685.full;n=4923;4923;-1
bmj4_12_e006685.full;n=2600;2600;-1
bmj4_12_e006685.full;n=1;1;-1
bmj4_12_e006685.full;n=354;354;-1
bmj4_12_e006685.full;n=3;3;-1
bmj4_12_e006685.full;n=66;66;-1
bmj4_12_e006685.full;n=1024;1024;-1
bmj4_12_e006685.full;n=4347;4347;-1
bmj4_12_e006685.full;n=10;10;-1
bmj4_12_e006685.full;n=1738;1738;-1
bmj4_12_e006685.full;n=56 754;56754;-1
bmj4_12_e006685.full;total of 1660;1660;-1
bmj4_12_e006713.full;100 000 men  and women;100000;-1
bmj4_12_e006713.full;  data from 1990;1990;-1
bmj4_12_e006720.full;16 647 eligible patients;16647;-1
bmj4_12_e006720.full;5 we then  grouped patients;5;-1
bmj4_12_e006720.full;16 647 patients;16647;-1
bmj4_12_e006720.full;73 106 patients;73106;-1
bmj4_12_e006720.full;18 emergency room patients;18;-1
bmj4_12_e006720.full;16 and discharged patients;16;-1
bmj4_12_e006720.full;23 Even though these  patients;23;-1
bmj4_12_e006720.full;total of 29;29;-1
bmj4_12_e006750.full;40 participants;40;-1
bmj4_12_e006750.full;130 consecutive patients;130;-1
bmj4_12_e006770.full;345  DIC patients;345;-1
bmj4_12_e006806.full;8 adult women;8;-1
bmj4_12_e006806.full;1500 participants;1500;-1
bmj4_12_e006806.full;150  million people;150;-1
bmj4_12_e006806.full;1 million  people;1;-1
bmj4_12_e006806.full;total of 20;20;-1
bmj4_12_e006838.full;234 participants;234;-1
bmj4_12_e006838.full;178 participants;178;-1
bmj4_12_e006838.full;71 patients;71;-1
bmj4_12_e006838.full;n=20;20;-1
bmj4_12_e006859.full;n=5;5;-1
bmj4_12_e006859.full;n=3;3;-1
bmj4_12_e006859.full;n=1;1;-1
bmj4_12_e006859.full;n=  37;37;-1
bmj4_12_e006977.full;2600  participants;2600;-1
bmj4_12_e006977.full;890 participants;890;-1
bmj4_12_e006977.full;60 participants;60;-1
bmj4_12_e006977.full;2600 participants;2600;-1
bmj4_12_e006977.full;30 participants;30;-1
bmj4_12_e006977.full;890 eligible participants;890;-1
bmj4_12_e006977.full;15 participants;15;-1
bmj4_12_e006977.full;176 older people;176;-1
bmj4_12_e006977.full;312 people;312;-1
bmj4_12_e006977.full;305 community dwell-  ing older people;305;-1
bmj4_12_e006977.full;890 participants are  recruited;890;-1
bmj4_12_e007064.full;5632 patients;5632;-1
bmj4_12_e007064.full;5632 eligible patients;5632;-1
bmj4_12_e007064.full;26 For these patients;26;-1
bmj4_12_e007064.full;5632  patients;5632;-1
bmj4_12_e007065.full;120 adult patients;120;16416
bmj4_12_e007065.full;7511 patients;7511;15097
bmj4_12_e007065.full;1 In patients;1;14969
bmj4_12_e007065.full;14 For  patients;14;14145
bmj4_12_e007065.full;52 patients;52;166
bmj4_12_e007065.full;60 patients;60;83
bmj4_12_e007065.full;12 In healthy elderly individuals;12;14502
bmj4_12_e007065.full;total of 2;2;6488
bmj4_12_e007130.full;1000  patients;1000;-1
bmj4_12_e007130.full;500  patients;500;-1
bmj4_12_e007130.full;5000 registered  patients;5000;-1
bmj4_12_e007130.full;500 patients;500;-1
bmj4_12_e007130.full;58 million people;58;-1
bmj4_12_e007130.full;20 per patient recruited;20;-1
bmj4_1_e003269.full;n=56;56;-1
bmj4_1_e003269.full;n=39;39;-1
bmj4_1_e003269.full;N=357;357;-1
bmj4_1_e003269.full;N=161;161;-1
bmj4_1_e003269.full;N=196;196;-1
bmj4_1_e003269.full;N=332;332;-1
bmj4_1_e003269.full;N=331;331;-1
bmj4_1_e003269.full;N=236;236;-1
bmj4_1_e003269.full;total of 1330;1330;-1
bmj4_1_e003269.full;total of 332;332;-1
bmj4_1_e003269.full;357 enrolled;357;-1
bmj4_1_e003269.full;357 children were enrolled;357;-1
bmj4_1_e003374.full;961 patients;961;-1
bmj4_1_e003374.full;961 Danish patients;961;-1
bmj4_1_e003374.full;total of 61;61;-1
bmj4_1_e003440.full;40 participants;40;-1
bmj4_1_e003440.full;41 participants;41;-1
bmj4_1_e003440.full;9 participants;9;-1
bmj4_1_e003440.full;81 participants;81;-1
bmj4_1_e003440.full;10 participants;10;-1
bmj4_1_e003440.full;84 participants;84;-1
bmj4_1_e003440.full;69 participants;69;-1
bmj4_1_e003440.full;35 participants;35;-1
bmj4_1_e003440.full;34 participants;34;-1
bmj4_1_e003440.full;32  participants;32;-1
bmj4_1_e003440.full;23 participants;23;-1
bmj4_1_e003440.full;28 participants;28;-1
bmj4_1_e003440.full;393 participants;393;-1
bmj4_1_e003440.full;231 individuals;231;-1
bmj4_1_e003440.full;N=40;40;-1
bmj4_1_e003440.full;N=41;41;-1
bmj4_1_e003440.full;N=81;81;-1
bmj4_1_e003440.full;n=51;51;-1
bmj4_1_e003440.full;n=30;30;-1
bmj4_1_e003440.full;n=23;23;-1
bmj4_1_e003440.full;n=28;28;-1
bmj4_1_e003440.full;n=17;17;-1
bmj4_1_e003440.full;n=13;13;-1
bmj4_1_e003440.full;n=81;81;-1
bmj4_1_e003440.full;n=25;25;-1
bmj4_1_e003440.full;N=66;66;-1
bmj4_1_e003440.full;n=14;14;-1
bmj4_1_e003440.full;N=51;51;-1
bmj4_1_e003440.full;n=12;12;-1
bmj4_1_e003440.full;N=30;30;-1
bmj4_1_e003440.full;n=11;11;-1
bmj4_1_e003440.full;n=4;4;-1
bmj4_1_e003440.full;total  of 50;50;-1
bmj4_1_e003440.full; database of 54;54;-1
bmj4_1_e003460.full;19 065 women;19065;-1
bmj4_1_e003460.full;13  NCCSP recommends women;13;-1
bmj4_1_e003460.full;13 673 women;13673;-1
bmj4_1_e003460.full;21 958 women;21958;-1
bmj4_1_e003460.full;19 340 women;19340;-1
bmj4_1_e003460.full;3 Four-year follow-up of women;3;-1
bmj4_1_e003460.full;1578 women;1578;-1
bmj4_1_e003460.full;27 Our population consisting of women;27;-1
bmj4_1_e003460.full;19 065 participants;19065;-1
bmj4_1_e003460.full;n=4715;4715;-1
bmj4_1_e003460.full;N=606;606;-1
bmj4_1_e003460.full;N=1445;1445;-1
bmj4_1_e003460.full;N=32;32;-1
bmj4_1_e003460.full;N=12;12;-1
bmj4_1_e003460.full;N=62;62;-1
bmj4_1_e003460.full;N=6;6;-1
bmj4_1_e003460.full;19 065 participants were enrolled;19065;-1
bmj4_1_e003462.full;2617 individuals;2617;-1
bmj4_1_e003462.full;n=233;233;-1
bmj4_1_e003462.full;n=205;205;-1
bmj4_1_e003462.full;n=113;113;-1
bmj4_1_e003462.full;n=146;146;-1
bmj4_1_e003462.full;n=179;179;-1
bmj4_1_e003462.full;n=240;240;-1
bmj4_1_e003462.full;n=152;152;-1
bmj4_1_e003462.full;n=45;45;-1
bmj4_1_e003462.full;n=131;131;-1
bmj4_1_e003462.full;n=97;97;-1
bmj4_1_e003462.full;n=62;62;-1
bmj4_1_e003462.full;n=74;74;-1
bmj4_1_e003462.full;n=92;92;-1
bmj4_1_e003462.full;n=134;134;-1
bmj4_1_e003462.full;n=69;69;-1
bmj4_1_e003462.full;n=145;145;-1
bmj4_1_e003462.full;n=102;102;-1
bmj4_1_e003462.full;n=68;68;-1
bmj4_1_e003462.full;n=82;82;-1
bmj4_1_e003462.full;n=73;73;-1
bmj4_1_e003462.full;n=28;28;-1
bmj4_1_e003462.full;total of 21;21;-1
bmj4_1_e003517.full;6  participants;6;-1
bmj4_1_e003517.full;3 participants;3;-1
bmj4_1_e003526.full;23  Prefer women;23;-1
bmj4_1_e003526.full;5  Prefer only women;5;-1
bmj4_1_e003526.full;31 million persons;31;-1
bmj4_1_e003526.full;12 persons;12;-1
bmj4_1_e003526.full;982 participants;982;-1
bmj4_1_e003526.full;25  Sampling and participants;25;-1
bmj4_1_e003526.full;29 We asked participants;29;-1
bmj4_1_e003536.full;330 adult patients;330;-1
bmj4_1_e003536.full;10 septic  shock patients;10;-1
bmj4_1_e003536.full;330 patients;330;-1
bmj4_1_e003536.full;192 patients;192;-1
bmj4_1_e003536.full;386 patients;386;-1
bmj4_1_e003536.full;14  enroled patients;14;-1
bmj4_1_e003536.full;184 remaining  patients;184;-1
bmj4_1_e003536.full;44 patients;44;-1
bmj4_1_e003536.full;91 patients;91;-1
bmj4_1_e003536.full;38 patients;38;-1
bmj4_1_e003536.full;1 Characteristics of the patients;1;-1
bmj4_1_e003536.full;9,493 patients;9493;-1
bmj4_1_e003536.full;n=93;93;-1
bmj4_1_e003536.full;n=91;91;-1
bmj4_1_e003536.full;n=44;44;-1
bmj4_1_e003536.full;total  of 330;330;-1
bmj4_1_e003536.full;total of  192;192;-1
bmj4_1_e003536.full; data set of 9,493;9493;-1
bmj4_1_e003627.full;100 consecutive patients;100;-1
bmj4_1_e003627.full;95 evaluable patients;95;-1
bmj4_1_e003627.full;78 patients;78;-1
bmj4_1_e003627.full;13 patients;13;-1
bmj4_1_e003627.full;100 patients;100;-1
bmj4_1_e003627.full;95 patients;95;-1
bmj4_1_e003627.full;53 patients;53;-1
bmj4_1_e003627.full;20 randomly selected  patients;20;-1
bmj4_1_e003627.full;20 patients;20;-1
bmj4_1_e003627.full;68 patients;68;-1
bmj4_1_e003627.full;100 mg daily  and two patients;100;-1
bmj4_1_e003627.full;47 patients;47;-1
bmj4_1_e003627.full;7 of the  patients;7;-1
bmj4_1_e003627.full;33 patients;33;-1
bmj4_1_e003627.full;20 randomly  selected patients;20;-1
bmj4_1_e003627.full;18 patients;18;-1
bmj4_1_e003627.full;68 allopurinol-treated patients;68;-1
bmj4_1_e003627.full;80 patients;80;-1
bmj4_1_e003627.full;N=100;100;-1
bmj4_1_e003627.full;95 evaluable patients enrolled;95;-1
bmj4_1_e003656.full;n=176;176;-1
bmj4_1_e003656.full;N=176;176;-1
bmj4_1_e003656.full;N=704;704;-1
bmj4_1_e003667.full;44 and women;44;-1
bmj4_1_e003667.full;11247 adults;11247;-1
bmj4_1_e003667.full;3351 Australian adults;3351;-1
bmj4_1_e003667.full;11 247 adults;11247;-1
bmj4_1_e003670.full;25  In adults;25;-1
bmj4_1_e003670.full;N=291;291;-1
bmj4_1_e003670.full;n=3;3;-1
bmj4_1_e003670.full;n=6;6;-1
bmj4_1_e003670.full;n=4;4;-1
bmj4_1_e003670.full;n=1290;1290;-1
bmj4_1_e003670.full;total of 136 213;136213;-1
bmj4_1_e003670.full;total of 10 892;10892;-1
bmj4_1_e003671.full;100 000 in women;100000;-1
bmj4_1_e003671.full;64 027 women;64027;-1
bmj4_1_e003671.full;43 411  women;43411;-1
bmj4_1_e003671.full;56 907 women;56907;-1
bmj4_1_e003671.full;100 000 women;100000;-1
bmj4_1_e003671.full;27 persons;27;-1
bmj4_1_e003671.full;187 persons;187;-1
bmj4_1_e003671.full;23  persons;23;-1
bmj4_1_e003671.full;10 000 screened persons;10000;-1
bmj4_1_e003671.full;10 000 screened  persons;10000;-1
bmj4_1_e003671.full;176 persons;176;-1
bmj4_1_e003671.full;1000 screened persons;1000;-1
bmj4_1_e003671.full;2011  and recruitment of eligible participants;2011;-1
bmj4_1_e003671.full;127 301 eligible  participants;127301;-1
bmj4_1_e003671.full;127 301 eligible participants;127301;-1
bmj4_1_e003671.full;1 Characteristic of participants;1;-1
bmj4_1_e003689.full;194 participants;194;-1
bmj4_1_e003689.full;16 Study participants;16;-1
bmj4_1_e003689.full;379 participants;379;-1
bmj4_1_e003689.full;3 compares endos-  copy participants;3;-1
bmj4_1_e003689.full;194 Aklavik H pylori Project participants;194;-1
bmj4_1_e003689.full;2008  All  participants;2008;-1
bmj4_1_e003689.full;1 Continued  All  participants;1;-1
bmj4_1_e003689.full;332 project  participants;332;-1
bmj4_1_e003689.full;2 Aklavik participants;2;-1
bmj4_1_e003689.full;33 Aklavik participants;33;-1
bmj4_1_e003689.full;3 Aklavik endoscopy participants;3;-1
bmj4_1_e003689.full;176 participants;176;-1
bmj4_1_e003689.full;194 endoscoped participants;194;-1
bmj4_1_e003689.full;189 Aklavik H pylori Project participants;189;-1
bmj4_1_e003689.full;401 individual patients;401;-1
bmj4_1_e003689.full;282 patients;282;-1
bmj4_1_e003689.full;401 H pylori-positive patients;401;-1
bmj4_1_e003689.full;401 unique patients;401;-1
bmj4_1_e003689.full;1040 patients;1040;-1
bmj4_1_e003689.full;600 people;600;-1
bmj4_1_e003689.full;22 people;22;-1
bmj4_1_e003689.full;200 individuals;200;-1
bmj4_1_e003689.full;14 individuals;14;-1
bmj4_1_e003689.full;5 individuals;5;-1
bmj4_1_e003689.full;10 individuals;10;-1
bmj4_1_e003689.full;n=194;194;-1
bmj4_1_e003689.full;n=115;115;-1
bmj4_1_e003690.full;30 women;30;-1
bmj4_1_e003690.full;40  participants;40;-1
bmj4_1_e003690.full;40 participants;40;-1
bmj4_1_e003690.full;350 million people;350;-1
bmj4_1_e003697.full;518 participants;518;-1
bmj4_1_e003697.full;66 participants;66;-1
bmj4_1_e003697.full;441 patients;441;-1
bmj4_1_e003697.full;234 patients;234;-1
bmj4_1_e003697.full;60 patients;60;-1
bmj4_1_e003697.full;352 patients;352;-1
bmj4_1_e003697.full;40 patients;40;-1
bmj4_1_e003697.full;10 patients;10;-1
bmj4_1_e003697.full;1 patients;1;-1
bmj4_1_e003697.full;n=  11;11;-1
bmj4_1_e003697.full;n  =2;2;-1
bmj4_1_e003697.full;n=  7;7;-1
bmj4_1_e003697.full;n=  30;30;-1
bmj4_1_e003697.full;n=  10;10;-1
bmj4_1_e003697.full;n=  18;18;-1
bmj4_1_e003697.full;n=  13;13;-1
bmj4_1_e003697.full;n=  6;6;-1
bmj4_1_e003697.full;n=  2;2;-1
bmj4_1_e003697.full;n=  8;8;-1
bmj4_1_e003697.full;N  =1;1;-1
bmj4_1_e003697.full;n=  64;64;-1
bmj4_1_e003697.full;n  =6;6;-1
bmj4_1_e003697.full;n=  46;46;-1
bmj4_1_e003697.full;n=  22;22;-1
bmj4_1_e003697.full;n=  65;65;-1
bmj4_1_e003697.full;n=  77;77;-1
bmj4_1_e003697.full;n=  44;44;-1
bmj4_1_e003697.full;n=  26;26;-1
bmj4_1_e003697.full;n=  24;24;-1
bmj4_1_e003697.full;n=  12;12;-1
bmj4_1_e003697.full;n=  55;55;-1
bmj4_1_e003697.full;n=  38;38;-1
bmj4_1_e003697.full;n=  17;17;-1
bmj4_1_e003697.full;n=  40;40;-1
bmj4_1_e003697.full;n=  19;19;-1
bmj4_1_e003697.full;n=  35;35;-1
bmj4_1_e003697.full;n  =3;3;-1
bmj4_1_e003697.full;n=  25;25;-1
bmj4_1_e003697.full;n=  84;84;-1
bmj4_1_e003697.full;n=  16;16;-1
bmj4_1_e003697.full;n=  1;1;-1
bmj4_1_e003697.full;n=  5;5;-1
bmj4_1_e003697.full;n=  23;23;-1
bmj4_1_e003697.full;n=  89;89;-1
bmj4_1_e003697.full;n=  28;28;-1
bmj4_1_e003697.full;n=  57;57;-1
bmj4_1_e003697.full;n=  51;51;-1
bmj4_1_e003697.full;n=  49;49;-1
bmj4_1_e003697.full;n=  29;29;-1
bmj4_1_e003697.full;n  =7;7;-1
bmj4_1_e003697.full;N  =8;8;-1
bmj4_1_e003697.full;N=58;58;-1
bmj4_1_e003697.full;N=100;100;-1
bmj4_1_e003698.full;3155 patients;3155;-1
bmj4_1_e003698.full;42  This study selected patients;42;-1
bmj4_1_e003698.full;3155 study patients;3155;-1
bmj4_1_e003698.full;9 Older people;9;-1
bmj4_1_e003698.full;8  Older adults;8;-1
bmj4_1_e003698.full;n=2985;2985;-1
bmj4_1_e003698.full;n=170;170;-1
bmj4_1_e003698.full;n=3154;3154;-1
bmj4_1_e003698.full; data from 2000;2000;-1
bmj4_1_e003699.full;40 participants;40;-1
bmj4_1_e003699.full;28 While participants;28;-1
bmj4_1_e003699.full;28 While participants were recruited;28;-1
bmj4_1_e003699.full;n=2;2;-1
bmj4_1_e003699.full;n=20;20;-1
bmj4_1_e003699.full;n=40;40;-1
bmj4_1_e003699.full;total of 40;40;-1
bmj4_1_e003699.full;40 participants were enrolled;40;-1
bmj4_1_e003706.full;1 Recruitment of  participants;1;-1
bmj4_1_e003706.full;13 Relatives of patients;13;-1
bmj4_1_e003706.full;46  patients;46;-1
bmj4_1_e003706.full;46 patients;46;-1
bmj4_1_e003706.full;2577 patients;2577;-1
bmj4_1_e003706.full;20 000 compared with patients;20000;-1
bmj4_1_e003706.full;460 partners were  also recruited;460;-1
bmj4_1_e003706.full;460 partners were recruited;460;-1
bmj4_1_e003706.full;n=387;387;-1
bmj4_1_e003706.full;n=149;149;-1
bmj4_1_e003706.full;n=536;536;-1
bmj4_1_e003706.full;n=438;438;-1
bmj4_1_e003706.full;n=318;318;-1
bmj4_1_e003706.full;n=120;120;-1
bmj4_1_e003706.full;n=418;418;-1
bmj4_1_e003706.full;n=268;268;-1
bmj4_1_e003706.full;n=232;232;-1
bmj4_1_e003720.full;2152 individuals;2152;-1
bmj4_1_e003720.full;329  individuals;329;-1
bmj4_1_e003720.full;120 individuals;120;-1
bmj4_1_e003720.full;306 individuals;306;-1
bmj4_1_e003720.full;20 individuals;20;-1
bmj4_1_e003720.full;2152 adults;2152;-1
bmj4_1_e003720.full;120 individuals recruited;120;-1
bmj4_1_e003720.full;n=306;306;-1
bmj4_1_e003720.full;n=113;113;-1
bmj4_1_e003735.full;N=458,322;458322;-1
bmj4_1_e003735.full;total of 51;51;-1
bmj4_1_e003735.full; data from 55;55;-1
bmj4_1_e003747.full;7  of participants;7;-1
bmj4_1_e003747.full;1838 patients;1838;-1
bmj4_1_e003747.full;78 patients;78;-1
bmj4_1_e003747.full;1 patients;1;-1
bmj4_1_e003747.full;5637 eli-  gible patients;5637;-1
bmj4_1_e003747.full;1916 patients;1916;-1
bmj4_1_e003747.full;1838  patients;1838;-1
bmj4_1_e003747.full;1358 patients;1358;-1
bmj4_1_e003747.full;480 patients;480;-1
bmj4_1_e003747.full;12 It is not known why some  patients;12;-1
bmj4_1_e003747.full;750 people;750;-1
bmj4_1_e003747.full;34,271 adults;34271;-1
bmj4_1_e003747.full;N=25;25;-1
bmj4_1_e003747.full; dataset  of 1916;1916;-1
bmj4_1_e003799.full;13 and young Swiss women;13;-1
bmj4_1_e003799.full;110 adults;110;-1
bmj4_1_e003799.full;n=84;84;-1
bmj4_1_e003799.full; data from 1;1;-1
bmj4_1_e003824.full;1309 patients;1309;-1
bmj4_1_e003824.full;534 patients;534;-1
bmj4_1_e003824.full;994 of these patients;994;-1
bmj4_1_e003824.full;994 Follow-up patients;994;-1
bmj4_1_e003824.full;534 Non-FU patients;534;-1
bmj4_1_e003824.full;n=1238;1238;-1
bmj4_1_e003824.full;N=994;994;-1
bmj4_1_e003824.full;N=534;534;-1
bmj4_1_e003824.full;N=460;460;-1
bmj4_1_e003824.full;n=994;994;-1
bmj4_1_e003824.full;n=534;534;-1
bmj4_1_e003832.full;368  individuals;368;-1
bmj4_1_e003832.full;15 individuals;15;-1
bmj4_1_e003835.full;11 TMs  recruited;11;-1
bmj4_1_e003835.full;n=10;10;-1
bmj4_1_e003835.full;n=1;1;-1
bmj4_1_e003835.full;n=3;3;-1
bmj4_1_e003835.full;n=20;20;-1
bmj4_1_e003835.full;n=6;6;-1
bmj4_1_e003835.full;n=2;2;-1
bmj4_1_e003835.full;n=4;4;-1
bmj4_1_e003839.full;16 513 patients;16513;-1
bmj4_1_e003839.full;8 A recent publication of patients;8;-1
bmj4_1_e003839.full;48 121 patients;48121;-1
bmj4_1_e003839.full;42 008 patients;42008;-1
bmj4_1_e003839.full;25 These patients;25;-1
bmj4_1_e003839.full;N=42 008;42008;-1
bmj4_1_e003839.full;N=16 513;16513;-1
bmj4_1_e003839.full;n=120;120;-1
bmj4_1_e003839.full;n=334;334;-1
bmj4_1_e003839.full;N=7921;7921;-1
bmj4_1_e003839.full;N=8592;8592;-1
bmj4_1_e003839.full;n  =1;1;-1
bmj4_1_e003839.full;total of 48 121;48121;-1
bmj4_1_e003845.full;23 450 persons;23450;-1
bmj4_1_e003845.full;37 890 persons;37890;-1
bmj4_1_e003845.full;673 patients;673;-1
bmj4_1_e003845.full;37 506 patients;37506;-1
bmj4_1_e003845.full;2005 patients;2005;-1
bmj4_1_e003845.full;n=838;838;-1
bmj4_1_e003845.full;n=953;953;-1
bmj4_1_e003845.full;total of 22 705;22705;-1
bmj4_1_e003845.full;total of  37 890;37890;-1
bmj4_1_e003845.full;total of 37 506;37506;-1
bmj4_1_e003845.full;total of 283 306;283306;-1
bmj4_1_e003845.full;total of 474 489;474489;-1
bmj4_1_e003883.full;500 participants;500;-1
bmj4_1_e003883.full;435 participants;435;-1
bmj4_1_e003883.full;509 adult patients;509;-1
bmj4_1_e003883.full;100 patients;100;-1
bmj4_1_e003883.full;400 patients;400;-1
bmj4_1_e003883.full;509 patients;509;-1
bmj4_1_e003883.full;443 patients;443;-1
bmj4_1_e003883.full;n=14;14;-1
bmj4_1_e003883.full;n=36;36;-1
bmj4_1_e003883.full;n=4;4;-1
bmj4_1_e003883.full;n=1;1;-1
bmj4_1_e003883.full;n=330;330;-1
bmj4_1_e003883.full;n=105;105;-1
bmj4_1_e003883.full;n=328;328;-1
bmj4_1_e003883.full;n=104;104;-1
bmj4_1_e003883.full;n=320;320;-1
bmj4_1_e003883.full;n=321;321;-1
bmj4_1_e003883.full;n=325;325;-1
bmj4_1_e003883.full;n=322;322;-1
bmj4_1_e003883.full;n=319;319;-1
bmj4_1_e003883.full;n=324;324;-1
bmj4_1_e003883.full;n=111;111;-1
bmj4_1_e003883.full;n=108;108;-1
bmj4_1_e003883.full;n=313;313;-1
bmj4_1_e003883.full;n=314;314;-1
bmj4_1_e003883.full;n=316;316;-1
bmj4_1_e003883.full;n=51;51;-1
bmj4_1_e003883.full;total of 509;509;-1
bmj4_1_e003883.full;509 patients were enrolled;509;-1
bmj4_1_e003883.full;324 enrolled;324;-1
bmj4_1_e003883.full;111 enrolled;111;-1
bmj4_1_e003885.full;82 participants;82;-1
bmj4_1_e003885.full;21 participants;21;-1
bmj4_1_e003885.full;82 consecutive outpatients;82;-1
bmj4_1_e003885.full;82 consecutive patients;82;-1
bmj4_1_e003885.full;37 patients;37;-1
bmj4_1_e003885.full;45 patients;45;-1
bmj4_1_e003885.full;n=15;15;-1
bmj4_1_e003885.full;n=43;43;-1
bmj4_1_e003885.full;n=21;21;-1
bmj4_1_e003885.full;total of 82;82;-1
bmj4_1_e003885.full;82 participants enrolled;82;-1
bmj4_1_e003885.full;21 participants were  enrolled;21;-1
bmj4_1_e003888.full;19 760 patients;19760;-1
bmj4_1_e003888.full;19 670 patients;19670;-1
bmj4_1_e003888.full;19 670 newly  diagnosed patients;19670;-1
bmj4_1_e003888.full;100 000 adults;100000;-1
bmj4_1_e003888.full;100 000  adults;100000;-1
bmj4_1_e003888.full;n=19 670;19670;-1
bmj4_1_e003888.full;n=  11;11;-1
bmj4_1_e003888.full;N  =8;8;-1
bmj4_1_e003902.full;n=333;333;-1
bmj4_1_e003902.full;n=234;234;-1
bmj4_1_e003902.full;n=4211;4211;-1
bmj4_1_e003902.full;n=3700;3700;-1
bmj4_1_e003902.full;n=251;251;-1
bmj4_1_e003902.full;n=319;319;-1
bmj4_1_e003902.full;N=800;800;-1
bmj4_1_e003902.full;N=20 647;20647;-1
bmj4_1_e003902.full;N  =2;2;-1
bmj4_1_e003902.full;N  =1;1;-1
bmj4_1_e003902.full;N  =7;7;-1
bmj4_1_e003902.full;N  =5;5;-1
bmj4_1_e003902.full;N  =3;3;-1
bmj4_1_e003902.full;N  =6;6;-1
bmj4_1_e003902.full;total of 27;27;-1
bmj4_1_e003917.full;5858 individuals;5858;-1
bmj4_1_e003917.full;91 and vulnerable individuals;91;-1
bmj4_1_e003917.full;3605 individuals;3605;-1
bmj4_1_e003917.full;2242 individuals;2242;-1
bmj4_1_e003917.full;1497 individuals;1497;-1
bmj4_1_e003917.full;3739 individuals;3739;-1
bmj4_1_e003917.full;6940 adults;6940;-1
bmj4_1_e003917.full;68  No other adults;68;-1
bmj4_1_e003917.full;3605 individuals recruited;3605;-1
bmj4_1_e003917.full;3335 indi-  viduals recruited;3335;-1
bmj4_1_e003917.full;total of 4139;4139;-1
bmj4_1_e003949.full;n=2773;2773;-1
bmj4_1_e003949.full;n=18 000;18000;-1
bmj4_1_e003949.full;n=2 737;2737;-1
bmj4_1_e003949.full;n=1 904;1904;-1
bmj4_1_e003949.full;n=607;607;-1
bmj4_1_e003949.full;n=226;226;-1
bmj4_1_e003954.full;13 754 men and women;13754;9331
bmj4_1_e003954.full;33 Obese women;33;16866
bmj4_1_e003954.full;90 patients;90;11822
bmj4_1_e003954.full;N=13 754;13754;1309
bmj4_1_e003954.full;n=7832;7832;1427
bmj4_1_e003954.full;n=5922;5922;1437
bmj4_1_e003954.full;total of 13 754;13754;9340
bmj4_1_e003954.full;total of 69;69;3551
bmj4_1_e003954.full; data from the 2007;2007;9425
bmj4_1_e003976.full;18 non-demented  patients;18;-1
bmj4_1_e003976.full;18 patients;18;-1
bmj4_1_e003976.full;5 These patients;5;-1
bmj4_1_e003976.full;13 patients;13;-1
bmj4_1_e003976.full;5 patients;5;-1
bmj4_1_e003976.full;3 patients;3;-1
bmj4_1_e003976.full;14 No patients;14;-1
bmj4_1_e003976.full;n=18;18;-1
bmj4_1_e003976.full;n=19;19;-1
bmj4_1_e003980.full;400 participants;400;2708
bmj4_1_e003980.full;864 participants;864;1137
bmj4_1_e003980.full;1000 participants;1000;1009
bmj4_1_e003985.full;7472 women;7472;-1
bmj4_1_e003985.full;22 A sub-  group of women;22;-1
bmj4_1_e003985.full;280 women;280;-1
bmj4_1_e003985.full;001  Single women;1;-1
bmj4_1_e003985.full;280 women recruited;280;-1
bmj4_1_e003985.full;n=6820;6820;-1
bmj4_1_e003985.full;n=652;652;-1
bmj4_1_e003985.full;n=5280;5280;-1
bmj4_1_e003985.full;n=507;507;-1
bmj4_1_e003985.full;n=813;813;-1
bmj4_1_e003985.full;n=2375;2375;-1
bmj4_1_e003985.full;n=2582;2582;-1
bmj4_1_e003986.full;130 women;130;-1
bmj4_1_e003986.full;20 women;20;-1
bmj4_1_e004001.full;2903 participants;2903;7914
bmj4_1_e004001.full;3240 participants;3240;3421
bmj4_1_e004001.full;2724  participants;2724;6823
bmj4_1_e004001.full;4059 CARDIA participants;4059;10508
bmj4_1_e004001.full;4403 Framingham Study  participants;4403;11221
bmj4_1_e004001.full;2500  uncomplicated patients;2500;10316
bmj4_1_e004001.full;423 patients;423;10392
bmj4_1_e004001.full;n=2903;2903;4596
bmj4_1_e004017.full;32 660 women;32660;-1
bmj4_1_e004017.full;n=76 766;76766;-1
bmj4_1_e004017.full;n=198;198;-1
bmj4_1_e004017.full;n=32 660;32660;-1
bmj4_1_e004017.full;n=195;195;-1
bmj4_1_e004018.full;719 random control participants;719;-1
bmj4_1_e004018.full;14  Control participants;14;-1
bmj4_1_e004018.full;719 control participants;719;-1
bmj4_1_e004018.full;171 patients;171;-1
bmj4_1_e004018.full;n=12;12;-1
bmj4_1_e004018.full;n=58;58;-1
bmj4_1_e004018.full;n=137;137;-1
bmj4_1_e004018.full;n=1000;1000;-1
bmj4_1_e004018.full;n=171;171;-1
bmj4_1_e004018.full;n=719;719;-1
bmj4_1_e004026.full;63 371 women;63371;-1
bmj4_1_e004026.full;5 Older women;5;-1
bmj4_1_e004026.full;30 We additionally excluded women;30;-1
bmj4_1_e004026.full;79 774 women;79774;-1
bmj4_1_e004026.full;15 553 women;15553;-1
bmj4_1_e004026.full;62 women;62;-1
bmj4_1_e004026.full;682 women;682;-1
bmj4_1_e004026.full;39 who planned  nulliparous women;39;-1
bmj4_1_e004026.full;12 944  women;12944;-1
bmj4_1_e004026.full;n=  33;33;-1
bmj4_1_e004026.full;n=  11;11;-1
bmj4_1_e004026.full;n=  18;18;-1
bmj4_1_e004026.full;n=  10;10;-1
bmj4_1_e004026.full;n=  16;16;-1
bmj4_1_e004026.full;total of 79 774;79774;-1
bmj4_1_e004027.full;n=2402;2402;-1
bmj4_1_e004027.full;n=2486;2486;-1
bmj4_1_e004027.full;n=2461;2461;-1
bmj4_1_e004027.full;n=2435;2435;-1
bmj4_1_e004027.full;n=1043;1043;-1
bmj4_1_e004027.full;n=1443;1443;-1
bmj4_1_e004027.full;n=1734;1734;-1
bmj4_1_e004027.full;n=752;752;-1
bmj4_1_e004027.full;n=570;570;-1
bmj4_1_e004027.full;n=809;809;-1
bmj4_1_e004027.full;n=555;555;-1
bmj4_1_e004027.full;n=537;537;-1
bmj4_1_e004027.full;n=1003;1003;-1
bmj4_1_e004027.full;n=558;558;-1
bmj4_1_e004027.full;n=473;473;-1
bmj4_1_e004027.full;n=390;390;-1
bmj4_1_e004027.full;n=42;42;-1
bmj4_1_e004027.full;n=20;20;-1
bmj4_1_e004027.full;n=937;937;-1
bmj4_1_e004027.full;n=707;707;-1
bmj4_1_e004027.full;n=719;719;-1
bmj4_1_e004039.full;160 English hospitals treating patients;160;-1
bmj4_1_e004039.full;1 Comparison of patients;1;-1
bmj4_1_e004039.full;n=69 086;69086;-1
bmj4_1_e004039.full;n=2;2;-1
bmj4_1_e004039.full; data from the 2011;2011;-1
bmj4_1_e004039.full; data from the 2010;2010;-1
bmj4_1_e004046.full;1 Overview of study participants;1;-1
bmj4_1_e004046.full;N=17;17;-1
bmj4_1_e004046.full;N=13;13;-1
bmj4_1_e004046.full;N=4;4;-1
bmj4_1_e004046.full;N=5313;5313;-1
bmj4_1_e004046.full;N=3756;3756;-1
bmj4_1_e004046.full;N=1557;1557;-1
bmj4_1_e004046.full;total of 5313;5313;-1
bmj4_1_e004052.full;80 033 patients;80033;-1
bmj4_1_e004052.full;65 909 patients;65909;-1
bmj4_1_e004052.full;8412  patients;8412;-1
bmj4_1_e004052.full;3031  patients;3031;-1
bmj4_1_e004052.full;1188 consecutive patients;1188;-1
bmj4_1_e004052.full;n=65 909;65909;-1
bmj4_1_e004052.full;n=99 473;99473;-1
bmj4_1_e004052.full;n=19 440;19440;-1
bmj4_1_e004052.full;n=2564;2564;-1
bmj4_1_e004052.full;total of 8412;8412;-1
bmj4_1_e004062.full;132 being women;132;-1
bmj4_1_e004062.full;201 patients;201;-1
bmj4_1_e004062.full;209 asthmatic adolescent and adults;209;-1
bmj4_1_e004066.full;90 participants;90;-1
bmj4_1_e004066.full;n=90;90;-1
bmj4_1_e004066.full;n=45;45;-1
bmj4_1_e004066.full;total of 90;90;-1
bmj4_1_e004069.full;131 811 patients;131811;-1
bmj4_1_e004069.full;3 Health costs and income of patients;3;-1
bmj4_1_e004073.full;5000 patients;5000;-1
bmj4_1_e004073.full;342 patients;342;-1
bmj4_1_e004073.full;5900 patients;5900;-1
bmj4_1_e004089.full;1250 participants;1250;-1
bmj4_1_e004089.full;22  For all participants;22;-1
bmj4_1_e004089.full;41 If anonymity of participants;41;-1
bmj4_1_e004089.full;28  Facebook enables individuals;28;-1
bmj4_1_e004089.full;1000 individuals;1000;-1
bmj4_1_e004089.full;1 compares individuals;1;-1
bmj4_1_e004089.full;10 million adults;10;-1
bmj4_1_e004089.full;1000 individuals recruited;1000;-1
bmj4_1_e004089.full;N=8000;8000;-1
bmj4_1_e004094.full;50 participants;50;-1
bmj4_1_e004094.full;50 patients;50;-1
bmj4_1_e004094.full;25 patients;25;-1
bmj4_1_e004094.full;176 potential patients;176;-1
bmj4_1_e004094.full;100 elderly patients;100;-1
bmj4_1_e004094.full;3 Identification of individuals;3;-1
bmj4_1_e004094.full;n=25;25;-1
bmj4_1_e004094.full;total of 16;16;-1
bmj4_1_e004097.full;1200 moderate-to-high risk patients;1200;-1
bmj4_1_e004097.full;700 patients;700;-1
bmj4_1_e004097.full;1200  patients;1200;-1
bmj4_1_e004097.full;800 patients;800;-1
bmj4_1_e004097.full;1200 patients;1200;-1
bmj4_1_e004097.full;998 patients;998;-1
bmj4_1_e004097.full;265 patients;265;-1
bmj4_1_e004097.full;29 patients;29;-1
bmj4_1_e004097.full;704 patients;704;-1
bmj4_1_e004097.full;650 patients;650;-1
bmj4_1_e004097.full;567  patients;567;-1
bmj4_1_e004097.full;200 million patients;200;-1
bmj4_1_e004097.full;10,701  adults;10701;-1
bmj4_1_e004097.full;n=2;2;-1
bmj4_1_e004097.full;n=27;27;-1
bmj4_1_e004097.full;294 were not enrolled;294;-1
bmj4_1_e004097.full;567  patients enrolled;567;-1
bmj4_1_e004105.full;330 community-dwelling patients;330;-1
bmj4_1_e004105.full;330  dyads of patients;330;-1
bmj4_1_e004105.full;36 million people;36;-1
bmj4_1_e004109.full;40s and women;40;-1
bmj4_1_e004109.full;695 participants;695;-1
bmj4_1_e004109.full;175 patients;175;-1
bmj4_1_e004109.full;2013  were recruited;2013;-1
bmj4_1_e004109.full;N=5;5;-1
bmj4_1_e004109.full;N=3;3;-1
bmj4_1_e004109.full;N=9;9;-1
bmj4_1_e004109.full;N=4;4;-1
bmj4_1_e004109.full;total of 520;520;-1
bmj4_1_e004119.full; data  from 2003;2003;-1
bmj4_1_e004119.full; data from 2007;2007;-1
bmj4_1_e004132.full;14  Potential participants;14;-1
bmj4_1_e004132.full;N=50;50;-1
bmj4_1_e004132.full;N=79;79;-1
bmj4_1_e004132.full;N=20;20;-1
bmj4_1_e004132.full;N=109;109;-1
bmj4_1_e004132.full;N=5;5;-1
bmj4_1_e004132.full;N=124;124;-1
bmj4_1_e004132.full;N=18;18;-1
bmj4_1_e004132.full;N=111;111;-1
bmj4_1_e004132.full;study population included 129;129;-1
bmj4_1_e004132.full;129 children enrolled;129;-1
bmj4_1_e004136.full;n=3;3;-1
bmj4_1_e004136.full;n=1;1;-1
bmj4_1_e004136.full;N=25;25;-1
bmj4_1_e004136.full;n=68;68;-1
bmj4_1_e004136.full;n=34;34;-1
bmj4_1_e004136.full;n=14;14;-1
bmj4_1_e004136.full;total of 74;74;-1
bmj4_1_e004137.full;450 patients;450;-1
bmj4_1_e004137.full;150  patients;150;-1
bmj4_1_e004137.full;7 inpatients;7;-1
bmj4_1_e004137.full;12 outpatients;12;-1
bmj4_1_e004137.full;118,465 patients;118465;-1
bmj4_1_e004137.full;6247 patients;6247;-1
bmj4_1_e004137.full;n=20;20;-1
bmj4_1_e004147.full;69 H&N patients;69;-1
bmj4_1_e004147.full;38 patients;38;-1
bmj4_1_e004147.full;4 where  people;4;-1
bmj4_1_e004147.full;850 000 people;850000;-1
bmj4_1_e004153.full;18 820  patients;18820;-1
bmj4_1_e004153.full;n=290;290;-1
bmj4_1_e004153.full;n=120;120;-1
bmj4_1_e004153.full;n=161;161;-1
bmj4_1_e004153.full;n=9;9;-1
bmj4_1_e004153.full;n=148;148;-1
bmj4_1_e004153.full;n=130;130;-1
bmj4_1_e004153.full;n=18;18;-1
bmj4_1_e004153.full;n=201;201;-1
bmj4_1_e004153.full;n=178;178;-1
bmj4_1_e004153.full;n=23;23;-1
bmj4_1_e004153.full;n=92;92;-1
bmj4_1_e004153.full;n=45;45;-1
bmj4_1_e004153.full;n=2;2;-1
bmj4_1_e004153.full;n=112;112;-1
bmj4_1_e004153.full;n=100;100;-1
bmj4_1_e004153.full;n=12;12;-1
bmj4_1_e004153.full;n=166;166;-1
bmj4_1_e004153.full;n=143;143;-1
bmj4_1_e004153.full;n=21;21;-1
bmj4_1_e004156.full;15 591 participants;15591;-1
bmj4_1_e004156.full;3070 participants;3070;-1
bmj4_1_e004156.full;4662 participants;4662;-1
bmj4_1_e004156.full;3 poly-  morphisms may help people;3;-1
bmj4_1_e004156.full;11 539 individuals;11539;-1
bmj4_1_e004156.full;3378 individuals;3378;-1
bmj4_1_e004156.full;3378  individuals;3378;-1
bmj4_1_e004156.full;3070 individuals;3070;-1
bmj4_1_e004156.full;n=14;14;-1
bmj4_1_e004156.full;total of 1532;1532;-1
bmj4_1_e004156.full;total of 15;15;-1
bmj4_1_e004158.full;20 participants;20;-1
bmj4_1_e004158.full;40 obese patients;40;-1
bmj4_1_e004158.full;50 patients;50;-1
bmj4_1_e004158.full;16 patients;16;-1
bmj4_1_e004158.full;20 patients;20;-1
bmj4_1_e004158.full;50  patients;50;-1
bmj4_1_e004158.full;270,770 patients;270770;-1
bmj4_1_e004165.full;n=1049;1049;-1
bmj4_1_e004165.full;n=1229;1229;-1
bmj4_1_e004165.full;n=180;180;-1
bmj4_1_e004165.full;n=15;15;-1
bmj4_1_e004165.full;total of 1259;1259;-1
bmj4_1_e004165.full;total of 1218;1218;-1
bmj4_1_e004165.full;total of  1229;1229;-1
bmj4_1_e004166.full;16  consecutive patients;16;-1
bmj4_1_e004166.full;16  patients;16;-1
bmj4_1_e004166.full;113 patients;113;-1
bmj4_1_e004166.full;18 patients;18;-1
bmj4_1_e004166.full;16 patients;16;-1
bmj4_1_e004166.full;5 patients;5;-1
bmj4_1_e004166.full;13 patients;13;-1
bmj4_1_e004166.full;113  fasciectomy-treated patients;113;-1
bmj4_1_e004166.full;2 patients;2;-1
bmj4_1_e004166.full;7 patients;7;-1
bmj4_1_e004166.full;9 patients;9;-1
bmj4_1_e004166.full;10 patients;10;-1
bmj4_1_e004166.full;24 patients;24;-1
bmj4_1_e004166.full;61 patients;61;-1
bmj4_1_e004166.full;total of 113;113;-1
bmj4_1_e004178.full;18  To identify individuals;18;-1
bmj4_1_e004178.full;19 By excluding individuals;19;-1
bmj4_1_e004178.full;n=287;287;-1
bmj4_1_e004178.full;n=  81;81;-1
bmj4_1_e004178.full;n=  15;15;-1
bmj4_1_e004178.full;n=  27;27;-1
bmj4_1_e004178.full;n=  84;84;-1
bmj4_1_e004178.full;n=  50;50;-1
bmj4_1_e004178.full;n=  52;52;-1
bmj4_1_e004178.full;n=  44;44;-1
bmj4_1_e004178.full;n  =1;1;-1
bmj4_1_e004178.full;n=  87;87;-1
bmj4_1_e004182.full; data from  2011;2011;-1
bmj4_1_e004182.full; data analysis from  2008;2008;-1
bmj4_1_e004188.full;2  overexpressing patients;2;-1
bmj4_1_e004188.full;10 000 people;10000;-1
bmj4_1_e004189.full;9 women;9;-1
bmj4_1_e004189.full;131 patients;131;-1
bmj4_1_e004189.full;17  patients;17;-1
bmj4_1_e004189.full;total of 131;131;-1
bmj4_1_e004189.full;total of 39;39;-1
bmj4_1_e004189.full; data from 27;27;-1
bmj4_1_e004195.full;1485 patients;1485;-1
bmj4_1_e004195.full;468 patients;468;-1
bmj4_1_e004195.full;3744  patients;3744;-1
bmj4_1_e004195.full;20  This trial enrolled;20;-1
bmj4_1_e004205.full;137 control participants;137;-1
bmj4_1_e004205.full;100 patients;100;-1
bmj4_1_e004205.full;607 patients;607;-1
bmj4_1_e004205.full;150 patients;150;-1
bmj4_1_e004205.full;total of 607;607;-1
bmj4_1_e004210.full;85 participants;85;-1
bmj4_1_e004210.full;2 seropositive  participants;2;-1
bmj4_1_e004210.full;1 seropositive participants;1;-1
bmj4_1_e004210.full;2 seropositive participants;2;-1
bmj4_1_e004210.full;2 dually infected participants;2;-1
bmj4_1_e004210.full;80 participants;80;-1
bmj4_1_e004210.full;85 study participants;85;-1
bmj4_1_e004210.full;39 participants;39;-1
bmj4_1_e004210.full;4 participants;4;-1
bmj4_1_e004210.full;11 participants;11;-1
bmj4_1_e004210.full;126 patients;126;-1
bmj4_1_e004210.full;2 coinfected patients;2;-1
bmj4_1_e004210.full;41 excluded individuals;41;-1
bmj4_1_e004210.full;n=44;44;-1
bmj4_1_e004210.full;n=41;41;-1
bmj4_1_e004210.full;n=9;9;-1
bmj4_1_e004210.full;n=8;8;-1
bmj4_1_e004210.full;n=6;6;-1
bmj4_1_e004210.full;n=5;5;-1
bmj4_1_e004210.full;n=3;3;-1
bmj4_1_e004210.full;n=1;1;-1
bmj4_1_e004210.full;n=11;11;-1
bmj4_1_e004210.full;n=2;2;-1
bmj4_1_e004210.full;n=85;85;-1
bmj4_1_e004210.full;n=74;74;-1
bmj4_1_e004210.full;n=56;56;-1
bmj4_1_e004210.full;total of 126;126;-1
bmj4_1_e004210.full;total of  198;198;-1
bmj4_1_e004214.full;3570 women;3570;-1
bmj4_1_e004214.full;26 women;26;-1
bmj4_1_e004214.full;13 587  participants;13587;-1
bmj4_1_e004214.full;13 587 participants;13587;-1
bmj4_1_e004214.full;total of 10 017;10017;-1
bmj4_1_e004266.full;2000 patients;2000;-1
bmj4_1_e004266.full;242 patients;242;-1
bmj4_1_e004266.full;242  patients;242;-1
bmj4_1_e004266.full;234 patients;234;-1
bmj4_1_e004266.full;N=242;242;-1
bmj4_1_e004266.full;N=195;195;-1
bmj4_1_e004266.full;N=47;47;-1
bmj4_1_e004268.full;n=100;100;22169
bmj4_1_e004268.full;n=69;69;22137
bmj4_1_e004268.full;n=139;139;5042
bmj4_1_e004268.full;n=91;91;4992
bmj4_1_e004268.full;n=169;169;3662
bmj4_1_e004268.full;total of 316;316;15491
bmj4_1_e004268.full;total of 208;208;1144
bmj4_1_e004274.full;17  participants;17;-1
bmj4_1_e004274.full;total of 100;100;-1
bmj4_1_e004283.full;30 000  persons;30000;-1
bmj4_1_e004283.full;30 329 participants;30329;-1
bmj4_1_e004283.full;29 664 REGARDS  participants;29664;-1
bmj4_1_e004283.full;30 239  community-dwelling individuals;30239;-1
bmj4_1_e004283.full;975  individuals;975;-1
bmj4_1_e004283.full;28 694 non-sepsis  individuals;28694;-1
bmj4_1_e004283.full;970 individuals;970;-1
bmj4_1_e004283.full;28 694 non-  sepsis individuals;28694;-1
bmj4_1_e004283.full;1310 non-sepsis individuals;1310;-1
bmj4_1_e004283.full;28 694 non-sepsis individuals;28694;-1
bmj4_1_e004283.full;30 239 community-dwelling adults;30239;-1
bmj4_1_e004283.full;n=970;970;-1
bmj4_1_e004283.full;n=28 694;28694;-1
bmj4_1_e004283.full;n=257;257;-1
bmj4_1_e004283.full;n=713;713;-1
bmj4_1_e004283.full;n=274;274;-1
bmj4_1_e004283.full;n=2318;2318;-1
bmj4_1_e004283.full; data from the 30 239;30239;-1
bmj4_1_e004283.full; data from the 30 329;30329;-1
bmj4_1_e004295.full;2206 participants;2206;-1
bmj4_1_e004295.full;15 166 participants;15166;-1
bmj4_1_e004295.full;1 Descriptive statistics of patients;1;-1
bmj4_1_e004295.full;n=101;101;-1
bmj4_1_e004295.full;n=1;1;-1
bmj4_1_e004295.full;n=18 290;18290;-1
bmj4_1_e004295.full;N=43 454;43454;-1
bmj4_1_e004295.full;N=28 477;28477;-1
bmj4_1_e004295.full;N=18 290;18290;-1
bmj4_1_e004295.full;N=10 187;10187;-1
bmj4_1_e004295.full;N=43 449;43449;-1
bmj4_1_e004295.full;total of 28 477;28477;-1
bmj4_1_e004295.full;total of 43 746;43746;-1
bmj4_1_e004295.full;total of 2206;2206;-1
bmj4_1_e004303.full;8 contexts where patients;8;-1
bmj4_1_e004303.full;7 patients;7;-1
bmj4_1_e004303.full;total of 70;70;-1
bmj4_1_e004311.full;total of 133;133;-1
bmj4_1_e004313.full;120 participants;120;21766
bmj4_1_e004313.full;100  participants;100;357
bmj4_1_e004313.full;28 can classify some patients;28;22733
bmj4_1_e004313.full;6 In patients;6;19959
bmj4_1_e004313.full;120 patients;120;177
bmj4_1_e004313.full;total of 24;24;4966
bmj4_1_e004389.full;102 postmenopausal women;102;-1
bmj4_1_e004389.full;30 participants;30;-1
bmj4_1_e004389.full;20 patients;20;-1
bmj4_1_e004389.full;70 000 people;70000;-1
bmj4_1_e004422.full;N=2693;2693;-1
bmj4_1_e004422.full;N=3444;3444;-1
bmj4_1_e004422.full;N=180;180;-1
bmj4_1_e004422.full;N=1179;1179;-1
bmj4_1_e004422.full;N=1334;1334;-1
bmj4_1_e004422.full;n=10;10;-1
bmj4_1_e004422.full;N=2403;2403;-1
bmj4_1_e004422.full;N=931;931;-1
bmj4_1_e004422.full;N=25;25;-1
bmj4_1_e004422.full;N=2513;2513;-1
bmj4_1_e004422.full;N=3160;3160;-1
bmj4_1_e004422.full;total of 3444;3444;-1
bmj4_1_e004422.full;  data of 1255;1255;-1
bmj4_1_e004437.full;165  patients;165;-1
bmj4_1_e004437.full;30 patients;30;-1
bmj4_1_e004465.full;12  Although patients;12;-1
bmj4_1_e004465.full;16  For patients;16;-1
bmj4_1_e004465.full;53 patients;53;-1
bmj4_1_e004465.full;32 deceased patients;32;-1
bmj4_1_e004465.full;150 patients;150;-1
bmj4_1_e004596.full;N=52;52;-1
bmj4_2_e003218.full;3 billion  individuals;3;-1
bmj4_2_e003218.full;n=2586;2586;-1
bmj4_2_e003218.full;n=1020;1020;-1
bmj4_2_e003218.full;n=2582;2582;-1
bmj4_2_e003218.full;n=148;148;-1
bmj4_2_e003218.full;n=304;304;-1
bmj4_2_e003218.full;n=2175;2175;-1
bmj4_2_e003218.full;n=168;168;-1
bmj4_2_e003218.full;n=86;86;-1
bmj4_2_e003218.full;n=82;82;-1
bmj4_2_e003218.full;n=1155;1155;-1
bmj4_2_e003218.full;n=829;829;-1
bmj4_2_e003312.full;35 million people;35;-1
bmj4_2_e003312.full;n=246;246;-1
bmj4_2_e003312.full; data from  2001;2001;-1
bmj4_2_e003312.full; data from  n=246;246;-1
bmj4_2_e003312.full; data from 30;30;-1
bmj4_2_e003419.full;898 patients;898;-1
bmj4_2_e003419.full;400 000 patients;400000;-1
bmj4_2_e003419.full;3201  patients;3201;-1
bmj4_2_e003419.full;114 patients;114;-1
bmj4_2_e003419.full;2 study of patients;2;-1
bmj4_2_e003419.full;600 patients;600;-1
bmj4_2_e003419.full;n=45;45;-1
bmj4_2_e003419.full;n=50;50;-1
bmj4_2_e003419.full;n=48;48;-1
bmj4_2_e003419.full;n=222;222;-1
bmj4_2_e003419.full;n=224;224;-1
bmj4_2_e003419.full;n=226;226;-1
bmj4_2_e003419.full;n=73;73;-1
bmj4_2_e003419.full;n=96;96;-1
bmj4_2_e003419.full;n=93;93;-1
bmj4_2_e003419.full;n=98;98;-1
bmj4_2_e003419.full;n=149;149;-1
bmj4_2_e003419.full;n=128;128;-1
bmj4_2_e003419.full;n=133;133;-1
bmj4_2_e003481.full;706  participants;706;6185
bmj4_2_e003481.full;2194  participants;2194;6141
bmj4_2_e003481.full;10 patients;10;2840
bmj4_2_e003481.full;1 Cardiac arrest patients;1;16819
bmj4_2_e003481.full;2010 patients;2010;17015
bmj4_2_e003481.full;2010  patients;2010;17141
bmj4_2_e003481.full;1 contained patients;1;29925
bmj4_2_e003481.full;n=1450;1450;239
bmj4_2_e003481.full;n=  70;70;8689
bmj4_2_e003481.full;n  =3;3;8719
bmj4_2_e003481.full;n=  21;21;12433
bmj4_2_e003481.full;n  =1;1;12466
bmj4_2_e003481.full;n=2900;2900;16900
bmj4_2_e003481.full;n  =4;4;21797
bmj4_2_e003481.full;n  =2;2;21935
bmj4_2_e003481.full;n  =8;8;25805
bmj4_2_e003481.full;n  =7;7;25874
bmj4_2_e003505.full;23 participants;23;13848
bmj4_2_e003505.full;39 participants;39;8307
bmj4_2_e003505.full;20 test participants;20;8275
bmj4_2_e003505.full;39  participants;39;7790
bmj4_2_e003505.full;2 diabetic subjects;2;35629
bmj4_2_e003505.full;n=39;39;8191
bmj4_2_e003505.full;n=19;19;880
bmj4_2_e003505.full;n=20;20;856
bmj4_2_e003505.full;N=39;39;794
bmj4_2_e003505.full;n  =3;3;5697
bmj4_2_e003505.full; data from the 39;39;389
bmj4_2_e003512.full;90,056 participants;90056;-1
bmj4_2_e003512.full;9014 patients;9014;-1
bmj4_2_e003512.full;9014  patients;9014;-1
bmj4_2_e003512.full;4512 patients;4512;-1
bmj4_2_e003512.full;4231 patients;4231;-1
bmj4_2_e003512.full;4502 patients;4502;-1
bmj4_2_e003512.full; data from 61;61;-1
bmj4_2_e003512.full; data  from 90,056;90056;-1
bmj4_2_e003579.full;4566 people;4566;-1
bmj4_2_e003642.full;2008 over two million people;2008;-1
bmj4_2_e003642.full;total of 575;575;-1
bmj4_2_e003644.full;2678 men and women;2678;-1
bmj4_2_e003644.full;10 women;10;-1
bmj4_2_e003644.full;04 women;4;-1
bmj4_2_e003644.full;10 people;10;-1
bmj4_2_e003644.full;12 041 individuals;12041;-1
bmj4_2_e003644.full;2869 adults;2869;-1
bmj4_2_e003644.full;n  =1;1;-1
bmj4_2_e003644.full;n=1412;1412;-1
bmj4_2_e003644.full;n=1263;1263;-1
bmj4_2_e003736.full;1240 women;1240;-1
bmj4_2_e003736.full;13 541  women;13541;-1
bmj4_2_e003736.full;910 women;910;-1
bmj4_2_e003736.full;13 541 women;13541;-1
bmj4_2_e003736.full;23 017 women;23017;-1
bmj4_2_e003736.full;1003 participants;1003;-1
bmj4_2_e003736.full;231 102 patients;231102;-1
bmj4_2_e003736.full;14 563 patients;14563;-1
bmj4_2_e003736.full;2741  patients;2741;-1
bmj4_2_e003736.full;1586  patients;1586;-1
bmj4_2_e003736.full;75 million people;75;-1
bmj4_2_e003736.full;200 000 people;200000;-1
bmj4_2_e003736.full;n=231 102;231102;-1
bmj4_2_e003736.full;total of 204 131;204131;-1
bmj4_2_e003757.full;n=26;26;-1
bmj4_2_e003757.full;n=51;51;-1
bmj4_2_e003757.full;n=21;21;-1
bmj4_2_e003757.full;n=37;37;-1
bmj4_2_e003757.full;n=17;17;-1
bmj4_2_e003757.full;n=9;9;-1
bmj4_2_e003757.full;n=45;45;-1
bmj4_2_e003757.full;n=6;6;-1
bmj4_2_e003757.full;n=77;77;-1
bmj4_2_e003757.full;n=56;56;-1
bmj4_2_e003768.full;n=164;164;5103
bmj4_2_e003768.full;n=81;81;5142
bmj4_2_e003768.full;n=83;83;5191
bmj4_2_e003768.full;n=52;52;5245
bmj4_2_e003768.full;n  =8;8;9775
bmj4_2_e003768.full;n  =5;5;10198
bmj4_2_e003768.full;total of 266;266;1881
bmj4_2_e003800.full;n=676;676;-1
bmj4_2_e003800.full;n=585;585;-1
bmj4_2_e003800.full;n=677;677;-1
bmj4_2_e003800.full;n=618;618;-1
bmj4_2_e003800.full;n=1353;1353;-1
bmj4_2_e003800.full;n=1203;1203;-1
bmj4_2_e003800.full;total of  1500;1500;-1
bmj4_2_e003800.full;total of 1353;1353;-1
bmj4_2_e003800.full;total of 1500;1500;-1
bmj4_2_e003800.full;total of 1283;1283;-1
bmj4_2_e003800.full;total of  1203;1203;-1
bmj4_2_e003800.full;  data, a total of 1353;1353;-1
bmj4_2_e003827.full;243 individuals;243;-1
bmj4_2_e003827.full;10 individuals;10;-1
bmj4_2_e003827.full;40 HDM-sensitised adults;40;-1
bmj4_2_e003827.full;13 recruited;13;-1
bmj4_2_e003827.full;22 where children  were recruited;22;-1
bmj4_2_e003827.full;n=82;82;-1
bmj4_2_e003827.full;n=71;71;-1
bmj4_2_e003827.full;n=62;62;-1
bmj4_2_e003827.full;total of 27;27;-1
bmj4_2_e003827.full;total of 160;160;-1
bmj4_2_e003843.full;110 depressed  subjects;110;4118
bmj4_2_e003843.full;220 control subjects;220;4090
bmj4_2_e003843.full;14 subjects;14;2461
bmj4_2_e003843.full;121 million people;121;12892
bmj4_2_e003846.full;3135 patients;3135;-1
bmj4_2_e003846.full;2840 of those patients;2840;-1
bmj4_2_e003846.full;total of 19;19;-1
bmj4_2_e003884.full;n=10;10;-1
bmj4_2_e003884.full;n  =1;1;-1
bmj4_2_e003884.full;n  =2;2;-1
bmj4_2_e003884.full;n  =3;3;-1
bmj4_2_e003884.full;n  =5;5;-1
bmj4_2_e003884.full;n  =6;6;-1
bmj4_2_e003926.full;34 Six studies targeted women;34;-1
bmj4_2_e003926.full;4 billion adults;4;-1
bmj4_2_e003926.full;n  =4;4;-1
bmj4_2_e003933.full;2656 men and  women;2656;-1
bmj4_2_e003933.full;4807 men  and women;4807;-1
bmj4_2_e003933.full;510,000 men and women;510000;-1
bmj4_2_e003933.full;1900  participants;1900;-1
bmj4_2_e003933.full;31 including  all patients;31;-1
bmj4_2_e003933.full;4581 individuals;4581;-1
bmj4_2_e003933.full;1900 adults;1900;-1
bmj4_2_e003933.full;N= 3608;3608;-1
bmj4_2_e003933.full;N = 2656;2656;-1
bmj4_2_e003933.full;N=1900;1900;-1
bmj4_2_e003933.full;n=1900;1900;-1
bmj4_2_e003941.full;8,218 men and women;8218;-1
bmj4_2_e003941.full;15,000 observations  among Swedish women;15000;-1
bmj4_2_e003941.full;N=2774;2774;-1
bmj4_2_e003941.full;n=180;180;-1
bmj4_2_e003941.full;n=536;536;-1
bmj4_2_e003941.full;n=1218;1218;-1
bmj4_2_e003941.full;n=80;80;-1
bmj4_2_e003941.full;n=606;606;-1
bmj4_2_e003941.full;n=1709;1709;-1
bmj4_2_e003941.full;n=761;761;-1
bmj4_2_e003941.full;n=455;455;-1
bmj4_2_e003941.full;n=1151;1151;-1
bmj4_2_e003941.full;n=1818;1818;-1
bmj4_2_e003941.full;n=1797;1797;-1
bmj4_2_e003941.full;N  =2;2;-1
bmj4_2_e003941.full;n=575;575;-1
bmj4_2_e003941.full;n=570;570;-1
bmj4_2_e003941.full;total  of 2393;2393;-1
bmj4_2_e003941.full;total of 2367;2367;-1
bmj4_2_e003947.full;2441 women;2441;9222
bmj4_2_e003947.full;2172 women;2172;9160
bmj4_2_e003947.full;2180 women;2180;4889
bmj4_2_e003947.full;2455 women;2455;4760
bmj4_2_e003947.full;249 women;249;1660
bmj4_2_e003947.full;N=716;716;4969
bmj4_2_e003947.full;N=1456;1456;4984
bmj4_2_e003947.full;N=2441;2441;4996
bmj4_2_e003947.full;N=4613;4613;5009
bmj4_2_e003947.full;N=2172;2172;10191
bmj4_2_e003960.full;2958 patients;2958;-1
bmj4_2_e003960.full;944 500 individuals;944500;-1
bmj4_2_e003960.full;31 we included all individuals;31;-1
bmj4_2_e003960.full;2021 individuals;2021;-1
bmj4_2_e003960.full;2708  individuals;2708;-1
bmj4_2_e003960.full;944 500 individuals enrolled;944500;-1
bmj4_2_e003960.full;  data from 944 500;944500;-1
bmj4_2_e003960.full; data from 1;1;-1
bmj4_2_e003968.full;4484 patients;4484;-1
bmj4_2_e003968.full;1050 patients;1050;-1
bmj4_2_e003968.full;5800  patients;5800;-1
bmj4_2_e003968.full;10 500 patients;10500;-1
bmj4_2_e003968.full;5596 patients;5596;-1
bmj4_2_e003968.full;3 Exclusions of patients;3;-1
bmj4_2_e003968.full;n=33;33;-1
bmj4_2_e003968.full;n=1721;1721;-1
bmj4_2_e003968.full;n=1136;1136;-1
bmj4_2_e003968.full;n=18;18;-1
bmj4_2_e003968.full;n=15;15;-1
bmj4_2_e003968.full;n=17 455;17455;-1
bmj4_2_e003968.full;n=5596;5596;-1
bmj4_2_e003968.full;n=262;262;-1
bmj4_2_e003968.full;n=400;400;-1
bmj4_2_e003968.full;n=35;35;-1
bmj4_2_e003968.full;n=1058;1058;-1
bmj4_2_e003968.full;total of 1050;1050;-1
bmj4_2_e003968.full;total of 4485;4485;-1
bmj4_2_e003973.full;4000 randomly selected adult participants;4000;-1
bmj4_2_e003973.full;4000 randomly selected participants;4000;-1
bmj4_2_e003973.full;13 538 participants;13538;-1
bmj4_2_e003973.full;41 499 participants;41499;-1
bmj4_2_e003973.full;3000 random participants;3000;-1
bmj4_2_e003973.full;1500 participants;1500;-1
bmj4_2_e003973.full;22 500 randomly selected participants;22500;-1
bmj4_2_e003973.full;1039 randomly selected participants;1039;-1
bmj4_2_e003973.full;278 patients;278;-1
bmj4_2_e003973.full;34 Most of  the patients;34;-1
bmj4_2_e003973.full;2363 patients;2363;-1
bmj4_2_e003973.full;76 206 patients;76206;-1
bmj4_2_e003973.full;23 000 patients;23000;-1
bmj4_2_e003973.full;50 000 patients;50000;-1
bmj4_2_e003973.full;n=508;508;-1
bmj4_2_e003973.full;n  =2;2;-1
bmj4_2_e003973.full;n  =1;1;-1
bmj4_2_e003973.full;n  =3;3;-1
bmj4_2_e003973.full;n  =5;5;-1
bmj4_2_e003973.full;n  =4;4;-1
bmj4_2_e003973.full;n  =6;6;-1
bmj4_2_e003973.full;n  =9;9;-1
bmj4_2_e003973.full;n  =7;7;-1
bmj4_2_e003973.full;total of 38;38;-1
bmj4_2_e003973.full; databases  of 29;29;-1
bmj4_2_e003983.full;20 women;20;-1
bmj4_2_e003983.full;15 women;15;-1
bmj4_2_e003983.full;29 women;29;-1
bmj4_2_e003983.full;20 All pregnant women;20;-1
bmj4_2_e003983.full;500 000 individuals;500000;-1
bmj4_2_e003983.full;n=260;260;-1
bmj4_2_e003983.full;n=224;224;-1
bmj4_2_e003983.full;n=157;157;-1
bmj4_2_e003983.full;n=67;67;-1
bmj4_2_e003983.full;N=260;260;-1
bmj4_2_e003983.full;N=224;224;-1
bmj4_2_e003983.full;n=481;481;-1
bmj4_2_e003983.full;n=448;448;-1
bmj4_2_e003983.full;n=400;400;-1
bmj4_2_e003983.full;n=454;454;-1
bmj4_2_e003983.full;n=484;484;-1
bmj4_2_e003983.full;n=409;409;-1
bmj4_2_e003983.full;n=411;411;-1
bmj4_2_e003983.full;n=449;449;-1
bmj4_2_e003991.full;839  patients;839;-1
bmj4_2_e003991.full;839 patients;839;-1
bmj4_2_e003991.full;260 patients;260;-1
bmj4_2_e003991.full;400 patients;400;-1
bmj4_2_e003991.full;800 patients;800;-1
bmj4_2_e003991.full;1  and exacerbation rate of patients;1;-1
bmj4_2_e003991.full;33 So most of the patients;33;-1
bmj4_2_e003991.full;total of 839;839;-1
bmj4_2_e004013.full;n=25;25;-1
bmj4_2_e004013.full;N=200;200;-1
bmj4_2_e004013.full;n=157;157;-1
bmj4_2_e004015.full;253  persons;253;-1
bmj4_2_e004015.full;248 persons;248;-1
bmj4_2_e004015.full;253 persons;253;-1
bmj4_2_e004015.full;248  persons;248;-1
bmj4_2_e004015.full;242  persons;242;-1
bmj4_2_e004015.full;42 persons;42;-1
bmj4_2_e004015.full;60 persons;60;-1
bmj4_2_e004015.full;56  persons;56;-1
bmj4_2_e004015.full;46 persons;46;-1
bmj4_2_e004015.full;27 persons;27;-1
bmj4_2_e004015.full;24 persons;24;-1
bmj4_2_e004015.full;n=1756;1756;-1
bmj4_2_e004020.full;9455 individuals;9455;-1
bmj4_2_e004020.full;total of 1632;1632;-1
bmj4_2_e004020.full; data from the 2011;2011;-1
bmj4_2_e004020.full; data from 54;54;-1
bmj4_2_e004033.full;13 864 participants;13864;-1
bmj4_2_e004033.full;11  Eligible participants;11;-1
bmj4_2_e004033.full;6 we excluded  participants;6;-1
bmj4_2_e004033.full;47 876 participants;47876;-1
bmj4_2_e004033.full;60 participants;60;-1
bmj4_2_e004033.full;1882 participants;1882;-1
bmj4_2_e004033.full;929 participants;929;-1
bmj4_2_e004033.full;47 876 patients;47876;-1
bmj4_2_e004033.full;13 864 patients;13864;-1
bmj4_2_e004033.full;462 293 adults;462293;-1
bmj4_2_e004033.full;total of 47 876;47876;-1
bmj4_2_e004033.full;total of 13 864;13864;-1
bmj4_2_e004033.full;total of 929;929;-1
bmj4_2_e004051.full;2151 women;2151;-1
bmj4_2_e004051.full;4 women;4;-1
bmj4_2_e004051.full;2151 included women;2151;-1
bmj4_2_e004051.full;496 women;496;-1
bmj4_2_e004051.full;1655 women;1655;-1
bmj4_2_e004051.full;64 women;64;-1
bmj4_2_e004051.full;40 women;40;-1
bmj4_2_e004051.full;N=2151;2151;-1
bmj4_2_e004051.full;n=496;496;-1
bmj4_2_e004051.full;n=1655;1655;-1
bmj4_2_e004051.full;total of 2151;2151;-1
bmj4_2_e004051.full;total of 13;13;-1
bmj4_2_e004051.full;total of 215;215;-1
bmj4_2_e004053.full;969  participants;969;-1
bmj4_2_e004053.full;n=1083;1083;-1
bmj4_2_e004053.full;n=1005;1005;-1
bmj4_2_e004053.full;n=1071;1071;-1
bmj4_2_e004053.full;n=550;550;-1
bmj4_2_e004053.full;n=163;163;-1
bmj4_2_e004053.full;n=126;126;-1
bmj4_2_e004053.full;n=130;130;-1
bmj4_2_e004053.full; data consist of a 10;10;-1
bmj4_2_e004053.full;  data from 1972;1972;-1
bmj4_2_e004070.full;n=76;76;-1
bmj4_2_e004070.full;n=31;31;-1
bmj4_2_e004070.full;n=64;64;-1
bmj4_2_e004071.full;0=women;0;-1
bmj4_2_e004071.full;2746 patients;2746;-1
bmj4_2_e004071.full;1271 patients;1271;-1
bmj4_2_e004071.full;2 Proportion of patients;2;-1
bmj4_2_e004071.full;n=2746;2746;-1
bmj4_2_e004071.full;n=1;1;-1
bmj4_2_e004071.full;n=7;7;-1
bmj4_2_e004071.full;n=1078;1078;-1
bmj4_2_e004071.full;n=71;71;-1
bmj4_2_e004071.full;n=2;2;-1
bmj4_2_e004071.full;n=1475;1475;-1
bmj4_2_e004071.full;n=1271;1271;-1
bmj4_2_e004071.full;n  =2;2;-1
bmj4_2_e004071.full;n  =1;1;-1
bmj4_2_e004071.full;n=2738;2738;-1
bmj4_2_e004071.full;N=1797;1797;-1
bmj4_2_e004076.full;32 Some women;32;-1
bmj4_2_e004076.full;33  Black and African-American women;33;-1
bmj4_2_e004076.full;31 Some African-American  women;31;-1
bmj4_2_e004076.full;47 Vulnerable women;47;-1
bmj4_2_e004076.full;6183  participants;6183;-1
bmj4_2_e004076.full;6183 individuals;6183;-1
bmj4_2_e004076.full;n=80;80;-1
bmj4_2_e004076.full;n  =2;2;-1
bmj4_2_e004076.full;n  =8;8;-1
bmj4_2_e004076.full;n  =3;3;-1
bmj4_2_e004076.full;n  =1;1;-1
bmj4_2_e004076.full;n  =4;4;-1
bmj4_2_e004078.full;350 participants;350;-1
bmj4_2_e004078.full;N=354;354;-1
bmj4_2_e004078.full;N  =3;3;-1
bmj4_2_e004078.full;n  =9;9;-1
bmj4_2_e004078.full;n  =8;8;-1
bmj4_2_e004078.full;n  =7;7;-1
bmj4_2_e004078.full;total of 787;787;-1
bmj4_2_e004081.full;1 women;1;-1
bmj4_2_e004081.full;20 RA  patients;20;-1
bmj4_2_e004081.full;10 patients;10;-1
bmj4_2_e004081.full;8 CD patients;8;-1
bmj4_2_e004081.full;2 patients;2;-1
bmj4_2_e004081.full;N=969;969;-1
bmj4_2_e004081.full;N=50;50;-1
bmj4_2_e004081.full;N=100;100;-1
bmj4_2_e004095.full;40 participants;40;-1
bmj4_2_e004095.full;5 We will exclude studies of patients;5;-1
bmj4_2_e004113.full;50 participants;50;-1
bmj4_2_e004113.full;10 patients;10;-1
bmj4_2_e004113.full;500 patients;500;-1
bmj4_2_e004113.full;28 through interview of the patients;28;-1
bmj4_2_e004113.full;36 a patients;36;-1
bmj4_2_e004113.full;170  GPs are recruited;170;-1
bmj4_2_e004113.full;total of 150;150;-1
bmj4_2_e004113.full;total of 500;500;-1
bmj4_2_e004120.full;30 participants;30;-1
bmj4_2_e004120.full;37 intervention patients;37;-1
bmj4_2_e004120.full;44 patients;44;-1
bmj4_2_e004120.full;20 patients;20;-1
bmj4_2_e004120.full;10 patients;10;-1
bmj4_2_e004120.full;40 patients;40;-1
bmj4_2_e004120.full;32 patients;32;-1
bmj4_2_e004120.full;n=2;2;-1
bmj4_2_e004120.full;n=1;1;-1
bmj4_2_e004120.full;n=136;136;-1
bmj4_2_e004120.full;n=154;154;-1
bmj4_2_e004120.full;n=147;147;-1
bmj4_2_e004120.full;n=92;92;-1
bmj4_2_e004120.full;n=88;88;-1
bmj4_2_e004120.full;n=25;25;-1
bmj4_2_e004120.full;n=38;38;-1
bmj4_2_e004120.full;n=20;20;-1
bmj4_2_e004120.full;n=114;114;-1
bmj4_2_e004120.full;n=75;75;-1
bmj4_2_e004120.full;n=103;103;-1
bmj4_2_e004120.full;n=71;71;-1
bmj4_2_e004120.full;n=33;33;-1
bmj4_2_e004120.full;n=32;32;-1
bmj4_2_e004120.full;n=132;132;-1
bmj4_2_e004120.full;n=130;130;-1
bmj4_2_e004120.full;n=30;30;-1
bmj4_2_e004120.full;total of 475;475;-1
bmj4_2_e004120.full;total of 1714;1714;-1
bmj4_2_e004123.full;n=2843;2843;-1
bmj4_2_e004123.full;n=686;686;-1
bmj4_2_e004123.full;n=722;722;-1
bmj4_2_e004123.full;n=1408;1408;-1
bmj4_2_e004123.full;n=1270;1270;-1
bmj4_2_e004123.full;n=660;660;-1
bmj4_2_e004123.full;n=610;610;-1
bmj4_2_e004123.full;n=1128;1128;-1
bmj4_2_e004123.full;n=70;70;-1
bmj4_2_e004123.full;n=72;72;-1
bmj4_2_e004123.full;n=437;437;-1
bmj4_2_e004123.full;n=833;833;-1
bmj4_2_e004123.full;n=819;819;-1
bmj4_2_e004123.full;n=451;451;-1
bmj4_2_e004123.full;n=134;134;-1
bmj4_2_e004123.full;n=450;450;-1
bmj4_2_e004123.full;n=874;874;-1
bmj4_2_e004123.full;N=396;396;-1
bmj4_2_e004123.full;n=618;618;-1
bmj4_2_e004123.full;n=651;651;-1
bmj4_2_e004123.full;N=1270;1270;-1
bmj4_2_e004123.full;total of  4900;4900;-1
bmj4_2_e004123.full;total of 1408;1408;-1
bmj4_2_e004131.full;N=524;524;172
bmj4_2_e004131.full;N=245 903;245903;201
bmj4_2_e004131.full;n=78;78;2599
bmj4_2_e004138.full;4487 women;4487;-1
bmj4_2_e004138.full;300 million women;300;-1
bmj4_2_e004138.full;4487  Australian women;4487;-1
bmj4_2_e004138.full;1462 women;1462;-1
bmj4_2_e004138.full;20 000 Dutch men  and women;20000;-1
bmj4_2_e004138.full;12 year follow  up of participants;12;-1
bmj4_2_e004138.full;27 000 participants;27000;-1
bmj4_2_e004138.full;000 primary care patients;0;-1
bmj4_2_e004138.full; data from 4;4;-1
bmj4_2_e004145.full;2  When patients;2;-1
bmj4_2_e004145.full;1562 patients;1562;-1
bmj4_2_e004145.full;460 patients;460;-1
bmj4_2_e004145.full;total of 30;30;-1
bmj4_2_e004148.full;750 women;750;5110
bmj4_2_e004148.full;319 women;319;5478
bmj4_2_e004148.full;n=5842;5842;2507
bmj4_2_e004148.full;n=3897;3897;2493
bmj4_2_e004148.full;n=2232;2232;2479
bmj4_2_e004148.full;n=2315;2315;2465
bmj4_2_e004148.full;n=437;437;11637
bmj4_2_e004148.full;n=321;321;11650
bmj4_2_e004148.full;n=139;139;11663
bmj4_2_e004148.full;n=100;100;11676
bmj4_2_e004148.full;total of 10;10;7034
bmj4_2_e004148.full;total of 1474;1474;3880
bmj4_2_e004148.full;total of 587;587;3682
bmj4_2_e004174.full;1 year and pregnant women;1;-1
bmj4_2_e004174.full;7 million  patients;7;-1
bmj4_2_e004174.full;7 million patients;7;-1
bmj4_2_e004174.full;2 million  patients;2;-1
bmj4_2_e004174.full;7  million people;7;-1
bmj4_2_e004174.full;100 000  people;100000;-1
bmj4_2_e004174.full;2 million people;2;-1
bmj4_2_e004174.full;7 million people;7;-1
bmj4_2_e004174.full;n=51;51;-1
bmj4_2_e004174.full;n=646 709;646709;-1
bmj4_2_e004174.full;n=244 078;244078;-1
bmj4_2_e004174.full;n=1 537 178;1537178;-1
bmj4_2_e004174.full;n=951 332;951332;-1
bmj4_2_e004174.full;total of 580 000;580000;-1
bmj4_2_e004174.full;total of 2;2;-1
bmj4_2_e004180.full;15  We further excluded participants;15;-1
bmj4_2_e004180.full;129 older patients;129;-1
bmj4_2_e004180.full;22 we categorised patients;22;-1
bmj4_2_e004180.full;128  patients;128;-1
bmj4_2_e004180.full;159 patients;159;-1
bmj4_2_e004180.full;225 older adults;225;-1
bmj4_2_e004180.full;129 older adults;129;-1
bmj4_2_e004180.full;n=51;51;-1
bmj4_2_e004180.full;n=9;9;-1
bmj4_2_e004180.full;n=3;3;-1
bmj4_2_e004180.full;n=2;2;-1
bmj4_2_e004180.full;n=1;1;-1
bmj4_2_e004180.full;n=129;129;-1
bmj4_2_e004180.full;n=15;15;-1
bmj4_2_e004180.full;n=58;58;-1
bmj4_2_e004180.full;n=56;56;-1
bmj4_2_e004180.full;n=114;114;-1
bmj4_2_e004180.full;n=108;108;-1
bmj4_2_e004180.full;n=148;148;-1
bmj4_2_e004180.full;n=54;54;-1
bmj4_2_e004180.full;n=158;158;-1
bmj4_2_e004185.full;1329 participants;1329;-1
bmj4_2_e004185.full;N=1329;1329;-1
bmj4_2_e004185.full;n=1329;1329;-1
bmj4_2_e004185.full;n=101;101;-1
bmj4_2_e004185.full;n=68;68;-1
bmj4_2_e004185.full;n=570;570;-1
bmj4_2_e004185.full;n=216;216;-1
bmj4_2_e004185.full;n=374;374;-1
bmj4_2_e004185.full;total of 1329;1329;-1
bmj4_2_e004185.full;total of 25;25;-1
bmj4_2_e004199.full;1 In patients;1;-1
bmj4_2_e004199.full;3000 thrombocytopenic adult patients;3000;-1
bmj4_2_e004199.full;622 allogeneic transplant patients;622;-1
bmj4_2_e004199.full;1402 BMT patients;1402;-1
bmj4_2_e004199.full;58 patients;58;-1
bmj4_2_e004199.full;1,402 patients;1402;-1
bmj4_2_e004199.full;21 000  individuals;21000;-1
bmj4_2_e004199.full;n=159;159;-1
bmj4_2_e004200.full;95 women;95;-1
bmj4_2_e004200.full;3 million are women;3;-1
bmj4_2_e004200.full;230 women;230;-1
bmj4_2_e004200.full;95 HIV-positive women;95;-1
bmj4_2_e004200.full;7 women;7;-1
bmj4_2_e004200.full;29 In patients;29;-1
bmj4_2_e004200.full;63 million  individuals;63;-1
bmj4_2_e004200.full;n=95;95;-1
bmj4_2_e004200.full;total of 230;230;-1
bmj4_2_e004200.full;total of 7;7;-1
bmj4_2_e004201.full;n=814;814;-1
bmj4_2_e004201.full;n=909;909;-1
bmj4_2_e004201.full;n=485;485;-1
bmj4_2_e004201.full;total of 46;46;-1
bmj4_2_e004201.full;total of 31;31;-1
bmj4_2_e004203.full;18 DNA positive young women;18;16747
bmj4_2_e004203.full;2004  participants;2004;7088
bmj4_2_e004203.full;16 seropositive individuals;16;5007
bmj4_2_e004203.full;450  consecutive adults;450;8074
bmj4_2_e004203.full;450 consecutive adults;450;2764
bmj4_2_e004203.full;n=1654;1654;8144
bmj4_2_e004203.full;n=450;450;1046
bmj4_2_e004203.full;n=399;399;1121
bmj4_2_e004203.full;n=51;51;1160
bmj4_2_e004203.full;n=424;424;1591
bmj4_2_e004203.full;n=440;440;2165
bmj4_2_e004203.full;n=445;445;2277
bmj4_2_e004203.full;n=427;427;2392
bmj4_2_e004203.full;n=442;442;2514
bmj4_2_e004226.full;296 women;296;-1
bmj4_2_e004226.full;590  women;590;-1
bmj4_2_e004226.full;1082 women;1082;-1
bmj4_2_e004226.full;1494 women;1494;-1
bmj4_2_e004226.full;590 women;590;-1
bmj4_2_e004226.full;240 older participants;240;-1
bmj4_2_e004226.full;n=1397;1397;-1
bmj4_2_e004226.full;n=832;832;-1
bmj4_2_e004226.full;n=439;439;-1
bmj4_2_e004226.full;n=1275;1275;-1
bmj4_2_e004226.full;n=552;552;-1
bmj4_2_e004226.full;n=334;334;-1
bmj4_2_e004226.full;n=170;170;-1
bmj4_2_e004226.full;n=382;382;-1
bmj4_2_e004226.full;n=126;126;-1
bmj4_2_e004226.full;n=208;208;-1
bmj4_2_e004226.full;total of 296;296;-1
bmj4_2_e004226.full;total of 1082;1082;-1
bmj4_2_e004226.full;total of 758;758;-1
bmj4_2_e004231.full;428 patients;428;-1
bmj4_2_e004231.full;499 patients;499;-1
bmj4_2_e004231.full;500 patients;500;-1
bmj4_2_e004231.full;428 patients were  recruited;428;-1
bmj4_2_e004231.full;428 patients recruited;428;-1
bmj4_2_e004231.full;n=322;322;-1
bmj4_2_e004231.full;n=212;212;-1
bmj4_2_e004231.full;n=134;134;-1
bmj4_2_e004231.full;n=123;123;-1
bmj4_2_e004231.full;N=428;428;-1
bmj4_2_e004231.full;N=134;134;-1
bmj4_2_e004231.full;N=123;123;-1
bmj4_2_e004231.full;n=31;31;-1
bmj4_2_e004231.full;N=256;256;-1
bmj4_2_e004231.full;N=212;212;-1
bmj4_2_e004231.full;N=190;190;-1
bmj4_2_e004231.full;n  =1;1;-1
bmj4_2_e004231.full;total of 1211;1211;-1
bmj4_2_e004231.full;total of 576;576;-1
bmj4_2_e004239.full;1476 unrelated healthy control participants;1476;-1
bmj4_2_e004239.full;829 patients;829;-1
bmj4_2_e004239.full;421 patients;421;-1
bmj4_2_e004239.full;408 patients;408;-1
bmj4_2_e004239.full;total of 43;43;-1
bmj4_2_e004242.full;2301 women;2301;9053
bmj4_2_e004242.full;1908 women;1908;914
bmj4_2_e004242.full;2235  women;2235;986
bmj4_2_e004242.full;43 women;43;1052
bmj4_2_e004242.full;607 women;607;1214
bmj4_2_e004242.full;84  women;84;1295
bmj4_2_e004242.full;56 women;56;5367
bmj4_2_e004242.full;n=229;229;2961
bmj4_2_e004242.full;n=1342;1342;633
bmj4_2_e004242.full;n=959;959;699
bmj4_2_e004242.full;n=1516;1516;1205
bmj4_2_e004242.full;n=509;509;1553
bmj4_2_e004242.full;n=22;22;2961
bmj4_2_e004242.full;n=10;10;1652
bmj4_2_e004242.full;n=72;72;5305
bmj4_2_e004242.full;n=73;73;5349
bmj4_2_e004242.full;total of 2301;2301;9062
bmj4_2_e004245.full;12  For patients;12;-1
bmj4_2_e004245.full;n=3;3;-1
bmj4_2_e004245.full;n=1;1;-1
bmj4_2_e004245.full;n=39;39;-1
bmj4_2_e004245.full;total of 40;40;-1
bmj4_2_e004247.full;8 individuals;8;-1
bmj4_2_e004247.full;13 600 adults;13600;-1
bmj4_2_e004247.full;n=463;463;-1
bmj4_2_e004247.full;N=72 751;72751;-1
bmj4_2_e004247.full;n=294;294;-1
bmj4_2_e004247.full;n=9200;9200;-1
bmj4_2_e004247.full;n=15;15;-1
bmj4_2_e004247.full;n=174;174;-1
bmj4_2_e004247.full;n=150;150;-1
bmj4_2_e004247.full;n=148;148;-1
bmj4_2_e004247.full;n=472;472;-1
bmj4_2_e004247.full;total of 50;50;-1
bmj4_2_e004250.full;111 participants;111;2924
bmj4_2_e004250.full;272 participants;272;2896
bmj4_2_e004250.full;272 patients;272;8404
bmj4_2_e004250.full;100 patients;100;2976
bmj4_2_e004250.full;17 patients;17;1165
bmj4_2_e004250.full;n=272;272;3506
bmj4_2_e004250.full;total of 272;272;1430
bmj4_2_e004251.full;766 patients;766;-1
bmj4_2_e004251.full;4249 patients;4249;-1
bmj4_2_e004251.full;19 patients;19;-1
bmj4_2_e004251.full;8458 insured patients;8458;-1
bmj4_2_e004251.full;100 000 patients;100000;-1
bmj4_2_e004251.full;3 They analysed all dialysis  patients;3;-1
bmj4_2_e004251.full;n=3040;3040;-1
bmj4_2_e004251.full;n=725;725;-1
bmj4_2_e004251.full;n=1791;1791;-1
bmj4_2_e004251.full;n=606;606;-1
bmj4_2_e004251.full;n=999;999;-1
bmj4_2_e004251.full;n=2041;2041;-1
bmj4_2_e004251.full;total of 4249;4249;-1
bmj4_2_e004252.full;25 patients;25;-1
bmj4_2_e004252.full;36 While all  patients;36;-1
bmj4_2_e004252.full;n=8;8;-1
bmj4_2_e004252.full;n=6;6;-1
bmj4_2_e004252.full;n=9;9;-1
bmj4_2_e004252.full;total of 25;25;-1
bmj4_2_e004252.full;total of 92;92;-1
bmj4_2_e004252.full;total of 36;36;-1
bmj4_2_e004254.full;432 randomised patients;432;-1
bmj4_2_e004254.full;432 patients;432;-1
bmj4_2_e004254.full;1328 patients;1328;-1
bmj4_2_e004258.full;100 patients;100;23207
bmj4_2_e004258.full;204 patients;204;17528
bmj4_2_e004258.full;20  Further follow-up of patients;20;17216
bmj4_2_e004258.full;87 patients;87;16167
bmj4_2_e004258.full;120 patients;120;16014
bmj4_2_e004258.full;total of  100;100;625
bmj4_2_e004273.full;4900 participants;4900;-1
bmj4_2_e004273.full;5135 participants;5135;-1
bmj4_2_e004273.full;3 billion  individuals;3;-1
bmj4_2_e004273.full;total of 4900;4900;-1
bmj4_2_e004273.full;total of  4900;4900;-1
bmj4_2_e004273.full;total of 5135;5135;-1
bmj4_2_e004273.full; data from 192;192;-1
bmj4_2_e004275.full;493 patients;493;-1
bmj4_2_e004275.full;58 000 patients;58000;-1
bmj4_2_e004275.full;74 000  patients;74000;-1
bmj4_2_e004275.full;407 prevalent patients;407;-1
bmj4_2_e004275.full;719 patients including  patients;719;-1
bmj4_2_e004275.full;407  patients;407;-1
bmj4_2_e004275.full;204  All patients;204;-1
bmj4_2_e004275.full;548  Proportion of patients;548;-1
bmj4_2_e004275.full;042  Proportion of patients;42;-1
bmj4_2_e004275.full;512  Proportion of patients;512;-1
bmj4_2_e004275.full;947  Proportion of patients;947;-1
bmj4_2_e004275.full;5D patients;5;-1
bmj4_2_e004275.full;5D individuals;5;-1
bmj4_2_e004275.full;N=203;203;-1
bmj4_2_e004275.full;N=204;204;-1
bmj4_2_e004275.full;N=407;407;-1
bmj4_2_e004275.full;total of 719;719;-1
bmj4_2_e004278.full;119 119 Management of patients;119119;-1
bmj4_2_e004278.full;118 118 Management of patients;118118;-1
bmj4_2_e004278.full;110 110 Early management of patients;110110;-1
bmj4_2_e004278.full;108 108 Management of patients;108108;-1
bmj4_2_e004278.full;106 106 Control of pain in adults;106106;-1
bmj4_2_e004289.full;9 large  numbers of people;9;-1
bmj4_2_e004320.full;100 000 people;100000;-1
bmj4_2_e004320.full;n=161;161;-1
bmj4_2_e004320.full;n=121;121;-1
bmj4_2_e004320.full;n=119;119;-1
bmj4_2_e004320.full;total of 543;543;-1
bmj4_2_e004324.full;66 participants;66;-1
bmj4_2_e004324.full;181 participants;181;-1
bmj4_2_e004324.full;94 participants;94;-1
bmj4_2_e004324.full;59 female participants;59;-1
bmj4_2_e004324.full;94 screened participants;94;-1
bmj4_2_e004324.full;724  patients;724;-1
bmj4_2_e004324.full;700 patients;700;-1
bmj4_2_e004324.full;94 adults;94;-1
bmj4_2_e004324.full;7 and adults;7;-1
bmj4_2_e004324.full;N=54;54;-1
bmj4_2_e004324.full;N=31;31;-1
bmj4_2_e004324.full;n=68;68;-1
bmj4_2_e004324.full;n=3;3;-1
bmj4_2_e004324.full;n=6;6;-1
bmj4_2_e004324.full;n=1;1;-1
bmj4_2_e004324.full;n=9;9;-1
bmj4_2_e004324.full;N=36;36;-1
bmj4_2_e004324.full;N=58;58;-1
bmj4_2_e004365.full;9459 women;9459;-1
bmj4_2_e004365.full;9615 women;9615;-1
bmj4_2_e004365.full;4370 women;4370;-1
bmj4_2_e004365.full;10 women;10;-1
bmj4_2_e004365.full;19,874 Danish  women;19874;-1
bmj4_2_e004365.full;n=47;47;-1
bmj4_2_e004365.full;n  =9;9;-1
bmj4_2_e004365.full;n=  94;94;-1
bmj4_2_e004365.full;n=  32;32;-1
bmj4_2_e004365.full;n=  28;28;-1
bmj4_2_e004365.full;n=  23;23;-1
bmj4_2_e004365.full;n=  53;53;-1
bmj4_2_e004365.full;n=  34;34;-1
bmj4_2_e004365.full;n=  21;21;-1
bmj4_2_e004365.full;n  =6;6;-1
bmj4_2_e004365.full;n  =1;1;-1
bmj4_2_e004365.full;total of 9615;9615;-1
bmj4_2_e004365.full;study population included 9459;9459;-1
bmj4_2_e004369.full;N=12;12;-1
bmj4_2_e004369.full;N=9;9;-1
bmj4_2_e004369.full;N=21;21;-1
bmj4_2_e004378.full;001  Successful people;1;-1
bmj4_2_e004378.full;001  Cool people;1;-1
bmj4_2_e004378.full;001  Rich people;1;-1
bmj4_2_e004378.full;002  Successful people;2;-1
bmj4_2_e004378.full;3000 individuals;3000;-1
bmj4_2_e004378.full;n=779;779;-1
bmj4_2_e004378.full;n=649;649;-1
bmj4_2_e004378.full;n=3384;3384;-1
bmj4_2_e004387.full;788 participants;788;-1
bmj4_2_e004387.full;31 Dietary information of the participants;31;-1
bmj4_2_e004387.full;1839 study participants;1839;-1
bmj4_2_e004387.full;91  participants;91;-1
bmj4_2_e004387.full;477 patients;477;-1
bmj4_2_e004387.full;494  patients;494;-1
bmj4_2_e004387.full;n=477;477;-1
bmj4_2_e004387.full;n=1271;1271;-1
bmj4_2_e004387.full;n=331;331;-1
bmj4_2_e004387.full;n=146;146;-1
bmj4_2_e004387.full;n=784;784;-1
bmj4_2_e004387.full;n=487;487;-1
bmj4_2_e004387.full;n  =1;1;-1
bmj4_2_e004387.full;n  =6;6;-1
bmj4_2_e004387.full;n  =3;3;-1
bmj4_2_e004387.full;n  =7;7;-1
bmj4_2_e004387.full;n  =4;4;-1
bmj4_2_e004391.full;n=328;328;-1
bmj4_2_e004391.full;n=17 000;17000;-1
bmj4_2_e004391.full;total of 31;31;-1
bmj4_2_e004418.full;347 patients;347;-1
bmj4_2_e004418.full;682 patients;682;-1
bmj4_2_e004418.full;total of 347;347;-1
bmj4_2_e004418.full;total of 752;752;-1
bmj4_2_e004418.full;total of 32;32;-1
bmj4_2_e004418.full;total of 682;682;-1
bmj4_2_e004425.full;32 037 patients;32037;-1
bmj4_2_e004425.full;64 312 patients;64312;-1
bmj4_2_e004425.full;26 267 patients;26267;-1
bmj4_2_e004425.full;11 389 for hospital score for patients;11389;-1
bmj4_2_e004425.full;22 122 patients;22122;-1
bmj4_2_e004425.full;1274 patients;1274;-1
bmj4_2_e004425.full;3059 patients;3059;-1
bmj4_2_e004425.full;3059  patients;3059;-1
bmj4_2_e004425.full;2959 patients;2959;-1
bmj4_2_e004425.full;3035 patients;3035;-1
bmj4_2_e004425.full;33 890 patients;33890;-1
bmj4_2_e004425.full;1298 patients;1298;-1
bmj4_2_e004425.full;700 more patients;700;-1
bmj4_2_e004425.full;100 patients;100;-1
bmj4_2_e004425.full;10 000 patients;10000;-1
bmj4_2_e004425.full;9461  patients;9461;-1
bmj4_2_e004425.full;15 individuals;15;-1
bmj4_2_e004425.full;n=2806;2806;-1
bmj4_2_e004425.full;n=2959;2959;-1
bmj4_2_e004425.full;N=1558;1558;-1
bmj4_2_e004425.full;N=1401;1401;-1
bmj4_2_e004425.full;N=1472;1472;-1
bmj4_2_e004425.full;N=1334;1334;-1
bmj4_2_e004425.full;n=3035;3035;-1
bmj4_2_e004425.full;N=3035;3035;-1
bmj4_2_e004425.full;N=1596;1596;-1
bmj4_2_e004425.full;N=1439;1439;-1
bmj4_2_e004425.full;N=2872;2872;-1
bmj4_2_e004425.full;N=1504;1504;-1
bmj4_2_e004425.full;N=1368;1368;-1
bmj4_2_e004425.full; dataset of 32 037;32037;-1
bmj4_2_e004427.full;74 941 women;74941;5068
bmj4_2_e004427.full;24 Two control  subjects;24;2298
bmj4_2_e004427.full;n  =2;2;3745
bmj4_2_e004427.full;n  =4;4;3778
bmj4_2_e004427.full;n  =1;1;3818
bmj4_2_e004427.full;n  =8;8;3891
bmj4_2_e004427.full;n=  21;21;20454
bmj4_2_e004427.full;n=  42;42;20465
bmj4_2_e004427.full;n=  86;86;20479
bmj4_2_e004427.full;n=  16;16;20487
bmj4_2_e004427.full;n=  12;12;20501
bmj4_2_e004427.full;n=  26;26;20512
bmj4_2_e004427.full;total of 217;217;9958
bmj4_2_e004429.full;4 million  people;4;-1
bmj4_2_e004498.full;21 women;21;-1
bmj4_2_e004498.full;n=21;21;-1
bmj4_2_e004523.full;2000 participants;2000;-1
bmj4_2_e004523.full;30 participants;30;-1
bmj4_2_e004523.full;43 Potential participants;43;-1
bmj4_2_e004523.full;50 000 patients;50000;-1
bmj4_2_e004523.full;25 patients;25;-1
bmj4_2_e004523.full;10 181 routinely attend-  ing patients;10181;-1
bmj4_2_e004523.full;9  million people;9;-1
bmj4_2_e004523.full;total of 65;65;-1
bmj4_2_e004523.full; data of 10 181;10181;-1
bmj4_2_e004567.full;71 793  patients;71793;-1
bmj4_2_e004567.full;6 and  non-white patients;6;-1
bmj4_2_e004567.full;71 000 patients;71000;-1
bmj4_2_e004567.full;71 793 patients;71793;-1
bmj4_2_e004567.full;15  As Chinese patients;15;-1
bmj4_2_e004567.full;2004  national surveys of patients;2004;-1
bmj4_2_e004567.full;8 million people;8;-1
bmj4_2_e004567.full;n  =4;4;-1
bmj4_2_e004567.full;n=69 276;69276;-1
bmj4_2_e004567.full;n=14 591;14591;-1
bmj4_2_e004567.full;total of 71 793;71793;-1
bmj4_2_e004567.full; data from 71 793;71793;-1
bmj4_2_e004605.full;n=1678;1678;2989
bmj4_2_e004605.full;n=912;912;2974
bmj4_2_e004605.full;n=766;766;2959
bmj4_2_e004605.full;n=187;187;1317
bmj4_2_e004605.full;n=174;174;1369
bmj4_2_e004605.full;n=325;325;1809
bmj4_2_e004605.full;n=282;282;1846
bmj4_2_e004605.full;n=160;160;1872
bmj4_2_e004605.full;n=145;145;1898
bmj4_2_e004605.full;n=237;237;1991
bmj4_2_e004605.full;n=231;231;2491
bmj4_2_e004605.full;n=229;229;2514
bmj4_2_e004605.full;n=69;69;2540
bmj4_2_e004605.full;n=326;326;3271
bmj4_2_e004605.full;n=240;240;3331
bmj4_2_e004605.full;n=139;139;3368
bmj4_2_e004605.full;n=207;207;3409
bmj4_2_e004605.full;n=253;253;3493
bmj4_2_e004605.full;n=238;238;3545
bmj4_2_e004605.full;n=111;111;3582
bmj4_2_e004605.full;n=164;164;3623
bmj4_2_e004605.full;n=1026;1026;3968
bmj4_2_e004605.full;n=391;391;4048
bmj4_2_e004605.full;n=261;261;4098
bmj4_2_e004605.full;n=166;166;4630
bmj4_2_e004605.full;n=53;53;4670
bmj4_2_e004605.full;n=100;100;4696
bmj4_2_e004605.full;n=48;48;4726
bmj4_2_e004605.full;n=50;50;4843
bmj4_2_e004605.full;n=73;73;4868
bmj4_2_e004605.full;n=52;52;4897
bmj4_2_e004605.full;total of 1678;1678;3942
bmj4_2_e004684.full;12 patients;12;-1
bmj4_2_e004684.full;66 patients;66;-1
bmj4_2_e004684.full;18 and patients;18;-1
bmj4_2_e004684.full;250 patients;250;-1
bmj4_2_e004684.full;28 and a trial involving patients;28;-1
bmj4_2_e004684.full;6 cardiac patients;6;-1
bmj4_2_e004684.full;24 patients;24;-1
bmj4_2_e004684.full;150 000 people;150000;-1
bmj4_2_e004684.full;832  people;832;-1
bmj4_2_e004886.full;2 participants;2;-1
bmj4_2_e004886.full;6500  substudy patients;6500;-1
bmj4_2_e004886.full;6500 patients;6500;-1
bmj4_2_e004886.full;10 000 patients;10000;-1
bmj4_2_e004886.full;6500 eligible patients;6500;-1
bmj4_2_e004886.full;3000 patients;3000;-1
bmj4_2_e004886.full;2 AKI substudy patients;2;-1
bmj4_2_e004886.full;2 patients;2;-1
bmj4_2_e004886.full;2  patients;2;-1
bmj4_2_e004886.full;200 million adults;200;-1
bmj4_2_e004886.full;n=4880;4880;-1
bmj4_2_e004886.full;n=3690;3690;-1
bmj4_2_e004886.full;n=1190;1190;-1
bmj4_2_e004886.full;6500 patients will be enrolled;6500;-1
bmj4_3_e003208.full;2404 men and women;2404;-1
bmj4_3_e003208.full;1580  women;1580;-1
bmj4_3_e003208.full;132 people;132;-1
bmj4_3_e003208.full;29  people;29;-1
bmj4_3_e003208.full;n=200;200;-1
bmj4_3_e003208.full;N=2262;2262;-1
bmj4_3_e003208.full;N=63;63;-1
bmj4_3_e003208.full;N=74;74;-1
bmj4_3_e003208.full;N=21;21;-1
bmj4_3_e003208.full;n=21;21;-1
bmj4_3_e003208.full;total of 2404;2404;-1
bmj4_3_e003208.full;total of 142;142;-1
bmj4_3_e003208.full;total  of 132;132;-1
bmj4_3_e003208.full;  data from 1994;1994;-1
bmj4_3_e003431.full;1 Weighted proportions of participants;1;-1
bmj4_3_e003431.full;2 Weighted proportions of participants;2;-1
bmj4_3_e003431.full;1118 patients;1118;-1
bmj4_3_e003431.full;410 patients;410;-1
bmj4_3_e003431.full;54 patients;54;-1
bmj4_3_e003431.full;19 In patients;19;-1
bmj4_3_e003431.full;20 Such patients;20;-1
bmj4_3_e003431.full;39 In patients;39;-1
bmj4_3_e003431.full;30  million people;30;-1
bmj4_3_e003431.full;n=7;7;-1
bmj4_3_e003431.full;n=3;3;-1
bmj4_3_e003431.full;n=17;17;-1
bmj4_3_e003431.full;total of 105;105;-1
bmj4_3_e003434.full;n=2674;2674;-1
bmj4_3_e003434.full;n=16 138;16138;-1
bmj4_3_e003434.full;n=1000;1000;-1
bmj4_3_e003434.full;n=6413;6413;-1
bmj4_3_e003434.full;n  =2;2;-1
bmj4_3_e003758.full;28 558 women;28558;-1
bmj4_3_e003758.full;57 175 women;57175;-1
bmj4_3_e003758.full;24 274women;24274;-1
bmj4_3_e003758.full;1070 women;1070;-1
bmj4_3_e003758.full;15 000 women;15000;-1
bmj4_3_e003758.full;34 000 if all patients;34000;-1
bmj4_3_e003758.full; data from the 2008;2008;-1
bmj4_3_e003759.full;16 000 asthma patients;16000;-1
bmj4_3_e003759.full;16 803 eligible individuals;16803;-1
bmj4_3_e003759.full;5 of individuals;5;-1
bmj4_3_e003759.full;47 614 individuals;47614;-1
bmj4_3_e003759.full;51 306 individuals;51306;-1
bmj4_3_e003759.full;18 013 individuals;18013;-1
bmj4_3_e003759.full;37 of individuals;37;-1
bmj4_3_e003759.full;n=38;38;-1
bmj4_3_e003759.full;n=31;31;-1
bmj4_3_e003759.full;n=667;667;-1
bmj4_3_e003759.full;n=18 013;18013;-1
bmj4_3_e003759.full;n=33 293;33293;-1
bmj4_3_e003759.full;N=14 989;14989;-1
bmj4_3_e003759.full;N=1245;1245;-1
bmj4_3_e003759.full;n=9564;9564;-1
bmj4_3_e003759.full;n=4349;4349;-1
bmj4_3_e003759.full;n=474;474;-1
bmj4_3_e003759.full;n=602;602;-1
bmj4_3_e003759.full;n=1090;1090;-1
bmj4_3_e003759.full;n=17;17;-1
bmj4_3_e003759.full;n=138;138;-1
bmj4_3_e003759.full;total of 47 614;47614;-1
bmj4_3_e003866.full;56 participants;56;-1
bmj4_3_e003866.full;2 participants;2;-1
bmj4_3_e003866.full;40000 subjects;40000;-1
bmj4_3_e003866.full;n=8;8;-1
bmj4_3_e003866.full;n=514;514;-1
bmj4_3_e003866.full;N=1798;1798;-1
bmj4_3_e003866.full;N=412;412;-1
bmj4_3_e003866.full;n=480;480;-1
bmj4_3_e003866.full;n=483;483;-1
bmj4_3_e003866.full;n=490;490;-1
bmj4_3_e003866.full;n=494;494;-1
bmj4_3_e003866.full;N=251;251;-1
bmj4_3_e003866.full;N=103;103;-1
bmj4_3_e003866.full;N=54;54;-1
bmj4_3_e003866.full;N=78;78;-1
bmj4_3_e003866.full;N=494;494;-1
bmj4_3_e003866.full;total of 56;56;-1
bmj4_3_e003901.full;5139 participants;5139;-1
bmj4_3_e003901.full;1259 participants;1259;-1
bmj4_3_e003901.full;4635 participants;4635;-1
bmj4_3_e003901.full;1057 participants;1057;-1
bmj4_3_e003901.full;4494 patients;4494;-1
bmj4_3_e003901.full;72 441  Number of patients;72441;-1
bmj4_3_e003901.full;87  patients;87;-1
bmj4_3_e003901.full;100 patients;100;-1
bmj4_3_e003901.full;05olderpeople;5;-1
bmj4_3_e003901.full;100 patients recruited;100;-1
bmj4_3_e003901.full;n=3270;3270;-1
bmj4_3_e003903.full;4 For low dependency inpatients;4;-1
bmj4_3_e003903.full;597 137 inpatients;597137;-1
bmj4_3_e003903.full;515 408  inpatients;515408;-1
bmj4_3_e003903.full;664 000 individuals;664000;-1
bmj4_3_e003921.full;2 508 916 patients;2508916;-1
bmj4_3_e003921.full;4 Distribution of patients;4;-1
bmj4_3_e003921.full;5 Distribution of patients;5;-1
bmj4_3_e004007.full;869 patients;869;-1
bmj4_3_e004007.full;94 patients;94;-1
bmj4_3_e004007.full;963 patients;963;-1
bmj4_3_e004007.full;736 patients;736;-1
bmj4_3_e004007.full;869  patients;869;-1
bmj4_3_e004007.full;n=664;664;-1
bmj4_3_e004007.full;n=869;869;-1
bmj4_3_e004007.full;n=94;94;-1
bmj4_3_e004058.full;100 000 residents in these  category women;100000;-1
bmj4_3_e004058.full;20  Men and women;20;-1
bmj4_3_e004058.full;100 000 residents in this category women;100000;-1
bmj4_3_e004058.full;8550 participants;8550;-1
bmj4_3_e004058.full;2000  people;2000;-1
bmj4_3_e004058.full;100 000 residents adults;100000;-1
bmj4_3_e004058.full;N=1555;1555;-1
bmj4_3_e004058.full;N=6995;6995;-1
bmj4_3_e004058.full;n=3310;3310;-1
bmj4_3_e004058.full;n=3685;3685;-1
bmj4_3_e004058.full;N=3310;3310;-1
bmj4_3_e004058.full;N=3685;3685;-1
bmj4_3_e004058.full;N=1092;1092;-1
bmj4_3_e004058.full;total of 8550;8550;-1
bmj4_3_e004058.full; data from 6995;6995;-1
bmj4_3_e004093.full;150 new patients;150;-1
bmj4_3_e004093.full;150  patients;150;-1
bmj4_3_e004093.full;n=72;72;-1
bmj4_3_e004093.full;n=81;81;-1
bmj4_3_e004093.full;n=68;68;-1
bmj4_3_e004093.full;n=78;78;-1
bmj4_3_e004093.full;n=69;69;-1
bmj4_3_e004093.full;n=82;82;-1
bmj4_3_e004093.full;total of 100;100;-1
bmj4_3_e004096.full;20 and patients;20;-1
bmj4_3_e004096.full;n=19;19;-1
bmj4_3_e004096.full;total of 7220;7220;-1
bmj4_3_e004107.full;872  participants;872;-1
bmj4_3_e004107.full;543 participants;543;-1
bmj4_3_e004107.full;23 pro-  portions of patients;23;-1
bmj4_3_e004107.full;2 diabetic patients;2;-1
bmj4_3_e004107.full;n=43;43;-1
bmj4_3_e004107.full;n=29;29;-1
bmj4_3_e004107.full;n=26;26;-1
bmj4_3_e004124.full;10 patients;10;-1
bmj4_3_e004173.full;14 541 pregnant women;14541;-1
bmj4_3_e004173.full;954  women;954;-1
bmj4_3_e004173.full;1 Flow chart of selection  of women;1;-1
bmj4_3_e004173.full;3451 women;3451;-1
bmj4_3_e004173.full;13 713 recruited women;13713;-1
bmj4_3_e004173.full;1477 women;1477;-1
bmj4_3_e004173.full;1268 of the remaining eligible women;1268;-1
bmj4_3_e004173.full;792 women;792;-1
bmj4_3_e004173.full;1268 women;1268;-1
bmj4_3_e004173.full;13 713 recruited;13713;-1
bmj4_3_e004173.full;n=3451;3451;-1
bmj4_3_e004173.full;n=5;5;-1
bmj4_3_e004173.full;N=11;11;-1
bmj4_3_e004173.full;n=7;7;-1
bmj4_3_e004173.full;n=971;971;-1
bmj4_3_e004173.full;n=999;999;-1
bmj4_3_e004173.full;n=10262;10262;-1
bmj4_3_e004173.full;n=8653;8653;-1
bmj4_3_e004173.full;n=3417;3417;-1
bmj4_3_e004173.full;n=7927;7927;-1
bmj4_3_e004173.full;n=3335;3335;-1
bmj4_3_e004173.full;n=8739;8739;-1
bmj4_3_e004173.full;n=3425;3425;-1
bmj4_3_e004173.full;n=9136;9136;-1
bmj4_3_e004173.full;n=3403;3403;-1
bmj4_3_e004173.full;n=9365;9365;-1
bmj4_3_e004173.full;n=3441;3441;-1
bmj4_3_e004173.full;n=10258;10258;-1
bmj4_3_e004173.full;N=1268;1268;-1
bmj4_3_e004173.full;n=1268;1268;-1
bmj4_3_e004173.full;n=269;269;-1
bmj4_3_e004173.full;n=412;412;-1
bmj4_3_e004173.full;n=582;582;-1
bmj4_3_e004173.full;n=256;256;-1
bmj4_3_e004173.full;n=391;391;-1
bmj4_3_e004173.full;n=534;534;-1
bmj4_3_e004173.full;n=267;267;-1
bmj4_3_e004173.full;n=411;411;-1
bmj4_3_e004173.full;n=577;577;-1
bmj4_3_e004173.full;n=261;261;-1
bmj4_3_e004173.full;n=409;409;-1
bmj4_3_e004173.full;n=568;568;-1
bmj4_3_e004173.full;n=580;580;-1
bmj4_3_e004173.full;n=578;578;-1
bmj4_3_e004173.full;n=268;268;-1
bmj4_3_e004173.full;n=581;581;-1
bmj4_3_e004173.full;n=271;271;-1
bmj4_3_e004173.full;n=415;415;-1
bmj4_3_e004173.full;total of 1268;1268;-1
bmj4_3_e004173.full;total of 3451;3451;-1
bmj4_3_e004173.full; data varied from 0;0;-1
bmj4_3_e004177.full;n=57;57;-1
bmj4_3_e004177.full;n=38;38;-1
bmj4_3_e004177.full;n=20;20;-1
bmj4_3_e004177.full;n=70;70;-1
bmj4_3_e004177.full;n=28;28;-1
bmj4_3_e004177.full;n=21;21;-1
bmj4_3_e004177.full;n=42;42;-1
bmj4_3_e004177.full;n=29;29;-1
bmj4_3_e004177.full;n  =4;4;-1
bmj4_3_e004177.full;n  =2;2;-1
bmj4_3_e004177.full;n=  29;29;-1
bmj4_3_e004179.full;218 patients;218;-1
bmj4_3_e004179.full;203 patients;203;-1
bmj4_3_e004179.full;91 patients;91;-1
bmj4_3_e004179.full;8  Eligible patients;8;-1
bmj4_3_e004179.full;203 eligible patients;203;-1
bmj4_3_e004179.full;34 patients;34;-1
bmj4_3_e004179.full;20 patients;20;-1
bmj4_3_e004179.full;23 patients;23;-1
bmj4_3_e004179.full;218 potentially eligible patients;218;-1
bmj4_3_e004179.full;N=203;203;-1
bmj4_3_e004183.full;164 participants;164;6036
bmj4_3_e004183.full;30 941 individuals;30941;12164
bmj4_3_e004183.full;n=30 941;30941;6969
bmj4_3_e004183.full;n=11 017;11017;6540
bmj4_3_e004183.full;n=6876;6876;6356
bmj4_3_e004183.full;n=256;256;6286
bmj4_3_e004183.full;n=29 650;29650;3411
bmj4_3_e004183.full;n=228;228;95
bmj4_3_e004183.full;n=27;27;36
bmj4_3_e004183.full;n=11;11;6540
bmj4_3_e004197.full;1206 women;1206;-1
bmj4_3_e004197.full;1293 women;1293;-1
bmj4_3_e004197.full;1222  women;1222;-1
bmj4_3_e004197.full;16 women;16;-1
bmj4_3_e004197.full;1206  women;1206;-1
bmj4_3_e004197.full;n=1293;1293;-1
bmj4_3_e004197.full;n=1222;1222;-1
bmj4_3_e004197.full;n=464;464;-1
bmj4_3_e004197.full;n=323;323;-1
bmj4_3_e004197.full;n=79;79;-1
bmj4_3_e004197.full;n=340;340;-1
bmj4_3_e004197.full;n=796;796;-1
bmj4_3_e004197.full;n=268;268;-1
bmj4_3_e004197.full;n=60;60;-1
bmj4_3_e004197.full;n=27;27;-1
bmj4_3_e004197.full;n=343;343;-1
bmj4_3_e004197.full;n=123;123;-1
bmj4_3_e004197.full;n=41;41;-1
bmj4_3_e004197.full;n=13;13;-1
bmj4_3_e004197.full;n=90;90;-1
bmj4_3_e004197.full;n=19;19;-1
bmj4_3_e004197.full;n=263;263;-1
bmj4_3_e004197.full;n=129;129;-1
bmj4_3_e004197.full;n=45;45;-1
bmj4_3_e004197.full;n=141;141;-1
bmj4_3_e004197.full;n=76;76;-1
bmj4_3_e004197.full;n=4;4;-1
bmj4_3_e004197.full;n=16;16;-1
bmj4_3_e004197.full;n=3;3;-1
bmj4_3_e004197.full;n=101;101;-1
bmj4_3_e004197.full;total of 1293;1293;-1
bmj4_3_e004216.full;1094 patients;1094;-1
bmj4_3_e004216.full;196 patients;196;-1
bmj4_3_e004216.full;1134 patients;1134;-1
bmj4_3_e004216.full;1094  patients;1094;-1
bmj4_3_e004216.full;50 psychotic patients;50;-1
bmj4_3_e004216.full;n=380;380;-1
bmj4_3_e004216.full;n=523;523;-1
bmj4_3_e004216.full;n=7;7;-1
bmj4_3_e004216.full;n=3;3;-1
bmj4_3_e004216.full;n=4;4;-1
bmj4_3_e004216.full;total of 1134;1134;-1
bmj4_3_e004227.full;4  Psychiatric patients;4;-1
bmj4_3_e004227.full;11 In patients;11;-1
bmj4_3_e004227.full;1482 patients;1482;-1
bmj4_3_e004227.full;100 patients;100;-1
bmj4_3_e004227.full;150 patients;150;-1
bmj4_3_e004227.full;125 patients;125;-1
bmj4_3_e004227.full;90 patients;90;-1
bmj4_3_e004227.full;96 patients;96;-1
bmj4_3_e004227.full;48 patients;48;-1
bmj4_3_e004227.full;total of 1482;1482;-1
bmj4_3_e004227.full;total of 150;150;-1
bmj4_3_e004227.full; data of GLP-1;1;-1
bmj4_3_e004244.full;1 Age of women;1;-1
bmj4_3_e004244.full;1 Mean age of women;1;-1
bmj4_3_e004244.full;total of 1;1;-1
bmj4_3_e004288.full;2033 patients;2033;-1
bmj4_3_e004288.full;17 In large studies of patients;17;-1
bmj4_3_e004288.full;162 000 patients;162000;-1
bmj4_3_e004288.full;5000 patients;5000;-1
bmj4_3_e004288.full;N=2033;2033;-1
bmj4_3_e004288.full;N=698;698;-1
bmj4_3_e004288.full;N=481;481;-1
bmj4_3_e004288.full;N=556;556;-1
bmj4_3_e004288.full;N=289;289;-1
bmj4_3_e004288.full;N=702;702;-1
bmj4_3_e004288.full;N=484;484;-1
bmj4_3_e004288.full;N=558;558;-1
bmj4_3_e004288.full;total of 2033;2033;-1
bmj4_3_e004288.full; database of  162 000;162000;-1
bmj4_3_e004308.full;21  Pregnant women;21;-1
bmj4_3_e004308.full;1000 participants;1000;-1
bmj4_3_e004308.full; data from 54;54;-1
bmj4_3_e004321.full;17 persons;17;-1
bmj4_3_e004321.full;1193  participants;1193;-1
bmj4_3_e004321.full;n=334;334;-1
bmj4_3_e004321.full;n=529;529;-1
bmj4_3_e004321.full;n=330;330;-1
bmj4_3_e004321.full;n=70;70;-1
bmj4_3_e004321.full;n=241;241;-1
bmj4_3_e004321.full;n=257;257;-1
bmj4_3_e004339.full;n=23;23;-1
bmj4_3_e004339.full;total of 46;46;-1
bmj4_3_e004355.full;12 000 randomly selected participants;12000;-1
bmj4_3_e004355.full;6070 participants;6070;-1
bmj4_3_e004355.full;N=2357;2357;-1
bmj4_3_e004355.full;N=671;671;-1
bmj4_3_e004355.full;N=679;679;-1
bmj4_3_e004355.full;N=2363;2363;-1
bmj4_3_e004355.full;N=6070;6070;-1
bmj4_3_e004355.full;N=1437;1437;-1
bmj4_3_e004355.full;N=2460;2460;-1
bmj4_3_e004355.full;N=1890;1890;-1
bmj4_3_e004355.full;N=283;283;-1
bmj4_3_e004363.full;20 women;20;-1
bmj4_3_e004363.full;10 RCT participants;10;-1
bmj4_3_e004363.full;20 participants;20;-1
bmj4_3_e004363.full;117  RCT participants;117;-1
bmj4_3_e004363.full;59  Study participants;59;-1
bmj4_3_e004363.full;117 patients;117;-1
bmj4_3_e004363.full;20  people;20;-1
bmj4_3_e004363.full;n=20;20;-1
bmj4_3_e004363.full;n=117;117;-1
bmj4_3_e004372.full;4079 ever married women;4079;-1
bmj4_3_e004372.full;14 Those women;14;-1
bmj4_3_e004372.full;12 961 women;12961;-1
bmj4_3_e004372.full;12 699 women;12699;-1
bmj4_3_e004372.full;4079 ever married  women;4079;-1
bmj4_3_e004372.full;701 pregnant women;701;-1
bmj4_3_e004372.full;n=4079;4079;-1
bmj4_3_e004384.full;2328 participants;2328;-1
bmj4_3_e004384.full;2328 non-  pregnant participants;2328;-1
bmj4_3_e004384.full;18 All participants;18;-1
bmj4_3_e004384.full;n=1150;1150;-1
bmj4_3_e004384.full;n=1178;1178;-1
bmj4_3_e004384.full;n=256;256;-1
bmj4_3_e004384.full;n=245;245;-1
bmj4_3_e004393.full;1213 participants;1213;-1
bmj4_3_e004393.full;1213  participants;1213;-1
bmj4_3_e004393.full;250 participants;250;-1
bmj4_3_e004393.full;50 000 participants;50000;-1
bmj4_3_e004393.full;100 people;100;-1
bmj4_3_e004393.full;10 people;10;-1
bmj4_3_e004393.full;2 people;2;-1
bmj4_3_e004393.full;1200  individuals;1200;-1
bmj4_3_e004393.full;n=450;450;-1
bmj4_3_e004393.full;n=768;768;-1
bmj4_3_e004393.full;N=2;2;-1
bmj4_3_e004393.full;total of 1213;1213;-1
bmj4_3_e004393.full;total  of 1213;1213;-1
bmj4_3_e004393.full;total of 116;116;-1
bmj4_3_e004393.full;350 partici-  pants enrolled;350;-1
bmj4_3_e004399.full;311 former participants;311;9464
bmj4_3_e004399.full;444 invited participants;444;4927
bmj4_3_e004399.full;378  participants;378;4835
bmj4_3_e004399.full;001 versus lean  participants;1;14309
bmj4_3_e004399.full;n=14;14;4576
bmj4_3_e004399.full;n=10;10;4520
bmj4_3_e004399.full;n  =1;1;1995
bmj4_3_e004399.full;n=134;134;7194
bmj4_3_e004399.full;n=64;64;7224
bmj4_3_e004399.full;n=113;113;7350
bmj4_3_e004407.full;1 Demographic features of subjects;1;-1
bmj4_3_e004407.full;7 All subjects;7;-1
bmj4_3_e004407.full;19 patients;19;-1
bmj4_3_e004407.full;3 Radiologic findings of patients;3;-1
bmj4_3_e004407.full;10  patients;10;-1
bmj4_3_e004407.full;17 Four patients;17;-1
bmj4_3_e004407.full;19 BAL findings of patients;19;-1
bmj4_3_e004407.full;n=14;14;-1
bmj4_3_e004407.full;n=5;5;-1
bmj4_3_e004417.full;37  Targeted engagement at women;37;-1
bmj4_3_e004417.full;75 000 individuals;75000;-1
bmj4_3_e004417.full;total of 97 700;97700;-1
bmj4_3_e004421.full;48 215 postmenopausal women;48215;-1
bmj4_3_e004421.full;48 215 women;48215;-1
bmj4_3_e004421.full;39 121 women;39121;-1
bmj4_3_e004421.full;38 969  women;38969;-1
bmj4_3_e004421.full;48 000 women;48000;-1
bmj4_3_e004421.full;455 women;455;-1
bmj4_3_e004421.full;452 women;452;-1
bmj4_3_e004421.full;50 639 women;50639;-1
bmj4_3_e004421.full;202 638 apparently healthy  women;202638;-1
bmj4_3_e004421.full;9398  women;9398;-1
bmj4_3_e004421.full;593 women;593;-1
bmj4_3_e004421.full;47 994 women;47994;-1
bmj4_3_e004421.full;8771 women;8771;-1
bmj4_3_e004421.full;39 123  women;39123;-1
bmj4_3_e004421.full;102 women;102;-1
bmj4_3_e004421.full;47 994  women;47994;-1
bmj4_3_e004421.full;39 353 women;39353;-1
bmj4_3_e004421.full;8871 women;8871;-1
bmj4_3_e004421.full;39 123 women;39123;-1
bmj4_3_e004421.full;384 women;384;-1
bmj4_3_e004421.full;154 women;154;-1
bmj4_3_e004421.full;200 women;200;-1
bmj4_3_e004421.full;1 UKCTOCS  participants;1;-1
bmj4_3_e004421.full;3302 participants;3302;-1
bmj4_3_e004421.full;74 were recruited;74;-1
bmj4_3_e004421.full;n=50 639;50639;-1
bmj4_3_e004421.full;n=50 640;50640;-1
bmj4_3_e004421.full;n=101 359;101359;-1
bmj4_3_e004428.full;29 665 control  participants;29665;-1
bmj4_3_e004428.full;15 054  patients;15054;-1
bmj4_3_e004428.full;2 diabetes patients;2;-1
bmj4_3_e004428.full;21  Older people;21;-1
bmj4_3_e004428.full;7000 individuals;7000;-1
bmj4_3_e004428.full;n=6015;6015;-1
bmj4_3_e004428.full;n=53;53;-1
bmj4_3_e004428.full;n=29;29;-1
bmj4_3_e004428.full;n=5933;5933;-1
bmj4_3_e004428.full;n=29 665;29665;-1
bmj4_3_e004428.full;total of 15 054;15054;-1
bmj4_3_e004428.full;total of 5933;5933;-1
bmj4_3_e004436.full;15 145 Chinese men and women;15145;-1
bmj4_3_e004436.full;7588 women;7588;-1
bmj4_3_e004436.full;16 500 people;16500;-1
bmj4_3_e004436.full;15 145  adults;15145;-1
bmj4_3_e004436.full;N=15 145;15145;-1
bmj4_3_e004436.full;total of 16 500;16500;-1
bmj4_3_e004441.full;37 patients;37;-1
bmj4_3_e004441.full;26 patients;26;-1
bmj4_3_e004441.full;5  In patients;5;-1
bmj4_3_e004441.full;26  patients;26;-1
bmj4_3_e004441.full;11 patients;11;-1
bmj4_3_e004441.full;26 control  patients;26;-1
bmj4_3_e004441.full;15  None of the control group patients;15;-1
bmj4_3_e004441.full;248 patients;248;-1
bmj4_3_e004449.full;40  NSTEMI participants;40;276
bmj4_3_e004449.full;102 patients;102;10332
bmj4_3_e004449.full;147 patients;147;449
bmj4_3_e004449.full;102  patients;102;918
bmj4_3_e004449.full;58 patients;58;1697
bmj4_3_e004449.full;13 patients;13;1806
bmj4_3_e004449.full;7  patients;7;1848
bmj4_3_e004449.full;8 patients;8;1698
bmj4_3_e004449.full;1967 patients;1967;11473
bmj4_3_e004449.full;19 patients;19;11512
bmj4_3_e004449.full;27 patients;27;12980
bmj4_3_e004449.full;58  patients;58;13719
bmj4_3_e004449.full;3 million people;3;5971
bmj4_3_e004449.full;62 were recruited;62;947
bmj4_3_e004449.full;n=8;8;10266
bmj4_3_e004449.full;n=4;4;10233
bmj4_3_e004449.full;n=9;9;10175
bmj4_3_e004449.full;n=53;53;10136
bmj4_3_e004449.full;n=28;28;10106
bmj4_3_e004449.full;n=3;3;721
bmj4_3_e004449.full;n=23;23;750
bmj4_3_e004449.full;total of 102;102;909
bmj4_3_e004453.full;14 541were recruited;14541;-1
bmj4_3_e004453.full;n=10 190;10190;-1
bmj4_3_e004453.full;n=137;137;-1
bmj4_3_e004453.full;n=165;165;-1
bmj4_3_e004453.full;n=68;68;-1
bmj4_3_e004453.full;n=920;920;-1
bmj4_3_e004453.full;n=8900;8900;-1
bmj4_3_e004453.full;n=2019;2019;-1
bmj4_3_e004453.full;N  =4;4;-1
bmj4_3_e004453.full;N  =7;7;-1
bmj4_3_e004453.full;N  =8;8;-1
bmj4_3_e004453.full;N  =3;3;-1
bmj4_3_e004453.full;N  =5;5;-1
bmj4_3_e004453.full;N  =6;6;-1
bmj4_3_e004453.full;N  =2;2;-1
bmj4_3_e004455.full;7 million people;7;-1
bmj4_3_e004455.full;22  A study of people;22;-1
bmj4_3_e004455.full;45 760 of  these people;45760;-1
bmj4_3_e004455.full;n=86;86;-1
bmj4_3_e004455.full;n=45 760;45760;-1
bmj4_3_e004461.full;6 Sexual minority women;6;-1
bmj4_3_e004461.full;n=0;0;-1
bmj4_3_e004461.full;n=1;1;-1
bmj4_3_e004462.full;n=215;215;-1
bmj4_3_e004462.full;n=10;10;-1
bmj4_3_e004462.full;n=12;12;-1
bmj4_3_e004462.full;n=2;2;-1
bmj4_3_e004462.full;n=200;200;-1
bmj4_3_e004462.full;n=15;15;-1
bmj4_3_e004462.full;n=127;127;-1
bmj4_3_e004476.full;1508 participants;1508;-1
bmj4_3_e004476.full;247  participants;247;-1
bmj4_3_e004476.full;45 and Up Study participants;45;-1
bmj4_3_e004476.full;2800 eligible people;2800;-1
bmj4_3_e004476.full;5  Trade people;5;-1
bmj4_3_e004476.full;45  and Up Study recruited;45;-1
bmj4_3_e004476.full;N=1261;1261;-1
bmj4_3_e004476.full;n=1261;1261;-1
bmj4_3_e004476.full; data from the 45;45;-1
bmj4_3_e004480.full;1100 patients;1100;-1
bmj4_3_e004480.full;12 262 patients;12262;-1
bmj4_3_e004480.full;17 370 patients;17370;-1
bmj4_3_e004480.full;17,370  patients;17370;-1
bmj4_3_e004480.full;50 patients;50;-1
bmj4_3_e004480.full;n=7614;7614;-1
bmj4_3_e004480.full;n=1686;1686;-1
bmj4_3_e004494.full;1  participants;1;-1
bmj4_3_e004494.full;11 000 eligible  patient participants;11000;-1
bmj4_3_e004494.full;29 Pilot participants;29;-1
bmj4_3_e004494.full;11 311 eligible patient participants;11311;-1
bmj4_3_e004494.full;11 302 participants;11302;-1
bmj4_3_e004494.full;2  Pilot participants;2;-1
bmj4_3_e004494.full;11 302  associated eligible patients;11302;-1
bmj4_3_e004494.full;1800 enrolled patients;1800;-1
bmj4_3_e004494.full;1800 patients;1800;-1
bmj4_3_e004494.full;n=2503;2503;-1
bmj4_3_e004494.full;n=8799;8799;-1
bmj4_3_e004494.full;n=11 302;11302;-1
bmj4_3_e004494.full;n=10 652;10652;-1
bmj4_3_e004494.full;n=10;10;-1
bmj4_3_e004494.full;86 per eligible enrolled;86;-1
bmj4_3_e004494.full;1800 enrolled;1800;-1
bmj4_3_e004495.full;175 participants;175;4222
bmj4_3_e004495.full;183 patients;183;21435
bmj4_3_e004495.full;35 patients;35;21010
bmj4_3_e004495.full;15 patients;15;15530
bmj4_3_e004495.full;90 patients;90;104
bmj4_3_e004495.full;90  patients;90;4293
bmj4_3_e004525.full;100 000 persons;100000;-1
bmj4_3_e004525.full;372  patients;372;-1
bmj4_3_e004525.full;100  patients;100;-1
bmj4_3_e004525.full;186 patients;186;-1
bmj4_3_e004525.full;8 adult SVT patients;8;-1
bmj4_3_e004525.full;125 000 people;125000;-1
bmj4_3_e004542.full;2822  patients;2822;-1
bmj4_3_e004542.full;255 patients;255;-1
bmj4_3_e004542.full;25  people;25;-1
bmj4_3_e004546.full;30 participants;30;-1
bmj4_3_e004546.full;120 participants;120;-1
bmj4_3_e004546.full;22 In  patients;22;-1
bmj4_3_e004546.full;30 patients;30;-1
bmj4_3_e004546.full;30  patients;30;-1
bmj4_3_e004546.full;80  patients;80;-1
bmj4_3_e004546.full;210 million people;210;-1
bmj4_3_e004571.full;48 outpatients;48;-1
bmj4_3_e004571.full;23 We defined stable patients;23;-1
bmj4_3_e004571.full;15 We excluded patients;15;-1
bmj4_3_e004571.full;381 patients;381;-1
bmj4_3_e004571.full;82 outpatients;82;-1
bmj4_3_e004571.full;53 patients;53;-1
bmj4_3_e004571.full;65 stable patients;65;-1
bmj4_3_e004571.full;17 patients;17;-1
bmj4_3_e004571.full;48 stable patients;48;-1
bmj4_3_e004571.full;22 patients;22;-1
bmj4_3_e004571.full;21 patients;21;-1
bmj4_3_e004571.full;23 patients;23;-1
bmj4_3_e004571.full;12 patients;12;-1
bmj4_3_e004571.full;total of 82;82;-1
bmj4_3_e004571.full;total of 22;22;-1
bmj4_3_e004571.full;53 patients enrolled;53;-1
bmj4_3_e004580.full;2008 participants;2008;-1
bmj4_3_e004580.full;2 Only participants;2;-1
bmj4_3_e004580.full;106  British adults;106;-1
bmj4_3_e004580.full; data  from the 2008;2008;-1
bmj4_3_e004595.full;11 900 patients;11900;-1
bmj4_3_e004595.full;12 000 patients;12000;-1
bmj4_3_e004595.full;total of 70;70;-1
bmj4_3_e004595.full;total of 44;44;-1
bmj4_3_e004600.full;total of 26;26;-1
bmj4_3_e004600.full;total of 325 922;325922;-1
bmj4_3_e004643.full;923 women;923;-1
bmj4_3_e004643.full;1 Married women;1;-1
bmj4_3_e004643.full;4 Knowledge  enables women;4;-1
bmj4_3_e004643.full;1997 women;1997;-1
bmj4_3_e004643.full;20 women;20;-1
bmj4_3_e004643.full;3 Distribution of women;3;-1
bmj4_3_e004643.full;n=1965;1965;-1
bmj4_3_e004643.full;total of 1997;1997;-1
bmj4_3_e004643.full;total of 12;12;-1
bmj4_3_e004648.full;1822 included patients;1822;-1
bmj4_3_e004648.full;1822 patients;1822;-1
bmj4_3_e004648.full;2195 patients;2195;-1
bmj4_3_e004648.full;373 patients;373;-1
bmj4_3_e004648.full;200 patients;200;-1
bmj4_3_e004648.full;1484 patients;1484;-1
bmj4_3_e004648.full;208 patients;208;-1
bmj4_3_e004648.full;1614 patients;1614;-1
bmj4_3_e004648.full;1822  patients;1822;-1
bmj4_3_e004712.full;400 women;400;-1
bmj4_3_e004712.full;999  patients;999;-1
bmj4_3_e004712.full;100  patients;100;-1
bmj4_3_e004712.full;509  patients;509;-1
bmj4_3_e004712.full;n=27;27;-1
bmj4_3_e004842.full;7000 substudy eligible patients;7000;-1
bmj4_3_e004842.full;4494 adult patients;4494;-1
bmj4_3_e004842.full;157 patients;157;-1
bmj4_3_e004842.full;191 patients;191;-1
bmj4_3_e004842.full;28 patients;28;-1
bmj4_3_e004842.full;40 patients;40;-1
bmj4_3_e004842.full;110  patients;110;-1
bmj4_3_e004842.full;20 patients;20;-1
bmj4_3_e004842.full;7500 patients;7500;-1
bmj4_3_e004842.full;7000 SIRS patients;7000;-1
bmj4_3_e004842.full;18  In all SIRS patients;18;-1
bmj4_3_e004842.full;1 SIRS patients;1;-1
bmj4_3_e004842.full;7000 patients;7000;-1
bmj4_3_e004842.full;4200 patients;4200;-1
bmj4_3_e004842.full;2 Subpopulation of SIRS patients;2;-1
bmj4_3_e004842.full;800  patients;800;-1
bmj4_3_e004842.full;800 patients;800;-1
bmj4_3_e004842.full;236  adults;236;-1
bmj4_3_e004842.full;n=6598;6598;-1
bmj4_3_e004842.full;n=4668;4668;-1
bmj4_3_e004842.full;n=1930;1930;-1
bmj4_3_e004842.full;n=4231;4231;-1
bmj4_3_e004842.full;n=3016;3016;-1
bmj4_3_e004842.full;n=1215;1215;-1
bmj4_3_e004862.full;643  patients;643;-1
bmj4_3_e004862.full;n  =5;5;-1
bmj4_3_e004862.full;n  =3;3;-1
bmj4_3_e004862.full;N=656;656;-1
bmj4_3_e004862.full;n=131;131;-1
bmj4_3_e004862.full;n=525;525;-1
bmj4_3_e004862.full;n  =4;4;-1
bmj4_3_e004877.full;36  Recruitment of the study participants;36;-1
bmj4_3_e004877.full;300  individuals per group of participants;300;-1
bmj4_3_e004877.full;10  patients;10;-1
bmj4_3_e004877.full;2 diabetes  patients;2;-1
bmj4_3_e004877.full;22 000 people;22000;-1
bmj4_3_e004877.full;64  people;64;-1
bmj4_3_e004877.full;6250 individuals;6250;-1
bmj4_3_e004877.full;1250 individuals;1250;-1
bmj4_3_e004877.full;300  individuals;300;-1
bmj4_3_e004877.full;n=1057;1057;-1
bmj4_3_e004877.full;n=863;863;-1
bmj4_3_e004877.full;n=1011;1011;-1
bmj4_3_e004877.full;n=597;597;-1
bmj4_3_e004877.full;n=340;340;-1
bmj4_3_e004914.full;160 patients;160;-1
bmj4_3_e004914.full;80 patients;80;-1
bmj4_3_e004914.full;6336  patients;6336;-1
bmj4_3_e004914.full;160 patients will be recruited;160;-1
bmj4_3_e004914.full;80 patients have been recruited;80;-1
bmj4_3_e004914.full;n=30;30;-1
bmj4_3_e004914.full;n=20;20;-1
bmj4_3_e004914.full;n=10;10;-1
bmj4_3_e004914.full;total of 160;160;-1
bmj4_3_e004972.full;36 Involving patients;36;-1
bmj4_3_e004972.full;N=80;80;-1
bmj4_3_e004973.full;525  women;525;-1
bmj4_3_e004973.full;267 control women;267;-1
bmj4_3_e004973.full;988 middle-  aged Finnish participants;988;-1
bmj4_3_e004973.full;3  million participants;3;-1
bmj4_3_e004973.full;1023 participants;1023;-1
bmj4_3_e004973.full;988 participants;988;-1
bmj4_3_e004973.full;2 diabetic  patients;2;-1
bmj4_3_e004973.full;16 In  individuals;16;-1
bmj4_3_e004973.full;163,944 Austrian adults;163944;-1
bmj4_3_e004973.full;n=1045;1045;-1
bmj4_3_e004973.full;n=41;41;-1
bmj4_3_e004973.full;n=161;161;-1
bmj4_3_e004973.full;n=767;767;-1
bmj4_3_e004973.full;n=76;76;-1
bmj4_3_e004973.full;n=720;720;-1
bmj4_3_e004973.full;n=124;124;-1
bmj4_3_e004973.full;n=144;144;-1
bmj4_3_e004973.full;n=319;319;-1
bmj4_3_e004973.full;n=81;81;-1
bmj4_3_e004973.full;n=82;82;-1
bmj4_3_e004973.full;n=298;298;-1
bmj4_3_e004973.full;n=103;103;-1
bmj4_3_e004973.full;n=314;314;-1
bmj4_3_e004973.full;n=83;83;-1
bmj4_3_e004973.full;n=105;105;-1
bmj4_3_e004973.full;n=16;16;-1
bmj4_3_e004973.full;n=2;2;-1
bmj4_3_e004973.full;n=9;9;-1
bmj4_3_e004973.full;n=8;8;-1
bmj4_3_e004973.full;n=15;15;-1
bmj4_3_e004973.full;n=17;17;-1
bmj4_3_e004973.full;n=53;53;-1
bmj4_3_e004973.full;total of 520;520;-1
bmj4_4_e003932.full;2 cohorts of patients;2;-1
bmj4_4_e003932.full;214 patients;214;-1
bmj4_4_e003932.full;450 surviving  patients;450;-1
bmj4_4_e003932.full;6 patients;6;-1
bmj4_4_e003932.full;20 patients;20;-1
bmj4_4_e003932.full;46  Almost half of the patients;46;-1
bmj4_4_e003932.full;2143 patients;2143;-1
bmj4_4_e003932.full;520 patients;520;-1
bmj4_4_e003932.full;6000 people;6000;-1
bmj4_4_e003932.full;n=117;117;-1
bmj4_4_e003975.full;7 million  participants;7;-1
bmj4_4_e003975.full;1 475 347 people;1475347;-1
bmj4_4_e003975.full;792 560 people;792560;-1
bmj4_4_e003975.full;4 million people;4;-1
bmj4_4_e003975.full;2010  Correponding number of people;2010;-1
bmj4_4_e003975.full;38 people;38;-1
bmj4_4_e003975.full;78 828 people;78828;-1
bmj4_4_e003975.full;31 282 people;31282;-1
bmj4_4_e003975.full;5000 people;5000;-1
bmj4_4_e003975.full;n=198 086;198086;-1
bmj4_4_e003975.full;n=128 982;128982;-1
bmj4_4_e003975.full;n=128 983;128983;-1
bmj4_4_e003975.full;n=28 489;28489;-1
bmj4_4_e003975.full;n=1 475 347;1475347;-1
bmj4_4_e003975.full;n=1 477 600;1477600;-1
bmj4_4_e003975.full;total of  78 828;78828;-1
bmj4_4_e004059.full;8423 participants;8423;-1
bmj4_4_e004059.full;857  participants;857;-1
bmj4_4_e004059.full;16 All participants;16;-1
bmj4_4_e004059.full;10 994 participants;10994;-1
bmj4_4_e004059.full;n=7983;7983;-1
bmj4_4_e004059.full;n=3011;3011;-1
bmj4_4_e004059.full;n=4919;4919;-1
bmj4_4_e004059.full;n=29;29;-1
bmj4_4_e004059.full;N=8423;8423;-1
bmj4_4_e004059.full;N=4919;4919;-1
bmj4_4_e004075.full;13 patients;13;-1
bmj4_4_e004075.full;6 and the age of the patients;6;-1
bmj4_4_e004075.full;5000 individuals;5000;-1
bmj4_4_e004075.full;245 individuals;245;-1
bmj4_4_e004075.full;163 individuals;163;-1
bmj4_4_e004075.full;n=82;82;-1
bmj4_4_e004075.full;n=163;163;-1
bmj4_4_e004075.full;n=245;245;-1
bmj4_4_e004075.full;n=19;19;-1
bmj4_4_e004075.full;n=24;24;-1
bmj4_4_e004075.full;n=9;9;-1
bmj4_4_e004075.full;total of 245;245;-1
bmj4_4_e004075.full;total of 8;8;-1
bmj4_4_e004075.full;total of 13;13;-1
bmj4_4_e004083.full;565 patients;565;-1
bmj4_4_e004083.full;total of 14;14;-1
bmj4_4_e004100.full;30  participants;30;-1
bmj4_4_e004100.full;30 participants;30;-1
bmj4_4_e004100.full;22 patients;22;-1
bmj4_4_e004100.full;25 patients;25;-1
bmj4_4_e004100.full;n  =1;1;-1
bmj4_4_e004100.full;n=  21;21;-1
bmj4_4_e004100.full;n=  51;51;-1
bmj4_4_e004100.full;n=  38;38;-1
bmj4_4_e004100.full;n=  69;69;-1
bmj4_4_e004100.full;n=  71;71;-1
bmj4_4_e004100.full;n=  49;49;-1
bmj4_4_e004100.full;n=  25;25;-1
bmj4_4_e004100.full;n=  35;35;-1
bmj4_4_e004100.full;n=  30;30;-1
bmj4_4_e004100.full;n=  47;47;-1
bmj4_4_e004100.full;n=  43;43;-1
bmj4_4_e004100.full;n=  18;18;-1
bmj4_4_e004100.full;n=17;17;-1
bmj4_4_e004194.full;45 women;45;12891
bmj4_4_e004194.full;44 participants;44;6071
bmj4_4_e004194.full;88 participants;88;5591
bmj4_4_e004194.full;45 female participants;45;2003
bmj4_4_e004194.full;122 participants;122;7102
bmj4_4_e004194.full;310 children  and adults;310;8916
bmj4_4_e004194.full;19 were recruited;19;13422
bmj4_4_e004194.full;n=99;99;1895
bmj4_4_e004259.full;105 participants;105;-1
bmj4_4_e004259.full;223 patients;223;-1
bmj4_4_e004259.full;112 patients;112;-1
bmj4_4_e004259.full;111  patients;111;-1
bmj4_4_e004259.full;250 patients;250;-1
bmj4_4_e004259.full;111 patients;111;-1
bmj4_4_e004259.full;109 patients;109;-1
bmj4_4_e004259.full;106 patients;106;-1
bmj4_4_e004259.full;41  patients;41;-1
bmj4_4_e004259.full;3 patients;3;-1
bmj4_4_e004259.full;n=112;112;-1
bmj4_4_e004259.full;n=111;111;-1
bmj4_4_e004259.full;total of 4;4;-1
bmj4_4_e004259.full; data from a 2;2;-1
bmj4_4_e004293.full;209 individuals;209;-1
bmj4_4_e004293.full;722 464 individuals;722464;-1
bmj4_4_e004293.full;1000 individuals;1000;-1
bmj4_4_e004293.full;n=721 915;721915;-1
bmj4_4_e004293.full;N=722 464;722464;-1
bmj4_4_e004293.full;N=428;428;-1
bmj4_4_e004293.full;N=52;52;-1
bmj4_4_e004293.full;N=120 846;120846;-1
bmj4_4_e004293.full;N=430;430;-1
bmj4_4_e004293.full;N=4280;4280;-1
bmj4_4_e004293.full;total of 167;167;-1
bmj4_4_e004327.full;607  participants;607;-1
bmj4_4_e004327.full;600 participants;600;-1
bmj4_4_e004327.full;3 Flow of participants;3;-1
bmj4_4_e004327.full;7  CTC typically requires patients;7;-1
bmj4_4_e004327.full;100 people;100;-1
bmj4_4_e004327.full;2500 people;2500;-1
bmj4_4_e004327.full;750 individuals;750;-1
bmj4_4_e004327.full;2819 adults;2819;-1
bmj4_4_e004327.full;n=17;17;-1
bmj4_4_e004353.full;46 subjects;46;-1
bmj4_4_e004353.full;13 subjects;13;-1
bmj4_4_e004353.full;10 They also  reported three subjects;10;-1
bmj4_4_e004353.full;32 ALS patients;32;-1
bmj4_4_e004353.full;13 patients;13;-1
bmj4_4_e004353.full;100 000  people;100000;-1
bmj4_4_e004353.full;3800 people;3800;-1
bmj4_4_e004353.full;4100 people;4100;-1
bmj4_4_e004353.full;4500 people;4500;-1
bmj4_4_e004353.full;4100  people;4100;-1
bmj4_4_e004353.full;100 000 people;100000;-1
bmj4_4_e004353.full;27  Indigenous people;27;-1
bmj4_4_e004353.full;38 people;38;-1
bmj4_4_e004353.full;n  =1;1;-1
bmj4_4_e004353.full;n=4;4;-1
bmj4_4_e004353.full;n=2;2;-1
bmj4_4_e004353.full;n=1;1;-1
bmj4_4_e004353.full;n=7;7;-1
bmj4_4_e004353.full;n=3;3;-1
bmj4_4_e004353.full;n=5;5;-1
bmj4_4_e004353.full;n=6;6;-1
bmj4_4_e004353.full;n=13;13;-1
bmj4_4_e004353.full;n=9;9;-1
bmj4_4_e004362.full;175 participants;175;-1
bmj4_4_e004362.full;350 participants;350;-1
bmj4_4_e004362.full;350 individuals;350;-1
bmj4_4_e004376.full;31 patients;31;17179
bmj4_4_e004376.full;29 patients;29;17023
bmj4_4_e004376.full;85 patients;85;14697
bmj4_4_e004376.full;10 patients;10;14313
bmj4_4_e004376.full;31 consecutive patients;31;13634
bmj4_4_e004376.full;7 We included only patients;7;13048
bmj4_4_e004376.full;4 patients;4;5907
bmj4_4_e004376.full;13  patients;13;5849
bmj4_4_e004376.full;3 patients;3;5778
bmj4_4_e004376.full;14 patients;14;5568
bmj4_4_e004376.full;28 patients;28;2856
bmj4_4_e004376.full;11  patients;11;2642
bmj4_4_e004376.full;2 patients;2;2526
bmj4_4_e004376.full;n=30;30;10817
bmj4_4_e004376.full;n=2;2;6641
bmj4_4_e004376.full;n=12;12;5033
bmj4_4_e004376.full;n=7;7;5015
bmj4_4_e004376.full;n=1;1;5033
bmj4_4_e004376.full;n=19;19;4579
bmj4_4_e004376.full;n=4;4;4548
bmj4_4_e004376.full;n=31;31;1183
bmj4_4_e004376.full;n=29;29;1178
bmj4_4_e004404.full;1400 young people;1400;-1
bmj4_4_e004404.full;1 Young people;1;-1
bmj4_4_e004404.full;21 and yet young people;21;-1
bmj4_4_e004404.full;29 Young people;29;-1
bmj4_4_e004404.full;19 Young  people;19;-1
bmj4_4_e004404.full;29 While sometimes young people;29;-1
bmj4_4_e004404.full;28 Young people;28;-1
bmj4_4_e004404.full;12c  Vicious circles  Young people;12;-1
bmj4_4_e004404.full;78  Some young people;78;-1
bmj4_4_e004404.full;N  =3;3;-1
bmj4_4_e004404.full;N  =1;1;-1
bmj4_4_e004404.full;  databases from 1997;1997;-1
bmj4_4_e004405.full;12 patients;12;-1
bmj4_4_e004405.full;10 044 patients;10044;-1
bmj4_4_e004405.full;6742 patients;6742;-1
bmj4_4_e004405.full;5027 patients;5027;-1
bmj4_4_e004405.full;6033  patients;6033;-1
bmj4_4_e004405.full;455 patients;455;-1
bmj4_4_e004405.full;460 patients;460;-1
bmj4_4_e004405.full;n=740;740;-1
bmj4_4_e004405.full;n=810;810;-1
bmj4_4_e004405.full;n=249;249;-1
bmj4_4_e004405.full;n=10 044;10044;-1
bmj4_4_e004405.full;n=6033;6033;-1
bmj4_4_e004405.full;total of 10 044;10044;-1
bmj4_4_e004409.full;32 women;32;-1
bmj4_4_e004409.full;47 patients;47;-1
bmj4_4_e004409.full;44 All patients;44;-1
bmj4_4_e004409.full;45 patients;45;-1
bmj4_4_e004409.full;N=11;11;-1
bmj4_4_e004409.full;N=6;6;-1
bmj4_4_e004409.full;N=5;5;-1
bmj4_4_e004409.full;N=10;10;-1
bmj4_4_e004409.full;N=7;7;-1
bmj4_4_e004409.full;N=8;8;-1
bmj4_4_e004409.full;N=26;26;-1
bmj4_4_e004409.full;N=21;21;-1
bmj4_4_e004409.full;N=36;36;-1
bmj4_4_e004409.full;N=20;20;-1
bmj4_4_e004409.full;N=16;16;-1
bmj4_4_e004423.full;804 persons;804;-1
bmj4_4_e004423.full;609  cancer patients;609;-1
bmj4_4_e004423.full;1 435 815 individuals;1435815;-1
bmj4_4_e004423.full;73 131 individuals;73131;-1
bmj4_4_e004423.full;131 individuals;131;-1
bmj4_4_e004434.full;1 Should women;1;-1
bmj4_4_e004434.full;7 million women;7;-1
bmj4_4_e004434.full;8  participants;8;-1
bmj4_4_e004434.full;n=19;19;-1
bmj4_4_e004434.full;n=16;16;-1
bmj4_4_e004434.full;n=17;17;-1
bmj4_4_e004434.full;n=9;9;-1
bmj4_4_e004434.full;total of 62;62;-1
bmj4_4_e004470.full;100 000 people;100000;-1
bmj4_4_e004470.full;100 000  people;100000;-1
bmj4_4_e004470.full;total of 164 752;164752;-1
bmj4_4_e004470.full;total of 55;55;-1
bmj4_4_e004474.full;43 Flows of patients;43;-1
bmj4_4_e004475.full;300 participants;300;-1
bmj4_4_e004475.full;80 participants;80;-1
bmj4_4_e004475.full;300  participants;300;-1
bmj4_4_e004475.full;7200 French adults;7200;-1
bmj4_4_e004475.full;1600 adolescents recruited;1600;-1
bmj4_4_e004475.full;total of 16;16;-1
bmj4_4_e004485.full;10 participants;10;-1
bmj4_4_e004485.full;N=179;179;-1
bmj4_4_e004485.full;N=147;147;-1
bmj4_4_e004485.full;total of 179;179;-1
bmj4_4_e004485.full;total of  70;70;-1
bmj4_4_e004487.full;7150 participants;7150;-1
bmj4_4_e004487.full;6744  participants;6744;-1
bmj4_4_e004487.full;total of 6744;6744;-1
bmj4_4_e004499.full;15 considered women;15;-1
bmj4_4_e004499.full;28 women;28;-1
bmj4_4_e004499.full;6 million women;6;-1
bmj4_4_e004499.full;142,475 women;142475;-1
bmj4_4_e004499.full;15 women;15;-1
bmj4_4_e004499.full;8 mention exclusion of such patients;8;-1
bmj4_4_e004522.full;24 000 inpatients;24000;-1
bmj4_4_e004522.full;225 000 outpatients;225000;-1
bmj4_4_e004528.full;3 For women;3;-1
bmj4_4_e004528.full;24  Rural women;24;-1
bmj4_4_e004528.full;141 million individuals;141;-1
bmj4_4_e004528.full;2011 CHNS were recruited;2011;-1
bmj4_4_e004528.full;N=11835;11835;-1
bmj4_4_e004528.full;N=12 561;12561;-1
bmj4_4_e004528.full;total of 11 835;11835;-1
bmj4_4_e004549.full;N=9183;9183;-1
bmj4_4_e004549.full;N=8762;8762;-1
bmj4_4_e004549.full;N=8974;8974;-1
bmj4_4_e004549.full;N=4753;4753;-1
bmj4_4_e004549.full;N=1147;1147;-1
bmj4_4_e004549.full;N=350;350;-1
bmj4_4_e004549.full;N=692;692;-1
bmj4_4_e004552.full;n=15;15;-1
bmj4_4_e004552.full;n=9;9;-1
bmj4_4_e004552.full;n=7;7;-1
bmj4_4_e004552.full;n=11;11;-1
bmj4_4_e004552.full;n=6;6;-1
bmj4_4_e004552.full;n=2;2;-1
bmj4_4_e004552.full;n=12;12;-1
bmj4_4_e004552.full;n=  14;14;-1
bmj4_4_e004552.full;n=31;31;-1
bmj4_4_e004552.full;n=28;28;-1
bmj4_4_e004579.full;n=488;488;-1
bmj4_4_e004579.full;n=571;571;-1
bmj4_4_e004579.full;n=174;174;-1
bmj4_4_e004579.full;n=454;454;-1
bmj4_4_e004579.full;n=115;115;-1
bmj4_4_e004579.full;n=58;58;-1
bmj4_4_e004579.full;n=28;28;-1
bmj4_4_e004579.full;N=269;269;-1
bmj4_4_e004579.full;N=305;305;-1
bmj4_4_e004579.full;n=574;574;-1
bmj4_4_e004579.full;n=572;572;-1
bmj4_4_e004579.full;n=569;569;-1
bmj4_4_e004579.full;n=563;563;-1
bmj4_4_e004579.full;n=559;559;-1
bmj4_4_e004579.full;n=561;561;-1
bmj4_4_e004579.full;n=556;556;-1
bmj4_4_e004579.full;n=433;433;-1
bmj4_4_e004579.full;n=557;557;-1
bmj4_4_e004579.full;n=521;521;-1
bmj4_4_e004579.full;n=535;535;-1
bmj4_4_e004579.full;n=441;441;-1
bmj4_4_e004579.full;n=173;173;-1
bmj4_4_e004579.full;N=234;234;-1
bmj4_4_e004579.full;N=254;254;-1
bmj4_4_e004579.full;n=472;472;-1
bmj4_4_e004579.full;n=486;486;-1
bmj4_4_e004579.full;n=485;485;-1
bmj4_4_e004579.full;n=479;479;-1
bmj4_4_e004579.full;n=475;475;-1
bmj4_4_e004579.full;n=471;471;-1
bmj4_4_e004579.full;n=404;404;-1
bmj4_4_e004579.full;n=402;402;-1
bmj4_4_e004579.full;n=453;453;-1
bmj4_4_e004579.full;n=467;467;-1
bmj4_4_e004579.full;n=163;163;-1
bmj4_4_e004579.full;n=482;482;-1
bmj4_4_e004579.full;n=478;478;-1
bmj4_4_e004579.full;n=469;469;-1
bmj4_4_e004579.full;n=468;468;-1
bmj4_4_e004579.full;n=461;461;-1
bmj4_4_e004579.full;n=324;324;-1
bmj4_4_e004579.full;n=323;323;-1
bmj4_4_e004579.full;n=409;409;-1
bmj4_4_e004579.full;n=358;358;-1
bmj4_4_e004579.full;n=61;61;-1
bmj4_4_e004579.full;total of 574;574;-1
bmj4_4_e004590.full;64  million people;64;-1
bmj4_4_e004602.full;40 participants;40;-1
bmj4_4_e004606.full;n=990;990;-1
bmj4_4_e004606.full;n=68;68;-1
bmj4_4_e004606.full;n=33;33;-1
bmj4_4_e004606.full;n=88;88;-1
bmj4_4_e004606.full;n=37;37;-1
bmj4_4_e004606.full;n=42;42;-1
bmj4_4_e004606.full;n=825;825;-1
bmj4_4_e004606.full;n=139;139;-1
bmj4_4_e004606.full;n=454;454;-1
bmj4_4_e004606.full;n=56;56;-1
bmj4_4_e004606.full;total of 990;990;-1
bmj4_4_e004619.full;2DM participants;2;-1
bmj4_4_e004619.full;2 diabetes mellitus participants;2;-1
bmj4_4_e004619.full;3986 participants;3986;-1
bmj4_4_e004619.full;1990 participants;1990;-1
bmj4_4_e004619.full;3620 participants;3620;-1
bmj4_4_e004619.full;4008 participants;4008;-1
bmj4_4_e004619.full;2005 participants;2005;-1
bmj4_4_e004619.full;2003 participants;2003;-1
bmj4_4_e004619.full;2 diabetic patients;2;-1
bmj4_4_e004619.full;total of 380;380;-1
bmj4_4_e004619.full;total of 4008;4008;-1
bmj4_4_e004625.full;n=21;21;-1
bmj4_4_e004625.full;total of 48;48;-1
bmj4_4_e004625.full;total of 352;352;-1
bmj4_4_e004625.full;total of 11;11;-1
bmj4_4_e004626.full;n=5;5;-1
bmj4_4_e004631.full;n=3553;3553;-1
bmj4_4_e004631.full;n=5680;5680;-1
bmj4_4_e004631.full;n=4596;4596;-1
bmj4_4_e004631.full;n=4636;4636;-1
bmj4_4_e004631.full;n=3774;3774;-1
bmj4_4_e004631.full;n=1224;1224;-1
bmj4_4_e004631.full;n=3629;3629;-1
bmj4_4_e004631.full;n=231;231;-1
bmj4_4_e004631.full;n=374;374;-1
bmj4_4_e004631.full;n=2646;2646;-1
bmj4_4_e004631.full;n=4157;4157;-1
bmj4_4_e004631.full;n=2428;2428;-1
bmj4_4_e004631.full;n  =4;4;-1
bmj4_4_e004631.full;n  =1;1;-1
bmj4_4_e004631.full;n  =2;2;-1
bmj4_4_e004631.full;n  =3;3;-1
bmj4_4_e004631.full;n  =8;8;-1
bmj4_4_e004631.full;n=1004;1004;-1
bmj4_4_e004631.full;n=769;769;-1
bmj4_4_e004631.full;n=263;263;-1
bmj4_4_e004631.full;n=935;935;-1
bmj4_4_e004631.full;n=985;985;-1
bmj4_4_e004631.full;n=291;291;-1
bmj4_4_e004631.full;  data from the 2012;2012;-1
bmj4_4_e004666.full;16 715 opioid-dependent people;16715;-1
bmj4_4_e004666.full;9645 people;9645;-1
bmj4_4_e004666.full;10 individuals;10;-1
bmj4_4_e004666.full;n=13 199;13199;-1
bmj4_4_e004666.full;n=5011;5011;-1
bmj4_4_e004666.full;n=12 852;12852;-1
bmj4_4_e004666.full;n=46;46;-1
bmj4_4_e004666.full;n=37;37;-1
bmj4_4_e004666.full;n=11;11;-1
bmj4_4_e004666.full;n=32;32;-1
bmj4_4_e004666.full;n=17;17;-1
bmj4_4_e004666.full;n=16 715;16715;-1
bmj4_4_e004666.full;n=3863;3863;-1
bmj4_4_e004666.full;n=51;51;-1
bmj4_4_e004666.full;n=43;43;-1
bmj4_4_e004666.full;n  =1;1;-1
bmj4_4_e004675.full;197  women;197;-1
bmj4_4_e004675.full;10 persons;10;-1
bmj4_4_e004675.full;594 participants;594;-1
bmj4_4_e004675.full;11 All ECHOES participants;11;-1
bmj4_4_e004675.full;6162  participants;6162;-1
bmj4_4_e004675.full;594 ECHOES participants;594;-1
bmj4_4_e004675.full;3960 patients;3960;-1
bmj4_4_e004675.full;782 patients;782;-1
bmj4_4_e004675.full;928 patients;928;-1
bmj4_4_e004675.full;3346 patients;3346;-1
bmj4_4_e004675.full;n  =3;3;-1
bmj4_4_e004675.full;n  =1;1;-1
bmj4_4_e004675.full;n  =8;8;-1
bmj4_4_e004675.full;n  =2;2;-1
bmj4_4_e004675.full;n  =6;6;-1
bmj4_4_e004675.full;n  =5;5;-1
bmj4_4_e004675.full;total of 6162;6162;-1
bmj4_4_e004682.full;27 participants;27;-1
bmj4_4_e004682.full;11 participants;11;-1
bmj4_4_e004682.full;11 jury participants;11;-1
bmj4_4_e004682.full;15 Indeed some patients;15;-1
bmj4_4_e004682.full;31 men were recruited;31;-1
bmj4_4_e004682.full;n=12;12;-1
bmj4_4_e004682.full;n=15;15;-1
bmj4_4_e004682.full;N=11;11;-1
bmj4_4_e004682.full;n=10;10;-1
bmj4_4_e004682.full;N=25;25;-1
bmj4_4_e004699.full;320  patients;320;-1
bmj4_4_e004699.full;21 and smoking adults;21;-1
bmj4_4_e004699.full;30  While children and adults;30;-1
bmj4_4_e004699.full;32 In adults;32;-1
bmj4_4_e004699.full;400 children recruited;400;-1
bmj4_4_e004703.full;40 participants;40;-1
bmj4_4_e004703.full;20 participants;20;-1
bmj4_4_e004706.full;1895 participants;1895;-1
bmj4_4_e004706.full;1556  participants;1556;-1
bmj4_4_e004706.full;1556 participants;1556;-1
bmj4_4_e004706.full;371 million people;371;-1
bmj4_4_e004706.full;total of 1895;1895;-1
bmj4_4_e004743.full;509  participants;509;15046
bmj4_4_e004743.full;21 participants;21;5641
bmj4_4_e004743.full;829 participants;829;2728
bmj4_4_e004743.full;380 participants;380;22393
bmj4_4_e004743.full;56 individuals;56;2854
bmj4_4_e004743.full;509 individuals;509;27383
bmj4_4_e004743.full;829 participants were recruited;829;2728
bmj4_4_e004743.full;n=509;509;8117
bmj4_4_e004743.full;n=117;117;8148
bmj4_4_e004743.full;n=392;392;8180
bmj4_4_e004743.full;n  =1;1;9767
bmj4_4_e004743.full;n  =3;3;9823
bmj4_4_e004743.full;N=380;380;28562
bmj4_4_e004743.full;N=777;777;28609
bmj4_4_e004743.full;N=509;509;28689
bmj4_4_e004743.full;total of 829;829;2719
bmj4_4_e004783.full;16 local women;16;-1
bmj4_4_e004783.full;233 700 women;233700;-1
bmj4_4_e004783.full;200 women;200;-1
bmj4_4_e004783.full;300 women;300;-1
bmj4_4_e004783.full;33 We recruited  women;33;-1
bmj4_4_e004783.full;16 women;16;-1
bmj4_4_e004783.full;10 in-depth groups of  women;10;-1
bmj4_4_e004783.full;33 We recruited;33;-1
bmj4_4_e004783.full;n=16;16;-1
bmj4_4_e004783.full;total of 16;16;-1
bmj4_4_e004794.full;2 diabetes  outpatients;2;-1
bmj4_4_e004794.full;2  diabetes outpatients;2;-1
bmj4_4_e004794.full;169 patients;169;-1
bmj4_4_e004794.full;2 diabetes outpatients;2;-1
bmj4_4_e004794.full;15 000 patients;15000;-1
bmj4_4_e004794.full;19 and patients;19;-1
bmj4_4_e004794.full;007  diabetes outpatients;7;-1
bmj4_4_e004794.full;29 Education drives individuals;29;-1
bmj4_4_e004794.full;n=99;99;-1
bmj4_4_e004794.full;n=70;70;-1
bmj4_4_e004794.full;n=169;169;-1
bmj4_4_e004807.full;85  of the cohort participants;85;-1
bmj4_4_e004807.full;N=7320;7320;-1
bmj4_4_e004807.full;n=5792;5792;-1
bmj4_4_e004807.full;n=214;214;-1
bmj4_4_e004807.full;n=675;675;-1
bmj4_4_e004807.full;n=639;639;-1
bmj4_4_e004807.full;n=11 648;11648;-1
bmj4_4_e004807.full;N  =7;7;-1
bmj4_4_e004807.full;n  =5;5;-1
bmj4_4_e004807.full;n  =2;2;-1
bmj4_4_e004807.full;n  =6;6;-1
bmj4_4_e004827.full;43 postmenopau-  sal women;43;-1
bmj4_4_e004827.full;43 postmenopausal women;43;-1
bmj4_4_e004827.full;2392 participants;2392;-1
bmj4_4_e004827.full;2392 individuals;2392;-1
bmj4_4_e004827.full;499 obese adults;499;-1
bmj4_4_e004827.full;5000 adults;5000;-1
bmj4_4_e004827.full;N=1930;1930;-1
bmj4_4_e004827.full;N=3601;3601;-1
bmj4_4_e004827.full;N=117;117;-1
bmj4_4_e004827.full;n=156;156;-1
bmj4_4_e004827.full;N  =1;1;-1
bmj4_4_e004827.full;N  =7;7;-1
bmj4_4_e004827.full;N  =2;2;-1
bmj4_4_e004827.full;N  =4;4;-1
bmj4_4_e004827.full;N  =6;6;-1
bmj4_4_e004827.full;N  =9;9;-1
bmj4_4_e004827.full;N  =3;3;-1
bmj4_4_e004827.full;N=469;469;-1
bmj4_4_e004827.full;N=826;826;-1
bmj4_4_e004827.full;N=297;297;-1
bmj4_4_e004827.full;N=800;800;-1
bmj4_4_e004827.full;N=2329;2329;-1
bmj4_4_e004827.full;N=613;613;-1
bmj4_4_e004827.full;N=130;130;-1
bmj4_4_e004827.full;N=207;207;-1
bmj4_4_e004827.full;N=76;76;-1
bmj4_4_e004827.full;N=200;200;-1
bmj4_4_e004852.full;149 patients;149;-1
bmj4_4_e004852.full;189 patients;189;-1
bmj4_4_e004852.full;4  The distribution of the patients;4;-1
bmj4_4_e004852.full;189 epilepsy patients;189;-1
bmj4_4_e004852.full;2 and the drug  state of the patients;2;-1
bmj4_4_e004852.full;22 In paediatric patients;22;-1
bmj4_4_e004852.full;189 adults;189;-1
bmj4_4_e004852.full;n=189;189;-1
bmj4_4_e004870.full;18 consecutive women;18;-1
bmj4_4_e004870.full;10 women;10;-1
bmj4_4_e004870.full;28 women;28;-1
bmj4_4_e004870.full;1665 women;1665;-1
bmj4_4_e004870.full;28 PE  women;28;-1
bmj4_4_e004870.full;18 women;18;-1
bmj4_4_e004870.full;8 women;8;-1
bmj4_4_e004870.full;10  women;10;-1
bmj4_4_e004870.full;05 versus women;5;-1
bmj4_4_e004870.full;19 women;19;-1
bmj4_4_e004870.full;5 women;5;-1
bmj4_4_e004870.full;26 women;26;-1
bmj4_4_e004870.full;10 consecutive  women;10;-1
bmj4_4_e004870.full;n=10;10;-1
bmj4_4_e004870.full;n=18;18;-1
bmj4_4_e004870.full;total of 1665;1665;-1
bmj4_4_e004870.full;total of 28;28;-1
bmj4_4_e004921.full;15 patients;15;792
bmj4_4_e004934.full;65 participants;65;-1
bmj4_4_e004934.full;147 participants;147;-1
bmj4_4_e004934.full;3141 patients;3141;-1
bmj4_4_e004934.full;65 patients;65;-1
bmj4_4_e004934.full;n=3141;3141;-1
bmj4_4_e004934.full;n=3076;3076;-1
bmj4_4_e004934.full;15  enrolled;15;-1
bmj4_4_e004952.full;90 056 participants;90056;-1
bmj4_4_e004952.full;34 925 patients;34925;-1
bmj4_4_e004952.full;13 029 patients;13029;-1
bmj4_4_e004952.full;22 patients;22;-1
bmj4_4_e004952.full;61 458 patients;61458;-1
bmj4_4_e004952.full;89  All patients;89;-1
bmj4_4_e004952.full;4444 patients;4444;-1
bmj4_4_e004952.full; data  from 90 056;90056;-1
bmj4_4_e004956.full;819 701 individual patients;819701;-1
bmj4_4_e004956.full;819 701  individual patients;819701;-1
bmj4_4_e004956.full;n=819 701;819701;-1
bmj4_4_e004956.full;n=2 186 642;2186642;-1
bmj4_4_e004956.full;n=5410;5410;-1
bmj4_4_e004956.full;n=301 008;301008;-1
bmj4_4_e004956.full;total of 5410;5410;-1
bmj4_4_e004958.full;354 204 patients;354204;-1
bmj4_4_e004958.full;22 000  people;22000;-1
bmj4_4_e004958.full;15 102 individuals;15102;-1
bmj4_4_e004958.full;354 204 individuals;354204;-1
bmj4_4_e004958.full;N=354 204;354204;-1
bmj4_4_e004958.full;N=15 102;15102;-1
bmj4_4_e004971.full;15 In human subjects;15;-1
bmj4_4_e005091.full;270 participants;270;-1
bmj4_4_e005091.full;480 participants;480;-1
bmj4_4_e005091.full;270 patients;270;-1
bmj4_4_e005091.full;361 patients;361;-1
bmj4_4_e005091.full;38 patients;38;-1
bmj4_4_e005091.full;110 patients;110;-1
bmj4_4_e005091.full;40 patients;40;-1
bmj4_4_e005091.full;150 000 people;150000;-1
bmj4_4_e005091.full;52 UK centres recruited;52;-1
bmj4_4_e005091.full;270 participants recruited;270;-1
bmj4_4_e005091.full;2013 we  recruited;2013;-1
bmj4_4_e005091.full;270 partici-  pants recruited;270;-1
bmj4_4_e005112.full;468 participants;468;-1
bmj4_4_e005112.full;00 after participants;0;-1
bmj4_4_e005112.full;486 patients;486;-1
bmj4_4_e005112.full;total of 29;29;-1
bmj4_4_e005112.full;total of 468;468;-1
bmj4_4_e005190.full;6 While LBQ women;6;-1
bmj4_4_e005190.full;34  women;34;-1
bmj4_4_e005190.full;45 and young women;45;-1
bmj4_4_e005190.full;20 persons;20;-1
bmj4_4_e005190.full;40 participants;40;-1
bmj4_4_e005190.full;n=440;440;-1
bmj4_4_e005190.full;n=44;44;-1
bmj4_4_e005312.full;586 000 people;586000;-1
bmj4_5_e003862.full;347 patients;347;-1
bmj4_5_e003862.full;7 In patients;7;-1
bmj4_5_e003862.full;9  Since patients;9;-1
bmj4_5_e003862.full;327 patients;327;-1
bmj4_5_e003862.full;220  patients;220;-1
bmj4_5_e003862.full;61 Thai patients;61;-1
bmj4_5_e003862.full;91 Nepalese patients;91;-1
bmj4_5_e003862.full;100 000 people;100000;-1
bmj4_5_e003862.full;n=54;54;-1
bmj4_5_e003862.full;n=347;347;-1
bmj4_5_e003862.full;n=1735;1735;-1
bmj4_5_e003862.full;total of 347;347;-1
bmj4_5_e004099.full;n=70;70;-1
bmj4_5_e004099.full;n=91;91;-1
bmj4_5_e004099.full;n=827;827;-1
bmj4_5_e004099.full;study population  includes 104 635;104635;-1
bmj4_5_e004099.full; data from 6;6;-1
bmj4_5_e004285.full;7350 patients;7350;-1
bmj4_5_e004285.full; data from 21;21;-1
bmj4_5_e004297.full;100 000  women;100000;-1
bmj4_5_e004297.full;100 000 persons;100000;-1
bmj4_5_e004297.full;50  more persons;50;-1
bmj4_5_e004297.full;100 000  persons;100000;-1
bmj4_5_e004297.full;2 526 145  non-institutionalised individuals;2526145;-1
bmj4_5_e004318.full;14 977 unique patients;14977;-1
bmj4_5_e004318.full;244 196 patients;244196;-1
bmj4_5_e004318.full;10  In patients;10;-1
bmj4_5_e004318.full;14 977 patients;14977;-1
bmj4_5_e004318.full;N=21 576;21576;-1
bmj4_5_e004318.full;N=515 990;515990;-1
bmj4_5_e004318.full;total of  14 977;14977;-1
bmj4_5_e004318.full;total of 515 990;515990;-1
bmj4_5_e004352.full;433 patients;433;-1
bmj4_5_e004352.full;1 patients;1;-1
bmj4_5_e004352.full;8 patients;8;-1
bmj4_5_e004352.full;468  patients;468;-1
bmj4_5_e004352.full;total of 433;433;-1
bmj4_5_e004352.full;total of 468;468;-1
bmj4_5_e004357.full;21 participants;21;9509
bmj4_5_e004357.full;12 participants;12;9285
bmj4_5_e004358.full;306 randomised patients;306;-1
bmj4_5_e004358.full;27 patients;27;-1
bmj4_5_e004358.full;13 patients;13;-1
bmj4_5_e004358.full;20 patients;20;-1
bmj4_5_e004358.full;1749 patients;1749;-1
bmj4_5_e004358.full;319 patients;319;-1
bmj4_5_e004358.full;306 patients;306;-1
bmj4_5_e004358.full;21 patients;21;-1
bmj4_5_e004358.full;118 patients;118;-1
bmj4_5_e004358.full;167 eligible  patients;167;-1
bmj4_5_e004358.full;1 Flow chart of patients;1;-1
bmj4_5_e004358.full;40 Only a few patients;40;-1
bmj4_5_e004358.full;N=167;167;-1
bmj4_5_e004358.full;n=105;105;-1
bmj4_5_e004358.full;n=62;62;-1
bmj4_5_e004358.full;n=  10;10;-1
bmj4_5_e004358.full;n=  62;62;-1
bmj4_5_e004358.full;N  =1;1;-1
bmj4_5_e004358.full;n=  52;52;-1
bmj4_5_e004358.full;n=  60;60;-1
bmj4_5_e004358.full;n=  55;55;-1
bmj4_5_e004358.full;n=  27;27;-1
bmj4_5_e004358.full;n=  43;43;-1
bmj4_5_e004358.full;n=  35;35;-1
bmj4_5_e004358.full;total of 306;306;-1
bmj4_5_e004358.full;total of 62;62;-1
bmj4_5_e004371.full;n=705;705;-1
bmj4_5_e004371.full;N  =5;5;-1
bmj4_5_e004371.full;N  =7;7;-1
bmj4_5_e004371.full;N=705;705;-1
bmj4_5_e004385.full;108 participants;108;-1
bmj4_5_e004385.full;1447 patients;1447;-1
bmj4_5_e004385.full;108 patients;108;-1
bmj4_5_e004385.full;25 randomised patients;25;-1
bmj4_5_e004385.full;180 patients;180;-1
bmj4_5_e004385.full;2000 patients;2000;-1
bmj4_5_e004385.full;100  patients;100;-1
bmj4_5_e004385.full;200 patients;200;-1
bmj4_5_e004385.full;1447 individual patients;1447;-1
bmj4_5_e004385.full;1235 patients;1235;-1
bmj4_5_e004385.full;980 patients;980;-1
bmj4_5_e004385.full;216 patients;216;-1
bmj4_5_e004385.full;216 ran-  domised patients;216;-1
bmj4_5_e004385.full;1230 patients;1230;-1
bmj4_5_e004385.full;1230  non-randomised patients;1230;-1
bmj4_5_e004385.full;23 patients;23;-1
bmj4_5_e004385.full;1446 patients;1446;-1
bmj4_5_e004385.full;216  randomised patients;216;-1
bmj4_5_e004385.full;543 patients;543;-1
bmj4_5_e004385.full;N=108;108;-1
bmj4_5_e004385.full;N=1446;1446;-1
bmj4_5_e004385.full;N=216;216;-1
bmj4_5_e004385.full;N=862;862;-1
bmj4_5_e004385.full;total of 2319;2319;-1
bmj4_5_e004385.full;1447 patients were  enrolled;1447;-1
bmj4_5_e004385.full;5 Flow chart of enrolled;5;-1
bmj4_5_e004401.full;824 women;824;-1
bmj4_5_e004401.full;780 women;780;-1
bmj4_5_e004401.full;7 million people;7;-1
bmj4_5_e004401.full;32 034 individuals;32034;-1
bmj4_5_e004401.full;n=32 034;32034;-1
bmj4_5_e004401.full;n=6092;6092;-1
bmj4_5_e004401.full;n=160;160;-1
bmj4_5_e004401.full;n=5;5;-1
bmj4_5_e004401.full;n=6;6;-1
bmj4_5_e004401.full;n=4;4;-1
bmj4_5_e004401.full;n=9;9;-1
bmj4_5_e004401.full;n=8056;8056;-1
bmj4_5_e004401.full;n=85;85;-1
bmj4_5_e004401.full;n=75;75;-1
bmj4_5_e004401.full;n=824;824;-1
bmj4_5_e004401.full;n=82;82;-1
bmj4_5_e004401.full;n=9689;9689;-1
bmj4_5_e004401.full;n=29;29;-1
bmj4_5_e004401.full;n=1510;1510;-1
bmj4_5_e004401.full;n=15;15;-1
bmj4_5_e004401.full;n=312;312;-1
bmj4_5_e004401.full;n=10 754;10754;-1
bmj4_5_e004401.full;n=320;320;-1
bmj4_5_e004401.full;n=92;92;-1
bmj4_5_e004401.full;n=2420;2420;-1
bmj4_5_e004401.full;total of 25;25;-1
bmj4_5_e004415.full;39 Pacifica  people;39;-1
bmj4_5_e004415.full;n=7;7;-1
bmj4_5_e004415.full;n=1;1;-1
bmj4_5_e004415.full;n=6;6;-1
bmj4_5_e004415.full;n=9;9;-1
bmj4_5_e004415.full;n=2;2;-1
bmj4_5_e004415.full;n=4;4;-1
bmj4_5_e004415.full;n = 20;20;-1
bmj4_5_e004415.full;total of 26;26;-1
bmj4_5_e004415.full;total of 105;105;-1
bmj4_5_e004430.full;47 398 adults;47398;-1
bmj4_5_e004430.full;1 Obesity rates of adults;1;-1
bmj4_5_e004454.full;33  Many of the participants;33;-1
bmj4_5_e004459.full;6 million women;6;-1
bmj4_5_e004459.full;n=276;276;-1
bmj4_5_e004459.full;n=11 233;11233;-1
bmj4_5_e004459.full;n=2776;2776;-1
bmj4_5_e004459.full;n=5349;5349;-1
bmj4_5_e004459.full;n=3108;3108;-1
bmj4_5_e004501.full;492 patients;492;-1
bmj4_5_e004501.full;75 patients;75;-1
bmj4_5_e004501.full;151  patients;151;-1
bmj4_5_e004501.full;320 patients;320;-1
bmj4_5_e004501.full;n=141;141;-1
bmj4_5_e004501.full;n=151;151;-1
bmj4_5_e004501.full;total of 66;66;-1
bmj4_5_e004516.full;3506 persons;3506;-1
bmj4_5_e004516.full;452 participants;452;-1
bmj4_5_e004516.full;4831 men recruited;4831;-1
bmj4_5_e004536.full;99 pregnant women;99;-1
bmj4_5_e004536.full;420 pregnant women;420;-1
bmj4_5_e004536.full;99 pregnant  women;99;-1
bmj4_5_e004536.full;95 patients;95;-1
bmj4_5_e004536.full;22 patients;22;-1
bmj4_5_e004536.full;62 patients;62;-1
bmj4_5_e004536.full;25 patients;25;-1
bmj4_5_e004536.full;1b-exposed patients;1;-1
bmj4_5_e004536.full;400 000 people;400000;-1
bmj4_5_e004536.full;N=96;96;-1
bmj4_5_e004536.full;N=86;86;-1
bmj4_5_e004536.full;N=88;88;-1
bmj4_5_e004536.full;N=14;14;-1
bmj4_5_e004536.full;N=63;63;-1
bmj4_5_e004536.full;N=552;552;-1
bmj4_5_e004536.full;N=1105;1105;-1
bmj4_5_e004538.full;1951 women;1951;-1
bmj4_5_e004538.full;2364  pregnant women;2364;-1
bmj4_5_e004538.full;600 000  people;600000;-1
bmj4_5_e004538.full;n=4;4;-1
bmj4_5_e004538.full;n=49;49;-1
bmj4_5_e004538.full;n=41;41;-1
bmj4_5_e004538.full;n=44;44;-1
bmj4_5_e004538.full;n=139;139;-1
bmj4_5_e004538.full;n=135;135;-1
bmj4_5_e004538.full;n=827;827;-1
bmj4_5_e004538.full;n=579;579;-1
bmj4_5_e004538.full;n=545;545;-1
bmj4_5_e004538.full;n=994;994;-1
bmj4_5_e004538.full;n=957;957;-1
bmj4_5_e004538.full;total of 1951;1951;-1
bmj4_5_e004551.full;691 738 women;691738;-1
bmj4_5_e004551.full;293 840 low-risk women;293840;-1
bmj4_5_e004551.full;100  women;100;-1
bmj4_5_e004551.full;100 women;100;-1
bmj4_5_e004551.full;288 309 women;288309;-1
bmj4_5_e004551.full;29 597 low-risk primiparous women;29597;-1
bmj4_5_e004551.full;79 792 low-risk  primiparous women;79792;-1
bmj4_5_e004551.full;39  Babies of primiparous women;39;-1
bmj4_5_e004551.full;22 With more women;22;-1
bmj4_5_e004551.full;42 In this study low-risk women;42;-1
bmj4_5_e004551.full;n=83 573;83573;-1
bmj4_5_e004551.full;n=204 399;204399;-1
bmj4_5_e004551.full;n=28 703;28703;-1
bmj4_5_e004551.full;n=99 212;99212;-1
bmj4_5_e004551.full;n=29 597;29597;-1
bmj4_5_e004551.full;n=79 792;79792;-1
bmj4_5_e004551.full;n=79 791;79791;-1
bmj4_5_e004551.full;n=58 300;58300;-1
bmj4_5_e004551.full;n=179 003;179003;-1
bmj4_5_e004556.full;n=194;194;-1
bmj4_5_e004556.full;n=68;68;-1
bmj4_5_e004556.full;n=20 194;20194;-1
bmj4_5_e004556.full;n=192;192;-1
bmj4_5_e004556.full;n=19 921;19921;-1
bmj4_5_e004556.full;total of 67;67;-1
bmj4_5_e004558.full;304 symptomatic patients;304;-1
bmj4_5_e004558.full;304 paediatric patients;304;-1
bmj4_5_e004558.full;17 In patients;17;-1
bmj4_5_e004558.full;304 patients;304;-1
bmj4_5_e004558.full;28 newly diagnosed patients;28;-1
bmj4_5_e004558.full;715 patients;715;-1
bmj4_5_e004558.full;130 patients;130;-1
bmj4_5_e004558.full;23  In contrast patients;23;-1
bmj4_5_e004558.full;25 and adults;25;-1
bmj4_5_e004558.full;n=130;130;-1
bmj4_5_e004558.full;n=62;62;-1
bmj4_5_e004558.full;n=45;45;-1
bmj4_5_e004558.full;n=67;67;-1
bmj4_5_e004558.full;n=15;15;-1
bmj4_5_e004558.full;n=8;8;-1
bmj4_5_e004558.full;n=12;12;-1
bmj4_5_e004558.full;n=3;3;-1
bmj4_5_e004558.full;n=5;5;-1
bmj4_5_e004558.full;n=2;2;-1
bmj4_5_e004558.full;n=55;55;-1
bmj4_5_e004558.full; data of 715;715;-1
bmj4_5_e004560.full;1073 participants;1073;-1
bmj4_5_e004560.full;2327 participants;2327;-1
bmj4_5_e004560.full;44 participants;44;-1
bmj4_5_e004560.full;332 participants;332;-1
bmj4_5_e004560.full;1073 consecutive  adults;1073;-1
bmj4_5_e004560.full;1411 adults;1411;-1
bmj4_5_e004560.full;n=1073;1073;-1
bmj4_5_e004560.full;n=591;591;-1
bmj4_5_e004560.full;n=363;363;-1
bmj4_5_e004560.full;n=39;39;-1
bmj4_5_e004560.full;n=14;14;-1
bmj4_5_e004560.full;n=43;43;-1
bmj4_5_e004560.full;n=18;18;-1
bmj4_5_e004560.full;n=5;5;-1
bmj4_5_e004560.full;n=62;62;-1
bmj4_5_e004560.full;n=49;49;-1
bmj4_5_e004565.full;79 participants;79;-1
bmj4_5_e004565.full;1000 participants;1000;-1
bmj4_5_e004565.full;12 participants;12;-1
bmj4_5_e004565.full;999 participants;999;-1
bmj4_5_e004565.full;889 participants;889;-1
bmj4_5_e004565.full;1000 ambulatory patients;1000;-1
bmj4_5_e004565.full;6529 potentially eligible patients;6529;-1
bmj4_5_e004565.full;405 patients;405;-1
bmj4_5_e004565.full;505  patients;505;-1
bmj4_5_e004565.full;10 patients;10;-1
bmj4_5_e004565.full;1000 individuals;1000;-1
bmj4_5_e004565.full;73  individuals;73;-1
bmj4_5_e004565.full;1000 participants  had been recruited;1000;-1
bmj4_5_e004565.full;n=999;999;-1
bmj4_5_e004565.full;total of 79;79;-1
bmj4_5_e004587.full;33 253 participants;33253;-1
bmj4_5_e004587.full;8651 patients;8651;-1
bmj4_5_e004587.full;804 patients;804;-1
bmj4_5_e004587.full;1000 patients;1000;-1
bmj4_5_e004587.full;1000  patients;1000;-1
bmj4_5_e004587.full;10 008 people;10008;-1
bmj4_5_e004587.full;N=33 253;33253;-1
bmj4_5_e004587.full;total of 33 253;33253;-1
bmj4_5_e004587.full;total of 159;159;-1
bmj4_5_e004598.full;37 276 men and women;37276;-1
bmj4_5_e004598.full;7620 women;7620;-1
bmj4_5_e004598.full;391 women;391;-1
bmj4_5_e004598.full;53 women;53;-1
bmj4_5_e004598.full;100 000 population in men and women;100000;-1
bmj4_5_e004598.full;384 women;384;-1
bmj4_5_e004598.full;100 000 population in men and  women;100000;-1
bmj4_5_e004598.full;37276 men and women;37276;-1
bmj4_5_e004598.full;276 men and women;276;-1
bmj4_5_e004598.full;11 878 patients;11878;-1
bmj4_5_e004598.full;14,434 myocardial infarction patients;14434;-1
bmj4_5_e004598.full;387 452 individuals;387452;-1
bmj4_5_e004623.full;N  =3;3;-1
bmj4_5_e004623.full;N  =2;2;-1
bmj4_5_e004623.full;N  =1;1;-1
bmj4_5_e004623.full;N  =8;8;-1
bmj4_5_e004623.full;N  =5;5;-1
bmj4_5_e004623.full;N  =4;4;-1
bmj4_5_e004623.full;N  =6;6;-1
bmj4_5_e004623.full;N  =7;7;-1
bmj4_5_e004623.full;N  =9;9;-1
bmj4_5_e004623.full;total of 11 690;11690;-1
bmj4_5_e004623.full;total of 100;100;-1
bmj4_5_e004630.full;15 women;15;-1
bmj4_5_e004630.full;3 no  Some participants;3;-1
bmj4_5_e004630.full;49 people;49;-1
bmj4_5_e004630.full;263  people;263;-1
bmj4_5_e004630.full;20 people;20;-1
bmj4_5_e004632.full;29 and Japanese participants;29;-1
bmj4_5_e004632.full;508 patients;508;-1
bmj4_5_e004632.full;500 patients;500;-1
bmj4_5_e004632.full;31 and Nigerian  individuals;31;-1
bmj4_5_e004632.full;N=500;500;-1
bmj4_5_e004632.full;total of 508;508;-1
bmj4_5_e004632.full;total of 178;178;-1
bmj4_5_e004632.full;508 patients were enrolled;508;-1
bmj4_5_e004633.full;750 eligible  patients;750;-1
bmj4_5_e004633.full;65 at-risk patients;65;-1
bmj4_5_e004633.full;n=40;40;-1
bmj4_5_e004633.full;n=2073;2073;-1
bmj4_5_e004633.full;n=460;460;-1
bmj4_5_e004652.full;2425 patients;2425;-1
bmj4_5_e004652.full;2071  patients;2071;-1
bmj4_5_e004652.full;1699 Greek patients;1699;-1
bmj4_5_e004652.full;354 patients;354;-1
bmj4_5_e004652.full;2 wild-type patients;2;-1
bmj4_5_e004652.full;2071 patients;2071;-1
bmj4_5_e004652.full;354 consecutive patients;354;-1
bmj4_5_e004652.full;2  wild-type patients;2;-1
bmj4_5_e004652.full;2 patients;2;-1
bmj4_5_e004652.full;total of 2425;2425;-1
bmj4_5_e004657.full;158 women;158;-1
bmj4_5_e004657.full;4 persons;4;-1
bmj4_5_e004657.full;5 persons;5;-1
bmj4_5_e004657.full;3 million individuals;3;-1
bmj4_5_e004657.full;811 000 individuals;811000;-1
bmj4_5_e004657.full;85 000 individuals;85000;-1
bmj4_5_e004657.full;N=183;183;-1
bmj4_5_e004657.full;N=74;74;-1
bmj4_5_e004657.full;N=42;42;-1
bmj4_5_e004657.full;N=11;11;-1
bmj4_5_e004657.full;N=71;71;-1
bmj4_5_e004657.full;N=17;17;-1
bmj4_5_e004657.full;N=6;6;-1
bmj4_5_e004657.full;N=16;16;-1
bmj4_5_e004657.full;N=14;14;-1
bmj4_5_e004657.full;N=28;28;-1
bmj4_5_e004657.full;N=12;12;-1
bmj4_5_e004657.full;N=5;5;-1
bmj4_5_e004657.full;N=7;7;-1
bmj4_5_e004657.full;N=4;4;-1
bmj4_5_e004657.full;N=8;8;-1
bmj4_5_e004657.full;N=30;30;-1
bmj4_5_e004669.full;25 852  individuals;25852;-1
bmj4_5_e004669.full;194 923 individuals;194923;-1
bmj4_5_e004669.full;25 852 individuals;25852;-1
bmj4_5_e004669.full; data analysis of the 2012;2012;-1
bmj4_5_e004679.full;1  patients;1;-1
bmj4_5_e004679.full;2 patients are returning patients;2;-1
bmj4_5_e004679.full;3 patients;3;-1
bmj4_5_e004679.full;1=patients;1;-1
bmj4_5_e004679.full;2=patients;2;-1
bmj4_5_e004679.full;3=patients;3;-1
bmj4_5_e004679.full;total of 1500;1500;-1
bmj4_5_e004692.full;19 participants;19;-1
bmj4_5_e004692.full;10 participants;10;-1
bmj4_5_e004692.full;23 Two individuals;23;-1
bmj4_5_e004692.full;19 individuals;19;-1
bmj4_5_e004692.full;n=50;50;-1
bmj4_5_e004692.full;total of 6664;6664;-1
bmj4_5_e004692.full;total of 74;74;-1
bmj4_5_e004692.full;total of 49;49;-1
bmj4_5_e004700.full;929 participants;929;2378
bmj4_5_e004700.full;929  patients;929;6911
bmj4_5_e004700.full;929 patients;929;956
bmj4_5_e004700.full;861 patients;861;7975
bmj4_5_e004700.full;14 Anaemic patients;14;10178
bmj4_5_e004700.full;15 In patients;15;14787
bmj4_5_e004700.full;N=258;258;3929
bmj4_5_e004700.full;N=603;603;3949
bmj4_5_e004700.full;11 Patients were enrolled;11;2523
bmj4_5_e004700.full;929 patients enrolled;929;956
bmj4_5_e004702.full;4354 women;4354;-1
bmj4_5_e004702.full;4727 women;4727;-1
bmj4_5_e004702.full;3329  Australian women;3329;-1
bmj4_5_e004702.full;416 women;416;-1
bmj4_5_e004702.full;180 Northern European women;180;-1
bmj4_5_e004702.full;234 Southern  European women;234;-1
bmj4_5_e004702.full;195 Asian women;195;-1
bmj4_5_e004702.full;27 000 participants;27000;-1
bmj4_5_e004709.full;2 women;2;-1
bmj4_5_e004709.full;45 000 patients per  year. These patients;45000;-1
bmj4_5_e004709.full;total of 80;80;-1
bmj4_5_e004725.full;1000 participants;1000;-1
bmj4_5_e004725.full;8 a significant proportion of people;8;-1
bmj4_5_e004725.full;n=1;1;-1
bmj4_5_e004725.full;n=601;601;-1
bmj4_5_e004725.full;n=598;598;-1
bmj4_5_e004725.full;n  =7;7;-1
bmj4_5_e004725.full;n  =3;3;-1
bmj4_5_e004725.full;n  =1;1;-1
bmj4_5_e004732.full;14 Can those admitted as inpatients;14;-1
bmj4_5_e004732.full;17 Are patients;17;-1
bmj4_5_e004732.full;6442 individuals;6442;-1
bmj4_5_e004732.full;6400 individuals;6400;-1
bmj4_5_e004732.full;n=22;22;-1
bmj4_5_e004732.full;n=14;14;-1
bmj4_5_e004732.full;n=13;13;-1
bmj4_5_e004738.full;3680 patients;3680;8578
bmj4_5_e004738.full;158 patients;158;2782
bmj4_5_e004738.full;3680  patients;3680;1909
bmj4_5_e004738.full;N=191;191;2234
bmj4_5_e004738.full;N=3489;3489;2261
bmj4_5_e004740.full;13 participants;13;-1
bmj4_5_e004740.full;n=255;255;-1
bmj4_5_e004740.full;n=32;32;-1
bmj4_5_e004740.full;n=35;35;-1
bmj4_5_e004740.full;n=42;42;-1
bmj4_5_e004746.full;2500 patients;2500;-1
bmj4_5_e004746.full;n=24;24;-1
bmj4_5_e004746.full;n=22;22;-1
bmj4_5_e004746.full;n=38;38;-1
bmj4_5_e004746.full;n=2;2;-1
bmj4_5_e004746.full;n=1;1;-1
bmj4_5_e004746.full;n=21;21;-1
bmj4_5_e004746.full;n=8;8;-1
bmj4_5_e004746.full;n=14;14;-1
bmj4_5_e004746.full;n=11;11;-1
bmj4_5_e004746.full;n=5;5;-1
bmj4_5_e004746.full;n=16;16;-1
bmj4_5_e004746.full;n=19;19;-1
bmj4_5_e004746.full;n=12;12;-1
bmj4_5_e004746.full;n=3;3;-1
bmj4_5_e004746.full; data from 68;68;-1
bmj4_5_e004749.full;total of 98;98;-1
bmj4_5_e004749.full;total of 1951;1951;-1
bmj4_5_e004750.full;n=764;764;-1
bmj4_5_e004750.full;N=342;342;-1
bmj4_5_e004750.full;N=222;222;-1
bmj4_5_e004750.full;n  =2;2;-1
bmj4_5_e004781.full;4 patients;4;-1
bmj4_5_e004781.full;3 patients;3;-1
bmj4_5_e004781.full;total of 10;10;-1
bmj4_5_e004781.full;total of 25;25;-1
bmj4_5_e004781.full;total of  74;74;-1
bmj4_5_e004812.full;11 For lower risk patients;11;-1
bmj4_5_e004812.full;n=144;144;-1
bmj4_5_e004812.full;total of 43;43;-1
bmj4_5_e004848.full;10 514 patients;10514;-1
bmj4_5_e004848.full;3000 patients;3000;-1
bmj4_5_e004848.full;420patients;420;-1
bmj4_5_e004848.full;3233 patients;3233;-1
bmj4_5_e004848.full;n  =2;2;-1
bmj4_5_e004848.full;n  =1;1;-1
bmj4_5_e004848.full;n  =5;5;-1
bmj4_5_e004848.full;total of 3233;3233;-1
bmj4_5_e004848.full;total of 38;38;-1
bmj4_5_e004878.full;413 study participants;413;-1
bmj4_5_e004878.full;600 adults;600;-1
bmj4_5_e004878.full;N=3;3;-1
bmj4_5_e004878.full;n=413;413;-1
bmj4_5_e004879.full;473 women;473;-1
bmj4_5_e004879.full;197 patients;197;-1
bmj4_5_e004879.full;10 patients;10;-1
bmj4_5_e004879.full;18 patients;18;-1
bmj4_5_e004879.full;40 patients;40;-1
bmj4_5_e004879.full;129  patients;129;-1
bmj4_5_e004879.full;total of 271;271;-1
bmj4_5_e004879.full;total of 960;960;-1
bmj4_5_e004885.full;240  patients;240;-1
bmj4_5_e004885.full;240 patients;240;-1
bmj4_5_e004885.full;total of 240;240;-1
bmj4_5_e004915.full;3265 women;3265;-1
bmj4_5_e004915.full;3265  women;3265;-1
bmj4_5_e004915.full;850  women;850;-1
bmj4_5_e004915.full;1 Smoking status of all women;1;-1
bmj4_5_e004915.full;850 preg-  nant women;850;-1
bmj4_5_e004915.full;2 Comparison of eligible women;2;-1
bmj4_5_e004915.full;12 Previous cohorts have  women;12;-1
bmj4_5_e004915.full;2500 potential participants;2500;-1
bmj4_5_e004915.full;850 participants;850;-1
bmj4_5_e004915.full;N=488;488;-1
bmj4_5_e004915.full;N=1101;1101;-1
bmj4_5_e004915.full;N=625;625;-1
bmj4_5_e004915.full;N=966;966;-1
bmj4_5_e004915.full;N=850;850;-1
bmj4_5_e004915.full;N=116;116;-1
bmj4_5_e004915.full;N=362;362;-1
bmj4_5_e004915.full;N=3265;3265;-1
bmj4_5_e004915.full;850  women enrolled;850;-1
bmj4_5_e004966.full;204 participants;204;-1
bmj4_5_e004966.full;204 patients;204;-1
bmj4_5_e004966.full;29  We are stratifying patients;29;-1
bmj4_5_e004966.full;total of 204;204;-1
bmj4_5_e004968.full;186 Japanese patients;186;-1
bmj4_5_e004968.full;8  Because patients;8;-1
bmj4_5_e004968.full;186 patients;186;-1
bmj4_5_e004968.full;59 patients;59;-1
bmj4_5_e004968.full;16 total aut-  opsied patients;16;-1
bmj4_5_e004968.full;184 patients;184;-1
bmj4_5_e004968.full;139 patients;139;-1
bmj4_5_e004968.full;179 patients;179;-1
bmj4_5_e004968.full;54 patients;54;-1
bmj4_5_e004968.full;78 cases were of  male patients;78;-1
bmj4_5_e004968.full;11 patients;11;-1
bmj4_5_e004968.full;3  patients;3;-1
bmj4_5_e004968.full;n=  13;13;-1
bmj4_5_e004968.full;n=  59;59;-1
bmj4_5_e004968.full;n=  8;8;-1
bmj4_5_e004968.full;n=  75;75;-1
bmj4_5_e004968.full;n=  57;57;-1
bmj4_5_e004968.full;n  =3;3;-1
bmj4_5_e004968.full;n  =4;4;-1
bmj4_5_e004968.full;n=  12;12;-1
bmj4_5_e004968.full;n=  55;55;-1
bmj4_5_e004968.full;n  =5;5;-1
bmj4_5_e004968.full;n  =1;1;-1
bmj4_5_e004968.full;n  =2;2;-1
bmj4_5_e004968.full;n=  2;2;-1
bmj4_5_e004968.full;n=  33;33;-1
bmj4_5_e004968.full;n=  31;31;-1
bmj4_5_e004968.full;n=  3;3;-1
bmj4_5_e004968.full;n=  10;10;-1
bmj4_5_e004968.full;n=  26;26;-1
bmj4_5_e004968.full;n  =6;6;-1
bmj4_5_e004968.full;n=  29;29;-1
bmj4_5_e004968.full;n=45;45;-1
bmj4_5_e004968.full;n=7;7;-1
bmj4_5_e004968.full;n=43;43;-1
bmj4_5_e004968.full;n=23;23;-1
bmj4_5_e004968.full;n=6;6;-1
bmj4_5_e004968.full;n=18;18;-1
bmj4_5_e004968.full;n=4;4;-1
bmj4_5_e004968.full;n=38;38;-1
bmj4_5_e004968.full;n=5;5;-1
bmj4_5_e004968.full;n=11;11;-1
bmj4_5_e004968.full;n=1;1;-1
bmj4_5_e004968.full;n=8;8;-1
bmj4_5_e004968.full;n=0;0;-1
bmj4_5_e004968.full;n=13;13;-1
bmj4_5_e004968.full;n=2;2;-1
bmj4_5_e004968.full;n=139;139;-1
bmj4_5_e004968.full;n=75;75;-1
bmj4_5_e004968.full;n=121;121;-1
bmj4_5_e004968.full;n=58;58;-1
bmj4_5_e004968.full;n=33;33;-1
bmj4_5_e004968.full;n=10;10;-1
bmj4_5_e004968.full;n=62;62;-1
bmj4_5_e004968.full;n=64;64;-1
bmj4_5_e004968.full;n=53;53;-1
bmj4_5_e004968.full;n=881;881;-1
bmj4_5_e004968.full;n=466;466;-1
bmj4_5_e004968.full;n=186;186;-1
bmj4_5_e004968.full;n=71;71;-1
bmj4_5_e004968.full;total of 184;184;-1
bmj4_5_e004968.full; data of 186;186;-1
bmj4_5_e004968.full; data of  186;186;-1
bmj4_5_e004975.full;18 playing population and adults;18;-1
bmj4_5_e004988.full;140 women;140;-1
bmj4_5_e004988.full;417 participants;417;-1
bmj4_5_e004988.full;195 UFO  participants;195;-1
bmj4_5_e004988.full;n=858;858;-1
bmj4_5_e004988.full;N=424;424;-1
bmj4_5_e004988.full;n=140;140;-1
bmj4_5_e004988.full;n=277;277;-1
bmj4_5_e004988.full;total of 650;650;-1
bmj4_5_e004990.full;50  women;50;22937
bmj4_5_e004990.full;30 As some women;30;22713
bmj4_5_e004990.full;30 women;30;18831
bmj4_5_e004990.full;1000  women;1000;12217
bmj4_5_e004990.full;407 women;407;1655
bmj4_5_e004990.full;814 women;814;877
bmj4_5_e004990.full;1078 women;1078;759
bmj4_5_e004990.full;285 women;285;422
bmj4_5_e004990.full;60  participants;60;2225
bmj4_5_e004990.full;n=904;904;28104
bmj4_5_e004990.full;n=66;66;28059
bmj4_5_e005011.full;48  patients;48;-1
bmj4_5_e005011.full;100  patients;100;-1
bmj4_5_e005011.full;n=761;761;-1
bmj4_5_e005011.full;n=242;242;-1
bmj4_5_e005011.full;total of  60;60;-1
bmj4_5_e005014.full;1910 participants;1910;-1
bmj4_5_e005014.full;9 because a small number of patients;9;-1
bmj4_5_e005014.full;total of 10;10;-1
bmj4_5_e005020.full;20 000 patients;20000;-1
bmj4_5_e005020.full;2748 patients;2748;-1
bmj4_5_e005020.full;39 and infrequently check their patients;39;-1
bmj4_5_e005020.full;2 Proportion of patients;2;-1
bmj4_5_e005020.full;2748 adults;2748;-1
bmj4_5_e005020.full;n=670;670;-1
bmj4_5_e005020.full;n=683;683;-1
bmj4_5_e005020.full;n=880;880;-1
bmj4_5_e005020.full;n=477;477;-1
bmj4_5_e005020.full;n=38;38;-1
bmj4_5_e005020.full;n=2145;2145;-1
bmj4_5_e005020.full;n=603;603;-1
bmj4_5_e005025.full;164 138 women;164138;-1
bmj4_5_e005025.full;104 310 women;104310;-1
bmj4_5_e005025.full;430,920 men and women;430920;-1
bmj4_5_e005025.full;200 000 participants;200000;-1
bmj4_5_e005025.full;5408 participants;5408;-1
bmj4_5_e005025.full;5251 participants;5251;-1
bmj4_5_e005025.full;430 920 individuals;430920;-1
bmj4_5_e005025.full;268 315 individuals;268315;-1
bmj4_5_e005025.full;n=164 005;164005;-1
bmj4_5_e005025.full;n=104 310;104310;-1
bmj4_5_e005031.full;5 people;5;-1
bmj4_5_e005031.full;n=18 558;18558;-1
bmj4_5_e005031.full;N=7156;7156;-1
bmj4_5_e005031.full;N=106;106;-1
bmj4_5_e005031.full;N=85;85;-1
bmj4_5_e005031.full;n=7347;7347;-1
bmj4_5_e005031.full;N=5317;5317;-1
bmj4_5_e005031.full;N=2030;2030;-1
bmj4_5_e005031.full; data from the 1958;1958;-1
bmj4_5_e005045.full;17 parents were recruited;17;-1
bmj4_5_e005045.full;n=15;15;-1
bmj4_5_e005045.full;n=9;9;-1
bmj4_5_e005045.full;n=4;4;-1
bmj4_5_e005045.full;n=5;5;-1
bmj4_5_e005049.full;100 000 women;100000;-1
bmj4_5_e005049.full;112 patients were women;112;-1
bmj4_5_e005049.full;112 female Han Chinese  patients;112;-1
bmj4_5_e005049.full;112 patients;112;-1
bmj4_5_e005049.full;77 patients;77;-1
bmj4_5_e005049.full;118 patients;118;-1
bmj4_5_e005049.full;32 patients;32;-1
bmj4_5_e005049.full;745 patients;745;-1
bmj4_5_e005049.full;total of 112;112;-1
bmj4_5_e005078.full;total of 37 128;37128;-1
bmj4_5_e005078.full;total of 122;122;-1
bmj4_5_e005078.full; database of 100;100;-1
bmj4_5_e005078.full; dataset of 40;40;-1
bmj4_5_e005095.full;22 569 women;22569;-1
bmj4_5_e005095.full;25  and women;25;-1
bmj4_5_e005137.full;250  patients;250;-1
bmj4_5_e005137.full;n=1102;1102;-1
bmj4_5_e005137.full;n=153;153;-1
bmj4_5_e005137.full;n=73;73;-1
bmj4_5_e005137.full;n=1333;1333;-1
bmj4_5_e005137.full;n=916;916;-1
bmj4_5_e005137.full;n=611;611;-1
bmj4_5_e005137.full;n=294;294;-1
bmj4_5_e005137.full;n=405;405;-1
bmj4_5_e005137.full;n=289;289;-1
bmj4_5_e005137.full;n=111;111;-1
bmj4_5_e005137.full;n=1112;1112;-1
bmj4_5_e005137.full;n=686;686;-1
bmj4_5_e005137.full;n=426;426;-1
bmj4_5_e005137.full;n=625;625;-1
bmj4_5_e005137.full;n=476;476;-1
bmj4_5_e005137.full;n=51;51;-1
bmj4_5_e005137.full;n=244;244;-1
bmj4_5_e005137.full;n=150;150;-1
bmj4_5_e005137.full;n=173;173;-1
bmj4_5_e005137.full;n=54;54;-1
bmj4_5_e005137.full;n=163;163;-1
bmj4_5_e005137.full;n=116;116;-1
bmj4_5_e005137.full;n=133;133;-1
bmj4_5_e005137.full;n=1609;1609;-1
bmj4_5_e005137.full;n=847;847;-1
bmj4_5_e005137.full;n=317;317;-1
bmj4_5_e005137.full;n=129;129;-1
bmj4_5_e005137.full;n=72;72;-1
bmj4_5_e005137.full;n=57;57;-1
bmj4_5_e005137.full;n=127;127;-1
bmj4_5_e005137.full;n=66;66;-1
bmj4_5_e005137.full;n=59;59;-1
bmj4_5_e005137.full;n=918;918;-1
bmj4_5_e005137.full;n=567;567;-1
bmj4_5_e005137.full;n=492;492;-1
bmj4_5_e005137.full;n=409;409;-1
bmj4_5_e005137.full;n=267;267;-1
bmj4_5_e005137.full;n=982;982;-1
bmj4_5_e005137.full;n=524;524;-1
bmj4_5_e005137.full;n=444;444;-1
bmj4_5_e005137.full;n=849;849;-1
bmj4_5_e005137.full;n=469;469;-1
bmj4_5_e005137.full;n=370;370;-1
bmj4_5_e005162.full;149 women;149;-1
bmj4_5_e005162.full;n=244;244;-1
bmj4_5_e005162.full;n  =2;2;-1
bmj4_5_e005162.full;total of 255;255;-1
bmj4_5_e005162.full; data from 6;6;-1
bmj4_5_e005172.full;93 We will provide participants;93;-1
bmj4_5_e005172.full;8  patients;8;-1
bmj4_5_e005172.full;2 diabetes patients;2;-1
bmj4_5_e005172.full;30 people;30;-1
bmj4_5_e005172.full;30 people recruited;30;-1
bmj4_5_e005218.full;500 million people;500;-1
bmj4_5_e005218.full;total of 598;598;-1
bmj4_5_e005218.full;total of 114;114;-1
bmj4_5_e005218.full;total of 83;83;-1
bmj4_5_e005251.full;12 participants;12;-1
bmj4_5_e005251.full;11 participants;11;-1
bmj4_5_e005251.full;1000  participants;1000;-1
bmj4_5_e005251.full;17 Clinicians influence their patients;17;-1
bmj4_5_e005251.full;9 A small proportion of  people;9;-1
bmj4_5_e005251.full;12 people;12;-1
bmj4_5_e005251.full;11 people;11;-1
bmj4_5_e005251.full;35 people;35;-1
bmj4_5_e005251.full; data set of 602;602;-1
bmj4_5_e005268.full;150 patients;150;1836
bmj4_5_e005268.full;90 patients;90;1936
bmj4_5_e005268.full;1 diabetes patients;1;15305
bmj4_5_e005268.full;total of 150;150;1827
bmj4_5_e005268.full;150 patients will be enrolled;150;1836
bmj4_5_e005268.full;90 patients enrolled;90;1936
bmj4_5_e005326.full;n=29;29;-1
bmj4_5_e005326.full;n=26;26;-1
bmj4_5_e005326.full;n=14;14;-1
bmj4_5_e005326.full;n=21;21;-1
bmj4_5_e005326.full;n=8;8;-1
bmj4_5_e005326.full;total of  254;254;-1
bmj4_5_e005390.full;n=22;22;-1
bmj4_5_e005390.full;n=39;39;-1
bmj4_5_e005390.full;n=19;19;-1
bmj4_5_e005390.full;n=20;20;-1
bmj4_5_e005416.full;13 patients;13;-1
bmj4_5_e005416.full;14 000 patients;14000;-1
bmj4_5_e005416.full;n=36;36;-1
bmj4_5_e005416.full;n=75;75;-1
bmj4_5_e005416.full;n=3;3;-1
bmj4_5_e005416.full;n=4;4;-1
bmj4_5_e005416.full;n=60;60;-1
bmj4_5_e005416.full;n=15;15;-1
bmj4_5_e005424.full;750 participants;750;-1
bmj4_5_e005424.full;90 000 Australian patients;90000;-1
bmj4_5_e005424.full;359 patients;359;-1
bmj4_5_e005424.full;750 patients;750;-1
bmj4_5_e005424.full;6336  patients;6336;-1
bmj4_5_e005437.full;4000 people;4000;-1
bmj4_5_e005437.full;2000 respondents will be recruited;2000;-1
bmj4_5_e005437.full;n=12;12;-1
bmj4_5_e005551.full;100 women;100;-1
bmj4_5_e005551.full;n=35;35;-1
bmj4_5_e005551.full;n=36;36;-1
bmj4_5_e005551.full;n=30;30;-1
bmj4_5_e005551.full; data from the 2010;2010;-1
bmj4_5_e005551.full; data from the 2007;2007;-1
bmj4_6_e003545.full;1537 eligible women;1537;-1
bmj4_6_e003545.full;1154 women;1154;-1
bmj4_6_e003545.full;1745  Australian women;1745;-1
bmj4_6_e003545.full;n=4299;4299;-1
bmj4_6_e003545.full;n=0;0;-1
bmj4_6_e003545.full;N=511;511;-1
bmj4_6_e003545.full;N=1026;1026;-1
bmj4_6_e003987.full;1000 IPC participants;1000;-1
bmj4_6_e003987.full;1000 IPC  participants;1000;-1
bmj4_6_e003987.full;n=70;70;-1
bmj4_6_e004301.full;1000 patients;1000;-1
bmj4_6_e004301.full;82 396 randomised patients;82396;-1
bmj4_6_e004301.full;78 296 patients;78296;-1
bmj4_6_e004301.full;22 included patients;22;-1
bmj4_6_e004301.full;79 808 patients;79808;-1
bmj4_6_e004301.full;n=21;21;-1
bmj4_6_e004301.full;n=18 201;18201;-1
bmj4_6_e004301.full;n=18 113;18113;-1
bmj4_6_e004301.full;n=14 264;14264;-1
bmj4_6_e004301.full;n=6706;6706;-1
bmj4_6_e004301.full;n=21 105;21105;-1
bmj4_6_e004301.full;N=83 015;83015;-1
bmj4_6_e004380.full;160 participants;160;-1
bmj4_6_e004380.full;1451 participants;1451;-1
bmj4_6_e004380.full;n=95;95;-1
bmj4_6_e004380.full;n=10;10;-1
bmj4_6_e004380.full;1990 and enrolled;1990;-1
bmj4_6_e004467.full;11 980 pregnant women;11980;-1
bmj4_6_e004467.full;11 980 pregnant  women;11980;-1
bmj4_6_e004467.full;2522 participants;2522;-1
bmj4_6_e004467.full;N=2522;2522;-1
bmj4_6_e004467.full;n=288;288;-1
bmj4_6_e004467.full;n=464;464;-1
bmj4_6_e004467.full;n=1589;1589;-1
bmj4_6_e004467.full;n=520;520;-1
bmj4_6_e004467.full;n=237;237;-1
bmj4_6_e004467.full;n=2348;2348;-1
bmj4_6_e004467.full;n=403;403;-1
bmj4_6_e004467.full;n=55;55;-1
bmj4_6_e004467.full;total of 2810;2810;-1
bmj4_6_e004471.full;37 million people;37;-1
bmj4_6_e004471.full;total of 942;942;-1
bmj4_6_e004471.full;total of 5314;5314;-1
bmj4_6_e004502.full;N=3137;3137;-1
bmj4_6_e004502.full;N=2968;2968;-1
bmj4_6_e004502.full;n=2004;2004;-1
bmj4_6_e004502.full;n=903;903;-1
bmj4_6_e004502.full;n=230;230;-1
bmj4_6_e004502.full;n=1017;1017;-1
bmj4_6_e004502.full;n=470;470;-1
bmj4_6_e004502.full;n=121;121;-1
bmj4_6_e004502.full;n=987;987;-1
bmj4_6_e004502.full;n=433;433;-1
bmj4_6_e004502.full;n=109;109;-1
bmj4_6_e004521.full;3 and of women;3;-1
bmj4_6_e004521.full;687 opioid-dependent  patients;687;-1
bmj4_6_e004521.full;42 676 patients;42676;-1
bmj4_6_e004521.full;1263 patients;1263;-1
bmj4_6_e004521.full;227  patients;227;-1
bmj4_6_e004521.full;576 control patients;576;-1
bmj4_6_e004521.full;4398 patients;4398;-1
bmj4_6_e004521.full;2 diabetic patients;2;-1
bmj4_6_e004521.full;50 045 people;50045;-1
bmj4_6_e004521.full;50,000 adults;50000;-1
bmj4_6_e004521.full;N=576;576;-1
bmj4_6_e004521.full;N=687;687;-1
bmj4_6_e004521.full;N=71;71;-1
bmj4_6_e004521.full;N=593;593;-1
bmj4_6_e004521.full;N=23;23;-1
bmj4_6_e004521.full;n=0;0;-1
bmj4_6_e004521.full;total of 2382;2382;-1
bmj4_6_e004521.full;total of 576;576;-1
bmj4_6_e004557.full;50 consecutive patients;50;-1
bmj4_6_e004557.full;50 patients;50;-1
bmj4_6_e004557.full;6336  patients;6336;-1
bmj4_6_e004635.full;23 patients;23;-1
bmj4_6_e004635.full;n=58;58;-1
bmj4_6_e004635.full;n=23;23;-1
bmj4_6_e004644.full;47 Significantly more women;47;-1
bmj4_6_e004644.full;4351  South African adult participants;4351;-1
bmj4_6_e004644.full;46 More  than a quarter of the adults;46;-1
bmj4_6_e004644.full;4351 South African adults;4351;-1
bmj4_6_e004644.full;n=4351;4351;-1
bmj4_6_e004644.full;N=4351;4351;-1
bmj4_6_e004644.full;total of 5089;5089;-1
bmj4_6_e004644.full; data from the 2000;2000;-1
bmj4_6_e004645.full;5000  people;5000;-1
bmj4_6_e004645.full;total of 21;21;-1
bmj4_6_e004646.full;n=300;300;-1
bmj4_6_e004646.full;total of 300;300;-1
bmj4_6_e004647.full;205 401  participants;205401;-1
bmj4_6_e004647.full;205 923 eligible participants;205923;-1
bmj4_6_e004647.full;1898 eligible participants;1898;-1
bmj4_6_e004647.full;72 438 eligible participants;72438;-1
bmj4_6_e004647.full;28 did not specify if participants;28;-1
bmj4_6_e004647.full;138 302 participants;138302;-1
bmj4_6_e004647.full;15 042 participants;15042;-1
bmj4_6_e004647.full;9610 participants;9610;-1
bmj4_6_e004647.full;2407 participants;2407;-1
bmj4_6_e004647.full;13 669 participants;13669;-1
bmj4_6_e004647.full;3071 participants;3071;-1
bmj4_6_e004647.full;35 192participants;35192;-1
bmj4_6_e004647.full;323 participants;323;-1
bmj4_6_e004647.full;1530 participants;1530;-1
bmj4_6_e004647.full;399 participants;399;-1
bmj4_6_e004647.full;1329 participants;1329;-1
bmj4_6_e004647.full;804 participants;804;-1
bmj4_6_e004647.full;140 000 participants;140000;-1
bmj4_6_e004647.full;n=200;200;-1
bmj4_6_e004668.full;2  million people;2;-1
bmj4_6_e004668.full;87,134 Thai adults;87134;-1
bmj4_6_e004668.full;total of 580;580;-1
bmj4_6_e004685.full;n=16 015;16015;-1
bmj4_6_e004685.full;n=16 542;16542;-1
bmj4_6_e004685.full;n=523;523;-1
bmj4_6_e004685.full;n=4;4;-1
bmj4_6_e004685.full;n=978;978;-1
bmj4_6_e004685.full;n=2794;2794;-1
bmj4_6_e004685.full;n=477;477;-1
bmj4_6_e004685.full;n=3299;3299;-1
bmj4_6_e004685.full;total of 118 581;118581;-1
bmj4_6_e004685.full;total of 17;17;-1
bmj4_6_e004685.full; data from the 2009;2009;-1
bmj4_6_e004685.full; data from the 2003;2003;-1
bmj4_6_e004711.full;185 000 people;185000;-1
bmj4_6_e004711.full;1  million people;1;-1
bmj4_6_e004736.full;24 participants;24;-1
bmj4_6_e004736.full;20 trial participants;20;-1
bmj4_6_e004736.full;33 participants;33;-1
bmj4_6_e004736.full;20  trial participants;20;-1
bmj4_6_e004736.full;2 Qualitative study participants;2;-1
bmj4_6_e004736.full;4 Details of interview participants;4;-1
bmj4_6_e004736.full;26 and was a benefit participants;26;-1
bmj4_6_e004744.full;1710 patients;1710;-1
bmj4_6_e004744.full;3  For hospitalised patients;3;-1
bmj4_6_e004744.full;36 patients;36;-1
bmj4_6_e004744.full;18 ITT patients;18;-1
bmj4_6_e004744.full;1674 patients;1674;-1
bmj4_6_e004744.full;1381  patients;1381;-1
bmj4_6_e004744.full;716  patients;716;-1
bmj4_6_e004744.full;402 patients;402;-1
bmj4_6_e004744.full;314 patients;314;-1
bmj4_6_e004744.full;638 patients;638;-1
bmj4_6_e004744.full;1173  patients;1173;-1
bmj4_6_e004744.full;624 patients;624;-1
bmj4_6_e004744.full;549 patients;549;-1
bmj4_6_e004744.full;698 patients;698;-1
bmj4_6_e004744.full;639  patients;639;-1
bmj4_6_e004744.full;203 patients;203;-1
bmj4_6_e004744.full;1521 patients;1521;-1
bmj4_6_e004744.full;1425 patients;1425;-1
bmj4_6_e004744.full;88 patients;88;-1
bmj4_6_e004744.full;N  =1;1;-1
bmj4_6_e004744.full;total of 1710;1710;-1
bmj4_6_e004744.full;total of 310;310;-1
bmj4_6_e004744.full;1710 patients enrolled;1710;-1
bmj4_6_e004744.full;203 patients were enrolled;203;-1
bmj4_6_e004753.full;3 women;3;-1
bmj4_6_e004753.full;12 participants;12;-1
bmj4_6_e004753.full;7 participants;7;-1
bmj4_6_e004753.full;5 participants;5;-1
bmj4_6_e004753.full;24 participants;24;-1
bmj4_6_e004753.full;3 participants;3;-1
bmj4_6_e004753.full;16 did not exclude ACLR participants;16;-1
bmj4_6_e004753.full;29 All of  the ACLR participants;29;-1
bmj4_6_e004753.full;65 female patients;65;-1
bmj4_6_e004753.full;n=12;12;-1
bmj4_6_e004753.full;n=7;7;-1
bmj4_6_e004753.full;n=5;5;-1
bmj4_6_e004773.full;n=32;32;4590
bmj4_6_e004773.full;n=21;21;4627
bmj4_6_e004773.full;n=8;8;4666
bmj4_6_e004773.full; data of 61;61;14046
bmj4_6_e004786.full;4 asked participants;4;-1
bmj4_6_e004786.full;N=205;205;-1
bmj4_6_e004786.full;N=107;107;-1
bmj4_6_e004786.full;n=80;80;-1
bmj4_6_e004786.full;n=84;84;-1
bmj4_6_e004786.full;total of 134;134;-1
bmj4_6_e004798.full;1 study used  all female participants;1;-1
bmj4_6_e004798.full;total of 1024;1024;-1
bmj4_6_e004805.full;3503 White British  women;3503;-1
bmj4_6_e004805.full;11 113 women;11113;-1
bmj4_6_e004805.full;3503 White British women;3503;-1
bmj4_6_e004805.full;9451 participants;9451;-1
bmj4_6_e004805.full;3503 White British  women recruited;3503;-1
bmj4_6_e004805.full;11 113 women  recruited;11113;-1
bmj4_6_e004805.full;n=64;64;-1
bmj4_6_e004805.full;n=1598;1598;-1
bmj4_6_e004805.full;n=345;345;-1
bmj4_6_e004805.full;N  =9;9;-1
bmj4_6_e004805.full;N  =3;3;-1
bmj4_6_e004805.full;N  =8;8;-1
bmj4_6_e004805.full;N  =1;1;-1
bmj4_6_e004813.full;486  invited participants;486;-1
bmj4_6_e004813.full;431 enrolled participants;431;-1
bmj4_6_e004813.full;890  patients;890;-1
bmj4_6_e004813.full;total of 22;22;-1
bmj4_6_e004813.full;431 enrolled;431;-1
bmj4_6_e004814.full;383 patients;383;8591
bmj4_6_e004814.full;16 patients;16;592
bmj4_6_e004814.full;166 patients;166;893
bmj4_6_e004814.full;254 patients;254;4027
bmj4_6_e004814.full;14 patients;14;4899
bmj4_6_e004814.full;173 patients;173;6380
bmj4_6_e004814.full;222 patients;222;8934
bmj4_6_e004814.full;29 patients;29;12377
bmj4_6_e004814.full;100 prospectively recruited;100;8504
bmj4_6_e004814.full;100 prospectively  recruited;100;3331
bmj4_6_e004814.full;n=383;383;4983
bmj4_6_e004814.full;n=100;100;1554
bmj4_6_e004814.full;n=218;218;6087
bmj4_6_e004814.full;n=27;27;6105
bmj4_6_e004814.full;n=69;69;6122
bmj4_6_e004814.full;n=16;16;6139
bmj4_6_e004814.full;n=53;53;6156
bmj4_6_e004816.full;N=3915;3915;-1
bmj4_6_e004816.full;n=3915;3915;-1
bmj4_6_e004816.full;total of 3915;3915;-1
bmj4_6_e004817.full;250 participants;250;-1
bmj4_6_e004817.full;10 participants;10;-1
bmj4_6_e004817.full;238 participants;238;-1
bmj4_6_e004817.full;46 Analysis of participants;46;-1
bmj4_6_e004817.full;120 clinical trial participants;120;-1
bmj4_6_e004817.full;247 participants;247;-1
bmj4_6_e004817.full;129 participants;129;-1
bmj4_6_e004817.full;118 participants;118;-1
bmj4_6_e004817.full;79 million people;79;-1
bmj4_6_e004817.full;n=125;125;-1
bmj4_6_e004817.full;n=3;3;-1
bmj4_6_e004817.full;n=6;6;-1
bmj4_6_e004817.full;N=247;247;-1
bmj4_6_e004817.full;n=247;247;-1
bmj4_6_e004817.full;n=17;17;-1
bmj4_6_e004817.full;n=9;9;-1
bmj4_6_e004817.full;n=91;91;-1
bmj4_6_e004817.full;n=156;156;-1
bmj4_6_e004817.full;n=129;129;-1
bmj4_6_e004817.full;n=118;118;-1
bmj4_6_e004817.full;n=62;62;-1
bmj4_6_e004817.full;n=185;185;-1
bmj4_6_e004817.full;total of  34;34;-1
bmj4_6_e004817.full;total of 1200;1200;-1
bmj4_6_e004817.full;250 participants enrolled;250;-1
bmj4_6_e004817.full;1200 infants were enrolled;1200;-1
bmj4_6_e004817.full; data from 247;247;-1
bmj4_6_e004818.full;1424 persons;1424;-1
bmj4_6_e004818.full;973 patients;973;-1
bmj4_6_e004818.full;17 patients;17;-1
bmj4_6_e004818.full;153 of these patients;153;-1
bmj4_6_e004818.full;43 patients;43;-1
bmj4_6_e004818.full;212 smear-positive  patients;212;-1
bmj4_6_e004818.full;2989 adults;2989;-1
bmj4_6_e004818.full;n=930;930;-1
bmj4_6_e004818.full;n=600;600;-1
bmj4_6_e004818.full;n=330;330;-1
bmj4_6_e004818.full;n=973;973;-1
bmj4_6_e004818.full;n=153;153;-1
bmj4_6_e004818.full;n=110;110;-1
bmj4_6_e004818.full;total of 1424;1424;-1
bmj4_6_e004818.full;364 were not enrolled;364;-1
bmj4_6_e004818.full;1002 were enrolled;1002;-1
bmj4_6_e004833.full;2096 patients;2096;-1
bmj4_6_e004833.full;205 patients;205;-1
bmj4_6_e004833.full;100 000 in adults;100000;-1
bmj4_6_e004833.full;N=18;18;-1
bmj4_6_e004833.full;N=33;33;-1
bmj4_6_e004833.full;N=7;7;-1
bmj4_6_e004833.full;N=3;3;-1
bmj4_6_e004833.full;N=2;2;-1
bmj4_6_e004833.full;N=9;9;-1
bmj4_6_e004833.full;n=43;43;-1
bmj4_6_e004833.full;n=10;10;-1
bmj4_6_e004837.full;310 511 patients;310511;-1
bmj4_6_e004837.full;95 977 patients;95977;-1
bmj4_6_e004837.full;11 653 patients;11653;-1
bmj4_6_e004837.full;7 Referral of all these patients;7;-1
bmj4_6_e004837.full;1989  patients;1989;-1
bmj4_6_e004837.full;310 511 patients. After excluding patients;310511;-1
bmj4_6_e004837.full;99 165 patients;99165;-1
bmj4_6_e004837.full;481 patients;481;-1
bmj4_6_e004837.full;19 of these patients;19;-1
bmj4_6_e004837.full;73 patients;73;-1
bmj4_6_e004837.full;n=95 977;95977;-1
bmj4_6_e004837.full;n=75;75;-1
bmj4_6_e004837.full;n=37;37;-1
bmj4_6_e004837.full;n=23;23;-1
bmj4_6_e004837.full;n=68;68;-1
bmj4_6_e004837.full;n=40;40;-1
bmj4_6_e004837.full;n=34;34;-1
bmj4_6_e004837.full;n=29;29;-1
bmj4_6_e004837.full;n=28;28;-1
bmj4_6_e004837.full;N=8738;8738;-1
bmj4_6_e004837.full;n=11 653;11653;-1
bmj4_6_e004837.full;n=48;48;-1
bmj4_6_e004837.full;n=38;38;-1
bmj4_6_e004837.full;total of 481;481;-1
bmj4_6_e004844.full;100 000 persons;100000;-1
bmj4_6_e004844.full;1000 persons;1000;-1
bmj4_6_e004844.full;36 million  people;36;-1
bmj4_6_e004853.full;1175 participants;1175;-1
bmj4_6_e004853.full;41 patients;41;-1
bmj4_6_e004853.full;14 patients;14;-1
bmj4_6_e004853.full;25 patients;25;-1
bmj4_6_e004853.full;100 patients;100;-1
bmj4_6_e004853.full;11 000 patients;11000;-1
bmj4_6_e004853.full;11 210 patients;11210;-1
bmj4_6_e004853.full;22 000 people;22000;-1
bmj4_6_e004853.full;56 million people;56;-1
bmj4_6_e004853.full;56 million  people;56;-1
bmj4_6_e004853.full;n=12;12;-1
bmj4_6_e004853.full;n=27;27;-1
bmj4_6_e004853.full;total of 360;360;-1
bmj4_6_e004853.full;total of 180 000;180000;-1
bmj4_6_e004860.full;60 404 men and women;60404;-1
bmj4_6_e004860.full;267 153 men and women;267153;-1
bmj4_6_e004860.full;100 000 participants;100000;-1
bmj4_6_e004860.full;60 404 participants;60404;-1
bmj4_6_e004860.full;20 A  validation study using participants;20;-1
bmj4_6_e004860.full;361 participants;361;-1
bmj4_6_e004860.full;7  we excluded people;7;-1
bmj4_6_e004860.full;46 million white adults;46;-1
bmj4_6_e004860.full;900 000 adults;900000;-1
bmj4_6_e004860.full;n=9411;9411;-1
bmj4_6_e004860.full;n=964;964;-1
bmj4_6_e004860.full;n=673;673;-1
bmj4_6_e004860.full;n=1893;1893;-1
bmj4_6_e004860.full;n=1950;1950;-1
bmj4_6_e004860.full;n=263;263;-1
bmj4_6_e004860.full;n=213;213;-1
bmj4_6_e004860.full;n=3857;3857;-1
bmj4_6_e004860.full;n=13 635;13635;-1
bmj4_6_e004860.full;n=15 059;15059;-1
bmj4_6_e004860.full;n=12 486;12486;-1
bmj4_6_e004860.full;n=7685;7685;-1
bmj4_6_e004860.full;n=26 922;26922;-1
bmj4_6_e004860.full;n=10 430;10430;-1
bmj4_6_e004860.full;n=2959;2959;-1
bmj4_6_e004860.full;n=4043;4043;-1
bmj4_6_e004860.full;n=1446;1446;-1
bmj4_6_e004860.full;n=1933;1933;-1
bmj4_6_e004860.full;n=2203;2203;-1
bmj4_6_e004860.full;n=669;669;-1
bmj4_6_e004860.full;n=1552;1552;-1
bmj4_6_e004860.full;100 000 participants enrolled;100000;-1
bmj4_6_e004860.full; data from the 45;45;-1
bmj4_6_e004863.full;7038 eligible pregnant women;7038;-1
bmj4_6_e004863.full;total of 100 000;100000;-1
bmj4_6_e004863.full;total of 24 256;24256;-1
bmj4_6_e004887.full;13 Equally pregnant  women;13;-1
bmj4_6_e004887.full;120 participants;120;-1
bmj4_6_e004887.full;19  Indigenous people;19;-1
bmj4_6_e004887.full;N=121;121;-1
bmj4_6_e004887.full;N=7;7;-1
bmj4_6_e004887.full;total of 120;120;-1
bmj4_6_e004887.full; data. A total of 120;120;-1
bmj4_6_e004887.full; data  from the 2008;2008;-1
bmj4_6_e004895.full;34  patients;34;-1
bmj4_6_e004895.full;62 patients;62;-1
bmj4_6_e004895.full;253 patients;253;-1
bmj4_6_e004895.full;121  patients;121;-1
bmj4_6_e004895.full;62  patients;62;-1
bmj4_6_e004895.full;250  patients;250;-1
bmj4_6_e004897.full;1 million people;1;-1
bmj4_6_e004897.full;n=930;930;-1
bmj4_6_e004897.full;n=570;570;-1
bmj4_6_e004897.full;n=360;360;-1
bmj4_6_e004897.full;total of 980;980;-1
bmj4_6_e004904.full;n=20;20;-1
bmj4_6_e004904.full;n=421;421;-1
bmj4_6_e004904.full;n=86;86;-1
bmj4_6_e004904.full;n=527;527;-1
bmj4_6_e004904.full;total of 630;630;-1
bmj4_6_e004904.full;total of 852 799;852799;-1
bmj4_6_e004982.full;100 participants;100;-1
bmj4_6_e004982.full;18 were recruited;18;-1
bmj4_6_e004982.full;total of  4;4;-1
bmj4_6_e005001.full;n=1011;1011;-1
bmj4_6_e005001.full;n=425;425;-1
bmj4_6_e005001.full;n=211;211;-1
bmj4_6_e005001.full;n=214;214;-1
bmj4_6_e005002.full;7 million  participants;7;-1
bmj4_6_e005002.full;2011 proportion of adults;2011;-1
bmj4_6_e005002.full; data ranged from 6;6;-1
bmj4_6_e005026.full;620 participants;620;4014
bmj4_6_e005026.full;1000 patients;1000;10806
bmj4_6_e005026.full;1900 patients;1900;6505
bmj4_6_e005026.full;1 patients;1;4112
bmj4_6_e005026.full;19 patients;19;14855
bmj4_6_e005026.full;n=155;155;10159
bmj4_6_e005026.full;n=293;293;3666
bmj4_6_e005026.full;n=310;310;12124
bmj4_6_e005026.full;n=243;243;12417
bmj4_6_e005026.full;n=21;21;12732
bmj4_6_e005026.full;n=46;46;12782
bmj4_6_e005026.full;n=150;150;16677
bmj4_6_e005026.full;total of  1321;1321;1428
bmj4_6_e005026.full;total of 310;310;3485
bmj4_6_e005026.full;total of 25;25;15046
bmj4_6_e005044.full;2911 women;2911;-1
bmj4_6_e005044.full;61  sedentary people;61;-1
bmj4_6_e005044.full;10 people;10;-1
bmj4_6_e005044.full;total of 2093;2093;-1
bmj4_6_e005053.full;n=5327;5327;-1
bmj4_6_e005053.full;n=24 436;24436;-1
bmj4_6_e005053.full;N=877 778;877778;-1
bmj4_6_e005053.full;total of 105 677;105677;-1
bmj4_6_e005053.full; data from  2004;2004;-1
bmj4_6_e005082.full;2010 and a comparison cohort of  women;2010;-1
bmj4_6_e005082.full;2010 and a  comparison cohort of women;2010;-1
bmj4_6_e005082.full;2010 and a comparison cohort of women;2010;-1
bmj4_6_e005082.full;304 803  women;304803;-1
bmj4_6_e005082.full;22 We identified all female patients;22;-1
bmj4_6_e005082.full;2010 and excluded  patients;2010;-1
bmj4_6_e005082.full;428 patients;428;-1
bmj4_6_e005082.full;62 376 patients;62376;-1
bmj4_6_e005082.full;n=62 376;62376;-1
bmj4_6_e005082.full;n=304 803;304803;-1
bmj4_6_e005097.full;7510 consecutive patients;7510;-1
bmj4_6_e005097.full;6591 patients;6591;-1
bmj4_6_e005097.full;7510 patients;7510;-1
bmj4_6_e005097.full;123 patients;123;-1
bmj4_6_e005097.full;796  patients;796;-1
bmj4_6_e005097.full;560 patients;560;-1
bmj4_6_e005097.full;9461  patients;9461;-1
bmj4_6_e005097.full;634 consecutive patients;634;-1
bmj4_6_e005097.full;11,483 patients;11483;-1
bmj4_6_e005097.full;n=4182;4182;-1
bmj4_6_e005097.full;n=2187;2187;-1
bmj4_6_e005097.full;n=222;222;-1
bmj4_6_e005097.full;total of 7510;7510;-1
bmj4_6_e005097.full;total of 796;796;-1
bmj4_6_e005125.full;7800 participants;7800;-1
bmj4_6_e005125.full;251 individuals;251;-1
bmj4_6_e005125.full;868 individuals;868;-1
bmj4_6_e005125.full;7800 participants recruited;7800;-1
bmj4_6_e005125.full;n=868;868;-1
bmj4_6_e005125.full;n=617;617;-1
bmj4_6_e005125.full;n=251;251;-1
bmj4_6_e005125.full;n=377;377;-1
bmj4_6_e005125.full;n=125;125;-1
bmj4_6_e005125.full;n=191;191;-1
bmj4_6_e005125.full;n=32;32;-1
bmj4_6_e005125.full;n=28;28;-1
bmj4_6_e005125.full;n=3421;3421;-1
bmj4_6_e005125.full;n=4562;4562;-1
bmj4_6_e005125.full;n=4923;4923;-1
bmj4_6_e005125.full;n=257;257;-1
bmj4_6_e005125.full;n=97;97;-1
bmj4_6_e005125.full;n=101;101;-1
bmj4_6_e005125.full;n=24;24;-1
bmj4_6_e005125.full;n=41;41;-1
bmj4_6_e005125.full;n=234;234;-1
bmj4_6_e005125.full;n=634;634;-1
bmj4_6_e005126.full;265 patients;265;4987
bmj4_6_e005126.full;233 patients;233;881
bmj4_6_e005126.full;145 patients;145;984
bmj4_6_e005126.full;1 Study patients;1;5723
bmj4_6_e005126.full;233 patients were recruited;233;881
bmj4_6_e005126.full;n=60;60;10205
bmj4_6_e005126.full;n=205;205;10221
bmj4_6_e005133.full;1003 participants;1003;-1
bmj4_6_e005133.full;103 inhabitants  younger participants;103;-1
bmj4_6_e005133.full;471 patients;471;-1
bmj4_6_e005133.full;11 and adults;11;-1
bmj4_6_e005133.full;n=1326;1326;-1
bmj4_6_e005133.full;total of 1003;1003;-1
bmj4_6_e005133.full; data from the 2006;2006;-1
bmj4_6_e005156.full;6363 women;6363;-1
bmj4_6_e005156.full;40 This  may be because women;40;-1
bmj4_6_e005156.full;534,906 individuals;534906;-1
bmj4_6_e005156.full;total of 12 429;12429;-1
bmj4_6_e005156.full;total of 11 144;11144;-1
bmj4_6_e005164.full;900 patients;900;-1
bmj4_6_e005164.full;2800 patients;2800;-1
bmj4_6_e005164.full;500  patients;500;-1
bmj4_6_e005164.full;800 patients;800;-1
bmj4_6_e005164.full;300 patients;300;-1
bmj4_6_e005164.full;600  control patients;600;-1
bmj4_6_e005164.full;60 centres will be recruited;60;-1
bmj4_6_e005187.full;1 112 831 women;1112831;-1
bmj4_6_e005187.full;1379 women;1379;-1
bmj4_6_e005187.full;603 women;603;-1
bmj4_6_e005187.full;540 women;540;-1
bmj4_6_e005187.full;277 women;277;-1
bmj4_6_e005187.full;574 women;574;-1
bmj4_6_e005187.full;12 women;12;-1
bmj4_6_e005187.full;26  followed women;26;-1
bmj4_6_e005187.full;27 compared women;27;-1
bmj4_6_e005187.full;N=64;64;-1
bmj4_6_e005187.full;N=532;532;-1
bmj4_6_e005187.full;N=51;51;-1
bmj4_6_e005187.full;N=72;72;-1
bmj4_6_e005187.full;total of 1 112 831;1112831;-1
bmj4_6_e005187.full;total of 1379;1379;-1
bmj4_6_e005191.full;5 transgender women;5;-1
bmj4_6_e005191.full;n=31;31;-1
bmj4_6_e005191.full;n=24;24;-1
bmj4_6_e005191.full;n=7;7;-1
bmj4_6_e005191.full;n=17;17;-1
bmj4_6_e005191.full;n=14;14;-1
bmj4_6_e005194.full;8444 women;8444;-1
bmj4_6_e005194.full;n=2125;2125;-1
bmj4_6_e005194.full;total of 536;536;-1
bmj4_6_e005194.full;total of 7881;7881;-1
bmj4_6_e005194.full; data from 1998;1998;-1
bmj4_6_e005194.full; data sets from 2003;2003;-1
bmj4_6_e005194.full; data sets from 1998;1998;-1
bmj4_6_e005194.full;  data sets from 1998;1998;-1
bmj4_6_e005194.full; data  sets from 2003;2003;-1
bmj4_6_e005208.full;594 patients;594;-1
bmj4_6_e005208.full;1669 patients;1669;-1
bmj4_6_e005208.full;1320 patients;1320;-1
bmj4_6_e005208.full;40 patients;40;-1
bmj4_6_e005208.full;297 patients;297;-1
bmj4_6_e005208.full;541 evaluable  patients;541;-1
bmj4_6_e005208.full;40  elderly patients;40;-1
bmj4_6_e005224.full;n=2;2;-1
bmj4_6_e005252.full;3  A majority of ED patients;3;-1
bmj4_6_e005252.full;528 patients;528;-1
bmj4_6_e005252.full;110 patients;110;-1
bmj4_6_e005252.full;625 patients;625;-1
bmj4_6_e005262.full;60 participants;60;-1
bmj4_6_e005262.full;107  participants;107;-1
bmj4_6_e005262.full;36 and enable trial participants;36;-1
bmj4_6_e005262.full;15 participants;15;-1
bmj4_6_e005262.full;20 and help patients;20;-1
bmj4_6_e005262.full;658 patients;658;-1
bmj4_6_e005262.full;total of 60;60;-1
bmj4_6_e005273.full;173  participants;173;-1
bmj4_6_e005273.full;132 participants;132;-1
bmj4_6_e005273.full;75 participants;75;-1
bmj4_6_e005273.full;18 participants;18;-1
bmj4_6_e005273.full;57 participants;57;-1
bmj4_6_e005273.full;75 people;75;-1
bmj4_6_e005273.full;670 000  people;670000;-1
bmj4_6_e005273.full;n=132;132;-1
bmj4_6_e005273.full;n=75;75;-1
bmj4_6_e005273.full;n=98;98;-1
bmj4_6_e005283.full;1166  participants;1166;-1
bmj4_6_e005283.full;1166 individuals;1166;-1
bmj4_6_e005283.full;41  Few older adults;41;-1
bmj4_6_e005285.full;30 women;30;-1
bmj4_6_e005285.full;17 women;17;-1
bmj4_6_e005285.full;9  women;9;-1
bmj4_6_e005285.full;16 women;16;-1
bmj4_6_e005285.full;7 women;7;-1
bmj4_6_e005285.full;30 participants;30;-1
bmj4_6_e005285.full;8,769  early-stage breast cancer patients;8769;-1
bmj4_6_e005285.full;n=6;6;-1
bmj4_6_e005285.full;n=3;3;-1
bmj4_6_e005295.full;210 potential participants;210;-1
bmj4_6_e005295.full;300 participants;300;-1
bmj4_6_e005295.full;210  potential participants;210;-1
bmj4_6_e005295.full;30 participants;30;-1
bmj4_6_e005295.full;3 million people;3;-1
bmj4_6_e005295.full;30 participants recruited;30;-1
bmj4_6_e005295.full;n=19;19;-1
bmj4_6_e005295.full;n=30;30;-1
bmj4_6_e005295.full;n=98;98;-1
bmj4_6_e005295.full;n=26;26;-1
bmj4_6_e005295.full;n=24;24;-1
bmj4_6_e005295.full;n=32;32;-1
bmj4_6_e005295.full;n=13;13;-1
bmj4_6_e005295.full;n=3;3;-1
bmj4_6_e005295.full;n=4;4;-1
bmj4_6_e005295.full;n=12;12;-1
bmj4_6_e005295.full;n=18;18;-1
bmj4_6_e005362.full;500 participants;500;-1
bmj4_6_e005362.full;22 Never-takers  are patients;22;-1
bmj4_6_e005362.full;450 patients;450;-1
bmj4_6_e005374.full;1000 participants;1000;-1
bmj4_6_e005374.full;4899 people;4899;-1
bmj4_6_e005374.full;n=1000;1000;-1
bmj4_6_e005374.full;n=23;23;-1
bmj4_6_e005374.full;n=214;214;-1
bmj4_6_e005374.full;n=239;239;-1
bmj4_6_e005374.full;n=198;198;-1
bmj4_6_e005374.full;n=189;189;-1
bmj4_6_e005374.full;N=1000;1000;-1
bmj4_6_e005374.full;N=999;999;-1
bmj4_6_e005374.full;total of 11 453;11453;-1
bmj4_6_e005379.full;50 patients;50;-1
bmj4_6_e005379.full;633  patients;633;-1
bmj4_6_e005379.full;367 patients;367;-1
bmj4_6_e005379.full;1511 patients;1511;-1
bmj4_6_e005379.full;01  Proportion of patients;1;-1
bmj4_6_e005379.full;001  Proportion of patients;1;-1
bmj4_6_e005379.full;98  Proportion of patients;98;-1
bmj4_6_e005379.full;2300 consecutive  patients;2300;-1
bmj4_6_e005379.full;n=2;2;-1
bmj4_6_e005379.full;N=148;148;-1
bmj4_6_e005379.full;n=30;30;-1
bmj4_6_e005379.full;n=1;1;-1
bmj4_6_e005379.full;N=106;106;-1
bmj4_6_e005379.full;N=49;49;-1
bmj4_6_e005379.full;N=72;72;-1
bmj4_6_e005379.full;N=76;76;-1
bmj4_6_e005379.full;N=23;23;-1
bmj4_6_e005379.full;N=125;125;-1
bmj4_6_e005379.full;total of 148;148;-1
bmj4_6_e005402.full;170000 participants;170000;-1
bmj4_6_e005402.full;56 963 patients;56963;-1
bmj4_6_e005402.full;3 Only patients;3;-1
bmj4_6_e005402.full;8714 patients;8714;-1
bmj4_6_e005402.full;48 249 patients;48249;-1
bmj4_6_e005402.full;11  Real-world  patients;11;-1
bmj4_6_e005402.full;11  Real-world patients;11;-1
bmj4_6_e005402.full;2,532 patients;2532;-1
bmj4_6_e005402.full;3 million people;3;-1
bmj4_6_e005402.full;18,686 people;18686;-1
bmj4_6_e005402.full;5963 people;5963;-1
bmj4_6_e005402.full;N=32 582;32582;-1
bmj4_6_e005402.full;N=20 499;20499;-1
bmj4_6_e005402.full;N=41 552;41552;-1
bmj4_6_e005402.full;N=34 682;34682;-1
bmj4_6_e005402.full;N=1428;1428;-1
bmj4_6_e005402.full;N=607;607;-1
bmj4_6_e005402.full;N=406;406;-1
bmj4_6_e005402.full;N=45 463;45463;-1
bmj4_6_e005402.full;N=33 219;33219;-1
bmj4_6_e005402.full;N=12 541;12541;-1
bmj4_6_e005402.full; data from 170000;170000;-1
bmj4_6_e005418.full;606 included patients;606;-1
bmj4_6_e005418.full;616  patients;616;-1
bmj4_6_e005418.full;10 patients;10;-1
bmj4_6_e005418.full;606 patients;606;-1
bmj4_6_e005418.full;606 study patients;606;-1
bmj4_6_e005418.full;334 patients;334;-1
bmj4_6_e005418.full;79 patients;79;-1
bmj4_6_e005442.full;14 829 participants;14829;-1
bmj4_6_e005442.full;1306  patients;1306;-1
bmj4_6_e005442.full;56 patients;56;-1
bmj4_6_e005442.full;20,053 patients;20053;-1
bmj4_6_e005442.full;total of 751;751;-1
bmj4_6_e005442.full;total of 12;12;-1
bmj4_6_e005476.full;12 women;12;-1
bmj4_6_e005476.full;13 Normal weight women;13;-1
bmj4_6_e005476.full;881 adults;881;-1
bmj4_6_e005476.full;3127 adults;3127;-1
bmj4_6_e005476.full;12 women was recruited;12;-1
bmj4_6_e005476.full;n=10;10;-1
bmj4_6_e005476.full;n=12;12;-1
bmj4_6_e005484.full;88 billion people;88;-1
bmj4_6_e005484.full;286  Young people;286;-1
bmj4_6_e005484.full;664  Middle-aged people;664;-1
bmj4_6_e005484.full;000  Older people;0;-1
bmj4_6_e005484.full;831 000 individuals;831000;-1
bmj4_6_e005484.full;total of 8553;8553;-1
bmj4_6_e005505.full;101 participants;101;-1
bmj4_6_e005505.full;39  Guideline care  All participants;39;-1
bmj4_6_e005505.full;11 These people;11;-1
bmj4_6_e005505.full;N=12612001180808;1,2612E+13;-1
bmj4_6_e005520.full;2  Pregnant women;2;-1
bmj4_6_e005520.full;188 pregnant women;188;-1
bmj4_6_e005520.full;7145 pregnant women;7145;-1
bmj4_6_e005520.full;2375 pregnant  women;2375;-1
bmj4_6_e005520.full;2251 pregnant women;2251;-1
bmj4_6_e005520.full;188 preg-  nant women;188;-1
bmj4_6_e005520.full;4 pregnant women;4;-1
bmj4_6_e005520.full;7145 pregnant women were recruited;7145;-1
bmj4_6_e005520.full;n=1040;1040;-1
bmj4_6_e005520.full;n=119;119;-1
bmj4_6_e005520.full;n=1525;1525;-1
bmj4_6_e005520.full;n=1450;1450;-1
bmj4_6_e005520.full;n=1319;1319;-1
bmj4_6_e005520.full;n=351;351;-1
bmj4_6_e005520.full;n=323;323;-1
bmj4_6_e005554.full;2 400 542 patients;2400542;-1
bmj4_6_e005554.full;n=2862;2862;-1
bmj4_6_e005554.full;n  =2;2;-1
bmj4_6_e005554.full;n=10;10;-1
bmj4_6_e005554.full;n=2913;2913;-1
bmj4_6_e005554.full;total of 2946;2946;-1
bmj4_6_e005554.full;total of 2926;2926;-1
bmj4_6_e005559.full;10 participants;10;-1
bmj4_6_e005559.full;10 trial participants;10;-1
bmj4_6_e005559.full;40 participants;40;-1
bmj4_6_e005559.full;10 start-up participants;10;-1
bmj4_6_e005559.full;17  In patients;17;-1
bmj4_6_e005559.full;22 HCV vasculitis  patients;22;-1
bmj4_6_e005559.full;255  patients;255;-1
bmj4_6_e005559.full;N=40;40;-1
bmj4_6_e005559.full;total of 3;3;-1
bmj4_6_e005661.full;700 000  people;700000;-1
bmj4_6_e005661.full;700 000 people;700000;-1
bmj4_6_e005676.full;4 and preg-  nant women;4;-1
bmj4_6_e005676.full;19 Pregnant women;19;-1
bmj4_6_e005676.full;10 106 women;10106;-1
bmj4_6_e005676.full;422 participants;422;-1
bmj4_6_e005676.full;10 000  participants;10000;-1
bmj4_6_e005676.full;10 106 women to be  recruited;10106;-1
bmj4_6_e005745.full;10 patients;10;-1
bmj4_6_e005745.full;140 patients;140;-1
bmj4_6_e005788.full;60 participants;60;9872
bmj4_6_e005788.full;26 All participants;26;452
bmj4_6_e005788.full;64 comparator participants;64;730
bmj4_6_e005788.full;20 older people;20;9853
bmj4_6_e005788.full;n=20;20;9855
bmj4_6_e005788.full;n=10;10;7185
bmj4_6_e005788.full;n=50;50;6653
bmj4_6_e005788.full;n=5;5;6653
bmj4_7_e004419.full;9028 participants;9028;-1
bmj4_7_e004419.full;7568 participants;7568;-1
bmj4_7_e004419.full;1 Characteristics of the study participants;1;-1
bmj4_7_e004419.full;1460 patients;1460;-1
bmj4_7_e004419.full;1247 patients;1247;-1
bmj4_7_e004419.full;31 patients;31;-1
bmj4_7_e004419.full;182 patients;182;-1
bmj4_7_e004419.full;2 diabetic  patients;2;-1
bmj4_7_e004419.full;95,783 individuals;95783;-1
bmj4_7_e004419.full;259 657 Chinese adults;259657;-1
bmj4_7_e004419.full;n=3517;3517;-1
bmj4_7_e004419.full;n=2769;2769;-1
bmj4_7_e004419.full;n=1282;1282;-1
bmj4_7_e004419.full;n=346;346;-1
bmj4_7_e004419.full;n=4513;4513;-1
bmj4_7_e004419.full;n=2709;2709;-1
bmj4_7_e004419.full;total of 9028;9028;-1
bmj4_7_e004419.full; data of 7568;7568;-1
bmj4_7_e004419.full; data from 20;20;-1
bmj4_7_e004466.full;257  women;257;-1
bmj4_7_e004466.full;258 women;258;-1
bmj4_7_e004466.full;412 patients;412;-1
bmj4_7_e004466.full;11 In patients;11;-1
bmj4_7_e004466.full;2  patients;2;-1
bmj4_7_e004466.full;21 patients;21;-1
bmj4_7_e004466.full;4 Chest X-ray stages of patients;4;-1
bmj4_7_e004466.full;N=196;196;-1
bmj4_7_e004466.full;N=28;28;-1
bmj4_7_e004466.full;n=418;418;-1
bmj4_7_e004466.full;n=412;412;-1
bmj4_7_e004466.full;total of 29;29;-1
bmj4_7_e004472.full;2 Rate of persons;2;-1
bmj4_7_e004472.full;14 LHINs reflect patients;14;-1
bmj4_7_e004472.full;132 600  individuals;132600;-1
bmj4_7_e004472.full;4 million individuals;4;-1
bmj4_7_e004472.full;n=105;105;-1
bmj4_7_e004481.full;250 participants;250;-1
bmj4_7_e004481.full;13e participants;13;-1
bmj4_7_e004481.full;n=271;271;-1
bmj4_7_e004481.full;n=244;244;-1
bmj4_7_e004481.full;n=540;540;-1
bmj4_7_e004481.full;n=553;553;-1
bmj4_7_e004481.full;n=6;6;-1
bmj4_7_e004481.full;n=2;2;-1
bmj4_7_e004481.full;n=3;3;-1
bmj4_7_e004481.full;n=16;16;-1
bmj4_7_e004481.full;n=60;60;-1
bmj4_7_e004481.full;n=30;30;-1
bmj4_7_e004481.full;n=27;27;-1
bmj4_7_e004481.full;n=8;8;-1
bmj4_7_e004481.full;n=1;1;-1
bmj4_7_e004481.full;n=122;122;-1
bmj4_7_e004481.full;n=121;121;-1
bmj4_7_e004481.full;n=238;238;-1
bmj4_7_e004481.full;n=230;230;-1
bmj4_7_e004481.full;n=51;51;-1
bmj4_7_e004481.full;n=123;123;-1
bmj4_7_e004481.full;total of 1093;1093;-1
bmj4_7_e004576.full;1049 participants;1049;9493
bmj4_7_e004576.full;1130 patients;1130;9625
bmj4_7_e004576.full;20 955 patients;20955;648
bmj4_7_e004576.full;713  patients;713;457
bmj4_7_e004576.full;1800 patients;1800;383
bmj4_7_e004576.full;n=544;544;9581
bmj4_7_e004576.full;n=586;586;9551
bmj4_7_e004576.full;n=61;61;5664
bmj4_7_e004576.full;n=45;45;5634
bmj4_7_e004576.full;n=504;504;8491
bmj4_7_e004576.full;n=565;565;8528
bmj4_7_e004576.full;total  of 2400;2400;402
bmj4_7_e004581.full;631  patients;631;-1
bmj4_7_e004581.full;631 patients;631;-1
bmj4_7_e004581.full;total of 631;631;-1
bmj4_7_e004581.full;total of 606;606;-1
bmj4_7_e004592.full;15 476 nulliparous women;15476;-1
bmj4_7_e004592.full;56 517 women;56517;-1
bmj4_7_e004592.full;69 women;69;-1
bmj4_7_e004592.full;15 476 women;15476;-1
bmj4_7_e004592.full;1894 women;1894;-1
bmj4_7_e004592.full;320 000 people;320000;-1
bmj4_7_e004592.full;N=15 476;15476;-1
bmj4_7_e004592.full;N=14 463;14463;-1
bmj4_7_e004592.full;N=1013;1013;-1
bmj4_7_e004592.full;total of 1894;1894;-1
bmj4_7_e004607.full;416 participants;416;-1
bmj4_7_e004607.full;416 par-  ticipants were recruited;416;-1
bmj4_7_e004607.full;n=42;42;-1
bmj4_7_e004607.full;n=416;416;-1
bmj4_7_e004607.full;total of 597;597;-1
bmj4_7_e004677.full;191 more  specific subjects;191;-1
bmj4_7_e004677.full;total of 9178;9178;-1
bmj4_7_e004694.full;8707 patients;8707;-1
bmj4_7_e004694.full;100 consecutive consenting  patients;100;-1
bmj4_7_e004694.full;30  consecutive patients;30;-1
bmj4_7_e004694.full;30 patients;30;-1
bmj4_7_e004694.full;12 patients;12;-1
bmj4_7_e004694.full;2 Concordance of patients;2;-1
bmj4_7_e004694.full;10 and CIRS  Proportion of patients;10;-1
bmj4_7_e004694.full;2011 survey of  patients;2011;-1
bmj4_7_e004694.full;n=20;20;-1
bmj4_7_e004694.full;n=5777;5777;-1
bmj4_7_e004694.full;n=2930;2930;-1
bmj4_7_e004767.full;178 participants;178;-1
bmj4_7_e004767.full;12  Control subjects;12;-1
bmj4_7_e004767.full;total of 178;178;-1
bmj4_7_e004767.full; database of 657;657;-1
bmj4_7_e004777.full;n=539;539;-1
bmj4_7_e004777.full;n=129;129;-1
bmj4_7_e004777.full;n=124;124;-1
bmj4_7_e004777.full;total of 848;848;-1
bmj4_7_e004782.full;163 participants;163;30710
bmj4_7_e004782.full;50 patients;50;30627
bmj4_7_e004782.full;50  patients;50;25044
bmj4_7_e004782.full;n=10;10;23824
bmj4_7_e004782.full;N=163;163;18879
bmj4_7_e004782.full;N=60;60;18848
bmj4_7_e004782.full;N=53;53;18821
bmj4_7_e004782.full;N=50;50;18809
bmj4_7_e004782.full;n=50;50;14130
bmj4_7_e004782.full;n=113;113;14112
bmj4_7_e004782.full;n=99;99;14086
bmj4_7_e004782.full;n=64;64;14065
bmj4_7_e004782.full;n=103;103;5922
bmj4_7_e004782.full;n=60;60;5900
bmj4_7_e004782.full;total of 163;163;22016
bmj4_7_e004787.full;5 000 000 individuals;5000000;-1
bmj4_7_e004787.full; data from 2005;2005;-1
bmj4_7_e004843.full;559 consecutive patients;559;-1
bmj4_7_e004843.full;56 surgical patients;56;-1
bmj4_7_e004843.full;n=  27;27;-1
bmj4_7_e004843.full;n=  41;41;-1
bmj4_7_e004843.full;n=  53;53;-1
bmj4_7_e004843.full;n=  28;28;-1
bmj4_7_e004843.full;n  =8;8;-1
bmj4_7_e004843.full;n  =9;9;-1
bmj4_7_e004843.full;n=  44;44;-1
bmj4_7_e004843.full;n=  12;12;-1
bmj4_7_e004843.full;n=  31;31;-1
bmj4_7_e004843.full;n  =2;2;-1
bmj4_7_e004843.full;n  =7;7;-1
bmj4_7_e004843.full;n  =6;6;-1
bmj4_7_e004843.full;n=  17;17;-1
bmj4_7_e004843.full;n=  47;47;-1
bmj4_7_e004843.full;n=  54;54;-1
bmj4_7_e004843.full;n  =1;1;-1
bmj4_7_e004843.full;n=  34;34;-1
bmj4_7_e004843.full;n=  18;18;-1
bmj4_7_e004843.full;n=  33;33;-1
bmj4_7_e004843.full;n=  56;56;-1
bmj4_7_e004843.full;n=  61;61;-1
bmj4_7_e004843.full;n=  11;11;-1
bmj4_7_e004843.full;n=  57;57;-1
bmj4_7_e004843.full;n=  82;82;-1
bmj4_7_e004843.full;n=  19;19;-1
bmj4_7_e004843.full;n=  10;10;-1
bmj4_7_e004843.full;n=  83;83;-1
bmj4_7_e004843.full;n=  42;42;-1
bmj4_7_e004843.full;n  =3;3;-1
bmj4_7_e004843.full;n=  16;16;-1
bmj4_7_e004843.full;n  =5;5;-1
bmj4_7_e004856.full;n=8;8;-1
bmj4_7_e004856.full; data  from 1998;1998;-1
bmj4_7_e004875.full;525 women;525;-1
bmj4_7_e004875.full;73 114 women;73114;-1
bmj4_7_e004875.full;10 000 per family per year for women;10000;-1
bmj4_7_e004875.full;19 999  per family per year for women;19999;-1
bmj4_7_e004875.full;29 999 per family per year for women;29999;-1
bmj4_7_e004875.full;30 000 per family per year for women;30000;-1
bmj4_7_e004875.full;61 491  male participants;61491;-1
bmj4_7_e004875.full;74 941 female participants;74941;-1
bmj4_7_e004875.full;61 491 male participants;61491;-1
bmj4_7_e004875.full;2 diabetes mellitus patients;2;-1
bmj4_7_e004875.full;133 024  Chinese adults;133024;-1
bmj4_7_e004875.full;133 024 Chinese  adults;133024;-1
bmj4_7_e004875.full;140,000 adults;140000;-1
bmj4_7_e004875.full;024 Chinese adults;24;-1
bmj4_7_e004875.full;n=1598;1598;-1
bmj4_7_e004875.full;n=3;3;-1
bmj4_7_e004875.full;n=126;126;-1
bmj4_7_e004875.full;n=114;114;-1
bmj4_7_e004875.full;n=1458;1458;-1
bmj4_7_e004875.full;n=109;109;-1
bmj4_7_e004875.full;n=1;1;-1
bmj4_7_e004875.full;total of 59 910;59910;-1
bmj4_7_e004875.full;study population included 61 491;61491;-1
bmj4_7_e004880.full;14  participants;14;-1
bmj4_7_e004880.full;79 participants;79;-1
bmj4_7_e004880.full;n=15;15;-1
bmj4_7_e004880.full;n=12;12;-1
bmj4_7_e004899.full;581 women;581;-1
bmj4_7_e004899.full;21,828 British men and women;21828;-1
bmj4_7_e004899.full;986 individuals;986;-1
bmj4_7_e004899.full;n=135;135;-1
bmj4_7_e004899.full;n=106;106;-1
bmj4_7_e004899.full;n=13;13;-1
bmj4_7_e004909.full;428 293 young people;428293;-1
bmj4_7_e004909.full;total of  428 293;428293;-1
bmj4_7_e004909.full; data  from 134;134;-1
bmj4_7_e004916.full;n=9;9;-1
bmj4_7_e004916.full;n  =9;9;-1
bmj4_7_e004916.full;n  =7;7;-1
bmj4_7_e004916.full;n  =1;1;-1
bmj4_7_e004916.full;total of 2036;2036;-1
bmj4_7_e004916.full;total of 3016;3016;-1
bmj4_7_e004916.full;total of 110;110;-1
bmj4_7_e004916.full;total  of 11;11;-1
bmj4_7_e004919.full;31 715 there will be no  people;31715;-1
bmj4_7_e004919.full;n=143;143;-1
bmj4_7_e004919.full;n=140;140;-1
bmj4_7_e004919.full;n=136;136;-1
bmj4_7_e004936.full;3 compared patients;3;-1
bmj4_7_e004936.full;266 patients;266;-1
bmj4_7_e004936.full;n=266;266;-1
bmj4_7_e004936.full;n=489;489;-1
bmj4_7_e004936.full;total of 30;30;-1
bmj4_7_e004948.full;152 participants;152;5406
bmj4_7_e004948.full;71 participants;71;3162
bmj4_7_e004948.full;55 patients;55;12677
bmj4_7_e004948.full;5 An  understanding of patients;5;11831
bmj4_7_e004948.full;717 patients;717;9374
bmj4_7_e004948.full;247 patients;247;9317
bmj4_7_e004948.full;71 patients;71;3060
bmj4_7_e004948.full;29 patients;29;1931
bmj4_7_e004948.full;20 patients;20;1887
bmj4_7_e004948.full;103 outpatients;103;15044
bmj4_7_e004948.full;N=71;71;9453
bmj4_7_e004948.full;n=44;44;2770
bmj4_7_e004948.full;n=15;15;2315
bmj4_7_e004948.full;n=9;9;2293
bmj4_7_e004948.full;n=6;6;2271
bmj4_7_e004948.full;N = 55;55;3580
bmj4_7_e004978.full;790 persons;790;-1
bmj4_7_e004978.full;48 patients;48;-1
bmj4_7_e004978.full;4 people;4;-1
bmj4_7_e004978.full;1 First Nations  people;1;-1
bmj4_7_e004978.full;13 735 people;13735;-1
bmj4_7_e004978.full;554 First Nations adults;554;-1
bmj4_7_e004978.full;500 First Nations adults;500;-1
bmj4_7_e004978.full;554 adults;554;-1
bmj4_7_e004978.full;47 For First  Nations adults;47;-1
bmj4_7_e004978.full;790 persons were recruited;790;-1
bmj4_7_e004978.full;N=725;725;-1
bmj4_7_e004978.full;n=554;554;-1
bmj4_7_e004978.full;N=554;554;-1
bmj4_7_e004978.full;N=536 253;536253;-1
bmj4_7_e004978.full;N=1 324 241;1324241;-1
bmj4_7_e004978.full;N=514;514;-1
bmj4_7_e004978.full;N=360 378;360378;-1
bmj4_7_e004978.full;N=901 509;901509;-1
bmj4_7_e004978.full;total of 790;790;-1
bmj4_7_e004984.full;218 matched patients;218;-1
bmj4_7_e004984.full;297 patients;297;-1
bmj4_7_e004984.full;549 patients;549;-1
bmj4_7_e004984.full;726 patients;726;-1
bmj4_7_e004984.full;428 patients;428;-1
bmj4_7_e004984.full;218 pairs of patients;218;-1
bmj4_7_e004984.full;1256 patients;1256;-1
bmj4_7_e004984.full;5 million people;5;-1
bmj4_7_e004984.full;N=218;218;-1
bmj4_7_e004984.full;total of 218;218;-1
bmj4_7_e004998.full;419 eligible and registered participants;419;-1
bmj4_7_e004998.full;200 outpatients;200;-1
bmj4_7_e004998.full;413 patients;413;-1
bmj4_7_e004998.full;n=419;419;-1
bmj4_7_e004998.full;n=103;103;-1
bmj4_7_e004998.full;n=26;26;-1
bmj4_7_e004998.full;n=22;22;-1
bmj4_7_e004998.full;n=13;13;-1
bmj4_7_e004998.full;n=166;166;-1
bmj4_7_e004998.full;N=419;419;-1
bmj4_7_e004998.full;N=413;413;-1
bmj4_7_e004998.full; data from 413;413;-1
bmj4_7_e005005.full;79 patients;79;9120
bmj4_7_e005005.full;76  Proportion of patients;76;12196
bmj4_7_e005005.full;n=53;53;2962
bmj4_7_e005005.full;n=26;26;3046
bmj4_7_e005015.full;5747  patients;5747;-1
bmj4_7_e005015.full;100 patients;100;-1
bmj4_7_e005015.full;597 patients;597;-1
bmj4_7_e005028.full;16 participants;16;-1
bmj4_7_e005028.full;n=16;16;-1
bmj4_7_e005030.full;24 Pregnant women;24;-1
bmj4_7_e005030.full;n=2354;2354;-1
bmj4_7_e005030.full;n=0;0;-1
bmj4_7_e005033.full;294 participants;294;-1
bmj4_7_e005033.full;294 patients;294;-1
bmj4_7_e005033.full;294  transplanted patients;294;-1
bmj4_7_e005033.full;45  non-transplanted patients;45;-1
bmj4_7_e005033.full;256  transplanted patients;256;-1
bmj4_7_e005033.full;83  patients;83;-1
bmj4_7_e005033.full;294 trans-  planted patients;294;-1
bmj4_7_e005033.full;142  patients;142;-1
bmj4_7_e005033.full;17 remaining patients;17;-1
bmj4_7_e005033.full;45 patients;45;-1
bmj4_7_e005033.full;137 evaluated patients;137;-1
bmj4_7_e005033.full;157 patients;157;-1
bmj4_7_e005033.full;12 remaining patients;12;-1
bmj4_7_e005033.full;38 transplanted patients;38;-1
bmj4_7_e005033.full;54 transplanted patients;54;-1
bmj4_7_e005033.full;83 patients;83;-1
bmj4_7_e005033.full;N=109;109;-1
bmj4_7_e005033.full;N=61;61;-1
bmj4_7_e005033.full;N=31;31;-1
bmj4_7_e005033.full;N=17;17;-1
bmj4_7_e005033.full;N=13;13;-1
bmj4_7_e005033.full;N=2;2;-1
bmj4_7_e005033.full;N=1;1;-1
bmj4_7_e005033.full;N=8;8;-1
bmj4_7_e005033.full;N=5;5;-1
bmj4_7_e005033.full;total of 83;83;-1
bmj4_7_e005066.full;n=356;356;-1
bmj4_7_e005066.full;n=923;923;-1
bmj4_7_e005066.full;n=3992;3992;-1
bmj4_7_e005066.full;n=567;567;-1
bmj4_7_e005069.full;34 We also report  women;34;-1
bmj4_7_e005069.full;0 million participants;0;-1
bmj4_7_e005069.full;1199 patients;1199;-1
bmj4_7_e005069.full;367 patients;367;-1
bmj4_7_e005069.full;5328 patients;5328;-1
bmj4_7_e005069.full;2185 patients;2185;-1
bmj4_7_e005069.full;1199  patients;1199;-1
bmj4_7_e005069.full;2  ambulatory patients;2;-1
bmj4_7_e005069.full;n=380;380;-1
bmj4_7_e005069.full;n=19;19;-1
bmj4_7_e005069.full;n=26;26;-1
bmj4_7_e005069.full;n=83;83;-1
bmj4_7_e005069.full;n=239;239;-1
bmj4_7_e005069.full;n=678;678;-1
bmj4_7_e005069.full;n=521;521;-1
bmj4_7_e005069.full;n=461;461;-1
bmj4_7_e005069.full;n=178;178;-1
bmj4_7_e005069.full;n=157;157;-1
bmj4_7_e005069.full;n=92;92;-1
bmj4_7_e005069.full;n=63;63;-1
bmj4_7_e005069.full;n=27;27;-1
bmj4_7_e005069.full;n=133;133;-1
bmj4_7_e005069.full;n=1199;1199;-1
bmj4_7_e005069.full;n=367;367;-1
bmj4_7_e005069.full;total of 1199;1199;-1
bmj4_7_e005070.full;691 women;691;-1
bmj4_7_e005070.full;1888 individuals;1888;-1
bmj4_7_e005070.full;1991 individuals;1991;-1
bmj4_7_e005070.full;n=1888;1888;-1
bmj4_7_e005070.full;n=1197;1197;-1
bmj4_7_e005070.full;n=691;691;-1
bmj4_7_e005070.full;total of 1888;1888;-1
bmj4_7_e005070.full;total of 1991;1991;-1
bmj4_7_e005075.full;N=2;2;-1
bmj4_7_e005075.full;n=1232;1232;-1
bmj4_7_e005075.full;n  =1;1;-1
bmj4_7_e005075.full;n=1130;1130;-1
bmj4_7_e005075.full;n=1074;1074;-1
bmj4_7_e005075.full;total of 1281;1281;-1
bmj4_7_e005077.full;264  women;264;-1
bmj4_7_e005077.full;379 women;379;-1
bmj4_7_e005077.full;742  participants;742;-1
bmj4_7_e005077.full;5292 patients;5292;-1
bmj4_7_e005077.full;908 patients;908;-1
bmj4_7_e005077.full;948 patients;948;-1
bmj4_7_e005077.full;1 It is not known why some patients;1;-1
bmj4_7_e005077.full;5292 consecutive patients;5292;-1
bmj4_7_e005077.full;908 eligible  patients;908;-1
bmj4_7_e005077.full;527 patients;527;-1
bmj4_7_e005077.full;908 eligible patients;908;-1
bmj4_7_e005077.full;948 eligible  patients;948;-1
bmj4_7_e005077.full;46 patients;46;-1
bmj4_7_e005077.full;1136 patients;1136;-1
bmj4_7_e005077.full;46 of the patients;46;-1
bmj4_7_e005077.full;93 416 consecutive patients;93416;-1
bmj4_7_e005089.full;985 were women;985;-1
bmj4_7_e005089.full;42 participants;42;-1
bmj4_7_e005089.full;2184  participants;2184;-1
bmj4_7_e005089.full;2184 participants;2184;-1
bmj4_7_e005089.full;2061 participants;2061;-1
bmj4_7_e005089.full;2184 randomly selected adults;2184;-1
bmj4_7_e005089.full;n=2061;2061;-1
bmj4_7_e005089.full;n=1076;1076;-1
bmj4_7_e005089.full;n=985;985;-1
bmj4_7_e005089.full;total of 140;140;-1
bmj4_7_e005089.full;total of 2061;2061;-1
bmj4_7_e005090.full;n=15;15;-1
bmj4_7_e005090.full;n=8;8;-1
bmj4_7_e005090.full;n=17;17;-1
bmj4_7_e005090.full;total of 341;341;-1
bmj4_7_e005090.full;total of 29;29;-1
bmj4_7_e005092.full;76  people;76;-1
bmj4_7_e005092.full;152 people;152;-1
bmj4_7_e005094.full;610 patients;610;-1
bmj4_7_e005103.full;7 A recent study of persons;7;-1
bmj4_7_e005103.full;1003  persons;1003;-1
bmj4_7_e005103.full;27 Randomly selected  individuals;27;-1
bmj4_7_e005103.full;118 000 working adults;118000;-1
bmj4_7_e005103.full;n=6979;6979;-1
bmj4_7_e005103.full;n=25 167;25167;-1
bmj4_7_e005103.full;n=56 634;56634;-1
bmj4_7_e005103.full;n=34 707;34707;-1
bmj4_7_e005103.full;n=1212;1212;-1
bmj4_7_e005103.full;n=3789;3789;-1
bmj4_7_e005103.full;n=5358;5358;-1
bmj4_7_e005103.full;n=1003;1003;-1
bmj4_7_e005103.full;n=518;518;-1
bmj4_7_e005103.full;n=100;100;-1
bmj4_7_e005103.full;n=4260;4260;-1
bmj4_7_e005103.full;n=4006;4006;-1
bmj4_7_e005103.full;total of 25 167;25167;-1
bmj4_7_e005108.full;N=749;749;-1
bmj4_7_e005108.full;N=664;664;-1
bmj4_7_e005108.full;N=244;244;-1
bmj4_7_e005108.full;total of 1601;1601;-1
bmj4_7_e005108.full; data from  2008;2008;-1
bmj4_7_e005122.full;928 participants;928;-1
bmj4_7_e005122.full;85 participants;85;-1
bmj4_7_e005122.full;34  participants;34;-1
bmj4_7_e005122.full;13 patients;13;-1
bmj4_7_e005122.full;248  patients;248;-1
bmj4_7_e005122.full;610 general practice patients;610;-1
bmj4_7_e005122.full;N=726;726;-1
bmj4_7_e005122.full;N=220;220;-1
bmj4_7_e005122.full;N=102;102;-1
bmj4_7_e005122.full;N=326;326;-1
bmj4_7_e005122.full;N=78;78;-1
bmj4_7_e005122.full;N=202;202;-1
bmj4_7_e005122.full;N=610;610;-1
bmj4_7_e005122.full;N  =7;7;-1
bmj4_7_e005122.full;N  =6;6;-1
bmj4_7_e005122.full;928 participants  were enrolled;928;-1
bmj4_7_e005122.full;928 participants  enrolled;928;-1
bmj4_7_e005142.full;1400 pairs of  pregnant women;1400;-1
bmj4_7_e005142.full;1512 participants;1512;-1
bmj4_7_e005142.full;15 140 participants;15140;-1
bmj4_7_e005142.full;15 140 eligible people;15140;-1
bmj4_7_e005142.full;18 318 individuals;18318;-1
bmj4_7_e005142.full;n=5500;5500;-1
bmj4_7_e005142.full;n=16 691;16691;-1
bmj4_7_e005142.full;n=5442;5442;-1
bmj4_7_e005142.full;n=5588;5588;-1
bmj4_7_e005142.full;n=3566;3566;-1
bmj4_7_e005142.full;n=15 140;15140;-1
bmj4_7_e005142.full;n=14 016;14016;-1
bmj4_7_e005142.full;n=12 807;12807;-1
bmj4_7_e005142.full;n=12 746;12746;-1
bmj4_7_e005142.full;n=5026;5026;-1
bmj4_7_e005142.full;n=4645;4645;-1
bmj4_7_e005142.full;n=4272;4272;-1
bmj4_7_e005142.full;n=4266;4266;-1
bmj4_7_e005142.full;n=3342;3342;-1
bmj4_7_e005142.full;n=3117;3117;-1
bmj4_7_e005142.full;n=2747;2747;-1
bmj4_7_e005142.full;n=2710;2710;-1
bmj4_7_e005142.full;n=5160;5160;-1
bmj4_7_e005142.full;n=4775;4775;-1
bmj4_7_e005142.full;n=4202;4202;-1
bmj4_7_e005142.full;n=4185;4185;-1
bmj4_7_e005142.full;n=1785;1785;-1
bmj4_7_e005142.full;n=1627;1627;-1
bmj4_7_e005142.full;n=1472;1472;-1
bmj4_7_e005142.full;n=1465;1465;-1
bmj4_7_e005142.full;total of 15 140;15140;-1
bmj4_7_e005158.full;32 participants;32;-1
bmj4_7_e005158.full;75 patients;75;-1
bmj4_7_e005158.full;8 patients;8;-1
bmj4_7_e005158.full;32 patients;32;-1
bmj4_7_e005158.full;18 patients;18;-1
bmj4_7_e005158.full;14  patients;14;-1
bmj4_7_e005158.full;14 patients;14;-1
bmj4_7_e005158.full;12 patients;12;-1
bmj4_7_e005158.full;18  patients;18;-1
bmj4_7_e005158.full;n=42;42;-1
bmj4_7_e005158.full;n=3;3;-1
bmj4_7_e005158.full;n=9;9;-1
bmj4_7_e005158.full;n  =3;3;-1
bmj4_7_e005158.full;n  =1;1;-1
bmj4_7_e005158.full;n  =6;6;-1
bmj4_7_e005158.full;n  =9;9;-1
bmj4_7_e005158.full;n  =5;5;-1
bmj4_7_e005158.full;32 were enrolled;32;-1
bmj4_7_e005165.full;866  participants;866;-1
bmj4_7_e005165.full;866 participants;866;-1
bmj4_7_e005165.full;n=2;2;-1
bmj4_7_e005165.full;n = 2;2;-1
bmj4_7_e005165.full;n=575;575;-1
bmj4_7_e005165.full;n=364;364;-1
bmj4_7_e005165.full;n=181;181;-1
bmj4_7_e005165.full;n=30;30;-1
bmj4_7_e005165.full;n=862;862;-1
bmj4_7_e005165.full;n=540;540;-1
bmj4_7_e005165.full;n=282;282;-1
bmj4_7_e005165.full;n=40;40;-1
bmj4_7_e005183.full;2500 women;2500;-1
bmj4_7_e005183.full;80 000  participants;80000;-1
bmj4_7_e005183.full;n=78 008;78008;-1
bmj4_7_e005183.full;n=78 720;78720;-1
bmj4_7_e005183.full;n=78 924;78924;-1
bmj4_7_e005183.full;n=78 388;78388;-1
bmj4_7_e005183.full;n=77 979;77979;-1
bmj4_7_e005183.full;n=79 701;79701;-1
bmj4_7_e005183.full;n=65 482;65482;-1
bmj4_7_e005183.full;n=76 450;76450;-1
bmj4_7_e005183.full;n=77 698;77698;-1
bmj4_7_e005183.full;n=5143;5143;-1
bmj4_7_e005183.full;n=72 865;72865;-1
bmj4_7_e005183.full;n=38 783;38783;-1
bmj4_7_e005183.full;n=36 063;36063;-1
bmj4_7_e005183.full;n=2720;2720;-1
bmj4_7_e005183.full;n=30 549;30549;-1
bmj4_7_e005183.full;n=28 665;28665;-1
bmj4_7_e005183.full;n=1884;1884;-1
bmj4_7_e005183.full;n=68 606;68606;-1
bmj4_7_e005183.full;n=64 148;64148;-1
bmj4_7_e005183.full;n=4458;4458;-1
bmj4_7_e005183.full;n=74 931;74931;-1
bmj4_7_e005183.full;n=69 960;69960;-1
bmj4_7_e005183.full;n=4971;4971;-1
bmj4_7_e005183.full;n=55 530;55530;-1
bmj4_7_e005183.full;n=52 387;52387;-1
bmj4_7_e005183.full;n=3143;3143;-1
bmj4_7_e005183.full;n=28 163;28163;-1
bmj4_7_e005183.full;n=265 569;265569;-1
bmj4_7_e005183.full;n=1594;1594;-1
bmj4_7_e005183.full;n=48 516;48516;-1
bmj4_7_e005183.full;n=45 770;45770;-1
bmj4_7_e005183.full;n=2746;2746;-1
bmj4_7_e005183.full; data of  79 701;79701;-1
bmj4_7_e005196.full;2764 patients;2764;-1
bmj4_7_e005196.full;13 293 for patients;13293;-1
bmj4_7_e005196.full;59 606 310 900 252 858 100 431  Total for all patients;5,96063E+22;-1
bmj4_7_e005196.full;n=2674;2674;-1
bmj4_7_e005196.full;n=1457;1457;-1
bmj4_7_e005196.full;n=1217;1217;-1
bmj4_7_e005196.full;n=1170;1170;-1
bmj4_7_e005196.full;n=149;149;-1
bmj4_7_e005196.full;n=138;138;-1
bmj4_7_e005196.full;n=2764;2764;-1
bmj4_7_e005196.full;n=12;12;-1
bmj4_7_e005196.full;n=8;8;-1
bmj4_7_e005196.full;n=1;1;-1
bmj4_7_e005196.full;n=22;22;-1
bmj4_7_e005196.full;total of 2764;2764;-1
bmj4_7_e005196.full;total of 18;18;-1
bmj4_7_e005199.full;4 million adults;4;-1
bmj4_7_e005199.full;total of  15 555;15555;-1
bmj4_7_e005199.full; data came from the 2010;2010;-1
bmj4_7_e005199.full; data from 192;192;-1
bmj4_7_e005202.full;350 000 cancer patients;350000;-1
bmj4_7_e005217.full;1129 registered patients;1129;-1
bmj4_7_e005217.full;1000 patients;1000;-1
bmj4_7_e005217.full;420 000 adults;420000;-1
bmj4_7_e005217.full;n=215;215;-1
bmj4_7_e005217.full; data from 2012;2012;-1
bmj4_7_e005234.full;N=90;90;-1
bmj4_7_e005234.full;n=16;16;-1
bmj4_7_e005234.full;n=90;90;-1
bmj4_7_e005244.full;10  participants;10;-1
bmj4_7_e005244.full;27  Study populations were patients;27;-1
bmj4_7_e005244.full;232  patients;232;-1
bmj4_7_e005244.full;32 patients;32;-1
bmj4_7_e005244.full;n=22;22;-1
bmj4_7_e005244.full;n=67;67;-1
bmj4_7_e005244.full;n=162;162;-1
bmj4_7_e005244.full;n=34;34;-1
bmj4_7_e005244.full;n=97;97;-1
bmj4_7_e005244.full;n=7;7;-1
bmj4_7_e005244.full;n=8;8;-1
bmj4_7_e005244.full;n=4;4;-1
bmj4_7_e005244.full;n=3;3;-1
bmj4_7_e005244.full;n=44;44;-1
bmj4_7_e005244.full;n=18;18;-1
bmj4_7_e005244.full;n=1795;1795;-1
bmj4_7_e005244.full;n=232;232;-1
bmj4_7_e005244.full;n=269;269;-1
bmj4_7_e005244.full;n=183;183;-1
bmj4_7_e005244.full;n=32;32;-1
bmj4_7_e005244.full;n=110;110;-1
bmj4_7_e005244.full;n=81;81;-1
bmj4_7_e005244.full;n=26;26;-1
bmj4_7_e005244.full;n  =7;7;-1
bmj4_7_e005244.full;n  =3;3;-1
bmj4_7_e005244.full;n  =5;5;-1
bmj4_7_e005244.full;n  =2;2;-1
bmj4_7_e005244.full;n  =1;1;-1
bmj4_7_e005244.full;n  =6;6;-1
bmj4_7_e005244.full;n  =8;8;-1
bmj4_7_e005244.full;n  =4;4;-1
bmj4_7_e005244.full;n  =  42;42;-1
bmj4_7_e005244.full;n  =  47;47;-1
bmj4_7_e005244.full;n=1;1;-1
bmj4_7_e005244.full;n=  83;83;-1
bmj4_7_e005244.full;n=  14;14;-1
bmj4_7_e005244.full;n=91 378;91378;-1
bmj4_7_e005244.full;n=5;5;-1
bmj4_7_e005244.full;n=19;19;-1
bmj4_7_e005244.full;n=15;15;-1
bmj4_7_e005244.full;n=6;6;-1
bmj4_7_e005244.full;n=12;12;-1
bmj4_7_e005244.full;n=222;222;-1
bmj4_7_e005244.full;total of 293;293;-1
bmj4_7_e005244.full;total of 22;22;-1
bmj4_7_e005244.full;total of 1300;1300;-1
bmj4_7_e005245.full;380 395 men and women;380395;-1
bmj4_7_e005245.full;101 935 male study participants;101935;-1
bmj4_7_e005245.full;521 448 individuals;521448;-1
bmj4_7_e005245.full;151 000 adults;151000;-1
bmj4_7_e005245.full;n=118 082;118082;-1
bmj4_7_e005245.full;n=928;928;-1
bmj4_7_e005245.full;n=11 411;11411;-1
bmj4_7_e005245.full;n=7592;7592;-1
bmj4_7_e005245.full;n=5266;5266;-1
bmj4_7_e005245.full;n=3246;3246;-1
bmj4_7_e005245.full;n=30 665;30665;-1
bmj4_7_e005245.full;n=8819;8819;-1
bmj4_7_e005245.full;n=39 041;39041;-1
bmj4_7_e005245.full;n=14 223;14223;-1
bmj4_7_e005245.full;n=328;328;-1
bmj4_7_e005245.full;n=6482;6482;-1
bmj4_7_e005245.full;n=25 146;25146;-1
bmj4_7_e005245.full;n=112 281;112281;-1
bmj4_7_e005245.full;n=6042;6042;-1
bmj4_7_e005245.full;n=1600;1600;-1
bmj4_7_e005245.full;n=14 287;14287;-1
bmj4_7_e005245.full;n=29 124;29124;-1
bmj4_7_e005245.full;n=0;0;-1
bmj4_7_e005245.full;total of 20 453;20453;-1
bmj4_7_e005246.full;225 patients;225;5085
bmj4_7_e005246.full;250 patients;250;3420
bmj4_7_e005246.full;108 patients;108;1807
bmj4_7_e005246.full;147 patients;147;14197
bmj4_7_e005246.full;n=108;108;4771
bmj4_7_e005246.full;n=117;117;4732
bmj4_7_e005246.full;n=119;119;2041
bmj4_7_e005246.full;n=131;131;2001
bmj4_7_e005246.full;n=28;28;4030
bmj4_7_e005246.full;n=80;80;4053
bmj4_7_e005246.full;n=46;46;4080
bmj4_7_e005246.full;n=71;71;4103
bmj4_7_e005246.full;n=97;97;5967
bmj4_7_e005246.full;n=100;100;5986
bmj4_7_e005248.full;80 patients;80;-1
bmj4_7_e005248.full;n=24;24;-1
bmj4_7_e005248.full;n=32;32;-1
bmj4_7_e005248.full; data of 227;227;-1
bmj4_7_e005269.full;35 and women;35;1765
bmj4_7_e005269.full;3822 participants;3822;8193
bmj4_7_e005269.full;1274  patients;1274;8174
bmj4_7_e005269.full;3822 adult patients;3822;1214
bmj4_7_e005269.full;57 million people;57;6840
bmj4_7_e005269.full;100 000 people;100000;6646
bmj4_7_e005269.full;N=1274;1274;3647
bmj4_7_e005269.full;N=2548;2548;3685
bmj4_7_e005269.full;total of 3822;3822;8202
bmj4_7_e005270.full;52 patients;52;-1
bmj4_7_e005270.full;18 patients;18;-1
bmj4_7_e005270.full;60 patients;60;-1
bmj4_7_e005270.full;527 patients;527;-1
bmj4_7_e005270.full;2165 patients;2165;-1
bmj4_7_e005270.full;n=24;24;-1
bmj4_7_e005270.full;n=28;28;-1
bmj4_7_e005270.full;n=15;15;-1
bmj4_7_e005270.full;n=0;0;-1
bmj4_7_e005270.full;n=1;1;-1
bmj4_7_e005270.full;n=12;12;-1
bmj4_7_e005270.full;n=11;11;-1
bmj4_7_e005270.full;n=14;14;-1
bmj4_7_e005270.full;n=7;7;-1
bmj4_7_e005270.full;n=5;5;-1
bmj4_7_e005270.full;n=23;23;-1
bmj4_7_e005270.full;n=25;25;-1
bmj4_7_e005270.full;total of 78;78;-1
bmj4_7_e005286.full;20 participants;20;-1
bmj4_7_e005286.full;80  participants;80;-1
bmj4_7_e005286.full;400 patients;400;-1
bmj4_7_e005286.full;80 patients;80;-1
bmj4_7_e005286.full;8  and patients;8;-1
bmj4_7_e005286.full;2,212 newly  diagnosed cancer patients;2212;-1
bmj4_7_e005286.full;10,297 patients;10297;-1
bmj4_7_e005290.full;527 women;527;26206
bmj4_7_e005290.full;495 women;495;26113
bmj4_7_e005290.full;495  women;495;9584
bmj4_7_e005290.full;266 women;266;9398
bmj4_7_e005290.full;243  women;243;9367
bmj4_7_e005290.full;243 women;243;4769
bmj4_7_e005290.full;266  women;266;4691
bmj4_7_e005290.full;n=243;243;4591
bmj4_7_e005290.full;n=266;266;4570
bmj4_7_e005292.full;30 participants;30;-1
bmj4_7_e005292.full;6  patients;6;-1
bmj4_7_e005292.full;437 patients;437;-1
bmj4_7_e005292.full;271 patients;271;-1
bmj4_7_e005292.full;7 patients;7;-1
bmj4_7_e005292.full;189 patients;189;-1
bmj4_7_e005292.full;177 patients;177;-1
bmj4_7_e005292.full;392 patients;392;-1
bmj4_7_e005292.full;60 patients;60;-1
bmj4_7_e005292.full;3 Proportions of patients;3;-1
bmj4_7_e005292.full;5 Proportions of patients;5;-1
bmj4_7_e005292.full;n=136;136;-1
bmj4_7_e005292.full;n=154;154;-1
bmj4_7_e005292.full;n=147;147;-1
bmj4_7_e005292.full;n=92;92;-1
bmj4_7_e005292.full;n=91;91;-1
bmj4_7_e005292.full;n=88;88;-1
bmj4_7_e005292.full;n=114;114;-1
bmj4_7_e005292.full;n=73;73;-1
bmj4_7_e005292.full;n=103;103;-1
bmj4_7_e005292.full;n=71;71;-1
bmj4_7_e005292.full;n=132;132;-1
bmj4_7_e005292.full;n=130;130;-1
bmj4_7_e005292.full;n=30;30;-1
bmj4_7_e005292.full;n  =8;8;-1
bmj4_7_e005292.full;n  =7;7;-1
bmj4_7_e005292.full;n=  49;49;-1
bmj4_7_e005292.full;n=  48;48;-1
bmj4_7_e005292.full;n=  16;16;-1
bmj4_7_e005292.full;n=  15;15;-1
bmj4_7_e005292.full;n=  24;24;-1
bmj4_7_e005304.full;10  since people;10;-1
bmj4_7_e005304.full;800 individuals;800;-1
bmj4_7_e005304.full;44 Therefore individuals;44;-1
bmj4_7_e005304.full;total of 389;389;-1
bmj4_7_e005305.full;9327 active patients;9327;-1
bmj4_7_e005305.full;14 969  active patients;14969;-1
bmj4_7_e005305.full;1564 patients;1564;-1
bmj4_7_e005305.full;9327  patients;9327;-1
bmj4_7_e005305.full;12 271 patients;12271;-1
bmj4_7_e005305.full;400 people;400;-1
bmj4_7_e005305.full;10 707 people;10707;-1
bmj4_7_e005305.full;n=9327;9327;-1
bmj4_7_e005305.full;n=4056;4056;-1
bmj4_7_e005305.full;total of 9;9;-1
bmj4_7_e005311.full;23 Older adults;23;-1
bmj4_7_e005318.full;40 participants;40;-1
bmj4_7_e005318.full;n=19;19;-1
bmj4_7_e005318.full;n=20;20;-1
bmj4_7_e005318.full;n=3;3;-1
bmj4_7_e005328.full;N=303;303;-1
bmj4_7_e005328.full;N=547;547;-1
bmj4_7_e005328.full;n=42;42;-1
bmj4_7_e005328.full;n=505;505;-1
bmj4_7_e005330.full;194 adult patients;194;-1
bmj4_7_e005330.full;736 con-  secutive adult patients;736;-1
bmj4_7_e005330.full;10 All patients;10;-1
bmj4_7_e005330.full;217 consecutive patients;217;-1
bmj4_7_e005330.full;194 patients;194;-1
bmj4_7_e005330.full;94 elective ICU patients;94;-1
bmj4_7_e005330.full;26 patients;26;-1
bmj4_7_e005330.full;137 patients;137;-1
bmj4_7_e005330.full;23 Our patients;23;-1
bmj4_7_e005330.full;17 For those patients;17;-1
bmj4_7_e005330.full;625 patients;625;-1
bmj4_7_e005330.full;736 consecutive adults;736;-1
bmj4_7_e005330.full;n=5;5;-1
bmj4_7_e005330.full;n=3;3;-1
bmj4_7_e005330.full;n=2;2;-1
bmj4_7_e005330.full;n=1;1;-1
bmj4_7_e005330.full;n=25;25;-1
bmj4_7_e005330.full;n=169;169;-1
bmj4_7_e005354.full;28,613 elderly women;28613;-1
bmj4_7_e005354.full;15 Recruited patients;15;-1
bmj4_7_e005354.full;16  Allopurinol washout  Once patients;16;-1
bmj4_7_e005354.full;2282 patients;2282;-1
bmj4_7_e005354.full;5706 patients;5706;-1
bmj4_7_e005354.full;2853 patients;2853;-1
bmj4_7_e005354.full;total of 456;456;-1
bmj4_7_e005354.full;total of 5706;5706;-1
bmj4_7_e005361.full;25 Included participants;25;-1
bmj4_7_e005361.full;177 participants;177;-1
bmj4_7_e005361.full;177 patients;177;-1
bmj4_7_e005361.full;1800 patients;1800;-1
bmj4_7_e005361.full;189 patients;189;-1
bmj4_7_e005361.full;n=177;177;-1
bmj4_7_e005361.full;n=75;75;-1
bmj4_7_e005361.full;n=35;35;-1
bmj4_7_e005361.full;n=67;67;-1
bmj4_7_e005361.full;total of 189;189;-1
bmj4_7_e005368.full;33 grouped participants;33;-1
bmj4_7_e005368.full;64 subjects;64;-1
bmj4_7_e005368.full;452 patients;452;-1
bmj4_7_e005368.full;64 patients;64;-1
bmj4_7_e005368.full;57 patients;57;-1
bmj4_7_e005368.full;total of 452;452;-1
bmj4_7_e005377.full;103 657 patients;103657;-1
bmj4_7_e005377.full;204 733 patients;204733;-1
bmj4_7_e005377.full;103 657  eligible patients;103657;-1
bmj4_7_e005377.full;13 million individuals;13;-1
bmj4_7_e005377.full;N=89 729;89729;-1
bmj4_7_e005377.full;N=204 733;204733;-1
bmj4_7_e005377.full;N=103 657;103657;-1
bmj4_7_e005381.full;219 patients;219;-1
bmj4_7_e005381.full;139 patients;139;-1
bmj4_7_e005381.full;309 patients;309;-1
bmj4_7_e005381.full;2 Distribution of the patients;2;-1
bmj4_7_e005381.full;916 patients;916;-1
bmj4_7_e005381.full;12 815 patients;12815;-1
bmj4_7_e005381.full;500 patients;500;-1
bmj4_7_e005381.full;n=122;122;-1
bmj4_7_e005381.full;n=9;9;-1
bmj4_7_e005381.full;n=69;69;-1
bmj4_7_e005381.full;N=219;219;-1
bmj4_7_e005381.full;N=143;143;-1
bmj4_7_e005381.full;N=37;37;-1
bmj4_7_e005381.full;N=39;39;-1
bmj4_7_e005381.full;total of 219;219;-1
bmj4_7_e005381.full;total of 309;309;-1
bmj4_7_e005381.full;total of  286;286;-1
bmj4_7_e005388.full;n=9195;9195;-1
bmj4_7_e005388.full;n=51;51;-1
bmj4_7_e005388.full; data from  1987;1987;-1
bmj4_7_e005388.full; data from 1985;1985;-1
bmj4_7_e005393.full;1 billion people;1;-1
bmj4_7_e005393.full;730 individuals;730;-1
bmj4_7_e005393.full;730  individuals;730;-1
bmj4_7_e005393.full;n=48;48;-1
bmj4_7_e005393.full;n=169;169;-1
bmj4_7_e005393.full;n=528;528;-1
bmj4_7_e005393.full;n=242;242;-1
bmj4_7_e005393.full;n=4;4;-1
bmj4_7_e005393.full;n=119;119;-1
bmj4_7_e005393.full;n=394;394;-1
bmj4_7_e005397.full;100 persons;100;-1
bmj4_7_e005397.full;100  persons;100;-1
bmj4_7_e005397.full;314 million people;314;-1
bmj4_7_e005397.full;212 million people;212;-1
bmj4_7_e005397.full;total of 23;23;-1
bmj4_7_e005408.full;10 000 people;10000;-1
bmj4_7_e005408.full;47 750 people;47750;-1
bmj4_7_e005408.full;51 094 people;51094;-1
bmj4_7_e005408.full;n=4243;4243;-1
bmj4_7_e005408.full;N=9;9;-1
bmj4_7_e005408.full;N=3;3;-1
bmj4_7_e005408.full;N=12;12;-1
bmj4_7_e005408.full;N=11;11;-1
bmj4_7_e005408.full;N=154;154;-1
bmj4_7_e005408.full;total of 191;191;-1
bmj4_7_e005408.full;total of 47 750;47750;-1
bmj4_7_e005408.full;total of 51 094;51094;-1
bmj4_7_e005408.full;total of 25;25;-1
bmj4_7_e005412.full;12 583 non-pregnant women;12583;-1
bmj4_7_e005412.full;n=2;2;-1
bmj4_7_e005412.full;n=6;6;-1
bmj4_7_e005412.full;n=761;761;-1
bmj4_7_e005412.full;n=879;879;-1
bmj4_7_e005412.full;N=712;712;-1
bmj4_7_e005412.full;N=666;666;-1
bmj4_7_e005412.full;N=682;682;-1
bmj4_7_e005412.full;N=645;645;-1
bmj4_7_e005412.full;N  =6;6;-1
bmj4_7_e005412.full;N=650;650;-1
bmj4_7_e005412.full;N=625;625;-1
bmj4_7_e005412.full;n=650;650;-1
bmj4_7_e005412.full;total of 12 583;12583;-1
bmj4_7_e005419.full;512 participants;512;-1
bmj4_7_e005419.full;940 youth  were recruited;940;-1
bmj4_7_e005419.full;n=940;940;-1
bmj4_7_e005419.full;n=100;100;-1
bmj4_7_e005419.full;n=840;840;-1
bmj4_7_e005429.full;13 000 patients;13000;-1
bmj4_7_e005429.full;13 Since  people;13;-1
bmj4_7_e005429.full;N=12 875;12875;-1
bmj4_7_e005429.full;n = 12 875;12875;-1
bmj4_7_e005475.full;n=11;11;-1
bmj4_7_e005475.full;n=16;16;-1
bmj4_7_e005475.full;n=18;18;-1
bmj4_7_e005475.full;n=14;14;-1
bmj4_7_e005475.full;n=59;59;-1
bmj4_7_e005475.full;n=32;32;-1
bmj4_7_e005524.full;23 Some understanding of  women;23;-1
bmj4_7_e005524.full;1144 British public participants;1144;-1
bmj4_7_e005524.full;1 people;1;-1
bmj4_7_e005524.full;1144 British adults;1144;-1
bmj4_7_e005524.full;n=1144;1144;-1
bmj4_7_e005524.full;N=660;660;-1
bmj4_7_e005524.full;N=697;697;-1
bmj4_7_e005533.full;n=11;11;-1
bmj4_7_e005533.full;n=3;3;-1
bmj4_7_e005533.full;n=44;44;-1
bmj4_7_e005533.full;n=10;10;-1
bmj4_7_e005533.full;n=4;4;-1
bmj4_7_e005533.full;n  =9;9;-1
bmj4_7_e005533.full;n  =6;6;-1
bmj4_7_e005533.full;n  =1;1;-1
bmj4_7_e005533.full;n  =2;2;-1
bmj4_7_e005533.full;n  =5;5;-1
bmj4_7_e005533.full;total of 3820;3820;-1
bmj4_7_e005535.full;n=329;329;-1
bmj4_7_e005535.full;n=254;254;-1
bmj4_7_e005535.full;n=129;129;-1
bmj4_7_e005535.full;n=115;115;-1
bmj4_7_e005535.full;n=244;244;-1
bmj4_7_e005535.full;n=142;142;-1
bmj4_7_e005535.full;n=28;28;-1
bmj4_7_e005535.full;n=21;21;-1
bmj4_7_e005535.full;n=33;33;-1
bmj4_7_e005535.full;n=18;18;-1
bmj4_7_e005535.full;n=8;8;-1
bmj4_7_e005535.full;n=31;31;-1
bmj4_7_e005535.full;n=20;20;-1
bmj4_7_e005535.full;n=35;35;-1
bmj4_7_e005535.full;n=13;13;-1
bmj4_7_e005535.full;n=7;7;-1
bmj4_7_e005535.full;n=9;9;-1
bmj4_7_e005535.full;n=102;102;-1
bmj4_7_e005535.full;total of 496;496;-1
bmj4_7_e005535.full;total of 914;914;-1
bmj4_7_e005535.full;  data from a 50;50;-1
bmj4_7_e005540.full;4  women;4;-1
bmj4_7_e005540.full;951 participants;951;-1
bmj4_7_e005540.full;14  million patients;14;-1
bmj4_7_e005540.full;272 patients;272;-1
bmj4_7_e005540.full;402 patients;402;-1
bmj4_7_e005540.full;402  patients;402;-1
bmj4_7_e005540.full;696 patients;696;-1
bmj4_7_e005540.full;4  women and patients;4;-1
bmj4_7_e005540.full;10 codes and identified patients;10;-1
bmj4_7_e005540.full;835 000 people;835000;-1
bmj4_7_e005540.full;2 200 000 people;2200000;-1
bmj4_7_e005540.full;77  individuals;77;-1
bmj4_7_e005540.full;n  =4;4;-1
bmj4_7_e005540.full;n  =5;5;-1
bmj4_7_e005540.full;N  =8;8;-1
bmj4_7_e005540.full;N  =7;7;-1
bmj4_7_e005540.full;N  =9;9;-1
bmj4_7_e005540.full;N  =4;4;-1
bmj4_7_e005540.full;N  =1;1;-1
bmj4_7_e005540.full;n=457;457;-1
bmj4_7_e005540.full;n=454;454;-1
bmj4_7_e005540.full;n=951;951;-1
bmj4_7_e005540.full;n=696;696;-1
bmj4_7_e005540.full;N=272;272;-1
bmj4_7_e005540.full;N=220;220;-1
bmj4_7_e005612.full;39  Clinicians will be recruited;39;-1
bmj4_7_e005613.full;15  control participants;15;7375
bmj4_7_e005613.full;15 normal  healthy control participants;15;3906
bmj4_7_e005613.full;15 control participants;15;1943
bmj4_7_e005613.full;16 patients;16;7400
bmj4_7_e005613.full;55 patients;55;4166
bmj4_7_e005613.full;8 patients;8;4107
bmj4_7_e005613.full;14  patients;14;4067
bmj4_7_e005613.full;17 patients;17;4020
bmj4_7_e005613.full;27 In patients;27;3192
bmj4_7_e005613.full;11 patients;11;569
bmj4_7_e005613.full;12 patients;12;768
bmj4_7_e005613.full;n=16;16;2910
bmj4_7_e005613.full;n=15;15;2933
bmj4_7_e005622.full;N=11;11;-1
bmj4_7_e005623.full;80 participants;80;-1
bmj4_7_e005623.full;68  participants;68;-1
bmj4_7_e005623.full;72 participants;72;-1
bmj4_7_e005623.full;2  people;2;-1
bmj4_7_e005623.full;326 people;326;-1
bmj4_7_e005623.full;80 people;80;-1
bmj4_7_e005623.full;76 people;76;-1
bmj4_7_e005623.full;80 adults;80;-1
bmj4_7_e005623.full;30 randomised adults;30;-1
bmj4_7_e005623.full;n=107;107;-1
bmj4_7_e005623.full;n=108;108;-1
bmj4_7_e005623.full;n=111;111;-1
bmj4_7_e005623.full;n=38;38;-1
bmj4_7_e005623.full;n=31;31;-1
bmj4_7_e005623.full;total  of 10;10;-1
bmj4_7_e005625.full;79 people;79;-1
bmj4_7_e005625.full;29 If people;29;-1
bmj4_7_e005625.full;27 adults;27;-1
bmj4_7_e005625.full;1DM were  recruited;1;-1
bmj4_7_e005625.full;n=15;15;-1
bmj4_7_e005625.full;n=25;25;-1
bmj4_7_e005625.full;N=27;27;-1
bmj4_7_e005625.full;total  of 27;27;-1
bmj4_7_e005625.full;total of 79;79;-1
bmj4_7_e005625.full;total of 27;27;-1
bmj4_7_e005632.full;28 812  postmenopausal women;28812;-1
bmj4_7_e005632.full;761 949 participants;761949;-1
bmj4_7_e005632.full;347 million people;347;-1
bmj4_7_e005632.full;26 million people;26;-1
bmj4_7_e005632.full;total of 519;519;-1
bmj4_7_e005632.full;total of 761 949;761949;-1
bmj4_7_e005634.full;4  As injured patients;4;-1
bmj4_7_e005634.full;300 consecutive  patients;300;-1
bmj4_7_e005634.full;124 consecutive patients;124;-1
bmj4_7_e005634.full;390 damage control laparotomy patients;390;-1
bmj4_7_e005634.full;700 million people;700;-1
bmj4_7_e005648.full;1885 patients;1885;-1
bmj4_7_e005648.full;1887 patients;1887;-1
bmj4_7_e005648.full;12  patients;12;-1
bmj4_7_e005648.full;n=334;334;-1
bmj4_7_e005648.full;n=92;92;-1
bmj4_7_e005648.full;n=91;91;-1
bmj4_7_e005648.full;n=158;158;-1
bmj4_7_e005648.full;n=197;197;-1
bmj4_7_e005648.full;n=271;271;-1
bmj4_7_e005648.full;n=246;246;-1
bmj4_7_e005648.full;n=163;163;-1
bmj4_7_e005648.full;n=176;176;-1
bmj4_7_e005648.full;n=37;37;-1
bmj4_7_e005648.full;n=47;47;-1
bmj4_7_e005648.full;n=15;15;-1
bmj4_7_e005648.full;n=8;8;-1
bmj4_7_e005648.full;n=219;219;-1
bmj4_7_e005648.full;n=71;71;-1
bmj4_7_e005648.full;n=181;181;-1
bmj4_7_e005648.full;n=88;88;-1
bmj4_7_e005648.full;n=114;114;-1
bmj4_7_e005648.full;n=32;32;-1
bmj4_7_e005648.full;n=134;134;-1
bmj4_7_e005648.full;n=54;54;-1
bmj4_7_e005648.full;n=21;21;-1
bmj4_7_e005648.full;n=52;52;-1
bmj4_7_e005648.full;n=110;110;-1
bmj4_7_e005648.full;n=20;20;-1
bmj4_7_e005668.full;8 million people;8;-1
bmj4_7_e005668.full;3 Working age adults;3;-1
bmj4_7_e005668.full;668 adults;668;-1
bmj4_7_e005668.full;total of 668;668;-1
bmj4_7_e005674.full;11 These patients;11;-1
bmj4_7_e005674.full;528  symptomatic patients;528;-1
bmj4_7_e005674.full;1,626 patients;1626;-1
bmj4_7_e005674.full;1000 people;1000;-1
bmj4_7_e005685.full;7879 participants;7879;-1
bmj4_7_e005685.full;26  Eligible participants;26;-1
bmj4_7_e005685.full;1183 participants;1183;-1
bmj4_7_e005685.full;51 804 patients;51804;-1
bmj4_7_e005685.full;835 000  people;835000;-1
bmj4_7_e005685.full;n=5544;5544;-1
bmj4_7_e005685.full;n=2335;2335;-1
bmj4_7_e005689.full;2677 Indigenous persons;2677;-1
bmj4_7_e005689.full;14 391  Indigenous persons;14391;-1
bmj4_7_e005689.full;2 and Indigenous young people;2;-1
bmj4_7_e005689.full;4338 Indigenous young people;4338;-1
bmj4_7_e005689.full;total of  2677;2677;-1
bmj4_7_e005689.full;total of 14 391;14391;-1
bmj4_7_e005707.full;15 patients;15;-1
bmj4_7_e005718.full;14 participants;14;-1
bmj4_7_e005718.full;1250 participants;1250;-1
bmj4_7_e005718.full;11  participants;11;-1
bmj4_7_e005718.full;709 participants;709;-1
bmj4_7_e005718.full;6  Older people;6;-1
bmj4_7_e005718.full;136 people;136;-1
bmj4_7_e005718.full;25 000 people;25000;-1
bmj4_7_e005718.full;33 In large cohorts of people;33;-1
bmj4_7_e005718.full;31 and adults;31;-1
bmj4_7_e005718.full;n=672;672;-1
bmj4_7_e005718.full;n=212;212;-1
bmj4_7_e005718.full;n=743;743;-1
bmj4_7_e005718.full;n=895;895;-1
bmj4_7_e005718.full;n=1372;1372;-1
bmj4_7_e005718.full;n=1250;1250;-1
bmj4_7_e005759.full;64 women;64;-1
bmj4_7_e005759.full;n=92;92;-1
bmj4_7_e005759.full;total of 92;92;-1
bmj4_7_e005866.full;412 patients;412;-1
bmj4_7_e005866.full;31 000 patients;31000;-1
bmj4_7_e005866.full;2 A  substantial number of patients;2;-1
bmj4_7_e005866.full;779 patients;779;-1
bmj4_7_e005866.full;412 patients will be recruited;412;-1
bmj4_7_e005866.full;n=427;427;-1
bmj4_7_e005866.full;412 patients have been enrolled;412;-1
bmj4_7_e005871.full;131 participants;131;-1
bmj4_7_e005871.full;262 dizzy  patients;262;-1
bmj4_7_e005871.full;35 In dizzy  patients;35;-1
bmj4_7_e005871.full;105  patients;105;-1
bmj4_7_e005871.full;5D requires patients;5;-1
bmj4_7_e005871.full;26  This item asks patients;26;-1
bmj4_7_e005871.full;20 patients;20;-1
bmj4_7_e005871.full;10 000 patients;10000;-1
bmj4_7_e005871.full;5 adults;5;-1
bmj4_7_e005871.full;14  adults;14;-1
bmj4_7_e005885.full;30 participants;30;-1
bmj4_7_e005885.full;35 participants;35;-1
bmj4_7_e005885.full;105 participants;105;-1
bmj4_7_e005885.full;105 patients;105;-1
bmj4_7_e005885.full;12  patients;12;-1
bmj4_7_e005885.full;total of 105;105;-1
bmj4_7_e005885.full;total  of 105;105;-1
bmj4_7_e005942.full;40 patients;40;-1
bmj4_7_e005942.full;16 In patients;16;-1
bmj4_7_e005942.full;9000 patients;9000;-1
bmj4_7_e005942.full;22 patients;22;-1
bmj4_7_e005942.full;14 patients;14;-1
bmj4_7_e005942.full;16 patients;16;-1
bmj4_7_e005942.full;32 patients;32;-1
bmj4_7_e005942.full;2 diabetic patients;2;-1
bmj4_7_e005942.full;n=22;22;-1
bmj4_7_e005942.full;n=14;14;-1
bmj4_7_e005942.full;n=16;16;-1
bmj4_7_e005942.full;n=32;32;-1
bmj4_7_e005942.full;total of 28;28;-1
bmj4_7_e005942.full;total of 27;27;-1
bmj4_8_e004714.full;1 780 977 patients;1780977;-1
bmj4_8_e004714.full;41 389 of these patients;41389;-1
bmj4_8_e004714.full;5 561 368 patients;5561368;-1
bmj4_8_e004714.full;41 389 patients;41389;-1
bmj4_8_e004714.full;n=48 090;48090;-1
bmj4_8_e004714.full;n=8976;8976;-1
bmj4_8_e004714.full;n=1 634 853;1634853;-1
bmj4_8_e004714.full;n=38 468;38468;-1
bmj4_8_e004714.full;n=351 526;351526;-1
bmj4_8_e004714.full;n=1 283 327;1283327;-1
bmj4_8_e004714.full;n=11 283;11283;-1
bmj4_8_e004714.full;n=27 185;27185;-1
bmj4_8_e004714.full;n=9205;9205;-1
bmj4_8_e004714.full;n=20 607;20607;-1
bmj4_8_e004714.full;n=76 179;76179;-1
bmj4_8_e004714.full;n=44 130;44130;-1
bmj4_8_e004714.full;n=297;297;-1
bmj4_8_e004714.full;n=610;610;-1
bmj4_8_e004714.full;n=1994;1994;-1
bmj4_8_e004714.full;total of 8397;8397;-1
bmj4_8_e004714.full; data from the 2010;2010;-1
bmj4_8_e004721.full;106 patients;106;6095
bmj4_8_e004721.full;n=80;80;5256
bmj4_8_e004721.full;n=26;26;5267
bmj4_8_e004721.full;n=204;204;5294
bmj4_8_e004721.full;total of 106;106;6104
bmj4_8_e004751.full;243 women;243;698
bmj4_8_e004751.full;3 Blood indices of elderly women;3;3715
bmj4_8_e004751.full;16 Elderly women;16;6574
bmj4_8_e004751.full;n=1004;1004;2410
bmj4_8_e004751.full;n=1025;1025;2428
bmj4_8_e004751.full; data from the 1992;1992;5236
bmj4_8_e004784.full;15 individuals;15;-1
bmj4_8_e004806.full;2254  participants;2254;-1
bmj4_8_e004806.full;2254 participants;2254;-1
bmj4_8_e004806.full;86 All trials excluded participants;86;-1
bmj4_8_e004806.full;1971 participants;1971;-1
bmj4_8_e004806.full;86 included  participants;86;-1
bmj4_8_e004806.full;1802 participants;1802;-1
bmj4_8_e004806.full;1577 participants;1577;-1
bmj4_8_e004806.full;87 participants;87;-1
bmj4_8_e004806.full;23 participants;23;-1
bmj4_8_e004806.full;24 participants;24;-1
bmj4_8_e004806.full;1635 participants;1635;-1
bmj4_8_e004806.full;124 participants;124;-1
bmj4_8_e004806.full;86 included participants;86;-1
bmj4_8_e004806.full;1515 participants;1515;-1
bmj4_8_e004806.full;56  participants;56;-1
bmj4_8_e004806.full;1983 participants;1983;-1
bmj4_8_e004806.full;167 034 participants;167034;-1
bmj4_8_e004806.full;1276 participants;1276;-1
bmj4_8_e004806.full;1798 participants;1798;-1
bmj4_8_e004806.full;1605 participants;1605;-1
bmj4_8_e004806.full;1238 participants;1238;-1
bmj4_8_e004806.full;41 068 participants;41068;-1
bmj4_8_e004806.full;2091 participants;2091;-1
bmj4_8_e004806.full;15 721 participants;15721;-1
bmj4_8_e004806.full;69 579 participants;69579;-1
bmj4_8_e004806.full;3667 participants;3667;-1
bmj4_8_e004806.full;1  diabetic participants;1;-1
bmj4_8_e004806.full;11 patients;11;-1
bmj4_8_e004806.full;52  Four trials included only patients;52;-1
bmj4_8_e004806.full;20985 patients;20985;-1
bmj4_8_e004806.full;1 diabetes mellitus patients;1;-1
bmj4_8_e004806.full;n=1971;1971;-1
bmj4_8_e004806.full;n=1577;1577;-1
bmj4_8_e004806.full;n=2091;2091;-1
bmj4_8_e004806.full;n=1635;1635;-1
bmj4_8_e004806.full;n=1983;1983;-1
bmj4_8_e004806.full;n=1276;1276;-1
bmj4_8_e004806.full;n=99;99;-1
bmj4_8_e004806.full;total of 1971;1971;-1
bmj4_8_e004806.full;total of 1802;1802;-1
bmj4_8_e004806.full;total of 1577;1577;-1
bmj4_8_e004806.full;total of 87;87;-1
bmj4_8_e004806.full;total of 1635;1635;-1
bmj4_8_e004806.full;total of 1515;1515;-1
bmj4_8_e004806.full;total of 56;56;-1
bmj4_8_e004806.full;total of 1276;1276;-1
bmj4_8_e004831.full;N=10;10;-1
bmj4_8_e004831.full;N=20;20;-1
bmj4_8_e004831.full;N=50;50;-1
bmj4_8_e004831.full;N=100;100;-1
bmj4_8_e004834.full;5377  unmarried women;5377;-1
bmj4_8_e004834.full;7440 women;7440;-1
bmj4_8_e004834.full;1884 women;1884;-1
bmj4_8_e004834.full;179 women;179;-1
bmj4_8_e004834.full;5377 married women;5377;-1
bmj4_8_e004834.full;1 Proportion of women;1;-1
bmj4_8_e004892.full;2533 patients;2533;-1
bmj4_8_e004892.full;2735 patients;2735;-1
bmj4_8_e004892.full;520  patients;520;-1
bmj4_8_e004892.full;604 patients;604;-1
bmj4_8_e004892.full;n=99;99;-1
bmj4_8_e004892.full;n=418;418;-1
bmj4_8_e004892.full;n=2533;2533;-1
bmj4_8_e004892.full;n=1650;1650;-1
bmj4_8_e004892.full;n=2154;2154;-1
bmj4_8_e004892.full;total of 2533;2533;-1
bmj4_8_e004892.full;2533 patients were enrolled;2533;-1
bmj4_8_e004892.full;2533 patients  enrolled;2533;-1
bmj4_8_e004930.full;1 Cancer staging of recruited subjects;1;8508
bmj4_8_e004930.full;27 patients;27;9388
bmj4_8_e004930.full;13 patients;13;1127
bmj4_8_e004930.full;14  patients;14;1014
bmj4_8_e004930.full;1 Cancer staging of recruited;1;8508
bmj4_8_e004930.full;total of 27;27;15845
bmj4_8_e004930.full;total of 13;13;2031
bmj4_8_e005012.full;145 patients;145;-1
bmj4_8_e005012.full;213 patients;213;-1
bmj4_8_e005012.full;145  patients;145;-1
bmj4_8_e005012.full;27  patients;27;-1
bmj4_8_e005012.full;125 patients;125;-1
bmj4_8_e005012.full;4 positive  patients;4;-1
bmj4_8_e005012.full;n=63;63;-1
bmj4_8_e005012.full;n=26;26;-1
bmj4_8_e005012.full;n=119;119;-1
bmj4_8_e005012.full;n=56;56;-1
bmj4_8_e005012.full;n=89;89;-1
bmj4_8_e005012.full;n=27;27;-1
bmj4_8_e005012.full;n=118;118;-1
bmj4_8_e005047.full;83 participants;83;-1
bmj4_8_e005047.full;29 participants;29;-1
bmj4_8_e005047.full;n=116;116;-1
bmj4_8_e005047.full;n=54;54;-1
bmj4_8_e005047.full;n=38;38;-1
bmj4_8_e005047.full;n=17;17;-1
bmj4_8_e005047.full;n=14;14;-1
bmj4_8_e005047.full;n=10;10;-1
bmj4_8_e005047.full;n=2;2;-1
bmj4_8_e005047.full;n=21;21;-1
bmj4_8_e005047.full;total of 63;63;-1
bmj4_8_e005047.full;total of 272;272;-1
bmj4_8_e005047.full;total  of 81;81;-1
bmj4_8_e005047.full;total of 69;69;-1
bmj4_8_e005051.full;N=250;250;9666
bmj4_8_e005051.full;total of 612;612;767
bmj4_8_e005141.full;4899 patients;4899;-1
bmj4_8_e005141.full;166 patients;166;-1
bmj4_8_e005141.full;2640 prospectively  assessed patients;2640;-1
bmj4_8_e005141.full;401 patients;401;-1
bmj4_8_e005141.full;2821 individuals;2821;-1
bmj4_8_e005141.full;total of 6556;6556;-1
bmj4_8_e005175.full;300 patients;300;12889
bmj4_8_e005175.full;300 consecutive patients;300;8481
bmj4_8_e005178.full;37 229 patients;37229;-1
bmj4_8_e005178.full;101 008 patients;101008;-1
bmj4_8_e005178.full;100 000 per month in targeted patients;100000;-1
bmj4_8_e005178.full;100 000 per month in non-targeted patients;100000;-1
bmj4_8_e005178.full;37 229  patients;37229;-1
bmj4_8_e005178.full;100 000 patients;100000;-1
bmj4_8_e005178.full;28  RESULTS  We recruited;28;-1
bmj4_8_e005181.full;3039 outpatients;3039;-1
bmj4_8_e005181.full;12  In patients;12;-1
bmj4_8_e005181.full;3039 patients;3039;-1
bmj4_8_e005181.full;2497  patients;2497;-1
bmj4_8_e005181.full;377 patients;377;-1
bmj4_8_e005181.full;165 patients;165;-1
bmj4_8_e005181.full;182 patients;182;-1
bmj4_8_e005181.full;50 patients;50;-1
bmj4_8_e005181.full;35 patients;35;-1
bmj4_8_e005181.full;9 The majority of the patients;9;-1
bmj4_8_e005181.full;8  In patients;8;-1
bmj4_8_e005181.full;n=182;182;-1
bmj4_8_e005181.full;n=3039;3039;-1
bmj4_8_e005181.full;n=2497;2497;-1
bmj4_8_e005181.full;n=377;377;-1
bmj4_8_e005181.full;n=165;165;-1
bmj4_8_e005181.full;n=135;135;-1
bmj4_8_e005181.full;n=28;28;-1
bmj4_8_e005181.full;n=19;19;-1
bmj4_8_e005181.full;N=35;35;-1
bmj4_8_e005181.full;total of 3039;3039;-1
bmj4_8_e005181.full;total of 69;69;-1
bmj4_8_e005227.full;n  =3;3;-1
bmj4_8_e005227.full;n  =2;2;-1
bmj4_8_e005230.full;45 567 men and women;45567;-1
bmj4_8_e005230.full;45 567 individuals;45567;-1
bmj4_8_e005230.full;n=4128;4128;-1
bmj4_8_e005230.full;n=4376;4376;-1
bmj4_8_e005230.full;n=1183;1183;-1
bmj4_8_e005230.full;n=169333;169333;-1
bmj4_8_e005230.full;n=45 567;45567;-1
bmj4_8_e005230.full;n=536 737 272 320 264 417 260 244 246 817;5,36737E+29;-1
bmj4_8_e005230.full;n=11 940;11940;-1
bmj4_8_e005230.full;n=11 750;11750;-1
bmj4_8_e005230.full;n=10 995;10995;-1
bmj4_8_e005230.full;n=10 882;10882;-1
bmj4_8_e005230.full;n  =1;1;-1
bmj4_8_e005230.full;n  =4;4;-1
bmj4_8_e005238.full;329  patients;329;-1
bmj4_8_e005240.full;1500 patients;1500;-1
bmj4_8_e005240.full;total of 23;23;-1
bmj4_8_e005240.full;total of 276 000;276000;-1
bmj4_8_e005281.full;13 million patients;13;-1
bmj4_8_e005281.full;51 804 patients;51804;-1
bmj4_8_e005281.full;3 million people;3;-1
bmj4_8_e005296.full;1336 women;1336;-1
bmj4_8_e005296.full;2262 subjects;2262;-1
bmj4_8_e005296.full;960 subjects;960;-1
bmj4_8_e005296.full;1710 subjects;1710;-1
bmj4_8_e005296.full;1354 subjects;1354;-1
bmj4_8_e005296.full;1302 subjects;1302;-1
bmj4_8_e005296.full;total of 2600;2600;-1
bmj4_8_e005317.full;164  participants;164;17539
bmj4_8_e005317.full;1c levels of the project participants;1;7768
bmj4_8_e005317.full;39 participants;39;2519
bmj4_8_e005317.full;1c values of the project participants;1;5142
bmj4_8_e005317.full;1c of  the FiLDCare Project participants;1;25296
bmj4_8_e005317.full;13 knowledge  of the project participants;13;26228
bmj4_8_e005317.full;2800 patients;2800;9422
bmj4_8_e005317.full;203 people;203;18207
bmj4_8_e005317.full;19  of people;19;9555
bmj4_8_e005317.full;549 people;549;9041
bmj4_8_e005317.full;1 Demographics of people;1;6382
bmj4_8_e005317.full;n=53 542;53542;7534
bmj4_8_e005317.full;n=21 877;21877;7081
bmj4_8_e005317.full;n=83;83;3406
bmj4_8_e005317.full;N=42;42;6482
bmj4_8_e005317.full;N=122;122;6495
bmj4_8_e005317.full;n=  16;16;7040
bmj4_8_e005317.full;n=  42;42;7062
bmj4_8_e005317.full;n=  12;12;7085
bmj4_8_e005317.full;n=  68;68;20497
bmj4_8_e005317.full;n=  96;96;20543
bmj4_8_e005317.full;n  =8;8;20645
bmj4_8_e005317.full;n=  81;81;20691
bmj4_8_e005317.full;n  =5;5;28231
bmj4_8_e005317.full;n  =1;1;28292
bmj4_8_e005317.full;n=  8;8;20691
bmj4_8_e005317.full;n=  44;44;32171
bmj4_8_e005317.full;n=  34;34;32190
bmj4_8_e005317.full;n=  78;78;32213
bmj4_8_e005317.full;total of 203;203;2273
bmj4_8_e005331.full;n=23 438;23438;-1
bmj4_8_e005331.full;n=5868;5868;-1
bmj4_8_e005331.full;n=3460;3460;-1
bmj4_8_e005331.full;n=4447;4447;-1
bmj4_8_e005331.full;n=9663;9663;-1
bmj4_8_e005332.full;1 521 773 patients;1521773;-1
bmj4_8_e005332.full;18 862 patients;18862;-1
bmj4_8_e005332.full;80 543 patients;80543;-1
bmj4_8_e005332.full;1 540 635 patients;1540635;-1
bmj4_8_e005332.full;12 More AM patients;12;-1
bmj4_8_e005332.full;n=25;25;-1
bmj4_8_e005332.full;n=28;28;-1
bmj4_8_e005332.full;n=26;26;-1
bmj4_8_e005332.full;n=1;1;-1
bmj4_8_e005332.full;n=18 862;18862;-1
bmj4_8_e005332.full; data of  1 540 635;1540635;-1
bmj4_8_e005332.full; data from 79;79;-1
bmj4_8_e005372.full;11 patients;11;-1
bmj4_8_e005372.full;N=145;145;-1
bmj4_8_e005372.full;N=49;49;-1
bmj4_8_e005372.full;total of 194;194;-1
bmj4_8_e005378.full;2 diabetic patients;2;-1
bmj4_8_e005385.full;9957 cohort subjects;9957;-1
bmj4_8_e005385.full;9470 subjects;9470;-1
bmj4_8_e005385.full;9957 adult consecutive inpatients;9957;-1
bmj4_8_e005405.full;N=196 814;196814;-1
bmj4_8_e005405.full;N=132 728;132728;-1
bmj4_8_e005405.full;N=329 542;329542;-1
bmj4_8_e005438.full;2022 patients;2022;-1
bmj4_8_e005438.full;10 074 consecutive patients;10074;-1
bmj4_8_e005438.full;n=1373;1373;-1
bmj4_8_e005438.full;n  =2;2;-1
bmj4_8_e005438.full;n  =5;5;-1
bmj4_8_e005438.full;n  =9;9;-1
bmj4_8_e005438.full;n  =4;4;-1
bmj4_8_e005438.full;total of 43;43;-1
bmj4_8_e005456.full;345 participants;345;-1
bmj4_8_e005456.full;361 adults;361;-1
bmj4_8_e005456.full;n=361;361;-1
bmj4_8_e005456.full;n  =3;3;-1
bmj4_8_e005458.full;436 438 persons;436438;-1
bmj4_8_e005458.full;403 305 individuals;403305;-1
bmj4_8_e005458.full;403 305 Salt Lake County adults;403305;-1
bmj4_8_e005458.full;n=403 305;403305;-1
bmj4_8_e005458.full;n=209 946;209946;-1
bmj4_8_e005458.full;n=193 359;193359;-1
bmj4_8_e005458.full;n  =2;2;-1
bmj4_8_e005458.full;n  =1;1;-1
bmj4_8_e005461.full;4583  mainstream patients;4583;-1
bmj4_8_e005461.full;4583 mainstream patients;4583;-1
bmj4_8_e005461.full;30 patients;30;-1
bmj4_8_e005461.full;2587 patients;2587;-1
bmj4_8_e005461.full;30 randomly selected patients;30;-1
bmj4_8_e005461.full;21 Such individuals;21;-1
bmj4_8_e005461.full;n=2587;2587;-1
bmj4_8_e005461.full;n=4583;4583;-1
bmj4_8_e005461.full;n=766;766;-1
bmj4_8_e005461.full;n=1821;1821;-1
bmj4_8_e005461.full;n=798;798;-1
bmj4_8_e005461.full;n=1997;1997;-1
bmj4_8_e005461.full;n=1199;1199;-1
bmj4_8_e005461.full;n=724;724;-1
bmj4_8_e005461.full;n=1058;1058;-1
bmj4_8_e005461.full;n=3352;3352;-1
bmj4_8_e005461.full;n=2294;2294;-1
bmj4_8_e005461.full;n=1772;1772;-1
bmj4_8_e005461.full;n=216;216;-1
bmj4_8_e005461.full;n=602;602;-1
bmj4_8_e005461.full;n=386;386;-1
bmj4_8_e005461.full;n=254;254;-1
bmj4_8_e005461.full;n=582;582;-1
bmj4_8_e005461.full;n=1395;1395;-1
bmj4_8_e005461.full;n=813;813;-1
bmj4_8_e005461.full;n=470;470;-1
bmj4_8_e005461.full;total of 2587;2587;-1
bmj4_8_e005461.full;total of 33;33;-1
bmj4_8_e005493.full;750 000 patients;750000;-1
bmj4_8_e005493.full;7 and patients;7;-1
bmj4_8_e005493.full;33 patients;33;-1
bmj4_8_e005493.full;5 of their patients;5;-1
bmj4_8_e005493.full;40 patients;40;-1
bmj4_8_e005493.full;6  million people;6;-1
bmj4_8_e005493.full;38 adults;38;-1
bmj4_8_e005493.full;40 patients are recruited;40;-1
bmj4_8_e005508.full;3000 people;3000;-1
bmj4_8_e005508.full;406 people;406;-1
bmj4_8_e005508.full;total of 256;256;-1
bmj4_8_e005508.full;total of  406;406;-1
bmj4_8_e005528.full;47 million  persons;47;-1
bmj4_8_e005528.full;4 patients;4;-1
bmj4_8_e005528.full;47 million  individuals;47;-1
bmj4_8_e005556.full;n=260;260;-1
bmj4_8_e005556.full;n=158;158;-1
bmj4_8_e005556.full;n=102;102;-1
bmj4_8_e005556.full;n=57;57;-1
bmj4_8_e005556.full;n=47;47;-1
bmj4_8_e005556.full;n=76;76;-1
bmj4_8_e005556.full;n=35;35;-1
bmj4_8_e005556.full;n=63;63;-1
bmj4_8_e005556.full;n=25;25;-1
bmj4_8_e005556.full;n=45;45;-1
bmj4_8_e005556.full;n=19;19;-1
bmj4_8_e005556.full;n=91;91;-1
bmj4_8_e005556.full;n=38;38;-1
bmj4_8_e005581.full;4145 patients;4145;-1
bmj4_8_e005581.full;2 CKD definitions whereby  patients;2;-1
bmj4_8_e005581.full;23 028 registered patients;23028;-1
bmj4_8_e005581.full;4145 eligible  patients;4145;-1
bmj4_8_e005581.full;32 patients;32;-1
bmj4_8_e005581.full;16 and limited number of patients;16;-1
bmj4_8_e005581.full;n=667;667;-1
bmj4_8_e005581.full;n=23 028;23028;-1
bmj4_8_e005581.full;n=7657;7657;-1
bmj4_8_e005581.full;n=4145;4145;-1
bmj4_8_e005581.full;n=1094;1094;-1
bmj4_8_e005581.full;n=2859;2859;-1
bmj4_8_e005581.full;n=2236;2236;-1
bmj4_8_e005581.full;n=1099;1099;-1
bmj4_8_e005581.full;n=3046;3046;-1
bmj4_8_e005581.full;n=2259;2259;-1
bmj4_8_e005581.full;n=642;642;-1
bmj4_8_e005581.full;n=63;63;-1
bmj4_8_e005581.full;n=297;297;-1
bmj4_8_e005581.full;n=141;141;-1
bmj4_8_e005581.full;n  =3;3;-1
bmj4_8_e005581.full;n  =6;6;-1
bmj4_8_e005581.full;n  =1;1;-1
bmj4_8_e005581.full;n  =2;2;-1
bmj4_8_e005581.full;n  =7;7;-1
bmj4_8_e005581.full;n  =5;5;-1
bmj4_8_e005581.full;n  =9;9;-1
bmj4_8_e005581.full;n  =4;4;-1
bmj4_8_e005593.full;181 patients;181;8204
bmj4_8_e005593.full;364 patients;364;3943
bmj4_8_e005593.full;1 Characteristics of the patients;1;2769
bmj4_8_e005593.full;2 Characteristics of the patients;2;6109
bmj4_8_e005593.full;44 patients;44;8589
bmj4_8_e005593.full;n=31;31;2921
bmj4_8_e005593.full;n=150;150;2966
bmj4_8_e005593.full;n=44;44;6218
bmj4_8_e005593.full;n=137;137;6249
bmj4_8_e005593.full;total of 181;181;2381
bmj4_8_e005598.full;78 women;78;-1
bmj4_8_e005598.full;38 women;38;-1
bmj4_8_e005598.full;61 women;61;-1
bmj4_8_e005598.full;228  participants;228;-1
bmj4_8_e005598.full;228 participants;228;-1
bmj4_8_e005598.full;22 participants;22;-1
bmj4_8_e005598.full;20 participants;20;-1
bmj4_8_e005598.full;1 Characteristics of the study participants;1;-1
bmj4_8_e005598.full;n=228;228;-1
bmj4_8_e005598.full;5 were  enrolled;5;-1
bmj4_8_e005611.full;n  =2;2;-1
bmj4_8_e005611.full;n  =3;3;-1
bmj4_8_e005611.full;n  =6;6;-1
bmj4_8_e005611.full;n  =1;1;-1
bmj4_8_e005611.full;n  =4;4;-1
bmj4_8_e005611.full;n=298;298;-1
bmj4_8_e005611.full;n=319;319;-1
bmj4_8_e005611.full;n=639;639;-1
bmj4_8_e005611.full;n=1109;1109;-1
bmj4_8_e005611.full;n=405;405;-1
bmj4_8_e005611.full;n=2770;2770;-1
bmj4_8_e005611.full;total of 2770;2770;-1
bmj4_8_e005615.full;163 patients;163;7139
bmj4_8_e005615.full;58 patients;58;6370
bmj4_8_e005615.full;14 patients;14;6210
bmj4_8_e005615.full;17 patients;17;1051
bmj4_8_e005615.full;3 Comparison of patients;3;8882
bmj4_8_e005615.full;24 patients;24;14073
bmj4_8_e005615.full;10  patients;10;14142
bmj4_8_e005615.full;122 patients;122;14289
bmj4_8_e005615.full;3035  patients;3035;19034
bmj4_8_e005615.full;5000 Japanese patients;5000;20905
bmj4_8_e005615.full;n=58;58;6936
bmj4_8_e005615.full;n=105;105;6899
bmj4_8_e005615.full;n=163;163;1887
bmj4_8_e005615.full;n=17;17;6429
bmj4_8_e005615.full;n=146;146;6455
bmj4_8_e005615.full;n=14;14;6455
bmj4_8_e005615.full;n=44;44;9007
bmj4_8_e005643.full;50 participants;50;8495
bmj4_8_e005643.full;100  patients;100;22358
bmj4_8_e005643.full;100 patients;100;8967
bmj4_8_e005643.full;total of 220;220;7455
bmj4_8_e005683.full;2105 men  and women;2105;-1
bmj4_8_e005683.full;1500 people;1500;-1
bmj4_8_e005683.full;3073 people;3073;-1
bmj4_8_e005683.full;N=2318;2318;-1
bmj4_8_e005683.full;N=1614;1614;-1
bmj4_8_e005683.full;N=1186;1186;-1
bmj4_8_e005683.full;N=1069;1069;-1
bmj4_8_e005683.full;n=42;42;-1
bmj4_8_e005683.full;N=579;579;-1
bmj4_8_e005683.full;N=1027;1027;-1
bmj4_8_e005683.full; data from the 2008;2008;-1
bmj4_8_e005710.full;14 330 individuals;14330;-1
bmj4_8_e005710.full;8  These individuals;8;-1
bmj4_8_e005710.full;2 765 586 individuals;2765586;-1
bmj4_8_e005710.full;632 725 individuals;632725;-1
bmj4_8_e005710.full;N=13 477 425;13477425;-1
bmj4_8_e005710.full;N=13 901 175;13901175;-1
bmj4_8_e005710.full;total of 14 330;14330;-1
bmj4_8_e005710.full;total of 25 534;25534;-1
bmj4_8_e005715.full;153 consecutive hospitalised patients;153;12490
bmj4_8_e005715.full;245 patients;245;7645
bmj4_8_e005715.full;92 patients;92;7309
bmj4_8_e005715.full;153 patients;153;7278
bmj4_8_e005715.full;1 Inclusion of the patients;1;4817
bmj4_8_e005715.full;131 patients;131;256
bmj4_8_e005715.full;22 patients;22;1719
bmj4_8_e005715.full;1c values of patients;1;5883
bmj4_8_e005715.full;10  patients;10;7651
bmj4_8_e005715.full;2,471 patients;2471;17278
bmj4_8_e005715.full;1256 patients;1256;18799
bmj4_8_e005715.full;N  =2;2;4430
bmj4_8_e005715.full;N  =1;1;4352
bmj4_8_e005715.full;n  =4;4;4217
bmj4_8_e005715.full;n  =8;8;4147
bmj4_8_e005715.full;N=22;22;2706
bmj4_8_e005715.full;N=43;43;2795
bmj4_8_e005715.full;N=88;88;2887
bmj4_8_e005715.full;N=131;131;6995
bmj4_8_e005715.full;N=142;142;7625
bmj4_8_e005729.full;n=8;8;-1
bmj4_8_e005734.full;12 women;12;-1
bmj4_8_e005734.full;2  participants;2;-1
bmj4_8_e005734.full;22  A brief description of the participants;22;-1
bmj4_8_e005734.full;5 patients;5;-1
bmj4_8_e005734.full;n=5;5;-1
bmj4_8_e005734.full;n=4;4;-1
bmj4_8_e005734.full;n=501;501;-1
bmj4_8_e005734.full;n=198;198;-1
bmj4_8_e005734.full;n=88;88;-1
bmj4_8_e005734.full;n=20;20;-1
bmj4_8_e005734.full;n=40;40;-1
bmj4_8_e005734.full;n=21;21;-1
bmj4_8_e005751.full;81 NCPs of whom four were  women;81;-1
bmj4_8_e005785.full;1000 women;1000;-1
bmj4_8_e005785.full;42 women;42;-1
bmj4_8_e005799.full;10 participants;10;-1
bmj4_8_e005809.full;3 million patients;3;-1
bmj4_8_e005809.full;8 million patients;8;-1
bmj4_8_e005809.full;100 patients;100;-1
bmj4_8_e005809.full;3 million  patients;3;-1
bmj4_8_e005809.full;6 758 649 patients;6758649;-1
bmj4_8_e005809.full;3 177 192 patients;3177192;-1
bmj4_8_e005809.full; data were ROC of 0;0;-1
bmj4_8_e005823.full;120 adult patients;120;-1
bmj4_8_e005823.full;38 patients;38;-1
bmj4_8_e005823.full;total of 100;100;-1
bmj4_8_e005823.full;total of 120;120;-1
bmj4_8_e005824.full;10 146 participants. These participants;10146;-1
bmj4_8_e005824.full;1 Flow of eligible  participants;1;-1
bmj4_8_e005824.full;10 146 participants;10146;-1
bmj4_8_e005824.full;10 146 people;10146;-1
bmj4_8_e005824.full;2541 individuals;2541;-1
bmj4_8_e005824.full;4844 individuals;4844;-1
bmj4_8_e005824.full;n=7803;7803;-1
bmj4_8_e005824.full;n=2343;2343;-1
bmj4_8_e005824.full;n=25 056;25056;-1
bmj4_8_e005824.full;n  =7;7;-1
bmj4_8_e005824.full;n  =2;2;-1
bmj4_8_e005824.full;total of 10 146;10146;-1
bmj4_8_e005837.full;n=17 929;17929;-1
bmj4_8_e005837.full;n=746;746;-1
bmj4_8_e005837.full;n=473;473;-1
bmj4_8_e005837.full;n=1485;1485;-1
bmj4_8_e005837.full;n=103;103;-1
bmj4_8_e005837.full;n=862;862;-1
bmj4_8_e005837.full;n=391;391;-1
bmj4_8_e005837.full;n=505;505;-1
bmj4_8_e005837.full;n=624;624;-1
bmj4_8_e005837.full;n=619;619;-1
bmj4_8_e005837.full;n=488;488;-1
bmj4_8_e005837.full;n=555;555;-1
bmj4_8_e005837.full;n=914;914;-1
bmj4_8_e005837.full;n=1712;1712;-1
bmj4_8_e005837.full;n=299;299;-1
bmj4_8_e005837.full;n=453;453;-1
bmj4_8_e005837.full;n=497;497;-1
bmj4_8_e005837.full;n=498;498;-1
bmj4_8_e005837.full;n=214;214;-1
bmj4_8_e005837.full;n=276;276;-1
bmj4_8_e005837.full;n=682;682;-1
bmj4_8_e005837.full;n=1446;1446;-1
bmj4_8_e005837.full;n=516;516;-1
bmj4_8_e005837.full;n=863;863;-1
bmj4_8_e005837.full;n=200;200;-1
bmj4_8_e005837.full;n=233;233;-1
bmj4_8_e005837.full;n= 699;699;-1
bmj4_8_e005837.full;n=66;66;-1
bmj4_8_e005837.full;n=1241;1241;-1
bmj4_8_e005837.full;n=269;269;-1
bmj4_8_e005837.full;n=36;36;-1
bmj4_8_e005837.full;n=12;12;-1
bmj4_8_e005837.full;n=5;5;-1
bmj4_8_e005837.full;n=4;4;-1
bmj4_8_e005837.full;n  =1;1;-1
bmj4_8_e005837.full;n  =7;7;-1
bmj4_8_e005837.full;n  =4;4;-1
bmj4_8_e005837.full;n  =8;8;-1
bmj4_8_e005837.full;n  =3;3;-1
bmj4_8_e005837.full;n  =5;5;-1
bmj4_8_e005837.full;n  =6;6;-1
bmj4_8_e005837.full;n  =9;9;-1
bmj4_8_e005837.full;n  =2;2;-1
bmj4_8_e005837.full;n=  27;27;-1
bmj4_8_e005837.full;  data from the 2006;2006;-1
bmj4_8_e005837.full; datasets from 29;29;-1
bmj4_8_e005867.full;8983  young people;8983;-1
bmj4_8_e005867.full;8,983  young people;8983;-1
bmj4_8_e005867.full;N=2210;2210;-1
bmj4_8_e005867.full;N  =2;2;-1
bmj4_8_e005873.full;4500 people;4500;-1
bmj4_8_e005873.full;4001 people;4001;-1
bmj4_8_e005873.full;n=754;754;-1
bmj4_8_e005873.full;n=590;590;-1
bmj4_8_e005873.full;n=601;601;-1
bmj4_8_e005873.full;n=4500;4500;-1
bmj4_8_e005873.full;n=4004;4004;-1
bmj4_8_e005873.full;n=4001;4001;-1
bmj4_8_e005873.full;N=754;754;-1
bmj4_8_e005873.full;N=590;590;-1
bmj4_8_e005873.full;N=601;601;-1
bmj4_8_e005873.full;N=660;660;-1
bmj4_8_e005873.full;N=530;530;-1
bmj4_8_e005873.full;N=541;541;-1
bmj4_8_e005873.full;n=14;14;-1
bmj4_8_e005873.full;n=1551;1551;-1
bmj4_8_e005873.full;n=584;584;-1
bmj4_8_e005873.full;n=496;496;-1
bmj4_8_e005873.full;n=472;472;-1
bmj4_8_e005873.full;n=39;39;-1
bmj4_8_e005873.full;n=16;16;-1
bmj4_8_e005873.full;n=7;7;-1
bmj4_8_e005873.full;N=1;1;-1
bmj4_8_e005873.full; data from the 2011;2011;-1
bmj4_8_e005894.full;400 women;400;-1
bmj4_8_e005894.full;694  women;694;-1
bmj4_8_e005894.full;1245 participants;1245;-1
bmj4_8_e005894.full;1010 people;1010;-1
bmj4_8_e005894.full;1291 individuals;1291;-1
bmj4_8_e005894.full;736 individuals;736;-1
bmj4_8_e005894.full;n=1245;1245;-1
bmj4_8_e005896.full;11  If studies also include participants;11;-1
bmj4_8_e005900.full;93  women;93;-1
bmj4_8_e005900.full;65 women;65;-1
bmj4_8_e005900.full;188 patients;188;-1
bmj4_8_e005900.full;11 All  patients;11;-1
bmj4_8_e005900.full;130  consecutive patients;130;-1
bmj4_8_e005900.full;25  patients;25;-1
bmj4_8_e005900.full;126 patients;126;-1
bmj4_8_e005900.full;130 patients;130;-1
bmj4_8_e005900.full;27 AIP patients;27;-1
bmj4_8_e005900.full;3 patients;3;-1
bmj4_8_e005900.full;84 patients;84;-1
bmj4_8_e005900.full;53 patients;53;-1
bmj4_8_e005900.full;5  patients;5;-1
bmj4_8_e005900.full;58 patients;58;-1
bmj4_8_e005900.full;9 patients;9;-1
bmj4_8_e005900.full;28 patients;28;-1
bmj4_8_e005900.full;128 patients;128;-1
bmj4_8_e005900.full;116 patients;116;-1
bmj4_8_e005900.full;35 patients;35;-1
bmj4_8_e005900.full;31 patients;31;-1
bmj4_8_e005900.full;188  patients;188;-1
bmj4_8_e005900.full;20 patients;20;-1
bmj4_8_e005900.full;158 patients;158;-1
bmj4_8_e005900.full;95 patients;95;-1
bmj4_8_e005900.full;30 patients;30;-1
bmj4_8_e005900.full;162 patients;162;-1
bmj4_8_e005900.full;143 patients;143;-1
bmj4_8_e005900.full;26 patients;26;-1
bmj4_8_e005900.full;11 patients;11;-1
bmj4_8_e005900.full;12 patients;12;-1
bmj4_8_e005900.full;27  patients;27;-1
bmj4_8_e005900.full;6 patients;6;-1
bmj4_8_e005900.full;25 patients;25;-1
bmj4_8_e005900.full;93 patients;93;-1
bmj4_8_e005900.full;14 patients;14;-1
bmj4_8_e005900.full;2 patients;2;-1
bmj4_8_e005900.full;2 criteria and five patients;2;-1
bmj4_8_e005900.full;n=117;117;-1
bmj4_8_e005900.full;n=27;27;-1
bmj4_8_e005900.full;n=188;188;-1
bmj4_8_e005900.full;n=130;130;-1
bmj4_8_e005900.full;n=93;93;-1
bmj4_8_e005900.full;n=95;95;-1
bmj4_8_e005900.full;total of 130;130;-1
bmj4_8_e005906.full;13 627 women;13627;7911
bmj4_8_e005906.full;43 participants were women;43;319
bmj4_8_e005906.full;506 women;506;609
bmj4_8_e005906.full;16286 pregnant  women;16286;19454
bmj4_8_e005906.full;53 370 participants;53370;2162
bmj4_8_e005906.full;13 627 participants;13627;2036
bmj4_8_e005906.full;549 participants;549;1891
bmj4_8_e005906.full;43 participants;43;319
bmj4_8_e005906.full;4 participants;4;384
bmj4_8_e005906.full;16 participants;16;455
bmj4_8_e005906.full;23  participants;23;532
bmj4_8_e005906.full;n=328;328;2038
bmj4_8_e005906.full;n=201;201;2050
bmj4_8_e005906.full;total of 53 370;53370;2171
bmj4_8_e005953.full;16 For patients;16;-1
bmj4_8_e005953.full;514 patients;514;-1
bmj4_8_e005953.full;280 patients;280;-1
bmj4_8_e005953.full;58  patients;58;-1
bmj4_8_e005953.full;126  patients;126;-1
bmj4_8_e005953.full;304 patients;304;-1
bmj4_8_e005953.full;8 In HIV-infected  adults;8;-1
bmj4_8_e005953.full;45 Dutch adults;45;-1
bmj4_8_e005953.full;93 adults;93;-1
bmj4_8_e005953.full;n=8;8;-1
bmj4_8_e005953.full;n=76;76;-1
bmj4_8_e005953.full;n=84;84;-1
bmj4_8_e005953.full;n=153;153;-1
bmj4_8_e005953.full;n=128;128;-1
bmj4_8_e005953.full;n=109;109;-1
bmj4_8_e005953.full;n=80;80;-1
bmj4_8_e005953.full;n=156;156;-1
bmj4_8_e005953.full;n=125;125;-1
bmj4_8_e005953.full;n=111;111;-1
bmj4_8_e005953.full;n=81;81;-1
bmj4_8_e005953.full;n=126;126;-1
bmj4_8_e005953.full;n=82;82;-1
bmj4_8_e005953.full;n=155;155;-1
bmj4_8_e005953.full;n=127;127;-1
bmj4_8_e005953.full;n=110;110;-1
bmj4_8_e005953.full;n=20;20;-1
bmj4_8_e005953.full;n=27;27;-1
bmj4_8_e005953.full;n=59;59;-1
bmj4_8_e005953.full;n=39;39;-1
bmj4_8_e005986.full;160 infertile  women;160;-1
bmj4_8_e005986.full;160 infertile women;160;-1
bmj4_8_e005986.full;160 participants;160;-1
bmj4_8_e005986.full;60 patients;60;-1
bmj4_8_e005986.full;60  Once patients;60;-1
bmj4_8_e005986.full;n=40;40;-1
bmj4_8_e005986.full;n=80;80;-1
bmj4_8_e005986.full;total of 160;160;-1
bmj4_8_e006004.full;1117  people;1117;-1
bmj4_8_e006005.full;114 participants;114;-1
bmj4_8_e006005.full;228 trial participants;228;-1
bmj4_8_e006005.full;256 trial participants;256;-1
bmj4_8_e006005.full;34 patients;34;-1
bmj4_8_e006005.full;109 knowlesi malaria patients;109;-1
bmj4_8_e006005.full;73 patients;73;-1
bmj4_8_e006005.full;60 patients;60;-1
bmj4_8_e006005.full;11 patients;11;-1
bmj4_8_e006005.full;20patients;20;-1
bmj4_8_e006116.full;200 patients;200;-1
bmj4_8_e006116.full;18 000 patients;18000;-1
bmj4_8_e006116.full;42 If patients;42;-1
bmj4_8_e006116.full;120 patients;120;-1
bmj4_8_e006116.full;100 patients;100;-1
bmj4_8_e006116.full;67 patients;67;-1
bmj4_8_e006116.full;332 patients;332;-1
bmj4_8_e006116.full;400 patients;400;-1
bmj4_8_e006116.full;200 patients will be recruited;200;-1
bmj4_8_e006116.full;total of 332;332;-1
bmj4_8_e006175.full;300 participants;300;13325
bmj4_8_e006175.full;199 participants;199;13387
bmj4_8_e006175.full;2  recruited;2;8790
bmj4_8_e006175.full;n=175;175;2469
bmj4_8_e006175.full;n=125;125;2490
bmj4_8_e006264.full;280 participants;280;-1
bmj4_8_e006264.full;1 Flow chart of the  participants;1;-1
bmj4_8_e006264.full;180  patients;180;-1
bmj4_8_e006264.full;10 people;10;-1
bmj4_8_e006264.full;n=40;40;-1
bmj4_8_e006264.full;n=280;280;-1
bmj4_9_e004760.full;10 000 participants;10000;-1
bmj4_9_e004760.full;20 000 patients;20000;-1
bmj4_9_e004760.full;4 inhibitor-treated  patients;4;-1
bmj4_9_e004760.full;10 000 patients;10000;-1
bmj4_9_e004760.full;10 000  patients;10000;-1
bmj4_9_e004760.full;9200 patients;9200;-1
bmj4_9_e004760.full;2 diabetic patients;2;-1
bmj4_9_e004760.full;366 million people;366;-1
bmj4_9_e004760.full;24 million people;24;-1
bmj4_9_e004760.full;total of 20 000;20000;-1
bmj4_9_e005065.full;71 300 persons;71300;-1
bmj4_9_e005065.full;19 because some persons;19;-1
bmj4_9_e005065.full;n=1480;1480;-1
bmj4_9_e005065.full;n=80;80;-1
bmj4_9_e005065.full;n=33 330;33330;-1
bmj4_9_e005065.full;n=2160;2160;-1
bmj4_9_e005065.full;n=626;626;-1
bmj4_9_e005065.full;n=72;72;-1
bmj4_9_e005065.full;n=281;281;-1
bmj4_9_e005065.full;n=590;590;-1
bmj4_9_e005065.full;n=294;294;-1
bmj4_9_e005065.full;n=689;689;-1
bmj4_9_e005065.full;n=187;187;-1
bmj4_9_e005065.full;n=327;327;-1
bmj4_9_e005065.full;n=34;34;-1
bmj4_9_e005065.full;n=29;29;-1
bmj4_9_e005065.full;n=320;320;-1
bmj4_9_e005065.full;n=179;179;-1
bmj4_9_e005065.full;n=49;49;-1
bmj4_9_e005065.full;n=18;18;-1
bmj4_9_e005065.full;4295 MSM  enrolled;4295;-1
bmj4_9_e005107.full;400 participants;400;-1
bmj4_9_e005107.full;200 participants;200;-1
bmj4_9_e005107.full;50 participants;50;-1
bmj4_9_e005107.full;30 inter-  vention participants;30;-1
bmj4_9_e005107.full;12 even though older adults;12;-1
bmj4_9_e005107.full;400 participants will be recruited;400;-1
bmj4_9_e005107.full;n=10;10;-1
bmj4_9_e005107.full;n=15;15;-1
bmj4_9_e005107.full;n=400;400;-1
bmj4_9_e005107.full;total of  400;400;-1
bmj4_9_e005107.full;total of 400;400;-1
bmj4_9_e005107.full;total of 30;30;-1
bmj4_9_e005115.full;1253 participants;1253;-1
bmj4_9_e005115.full;1192 participants;1192;-1
bmj4_9_e005115.full;25 874 participants;25874;-1
bmj4_9_e005115.full;167 590 participants;167590;-1
bmj4_9_e005124.full;total of 310;310;1016
bmj4_9_e005221.full;297 participants;297;-1
bmj4_9_e005221.full;1 Flow diagram of participants;1;-1
bmj4_9_e005221.full;297 working adults;297;-1
bmj4_9_e005221.full;923 adults;923;-1
bmj4_9_e005221.full;n=184;184;-1
bmj4_9_e005221.full;n=297;297;-1
bmj4_9_e005221.full;n=51;51;-1
bmj4_9_e005221.full;n=167;167;-1
bmj4_9_e005221.full;n=79;79;-1
bmj4_9_e005223.full;1500 patients;1500;-1
bmj4_9_e005223.full;100 000 patients;100000;-1
bmj4_9_e005223.full;3 726 380 people;3726380;-1
bmj4_9_e005223.full;7  million people;7;-1
bmj4_9_e005223.full;114 255  individuals;114255;-1
bmj4_9_e005223.full;1500 patients  enrolled;1500;-1
bmj4_9_e005223.full; data from  2011;2011;-1
bmj4_9_e005223.full; data from 2004;2004;-1
bmj4_9_e005241.full;99 and women;99;-1
bmj4_9_e005241.full;56 865 participants;56865;-1
bmj4_9_e005241.full;24 Study participants;24;-1
bmj4_9_e005241.full;297 148 participants;297148;-1
bmj4_9_e005241.full;293 488 participants;293488;-1
bmj4_9_e005241.full;86 810 participants;86810;-1
bmj4_9_e005241.full;n  =4;4;-1
bmj4_9_e005241.full;n  =  15;15;-1
bmj4_9_e005241.full;n  =5;5;-1
bmj4_9_e005241.full;n  =1;1;-1
bmj4_9_e005241.full;total of 56 865;56865;-1
bmj4_9_e005265.full;864 consecutive patients;864;-1
bmj4_9_e005265.full;125  patients;125;-1
bmj4_9_e005265.full;300 patients;300;-1
bmj4_9_e005265.full;25 000 patients;25000;-1
bmj4_9_e005265.full;847 patients;847;-1
bmj4_9_e005265.full;864  patients;864;-1
bmj4_9_e005265.full;432 patients;432;-1
bmj4_9_e005265.full;528  symptomatic patients;528;-1
bmj4_9_e005265.full;total of 864;864;-1
bmj4_9_e005265.full;total of 847;847;-1
bmj4_9_e005284.full;n=8;8;-1
bmj4_9_e005284.full;n=2;2;-1
bmj4_9_e005284.full;n=10;10;-1
bmj4_9_e005284.full;n=6;6;-1
bmj4_9_e005284.full;n=14;14;-1
bmj4_9_e005284.full;N=28;28;-1
bmj4_9_e005284.full;N=13;13;-1
bmj4_9_e005284.full;N=24;24;-1
bmj4_9_e005284.full;N=31;31;-1
bmj4_9_e005284.full; data from 661;661;-1
bmj4_9_e005297.full;49 Since  patients;49;-1
bmj4_9_e005297.full; data from 10;10;-1
bmj4_9_e005351.full;511 participants;511;-1
bmj4_9_e005351.full;547 participants;547;-1
bmj4_9_e005351.full;511 study participants;511;-1
bmj4_9_e005351.full;total of 547;547;-1
bmj4_9_e005351.full;total of 511;511;-1
bmj4_9_e005351.full;total  of 61;61;-1
bmj4_9_e005351.full;total of 166;166;-1
bmj4_9_e005357.full;9056 participants;9056;-1
bmj4_9_e005357.full;9203 participants;9203;-1
bmj4_9_e005357.full;1 Proportion of participants;1;-1
bmj4_9_e005357.full;2 Proportion of participants;2;-1
bmj4_9_e005357.full;8983  young people;8983;-1
bmj4_9_e005357.full;11 individuals;11;-1
bmj4_9_e005357.full;N=9203;9203;-1
bmj4_9_e005357.full;n=19 430;19430;-1
bmj4_9_e005357.full;n=1017;1017;-1
bmj4_9_e005357.full;n=172;172;-1
bmj4_9_e005357.full;n=11;11;-1
bmj4_9_e005357.full;n=147;147;-1
bmj4_9_e005357.full;N=9056;9056;-1
bmj4_9_e005357.full;n=9056;9056;-1
bmj4_9_e005357.full;n=4995;4995;-1
bmj4_9_e005357.full;n=4208;4208;-1
bmj4_9_e005357.full;n=7031;7031;-1
bmj4_9_e005357.full;N=40;40;-1
bmj4_9_e005357.full;total of 10 220;10220;-1
bmj4_9_e005357.full;total of 20;20;-1
bmj4_9_e005376.full;100 000 patients;100000;-1
bmj4_9_e005376.full;25 We considered patients;25;-1
bmj4_9_e005376.full;4 Proportion of patients;4;-1
bmj4_9_e005376.full;8 Proportions of patients;8;-1
bmj4_9_e005399.full;5 640 313 participants;5640313;-1
bmj4_9_e005399.full;90,056 participants;90056;-1
bmj4_9_e005399.full;170,000 participants;170000;-1
bmj4_9_e005399.full;35 defined as patients;35;-1
bmj4_9_e005399.full;7 million patients;7;-1
bmj4_9_e005399.full;175,000 people;175000;-1
bmj4_9_e005399.full;n=0;0;-1
bmj4_9_e005399.full;total of 12;12;-1
bmj4_9_e005399.full;total of 13;13;-1
bmj4_9_e005399.full;  data analysis of 22;22;-1
bmj4_9_e005399.full; database of 11;11;-1
bmj4_9_e005399.full; data  from 90,056;90056;-1
bmj4_9_e005399.full; data  from 170,000;170000;-1
bmj4_9_e005399.full; data  from 175,000;175000;-1
bmj4_9_e005400.full;1090 women;1090;-1
bmj4_9_e005400.full;94 000  women;94000;-1
bmj4_9_e005400.full;2 million women;2;-1
bmj4_9_e005400.full;157 997 women;157997;-1
bmj4_9_e005400.full;146 338 women;146338;-1
bmj4_9_e005400.full;10 689 of these women;10689;-1
bmj4_9_e005400.full;92 834 women;92834;-1
bmj4_9_e005400.full;1090  women;1090;-1
bmj4_9_e005400.full;87 334 women;87334;-1
bmj4_9_e005400.full;86 284 women;86284;-1
bmj4_9_e005400.full;1 121 women;1121;-1
bmj4_9_e005400.full;5508 women;5508;-1
bmj4_9_e005400.full;92 834 UKCTOCS participants;92834;-1
bmj4_9_e005400.full;202 638  were recruited;202638;-1
bmj4_9_e005400.full;total of 157 997;157997;-1
bmj4_9_e005400.full;total of 10 689;10689;-1
bmj4_9_e005400.full; data. The HR of 1;1;-1
bmj4_9_e005462.full;1221  young Danish men recruited;1221;-1
bmj4_9_e005462.full;N=1221;1221;-1
bmj4_9_e005462.full;N=1194;1194;-1
bmj4_9_e005462.full;N=553;553;-1
bmj4_9_e005462.full;N  =5;5;-1
bmj4_9_e005462.full;N  =1;1;-1
bmj4_9_e005462.full;total of 1221;1221;-1
bmj4_9_e005462.full;total of 553;553;-1
bmj4_9_e005480.full;16 Survey participants;16;-1
bmj4_9_e005480.full;18 533  individuals;18533;-1
bmj4_9_e005480.full;31 598 individuals;31598;-1
bmj4_9_e005480.full;7850 individuals;7850;-1
bmj4_9_e005480.full;6046 individuals;6046;-1
bmj4_9_e005480.full;13 896 individuals;13896;-1
bmj4_9_e005480.full;13 896 adults;13896;-1
bmj4_9_e005480.full;total of 13 896;13896;-1
bmj4_9_e005480.full; data from HSE 2009;2009;-1
bmj4_9_e005525.full;702  patients;702;-1
bmj4_9_e005525.full;391 patients;391;-1
bmj4_9_e005525.full;311 patients;311;-1
bmj4_9_e005525.full;702 patients;702;-1
bmj4_9_e005525.full;1 Flow diagram of  patients;1;-1
bmj4_9_e005525.full;n=391;391;-1
bmj4_9_e005525.full;n=311;311;-1
bmj4_9_e005532.full;2742 patients;2742;-1
bmj4_9_e005532.full;1718 patients;1718;-1
bmj4_9_e005532.full;475 consecutive outpatients;475;-1
bmj4_9_e005532.full;total of 58;58;-1
bmj4_9_e005549.full;N=3;3;-1
bmj4_9_e005549.full;N=1;1;-1
bmj4_9_e005549.full;N=7;7;-1
bmj4_9_e005549.full;n=37;37;-1
bmj4_9_e005549.full;N=40;40;-1
bmj4_9_e005549.full;N=9;9;-1
bmj4_9_e005549.full;N=160;160;-1
bmj4_9_e005549.full;N  =1;1;-1
bmj4_9_e005575.full;1  Symptomatic participants;1;-1
bmj4_9_e005575.full;97  participants;97;-1
bmj4_9_e005575.full;801 individuals;801;-1
bmj4_9_e005575.full;n=801;801;-1
bmj4_9_e005575.full;n=97;97;-1
bmj4_9_e005575.full;n=34;34;-1
bmj4_9_e005575.full;n=63;63;-1
bmj4_9_e005575.full;n=38;38;-1
bmj4_9_e005575.full;n=59;59;-1
bmj4_9_e005575.full;N=1720;1720;-1
bmj4_9_e005575.full;N=801;801;-1
bmj4_9_e005575.full;N=100;100;-1
bmj4_9_e005575.full;N=153;153;-1
bmj4_9_e005575.full;N=34;34;-1
bmj4_9_e005575.full;N=63;63;-1
bmj4_9_e005575.full;N=37;37;-1
bmj4_9_e005575.full;N=59;59;-1
bmj4_9_e005628.full;100 000 persons;100000;-1
bmj4_9_e005628.full;100 000  persons;100000;-1
bmj4_9_e005628.full;total of 335 609;335609;-1
bmj4_9_e005629.full;5036 participants;5036;-1
bmj4_9_e005629.full;5209 participants;5209;-1
bmj4_9_e005629.full;5036 eligible study participants;5036;-1
bmj4_9_e005629.full;n=5036;5036;-1
bmj4_9_e005629.full;n=576;576;-1
bmj4_9_e005635.full;74  experimental participants;74;901
bmj4_9_e005635.full;74 control participants;74;867
bmj4_9_e005635.full;11 These patients;11;12067
bmj4_9_e005635.full;800 patients;800;9424
bmj4_9_e005647.full;25 000 people;25000;-1
bmj4_9_e005647.full;total of 1136;1136;-1
bmj4_9_e005647.full;total of  1136;1136;-1
bmj4_9_e005647.full;total of  1206;1206;-1
bmj4_9_e005651.full;1 Flow of participants;1;-1
bmj4_9_e005651.full;10 000 patients;10000;-1
bmj4_9_e005651.full;4701 patients;4701;-1
bmj4_9_e005651.full;50 surgical patients;50;-1
bmj4_9_e005651.full;200 patients;200;-1
bmj4_9_e005651.full;2000 patients;2000;-1
bmj4_9_e005651.full;6000 patients;6000;-1
bmj4_9_e005651.full;22 000 patients;22000;-1
bmj4_9_e005651.full;2500 patients;2500;-1
bmj4_9_e005651.full;1200 patients;1200;-1
bmj4_9_e005651.full;80 million  individuals;80;-1
bmj4_9_e005651.full;n=13;13;-1
bmj4_9_e005651.full;N=200;200;-1
bmj4_9_e005651.full;N=400;400;-1
bmj4_9_e005651.full;N=50;50;-1
bmj4_9_e005651.full;N=100;100;-1
bmj4_9_e005651.full;N=90;90;-1
bmj4_9_e005651.full;N=80;80;-1
bmj4_9_e005651.full;N=70;70;-1
bmj4_9_e005665.full;1026 patients;1026;-1
bmj4_9_e005665.full;878 patients;878;-1
bmj4_9_e005665.full;962 patients;962;-1
bmj4_9_e005665.full;1025 CDI group  patients;1025;-1
bmj4_9_e005665.full;101 patients;101;-1
bmj4_9_e005665.full;924 patients;924;-1
bmj4_9_e005665.full;11 patients;11;-1
bmj4_9_e005665.full;102 patients;102;-1
bmj4_9_e005665.full;total of 1026;1026;-1
bmj4_9_e005665.full;total of 962;962;-1
bmj4_9_e005665.full; data from 924;924;-1
bmj4_9_e005687.full;600 study participants;600;-1
bmj4_9_e005687.full;300 participants;300;-1
bmj4_9_e005702.full;10 patients;10;-1
bmj4_9_e005702.full;60 patients;60;-1
bmj4_9_e005744.full;2649  postmenopausal women;2649;-1
bmj4_9_e005744.full;100  participants;100;-1
bmj4_9_e005744.full;400 eligible patients;400;-1
bmj4_9_e005744.full;20  patients;20;-1
bmj4_9_e005744.full;9 A high pro-  portion of people;9;-1
bmj4_9_e005744.full;4200 people;4200;-1
bmj4_9_e005768.full;10 persons;10;-1
bmj4_9_e005768.full;32 832 participants;32832;-1
bmj4_9_e005768.full;32 832 study participants;32832;-1
bmj4_9_e005768.full;4 million people;4;-1
bmj4_9_e005768.full;n=1242;1242;-1
bmj4_9_e005768.full;n=3;3;-1
bmj4_9_e005768.full;N=32 832;32832;-1
bmj4_9_e005768.full;N=313;313;-1
bmj4_9_e005768.full;n  =3;3;-1
bmj4_9_e005768.full;N  =1;1;-1
bmj4_9_e005768.full;N  =4;4;-1
bmj4_9_e005768.full;N  =8;8;-1
bmj4_9_e005768.full;N  =2;2;-1
bmj4_9_e005768.full;n=313;313;-1
bmj4_9_e005768.full;N=15 279;15279;-1
bmj4_9_e005768.full;N=4794;4794;-1
bmj4_9_e005768.full;N=8307;8307;-1
bmj4_9_e005768.full;N=2480;2480;-1
bmj4_9_e005768.full;N=2099;2099;-1
bmj4_9_e005768.full;N=8162;8162;-1
bmj4_9_e005768.full;total of 32 832;32832;-1
bmj4_9_e005789.full;109 patients;109;-1
bmj4_9_e005789.full;17 a group of patients;17;-1
bmj4_9_e005789.full;22 nor did patients;22;-1
bmj4_9_e005789.full;17 no patients;17;-1
bmj4_9_e005789.full;18 included patients;18;-1
bmj4_9_e005789.full;19 included  patients;19;-1
bmj4_9_e005789.full;11 In adults;11;-1
bmj4_9_e005789.full;n=  14;14;-1
bmj4_9_e005789.full;n=  81;81;-1
bmj4_9_e005789.full;n=  8;8;-1
bmj4_9_e005789.full;n=  16;16;-1
bmj4_9_e005789.full;n=  26;26;-1
bmj4_9_e005789.full;n=  10;10;-1
bmj4_9_e005789.full;n=  32;32;-1
bmj4_9_e005789.full;n=  69;69;-1
bmj4_9_e005789.full;n=  19;19;-1
bmj4_9_e005789.full;n=  13;13;-1
bmj4_9_e005789.full;n=  11;11;-1
bmj4_9_e005789.full;n=  21;21;-1
bmj4_9_e005789.full;n=  65;65;-1
bmj4_9_e005789.full;n=  18;18;-1
bmj4_9_e005789.full;total of 266;266;-1
bmj4_9_e005801.full;128  participants;128;10169
bmj4_9_e005801.full;73 participants;73;6458
bmj4_9_e005801.full;128 participants;128;6542
bmj4_9_e005801.full;128 consecutive patients;128;10334
bmj4_9_e005801.full;92 patients;92;9620
bmj4_9_e005801.full;73 patients;73;9518
bmj4_9_e005801.full;37 patients;37;8967
bmj4_9_e005801.full;4184 LBP and patients;4184;137
bmj4_9_e005801.full;150 eligible patients;150;192
bmj4_9_e005801.full;128 patients;128;265
bmj4_9_e005801.full;22 patients;22;475
bmj4_9_e005801.full;55 patients;55;965
bmj4_9_e005801.full;65 patients;65;1893
bmj4_9_e005801.full;66 patients;66;2048
bmj4_9_e005801.full;58 patients;58;2183
bmj4_9_e005801.full;35 patients;35;2427
bmj4_9_e005801.full;23 patients;23;3076
bmj4_9_e005801.full;4 patients;4;3338
bmj4_9_e005801.full;27  patients;27;4046
bmj4_9_e005801.full;73  patients;73;4156
bmj4_9_e005801.full;27 patients;27;23922
bmj4_9_e005801.full;5  people;5;17083
bmj4_9_e005801.full;n=36;36;1103
bmj4_9_e005801.full;n=73;73;5028
bmj4_9_e005801.full;n=55;55;5043
bmj4_9_e005801.full;total of 128;128;10343
bmj4_9_e005801.full;total of 4184;4184;128
bmj4_9_e005815.full;20 participants;20;-1
bmj4_9_e005815.full;5 classes are recruited;5;-1
bmj4_9_e005815.full;400 children will be recruited;400;-1
bmj4_9_e005848.full;n=1360;1360;-1
bmj4_9_e005848.full;n=140;140;-1
bmj4_9_e005848.full;n=145;145;-1
bmj4_9_e005848.full;n=68;68;-1
bmj4_9_e005864.full;3660 patients;3660;-1
bmj4_9_e005864.full;3600  patients;3600;-1
bmj4_9_e005864.full;3600 patients;3600;-1
bmj4_9_e005864.full;3664 patients;3664;-1
bmj4_9_e005864.full;1188 patients;1188;-1
bmj4_9_e005864.full;12 and patients;12;-1
bmj4_9_e005864.full;2500 patients;2500;-1
bmj4_9_e005864.full;total of 3664;3664;-1
bmj4_9_e005874.full;1510 patients;1510;-1
bmj4_9_e005874.full;n=16;16;-1
bmj4_9_e005874.full;n=11;11;-1
bmj4_9_e005874.full;n=10;10;-1
bmj4_9_e005874.full;n=3;3;-1
bmj4_9_e005874.full;n=5;5;-1
bmj4_9_e005874.full;n= 4;4;-1
bmj4_9_e005874.full;n=2;2;-1
bmj4_9_e005874.full;n=9;9;-1
bmj4_9_e005874.full;n=1;1;-1
bmj4_9_e005874.full;n=8;8;-1
bmj4_9_e005878.full;13 983 adults;13983;-1
bmj4_9_e005878.full;8420 adults;8420;-1
bmj4_9_e005878.full;8610 adults;8610;-1
bmj4_9_e005878.full;17 030 adults;17030;-1
bmj4_9_e005878.full;n=13983;13983;-1
bmj4_9_e005878.full;N=13 983;13983;-1
bmj4_9_e005878.full;total of 8420;8420;-1
bmj4_9_e005878.full;total of 8610;8610;-1
bmj4_9_e005898.full;9  patients;9;-1
bmj4_9_e005898.full;21 studies  and groups of patients;21;-1
bmj4_9_e005898.full;41 of the patients;41;-1
bmj4_9_e005898.full;51 In patients;51;-1
bmj4_9_e005898.full;36 of outpatients;36;-1
bmj4_9_e005898.full;n=10;10;-1
bmj4_9_e005898.full;n=17;17;-1
bmj4_9_e005898.full;n=3;3;-1
bmj4_9_e005898.full;n=4;4;-1
bmj4_9_e005898.full;n=21;21;-1
bmj4_9_e005898.full;n=14;14;-1
bmj4_9_e005898.full;n=6;6;-1
bmj4_9_e005898.full;n=19;19;-1
bmj4_9_e005898.full;n=15;15;-1
bmj4_9_e005898.full;n=56;56;-1
bmj4_9_e005898.full;n=8;8;-1
bmj4_9_e005898.full;n=45;45;-1
bmj4_9_e005898.full;n=27;27;-1
bmj4_9_e005898.full;n=16;16;-1
bmj4_9_e005898.full;n=2;2;-1
bmj4_9_e005898.full;n=1;1;-1
bmj4_9_e005898.full;total of 1491;1491;-1
bmj4_9_e005898.full; data of the 21;21;-1
bmj4_9_e005923.full;41 All  participants;41;-1
bmj4_9_e005923.full;23 participants;23;-1
bmj4_9_e005923.full;66 individuals;66;-1
bmj4_9_e005923.full;23 self-referred adults;23;-1
bmj4_9_e005923.full;N=23;23;-1
bmj4_9_e005923.full;n=2;2;-1
bmj4_9_e005923.full;n=0;0;-1
bmj4_9_e005923.full;n=30;30;-1
bmj4_9_e005923.full;total of 66;66;-1
bmj4_9_e005931.full;550 new patients;550;-1
bmj4_9_e005931.full;1000 adult  patients;1000;-1
bmj4_9_e005931.full;1000 patients;1000;-1
bmj4_9_e005931.full;550  patients;550;-1
bmj4_9_e005931.full;275 patients;275;-1
bmj4_9_e005968.full;102 consecutive  outpatients;102;-1
bmj4_9_e005968.full;104 patients;104;-1
bmj4_9_e005968.full;102  consecutive patients;102;-1
bmj4_9_e005968.full;102 patients;102;-1
bmj4_9_e005968.full;84 patients;84;-1
bmj4_9_e005968.full;13 patients;13;-1
bmj4_9_e005968.full;5 patients;5;-1
bmj4_9_e005968.full;37 patients;37;-1
bmj4_9_e006016.full;1000 women;1000;-1
bmj4_9_e006016.full;15 These  women;15;-1
bmj4_9_e006016.full;34 additional women;34;-1
bmj4_9_e006016.full;36 women;36;-1
bmj4_9_e006016.full;15  women;15;-1
bmj4_9_e006016.full;50 women;50;-1
bmj4_9_e006016.full;2 participants;2;-1
bmj4_9_e006016.full;15 participants;15;-1
bmj4_9_e006016.full;1 participants;1;-1
bmj4_9_e006016.full;1  participants;1;-1
bmj4_9_e006016.full;17 Trial participants;17;-1
bmj4_9_e006016.full;n=15;15;-1
bmj4_9_e006016.full;n=34;34;-1
bmj4_9_e006016.full;n=13;13;-1
bmj4_9_e006016.full;n=16;16;-1
bmj4_9_e006016.full;n=18;18;-1
bmj4_9_e006016.full;n=6;6;-1
bmj4_9_e006021.full;58  While online access allows patients;58;-1
bmj4_9_e006021.full;76 and patients;76;-1
bmj4_9_e006021.full;97 103 106 112 116 120 121  While patients;9,71031E+19;-1
bmj4_9_e006021.full;n=17;17;-1
bmj4_9_e006021.full;n=13;13;-1
bmj4_9_e006021.full;n=3;3;-1
bmj4_9_e006021.full;n=5;5;-1
bmj4_9_e006021.full;n=16;16;-1
bmj4_9_e006021.full;n=8;8;-1
bmj4_9_e006021.full;total of 143;143;-1
bmj4_9_e006044.full;7,030 individuals;7030;-1
bmj4_9_e006044.full;total of 780;780;-1
bmj4_9_e006047.full;21  RESULTS  participants;21;578
bmj4_9_e006047.full;9  Manual participants;9;19340
bmj4_9_e006047.full;16 people;16;3364
bmj4_9_e006047.full;n  =2;2;2475
bmj4_9_e006047.full;n  =1;1;2719
bmj4_9_e006047.full;n  =6;6;2749
bmj4_9_e006065.full;25 000 of these patients;25000;-1
bmj4_9_e006065.full;1000 patients;1000;-1
bmj4_9_e006065.full;1000  patients;1000;-1
bmj4_9_e006084.full;3  female patients;3;-1
bmj4_9_e006084.full;n=216;216;-1
bmj4_9_e006084.full;n=165;165;-1
bmj4_9_e006084.full;n=36;36;-1
bmj4_9_e006084.full;n=33;33;-1
bmj4_9_e006084.full;n=30;30;-1
bmj4_9_e006084.full;n=26;26;-1
bmj4_9_e006084.full;n=24;24;-1
bmj4_9_e006084.full;n=21;21;-1
bmj4_9_e006084.full;n=20;20;-1
bmj4_9_e006084.full;n=5;5;-1
bmj4_9_e006084.full;n=4;4;-1
bmj4_9_e006084.full;n=1;1;-1
bmj4_9_e006084.full;total of 10;10;-1
bmj4_9_e006084.full;total of 288;288;-1
bmj4_9_e006084.full;total of 20;20;-1
bmj4_9_e006096.full;100 participants;100;1134
bmj4_9_e006096.full;1300 children will be  recruited;1300;186
bmj4_9_e006096.full;200 children recruited;200;2049
bmj4_9_e006096.full;total of 1000;1000;1533
bmj4_9_e006096.full;total of 1300;1300;177
bmj4_9_e006096.full;total of 10;10;1533
bmj4_9_e006096.full;1000 children enrolled;1000;9191
bmj4_9_e006096.full;200 children enrolled;200;8111
bmj4_9_e006136.full;228 patients;228;-1
bmj4_9_e006136.full;6  We enrolled patients;6;-1
bmj4_9_e006136.full;253 patients;253;-1
bmj4_9_e006136.full;21  patients;21;-1
bmj4_9_e006136.full;15 patients;15;-1
bmj4_9_e006136.full;6 patients;6;-1
bmj4_9_e006136.full;53 patients;53;-1
bmj4_9_e006136.full;n=53;53;-1
bmj4_9_e006136.full;6  We enrolled;6;-1
bmj4_9_e006143.full;28 192 pregnant women;28192;14427
bmj4_9_e006143.full;75 200 fathers. Pregnant women;75200;7773
bmj4_9_e006143.full;28 192  nulliparous women;28192;6183
bmj4_9_e006143.full;28 192 women;28192;2756
bmj4_9_e006143.full;28 192 pregnant  women;28192;3797
bmj4_9_e006143.full;2997 women;2997;13269
bmj4_9_e006143.full;34 Participants were  recruited;34;7980
bmj4_9_e006143.full;n=1491;1491;13965
bmj4_9_e006143.full;n=2493;2493;13881
bmj4_9_e006143.full;n=63 808;63808;6604
bmj4_9_e006143.full;n=1475;1475;6486
bmj4_9_e006143.full;n=29 111;29111;6437
bmj4_9_e006143.full;n=736;736;6264
bmj4_9_e006143.full;n=4294;4294;6227
bmj4_9_e006143.full;n=450;450;4327
bmj4_9_e006143.full;n=1976;1976;4313
bmj4_9_e006143.full;n=979;979;4291
bmj4_9_e006143.full;n=11;11;4269
bmj4_9_e006143.full;n=584;584;1390
bmj4_9_e006143.full;n=632;632;840
bmj4_9_e006145.full;17 000 women;17000;-1
bmj4_9_e006145.full;10 million eligible  women;10;-1
bmj4_9_e006145.full;1789 women;1789;-1
bmj4_9_e006145.full;300 women;300;-1
bmj4_9_e006145.full;5000 women;5000;-1
bmj4_9_e006204.full;103 participants;103;21881
bmj4_9_e006204.full;45 participants;45;17672
bmj4_9_e006204.full;40 participants;40;16816
bmj4_9_e006204.full;124 participants;124;501
bmj4_9_e006204.full;280  participants;280;575
bmj4_9_e006204.full;321 participants;321;8331
bmj4_9_e006204.full;280 participants;280;8433
bmj4_9_e006204.full;8 patients;8;16768
bmj4_9_e006204.full;64  patients;64;17
bmj4_9_e006204.full;1 diabetic patients;1;17270
bmj4_9_e006204.full;250 000 individuals;250000;28718
bmj4_9_e006204.full;280 adults;280;29868
bmj4_9_e006204.full;8 adults;8;15249
bmj4_9_e006204.full;1DM  were recruited;1;18502
bmj4_9_e006204.full;15  DAFNE graduates were recruited;15;7604
bmj4_9_e006204.full;321 participants  were recruited;321;8331
bmj4_9_e006204.full;total of 5;5;26562
bmj4_9_e006204.full;total of 103;103;21890
bmj4_9_e006204.full;total of 321;321;8322
bmj4_9_e006258.full;39 748 patients;39748;-1
bmj4_9_e006258.full;40 000 people;40000;-1
bmj4_9_e006258.full;63 558 people;63558;-1
bmj4_9_e006258.full;39 748 people;39748;-1
bmj4_9_e006258.full;n=25 961;25961;-1
bmj4_9_e006258.full; data from 2012;2012;-1
bmj4_9_e006258.full; data from 2002;2002;-1
bmj4_9_e006318.full;65 women;65;-1
bmj4_9_e006318.full;65 participants;65;-1
bmj4_9_e006318.full;160  participants;160;-1
bmj4_9_e006318.full;42 patients;42;-1
bmj4_9_e006318.full;160 female  patients;160;-1
bmj4_9_e006318.full;26 patients;26;-1
bmj4_9_e006318.full;80 parti-  cipants recruited;80;-1
bmj4_9_e006318.full;total of 16 595;16595;-1
bmj4_9_e006318.full;total of 160;160;-1
bmj4_9_e006436.full;184 women;184;-1
bmj4_9_e006436.full;21 All women;21;-1
bmj4_9_e006436.full;16 primipar-  ous women;16;-1
bmj4_9_e006436.full;n=0;0;-1
bmj4_9_e006436.full;n=184;184;-1
bmj4_9_e006436.full;n=368;368;-1
p115-lee;1 required   subjects;1;-1
p115-lee;2 required subjects;2;-1
p115-lee;1 Subjects   Fifty-six subjects;1;-1
p153-bisseret;900 persons;900;-1
p155-ware;n = 2;2;-1
p161-jackson;16 adult subjects;16;-1
p161-jackson;16   subjects;16;-1
p161-jackson;16 subjects;16;-1
p161-jackson; data of the 16;16;-1
p191-poltrock;25 people;25;-1
p197-grudin;200 individuals;200;-1
p211-mackay;13 participants;13;-1
p211-mackay;60   people;60;-1
p211-mackay;25 people;25;-1
p211-mackay;total of 190;190;-1
p217-hendrickson;36 subjects;36;-1
p217-hendrickson;n = 17;17;-1
p217-hendrickson;n = 35;35;-1
p217-hendrickson;n = 59;59;-1
p217-hendrickson;n = 3;3;-1
p217-hendrickson;n = 6;6;-1
p217-hendrickson;n = 10;10;-1
p241-hauptmann;36 subjects;36;-1
p241-hauptmann;3 percent of the subjects;3;-1
p241-hauptmann;total of 2397;2397;-1
p289-whalen;10 people;10;-1
p289-whalen;7 people;7;-1
p289-whalen;total of 415;415;-1
p311-hunt;25 of these individuals;25;-1
p347-halstead-nussloch;22 participants;22;-1
p347-halstead-nussloch;22   participants;22;-1
p353-ehrlich;4 people;4;-1
p353-ehrlich;80 volunteers were recruited;80;-1
p37-yoder;15 people;15;-1
p375-gillan;total of 68;68;-1
p381-cole;90   subjects;90;-1
p381-cole;18   control subjects;18;-1
p381-cole;18   contingency table subjects;18;-1
p381-cole;18   probability map subjects;18;-1
p381-cole;18   signal detection curve subjects;18;-1
p381-cole;18   detection bars subjects;18;-1
p381-cole;18 subjects;18;-1
p381-cole;1000 people;1000;-1
p381-cole;101 people;101;-1
p381-cole;total of   16;16;-1
p43-sheffield;8 subjects;8;-1
p43-sheffield;7 other subjects;7;-1
p43-sheffield;110 subjects;110;-1
p43-sheffield;total of 110;110;-1
p43-sheffield;   data from 4;4;-1
p75-spenke; database of 10;10;-1
p81-black;42 subjects;42;-1
p81-black;total of 42;42;-1
p117-card;01 tbm subjects;1;-1
p145-cushman;5812   ABSTRACT   Forty-two subjects;5812;-1
p145-cushman;42 subjects;42;-1
p145-cushman;N = 42;42;-1
p19-dillon;total of 55;55;-1
p209-jacobs;290 persons;290;-1
p213-jellinek;n   = 2;2;-1
p213-jellinek;n = 1;1;-1
p213-jellinek;n =   0;0;-1
p221-walker;n = 730;730;-1
p221-walker;n = 947;947;-1
p221-walker;n = 792;792;-1
p221-walker;n   = 844;844;-1
p221-walker;n = 771;771;-1
p221-walker;n   = 864;864;-1
p221-walker;n = 921;921;-1
p221-walker;n = 813;813;-1
p221-walker;n = 960;960;-1
p221-walker;n = 847;847;-1
p221-walker;n = 926;926;-1
p221-walker;n =   987;987;-1
p221-walker;n = 1094;1094;-1
p227-gillan;3 female   subjects;3;-1
p227-gillan;4 female subjects;4;-1
p235-lewis;15   subjects;15;-1
p249-nielsen;34 people;34;-1
p249-nielsen;total of 52;52;-1
p249-nielsen;total of 48;48;-1
p249-nielsen;total of 34;34;-1
p269-campbell;total of 14;14;-1
p287-zachary;20 individuals;20;-1
p313-tang;0 allows multiple participants;0;-1
p313-tang;4 people;4;-1
p391-gillan;n = 13;13;-1
p391-gillan;n =   11;11;-1
p451-salomon;total of 1802;1802;-1
p99-gong;13 participants;13;-1
p119-jeffries;7 Such people;7;-1
p125-koenemann;6 subjects;6;-1
p137-lohse;28 subjects;28;-1
p137-lohse; data from 28;28;-1
p145-lundell;total of 21;21;-1
p153-mackay;0 people;0;-1
p153-mackay;total of 226;226;-1
p153-mackay;total of 102;102;-1
p161-mackenzie;n = 16;16;-1
p203-mantei;2 video configuration of all  participants;2;-1
p237-murakami;total of  252;252;-1
p257-palmiter;1  people;1;-1
p293-sebrechts;11 subjects;11;-1
p293-sebrechts;67  N = number of subjects;67;-1
p293-sebrechts;n = 4;4;-1
p329-tetzlaff;2 participants;2;-1
p335-thovtrup;15 participants;15;-1
p351-wenzel;12 of the  subjects;12;-1
p351-wenzel;3 subjects;3;-1
p351-wenzel;10 kHz region of the subjects;10;-1
p351-wenzel;16 subjects;16;-1
p351-wenzel;12 subjects;12;-1
p351-wenzel;12 individual subjects;12;-1
p351-wenzel;11 of the subjects;11;-1
p351-wenzel;8 experienced subjects;8;-1
p351-wenzel;8 subjects;8;-1
p351-wenzel;16  subjects;16;-1
p351-wenzel;total of 18;18;-1
p351-wenzel; data from 6;6;-1
p351-wenzel; data from 18;18;-1
p445-cypher;7 subjects;7;-1
p445-cypher;5 subjects;5;-1
p447-don;total of 589;589;-1
p453-lunati;172 confer-  ence participants;172;-1
p459-plaisant;14  subjects;14;-1
p11-koons;2 subjects;2;-1
p11-koons;1 subjects;1;-1
p11-koons;N=8;8;-1
p11-koons;N=5;5;-1
p127-ballas;12 subjects;12;-1
p127-ballas;20 subjects;20;-1
p149-mulligan;50 people;50;-1
p157-garber;4 people;4;-1
p165-peck;total of 30;30;-1
p19-mynatt;n =  1;1;-1
p19-mynatt;n  = 0;0;-1
p19-mynatt;n = 1;1;-1
p19-mynatt;n = 200;200;-1
p19-mynatt;n= 235;235;-1
p19-mynatt;n = 152;152;-1
p19-mynatt;n = 269;269;-1
p195-myers;74 individuals;74;-1
p195-myers;10 individuals;10;-1
p195-myers;N = 63;63;-1
p195-myers;N = 42;42;-1
p195-myers;N= 18;18;-1
p195-myers;N =25;25;-1
p195-myers;N  =27;27;-1
p195-myers;N = 15;15;-1
p195-myers;N= 22;22;-1
p195-myers;N = 26;26;-1
p211-jacob;14 women;14;-1
p211-jacob;40 subjects;40;-1
p219-mackenzie;n = 78;78;-1
p219-mackenzie;total of 1170;1170;-1
p27-gaver;6,000 miles away  with those of people;6000;-1
p295-teal;2k!&& Fourteen subjects;2;15036
p295-teal;6 as subjects;6;3565
p307-gray;24 curn?nt participants;24;-1
p307-gray;total  of 78,240;78240;-1
p37-fish;22 other people;22;-1
p397-karat;48 participants;48;-1
p397-karat;8 people;8;-1
p397-karat;total of 48;48;-1
p397-karat;total of  47;47;-1
p405-pausch;0  subjects;0;-1
p413-degen;1992  All participants;1992;-1
p419-resnick;12 subjects;12;-1
p419-resnick;6 subjects;6;-1
p419-resnick;12 younger  subjects;12;-1
p419-resnick;6 older subjects;6;-1
p419-resnick;6 older  subjects;6;-1
p419-resnick;40 different people;40;-1
p419-resnick;total of 72;72;-1
p455-muller;n=5;5;-1
p455-muller;n=2;2;-1
p471-rieman;100  individuals;100;-1
p49-sellen;15 women;15;-1
p49-sellen;48  subjects;48;-1
p541-dourish;22 people;22;-1
p557-nielsen;total of 27;27;-1
p557-nielsen;total of 40;40;-1
p565-mrazek;135 people;135;-1
p619-ahlberg;4 subjects;4;-1
p619-ahlberg;total of 18;18;-1
p627-mander;10 participants;10;-1
p639-de_cecco;total of 6;6;-1
p65-raffler;35 people;35;-1
p75-osborn;60 subjects;60;-1
p75-osborn;100 individuals;100;-1
p149-nilsen;26 Novice subjects;26;-1
p149-nilsen;total of 26;26;-1
p157-fischer;n  =3;3;-1
p179-stifelman;93  Method  Six participants;93;-1
p187-takeuchi;32  volunteer subjects;32;-1
p194-frishberg;14 deaf people;14;-1
p198-bailey;n = 6;6;-1
p198-bailey;n = 9;9;-1
p198-bailey;n = 1;1;-1
p198-bailey;n  = 2;2;-1
p198-bailey;n =  10;10;-1
p198-bailey;n = 5;5;-1
p206-nielsen;15 subjects;15;-1
p206-nielsen;N=41;41;-1
p214-nielsen;n=9;9;-1
p214-nielsen;total of 3000;3000;-1
p228-gaver;n= 01;1;-1
p236-alm;n =  4;4;-1
p236-alm;n = 20;20;-1
p236-alm;n = 14;14;-1
p236-alm;n = 22;22;-1
p236-alm;n = 6;6;-1
p308-desmarais;26 subjects;26;-1
p308-desmarais;6 display scores of two subjects;6;-1
p321-rieman;total of 69;69;-1
p327-nardi;total  of 14;14;-1
p355-tognazzini;300 people;300;-1
p367-taylor;total of 84;84;-1
p37-ware;2  involved subjects;2;-1
p37-ware;3D data?  Seven subjects;3;-1
p37-ware;4  subjects;4;-1
p37-ware;total of 60;60;-1
p391-pedersen;8 people;8;-1
p399-baecker;40  subjects;40;-1
p399-baecker;60 individuals;60;-1
p446-byrne;15 subjects;15;-1
p446-byrne;45 subjects;45;-1
p446-byrne;total of 216;216;-1
p446-byrne;total of 3240;3240;-1
p454-golovchinsky;20 participants;20;-1
p454-golovchinsky;27 subjects;27;-1
p465-mohageg;200 subjects;200;-1
p474-kabbash;24 subjects;24;-1
p488-mackenzie;4 fully within-subjects;4;-1
p488-mackenzie;n = 48;48;-1
p488-mackenzie;  data rate of 38;38;-1
p494-lee;n = 8;8;-1
p494-lee;n = 1;1;-1
p494-lee;n = 2;2;-1
p494-lee;  database of 10,000;10000;-1
p500-instone;15 subjects;15;-1
p500-instone;n =  8;8;-1
p500-instone;n = 0;0;-1
p500-instone;n =  1;1;-1
p51-eisenstadt;2,000,000 people;2000000;-1
p57-weiler;n=33;33;-1
p61-stasko;10 subjects;10;554
p61-stasko;total of 45;45;4504
p61-stasko;total of 10;10;545
p74-fix;1 asked subjects;1;-1
p74-fix;2 required subjects;2;-1
p74-fix;7 gave  subjects;7;-1
p74-fix;8 asked subjects;8;-1
p74-fix;10 required subjects;10;-1
p10-ballay;22 people;22;-1
p131-whittaker;50  people;50;-1
p131-whittaker;97 other people;97;-1
p131-whittaker;20 internal and external people;20;-1
p131-whittaker;N= 152;152;-1
p131-whittaker;N=142;142;-1
p131-whittaker;N= 294;294;-1
p131-whittaker;total of 294;294;-1
p131-whittaker;total of 55;55;-1
p145-mcdaniel;  data from 5;5;-1
p152-nielsen; database of  249;249;-1
p152-nielsen; database of 249;249;-1
p159-chase;00001  five subjects;1;5656
p159-chase;total of 180;180;2927
p16-lemaire; data from  24;24;-1
p173-brewster;12 subjects;12;-1
p173-brewster;12 of the subjects;12;-1
p180-rao;total of 6794;6794;-1
p198-bennett;7 people;7;-1
p198-bennett;12 people;12;-1
p205-oviatt;10 subjects;10;-1
p205-oviatt;N = 17;17;-1
p205-oviatt;N = 14;14;-1
p205-oviatt;N =  14;14;-1
p205-oviatt;N = 16;16;-1
p205-oviatt;total of 1;1;-1
p238-card;total of 55;55;-1
p238-card; data from 1993;1993;-1
p258-kurtenbach;total of 8;8;-1
p258-kurtenbach;total of 3,013;3013;-1
p258-kurtenbach;total of  1,945;1945;-1
p271-whittaker;17meetingparticipants;17;-1
p271-whittaker;30 subjects;30;-1
p271-whittaker;17 people;17;-1
p271-whittaker;3 users were salespeople;3;-1
p271-whittaker;37 people;37;-1
p271-whittaker;12people;12;-1
p30-nishiyama;20 people;20;-1
p30-nishiyama;290 YO people;290;-1
p318-rao;total of 7429;7429;-1
p323-vora;10 subjects;10;-1
p344-irving;n = 19;19;-1
p344-irving;n = 6;6;-1
p344-irving;n= 6;6;-1
p351-gong;17  Formal Recruit and train subjects;17;-1
p37-tang;10 women;10;-1
p37-tang;20 people;20;-1
p411-douglas;23 subjects;23;-1
p411-douglas;11 subjects;11;-1
p411-douglas;12 subjects;12;-1
p411-douglas;n = 1;1;-1
p417-kabbash;9 subjects;9;-1
p417-kabbash;10 subjects;10;-1
p417-kabbash;total of 240;240;-1
p445-howes;total of 19;19;-1
p445-howes;total of 23;23;-1
p459-zhai;12  subjects;12;-1
p459-zhai;7 demonstrates subjects;7;-1
p58-weber;15 participants;15;-1
p65-ogozalek;64 elderly  participants;64;-1
p72-nass;33 subjects;33;-1
p72-nass;1 Results  Although subjects;1;-1
p72-nass;44 subjects;44;-1
p72-nass;66 subjects;66;-1
p72-nass;48 subjects;48;-1
p72-nass;5  When people;5;-1
p72-nass;N = 44;44;-1
p72-nass;total of 25;25;-1
p72-nass;total of 15;15;-1
p79-smets;total of 45;45;-1
p79-smets;total of 20;20;-1
p85-walker;49 people;49;-1
p85-walker;n=15;15;-1
p85-walker;n=12;12;-1
p11-kieras;total of 50;50;-1
p114-kline;2 is not aimed solely at people;2;-1
p130-muller;total of 410;410;-1
p130-muller;total of 38;38;-1
p162-karat;200 people;200;-1
p194-hill;291 participants;291;-1
p194-hill;291 total participants;291;-1
p194-hill; data set   of 55,000;55000;-1
p202-maltz;50 people;50;-1
p202-maltz;10 people;10;-1
p210-shardanand;2000 people;2000;-1
p210-shardanand;1000 people;1000;-1
p210-shardanand; database from 575;575;-1
p218-johnson;12 subjects;12;9927
p226-hix;total   of 8;8;-1
p304-knep;total of 20;20;-1
p304-knep;total of 296;296;-1
p310-ware;10 subjects;10;-1
p317-harrison;16 subjects;16;-1
p317-harrison;total of 180;180;-1
p317-harrison;total of 16;16;-1
p346-shipman;50   studies of the way people;50;-1
p354-isaacs;141 people;141;-1
p354-isaacs;250 people;250;-1
p362-olson;30 people;30;-1
p401-lamping;4 subjects;4;-1
p421-franzke;72 subjects;72;-1
p421-franzke;total of 72;72;-1
p429-john;total of 4;4;-1
p437-roesler;total of 209;209;-1
p437-roesler;total of 131;131;-1
p450-takeuchi;7   volunteer subjects;7;-1
p495-whittaker;30 people;30;-1
p503-frankish;24 subjects;24;-1
p503-frankish;1   asked subjects;1;-1
p503-frankish;total of 24;24;-1
p503-frankish;total of 18;18;-1
p525-wagner;4 participants;4;-1
p525-wagner;6   participants;6;-1
p558-perkins;130 people;130;-1
p74-wiedenbeck;51 subjects;51;-1
p74-wiedenbeck;95 MOSAIC OF CREATIVITY   subjects;95;-1
p74-wiedenbeck;total of 51;51;-1
p82-harrison;176 subjects;176;-1
p82-harrison;58 subjects;58;-1
p82-harrison;118 subjects;118;-1
p82-harrison;25 people;25;-1
p82-harrison;n = 58;58;-1
p82-harrison;n = 118;118;-1
p90-mittal;40 people;40;-1
p118-pirolli;N = 10;10;-1
p205-koenemann;n=64;64;-1
p205-koenemann;n=16;16;-1
p205-koenemann;Total of 6747;6747;-1
p205-koenemann;total of 1259;1259;-1
p213-pirolli;12   participants;12;-1
p213-pirolli;3 were aimed at providing participants;3;-1
p213-pirolli;4 wc had asked all participants;4;-1
p213-pirolli;N = 4;4;-1
p213-pirolli;N = 8;8;-1
p228-hartson;n = 12;12;264
p228-hartson;n = 14;14;239
p236-virzi;10 subjects;10;7308
p236-virzi;10   subjects;10;105
p236-virzi;2 relatively few of the subjects;2;1069
p236-virzi;total of 38;38;7657
p236-virzi;total of 21;21;386
p268-ackerman;9 participants;9;-1
p276-whittaker;20 participants;20;-1
p276-whittaker;n = 3;3;-1
p276-whittaker;n = 2;2;-1
p284-kraut;157 participants;157;-1
p284-kraut;126 participants;126;-1
p284-kraut;157   individuals;157;-1
p284-kraut;n=48;48;-1
p292-graham;5 effectively   describe subjects;5;-1
p300-mithal;6 subjects;6;-1
p308-zhai;10 subjects;10;-1
p308-zhai;5 subjects;5;-1
p308-zhai;4 subjects;4;-1
p308-zhai;6 DOF input devices were recruited;6;-1
p308-zhai;data from all 10;10;-1
p316-perez-quinones;12 seconds long and participants;12;-1
p316-perez-quinones;total of 29;29;-1
p316-perez-quinones;total of 7;7;-1
p332-bhavnani;43 subjects;43;-1
p340-page;101 participants;101;-1
p340-page;n = 117;117;-1
p340-page;total of 101;101;-1
p368-miller;6   participants;6;-1
p383-kamba;16 subjects;16;-1
p391-harrison;total of 540;540;-1
p391-harrison;total of 10;10;-1
p399-douglas;100 subjects;100;-1
p473-sullivan;560   subjects;560;-1
p489-hopper;400   people;400;-1
p506-druin;50 children of CHI participants;50;-1
p95-oviatt;18 subjects;18;-1
p95-oviatt;N = 17;17;-1
p95-oviatt;N = 16;16;-1
p95-oviatt;N = 14;14;-1
p11-baldonado;1  Description  Five subjects;1;-1
p115-tractinsky;26 people;26;-1
p131-borchers;104 participants;104;-1
p131-borchers;570 of the participants;570;-1
p155-muller;49 million people;49;-1
p162-chin;total of 17;17;-1
p202-moran;1997  brief study of people;1997;-1
p250-kandogan;12 subjects;12;-1
p250-kandogan;total of 12;12;-1
p258-wilcox;12 subjects;12;-1
p258-wilcox;29 subjects;29;-1
p258-wilcox;3 subjects;3;-1
p258-wilcox;2 subjects;2;-1
p258-wilcox;14 subjects;14;-1
p258-wilcox;6  subjects;6;-1
p258-wilcox;n=14;14;-1
p258-wilcox;n=15;15;-1
p258-wilcox;n=29;29;-1
p266-worden;8 participants;8;-1
p27-hinckley;16 subjects;16;-1
p27-hinckley;6 subjects;6;-1
p27-hinckley;8 female  subjects;8;-1
p27-hinckley;N=8;8;-1
p279-bellotti;25 people;25;-1
p295-accot;13 subjects;13;-1
p295-accot;n = 1;1;-1
p3-pirolli;8  participants;8;-1
p3-pirolli;N = 8;8;-1
p3-pirolli;N = 533;533;-1
p303-balakrishnan;7?ight  conditions where subjects;7;-1
p303-balakrishnan;10 subjects;10;-1
p303-balakrishnan;n  = 45,000;45000;-1
p311-balakrishnan;3D movement  required subjects;3;-1
p311-balakrishnan;5 compares subjects;5;-1
p311-balakrishnan;14 subjects;14;-1
p311-balakrishnan;n  = 5376;5376;-1
p319-sellen;25 people;25;-1
p319-sellen;5 people;5;-1
p327-arai;n  =  1;1;-1
p335-o_hara;4 of the subjects;4;-1
p335-o_hara;5 subjects;5;-1
p35-kurtenbach;total of 64;64;-1
p35-kurtenbach;total of 6;6;-1
p351-rader; data  from 23;23;-1
p359-lester;N= 100;100;-1
p391-yamaguchi;50 people;50;-1
p399-tauscher;23 participants;23;-1
p399-tauscher;23 subjects;23;-1
p399-tauscher;55 subjects;55;-1
p399-tauscher;1997  All subjects;1997;-1
p407-golovchinsky;24 subjects;24;-1
p407-golovchinsky;16 subjects;16;-1
p407-golovchinsky;n=5;5;-1
p407-golovchinsky;n=3;3;-1
p407-golovchinsky;n=8;8;-1
p407-golovchinsky;n=6;6;-1
p407-golovchinsky;n=9;9;-1
p415-oviatt;18 subjects;18;-1
p415-oviatt;8 subjects;8;-1
p415-oviatt;N = 9;9;-1
p415-oviatt;N= 14;14;-1
p423-kurze;1 Characteristics of the blind subjects;1;-1
p423-kurze;1U bll  subjects;1;-1
p423-kurze;2 late blind people;2;-1
p43-fitzmaurice;total of 4;4;-1
p43-fitzmaurice;total of 1800;1800;-1
p431-lai;total of  4018;4018;-1
p471-grisedale;630 million people;630;-1
p471-grisedale;6 people;6;-1
p471-grisedale;9,000 people;9000;-1
p471-grisedale;45 people;45;-1
p494-lambourne;30 people;30;-1
p536-kiesler;133  individuals;133;-1
p540-volbracht;81 participants;81;-1
p540-volbracht;81 subjects;81;-1
p540-volbracht;27 subjects;27;-1
p540-volbracht; data from T5;5;-1
p75-barrett;120 people;120;-1
p103-moon;1   A between-subjects;1;-1
p103-moon;2   A between-subjects;2;-1
p103-moon;N=123;123;-1
p103-moon;N=23;23;-1
p109-carey;31   participants;31;-1
p117-plante;20 subjects;20;-1
p124-faraday;8 All subjects;8;-1
p132-aaltonen;total of 44;44;-1
p148-nass;36 subjects;36;-1
p148-nass;total of 12;12;-1
p155-christian;n = 100;100;-1
p155-christian;n = 20;20;-1
p155-christian;n = 250;250;-1
p155-christian;n = 500;500;-1
p155-christian;total of 1801;1801;-1
p163-elvins;26 subjects;26;-1
p163-elvins;26   subjects;26;-1
p163-elvins;3D   worldlets enabled subjects;3;-1
p17-harrison;15 different people;15;-1
p17-harrison;n=7;7;-1
p17-harrison;total of 8;8;-1
p179-xiao;45   were subjects;45;-1
p179-xiao;total of 45;45;-1
p219-risden;65 subjects;65;-1
p219-risden;35 subjects;35;-1
p219-risden;70 individuals;70;-1
p219-risden;n = 36;36;-1
p219-risden;n = 34;34;-1
p233-o_hara;2 subjects;2;-1
p241-adler;15 subjects;15;-1
p241-adler;6   of these people;6;-1
p25-larson;19 subjects;19;-1
p25-larson;total of 24;24;-1
p257-friedlander;12 subjects;12;-1
p288-strommen;total of 12;12;-1
p320-zhai;16 subjects;16;-1
p328-masui;10,000 people;10000;-1
p328-masui;1,057 people;1057;-1
p328-masui;967 people;967;-1
p328-masui;126 people;126;-1
p328-masui;796 people;796;-1
p328-masui;899 people;899;-1
p328-masui;118 people;118;-1
p328-masui;718 people;718;-1
p328-masui;300 people;300;-1
p328-masui;31 people;31;-1
p328-masui;448 people;448;-1
p328-masui;n = 3;3;-1
p328-masui;n = 1;1;-1
p33-pirolli;N = 742,833;742833;-1
p336-mackenzie;12 participants;12;-1
p336-mackenzie;total of 19,440;19440;-1
p344-rekimoto;3 people;3;-1
p352-schiano;N = 558;558;-1
p352-schiano;N = 559;559;-1
p352-schiano;N = 515;515;-1
p352-schiano;n=81;81;-1
p352-schiano;n=99;99;-1
p352-schiano;total of 3122;3122;-1
p352-schiano;total of 3;3;-1
p360-roberts;330 participants;330;-1
p360-roberts;6 participants;6;-1
p360-roberts;6 people;6;-1
p360-roberts;2 people;2;-1
p360-roberts;3 individuals;3;-1
p368-kraut;229 individuals;229;-1
p368-kraut;386 individuals;386;-1
p368-kraut;179   individuals;179;-1
p368-kraut;N= 179;179;-1
p368-kraut; data from 179;179;-1
p384-dobson;3 patients;3;-1
p400-chi;total of 7,588;7588;-1
p41-abrams;50 participants;50;-1
p41-abrams;N = 7;7;-1
p432-sumner;6 participants;6;-1
p432-sumner;5000 students enrolled;5000;-1
p456-wojahn;29 subjects;29;-1
p456-wojahn;30 subjects;30;-1
p480-rowe;13 participants;13;3812
p496-rocco;3 subjects;3;-1
p496-rocco;6   subjects;6;-1
p511-gutwin;10   women;10;-1
p550-lange;150   people;150;-1
p558-mackay;15 people;15;-1
p582-walker;total of 6481;6481;-1
p582-walker; data consists of 144;144;-1
p65-johnson;total of 43;43;-1
p87-boyarski;4 participants;4;2152
p87-boyarski;16   participants;16;9872
p87-boyarski;N=16;16;796
p87-boyarski;n=16;16;6128
p9-balakrishnan;12 subjects;12;-1
p9-balakrishnan;6 compares subjects;6;-1
p104-singer;16 people;16;-1
p104-singer;total of 17;17;-1
p112-fukumoto;3 subjects;3;-1
p112-fukumoto;5 subjects;5;-1
p112-fukumoto;2 subjects;2;-1
p128-cohen;total of 48;48;-1
p136-omoigui;1 Conditions Tested  All subjects;1;-1
p136-omoigui;15 subjects;15;-1
p152-johnson;400 participants;400;-1
p17-palen;40 subjects;40;-1
p17-palen;20,000 people;20000;-1
p207-bruckman;211   adults;211;-1
p207-bruckman;total of 35,047;35047;-1
p207-bruckman;total of 314;314;-1
p207-bruckman;total of 1;1;-1
p207-bruckman;total of 1,275;1275;-1
p207-bruckman;total of 2,970;2970;-1
p207-bruckman;total of 3;3;-1
p207-bruckman;total of 2125;2125;-1
p215-douglas;25 participants;25;-1
p215-douglas;total of 270;270;-1
p215-douglas;total of 720;720;-1
p238-kuno;n = 5;5;-1
p238-kuno;n=5;5;-1
p238-kuno;n=15;15;-1
p25-mackenzie;11  participants;11;-1
p25-mackenzie;20 within-subjects;20;-1
p254-salvucci;total of 48;48;-1
p32-goldstein;24 subjects;24;-1
p32-goldstein;20 subjects;20;-1
p32-goldstein;20  subjects;20;-1
p32-goldstein;15 subjects;15;-1
p32-goldstein;3 subjects;3;-1
p330-jacko;total of 250;250;-1
p338-davis;10 people;10;-1
p338-davis;15  people;15;-1
p354-nelson;14  people;14;-1
p354-nelson;13 people;13;-1
p370-want; data rate of 500;500;-1
p402-byrne;11 undergraduate participants;11;-1
p402-byrne;total of 108;108;-1
p418-soto;48   participants;48;-1
p434-salber;total of 892;892;-1
p450-guiard;2s condition  all eight participants;2;-1
p450-guiard;total of 4,000;4000;-1
p458-faraday;98 subjects;98;-1
p458-faraday;98 subjects were recruited;98;-1
p466-accot;5 groups of subjects;5;-1
p536-moher;2 subjects;2;-1
p552-amento;3 sites and TopicShop subjects;3;-1
p552-amento;16 subjects;16;-1
p552-amento;total of 639;639;-1
p56-balakrishnan;10 participants;10;-1
p56-balakrishnan;2 compares participants;2;-1
p56-balakrishnan;4 compares participants;4;-1
p56-balakrishnan;2 participants;2;-1
p56-balakrishnan;n   = 3200;3200;-1
p560-czerwinski;15 subjects;15;-1
p560-czerwinski;20  subjects;20;-1
p560-czerwinski;9 subjects;9;-1
p560-czerwinski;n = 3;3;-1
p568-karat;24 subjects;24;-1
p568-karat;12   subjects;12;-1
p568-karat;12 subjects;12;-1
p568-karat;N= 12;12;-1
p568-karat;N=12;12;-1
p568-karat;N=24;24;-1
p568-karat;total of 30;30;-1
p568-karat;24 users who   enrolled;24;-1
p568-karat; data from 12;12;-1
p576-oviatt;81 Procedure   Sixteen people;81;19721
p584-suhm;N=12;12;-1
p584-suhm;N=6;6;-1
p592-druin;25 adult participants;25;-1
p608-curtis;200 people;200;-1
p64-lindeman;2 within-  subjects;2;-1
p64-lindeman;32 unpaid subjects;32;-1
p64-lindeman;30 of the subjects;30;-1
p64-lindeman;15 of the subjects;15;-1
p64-lindeman;19 subjects;19;-1
p64-lindeman;15 subjects;15;-1
p64-lindeman;N = 32;32;-1
p64-lindeman;total of 32;32;-1
p72-erickson;8 participants;8;-1
p1-mcclard;25 web sites participants;25;-1
p1-mcclard;40 individuals;40;-1
p1-mcclard;23 adults;23;-1
p113-watson;30 participants;30;-1
p113-watson;001   model type participants;1;-1
p113-watson;10   repetition participants;10;-1
p113-watson;001   simp x rep participants;1;-1
p113-watson;10 individuals;10;-1
p113-watson;total of 90;90;-1
p113-watson;total of 60;60;-1
p145-chen;15   subjects;15;18236
p145-chen;10 required subjects;10;3881
p145-chen;total of 30;30;6185
p153-woodruff;   data consists of 1151;1151;-1
p169-li;1   Five  participants;1;-1
p169-li;30 participants;30;-1
p17-cheverst;60   people;60;-1
p177-he;24 participants;24;-1
p177-he;24 subjects;24;-1
p185-boreczky;12 participants;12;-1
p193-schiano;n = 99;99;-1
p193-schiano;n = 82;82;-1
p193-schiano;n =   25;25;-1
p193-schiano;n = 17;17;-1
p193-schiano;n = 4;4;-1
p193-schiano;total of 14;14;-1
p201-hassenzahl;6 women;6;-1
p201-hassenzahl;20 participants;20;-1
p201-hassenzahl;N=140;140;-1
p201-hassenzahl;N=139;139;-1
p241-maglio;10 participants;10;171
p241-maglio;6 participants;6;115
p249-zellweger;N=30;30;-1
p25-masliah;4 female   subjects;4;-1
p25-masliah;8 subjects;8;-1
p25-masliah;4 subjects;4;-1
p25-masliah;total of   8640;8640;-1
p25-masliah;total of  56;56;-1
p265-tanriverdi;24 subjects;24;-1
p265-tanriverdi;n = 6;6;-1
p265-tanriverdi;n = 1;1;-1
p265-tanriverdi;n = 0;0;-1
p297-bouch;30 male participants;30;-1
p297-bouch;15 participants;15;-1
p297-bouch;14 participants;14;-1
p297-bouch;4 participants;4;-1
p305-lee;289 people;289;9054
p305-lee;total of 289;289;9063
p321-lai;78 subjects;78;-1
p321-lai;36 subjects;36;-1
p321-lai;10 subjects;10;-1
p321-lai;N=36;36;-1
p321-lai;N=49;49;-1
p321-lai;N=22;22;-1
p329-nass;72   participants;72;-1
p329-nass;41 of the participants;41;-1
p329-nass;11 million people;11;-1
p329-nass;total of 72;72;-1
p33-balakrishnan;8 participants;8;-1
p33-balakrishnan;8   participants;8;-1
p33-balakrishnan;total of 6;6;-1
p337-rosenbaum;13 participants;13;-1
p337-rosenbaum;99 panel participants;99;-1
p337-rosenbaum;84 people;84;-1
p337-rosenbaum;20 HCI people;20;-1
p337-rosenbaum;total of 111;111;-1
p337-rosenbaum;total of 134;134;-1
p337-rosenbaum; data from 134;134;-1
p345-frokjar;38   participants;38;-1
p345-frokjar;87 subjects;87;-1
p345-frokjar;4 subjects;4;-1
p345-frokjar;83 subjects;83;-1
p345-frokjar;81 subjects;81;-1
p345-frokjar;12 of the subjects;12;-1
p345-frokjar;N=1555;1555;-1
p345-frokjar;N=147;147;-1
p345-frokjar;N=566;566;-1
p345-frokjar;N=216;216;-1
p345-frokjar;N=192;192;-1
p345-frokjar;N=310;310;-1
p345-frokjar;N=307;307;-1
p345-frokjar;N=305;305;-1
p345-frokjar;N=314;314;-1
p345-frokjar;N=319;319;-1
p345-frokjar;N=12;12;-1
p345-frokjar;total of 1740;1740;-1
p345-frokjar;total of 19;19;-1
p353-spencer;8 people;8;-1
p360-long;total of 3;3;-1
p376-pauws;24 participants;24;-1
p384-jancke;1500 people;1500;-1
p384-jancke;36 people;36;-1
p392-espinosa;60 participants;60;-1
p392-espinosa;20 teams of three   people;20;-1
p392-espinosa;60 participants were recruited;60;-1
p400-taylor;N = 180;180;11437
p408-arsenault;2 subjects;2;-1
p408-arsenault;13 subjects;13;-1
p408-arsenault;total of  8;8;-1
p408-arsenault;total of  96;96;-1
p41-myers;12 subjects;12;-1
p41-myers;12 differ-   ent subjects;12;-1
p41-myers;12 new subjects;12;-1
p41-myers;total of  48;48;-1
p438-brown;2,000 non-   research staff. The subjects;2000;-1
p438-brown;1 subjects;1;-1
p438-brown;22 subjects;22;-1
p438-brown;22 individuals;22;-1
p462-smith;150 V-   Chat participants;150;-1
p462-smith;00   What do people;0;-1
p462-smith;3D V-Chat Features   Do people;3;-1
p462-smith;20 other people;20;-1
p462-smith;total of 119;119;-1
p462-smith;total of 1979;1979;-1
p470-jensen;90 adult subjects;90;-1
p470-jensen;66 subjects;66;-1
p470-jensen;total of 90;90;-1
p470-jensen;total of   66;66;-1
p478-patrick;67 participants;67;19392
p478-patrick;19 participants;19;19303
p478-patrick;48 participants;48;19120
p478-patrick;69 participants;69;4525
p478-patrick;total of 10;10;11922
p486-conway;n=3;3;-1
p49-rickenberg;42 subjects;42;2131
p49-rickenberg;159 potential subjects;159;2054
p49-rickenberg;20 people;20;2723
p502-baumeister;total of 4;4;-1
p518-damm;4 university people;4;-1
p526-frohlich;12 subjects;12;-1
p532-wang;3D pointing task where subjects;3;-1
p540-poupyrev;18 subjects;18;-1
p540-poupyrev;24 subjects;24;-1
p540-poupyrev;n=3;3;-1
p57-isbister; data from 45;45;2594
p73-nonnecke;N=109;109;-1
p73-nonnecke;N=77;77;-1
p73-nonnecke;N=21;21;-1
p89-whittaker;total of 184;184;-1
p9-silfverberg;N =   2;2;-1
p9-silfverberg;total of 30;30;-1
p104-yeo;17 participants;17;-1
p104-yeo;n=8;8;-1
p104-yeo;n=9;9;-1
p104-yeo;n=6;6;-1
p104-yeo;n=11;11;-1
p104-yeo;n=7;7;-1
p104-yeo;n=10;10;-1
p104-yeo;n=4;4;-1
p104-yeo;n=13;13;-1
p112-gray;24 participants;24;-1
p112-gray;8 participants;8;-1
p120-salvucci;11   remaining participants;11;-1
p120-salvucci;total of 32;32;-1
p120-salvucci;total   of 16;16;-1
p158-gong;9 participants;9;-1
p158-gong;18 participants;18;-1
p158-gong;4 people;4;-1
p158-gong;9 people;9;-1
p158-gong;11   people;11;-1
p158-gong;6 people;6;-1
p158-gong;N = 24;24;-1
p166-baldis;5 percent of the participants;5;-1
p166-baldis;5 participants;5;-1
p166-baldis;3 within subjects;3;-1
p182-stifelman;total of 24;24;-1
p182-stifelman;total of 6;6;-1
p190-rodden;18 participants;18;-1
p198-woodruff;6 women;6;-1
p206-lai;24 participants;24;-1
p206-lai;10 participants;10;-1
p206-lai;3 participants;3;-1
p206-lai;4 of the younger subjects;4;-1
p206-lai;5 older subjects;5;-1
p206-lai;24 young   people;24;-1
p206-lai;24 licensed drivers were recruited;24;-1
p206-lai;total of 24;24;-1
p213-buyukkokten;15 individuals;15;-1
p229-bhavnani;total of 87;87;-1
p229-bhavnani;total of 84;84;-1
p245-corbett;total of 42;42;-1
p277-dumais;15   participants;15;14946
p277-dumais;20 people;20;7613
p277-dumais;total of 30;30;7162
p285-bernheim_brush;8 participants;8;-1
p285-bernheim_brush;12 participants;12;-1
p285-bernheim_brush;12 participants were recruited;12;-1
p285-bernheim_brush;total of 216;216;-1
p285-bernheim_brush;total of 302;302;-1
p293-hornbak;20 subjects;20;-1
p293-hornbak;3 within-subjects;3;-1
p293-hornbak;11   subjects;11;-1
p293-hornbak;10   subjects;10;-1
p293-hornbak;11 subjects;11;-1
p293-hornbak;N=58;58;-1
p293-hornbak;N=354;354;-1
p293-hornbak;N=20;20;-1
p293-hornbak;N=19;19;-1
p293-hornbak;total of 106;106;-1
p301-vertegaal;19 male subjects;19;-1
p309-garau;100 participants;100;-1
p309-garau;n=6;6;-1
p309-garau;n=5;5;-1
p309-garau;N=24;24;-1
p309-garau;N=26;26;-1
p309-garau;n=2;2;-1
p309-garau;total of 15;15;-1
p333-mynatt;15 subjects;15;-1
p333-mynatt;550 million adults;550;-1
p333-mynatt;44 million adults;44;-1
p341-svensson;12 subjects;12;-1
p341-svensson;10 subjects;10;-1
p341-svensson;2 subjects;2;-1
p341-svensson;9 subjects;9;-1
p349-wang;12 subjects;12;-1
p349-wang;1 subjects;1;-1
p349-wang;total of 39;39;-1
p372-carroll;80 million people;80;-1
p372-carroll;157 individuals;157;-1
p380-bers;n = 5;5;-1
p380-bers;n =1;1;-1
p380-bers;n = 6;6;-1
p380-bers;n =0;0;-1
p380-bers;n   = 5;5;-1
p380-bers;n = 1;1;-1
p380-bers;n   =1;1;-1
p380-bers;n =   5;5;-1
p380-bers;n =   1;1;-1
p380-bers;n =2;2;-1
p380-bers;n = 3;3;-1
p380-bers;n = 4;4;-1
p380-bers;total of   16;16;-1
p380-bers;total of 94;94;-1
p396-bickmore;31 people;31;-1
p404-aberg;35 people;35;-1
p412-couper;434 persons;434;-1
p412-couper;202 participants;202;-1
p412-couper;20   subjects;20;-1
p412-couper;n=3047;3047;-1
p412-couper;total of 3,047;3047;-1
p418-tan;5 women;5;-1
p418-tan;3 participants;3;-1
p418-tan;13 participants;13;-1
p418-tan;13  participants;13;-1
p418-tan;7 participants;7;-1
p426-mason;n = 1129;1129;-1
p426-mason;n = 952;952;-1
p426-mason;n = 1160;1160;-1
p426-mason;n = 920;920;-1
p434-cockburn;28 subjects;28;-1
p434-cockburn;2D Even subjects;2;-1
p434-cockburn;28   Even subjects;28;-1
p434-cockburn;3D Odd subjects;3;-1
p434-cockburn;27   Odd subjects;27;-1
p434-cockburn;14 subjects;14;-1
p442-liu;total of 24;24;-1
p450-rui;5 subjects;5;-1
p450-rui;4   people;4;-1
p450-rui;12 people;12;-1
p450-rui;13 people;13;-1
p450-rui;n = 12;12;-1
p450-rui;n = 13;13;-1
p458-grudin;18 participants;18;-1
p458-grudin;18 interview participants;18;-1
p458-grudin;7 people;7;-1
p466-borovoy;500 children and adults;500;-1
p490-chi;8 participants;8;-1
p490-chi;N = 8;8;-1
p490-chi;n=5;5;-1
p490-chi;n=1;1;-1
p490-chi;n = 1;1;-1
p498-card;14   participants;14;-1
p498-card;N = 3;3;-1
p498-card;N = 6;6;-1
p498-card;N =3;3;-1
p498-card;N=6;6;-1
p522-shoemaker;16 participants;16;-1
p53-ivory;n = 6;6;23086
p53-ivory;N = 2910;2910;23076
p530-jancke;100 people;100;-1
p530-jancke;220 people;220;-1
p530-jancke;n=20;20;-1
p530-jancke;n=71;71;-1
p61-fogg;1400 participants;1400;-1
p61-fogg;1410 participants;1410;-1
p61-fogg;1400 people;1400;-1
p61-fogg;20 people;20;-1
p61-fogg;30 people;30;-1
p61-fogg;1441 people;1441;-1
p61-fogg;n = 0;0;-1
p77-tsukahara;13  subjects;13;-1
p77-tsukahara;13 subjects;13;-1
p77-tsukahara;41 pairs of people;41;-1
p77-tsukahara; data from 13;13;-1
p85-duh;3 women;3;-1
p85-duh;40   subjects;40;-1
p85-duh;3 subjects;3;-1
p9-mackenzie;3   participants;3;-1
p9-mackenzie;12 participants;12;-1
p9-mackenzie;10 within-subjects;10;-1
p105-pierce;total of 15;15;-1
p135-bos;198 total subjects;198;-1
p135-bos;N=14;14;-1
p135-bos;N=16;16;-1
p163-mcgrenere;20 participants;20;-1
p163-mcgrenere;10 feature-  keen participants;10;-1
p163-mcgrenere;19 participants;19;-1
p163-mcgrenere;19   If we consider all participants;19;-1
p163-mcgrenere;13 participants;13;-1
p163-mcgrenere;7 participants;7;-1
p163-mcgrenere;3   participants;3;-1
p163-mcgrenere;17 participants;17;-1
p163-mcgrenere;7   participants;7;-1
p163-mcgrenere;N=19;19;-1
p163-mcgrenere;N=20;20;-1
p17-zhai;total of 236743;236743;-1
p171-herbsleb;10 people;10;-1
p171-herbsleb;2 other people;2;-1
p179-isaacs;135 different pairs of   participants;135;-1
p179-isaacs;28 participants;28;-1
p179-isaacs;13 people;13;-1
p179-isaacs;32 people;32;-1
p179-isaacs;1   Four people;1;-1
p179-isaacs;28 people;28;-1
p179-isaacs;6 people;6;-1
p179-isaacs;3 people;3;-1
p179-isaacs;37      pairs of people;37;-1
p179-isaacs; data come from 28;28;-1
p195-czerwinski;18   participants;18;-1
p195-czerwinski;13 of   the participants;13;-1
p203-cocoburn;69 subjects;69;-1
p203-cocoburn;13 subjects;13;-1
p211-ehret;10 participants;10;-1
p227-sellen;24 participants;24;-1
p227-sellen;24   participants;24;-1
p227-sellen;1 across participants;1;-1
p227-sellen;24   people;24;-1
p227-sellen;4 people;4;-1
p227-sellen;n=19;19;-1
p227-sellen;n=13;13;-1
p227-sellen;n=8;8;-1
p227-sellen;n=6;6;-1
p227-sellen;n=4;4;-1
p227-sellen;n=3;3;-1
p243-heer;n=67;67;-1
p243-heer;n=95;95;-1
p243-heer;n=80;80;-1
p243-heer;n=78;78;-1
p243-heer;n=60;60;-1
p243-heer;n=89;89;-1
p243-heer;n=83;83;-1
p243-heer;total of 105;105;-1
p243-heer;total of 320;320;-1
p25-isokoski;6 people;6;-1
p259-baudisch;8 subjects;8;-1
p259-baudisch;N=12;12;-1
p267-gutwin;3 within-participants;3;-1
p267-gutwin;total of 4000;4000;-1
p275-whittaker;total of 1746;1746;-1
p291-pirhonen;n = 25;25;-1
p315-terveen;24 subjects;24;-1
p315-terveen;8 of the subjects;8;-1
p315-terveen;4 of these   subjects;4;-1
p315-terveen;4   subjects;4;-1
p323-fiore;22 participants;22;-1
p323-fiore;4,000 participants;4000;-1
p323-fiore;22 subjects;22;-1
p323-fiore;22   people;22;-1
p323-fiore;total of 340;340;-1
p33-myers;5 women;5;-1
p33-myers;4 women;4;-1
p331-snowden;100 people;100;-1
p331-snowden;1   and people;1;-1
p339-jacob;13 subjects;13;-1
p347-sharlin;16 participants;16;-1
p347-sharlin;7 of the participants;7;-1
p347-sharlin;12 participants;12;-1
p347-sharlin;43 participants;43;-1
p363-bayles;2,222   women;2222;-1
p363-bayles;8 participants;8;-1
p363-bayles;5 participants;5;-1
p363-bayles;13 participants;13;-1
p363-bayles;N=66;66;-1
p367-ivory;total of 9;9;-1
p367-ivory;  data consists of 5,346;5346;-1
p375-farnham;3 participants;3;-1
p375-farnham;35   patients;35;-1
p375-farnham;009  Meet other Hutch patients;9;-1
p375-farnham;84 people;84;-1
p375-farnham;59     people;59;-1
p375-farnham;11 people;11;-1
p375-farnham;N = 33;33;-1
p375-farnham;N = 13;13;-1
p375-farnham;total of 37;37;-1
p383-muller;n=18;18;-1
p383-muller;n=2;2;-1
p407-mcgee;total of 55;55;1120
p41-fukayama;14  subjects;14;7266
p41-fukayama;13 people;13;2784
p423-robertson;n=1;1;-1
p431-aoki;n=6;6;-1
p431-aoki;n=8;8;-1
p447-jensen;462 participants;462;-1
p447-jensen;353 participants;353;-1
p447-jensen;334 participants;334;-1
p447-jensen;2 participants;2;-1
p447-jensen;7 participants;7;-1
p447-jensen;N = 315;315;-1
p447-jensen;total of 462;462;-1
p447-jensen;total   of 353;353;-1
p447-jensen;total of 334;334;-1
p447-jensen;total of 7;7;-1
p447-jensen; data   from 15;15;-1
p463-blackmon;6 experimental participants;6;-1
p463-blackmon;23 experimental participants;23;-1
p463-blackmon;20 experimental participants;20;-1
p463-blackmon;1 participants;1;-1
p463-blackmon;20 experimental   participants;20;-1
p463-blackmon; data from 20;20;-1
p471-vredenburg;10 people;10;-1
p471-vredenburg;20 people;20;-1
p471-vredenburg;5 people;5;-1
p471-vredenburg;10 individuals;10;-1
p471-vredenburg;n=102;102;-1
p471-vredenburg;total of 191;191;-1
p471-vredenburg;total of 18;18;-1
p57-mcguffin;12 subjects;12;-1
p65-hinckley;14 subjects;14;-1
p65-hinckley;3 Three subjects;3;-1
p65-hinckley;14   subjects;14;-1
p65-hinckley;7 subjects;7;-1
p65-hinckley;10 subjects;10;-1
p65-hinckley;13 subjects;13;-1
p65-hinckley;10 of   these subjects;10;-1
p65-hinckley;27 people;27;-1
p65-hinckley;total of 400;400;-1
p89-brush;450   people;450;-1
p89-brush;250 people;250;-1
p89-brush;39 people;39;-1
p89-brush;7 people;7;-1
p89-brush;90   people;90;-1
p89-brush;12   people;12;-1
p89-brush;188 people;188;-1
p89-brush;30 people;30;-1
p89-brush;total of 562;562;-1
p97-hudson;3 other people;3;-1
p97-hudson;3 people;3;-1
p1-yee;24   participants;24;-1
p1-yee;24 participants;24;-1
p105-albinsson;total of 4;4;-1
p121-riegelsberger;115 participants;115;-1
p121-riegelsberger;69   participants;69;-1
p121-riegelsberger;13 participants;13;-1
p121-riegelsberger;110 participants;110;-1
p121-riegelsberger;5 participants;5;-1
p121-riegelsberger;n=115;115;-1
p137-good;12 participants;12;-1
p137-good;2 participants;2;-1
p145-bederson;60 percent of the   participants;60;-1
p145-bederson;3 percent   of the participants;3;-1
p153-coventry;100 participants;100;-1
p153-coventry;300 participants;300;-1
p153-coventry;200 participants;200;-1
p153-coventry;411 participants;411;-1
p153-coventry;42 people;42;-1
p153-coventry;1,000 people;1000;-1
p153-coventry;total of 411;411;-1
p153-coventry;1,000 people enrolled;1000;-1
p161-ho-ching;2 within subjects;2;4714
p169-mankoff;10 participants;10;-1
p169-mankoff;8 participants;8;-1
p169-mankoff;8 people;8;-1
p169-mankoff;total of 60;60;-1
p169-mankoff;total of 26;26;-1
p177-zhai;total of 720;720;-1
p193-accot;n = 1;1;-1
p193-accot;n = 2;2;-1
p201-gutwin;3 within-participants;3;-1
p201-gutwin;20 participants;20;-1
p241-hook;12 subjects;12;-1
p241-hook;21 subjects;21;-1
p241-hook;total of 12;12;-1
p249-hornof;n=4;4;-1
p249-hornof;n=2;2;-1
p257-hudson;total of 672;672;-1
p257-hudson;total of 56;56;-1
p273-friedman;182 participants;182;-1
p273-friedman;30 randomly chosen participants;30;-1
p273-friedman;N=182;182;-1
p273-friedman;total of 20;20;-1
p281-shechtman;68 assertive participants;68;-1
p281-shechtman;64 nonassertive participants;64;-1
p281-shechtman;130 participants;130;-1
p281-shechtman;142 initial participants;142;-1
p289-lee;72   participants;72;-1
p289-lee;80   participants;80;-1
p289-lee;total of 72;72;-1
p289-lee;total of 80;80;-1
p305-wilson;16 participants;16;-1
p305-wilson;16   participants;16;-1
p321-luchini;total of 32;32;-1
p321-luchini;total of   6;6;-1
p329-kaikkonen;30 subjects;30;-1
p329-kaikkonen;total of 30;30;-1
p33-jacko;32 young participants;32;-1
p33-jacko;2 participants;2;-1
p33-jacko;10   million individuals;10;-1
p33-jacko;n=29;29;-1
p33-jacko;n=30;30;-1
p33-jacko;n=12;12;-1
p33-jacko;n=8;8;-1
p33-jacko;n=10;10;-1
p337-newcomb;5 participants;5;-1
p337-newcomb;46 participants;46;-1
p337-newcomb;8 participants;8;-1
p337-newcomb;40s and three of the   participants;40;-1
p345-bellotti;7 participants;7;-1
p345-bellotti;9 participants;9;-1
p345-bellotti;11 people;11;-1
p361-venolia;6 participants;6;-1
p361-venolia;n = 6;6;-1
p361-venolia;n=4;4;-1
p385-bargeron;13 participants;13;-1
p385-bargeron;18 participants;18;-1
p401-yee;32 participants;32;-1
p401-yee;n=139;139;-1
p401-yee;n=21;21;-1
p41-hwang;4 factorial within-subjects;4;-1
p433-berg;4   people;4;-1
p441-grinter;2 people;2;-1
p441-grinter;13 different  people;13;-1
p441-grinter;4 people;4;-1
p441-grinter;7 people;7;-1
p457-rui;50 people;50;-1
p457-rui;20   people;20;-1
p465-chen;16 subjects;16;-1
p473-brewster;2 participants;2;-1
p481-baudisch;12 subjects;12;-1
p481-baudisch;11 subjects;11;-1
p481-baudisch;6 subjects;6;-1
p497-blackmon;85 participants;85;-1
p497-blackmon;204   people;204;-1
p497-blackmon;total of 40;40;-1
p497-blackmon; data from all 204;204;-1
p505-chi;244 subjects;244;-1
p505-chi;1952 sessions   because some subjects;1952;-1
p505-chi;total of   244;244;-1
p505-chi;total of   8;8;-1
p505-chi;total of 1386;1386;-1
p529-garau;48 participants;48;-1
p529-garau;n=6;6;-1
p529-garau;n=2;2;-1
p529-garau;n=5;5;-1
p529-garau;n = 5;5;-1
p561-mueller;56 volunteers were recruited;56;-1
p577-brown;30 participants;30;-1
p577-brown;18 male  participants;18;-1
p585-cosley;total of 536;536;-1
p585-cosley;total of  274;274;-1
p585-cosley;total of 1599;1599;-1
p585-cosley;total of 1892;1892;-1
p585-cosley;total of 30;30;-1
p73-tang;75 participants;75;-1
p89-klemmer;13 participants;13;-1
p89-klemmer;total of 31;31;-1
p97-zhai;total of 100;100;-1
p1-intille;20 subjects;20;-1
p1-intille;19 subjects;19;-1
p1-intille;18 subjects;18;-1
p113-gonzalez;14 people;14;-1
p113-gonzalez;n=30;30;-1
p113-gonzalez;n=46;46;-1
p113-gonzalez;n=4;4;-1
p113-gonzalez;n=1;1;-1
p113-gonzalez;n=10;10;-1
p113-gonzalez;n=33;33;-1
p113-gonzalez;total of 477;477;-1
p129-hancock;2 participants;2;-1
p129-hancock;30 subjects;30;-1
p129-hancock;28 subjects;28;-1
p129-hancock;n = 27;27;-1
p129-hancock;n = 23;23;-1
p129-hancock;n = 13;13;-1
p129-hancock;n = 9;9;-1
p129-hancock;total of   1198;1198;-1
p159-hourizi;4   participants;4;-1
p159-hourizi;2 participants;2;-1
p17-hamalainen;10 people;10;-1
p17-hamalainen;total of 10;10;-1
p191-fussell;N = 80;80;-1
p199-harter;12 participants;12;-1
p207-fogarty;3 subjects;3;-1
p207-fogarty;10 subjects;10;-1
p207-fogarty;total of 15;15;-1
p215-cadiz;7,000 people;7000;-1
p215-cadiz;4 people;4;-1
p215-cadiz;4,300 people;4300;-1
p215-cadiz;7,342 people;7342;-1
p215-cadiz;480 people;480;-1
p215-cadiz;750 people;750;-1
p215-cadiz;246 people;246;-1
p215-cadiz;153 people;153;-1
p215-cadiz;3   Seeing people;3;-1
p215-cadiz;2   Seeing people;2;-1
p215-cadiz;178 people;178;-1
p215-cadiz;148 people;148;-1
p215-cadiz;71 people;71;-1
p215-cadiz;n = 236;236;-1
p215-cadiz;n = 180;180;-1
p215-cadiz;N = 245;245;-1
p223-paulos;150 people;150;-1
p223-paulos;0 people;0;-1
p223-paulos;1 people;1;-1
p223-paulos;63 people;63;-1
p223-paulos;8 As individuals;8;-1
p223-paulos;n=23;23;-1
p231-olsen;8 participants;8;-1
p231-olsen;8 subjects;8;-1
p231-olsen;8 people;8;-1
p231-olsen;total of 64;64;-1
p239-lecuyer;3 women;3;-1
p239-lecuyer;4   women;4;-1
p239-lecuyer;20 participants;20;-1
p239-lecuyer;10 participants;10;-1
p239-lecuyer;n=24;24;-1
p239-lecuyer;n=88;88;-1
p239-lecuyer;n=29;29;-1
p239-lecuyer;n=21;21;-1
p239-lecuyer;n=84;84;-1
p239-lecuyer;n=30;30;-1
p239-lecuyer;n=54;54;-1
p255-baudisch;7 participants;7;-1
p263-schwesig;N=100;100;-1
p263-schwesig;N=0;0;-1
p271-adamczyk;total of 10;10;-1
p279-huang;17 different people;17;-1
p279-huang;8 people;8;-1
p279-huang;total of 165;165;-1
p279-huang;total of 17;17;-1
p287-robertson;16 participants;16;-1
p287-robertson;22 additional participants;22;-1
p287-robertson;n=16;16;-1
p287-robertson;n=22;22;-1
p287-robertson; data from the 16;16;-1
p295-vemuri;34 subjects;34;-1
p295-vemuri;15 subjects;15;-1
p295-vemuri;1 examined subjects;1;-1
p311-jacko;n = 6;6;-1
p311-jacko;N = 0;0;-1
p311-jacko;N = 1;1;-1
p311-jacko;total of 105;105;-1
p319-vonahn;15   participants;15;-1
p319-vonahn;15 participants;15;-1
p319-vonahn;5,000 people;5000;-1
p319-vonahn;13,630 people;13630;-1
p319-vonahn;33 people;33;-1
p319-vonahn;5,000   people;5000;-1
p319-vonahn;107,000 people;107000;-1
p319-vonahn;total of 13,630;13630;-1
p327-beamish;n=101;101;-1
p33-dey;14 participants;14;-1
p33-dey;2 people;2;-1
p335-mcgee;30 participants;30;-1
p343-stamant;10 trials across all participants;10;-1
p351-pavlovych;12 participants;12;-1
p359-po;total of 4;4;-1
p359-po;total of 192;192;-1
p367-baudisch;8 participants;8;-1
p367-baudisch;2 within-participants;2;-1
p375-muller;04 participants;4;-1
p375-muller;33 people;33;-1
p375-muller;n = 1;1;-1
p375-muller;n = 3;3;-1
p375-muller;n = 2;2;-1
p375-muller;n = 5;5;-1
p375-muller;n = 90;90;-1
p375-muller;total of 33;33;-1
p383-baker;N=140;140;-1
p383-baker;n = 0;0;-1
p383-baker;total of 563;563;-1
p407-moffatt;4 non-aphasic participants;4;-1
p407-moffatt;8 male participants;8;-1
p407-moffatt;9 participants;9;-1
p407-moffatt;3 participants;3;-1
p407-moffatt;5 participants;5;-1
p407-moffatt;2 There were no participants;2;-1
p407-moffatt;1 million   people;1;-1
p407-moffatt;100,000 people;100000;-1
p407-moffatt;15 famous people;15;-1
p407-moffatt;N=8;8;-1
p407-moffatt;N=9;9;-1
p407-moffatt; databases of 15;15;-1
p415-teevan;5 women;5;-1
p415-teevan;15   participants;15;-1
p415-teevan;4 Two participants;4;-1
p415-teevan;n=23;23;-1
p415-teevan;n=95;95;-1
p423-isokoski;12 participants;12;-1
p423-isokoski;n=25;25;-1
p423-isokoski;total of   30;30;-1
p431-gergle;total of 16;16;-1
p447-grossman;total of 198;198;-1
p447-grossman;total of   116;116;-1
p447-grossman;total of 576;576;-1
p471-jensen;n=63;63;-1
p471-jensen;n=39;39;-1
p471-jensen;n=65;65;-1
p471-jensen;total of 55,158;55158;-1
p487-ramos;3   participants;3;-1
p487-ramos;12 participants;12;-1
p487-ramos;total of 1326;1326;-1
p49-schiano;n =1;1;-1
p49-schiano;n = 3;3;-1
p49-schiano;n = 1;1;-1
p49-schiano;total   of 14;14;-1
p49-schiano;total of 216;216;-1
p49-schiano;total of 9;9;-1
p49-schiano;total of 1080;1080;-1
p495-bitton;23 persons;23;-1
p495-bitton;3   persons;3;-1
p495-bitton;7 participants;7;-1
p495-bitton;4 people;4;-1
p495-bitton;50 people;50;-1
p495-bitton;total of 23;23;-1
p503-gutwin;2 within-subjects;2;-1
p511-hughes;65 men and women;65;-1
p511-hughes;N=50;50;-1
p511-hughes;N=52;52;-1
p527-whittaker;6 women;6;9223
p535-mccarthy;total of 6;6;-1
p543-lampe;n=47,474;47474;-1
p543-lampe;n=28,277;28277;-1
p559-erickson;12 participants;12;-1
p559-erickson;140   people;140;-1
p575-viegas;100,000 subjects;100000;-1
p583-boardman;31 participants;31;-1
p583-boardman;8 of the participants;8;-1
p583-boardman;29 participants;29;-1
p583-boardman;2   participants;2;-1
p583-boardman;31   participants;31;-1
p583-boardman;1 participants;1;-1
p583-boardman;2 participants;2;-1
p583-boardman;21 participants;21;-1
p583-boardman;21 multiple-strategy   participants;21;-1
p583-boardman;10 participants;10;-1
p583-boardman;2    Eight participants;2;-1
p583-boardman;3 participants;3;-1
p583-boardman;2 we also invited participants;2;-1
p583-boardman;29 participants were recruited;29;-1
p583-boardman;n=31;31;-1
p583-boardman;n=8;8;-1
p583-boardman;n=4;4;-1
p607-mizobuchi;12 participants;12;-1
p607-mizobuchi;n = 28;28;-1
p607-mizobuchi;total of 60;60;-1
p607-mizobuchi;total of 44;44;-1
p631-ludford;230 subjects;230;1031
p631-ludford;163 subjects;163;942
p631-ludford;245   people;245;10595
p631-ludford;29   people;29;9167
p631-ludford;15 people;15;6732
p631-ludford;2 postulated people;2;2476
p631-ludford;3 stated people;3;3687
p631-ludford;6 predicted people;6;6522
p631-ludford;total of 1473;1473;997
p639-ingmarsson;5 participants;5;-1
p639-ingmarsson;total of 81;81;-1
p65-lee;10 participants;10;-1
p65-lee;20   participants;20;-1
p65-lee;40 subjects;40;-1
p65-lee;total of 741;741;-1
p65-lee; database of   840;840;-1
p663-sillence;21 million people;21;-1
p671-lyons;total of 40;40;-1
p679-jiang;4000 people;4000;-1
p687-lin;N=29;29;-1
p687-lin;n=25;25;-1
p695-everett;1  participants;1;-1
p695-everett;12 participants;12;-1
p703-cornett;5   participants;5;-1
p703-cornett;19 participants;19;-1
p703-cornett;14   subjects;14;-1
p703-cornett;5 subjects;5;-1
p703-cornett;19 subjects;19;-1
p703-cornett;8 subjects;8;-1
p703-cornett;total of 8;8;-1
p719-lin;8 women;8;-1
p719-lin;12 subjects;12;-1
p727-paek;3 minute timer reminded   participants;3;-1
p727-paek;18 participants;18;-1
p727-paek;18 adults;18;-1
p73-tory;8 participants;8;-1
p735-bellotti;8 participants;8;-1
p735-bellotti;7   participants;7;-1
p735-bellotti;20 people;20;-1
p81-wigdor;5 women;5;-1
p81-wigdor;5 participants;5;-1
p81-wigdor;15 participants;15;-1
p81-wigdor;total of 109020;109020;-1
p89-findlater;27   subjects;27;-1
p89-findlater;27 subjects;27;-1
p89-findlater;3 subjects;3;-1
p89-findlater;3 of the   subjects;3;-1
p89-findlater;8 subjects;8;-1
p89-findlater;15 subjects;15;-1
p89-findlater;n=788;788;-1
p89-findlater;N=27;27;-1
p89-findlater;total of 27;27;-1
p9-law;19 participants;19;-1
p9-law;17   participants;17;-1
p9-law;17 participants;17;-1
p9-law;9   participants;9;-1
p9-law;11 participants;11;-1
p9-law;15 participants;15;-1
p9-law;n = 0;0;-1
p9-law;total of 95;95;-1
p9-law; data of 17;17;-1
p97-kieras;total of 70;70;-1
p1-carroll;N=157;157;-1
p1-carroll;N=146;146;-1
p101-patil;36 participants;36;17386
p101-patil;25 participants;25;6343
p101-patil;6 participants;6;17385
p101-patil;N=36;36;30379
p101-patil;N=13;13;2494
p101-patil;N=33;33;2436
p101-patil;total of 36;36;17395
p11-cosley;68 subjects;68;-1
p11-cosley;60 subjects;60;-1
p11-cosley;204 subjects;204;-1
p11-cosley;total of 204;204;-1
p111-marshall;20   participants;20;-1
p111-marshall;20 diverse individuals;20;-1
p141-sadasivan;3 subjects;3;13322
p141-sadasivan;6 subjects;6;13096
p141-sadasivan;6  subjects;6;12875
p141-sadasivan;16  subjects;16;12760
p141-sadasivan;16 subjects;16;12677
p141-sadasivan;8 subjects;8;12664
p141-sadasivan; data of 3;3;13331
p141-sadasivan; data from all 16;16;12692
p151-fono;total of 50;50;-1
p161-hornof;n=1;1;-1
p171-voida;8 self-selected  participants;8;-1
p171-voida;22 total  individuals;22;-1
p171-voida;total of 806;806;-1
p181-aoki;4 Teens and young adults;4;-1
p191-voida;13   participants;13;-1
p191-voida;13 participants;13;-1
p201-karlson;20 participants;20;-1
p201-karlson;12 of the   participants;12;-1
p201-karlson;7 participants;7;-1
p201-karlson;2 participants;2;-1
p21-birnholtz;39   participants;39;-1
p21-birnholtz;77 individuals;77;-1
p21-birnholtz;22 individuals;22;-1
p21-birnholtz;35   individuals;35;-1
p21-birnholtz;n=77;77;-1
p21-birnholtz;n=22;22;-1
p21-birnholtz;total of 65;65;-1
p21-birnholtz;total of 39;39;-1
p21-birnholtz;total of 532;532;-1
p211-gong;N=8;8;-1
p211-gong;total of 4420;4420;-1
p211-gong;total of 4307;4307;-1
p231-ou;total of 18;18;-1
p241-oviatt;13 participants;13;13203
p241-oviatt;24 participants;24;8165
p241-oviatt;22   participants;22;8263
p241-oviatt;25 participants;25;8694
p241-oviatt;25 adults;25;27673
p251-ayatsuka;4 subjects;4;-1
p261-gnanayutham;500 million people;500;21294
p261-gnanayutham;3 million people;3;20741
p261-gnanayutham;10,000 people;10000;20448
p271-lindeman;28 subjects;28;-1
p271-lindeman;16 subjects;16;-1
p271-lindeman;total of 28;28;-1
p291-po;total of 5;5;-1
p301-baudisch;50   were recruited;50;-1
p31-blackmon;20 experimental participants;20;15415
p31-blackmon;38 experimental participants;38;15121
p31-blackmon;23 experimental participants;23;15011
p31-blackmon;113 experimental participants;113;2940
p31-blackmon;total of 164;164;16715
p31-blackmon;total of 64;64;2399
p31-blackmon;total of 93;93;2202
p31-blackmon; dataset of 164;164;6746
p321-mark;N=2246;2246;-1
p321-mark;N=1281;1281;-1
p321-mark;N=1282;1282;-1
p331-fogarty;2 notified participants;2;-1
p331-fogarty;total of 475;475;-1
p341-paulos;47 individuals;47;-1
p341-paulos;15 individuals;15;-1
p341-paulos;total of 54;54;-1
p351-jung;8   persons;8;-1
p351-jung;total of 460;460;-1
p351-jung;total of 26;26;-1
p361-bezerianos;6 participants;6;-1
p361-bezerianos;3 participants;3;-1
p361-bezerianos;4 participants;4;-1
p361-bezerianos;2 participants;2;-1
p361-bezerianos;9 participants;9;-1
p361-bezerianos;5 participants;5;-1
p361-bezerianos;total of 57;57;-1
p361-bezerianos;total of 22;22;-1
p371-nacenta;10 right-handed   participants;10;-1
p371-nacenta;3 within-participants;3;-1
p371-nacenta;8 right-handed participants;8;-1
p371-nacenta;18 subjects;18;-1
p371-nacenta;10   people;10;-1
p371-nacenta;2   people;2;-1
p371-nacenta;8 people;8;-1
p371-nacenta;total   of 72;72;-1
p371-nacenta;total of 240;240;-1
p391-hornaek;N = 43;43;-1
p391-hornaek;N = 36;36;-1
p391-hornaek;N = 4;4;-1
p391-hornaek;N=21;21;-1
p391-hornaek;N=22;22;-1
p391-hornaek;N = 321;321;-1
p391-hornaek;N = 298;298;-1
p391-hornaek;N = 28;28;-1
p391-hornaek;N = 29;29;-1
p391-hornaek;total of 117;117;-1
p401-sauro;129 total   participants;129;-1
p401-sauro;total of 57;57;-1
p41-mankoff;8 participants;8;-1
p41-mankoff;10   participants;10;-1
p41-mankoff;3 participants;3;-1
p41-mankoff;10 participants;10;-1
p41-mankoff;5 randomly   selected participants;5;-1
p41-mankoff;196,000 people;196000;-1
p421-heer;8 participants;8;-1
p421-heer;8 subjects;8;-1
p421-heer;total of 1541;1541;-1
p431-robertson;8 participants;8;-1
p441-aragon;17 pilots recruited;17;12214
p441-aragon;total of 28;28;8847
p441-aragon; database from 1989;1989;36086
p451-hinckley;2 participants;2;-1
p451-hinckley;15 participants;15;-1
p451-hinckley;n   =8160;8160;-1
p451-hinckley;N=64;64;-1
p451-hinckley;N=60;60;-1
p461-li;15 participants;15;-1
p461-li;n=284;284;-1
p461-li;n=286;286;-1
p461-li;n=1513;1513;-1
p471-vetere;5 people;5;-1
p481-costanza;5 women;5;-1
p481-costanza;10 adults;10;-1
p491-anttonen;15 women;15;-1
p491-anttonen;24 participants;24;-1
p491-anttonen;24   participants;24;-1
p491-anttonen; data from 24;24;-1
p501-tee;3   participants;3;-1
p51-kaur;12 male participants;12;-1
p51-kaur;24 participants;24;-1
p51-kaur;8 participants;8;-1
p51-kaur;3 shows the responses of the participants;3;-1
p511-wu;18 people;18;-1
p511-wu;15 people;15;-1
p511-wu;8   individuals;8;-1
p511-wu;total of 18;18;-1
p511-wu;total of 15;15;-1
p531-kam;total of 7;7;-1
p541-kelleher;3 participants;3;-1
p541-kelleher;5 participants;5;-1
p541-kelleher;11 participants;11;-1
p541-kelleher;total of 11;11;-1
p551-yee;7 people;7;-1
p551-yee;total of 34;34;-1
p561-schneider;44  participants;44;-1
p561-schneider;24 participants;24;-1
p561-schneider;36 participants;36;-1
p561-schneider;3 million people;3;-1
p561-schneider;5 million people;5;-1
p561-schneider;669 individuals;669;-1
p571-lee;N=20;20;-1
p571-lee;total of 4;4;-1
p581-salvucci;total of 90;90;-1
p601-kruger;18 participants;18;-1
p61-ahlstroem;18 participants;18;-1
p61-ahlstroem;18 subjects;18;-1
p61-ahlstroem;n =  9720;9720;-1
p61-ahlstroem;total of 9261;9261;-1
p611-voida;3 of the subjects;3;-1
p611-voida;total of 103;103;-1
p611-voida;total of 21;21;-1
p621-shklovski;40 million people;40;-1
p621-shklovski;15 million people;15;-1
p621-shklovski;2 adults;2;-1
p621-shklovski;total of 11;11;-1
p651-johnson;10 people;10;-1
p651-johnson;78th floor where hundreds   of people;78;-1
p651-johnson;28   individuals;28;-1
p661-choi;24   study participants;24;-1
p661-choi;24 people;24;-1
p661-choi;total of 52;52;-1
p681-lam;9 participants;9;16186
p681-lam;11 participants;11;9215
p681-lam;11 of the participants;11;9013
p681-lam;total of 45;45;4358
p691-dabbish;121 people;121;-1
p691-dabbish;11 individuals;11;-1
p691-dabbish;N=581;581;-1
p691-dabbish;N=121;121;-1
p691-dabbish;total of 581;581;-1
p701-garfinkel;n = 1286;1286;-1
p701-garfinkel;n = 406;406;-1
p701-garfinkel;total of 1083;1083;-1
p71-cockburn;27 participants;27;-1
p71-cockburn;n=27;27;-1
p71-cockburn;n=7;7;-1
p71-cockburn;n=12;12;-1
p71-cockburn;n=20;20;-1
p71-cockburn;n=35;35;-1
p711-chellapilla;73   participants;73;-1
p711-chellapilla;3   participants;3;-1
p711-chellapilla;76 users were recruited;76;-1
p731-lee;23 participants;23;3064
p771-gutwin;3 within-subjects;3;-1
p771-gutwin;1   Twelve people;1;-1
p771-gutwin;total of 384;384;-1
p781-hamalainen;3   persons;3;-1
p781-hamalainen;35   participants;35;-1
p781-hamalainen;21 of the   participants;21;-1
p781-hamalainen;34 participants;34;-1
p781-hamalainen;46 user study participants;46;-1
p781-hamalainen;34 subjects;34;-1
p781-hamalainen;12 subjects;12;-1
p781-hamalainen;20 subjects;20;-1
p781-hamalainen;19 subjects;19;-1
p781-hamalainen;34   subjects;34;-1
p781-hamalainen;12   subjects;12;-1
p781-hamalainen;total of 20;20;-1
p791-khan;12 subjects;12;-1
p791-khan;3 of the subjects;3;-1
p799-nguyen;23 participants;23;-1
p809-wang;48 participants;48;-1
p809-wang;N=48;48;-1
p809-wang;N=96;96;-1
p81-consolvo;16 non-technical participants;16;-1
p81-consolvo;16 non-technical   participants;16;-1
p81-consolvo;16 participants;16;-1
p81-consolvo;16 study participants;16;-1
p81-consolvo;12 participants;12;-1
p81-consolvo;17 people;17;-1
p81-consolvo;14 people;14;-1
p81-consolvo;total of   2,015;2015;-1
p819-williams;total of 17;17;-1
p829-chiasson;18 women;18;-1
p849-louca;total of 36;36;-1
p869-beckwith;24 female participants;24;-1
p869-beckwith;n=26;26;-1
p869-beckwith;n=27;27;-1
p869-beckwith;n=23;23;-1
p869-beckwith;n=24;24;-1
p879-millen;33   people;33;-1
p879-millen;n = 4;4;-1
p879-millen;total of 2062;2062;-1
p889-brush;110 people;110;-1
p889-brush;1,532 people;1532;-1
p889-brush;N = 7311;7311;-1
p889-brush;N=44;44;-1
p889-brush;N=83;83;-1
p889-brush;N=127;127;-1
p889-brush;total of 215;215;-1
p899-carter;11 participants;11;-1
p899-carter;12 events of other people;12;-1
p909-ho;25 subjects;25;20002
p909-ho;5 subjects;5;20001
p909-ho;n=25;25;6304
p909-ho;n=8;8;5963
p909-ho;n=28;28;5640
p909-ho;n = 9;9;5199
p909-ho;N=25;25;4367
p1-cockburn;32 participants;32;-1
p1-cockburn;14 participants;14;-1
p1-cockburn;n=13;13;-1
p1-cockburn;n=32;32;-1
p1-cockburn;n=14;14;-1
p1009-iachello;30 participants;30;-1
p1019-li;n=9;9;-1
p1019-li;n=47;47;-1
p1019-li;n=7;7;-1
p1019-li;n=1;1;-1
p1023-hazlett;n   = 11;11;-1
p1027-mandryk;12 participants;12;-1
p1027-mandryk;12   participants;12;-1
p1027-mandryk;12 subjects;12;-1
p1027-mandryk;n=19;19;-1
p1027-mandryk;n=13;13;-1
p1027-mandryk;n=6;6;-1
p1037-cosley;2,723 subjects;2723;-1
p1037-cosley;437 subjects;437;-1
p1037-cosley;1,982 subjects;1982;-1
p1037-cosley;2,723  subjects;2723;-1
p1037-cosley;119 people;119;-1
p1037-cosley;N = 1;1;-1
p1037-cosley;N = 44;44;-1
p1037-cosley;N = 357;357;-1
p1037-cosley;N = 11;11;-1
p1037-cosley;N = 12;12;-1
p1037-cosley;total of 2,723;2723;-1
p1037-cosley;total of  2,755;2755;-1
p1047-brzozowski;8   women;8;-1
p1047-brzozowski;25 subjects;25;-1
p1047-brzozowski;4 people;4;-1
p1057-bonhard;100   participants;100;24440
p1057-bonhard;100 participants;100;20588
p1057-bonhard;4 participants;4;6470
p1057-bonhard;n = 3;3;7866
p1057-bonhard;n=3;3;7958
p1057-bonhard;n = 2;2;8580
p1057-bonhard;total of 100;100;10684
p1057-bonhard;total of 48;48;5488
p1057-bonhard;total of   151;151;8998
p1067-ahlstroem;24 participants;24;-1
p1067-ahlstroem;12 subjects;12;-1
p1067-ahlstroem;n=13;13;-1
p1067-ahlstroem;total of 79;79;-1
p1067-ahlstroem;total of 104;104;-1
p1077-zhao;5 women;5;-1
p1077-zhao;5   women;5;-1
p1077-zhao;9 subjects;9;-1
p1097-wang;12 participants;12;-1
p1097-wang;36 people;36;-1
p11-nekrasovski;40 subjects;40;-1
p11-nekrasovski;42 subjects;42;-1
p11-nekrasovski;N=40;40;-1
p11-nekrasovski;total of   600,000;600000;-1
p11-nekrasovski;total of 40;40;-1
p11-nekrasovski;total of 35;35;-1
p1107-jiang;14 participants;14;-1
p1107-jiang;n=2;2;-1
p1107-jiang;n=3;3;-1
p1107-jiang;n=5;5;-1
p111-millen;686 individuals;686;-1
p111-millen;n =   686;686;-1
p1111-eisenstein;2 women;2;-1
p1111-eisenstein;20 trials and participants;20;-1
p1111-eisenstein;3We asked participants;3;-1
p1111-eisenstein;4 within-subjects;4;-1
p1111-eisenstein;12 people;12;-1
p1111-eisenstein;n = 1;1;-1
p1111-eisenstein;n=1;1;-1
p1111-eisenstein;n = 1517;1517;-1
p1111-eisenstein;n = 1755;1755;-1
p1111-eisenstein;total of 720;720;-1
p1111-eisenstein;total of 8;8;-1
p1115-biocca;total of 48;48;-1
p1123-wall;5 participants;5;-1
p1133-petrie;17   were women;17;-1
p1133-petrie;8 participants;8;-1
p1133-petrie;16 participants;16;-1
p1133-petrie;50 disabled people;50;-1
p1133-petrie;51 disabled people;51;-1
p1133-petrie;50   people;50;-1
p1133-petrie;total of 1000;1000;-1
p1133-petrie; data from 16;16;-1
p1153-zanbaka;N = 41;41;-1
p1153-zanbaka;N = 97;97;-1
p1153-zanbaka;N = 47;47;-1
p1153-zanbaka;N =   44;44;-1
p1153-zanbaka;N =   47;47;-1
p1153-zanbaka;total of 138;138;-1
p1163-isbister;12 individual participants;12;-1
p1177-pearson;N=20;20;-1
p1191-kirk;96 participants;96;2580
p1191-kirk;total of 96;96;2589
p1201-morris;2 people;2;-1
p1201-morris;n=5;5;-1
p1201-morris;n=4;4;-1
p121-pu;20 subjects;20;-1
p121-pu;10 subjects;10;-1
p121-pu;40 recruited;40;-1
p1211-salovaara;8 people;8;-1
p1211-salovaara;5 people;5;-1
p1211-salovaara;total of 253;253;-1
p1221-esbjornsson;16 000   participants;16000;-1
p1233-mccurdy;10 participants;10;-1
p1233-mccurdy;10 individuals;10;-1
p1233-mccurdy;n=775;775;-1
p1243-tohidi;48 participants;48;14337
p1243-tohidi;N = 12;12;3472
p1243-tohidi;N = 6;6;842
p1243-tohidi;total of 48;48;14346
p1243-tohidi;total of 24;24;3537
p1243-tohidi;total of 337;337;1414
p1253-guan;24 subjects;24;-1
p1253-guan;n = 1;1;-1
p1253-guan;n = 4;4;-1
p1253-guan;total of 49;49;-1
p1263-benko;7 subjects;7;-1
p1263-benko;4 subjects;4;-1
p1263-benko;total of 25;25;-1
p1263-benko;total of 288;288;-1
p1283-agarawala;6 participants;6;-1
p1293-weisz;26   participants;26;-1
p1293-weisz;196 people;196;-1
p1293-weisz;885 distinct people;885;-1
p1293-weisz;6 people;6;-1
p1293-weisz;9 people;9;-1
p1293-weisz;N=15;15;-1
p1293-weisz;total of 1,843;1843;-1
p1293-weisz;total of 5,799;5799;-1
p1293-weisz;total of   101;101;-1
p1303-gergle;27 pairs recruited;27;-1
p1303-gergle;total of 24;24;-1
p1303-gergle;total   of 36;36;-1
p131-zheng;20 participants;20;-1
p131-zheng;20 subjects;20;-1
p131-zheng;5 people;5;-1
p131-zheng;20 people;20;-1
p131-zheng;N=20;20;-1
p131-zheng;total of 158;158;-1
p131-zheng;total of 20;20;-1
p1313-bos;130 participants;130;-1
p1313-bos;N=39;39;-1
p1313-bos;N=26;26;-1
p1313-bos;total of 130;130;-1
p1313-bos; dataset of 193;193;-1
p171-luk;N=15;15;-1
p171-luk;N=8;8;-1
p171-luk;N=3;3;-1
p181-hinckley;4 participants;4;-1
p181-hinckley;2 participants;2;-1
p181-hinckley;N=16;16;-1
p181-hinckley;N=4;4;-1
p181-hinckley;total of 519;519;-1
p21-appert;2 participants;2;-1
p21-appert;6  participants;6;-1
p221-voida;7 individuals;7;-1
p231-beckwith;37 participants;37;-1
p231-beckwith;39 participants;39;-1
p241-prabaker;total of 45;45;2955
p241-prabaker;total of 20;20;945
p251-gweon;50 participants;50;-1
p251-gweon;21 participants;21;-1
p251-gweon;N=36;36;-1
p251-gweon;N=20;20;-1
p251-gweon;N=40;40;-1
p261-cutrell;225 people;225;-1
p261-cutrell; data from 225;225;-1
p271-bergman;10   women;10;5343
p275-kaye;7 people;7;-1
p285-hsieh;10 people;10;-1
p285-hsieh;total of 10;10;-1
p289-nacenta;12 right-handed   participants;12;-1
p289-nacenta;4 within-participants;4;-1
p289-nacenta;n = 0;0;-1
p289-nacenta;total   of 128;128;-1
p289-nacenta;total of 384;384;-1
p289-nacenta;total of  4608;4608;-1
p299-irani;3 within-participants;3;-1
p299-irani;12 participants;12;-1
p299-irani;total of 4320;4320;-1
p309-wigdor;8 participants;8;-1
p309-wigdor;8   participants;8;-1
p309-wigdor;28 were recruited;28;-1
p309-wigdor;25 were recruited;25;-1
p309-wigdor;total of 2560;2560;-1
p319-yin;16 participants;16;-1
p319-yin;16   participants;16;-1
p339-burke;10 participants;10;-1
p339-burke;6 participants;6;-1
p339-burke;n=84;84;-1
p339-burke;total of 212;212;-1
p349-latulipe;34 participants;34;-1
p349-latulipe;34 undergraduate participants;34;-1
p349-latulipe;3 participants;3;-1
p349-latulipe;total of 3808;3808;-1
p35-roto;20 participants;20;-1
p35-roto;18 participants;18;-1
p35-roto;10 participants;10;-1
p35-roto;2 participants;2;-1
p35-roto;20   participants;20;-1
p35-roto;8   subjects;8;-1
p35-roto;20 subjects;20;-1
p35-roto;12   subjects;12;-1
p373-plouznikoff;3 women;3;-1
p373-plouznikoff;2 women;2;-1
p373-plouznikoff;8 test subjects;8;-1
p377-jakobsen;13 participants;13;-1
p377-jakobsen;16 participants;16;-1
p377-jakobsen;N=32;32;-1
p377-jakobsen;N=16;16;-1
p377-jakobsen;total of 6;6;-1
p397-myers;10   participants;10;-1
p397-myers;12 participants;12;-1
p407-ducheneaut;N = 2168;2168;-1
p407-ducheneaut;total of 47;47;-1
p457-consolvo;N=13;13;-1
p475-wilson;14 right-handed participants;14;-1
p475-wilson;2 within-subjects;2;-1
p475-wilson;9 subjects;9;-1
p475-wilson;n=13;13;-1
p479-wobbrock;n = 16;16;-1
p479-wobbrock;total of 90;90;-1
p489-wobbrock;5   subjects;5;-1
p493-munteanu;48 participants;48;-1
p493-munteanu;25 across all participants;25;-1
p493-munteanu;8 subjects;8;-1
p493-munteanu;40 subjects;40;-1
p493-munteanu;48  subjects;48;-1
p503-dillon;26   participants;26;-1
p503-dillon;26 participants;26;-1
p503-dillon;5 participants;5;-1
p503-dillon;25 participants;25;-1
p531-coughlan;4 participants;4;-1
p531-coughlan;2 of   the participants;2;-1
p55-von_ahn;14,153 different people;14153;-1
p55-von_ahn;14,153 people;14153;-1
p55-von_ahn;total of 14,153;14153;-1
p561-luff;26 pairs of participants;26;-1
p571-yeh;14 participants;14;-1
p581-dhamija;22 participants;22;-1
p581-dhamija;10 participants;10;-1
p581-dhamija;12 participants;12;-1
p581-dhamija;19 participants;19;-1
p581-dhamija;8 participants;8;-1
p581-dhamija;2 participants;2;-1
p581-dhamija;7 participants;7;-1
p581-dhamija;11 participants;11;-1
p581-dhamija;13 participants;13;-1
p581-dhamija;20 participants;20;-1
p581-dhamija;17 participants;17;-1
p581-dhamija;15 participants;15;-1
p581-dhamija;9 participants;9;-1
p581-dhamija;5 participants;5;-1
p581-dhamija;72 people;72;-1
p581-dhamija;72 individuals;72;-1
p581-dhamija;22 participants were recruited;22;-1
p581-dhamija;n=22;22;-1
p601-wu;30 subjects;30;-1
p601-wu;18 subjects;18;-1
p601-wu;13   subjects;13;-1
p601-wu;7 subjects;7;-1
p601-wu;17 subjects;17;-1
p601-wu;12 subjects;12;-1
p601-wu;10 subjects;10;-1
p601-wu;20 subjects;20;-1
p601-wu;total of 30;30;-1
p621-eng;total of 12;12;-1
p631-west;30 participants;30;-1
p631-west;88 people;88;-1
p631-west; data from 88;88;-1
p653-brewster;12 new participants;12;-1
p667-bentley;6 interview participants;6;-1
p667-bentley;13 participants;13;-1
p681-raffle;total of 26;26;-1
p701-kamvar;n = 2;2;-1
p701-kamvar;n = 1;1;-1
p701-kamvar;n = 14;14;-1
p701-kamvar;n =   9;9;-1
p701-kamvar;n = 3;3;-1
p701-kamvar;n =   16;16;-1
p701-kamvar;n = 9;9;-1
p701-kamvar;n = 28;28;-1
p701-kamvar;n =   17;17;-1
p701-kamvar;N=1;1;-1
p701-kamvar;n = 51;51;-1
p701-kamvar;n =   49;49;-1
p701-kamvar;n   = 29;29;-1
p701-kamvar;n = 30;30;-1
p701-kamvar;n = 36;36;-1
p701-kamvar;n   = 3;3;-1
p701-kamvar;n = 72;72;-1
p701-kamvar;n = 64;64;-1
p711-karlson;4 participants;4;-1
p711-karlson;4 trials within subjects;4;-1
p721-ranjan;13 participants;13;-1
p721-ranjan;13   participants;13;-1
p721-ranjan;3   participants;3;-1
p721-ranjan;2 participants;2;-1
p721-ranjan;n = 1;1;-1
p721-ranjan;total of 2;2;-1
p721-ranjan;total of    13;13;-1
p731-avrahami;16 participants;16;-1
p731-avrahami;2   of the participants;2;-1
p731-avrahami;73,906   messages from participants;73906;-1
p731-avrahami;n=22;22;-1
p731-avrahami;n=34;34;-1
p731-avrahami;n=32;32;-1
p741-iqbal;N=337;337;-1
p741-iqbal;N=134;134;-1
p741-iqbal;total of 360;360;-1
p741-iqbal;total   of 337;337;-1
p741-iqbal;total of 38;38;-1
p741-iqbal;total of 144;144;-1
p75-von_ahn;267 people;267;-1
p75-von_ahn;total of 267;267;-1
p751-faaborg;19,000 participants;19000;-1
p751-faaborg;34 subjects;34;-1
p751-faaborg;10 subjects;10;-1
p751-faaborg;17 people;17;-1
p751-faaborg;total of 10;10;-1
p751-faaborg;total of 34;34;-1
p751-faaborg; data from   34;34;-1
p771-santella;8 subjects;8;-1
p771-santella;total of 8;8;-1
p781-apted;1 asked participants;1;-1
p79-von_ahn;129 people;129;-1
p79-von_ahn;5,000 people;5000;-1
p79-von_ahn;total of 129;129;-1
p791-adar;55 survey participants;55;-1
p791-adar;47 survey participants;47;-1
p791-adar;49 participants;49;-1
p791-adar;6   participants;6;-1
p791-adar;76   individuals;76;-1
p811-wattenberg;146 people;146;-1
p821-hawkey;155 participants;155;-1
p821-hawkey;10 participants;10;-1
p821-hawkey;132 participants;132;-1
p841-hamzah;2 women;2;16477
p861-grossman;N = 8;8;-1
p861-grossman;total of 2;2;-1
p871-ohara;21 participants;21;-1
p871-ohara;21 participants were recruited;21;-1
p881-paulos;31 participants;31;-1
p885-liu;900  million people;900;-1
p889-ludford;20 qualified subjects;20;-1
p889-ludford;12 of the   subjects;12;-1
p889-ludford;1 and describe subjects;1;-1
p889-ludford;20 subjects;20;-1
p889-ludford;total of   77;77;-1
p899-dey;6 women;6;-1
p899-dey;15 participants;15;-1
p899-dey;8 participants;8;-1
p899-dey;9 participants;9;-1
p899-dey;3 subjects;3;-1
p899-dey;9 subjects;9;-1
p899-dey;53 million American adults;53;-1
p899-dey;total of 15;15;-1
p909-howard;N=10;10;-1
p913-kramer;60 minutes and   participants;60;-1
p913-kramer;N = 148;148;-1
p917-vannimwegen;43 subjects;43;-1
p917-vannimwegen;20 subjects;20;-1
p927-mamykina;15   individuals;15;-1
p93-tang;1 other people;1;-1
p951-drenner;total of 455;455;-1
p951-drenner; data from the 32;32;-1
p955-rashid;32 subjects;32;-1
p959-arguello;N = 6,174;6174;-1
p959-arguello;N = 2,423;2423;-1
p959-arguello;N = 3,751;3751;-1
p959-arguello;N= 6172;6172;-1
p969-shklovski;40   million people;40;-1
p969-shklovski;1,156 individuals;1156;-1
p989-matthews;   data from 11;11;-1
p1009-kaiser;20 participants;20;-1
p1009-kaiser;20 meeting participants;20;-1
p1009-kaiser;N=32;32;-1
p1009-kaiser;N=33;33;-1
p1009-kaiser;N=23;23;-1
p1019-ding;100 participants;100;-1
p1019-ding;15 people;15;-1
p1019-ding;116 people;116;-1
p1019-ding;10 people;10;-1
p1029-heer;6 subjects;6;-1
p1029-heer;12   subjects;12;-1
p1029-heer;24 lab study   subjects;24;-1
p1029-heer;total of 179;179;-1
p1039-kirk;48 participants;48;5260
p1039-kirk;total of 48;48;5269
p1049-johnsen;33 participants;33;-1
p1049-johnsen;16   participants;16;-1
p1049-johnsen;n=33;33;-1
p1059-baker;total of 128,887;128887;-1
p1059-baker; data from 11;11;-1
p1087-ramachandran;7 participants;7;-1
p1087-ramachandran;64 participants;64;-1
p1087-ramachandran;7 billion people;7;-1
p1097-kam;total of 6;6;24
p1097-kam;total of 9;9;17321
p1107-ballagas;16 participants;16;-1
p1107-ballagas;16  participants;16;-1
p1107-ballagas;2 participants;2;-1
p111-reilly;120 participants;120;-1
p111-reilly;15 participants;15;-1
p111-reilly;120   participants;120;-1
p111-reilly;20 participants;20;-1
p111-reilly;45 participants;45;-1
p111-reilly;4 all participants;4;-1
p111-reilly;total of 120;120;-1
p1127-oulasvirta;3 participants;3;-1
p1137-kristensson;16 participants;16;-1
p1137-kristensson;2 were recruited;2;-1
p1137-kristensson;n = 16;16;-1
p1147-hancock;9 participants;9;-1
p1147-hancock;7 participants;7;-1
p1147-hancock;3 within-  subjects;3;-1
p1157-terrenghi;12 participants;12;-1
p1157-terrenghi;12   participants;12;-1
p1157-terrenghi;12 of the participants;12;-1
p1157-terrenghi;4 participants;4;-1
p1157-terrenghi;3 of the participants;3;-1
p1157-terrenghi;9 of   the participants;9;-1
p1157-terrenghi;4 subjects;4;-1
p1167-girgensohn;16 participants;16;-1
p1167-girgensohn;13 of the subjects;13;-1
p1177-ranjan;2 within-participants;2;-1
p1187-schrammel;8 women;8;-1
p1187-schrammel;5 women;5;-1
p1187-schrammel;9 persons;9;-1
p1187-schrammel;5 persons;5;-1
p1187-schrammel;16 participants;16;-1
p1187-schrammel;10 other   participants;10;-1
p1187-schrammel;8 of the subjects;8;-1
p1187-schrammel;8 subjects;8;-1
p1191-kuno;total of 11;11;-1
p1195-tsandilas;12 participants;12;-1
p1195-tsandilas;8 participants;8;-1
p1215-pietriga;12 participants;12;-1
p1215-pietriga;n = 18;18;-1
p1215-pietriga;n = 17;17;-1
p1215-pietriga;n = 14;14;-1
p1215-pietriga;n  = 21;21;-1
p1235-ludford;12 women;12;26762
p1235-ludford;20 subjects;20;26800
p1235-ludford;2 random subjects;2;26458
p1235-ludford;5   subjects;5;19268
p1235-ludford;9 subjects;9;18119
p1235-ludford;4 subjects;4;17877
p1235-ludford;1   subjects;1;13545
p1235-ludford;29 subjects;29;12387
p1235-ludford;2 because we did not collect   subjects;2;9977
p1235-ludford;1 subjects;1;9674
p1235-ludford;2 subjects;2;9023
p1235-ludford;29   subjects;29;5818
p1235-ludford;3 subjects;3;4914
p1235-ludford;10   subjects;10;1664
p1235-ludford;total of 344;344;26055
p1245-strachan;6 participants;6;-1
p1249-disalvo;26 people;26;-1
p1249-disalvo;total of 117;117;-1
p125-carter;13 participants;13;-1
p1253-lampe;N=6152;6152;-1
p1253-lampe;n = 28,243;28243;-1
p1253-lampe;n = 7,409;7409;-1
p1253-lampe;n =   6,234;6234;-1
p1253-lampe;n = 3,808;3808;-1
p1253-lampe;n = 10,792;10792;-1
p1253-lampe;total of   2,416,331;2416331;-1
p1253-lampe;total of 428;428;-1
p1273-jacucci;N=8;8;-1
p1273-jacucci;total of 293;293;-1
p1273-jacucci;total of 33;33;-1
p1283-nichols;3 subjects;3;-1
p1283-nichols;n = 64;64;-1
p1283-nichols;N = 8;8;-1
p1283-nichols;N = 16;16;-1
p1303-fraser;n=1;1;-1
p1333-guimbretiere;3 center dots required participants;3;-1
p1343-hu;N = 32;32;-1
p1343-hu;total of 32;32;-1
p1347-atterer;33 subjects;33;-1
p1361-bentley;10 participants;10;-1
p1375-ramos;16 participants;16;-1
p1375-ramos;14 participants;14;-1
p1375-ramos;16 people;16;-1
p1375-ramos;14 people;14;-1
p1385-cechanowicz;4 within-participants;4;-1
p1385-cechanowicz;9 participants;9;-1
p1385-cechanowicz;8 participants;8;-1
p1385-cechanowicz;25 were recruited;25;-1
p1385-cechanowicz;total of 5280;5280;-1
p1395-zhao;12 participants;12;-1
p1395-zhao;12   participants;12;-1
p1395-zhao;3 participants;3;-1
p1405-andreasen;24 test subjects;24;-1
p1405-andreasen;18   test subjects;18;-1
p1405-andreasen;n=25;25;-1
p1405-andreasen;N=6;6;-1
p1405-andreasen;N=24;24;-1
p1405-andreasen;total of 24;24;-1
p1405-andreasen;total of 126;126;-1
p1405-andreasen;total of 46;46;-1
p1415-lindgaard;53 participants;53;-1
p1415-lindgaard;76 test participants;76;-1
p1415-lindgaard;4 organizers and   participants;4;-1
p1415-lindgaard;n = 9;9;-1
p1415-lindgaard;n = 6;6;-1
p1415-lindgaard;n = 12;12;-1
p1415-lindgaard;total of 53;53;-1
p1415-lindgaard;total of 76;76;-1
p1425-mackay;2 within-  subjects;2;-1
p1425-mackay;2 within-subjects;2;-1
p1425-mackay;16 subjects;16;-1
p1425-mackay;12 subjects;12;-1
p1435-wong;3 participants;3;-1
p1435-wong;6 people;6;-1
p1445-zimmerman;9 women;9;-1
p1445-zimmerman;12 errors and VIO participants;12;-1
p1445-zimmerman;13 of   the participants;13;-1
p1445-zimmerman;20   participants;20;-1
p1445-zimmerman;13 participants;13;-1
p1445-zimmerman;20 practice tasks   participants;20;-1
p1445-zimmerman;20   training tasks aided some participants;20;-1
p145-hartmann;n = 4;4;-1
p145-hartmann;n = 5;5;-1
p1455-kelleher;76 participants;76;-1
p1455-kelleher;total of 88;88;-1
p1465-nguyen;169 participants;169;-1
p1465-nguyen;3  participants;3;-1
p1495-cao;5 participants;5;-1
p1495-cao;n = 1;1;-1
p1505-holleis;9 persons;9;-1
p1505-holleis;19   participants;19;-1
p1505-holleis;11   people;11;-1
p1505-holleis;10 people;10;-1
p1505-holleis;19 people;19;-1
p1505-holleis;9   people;9;-1
p1505-holleis;total   of 121;121;-1
p1505-holleis;total of 110;110;-1
p1535-jefferson;n =  345;345;-1
p1535-jefferson;n = 345;345;-1
p1543-gergle;N=293;293;-1
p1543-gergle;N=217;217;-1
p155-jones;391   participants;391;-1
p155-jones;277 participants;277;-1
p155-jones;114 participants;114;-1
p155-jones;114 people;114;-1
p1553-dahlback;N = 96;96;-1
p1561-zanbaka;total of 85;85;-1
p1571-cockburn;14 volunteer participants;14;-1
p1571-cockburn;22 volunteer participants;22;-1
p1571-cockburn;1 involved   training participants;1;-1
p1571-cockburn;3 assessed participants;3;-1
p1571-cockburn;2 was apparently beyond   participants;2;-1
p1571-cockburn;n=5;5;-1
p1571-cockburn;n=10;10;-1
p1571-cockburn;n=4;4;-1
p1571-cockburn;n=2;2;-1
p1581-pawar;n=5;5;-1
p1581-pawar;n = 1;1;-1
p1581-pawar;n=1;1;-1
p1581-pawar;N=140;140;-1
p1581-pawar;N=98;98;-1
p1581-pawar;N=238;238;-1
p159-brewster;12 right-handed participants;12;-1
p1591-grossman;14 participants;14;-1
p1591-grossman;total of 60;60;-1
p1591-grossman;total of 20;20;-1
p1591-grossman;total of 600;600;-1
p1591-grossman;total of 72;72;-1
p1591-grossman;total of 14;14;-1
p1591-grossman;total of 30;30;-1
p163-clarkson;total of 20,713;20713;-1
p167-hachet;n = 3;3;3818
p167-hachet;n = 5;5;3801
p167-hachet;n  = 0;0;3400
p171-byrne;2 participants;2;-1
p171-byrne;81   participants;81;-1
p171-byrne;81 local residents recruited;81;-1
p191-ball;32 participants;32;-1
p191-ball;32 of the participants;32;-1
p201-chapuis;total of 5229;5229;4548
p211-hutchings;12 enrolled participants;12;515
p211-hutchings;6 participants;6;1228
p211-hutchings;3 participants;3;1576
p211-hutchings;12 individual participants;12;4674
p211-hutchings;total of 24;24;2160
p211-hutchings;12 enrolled;12;515
p215-tse;6 computer-proficient participants;6;-1
p215-tse;total of 476;476;-1
p219-tang;40 participants;40;-1
p219-tang;total of 40;40;-1
p233-brumby;n = 0;0;-1
p233-brumby; data from 15;15;-1
p243-salvucci;17 participants;17;-1
p243-salvucci;12 remaining participants;12;-1
p243-salvucci;total of 99;99;-1
p243-salvucci;total of 17;17;-1
p271-hurst;44 participants;44;-1
p271-hurst;37 participants;37;-1
p271-hurst;4 participants;4;-1
p271-hurst;n = 19;19;-1
p271-hurst; data from 44;44;-1
p271-hurst; data from 37;37;-1
p281-dickinson;n=11;11;-1
p281-dickinson;n=10;10;-1
p303-tian;total of 4;4;-1
p307-ziefle;20 participants;20;-1
p317-kattinakere;total of 576;576;-1
p317-kattinakere;total of 960;960;-1
p327-guiard;16 participants;16;-1
p327-guiard;16   participants;16;-1
p327-guiard;12   participants;12;-1
p327-guiard;N = 3;3;-1
p327-guiard;n = 1,270;1270;-1
p327-guiard;N=6;6;-1
p327-guiard;N=3;3;-1
p327-guiard;N=11;11;-1
p327-guiard;N = 5;5;-1
p327-guiard;total of 12;12;-1
p327-guiard;total of 3;3;-1
p327-guiard;total of 135;135;-1
p337-tabard;3  women;3;-1
p337-tabard;12 participants;12;-1
p347-miller;2 caused two Kodak Culture participants;2;-1
p347-miller;10   people;10;-1
p347-miller;40 people;40;-1
p357-ahern;15   participants;15;-1
p357-ahern;350 people;350;-1
p357-ahern;total of 580;580;-1
p367-cui;5 individuals;5;-1
p377-kellar;5 of   these participants;5;-1
p377-kellar;11 participants;11;-1
p377-kellar;11   participants;11;-1
p377-kellar;total of 173;173;-1
p387-hartmann;7 participants;7;-1
p387-hartmann;20 participants;20;-1
p387-hartmann;n = 4;4;-1
p387-hartmann;n = 3;3;-1
p387-hartmann;n =   4;4;-1
p387-hartmann;n = 2;2;-1
p387-hartmann;n =   2;2;-1
p387-hartmann;n = 1;1;-1
p397-petrie;2 women;2;-1
p397-petrie;5   participants;5;-1
p397-petrie;2   participants;2;-1
p397-petrie;0   Sighted participants;0;-1
p397-petrie;0   Both blind and sighted   participants;0;-1
p397-petrie;5   Sighted participants;5;-1
p397-petrie;9   Both blind and sighted   participants;9;-1
p397-petrie;N=6;6;-1
p397-petrie;N= 5;5;-1
p397-petrie;total of 7;7;-1
p397-petrie;total of 312;312;-1
p407-cutrell;4 participants;4;-1
p407-cutrell;18 participants;18;-1
p41-gluck;3 of the subjects;3;-1
p41-gluck;N=12;12;-1
p41-gluck;N=20;20;-1
p41-gluck;total of 26;26;-1
p417-guan;4 participants;4;-1
p417-guan;18 participants;18;-1
p417-guan;n=3;3;-1
p417-guan;n=6;6;-1
p417-guan;n=5;5;-1
p417-guan;n=4;4;-1
p421-kumar;20   able-bodied subjects;20;-1
p421-kumar;4 subjects;4;-1
p421-kumar;3 within subjects;3;-1
p421-kumar;total of 1;1;-1
p435-lampe;N=30,773;30773;-1
p445-vasalou;29 participants;29;-1
p445-vasalou;total of 85;85;-1
p445-vasalou;total of 29;29;-1
p449-hancock;40   women;40;-1
p449-hancock;80 participants;80;-1
p449-hancock;N =   71;71;-1
p463-grossman;2D pointing task required participants;2;-1
p473-wigdor;5 women;5;-1
p473-wigdor;12 participants;12;-1
p473-wigdor;8 participants;8;-1
p473-wigdor;47 were recruited;47;-1
p473-wigdor;n = 13;13;-1
p473-wigdor;total of 81;81;-1
p483-grossman;3 participants;3;-1
p483-grossman;total of 198;198;-1
p483-grossman;total of 12;12;-1
p493-zimmerman;22 participants;22;-1
p51-avrahami;total of 672;672;-1
p523-obrien;9 pairs of participants;9;-1
p523-obrien;18 participants;18;-1
p523-obrien;18   participants;18;-1
p527-woodruff;13 women;13;-1
p527-woodruff;29 participants;29;-1
p527-woodruff;total of 20;20;-1
p527-woodruff;total of 29;29;-1
p557-cherubini;400 people;400;-1
p577-ellis;8   participants;8;-1
p577-ellis;8 participants;8;-1
p577-ellis;2 people;2;-1
p577-ellis;3,060 individuals;3060;-1
p577-ellis;458 individuals;458;-1
p577-ellis;total of 3,975;3975;-1
p587-wang;24 participants;24;-1
p587-wang;24 subjects;24;-1
p597-obendorf;15 participants;15;-1
p597-obendorf;25 participants;25;-1
p597-obendorf;11 participants;11;-1
p607-good;31 subjects;31;-1
p607-good;222 subjects;222;-1
p607-good;3 between-subjects;3;-1
p607-good;3 within-  subjects;3;-1
p607-good;240 subjects;240;-1
p617-hornbaek;129 participants;129;-1
p617-hornbaek;N = 19;19;-1
p617-hornbaek;N = 51;51;-1
p617-hornbaek;N = 25;25;-1
p617-hornbaek; data of 73;73;-1
p647-forlines;12 participants;12;-1
p647-forlines;12 individuals;12;-1
p657-vogel;7 participants;7;-1
p657-vogel;5 participants;5;-1
p657-vogel;n=4;4;-1
p667-wobbrock;15   within-subjects;15;-1
p667-wobbrock;6 subjects;6;-1
p667-wobbrock;28 were recruited;28;-1
p677-iqbal;14   of the participants;14;-1
p677-iqbal;27 people;27;-1
p687-rattenbury;10 participants;10;-1
p697-iqbal;24   observers were recruited;24;-1
p697-iqbal;total of 3074;3074;-1
p697-iqbal;total of 4;4;-1
p71-kalnikaite;14 women;14;-1
p71-kalnikaite;6 suggests this is because   people;6;-1
p747-butler;220   people;220;-1
p747-butler;3 people;3;-1
p757-ramos;12 participants;12;-1
p757-ramos;6 participants;6;-1
p757-ramos;n=5;5;-1
p757-ramos;n=4;4;-1
p757-ramos;n=0;0;-1
p757-ramos;n=1;1;-1
p757-ramos;n=2;2;-1
p757-ramos;n=3;3;-1
p767-seager;n =21;21;-1
p805-fjeld;5 women;5;-1
p809-patten;15 subjects;15;-1
p81-sellen;7 participants;7;-1
p81-sellen;10 of   the original subjects;10;-1
p81-sellen;19 subjects;19;-1
p81-sellen;15 subjects;15;-1
p81-sellen;10 subjects;10;-1
p81-sellen;16 subjects;16;-1
p81-sellen;9 subjects;9;-1
p81-sellen;total of 10;10;-1
p819-costanza;8 women;8;-1
p819-costanza;12 subjects;12;-1
p819-costanza;2 subjects;2;-1
p819-costanza;4 subjects;4;-1
p819-costanza;3  subjects;3;-1
p819-costanza;10 subjects;10;-1
p819-costanza;5 buttons allowed subjects;5;-1
p819-costanza;12 adults;12;-1
p819-costanza;total of 235;235;-1
p819-costanza;total of 112;112;-1
p829-seay;4490 survey participants;4490;-1
p829-seay;430 million people;430;-1
p829-seay;total of 4490;4490;-1
p839-ducheneaut;5 participants;5;-1
p849-batcheller;32 participants;32;-1
p849-batcheller;12 participants;12;-1
p857-ohara;10 female participants;10;-1
p857-ohara;10 other people;10;-1
p867-song;20 women;20;24255
p867-song;36 participants;36;25267
p867-song;36   participants;36;7727
p867-song;35 participants;35;3219
p867-song;1   and all these allow people;1;2297
p867-song;n =   19;19;890
p867-song;n = 27;27;847
p867-song;n = 28;28;802
p867-song;n = 87;87;1927
p867-song;n = 88;88;1995
p867-song;n = 90;90;2054
p877-weisz;85 participants;85;-1
p877-weisz;57 participants;57;-1
p877-weisz;n = 5;5;-1
p877-weisz;n =   7;7;-1
p877-weisz;n =   11;11;-1
p877-weisz;n = 6;6;-1
p877-weisz;N = 84;84;-1
p877-weisz;N = 54;54;-1
p887-moncur;172 participants;172;-1
p887-moncur;0 participants;0;-1
p887-moncur;total of 172;172;-1
p895-singh;45 persons;45;-1
p895-singh;45 married persons;45;-1
p895-singh;11 de facto persons;11;-1
p895-singh;12 persons;12;-1
p895-singh;100,000 a year. Seven participants;100000;-1
p895-singh;37 participants;37;-1
p895-singh;18 participants;18;-1
p895-singh;108 people;108;-1
p895-singh;18 people;18;-1
p895-singh;11 indigenous people;11;-1
p895-singh;400   people;400;-1
p895-singh;30 people;30;-1
p895-singh;34 people;34;-1
p905-kumaraguru;10 participants;10;-1
p905-kumaraguru;30   participants;30;-1
p905-kumaraguru;3   participants;3;-1
p905-kumaraguru;8 participants;8;-1
p905-kumaraguru;8   participants;8;-1
p905-kumaraguru;3 participants;3;-1
p905-kumaraguru;n = 5;5;-1
p905-kumaraguru;n = 4;4;-1
p905-kumaraguru;n =   5;5;-1
p905-kumaraguru;total of 30;30;-1
p91-birnholtz;3 individuals;3;15401
p915-mahlke;24 women;24;-1
p919-pfeil;n=17;17;-1
p919-pfeil;total of 400;400;-1
p929-hancock;n = 20;20;-1
p947-brush;4 participants;4;-1
p947-brush;3 people;3;-1
p947-brush;8 people;8;-1
p961-perugini;40 participants;40;-1
p961-perugini;29 participants;29;-1
p961-perugini;20 participants;20;-1
p971-ames;13 participants;13;-1
p971-ames;13 interview participants;13;-1
p971-ames;500 people;500;-1
p971-ames;50 people;50;-1
p971-ames;n=172;172;-1
p971-ames;n = 2;2;-1
p971-ames;n = 4087;4087;-1
p971-ames;n = 18417;18417;-1
p971-ames;n =   24089;24089;-1
p981-bauer;76 subjects;76;-1
p981-bauer;total of 76;76;-1
p991-makela;50 participants;50;-1
p991-makela;50 people;50;-1
p995-rivadeneira;total of 40;40;-1
p999-shoemaker;9 women;9;-1
p999-shoemaker;16 participants;16;-1
p999-shoemaker;16   participants;16;-1
p999-shoemaker;total of 1536;1536;-1
p1013-kamvar;n=1;1;-1
p1017-guy;0 gives people;0;-1
p1017-guy;10 people;10;-1
p1017-guy;1000 people;1000;-1
p1017-guy;5   people;5;-1
p1017-guy;107 of the people;107;-1
p1017-guy;273 people;273;-1
p1017-guy;7 people;7;-1
p1017-guy;18 people;18;-1
p1017-guy;3 revealed what people;3;-1
p1017-guy;1  people;1;-1
p1027-joinson;601   Finding people;601;-1
p1027-joinson;508   Meeting new people;508;-1
p1027-joinson;509   Stalking other people;509;-1
p1027-joinson;719   Viewing other people;719;-1
p1027-joinson;531   Seeing what people;531;-1
p1027-joinson;241 Facebook users recruited;241;-1
p1027-joinson;n = 151;151;-1
p1027-joinson;n = 16;16;-1
p1027-joinson;n = 78;78;-1
p1027-joinson;n = 85;85;-1
p1027-joinson;n = 61;61;-1
p1027-joinson;n = 50;50;-1
p1027-joinson;n = 26;26;-1
p1027-joinson;n = 22;22;-1
p1027-joinson;n = 56;56;-1
p1027-joinson;n = 241;241;-1
p1027-joinson;n = 4;4;-1
p1027-joinson;n = 5;5;-1
p1027-joinson;n = 3;3;-1
p1027-joinson;n=44;44;-1
p1027-joinson;n = 137;137;-1
p1027-joinson;total of 46;46;-1
p103-birnholtz;4   individuals;4;-1
p103-birnholtz;total of 26;26;-1
p1041-thom-santelli;33 individuals;33;-1
p1045-stoll;20 participants;20;-1
p1045-stoll;10 participants;10;-1
p1045-stoll;10   participants;10;-1
p1045-stoll;9 subjects;9;-1
p1045-stoll;11 subjects;11;-1
p1045-stoll;20 participants recruited;20;-1
p1045-stoll;total of 20;20;-1
p1065-egelman;20 participants;20;-1
p1065-egelman;46 participants;46;-1
p1065-egelman;25 of the participants;25;-1
p1065-egelman;47 participants;47;-1
p1065-egelman;311,449 people;311449;-1
p1065-egelman;282 individuals;282;-1
p1089-shami;N = 670;670;-1
p1093-ehrlich;75 participants;75;-1
p1093-ehrlich;75 people;75;-1
p1093-ehrlich;total of 78;78;-1
p1093-ehrlich;total of 110;110;-1
p1097-nov;N =   193;193;-1
p1097-nov;n =   32;32;-1
p1097-nov;n =   149;149;-1
p1097-nov;n = 634;634;-1
p1097-nov;n =   802;802;-1
p1097-nov;n = 10;10;-1
p1097-nov;n = 5;5;-1
p1097-nov;N = 237;237;-1
p1097-nov;total of 237;237;-1
p11-wyche;11 women;11;-1
p11-wyche;7 women;7;-1
p11-wyche;16 individuals;16;-1
p1111-baumer;900  million people;900;-1
p1111-baumer;23 individuals;23;-1
p1111-baumer;57 million American adults;57;-1
p1111-baumer;total  of 15;15;-1
p1121-gill;00      participants;0;-1
p1121-gill;33 participants;33;-1
p1121-gill;N=1260;1260;-1
p1125-kramer;900   million people;900;-1
p1139-bach;16 participants;16;-1
p1139-bach;10 participants;10;-1
p1139-bach;16 subjects;16;-1
p1139-bach;8 subjects;8;-1
p1139-bach;8=subjects;8;-1
p1139-bach;16 test subjects;16;-1
p1139-bach;16   subjects;16;-1
p1139-bach;3 subjects;3;-1
p1139-bach;16 people;16;-1
p1149-mueller-tomfelde;22 participants;22;-1
p1149-mueller-tomfelde;9 participants;9;-1
p1149-mueller-tomfelde;22 participants were recruited;22;-1
p1153-goldberg;18 participants;18;-1
p1153-goldberg;total of 576;576;-1
p1157-bellotti;10   participants;10;-1
p1157-bellotti;21 participants;21;-1
p1157-bellotti;12 people;12;-1
p1157-bellotti;total of 60;60;-1
p1187-mackay;18 participants;18;-1
p1187-mackay;24 participants;24;-1
p1187-mackay;24   participants;24;-1
p1187-mackay;total of 204;204;-1
p1187-mackay;total of 1183;1183;-1
p1187-mackay;total of 428;428;-1
p1197-adar;612,000 people;612000;-1
p1207-morris;16 paid participants;16;-1
p1207-morris;1 Three participants;1;-1
p1207-morris;15 participants;15;-1
p1207-morris;740 people;740;-1
p1207-morris;n = 36;36;-1
p1207-morris;n = 170;170;-1
p1207-morris;n = 4;4;-1
p1207-morris;n = 2;2;-1
p1207-morris;n =   4;4;-1
p1207-morris;n = 3;3;-1
p1207-morris;n = 5;5;-1
p121-guo;8 participants;8;15289
p121-guo;2 within-subjects;2;7146
p121-guo;8 participants recruited;8;15289
p121-guo;total of 58;58;16417
p1217-isenberg;24 paid participants;24;-1
p1217-isenberg;15 participants;15;-1
p1217-isenberg;15 oc-  casions of participants;15;-1
p1217-isenberg;47 occasions participants;47;-1
p1227-balakrishnan;94 participants;94;-1
p1227-balakrishnan;N = 47;47;-1
p1227-balakrishnan; data from 47;47;-1
p1247-findlater;36 subjects;36;-1
p1247-findlater;4 subjects;4;-1
p1247-findlater;34 subjects;34;-1
p1247-findlater;3 subjects;3;-1
p1247-findlater;17 subjects;17;-1
p1247-findlater;N = 36;36;-1
p1247-findlater;N = 34;34;-1
p1247-findlater;N=34;34;-1
p1247-findlater;N =34;34;-1
p1247-findlater;total of 126;126;-1
p1247-findlater; data of 34;34;-1
p1257-gajos;6 able-bodied participants;6;-1
p1257-gajos;11 participants;11;-1
p1257-gajos;11 motor-impaired  participants;11;-1
p1257-gajos;11 motor-impaired participants;11;-1
p1257-gajos;n=35;35;-1
p1257-gajos;n=24;24;-1
p1257-gajos;N=34;34;-1
p1257-gajos;n=64;64;-1
p1257-gajos;N=763;763;-1
p1257-gajos;N=153;153;-1
p1257-gajos;N=54;54;-1
p1257-gajos;N=99;99;-1
p1257-gajos;N=63;63;-1
p1257-gajos;N=33;33;-1
p1257-gajos;n=26;26;-1
p1257-gajos;total of 765;765;-1
p1267-findlater;3   participants;3;-1
p1267-findlater;7 participants;7;-1
p1267-findlater;4 participants;4;-1
p1267-findlater;6 participants;6;-1
p1267-findlater;11 participants;11;-1
p1267-findlater;3 of those participants;3;-1
p1267-findlater;2 people;2;-1
p1271-gajos;23 participants;23;-1
p1271-gajos;16 participants;16;-1
p1271-gajos;N=1049;1049;-1
p1271-gajos;N=87;87;-1
p1271-gajos;N=86;86;-1
p1271-gajos;N=88;88;-1
p1271-gajos;N=44;44;-1
p1275-moscovich;6 women;6;-1
p1275-moscovich;5 women;5;-1
p1285-peltonen;1199   persons;1199;-1
p1285-peltonen;1199 persons;1199;-1
p1285-peltonen;202 persons;202;-1
p1295-shi;2 within-participants;2;-1
p1295-shi;14 participants;14;-1
p1295-shi;total of 13440;13440;-1
p1303-li;10 participants;10;-1
p1303-li;n=6;6;-1
p131-yamazaki;46 participants;46;-1
p1313-lin;12 participants;12;-1
p1333-elmqvist;12 participants;12;-1
p1333-elmqvist;12 unpaid subjects;12;-1
p1333-elmqvist;2 within-subjects;2;-1
p1343-pietriga;total of  11500;11500;-1
p1343-pietriga;total of 380;380;-1
p1361-fitzmaurice;6 women;6;-1
p1361-fitzmaurice;12 subjects;12;-1
p1361-fitzmaurice;3 of the subjects;3;-1
p1361-fitzmaurice;total of 12;12;-1
p1361-fitzmaurice;total of 7;7;-1
p1381-tanvir;11 participants;11;-1
p1381-tanvir;total of 180;180;-1
p1389-li;8 of participants;8;-1
p1389-li;6 participants;6;-1
p1389-li;8 participants;8;-1
p1389-li;n=8;8;-1
p1399-karlson;n=12;12;-1
p1399-karlson;n=24;24;-1
p1399-karlson;n=3;3;-1
p1399-karlson;n=5;5;-1
p1399-karlson;n=4;4;-1
p1399-karlson; data of the 4;4;-1
p1409-rohs;12 subjects;12;-1
p145-costabile;n = 24;24;-1
p145-costabile;n = 29;29;-1
p145-costabile;n = 38;38;-1
p145-costabile;n = 4;4;-1
p145-costabile;n = 1;1;-1
p145-costabile;n =1;1;-1
p145-costabile;n=8;8;-1
p145-costabile;n=9;9;-1
p145-costabile;total of 42;42;-1
p145-costabile;total of 99;99;-1
p145-costabile;total of 11;11;-1
p145-costabile;total of 36;36;-1
p1453-pinelle;total of 285;285;-1
p1463-szentgyorgyi;60 participants;60;-1
p1463-szentgyorgyi;5 people;5;-1
p1463-szentgyorgyi;3 people;3;-1
p1463-szentgyorgyi;15 individuals;15;-1
p1463-szentgyorgyi;30 individuals;30;-1
p1463-szentgyorgyi;60   individuals;60;-1
p1473-reeder;36 participants;36;-1
p1473-reeder;18 participants;18;-1
p1483-mclachlan;14 participants;14;-1
p1483-mclachlan;total of 13;13;-1
p1483-mclachlan;total of 24;24;-1
p1483-mclachlan; data sets of 4000;4000;-1
p1497-vertanen;3 women;3;-1
p1497-vertanen;16 volunteer participants;16;-1
p1497-vertanen;n = 26;26;-1
p1497-vertanen;n = 2;2;-1
p1497-vertanen;n = 5;5;-1
p1497-vertanen;n =   4;4;-1
p1497-vertanen;24 novices who enrolled;24;-1
p1511-mcquiggan;n = 33;33;-1
p1511-mcquiggan;n = 14;14;-1
p1511-mcquiggan;n = 3;3;-1
p1511-mcquiggan;n = 2;2;-1
p1511-mcquiggan;n = 26;26;-1
p1511-mcquiggan;n = 4;4;-1
p1511-mcquiggan;n   = 2;2;-1
p1511-mcquiggan;n = 55;55;-1
p1511-mcquiggan;n = 90;90;-1
p1511-mcquiggan;n =47;47;-1
p1511-mcquiggan;n = 43;43;-1
p1511-mcquiggan;n = 29;29;-1
p1511-mcquiggan;n = 18;18;-1
p1511-mcquiggan;n = 17;17;-1
p1511-mcquiggan;n = 35;35;-1
p1511-mcquiggan;total of 90;90;-1
p1521-mcginn;66 people;66;-1
p1535-kang;17 persons;17;-1
p1535-kang;180 participants;180;-1
p1545-geyer;50 people;50;-1
p1545-geyer;50   people;50;-1
p1545-geyer;116 people;116;-1
p1545-geyer;126 people;126;-1
p1545-geyer;17 people;17;-1
p1545-geyer; data from 285;285;-1
p1545-geyer; data from 9;9;-1
p155-ogan;35 participants;35;20544
p1555-salminen;11 participants;11;-1
p1555-salminen;12   subjects;12;-1
p1555-salminen;total of 12;12;-1
p1555-salminen;total of 528;528;-1
p1555-salminen; data from 11;11;-1
p1563-forlines;10 women;10;-1
p1563-forlines;24 participants;24;-1
p1563-forlines;12 participants;12;-1
p1563-forlines;n =    9216;9216;-1
p1563-forlines;n =    18432;18432;-1
p1573-hoggan;3 female participants;3;-1
p1573-hoggan;12 participants;12;-1
p1573-hoggan;12 participants were recruited;12;-1
p1593-satchell;18 participants;18;-1
p1603-gilbert;50 rural participants;50;-1
p1603-gilbert;50 urban participants;50;-1
p1603-gilbert;50 random rural participants;50;-1
p1603-gilbert;50 random urban   participants;50;-1
p1603-gilbert;2,500 people;2500;-1
p1603-gilbert;63 rural people;63;-1
p1603-gilbert;N  =   3379;3379;-1
p1603-gilbert;N = 2101;2101;-1
p1603-gilbert;N = 3067;3067;-1
p1603-gilbert;N = 1777;1777;-1
p1603-gilbert;N = 2069;2069;-1
p1603-gilbert;N = 1290;1290;-1
p1613-wobbrock;16 participants;16;-1
p1613-wobbrock;N = 90;90;-1
p1613-wobbrock;N = 18;18;-1
p1613-wobbrock;N = 180;180;-1
p1613-wobbrock;N=90;90;-1
p1613-wobbrock;total of   12;12;-1
p1623-dixon;12 participants;12;-1
p1623-dixon;6 new   participants;6;-1
p1623-dixon;total of 300;300;-1
p1623-dixon;total of 36;36;-1
p1623-dixon;total of 270;270;-1
p1623-dixon;total of 18;18;-1
p1633-mackenzie;18 participants;18;-1
p1633-mackenzie;total of   5,400;5400;-1
p1637-convertino;17 of the participants;17;-1
p1637-convertino;N=8;8;-1
p1647-amershi;36 paid participants;36;-1
p1647-amershi;19 participants;19;-1
p1647-amershi;17 participants;17;-1
p1647-amershi;11   participants;11;-1
p1647-amershi;16   participants;16;-1
p1647-amershi;9   participants;9;-1
p1647-amershi;15 participants;15;-1
p1647-amershi;5,000 people;5000;-1
p1647-amershi;12 groups of three   people;12;-1
p1647-amershi;n   = 36;36;-1
p1647-amershi;N=32;32;-1
p1647-amershi;N=19;19;-1
p1647-amershi;N=15;15;-1
p1647-amershi;N=33;33;-1
p1647-amershi;n=3;3;-1
p1647-amershi;n=2;2;-1
p1647-amershi;n=1;1;-1
p1647-amershi;N=16;16;-1
p1647-amershi;N=17;17;-1
p1647-amershi;n=4;4;-1
p1657-morris;109 people;109;-1
p1657-morris;204 people;204;-1
p1657-morris;n = 36;36;-1
p1657-morris;n=109;109;-1
p1665-jonsson;100 participants;100;-1
p1665-jonsson;total of 100;100;-1
p1675-leshed;n=27;27;-1
p1685-graf;12 participants;12;-1
p1685-graf;20 participants;20;-1
p1689-aliakseyeu;8 participants;8;-1
p1689-aliakseyeu;8 subjects;8;-1
p1689-aliakseyeu;total of 12;12;-1
p1689-aliakseyeu;total of    8;8;-1
p1709-casiez;16 participants;16;-1
p1719-leshed;14   participants;14;-1
p1719-leshed;8 participants;8;-1
p1719-leshed;18 participants;18;-1
p1719-leshed;54 people;54;-1
p1719-leshed;14 people;14;-1
p1719-leshed;7000 people;7000;-1
p173-kindberg;n = 21;21;-1
p173-kindberg;n = 20;20;-1
p173-kindberg;n=77;77;-1
p173-kindberg;n=39;39;-1
p1739-naaman;9 participants;9;-1
p1739-naaman;3 Four participants;3;-1
p1739-naaman;500 people;500;-1
p1739-naaman;n= 26;26;-1
p1739-naaman;N=69;69;-1
p1739-naaman;total of 128;128;-1
p1759-secretan;n = 3;3;-1
p1759-secretan;n = 1;1;-1
p1759-secretan;n = 15;15;-1
p1759-secretan;n = 114;114;-1
p1759-secretan;n = 5;5;-1
p1759-secretan;n = 0;0;-1
p1769-elmqvist;3D navigation helped participants;3;-1
p1769-elmqvist;35 subjects;35;-1
p1789-stewart;11   participants;11;-1
p1793-kruk;20  participants;20;-1
p1797-consolvo;12 participants;12;-1
p1797-consolvo;10 participants;10;-1
p1797-consolvo;n=12;12;-1
p1797-consolvo;n=75;75;-1
p1797-consolvo;total of 532;532;-1
p1797-consolvo;total of 325;325;-1
p1807-ballegaard;total of 70;70;-1
p1817-morris;7 women;7;11900
p1817-morris;26 participants;26;26898
p1817-morris;28 participants;28;10423
p1817-morris;11 participants;11;6719
p1817-morris;15 participants;15;6610
p1817-morris;12 participants;12;5065
p1817-morris;7 participants;7;5027
p1817-morris;6 participants;6;26897
p1817-morris;9 participants;9;4756
p1817-morris;13 participants;13;4612
p1817-morris;5 participants;5;6609
p1817-morris;1 million people;1;32630
p183-sasamoto;38 participants;38;-1
p183-sasamoto;18 participants;18;-1
p183-sasamoto;9 participants;9;-1
p183-sasamoto;38  participants;38;-1
p183-sasamoto;38 people;38;-1
p183-sasamoto;total of 28;28;-1
p183-sasamoto;total of 38;38;-1
p193-toomim;8  Specific people;8;-1
p193-toomim;31 people;31;-1
p193-toomim;total of 179;179;-1
p197-jakobsson;46 subjects;46;-1
p197-jakobsson;26 subjects;26;-1
p197-jakobsson;n = 0;0;-1
p219-ashbrook;14 participants;14;-1
p219-ashbrook;3 Latin-square  within-subjects;3;-1
p219-ashbrook;total of 504;504;-1
p223-hsieh;27 people;27;-1
p223-hsieh;n=4;4;-1
p223-hsieh;n=3;3;-1
p227-ranjan;11 participants;11;-1
p227-ranjan;3   people;3;-1
p247-karrer;30 participants;30;2347
p255-elias;total of 27;27;-1
p265-perer;60 participants;60;-1
p275-danis;n=1,472;1472;-1
p275-danis;n=972;972;-1
p275-danis;total of 3,084;3084;-1
p285-yatani;total of 3;3;-1
p295-olwal;12 male participants;12;-1
p305-castellucci;n = 23;23;-1
p309-laukkanen;18 participants;18;-1
p309-laukkanen;18 right handed participants;18;-1
p313-woodruff;30 women;30;-1
p313-woodruff;56   participants;56;-1
p313-woodruff;total of 35;35;-1
p313-woodruff;total of 56;56;-1
p323-huang;35 participants;35;-1
p323-huang;22 participants;22;-1
p323-huang;79   participants;79;-1
p323-huang;19   participants;19;-1
p323-huang;17 of the participants;17;-1
p323-huang;10 participants;10;-1
p323-huang;21 participants;21;-1
p323-huang;79 participants;79;-1
p323-huang;n=79;79;-1
p323-huang;n=10;10;-1
p343-freier;30 participants;30;-1
p343-freier;14   participants;14;-1
p343-freier;16 participants;16;-1
p343-freier;N=30;30;-1
p343-freier;n=16;16;-1
p343-freier;n=14;14;-1
p353-moraveji;total of 58;58;-1
p363-chang;n=13;13;-1
p363-chang; data from the 5;5;-1
p373-munteanu;15 participants;15;-1
p373-munteanu;12 participants;12;-1
p373-munteanu;total of 21;21;-1
p373-munteanu;26 students  were enrolled;26;-1
p383-grossman;total of 198;198;-1
p39-duggan;11 participants;11;-1
p39-duggan;34 participants;34;-1
p39-duggan;11   participants;11;-1
p39-duggan;N = 15;15;-1
p39-duggan;N = 8;8;-1
p39-duggan;N = 19;19;-1
p39-duggan;N = 26;26;-1
p403-cosley;36 people;36;-1
p403-cosley;5 people;5;-1
p403-cosley;total of 36;36;-1
p413-davis;18 participants;18;2289
p413-davis;7   participants;7;589
p413-davis;n = 6;6;1395
p413-davis;n = 3;3;1336
p433-sohn;20 participants;20;-1
p433-sohn;15 participants;15;-1
p433-sohn;5   participants;5;-1
p433-sohn;17 participants;17;-1
p433-sohn;3 participants;3;-1
p433-sohn;20 people;20;-1
p433-sohn;9 people;9;-1
p433-sohn;3 different people;3;-1
p443-kim;44 participants;44;-1
p443-kim;1000 new participants;1000;-1
p453-kittur;total of 210;210;-1
p457-wang;20 participants;20;-1
p457-wang;3 patients;3;-1
p457-wang;2 patients;2;-1
p457-wang;11   patients;11;-1
p457-wang;45 patients;45;-1
p477-mamykina;135   # of participants;135;-1
p477-mamykina;2 participants;2;-1
p477-mamykina;5 participants;5;-1
p477-mamykina;25 newly diagnosed individuals;25;-1
p477-mamykina;49 individuals;49;-1
p507-harrison;n=24;24;-1
p511-lindley;n = 248;248;-1
p511-lindley;n =   198;198;-1
p515-saponas;90 minutes and participants;90;-1
p525-zhang;12 subjects;12;-1
p525-zhang;7 subjects;7;-1
p525-zhang;14 subjects;14;-1
p525-zhang;total of 108;108;-1
p53-petrelli;10 women;10;-1
p53-petrelli;16 people;16;-1
p53-petrelli;15   people;15;-1
p535-kaneko;n = 7825;7825;-1
p535-kaneko;n = 4;4;-1
p535-kaneko; data from the 3;3;-1
p539-ratwani;total   of 12;12;-1
p543-bauer;29 study participants;29;-1
p543-bauer;10 participants;10;-1
p543-bauer;6 other participants;6;-1
p543-bauer;total of 244;244;-1
p553-larsen;15 people;15;-1
p573-clawson;8 participants;8;-1
p573-clawson;total of 400;400;-1
p573-clawson;total of 249,555;249555;-1
p583-martin;56   participants;56;-1
p583-martin;24 participants;24;-1
p583-martin;8 participants;8;-1
p593-zhai;12 participants;12;-1
p593-zhai;n = 80;80;-1
p593-zhai;n = 68;68;-1
p593-zhai;n = 60;60;-1
p593-zhai;total of 19;19;-1
p597-carmien;64 million persons;64;-1
p597-carmien;1600 persons;1600;-1
p597-carmien;9 people;9;-1
p617-subrahmaniyan;31 participants;31;-1
p617-subrahmaniyan;30 successful   participants;30;-1
p617-subrahmaniyan;30 participants;30;-1
p627-ledantec;13 participants;13;-1
p627-ledantec;28 participants;28;-1
p63-jokela;15 participants;15;-1
p63-jokela;total of 24;24;-1
p63-jokela;total of 15;15;-1
p63-jokela;total of   372;372;-1
p657-kapoor;44 participants;44;17279
p657-kapoor;41 participants;41;16575
p657-kapoor;11 subjects;11;16722
p657-kapoor;41 subjects;41;16602
p657-kapoor;37 subjects;37;16308
p667-patel;20 different people;20;-1
p685-hayes;28   participants;28;-1
p685-hayes;6 individuals;6;-1
p685-hayes;n = 7;7;-1
p685-hayes;n= 15;15;-1
p685-hayes;total of 8;8;-1
p685-hayes;total of 22;22;-1
p695-lanir;N=474;474;-1
p695-lanir;total of 117;117;-1
p695-lanir;total of 47;47;-1
p705-quinn;31 study participants;31;-1
p705-quinn;2 such   participants;2;-1
p705-quinn;2 participants;2;-1
p715-leong;12 participants;12;-1
p715-leong;12 participants were recruited;12;-1
p725-simon;total of 62;62;32816
p725-simon; database of 298;298;35527
p743-luk;18 participants;18;-1
p743-luk;73 participants;73;-1
p743-luk;73   participants;73;-1
p753-derenzi;n=24;24;1301
p753-derenzi;n=28;28;1288
p753-derenzi;n=20;20;1255
p753-derenzi;n=18;18;1242
p753-derenzi;n=7;7;1210
p753-derenzi;n=3;3;1199
p753-derenzi;n=9;9;1152
p753-derenzi;n=21;21;1140
p753-derenzi;n=1;1;1242
p753-derenzi;n=5;5;1099
p753-derenzi;n=299;299;1081
p753-derenzi;n=359;359;1067
p753-derenzi;n=15;15;3404
p753-derenzi;n=39;39;3417
p753-derenzi;n=12;12;3488
p753-derenzi;n=72;72;3540
p753-derenzi;n=84;84;3553
p753-derenzi;n=13;13;3889
p753-derenzi;n=6;6;3923
p753-derenzi;n=4;4;3956
p753-derenzi;n=27;27;4033
p753-derenzi;total of 24;24;13966
p753-derenzi;total of 23;23;6133
p753-derenzi; data from 21,600;21600;15661
p763-cheng;2 women;2;-1
p763-cheng;91 women;91;-1
p763-cheng;total of 231;231;-1
p767-dearman;27 participants;27;-1
p767-dearman;21 industry participants;21;-1
p767-dearman;170 devices participants;170;-1
p767-dearman;20 participants;20;-1
p767-dearman;17 participants;17;-1
p767-dearman;14 industry   participants;14;-1
p767-dearman;27 people;27;-1
p777-nacenta;4 participants;4;-1
p777-nacenta;total of 150;150;-1
p777-nacenta;total of 450;450;-1
p777-nacenta;total of 3;3;-1
p777-nacenta;total of 9;9;-1
p787-gustafson;18 participants;18;-1
p787-gustafson;16 participants;16;-1
p787-gustafson;30 were recruited;30;-1
p797-fiore;41   women;41;-1
p797-fiore;65 participants;65;-1
p797-fiore;7 million American adults;7;-1
p797-fiore;n = 168;168;-1
p797-fiore;n = 114;114;-1
p797-fiore;total of 200;200;-1
p797-fiore;total of 29,120;29120;-1
p807-shklovski;total of 1872;1872;-1
p807-shklovski;total of 2031;2031;-1
p817-brzozowski;1,117 people;1117;-1
p821-grimes;7 women;7;-1
p821-grimes;15 participants;15;-1
p821-grimes;12 participants;12;-1
p821-grimes;7   participants;7;-1
p821-grimes;15   participants;15;-1
p821-grimes;15 people;15;-1
p821-grimes;total of 1474;1474;-1
p825-wu;31 people;31;-1
p835-grimes; data from 8;8;-1
p835-grimes; data from 2;2;-1
p845-shenoy;total of   2400;2400;-1
p845-shenoy;total of 120;120;-1
p855-hartmann;67 participants;67;-1
p855-hartmann;12 participants;12;-1
p855-hartmann;392 participants;392;-1
p855-hartmann;16 participants;16;-1
p855-hartmann;n = 6;6;-1
p855-hartmann;n = 4;4;-1
p855-hartmann;n = 3;3;-1
p855-hartmann;n = 5;5;-1
p855-hartmann;N = 360;360;-1
p855-hartmann;N=67;67;-1
p855-hartmann;N=360;360;-1
p865-harper;total of 276;276;-1
p875-katsanos;18 participants;18;-1
p883-everett;66 participants;66;-1
p883-everett;101 participants;101;-1
p883-everett;50   female participants;50;-1
p883-everett;64 participants;64;-1
p883-everett;8 participants;8;-1
p883-everett;2 participants;2;-1
p883-everett;3 between-subjects;3;-1
p883-everett;66   million people;66;-1
p883-everett;32   people;32;-1
p883-everett; data from   1;1;-1
p893-schmettow;30 participants;30;-1
p893-schmettow;n = 30;30;-1
p903-hornbaek;N = 290;290;-1
p903-hornbaek;total of 290;290;-1
p929-hoffmann;10 participants;10;-1
p929-hoffmann;8 participants;8;-1
p939-biehl;9 individuals;9;-1
p939-biehl;6 individuals;6;-1
p949-kobayashi;N = 100;100;-1
p949-kobayashi;N = 400;400;-1
p959-heer;N = 11;11;-1
p959-heer;N = 5;5;-1
p959-heer;total of 28;28;-1
p969-oviatt;12 subjects;12;-1
p979-lohr;16 test subjects;16;-1
p989-evans;11 participants;11;-1
p989-evans;n=8;8;-1
p989-evans;n=9;9;-1
p989-evans;total of 607;607;-1
p999-chau;240 seconds since we   stopped subjects;240;-1
p999-chau;total of   7;7;-1
p1005-bi;4 are four dual-monitor participants;4;-1
p1015-golovchinsky;n=4;4;-1
p1025-maeda;24 participants;24;-1
p1029-bao;total of 24,123;24123;-1
p1033-chetty;2 pools of participants;2;-1
p1033-chetty;8 external participants;8;-1
p1033-chetty;12 external   participants;12;-1
p1033-chetty;2   internal participants;2;-1
p1033-chetty;11 participants;11;-1
p1033-chetty;12 participants;12;-1
p1033-chetty;N=89;89;-1
p1033-chetty;N=51;51;-1
p1033-chetty;N=88;88;-1
p1033-chetty;N=62;62;-1
p1033-chetty;N = 89;89;-1
p1033-chetty;N=72;72;-1
p1033-chetty;N=38;38;-1
p1033-chetty;N=37;37;-1
p1033-chetty;total of 89;89;-1
p1033-chetty;total of 583;583;-1
p1043-froehlich;14 participants;14;-1
p1043-froehlich;13 participants;13;-1
p1043-froehlich;500,000   people;500000;-1
p1043-froehlich;N=13;13;-1
p1043-froehlich;n=20;20;-1
p1043-froehlich;total of 63;63;-1
p105-lim;193 people;193;-1
p105-lim;24 people;24;-1
p105-lim;18 people;18;-1
p105-lim;N=106;106;-1
p1053-odom;22 were women;22;-1
p1053-odom;38 participants;38;-1
p1053-odom;5   participants;5;-1
p1063-wang;12 participants;12;-1
p1063-wang;12 subjects;12;-1
p1063-wang;total of 23;23;-1
p1083-wobbrock;20 participants;20;-1
p1083-wobbrock;20 non-technical participants;20;-1
p1083-wobbrock;20   participants;20;-1
p1083-wobbrock;14 participants;14;-1
p1083-wobbrock;20 new participants;20;-1
p1083-wobbrock;12 people;12;-1
p1083-wobbrock;N=1074;1074;-1
p1083-wobbrock;total of   20;20;-1
p1093-forlines;12 participants;12;-1
p1093-forlines;5 male   participants;5;-1
p1093-forlines;12 random layout experiment one participants;12;-1
p1093-forlines;12 RSVP layout Experiment Three participants;12;-1
p1093-forlines;12 individuals;12;-1
p1121-haynes;total of 34;34;-1
p1121-haynes;total of 215;215;-1
p113-rukzio;12 paid participants;12;-1
p113-rukzio;12 participants;12;-1
p113-rukzio;8 participants;8;-1
p113-rukzio;8   participants;8;-1
p113-rukzio;n   = 29;29;-1
p113-rukzio;n = 58;58;-1
p113-rukzio;n=8;8;-1
p113-rukzio;total   of 2;2;-1
p1151-ducheneaut;n = 2;2;-1
p1151-ducheneaut;n = 93;93;-1
p1151-ducheneaut;n = 4;4;-1
p1151-ducheneaut;n   = 4;4;-1
p1151-ducheneaut;n = 3;3;-1
p1151-ducheneaut;n =   3;3;-1
p1161-neustaedter;20 SL participants;20;-1
p1161-neustaedter;20 participants;20;-1
p1171-bedwell;10 participants;10;-1
p1171-bedwell;40   participants;40;-1
p1171-bedwell;40 participants;40;-1
p1171-bedwell;3 participants;3;-1
p1171-bedwell;26 participants;26;-1
p1197-law;54 participants;54;-1
p1197-law;100 participants;100;-1
p1197-law;80 of the participants;80;-1
p1197-law;total of 49,088;49088;-1
p1197-law;total of 512,770;512770;-1
p1197-law;total of 30,237;30237;-1
p1207-hacker;102 people;102;-1
p1217-hansen;170 mixes  participants;170;4400
p1217-hansen;52 subjects;52;6642
p1217-hansen;n=52;52;4183
p1227-piper;n=20;20;-1
p1227-piper;n=24;24;-1
p1227-piper;n=1;1;-1
p1227-piper;n=3;3;-1
p1227-piper;n=5;5;-1
p1227-piper;n=0;0;-1
p1227-piper;N=29;29;-1
p123-bell;10 participants;10;-1
p123-bell;16   participants;16;-1
p123-bell; data of   7;7;-1
p1255-lepape;18 participants;18;-1
p1255-lepape;9 field dependent participants;9;-1
p1255-lepape;90 non-solicited participants;90;-1
p1255-lepape;90 participants;90;-1
p1255-lepape;9 participants;9;-1
p1255-lepape;9  participants;9;-1
p1255-lepape;9 field indepen-  dent participants;9;-1
p1255-lepape;9 field  dependent participants;9;-1
p1255-lepape;0 in-  strument also measured participants;0;-1
p1255-lepape;5 levels of the  within-subjects;5;-1
p1255-lepape;2 levels of the between-  subjects;2;-1
p1255-lepape;total of 18;18;-1
p1255-lepape;total of 90;90;-1
p1265-bickmore;49 participants;49;-1
p1265-bickmore;749 patients;749;-1
p1265-bickmore;750 patients;750;-1
p1265-bickmore;30 non-hospitalized people;30;-1
p1265-bickmore;n=19;19;-1
p1265-bickmore;n=11;11;-1
p1265-bickmore;n=23;23;-1
p1265-bickmore;n=8;8;-1
p1265-bickmore;n=9;9;-1
p1265-bickmore;n=10;10;-1
p1265-bickmore;n=15;15;-1
p1265-bickmore;total of 30;30;-1
p1283-talbot;5 participants;5;-1
p1323-mankowski;total of 12;12;-1
p1327-hudson;441 participants;441;-1
p1327-hudson;1   indicated a primarily people;1;-1
p1327-hudson;n = 441;441;-1
p133-kim;24 subjects;24;-1
p1341-mentis;N=1546;1546;3547
p1341-mentis;N=2596;2596;95
p1341-mentis;n=12;12;1534
p1341-mentis;N=880;880;2142
p1341-mentis;N=870;870;2321
p1341-mentis;N=676;676;2904
p1351-love;1 served as subjects;1;-1
p1351-love;46 subjects;46;-1
p1351-love;N = 713;713;-1
p1361-harry;total of 224;224;-1
p1361-harry;total of 676;676;-1
p1381-adar; data of 612,000;612000;-1
p1391-chapuis;9 standard forcing participants;9;-1
p1391-chapuis;total of 4,320;4320;-1
p1391-chapuis;total of 19,440;19440;-1
p1401-wobbrock;2 within-subjects;2;-1
p1401-wobbrock;3 within-subjects;3;-1
p1401-wobbrock;16 people;16;-1
p1401-wobbrock;8 people;8;-1
p1401-wobbrock;n = 16;16;-1
p1401-wobbrock;N=48;48;-1
p1401-wobbrock;N=72;72;-1
p1411-raiha;13 participants;13;-1
p1411-raiha;3 within-subjects;3;-1
p1419-diefenbach;600   participants;600;-1
p1419-diefenbach;277 participants;277;-1
p1419-diefenbach;2 between-subjects;2;-1
p1419-diefenbach;N=422;422;-1
p1419-diefenbach;n=16;16;-1
p1419-diefenbach;N=134;134;-1
p1419-diefenbach;n=19;19;-1
p1419-diefenbach;N=123;123;-1
p1419-diefenbach;n=18;18;-1
p1427-heath;1 a total of six different participants;1;-1
p1437-yamazaki;8 persons;8;-1
p1437-yamazaki;n=   53;53;-1
p1437-yamazaki;total of   11;11;-1
p1457-won;17   participants;17;-1
p1457-won;17 participants;17;-1
p1457-won;12 participants;12;-1
p1477-vankleek;42   participants;42;3681
p1477-vankleek;42 participants;42;8273
p1481-thom-santelli;1 Eight of the participants;1;-1
p1481-thom-santelli;total of 1172;1172;-1
p1495-kittur;N = 20;20;-1
p1495-kittur;N   = 1;1;-1
p1495-kittur;total of   10,002;10002;-1
p1505-pirolli;2,500   participants;2500;-1
p1513-garzonis;4 participants;4;22323
p1513-garzonis;12 participants;12;21610
p1513-garzonis;2 participants;2;21609
p1513-garzonis;112   participants;112;12475
p1513-garzonis;12   participants;12;12474
p1513-garzonis;8 participants;8;10489
p153-hsiao;total of 20;20;-1
p153-hsiao;total of 15;15;-1
p1531-keranen;8 participants;8;-1
p1531-keranen;6 participants;6;-1
p1531-keranen;6 participants were recruited;6;-1
p1531-keranen;total of 244;244;-1
p1535-choi;2 women;2;-1
p1535-choi;3   women;3;-1
p1539-mueller;39 participants;39;-1
p1549-waern;52 participants;52;-1
p1559-voida;36 participants;36;-1
p1559-voida;36 individuals;36;-1
p1559-voida;28 individuals;28;-1
p1569-ko;10 participants;10;-1
p1569-ko;10 Whyline participants;10;-1
p1569-ko;3 control participants;3;-1
p1579-jakobsen;16   participants;16;-1
p1579-jakobsen;2 participants;2;-1
p1579-jakobsen;7 participants;7;-1
p1579-jakobsen;50 probes were answered   after participants;50;-1
p1579-jakobsen;N = 36;36;-1
p1579-jakobsen;N = 14;14;-1
p1579-jakobsen;N = 83;83;-1
p1589-brandt;20 participants;20;-1
p1589-brandt;13 participants;13;-1
p1589-brandt;3 participants;3;-1
p1589-brandt;13 million people;13;-1
p1599-sauro;26 participants;26;-1
p1599-sauro;20 participants;20;-1
p1599-sauro;10 participants;10;-1
p1599-sauro;n=26;26;-1
p1599-sauro;n = 10;10;-1
p1599-sauro;n = 52;52;-1
p1599-sauro;n = 231;231;-1
p1599-sauro;n = 236;236;-1
p1599-sauro;n = 234;234;-1
p1599-sauro;total of 26;26;-1
p1599-sauro;total of 211;211;-1
p1599-sauro;total of 6;6;-1
p1609-sauro;n = 296;296;-1
p1609-sauro;n = 93;93;-1
p1609-sauro;total of 30;30;-1
p1609-sauro; data-sets from 90;90;-1
p1609-sauro; data came from 12;12;-1
p1619-bruun;10 persons;10;-1
p1619-bruun;24   participants;24;-1
p1619-bruun;10 participants;10;-1
p1619-bruun;6 participants;6;-1
p1619-bruun;9   participants;9;-1
p1619-bruun;8 participants;8;-1
p1619-bruun;40 test participants;40;-1
p1619-bruun;40 test subjects;40;-1
p1619-bruun;N=10;10;-1
p1619-bruun;total of 40;40;-1
p1619-bruun;total of 46;46;-1
p1619-bruun;total of 62;62;-1
p1619-bruun;total of 15;15;-1
p1619-bruun;total of 29;29;-1
p1619-bruun;total of 21;21;-1
p1619-bruun;total of 7;7;-1
p1629-brumby;2   within-subjects;2;7883
p1629-brumby;total   of 160;160;5991
p1629-brumby;total of 640;640;5881
p1639-nylander;19 participants;19;-1
p1643-takayama;N=48;48;-1
p1647-karlson;1 lists participants;1;-1
p1651-eckles;65 participants;65;-1
p1651-eckles;71 university students recruited;71;-1
p1651-eckles;N=71;71;-1
p1655-findlater;4 participants;4;-1
p1655-findlater;23 participants;23;-1
p1655-findlater;11 High accuracy participants;11;-1
p1655-findlater;12 Low accuracy participants;12;-1
p1655-findlater;3 participants;3;-1
p1655-findlater;5 participants;5;-1
p1655-findlater;24 new participants;24;-1
p1655-findlater;12 participants;12;-1
p1655-findlater;N = 23;23;-1
p1655-findlater;N=23;23;-1
p1655-findlater;N=2;2;-1
p1655-findlater;N = 24;24;-1
p1655-findlater;total of 48;48;-1
p1683-chin;00   adults;0;-1
p1683-chin;N=34;34;-1
p1683-chin;N=35;35;-1
p1683-chin;total of 276;276;-1
p1693-lindley;18 participants;18;-1
p1693-lindley;18   adults;18;-1
p1703-leonardi;12 women;12;-1
p1703-leonardi;8 participants;8;-1
p1703-leonardi;19 older people;19;-1
p1703-leonardi;11   people;11;-1
p1713-kientz;8 participants;8;-1
p1723-petrelli;6 participants;6;-1
p1723-petrelli;20 adults;20;-1
p173-zhao;8 more participants;8;-1
p173-zhao;total of 14;14;-1
p1733-hilliges;20 participants;20;-1
p1733-hilliges;24 participants;24;-1
p1741-medhi;58 participants;58;-1
p1741-medhi;20 participants;20;-1
p1741-medhi;18   participants;18;-1
p1741-medhi;90   subjects;90;-1
p1741-medhi;58   subjects;58;-1
p1741-medhi;90 subjects;90;-1
p1741-medhi;58 subjects;58;-1
p1741-medhi;56   subjects;56;-1
p1741-medhi;24 of these   subjects;24;-1
p1741-medhi;20 subjects;20;-1
p1741-medhi;2 male   subjects;2;-1
p1741-medhi;13 subjects;13;-1
p1741-medhi;59   people;59;-1
p1741-medhi;total of 90;90;-1
p1741-medhi;total of 58;58;-1
p1741-medhi;total of 20;20;-1
p1751-findlater;32 women;32;-1
p1751-findlater;12 semiliterate   participants;12;-1
p1751-findlater;12   participants;12;-1
p1751-findlater;10 trials and participants;10;-1
p1751-findlater;14 participants;14;-1
p1751-findlater;12 participants;12;-1
p1751-findlater;3 participants;3;-1
p1751-findlater;6 other participants;6;-1
p1751-findlater;4 participants;4;-1
p1751-findlater;4 Literate participants;4;-1
p1751-findlater;3 of the Illiterate participants;3;-1
p1751-findlater;4 Illiterate   participants;4;-1
p1751-findlater;8 remaining participants;8;-1
p1751-findlater;16 semiliterate participants;16;-1
p1751-findlater;4   illiterate participants;4;-1
p1751-findlater;8 participants;8;-1
p1751-findlater;35 million people;35;-1
p1751-findlater;10 million people;10;-1
p1751-findlater;785 million adults;785;-1
p1751-findlater;N = 12;12;-1
p1751-findlater;total of 8;8;-1
p1751-findlater;total of 100;100;-1
p1751-findlater;total of 50;50;-1
p1761-frohlich;50 per   cent of women;50;-1
p1761-frohlich;13   all-women;13;-1
p1761-frohlich;3,020 people;3020;-1
p1761-frohlich;79 people;79;-1
p1761-frohlich;15 people;15;-1
p1761-frohlich;20   people;20;-1
p1761-frohlich;n=22;22;-1
p1761-frohlich;n=19;19;-1
p1771-paul;2 participants;2;-1
p1771-paul;1 participants;1;-1
p1771-paul;18 participants;18;-1
p1771-paul;8 participants;8;-1
p1771-paul;12   participants;12;-1
p1771-paul;6   participants;6;-1
p1781-wiltse;23 participants;23;-1
p1781-wiltse;total of 23;23;-1
p1795-nelson;18 participants;18;-1
p1795-nelson;100 random   people;100;-1
p1795-nelson;N = 18;18;-1
p1799-jin;13 participants;13;-1
p1799-jin;n=36;36;-1
p1799-jin;n=2;2;-1
p1799-jin;n=1;1;-1
p1799-jin;n=53;53;-1
p1799-jin;n=57;57;-1
p1799-jin;n=3;3;-1
p1799-jin;total of 11;11;-1
p1829-bigham;150  participants;150;-1
p1829-bigham;162 participants;162;-1
p1829-bigham;14 blind participants;14;-1
p1829-bigham;N=6;6;-1
p1829-bigham;N = 161;161;-1
p1829-bigham;total of 100;100;-1
p183-house;total of 12;12;-1
p183-house;total of 42;42;-1
p1839-talbot;45 million people;45;-1
p1839-talbot;45 million blind  people;45;-1
p1839-talbot; data rate of 44;44;-1
p1849-hoffmann;574 participants;574;8093
p1849-hoffmann;N=1345;1345;8726
p1849-hoffmann;N=1039;1039;8684
p1849-hoffmann;N=1041;1041;8644
p1849-hoffmann;N=1432;1432;8501
p1849-hoffmann;N=1434;1434;8461
p1849-hoffmann;total of 2473;2473;5416
p1859-toomim;total of 21;21;-1
p1859-toomim;total of 8;8;-1
p1869-zimmerman;17 participants;17;3095
p1869-zimmerman;12 participants;12;2819
p1869-zimmerman;3 participants;3;2740
p1869-zimmerman;total of   40;40;1562
p1879-costanza;6 of the sessions participants;6;-1
p1879-costanza;N=65000;65000;-1
p1879-costanza;N=144;144;-1
p1879-costanza;N=14;14;-1
p1879-costanza;total of 1;1;-1
p1879-costanza;total of  6;6;-1
p1879-costanza;total of  161;161;-1
p1879-costanza;total of 161;161;-1
p1879-costanza;total  of 58;58;-1
p1879-costanza;total of 219;219;-1
p1889-morrison;37 people;37;-1
p1889-morrison;total   of 184;184;-1
p1899-chung;12 participants;12;-1
p1899-chung;12   participants;12;-1
p1899-chung;n=8;8;-1
p1899-chung;n = 3;3;-1
p1903-fischer;16   participants;16;-1
p1903-fischer;16 participants;16;-1
p1903-fischer;N=85;85;-1
p1923-baudisch;40   were recruited;40;3336
p1923-baudisch;47   were recruited;47;10480
p1923-baudisch;total of   5;5;9731
p193-sung;26 women;26;-1
p193-sung;13 women;13;-1
p193-sung;26 people;26;-1
p1933-hinckley;3 people;3;-1
p1933-hinckley;2 other people;2;-1
p1943-rahman;9 participants;9;-1
p1943-rahman;10 participants;10;-1
p1943-rahman;2 within-participants;2;-1
p1943-rahman;35 were recruited;35;-1
p1943-rahman;total of 9;9;-1
p1943-rahman;total of 90;90;-1
p1943-rahman;total of 120;120;-1
p1953-cosley;23 participants;23;-1
p1953-cosley;23   participants;23;-1
p1953-cosley;8 participants;8;-1
p1953-cosley;23 people;23;-1
p1953-cosley;1 Do people;1;-1
p1953-cosley;total of 23;23;-1
p1953-cosley;total of 1822;1822;-1
p1953-cosley;total of   139;139;-1
p1973-koleva;10 external participants;10;-1
p1983-schechter;18 participants;18;-1
p1983-schechter;43 prospective participants;43;-1
p1983-schechter;19 participants;19;-1
p1983-schechter;9 pairs of participants;9;-1
p1983-schechter;43 individuals;43;-1
p1983-schechter;total of 118;118;-1
p1983-schechter;total of 89;89;-1
p1993-klasnja;11   participants;11;-1
p1993-klasnja;3 Potential participants;3;-1
p1993-klasnja;4   Six participants;4;-1
p1993-klasnja;N=72;72;-1
p1993-klasnja;N=22;22;-1
p1993-klasnja;N=20;20;-1
p1993-klasnja;N=9;9;-1
p1993-klasnja;N=8;8;-1
p1993-klasnja;N=24;24;-1
p1993-klasnja;N=11;11;-1
p2003-tsai;56 participants;56;-1
p2003-tsai;3 people;3;-1
p2003-tsai;2  people;2;-1
p2003-tsai;2 people;2;-1
p2003-tsai;6 people;6;-1
p2003-tsai;n = 30;30;-1
p2003-tsai;n = 26;26;-1
p2003-tsai;n = 56;56;-1
p2003-tsai;total of 233;233;-1
p201-chen;600 subjects;600;-1
p201-chen;total of   30;30;-1
p2013-medynskiy;12 subjects;12;-1
p2013-medynskiy;total of 12;12;-1
p2023-teevan;128   participants;128;10943
p2023-teevan;197 people;197;24293
p2023-teevan;276 people;276;3655
p2033-andre;total of 92;92;-1
p2037-schrammel;16 test persons;16;4220
p2037-schrammel;24 test participants;24;1260
p2037-schrammel;5 participants;5;3938
p2051-coyle;total of 22;22;-1
p2061-zhou;16 patients;16;-1
p2061-zhou;16   patients;16;-1
p2061-zhou;32   patients;32;-1
p2061-zhou;10 patients;10;-1
p2071-yardi;96 participants;96;-1
p2071-yardi;2 shows the breakdown of the participants;2;-1
p2071-yardi;37 participants;37;-1
p2071-yardi;19 participants;19;-1
p2071-yardi;96   participants;96;-1
p2071-yardi;41 participants;41;-1
p2071-yardi;26 participants;26;-1
p2071-yardi;n=96;96;-1
p2071-yardi;n=52;52;-1
p2081-santelli;3 participants;3;-1
p2081-santelli;111 people;111;-1
p2091-brush;130 people;130;-1
p2091-brush;N=549;549;-1
p2091-brush;N=547;547;-1
p2091-brush;N=241;241;-1
p2091-brush;N=308;308;-1
p2091-brush;N=240;240;-1
p2091-brush;N=519;519;-1
p2091-brush;N=487;487;-1
p2091-brush;N=379;379;-1
p2091-brush;N=490;490;-1
p2091-brush;N=353;353;-1
p2095-rader;12 women;12;-1
p2099-takayama;N=40;40;-1
p21-buscher;20   participants;20;-1
p21-buscher;20 participants;20;-1
p21-buscher;3 participants;3;-1
p21-buscher;n=10;10;-1
p21-buscher; data from 2,126;2126;-1
p211-gilbert;23   women;23;-1
p211-gilbert;35 participants;35;-1
p211-gilbert;1,261 people;1261;-1
p211-gilbert;N  = 4368;4368;-1
p211-gilbert; dataset of 2,184;2184;-1
p2119-lim;200 participants;200;-1
p2119-lim;211 online participants;211;-1
p2119-lim;53 participants;53;-1
p2119-lim;18 participants;18;-1
p2119-lim;39 of the participants;39;-1
p2119-lim;158 participants;158;-1
p2119-lim;37   participants;37;-1
p2119-lim;115 participants;115;-1
p2119-lim;53 participants were recruited;53;-1
p2119-lim;158 participants were recruited;158;-1
p2119-lim;n=31;31;-1
p2119-lim;n=30;30;-1
p2119-lim;n=29;29;-1
p2119-lim;n=37;37;-1
p2119-lim;total of 24;24;-1
p2129-pinelle;4 participants;4;-1
p2129-pinelle;18 paid participants;18;-1
p2129-pinelle;18 participants;18;-1
p2139-tuddenham;18 paid participants;18;-1
p2153-farnham;163 people;163;-1
p2153-farnham;17 people;17;-1
p2153-farnham;23   new people;23;-1
p2153-farnham;69 people;69;-1
p2153-farnham;82 people;82;-1
p2153-farnham;N =   54;54;-1
p2153-farnham;N = 54;54;-1
p2153-farnham;total of 163;163;-1
p2157-moraveji;4 people;4;-1
p2157-moraveji;total   of 10;10;-1
p2157-moraveji;total of 8;8;-1
p2157-moraveji; data from Day 1;1;-1
p2181-magielse;8 participants;8;-1
p2181-magielse;3 participants;3;-1
p2181-magielse;N=32;32;-1
p2181-magielse;N = 5;5;-1
p2195-yun;14 participants;14;-1
p2195-yun;8 participants;8;-1
p2195-yun;n = 5;5;-1
p2195-yun;n=3;3;-1
p2195-yun;total of 14;14;-1
p2195-yun;total of 56;56;-1
p2209-oliveira;5 women;5;-1
p2209-oliveira;8 women;8;-1
p2209-oliveira;6 participants;6;-1
p2209-oliveira;4 participants;4;-1
p2209-oliveira;n = 16;16;-1
p2209-oliveira;n = 13;13;-1
p2209-oliveira; data from 6;6;-1
p221-rao;56 participants;56;5871
p221-rao;N=56;56;11404
p221-rao;total of 40;40;3796
p2243-spelmezan;19 participants;19;-1
p2243-spelmezan;n = 7;7;-1
p2243-spelmezan;total of 29;29;-1
p2253-hoggan;12 participants;12;-1
p2257-dunlop;9 male subjects;9;-1
p2257-dunlop;n=479;479;-1
p2257-dunlop;N = 1161;1161;-1
p2257-dunlop;N = 78;78;-1
p2261-harrison;15 participants;15;-1
p2265-hoffmann;24 participants;24;-1
p2265-hoffmann; database of 46000;46000;-1
p2269-bragdon;24 participants;24;-1
p2269-bragdon;5 participants;5;-1
p2269-bragdon;3 participants;3;-1
p2269-bragdon;2 participants;2;-1
p2269-bragdon;44 participants;44;-1
p2269-bragdon;11 participants;11;-1
p2269-bragdon;4 asked participants;4;-1
p2269-bragdon;n =   4;4;-1
p2269-bragdon;n = 4;4;-1
p2289-appert;6 of the participants;6;-1
p2289-appert;3 participants;3;-1
p2289-appert;n = 31;31;-1
p2289-appert;total of 60;60;-1
p229-bunt;3Some participants;3;-1
p2299-holten;108  Thirty test subjects;108;-1
p2309-ludwig;8 women;8;-1
p2309-ludwig;15   subjects;15;-1
p2309-ludwig;8 subjects;8;-1
p2309-ludwig;9 subjects;9;-1
p2309-ludwig;total of 192;192;-1
p2319-moscovich;total of 384;384;-1
p2329-lottridge;n= 1;1;-1
p2329-lottridge;n=6;6;-1
p2329-lottridge;n=4;4;-1
p2329-lottridge;n=5;5;-1
p2329-lottridge;n=12;12;-1
p2339-convertino;36   participants;36;-1
p2339-convertino;48 participants;48;-1
p2353-pan;48   participants;48;-1
p2353-pan;48 students as participants;48;-1
p239-luther;15 participants;15;-1
p239-luther;N=15;15;-1
p259-voida;n = 22;22;-1
p259-voida;n = 1;1;-1
p269-bergman;96 participants;96;32637
p269-bergman;84 participants;84;21548
p269-bergman;70   participants;70;13873
p269-bergman;59 participants;59;13779
p269-bergman;11 participants;11;12759
p269-bergman;233 participants;233;10552
p269-bergman;3 of these participants;3;10286
p269-bergman;3 participants;3;10550
p269-bergman;64 participants;64;4774
p269-bergman;9   participants;9;5217
p269-bergman;70 participants;70;6435
p269-bergman;N = 190;190;10489
p269-bergman;N = 38;38;10473
p269-bergman;N = 5;5;10454
p279-oleksik;5 participants;5;-1
p279-oleksik;7   participants;7;-1
p279-oleksik;16 participants;16;-1
p279-oleksik;16 study participants;16;-1
p279-oleksik;11   participants;11;-1
p279-oleksik;7 participants;7;-1
p279-oleksik;total of 131;131;-1
p289-fekete;6 participants;6;-1
p289-fekete;total of 2,304;2304;-1
p299-harrison;15 participants;15;5306
p309-zhai;9 mm respectively and women;9;-1
p309-zhai;12      participants;12;-1
p309-zhai;13 participants;13;-1
p309-zhai;13   participants;13;-1
p309-zhai;total of 13;13;-1
p309-zhai;total of 3;3;-1
p309-zhai;total   of 4;4;-1
p31-kam;3 participants;3;-1
p31-kam;total of 28;28;-1
p31-kam;total of 23;23;-1
p31-kam;total of 18;18;-1
p319-egelman;89 participants;89;15011
p319-egelman;2008 using participants;2008;2258
p319-egelman;5  We randomly assigned participants;5;5542
p319-egelman;7We asked participants;7;13346
p319-egelman;total of 89;89;15020
p329-kostakos;12 participants;12;-1
p329-kostakos;total of 56;56;-1
p337-nanayakkara;43 deaf participants;43;-1
p337-nanayakkara;43 participants;43;-1
p337-nanayakkara;19 profoundly deaf   participants;19;-1
p337-nanayakkara;43   participants;43;-1
p337-nanayakkara;20 male subjects;20;-1
p337-nanayakkara;21 female   subjects;21;-1
p337-nanayakkara;5 subjects;5;-1
p337-nanayakkara;28 male subjects;28;-1
p337-nanayakkara;15 female   subjects;15;-1
p337-nanayakkara;11 particularly enthusiastic   subjects;11;-1
p337-nanayakkara;41 people;41;-1
p337-nanayakkara;4 illustrate  ired people;4;-1
p337-nanayakkara;1  Profoundly  aired people;1;-1
p347-harada;46 million adults;46;-1
p347-harada;50,000 children and adults;50000;-1
p357-majaranta;10 participants;10;-1
p357-majaranta;6 participants;6;-1
p357-majaranta;3 participants;3;-1
p361-ma;25 participants;25;-1
p361-ma;n=22;22;-1
p361-ma;n=72;72;-1
p361-ma;n = 49;49;-1
p361-ma;n = 44;44;-1
p365-wakkary;total of 1;1;-1
p375-aoki;20 people;20;-1
p405-consolvo;12 participants;12;-1
p405-consolvo;28 participants;28;-1
p405-consolvo;n=19;19;-1
p405-consolvo;n=13;13;-1
p405-consolvo;N=40;40;-1
p41-thorlacius;8 subjects;8;-1
p41-thorlacius;48 people;48;-1
p41-thorlacius;N = 412;412;-1
p41-thorlacius;total of 86;86;-1
p41-thorlacius;total of 2;2;-1
p423-nguyen;124 participants;124;-1
p443-park;75 participants;75;-1
p443-park;25   participants;25;-1
p443-park;33 participants;33;-1
p443-park;16 participants;16;-1
p443-park;33 participants were recruited;33;-1
p453-hailpern;5 subjects;5;-1
p453-hailpern;2  Only one of five subjects;2;-1
p453-hailpern;4  Although some subjects;4;-1
p453-hailpern;n=1;1;-1
p463-newton;n=128;128;-1
p471-fiebrink;4 participants;4;-1
p471-fiebrink;34   participants;34;-1
p471-fiebrink;24   participants;24;-1
p471-fiebrink;34 participants;34;-1
p471-fiebrink;23 participants;23;-1
p471-fiebrink;25 participants;25;-1
p471-fiebrink;29 subjects;29;-1
p471-fiebrink;N=23;23;-1
p471-fiebrink;total of 34;34;-1
p481-weiss;total of 21;21;274
p491-guo;23 participants;23;-1
p51-patel;45 participants;45;-1
p51-patel;38 participants;38;-1
p51-patel;7  participants;7;-1
p51-patel;480 million illiterate  people;480;-1
p51-patel;45 participants recruited;45;-1
p517-hancock;50 participants;50;-1
p517-hancock;43 participants;43;-1
p517-hancock;N = 132;132;-1
p517-hancock;total of 50;50;-1
p517-hancock;total of 6996;6996;-1
p527-scissors;N=124;124;-1
p527-scissors;N=52;52;-1
p527-scissors;N=310;310;-1
p527-scissors;total of 24,002;24002;-1
p547-lichtschlag;n=13;13;-1
p547-lichtschlag;n=18;18;-1
p55-wyche;4   women;4;-1
p55-wyche;54 year   old woman   Other participants;54;-1
p557-vogel;22 participants;22;-1
p557-vogel;22 people;22;-1
p567-kristensson;n = 27;27;-1
p567-kristensson;n = 3;3;-1
p571-bonanni;3 women;3;-1
p571-bonanni;14 individuals;14;-1
p575-beauvisage;2,730 individuals;2730;-1
p575-beauvisage;1,434 individuals;1434;-1
p585-huang;3 increased people;3;-1
p585-huang;total of 896;896;-1
p595-geerts;17 participants;17;-1
p595-geerts;48 participants;48;-1
p595-geerts;29 female participants;29;-1
p595-geerts;15   participants;15;-1
p595-geerts;33   participants;33;-1
p595-geerts;16 female participants;16;-1
p595-geerts;36 participants;36;-1
p595-geerts;13 participants;13;-1
p595-geerts;23 participants;23;-1
p605-pirolli;2 represent people;2;-1
p605-pirolli;n = 1;1;-1
p615-budiu;27 participants;27;-1
p615-budiu;20 participants;20;-1
p615-budiu;7   participants;7;-1
p615-budiu;7 extra   participants;7;-1
p615-budiu;7   more  participants;7;-1
p615-budiu;2Tag encourages   people;2;-1
p615-budiu;n = 96;96;-1
p615-budiu;n =   37;37;-1
p615-budiu;n =0;0;-1
p625-kammerer;15 participants;15;-1
p625-kammerer;20 people;20;-1
p625-kammerer;N=15;15;-1
p625-kammerer;N=14;14;-1
p635-sellen;10 participants;10;-1
p635-sellen;3 working individuals;3;-1
p639-karapanos;total of 118;118;-1
p659-akers;35   participants;35;-1
p659-akers;35 participants;35;-1
p659-akers;27 participants;27;-1
p659-akers;70   participants;70;-1
p659-akers;3 participants;3;-1
p659-akers;7 participants;7;-1
p659-akers;43 participants;43;-1
p659-akers;8 participants;8;-1
p659-akers;90 minutes were spent training participants;90;-1
p659-akers;n = 12;12;-1
p659-akers;n = 10;10;-1
p659-akers;N = 110;110;-1
p659-akers;total of 70;70;-1
p669-wang;23   participants;23;-1
p669-wang;25 participants;25;-1
p669-wang;total of 16;16;-1
p69-shami;3 people;3;-1
p699-bartneck;n=2;2;-1
p699-bartneck;n = 40;40;-1
p699-bartneck;n = 11;11;-1
p699-bartneck;n=758;758;-1
p699-bartneck;n=64;64;-1
p699-bartneck;n=12;12;-1
p699-bartneck;n=76;76;-1
p719-law;41    To make people;41;-1
p719-law;N=200;200;-1
p719-law;N=235;235;-1
p729-karapanos;6 participants;6;-1
p729-karapanos;6 individuals;6;-1
p729-karapanos;N=71;71;-1
p729-karapanos;N=33;33;-1
p729-karapanos;N=12;12;-1
p729-karapanos;N=21;21;-1
p729-karapanos;N=38;38;-1
p729-karapanos;N=50;50;-1
p729-karapanos;N=113;113;-1
p729-karapanos;N=43;43;-1
p729-karapanos;N=70;70;-1
p729-karapanos;N=18;18;-1
p729-karapanos;N=11;11;-1
p729-karapanos;N=8;8;-1
p729-karapanos;N=130;130;-1
p729-karapanos;N=69;69;-1
p729-karapanos;N=61;61;-1
p729-karapanos;N=23;23;-1
p729-karapanos;N=13;13;-1
p729-karapanos;n=3;3;-1
p729-karapanos;n=5;5;-1
p729-karapanos;total of 482;482;-1
p749-wyche;15 women;15;-1
p749-wyche;20 individuals;20;-1
p759-harper;30 people;30;-1
p759-harper;total of   1,106;1106;-1
p779-nam;26 participants;26;-1
p779-nam; data of 2;2;-1
p789-cheng;10 unpaid participants;10;-1
p789-cheng;10 participants;10;-1
p789-cheng;8   participants;8;-1
p789-cheng;20 unpaid participants;20;-1
p789-cheng;20 participants;20;-1
p789-cheng;20   participants;20;-1
p79-wu;12   participants;12;-1
p79-wu;total of 12;12;-1
p799-diakopoulos;10 participants;10;-1
p799-diakopoulos;10   participants;10;-1
p839-seitinger;50 people;50;-1
p87-herring;N=11;11;-1
p889-everitt;100 participants;100;-1
p889-everitt;110 participants;110;-1
p889-everitt;100   participants;100;-1
p889-everitt;69 participants;69;-1
p889-everitt;110 people;110;-1
p889-everitt;total of 110;110;-1
p889-everitt; data from   100;100;-1
p899-bauer;1,500 people;1500;-1
p899-bauer;170  people;170;-1
p899-bauer;70 people;70;-1
p899-bauer;200 people;200;-1
p909-cramer;N=43;43;-1
p909-cramer;N=12;12;-1
p909-cramer;N=19;19;-1
p909-cramer;N=15;15;-1
p909-cramer;N=22;22;-1
p909-cramer;N=4;4;-1
p909-cramer;N=14;14;-1
p909-cramer;N=16;16;-1
p909-cramer;N=25;25;-1
p909-cramer;n=5;5;-1
p909-cramer;n=3;3;-1
p913-deluca;24 participants;24;-1
p913-deluca;13 participants;13;-1
p913-deluca;11 participants;11;-1
p917-taylor;total of 395;395;-1
p927-roudaut;12 participants;12;-1
p927-roudaut;total of 16;16;-1
p937-kratz;12 participants;12;-1
p941-harrison;n=18;18;-1
p941-harrison;n=22;22;-1
p945-burke;n=17;17;-1
p945-burke;n=53;53;-1
p945-burke;N=50,929;50929;-1
p945-burke;N=89,363;89363;-1
p945-burke;n=9;9;-1
p945-burke;n=69;69;-1
p945-burke;n=8;8;-1
p945-burke;total of 2;2;-1
p945-burke;total of 220;220;-1
p965-binder;232 participants;232;-1
p965-binder;total of 232;232;-1
p975-horn;104 of the participants;104;11146
p975-horn;20,000 people;20000;22729
p975-horn;260 individuals;260;11260
p975-horn;N=260;260;4606
p975-horn;N=32;32;4587
p975-horn;N=73;73;4570
p975-horn;N=72;72;4553
p975-horn;N=83;83;4540
p975-horn;N = 25;25;257
p975-horn;N = 39;39;270
p975-horn;total of 260;260;11269
p103-wang;4 insurance salespersons;4;-1
p103-wang;48 participants;48;-1
p103-wang;16 participants;16;-1
p103-wang;5  Two participants;5;-1
p103-wang;4 participants;4;-1
p103-wang;n=28;28;-1
p103-wang;n=24;24;-1
p1039-steptoe;22 participants;22;-1
p1039-steptoe;0 representing  participants;0;-1
p1039-steptoe;27 participants;27;-1
p1039-steptoe;N=22;22;-1
p1039-steptoe;N=27;27;-1
p1039-steptoe;total of 22;22;-1
p1039-steptoe;total of 132;132;-1
p1039-steptoe;total of 27;27;-1
p1039-steptoe;total of 24;24;-1
p1059-smyth;27 participants;27;-1
p1059-smyth;4 participants;4;-1
p1059-smyth;250,000   people;250000;-1
p1079-vieweg;n=05;5;-1
p1079-vieweg; data set of 4,592,466;4592466;-1
p1089-bianchi;12 participants;12;-1
p1089-bianchi;12 subjects;12;-1
p1089-bianchi;total of 60;60;-1
p1089-bianchi;total of 10;10;-1
p1089-bianchi;total of 360;360;-1
p1093-kim;21 participants;21;-1
p1093-kim;3 participants;3;-1
p1093-kim;n = 4;4;-1
p1103-deluca;24 participants;24;-1
p1107-forget;51 participants;51;-1
p1111-lipford;23 participants;23;-1
p1111-lipford;8 participants;8;-1
p1111-lipford;2 participants;2;-1
p1111-lipford;n=21;21;-1
p1115-hourcade;64   pixels of the target and participants;64;-1
p1115-hourcade;149 tasks where   participants;149;-1
p1115-hourcade;19 of the participants;19;-1
p1115-hourcade;18 participants;18;-1
p1115-hourcade;n=66;66;-1
p1115-hourcade;n=77;77;-1
p1115-hourcade;n=0;0;-1
p1115-hourcade;total of 54;54;-1
p1125-moffatt;12 participants;12;21632
p1125-moffatt;24 participants;24;21572
p1125-moffatt;12 older adults;12;28727
p1125-moffatt;N = 0;0;20113
p1125-moffatt;N=0;0;17621
p1125-moffatt;N=1;1;17492
p1125-moffatt;N=23;23;9859
p1125-moffatt;N=24;24;9149
p1125-moffatt;total of 24;24;21581
p1125-moffatt;total of   324;324;16928
p1155-cheng;33 persons;33;-1
p1155-cheng;6 representative  participants;6;-1
p1155-cheng;33 participants;33;-1
p1155-cheng;5 participants;5;-1
p1175-faridani;12 study participants;12;9227
p1175-faridani;12 participants;12;4099
p1175-faridani;6   participants;6;8967
p1175-faridani;12 people;12;9160
p1175-faridani;total of 782;782;7152
p1185-chen;total of 30;30;-1
p1195-diakopoulos;664 people;664;-1
p1195-diakopoulos;762 people;762;-1
p1195-diakopoulos;n =   1;1;-1
p1199-chi;8   were regular participants;8;-1
p1199-chi;n=6;6;-1
p1199-chi;n=7;7;-1
p1199-chi;n=2;2;-1
p1199-chi;n=3;3;-1
p1213-maitland;15    A few participants;15;-1
p1213-maitland;18 patients;18;-1
p1213-maitland;n=14;14;-1
p123-zhang;n=0;0;-1
p123-zhang;n=3;3;-1
p123-zhang;n=2;2;-1
p1233-bao;4 participants;4;-1
p1241-wang;11 participants;11;-1
p1241-wang;n = 19;19;-1
p1241-wang;n = 12;12;-1
p1241-wang;n = 51;51;-1
p1241-wang;n = 47;47;-1
p1241-wang;n = 46;46;-1
p1241-wang;n=1;1;-1
p1241-wang;   data from 133;133;-1
p1251-yarosh;26 participants;26;-1
p1251-yarosh;24 participants;24;-1
p1251-yarosh;26      participants;26;-1
p1251-yarosh;total of 24;24;-1
p1261-forlizzi;N=5;5;-1
p1261-forlizzi;N=3;3;-1
p1261-forlizzi;N=2;2;-1
p1271-jensen;7 women;7;-1
p1271-jensen;9 participants;9;-1
p1271-jensen;1 was defined as   participants;1;-1
p1271-jensen;9 violations and audio-visual participants;9;-1
p1271-jensen;2 and participants;2;-1
p1271-jensen;4 and audio-visual   participants;4;-1
p1271-jensen;30 subjects;30;-1
p1271-jensen;30 people;30;-1
p1271-jensen;N=10;10;-1
p1271-jensen;N=460;460;-1
p1271-jensen;N=61;61;-1
p1271-jensen;N=1;1;-1
p1271-jensen;N=522;522;-1
p1271-jensen;N=77;77;-1
p1271-jensen;N=40;40;-1
p1271-jensen;N=8;8;-1
p1271-jensen;N=34;34;-1
p1271-jensen;N=9;9;-1
p1271-jensen;N=985;985;-1
p1271-jensen;N=2905;2905;-1
p1271-jensen;N=87;87;-1
p1271-jensen;N=3977;3977;-1
p1271-jensen;total   of 43;43;-1
p1271-jensen;total of 3977;3977;-1
p1271-jensen;total of 2905;2905;-1
p1271-jensen;total of 87;87;-1
p1281-iqbal;18 participants;18;-1
p1281-iqbal;18 people;18;-1
p1281-iqbal;total of 1,620;1620;-1
p1281-iqbal;total of 96;96;-1
p1291-woelfer;34 young people;34;-1
p1291-woelfer;6 young people;6;-1
p1291-woelfer;100 young people;100;-1
p1291-woelfer;N=100;100;-1
p1321-jankowski;10 of the participants;10;-1
p1321-jankowski;14   participants;14;-1
p1321-jankowski;6 participants;6;-1
p1321-jankowski;9 participants;9;-1
p1321-jankowski;20   subjects;20;-1
p1321-jankowski;20 subjects;20;-1
p1321-jankowski;total of 320;320;-1
p133-barkhuus;18   participants;18;-1
p133-barkhuus;13 female and five male participants;13;-1
p133-barkhuus;18 participants;18;-1
p1335-xu;8 people;8;-1
p1339-huhtala;26 participants;26;-1
p1339-huhtala;total of 24;24;-1
p1339-huhtala;total of 52;52;-1
p1343-kapoor;8 of the participants;8;-1
p1343-kapoor;16 participants;16;-1
p1353-teevan;30 participants;30;-1
p1353-teevan;30 people;30;-1
p1353-teevan;07   Personal home pages of people;7;-1
p1361-leskovec;total of  4;4;-1
p1371-ahlstrom;24 participants;24;-1
p1371-ahlstrom;total of 30;30;-1
p1371-ahlstrom; data from 3456;3456;-1
p1381-stavness;10   subjects;10;-1
p1381-stavness;total of 40;40;-1
p1391-yang;916  Results  For all participants;916;-1
p1417-beaton;30 participants;30;-1
p1417-beaton;10 participants;10;-1
p1417-beaton;30 participants were recruited;30;-1
p1417-beaton;total of 30;30;-1
p1427-shaer;17 participants;17;-1
p1427-shaer;16 participants;16;-1
p143-birnholtz;45 million individuals;45;-1
p1457-munson;87 women;87;-1
p1457-munson;44 subjects;44;-1
p1457-munson;39 subjects;39;-1
p1457-munson;5 subjects;5;-1
p1457-munson;108 subjects;108;-1
p1457-munson;40 subjects;40;-1
p1457-munson;30 subjects;30;-1
p1457-munson;30 individuals;30;-1
p1457-munson;10 diversity-seeking individuals;10;-1
p1457-munson;n=145;145;-1
p1457-munson;n = 112;112;-1
p1457-munson;n = 121;121;-1
p1457-munson;total of 8;8;-1
p1457-munson;total of 16;16;-1
p1457-munson; data daily from 22;22;-1
p1457-munson; data from the 10;10;-1
p1467-lackaff;48   participants;48;-1
p1467-lackaff;6 participants;6;-1
p1467-lackaff;38 total participants;38;-1
p1467-lackaff;85 individuals;85;-1
p1467-lackaff;N  = 85;85;-1
p1467-lackaff;total of 85;85;-1
p1471-cramer;44 participants;44;-1
p1471-cramer;44   participants;44;-1
p1471-cramer;37   participants;37;-1
p1471-cramer;n=5;5;-1
p1475-oulasvirta;n=3;3;-1
p1475-oulasvirta;n=12;12;-1
p1485-williamson;25 participants;25;-1
p1485-williamson;1 this provoked participants;1;-1
p1485-williamson;5 people;5;-1
p1485-williamson;65  were recruited;65;-1
p1495-engstrom;16 people;16;-1
p15-wang;9 participants;9;-1
p15-wang;total of 52;52;-1
p1515-grossman;16 participants;16;-1
p1515-grossman;10   participants;10;-1
p1515-grossman;10 participants;10;-1
p1515-grossman;total of 118;118;-1
p1515-grossman;total of 54;54;-1
p1525-dixon;total of 12;12;-1
p153-mancini;4 participants;4;-1
p1535-chang;n =  3;3;-1
p1545-harrison;20 participants;20;-1
p1545-harrison;6 participants;6;-1
p1545-harrison;10 participants;10;-1
p1545-harrison;16 participants;16;-1
p1545-harrison;total of 25;25;-1
p1545-harrison;total   of 18;18;-1
p1545-harrison;total of 64;64;-1
p1549-harrison;10 participants;10;8815
p1549-harrison;0 were   recruited;0;2926
p1549-harrison;n=19;19;7556
p1549-harrison;n=1;1;7556
p1549-harrison;total of 170;170;8605
p1553-stutzman;494 individuals;494;-1
p1553-stutzman;n=422;422;-1
p1553-stutzman;n=423;423;-1
p1553-stutzman;n=421;421;-1
p1553-stutzman;n=415;415;-1
p1553-stutzman;n=425;425;-1
p1553-stutzman;n=396;396;-1
p1553-stutzman;n=416;416;-1
p1553-stutzman;n=411;411;-1
p1553-stutzman;total of 494;494;-1
p1563-besmer;14 total participants;14;-1
p1563-besmer;2 asked participants;2;-1
p1563-besmer;3 instructed participants;3;-1
p1563-besmer;17 participants;17;-1
p1563-besmer;6 people;6;-1
p1563-besmer;n = 8;8;-1
p1563-besmer;n = 12;12;-1
p1563-besmer;n = 2;2;-1
p1563-besmer;n = 9;9;-1
p1563-besmer;n = 5;5;-1
p1563-besmer;n = 11;11;-1
p1563-besmer;n = 10;10;-1
p1563-besmer;n = 6;6;-1
p1563-besmer;n = 1;1;-1
p1563-besmer;n = 14;14;-1
p1563-besmer;n = 3;3;-1
p1563-besmer;n = 7;7;-1
p1563-besmer;n =  6;6;-1
p1563-besmer;total of 17;17;-1
p1573-kelley;764 participants;764;-1
p1573-kelley;700 participants;700;-1
p1573-kelley;25 additional  participants;25;-1
p1573-kelley;78  participants;78;-1
p1573-kelley;79 layered-format condition participants;79;-1
p1573-kelley;N=764;764;-1
p1583-raffle;24 participants;24;-1
p1603-tian;n = 7;7;-1
p1603-tian;total of 25;25;-1
p1613-saerbeck;total of 29;29;-1
p1623-balaam;N = 15;15;-1
p163-karkkainen;13   participants;13;-1
p163-karkkainen;13 participants;13;-1
p163-karkkainen;10 participants;10;-1
p163-karkkainen;total of 13;13;-1
p1633-hirano;1 All research participants;1;-1
p1633-hirano;n=10;10;-1
p1633-hirano;n=3;3;-1
p1633-hirano;n=13;13;-1
p1633-hirano;n=8;8;-1
p1633-hirano;total of 97;97;-1
p1643-cao;total of 768;768;-1
p1647-lee_revised;15 women;15;-1
p1647-lee_revised;31 participants;31;-1
p1647-lee_revised;n=1023;1023;-1
p1647-lee_revised;total of 1,023;1023;-1
p1657-schwarz;14 participants;14;-1
p1665-ko;n=496,750;496750;-1
p1665-ko;n=420,989;420989;-1
p1665-ko;n=148,902;148902;-1
p1665-ko;n=84253;84253;-1
p1665-ko;n=102,355;102355;-1
p1665-ko;n=421,005;421005;-1
p1665-ko;n=35,656;35656;-1
p1665-ko;n=496,766;496766;-1
p1665-ko;n=496766;496766;-1
p1675-civan;25 people;25;-1
p1685-thomsantelli;15 novice participants;15;-1
p1685-thomsantelli;15 more expert   participants;15;-1
p1685-thomsantelli;5 participants;5;-1
p1685-thomsantelli;n=3044;3044;-1
p1685-thomsantelli;N=7019;7019;-1
p1685-thomsantelli;total of 7,019;7019;-1
p1695-weaver;12 partic-  ipant within-subjects;12;24028
p1695-weaver;total of 120;120;2860
p1715-mcgookin;4 women;4;-1
p1715-mcgookin;2 women;2;-1
p1715-mcgookin;4 participants;4;-1
p1725-pan;6 Chinese participants;6;13096
p173-skeels;2   participants;2;-1
p173-skeels;2 participants;2;-1
p1735-sahami;20 participants;20;-1
p1735-sahami;347 participants;347;-1
p1735-sahami;11 participants;11;-1
p1739-morris;249 examples of questions   participants;249;-1
p1739-morris;624 people;624;-1
p1739-morris;242 reasons people;242;-1
p1739-morris;n = 4;4;-1
p1739-morris;n = 1;1;-1
p1739-morris;N = 230;230;-1
p1739-morris;n = 3;3;-1
p1739-morris;N = 234;234;-1
p1739-morris;total of 249;249;-1
p1749-toma;N = 98;98;-1
p1749-toma;N = 88;88;-1
p1753-kirman;total of 215;215;-1
p1753-kirman;total of 364;364;-1
p1757-neustaedter;175 people;175;-1
p1757-neustaedter;104 people;104;-1
p1757-neustaedter;104   people;104;-1
p1757-neustaedter;53 people;53;-1
p1757-neustaedter;27 people;27;-1
p1757-neustaedter;180 people;180;-1
p1757-neustaedter;115 people;115;-1
p1757-neustaedter;174   people;174;-1
p1757-neustaedter;117 people;117;-1
p1757-neustaedter;29   individuals;29;-1
p1757-neustaedter;156 individuals;156;-1
p1757-neustaedter;3   different local individuals;3;-1
p1757-neustaedter;total of 206;206;-1
p1757-neustaedter;total of 172;172;-1
p1757-neustaedter;total of 150;150;-1
p1767-zhou;70 patients;70;-1
p1767-zhou;24 patients;24;-1
p1767-zhou;3 million people;3;-1
p1767-zhou;total of 260;260;-1
p1787-chen;6 entire   patients;6;-1
p1787-chen;3   patients;3;-1
p1787-chen;total of 57;57;-1
p1787-chen;total of 120;120;-1
p1797-yoo;10 people;10;-1
p1817-reddy;12 users recruited;12;-1
p1817-reddy;total of 208;208;-1
p1817-reddy;total of 14;14;-1
p1821-massimi;8   Some participants;8;-1
p1821-massimi;8   For other people;8;-1
p1821-massimi;5 individuals;5;-1
p1821-massimi;n = 41;41;-1
p1821-massimi;n =18;18;-1
p1821-massimi;n = 28;28;-1
p1821-massimi;n = 40;40;-1
p1821-massimi;n = 16;16;-1
p1821-massimi;n = 25;25;-1
p1821-massimi;n =   11;11;-1
p1821-massimi;n = 6;6;-1
p1821-massimi;n = 17;17;-1
p1821-massimi;n = 11;11;-1
p1821-massimi;n = 13;13;-1
p1821-massimi;n = 18;18;-1
p183-unruh;14 patients;14;-1
p183-unruh;n=14;14;-1
p1831-odom;5 women;5;-1
p1831-odom;11 participants;11;-1
p1831-odom;total of 11;11;-1
p1841-blom;13 women;13;-1
p1841-blom;13 participants;13;-1
p1841-blom;12 participants;12;-1
p1841-blom;19 participants;19;-1
p1841-blom;13 women were recruited;13;-1
p1841-blom;total of 19;19;-1
p1851-kuznetsov;4 participants;4;-1
p1851-kuznetsov;1 billion people;1;-1
p1851-kuznetsov;total of 103;103;-1
p1861-kim;6 individual   participants;6;-1
p1861-kim;14 people;14;-1
p1861-kim;14 people were recruited;14;-1
p1861-kim;total of 41;41;-1
p1875-huh;10 mentioned   people;10;-1
p1879-wilcox;n = 5;5;-1
p1879-wilcox;n = 16;16;-1
p1879-wilcox;total of 12;12;-1
p1889-ramachandran;n=5;5;-1
p1899-sarcevic;1200 trauma patients;1200;-1
p1899-sarcevic;60 different   patients;60;-1
p1899-sarcevic;15 people;15;-1
p1899-sarcevic;13 people;13;-1
p1909-burke;60 participants;60;-1
p1909-burke;N=1193;1193;-1
p1909-burke;n=155;155;-1
p1909-burke;N=487;487;-1
p1909-burke;N=993;993;-1
p1917-panciera;3  million people;3;-1
p1927-lampe;n=5;5;-1
p1927-lampe;n=4;4;-1
p1927-lampe;n=3;3;-1
p1927-lampe;n=2;2;-1
p193-klasnja;4 participants;4;-1
p193-klasnja;15   breast cancer patients;15;-1
p193-klasnja;15 patients;15;-1
p1937-gonzales;126 participants;126;-1
p1941-komatsu;9   women;9;-1
p1941-komatsu;19 participants;19;-1
p1941-komatsu;19   participants;19;-1
p1941-komatsu;14 participants;14;-1
p1941-komatsu;14   participants;14;-1
p1945-ma;10 participants;10;-1
p1945-ma;2000 subjects;2000;-1
p1945-ma;240 people;240;-1
p1945-ma;total of 327;327;-1
p1955-wu;93 subjects;93;-1
p1955-wu;N=4009;4009;-1
p1955-wu;N=1614;1614;-1
p1965-dugan;900   million people;900;-1
p1965-dugan;N = 3571;3571;-1
p1965-dugan;N = 225;225;-1
p1965-dugan;n=41;41;-1
p1965-dugan;n=2865;2865;-1
p1965-dugan;n=33;33;-1
p1965-dugan;n=8;8;-1
p1965-dugan;total of 509;509;-1
p1965-dugan;total of 225;225;-1
p1965-dugan;total of 495;495;-1
p1985-pierce;15 participants;15;-1
p1985-pierce;8 participants;8;-1
p1985-pierce;total of 72;72;-1
p1999-froehlich;15 participants;15;-1
p1999-froehlich;11 participants;11;-1
p1999-froehlich;N=100;100;-1
p2009-karlson;5 women;5;-1
p2009-karlson;24 participants;24;-1
p2009-karlson;N=358;358;-1
p2009-karlson;N=328;328;-1
p2009-karlson;N=386;386;-1
p2009-karlson;total of 467;467;-1
p2019-lee;75 participants;75;-1
p2019-lee;20 participants;20;-1
p2019-lee;10 participants;10;-1
p2019-lee;7 people;7;-1
p2019-lee;10 people;10;-1
p2023-ilinkin;15 participants;15;-1
p2023-ilinkin;2005 and none   of the participants;2005;-1
p2023-ilinkin;total of 400;400;-1
p2027-peesapati;91   people;91;-1
p2027-peesapati;11,000 memory triggers and people;11000;-1
p2027-peesapati;20 people;20;-1
p2027-peesapati;91 people;91;-1
p2027-peesapati;33   people;33;-1
p2027-peesapati;75 people;75;-1
p2027-peesapati;17 people;17;-1
p2027-peesapati;total of 61;61;-1
p2027-peesapati;total of 120;120;-1
p2027-peesapati; data from 91;91;-1
p203-heer;50 subjects;50;-1
p203-heer;117 subjects;117;-1
p203-heer;13 of subjects;13;-1
p203-heer;N=50;50;-1
p203-heer;N=24;24;-1
p203-heer;total of 70;70;-1
p203-heer;total of 108;108;-1
p203-heer;total of 72;72;-1
p203-heer;total of 48;48;-1
p203-heer;total of 2,880;2880;-1
p203-heer;total of 186;186;-1
p203-heer;total of  70;70;-1
p2037-bach;4   people;4;-1
p2041-isbister;41 individuals;41;-1
p2045-kalnikaite;18 participants;18;19882
p2045-kalnikaite;total of 8;8;7166
p2065-bailey;N=24;24;-1
p2065-bailey;N=8;8;-1
p2065-bailey;N=1613;1613;-1
p2065-bailey;N=1;1;-1
p2065-bailey;total of 1491;1491;-1
p2075-cavender;14 participants;14;-1
p2075-cavender;total of 106;106;-1
p2083-zhang;n=2;2;-1
p2083-zhang;n = 1;1;-1
p2093-kern;30 participants;30;-1
p2093-kern;30   participants;30;-1
p2093-kern;22 participants;22;-1
p2093-kern;6 of the observed participants;6;-1
p2093-kern;13 participants;13;-1
p2093-kern;6 participants;6;-1
p2093-kern;2   participants;2;-1
p2093-kern;5 participants;5;-1
p2093-kern;2 participants;2;-1
p2093-kern;16 participants;16;-1
p2093-kern;11 participants;11;-1
p2093-kern;4 subjects;4;-1
p2093-kern;16 subjects;16;-1
p2093-kern;4   people;4;-1
p2093-kern;6 people;6;-1
p2093-kern;3 people;3;-1
p2093-kern;3   people;3;-1
p2093-kern;n =   25;25;-1
p2093-kern;n = 24;24;-1
p2093-kern;n = 28;28;-1
p2093-kern;n = 625;625;-1
p2093-kern;n = 1999;1999;-1
p2093-kern; data rate of 120;120;-1
p2103-hornof;5 within-subjects;5;-1
p2123-wilcox;18 patient participants;18;-1
p2123-wilcox;18 patients;18;-1
p2123-wilcox;16 physicians whose patients;16;-1
p213-freire;7 participants;7;-1
p2159-ashbrook;16 participants;16;9955
p2159-ashbrook;15 participants;15;9667
p2159-ashbrook;total of 16;16;9964
p2169-li;10   participants;10;-1
p2169-li;N = 16;16;-1
p2169-li;n = 155;155;-1
p2169-li;n = 2;2;-1
p2173-jones;11   participants;11;-1
p2173-jones;n=1;1;-1
p2173-jones;total of 2604;2604;-1
p2173-jones;total of 225;225;-1
p2183-liu;12 participants;12;7300
p2183-liu;24   participants;24;4159
p2183-liu;n = 1;1;21708
p2183-liu;n = 2;2;21619
p2183-liu;n = 60;60;1612
p2183-liu;total of 9,200,000;9200000;29469
p2183-liu;total of 263;263;21876
p2183-liu;total of 31;31;7268
p2193-liao;105   Chinese participants;105;682
p2193-liao;19   were regular community participants;19;5209
p2193-liao;N=16;16;14214
p2203-liu;745 million   people;745;-1
p2203-liu;1 MEA model of rural people;1;-1
p2203-liu;2 MEA model of rural people;2;-1
p2213-fu;16 participants;16;-1
p2213-fu;total of 16;16;-1
p2223-tuddenham;12 participants;12;4629
p2223-tuddenham;12 subjects;12;17956
p2223-tuddenham;n=   5;5;12746
p2223-tuddenham;n= 4;4;12706
p223-song;18 participants;18;-1
p2233-lepinski;total of 64;64;-1
p2257-lee;3 of the participants;3;-1
p2267-jacucci;2 adults;2;-1
p2267-jacucci;n=30;30;-1
p2267-jacucci;N=75;75;-1
p2267-jacucci;N=12;12;-1
p2267-jacucci;total of   195;195;-1
p2297-nakatsuma;N = 9;9;-1
p2297-nakatsuma;n = 00010010000010010;1,001E+13;-1
p2297-nakatsuma;N = 0;0;-1
p2317-costanza;20 subjects;20;-1
p2317-costanza;3 questions subjects;3;-1
p2317-costanza;13 subjects;13;-1
p2317-costanza;2 subjects;2;-1
p2327-farooq;24 users were recruited;24;-1
p2327-farooq;n = 13;13;-1
p2327-farooq;n = 5;5;-1
p2327-farooq;N   = 92;92;-1
p2327-farooq;N = 55;55;-1
p2327-farooq;total of 24;24;-1
p2327-farooq;total of 51;51;-1
p2327-farooq;total of 41;41;-1
p233-pace;500 participants;500;-1
p233-pace;441 participants;441;-1
p233-pace;159 participants;159;-1
p233-pace;441 overall participants;441;-1
p233-pace;45}   Other participants;45;-1
p233-pace;62 participants;62;-1
p2347-sauro;n = 5;5;-1
p2347-sauro; data from 61;61;-1
p2351-lindley;total of 24;24;-1
p2371-petrelli;23 people;23;-1
p2381-olmsted-hawala;10 participants;10;-1
p2381-olmsted-hawala;20 participants;20;-1
p2381-olmsted-hawala;80 participants;80;-1
p2391-kaptein;10 experimental subjects;10;12279
p2391-kaptein;2 mixed subjects;2;12495
p2391-kaptein;N = 200;200;12551
p2391-kaptein;N = 40;40;12564
p2391-kaptein;N = 10;10;12580
p2391-kaptein;total of 200;200;11438
p2391-kaptein; data of the 2;2;11268
p2399-downs;30   and women;30;-1
p2399-downs;30 and   women;30;-1
p2399-downs;1,962 participants;1962;-1
p2399-downs;1,962   people;1962;-1
p2399-downs;n=482;482;-1
p2399-downs;n=76;76;-1
p2399-downs;n=111;111;-1
p2399-downs;n=15;15;-1
p2399-downs;n=36;36;-1
p2399-downs;n=296;296;-1
p2399-downs;n=21;21;-1
p2399-downs;n=187;187;-1
p2399-downs;n=172;172;-1
p2399-downs;n=69;69;-1
p2399-downs;n=123;123;-1
p2399-downs;n=162;162;-1
p2399-downs;n=22;22;-1
p2399-downs;n=114;114;-1
p2399-downs;n=96;96;-1
p2399-downs;n=120;120;-1
p2399-downs;n=98;98;-1
p2399-downs;n=609;609;-1
p2399-downs;total of 1,726;1726;-1
p2403-bohme;N = 81,920;81920;-1
p2403-bohme;N = 9,378;9378;-1
p2403-bohme;N = 36,923;36923;-1
p2407-rosner;N=11;11;-1
p2407-rosner;N=3;3;-1
p2407-rosner;N=2;2;-1
p2407-rosner;N=1;1;-1
p2407-rosner;N=4;4;-1
p2407-rosner;N=5;5;-1
p2407-rosner;total of 161;161;-1
p243-berkovsky;180   participants;180;21827
p243-berkovsky;180 participants;180;26126
p243-berkovsky;25 participants;25;4781
p243-berkovsky;6   billion individuals;6;25445
p243-berkovsky;12 and recruited;12;4813
p2431-yang;40 were recruited;40;-1
p2441-liao;n = 5;5;-1
p2471-patel;8 participants;8;-1
p2471-patel;73 participants;73;-1
p2471-patel;8   participants;8;-1
p2471-patel;total of 8;8;-1
p2471-patel;total of 73;73;-1
p2481-tsujita;9 female participants;9;-1
p2481-tsujita;11 people;11;-1
p2481-tsujita;8 people;8;-1
p2481-tsujita;3 people;3;-1
p2481-tsujita;total   of 11;11;-1
p2491-shastri;10 participants;10;-1
p2491-shastri;11 participants;11;-1
p2491-shastri;5 participants;5;-1
p2491-shastri;6 participants;6;-1
p2491-shastri;total of 11;11;-1
p2491-shastri;total of 5;5;-1
p2491-shastri; data of 10;10;-1
p2499-vaananenvainiomattila;N=11;11;-1
p2499-vaananenvainiomattila;N=8;8;-1
p2499-vaananenvainiomattila;N=7;7;-1
p25-lawrance;2 predict   where participants;2;-1
p25-lawrance;1,209 of our participants;1209;-1
p25-lawrance;2,400 of the   participants;2400;-1
p25-lawrance;N=1209;1209;-1
p25-lawrance;total of   2;2;-1
p2503-bragdon;9 participants;9;-1
p2503-bragdon;total of 17;17;-1
p253-el-nasr;60 participants;60;29508
p253-el-nasr;3 participants;3;29478
p253-el-nasr;45   participants;45;22312
p253-el-nasr;4 participants;4;11077
p253-el-nasr;total   of 60;60;29519
p253-el-nasr;total of 60;60;26856
p253-el-nasr;total of 215;215;16906
p253-el-nasr;total of 25;25;11291
p253-el-nasr;total of 3000;3000;4969
p2533-chu;15 people;15;-1
p2553-li;24   persons;24;-1
p2553-li;8 subjects;8;-1
p2553-li;7 subjects;7;-1
p2553-li;N=56;56;-1
p2553-li;total of 56;56;-1
p2563-flatla;16 participants;16;-1
p2563-flatla;total of 7600;7600;-1
p2563-flatla; data from 16;16;-1
p2563-flatla;   data from 16;16;-1
p2563-flatla; data from 125;125;-1
p2573-bateman;20 participants;20;10232
p2573-bateman;40 were recruited;40;10315
p2573-bateman;n=2;2;1654
p2573-bateman;n=0;0;1674
p2583-sambasivan;12 women;12;-1
p2583-sambasivan;N=8;8;-1
p2583-sambasivan;N=18;18;-1
p2607-sambasivan;22 women;22;-1
p2607-sambasivan;N=3;3;-1
p2607-sambasivan;N=25;25;-1
p2615-malacria;12 participants;12;-1
p2625-chan;39 participants;39;15359
p2625-chan;16 participants;16;967
p2625-chan;16 participants were recruited;16;967
p263-vogel;12 people;12;-1
p273-appert;16 participants;16;-1
p273-appert;8 participants;8;-1
p273-appert;6 participants;6;-1
p273-appert;5 participants;5;-1
p273-appert;12 participants;12;-1
p291-hecht;n = 25;25;-1
p305-hsieh;n=400;400;-1
p305-hsieh;n=235;235;-1
p305-hsieh;n=104;104;-1
p305-hsieh;n=61;61;-1
p305-hsieh;n=333;333;-1
p305-hsieh;n=399;399;-1
p305-hsieh;total of 22,205;22205;-1
p329-dearman;N=134;134;-1
p333-hoggan;total of 36;36;-1
p343-gunaratne;12 participants;12;-1
p343-gunaratne;12   participants;12;-1
p343-gunaratne;11 participants;11;-1
p343-gunaratne;10   participants;10;-1
p343-gunaratne;10 participants;10;-1
p343-gunaratne;11   participants;11;-1
p343-gunaratne;12 people;12;-1
p343-gunaratne;n = 4;4;-1
p35-aula;179 participants;179;-1
p35-aula;23 participants;23;-1
p35-aula;40 people;40;-1
p35-aula;23 participants were recruited;23;-1
p353-quinn;64 women;64;-1
p353-quinn;1 All participants;1;-1
p353-quinn;n = 12;12;-1
p353-quinn;n=49;49;-1
p353-quinn;n = 51;51;-1
p353-quinn;n = 49;49;-1
p353-quinn;n = 70;70;-1
p353-quinn;n   = 83;83;-1
p363-villamarin-salomon;11 subjects;11;-1
p363-villamarin-salomon;37 people;37;-1
p363-villamarin-salomon;n=12;12;-1
p363-villamarin-salomon;n=11;11;-1
p363-villamarin-salomon;n=7;7;-1
p363-villamarin-salomon;total of 37;37;-1
p373-sheng;487 participants;487;-1
p373-sheng;515 participants;515;-1
p373-sheng;1001 participants;1001;-1
p383-inglesant;32   participants;32;-1
p383-inglesant;4   participants;4;-1
p383-inglesant;2 participants;2;-1
p383-inglesant;14   participants;14;-1
p383-inglesant;15 participants;15;-1
p383-inglesant;3 participants;3;-1
p383-inglesant;5 non-security   specialist participants;5;-1
p383-inglesant;total of 53;53;-1
p393-kang;48 participants;48;7550
p393-kang;24 of the participants;24;7123
p393-kang;2 participants;2;7002
p393-kang;11 participants;11;7657
p393-kang;47   participants;47;11668
p393-kang;48 participants were recruited;48;7550
p393-kang;n = 13;13;7358
p393-kang;n = 3;3;463
p393-kang;total of 48;48;7559
p403-chin;n=21;21;-1
p403-chin;n =68;68;-1
p413-druin;18 participants;18;-1
p413-druin;total of 68;68;-1
p413-druin;total of 31;31;-1
p433-lee;12  participants;12;-1
p433-lee;15 participants;15;-1
p433-lee;28 participants;28;-1
p433-lee;7 participants;7;-1
p433-lee;16 participants;16;-1
p433-lee;16 people;16;-1
p45-kelly;4 displays subjects;4;968
p45-kelly;15 subjects;15;4566
p45-kelly;23 people;23;11272
p45-kelly;n=106;106;12210
p45-kelly;total of 722;722;5990
p45-kelly;total of 32;32;5735
p453-harrison;13   participants;13;-1
p493-hartmann;12 participants;12;-1
p493-hartmann;2 participants;2;-1
p5-arif;12 participants;12;-1
p513-brandt;2024 individuals;2024;-1
p513-brandt;total of 17012;17012;-1
p513-brandt;total of 3572;3572;-1
p537-saeed;30,000 paying participants;30000;-1
p537-saeed;13,000   people;13000;-1
p537-saeed;22 people;22;-1
p537-saeed;total of 22;22;-1
p557-li;37 participants;37;-1
p557-li;68 people;68;-1
p567-marshall;8 women;8;-1
p567-marshall;10 of the   participants;10;-1
p567-marshall;10 people;10;-1
p567-marshall;3   people;3;-1
p567-marshall;2 people;2;-1
p567-marshall;3 people;3;-1
p581-holz;12 participants;12;-1
p591-bailly;12 participants;12;-1
p595-vertanen;n = 0;0;-1
p599-brandl;12   participants;12;-1
p599-brandl;10 participants;10;-1
p645-mazurek[1];33 participants;33;-1
p645-mazurek[1];27 participants;27;-1
p645-mazurek[1];33 people;33;-1
p645-mazurek[1];5B first said she would trust  people;5;-1
p65-bi;12 participants;12;-1
p65-bi;11 participants;11;-1
p655-judge;3 participants;3;-1
p655-judge;2 people;2;-1
p655-judge;3 people;3;-1
p655-judge;21 individuals;21;-1
p655-judge;21 adults;21;-1
p673-dubroy;21   participants;21;-1
p673-dubroy;107 participants;107;-1
p673-dubroy;25 participants;25;-1
p673-dubroy;8 participants;8;-1
p673-dubroy;5 participants;5;-1
p673-dubroy;6 of the participants;6;-1
p673-dubroy;17 participants;17;-1
p673-dubroy;21 participants;21;-1
p673-dubroy;17   participants;17;-1
p673-dubroy;10 participants;10;-1
p673-dubroy;14 participants;14;-1
p673-dubroy;14   participants;14;-1
p673-dubroy;11 participants;11;-1
p673-dubroy;4 participants;4;-1
p673-dubroy;12   participants;12;-1
p673-dubroy;7 participants;7;-1
p673-dubroy;5   participants;5;-1
p673-dubroy;5 more participants;5;-1
p673-dubroy;55 of the subjects;55;-1
p673-dubroy;23 people;23;-1
p673-dubroy;21 people;21;-1
p673-dubroy;8 people;8;-1
p673-dubroy;6 people;6;-1
p673-dubroy;4 people;4;-1
p673-dubroy;total of 338;338;-1
p683-chevalier;16 participants;16;-1
p683-chevalier; dataset of 400;400;-1
p693-cho;20   minutes and participants;20;-1
p693-cho;12   participants;12;-1
p693-cho;12 participants;12;-1
p693-cho;3 subjects;3;-1
p703-dorn;2 il-  lustrates participants;2;-1
p703-dorn;12 people;12;-1
p703-dorn;N = 26;26;-1
p713-grigoreanu;total of 45;45;-1
p723-li;16   participants;16;-1
p723-li;14 participants;14;-1
p733-patel;51 pilot participants;51;-1
p733-patel;51 participants;51;-1
p733-patel;17 participants;17;-1
p733-patel;2Usage data includes these participants;2;-1
p733-patel;40 non-participants;40;-1
p733-patel;12  new participants;12;-1
p733-patel;63 individuals;63;-1
p733-patel;total of 610;610;-1
p743-kumar;18 participants;18;-1
p743-kumar;2 of the participants;2;-1
p743-kumar;4 participants;4;-1
p743-kumar;5 participants;5;-1
p743-kumar;2   participants;2;-1
p743-kumar;13 participants;13;-1
p743-kumar;9 adults;9;-1
p743-kumar;n=12;12;-1
p743-kumar;n = 12;12;-1
p743-kumar;total of 180;180;-1
p743-kumar;total of   46;46;-1
p743-kumar; data from   13;13;-1
p75-branham;10 participants;10;-1
p75-branham;10 subjects;10;-1
p753-smyth;16 participants;16;-1
p763-muller;88270 people;88270;-1
p763-muller;5149 people;5149;-1
p763-muller;13269 people;13269;-1
p763-muller;total of 728509;728509;-1
p767-jensen;10 of the participants were women;10;-1
p767-jensen;10 of the participants;10;-1
p767-jensen;12   participants;12;-1
p767-jensen;17   participants;17;-1
p777-rader;48 participants;48;-1
p777-rader;64 participants;64;-1
p777-rader;N=374;374;-1
p777-rader;N=371;371;-1
p777-rader;total of 24;24;-1
p777-rader;total of 1138;1138;-1
p787-balakrishnan;22   participants;22;-1
p787-balakrishnan;22 participants;22;-1
p791-huang;16 subjects;16;6824
p791-huang;10 subjects;10;6484
p791-huang;2 is a within-subjects;2;19233
p791-huang;10 subjects recruited;10;21084
p801-stewart;6 participants;6;-1
p801-stewart;12 participants;12;-1
p801-stewart;9 within-subjects;9;-1
p801-stewart;2 within-subjects;2;-1
p811-fu;15 participants;15;-1
p811-fu;8 participants;8;-1
p841-turner;40 people;40;-1
p841-turner;32 people;32;-1
p841-turner;27 people;27;-1
p841-turner;2009 survey and people;2009;-1
p841-turner;n=27;27;-1
p841-turner;total  of 40;40;-1
p841-turner;total  of 32;32;-1
p85-salvucci;total of 20;20;-1
p855-yuksel;38 subjects;38;-1
p859-kuikkaniemi;36 players recruited;36;-1
p859-kuikkaniemi;N=36;36;-1
p869-sjolie;11 initial subjects;11;-1
p869-sjolie;total of 18;18;-1
p869-sjolie;total of 758;758;-1
p879-appert;6 participants;6;-1
p883-nieuwenhuizen;3 within-  subjects;3;-1
p887-rico;11 participants;11;-1
p887-rico;8 participants;8;-1
p887-rico;total of 33;33;-1
p907-piper;20 participants;20;-1
p907-piper;20 older adults;20;-1
p907-piper;10 young adults;10;-1
p917-denning;11 participants;11;-1
p917-denning;13 participants;13;-1
p917-denning;13 patients;13;-1
p917-denning;13 individuals;13;-1
p917-denning;N = 2;2;-1
p917-denning;n = 69;69;-1
p917-denning;n = 1;1;-1
p917-denning;n  = 6;6;-1
p917-denning;N = 11;11;-1
p917-denning;N= 11;11;-1
p917-denning;total of 17;17;-1
p93-parnin;5 subjects;5;-1
p93-parnin;27 people;27;-1
p93-parnin;3 people;3;-1
p93-parnin;5 people;5;-1
p93-parnin;7 people;7;-1
p93-parnin;N=14;14;-1
p93-parnin;N=9;9;-1
p951-capra;30 people;30;-1
p961-assogba;16 participants;16;-1
p961-assogba;16   participants;16;-1
p961-assogba;n=2;2;-1
p961-assogba;n=3;3;-1
p971-bernstein;40 participants;40;27087
p971-bernstein;18 participants;18;2308
p971-bernstein;60   participants;60;554
p971-bernstein;100 individuals;100;15837
p971-bernstein;N=60;60;38256
p971-bernstein;N=40;40;24569
p971-bernstein;N=39;39;23557
p971-bernstein;N=38;38;23061
p971-bernstein;N=100;100;12549
p971-bernstein;N=58;58;3942
p971-bernstein;N = 58;58;4931
p971-bernstein;total of 713;713;1769
p985-cherubini;16 participants;16;-1
p985-cherubini;4 participants;4;-1
p985-cherubini;17 participants;17;-1
p985-cherubini;14 participants;14;-1
p985-cherubini;20 participants;20;-1
p985-cherubini;3  Four subjects;3;-1
p985-cherubini;6These four subjects;6;-1
p985-cherubini;n = 200;200;-1
p985-cherubini;N = 204;204;-1
p985-cherubini;N = 51;51;-1
p999-terry;2 presents participants;2;-1
p999-terry;10 people;10;-1
p999-terry;4   million people;4;-1
p999-terry;27 individuals;27;-1
p999-terry;total of 12;12;-1
pap244-haller;2   groups were comprised of participants;2;-1
pap244-haller;39 participants;39;-1
p1-cramer;n=7;7;-1
p1-cramer;n=12;12;-1
p1-cramer;n=6;6;-1
p1-cramer;n=10;10;-1
p1-cramer;n=60;60;-1
p1-cramer;n=158;158;-1
p1-cramer;total of 202;202;-1
p1001-massimi;2   Some participants;2;-1
p1001-massimi;total of 24;24;-1
p1011-roudaut;12 right-handed participants;12;-1
p1011-roudaut;6 new right-handed participants;6;-1
p1021-beyer;15 people;15;-1
p103-nacke;50 individuals;50;-1
p1041-dalsgaard;131 people;131;-1
p1071-starbird;5 million people;5;-1
p1081-marshall;5 people;5;-1
p1081-marshall;50 people;50;-1
p1091-kwak;22 participants;22;8085
p1091-kwak;1000  people;1000;1441
p1091-kwak;70 people;70;1400
p1091-kwak;39 people;39;10091
p1091-kwak;14 people;14;14305
p1091-kwak;11 people;11;15713
p1091-kwak;8 people;8;16358
p1091-kwak;4 people;4;14306
p1091-kwak;10 people;10;21665
p11-raij;66 participants;66;9018
p11-raij;6 ask participants;6;2475
p11-raij;7 asks participants;7;869
p11-raij;66 participants were recruited;66;9018
p11-raij;N = 36;36;25791
p11-raij;N = 30;30;25683
p1101-kivran-swaine;N=245,586;245586;-1
p1101-kivran-swaine; dataset of 245,586;245586;-1
p1105-golbeck;47 subjects;47;-1
p1109-shklovski;24 women;24;-1
p1119-scissors;40 people;40;-1
p1119-scissors;5 people;5;-1
p1119-scissors;44 individuals;44;-1
p1119-scissors;N=44;44;-1
p1129-zhao;57 participants;57;-1
p1129-zhao;57   participants;57;-1
p1129-zhao;114 subjects;114;-1
p113-furniss;22 participants;22;-1
p1133-hu;22 participants;22;-1
p1133-hu;N = 162;162;-1
p1137-setlock;1   Method   Pairs of participants;1;-1
p1137-setlock;24 participants;24;-1
p1141-duggan;4 participants;4;-1
p1141-duggan;28 participants;28;-1
p1151-hill;18 participants;18;-1
p1151-hill;6 participants;6;-1
p1151-hill;5 seconds because participants;5;-1
p1151-hill;n=18;18;-1
p1161-elling;24 participants;24;-1
p1161-elling;40 participants;40;-1
p1161-elling;N=20;20;-1
p1175-davidoff;23 people;23;-1
p1185-yarosh;10 participants;10;-1
p1185-yarosh;14 adults;14;-1
p1195-raffle;61 families were recruited;61;-1
p1195-raffle;N=25;25;-1
p1195-raffle;N=13;13;-1
p1195-raffle;N=15;15;-1
p1195-raffle;N=14;14;-1
p1195-raffle;N=12;12;-1
p1195-raffle;N=16;16;-1
p1195-raffle; data from the 19;19;-1
p1215-dork;19 women;19;-1
p1215-dork;202 elderly people;202;-1
p1215-dork;194 people;194;-1
p1225-huang;38 participants;38;-1
p1225-huang;32   subjects;32;-1
p1225-huang;20 thousand people;20;-1
p1225-huang;n = 45;45;-1
p1225-huang;N=1194;1194;-1
p1225-huang;N=96;96;-1
p1225-huang;total of 120;120;-1
p1235-yamamoto;960 participants;960;-1
p1235-yamamoto;48 people;48;-1
p1235-yamamoto;470 people;470;-1
p1235-yamamoto;309 people;309;-1
p1235-yamamoto;181 people;181;-1
p1235-yamamoto;960 participants were recruited;960;-1
p1235-yamamoto;total of 960;960;-1
p1235-yamamoto;total of 121;121;-1
p1245-schwarz;26 paid participants;26;-1
p1245-schwarz;2,500 participants;2500;-1
p1245-schwarz;n = 21;21;-1
p1245-schwarz;total of 1,000;1000;-1
p1245-schwarz;total of 1456;1456;-1
p1245-schwarz; data set of 1,000;1000;-1
p1245-schwarz; data   set of 1,000;1000;-1
p1255-marshall;82 participants;82;-1
p1255-marshall;30 participants;30;-1
p1255-marshall;41 participants;41;-1
p1255-marshall;11 participants;11;-1
p1255-marshall;52 participants;52;-1
p1275-andersen;4915 people;4915;-1
p1275-andersen;4984 people;4984;-1
p1275-andersen;3892 people;3892;-1
p1275-andersen;7765 people;7765;-1
p1275-andersen;5050 people;5050;-1
p1275-andersen;4162 people;4162;-1
p1275-andersen;4207 people;4207;-1
p1275-andersen;2281 people;2281;-1
p1283-kazi;total of 159;159;-1
p1293-dijkstra;8 participants;8;-1
p1293-dijkstra;15 participants;15;-1
p1293-dijkstra;3   within-subjects;3;-1
p1303-lahey;10 participants;10;-1
p1303-lahey;3 participants;3;-1
p1303-lahey;5 participants;5;-1
p1303-lahey;3   participants;3;-1
p1303-lahey;8 participants;8;-1
p1303-lahey;6   participants;6;-1
p1303-lahey;2 participants;2;-1
p1303-lahey;7 participants;7;-1
p1303-lahey;6 participants;6;-1
p1303-lahey;N=0;0;-1
p1303-lahey;total of 87;87;-1
p1303-lahey;total of 80;80;-1
p1303-lahey;total of 24;24;-1
p1313-karrer;8 persons;8;-1
p1313-karrer;13 participants;13;-1
p1313-karrer;16 participants;16;-1
p1313-karrer;59 participants;59;-1
p1313-karrer;6 participants;6;-1
p1313-karrer;4 participants;4;-1
p1313-karrer;18  participants;18;-1
p1313-karrer;16 people;16;-1
p1313-karrer;14 people;14;-1
p1313-karrer;n   =   60;60;-1
p1313-karrer;n   =   29;29;-1
p1323-song;total of 1280;1280;-1
p133-baumer;40  participants;40;-1
p1333-song;10   participants;10;-1
p1333-song;total of 10;10;-1
p1353-valkov;200ms after subjects;200;6344
p1353-valkov;9 female subjects;9;4184
p1353-valkov;15 subjects;15;4024
p1353-valkov;7 subjects;7;3946
p1353-valkov;11 of the subjects;11;3831
p1353-valkov;11 subjects;11;3708
p1353-valkov;45 trials subjects;45;3298
p1363-williams;35   were recruited;35;-1
p1373-guy;132 participants;132;-1
p1373-guy;100 related people;100;-1
p1373-guy;16,764 unique people;16764;-1
p1373-guy;13,957 people;13957;-1
p1373-guy;332 people;332;-1
p1373-guy;132 people;132;-1
p1373-guy;10 people;10;-1
p1373-guy;2 of the people;2;-1
p1373-guy;4 of the people;4;-1
p1373-guy;55,000 other individuals;55000;-1
p1373-guy;total of   38,768;38768;-1
p1393-yu;1047 participants;1047;-1
p1393-yu;247   participants;247;-1
p1393-yu;400 new   participants;400;-1
p1393-yu;200 participants;200;-1
p1393-yu;60   participants;60;-1
p1393-yu;247 participants;247;-1
p1393-yu;60 participants;60;-1
p1393-yu;400 participants;400;-1
p1393-yu;N=160;160;-1
p1393-yu;N=155;155;-1
p1393-yu;total of 1047;1047;-1
p1403-quinn;500people;500;-1
p1423-kumar;120,000   people;120000;-1
p1423-kumar;15 people;15;-1
p1423-kumar;3,000 people;3000;-1
p143-wobbrock;24 participants;24;-1
p143-wobbrock;10 participants;10;-1
p143-wobbrock;N=780;780;-1
p1433-oreglia;28 people;28;-1
p1441-romero;24 participants;24;-1
p1441-romero;33 participants;33;-1
p1451-jakobsen;19 participants;19;-1
p1451-jakobsen;12 shows how much of the time participants;12;-1
p1461-hullman;300 subjects;300;-1
p1461-hullman;50 subjects;50;-1
p1461-hullman;5 people;5;-1
p1461-hullman;N=50;50;-1
p1461-hullman;N=25;25;-1
p1461-hullman;n=0;0;-1
p1461-hullman;total of 6;6;-1
p1461-hullman;total of   7;7;-1
p1461-hullman;total of 7;7;-1
p1461-hullman;total of 1500;1500;-1
p147-fiebrink;n = 4;4;-1
p1471-veas;16 participants;16;6699
p1471-veas;40 participants;40;3649
p1471-veas;20 participants;20;3445
p1471-veas;10 participants;10;9204
p1471-veas;40 individuals;40;8834
p1471-veas;n = 800;800;3401
p1471-veas;n=14;14;2411
p1471-veas;n=23;23;2438
p1471-veas;N = 880;880;15159
p1471-veas; data of H2;2;2301
p1501-byrne;15 study participants;15;-1
p1501-byrne;total of 16;16;-1
p1531-kelly;3 subjects;3;7380
p1531-kelly;8 remote subjects;8;1420
p1531-kelly;11 statements asked subjects;11;7380
p1531-kelly;n=32;32;1293
p1531-kelly;n=12;12;12728
p1531-kelly;n=14;14;12934
p1531-kelly;n=10;10;12945
p1531-kelly;n=23;23;13224
p1531-kelly;n=17;17;13393
p1531-kelly;n=16;16;13682
p1531-kelly;n=8;8;13863
p1541-yatani;total of 1200;1200;4654
p157-amershi;90 minutes and participants;90;-1
p157-amershi;N=30;30;-1
p157-amershi;N=11;11;-1
p1591-chiu;12 unpaid participants;12;3121
p1591-chiu;12 participants;12;2788
p1601-kaser;4 persons;4;-1
p1601-kaser;5 participants;5;-1
p1601-kaser;5 subjects;5;-1
p1601-kaser;total of 5;5;-1
p1619-guiard;16 participants;16;-1
p1619-guiard;853 over all participants;853;-1
p1619-guiard;8 were participants;8;-1
p1619-guiard;n= 1;1;-1
p1629-blanch;total of 360;360;-1
p1629-blanch;total of 17;17;-1
p1639-wobbrock;21   subjects;21;20611
p1639-wobbrock;21 subjects;21;522
p1653-wobbrock;21 participants;21;-1
p1653-wobbrock;21 subjects;21;-1
p1653-wobbrock;N=72;72;-1
p1653-wobbrock;N=90;90;-1
p1653-wobbrock;N=18;18;-1
p1653-wobbrock;total of 7560;7560;-1
p1653-wobbrock;total of 30,240;30240;-1
p1657-brown;20   participants;20;-1
p1677-zimmerman;28 participants;28;-1
p1677-zimmerman;11 participants;11;-1
p1677-zimmerman;3 participants;3;-1
p1677-zimmerman;14 participants;14;-1
p1677-zimmerman;3 ratings across all participants;3;-1
p1677-zimmerman;28   participants;28;-1
p1697-woelfer;12 participants;12;-1
p1697-woelfer;10 participants;10;-1
p1697-woelfer;2 participants;2;-1
p1697-woelfer;8 participants;8;-1
p1697-woelfer;n =   21;21;-1
p1697-woelfer;n = 35;35;-1
p1697-woelfer;n = 10;10;-1
p1697-woelfer;n = 2;2;-1
p1697-woelfer;n = 12;12;-1
p1697-woelfer;n = 4;4;-1
p1697-woelfer;n = 3;3;-1
p1697-woelfer;n = 1;1;-1
p1707-woelfer;5 women;5;-1
p1707-woelfer;4 women;4;-1
p1707-woelfer;43 participants;43;-1
p1707-woelfer;5 additional young   people;5;-1
p1707-woelfer;total of 50;50;-1
p1707-woelfer;total of 146;146;-1
p1707-woelfer;total of   32;32;-1
p1707-woelfer;total of 8;8;-1
p1717-diakopoulos;N=47;47;-1
p1717-diakopoulos;N=41;41;-1
p1717-diakopoulos;N=39;39;-1
p1717-diakopoulos;N=82;82;-1
p1717-diakopoulos;N=45;45;-1
p1727-sedlmair;10 participants;10;-1
p1747-wongsuphasawat;10 participants;10;-1
p1747-wongsuphasawat;7,041 patients;7041;-1
p1747-wongsuphasawat;4,591 patients;4591;-1
p1747-wongsuphasawat;1,016 patients;1016;-1
p1747-wongsuphasawat;193 patients;193;-1
p1747-wongsuphasawat;38 patients;38;-1
p1747-wongsuphasawat;181 ICU patients;181;-1
p1747-wongsuphasawat;6  patients;6;-1
p1747-wongsuphasawat;6 patients;6;-1
p1747-wongsuphasawat;2 view and  noted down these patients;2;-1
p177-nancel;12 participants;12;-1
p177-nancel;4 participants;4;-1
p177-nancel;n = 25;25;-1
p1777-jones;22 participants;22;-1
p1777-jones;22   participants;22;-1
p1777-jones;1 participants;1;-1
p1777-jones;10 participants;10;-1
p1777-jones;n=22;22;-1
p1777-jones;total of 1,014;1014;-1
p1787-lucero;20 participants;20;-1
p1787-lucero;total of 20;20;-1
p1797-moraveji;total of   12,143;12143;-1
p1797-moraveji;total of 18;18;-1
p1807-sharma;1   participants;1;-1
p1807-sharma;2 participants;2;-1
p1807-sharma;2   participants;2;-1
p1807-sharma;1 participants;1;-1
p1807-sharma;10 percent of the subjects;10;-1
p1807-sharma;n=60;60;-1
p1807-sharma;n= 23;23;-1
p1807-sharma;n = 60;60;-1
p1807-sharma;n=2;2;-1
p1807-sharma;n=16;16;-1
p1807-sharma;n=11;11;-1
p1807-sharma;n=6;6;-1
p1807-sharma;n= 6;6;-1
p1807-sharma;n= 2;2;-1
p1817-fourney;  data set of 74,795;74795;-1
p1831-zhang;20 participants;20;-1
p1831-zhang;25 participants;25;-1
p1831-zhang;total of 235,707;235707;-1
p1831-zhang;total of 4,135;4135;-1
p1845-latulipe;49 participants;49;-1
p1865-cranshaw;29 identifiable participants;29;-1
p1865-cranshaw;4 participants;4;-1
p1865-cranshaw;21 participants;21;-1
p1865-cranshaw;32 people;32;-1
p1865-cranshaw;total of 39;39;-1
p1865-cranshaw;total of 1228;1228;-1
p1865-cranshaw;total of 711;711;-1
p187-bragdon;10 participants;10;-1
p1875-aragon;150 people;150;-1
p1875-aragon;12 people;12;-1
p1889-chetty;21 adult   participants;21;-1
p1889-chetty;4 adults;4;-1
p1889-chetty;total of 21;21;-1
p1899-hincapie-ramos;8 of the potential participants;8;-1
p1899-hincapie-ramos;8 initial participants;8;-1
p1899-hincapie-ramos;28  people;28;-1
p1899-hincapie-ramos;300 people;300;-1
p1899-hincapie-ramos;total of 7264;7264;-1
p1909-chong;18 participants;18;-1
p1909-chong;17 participants;17;-1
p1909-chong;4 participants;4;-1
p1909-chong;9 participants;9;-1
p1909-chong;n=26;26;-1
p1909-chong;n=2;2;-1
p1909-chong;n=3;3;-1
p1909-chong;n=4;4;-1
p1909-chong;n=1;1;-1
p1929-deckers;12 participants;12;-1
p1929-deckers;2   subjects;2;-1
p1929-deckers;n=13;13;-1
p1929-deckers;n=12;12;-1
p1959-toups;2eC improved participants;2;2167
p1959-toups;total of 28;28;3543
p1969-martin;8 participants;8;-1
p1969-martin;4 participants;4;-1
p1969-martin;5 participants;5;-1
p1969-martin;6 of the participants;6;-1
p197-ruiz;20   participants;20;-1
p197-ruiz;n = 28;28;-1
p1989-howison;total of 22;22;-1
p2009-dragicevic;12 participants;12;-1
p2009-dragicevic;n = 1;1;-1
p2009-dragicevic;n = 60;60;-1
p2009-dragicevic;n=200;200;-1
p2009-dragicevic;n = 200;200;-1
p2009-dragicevic;n = 0;0;-1
p2009-dragicevic;total of 36;36;-1
p2029-srikulwong;4 participants;4;17304
p2029-srikulwong;20 participants;20;14653
p2029-srikulwong;30 minutes after   participants;30;12990
p2029-srikulwong;2 allowed participants;2;8976
p2029-srikulwong;2 took place after participants;2;4914
p2029-srikulwong;12 participants;12;3943
p2039-kim;6 more participants;6;-1
p2039-kim;4 more participants;4;-1
p2043-ashbrook;18 participants;18;-1
p2043-ashbrook;3 within-subjects;3;-1
p2055-hayashi;30 participants;30;-1
p2055-hayashi;11 participants;11;-1
p2055-hayashi;15 participants;15;-1
p2065-reeder;54 participants;54;-1
p2065-reeder;18 participants;18;-1
p207-lu;12   participants;12;-1
p207-lu;10 participants;10;-1
p207-lu;8 participants;8;-1
p2075-lin;22 participants;22;-1
p2075-lin;7 participants;7;-1
p2075-lin;3 are participants;3;-1
p2075-lin;9 participants;9;-1
p2075-lin;6 participants;6;-1
p2075-lin;15 Type A and Type AB subjects;15;-1
p2075-lin;5 million people;5;-1
p2075-lin;9 people;9;-1
p2075-lin;14   people;14;-1
p2075-lin;6 Type AB people;6;-1
p2075-lin;n = 27;27;-1
p2075-lin;n=49;49;-1
p2085-mazurek;24 participants;24;-1
p2085-mazurek;24 adult participants;24;-1
p2085-mazurek;11 participants;11;-1
p2085-mazurek;11 people;11;-1
p2085-mazurek;total of 4481;4481;-1
p21-das;3 million persons;3;8730
p21-das;14 cancer patients;14;10818
p21-das;47 patients;47;5010
p21-das;14 patients;14;751
p21-das;n=6;6;571
p21-das;n=2;2;546
p21-das;n=4;4;515
p21-das;n=1;1;490
p21-das;n=14;14;1568
p2105-lennon;N=379;379;-1
p2115-brush;31 people;31;-1
p2115-brush;7   Log people;7;-1
p2115-brush;1 noted people;1;-1
p2115-brush;N=29;29;-1
p2145-gabrielli;24 participants;24;-1
p2145-gabrielli;60 people;60;-1
p2149-ryokai;total of 19;19;-1
p2153-grandhi;3 participants;3;-1
p2153-grandhi;30 participants;30;-1
p2153-grandhi;30 subjects;30;-1
p2153-grandhi;37 individuals;37;-1
p2153-grandhi;N=914;914;-1
p2153-grandhi;N=502;502;-1
p2153-grandhi;N=248;248;-1
p2153-grandhi;N=268;268;-1
p2153-grandhi;N=99;99;-1
p2153-grandhi;N=32;32;-1
p2153-grandhi;N=103;103;-1
p2153-grandhi;N=28;28;-1
p2153-grandhi;N= 69;69;-1
p2153-grandhi;N=62;62;-1
p2153-grandhi;N= 61;61;-1
p2153-grandhi;N=70;70;-1
p2153-grandhi;N=61;61;-1
p2153-grandhi;N=56;56;-1
p2153-grandhi;N=75;75;-1
p2153-grandhi;N=64;64;-1
p2153-grandhi;N=67;67;-1
p2153-grandhi;N=63;63;-1
p2153-grandhi;N=68;68;-1
p2153-grandhi;N=23;23;-1
p2153-grandhi;N=4;4;-1
p2153-grandhi;N=15;15;-1
p2153-grandhi;N=7;7;-1
p2153-grandhi;N=14;14;-1
p2153-grandhi;N=3;3;-1
p2153-grandhi;N=11;11;-1
p2153-grandhi;N=16;16;-1
p2153-grandhi;N=13;13;-1
p2153-grandhi;N=2;2;-1
p2153-grandhi;N=20;20;-1
p2153-grandhi;N=   369;369;-1
p2153-grandhi;N= 125;125;-1
p2153-grandhi;N= 244;244;-1
p2153-grandhi;total of 1628;1628;-1
p2163-chang;total of 200;200;-1
p217-chen;38 subjects;38;-1
p217-chen;3 subjects;3;-1
p217-chen;35 subjects;35;-1
p217-chen;29   subjects;29;-1
p217-chen;6 subjects;6;-1
p217-chen;2   subjects;2;-1
p217-chen;8 subjects;8;-1
p217-chen;19   subjects;19;-1
p217-chen;16 subjects;16;-1
p217-chen;19 subjects;19;-1
p217-chen;35   subjects;35;-1
p217-chen;20 people;20;-1
p217-chen;248   people;248;-1
p217-chen;total   of 60;60;-1
p2173-alvarez;N=192;192;-1
p2173-alvarez;n=51;51;-1
p2173-alvarez;n=21;21;-1
p2173-alvarez;n=   41;41;-1
p2173-alvarez;n=32;32;-1
p2173-alvarez;n=43;43;-1
p2173-alvarez;n=47;47;-1
p2173-alvarez;n=33;33;-1
p2177-ko;n=647;647;-1
p2187-dong;16 subjects;16;-1
p2187-dong;n=24;24;-1
p2187-dong;total of 32;32;-1
p2197-kumar;39 participants;39;-1
p2197-kumar;n = 4;4;-1
p2197-kumar;n = 1;1;-1
p2197-kumar;n = 58;58;-1
p2197-kumar;n = 7;7;-1
p2197-kumar;n =  58;58;-1
p2197-kumar;N = 100;100;-1
p2207-hartmann;n=2;2;-1
p2215-sauro;n=161;161;17277
p2215-sauro;n=213;213;17267
p2215-sauro;n = 51;51;2022
p2215-sauro;n =   110;110;2076
p2215-sauro;n = 110;110;2631
p2215-sauro;n = 107;107;6790
p2215-sauro;n   = 106;106;6825
p2215-sauro;n = 106;106;9279
p2215-sauro;total   of 21;21;13048
p2225-madathil;48   participants;48;-1
p2225-madathil;36 test participants;36;-1
p2239-light;8 people;8;-1
p2243-chilana;N=333;333;-1
p2275-toomim;1,176 participants;1176;-1
p2275-toomim;N=1,176;1176;-1
p2275-toomim;total of 4;4;-1
p2285-lelis;3a illustrates   participants;3;-1
p2285-lelis;4a illustrates participants;4;-1
p2285-lelis;4c illustrates participants;4;-1
p2285-lelis;n = 4;4;-1
p2285-lelis;total of 90;90;-1
p2295-egelman;33 participants;33;-1
p2295-egelman;40 participants;40;-1
p2295-egelman;73 participants;73;-1
p2295-egelman;3  We asked participants;3;-1
p2295-egelman;46 participants;46;-1
p2295-egelman;22 people;22;-1
p2295-egelman; data from a 2008;2008;-1
p2315-uzun;40 participants;40;-1
p2325-mathiasen;4 participants;4;-1
p2335-morrison;60   people;60;-1
p2335-morrison;4   people;4;-1
p2345-laviola;40 participants;40;-1
p2345-laviola;3D   participants;3;-1
p2345-laviola;20 participants;20;-1
p2345-laviola;3D Questions   Three people;3;-1
p2355-bateman;24 participants;24;-1
p237-hecht; dataset of 76;76;-1
p2375-kuznetsov;22 participants;22;-1
p2385-pierce;18 participants;18;-1
p2385-pierce;7 participants;7;-1
p2385-pierce;11 participants;11;-1
p2385-pierce;18   individuals;18;-1
p2385-pierce;7 participants were recruited;7;-1
p2385-pierce;11 participants were recruited;11;-1
p2409-lindqvist;2  women;2;-1
p2409-lindqvist;18 remaining participants;18;-1
p2409-lindqvist;14 participants;14;-1
p2409-lindqvist;219 participants;219;-1
p2409-lindqvist;45 participants;45;-1
p2409-lindqvist;67 participants;67;-1
p2409-lindqvist;29 participants;29;-1
p2409-lindqvist;83 participants;83;-1
p2409-lindqvist;128 participants;128;-1
p2409-lindqvist;9 participants;9;-1
p2409-lindqvist;3 participants;3;-1
p2409-lindqvist;37 participants;37;-1
p2409-lindqvist;30 participants;30;-1
p2409-lindqvist;50 people;50;-1
p2409-lindqvist;N=6;6;-1
p2409-lindqvist;N=18;18;-1
p2409-lindqvist;N=219;219;-1
p2419-mancini;5 participants;5;-1
p2419-mancini;total of 10;10;-1
p2419-mancini;total of 1092;1092;-1
p2429-dearman;12 participants;12;-1
p2429-dearman;n=9;9;-1
p2429-dearman;n=0;0;-1
p2429-dearman;n=1;1;-1
p2429-dearman;n=4;4;-1
p2429-dearman;n=3;3;-1
p2429-dearman;n=2;2;-1
p2429-dearman;total of 195;195;-1
p2439-pakanen;total of 20;20;-1
p2439-pakanen;total of 106;106;-1
p2439-pakanen;total of   20;20;-1
p2439-pakanen;total of 122;122;-1
p2449-kelley;27 participants;27;-1
p2449-kelley;111  people;111;-1
p2453-findlater;8 participants;8;-1
p2453-findlater;14 participants;14;-1
p2453-findlater;4 participants;4;-1
p2453-findlater;12 participants;12;-1
p2453-findlater;3 participants;3;-1
p2453-findlater;N = 20;20;-1
p2453-findlater;N = 7;7;-1
p2463-sporka;1The participants;1;-1
p2463-sporka;3 participants;3;-1
p2463-sporka;total of 64;64;-1
p247-geyer;50   people;50;-1
p247-geyer;total of 254;254;-1
p2477-paek;total of 295;295;-1
p2477-paek;total of 164;164;-1
p2481-levesque;12 participants;12;-1
p2481-levesque;total of 24;24;-1
p2491-casiez;12 participants;12;-1
p2491-casiez;total of 9;9;-1
p2501-holz;12 participants;12;-1
p2501-holz;9 participants;9;-1
p2501-holz;6 participants;6;-1
p2501-holz;75mm   across participants;75;-1
p2501-holz;30 participants;30;-1
p2501-holz;5 participants;5;-1
p2501-holz;12   participants;12;-1
p2501-holz;2 participants;2;-1
p2511-bi;10 participants;10;-1
p2511-bi;total of 270;270;-1
p2541-bakke;52 subjects;52;4628
p2541-bakke;26 subjects;26;4492
p2541-bakke;36 subjects;36;3982
p2541-bakke;16 subjects;16;3777
p2541-bakke;5 of these subjects;5;5482
p2551-suzuki;129 participants;129;-1
p2551-suzuki;total of 129;129;-1
p2555-wilson;n=29;29;5535
p2555-wilson;n=3;3;850
p2555-wilson;n=2;2;5535
p2555-wilson;n =2;2;923
p2555-wilson;n=1;1;1537
p2555-wilson;n=4;4;4491
p2555-wilson;n=30;30;6427
p2555-wilson;n = 3;3;14858
p2555-wilson;n =4;4;15615
p2555-wilson;n =3;3;15649
p2555-wilson;n =   3;3;16179
p2555-wilson;total of 24;24;6890
p257-bardzell;2 participants;2;-1
p257-bardzell;total of 14;14;-1
p257-bardzell;total of 30;30;-1
p2575-rogers;10 participants;10;-1
p2575-rogers;6 participants;6;-1
p2575-rogers;n  = 0;0;-1
p2595-komanduri;5,000 participants;5000;-1
p2595-komanduri;6,212 participants;6212;-1
p2595-komanduri;5,103 participants;5103;-1
p2595-komanduri;8 participants;8;-1
p2595-komanduri;1,108 prospective participants;1108;-1
p2595-komanduri;8  participants;8;-1
p2595-komanduri;16 participants;16;-1
p2595-komanduri;8survey participants;8;-1
p2595-komanduri;1,224 participants;1224;-1
p2595-komanduri;1 We recruited;1;-1
p2595-komanduri;total of 6,212;6212;-1
p2605-khot;30 participants;30;-1
p2605-khot;20   graduated participants;20;-1
p2605-khot;10 shows the   responses of the participants;10;-1
p2605-khot;14 participants;14;-1
p2605-khot;20 participants;20;-1
p2605-khot;7 participants;7;-1
p2615-denning;103 participants;103;-1
p2615-denning;77 participants;77;-1
p2615-denning;38 participants;38;-1
p2615-denning;n = 9;9;-1
p2615-denning;n = 28;28;-1
p2619-kaye;60 women;60;-1
p2619-kaye;62 women;62;-1
p2619-kaye;32 people;32;-1
p2619-kaye;122 people;122;-1
p2619-kaye;443 people;443;-1
p2619-kaye;36 people;36;-1
p2619-kaye;142 reports of people;142;-1
p2619-kaye;60 women recruited;60;-1
p2619-kaye;total of 318;318;-1
p2623-fidas;210 participants;210;-1
p2623-fidas;210 people;210;-1
p2623-fidas;N=192;192;-1
p2623-fidas;N=92;92;-1
p2623-fidas;N=70;70;-1
p2623-fidas;N=42;42;-1
p2623-fidas;N=6;6;-1
p2623-fidas;N=191;191;-1
p2623-fidas;n=2;2;-1
p2623-fidas;total of 210;210;-1
p2627-hayashi;20 participants;20;-1
p2627-hayashi;11 participants;11;-1
p2627-hayashi;15   participants;15;-1
p2627-hayashi;11   participants;11;-1
p2631-weilenmann;n=   011;11;-1
p2665-rosner;10 key participants;10;-1
p2669-karlson;16   people;16;-1
p2669-karlson;16 people;16;-1
p2669-karlson;N=14;14;-1
p267-sambasivan;2 women;2;-1
p267-sambasivan;10 people;10;-1
p267-sambasivan;63 people;63;-1
p267-sambasivan;n=35;35;-1
p267-sambasivan;n=23;23;-1
p267-sambasivan;n=230;230;-1
p267-sambasivan;n=627;627;-1
p267-sambasivan;total of 330;330;-1
p2689-bargas;6  Frustration When people;6;-1
p2689-bargas;n = 1254;1254;-1
p2689-bargas;n = 906;906;-1
p2689-bargas;n = 449;449;-1
p2689-bargas;n = 348;348;-1
p2689-bargas;n = 457;457;-1
p2689-bargas;n = 51;51;-1
p2689-bargas;n = 398;398;-1
p2689-bargas;N = 66;66;-1
p2689-bargas;n = 40;40;-1
p2689-bargas;n = 22;22;-1
p2689-bargas;n = 13;13;-1
p2689-bargas;n  = 30;30;-1
p2689-bargas;n = 14;14;-1
p2689-bargas;n = 30;30;-1
p2689-bargas;n = 45;45;-1
p2689-bargas;n = 15;15;-1
p2689-bargas;n = 27;27;-1
p2689-bargas;n = 33;33;-1
p2689-bargas;n = 11;11;-1
p2689-bargas;n = 35;35;-1
p2689-bargas;n = 5;5;-1
p2689-bargas;n = 1;1;-1
p2689-bargas;n = 16;16;-1
p2689-bargas;total of 66;66;-1
p2689-bargas;total of 51;51;-1
p2689-bargas;total of 45;45;-1
p2699-ma;total of 18;18;-1
p2699-ma;total of 60;60;-1
p2707-cowan;16 participants;16;-1
p2707-cowan;12 participants;12;-1
p2707-cowan;14 participants;14;-1
p2707-cowan;8 participants;8;-1
p2707-cowan;n = 6;6;-1
p2707-cowan;n = 7;7;-1
p2707-cowan;n =   6;6;-1
p2707-cowan;total of 448;448;-1
p2717-ruiz; data captured from 99;99;-1
p2725-rohs;N=12;12;-1
p2729-khalilbeigi;11 volunteer participants;11;-1
p2729-khalilbeigi;11 participants;11;-1
p2729-khalilbeigi;8 participants;8;-1
p2733-robinson;36 participants;36;-1
p2733-robinson;16 participants;16;-1
p2733-robinson;15 participants;15;-1
p2737-maeda;18 participants;18;-1
p2741-scarr;20 participants;20;-1
p2761-hendy;12 participants;12;-1
p2761-hendy;12 additional participants;12;-1
p2761-hendy;N=12;12;-1
p2765-miller;20 participants;20;-1
p2789-mcpherson;10 subjects;10;20512
p2789-mcpherson;5 subjects;5;20264
p2799-riecke;19 participants;19;-1
p2799-riecke;total of 19;19;-1
p2803-lennon;11   participants;11;-1
p2803-lennon;11 participants;11;-1
p2803-lennon;12 participants;12;-1
p2803-lennon;total of 764;764;-1
p2803-lennon; data points from 12;12;-1
p2807-dow;84 participants;84;-1
p2807-dow;28 participants;28;-1
p2807-dow;30 individuals;30;-1
p2817-shaer;48 participants;48;-1
p2817-shaer;56 percent of the   participants;56;-1
p2817-shaer;39   percent of the participants;39;-1
p2827-yamashita;32 participants;32;-1
p2837-white;350 participants;350;-1
p2837-white;30 participants;30;-1
p2837-white;182 participants;182;-1
p2837-white;54 participants;54;-1
p2837-white;30,000 people;30000;-1
p2837-white;n =5;5;-1
p2847-gazan;500 individuals;500;-1
p2847-gazan;n=478;478;-1
p2847-gazan;n=41;41;-1
p2847-gazan;total of 125;125;-1
p2847-gazan;total of 61;61;-1
p2847-gazan;total   of 97;97;-1
p2857-mamykina;140,000 people;140000;-1
p2857-mamykina;n=6;6;-1
p2857-mamykina;n=2;2;-1
p2857-mamykina;n=4;4;-1
p2857-mamykina;total of   300;300;-1
p2867-shroff;35 low-income women;35;-1
p2867-shroff;35 women;35;-1
p2867-shroff;500 women;500;-1
p2867-shroff;11 women;11;-1
p2867-shroff;28 women;28;-1
p2867-shroff;8 women;8;-1
p2867-shroff;82 participants;82;-1
p2867-shroff;18 were new participants;18;-1
p2867-shroff;total of 47;47;-1
p2867-shroff;total of 15;15;-1
p2867-shroff;total of 82;82;-1
p287-vihavainen;3   None of the participants;3;-1
p287-vihavainen;4   Most of the participants;4;-1
p287-vihavainen;3   Two participants;3;-1
p287-vihavainen;3   Three participants;3;-1
p2877-mejova;16 participants;16;-1
p2877-mejova;24 participants;24;-1
p2877-mejova;16 manager participants;16;-1
p2887-laqua;10 participants;10;4552
p2887-laqua;14   participants;14;4483
p2887-laqua;28 active participants;28;2519
p2887-laqua;16   participants;16;1497
p2887-laqua;24   participants;24;2030
p2887-laqua;11 participants;11;3205
p2887-laqua;13 participants;13;3361
p2887-laqua;24 participants;24;3776
p2887-laqua;n = 0;0;4624
p2887-laqua;total of 34;34;4745
p2897-zadeh;n = 4;4;-1
p2897-zadeh;n = 2;2;-1
p2897-zadeh;n = 91;91;-1
p2897-zadeh; dataset of 549;549;-1
p29-wilcox;30 participants;30;-1
p2907-van-kleek;420 participants;420;-1
p2907-van-kleek;5 individuals;5;-1
p2907-van-kleek;n=473;473;-1
p2907-van-kleek;n=1;1;-1
p2907-van-kleek;n = 420;420;-1
p2907-van-kleek;n = 165;165;-1
p2907-van-kleek;n = 201;201;-1
p2907-van-kleek;n = 39;39;-1
p2907-van-kleek;n = 29;29;-1
p2907-van-kleek;N=66,151;66151;-1
p2907-van-kleek;n = 5;5;-1
p2917-thayer;7 women;7;-1
p2917-thayer;39 participants;39;-1
p2917-thayer;21 participants;21;-1
p2927-tashman;13 of whom were women;13;-1
p2927-tashman;20 participants;20;-1
p2927-tashman;24 people;24;-1
p2937-coyle;n=6;6;-1
p2937-coyle;n=216;216;-1
p2947-matthews;5 participants;5;-1
p2947-matthews;11 female participants;11;-1
p2947-matthews;17 participants;17;-1
p2947-matthews;18   phone participants;18;-1
p2947-matthews;7 of the participants;7;-1
p2947-matthews;1  Profile of participants;1;-1
p2947-matthews;4 individuals;4;-1
p2947-matthews;8 adults;8;-1
p2947-matthews;n=20;20;-1
p2947-matthews;n=5;5;-1
p2947-matthews;n=32;32;-1
p2947-matthews;n=28;28;-1
p2947-matthews;n=14;14;-1
p2947-matthews;n =1;1;-1
p2947-matthews;total of 9;9;-1
p2957-kuznetsov;7   participants;7;-1
p2957-kuznetsov;7 participants;7;-1
p2967-disalvo;21 Glitch participants;21;7824
p2967-disalvo;10 participants;10;3456
p2967-disalvo;23 participants;23;2285
p2967-disalvo;23   participants;23;578
p2967-disalvo;21   participants;21;902
p2967-disalvo;1   because participants;1;2870
p2967-disalvo;2 within-subjects;2;393
p2967-disalvo;N=20;20;3603
p297-yew;total of 43;43;-1
p297-yew;total of 109;109;-1
p297-yew; dataset of 9,364;9364;-1
p297-yew; dataset of 100;100;-1
p297-yew; dataset of 1,580;1580;-1
p2975-pedersen;16  persons;16;-1
p2975-pedersen;total of 16;16;-1
p3005-cohe;3 subjects;3;-1
p3009-weiss;11 participants;11;-1
p3013-jetter;72   participants;72;-1
p3013-jetter;7 participants;7;-1
p3013-jetter;7   subjects;7;-1
p3013-jetter;n = 401;401;-1
p3023-hinrichs;20  adults;20;-1
p3023-hinrichs;35 adults;35;-1
p3023-hinrichs;40  adults;40;-1
p3033-marshall;184 people;184;-1
p3033-marshall;183   people;183;-1
p3033-marshall;204 people;204;-1
p3033-marshall;284 people;284;-1
p3033-marshall;158 individuals;158;-1
p3033-marshall;121 individuals;121;-1
p3053-choe;N = 230;230;-1
p3053-choe;N = 16;16;-1
p3053-choe;N = 4;4;-1
p3053-choe;n = 62;62;-1
p3053-choe;n =   144;144;-1
p3053-choe;n = 89;89;-1
p3053-choe;total of 34;34;-1
p3063-klasnja;20 participants;20;-1
p3063-klasnja;77   participants;77;-1
p3063-klasnja;N=77;77;-1
p3063-klasnja;N=30;30;-1
p3063-klasnja;N=47;47;-1
p3073-balaam;total of 6621;6621;-1
p3083-taylor;10 patients;10;-1
p3083-taylor;24 patients;24;-1
p3083-taylor;17 patients;17;-1
p3083-taylor;900,000 people;900000;-1
p3083-taylor;2009 survey of   individuals;2009;-1
p3083-taylor;n=26;26;-1
p3103-oulasvirta;5 within-subjects;5;-1
p3103-oulasvirta;3 within-subjects;3;-1
p311-geerts;36 participants;36;-1
p311-geerts;15 participants;15;-1
p311-geerts;21 participants;21;-1
p311-geerts;36   people;36;-1
p311-geerts;N=15;15;-1
p311-geerts;N=21;21;-1
p311-geerts;total of 36;36;-1
p3113-kim;2   women;2;-1
p3113-kim;total of 12;12;-1
p3113-kim;total of 24;24;-1
p3123-bogunovich;total of 20;20;-1
p3127-dabbish;36 individuals;36;-1
p3127-dabbish;n=23;23;-1
p3127-dabbish;n=17;17;-1
p3127-dabbish;n=16;16;-1
p3127-dabbish;n=466;466;-1
p3127-dabbish;total   of 96;96;-1
p3127-dabbish;total of 889;889;-1
p3127-dabbish; data from 36;36;-1
p3131-willett;24 paid participants;24;-1
p3131-willett;12 participants;12;-1
p3131-willett;12 paid participants;12;-1
p3131-willett;n=26;26;-1
p3131-willett;n=25;25;-1
p3131-willett;n=15;15;-1
p3131-willett;n=10;10;-1
p3131-willett;n=4;4;-1
p3131-willett;n=12;12;-1
p3131-willett;n=7;7;-1
p3131-willett;n=2;2;-1
p3131-willett;n=23;23;-1
p3131-willett;n=3082;3082;-1
p3131-willett;n=1480;1480;-1
p3131-willett;n=3;3;-1
p3131-willett;n=6;6;-1
p3131-willett;total of 123;123;-1
p3141-huh;total of  3,293;3293;-1
p3141-huh;total of 12;12;-1
p315-maitland;n=6;6;-1
p315-maitland;n=2;2;-1
p315-maitland;n=9;9;-1
p3151-costa;total of 8,257;8257;-1
p3151-costa;total of   1,724;1724;-1
p3151-costa;total of 161;161;-1
p3165-chi;10 participants;10;-1
p3169-edge;23 participants;23;-1
p3169-edge;5   participants;5;-1
p3169-edge;4 Five participants;4;-1
p3169-edge;12 of the finishing   participants;12;-1
p3169-edge;N=23;23;-1
p3179-trusty;18 participants;18;35752
p3179-trusty;21 participants;21;16966
p3179-trusty;18 study participants;18;14014
p3179-trusty;21 participants recruited;21;16966
p3189-miyata;N = 17;17;-1
p3189-miyata;N = 6;6;-1
p3189-miyata;N=1000;1000;-1
p3199-pearson;16 participants;16;-1
p3207-nguyen;n = 12;12;-1
p3207-nguyen;n = 9;9;-1
p3207-nguyen;n = 21;21;-1
p3207-nguyen;n = 146;146;-1
p3207-nguyen;n = 183;183;-1
p3207-nguyen;n = 337;337;-1
p3217-lampinen;27 participants;27;-1
p3217-lampinen;18 participants;18;-1
p3217-lampinen;2   Our participants;2;-1
p3217-lampinen;1   While participants;1;-1
p3217-lampinen;2   Some participants;2;-1
p3217-lampinen;27 people;27;-1
p3227-gill;146   participants;146;-1
p3227-gill;118 participants;118;-1
p3227-gill;62 participants;62;-1
p3227-gill;6 participants;6;-1
p3227-gill;total of 82;82;-1
p3227-gill;total of 72;72;-1
p3227-gill;total of 16;16;-1
p3237-yardi;16 participants;16;-1
p3237-yardi;30   people;30;-1
p3237-yardi;total of 41;41;-1
p3247-azenkot;4 women;4;-1
p3247-azenkot;3 women;3;-1
p3247-azenkot;10 participants;10;-1
p3247-azenkot;2 participants;2;-1
p3247-azenkot;2 other participants;2;-1
p3247-azenkot;4 participants;4;-1
p3247-azenkot;13   blind and deaf-blind people;13;-1
p3247-azenkot;3 million legally blind   people;3;-1
p3247-azenkot;50,000 deaf-blind people;50000;-1
p3247-azenkot;61   deaf-blind people;61;-1
p3247-azenkot;7 deaf-blind   people;7;-1
p3247-azenkot;10 blind people;10;-1
p3247-azenkot;6 blind adults;6;-1
p3247-azenkot;7   deaf-blind adults;7;-1
p3247-azenkot;10   blind adults;10;-1
p325-lee;119 participants;119;-1
p325-lee;2   Thirty-nine percent of the participants;2;-1
p325-lee;100 participants;100;-1
p325-lee;N = 21;21;-1
p325-lee;N = 20;20;-1
p325-lee;N=20;20;-1
p325-lee;n = 4;4;-1
p325-lee;N = 59;59;-1
p325-lee;N = 60;60;-1
p325-lee;N = 19;19;-1
p325-lee;N=69;69;-1
p325-lee;N=29;29;-1
p325-lee;N=5;5;-1
p3257-pasquero;n=48;48;-1
p3257-pasquero;total of 5;5;-1
p3257-pasquero;total of 80;80;-1
p3267-karuei;16 participants;16;-1
p3267-karuei;2 participants;2;-1
p3267-karuei;1 participants;1;-1
p3267-karuei;32 participants;32;-1
p3267-karuei;total of 560;560;-1
p3277-pasquero;120  A J G E D B C F H I  participants;120;-1
p3277-pasquero;8 per-  sons was recruited;8;-1
p3277-pasquero;total of 24;24;-1
p3281-lylykangas;n=16;16;-1
p3281-lylykangas;total of 16;16;-1
p3285-tashman;12 women;12;-1
p3285-tashman;14 participants;14;-1
p3285-tashman;18   participants;18;-1
p3285-tashman;18 participants;18;-1
p33-lee;4 women;4;-1
p33-lee;9   women;9;-1
p33-lee;4 people;4;-1
p33-lee;N=54;54;-1
p3305-hunter;24 participants;24;-1
p3305-hunter;6 people;6;-1
p3305-hunter;8   people;8;-1
p3333-ni;18 paid participants;18;-1
p3333-ni;18 participants;18;-1
p3333-ni;2 participants;2;-1
p335-kaptein;112 participants;112;-1
p335-kaptein;3 between-  participants;3;-1
p335-kaptein;3 between-participants;3;-1
p335-kaptein;136 possible  participants;136;-1
p335-kaptein;2  between-subjects;2;-1
p335-kaptein;112 participants were recruited;112;-1
p335-kaptein;N = 112;112;-1
p335-kaptein;N = 10;10;-1
p335-kaptein;N = 12;12;-1
p335-kaptein;total of 112;112;-1
p3353-zhou;2 patients;2;-1
p3363-kandel;12 participants;12;-1
p3363-kandel;2We divided subjects;2;-1
p3401-sukumaran;2 was a between-participants;2;1331
p3401-sukumaran;N = 12;12;11918
p3401-sukumaran;N   = 50;50;374
p3401-sukumaran;total of 24;24;13791
p3401-sukumaran;total of 72;72;5423
p3411-antin;32 potential participants;32;-1
p3411-antin;20 interview participants;20;-1
p3411-antin;1  illustrates participants;1;-1
p3411-antin;310 people;310;-1
p3411-antin;total of 20;20;-1
p3411-antin;total of  32;32;-1
p3421-monroy;n = 932;932;-1
p3421-monroy;n = 388;388;-1
p3421-monroy;n = 12;12;-1
p3431-zhu;300 individuals;300;-1
p3435-hsieh;427 participants;427;-1
p3435-hsieh;97 participants;97;-1
p3439-wainer;38 participants;38;-1
p3439-wainer;9 billion   people;9;-1
p3439-wainer;n = 19;19;-1
p3439-wainer;n=10;10;-1
p3439-wainer;n=9;9;-1
p3439-wainer;total   of 42;42;-1
p3439-wainer;total of 38;38;-1
p3439-wainer;total of 2,356;2356;-1
p3449-whittaker;32 interview   participants;32;14717
p3449-whittaker;345 people;345;8561
p345-schwanda;16 participants;16;-1
p345-schwanda;11 million   people;11;-1
p345-schwanda;16 adults;16;-1
p3459-chi;1 Study Setup   We recruited;1;-1
p3459-chi;n =   6;6;-1
p3459-chi;n = 6;6;-1
p3459-chi;n = 7;7;-1
p3459-chi;n = 5;5;-1
p3459-chi;n = 3;3;-1
p3459-chi;n = 1;1;-1
p3459-chi;n =   1;1;-1
p3469-blythe;113   women;113;-1
p3469-blythe;200 participants;200;-1
p3469-blythe;224   people;224;-1
p3469-blythe;224 people;224;-1
p3469-blythe;10 people;10;-1
p349-schwind;123 paid subjects;123;-1
p349-schwind; data from 123;123;-1
p363-pan;1 subjects;1;-1
p363-pan;11 subjects;11;-1
p363-pan;3 subjects;3;-1
p363-pan;21 of these caused subjects;21;-1
p363-pan;n = 11;11;-1
p363-pan;N=2;2;-1
p363-pan;n = 40;40;-1
p363-pan;n=11;11;-1
p363-pan;n=5;5;-1
p363-pan;n=2;2;-1
p363-pan;total   of 80;80;-1
p363-pan;total of 30;30;-1
p363-pan; data from E1;1;-1
p373-hirshfield;10 participants;10;-1
p373-hirshfield;10 subjects;10;-1
p373-hirshfield;10   subjects;10;-1
p373-hirshfield;total of 192;192;-1
p393-choi;11 successful participants;11;-1
p393-choi;6 of the participants;6;-1
p403-bragdon;15 participants;15;-1
p413-kane;6 of the blind   participants;6;-1
p413-kane;8 of the blind participants;8;-1
p413-kane;10 blind participants;10;-1
p413-kane;9 blind  participants;9;-1
p413-kane;9 sighted participants;9;-1
p413-kane;3 sighted  participants;3;-1
p413-kane;10 participants;10;-1
p413-kane;2 blind participants;2;-1
p413-kane;10 sighted people;10;-1
p413-kane;10 blind people;10;-1
p413-kane;N=880;880;-1
p413-kane;N=785;785;-1
p413-kane;N=2335;2335;-1
p413-kane;N=780;780;-1
p413-kane;N=1213;1213;-1
p413-kane;N=528;528;-1
p413-kane;N=233;233;-1
p413-kane;N=60;60;-1
p413-kane;N=3624;3624;-1
p413-kane;N=1250;1250;-1
p413-kane;N=1166;1166;-1
p413-kane;total of 20;20;-1
p413-kane;total of 40;40;-1
p413-kane;total of 15;15;-1
p413-kane;total of   2335;2335;-1
p423-purpura;26 student subjects;26;-1
p433-assogba;80 different subjects;80;-1
p433-assogba;100 different possible subjects;100;-1
p443-hourcade;500,000 people;500000;-1
p443-hourcade;87   million people;87;-1
p453-jayatilaka;44 participants;44;-1
p453-jayatilaka;13 participants;13;-1
p453-jayatilaka;2  participants;2;-1
p453-jayatilaka;total of 2;2;-1
p453-jayatilaka; data from 44;44;-1
p463-iqbal;4 within subjects;4;9277
p463-iqbal;18   pairs were recruited;18;13701
p463-iqbal;total of 18;18;13710
p463-iqbal;total of 20;20;6531
p473-brumby;12 participants;12;-1
p483-doring;12 participants;12;-1
p483-doring;4 participants;4;-1
p483-doring;3   participants;3;-1
p483-doring;11 participants;11;-1
p483-doring;6 people;6;-1
p493-kim;32 participants;32;-1
p493-kim;18 elder participants;18;-1
p493-kim;14 younger   participants;14;-1
p493-kim;total of 4;4;-1
p503-erickson;30   participants;30;-1
p503-erickson;502 people;502;-1
p503-erickson;350 people;350;-1
p503-erickson;25 people;25;-1
p513-junuzovic;58 participants;58;-1
p513-junuzovic;48 participants;48;-1
p513-junuzovic;n=15;15;-1
p523-zhou;total of 104;104;-1
p53-zhu;total of 30;30;-1
p561-ozenc;631 participants;631;-1
p561-ozenc;16 participants;16;-1
p561-ozenc;9 participants;9;-1
p561-ozenc;1 Please note all participants;1;-1
p561-ozenc;16 participants were recruited;16;-1
p571-burke;19 participants;19;-1
p571-burke;N=1193;1193;-1
p571-burke;N=415;415;-1
p581-jianqiang;10   individuals;10;-1
p581-jianqiang;12 non-volunteers were recruited;12;-1
p585-yoder;total of 574;574;-1
p589-mankoff;150 survey participants;150;-1
p589-mankoff;150 participants;150;-1
p589-mankoff;20 patients;20;-1
p589-mankoff;n = 6;6;-1
p589-mankoff;n = 51;51;-1
p589-mankoff;n = 98;98;-1
p599-kim;22 items asked participants;22;-1
p599-kim;3 From a total of ninety-five participants;3;-1
p599-kim;N = 99;99;-1
p599-kim;N = 93;93;-1
p599-kim;total of 22;22;-1
p609-hailpern;64 participants;64;-1
p609-hailpern;3  All participants;3;-1
p609-hailpern;16   subjects;16;-1
p609-hailpern;n=6;6;-1
p609-hailpern;n=5;5;-1
p609-hailpern;total of   45;45;-1
p623-wacharamanotham;N = 6;6;-1
p63-nakanishi;2 two-way between-subjects;2;-1
p63-nakanishi;2 two-way   between-subjects;2;-1
p637-yoshizaki;11 participants;11;9023
p647-liu;n=6;6;-1
p647-liu;n=4;4;-1
p657-mamykina;58 participants;58;-1
p657-mamykina;N=21;21;-1
p657-mamykina;N=20;20;-1
p657-mamykina;N=17;17;-1
p657-mamykina;n=20;20;-1
p671-kim;29 women;29;-1
p671-kim;45 participants;45;-1
p671-kim;27   participants;27;-1
p671-kim;14 participants;14;-1
p671-kim;8 participants;8;-1
p695-kannabiran;total of 70;70;-1
p705-shinohara;1 lists participants;1;-1
p705-shinohara;20 people;20;-1
p705-shinohara;1   did not want people;1;-1
p705-shinohara;20 individuals;20;-1
p715-epp;12 participants;12;-1
p715-epp;1129   samples over all participants;1129;-1
p715-epp;n=28;28;-1
p715-epp;n=94;94;-1
p725-pollak;34 subjects;34;-1
p725-pollak;34   subjects;34;-1
p725-pollak;315 individuals;315;-1
p725-pollak;34 individuals;34;-1
p725-pollak;N=70;70;-1
p725-pollak;N=315;315;-1
p725-pollak;N=711;711;-1
p725-pollak;N=437;437;-1
p725-pollak;N=861;861;-1
p725-pollak;N=308;308;-1
p725-pollak;N=638;638;-1
p725-pollak;N=531;531;-1
p73-marshall;43 participants;43;-1
p73-marshall;7 people;7;-1
p73-marshall;16 people;16;-1
p73-marshall;total of   43;43;-1
p73-marshall;total of 72;72;-1
p735-lewis;12 women;12;2626
p735-lewis;9 women;9;2933
p735-lewis;240 participants;240;20877
p735-lewis;31 participants;31;19507
p735-lewis;27 participants;27;2916
p735-lewis;240 total Turkers recruited;240;3232
p745-guillory;N= 84;84;-1
p749-harris;N = 36;36;-1
p749-harris;n = 12;12;-1
p753-yee;500 participants;500;-1
p753-yee; data from   1,040;1040;-1
p763-cheung;total of 127;127;-1
p773-yee;281 women;281;3814
p773-yee;252 participants;252;428
p773-yee;1,084 participants;1084;3787
p773-yee;252 participants were   recruited;252;428
p773-yee; data from 1,040;1040;6988
p777-pfeifer;25   participants;25;-1
p777-pfeifer;25 participants;25;-1
p777-pfeifer;total of 25;25;-1
p781-marathe;133 participants;133;-1
p781-marathe;12  young adults;12;-1
p781-marathe;N=76;76;-1
p781-marathe;N=57;57;-1
p791-cohn;10 participants;10;-1
p791-cohn;10 people;10;-1
p801-hinckley;10 subjects;10;-1
p811-holz;12 participants;12;31081
p811-holz;6 participants;6;26690
p811-holz;4 participants;4;26407
p811-holz;3 participants;3;25752
p811-holz;15 participants;15;3336
p821-grandhi;16 participants;16;-1
p821-grandhi;2 where participants;2;-1
p821-grandhi;3 where   participants;3;-1
p821-grandhi;16 subjects;16;-1
p821-grandhi;total of 19;19;-1
p825-lozano;total of 3;3;-1
p825-lozano;total of 8;8;-1
p829-huot;18 participants;18;-1
p829-huot;10 participants;10;-1
p829-huot;5 participants;5;-1
p829-huot;14 subjects;14;-1
p829-huot;4 new subjects;4;-1
p829-huot;total of 18;18;-1
p829-huot;total of 3;3;-1
p83-noguchi;4 women;4;-1
p83-noguchi;21 participants;21;-1
p839-hasan;12 right-handed participants;12;-1
p839-hasan;11,664 trials in total. All   the participants;11664;-1
p839-hasan;1D experiment subjects;1;-1
p849-xin;1 allowed   participants;1;-1
p849-xin;12 subjects;12;-1
p849-xin;12 individuals;12;-1
p859-quinn;5 within-subjects;5;-1
p867-balaam;8 women;8;-1
p867-balaam;16 adults;16;-1
p867-balaam;16   adults;16;-1
p867-balaam;n = 0;0;-1
p877-hazlewood;25 people;25;-1
p877-hazlewood;200 people;200;-1
p887-deluca;24 participants;24;-1
p887-deluca;32 participants;32;-1
p887-deluca;n=4;4;-1
p887-deluca;n=3;3;-1
p895-jimenez;n = 27;27;-1
p895-jimenez;n = 4;4;-1
p895-jimenez;n = 5;5;-1
p895-jimenez;n = 2;2;-1
p895-jimenez;n = 28;28;-1
p895-jimenez;n = 29;29;-1
p905-leshed;13 people;13;-1
p905-leshed;2010 we   interviewed individuals;2010;-1
p905-leshed;n=38;38;-1
p915-voida;23 participants;23;-1
p915-voida;4 million people;4;-1
p925-kandogan;12 participants;12;-1
p925-kandogan;18 participants;18;-1
p925-kandogan;6 participants;6;-1
p93-narumi;44 participants;44;-1
p93-narumi;10 illustrates participants;10;-1
p93-narumi;11 Comparison of the ratio of subjects;11;-1
p93-narumi;n = 20;20;-1
p93-narumi;n = 9;9;-1
p93-narumi;n = 1;1;-1
p93-narumi;n = 14;14;-1
p93-narumi;n = 10;10;-1
p935-bahamondez;8 participants;8;-1
p935-bahamondez;total of 37;37;-1
p955-paruthi;20 participants;20;-1
p955-paruthi;17 participants;17;-1
p955-paruthi;9 participants;9;-1
p955-paruthi;17 participants  were enrolled;17;-1
p959-waldner;15 participants;15;-1
p959-waldner;12 participants;12;-1
p979-martin;total of 6;6;-1
p983-john;3 participants;3;-1
p983-john;77 participants;77;-1
p983-john;4 participants;4;-1
p983-john;total of 277;277;-1
p983-john;total of 254;254;-1
p1-kulesza;62 participants;62;20522
p1037-cheema;19 participants;19;-1
p1037-cheema;n = 6;6;-1
p1037-cheema;n = 5;5;-1
p1037-cheema;n =  4;4;-1
p1065-kairam;2 summarizes participants;2;-1
p1065-kairam; data set of   64,005;64005;-1
p1065-kairam; data set of 34;34;-1
p1075-bao;27 participants;27;-1
p1085-muralidharan;11 participants;11;-1
p1085-muralidharan;12 participants;12;-1
p1085-muralidharan;18 people;18;-1
p1085-muralidharan;N=11;11;-1
p1085-muralidharan;N=12;12;-1
p1085-muralidharan;N=5;5;-1
p1085-muralidharan;N=7;7;-1
p1085-muralidharan;N = 12;12;-1
p1085-muralidharan; data from 3;3;-1
p109-narumi;12 subjects;12;-1
p1095-correll;74 original participants;74;-1
p1095-correll;74 participants;74;-1
p1095-correll;5 participants;5;-1
p1095-correll;total of 1080;1080;-1
p11-szafir;1 between-participants;1;-1
p11-szafir;30 participants;30;-1
p11-szafir;total of 30;30;-1
p1105-kaptein;176 participants;176;7731
p1105-kaptein;N=10;10;2957
p1105-kaptein;N=40;40;2963
p1105-kaptein;N=200;200;2973
p1115-wallner;40 participants;40;-1
p1135-johnson;1   where no participants;1;-1
p1149-kumar;21 participants;21;-1
p1149-kumar;40 participants;40;-1
p1149-kumar;n=10;10;-1
p1149-kumar;n=11;11;-1
p1159-kodagoda;24   F   participants;24;-1
p1159-kodagoda;24   participants;24;-1
p1159-kodagoda;N = 12;12;-1
p1169-vines;6 participants;6;-1
p1179-uzor;9 participants;9;-1
p1179-uzor;total of 4;4;-1
p1189-vines;16 people;16;-1
p1209-friess;total of 17;17;-1
p1219-matthews;12 participants;12;-1
p1219-matthews;5 participants;5;-1
p1219-matthews;3   participants;3;-1
p1219-matthews;6 participants;6;-1
p1219-matthews;5   participants;5;-1
p1219-matthews;3 participants;3;-1
p1219-matthews;7 participants;7;-1
p1219-matthews;1   These two participants;1;-1
p1229-alexander;19 participants;19;-1
p1229-alexander;19   participants;19;-1
p1229-alexander;10 participants;10;-1
p1229-alexander;10 volunteer participants;10;-1
p1229-alexander;8 factor within subjects;8;-1
p1229-alexander;5 factor within subjects;5;-1
p1229-alexander;8 factor within   subjects;8;-1
p1229-alexander;total of 537;537;-1
p1229-alexander;total of 5;5;-1
p1229-alexander;total of 96;96;-1
p1229-alexander;total of 10;10;-1
p1229-alexander;total of 1440;1440;-1
p1239-bailly;12 participants;12;-1
p1239-bailly;12   participants;12;-1
p1239-bailly;7   participants;7;-1
p1239-bailly;6 participants;6;-1
p1239-bailly;4   participants;4;-1
p1239-bailly;2 participants;2;-1
p1239-bailly;4 participants;4;-1
p1239-bailly;12 novel participants;12;-1
p1249-richter;18   random participants;18;-1
p1249-richter; database of 18;18;-1
p1253-ghomi;12  participants;12;8532
p1253-ghomi;6 participants;6;4874
p1253-ghomi;14 participants;14;4677
p1263-mcgookin;total of 10;10;6091
p1273-baur; data set of 1,000;1000;-1
p1287-tu;15 subjects;15;-1
p1287-tu;N = 40;40;-1
p1287-tu;N = 500;500;-1
p1287-tu;N = 100;100;-1
p1297-song;12 participants;12;-1
p1297-song;12  participants;12;-1
p1311-morrison;30 locally-based participants;30;-1
p1311-morrison;11 local participants;11;-1
p1311-morrison;10,806 registered users were recruited;10806;-1
p1311-morrison; data came from 40;40;-1
p1321-dell;450 male participants;450;-1
p1321-dell;450 participants;450;-1
p1321-dell;1 If participants;1;-1
p1321-dell;450  participants;450;-1
p1321-dell;1 recorded participants;1;-1
p1321-dell;n =  144;144;-1
p1321-dell;n = 44;44;-1
p1321-dell;n = 36;36;-1
p1321-dell;n = 28;28;-1
p1321-dell;n = 38;38;-1
p1321-dell;n = 66;66;-1
p1321-dell;n =  70;70;-1
p1321-dell;n =  78;78;-1
p1321-dell;n =  93;93;-1
p1321-dell;n = 46;46;-1
p1321-dell;n = 47;47;-1
p1321-dell;total of 450;450;-1
p1321-dell;total of 200;200;-1
p1321-dell;total of 250;250;-1
p1331-weibel;28 participants;28;-1
p1341-huang;36 subjects;36;19370
p1341-huang;32 subjects;32;8533
p1341-huang;38 subjects;38;6440
p1341-huang;35 other subjects;35;23133
p1341-huang;N = 36;36;220
p1341-huang;N = 27;27;2571
p1341-huang;total  of 120;120;11757
p1341-huang;total of 18,554;18554;13886
p1341-huang; data of all 35;35;23120
p1341-huang; data of 35;35;23391
p1361-taylor;total of 1,783;1783;-1
p1371-lewis;7  million people;7;-1
p1371-lewis;total of 33;33;-1
p139-wang;400 participants;400;-1
p139-wang;1st group of participants;1;-1
p139-wang;2nd group of participants;2;-1
p139-wang;6 participants;6;-1
p139-wang;8 participants;8;-1
p139-wang;248 subjects;248;-1
p139-wang;22 subjects;22;-1
p1391-dearman;15 participants;15;-1
p1391-dearman;n=1;1;-1
p1391-dearman;total of 100;100;-1
p1401-bauer;12 participants;12;-1
p1401-bauer;8 participants;8;-1
p1401-bauer;9}   Several participants;9;-1
p1401-bauer;11}   Five of the participants;11;-1
p1401-bauer;5}   Several participants;5;-1
p1401-bauer;40 million people;40;-1
p1401-bauer;12   people;12;-1
p1401-bauer;12 adults;12;-1
p1401-bauer;N=1;1;-1
p1401-bauer;N=3;3;-1
p1401-bauer;N=4;4;-1
p1401-bauer;N=11;11;-1
p1411-vardoulakis;25 remaining participants;25;-1
p1411-vardoulakis;22 participants;22;-1
p1411-vardoulakis;24 participants;24;-1
p1411-vardoulakis;9 participants;9;-1
p1411-vardoulakis;13 participants;13;-1
p1411-vardoulakis;11 participants;11;-1
p1411-vardoulakis;5 participants;5;-1
p1411-vardoulakis;3 participants;3;-1
p1411-vardoulakis;23 participants;23;-1
p1411-vardoulakis;25 patients;25;-1
p1411-vardoulakis;27 patients;27;-1
p1411-vardoulakis;1162 patients;1162;-1
p1411-vardoulakis;21 patients;21;-1
p1411-vardoulakis;12   Six patients;12;-1
p1411-vardoulakis;10 patients;10;-1
p1411-vardoulakis;11 patients;11;-1
p1411-vardoulakis;6 patients;6;-1
p1411-vardoulakis;25 emergency department patients;25;-1
p1411-vardoulakis;12 people;12;-1
p1411-vardoulakis;total of 27;27;-1
p1411-vardoulakis;total of 8;8;-1
p1411-vardoulakis;total of 106;106;-1
p1421-doherty;n=18;18;24956
p1421-doherty;n=43;43;3245
p1421-doherty;n=45;45;641
p1421-doherty;n=39;39;494
p1421-doherty;n=25;25;442
p1421-doherty;n=0;0;500
p1421-doherty;n=13;13;509
p1421-doherty;n=4;4;3245
p1421-doherty;n=5;5;573
p1421-doherty;n=3;3;494
p1421-doherty;n=9;9;608
p1421-doherty;n=2;2;442
p1421-doherty;n=6;6;2800
p1421-doherty;n=11;11;2936
p1421-doherty;n=17;17;2968
p1431-toscos;15,000 young people;15000;-1
p1431-toscos;1D and their parents were recruited;1;-1
p1431-toscos;n=13;13;-1
p1431-toscos;n=11;11;-1
p1431-toscos;n=24;24;-1
p1431-toscos;total of 48;48;-1
p1431-toscos; data from a 12;12;-1
p1451-davies;29 participants;29;-1
p1451-davies;total of 87;87;-1
p1451-davies;total   of 30;30;-1
p1471-piorkowski;total of 18;18;-1
p1481-sood;N = 5265;5265;-1
p1481-sood;N = 5017;5017;-1
p1481-sood;N =   6354;6354;-1
p1481-sood;   data set of 1;1;-1
p149-piper;5All participants;5;-1
p149-piper;70 people;70;-1
p149-piper;70 adults;70;-1
p149-piper;n=37;37;-1
p149-piper;n=19;19;-1
p1491-moghaddam;703 unique participants;703;-1
p1491-moghaddam;1404 unique participants;1404;-1
p1491-moghaddam;1934 participants;1934;-1
p1491-moghaddam;2 said participants;2;-1
p1491-moghaddam;440,000 people;440000;-1
p1491-moghaddam;N=17;17;-1
p1491-moghaddam;n=14;14;-1
p1491-moghaddam;n=3;3;-1
p1491-moghaddam;N=322;322;-1
p1491-moghaddam;N=577;577;-1
p1491-moghaddam;n=4;4;-1
p1491-moghaddam;N=200;200;-1
p1491-moghaddam;N=141;141;-1
p1491-moghaddam;n=8;8;-1
p1491-moghaddam;n=2;2;-1
p1491-moghaddam;n=1;1;-1
p1491-moghaddam;n=7;7;-1
p1491-moghaddam;n=5;5;-1
p1501-powell;n = 18901;18901;-1
p1501-powell;n = 17532;17532;-1
p1501-powell;total of 112;112;-1
p1501-powell;total of 114;114;-1
p1501-powell;total of 18,901;18901;-1
p1515-wang;total of 34,827;34827;-1
p1529-ley;500   people;500;-1
p1529-ley;19 people;19;-1
p1539-heimerl;328 participants;328;-1
p1549-chilana;20   participants;20;-1
p1549-chilana;20 participants;20;-1
p1549-chilana;total of 58;58;-1
p1549-chilana; data set of 53;53;-1
p1559-kriplean;3We recruited over a hundred participants;3;-1
p1559-kriplean;3We recruited;3;-1
p1569-tang; dataset of   15;15;-1
p1603-bentley;87 participants;87;-1
p1603-bentley;n=5;5;-1
p1603-bentley;n=9;9;-1
p1603-bentley;n=0;0;-1
p1611-boari;24 participants;24;-1
p1611-boari;7   participants;7;-1
p1611-boari;n=10;10;-1
p1631-seitlinger;39 participants;39;-1
p1631-seitlinger;39 adults;39;-1
p1631-seitlinger;n = 19;19;-1
p1631-seitlinger;n = 20;20;-1
p1631-seitlinger;total of 48;48;-1
p1651-back;24 participants;24;-1
p1651-back;24 participants were recruited;24;-1
p1651-back;n = 2;2;-1
p1655-ziemkiewicz;total of 28;28;-1
p1655-ziemkiewicz;total of 12;12;-1
p1659-metoyer;total of 10;10;-1
p1659-metoyer;total of 20;20;-1
p1683-harrison;265 participants;265;-1
p1683-harrison;27 participants;27;-1
p1683-harrison;13 participants;13;-1
p1683-harrison;302 participants;302;-1
p1683-harrison;37   participants;37;-1
p1683-harrison;3 people;3;-1
p1683-harrison;n=3;3;-1
p1683-harrison; data from 265;265;-1
p1693-baur;12 participants;12;-1
p1693-baur;total of 4;4;-1
p1693-baur;total of 12;12;-1
p1713-hayashi;17 participants;17;-1
p1717-williamson;20 participants;20;-1
p1717-williamson;N = 20;20;-1
p1727-kazi;total of 66;66;-1
p1727-kazi;total of 9;9;-1
p1737-fothergill;30 people;30;-1
p1737-fothergill;n = 0;0;-1
p1747-kratz;n = 1;1;10402
p1751-woo;total of 24;24;-1
p1755-dugan;21 participants;21;-1
p1755-dugan;10   people;10;-1
p1755-dugan;100 people;100;-1
p1755-dugan;21   employees who were recruited;21;-1
p1755-dugan;n=21;21;-1
p1755-dugan; data   from 1;1;-1
p1765-birnholtz;2 within-participants;2;-1
p1765-birnholtz;N = 433;433;-1
p1775-guy;661   participants;661;-1
p1775-guy;265,940 people;265940;-1
p1775-guy;150 familiar people;150;-1
p1775-guy;150 people;150;-1
p1775-guy;200 searched people;200;-1
p1775-guy;total of 1,119,121;1119121;-1
p1785-bateman;90 participants;90;-1
p1785-bateman;12 specific elements of people;12;-1
p1785-bateman;90 people;90;-1
p179-sodhi;10 right-handed participants;10;7420
p179-sodhi;90 minutes and participants;90;7163
p179-sodhi;10 participants;10;2441
p179-sodhi;n = 438;438;6625
p179-sodhi;total of 900;900;2414
p1795-yuan;48 participants;48;25954
p1833-densmore; data from 59;59;-1
p1843-gupta;2 people;2;-1
p1843-gupta;10 people;10;-1
p1843-gupta;n = 8,772;8772;-1
p1843-gupta;n   = 8,000;8000;-1
p1843-gupta;n = 14;14;-1
p1843-gupta;n = 72;72;-1
p1843-gupta;total of 21,132;21132;-1
p1853-mueller;32 participants;32;-1
p1853-mueller;14 participants;14;-1
p1853-mueller;16   participants;16;-1
p1853-mueller;   data from 32;32;-1
p1863-gao;11 participants;11;8965
p1863-gao;24 participants;24;165
p1863-gao;17   participants;17;4951
p1863-gao;n=49;49;8687
p1863-gao;n=48;48;8746
p1873-gerling;36 older adults;36;-1
p1883-zyto;N=26;26;-1
p1883-zyto;N=37;37;-1
p1883-zyto;N=27;27;-1
p1883-zyto;n=2;2;-1
p1883-zyto;N = 28;28;-1
p1883-zyto;total of  3275;3275;-1
p1883-zyto;total of 18;18;-1
p189-voelker;24 participants;24;-1
p189-voelker;8 participants;8;-1
p189-voelker;16 participants;16;-1
p189-voelker;14 participants;14;-1
p189-voelker;n=27;27;-1
p189-voelker;n=26;26;-1
p189-voelker;total of 16;16;-1
p189-voelker;total of 14;14;-1
p1897-heinrichs;12 participants;12;-1
p1901-cohn;8 participants;8;-1
p1901-cohn;total of 960;960;-1
p1901-cohn;total of 800;800;-1
p1901-cohn;total of 522;522;-1
p1901-cohn;total of 180;180;-1
p1911-gupta;6 individuals;6;-1
p1911-gupta;N=10;10;-1
p1911-gupta;N=5;5;-1
p1911-gupta;N=4;4;-1
p1915-rofouei;7 pairs of participants;7;-1
p1915-rofouei;4 participants;4;-1
p1915-rofouei;8 people;8;-1
p1915-rofouei;5   people;5;-1
p1915-rofouei;3 people;3;-1
p1915-rofouei;14   adults;14;-1
p1947-evans;12 participants;12;-1
p1947-evans;9 participants;9;-1
p1947-evans;10 mousing participants;10;-1
p1957-appert;12 participants;12;-1
p1957-appert;7 participants;7;-1
p1967-voida;23 participants;23;-1
p1967-voida;250 people;250;-1
p1977-dombrowski;4 All names of participants;4;-1
p1977-dombrowski;30 people;30;-1
p1987-boujarwah;100   participants;100;-1
p1987-boujarwah;300   participants;300;-1
p1987-boujarwah;total of 100;100;-1
p1987-boujarwah;total of 300;300;-1
p199-benko;10 participants;10;-1
p199-benko;total of 96;96;-1
p1997-judge;15 participants;15;-1
p1997-judge;8 participants;8;-1
p1997-judge;7 participants;7;-1
p1997-judge;4   participants;4;-1
p1997-judge;N=8;8;-1
p1997-judge;N=7;7;-1
p2005-benford;50 participants;50;-1
p2015-ferreira;100 people;100;-1
p2015-ferreira;96 people;96;-1
p2025-coyle;21 participants;21;-1
p2025-coyle;18 participants;18;-1
p2025-coyle;24 participants;24;-1
p2025-coyle;27 participants;27;-1
p2025-coyle;24 counter balanced   participants;24;-1
p2025-coyle;n = 2;2;-1
p2025-coyle;n = 16;16;-1
p2035-nobarany;7 participants;7;-1
p2035-nobarany;7   participants;7;-1
p2035-nobarany;10 participants;10;-1
p2035-nobarany;16 new participants;16;-1
p2035-nobarany;9 participants;9;-1
p2035-nobarany;3 participants;3;-1
p2035-nobarany;4 participants;4;-1
p2035-nobarany;2 participants;2;-1
p2035-nobarany;9   participants;9;-1
p2035-nobarany;N=7;7;-1
p2035-nobarany;n=2;2;-1
p2035-nobarany;N=16;16;-1
p2045-shirazi;22 participants;22;-1
p2045-shirazi;22 right-handed   participants;22;-1
p2045-shirazi;N=0;0;-1
p2049-alankus;total of 55;55;-1
p2059-horn;19 women;19;-1
p2059-horn;31 women;31;-1
p2059-horn;1 participants;1;-1
p2059-horn;98   participants;98;-1
p2059-horn;84   individuals;84;-1
p2059-horn;104   individuals;104;-1
p2059-horn;29 adults;29;-1
p2059-horn;59 adults;59;-1
p2059-horn; data from the 50;50;-1
p2079-bonsignore;n=51;51;-1
p2083-dong;11 participants;11;-1
p2087-bonner;10 participants;10;-1
p2087-bonner;12 participants;12;-1
p209-hennecke;16 participants;16;-1
p209-hennecke;48 people;48;-1
p2097-park;3 patients;3;-1
p21-amershi;n=385;385;-1
p21-amershi;n=136;136;-1
p21-amershi;total of 2077;2077;-1
p2107-petrie;13 were women;13;-1
p2107-petrie;30 participants;30;-1
p2107-petrie;16 participants;16;-1
p2107-petrie;26 participants;26;-1
p2107-petrie;n = 10;10;-1
p2107-petrie;n = 66;66;-1
p2107-petrie;total of 947;947;-1
p2117-bruun;53 participants;53;7649
p2117-bruun;n=8;8;12618
p2117-bruun;n=7;7;12588
p2117-bruun;n=6;6;12579
p2117-bruun;n=10;10;12504
p2117-bruun;n=23;23;195
p2117-bruun;n=19;19;84
p2117-bruun;n=16;16;452
p2117-bruun;n=20;20;1046
p2117-bruun;n=21;21;2777
p2117-bruun;n=36;36;2791
p2117-bruun;n=28;28;2805
p2117-bruun;n=45;45;2833
p2117-bruun;n=15;15;2848
p2117-bruun;n=3;3;2791
p2117-bruun;n=13;13;5850
p2117-bruun;n=14;14;5901
p2117-bruun;n= 1;1;8852
p2117-bruun;n=5;5;8906
p2117-bruun;n=4;4;2833
p2117-bruun;n = 1;1;9033
p2117-bruun;n=1;1;12504
p2117-bruun;total of 1;1;8030
p2117-bruun;total of 29;29;1579
p2117-bruun;total of 13;13;1718
p2117-bruun;total of 38;38;4744
p2117-bruun;total of 40;40;5116
p2117-bruun;total of 14;14;12619
p2127-folstad;224 people;224;-1
p2127-folstad;n=112;112;-1
p2127-folstad;n=43;43;-1
p2127-folstad;n=141;141;-1
p2127-folstad;n=106;106;-1
p2127-folstad;n=107;107;-1
p2127-folstad;n=41;41;-1
p2127-folstad;n=142;142;-1
p2127-folstad;n=105;105;-1
p2127-folstad;n=102;102;-1
p2127-folstad;n=40;40;-1
p2127-folstad;n=67;67;-1
p2127-folstad;n=38;38;-1
p2127-folstad;n=66;66;-1
p2127-folstad;n=101;101;-1
p217-zhang;10 participants;10;-1
p217-zhang;11 subjects;11;-1
p2193-solovey;3 participants;3;-1
p2193-solovey;11 participants;11;-1
p2193-solovey;12 subjects;12;-1
p2193-solovey;N=6;6;-1
p2203-cheng;20 participants;20;-1
p2203-cheng;total of 513;513;-1
p2203-cheng;total of 618;618;-1
p2211-joshi;total of 50;50;-1
p2221-jain;4 participants;4;8878
p2221-jain;4   participants;4;7083
p2221-jain;12 participants;12;1026
p2231-dearman;6 pairs of participants;6;-1
p2231-dearman;1   All of the participants;1;-1
p2239-fitchett;n =  5;5;-1
p2243-nowak;52 participants;52;8497
p2243-nowak;n = 22;22;8461
p2243-nowak;total of 52;52;8506
p2247-yarosh;35 participants;35;-1
p2247-yarosh;25 of the participants;25;-1
p2247-yarosh;31 participants;31;-1
p2247-yarosh;32 of the participants;32;-1
p2247-yarosh;3 participants;3;-1
p2247-yarosh;34 participants;34;-1
p2247-yarosh;8 participants;8;-1
p2247-yarosh;N=35;35;-1
p2247-yarosh;N=6;6;-1
p2247-yarosh;N=4;4;-1
p2247-yarosh;N=2;2;-1
p2247-yarosh;N=8;8;-1
p2247-yarosh;N=7;7;-1
p2247-yarosh;N=10;10;-1
p2247-yarosh;N=16;16;-1
p2247-yarosh;N=9;9;-1
p2247-yarosh;N=31;31;-1
p2247-yarosh;N=32;32;-1
p2247-yarosh;N=34;34;-1
p2257-zhu;200 as   total participants;200;-1
p2257-zhu;433 valid   participants;433;-1
p2257-zhu;3   the ip addresses of the participants;3;-1
p2257-zhu;4,627 participants;4627;-1
p2257-zhu;12 people;12;-1
p2267-lazar;20 blind participants;20;-1
p2267-lazar;89 blind participants;89;-1
p2267-lazar;20 participants;20;-1
p2267-lazar;10 participants;10;-1
p2267-lazar;10 blind participants;10;-1
p2267-lazar;10   participants;10;-1
p2267-lazar;20 participants were recruited;20;-1
p2267-lazar;total of 20;20;-1
p227-willett;n=4;4;-1
p227-willett;n=2;2;-1
p2277-kumar;24 participants;24;-1
p2277-kumar;24   participants;24;-1
p2277-kumar;18   participants;18;-1
p2277-kumar;21 participants;21;-1
p2277-kumar;3   participants;3;-1
p2277-kumar;2 within-subjects;2;-1
p2307-vogel;3 participants;3;-1
p2307-vogel;7 participants;7;-1
p2307-vogel;24 participants;24;-1
p2307-vogel;8 participants;8;-1
p2307-vogel;24 people;24;-1
p2327-zhang;8 participants;8;-1
p2327-zhang;3 participants;3;-1
p2327-zhang;24 participants;24;-1
p2327-zhang;27 participants;27;-1
p2327-zhang;total of 12;12;-1
p2327-zhang; data from 8;8;-1
p2337-thieme;22 participants;22;-1
p2337-thieme;7 people;7;-1
p2337-thieme;18 were recruited;18;-1
p2337-thieme;n = 40;40;-1
p2337-thieme;n = 0;0;-1
p2347-kjeldskov;2 adults;2;-1
p2347-kjeldskov;total of 347;347;-1
p2347-kjeldskov;total of   1851;1851;-1
p2357-foster;65 participants;65;-1
p2357-foster;5 people;5;-1
p2357-foster;20 people;20;-1
p2357-foster;total of 65;65;-1
p2357-foster;total of   631;631;-1
p2367-froehlich;20 participants;20;-1
p2367-froehlich;19 participants;19;-1
p2367-froehlich;20 adults;20;-1
p2367-froehlich;20 participants   recruited;20;-1
p2367-froehlich;n=15;15;-1
p2367-froehlich;n=18;18;-1
p2367-froehlich;N=11;11;-1
p2367-froehlich;N=651;651;-1
p2367-froehlich;total of 712;712;-1
p237-bernstein;361 participants;361;-1
p237-bernstein;361 people;361;-1
p2397-kano;1608   participants;1608;4990
p2397-kano;20 participants;20;4444
p2397-kano;N = 20;20;929
p2397-kano;N=20;20;2164
p2401-follmer;total of 6;6;-1
p2421-hilliges;40 were recruited;40;-1
p2441-brecht;470 participants;470;-1
p2441-brecht;718 participants;718;-1
p2451-diakopoulos;60 people;60;-1
p2451-diakopoulos;total of 741;741;-1
p2451-diakopoulos; dataset of 1000;1000;-1
p2451-diakopoulos; dataset   of 1000;1000;-1
p2461-liao;8 expert participants;8;-1
p2469-bogart;total of 110;110;-1
p247-fisher;21 participants;21;-1
p247-fisher;30 people;30;-1
p247-fisher;5 people;5;-1
p247-fisher;N = 21;21;-1
p2479-teo;0 did not match participants;0;-1
p2479-teo;60 undergraduate participants;60;-1
p2479-teo;total of 4979;4979;-1
p2519-pedro;9,526 people;9526;-1
p2519-pedro;total of  100;100;-1
p2523-zhang;3 participants;3;-1
p2523-zhang;6 participants;6;-1
p2523-zhang;2 participants;2;-1
p2523-zhang;3   participants;3;-1
p2527-casiez;n = 10;10;-1
p2527-casiez;n=14;14;-1
p2527-casiez;n = 1;1;-1
p2531-kim;14 participants;14;-1
p2531-kim;total of 5;5;-1
p2531-kim;total of 9;9;-1
p2541-karnik;10 participants;10;-1
p2541-karnik;3 factor within-subjects;3;-1
p2541-karnik;total of 135;135;-1
p2541-karnik;total of 1350;1350;-1
p2561-amini;18 participants;18;-1
p2561-amini;6 participants;6;-1
p2561-amini;24 participants;24;-1
p2561-amini;N=18;18;-1
p2561-amini;N=6;6;-1
p2561-amini;total of 96;96;-1
p2561-amini;total of 464;464;-1
p2565-mulloni;4 participants;4;-1
p2565-mulloni;n = 29;29;-1
p2565-mulloni;n = 24;24;-1
p2565-mulloni;n = 30;30;-1
p2565-mulloni;total of 180;180;-1
p2569-huhn;27 participants;27;-1
p2569-huhn;12 participants;12;-1
p2569-huhn;70 participants;70;-1
p2569-huhn;15 participants;15;-1
p2569-huhn;2 participants;2;-1
p2569-huhn;53 participants;53;-1
p2569-huhn;N=53;53;-1
p257-scarr;1200 monitor   prompted participants;1200;-1
p257-scarr;18 participants;18;-1
p257-scarr;14   participants;14;-1
p257-scarr;18 participants were recruited;18;-1
p257-scarr;total of 10;10;-1
p2579-boonsuk;20 participants;20;-1
p2579-boonsuk;18 participants;18;-1
p2579-boonsuk;5 participants;5;-1
p2579-boonsuk;n=18;18;-1
p2579-boonsuk;total of 20;20;-1
p2579-boonsuk;total of 15;15;-1
p2589-escobedo;n   = 12;12;4463
p2609-hourcade;n=3;3;123
p2629-wallace;6   million people;6;-1
p2629-wallace;65 and older are people;65;-1
p2639-muller;8 persons;8;-1
p2649-brehmer;36 participants;36;-1
p2649-brehmer;N = 36;36;-1
p2649-brehmer; data from 36;36;-1
p2659-henze;6 persons;6;12985
p2659-henze; data from 80,424;80424;4558
p2659-henze; data from  72,945;72945;2781
p2659-henze; data from  26,586;26586;12051
p2659-henze; data from 13,013;13013;12544
p2659-henze; data from  13,013;13013;23199
p2669-dunlop;n = 10;10;-1
p2669-dunlop;total   of 5 171 840;5171840;-1
p2679-findlater;20 participants;20;-1
p2679-findlater;6 new participants;6;-1
p2679-findlater;5 participants;5;-1
p2679-findlater;1 before participants;1;-1
p2679-findlater;6 participants;6;-1
p2679-findlater; data from 20;20;-1
p2683-nicolau;22 participants;22;-1
p2683-nicolau;13 of the participants;13;-1
p2683-nicolau;total of 63;63;-1
p2687-goel;16 participants;16;-1
p2687-goel;16   participants;16;-1
p2687-goel;N=16;16;-1
p2687-goel;total of 1920;1920;-1
p2687-goel; data from 16;16;-1
p2697-oney;20 participants;20;-1
p2697-oney;1 asked participants;1;-1
p2697-oney;3 asked participants;3;-1
p2697-oney;10 control participants;10;-1
p2697-oney;10 Codelet participants;10;-1
p2707-xie;9 participants;9;-1
p2707-xie;8 participants;8;-1
p2707-xie;27 participants;27;-1
p2717-banovic;16 p   was randoml  e participants;16;-1
p2717-banovic;7 of   participants;7;-1
p2717-banovic;n=27;27;-1
p2717-banovic;n=6;6;-1
p2717-banovic;n=8;8;-1
p2717-banovic;n=1;1;-1
p2717-banovic;N=3;3;-1
p2717-banovic;N=27;27;-1
p2717-banovic;N=17;17;-1
p2727-muller;1011 non-contributing participants;1011;-1
p2727-muller;13,000 people;13000;-1
p2727-muller;300,000 people;300000;-1
p2727-muller;1250 people;1250;-1
p2727-muller;275 people;275;-1
p2727-muller;135   people;135;-1
p2727-muller;37 people;37;-1
p2727-muller;n=1;1;-1
p2727-muller;total of 701;701;-1
p2731-gilbert;150K people;150;-1
p2731-gilbert;16 people;16;-1
p2731-gilbert;100 people;100;-1
p2731-gilbert;10,000  people;10000;-1
p2731-gilbert;10,000 people;10000;-1
p2731-gilbert;144,232 unique people;144232;-1
p2731-gilbert;total of 1;1;-1
p2751-hu;26  media people;26;-1
p2751-hu;18 media people;18;-1
p2769-tossell;24 participants;24;-1
p2769-tossell;N = 23;23;-1
p2769-tossell;N = 25;25;-1
p2769-tossell;n = 3;3;-1
p2769-tossell;n = 96;96;-1
p2769-tossell;n = 1;1;-1
p2769-tossell;n = 43;43;-1
p2769-tossell;n = 5;5;-1
p2769-tossell;n = 62;62;-1
p2769-tossell;n = 25;25;-1
p2769-tossell;n = 9;9;-1
p2769-tossell;n = 61;61;-1
p2769-tossell;total of 2,080;2080;-1
p2769-tossell; data   from 24;24;-1
p277-yang;29 participants;29;-1
p277-yang;15 participants;15;-1
p277-yang;N=29;29;-1
p2779-olsson;1 might   also have led people;1;-1
p2779-olsson;N=90;90;-1
p2779-olsson;total of 18;18;-1
p2789-yi;6 participants;6;-1
p2793-merritt;32 participants;32;-1
p2793-merritt;9 presented participants;9;-1
p2793-merritt;10 presented participants;10;-1
p2793-merritt;11 presented participants;11;-1
p2803-yee;2,071 US participants;2071;-1
p2803-yee;645 Hong Kong and Taiwan   participants;645;-1
p2803-yee;514 participants;514;-1
p2803-yee;500 participants;500;-1
p2803-yee;500   participants;500;-1
p2811-yee; data from 1,037;1037;-1
p2815-muller;31,159 people;31159;-1
p2815-muller;8750 people;8750;-1
p2815-muller;828   people;828;-1
p2815-muller;n = 18;18;-1
p2815-muller;n =   16;16;-1
p2815-muller;n = 17;17;-1
p2815-muller;n =   11;11;-1
p2815-muller;n = 828;828;-1
p2815-muller;n = 192;192;-1
p2815-muller;n = 190;190;-1
p2815-muller;n = 88;88;-1
p2815-muller;n = 6;6;-1
p2815-muller;n = 1;1;-1
p2825-woelfer;11 women;11;-1
p2825-woelfer;23   participants;23;-1
p2825-woelfer;13 participants;13;-1
p2825-woelfer;3 of the participants;3;-1
p2825-woelfer;3 million people;3;-1
p2835-draxler;138 persons;138;-1
p2835-draxler;5 of the previous participants;5;-1
p2845-bardram;12 participants;12;-1
p2865-jansen;12 participants;12;-1
p2865-jansen;7 subjects;7;-1
p2865-jansen;3 subjects;3;-1
p2865-jansen;2 subjects;2;-1
p2865-jansen;10 subjects;10;-1
p287-javed;12 participants;12;-1
p2875-lu;12 participants;12;-1
p2875-lu;11 participants;11;-1
p2875-lu;11   participants;11;-1
p2875-lu; data of 1;1;-1
p2895-ouyang;22 participants;22;-1
p2895-ouyang;n = 29;29;-1
p2895-ouyang;n=4;4;-1
p2895-ouyang;n=5;5;-1
p2895-ouyang;total of 1,970;1970;-1
p2895-ouyang;total of 26;26;-1
p2895-ouyang;total of 45;45;-1
p2895-ouyang;total of 50;50;-1
p2895-ouyang;total of 414;414;-1
p2905-wohn;total of 148;148;-1
p2915-masli;953 subjects;953;-1
p2915-masli;951 subjects;951;-1
p2915-masli;177 subjects;177;-1
p2915-masli;21 subjects;21;-1
p2925-antin;3 motivations participants;3;-1
p2925-antin;2010 we recruited;2010;-1
p2925-antin;2010 we  recruited;2010;-1
p2925-antin;N = 1132;1132;-1
p2925-antin;N = 898;898;-1
p2943-holland;21 of   these subjects;21;-1
p2943-holland;total of 14;14;-1
p2953-jianu;16 were  women;16;7388
p2953-jianu;15 control  subjects;15;17821
p2953-jianu;36 subjects;36;7411
p2953-jianu;15 con-  trol subjects;15;4262
p2953-jianu;13  control subjects;13;3182
p2953-jianu;19 test subjects;19;3157
p2953-jianu;total of 36;36;7420
p2953-jianu;total of 28;28;3503
p2953-jianu; datasets from 13;13;3197
p2963-navalpakkam;90 participants;90;-1
p2963-navalpakkam;30 participants;30;-1
p2963-navalpakkam;20 participants;20;-1
p2963-navalpakkam;3 participants;3;-1
p2963-navalpakkam;2 participants;2;-1
p297-muller;2s people;2;-1
p297-muller;5 people;5;-1
p297-muller;16 partic-  ipants recruited;16;-1
p297-muller;n=16;16;-1
p2977-bergman;289   participants;289;10382
p2977-bergman;N=246;246;880
p2977-bergman;N= 43;43;928
p2977-bergman;total of 4,209;4209;1926
p2981-stellmach;24 participants;24;-1
p2981-stellmach;19 participants;19;-1
p2981-stellmach;8 participants;8;-1
p2981-stellmach;14 participants;14;-1
p2981-stellmach;9 participants;9;-1
p2991-vitak;15 participants;15;-1
p3001-raiha;10   participants;10;-1
p3001-raiha;10 participants;10;-1
p3011-bulling;12 participants;12;-1
p3011-bulling;n  = 25;25;-1
p3011-bulling;n =  25;25;-1
p3011-bulling;n = 33;33;-1
p3011-bulling;n = 34;34;-1
p3011-bulling;n = 3;3;-1
p3011-bulling;n = 2;2;-1
p3011-bulling;n = 4;4;-1
p3011-bulling;total of 240;240;-1
p3011-bulling;total of 40;40;-1
p3021-chetty;51 participants;51;-1
p3021-chetty;19 participants;19;-1
p3031-chin;20 older   adults;20;-1
p3031-chin;n=20;20;-1
p3031-chin;n=65;65;-1
p3061-kuhn;total of 1134;1134;-1
p3061-kuhn;total of 14;14;-1
p3061-kuhn;total of 88;88;-1
p307-fischer;3 people;3;-1
p3071-schneider;56 participants;56;-1
p3071-schneider;n = 90;90;-1
p3071-schneider;n = 78;78;-1
p3081-cataldo;total of 161;161;-1
p3091-rae;17 participants;17;-1
p3091-rae;n = 40;40;-1
p3091-rae;n = 14;14;-1
p3091-rae;total  of 17;17;-1
p31-leiva;2 may encourage people;2;-1
p31-leiva;2 will allow more  people;2;-1
p31-leiva;n=2;2;-1
p3101-voida;total of 2;2;3808
p3111-tang;15 participants;15;-1
p3111-tang;total of 94;94;-1
p3121-lee;10 participants;10;-1
p3121-lee;17 participants;17;-1
p3121-lee;14   people;14;-1
p3121-lee;10 people;10;-1
p3131-pielot; data from 8,187;8187;-1
p3141-lee;5 women;5;-1
p3141-lee;total of 120;120;-1
p3141-lee;total of 144;144;-1
p3157-gajos;18 participants;18;24300
p3157-gajos;18  diverse participants;18;22306
p3157-gajos;total of 34;34;5646
p3157-gajos;total of 7847;7847;5574
p3157-gajos;total of 68;68;14569
p3167-dixon;total of 31;31;-1
p317-tenkoppel;2 persons;2;-1
p317-tenkoppel;250 people;250;-1
p3177-yem;2 within-subjects;2;-1
p3181-hutchings;4 participants;4;-1
p3195-lampe;614 people;614;-1
p3195-lampe;n = 15;15;-1
p3195-lampe;n = 120;120;-1
p3195-lampe;n = 40;40;-1
p3195-lampe;n = 1;1;-1
p3205-chang;6 participants;6;-1
p3215-lee;555 participants;555;-1
p3215-lee;86 participants;86;-1
p3215-lee;83  participants;83;-1
p3215-lee;total  of 248,646;248646;-1
p337-odom;36 people;36;-1
p337-odom;5 of these   young adults;5;-1
p347-wang;20 people;20;-1
p347-wang;17 people;17;-1
p347-wang;total of 17;17;-1
p367-barkhuus;90s more and more people;90;-1
p377-klemperer;18 participants;18;-1
p377-klemperer;13 participants;13;-1
p377-klemperer;9 participants;9;-1
p377-klemperer;8 participants;8;-1
p377-klemperer;10 participants;10;-1
p377-klemperer;14 participants;14;-1
p377-klemperer;152 people;152;-1
p377-klemperer;39 people;39;-1
p377-klemperer;18 people;18;-1
p387-gulotta;10 participants;10;-1
p387-gulotta;9 participants;9;-1
p39-ogan;12 participants;12;4878
p39-ogan;n=6;6;12364
p39-ogan; data consists of 3,433;3433;4835
p391-tang;30 participants;30;-1
p391-tang;18 participants;18;-1
p391-tang;10 participants;10;-1
p395-sundar;141 participants;141;-1
p395-sundar;N=141;141;-1
p405-guy;10 visually impaired participants;10;-1
p405-guy;2 participants;2;-1
p405-guy;6 participants;6;-1
p405-guy;10 participants;10;-1
p405-guy;5 participants;5;-1
p405-guy;4   visually impaired individuals;4;-1
p405-guy;total of 14;14;-1
p433-power;17 participants;17;-1
p433-power;n = 39;39;-1
p433-power;total of 10;10;-1
p453-park;N=20;20;1543
p483-sato;12 participants;12;-1
p49-kreitmayer;30 participants;30;-1
p49-kreitmayer;26 participants;26;-1
p493-vi;total of   1920;1920;1332
p493-vi; data from F4;4;484
p513-mustafa;n=0;0;1536
p521-lindsay;65   million people;65;-1
p521-lindsay;6 people;6;-1
p531-moncur;n=2;2;-1
p531-moncur;n=3;3;-1
p531-moncur;n=1;1;-1
p531-moncur;n=4;4;-1
p531-moncur;n=5;5;-1
p541-mccay-peet;189 participants;189;-1
p541-mccay-peet;200 participants;200;-1
p541-mccay-peet;N=191;191;-1
p541-mccay-peet;N=81;81;-1
p541-mccay-peet;N=46;46;-1
p541-mccay-peet;N=88;88;-1
p541-mccay-peet;N=189;189;-1
p541-mccay-peet;N=2;2;-1
p541-mccay-peet;N = 189;189;-1
p541-mccay-peet;N=190;190;-1
p541-mccay-peet;N = 157;157;-1
p541-mccay-peet;N = 24;24;-1
p541-mccay-peet;N = 8;8;-1
p541-mccay-peet;N=99;99;-1
p541-mccay-peet;N=90;90;-1
p551-yang;549   individuals;549;-1
p551-yang; dataset of 15;15;-1
p555-mark;13   participants;13;13052
p555-mark;13 participants;13;5410
p555-mark;total of 13;13;13061
p555-mark;total of 5,643;5643;5457
p565-topkara;428 people;428;2362
p565-topkara;N=13;13;397
p565-topkara;N=10;10;358
p565-topkara;N=7;7;320
p569-raban;62,332   system participants;62332;-1
p569-raban;30 participants;30;-1
p569-raban;281   people;281;-1
p569-raban;9 people;9;-1
p569-raban;21   people;21;-1
p569-raban;N=281;281;-1
p569-raban;total of 9,506;9506;-1
p569-raban;total of 175;175;-1
p579-malheiros;30 participants;30;25946
p579-malheiros;5 participants;5;1247
p579-malheiros;17 participants;17;7132
p579-malheiros;18 participants;18;7384
p579-malheiros;9 participants;9;9569
p579-malheiros;n=25;25;1024
p579-malheiros;n=30;30;169
p589-leon;45 participants;45;-1
p589-leon;3  participants;3;-1
p589-leon;total of 45;45;-1
p59-andersen; data  from 22,417;22417;-1
p599-hietanen;N=8;8;-1
p599-hietanen;N=16;16;-1
p609-wisniewski;21 participants;21;-1
p609-wisniewski;16 participants;16;-1
p609-wisniewski;37   Two participants;37;-1
p609-wisniewski;37    Four other participants;37;-1
p609-wisniewski;100 new people;100;-1
p609-wisniewski;37    Ignoring   When individuals;37;-1
p609-wisniewski; data from 21;21;-1
p619-gurevich;10 participants;10;-1
p627-norris;12   participants;12;-1
p651-vihavainen;43 participants;43;-1
p651-vihavainen;N=16;16;-1
p675-erickson;3   women;3;-1
p675-erickson;15 participants;15;-1
p675-erickson;8   billion people;8;-1
p675-erickson;25 people;25;-1
p675-erickson;11 people;11;-1
p675-erickson;18 people;18;-1
p675-erickson;3 people;3;-1
p675-erickson;total of 16;16;-1
p675-erickson;total of 61;61;-1
p685-arroyo;5 people;5;-1
p689-kehr;n=22;22;-1
p689-kehr;N=10;10;-1
p689-kehr;N=14;14;-1
p695-lee;21 participants;21;-1
p705-andrist;96 participants;96;-1
p705-andrist;20 participants;20;-1
p715-halvey;n = 28;28;-1
p715-halvey;n = 29;29;-1
p715-halvey;n = 26;26;-1
p715-halvey;n = 24;24;-1
p715-halvey;n=3;3;-1
p715-halvey;n=2;2;-1
p715-halvey;n=1;1;-1
p715-halvey;n= 2;2;-1
p715-halvey;n =2;2;-1
p715-halvey;n = 1;1;-1
p715-halvey;total of 24;24;-1
p715-halvey;total of 30;30;-1
p725-sugiura;51 participants;51;-1
p725-sugiura;30   participants;30;-1
p725-sugiura;32 participants;32;-1
p725-sugiura;30 participants;30;-1
p753-neustaedter;7   Some participants;7;-1
p753-neustaedter;7   Shared Activities   Seven participants;7;-1
p753-neustaedter;9   Two participants;9;-1
p753-neustaedter;4   Several participants;4;-1
p753-neustaedter;6   Some people;6;-1
p763-park;total of 21;21;-1
p767-kramer;n = 61,289;61289;-1
p771-zhao;20 participants;20;-1
p771-zhao;20   participants;20;-1
p771-zhao;20 people;20;-1
p771-zhao;10 individuals;10;-1
p771-zhao;total of 20;20;-1
p781-odom;13 participants;13;-1
p781-odom;13 people;13;-1
p781-odom;total of 13;13;-1
p79-cox;40 participants;40;-1
p79-cox;22 participants;22;-1
p79-cox;20 participants;20;-1
p79-cox;10 participants;10;-1
p79-cox;n = 20;20;-1
p79-cox;N = 13;13;-1
p79-cox;N = 16;16;-1
p79-cox;N = 11;11;-1
p79-cox;n =  110;110;-1
p79-cox;n = 81;81;-1
p79-cox;n= 106;106;-1
p79-cox;n = 83;83;-1
p791-sambasivan;2 billion people;2;-1
p791-sambasivan;n=19;19;-1
p791-sambasivan;n=1;1;-1
p791-sambasivan;n=17;17;-1
p791-sambasivan;n=7;7;-1
p791-sambasivan;n=4;4;-1
p791-sambasivan;n=15;15;-1
p791-sambasivan;n=3;3;-1
p791-sambasivan;n=2;2;-1
p791-sambasivan;n=6;6;-1
p791-sambasivan;n=5;5;-1
p791-sambasivan;n=10;10;-1
p791-sambasivan;n=9;9;-1
p791-sambasivan;total of 302;302;-1
p791-sambasivan;total of 120;120;-1
p801-xin;20 participants;20;-1
p805-hasan;3 within-subjects;3;-1
p805-hasan;35 were recruited;35;-1
p815-findlater;12 participants;12;-1
p815-findlater;20 participants;20;-1
p815-findlater;8 participants;8;-1
p815-findlater;5   participants;5;-1
p815-findlater;3 within-subjects;3;-1
p815-findlater;N=36;36;-1
p815-findlater;N=24;24;-1
p829-jung;N = 16;16;9219
p829-jung;total of 146;146;3398
p839-xu;6 women;6;-1
p839-xu;1,445 responses from the participants;1445;-1
p839-xu;6 provides an overview of the participants;6;-1
p839-xu;n = 60;60;-1
p839-xu;n=1184;1184;-1
p839-xu;n=1217;1217;-1
p839-xu;n=1445;1445;-1
p839-xu;n = 1095;1095;-1
p849-mcduff;23 cases   where participants;23;-1
p849-mcduff;6 participants;6;-1
p849-mcduff;62 people;62;-1
p849-mcduff;n=3;3;-1
p849-mcduff;n=5;5;-1
p849-mcduff;n=4;4;-1
p859-slovak;8 women;8;-1
p859-slovak;6 women;6;-1
p859-slovak;13 pairs  of participants;13;-1
p869-waern;1 and now attracts new participants;1;-1
p879-dabbish;457 participants;457;-1
p879-dabbish;4 participants;4;-1
p879-dabbish;1 million people;1;-1
p879-dabbish;total of 457;457;-1
p889-vankleek;101 participants;101;-1
p889-vankleek;7 people;7;-1
p89-schild;60 participants;60;-1
p89-schild;40 participants;40;-1
p89-schild;51 participants;51;-1
p899-haque;22,000 new BC   patients;22000;-1
p899-haque;45 rural   BC patients;45;-1
p899-haque;1,405 patients;1405;-1
p899-haque;21 patients;21;-1
p899-haque;39 BC   patients;39;-1
p899-haque;7   patients;7;-1
p899-haque;10 BC patients;10;-1
p899-haque;10 patients;10;-1
p899-haque;15 other patients;15;-1
p899-haque;39 BC patients;39;-1
p899-haque;45 BC patients;45;-1
p899-haque;21   other patients;21;-1
p899-haque;3   patients;3;-1
p899-haque;6 patients;6;-1
p899-haque;29 visits of other   BC patients;29;-1
p899-haque;30 SMSs patients;30;-1
p899-haque;43 patients;43;-1
p899-haque;2 different   classes of people;2;-1
p899-haque;total of 107;107;-1
p899-haque;total of 40;40;-1
p919-comber;501 geriatric patients;501;-1
p919-comber;total of 16;16;-1
p947-brynjarsdottir;52 participants;52;-1
p977-sae-bae;34 participants;34;-1
p977-sae-bae;18 participants;18;-1
p977-sae-bae;26 participants;26;-1
p977-sae-bae;29 participants;29;-1
p977-sae-bae;28 participants;28;-1
p987-deluca;48 participants;48;-1
p987-deluca;38 participants;38;-1
p987-deluca;34 participants;34;-1
p987-deluca;31 participants;31;-1
p987-deluca;19 participants;19;-1
p987-deluca;31 valid   participants;31;-1
p987-deluca;26 participants;26;-1
p987-deluca;3 participants;3;-1
p987-deluca;3 accuracies of participants;3;-1
p987-deluca; data of the 31;31;-1
p987-deluca; data of 26;26;-1
p99-parker;43 participants;43;-1
p99-parker;20 participants;20;-1
p99-parker;10 participants;10;-1
p99-parker;n=22;22;-1
p99-parker;n=10;10;-1
p99-parker;n=5;5;-1
p99-parker;n=1;1;-1
p99-parker;n=28;28;-1
p99-parker;n=9;9;-1
p99-parker;n=3;3;-1
p99-parker;n=19;19;-1
p99-parker;n=20;20;-1
p99-parker;n=0;0;-1
p99-parker;n=30;30;-1
p99-parker;total of 1585;1585;-1
p997-hayashi;59 participants;59;-1
p997-hayashi;20 participants;20;-1
p997-hayashi;35 participants;35;-1
p997-hayashi;10   participants;10;-1
p1-zhao;13 participants;13;-1
p1-zhao;13 people;13;-1
p1-zhao;total of 13;13;-1
p1001-szafir;2 between-participants;2;-1
p1001-szafir;48 participants;48;-1
p1001-szafir;total of 48;48;-1
p1011-kuksenok;total of 40;40;-1
p1041-devendorf;5 participants;5;-1
p1041-devendorf;10 participants;10;-1
p1041-devendorf;26 people;26;-1
p1041-devendorf;16 people;16;-1
p1041-devendorf;10 people;10;-1
p1041-devendorf;total of 16;16;-1
p1071-isaacs;5 women;5;-1
p1071-isaacs;17 women;17;-1
p1071-isaacs;43 participants;43;-1
p1071-isaacs;10 participants;10;-1
p1071-isaacs;6 participants;6;-1
p1071-isaacs;4 participants;4;-1
p1071-isaacs;30 participants;30;-1
p1071-isaacs;38 participants;38;-1
p1071-isaacs;33   participants;33;-1
p1071-isaacs;17 Recording group   participants;17;-1
p1071-isaacs;16 Reflection participants;16;-1
p1081-rice;12 participants;12;-1
p1081-rice;60 participants;60;-1
p1081-rice;20 participants;20;-1
p1081-rice;36 older adults;36;-1
p109-rau;N = 429;429;-1
p109-rau;N = 428;428;-1
p109-rau;N = 169;169;-1
p109-rau;total of   599;599;-1
p109-rau;total of 10;10;-1
p1091-warnock;15 participants;15;-1
p1095-bentley;60   participants;60;-1
p1099-nacenta;33 participants;33;-1
p1099-nacenta;18 participants;18;-1
p1099-nacenta;total of 22;22;-1
p11-jung;98 lab participants;98;-1
p11-jung;457    Meeting   new   people;457;-1
p11-jung;1 There are several people;1;-1
p11-jung;9 I do not know people;9;-1
p11-jung;7 New people;7;-1
p11-jung;N=98;98;-1
p11-jung;N=22;22;-1
p11-jung;N=76;76;-1
p11-jung;total of 98;98;-1
p1109-anderson;36 subjects;36;-1
p1109-anderson;total of 36;36;-1
p1109-anderson;total of 10;10;-1
p1119-annett;20 participants;20;-1
p1129-oh;20 participants;20;-1
p1129-oh;9 gesture features   participants;9;-1
p1129-oh;2 we also asked participants;2;-1
p1129-oh;14   participants;14;-1
p1129-oh;14 participants;14;-1
p1129-oh;6 participants;6;-1
p1129-oh;9 participants;9;-1
p1129-oh;13 participants;13;-1
p1129-oh;18 participants;18;-1
p1129-oh;3   participants;3;-1
p1129-oh;N = 17;17;-1
p1129-oh;N=20;20;-1
p1129-oh;N = 238;238;-1
p1129-oh;N = 20;20;-1
p1129-oh;total of 244;244;-1
p1139-monserrat;15 participants;15;-1
p1139-monserrat;5 participants;5;-1
p1139-monserrat;14 new participants;14;-1
p1139-monserrat;total of 4;4;-1
p1159-matejka;3 participants;3;2341
p1159-matejka;12 participants;12;1091
p1159-matejka;total of 128;128;2135
p1159-matejka;total of 16;16;8984
p1169-nguyen;10 participants;10;-1
p1173-rodden;5 participants;5;-1
p1173-rodden;17 participants;17;-1
p1183-neustaedter;13   For other participants;13;-1
p1183-neustaedter;15   Several participants;15;-1
p1183-neustaedter;20 people;20;-1
p1193-schwartz;46 participants;46;-1
p1193-schwartz;16 participants;16;-1
p1203-erickson;4 women;4;-1
p1203-erickson;18   participants;18;-1
p1203-erickson;561   participants;561;-1
p1203-erickson;116   participants;116;-1
p1203-erickson;266 participants;266;-1
p1213-salivia;16 participants;16;-1
p1213-salivia;16 of the participants;16;-1
p1213-salivia;14 participants;14;-1
p1213-salivia;5  where participants;5;-1
p1213-salivia;3 Cerebral Palsy patients;3;-1
p1213-salivia;3 Carpal Tunnel Syndrome patients;3;-1
p1213-salivia;2 other individuals;2;-1
p1213-salivia;2 other individuals were recruited;2;-1
p1213-salivia;total of 69;69;-1
p1213-salivia;total of 553;553;-1
p1223-anthony;12 participants;12;-1
p1223-anthony;15 participants;15;-1
p1223-anthony;11   participants;11;-1
p1223-anthony;12 survey participants;12;-1
p1223-anthony;6 people;6;-1
p1223-anthony;5 people;5;-1
p1223-anthony;4 were adults;4;-1
p1223-anthony;N = 60;60;-1
p1223-anthony;N = 8;8;-1
p1223-anthony;n = 1;1;-1
p1223-anthony;N = 187;187;-1
p1223-anthony;total of 480;480;-1
p1233-uzor;4 participants;4;-1
p1233-uzor;3 participants;3;-1
p1233-uzor;2 participants;2;-1
p1243-boulanger;800,000   people;800000;-1
p1243-boulanger;N=6;6;-1
p1243-boulanger;N=5;5;-1
p1247-ananthanarayan;6 participants;6;-1
p1247-ananthanarayan;4 participants;4;-1
p1247-ananthanarayan;2 participants;2;-1
p1251-macvean;19 participants;19;-1
p1251-macvean;12 participants;12;-1
p1251-macvean;4 participants;4;-1
p1261-hernandez;800,000 people;800000;-1
p1261-hernandez;total of   59;59;-1
p1279-jung;28 participants;28;-1
p1279-jung;3 participants;3;-1
p129-jacobs; data from 1959;1959;-1
p129-jacobs; data from   1959;1959;-1
p1299-wagner;total of 20480;20480;-1
p1299-wagner;total of 375;375;-1
p1309-velloso;10 participants;10;-1
p1309-velloso;n = 31;31;-1
p1309-velloso;n = 5;5;-1
p1309-velloso;n = 4;4;-1
p1319-pece;36  unpaid participants;36;-1
p1319-pece;total of 36;36;-1
p1329-norris;28 participants;28;-1
p1329-norris;19    Here participants;19;-1
p1329-norris;n=   4;4;-1
p1329-norris;total of 28;28;-1
p1329-norris;total of 6;6;-1
p1329-norris;total of 4;4;-1
p1343-faste;total of 51;51;-1
p1363-bi;12 participants;12;-1
p1363-bi;11 participants;11;-1
p1373-banovic;18 participants;18;-1
p1373-banovic;n=969;969;-1
p1373-banovic;n=1133;1133;-1
p1373-banovic;n=1178;1178;-1
p1373-banovic;n=924;924;-1
p1373-banovic;n=964;964;-1
p1373-banovic;n=973;973;-1
p1373-banovic;n=952;952;-1
p1373-banovic;n=999;999;-1
p1373-banovic;n=1002;1002;-1
p1373-banovic;n=0;0;-1
p1373-banovic;N=54;54;-1
p1373-banovic;N=36;36;-1
p1383-aceituno;12 participants;12;-1
p1383-aceituno;3 participants;3;-1
p1401-puppendahl;18 participants;18;-1
p1401-puppendahl;n = 1;1;-1
p1441-leithinger;10 participants;10;-1
p1441-leithinger;3 participants;3;-1
p1441-leithinger;total of 10;10;-1
p1451-perrault;30 women;30;-1
p1451-perrault;12 participants;12;-1
p1451-perrault;3 participants;3;-1
p1451-perrault;3 within-  subjects;3;-1
p1451-perrault;total of   36;36;-1
p1451-perrault;total of   10;10;-1
p1451-perrault;total of 45;45;-1
p1465-pohl;total of 50;50;-1
p1469-vonzadow;total of 18;18;-1
p1479-mentis;total of 25;25;-1
p1489-bird;90,000 individuals;90000;-1
p1489-bird;total of 10;10;-1
p149-fosh;29   participants;29;-1
p149-fosh;29   people;29;-1
p149-fosh;17 visitors were recruited;17;-1
p149-fosh;12 were recruited;12;-1
p1499-mirza-babaei;24 participants;24;-1
p1499-mirza-babaei;24   participants;24;-1
p1499-mirza-babaei;   data.  Proc. of CHI'12;12;-1
p1519-bowser;48 participants;48;-1
p1519-bowser;5 participants;5;-1
p1519-bowser;total of 6;6;-1
p1529-hansen;total of 15;15;-1
p1539-ogonowski;27 participants;27;-1
p1539-ogonowski;15   participants;15;-1
p1539-ogonowski;12 participants;12;-1
p1539-ogonowski;27   participants;27;-1
p1539-ogonowski;8 participants;8;-1
p1539-ogonowski;10 less technically adept   participants;10;-1
p1559-chong;61 participants;61;-1
p1559-chong;28 people;28;-1
p1559-chong;n=3;3;-1
p1559-chong;n=2;2;-1
p1559-chong;N=1877;1877;-1
p1559-chong;total of 496;496;-1
p1569-brown;16 participants;16;2151
p1579-prior;2 Gathering of   participants;2;-1
p1579-prior;4 adults;4;-1
p1589-jacobs;17   participants;17;-1
p159-teather;4 within-subjects;4;-1
p159-teather;3 within-subjects;3;-1
p159-teather;total of 1920;1920;-1
p159-teather;total of 30720;30720;-1
p159-teather;total of 2592;2592;-1
p159-teather;total of   31104;31104;-1
p1599-yang;14 participants;14;-1
p1599-yang;4 participants;4;-1
p1609-kuttal;16 participants;16;-1
p1609-kuttal;16  participants;16;-1
p1619-thiry;total of 334;334;-1
p1629-mankoff;total of 205;205;-1
p1659-obrist;14 participants;14;-1
p1659-obrist;16Hz participants;16;-1
p1659-obrist;250Hz participants;250;-1
p1659-obrist;250Hz thus participants;250;-1
p1659-obrist;total of 14;14;-1
p1659-obrist;total of 247;247;-1
p1659-obrist;total of 272;272;-1
p1669-atkinson;30 participants;30;-1
p1669-atkinson;50 female participants;50;-1
p1669-atkinson;10 participants;10;-1
p1669-atkinson;total of 14;14;-1
p1669-atkinson;total of 21;21;-1
p1679-park;total   of 600;600;-1
p1689-tam;5 participants;5;-1
p1689-tam;78   participants;78;-1
p169-schild;3D   d prior exper  e participants;3;-1
p169-schild;n=16;16;-1
p169-schild;n=30;30;-1
p169-schild;n=1;1;-1
p1699-kukka;10 participants;10;-1
p1699-kukka;233 people;233;-1
p1699-kukka;n=32;32;-1
p1699-kukka;N=32;32;-1
p1699-kukka;N = 924;924;-1
p1699-kukka;N=920;920;-1
p1699-kukka;total of 1863;1863;-1
p1709-alt;20 participants;20;-1
p1709-alt;20 subjects;20;-1
p1709-alt;n=7;7;-1
p1719-schmidt;14 participants;14;-1
p1719-schmidt;10 participants;10;-1
p1719-schmidt;total of 10;10;-1
p1729-beyer;205   people;205;-1
p1729-beyer;20 people;20;-1
p1729-beyer;total of 4;4;-1
p1729-beyer;total of 79;79;-1
p1729-beyer;total   of 59;59;-1
p1739-sun;100 patients;100;-1
p1739-sun;3 patients;3;-1
p1739-sun;65 patients;65;-1
p1739-sun;409 threads had patients;409;-1
p1739-sun;3    When patients;3;-1
p1739-sun;100   patients;100;-1
p1739-sun;100 randomly selected patients;100;-1
p1739-sun;total of 1172;1172;-1
p1749-curmi;3 participants;3;-1
p1749-curmi;total of 164;164;-1
p1749-curmi;total of 17;17;-1
p1749-curmi;total of 24;24;-1
p1749-curmi;total   of 12;12;-1
p1759-pang;17 participants;17;-1
p1759-pang;10 people;10;-1
p1759-pang;3   groups of people;3;-1
p1759-pang;97 people;97;-1
p1759-pang;13 individuals;13;-1
p1759-pang;n = 3;3;-1
p1759-pang;n = 2;2;-1
p1769-yun;9 participants;9;-1
p1769-yun;21 participants;21;-1
p1769-yun;300 asthmatic subjects;300;-1
p1769-yun;300   asthma patients;300;-1
p1769-yun;26 patients;26;-1
p1769-yun;15,000 patients;15000;-1
p1769-yun;21   pediatric asthma patients;21;-1
p1769-yun;30 pediatric   patients;30;-1
p1769-yun;1 patients;1;-1
p1769-yun;200 million people;200;-1
p1769-yun;16 young adults;16;-1
p1769-yun;1 Review   Patients were recruited;1;-1
p1769-yun;n=118;118;-1
p1769-yun;n=115;115;-1
p1769-yun;total of 2095;2095;-1
p1769-yun;1 were enrolled;1;-1
p1779-lafreniere;16 participants;16;-1
p1779-lafreniere;N = 64;64;-1
p1779-lafreniere;N = 16;16;-1
p1789-leitner;20 participants;20;-1
p1789-leitner;18 participants;18;-1
p1789-leitner;2 female participants;2;-1
p1789-leitner;8 participants;8;-1
p1789-leitner;8   participants;8;-1
p1789-leitner;6 participants;6;-1
p1789-leitner;total of 4,283;4283;-1
p179-sodhi;8 participants;8;-1
p179-sodhi;n=3;3;-1
p179-sodhi;n=4;4;-1
p1809-wilfinger;20 participants;20;-1
p1809-wilfinger;13  participants;13;-1
p1809-wilfinger;36 participants;36;-1
p1809-wilfinger;n=20;20;-1
p1813-gulotta;7   women;7;-1
p1813-gulotta;10 adults;10;-1
p1823-sas;24 people;24;-1
p1823-sas;n = 42;42;-1
p1823-sas;n = 2;2;-1
p1823-sas;n = 1;1;-1
p1833-odom;48 participants;48;-1
p1833-odom;48 young adults;48;-1
p1843-weilenmann;16 participants;16;-1
p1843-weilenmann;16 of the recruited participants;16;-1
p1843-weilenmann;16 individuals;16;-1
p1843-weilenmann;16 individuals recruited;16;-1
p1843-weilenmann;16 of the recruited;16;-1
p1883-moncur;n=2;2;-1
p1883-moncur;n=1;1;-1
p1883-moncur;n=3;3;-1
p1883-moncur;n=5;5;-1
p1883-moncur;n=10;10;-1
p1883-moncur;n=4;4;-1
p1883-moncur;n=6;6;-1
p189-lee;total of 12;12;-1
p1891-doucette;32 participants;32;-1
p1901-deckers;24 participants;24;-1
p1901-deckers;N=12;12;-1
p1901-deckers;N=24;24;-1
p1901-deckers;n=7;7;-1
p1901-deckers;n=14;14;-1
p1911-cafaro;2 people;2;-1
p1911-cafaro;60 people;60;-1
p1911-cafaro;4 tests   people;4;-1
p1911-cafaro;total of 80;80;-1
p1921-rae;20  and remote participants;20;-1
p1921-rae;2 told remote  participants;2;-1
p1921-rae;58 adults;58;-1
p1921-rae;n = 29;29;-1
p1921-rae;total of 58;58;-1
p1921-rae;total of 22;22;-1
p193-ortega;4 participants;4;-1
p1941-oleary;20 participants;20;-1
p1941-oleary;50 people;50;-1
p1941-oleary;8 people;8;-1
p1941-oleary;6 people;6;-1
p1941-oleary;2Speech were not recruited;2;-1
p1955-bauer;5 people;5;-1
p1955-bauer;total of 240;240;-1
p1959-wyche;11 women;11;-1
p1959-wyche;2 women;2;-1
p1959-wyche;4 billion people;4;-1
p1959-wyche;10 people;10;-1
p1959-wyche;13 individuals;13;-1
p1969-shrinivasan;11 participants;11;-1
p1969-shrinivasan;45 people;45;-1
p1979-wulf;2012 there were already more persons;2012;-1
p1979-wulf;1990s where Palestinian   people;1990;-1
p1979-wulf;200 people;200;-1
p1979-wulf;total of 791;791;-1
p1999-chilton;5   people;5;-1
p1999-chilton;n=64;64;-1
p2009-settles;7,000 participants;7000;-1
p2009-settles;n = 226;226;-1
p2009-settles;n = 45;45;-1
p2009-settles;n = 30;30;-1
p2009-settles;n = 151;151;-1
p2009-settles;n = 195;195;-1
p2009-settles;n = 80;80;-1
p2019-pace;N = 300;300;-1
p2019-pace;N   = 300;300;-1
p2029-fields;20 million people;20;-1
p2033-lasecki;24  local participants;24;-1
p2033-lasecki;24 local participants;24;-1
p2033-lasecki;139 unique workers recruited;139;-1
p2033-lasecki;N = 4;4;-1
p2033-lasecki;total of 206;206;-1
p2049-reinecke;22  participants;22;-1
p2049-reinecke;8 participants;8;-1
p2049-reinecke;184 participants;184;-1
p2049-reinecke;122 participants;122;-1
p2049-reinecke;2 across all participants;2;-1
p2049-reinecke;69 across all participants;69;-1
p2049-reinecke;500 participants;500;-1
p2049-reinecke;306  participants;306;-1
p2049-reinecke;242 participants;242;-1
p2049-reinecke;n = 21;21;-1
p2049-reinecke;n = 32;32;-1
p2049-reinecke;N = 367;367;-1
p2049-reinecke;  data consist of 184;184;-1
p2059-hart;N=40;40;-1
p2059-hart;N=5;5;-1
p2059-hart;n   =8;8;-1
p2059-hart;n =6;6;-1
p2059-hart;n =2;2;-1
p2059-hart;n =7;7;-1
p2059-hart;n =4;4;-1
p2059-hart;total of 11;11;-1
p2059-hart;total of 366;366;-1
p2059-hart;total of 181;181;-1
p2059-hart;total of 80;80;-1
p2059-hart;total of 56;56;-1
p2069-flatla;24 male participants;24;-1
p2069-flatla;24 new participants;24;-1
p2069-flatla;n =  1;1;-1
p207-komarov;100 participants;100;-1
p207-komarov;14 participants;14;-1
p207-komarov;96 MTurk participants;96;-1
p207-komarov;6 participants;6;-1
p207-komarov;90 participants;90;-1
p207-komarov;92 participants;92;-1
p207-komarov;13 participants;13;-1
p207-komarov;123 MTurk participants;123;-1
p207-komarov;9 MTurk participants;9;-1
p207-komarov;114 participants;114;-1
p207-komarov;283  MTurk participants;283;-1
p207-komarov;35 participants;35;-1
p207-komarov;290 participants;290;-1
p207-komarov;14 subjects;14;-1
p207-komarov;n = 324;324;-1
p207-komarov; data from 283;283;-1
p207-komarov; data from 35;35;-1
p2079-tuch;500 participants;500;-1
p2079-tuch;45 participants;45;-1
p2079-tuch;938 participants;938;-1
p2079-tuch;15 participants;15;-1
p2079-tuch;N = 368;368;-1
p2079-tuch;N = 323;323;-1
p2079-tuch;n = 30;30;-1
p2079-tuch;N = 338;338;-1
p2079-tuch;N = 691;691;-1
p2079-tuch;N=323;323;-1
p2079-tuch;N=368;368;-1
p2079-tuch;n = 145;145;-1
p2079-tuch;n = 199;199;-1
p2079-tuch;N=145;145;-1
p2079-tuch;N=199;199;-1
p2079-tuch;total of 938;938;-1
p2089-hedegaard;N = 4;4;-1
p2089-hedegaard;total of 6655;6655;-1
p2099-lewis;n = 273;273;-1
p2099-lewis;n = 285;285;-1
p2099-lewis;n = 402;402;-1
p2099-lewis;n = 389;389;-1
p2099-lewis;n = 791;791;-1
p21-bernstein;n = 457;457;-1
p21-bernstein;n = 60;60;-1
p21-bernstein;n = 99;99;-1
p21-bernstein;n = 24;24;-1
p21-bernstein;n = 17;17;-1
p21-bernstein;n = 137;137;-1
p21-bernstein;n = 283;283;-1
p21-bernstein;N=295;295;-1
p21-bernstein;N=270;270;-1
p21-bernstein;n = 20;20;-1
p21-bernstein;n =  12;12;-1
p2103-sko;1300 participants;1300;-1
p2103-sko;1300 formal test  participants;1300;-1
p2103-sko;900 participants;900;-1
p2103-sko;total of  900;900;-1
p2107-paneels;2 participants;2;-1
p2117-brady;N=27;27;-1
p2127-harada;47 people;47;-1
p2137-bohmer;130 participants;130;-1
p2137-bohmer;22 participants;22;-1
p2137-bohmer;10 participants;10;-1
p2137-bohmer;76 participants;76;-1
p2137-bohmer;6All iPhone participants;6;-1
p2137-bohmer;29 participants;29;-1
p2137-bohmer;82 participants;82;-1
p2137-bohmer;26 participants;26;-1
p2137-bohmer;6 participants;6;-1
p2137-bohmer;1,400 screenshots of our participants;1400;-1
p2137-bohmer;83 subjects;83;-1
p2137-bohmer;132 people;132;-1
p2137-bohmer;n = 3;3;-1
p2137-bohmer;N = 101;101;-1
p2137-bohmer; data from 132;132;-1
p2147-shahreza;48 participants;48;-1
p2147-shahreza;total of 48;48;-1
p2157-wiese;11 women;11;-1
p2157-wiese;693   participants;693;-1
p2157-wiese;32   participants;32;-1
p2157-wiese;15 participants;15;-1
p2157-wiese;600   participants;600;-1
p2157-wiese;650 participants;650;-1
p2157-wiese;920 locations participants;920;-1
p2157-wiese;28 participants;28;-1
p2157-wiese;93 OWork participants;93;-1
p2157-wiese;32 participants;32;-1
p2157-wiese;31 participants;31;-1
p2157-wiese;23 participants;23;-1
p2157-wiese;24 participants;24;-1
p2157-wiese;29 participants;29;-1
p2157-wiese;26 participants;26;-1
p2157-wiese;18 participants;18;-1
p2157-wiese;13 participants;13;-1
p2157-wiese;9 participants;9;-1
p2157-wiese;419 people;419;-1
p2157-wiese;537 people;537;-1
p2157-wiese;N=650;650;-1
p2157-wiese;N=693;693;-1
p2157-wiese;N=380;380;-1
p2157-wiese;N=169;169;-1
p2157-wiese;total of 93;93;-1
p2157-wiese; data from 693;693;-1
p2157-wiese; data in-situ from 32;32;-1
p2157-wiese; data from 15;15;-1
p2157-wiese; data from 32;32;-1
p2157-wiese; data from   32;32;-1
p2157-wiese;   data from 15;15;-1
p2167-xu;18 participants;18;-1
p2167-xu;21 participants;21;-1
p2167-xu;6   participants;6;-1
p2167-xu;9 participants;9;-1
p2167-xu;15 participants;15;-1
p2167-xu;6 participants;6;-1
p2167-xu;18   participants;18;-1
p217-chilana;7 people;7;-1
p217-chilana;n=121;121;-1
p217-chilana;n=33;33;-1
p217-chilana;n=9;9;-1
p217-chilana;n=5;5;-1
p217-chilana;N=121;121;-1
p2171-warr;14 participants;14;-1
p2171-warr;3 participants;3;-1
p2171-warr;3 within-subjects;3;-1
p2171-warr;N=13;13;-1
p2185-laput;14 participants;14;-1
p2185-laput;total of 386;386;-1
p2195-mcpherson;5 participants;5;11457
p2195-mcpherson;7 were currently enrolled;7;12999
p2213-akpan;30 participants;30;-1
p2213-akpan;1647 people;1647;-1
p2213-akpan;600 children and adults;600;-1
p2223-pohl;12 participants;12;-1
p2233-xu;4 persons;4;-1
p2233-xu;23 participants;23;-1
p2233-xu;28 participants;28;-1
p2233-xu;2 subjects;2;-1
p2233-xu;3 subjects;3;-1
p2233-xu;4 subjects;4;-1
p2243-lanir;20 participants;20;7055
p2243-lanir;N = 20;20;4562
p2253-zhu;959   # of people;959;-1
p2253-zhu;106 362   # of people;106362;-1
p2253-zhu;45 183   # of people;45183;-1
p2253-zhu;48 164   # of people;48164;-1
p2253-zhu;47 126   # of people;47126;-1
p2263-houben;145 participants;145;-1
p2273-voida;24   individuals;24;-1
p2287-cassidy;16 participants;16;-1
p2287-cassidy;n = 2;2;-1
p2291-jota;45 participants;45;-1
p2291-jota;total of 288;288;-1
p2291-jota;total of 10;10;-1
p2301-drucker;6   women;6;-1
p2301-drucker;17 participants;17;-1
p2301-drucker;n=47;47;-1
p2311-nebeling;84 participants;84;-1
p2311-nebeling;13 participants;13;-1
p2311-nebeling;50 participants;50;-1
p2311-nebeling;39 participants;39;-1
p2311-nebeling;total of 84;84;-1
p2325-roy;total   of 7;7;-1
p2325-roy;total of 2;2;-1
p2329-fitchett;n = 3;3;-1
p2329-fitchett;n = 5;5;-1
p2339-van-kleek;8 participants;8;-1
p2339-van-kleek;3 participants;3;-1
p2339-van-kleek;4 participants;4;-1
p2339-van-kleek;20 participants;20;-1
p2339-van-kleek;5 studying other subjects;5;-1
p2339-van-kleek;total of 20;20;-1
p2349-monroe;20 participants;20;-1
p2349-monroe;500 patients;500;-1
p2359-liao;28 participants;28;-1
p2359-liao;224   cases participants;224;-1
p2369-egelman;87 eligible participants;87;-1
p2369-egelman;65 participants;65;-1
p2369-egelman;45 participants;45;-1
p2369-egelman;14 participants;14;-1
p2369-egelman;12 participants;12;-1
p2369-egelman;36 participants;36;-1
p2369-egelman;38 participants;38;-1
p2369-egelman;34 participants;34;-1
p2369-egelman;32 participants;32;-1
p2369-egelman;65 subjects;65;-1
p2369-egelman;250 million  people;250;-1
p2369-egelman;250 million people;250;-1
p237-steimle;10 volunteer participants;10;-1
p237-steimle;5   participants;5;-1
p237-steimle;10 participants;10;-1
p237-steimle; data of hands from 10;10;-1
p2379-egelman;47 participants;47;-1
p2379-egelman;51 participants;51;-1
p2379-egelman;4 participants;4;-1
p2379-egelman;40 participants;40;-1
p2379-egelman;200 participants;200;-1
p2379-egelman;541 participants;541;-1
p2379-egelman;763 participants;763;-1
p2379-egelman;5We excluded participants;5;-1
p2379-egelman;2 PPM  All participants;2;-1
p2379-egelman;331 participants;331;-1
p2379-egelman;218 participants;218;-1
p2379-egelman;37 participants;37;-1
p2379-egelman;n = 51;51;-1
p2379-egelman;n=15;15;-1
p2379-egelman;n=16;16;-1
p2379-egelman;n = 541;541;-1
p2379-egelman;n = 331;331;-1
p2379-egelman;n = 244;244;-1
p2379-egelman;total of 541;541;-1
p2389-de-luca;20 participants;20;-1
p2389-de-luca;24 participants;24;-1
p2389-de-luca;21 participants;21;-1
p2389-de-luca;n = 24;24;-1
p2399-de-luca;16 participants;16;-1
p2399-de-luca;20 of those participants;20;-1
p2399-de-luca;20 participants;20;-1
p2399-de-luca;13 participants;13;-1
p2399-de-luca;19 participants;19;-1
p2399-de-luca;39 people;39;-1
p2403-wiseman;total of 42;42;2188
p2407-kulkarni;560 participants;560;-1
p2407-kulkarni;252 participants;252;-1
p2407-kulkarni;59 participants;59;-1
p2407-kulkarni;8 participants;8;-1
p2407-kulkarni;2 Between-subjects;2;-1
p2407-kulkarni;110 people;110;-1
p2407-kulkarni;N = 560;560;-1
p2407-kulkarni;N = 308;308;-1
p2407-kulkarni;N = 59;59;-1
p2407-kulkarni;n=3;3;-1
p2407-kulkarni;n=1;1;-1
p2407-kulkarni;n=2;2;-1
p2417-hillman;6    When participants;6;-1
p2417-hillman;3   While some participants;3;-1
p2417-hillman;7   Other participants;7;-1
p2417-hillman;15   Several participants;15;-1
p2417-hillman;17 people;17;-1
p2417-hillman;5 people;5;-1
p2417-hillman;18 people;18;-1
p2417-hillman;7   people;7;-1
p2417-hillman;1   In some instances people;1;-1
p2427-gilbert;903 people;903;-1
p2427-gilbert;N=588;588;-1
p2427-gilbert;N=672;672;-1
p2427-gilbert;N=955;955;-1
p2427-gilbert;total of 2;2;-1
p2427-gilbert; datasets of 217,174;217174;-1
p2437-parker;n=180;180;-1
p2437-parker;   database of 32;32;-1
p2447-clear;31 participants;31;-1
p2457-comber;n=7;7;-1
p2457-comber;n=10;10;-1
p2457-comber;n=5;5;-1
p2457-comber;n=6;6;-1
p2457-comber;n=4;4;-1
p2467-orji;total of 710;710;-1
p2467-orji; data from 3000;3000;-1
p2477-sen;10 trial primary participants;10;-1
p2477-sen;2 GB data plan and   charging participants;2;-1
p2477-sen;5 people;5;-1
p2477-sen;total of 155;155;-1
p2487-desa;56 participants;56;-1
p2487-desa;total of 56;56;-1
p2487-desa;total of 70;70;-1
p2497-lawson;3 women;3;10173
p2497-lawson;8 participants;8;3158
p2497-lawson;4 of the participants;4;3499
p2497-lawson;31 participants;31;5012
p2497-lawson;n = 10;10;1004
p2497-lawson;n = 82;82;99
p2497-lawson;n = 79;79;42
p2497-lawson;n = 31;31;3174
p2497-lawson;total of   147;147;12107
p2507-erete;15 participants;15;-1
p2507-erete;16 participants;16;-1
p2507-erete;4 participants;4;-1
p2507-erete;1 provides a full list of the participants;1;-1
p2507-erete;10 participants;10;-1
p2507-erete;15 people;15;-1
p2507-erete;total of 16;16;-1
p2517-clarke;6 South Asian   women;6;-1
p2517-clarke;5 of   the women;5;-1
p2517-clarke;3 of the women;3;-1
p2517-clarke;1 of the women;1;-1
p2527-yoo;20   individuals;20;-1
p2527-yoo;109 individuals;109;-1
p2527-yoo;109 Rwandan adults;109;-1
p2527-yoo;total of 109;109;-1
p2547-roudaut;12 right-handed participants;12;-1
p2547-roudaut;6 new participants;6;-1
p2547-roudaut;5min of game play participants;5;-1
p2547-roudaut;12 new right-handed participants;12;-1
p2547-roudaut;8 new right-handed participants;8;-1
p2547-roudaut;3 within-subjects;3;-1
p2557-fan;20 participants;20;-1
p2557-fan;20   participants;20;-1
p2557-fan;10 participants;10;-1
p2557-fan;9 participants;9;-1
p2557-fan;4 participants;4;-1
p2557-fan;5 participants;5;-1
p2557-fan;42 participants;42;-1
p2557-fan;3 people;3;-1
p2557-fan;total of 42;42;-1
p2567-lee;1 consisted of seven  participants;1;-1
p2567-lee;3 included four  participants;3;-1
p2567-lee;17 participants;17;-1
p257-lu;7 participants;7;-1
p257-lu;7   participants;7;-1
p2577-lopes;10 right-handed participants;10;-1
p2577-lopes;10 participants;10;-1
p2577-lopes;n=4;4;-1
p2577-lopes;n=3;3;-1
p2577-lopes;n=1;1;-1
p2577-lopes;n=5;5;-1
p2577-lopes;n= 3;3;-1
p2577-lopes;total of 132;132;-1
p2581-chen;11 participants;11;-1
p2581-chen; data   from 10;10;-1
p2593-jansen;16 participants;16;-1
p2593-jansen;4 participants;4;-1
p2593-jansen;16 subjects;16;-1
p2593-jansen;total of 13;13;-1
p2637-yamashita;15 individuals;15;-1
p2637-yamashita;n= 40;40;-1
p2637-yamashita;N=11;11;-1
p2637-yamashita;N=13;13;-1
p2657-kang;23 women;23;-1
p2657-kang;44 participants;44;-1
p2657-kang;44 people;44;-1
p2657-kang;N = 44;44;-1
p2667-knijnenburg;300 participants;300;-1
p2667-knijnenburg;N=291;291;-1
p2687-luger;8   million adults;8;-1
p2687-luger;total of 50;50;-1
p2697-correll;210 participants;210;23655
p2697-correll;109 female participants;109;23143
p2697-correll;20 participants;20;21093
p2697-correll;20 subjects;20;12597
p2697-correll;60 total subjects;60;989
p2697-correll;total of 40;40;20320
p2697-correll;total of 45;45;12510
p2697-correll;total of 36;36;840
p2707-hullman;10 subjects;10;-1
p2707-hullman;total of 393;393;-1
p2717-wang;18 undergraduate student participants;18;2007
p2717-wang;3 participants;3;1791
p2717-wang;15 participants;15;1703
p2717-wang;11 participants;11;6634
p2717-wang;n=60;60;83
p2717-wang;n=57;57;30
p2717-wang;n=2;2;1262
p2717-wang;n=1;1;1356
p2717-wang; data from 3;3;1802
p2717-wang; data   from 15;15;1716
p2725-hakansson;10 women;10;-1
p2725-hakansson;19   adults;19;-1
p2735-lomas;370 million people;370;-1
p2735-lomas;total of 11;11;-1
p2735-lomas;total of 24;24;-1
p2755-wyche;12 women;12;-1
p2755-wyche;10 additional   participants;10;-1
p2765-oulasvirta;N=6;6;-1
p2765-oulasvirta;N=20;20;-1
p2765-oulasvirta;total of 5;5;-1
p277-vatavu;8 participants;8;-1
p277-vatavu;N=40;40;-1
p2775-yin;12 participants;12;15534
p2775-yin;6 participants;6;14888
p2785-fuccella;12 participants;12;-1
p2785-fuccella;total of 13,653;13653;-1
p2785-fuccella;total of 12;12;-1
p2795-goel;16 participants;16;-1
p2795-goel;16   participants;16;-1
p2795-goel;6 participants;6;-1
p2795-goel;7 participants;7;-1
p2795-goel; data from 16;16;-1
p2803-ali-raza;50 participants;50;-1
p2803-ali-raza;1,000   new people;1000;-1
p2803-ali-raza;27,000 people;27000;-1
p2803-ali-raza;total of 1,023,824;1023824;-1
p2803-ali-raza;total of 530;530;-1
p2803-ali-raza;total of 23,288;23288;-1
p2813-medhi;60   participants;60;-1
p2813-medhi;60 participants;60;-1
p2813-medhi;7 test participants;7;-1
p2813-medhi;6   participants;6;-1
p2813-medhi;20 participants;20;-1
p2813-medhi;25 participants;25;-1
p2813-medhi;15 participants;15;-1
p2813-medhi;3 between-subjects;3;-1
p2813-medhi;800 million people;800;-1
p2813-medhi;8 people;8;-1
p2813-medhi;60 participants were recruited;60;-1
p2813-medhi;n = 60;60;-1
p2813-medhi;total of 40;40;-1
p2813-medhi;total of 9;9;-1
p2823-wyche;28 participants;28;-1
p2823-wyche;100 people;100;-1
p2823-wyche;28 young adults;28;-1
p2833-cuendet;10 women;10;-1
p2833-cuendet;2 women;2;-1
p2833-cuendet;23 participants;23;-1
p2833-cuendet;20 participants;20;-1
p2833-cuendet;total of 147;147;-1
p2833-cuendet;total of  23;23;-1
p2843-spaulding;10 research participants;10;-1
p285-stellmach;16 participants;16;-1
p2911-birnbaum;10 eligible participants;10;-1
p2911-birnbaum;28 participants;28;-1
p2911-birnbaum;total of 209;209;-1
p2911-birnbaum;total of 22;22;-1
p2911-birnbaum;total of 641;641;-1
p2911-birnbaum;total of 8;8;-1
p2911-birnbaum;total of 5;5;-1
p2921-gouveia;12 participants;12;-1
p2921-gouveia;12   participants;12;-1
p2921-gouveia;n = 15;15;-1
p2921-gouveia;n = 7;7;-1
p2921-gouveia;n = 16;16;-1
p2921-gouveia;n   =  42;42;-1
p2921-gouveia;n=1;1;-1
p2921-gouveia;n=4;4;-1
p2921-gouveia;n=2;2;-1
p2921-gouveia;n=5;5;-1
p2921-gouveia;n=3;3;-1
p2921-gouveia;total of 12;12;-1
p2921-gouveia;total of 274;274;-1
p2931-moller;n = 2;2;3830
p2931-moller;n = 10;10;3631
p2941-mcdonald;8 participants;8;-1
p2949-harrison;963 participants;963;24707
p2949-harrison;10  datasets and allowed participants;10;15862
p2949-harrison;40 participants;40;9536
p2949-harrison;41 participants;41;739
p2949-harrison;87 participants;87;1024
p2949-harrison;13 participants;13;1150
p2949-harrison;n = 40;40;9540
p2949-harrison;n = 197;197;1116
p2949-harrison;total of 9;9;11540
p2949-harrison;total of 16;16;5364
p2949-harrison;  datasets from 10;10;15494
p2959-ankolekar;16 participants;16;-1
p2959-ankolekar;5 control participants;5;-1
p2959-ankolekar;N=60;60;-1
p2959-ankolekar;N=53;53;-1
p2959-ankolekar;N=62;62;-1
p2959-ankolekar;N=15;15;-1
p2979-ichino;total of 42;42;-1
p2979-ichino;total of 51;51;-1
p2979-ichino;total of 22;22;-1
p2999-feild;48 participants;48;-1
p2999-feild;N=48;48;-1
p2999-feild;N=38;38;-1
p2999-feild;N=27;27;-1
p2999-feild;N=96;96;-1
p2999-feild;N=28;28;-1
p2999-feild;N=25;25;-1
p2999-feild;N=32;32;-1
p2999-feild;N=7;7;-1
p2999-feild;total of 12;12;-1
p3009-zhao;30   participants;30;-1
p3009-zhao;11 participants;11;-1
p3009-zhao;total of 95;95;-1
p3009-zhao;total of 837;837;-1
p3019-agapie;84 participants;84;-1
p3019-agapie;2 factorial between-subjects;2;-1
p3023-baxter;n = 35;35;-1
p3027-serrano;12 participants;12;-1
p3027-serrano;12 people;12;-1
p3027-serrano;N = 7;7;-1
p3027-serrano;N = 4;4;-1
p3027-serrano;N=5;5;-1
p3027-serrano;N = 5;5;-1
p3027-serrano;N = 6;6;-1
p3027-serrano;total of 22;22;-1
p3027-serrano;total of 12;12;-1
p3027-serrano;total of 64;64;-1
p3037-cheng;64 participants;64;10916
p3037-cheng;18 participants;18;2019
p3037-cheng;N=18;18;12246
p3037-cheng;total of 12;12;1749
p3037-cheng;total of 30;30;7861
p3051-cheng;6 participants;6;-1
p3051-cheng;N=16;16;-1
p3051-cheng;N=513;513;-1
p3051-cheng;total of 44;44;-1
p3051-cheng;total of 162000;162000;-1
p3051-cheng;total of 108;108;-1
p3051-cheng;total of 80;80;-1
p3051-cheng; data of 6;6;-1
p3063-piorkowski;9 participants;9;-1
p3063-piorkowski;total of 660;660;-1
p3073-kramer;33 subjects;33;3181
p3073-kramer;N = 1;1;7847
p3073-kramer;N = 10;10;7855
p3073-kramer;N = 20;20;7867
p3083-kumar;total of 480;480;-1
p309-lee;3 women;3;-1
p309-lee;total of 80;80;-1
p3093-grigoreanu;total of 22;22;-1
p3101-lin;160 different participants;160;-1
p3101-lin;40 participants;40;-1
p3101-lin;total of 1600;1600;-1
p3101-lin;total of 79;79;-1
p3111-ofek;24   pairs of participants;24;-1
p3111-ofek;N=16160;16160;-1
p3111-ofek;N =10816;10816;-1
p3111-ofek;N=10816;10816;-1
p3111-ofek;N=12169;12169;-1
p3111-ofek;N=11729;11729;-1
p3111-ofek;N=10712;10712;-1
p3111-ofek;N=1816;1816;-1
p3111-ofek;total   of 13;13;-1
p3111-ofek;total of 312;312;-1
p3111-ofek;total of 16771;16771;-1
p3111-ofek;total of 216;216;-1
p3121-gartenberg;22 participants;22;-1
p3121-gartenberg;45 participants;45;-1
p313-gibson;26 participants;26;-1
p313-gibson;N=42;42;-1
p313-gibson;N=43;43;-1
p313-gibson;N=6;6;-1
p3135-you;N = 121;121;-1
p3135-you;n = 62;62;-1
p3135-you;n =   56;56;-1
p3135-you;n = 56;56;-1
p3135-you;n = 52;52;-1
p3139-scarr;14 participants;14;-1
p3139-scarr;13   participants;13;-1
p3139-scarr;15 participants;15;-1
p3139-scarr;15 participants were recruited;15;-1
p3149-ion;6 fema  were recruited;6;-1
p3149-ion;n   =   1;1;-1
p3149-ion;total of 56;56;-1
p3173-kaufmann;56   participants;56;-1
p3177-marcu;n=14;14;-1
p3187-venkatesh;3  With more participants;3;-1
p3187-venkatesh;550  participants;550;-1
p3187-venkatesh;total of 51;51;-1
p3187-venkatesh;total of 326;326;-1
p3207-hong;total of 73;73;-1
p3217-perin;2 presents participants;2;-1
p3217-perin;9 participants;9;-1
p3217-perin;N=2;2;-1
p3217-perin;N=8;8;-1
p3217-perin;N=32;32;-1
p3227-matejka;total of 285;285;-1
p3227-matejka; dataset of 1335;1335;-1
p323-nicholson;65 participants;65;-1
p323-nicholson;172 university   participants;172;-1
p323-nicholson;2 participants;2;-1
p323-nicholson;3 participants;3;-1
p323-nicholson;36 younger   participants;36;-1
p323-nicholson;36 older participants;36;-1
p323-nicholson;n = 18;18;-1
p323-nicholson;n = 20;20;-1
p323-nicholson;n =   18;18;-1
p323-nicholson;n = 70;70;-1
p3237-fuchs;24 participants;24;-1
p3237-fuchs;24  participants;24;-1
p3237-fuchs;N = 32;32;-1
p3247-dunne;36 participants;36;-1
p3247-dunne;total of 31;31;-1
p3257-baumer;28 people;28;-1
p3257-baumer;N=410;410;-1
p3257-baumer;total  of  46;46;-1
p3267-de-choudhury;total of 36,948;36948;-1
p3267-de-choudhury;total of   40,426;40426;-1
p3277-sleeper;32 conversational-regret  participants;32;-1
p3277-sleeper;350  participants;350;-1
p3277-sleeper;1127 participants;1127;-1
p3277-sleeper;32 participants;32;-1
p3277-sleeper;78 participants;78;-1
p3277-sleeper;49 participants;49;-1
p3277-sleeper;98 Twitter-  regret participants;98;-1
p3277-sleeper;1,221 people;1221;-1
p3287-spiliotopoulos;3 of participants;3;-1
p3287-spiliotopoulos;96 participants;96;-1
p3287-spiliotopoulos;739   Finding people;739;-1
p3287-spiliotopoulos;817   Stalking other people;817;-1
p3287-spiliotopoulos;833   Viewing other people;833;-1
p3287-spiliotopoulos;3 of participants were   recruited;3;-1
p3287-spiliotopoulos;n = 159;159;-1
p3287-spiliotopoulos;n = 44;44;-1
p3287-spiliotopoulos;n = 5;5;-1
p3287-spiliotopoulos;n = 90;90;-1
p3287-spiliotopoulos;n = 79;79;-1
p3287-spiliotopoulos;n = 4;4;-1
p3287-spiliotopoulos;n = 2;2;-1
p3287-spiliotopoulos;total of 208;208;-1
p333-lauckner;310 participants;310;-1
p333-lauckner;2 within-subjects;2;-1
p333-lauckner;400 people;400;-1
p333-lauckner;40,000 people;40000;-1
p333-lauckner;310 participants were recruited;310;-1
p333-lauckner;N=274;274;-1
p3331-leahu;5 women;5;-1
p3331-leahu;12 participants;12;-1
p3335-schmidt;10 participants;10;-1
p3335-schmidt;12 participants;12;-1
p3345-wallace;84 of the participants;84;-1
p3345-wallace;4 participants;4;-1
p3355-jokela;24 participants;24;-1
p3355-jokela;24   participants;24;-1
p3355-jokela;total of 24;24;-1
p3365-segura;13 participants;13;-1
p3375-mentis;total of 20;20;-1
p3385-ramos;8 participants;8;-1
p3393-kelley;20 participants;20;-1
p3393-kelley;366 MTurk participants;366;-1
p3393-kelley;15 participants;15;-1
p3393-kelley;125 participants;125;-1
p3393-kelley;366 participants;366;-1
p3393-kelley;49 people;49;-1
p3393-kelley;n=10;10;-1
p3393-kelley;n=120;120;-1
p3393-kelley;n=123;123;-1
p3403-khovanskaya;23 participants;23;-1
p3403-khovanskaya;11 participants;11;-1
p3403-khovanskaya;15 participants;15;-1
p3413-yarosh;16   people;16;-1
p3423-ronen;255   participants;255;-1
p3423-ronen;118 participants;118;-1
p3423-ronen;44 participants;44;-1
p3423-ronen;12 participants;12;-1
p3423-ronen;575 people;575;-1
p3423-ronen;200   people;200;-1
p3423-ronen;n=94;94;-1
p3423-ronen;n=195;195;-1
p3423-ronen;n=196;196;-1
p3427-panjwani;25  participants;25;-1
p3427-panjwani;25 participants;25;-1
p3427-panjwani;6  Protocol  All participants;6;-1
p3427-panjwani;13  participants;13;-1
p3427-panjwani;6 participants;6;-1
p3427-panjwani;6  participants;6;-1
p3427-panjwani;total of 94;94;-1
p3427-panjwani;total of 13;13;-1
p343-findlater;40 participants;40;-1
p343-findlater;20 younger adults;20;-1
p343-findlater;20 adults;20;-1
p343-findlater;9 older adults;9;-1
p343-findlater;N = 39;39;-1
p343-findlater;N=20;20;-1
p343-findlater;N=19;19;-1
p3431-hering;4 participants;4;-1
p3431-hering;8   participants;8;-1
p3431-hering;8 participants;8;-1
p3451-gaver;7 participants;7;-1
p3461-valkanova;14 participants;14;-1
p3461-valkanova;14   participants;14;-1
p3461-valkanova;30 participants;30;-1
p3461-valkanova;20 people;20;-1
p3461-valkanova;N=198;198;-1
p3461-valkanova;N=344;344;-1
p3461-valkanova;N=33;33;-1
p3461-valkanova;N=74;74;-1
p3461-valkanova;N=58;58;-1
p3461-valkanova;N=145;145;-1
p3461-valkanova;N=172;172;-1
p3461-valkanova;N=184;184;-1
p3461-valkanova;N=309;309;-1
p3471-denef;300 people;300;-1
p3471-denef;200 people;200;-1
p3471-denef;1401 people;1401;-1
p3471-denef;150   people;150;-1
p3471-denef;2,000 people;2000;-1
p3471-denef;total of 6,125;6125;-1
p3471-denef;total of 371;371;-1
p3481-hu;132 people;132;-1
p35-shi;total of 1463;1463;-1
p351-huisman;36 female participants;36;2110
p351-huisman;31 participants;31;3577
p351-huisman;001  Once participants;1;8412
p351-huisman;N = 93;93;5428
p351-huisman;N = 82;82;2062
p351-huisman;total of 31;31;3568
p371-massung;16   participants;16;-1
p371-massung;48 participants;48;-1
p371-massung;16 participants;16;-1
p371-massung;18   participants;18;-1
p371-massung;n = 48;48;-1
p381-reitmaier;34 people;34;-1
p395-qu;1,081 people;1081;-1
p395-qu;268 people;268;-1
p395-qu;total of 128,845;128845;-1
p419-yoo;4 women;4;-1
p419-yoo;2 women;2;-1
p419-yoo;3 million people;3;-1
p439-green;10 student subjects;10;-1
p439-green;N = 432;432;-1
p439-green;N = 1296;1296;-1
p459-tausczik;621 individuals;621;-1
p473-peck;16 participants;16;-1
p473-peck;7 participants;7;-1
p473-peck;8 participants;8;-1
p483-alper;11 participants;11;-1
p483-alper;total of 96;96;-1
p49-liu;50 people;50;-1
p49-liu;total of 11,806;11806;-1
p49-liu;total of 54;54;-1
p503-muller;511 people;511;18831
p503-muller;5 activities of other people;5;16942
p503-muller;311 people;311;10741
p503-muller;5 brought   people;5;1148
p513-matthews;26 participants;26;-1
p513-matthews;13   participants;13;-1
p513-matthews; data from 45;45;-1
p533-lee;total  of 18,869,566;18869566;-1
p533-lee;total of 245;245;-1
p543-bi;40 participants;40;1852
p543-bi;40 subjects;40;5755
p553-kim;8   plots two extreme participants;8;-1
p553-kim;n   = 7;7;-1
p553-kim;total of 24058;24058;-1
p563-bailly;12 participants;12;-1
p563-bailly;20 participants;20;-1
p563-bailly;18   participants;18;-1
p563-bailly;15 participants;15;-1
p563-bailly;7 participants;7;-1
p563-bailly;n=29;29;-1
p563-bailly;n=28;28;-1
p583-gomes;14 participants;14;-1
p583-gomes;6 participants;6;-1
p583-gomes;6   participants;6;-1
p583-gomes;total of 17;17;-1
p607-warren;total of 108;108;-1
p621-huang;300 subjects;300;10953
p621-huang;50 subjects;50;1375
p621-huang;300 subjects were recruited;300;10953
p631-hara;6 million individuals;6;-1
p631-hara;N=2;2;-1
p631-hara;N=6;6;-1
p631-hara;N=3;3;-1
p631-hara;N=1000;1000;-1
p631-hara;N  =  142;142;-1
p631-hara;total of 402;402;-1
p631-hara;total of 13,379;13379;-1
p651-davis;20 participants;20;-1
p651-davis;2 participants;2;-1
p651-davis;n = 10;10;-1
p661-zhu;10 participants;10;-1
p661-zhu;400 people;400;-1
p661-zhu;2 people;2;-1
p671-edge;20 participants;20;-1
p671-edge;12 participants;12;-1
p671-edge;20 people;20;-1
p671-edge;8 people;8;-1
p681-liu;12 participants;12;-1
p685-birk;N=31;31;-1
p69-ban;15 right-handed  subjects;15;2792
p695-huang;300 participants;300;-1
p695-huang;200 matches as some people;200;-1
p695-huang;300 people;300;-1
p695-huang;70 people;70;-1
p695-huang;65 people;65;-1
p695-huang; data from 300;300;-1
p705-graham;20 participants;20;-1
p705-graham;total of 200;200;-1
p705-graham;total of 1,282;1282;-1
p705-graham;total of 24;24;-1
p715-peyton;N=4705;4705;-1
p715-peyton; data from our 14;14;-1
p725-branzel;12 participants;12;-1
p725-branzel;20 study participants;20;-1
p725-branzel;100 additional people;100;-1
p725-branzel;   databases of 20;20;-1
p725-branzel; data-  base of 120;120;-1
p725-branzel; data from a   1;1;-1
p725-branzel; data from 12;12;-1
p725-branzel; data   from 100;100;-1
p735-sutcliffe;23 of the participants;23;-1
p735-sutcliffe;total of 48;48;-1
p745-voelker;N=320;320;-1
p745-voelker;N=384;384;-1
p745-voelker;N=64;64;-1
p745-voelker;total of 64;64;-1
p755-mollers;10 right-handed participants;10;-1
p755-mollers;14 right-handed people;14;-1
p763-denny;111 study a common  set of subjects;111;-1
p763-denny;n=516;516;-1
p763-denny;n=515;515;-1
p763-denny;n = 516;516;-1
p763-denny;total of 1031;1031;-1
p763-denny;total of 2620;2620;-1
p763-denny;total of 519;519;-1
p763-denny;total of 26;26;-1
p763-denny;total of 22;22;-1
p763-denny;1031 students enrolled;1031;-1
p783-farzan;total of 36;36;-1
p783-farzan;total of 840;840;-1
p797-birnholtz;N=175;175;-1
p797-birnholtz;N=111;111;-1
p797-birnholtz;180 enrolled;180;-1
p797-birnholtz;137 enrolled;137;-1
p801-starbird;44   patients;44;-1
p801-starbird;800 patients;800;-1
p801-starbird;200 injured patients;200;-1
p801-starbird;200 patients;200;-1
p801-starbird;300,000 injured people;300000;-1
p811-lee;10   participants;10;-1
p811-lee;932 participants;932;-1
p811-lee;173 participants;173;-1
p811-lee;759   participants;759;-1
p811-lee;759 participants;759;-1
p811-lee;932 participants were recruited;932;-1
p811-lee;n=396;396;-1
p811-lee;n=360;360;-1
p811-lee;n=380;380;-1
p811-lee;n=379;379;-1
p811-lee;n=426;426;-1
p811-lee;n=101;101;-1
p811-lee;n=57;57;-1
p811-lee;n=68;68;-1
p811-lee;n=226;226;-1
p811-lee;n=116;116;-1
p811-lee;n=104;104;-1
p811-lee;n=159;159;-1
p811-lee;n=107;107;-1
p811-lee;n=40;40;-1
p811-lee;n=53;53;-1
p811-lee;n=199;199;-1
p811-lee;n=114;114;-1
p811-lee;n=96;96;-1
p811-lee;n=170;170;-1
p821-hutto;n=300;300;-1
p821-hutto;n=86;86;-1
p821-hutto;n=97;97;-1
p821-hutto;n=106;106;-1
p821-hutto;n=25;25;-1
p821-hutto;n=222;222;-1
p821-hutto;n=45;45;-1
p821-hutto;n=0;0;-1
p821-hutto;n=36;36;-1
p821-hutto;n=28;28;-1
p821-hutto;N=1,836;1836;-1
p821-hutto; data from 507;507;-1
p831-nancel;2 women;2;2285
p831-nancel;3D  coordinates of the participants;3;5620
p831-nancel;12 participants;12;2310
p831-nancel;7 participants;7;3360
p831-nancel;15 participants;15;11360
p831-nancel;n = 0;0;8232
p841-walter;166 participants;166;-1
p841-walter;n=26;26;-1
p841-walter;N=384;384;-1
p851-zhang;14 participants;14;-1
p851-zhang;total of 168;168;-1
p851-zhang;total of 84;84;-1
p869-jones;10 participants;10;-1
p869-jones;N=15;15;-1
p889-gustafson;12 participants;12;-1
p889-gustafson;11 participants;11;-1
p889-gustafson;10 participants;10;-1
p889-gustafson;1   We recruited;1;-1
p89-lomas;70K subjects;70;-1
p89-lomas;3 between-subjects;3;-1
p89-lomas;25 between-subjects;25;-1
p89-lomas;total of 25;25;-1
p89-lomas; data from   69,642;69642;-1
p899-hasan;12 participants;12;-1
p899-hasan;4 within-subjects;4;-1
p899-hasan;3 within-subjects;3;-1
p899-hasan;n = 480;480;-1
p899-hasan;N=12;12;-1
p899-hasan;total of 240;240;-1
p899-hasan;total of 54;54;-1
p899-hasan;total of 5;5;-1
p899-hasan;total of 60;60;-1
p941-yuill;4 people;4;-1
p941-yuill;48 adults;48;-1
p941-yuill;n = 3;3;-1
p941-yuill;n = 2;2;-1
p951-leong;11 people;11;-1
p951-leong;total of 11;11;-1
p961-birnholtz;130 total participants;130;-1
p961-birnholtz;N = 12;12;-1
p961-birnholtz; data set of 100;100;-1
p971-gross;total of 91;91;-1
p981-cui;31 groups of people;31;-1
p981-cui;N=19;19;-1
p991-coughlan;20   people;20;-1
p1001-unander-scharin;100 persons;100;-1
p101-patil;16 participants;16;-1
p101-patil;20 participants;20;-1
p101-patil;35 participants;35;-1
p101-patil;10 participants;10;-1
p101-patil;27 individuals;27;-1
p101-patil;N = 35;35;-1
p101-patil;N = 662;662;-1
p101-patil;N = 650;650;-1
p101-patil;n = 5;5;-1
p101-patil;n = 6;6;-1
p1011-hakkila;20 participants;20;-1
p1011-hakkila;20 subjects;20;-1
p1011-hakkila;3 people;3;-1
p1011-hakkila;n=19;19;-1
p1011-hakkila;n = 20;20;-1
p1029-athukorala;N = 1;1;-1
p1029-athukorala;n = 4;4;-1
p1029-athukorala;n = 5;5;-1
p1029-athukorala;n  = 45;45;-1
p1029-athukorala;n = 36;36;-1
p1029-athukorala;n = 27;27;-1
p1029-athukorala;n = 33;33;-1
p1029-athukorala;total of 1,140;1140;-1
p1039-ryokai;total of 16;16;-1
p1059-kihm;9 participants;9;-1
p1063-hincapie-ramos;16 participants;16;-1
p1063-hincapie-ramos;12 participants;12;-1
p1063-hincapie-ramos;4 participants;4;-1
p1063-hincapie-ramos;total of 16;16;-1
p1063-hincapie-ramos;total of 2;2;-1
p1063-hincapie-ramos;total of 4;4;-1
p1063-hincapie-ramos; data from 4;4;-1
p1073-markussen;6   participants;6;-1
p1073-markussen;2 categorizes participants;2;-1
p1073-markussen;N = 17,968;17968;-1
p1073-markussen;total of 6;6;-1
p1073-markussen;total of 648;648;-1
p1083-wacharamanotham;8 participants;8;-1
p1083-wacharamanotham;10 participants;10;-1
p1083-wacharamanotham;25 were recruited;25;-1
p1083-wacharamanotham; data from 157;157;-1
p1093-kulshreshth;36 participants;36;-1
p1093-kulshreshth;70 minutes and all participants;70;-1
p1093-kulshreshth;22 people;22;-1
p1093-kulshreshth;32 people;32;-1
p1093-kulshreshth;total of 180;180;-1
p1093-kulshreshth;total of  2;2;-1
p1093-kulshreshth;total  of 40;40;-1
p11-reinecke;40 thousand participants;40;-1
p11-reinecke;40,000 participants;40000;-1
p11-reinecke;22 participants;22;-1
p11-reinecke;242 participants;242;-1
p11-reinecke;32,222 participants;32222;-1
p11-reinecke;18,448 participants;18448;-1
p11-reinecke;n = 32;32;-1
p1103-ng;n = 2;2;-1
p1103-ng;n = 6;6;-1
p111-zhang;N = 220;220;-1
p1113-spindler;40 participants;40;-1
p1113-spindler;40   participants;40;-1
p1113-spindler;10 participants;10;-1
p1113-spindler;N = 5;5;-1
p1113-spindler;N = 7;7;-1
p1113-spindler;N = 8;8;-1
p1113-spindler;N = 31;31;-1
p1113-spindler;N = 4;4;-1
p1123-ren;138 people;138;-1
p1133-wilson;n = 25;25;-1
p1133-wilson;n = 10;10;-1
p1133-wilson;n = 57;57;-1
p1133-wilson;n = 68;68;-1
p1133-wilson;n = 27;27;-1
p1133-wilson;n = 63;63;-1
p1133-wilson;n = 82;82;-1
p1133-wilson;n = 79;79;-1
p1133-wilson;total of 64;64;-1
p1143-choe;3 items people;3;-1
p1143-choe;n = 8;8;-1
p115-shami;n=0;0;-1
p115-shami;n=175;175;-1
p115-shami;n=2;2;-1
p115-shami;n=239;239;-1
p115-shami;n=98;98;-1
p115-shami;n=1;1;-1
p115-shami;n=13;13;-1
p115-shami;n=49;49;-1
p115-shami;n=21;21;-1
p115-shami;N = 227,241;227241;-1
p115-shami;N=227,241;227241;-1
p1153-jang;8 participants;8;-1
p1153-jang;21 participants;21;-1
p1153-jang;18 participants;18;-1
p1153-jang;18 subjects;18;-1
p1153-jang;3 people;3;-1
p1153-jang;n=3;3;-1
p1153-jang;n=4;4;-1
p1153-jang;n = 1857;1857;-1
p1153-jang;n = 1135;1135;-1
p1153-jang;n = 591;591;-1
p1153-jang;n = 749;749;-1
p1153-jang;n = 1;1;-1
p1153-jang;n = 0;0;-1
p1153-jang;n = 2;2;-1
p1153-jang;n = 4;4;-1
p1153-jang;n = 3;3;-1
p1163-rooksby;18 participants;18;-1
p1163-rooksby;22 participants;22;-1
p1163-rooksby;22 people;22;-1
p1163-rooksby;23   people;23;-1
p1173-bates;33 under-  graduate student participants;33;-1
p1173-bates;33 participants;33;-1
p1173-bates;16 of the participants;16;-1
p1173-bates;8  participants;8;-1
p1173-bates;20 participants;20;-1
p1173-bates;11 participants;11;-1
p1173-bates;23 interviewed participants;23;-1
p1173-bates;total of 191;191;-1
p1173-bates; data from 33;33;-1
p1187-al-hajri;5 participants;5;-1
p1187-al-hajri;2 participants;2;-1
p1187-al-hajri;187 million people;187;-1
p1187-al-hajri;n = 6;6;-1
p119-schuler;6 persons;6;-1
p119-schuler;36 participants;36;-1
p119-schuler;100 people;100;-1
p119-schuler;6 people;6;-1
p119-schuler;23 people;23;-1
p119-schuler;36 individuals;36;-1
p119-schuler;total of 36;36;-1
p1197-hunter;12 participants;12;-1
p1197-hunter;9 shows the age of the adults;9;-1
p1207-freeman;4 people;4;-1
p1217-craggs;95 participants;95;-1
p1217-craggs;N = 15;15;-1
p1217-craggs;N = 124;124;-1
p1217-craggs;N =  724;724;-1
p1217-craggs;total of 904;904;-1
p1221-nicholson;1 looked at participants;1;-1
p1221-nicholson;2 looked at participants;2;-1
p1221-nicholson;24 participants;24;-1
p1221-nicholson;16 different participants;16;-1
p1225-yu;1 participants;1;-1
p1235-zhao;3 paid participants;3;-1
p1235-zhao;10 participants;10;-1
p1235-zhao;4 participants;4;-1
p1235-zhao;12 participants;12;-1
p1235-zhao;3 participants;3;-1
p1235-zhao;3  participants;3;-1
p1235-zhao;3 people;3;-1
p1245-yu;2 as input and asked new   participants;2;-1
p1255-chilton;48 participants;48;-1
p1255-chilton;48 people;48;-1
p1255-chilton;total of 48;48;-1
p1265-benson;n = 1005;1005;-1
p1275-seckler;65   participants;65;10795
p1275-seckler;3 visualize scan   paths of participants;3;3188
p1275-seckler;1 Let people;1;7757
p1275-seckler;N   = 65;65;21602
p1275-seckler;N = 23;23;9616
p1275-seckler;N=31;31;2478
p1275-seckler;N=33;33;2529
p1275-seckler;N=30;30;2575
p1275-seckler;n=32;32;6541
p1285-chiravirakul;16   participants;16;19
p1285-chiravirakul;2 a between-subjects;2;16262
p1295-hoare;2600 individuals;2600;-1
p1295-hoare;14 adults;14;-1
p1305-barkhuus;13 participants;13;-1
p1305-barkhuus;30 and   under and five people;30;-1
p1315-hamilton;5,000 live participants;5000;-1
p1315-hamilton;500 participants;500;-1
p1315-hamilton;150 people;150;-1
p1335-culotta;total of 80;80;-1
p1345-murnane;224 people;224;-1
p1345-murnane;226 people;226;-1
p1345-murnane;653   individuals;653;-1
p1355-huh;2 wondered   what patients;2;-1
p1355-huh;6 also mentioned peer patients;6;-1
p1365-de-choudhury;38   participants;38;-1
p1365-de-choudhury;n = 35;35;-1
p1365-de-choudhury;n=197;197;-1
p1365-de-choudhury;n = 3;3;-1
p1365-de-choudhury;n = 4;4;-1
p1365-de-choudhury;n = 5;5;-1
p1365-de-choudhury;n = 6;6;-1
p1365-de-choudhury;total of 38;38;-1
p1377-kim;3 women;3;-1
p1377-kim;12 participants;12;-1
p1377-kim;39 were recruited;39;-1
p1377-kim;total of 3888;3888;-1
p1387-goel;10 participants;10;-1
p1387-goel;3   participants;3;-1
p139-andre;716   participants;716;-1
p139-andre;n=2;2;-1
p139-andre;total of 431;431;-1
p139-andre;total   of 79;79;-1
p139-andre; data from the 1;1;-1
p1397-pan;3 are participants;3;10124
p1397-pan;1  Method  Twelve participants;1;2805
p1397-pan;7 participants;7;1080
p1397-pan;2  Method  Twenty-four participants;2;724
p1397-pan;12 participants;12;1221
p1397-pan;15 participants;15;1925
p1415-muller;100 persons;100;-1
p1415-muller;30888 people;30888;-1
p1425-fortin;total of 1297;1297;-1
p1425-fortin;total of 29;29;-1
p1435-greis;114 participants;114;-1
p1435-greis;50 participants;50;-1
p1435-greis;89 participants;89;-1
p1435-greis;101 participants;101;-1
p1435-greis;10 participants;10;-1
p1435-greis;7 participants;7;-1
p1435-greis;13 participants;13;-1
p1435-greis;9 participants;9;-1
p1435-greis;23 participants;23;-1
p1435-greis;14 participants;14;-1
p1435-greis;116 people;116;-1
p1439-sauppe;16 native-English-speaking participants;16;-1
p1439-sauppe;10 participants;10;-1
p1439-sauppe;total of 16;16;-1
p1449-pereira;27 participants;27;-1
p1449-pereira;18 participants;18;-1
p1449-pereira;n = 6;6;-1
p1449-pereira;n = 5;5;-1
p1449-pereira;n = 3;3;-1
p1459-lohse;32 participants;32;-1
p1467-bidwell;22 participants;22;-1
p1467-bidwell;22 subjects;22;-1
p1467-bidwell;22 of the subjects;22;-1
p1467-bidwell;N=20;20;-1
p1471-lee;2557395   people;2557395;-1
p149-woodruff;3   women;3;-1
p149-woodruff;10 women;10;-1
p149-woodruff;1 These participants;1;-1
p149-woodruff;09   Some participants;9;-1
p149-woodruff;05   A number of participants;5;-1
p149-woodruff;02   Some participants;2;-1
p149-woodruff;7 people;7;-1
p149-woodruff;21 people;21;-1
p1495-leavitt; dataset of 2458;2458;-1
p1505-hughes;776,000 people;776000;-1
p1505-hughes;5 million   people;5;-1
p1505-hughes;8,175,133 people;8175133;-1
p1505-hughes;N=1;1;-1
p1505-hughes;N=2;2;-1
p1505-hughes;N=3;3;-1
p1505-hughes;total of 26;26;-1
p1505-hughes;total of 272;272;-1
p1505-hughes; data from 840;840;-1
p1525-hailpern;8  We asked participants;8;-1
p1525-hailpern;2 subjects;2;-1
p1525-hailpern;5 point scale  All were recruited;5;-1
p1545-yue;1,000 US   participants;1000;-1
p1545-yue;11 participants;11;-1
p1545-yue;250 participants;250;-1
p1545-yue;1,013   participants;1013;-1
p1545-yue;312   participants;312;-1
p1545-yue;1,000 participants;1000;-1
p1545-yue;1000 people;1000;-1
p1545-yue;total of 272;272;-1
p1545-yue; dataset of 33,180;33180;-1
p1555-vigo;11 female participants;11;-1
p1555-vigo;5 participants;5;-1
p1555-vigo;2557284  of individuals;2557284;-1
p1559-sun;15 participants;15;-1
p1559-sun;11 participants;11;-1
p1559-sun;6 participants;6;-1
p1559-sun;3 people;3;-1
p1571-trinh;12 participants;12;40201
p1571-trinh;12   participants;12;8676
p1571-trinh;N=12;12;43171
p1581-chi;10 participants;10;-1
p1581-chi;12 participants;12;-1
p1581-chi;20 recordings of participants;20;-1
p1581-chi;N = 60;60;-1
p1581-chi;N = 70;70;-1
p1581-chi;N=60;60;-1
p1581-chi;N=70;70;-1
p159-chen;12 participants;12;-1
p159-chen;10 participants;10;-1
p1591-pschetz;15 participants;15;-1
p1595-joshi;11 rural   participants;11;-1
p1595-joshi;15 participants;15;-1
p1595-joshi;9 participants;9;-1
p1595-joshi;35 participants;35;-1
p1595-joshi;10   participants;10;-1
p1595-joshi;54 participants;54;-1
p1595-joshi;47 participants;47;-1
p1595-joshi;14 participants;14;-1
p1595-joshi;10 participants;10;-1
p1595-joshi;24 participants;24;-1
p1595-joshi;35 million   people;35;-1
p1595-joshi;4 million people;4;-1
p1595-joshi;170,000 people;170000;-1
p1595-joshi;total of 54;54;-1
p1595-joshi;total of 50;50;-1
p1595-joshi;total of 216;216;-1
p1605-brown;20 Afro-Caribbean women;20;-1
p1605-brown;20 participants;20;-1
p1605-brown;65 participants;65;-1
p1605-brown;total of 20;20;-1
p1615-haimson;100 people;100;-1
p1625-vlahovic;n = 9;9;-1
p1625-vlahovic;n = 1;1;-1
p1625-vlahovic;n = 2;2;-1
p1625-vlahovic;n = 0;0;-1
p1625-vlahovic;n = 5;5;-1
p1625-vlahovic;N=1000;1000;-1
p1625-vlahovic;N=974;974;-1
p1625-vlahovic;N=638;638;-1
p1625-vlahovic;N = 638;638;-1
p1625-vlahovic;n = 6;6;-1
p1625-vlahovic;n =   4;4;-1
p1645-gray;11 participants;11;-1
p1645-gray;10 participants;10;-1
p1645-gray;total of 111;111;-1
p1655-darlow;33 participants;33;-1
p1655-darlow;2 presented participants;2;-1
p1655-darlow;137 participants;137;-1
p1655-darlow;137 participants were recruited;137;-1
p1665-nielsen;28 participants;28;-1
p1665-nielsen;3   participants;3;-1
p1675-zhang;10 participants;10;-1
p1675-zhang;total of 20;20;-1
p1685-lu;4 participants;4;-1
p1685-lu;3 participants;3;-1
p1685-lu;10 participants;10;-1
p1685-lu;9   people;9;-1
p1685-lu;4 programmers recruited;4;-1
p1685-lu;n = 32;32;-1
p1685-lu;total of 341;341;-1
p1685-lu;total of 26;26;-1
p1685-lu;total of 2400;2400;-1
p1685-lu;total of 700;700;-1
p169-oakley;total of 13;13;-1
p169-oakley;total of 27;27;-1
p169-oakley; data from the 48;48;-1
p1695-taylor;11 participants;11;-1
p1695-taylor;11 subjects;11;-1
p1695-taylor;11 subjects recruited;11;-1
p1695-taylor;total of 28;28;-1
p1695-taylor; data set of 28;28;-1
p1705-nicolau;11 blind people;11;17863
p1705-nicolau;n=1;1;2758
p1705-nicolau;n=2;2;2748
p1705-nicolau;n=3;3;2694
p1705-nicolau;n=4;4;2661
p1705-nicolau;n=5;5;2624
p1705-nicolau;N   =3;3;201
p1705-nicolau;total of 168;168;13031
p1705-nicolau;total of   263;263;12176
p1709-leiva;n = 6;6;-1
p1713-qi;11 total participants;11;-1
p1713-qi;19 unique   participants;19;-1
p1713-qi;16 total unique participants;16;-1
p1713-qi;9 of the art and design participants;9;-1
p1713-qi;19   participants;19;-1
p1713-qi;17 participants;17;-1
p1713-qi;19 total participants;19;-1
p1713-qi;total of 19;19;-1
p1747-nicosia;18 participants;18;-1
p1747-nicosia;16 participants;16;-1
p1747-nicosia;2 participants;2;-1
p1747-nicosia;3 of participants;3;-1
p1747-nicosia;3  of the participants;3;-1
p1747-nicosia;3 of  the participants;3;-1
p1747-nicosia;6 these participants;6;-1
p1747-nicosia;11 participants;11;-1
p1747-nicosia;n = 54;54;-1
p1757-zade;20 participants;20;-1
p1757-zade;18 participants;18;-1
p1757-zade;11 participants;11;-1
p1757-zade;5 participants;5;-1
p1757-zade;6 participants;6;-1
p1757-zade;5  participants;5;-1
p1757-zade;1  We setup a simple within-subjects;1;-1
p1767-trafton;N = 33;33;-1
p1767-trafton;N = 30;30;-1
p1767-trafton;N = 18;18;-1
p1767-trafton;N =   16;16;-1
p1767-trafton;N = 14;14;-1
p1767-trafton;N = 16;16;-1
p1767-trafton;N = 29;29;-1
p1767-trafton;N = 25;25;-1
p1787-hyde;n = 2;2;-1
p1787-hyde;N  = 54;54;-1
p1787-hyde;N  = 52;52;-1
p1787-hyde;N  = 69;69;-1
p179-weigel;22 voluntary participants;22;-1
p179-weigel;18 participants;18;-1
p179-weigel;3 participants;3;-1
p179-weigel;3 we asked participants;3;-1
p179-weigel;total of 880;880;-1
p1797-hashish;7yr girl   Two participants;7;-1
p1807-tewari;12 participants;12;17574
p1807-tewari;total of 127;127;19579
p1821-gossen;17 adults;17;-1
p1825-alper;9 participants;9;-1
p1825-alper;12 participants;12;-1
p1825-alper;total  of 24;24;-1
p1835-carenini;7 non-student participants;7;-1
p1835-carenini;62 subjects;62;-1
p1835-carenini;total of 5;5;-1
p1835-carenini;total of 80;80;-1
p1845-sheinin;2 women;2;-1
p1845-sheinin;1718   participants;1718;-1
p1845-sheinin;12 participants;12;-1
p1855-chen;44 participants;44;-1
p1855-chen;16 individuals;16;-1
p1855-chen;48 young adults;48;-1
p1855-chen;N = 44;44;-1
p1855-chen;n = 3;3;-1
p1855-chen;n = 5;5;-1
p1865-park;15 participants;15;-1
p1865-park;12 participants;12;-1
p1865-park;3 within-subjects;3;-1
p1865-park;n = 3;3;-1
p1865-park;n = 1;1;-1
p1865-park;n   = 4;4;-1
p1865-park;n = 2;2;-1
p1865-park;total of 600;600;-1
p1875-zaczynski;20 participants;20;-1
p1875-zaczynski;20 participants were recruited;20;-1
p1875-zaczynski;total of 10;10;-1
p1875-zaczynski;total of 4;4;-1
p1905-huang;24 participants;24;-1
p1905-huang;total of 24;24;-1
p1909-wang;15 participants;15;-1
p1909-wang;15 people;15;-1
p1909-wang;15   people;15;-1
p1909-wang;n = 55;55;-1
p1913-haddad;36   participants;36;-1
p1913-haddad;20 Caucasian   participants;20;-1
p1913-haddad;16 East Asian participants;16;-1
p1913-haddad;20 Caucasian participants;20;-1
p1913-haddad;20 East Asian   participants;20;-1
p1913-haddad;8 East   Asian participants;8;-1
p1913-haddad;n=8;8;-1
p1913-haddad;N = 28;28;-1
p1913-haddad;n   = 28;28;-1
p1913-haddad;n = 10;10;-1
p1913-haddad;n   = 12;12;-1
p1913-haddad;n = 14;14;-1
p1923-meurer;21 older   adults;21;-1
p1923-meurer;21 older adults;21;-1
p1923-meurer;N=21;21;-1
p1923-meurer;N = 21;21;-1
p1933-arreola;65 older adults;65;-1
p1933-arreola;4 older adults;4;-1
p1933-arreola;n=3;3;-1
p1937-vaisutis;2 women;2;-1
p1961-odom;9 people;9;-1
p197-pucihar;15 participants;15;-1
p197-pucihar;13 participants;13;-1
p197-pucihar;15   participants;15;-1
p197-pucihar;2 factor within-subjects;2;-1
p1981-ng;6 ki  ealistic object   e participants;6;-1
p1981-ng;total of 34;34;-1
p1991-lehtovirta;20 participants;20;-1
p1991-lehtovirta;20   participants;20;-1
p1991-lehtovirta;20 subjects;20;-1
p1991-lehtovirta;n = 0;0;-1
p1991-lehtovirta; data from the 20;20;-1
p2001-tsandilas;7 women;7;-1
p2001-tsandilas;10 participants;10;-1
p2001-tsandilas;12 participants;12;-1
p2001-tsandilas;total of 3935;3935;-1
p2001-tsandilas;total of 16;16;-1
p2005-mohdnoor;20 users were recruited;20;-1
p2005-mohdnoor;n = 1;1;-1
p2009-schwarz;10 participants;10;-1
p2009-schwarz;3 people;3;-1
p2009-schwarz;total of 2,700;2700;-1
p2013-nguyen;13  participants;13;-1
p2013-nguyen;16 participants;16;-1
p2017-gupta;42 participants;42;2525
p2017-gupta;N = 20;20;1178
p2027-chen;3D Models   We recruited;3;-1
p2027-chen;total of 24;24;-1
p2037-broy;30 participants;30;-1
p2037-broy;11 participants;11;-1
p2037-broy;n = 1;1;-1
p2037-broy;n = 2;2;-1
p2037-broy;n = 3;3;-1
p2051-joshi;n=1;1;-1
p2051-joshi;n=6;6;-1
p2051-joshi;n=3;3;-1
p2051-joshi;n=5;5;-1
p2051-joshi;n=2;2;-1
p2055-crnovrsanin;13 participants;13;-1
p2055-crnovrsanin;n = 0;0;-1
p2065-walber;5 persons;5;-1
p2065-walber;33 participants;33;-1
p2065-walber;9 participants;9;-1
p2065-walber;18 participants;18;-1
p2065-walber;20 people;20;-1
p2065-walber;N = 66;66;-1
p2065-walber;n = 33;33;-1
p2065-walber;n = 18;18;-1
p2065-walber;total of 33;33;-1
p2065-walber; data rate of 60;60;-1
p2065-walber; data of all 33;33;-1
p207-schild;40 participants;40;-1
p207-schild;44 subjects;44;-1
p207-schild;9 subjects;9;-1
p207-schild;18 subjects;18;-1
p207-schild;13 subjects;13;-1
p2075-jiang;12 participants;12;392
p2075-jiang;12   subjects;12;3107
p2075-jiang;12 subjects;12;3872
p2075-jiang;total of 72;72;358
p2085-may;26 participants;26;-1
p2085-may;22 remaining participants;22;-1
p2085-may;22 participants;22;-1
p2085-may;25 participants;25;-1
p2085-may;21 participants;21;-1
p2085-may;3   Method   Twelve participants;3;-1
p2085-may;n=29;29;-1
p2085-may;n=19;19;-1
p2085-may;n= 30;30;-1
p2085-may;n=18;18;-1
p2095-kizilcec;22 participants;22;-1
p2095-kizilcec;n=22;22;-1
p2095-kizilcec;n=39;39;-1
p2095-kizilcec;n=42;42;-1
p2095-kizilcec;n=13;13;-1
p2095-kizilcec;n=0;0;-1
p21-sonderegger;60 participants;60;-1
p21-sonderegger;2 between-participants;2;-1
p21-sonderegger;10 participants;10;-1
p2103-lui;total of 146;146;-1
p2153-rae;32 adults;32;-1
p2153-rae;N = 40;40;-1
p2153-rae;n = 31;31;-1
p2153-rae;n = 15;15;-1
p2153-rae;n = 16;16;-1
p2153-rae;total of 35;35;-1
p2153-rae;total of 32;32;-1
p2163-procyk;16 participants;16;-1
p217-mauderer;15 participants;15;-1
p217-mauderer;16 participants;16;-1
p217-mauderer;N = 32;32;-1
p217-mauderer;N =  32;32;-1
p2173-pan;48 participants;48;-1
p2177-cohen;14 participants;14;-1
p2177-cohen;14 people;14;-1
p2177-cohen;14 people   we recruited;14;-1
p2181-garner;25 participants;25;-1
p2181-garner;12 of these   participants;12;-1
p2181-garner;7 participants;7;-1
p2181-garner;8 of the study participants;8;-1
p2181-garner;total of 8;8;-1
p2181-garner;total of 4;4;-1
p2201-gerling;1 where participants;1;-1
p2201-gerling;n=1;1;-1
p2201-gerling;n=2;2;-1
p2201-gerling;n=7061;7061;-1
p2201-gerling;n=10292;10292;-1
p2201-gerling;n=4;4;-1
p2211-mueller;134 participants;134;-1
p2211-mueller;134   participants;134;-1
p2211-mueller;14 participants;14;-1
p2211-mueller;75 participants;75;-1
p2211-mueller;59 participants;59;-1
p2211-mueller;5 people;5;-1
p2221-meng;8 subjects;8;1132
p2241-scarr;12 participants;12;-1
p2241-scarr;12 Study Two participants;12;-1
p2255-balata;15 participants;15;-1
p2255-balata;n = 40;40;-1
p2259-lee;6 participants;6;-1
p2259-lee;4 participants;4;-1
p2259-lee;3 of these participants;3;-1
p2259-lee;12   participants;12;-1
p2259-lee;12 older adults;12;-1
p2259-lee;12 older   adults;12;-1
p2259-lee;total of 12;12;-1
p2269-stawarz;N=589;589;-1
p2269-stawarz;N=382;382;-1
p2269-stawarz;N=45;45;-1
p227-valkov;4 female subjects;4;-1
p227-valkov;20 subjects;20;-1
p227-valkov;75 trials subjects;75;-1
p227-valkov;2 female subjects;2;-1
p227-valkov;12 subjects;12;-1
p227-valkov;total of 150;150;-1
p2279-suh;40 participants;40;-1
p2279-suh;14 participants;14;-1
p2279-suh;total of 19;19;-1
p2279-suh;total of 670;670;-1
p2279-suh; data from 14;14;-1
p2289-nguyen;2 result shows none of the   subjects;2;-1
p2289-nguyen;14 subjects;14;-1
p2289-nguyen;10 subjects;10;-1
p2289-nguyen;4 subjects;4;-1
p2289-nguyen;2 subjects;2;-1
p2289-nguyen;3 subjects;3;-1
p2289-nguyen;15 test and people;15;-1
p2289-nguyen;N=28;28;-1
p2293-cairns;64 fo  women;64;-1
p2293-cairns;28 participants;28;-1
p2297-bi;40 participants;40;-1
p2297-bi;24 participants;24;-1
p2307-weir;10 participants;10;-1
p2307-weir;8 participants;8;-1
p2307-weir;16 participants;16;-1
p2307-weir;28 people;28;-1
p2307-weir;n = 25;25;-1
p2307-weir;n = 22;22;-1
p2307-weir;n =  29;29;-1
p2307-weir;n =  25;25;-1
p2307-weir;n = 1272;1272;-1
p2307-weir;n = 4461;4461;-1
p2307-weir; data. Next,  from the 2333;2333;-1
p2327-lee;59  participants;59;7163
p2327-lee;24 participants;24;10944
p2327-lee;n = 26;26;5570
p2327-lee; data from 95;95;20304
p2337-schaub;95 participants;95;-1
p2337-schaub;8 participants;8;-1
p2337-schaub;67 participants;67;-1
p2337-schaub;7 participants;7;-1
p2337-schaub;4 participants;4;-1
p2337-schaub;3 participants;3;-1
p2337-schaub;n=11;11;-1
p2337-schaub;n=2,579;2579;-1
p2337-schaub;n=2,471;2471;-1
p2337-schaub;n=95;95;-1
p2337-schaub;n=77;77;-1
p2337-schaub;n=45;45;-1
p2337-schaub;n=7;7;-1
p2337-schaub;n=94;94;-1
p2337-schaub;n=61;61;-1
p2337-schaub;n=48;48;-1
p2337-schaub;n=43;43;-1
p2337-schaub;n=22;22;-1
p2337-schaub;n=10;10;-1
p2337-schaub;n=8;8;-1
p2347-shklovski;5   women;5;-1
p2347-shklovski;116 women;116;-1
p2347-shklovski;n=2;2;-1
p2347-shklovski;n=1;1;-1
p2347-shklovski;N=89;89;-1
p2347-shklovski;total of 272;272;-1
p2347-shklovski; data from   2;2;-1
p2357-davies;total of 84;84;-1
p237-adams;n=7;7;-1
p237-adams;total of 49;49;-1
p2377-denning;10 participants;10;-1
p2377-denning;5 participants;5;-1
p2377-denning;8 participants;8;-1
p2377-denning;12 of the participants;12;-1
p2377-denning;6 of the participants;6;-1
p2377-denning;13 participants;13;-1
p2377-denning;31 individuals;31;-1
p2377-denning;4 additional individuals;4;-1
p2377-denning;total of 12;12;-1
p2421-wisniewski;total of 84;84;-1
p2421-wisniewski;total of 676;676;-1
p2421-wisniewski;total of   21;21;-1
p2421-wisniewski;total of 752;752;-1
p2421-wisniewski;total of 848;848;-1
p2421-wisniewski;total of 80;80;-1
p2431-zhao;9 women;9;-1
p2431-zhao;14 participants;14;-1
p2441-schirra;33   participants;33;-1
p2441-schirra;11 participants;11;-1
p2441-schirra;n=1,304;1304;-1
p2441-schirra;n=165;165;-1
p2441-schirra;n=102;102;-1
p2461-massey;27 participants;27;-1
p2461-massey;1      participants;1;-1
p2461-massey;11 participants;11;-1
p2461-massey;16 participants;16;-1
p2461-massey;12 participants;12;-1
p2461-massey;18 participants;18;-1
p2461-massey;17 participants;17;-1
p2461-massey;27 people;27;-1
p2461-massey;18 people;18;-1
p2461-massey;N=27;27;-1
p2461-massey;N=68;68;-1
p247-muller;17 participants;17;-1
p247-muller;n =  36;36;-1
p247-muller;n = 14;14;-1
p247-muller;n = 21;21;-1
p2471-forte;20 participants;20;-1
p2471-forte;244 English-  speaking participants;244;-1
p2471-forte;2,500  participants;2500;-1
p2471-forte;n=17;17;-1
p2471-forte;n=16;16;-1
p2471-forte;n=4;4;-1
p2471-forte;n=5;5;-1
p2471-forte;total of 12;12;-1
p2481-lieber;7 participants;7;-1
p2481-lieber;9 subjects;9;-1
p2481-lieber;4 subjects;4;-1
p2481-lieber;N = 34;34;-1
p2491-fast;total of 49,735;49735;-1
p2501-atachiants;22 people;22;-1
p2511-henley;n = 99;99;-1
p2511-henley;n = 98;98;-1
p2511-henley;n = 10;10;-1
p2521-ayoade;15 participants;15;-1
p2521-ayoade;2 participants;2;-1
p2521-ayoade;3 of the participants;3;-1
p2521-ayoade;4 of the participants;4;-1
p2521-ayoade;n=1;1;-1
p2521-ayoade;n=3;3;-1
p2521-ayoade;n=2;2;-1
p2521-ayoade; data from 15;15;-1
p2531-mazilu;5 participants;5;-1
p2531-mazilu;5 additional patients;5;-1
p2531-mazilu;2557278  A particular problem of PD patients;2557278;-1
p2531-mazilu;18 PD patients;18;-1
p2531-mazilu;5 PD patients;5;-1
p2531-mazilu;13 PD patients;13;-1
p2531-mazilu;18 PD  patients;18;-1
p2531-mazilu;18 patients;18;-1
p2531-mazilu;5 patients;5;-1
p2531-mazilu;4 patients;4;-1
p2531-mazilu;40 PD patients;40;-1
p2531-mazilu;23 PD patients;23;-1
p2531-mazilu;1 million people;1;-1
p2531-mazilu;total of 5;5;-1
p2531-mazilu; data from the 18;18;-1
p2551-mcnaney;4 of the participants;4;-1
p2551-mcnaney;5 of the participants;5;-1
p2551-mcnaney;3 and   other participants;3;-1
p2551-mcnaney;4 participants;4;-1
p2551-mcnaney;5 PD patients;5;-1
p2551-mcnaney;4 PD patients;4;-1
p2551-mcnaney;10 million people;10;-1
p2551-mcnaney;5 people;5;-1
p2559-gronvall;120 people;120;-1
p2559-gronvall;129 people;129;-1
p2569-ramakers;16 participants;16;-1
p2569-ramakers;11 participants;11;-1
p2569-ramakers;3 participants;3;-1
p2569-ramakers;2 participants;2;-1
p2569-ramakers;8 participants;8;-1
p257-bryan;10 participants;10;-1
p2579-pedersen;187 participants;187;-1
p2579-pedersen;14 participants;14;-1
p2579-pedersen;200 participants;200;-1
p2579-pedersen;2 participants;2;-1
p2579-pedersen;5 participants;5;-1
p2579-pedersen;93 participants;93;-1
p2579-pedersen;54 par-  ticipants recruited;54;-1
p2589-dimitriadis;n =   1;1;-1
p2589-dimitriadis;n =  1;1;-1
p2597-heo;14   participants;14;-1
p2597-heo;total of 192;192;-1
p2607-au;29 were recruited;29;-1
p2607-au;n = 100;100;-1
p2607-au;total  of 8;8;-1
p2607-au;total of  8;8;-1
p2607-au;total of 28,800;28800;-1
p2617-gutwin;10 within-participants;10;-1
p2617-gutwin;16 participants;16;-1
p2627-luo;12 participants;12;-1
p2627-luo;6 participants;6;-1
p2627-luo;12 people;12;-1
p2637-bursztein;76 participants;76;-1
p2647-harbach;5 participants;5;-1
p2647-harbach;49 participants;49;-1
p2647-harbach;n = 36;36;-1
p2647-harbach;n=18;18;-1
p2647-harbach;n=157;157;-1
p2647-harbach;n=175;175;-1
p2657-shay;294 participants;294;-1
p2657-shay;1,501   participants;1501;-1
p2657-shay;89 and participants;89;-1
p2657-shay;89 participants;89;-1
p2657-shay;205 participants;205;-1
p2657-shay;89   participants;89;-1
p2657-shay;6 participants;6;-1
p2657-shay;34   participants;34;-1
p2657-shay;23 participants;23;-1
p2657-shay;12 participants;12;-1
p2657-shay;13 participants;13;-1
p2657-shay;294 people;294;-1
p2657-shay;33 people;33;-1
p2657-shay;470 people;470;-1
p2657-shay;20 people;20;-1
p2657-shay;N=89;89;-1
p2657-shay;N=205;205;-1
p2657-shay;N=111;111;-1
p2657-shay;N=94;94;-1
p2657-shay;N=294;294;-1
p2657-shay;N=1501;1501;-1
p2657-shay; data from 1,501;1501;-1
p267-marentakis;total of 90;90;-1
p2675-balestrini;22 participants;22;-1
p2675-balestrini;90 per cent of the participants;90;-1
p2675-balestrini;600 people;600;-1
p2675-balestrini;400 people;400;-1
p2675-balestrini;125 year anniversary and invited people;125;-1
p2685-durrant;n=4;4;-1
p2685-durrant;n=3;3;-1
p2685-durrant;n=12;12;-1
p2685-durrant;n=5;5;-1
p2685-durrant;n=1;1;-1
p2695-ahmed;51 women;51;-1
p2695-ahmed;7 women;7;-1
p2695-ahmed;11 women;11;-1
p2695-ahmed;72 participants;72;-1
p2695-ahmed;618 people;618;-1
p2695-ahmed;total of 11;11;-1
p2695-ahmed;total of 618;618;-1
p2695-ahmed;total of 34;34;-1
p2705-oduor;6 women;6;-1
p2705-oduor;2 women;2;-1
p2705-oduor;5 women;5;-1
p2705-oduor;24   participants;24;-1
p2705-oduor;24 people;24;-1
p2725-piccardi;20 participants;20;-1
p2725-piccardi;14 participants;14;-1
p2725-piccardi;10 participants;10;-1
p2725-piccardi;698,989 people;698989;-1
p2725-piccardi;N=20;20;-1
p2725-piccardi;N=17;17;-1
p2725-piccardi;N=10;10;-1
p2735-rzeszotarski;31 participants;31;-1
p2735-rzeszotarski;184 participants;184;-1
p2735-rzeszotarski;135 participants;135;-1
p2735-rzeszotarski;N=3577;3577;-1
p2745-liao;76 participants;76;-1
p2745-liao;426 cases where participants;426;-1
p2745-liao;76 participants were recruited;76;-1
p2745-liao;N=1170;1170;-1
p2755-rzeszotarski;N=5,859,592;5859592;-1
p2759-gilbert;600 participants;600;-1
p2759-gilbert;93 participants;93;-1
p2759-gilbert;507 people;507;-1
p2759-gilbert;600 participants were recruited;600;-1
p2773-hamilton;8 participants;8;-1
p2773-hamilton;4 participants;4;-1
p2773-hamilton;2 of the participants;2;-1
p2773-hamilton;7 participants;7;-1
p2773-hamilton;6 participants;6;-1
p2773-hamilton;4 of the participants;4;-1
p2773-hamilton;3 of the participants;3;-1
p2773-hamilton;3 participants;3;-1
p2773-hamilton;total of 10;10;-1
p2783-yang;2 included participants;2;-1
p2783-yang;n = 4;4;-1
p2783-yang;n = 5;5;-1
p2793-nebeling;12 participants;12;-1
p2803-singh;12 patients;12;-1
p2803-singh;15 patients;15;-1
p2803-singh;14 people;14;-1
p2803-singh;25 people;25;-1
p2803-singh;2 people;2;-1
p2803-singh;30 people;30;-1
p2803-singh;8 people;8;-1
p2803-singh;14 individuals;14;-1
p281-zhu;N=5673;5673;-1
p281-zhu; data of   5673;5673;-1
p281-zhu; data from   5673;5673;-1
p2813-uzor;9 participants;9;-1
p2813-uzor;8 participants;8;-1
p2823-miller;total of 502;502;-1
p2833-mauriello;52 participants;52;-1
p2833-mauriello;11 participants;11;-1
p2833-mauriello;7 people;7;-1
p2833-mauriello;N=52;52;-1
p2833-mauriello;N=4;4;-1
p2833-mauriello;n=5;5;-1
p2833-mauriello;N=19;19;-1
p2833-mauriello;N=18;18;-1
p2833-mauriello;N=7;7;-1
p2833-mauriello;N=6;6;-1
p2833-mauriello;N=8;8;-1
p2833-mauriello;N=9;9;-1
p2833-mauriello;total of 52;52;-1
p2833-mauriello; data from the 10;10;-1
p2843-obrist;439   participants;439;-1
p2843-obrist;2 asked participants;2;-1
p2843-obrist;4 participants;4;-1
p2843-obrist;554 participants;554;-1
p2843-obrist;439 participants;439;-1
p2843-obrist;n = 11;11;-1
p2843-obrist;n = 10;10;-1
p2843-obrist;n = 6;6;-1
p2843-obrist;n = 14;14;-1
p2843-obrist;n =   127;127;-1
p2843-obrist;n = 27;27;-1
p2843-obrist;n = 37;37;-1
p2843-obrist;n = 5;5;-1
p2843-obrist;n   = 30;30;-1
p2843-obrist;n = 32;32;-1
p2843-obrist;n = 12;12;-1
p2843-obrist;n = 7;7;-1
p2843-obrist;n = 296;296;-1
p2843-obrist;total of 554;554;-1
p2853-obrist;20 participants;20;-1
p2853-obrist;16   participants;16;-1
p2863-seah;6 participants;6;-1
p2863-seah;total of 15;15;-1
p2863-seah;total of 27;27;-1
p2863-seah;total of 36;36;-1
p2873-wei;768 participants;768;-1
p2873-wei;20 field study participants;20;-1
p2873-wei;208 participants;208;-1
p2873-wei;20   participants;20;-1
p2873-wei;728 field study participants;728;-1
p2873-wei;13 participants;13;-1
p2873-wei;20 people;20;-1
p2873-wei;242 people;242;-1
p2873-wei;768 individuals;768;-1
p2873-wei;total of 768;768;-1
p2873-wei;total of 899;899;-1
p2873-wei;total of 38;38;-1
p2883-wagner;20 participants;20;-1
p2883-wagner;18 right-handed participants;18;-1
p2883-wagner;5 participants;5;-1
p2883-wagner;10 illustrates participants;10;-1
p2883-wagner;9 participants;9;-1
p2883-wagner;3 POSTURE ID within  subjects;3;-1
p2883-wagner;n = 96;96;-1
p2883-wagner;n =  100;100;-1
p2883-wagner;n = 99;99;-1
p2883-wagner;n=126;126;-1
p2883-wagner;n=94;94;-1
p2883-wagner;n = 7;7;-1
p2883-wagner;n = 11;11;-1
p2883-wagner;n = 0;0;-1
p2883-wagner;n  = 0;0;-1
p2883-wagner;n  = 1;1;-1
p2883-wagner;n = 3;3;-1
p2883-wagner;n = 2572;2572;-1
p2883-wagner;n = 3330;3330;-1
p2883-wagner;n = 2416;2416;-1
p2883-wagner;n = 3062;3062;-1
p2883-wagner;n = 3373;3373;-1
p2883-wagner;n = 3433;3433;-1
p2883-wagner;n = 2469;2469;-1
p2883-wagner;n = 2319;2319;-1
p2883-wagner;n =  2619;2619;-1
p2883-wagner;n = 2824;2824;-1
p2883-wagner;n = 4041;4041;-1
p2883-wagner;total of 12;12;-1
p2883-wagner;total of 2421;2421;-1
p2883-wagner;total of 5;5;-1
p2883-wagner; data from 20;20;-1
p2893-olafsdottir;10 right-handed participants;10;-1
p2893-olafsdottir;10 participants;10;-1
p2893-olafsdottir;12 participants;12;-1
p2903-alzayat;n = 26;26;-1
p2903-alzayat;n = 24;24;-1
p291-matthews;28 participants;28;-1
p291-matthews;3 participants;3;-1
p291-matthews;N=278;278;-1
p291-matthews;N=186;186;-1
p291-matthews;N=60;60;-1
p291-matthews;N=26;26;-1
p291-matthews;N=6;6;-1
p291-matthews;N=128;128;-1
p291-matthews;N=84;84;-1
p291-matthews;N=47;47;-1
p291-matthews;total of 278;278;-1
p291-matthews; dataset of 10,000;10000;-1
p291-matthews; dataset of   1101;1101;-1
p2913-harrison;7 participants;7;-1
p2913-harrison;6 new participants;6;-1
p2913-harrison;7 independent participants;7;-1
p2917-chowdhury;15   participants;15;-1
p2917-chowdhury;65 participants;65;-1
p2917-chowdhury;100 participants;100;-1
p2917-chowdhury;20   participants;20;-1
p2917-chowdhury;40 subjects;40;-1
p2917-chowdhury;2 subjects;2;-1
p2917-chowdhury;3   subjects;3;-1
p2927-shay;8,143 participants;8143;-1
p2927-shay;8,143 on-  line participants;8143;-1
p2927-shay;15,108 participants;15108;-1
p2927-shay;006  Storage participants;6;-1
p2927-shay;8 participants;8;-1
p2937-deluca;32 participants;32;-1
p2937-deluca;14 participants;14;-1
p2937-deluca;28 participants;28;-1
p2937-deluca;16 participants;16;-1
p2937-deluca;n = 32;32;-1
p2937-deluca;total of 140;140;-1
p2947-thorpe;35 participants;35;-1
p2947-thorpe;35  participants;35;-1
p2947-thorpe;34  participants;34;-1
p2947-thorpe;34 participants;34;-1
p2947-thorpe;n = 17;17;-1
p2951-burgbacher;16 participants;16;-1
p2951-burgbacher; data from 11;11;-1
p2951-burgbacher; data from 16;16;-1
p2985-eveleigh;299 participants;299;-1
p2985-eveleigh;16 questions covering participants;16;-1
p2985-eveleigh;1 participants;1;-1
p2985-eveleigh;3 further   participants;3;-1
p2985-eveleigh;299   participants;299;-1
p2985-eveleigh;N=254;254;-1
p2985-eveleigh;N=214;214;-1
p2985-eveleigh;N=69;69;-1
p2985-eveleigh;N=93;93;-1
p2985-eveleigh;N=61;61;-1
p2985-eveleigh;N=80;80;-1
p2985-eveleigh;N=146;146;-1
p3005-gao; data from 2013;2013;-1
p301-zhu;10   participants;10;-1
p301-zhu;4   participants;4;-1
p301-zhu;10 participants;10;-1
p301-zhu; dataset of   9495;9495;-1
p3015-garbett;n=10;10;-1
p3015-garbett;n=7;7;-1
p3025-mark;32 participants;32;13563
p3025-mark;5 people;5;8121
p3025-mark;total of 160;160;13522
p3025-mark; data on each of the 32;32;13584
p3035-shrot;9 subjects;9;-1
p3035-shrot;7 subjects;7;-1
p3035-shrot;20 subjects;20;-1
p3035-shrot;12 subjects;12;-1
p3035-shrot;30 people;30;-1
p3035-shrot;18 people;18;-1
p3045-bohmer;12 participants;12;-1
p3055-sahami-shirazi;40,191 participants;40191;-1
p3055-sahami-shirazi;40,191 people;40191;-1
p3055-sahami-shirazi;n=4;4;-1
p3055-sahami-shirazi;n=0;0;-1
p3055-sahami-shirazi;n=16;16;-1
p3055-sahami-shirazi;n=52;52;-1
p3055-sahami-shirazi;n=18;18;-1
p3055-sahami-shirazi;n=14;14;-1
p3055-sahami-shirazi;n=63;63;-1
p3065-solomon;99 subjects;99;-1
p3065-solomon;total of  1,188;1188;-1
p3065-solomon;total of 6;6;-1
p3075-kulesza;N=156;156;-1
p3085-loepp;35 participants;35;-1
p3095-lasecki;3 participants;3;-1
p3099-deng;total of 4;4;-1
p31-kong;total of 400;400;-1
p31-kong; data recall of 0;0;-1
p31-kong; data from 20;20;-1
p311-halfaker;1,000 people;1000;-1
p3113-manduchi;18 blind participants;18;-1
p3113-manduchi;20 participants;20;-1
p3113-manduchi;18 participants;18;-1
p3113-manduchi;17   participants;17;-1
p3113-manduchi;N=18;18;-1
p3113-manduchi;N=23;23;-1
p3113-manduchi;total of 18;18;-1
p3113-manduchi;total of 20;20;-1
p3113-manduchi;total of 48;48;-1
p3113-manduchi;total of 40;40;-1
p3123-ye;114 participants;114;-1
p3123-ye;101 sighted participants;101;-1
p3123-ye;10  participants;10;-1
p3123-ye;101  sighted participants;101;-1
p3123-ye;215 participants;215;-1
p3123-ye;145 participants;145;-1
p3123-ye;1 Five participants;1;-1
p3123-ye;32  VI participants;32;-1
p3123-ye;11 VI participants;11;-1
p3123-ye;10 visually impaired  participants;10;-1
p3123-ye;5 participants;5;-1
p3123-ye;3 participants;3;-1
p3123-ye;2 participants;2;-1
p3123-ye;215 people;215;-1
p3123-ye;10  people;10;-1
p3123-ye;N = 114;114;-1
p3123-ye;N = 101;101;-1
p3123-ye;N=103;103;-1
p3123-ye;total of 247;247;-1
p3123-ye; data from 101;101;-1
p3123-ye; data  from 145;145;-1
p3133-wu;285 million visually  impaired people;285;-1
p3133-wu;191 blind people;191;-1
p3133-wu;15 blind people;15;-1
p3133-wu;191 blind people recruited;191;-1
p3143-schmidt;30 participants;30;-1
p3143-schmidt;20 participants;20;-1
p3143-schmidt;n = 5;5;-1
p3143-schmidt;total of 2;2;-1
p3153-liang;total of 12;12;-1
p3167-le-goc; dataset  of 32000;32000;-1
p3171-ens;2 participants;2;-1
p3171-ens;4 within-participants;4;-1
p3171-ens;10 participants;10;-1
p3171-ens;3 within-participants;3;-1
p3171-ens;12   participants;12;-1
p3171-ens;2 within-participants;2;-1
p3171-ens;8   participants;8;-1
p3171-ens;12 participants;12;-1
p3181-serrano;12 subjects;12;-1
p3181-serrano;total of 11;11;-1
p3191-lissermann;2 volunteer participants;2;-1
p3191-lissermann;32   participants;32;-1
p3201-lauber;2557063      virtual traffic participants;2557063;-1
p3201-lauber;26 subjects;26;-1
p3201-lauber;N=25;25;-1
p3201-lauber;n=10;10;-1
p3201-lauber;n=2;2;-1
p3205-wang;total of 18;18;-1
p3205-wang;total of 72;72;-1
p3215-bachynskyi;16 subjects;16;-1
p3215-bachynskyi;n = 0;0;-1
p3215-bachynskyi;n = 960;960;-1
p3215-bachynskyi;total of 25;25;-1
p3225-morris;114 participants;114;-1
p3225-morris;30 participants;30;-1
p3225-morris;100 participants;100;-1
p3225-morris;94 participants;94;-1
p3225-morris;20 participants;20;-1
p3235-vosoughi;5 participants;5;-1
p3235-vosoughi;total of 6;6;-1
p3235-vosoughi;total of 320;320;-1
p3239-masden;13 participants;13;-1
p3249-cranshaw;20 recruited participants;20;-1
p3249-cranshaw;20 participants;20;-1
p3249-cranshaw;20 recruited;20;-1
p3259-laureyssens;55 game  participants;55;-1
p3259-laureyssens;30 people;30;-1
p3259-laureyssens;n=276;276;-1
p3259-laureyssens;n=38;38;-1
p3259-laureyssens;n=17;17;-1
p3259-laureyssens;n=46;46;-1
p3259-laureyssens;n=35;35;-1
p3259-laureyssens;n=34;34;-1
p3259-laureyssens;n=30;30;-1
p3259-laureyssens;n=16;16;-1
p3259-laureyssens;n=20;20;-1
p3259-laureyssens;total of 247;247;-1
p3269-mcgookin;13 participants;13;-1
p3289-chan;36 of the participants;36;-1
p3289-chan;N = 563;563;-1
p3289-chan;N = 205;205;-1
p3299-yue;60 pairs of participants;60;-1
p3299-yue;120 people;120;-1
p3299-yue;total of   60;60;-1
p3309-reitberger;n=14;14;-1
p3309-reitberger;total of   21;21;-1
p3309-reitberger;total   of 505;505;-1
p331-mangano;total of 79;79;-1
p3319-pielot;84 participants;84;-1
p3319-pielot;13 participants;13;-1
p3319-pielot;4 participants;4;-1
p3319-pielot;24 participants;24;-1
p3319-pielot;102 people;102;-1
p3319-pielot;n = 4;4;-1
p3319-pielot;n =  3;3;-1
p3319-pielot;n =  18;18;-1
p3319-pielot;n = 6;6;-1
p3319-pielot;n = 2;2;-1
p3319-pielot;n = 23;23;-1
p3319-pielot;n = 9;9;-1
p3319-pielot;n = 8;8;-1
p3319-pielot;n = 3;3;-1
p3319-pielot;n = 18;18;-1
p3319-pielot;n = 5;5;-1
p3319-pielot;n = 7;7;-1
p3319-pielot;total of 6,423;6423;-1
p3319-pielot; data from 24;24;-1
p3349-liu;N = 9675;9675;-1
p3359-wohn;90 percent of the   people;90;-1
p3359-wohn;N=264,934;264934;-1
p3359-wohn;N=69,269;69269;-1
p3359-wohn;N=138,166;138166;-1
p3359-wohn;N= 28,608;28608;-1
p3359-wohn;N= 40,661;40661;-1
p3359-wohn; data of a 3;3;-1
p3369-li;24 participants;24;-1
p3369-li;8   participants;8;-1
p3369-li;6 participants;6;-1
p3369-li;2 participants;2;-1
p3369-li;4 untrained people;4;-1
p3369-li;4 trained   people;4;-1
p3369-li;30 were recruited;30;-1
p3369-li;total of 12;12;-1
p3379-dontcheva;5350 people;5350;-1
p3379-dontcheva;3512 people;3512;-1
p3379-dontcheva;8 people;8;-1
p3379-dontcheva;1290 people;1290;-1
p3389-dunwell;1,108 participants;1108;-1
p3389-dunwell;5 participants;5;-1
p3389-dunwell;31   participants;31;-1
p3389-dunwell;31 participants;31;-1
p3389-dunwell;n=1,108;1108;-1
p3389-dunwell;n=1,028;1028;-1
p3389-dunwell;n=28;28;-1
p3389-dunwell;n=99,683;99683;-1
p3389-dunwell;n=954;954;-1
p3389-dunwell;n=315,217;315217;-1
p3389-dunwell;n=99,608;99608;-1
p3389-dunwell;n=969;969;-1
p3389-dunwell;n=315,883;315883;-1
p3389-dunwell;n=814;814;-1
p3389-dunwell;n=337;337;-1
p3389-dunwell;n=743;743;-1
p3389-dunwell;n=31;31;-1
p3389-dunwell;n=618;618;-1
p3389-dunwell;n=111;111;-1
p3389-dunwell;total of 1,108;1108;-1
p3389-dunwell;total of 99,683;99683;-1
p3389-dunwell; data arising from 99,683;99683;-1
p3399-monserrat;18 participants;18;-1
p3399-monserrat;18   participants;18;-1
p3399-monserrat;n=7;7;-1
p3399-monserrat;n=6;6;-1
p3403-hsu;23 participants;23;-1
p3403-hsu;13 participants;13;-1
p3403-hsu;48 participants;48;-1
p3403-hsu;48 participants were recruited;48;-1
p3403-hsu;N=26;26;-1
p3403-hsu;N=27;27;-1
p341-benjamin;9 paid participants;9;-1
p341-benjamin;21 paid participants;21;-1
p341-benjamin;21 participants;21;-1
p3413-gerling;40 participants;40;21380
p3413-gerling;3700 participants;3700;3428
p3423-ruggiero;5 million people;5;-1
p3423-ruggiero;744,313 people;744313;-1
p3423-ruggiero;n=718;718;-1
p3423-ruggiero;n=279;279;-1
p3423-ruggiero;n=3829;3829;-1
p3423-ruggiero;n= 5139;5139;-1
p3423-ruggiero;n=5139;5139;-1
p3423-ruggiero;n=24;24;-1
p3423-ruggiero;total of 346;346;-1
p3423-ruggiero;total   of 200;200;-1
p3433-fiore;1,000 participants;1000;-1
p3433-fiore;15 participants;15;-1
p3433-fiore;60   participants;60;-1
p3433-fiore;77,000 people;77000;-1
p3433-fiore;24,000   people;24000;-1
p3433-fiore;15,700 people;15700;-1
p3433-fiore;229,500   people;229500;-1
p3433-fiore;627 people;627;-1
p3433-fiore;1B were successfully recruited;1;-1
p3433-fiore;15 ad were successfully recruited;15;-1
p3433-fiore;60 were   successfully recruited;60;-1
p3433-fiore;60 incentive   were recruited;60;-1
p3433-fiore;15   were recruited;15;-1
p3443-schwarz;16 participants;16;25959
p3443-schwarz;30 participants;30;14620
p3443-schwarz;total of 20;20;10560
p3443-schwarz;total of 1,785;1785;7315
p3443-schwarz;total of 40;40;3565
p3443-schwarz;total of 27;27;93
p3453-hayashi;75 participants;75;-1
p3453-hayashi;10,000  combinations of seven participants;10000;-1
p3453-hayashi;36 participants;36;-1
p3453-hayashi;27 participants;27;-1
p3453-hayashi;20 participants;20;-1
p3453-hayashi;10,000 combinations  of N participants;10000;-1
p3453-hayashi;12 participants;12;-1
p3453-hayashi;N=3;3;-1
p3453-hayashi;N=25;25;-1
p3463-cheng;14 participants;14;-1
p3463-cheng;11 participants;11;-1
p3463-cheng;5 people;5;-1
p3473-downs;10 pairs of participants;10;-1
p3473-downs;148 participants;148;-1
p3473-downs;134   participants;134;-1
p3473-downs;n=26;26;-1
p3473-downs;n=8;8;-1
p3473-downs;total of 67;67;-1
p3493-plasencia;total of 1080;1080;-1
p3503-ahmaniemi;16 participants;16;-1
p3503-ahmaniemi;4 participants;4;-1
p3503-ahmaniemi;6 participants;6;-1
p3503-ahmaniemi;9 participants;9;-1
p3503-ahmaniemi;12   participants;12;-1
p3503-ahmaniemi;8 participants;8;-1
p351-kazi;8 participants;8;-1
p3513-winkler;16 participants;16;-1
p3513-winkler;12 participants;12;-1
p3513-winkler;15 untrained right-  handed participants;15;-1
p3513-winkler;3 participants;3;-1
p3523-hornaek;N = 28;28;-1
p3523-hornaek;N = 7;7;-1
p3523-hornaek;N = 3;3;-1
p3523-hornaek;N = 4;4;-1
p3523-hornaek;N = 22;22;-1
p3523-hornaek;N =   22;22;-1
p3523-hornaek;N = 2;2;-1
p3523-hornaek;N = 6;6;-1
p3553-liu;N=702;702;-1
p3553-liu;N=2450;2450;-1
p3553-liu;n=0;0;-1
p3553-liu;N=28;28;-1
p3553-liu;total of 3152;3152;-1
p3563-de-choudhury;80 women;80;5463
p3563-de-choudhury;6   million people;6;21176
p3573-crivellaro;200 people;200;-1
p3573-crivellaro;8,000 people;8000;-1
p3573-crivellaro;total   of 4607;4607;-1
p3573-crivellaro;total of 1,047,591;1047591;-1
p3583-voida;12      participants;12;-1
p3597-prasad;1,222,000 persons;1222000;-1
p3597-prasad;16 participants;16;-1
p3597-prasad;total of 48;48;-1
p3597-prasad;total of 16;16;-1
p3597-prasad;total of 32;32;-1
p3597-prasad;total of 50;50;-1
p3607-moller;12 people;12;3164
p3607-moller;n = 1;1;3071
p3631-lee;N = 49;49;-1
p3631-lee;n = 0;0;-1
p3635-truong;10 participants;10;-1
p3635-truong;4   participants;4;-1
p3635-truong;4 participants;4;-1
p3635-truong;3   billion people;3;-1
p3635-truong;total of 16,398;16398;-1
p3635-truong;total of 8,280;8280;-1
p3645-vaish;82 participants;82;-1
p3645-vaish;n   = 3;3;-1
p3645-vaish;n = 6;6;-1
p3645-vaish;n =   6;6;-1
p3645-vaish;n = 5;5;-1
p3645-vaish;N=22;22;-1
p3645-vaish;N=11,014;11014;-1
p3645-vaish;N=5405;5405;-1
p3645-vaish; dataset of 11,014;11014;-1
p3655-forlines;30 students were recruited;30;-1
p3665-sampath;n = 20;20;-1
p3665-sampath;total of 62;62;-1
p3675-marshall;14 people;14;-1
p3705-geymayer;18 participants;18;-1
p3705-geymayer;10 participants;10;-1
p371-cairns;15 women;15;-1
p371-cairns;30 participants;30;-1
p371-cairns;10 participants;10;-1
p371-cairns;19 of the participants;19;-1
p3787-vi;90mins per participants;90;11624
p3787-vi;11 participants;11;18155
p3787-vi;320 trials per   participants;320;18486
p3787-vi;total of 1200;1200;1198
p3787-vi;total of 3520;3520;18527
p3797-afergan;12 participants;12;-1
p3797-afergan;12 subjects;12;-1
p3797-afergan;2557230  To keep people;2557230;-1
p3807-pike;n = 80;80;-1
p3807-pike;n =  80;80;-1
p3807-pike;n = 40;40;-1
p3807-pike; data from all 16;16;-1
p381-tan;10 participants;10;-1
p381-tan;total of 19;19;-1
p3835-khot;3 female participants;3;-1
p3835-khot;7 participants;7;-1
p3855-weichel;10 participants;10;-1
p3855-weichel;n = 20;20;-1
p3865-bailly;22 participants;22;1741
p3865-bailly;n=21;21;3777
p3899-oulasvirta; data from 1954;1954;-1
p3903-hope;22 participants;22;-1
p3903-hope;22 older adults;22;-1
p3903-hope;22   older adults;22;-1
p3903-hope;18 million   older adults;18;-1
p3903-hope;n=7;7;-1
p3903-hope;n=1;1;-1
p3913-rogers;5 older   people;5;-1
p3923-norval;30 participants;30;-1
p3923-norval;30   participants;30;-1
p3923-norval;8 people;8;-1
p3923-norval;7 people;7;-1
p3923-norval;25   older adults;25;-1
p3923-norval;5 adults;5;-1
p3923-norval;7 people were recruited;7;-1
p3923-norval;n = 40;40;-1
p3923-norval;n = 55;55;-1
p3923-norval;n = 1;1;-1
p3923-norval;n = 5;5;-1
p3923-norval;n = 4;4;-1
p3923-norval;N = 25;25;-1
p3923-norval;n = 6;6;-1
p3923-norval;n = 8;8;-1
p3923-norval;n = 3;3;-1
p3943-bardzell;N=156;156;-1
p3943-bardzell;N=28;28;-1
p3943-bardzell;N = 202;202;-1
p3953-scissors;8   participants;8;-1
p3953-scissors;1 A few participants;1;-1
p3953-scissors;N = 182;182;-1
p3963-mullenbach;24   participants;24;-1
p3963-mullenbach;12 participants;12;-1
p3963-mullenbach;12 people;12;-1
p3963-mullenbach;n=12;12;-1
p3963-mullenbach;n=6;6;-1
p3963-mullenbach;n=4;4;-1
p3963-mullenbach;n=3;3;-1
p3963-mullenbach;n=2;2;-1
p3963-mullenbach;n=5;5;-1
p3963-mullenbach;total of 24;24;-1
p3977-siriaraya;total of 9;9;-1
p3997-zhou;20 patients;20;-1
p4007-lafreniere;21 participants;21;-1
p4007-lafreniere;92 and participants;92;-1
p4007-lafreniere;12 participants;12;-1
p4007-lafreniere;12 study participants;12;-1
p4007-lafreniere;92 and participants recruited;92;-1
p4007-lafreniere;total of 21;21;-1
p4007-lafreniere;total of 2439;2439;-1
p4017-kim;total of 8,355;8355;-1
p4027-wang;6 older participants;6;-1
p4027-wang;6 young participants;6;-1
p4027-wang;12 participants;12;-1
p4037-bunt;16 participants;16;-1
p4037-bunt;11 participants;11;-1
p4037-bunt;7 participants;7;-1
p4047-hong;22 participants;22;-1
p4047-hong;11   of the participants;11;-1
p4047-hong;6   participants;6;-1
p4047-hong;6 participants;6;-1
p4047-hong;2   participants;2;-1
p4047-hong;4 participants;4;-1
p4047-hong;total of   542;542;-1
p4047-hong; data from 22;22;-1
p4057-solovey;28 male participants;28;-1
p4057-solovey;20 participants;20;-1
p4057-solovey;13 of the participants;13;-1
p4057-solovey;13 participants;13;-1
p4057-solovey;99 participants;99;-1
p4057-solovey;20 subjects;20;-1
p4057-solovey;99 subjects;99;-1
p4057-solovey;13 subjects;13;-1
p4057-solovey;3,331 people;3331;-1
p4057-solovey;146 individuals;146;-1
p4057-solovey; data from 20;20;-1
p4057-solovey; data from 99;99;-1
p4067-politis;3 within subjects;3;-1
p4077-rovelo;16 participants;16;-1
p4087-reetz;8 participants;8;-1
p4087-reetz;17 participants;17;-1
p4097-probst;10 unpaid   participants;10;-1
p4097-probst;12 unpaid participants;12;-1
p41-mark;48 participants;48;-1
p41-mark;9   participants;9;-1
p41-mark;19 participants;19;-1
p41-mark;46 participants;46;-1
p41-mark;26 people;26;-1
p41-mark;N=46;46;-1
p41-mark;n=7;7;-1
p41-mark;n=1;1;-1
p41-mark;total of 48;48;-1
p41-mark;total of 26;26;-1
p41-mark; data from 9;9;-1
p41-mark; data ranging from 2;2;-1
p4107-valdes;9 participants;9;-1
p4107-valdes;total of 560;560;-1
p411-hachisu;1 because participants;1;-1
p411-hachisu;24 people;24;-1
p411-hachisu;n=5;5;-1
p4117-winkler;6 participants;6;-1
p4127-radle;16 participants;16;-1
p4127-radle;16   participants;16;-1
p4127-radle;12 of the participants;12;-1
p4127-radle;4 within-subjects;4;-1
p4127-radle;n = 19;19;-1
p4147-liu;12 participants;12;3866
p4147-liu;11 summarizes participants;11;19192
p4147-liu;n = 6;6;1699
p4147-liu;n = 12;12;33
p4157-brubaker;10   women;10;-1
p4157-brubaker;20 interview participants;20;-1
p4157-brubaker;20 participants;20;-1
p4177-forghani;20 participants;20;-1
p4177-forghani;18 participants;18;-1
p4177-forghani;20   participants;20;-1
p4187-burke;6 people;6;-1
p4187-burke;N = 11,701;11701;-1
p4187-burke;n = 3,649;3649;-1
p4187-burke;n = 5;5;-1
p4187-burke;n = 1;1;-1
p4187-burke;N=40,521;40521;-1
p4187-burke;n = 1480;1480;-1
p4187-burke;n = 7366;7366;-1
p421-pedersen;12  participants;12;-1
p421-pedersen;12 participants;12;-1
p421-pedersen;10 participants;10;-1
p421-pedersen;5 within-subjects;5;-1
p431-rendl;8 unpaid participants;8;-1
p431-rendl;2 within-subjects;2;-1
p431-rendl;n = 22;22;-1
p431-rendl;n = 5;5;-1
p431-rendl;n = 3;3;-1
p435-kangas;12 volunteer participants;12;-1
p477-min;27   participants;27;-1
p477-min;17 participants;17;-1
p477-min;27 participants;27;-1
p477-min;122 drug-free subjects;122;-1
p477-min;27   people;27;-1
p487-fritz;30 participants;30;-1
p487-fritz;15 participants;15;-1
p501-vines;23 participants;23;-1
p501-vines;38 participants;38;-1
p501-vines;17 of the participants;17;-1
p501-vines;21 participants;21;-1
p501-vines;21   While some participants;21;-1
p501-vines;5 unemployed   young people;5;-1
p501-vines;11 older   people;11;-1
p501-vines;38 low-income   individuals;38;-1
p501-vines;5 individuals;5;-1
p501-vines;17 individuals;17;-1
p501-vines;3 of the older adults;3;-1
p501-vines;38 participants were recruited;38;-1
p51-hernandez;24 participants;24;-1
p51-hernandez;32 participants;32;-1
p51-hernandez;96 participants;96;-1
p51-hernandez;21 participants;21;-1
p51-hernandez;12 participants;12;-1
p51-hernandez;118 of the participants;118;-1
p51-hernandez;39 participants;39;-1
p51-hernandez;15 participants;15;-1
p51-hernandez;24   participants;24;-1
p51-hernandez;18 participants;18;-1
p51-hernandez;6 participants;6;-1
p51-hernandez;16   participants;16;-1
p51-hernandez;17 participants;17;-1
p51-hernandez;15   subjects;15;-1
p51-hernandez;14 people;14;-1
p51-hernandez;50 individuals;50;-1
p51-hernandez; data from 24;24;-1
p511-smith-clarke;5 million people;5;-1
p521-kaye;14 people;14;-1
p521-kaye;14 individuals;14;-1
p531-dillahunt;12 participants;12;-1
p531-dillahunt;N=25;25;-1
p531-dillahunt;N=12;12;-1
p541-setlur;N = 4;4;-1
p541-setlur; dataset, out of 28;28;-1
p551-albers;582 participants;582;78
p551-albers;8 participants;8;129
p551-albers;64 participants;64;186
p551-albers;360 participants;360;414
p551-albers;37 addi-  tional participants;37;651
p551-albers;total of 44;44;7909
p551-albers;total  of 582;582;88
p581-greenberg;2  women;2;-1
p581-greenberg;11 participants;11;-1
p581-greenberg;7 participants;7;-1
p581-greenberg;68,000 people;68000;-1
p581-greenberg;N=16,060;16060;-1
p581-greenberg;N=303;303;-1
p581-greenberg;N=1,230;1230;-1
p581-greenberg;N = 16,064;16064;-1
p581-greenberg;N = 306;306;-1
p581-greenberg;n = 306;306;-1
p581-greenberg; data come from 11;11;-1
p591-xu;7 million people;7;-1
p591-xu; data   from 8,529;8529;-1
p601-bigham;total of 6;6;-1
p601-bigham; data sets of 100;100;-1
p605-hazzard;22 participants;22;-1
p605-hazzard;35 examples   of participants;35;-1
p605-hazzard;53 occasions participants;53;-1
p605-hazzard;3 witnessed only five participants;3;-1
p605-hazzard;13 participants;13;-1
p605-hazzard;6 participants;6;-1
p61-sun;49 participants;49;22009
p61-sun;23 male subjects;23;6415
p61-sun;24 subjects;24;4619
p61-sun;total of 100;100;9972
p615-heller;24 participants;24;-1
p615-heller; data from 9;9;-1
p635-wein;89 participants;89;-1
p635-wein;87 participants;87;-1
p635-wein;N=89;89;-1
p639-robinson;13 participants;13;3243
p639-robinson;16 new participants;16;904
p643-matthews;2   participants;2;-1
p643-matthews;120 million people;120;-1
p643-matthews;N=15;15;-1
p653-adams;47 participants;47;-1
p653-adams;17 participants;17;-1
p653-adams;44 interested participants;44;-1
p653-adams;n=100;100;-1
p653-adams;n=1885;1885;-1
p653-adams;n=586;586;-1
p653-adams;total of 34;34;-1
p653-adams;total of 25;25;-1
p663-jacobs;8   While participants;8;-1
p663-jacobs;8   By providing participants;8;-1
p663-jacobs;230,000 people;230000;-1
p673-threatt;133,000 people;133000;-1
p683-vines;37 participants;37;-1
p683-vines;5 participants;5;-1
p683-vines;7 people;7;-1
p683-vines;8 people;8;-1
p71-tan;total of 77;77;-1
p723-gilliot;12 participants;12;-1
p733-mott;16 participants;16;-1
p733-mott;6 participants;6;-1
p733-mott;9 participants;9;-1
p733-mott;6   participants;6;-1
p733-mott;3 within-subjects;3;-1
p733-mott;N=16;16;-1
p733-mott;total of 3;3;-1
p733-mott;total of 6480;6480;-1
p733-mott;total of 2;2;-1
p733-mott;total of 14;14;-1
p743-pasqual;17   able-bodied participants;17;-1
p743-pasqual;17 participants;17;-1
p743-pasqual;17 subjects;17;-1
p743-pasqual; data from the 1;1;-1
p743-pasqual; data from the 2;2;-1
p753-su;6 participants;6;-1
p753-su;28 were recruited;28;-1
p753-su;total of 1,800;1800;-1
p753-su;total of 300;300;-1
p753-su;total of 900;900;-1
p753-su;total of  150;150;-1
p753-su;total of 27;27;-1
p753-su;total of 77,760;77760;-1
p773-schoenebeck;1   Some participants;1;-1
p773-schoenebeck;n=142;142;-1
p773-schoenebeck;n=4393;4393;-1
p773-schoenebeck;n=532;532;-1
p773-schoenebeck;n=45;45;-1
p773-schoenebeck;n=42;42;-1
p773-schoenebeck;n=61;61;-1
p783-rector;777 participants;777;-1
p783-rector;49 participants;49;-1
p783-rector;15 participants;15;-1
p783-rector;3 people;3;-1
p783-rector;49 individuals;49;-1
p783-rector; data from all 55;55;-1
p783-rector; data from all 49;49;-1
p793-grevet;19 participants;19;-1
p803-ur;20 participants;20;-1
p803-ur;318  MTurk participants;318;-1
p803-ur;226 participants;226;-1
p803-ur;163 participants;163;-1
p803-ur;n = 30;30;-1
p803-ur;n = 32;32;-1
p803-ur;total of 1,590;1590;-1
p803-ur;total of 62;62;-1
p803-ur;total of 77;77;-1
p803-ur;total of 513;513;-1
p803-ur;total of 858;858;-1
p81-kobsa;390 participants;390;-1
p81-kobsa;16 participants;16;-1
p81-kobsa;100 Craigslist   participants;100;-1
p81-kobsa;390 subjects;390;-1
p81-kobsa;8 subjects;8;-1
p81-kobsa;N=99;99;-1
p81-kobsa;total of 14;14;-1
p81-kobsa; data of 390;390;-1
p813-costanza;10 participants;10;-1
p813-costanza;5 participants;5;-1
p823-yang;16 participants;16;-1
p823-yang;23   participants;23;-1
p823-yang;total of   508;508;-1
p843-gao;42 participants;42;-1
p843-gao;28 of the participants;28;-1
p843-gao;N = 14;14;-1
p843-gao;total of 42;42;-1
p853-kovacs;6 students enrolled;6;-1
p853-kovacs;8 undergraduates enrolled;8;-1
p863-li;n = 4;4;-1
p863-li;total of 90;90;-1
p887-perin;143 participants;143;33171
p887-perin;62 participants;62;1103
p887-perin;34 participants;34;4493
p897-rzeszotarski;16 participants;16;-1
p897-rzeszotarski;15   participants;15;-1
p897-rzeszotarski;20 participants;20;-1
p897-rzeszotarski;2   participants;2;-1
p897-rzeszotarski;N=186;186;-1
p897-rzeszotarski; dataset   of 73;73;-1
p897-rzeszotarski; dataset of 133;133;-1
p907-hong;25   participants;25;-1
p907-hong;13 participants;13;-1
p907-hong;25 participants;25;-1
p907-hong;n=25;25;-1
p91-tan;568 participants;568;-1
p91-tan;1We asked participants;1;-1
p91-tan;2Entirely removing these participants;2;-1
p91-tan;3This question measured participants;3;-1
p91-tan;102 people;102;-1
p91-tan;53  people;53;-1
p91-tan;74 recruited;74;-1
p927-mekler;14 studies participants;14;-1
p927-mekler;10 studies  where only male participants;10;-1
p927-mekler;2 studies let participants;2;-1
p927-mekler;n=49;49;-1
p927-mekler;n=44;44;-1
p927-mekler;n=56;56;-1
p927-mekler;n=52;52;-1
p927-mekler;n=22;22;-1
p927-mekler;n=13;13;-1
p927-mekler;n=12;12;-1
p927-mekler;n=47;47;-1
p927-mekler;n=46;46;-1
p927-mekler;n=82;82;-1
p927-mekler;n=11;11;-1
p927-mekler;n=2;2;-1
p927-mekler;n=75;75;-1
p927-mekler;n=15;15;-1
p927-mekler;n=8;8;-1
p927-mekler;n=29;29;-1
p927-mekler;n=54;54;-1
p927-mekler;n=21;21;-1
p927-mekler;n=5;5;-1
p927-mekler;total of  3;3;-1
p927-mekler;total of 87;87;-1
p937-vicencio-moreira;12 pla  participants;12;-1
p947-bonsignore;n=10;10;-1
p951-silpasuwanchai;Total of 384;384;-1
p955-gou;256 participants;256;-1
p955-gou;650 invited participants;650;-1
p955-gou;N=224;224;-1
p975-kim;29 participants;29;-1
p975-kim;n = 870;870;-1
p991-maranan;n = 1;1;-1
p991-maranan;n = 0;0;-1
p1005-speicher;N=89;89;-1
p1005-speicher;N=4;4;-1
p1005-speicher;N=2;2;-1
p1005-speicher;total of 27;27;-1
p1005-speicher;total  of 20;20;-1
p1005-speicher;total  of 40;40;-1
p1005-speicher;total of 110;110;-1
p1015-yannier;1 Children were recruited;1;21692
p1025-norooz;30 participants;30;-1
p1025-norooz;16 participants;16;-1
p1025-norooz;total of 30;30;-1
p1035-bai;n = 0;0;-1
p1045-yannier;n=45;45;-1
p105-munteanu;2Such as allowing participants;2;-1
p105-munteanu;11  visually  impaired  participants;11;-1
p105-munteanu;14  people;14;-1
p105-munteanu;11 adults;11;-1
p105-munteanu;n=6;6;-1
p105-munteanu;11 adults enrolled;11;-1
p1055-brady;350 participants;350;-1
p1055-brady;91 participants;91;-1
p1055-brady;350 survey participants;350;-1
p1055-brady;142 participants;142;-1
p1055-brady;207 participants;207;-1
p1055-brady;17   participants;17;-1
p1055-brady;58 of the participants;58;-1
p1055-brady;91   participants;91;-1
p1055-brady;70,000 visual questions for blind people;70000;-1
p1055-brady;7337 people;7337;-1
p1055-brady;14 people;14;-1
p1055-brady;9 people;9;-1
p1055-brady;3 people;3;-1
p1055-brady;N=350;350;-1
p1055-brady;N=756;756;-1
p1065-dergousoff;13,000   participants;13000;-1
p1065-dergousoff;260 people;260;-1
p1065-dergousoff;80 people;80;-1
p1065-dergousoff;n=4;4;-1
p1065-dergousoff;n=3;3;-1
p1065-dergousoff;n=5;5;-1
p1065-dergousoff;n=1;1;-1
p1065-dergousoff; data from 841;841;-1
p1075-shih;N=212;212;-1
p1075-shih;total of 446;446;-1
p1085-bellotti;2,500 individuals;2500;-1
p1085-bellotti;total of 43;43;-1
p1095-lessel;2 other persons;2;-1
p1095-lessel;87 participants;87;-1
p1095-lessel;123 participants;123;-1
p1095-lessel;36 participants;36;-1
p1095-lessel;184  people;184;-1
p1095-lessel;35 people;35;-1
p1095-lessel;N=184;184;-1
p1095-lessel;n=5;5;-1
p1095-lessel;n=6;6;-1
p1095-lessel;n=3;3;-1
p1095-lessel;n=22;22;-1
p1095-lessel;n=2;2;-1
p1095-lessel;n=74;74;-1
p1095-lessel;n=110;110;-1
p1095-lessel;n=4;4;-1
p1095-lessel;n=148;148;-1
p1095-lessel;n=36;36;-1
p1105-ganglbauer;N = 843;843;-1
p1105-ganglbauer;N = 178;178;-1
p1105-ganglbauer;N = 96;96;-1
p1105-ganglbauer;N = 66;66;-1
p1105-ganglbauer;N = 194;194;-1
p1105-ganglbauer;N = 116;116;-1
p1105-ganglbauer;N = 111;111;-1
p1105-ganglbauer;N  = 208;208;-1
p1105-ganglbauer;N = 128;128;-1
p1105-ganglbauer;N =  128;128;-1
p1115-gaver;total of 21;21;-1
p1135-munson;136 were women;136;-1
p1135-munson;165 adult subjects;165;-1
p1135-munson;165   subjects;165;-1
p1135-munson;n=81;81;-1
p1145-macleod;19 participants;19;-1
p1145-macleod;10,000 people;10000;-1
p1145-macleod;350 million people;350;-1
p1145-macleod;150 people;150;-1
p1145-macleod;1 told people;1;-1
p1163-miniukovich;62 participants;62;3705
p1163-miniukovich;40 participants;40;3348
p1163-miniukovich;21   participants;21;3306
p1163-miniukovich;53 participants;53;9421
p1163-miniukovich;10 participants;10;9804
p1163-miniukovich;34 participants;34;9896
p1163-miniukovich;42 participants;42;9942
p1163-miniukovich;27 participants;27;10174
p1163-miniukovich;2 used between-subjects;2;16488
p1163-miniukovich;N = 62;62;25306
p1163-miniukovich;N =   53;53;25278
p1163-miniukovich;n = 6;6;917
p1163-miniukovich;n = 275;275;164
p1163-miniukovich;n =   3;3;152
p1163-miniukovich;n = 2;2;164
p1163-miniukovich;n   = 275;275;89
p1163-miniukovich;n = 3;3;75
p1163-miniukovich;n = 1;1;54
p1163-miniukovich;n = 300;300;11111
p1173-lee;8 participants;8;-1
p1173-lee;3   female participants;3;-1
p1173-lee;total of 720;720;-1
p1187-harrison;1,278  participants;1278;-1
p1187-harrison;1,278 participants;1278;-1
p1187-harrison;total of 1,278;1278;-1
p1191-haroz;12 women;12;-1
p1191-haroz;4 women;4;-1
p1191-haroz;30 subjects;30;-1
p1191-haroz;50 subjects;50;-1
p1191-haroz;4 Results   All subjects;4;-1
p1191-haroz;10 subjects;10;-1
p1201-zaman;N = 4;4;-1
p1201-zaman;total of 6;6;-1
p1211-kim;13 people;13;-1
p1225-slegers;13 women;13;-1
p1225-slegers;30   participants;30;-1
p1225-slegers;20 participants;20;-1
p1229-lee;8 participants;8;5395
p1233-hong;3 participants;3;-1
p1233-hong;24 participants;24;-1
p1233-hong;12 participants;12;-1
p1233-hong;12   participants;12;-1
p1237-oakley;18 participants;18;9973
p1237-oakley;16 participants;16;1304
p1237-oakley;total of 90;90;10768
p1237-oakley;total of 36;36;3335
p1237-oakley;total of 37;37;370
p1237-oakley;total of 27;27;323
p125-kulshreshth;32 participants;32;-1
p125-kulshreshth;120 minutes and all participants;120;-1
p125-kulshreshth;3D did not help people;3;-1
p125-kulshreshth;30 people;30;-1
p125-kulshreshth;17 people;17;-1
p125-kulshreshth;17  people;17;-1
p125-kulshreshth;9 people;9;-1
p125-kulshreshth;15 people;15;-1
p125-kulshreshth;26 people;26;-1
p125-kulshreshth;total of 16;16;-1
p1257-pearson;18 participants;18;-1
p1257-pearson;16  further participants;16;-1
p1257-pearson;34 participants;34;-1
p1257-pearson;15 participants;15;-1
p1257-pearson;12 participants;12;-1
p1257-pearson;47  staff and student participants;47;-1
p1257-pearson;21 participants;21;-1
p1257-pearson;42 participants;42;-1
p1257-pearson;14 participants;14;-1
p1257-pearson;300 people;300;-1
p1257-pearson;total of 300;300;-1
p1267-vissers;4 women;4;-1
p1267-vissers;8   participants;8;-1
p1277-savage;n = 93;93;-1
p1285-kwon;n=50;50;-1
p1285-kwon;n=26;26;-1
p1305-remy;7 participants;7;-1
p1315-berard;7 participants;7;-1
p1325-vatavu;20 participants;20;-1
p1325-vatavu;20  participants;20;-1
p1325-vatavu;5 participants;5;-1
p1325-vatavu;10  pairs of participants;10;-1
p1325-vatavu;12 participants;12;-1
p1325-vatavu;18 participants;18;-1
p1325-vatavu;n =  1;1;-1
p1325-vatavu;n = 12;12;-1
p1325-vatavu;n=12;12;-1
p1325-vatavu;N=840;840;-1
p1325-vatavu;N=80;80;-1
p1325-vatavu;N=800;800;-1
p1325-vatavu;N=160;160;-1
p1325-vatavu;N=200;200;-1
p1325-vatavu;N=378;378;-1
p1325-vatavu;N=36;36;-1
p1325-vatavu;N=144;144;-1
p1335-li;2 participants;2;-1
p1335-li;48 participants;48;-1
p1335-li;29 female participants;29;-1
p1335-li;19 male participants;19;-1
p1335-li;45 right-handed  participants;45;-1
p1335-li;03  Some participants;3;-1
p1335-li;46  Some participants;46;-1
p1345-mitra;700 people;700;-1
p1345-mitra;7 people;7;-1
p1345-mitra;2,000 people;2000;-1
p1345-mitra;N=68,000;68000;-1
p1345-mitra;total of 34;34;-1
p1345-mitra;total of 68,000;68000;-1
p1345-mitra;total of 45;45;-1
p1345-mitra;total of 42;42;-1
p135-ivkovic;6 within-participants;6;4197
p135-ivkovic;2 within-participants;2;3930
p1355-robb;32 participants;32;-1
p1355-robb;32 feedback participants;32;-1
p1355-robb;16   feedback participants;16;-1
p1355-robb;12 designer participants;12;-1
p1355-robb;12   participants;12;-1
p1355-robb;5 participants;5;-1
p1375-lasecki;N = 57;57;-1
p1375-lasecki;N = 71;71;-1
p1375-lasecki;N = 67;67;-1
p1375-lasecki;N = 84;84;-1
p1375-lasecki;N = 59;59;-1
p1379-robert;total of 4;4;-1
p1383-hang;38 persons;38;-1
p1383-hang;19 persons;19;-1
p1383-hang;19 participants;19;-1
p1383-hang;18 participants;18;-1
p1383-hang;11 participants;11;-1
p1383-hang;n=0;0;-1
p1383-hang;n=17;17;-1
p1383-hang;n = 14;14;-1
p1383-hang;total of 372;372;-1
p1393-buschek;28 participants;28;-1
p1403-von-zezschwitz;18 participants;18;6126
p1403-von-zezschwitz;16 participants;16;395
p1403-von-zezschwitz;n = 4;4;2652
p1403-von-zezschwitz;n=3;3;2563
p1403-von-zezschwitz;n=5;5;1867
p1403-von-zezschwitz;n=4;4;1942
p1403-von-zezschwitz;n=1;1;2313
p1407-winkler;18 participants;18;-1
p1407-winkler;13 participants;13;-1
p1407-winkler;36 degrees because  people;36;-1
p1411-de-luca;383 participants;383;-1
p1411-de-luca;17 participants;17;-1
p1411-de-luca;158 participants;158;-1
p1411-de-luca;n = 383;383;-1
p1415-patil;26  participants;26;-1
p1415-patil;10 participants;10;-1
p1415-patil;35 participants;35;-1
p1429-perrier;100 women;100;-1
p1429-perrier;100 pregnant women;100;-1
p1429-perrier;22 pregnant women;22;-1
p1429-perrier;100  women;100;-1
p1429-perrier;100 pregnant  women;100;-1
p1429-perrier;38 participants;38;-1
p1429-perrier;85 participants;85;-1
p1429-perrier;34 participants;34;-1
p1429-perrier;7 participants;7;-1
p1429-perrier;100 participants;100;-1
p1429-perrier;97 participants;97;-1
p1429-perrier;41 participants;41;-1
p1429-perrier;6 people;6;-1
p1429-perrier;total of 944;944;-1
p1429-perrier;total of 73;73;-1
p1429-perrier;total of 50;50;-1
p1429-perrier;total of 5028;5028;-1
p1429-perrier; data from 100;100;-1
p1429-perrier;  data from two 45;45;-1
p1439-liao;67 participants;67;-1
p145-denisova;7  women;7;-1
p145-denisova;40 participants;40;-1
p145-denisova;20 participants;20;-1
p145-denisova;20 people;20;-1
p145-denisova;40 participants was recruited;40;-1
p1459-amini;4 participants;4;-1
p1459-amini;5 participants;5;-1
p1459-amini;4   participants;4;-1
p1459-amini; data   videos from 8;8;-1
p1469-pandey;250 unique participants;250;-1
p1469-pandey;80 unique participants;80;-1
p1469-pandey;80 participants;80;-1
p1469-pandey;38 of those participants;38;-1
p1469-pandey;38 selected participants;38;-1
p1469-pandey;40 participants;40;-1
p1469-pandey; data. Out of the 80;80;-1
p1479-aseniero;15 participants;15;-1
p149-lee;1,257 participants;1257;-1
p149-lee;19 participants;19;-1
p149-lee; data from 56;56;-1
p1499-chang;11 participants;11;-1
p1499-chang;18 participants;18;-1
p1499-chang;15 participants;15;-1
p1499-chang;n = 2;2;-1
p1499-chang;n = 1;1;-1
p1499-chang;n = 5;5;-1
p15-abdelrahman;n = 30;30;-1
p15-abdelrahman;n= 1000;1000;-1
p1509-girouard;158 participants;158;-1
p1509-girouard;105 participants;105;-1
p1523-muller;16 participants;16;-1
p1523-muller;13 participants;13;-1
p1523-muller;16   participants;16;-1
p1523-muller;6 participants;6;-1
p1523-muller;5   participants;5;-1
p1523-muller;5 participants;5;-1
p1523-muller;3   participants;3;-1
p1523-muller;4 participants;4;-1
p1523-muller;N=16;16;-1
p1523-muller;n   = 20;20;-1
p153-eslami;40 participants;40;-1
p153-eslami;150,000. Our participants;150000;-1
p153-eslami;15 Aware participants;15;-1
p153-eslami;2As participants;2;-1
p153-eslami;40  original participants;40;-1
p153-eslami;19 people;19;-1
p153-eslami;n=12;12;-1
p153-eslami;n=15;15;-1
p153-eslami;n=11;11;-1
p153-eslami;n=5;5;-1
p153-eslami;n=19;19;-1
p153-eslami;n=9;9;-1
p153-eslami;n=21;21;-1
p153-eslami;n=4;4;-1
p153-eslami;n=13;13;-1
p153-eslami;n=24;24;-1
p153-eslami;n=6;6;-1
p1535-kim;n=27;27;-1
p1535-kim;n=3;3;-1
p1535-kim;n=1;1;-1
p1535-kim;n=13;13;-1
p1535-kim;total of 574;574;-1
p1545-orourke; data from 28;28;-1
p1555-glassman;25 student participants;25;-1
p1555-glassman;n=3;3;-1
p1555-glassman;n=13;13;-1
p1555-glassman;n=24;24;-1
p1555-glassman;n=0;0;-1
p1555-glassman;total of 36;36;-1
p1565-nguyen;6 participants;6;-1
p1569-cheng;2 faculty participants;2;-1
p1569-cheng;15 participants;15;-1
p1569-cheng;3 participants;3;-1
p1569-cheng;1 participants;1;-1
p1569-cheng;2 participants;2;-1
p1569-cheng;8 participants;8;-1
p1569-cheng;9   participants;9;-1
p1583-zhao;2 women;2;-1
p1583-zhao;18 women;18;-1
p1583-zhao;10   participants;10;-1
p1583-zhao;36 participants;36;-1
p1583-zhao;18 pairs   of participants;18;-1
p1583-zhao;40 adults;40;-1
p1583-zhao;18 elders were recruited;18;-1
p1583-zhao;n=35;35;-1
p1583-zhao;n=8;8;-1
p1583-zhao;n=15;15;-1
p1583-zhao;n=13;13;-1
p1583-zhao;n=5;5;-1
p1583-zhao;n=4;4;-1
p1583-zhao;total of 18;18;-1
p1593-neves;8  participants;8;-1
p1593-neves;400  million  people;400;-1
p1603-lee;total of   372;372;-1
p1617-marlow;184 participants;184;-1
p1621-salehi;216 participants;216;-1
p1621-salehi;1 as   groups of people;1;-1
p1621-salehi;100 individuals;100;-1
p1641-clark;30 participants;30;-1
p1641-clark;30  research subjects;30;-1
p1641-clark;30 subjects;30;-1
p1645-hoyle;36 participants;36;-1
p1645-hoyle;36  participants;36;-1
p1645-hoyle;1,015 images. We found that people;1015;-1
p1645-hoyle;N=36;36;-1
p1645-hoyle;N=75;75;-1
p1645-hoyle;N=186;186;-1
p1649-portnoff;500 participants;500;-1
p1649-portnoff;492 participants;492;-1
p1649-portnoff;98 participants;98;-1
p1649-portnoff;15 participants;15;-1
p1649-portnoff;46 participants;46;-1
p1649-portnoff;81 participants;81;-1
p1649-portnoff;179 participants;179;-1
p1649-portnoff;n = 98;98;-1
p1649-portnoff;n = 28;28;-1
p1649-portnoff;n = 20;20;-1
p1649-portnoff;n = 22;22;-1
p1649-portnoff;n = 94;94;-1
p1649-portnoff;n = 27;27;-1
p1649-portnoff;n = 18;18;-1
p1649-portnoff;n = 44;44;-1
p1649-portnoff;n = 37;37;-1
p1659-su;35 people;35;-1
p1659-su;10 people;10;-1
p1659-su;9 other people;9;-1
p1669-egelman;1,500 participants;1500;-1
p1669-egelman;2 depicts some of participants;2;-1
p1669-egelman;250 participants;250;-1
p1669-egelman;1,234  participants;1234;-1
p1669-egelman;23 participants;23;-1
p1669-egelman;85,000 individuals;85000;-1
p1669-egelman;n = 304;304;-1
p1669-egelman;total of 26;26;-1
p1669-egelman;total of 64;64;-1
p1669-egelman;total of 162;162;-1
p1669-egelman;total of 274;274;-1
p1679-kendall;34 adults;34;-1
p1679-kendall;n=36;36;-1
p1679-kendall;n=2,181;2181;-1
p1689-okane;41 participants;41;-1
p1689-okane;n=20;20;-1
p1689-okane;n=9;9;-1
p1689-okane;n=12;12;-1
p1699-paay;18 participants;18;-1
p1699-paay;9 of the same participants;9;-1
p1699-paay;18   participants;18;-1
p1699-paay;9 participants;9;-1
p1699-paay;total of 18;18;-1
p1709-balaam;3000 women;3000;-1
p1709-balaam;total of   1810;1810;-1
p1709-balaam;total of 109;109;-1
p1719-hyde;26 participants;26;-1
p1719-hyde;59 participants;59;-1
p1719-hyde;1,813 participants;1813;-1
p1719-hyde;35   Five participants;35;-1
p1719-hyde; data from   59;59;-1
p173-rader;n=26;26;-1
p173-rader;n=193;193;-1
p173-rader;N=341;341;-1
p173-rader;N=38;38;-1
p173-rader;N=85;85;-1
p173-rader;n=341;341;-1
p173-rader;n=85;85;-1
p173-rader;n=38;38;-1
p173-rader;total of 505;505;-1
p1739-trinh;60 participants;60;-1
p1739-trinh;30 participants;30;-1
p1739-trinh;13 participants;13;-1
p1739-trinh;12 remaining participants;12;-1
p1739-trinh;12 participants;12;-1
p1739-trinh;60 participants were   recruited;60;-1
p1739-trinh;40   students were recruited;40;-1
p1739-trinh;12 judges were recruited;12;-1
p1739-trinh;N=12;12;-1
p1769-jackson;10 people;10;-1
p1779-gannon;10 participants;10;-1
p1779-gannon;3D modeling participants;3;-1
p1817-bachynskyi;40 participants;40;-1
p1817-bachynskyi;38 of  the subjects;38;-1
p1817-bachynskyi;N=40;40;-1
p1817-bachynskyi;total of 109;109;-1
p1827-deber;14 right-  handed participants;14;-1
p1827-deber;10 participants;10;-1
p1827-deber;15 right-handed participants;15;-1
p1827-deber;n =    9,792;9792;-1
p1827-deber;total of 24;24;-1
p1827-deber;total of 8,556;8556;-1
p1827-deber;total of 8;8;-1
p1827-deber;total of   11;11;-1
p1827-deber;total of 51;51;-1
p183-hale;50,000 individuals;50000;-1
p1837-avrahami;5 women;5;-1
p1837-avrahami;12 participants;12;-1
p1837-avrahami;total of 504;504;-1
p1837-avrahami;total of 6,048;6048;-1
p1837-avrahami;total of 4608;4608;-1
p1847-tung;30  participants;30;-1
p1847-tung;30 participants;30;-1
p1847-tung; data of 30;30;-1
p1851-kato;10 participants;10;-1
p1855-nebeling;16 participants;16;-1
p1855-nebeling;25 people;25;-1
p1855-nebeling;N=16;16;-1
p1855-nebeling;n=1;1;-1
p1895-ammari;66 instances where   participants;66;-1
p1895-ammari;14   instances where participants;14;-1
p1895-ammari;n=62;62;-1
p1895-ammari;n=25;25;-1
p1895-ammari;n=34;34;-1
p1895-ammari;n=43;43;-1
p1895-ammari;total of 212;212;-1
p1905-ammari;19   Two participants;19;-1
p1905-ammari;n=31;31;-1
p1905-ammari;n=30;30;-1
p1905-ammari;n=35;35;-1
p1905-ammari;n=24;24;-1
p1905-ammari;n=10;10;-1
p1905-ammari;n=9;9;-1
p1905-ammari;n=6;6;-1
p1905-ammari;n=19;19;-1
p1905-ammari;n=12;12;-1
p1905-ammari;n=32;32;-1
p1935-laput;n=0;0;-1
p1935-laput;total of 332;332;-1
p1945-lasecki;5 images of different  people;5;-1
p1955-otterbacher;14,628 images of women;14628;1426
p1955-otterbacher;2,425 images of women;2425;5049
p1955-otterbacher;46,392 images of people;46392;5604
p1965-simm;8 participants;8;-1
p197-sen; dataset of 198;198;-1
p1975-sugarman;18 people;18;-1
p1975-sugarman;3   Previously enrolled;3;-1
p1985-kjeldskov;total of 631;631;-1
p1989-yun;11 participants;11;-1
p1989-yun;2 participants;2;-1
p1989-yun;n=6;6;-1
p1989-yun;n   = 12;12;-1
p1989-yun;n=45;45;-1
p1993-mauriello;6   participants;6;-1
p1993-mauriello;7 participants;7;-1
p1993-mauriello;2 participants;2;-1
p1993-mauriello;9 participants;9;-1
p1993-mauriello;10 participants;10;-1
p2003-jensen;10 participants;10;-1
p2003-jensen;7 of the participants;7;-1
p2003-jensen;4 participants;4;-1
p2003-jensen;4   participants;4;-1
p2013-knaving;total of 15;15;-1
p2013-knaving;total of 25;25;-1
p2023-mueller;13 participants;13;-1
p2033-kosmalla;20 participants;20;-1
p2033-kosmalla; data of a 9;9;-1
p2043-akshita;total of 110;110;-1
p2053-obrist;16 participants;16;25495
p2053-obrist;10 participants;10;15190
p2053-obrist;30 participants;30;10763
p2053-obrist;5 male participants;5;10620
p2053-obrist;n=30;30;20112
p2053-obrist;total of 10;10;14439
p2053-obrist;total of 30;30;10772
p2063-wilson;15 participants;15;-1
p2063-wilson;n   = 22;22;-1
p207-menking;2   women;2;-1
p207-menking;10 of these women;10;-1
p207-menking;20   participants;20;-1
p207-menking;1 Participants were   recruited;1;-1
p2073-valtchanov;53 participants;53;-1
p2073-valtchanov;9   individuals;9;-1
p211-huang;200,000 signa-  tures from people;200000;-1
p211-huang;20   people;20;-1
p211-huang;10,000 people;10000;-1
p211-huang;3,000,000 people;3000000;-1
p211-huang; data from 21,280;21280;-1
p2113-bae;29 participants;29;-1
p2125-zheng;12 participants;12;-1
p2125-zheng;6 participants;6;-1
p2125-zheng;262,447 people;262447;-1
p2135-dobbelstein;14 participants;14;-1
p2139-lauber;15 subjects;15;-1
p2139-lauber;5 subjects;5;-1
p2139-lauber;16 subjects;16;-1
p2139-lauber;3   subjects;3;-1
p2139-lauber;total of 9;9;-1
p2139-lauber;total of 24;24;-1
p2139-lauber;total of 16;16;-1
p2143-mcgill;12 participants;12;-1
p2143-mcgill;7 people;7;-1
p2143-mcgill;5 people;5;-1
p2143-mcgill;12 participants  were recruited;12;-1
p2143-mcgill;n=81;81;-1
p2143-mcgill;n=76;76;-1
p2143-mcgill;n=68;68;-1
p2143-mcgill;n=25;25;-1
p2143-mcgill;n=27;27;-1
p2153-apostolopoulos;16 subjects;16;-1
p2153-apostolopoulos;n = 3;3;-1
p2157-schmidt;12 participants;12;-1
p2161-laput;total of   180;180;-1
p2161-laput;total of 200;200;-1
p2161-laput;total of 36;36;-1
p2191-sato;total of 20;20;-1
p2201-jung;73 participants;73;-1
p2201-jung;10 participants;10;-1
p2201-jung;6   participants;6;-1
p2201-jung;N=73;73;-1
p221-malu;6 participants;6;-1
p221-malu;12 participants;12;-1
p221-malu;4 participants;4;-1
p221-malu;1 participants;1;-1
p221-malu;10 participants;10;-1
p221-malu;3 participants;3;-1
p221-malu;8   participants;8;-1
p221-malu;N = 8;8;-1
p221-malu;N = 2;2;-1
p221-malu;N = 7;7;-1
p221-malu;N = 12;12;-1
p221-malu;N = 5;5;-1
p221-malu;N = 6;6;-1
p221-malu;N = 4;4;-1
p221-malu;N =   3;3;-1
p221-malu;N = 10;10;-1
p221-malu;N =   10;10;-1
p221-malu;total of 8;8;-1
p2211-zhang;24 participants;24;-1
p2221-jokinen;18 participants;18;-1
p2221-jokinen;15 participants;15;-1
p2221-jokinen;18 participants were recruited;18;-1
p2221-jokinen;N = 18;18;-1
p2231-cramer;10 participants;10;-1
p2231-cramer;98 participants;98;-1
p2231-cramer;98   participants;98;-1
p2231-cramer;3 participants;3;-1
p2231-cramer;237 participants;237;-1
p2231-cramer;83 participants;83;-1
p2231-cramer;60 participants;60;-1
p2231-cramer;N=98;98;-1
p2231-cramer;N=237;237;-1
p2231-cramer;n=1;1;-1
p2231-cramer;n=240;240;-1
p2231-cramer;N=177;177;-1
p2235-harteveld;145 participants;145;-1
p2235-harteveld;20 participants;20;-1
p2235-harteveld;145 participants were recruited;145;-1
p2245-iacovides;5139 participants;5139;-1
p2245-iacovides;12 participants;12;-1
p2255-vicencio-moreira;N=30;30;-1
p2265-johnson;n=68;68;-1
p2265-johnson;n=80;80;-1
p2265-johnson;n=50;50;-1
p2265-johnson;n=32;32;-1
p2265-johnson;n=55;55;-1
p2265-johnson;n=143;143;-1
p2265-johnson;n=33;33;-1
p2275-strohmayer;total of 20;20;-1
p2285-dillahunt;20 participants;20;-1
p2285-dillahunt;20,000 or less. Eighteen   participants;20000;-1
p2285-dillahunt;16 participants;16;-1
p2285-dillahunt;20 individuals;20;-1
p2285-dillahunt;N=12;12;-1
p2285-dillahunt;N=8;8;-1
p2285-dillahunt;N=13;13;-1
p2285-dillahunt;N=20;20;-1
p2285-dillahunt;N=5;5;-1
p2285-dillahunt;N=4;4;-1
p2285-dillahunt;N=1;1;-1
p2285-dillahunt;N=2;2;-1
p2285-dillahunt;N=18;18;-1
p2285-dillahunt;N=7;7;-1
p2285-dillahunt;N=10;10;-1
p2285-dillahunt;N=14;14;-1
p2305-pater;179 total participants;179;-1
p2305-pater;13 participants;13;-1
p2305-pater;43   We anticipated participants;43;-1
p2305-pater;N=119;119;-1
p231-williams;8 participants;8;-1
p231-williams;14 participants;14;-1
p231-williams;6 participants;6;-1
p231-williams;2 participants;2;-1
p231-williams;3 participants;3;-1
p231-williams;8   participants;8;-1
p231-williams;4 participants;4;-1
p231-williams;14   participants;14;-1
p231-williams;9 participants;9;-1
p231-williams;7 participants;7;-1
p231-williams;7 all participants;7;-1
p231-williams;5 participants;5;-1
p231-williams;11   participants;11;-1
p231-williams;10 participants;10;-1
p231-williams;14   individuals;14;-1
p231-williams;N = 7;7;-1
p231-williams;n =   7;7;-1
p231-williams;n = 8;8;-1
p231-williams;n = 7;7;-1
p231-williams;N = 10;10;-1
p2315-al-ameen;25 women;25;4602
p2315-al-ameen;2 women;2;7437
p2315-al-ameen;37 participants;37;27784
p2315-al-ameen;31 of the participants;31;5316
p2315-al-ameen; data from 37;37;1838
p2325-dandapat;50 participants;50;-1
p2325-dandapat;70 participants;70;-1
p2325-dandapat;50 recruited participants;50;-1
p2325-dandapat;10 participants;10;-1
p2325-dandapat;15 participants;15;-1
p2325-dandapat;5 individuals;5;-1
p2325-dandapat;10 pairs of individuals;10;-1
p2325-dandapat;70  volunteers recruited;70;-1
p2325-dandapat;50 recruited;50;-1
p2325-dandapat;n = 3;3;-1
p2335-meutzner;1104 different participants;1104;-1
p2339-von-zezschwitz;298 participants;298;-1
p2339-von-zezschwitz;15 participants;15;-1
p2339-von-zezschwitz;n = 298;298;-1
p2339-von-zezschwitz;n=2;2;-1
p2339-von-zezschwitz;n=5;5;-1
p2339-von-zezschwitz;n=1;1;-1
p2339-von-zezschwitz;n=3;3;-1
p2339-von-zezschwitz;n=4;4;-1
p2343-song;101 participants;101;-1
p2343-song;83 of the participants;83;-1
p2343-song;101  participants;101;-1
p2343-song;total of 101;101;-1
p2353-zhong;3 within-subjects;3;-1
p2353-zhong;10 blind people;10;-1
p2353-zhong;total of 50;50;-1
p2353-zhong;total of 30;30;-1
p2353-zhong;total of   125;125;-1
p2373-branham;10 pairs of   participants;10;-1
p2373-branham;285 million people;285;-1
p2373-branham;8 million   people;8;-1
p2383-higuchi;32 participants;32;29989
p2383-higuchi;32 subjects;32;8835
p2383-higuchi;12 subjects;12;8084
p2383-higuchi;20 subjects;20;7330
p2383-higuchi;4 cells over all subjects;4;1167
p2383-higuchi;total of 32;32;29998
p2393-avellino;12 right-handed participants;12;-1
p2393-avellino;2 participants;2;-1
p2393-avellino;4 participants;4;-1
p2397-johnson;24 participants;24;-1
p2397-johnson;60 minutes and all participants;60;-1
p2397-johnson;16 of the participants;16;-1
p2397-johnson;N = 24;24;-1
p2397-johnson;N =  24;24;-1
p2397-johnson;n = 24;24;-1
p2397-johnson;total of 24;24;-1
p2407-butler; data from 2,377;2377;-1
p241-jain;24   deaf and hard of hearing participants;24;-1
p241-jain;4 new participants;4;-1
p241-jain;4   participants;4;-1
p241-jain;24 deaf and hard of hearing   participants;24;-1
p241-jain;19   participants;19;-1
p241-jain;24 participants;24;-1
p241-jain;16 participants;16;-1
p241-jain;18 participants;18;-1
p241-jain;4 participants;4;-1
p241-jain;14 participants;14;-1
p241-jain;3   more participants;3;-1
p241-jain;2 participants;2;-1
p241-jain;8 participants;8;-1
p241-jain;5 participants;5;-1
p241-jain;9 participants;9;-1
p241-jain;3   participants;3;-1
p241-jain;N=9;9;-1
p241-jain;N=15;15;-1
p241-jain;N=24;24;-1
p2417-rooksby;20   people;20;-1
p2427-darzentas;8 participants;8;-1
p2467-nissen;24 people;24;-1
p2477-devendorf;14   individuals;14;-1
p2487-alvina;3 women;3;-1
p2487-alvina;5 women;5;-1
p2487-alvina;4 women;4;-1
p2487-alvina;8   participants;8;-1
p2487-alvina;8 participants;8;-1
p2487-alvina;12 participants;12;-1
p2487-alvina;6 participants;6;-1
p2487-alvina;2   participants;2;-1
p2487-alvina;N = 3;3;-1
p2487-alvina;total of 40;40;-1
p2487-alvina;total of 15;15;-1
p2497-roumen;25 participants;25;-1
p2497-roumen;20   participants;20;-1
p2501-ion;8 participants;8;-1
p2505-pfeiffer;18 participants;18;-1
p2505-pfeiffer;10 participants;10;-1
p2505-pfeiffer;40 walking trials we asked participants;40;-1
p2505-pfeiffer;9 participants;9;-1
p2505-pfeiffer;4 male participants;4;-1
p2505-pfeiffer;4 right  turns and took participants;4;-1
p2505-pfeiffer;n=25;25;-1
p2505-pfeiffer; data from P4;4;-1
p2515-lopes;12 participants;12;-1
p2515-lopes;6 participants;6;-1
p2515-lopes;5 participants;5;-1
p2515-lopes;n=25;25;-1
p2525-dehais;7 participants;7;-1
p2525-dehais;7 subjects;7;-1
p2525-dehais;N=16;16;-1
p2535-sutherland;2 because participants;2;-1
p2535-sutherland;N = 23;23;-1
p2535-sutherland;N = 26;26;-1
p2535-sutherland;N = 22;22;-1
p2535-sutherland;total of 81;81;-1
p2545-schwarz;total of 140;140;-1
p255-goel;total of 60;60;-1
p2555-li;11 participants;11;-1
p2555-li;10 participants;10;-1
p2555-li;10   participants;10;-1
p2555-li;total of 240;240;-1
p2555-li;total of 10;10;-1
p2569-oppermann;36 participants;36;-1
p259-zhao;12  participants;12;-1
p259-zhao;total of 16;16;-1
p2593-lee;total of 98;98;-1
p2613-birnholtz;N=2803;2803;-1
p2633-mejova;135 persons;135;-1
p2633-mejova;398 persons;398;-1
p2633-mejova;69 participants;69;-1
p2633-mejova;11 participants;11;-1
p2643-hollis;9 women;9;20607
p2643-hollis;11 women;11;11868
p2643-hollis;19   participants;19;11920
p2643-hollis;16 participants;16;11835
p2643-hollis;6 participants;6;11834
p2643-hollis;3 participants;3;11178
p2643-hollis;4   participants;4;11261
p2643-hollis;N = 4;4;19523
p2643-hollis;n = 21;21;11853
p2643-hollis;n = 22;22;11774
p2643-hollis;n = 5;5;3284
p2643-hollis;n=4;4;3197
p2643-hollis;n = 3;3;2566
p2643-hollis;n=27;27;2112
p2643-hollis;n=6;6;2059
p2643-hollis;n = 4;4;1428
p2643-hollis;n = 2;2;11853
p2643-hollis;N=3;3;8585
p2643-hollis;N=5;5;11100
p2643-hollis;total of   12;12;7348
p2653-stawarz;133 participants;133;-1
p2653-stawarz;16 participants;16;-1
p2653-stawarz;n=22;22;-1
p2653-stawarz;N=13;13;-1
p2653-stawarz;n=21;21;-1
p2653-stawarz;N=14;14;-1
p2653-stawarz;N=16;16;-1
p2653-stawarz;N=15;15;-1
p2653-stawarz;N=18;18;-1
p2653-stawarz;N=20;20;-1
p2653-stawarz;n=19;19;-1
p2653-stawarz;N=45;45;-1
p2653-stawarz;n=17;17;-1
p2653-stawarz;N=51;51;-1
p2653-stawarz;n=15;15;-1
p2653-stawarz;N=38;38;-1
p2653-stawarz;n=20;20;-1
p2653-stawarz;N=29;29;-1
p2653-stawarz;n= 94;94;-1
p2653-stawarz;n=76;76;-1
p2653-stawarz;n= 75;75;-1
p2653-stawarz;N=115;115;-1
p2663-lawson;n=12;12;-1
p2663-lawson;n=1;1;-1
p269-liu;20 subjects;20;-1
p269-liu;28 subjects;28;-1
p2693-wacharamanotham;10 participants;10;-1
p2707-matejka;31 valid participants;31;-1
p2707-matejka;43 valid   participants;43;-1
p2707-matejka;total of 243;243;-1
p2711-ragan;43 participants;43;-1
p2711-ragan;14   participants;14;-1
p2711-ragan;total of 52;52;-1
p2739-carrascal;18 participants;18;19602
p2739-carrascal;18  participants;18;10794
p2739-carrascal;N=14;14;18861
p2739-carrascal;total of 394;394;10851
p2739-carrascal;total of 843;843;7966
p2739-carrascal;total of 535;535;6584
p2739-carrascal;total of 12;12;1242
p2749-bentley;200 diverse participants;200;-1
p2749-bentley;40 participants;40;-1
p2749-bentley;200   diverse participants;200;-1
p2749-bentley;200 participants;200;-1
p2749-bentley;50 participants;50;-1
p2749-bentley;200   participants;200;-1
p2749-bentley;15 other people;15;-1
p2749-bentley;200   people;200;-1
p2749-bentley;n = 30;30;-1
p2749-bentley;total of 25;25;-1
p2749-bentley; data from 200;200;-1
p2759-reda;13 columns giving participants;13;-1
p2759-reda;n = 31;31;-1
p2759-reda;n = 4;4;-1
p2759-reda;n = 3;3;-1
p2759-reda;n = 126;126;-1
p2759-reda;n = 86;86;-1
p2759-reda;N = 1327;1327;-1
p2759-reda;N = 145;145;-1
p2769-lischke;89 PPI can improve participants;89;-1
p2769-lischke;16 participants;16;-1
p2773-malacria;4 within-subjects;4;-1
p2773-malacria;n = 1;1;-1
p2773-malacria;total of 360;360;-1
p2777-guillon;6  women;6;-1
p2777-guillon;18 participants;18;-1
p2777-guillon;total of 10368;10368;-1
p2787-xu;12 participants;12;-1
p279-cao;20 people;20;-1
p2797-slovak;4 people;4;-1
p2801-carter;200 participants;200;-1
p2805-ammari;15   Some participants;15;-1
p2805-ammari;n=12;12;-1
p2805-ammari;n=38;38;-1
p2805-ammari;total of 45;45;-1
p2815-kim;3D printin  people;3;-1
p2815-kim;n = 6;6;-1
p2815-kim;n = 18;18;-1
p2833-harding;25 participants;25;-1
p2843-kim;38 participants;38;-1
p2843-kim;182 people;182;-1
p2843-kim;n=20;20;-1
p2843-kim;Total of 182;182;-1
p2843-kim;total of 404;404;-1
p2853-crivellaro;30 participants;30;-1
p2853-crivellaro;19 participants;19;-1
p2853-crivellaro;6   participants;6;-1
p2853-crivellaro;11 new participants;11;-1
p2853-crivellaro;total of 30;30;-1
p2873-egelman;479 participants;479;-1
p2873-egelman;2,184 additional participants;2184;-1
p2873-egelman;500 new participants;500;-1
p2873-egelman;456 participants;456;-1
p2873-egelman;80 participants;80;-1
p2873-egelman;5 participants;5;-1
p2873-egelman;68 participants;68;-1
p2873-egelman;500 participants;500;-1
p2873-egelman;n  =  6;6;-1
p2873-egelman;n =  4;4;-1
p2873-egelman;n =  1;1;-1
p2873-egelman;total of 503;503;-1
p2883-anderson;25   participants;25;2510
p2883-anderson;76 participants;76;6493
p2883-anderson;total of 13;13;4481
p2883-anderson; data from 76;76;6482
p289-du;8 participants;8;-1
p289-du;16  participants;16;-1
p289-du;total of 10,000;10000;-1
p289-du;total of 16;16;-1
p2893-felt;100 study participants;100;-1
p2893-felt;total of  7,537;7537;-1
p2893-felt;total of 7,537;7537;-1
p2903-shay;7,262 participants;7262;-1
p2903-shay;6,435 Part One participants;6435;-1
p2903-shay;8   of participants;8;-1
p2903-shay;9 illustrates participants;9;-1
p2903-shay;3,934 participants;3934;-1
p2903-shay; data from the 3,934;3934;-1
p2923-patel;11 participants;11;-1
p2933-khot;400 participants;400;-1
p2943-tajadura-jamenez;19 participants;19;-1
p2953-mariakakis;8 p  whom volunt   participants;8;-1
p2953-mariakakis;17 subjects;17;-1
p2953-mariakakis;n  = 62;62;-1
p2963-jo;13 participants;13;-1
p2981-zuger;2  arithmetic exercise participants;2;-1
p2981-zuger;10 lab study participants;10;-1
p2981-zuger;10  field study participants;10;-1
p2981-zuger;20 participants;20;-1
p2981-zuger;7 participants;7;-1
p2981-zuger;5 participants;5;-1
p2981-zuger;n=72;72;-1
p2981-zuger;n=139;139;-1
p2981-zuger;total of 30;30;-1
p2981-zuger;total  of 30;30;-1
p2981-zuger;  data ratings from 1;1;-1
p299-perrault;12 participants;12;4461
p299-perrault;16 new participants;16;4744
p299-perrault;11 participants;11;12326
p299-perrault;5 items and passive participants;5;12567
p299-perrault;9 participants;9;18134
p299-perrault;total of 200;200;1942
p299-perrault;total of 384;384;7009
p299-perrault;total of 150;150;18430
p2991-weigel;total of 4,320;4320;-1
p3001-chen;20  subjects;20;-1
p3001-chen;n = 24;24;-1
p3001-chen;n = 175;175;-1
p3001-chen;n = 68;68;-1
p3001-chen;n = 22;22;-1
p3001-chen;n = 150;150;-1
p3001-chen;total of 20;20;-1
p3001-chen; database of  20;20;-1
p3011-holz;12 participants;12;-1
p3011-holz;11 participants;11;-1
p3015-kao;10 participants;10;-1
p3015-kao;total of 60;60;-1
p3019-fukahori;20 participants;20;-1
p3019-fukahori; data from FSR 402;402;-1
p3029-fairclough;14 participants;14;-1
p3029-fairclough;16 participants;16;-1
p3029-fairclough;N=14;14;-1
p3029-fairclough;N=1;1;-1
p3029-fairclough;total of 40;40;-1
p3039-maior;N = 15;15;-1
p3043-baker;2 within-subjects;2;-1
p3043-baker;n = 2;2;-1
p3043-baker;n = 4;4;-1
p3043-baker;n = 5;5;-1
p3043-baker;total of 6;6;-1
p3043-baker;total of 42;42;-1
p3053-ou;27 participants;27;-1
p3053-ou;16 participants;16;-1
p3053-ou;30  participants;30;-1
p3053-ou;1 between-subjects;1;-1
p3053-ou;total of  81;81;-1
p3053-ou;total of 16;16;-1
p3063-lerner;14 participants;14;-1
p3063-lerner;10 participants;10;-1
p3063-lerner;total of 541;541;-1
p3063-lerner;total of 260;260;-1
p3063-lerner;total of 7;7;-1
p3063-lerner;total of 12;12;-1
p309-omirou;total of 8;8;-1
p3093-chetty;1 When participants;1;-1
p3103-neate;18 participants;18;-1
p3103-neate;11 participants;11;-1
p3107-hou;2   participants;2;-1
p3107-hou;15 participants;15;-1
p3107-hou;6 participants;6;-1
p3107-hou;20 people;20;-1
p3107-hou;N=25;25;-1
p3107-hou;N=23;23;-1
p3127-koeman;total of 43;43;-1
p313-shovman;n = 833;833;-1
p3147-pine;43,000 people;43000;-1
p3157-green;11 participants;11;-1
p3167-semaan;14 participants;14;-1
p3167-semaan;21 subjects;21;-1
p3167-semaan;8 subjects;8;-1
p317-achibet;16 participants;16;-1
p317-achibet;4  of these participants;4;-1
p317-achibet;12 re-  maining participants;12;-1
p317-achibet;12  remaining participants;12;-1
p317-achibet;n = 0;0;-1
p317-achibet;n = 1;1;-1
p317-achibet;n = 6;6;-1
p317-achibet;n = 4;4;-1
p317-achibet;n = 2;2;-1
p317-achibet;n = 7;7;-1
p317-achibet;n = 5;5;-1
p317-achibet;n = 3;3;-1
p3187-tsugawa;209 participants;209;-1
p3187-tsugawa;219 people;219;-1
p3187-tsugawa;10,000  people;10000;-1
p3187-tsugawa;total of  84,255;84255;-1
p3197-abbar;067 people;67;-1
p3197-abbar;N = 191;191;-1
p3197-abbar;total  of 2;2;-1
p3197-abbar;total of 30;30;-1
p3207-cordeiro;27 participants;27;-1
p3207-cordeiro;14 participants;14;-1
p3207-cordeiro;13 participants;13;-1
p3207-cordeiro;1 contained participants;1;-1
p3207-cordeiro;2 contained   only participants;2;-1
p3207-cordeiro;1  participants;1;-1
p3207-cordeiro;2 participants;2;-1
p3207-cordeiro;257 people;257;-1
p3207-cordeiro;27 people;27;-1
p3207-cordeiro;10 people;10;-1
p3207-cordeiro;total of 27;27;-1
p3207-cordeiro;total of 3569;3569;-1
p3217-mamykina;30 participants;30;-1
p3217-mamykina;10   people;10;-1
p3217-mamykina;70 people;70;-1
p3217-mamykina;10 people;10;-1
p3217-mamykina;n=9;9;-1
p3217-mamykina;n=13;13;-1
p3217-mamykina;n=2;2;-1
p3217-mamykina;n=7;7;-1
p3217-mamykina;n=3;3;-1
p3237-taher;17   participants;17;-1
p3237-taher;17 participants;17;-1
p3237-taher;40 minutes and participants;40;-1
p3237-taher;5   participants;5;-1
p3247-stusak;40 participants;40;10668
p3247-stusak;24 participants;24;5996
p3251-ottley;54 participants;54;-1
p3251-ottley;N= 91;91;-1
p3251-ottley;N=91;91;-1
p3251-ottley;total of 108;108;-1
p3255-tsandilas;total of 1038;1038;-1
p327-perelman;12 participants;12;-1
p327-perelman;15   participants;15;-1
p327-perelman;12 subjects;12;-1
p327-perelman;4 within-subjects;4;-1
p3275-clarke;49 participants;49;-1
p3307-simeone;20 participants;20;-1
p3307-simeone;4 participants;4;-1
p3307-simeone;total of 1540;1540;-1
p3307-simeone;total of 9;9;-1
p3317-miksik;285 million people;285;-1
p3327-tung;5  persons;5;-1
p3327-tung;24  participants;24;-1
p3327-tung;24 participants;24;-1
p3327-tung;7 participants;7;-1
p3327-tung;17 participants;17;-1
p3327-tung;total of 2448;2448;-1
p3327-tung;total  of 2448;2448;-1
p3327-tung;total  of 24;24;-1
p3355-lu;14 participants;14;-1
p3355-lu;94 participants;94;-1
p3355-lu;5 participants;5;-1
p3355-lu;total of 540;540;-1
p3355-lu;total of 3,834;3834;-1
p3355-lu;total of   642,670;642670;-1
p3355-lu;total of 9,995;9995;-1
p3355-lu;total of 25;25;-1
p3355-lu; dataset of 300;300;-1
p3365-smith;14 participants;14;-1
p3365-smith;total of 14;14;-1
p337-amershi;14 participants;14;-1
p3375-putze;20 participants;20;19987
p3375-putze;10 participants;10;19740
p3375-putze;11 participants;11;2359
p3375-putze;total of 20;20;1112
p3375-putze; data from 20;20;16130
p3375-putze; data from 11;11;2370
p3385-vigo;n = 1;1;-1
p3385-vigo;n = 2;2;-1
p3385-vigo;n = 4;4;-1
p3385-vigo;n = 16;16;-1
p3385-vigo;n = 9;9;-1
p3385-vigo;n = 8;8;-1
p3395-zhang;12 participants;12;-1
p3395-zhang;6 female participants;6;-1
p3395-zhang;12 people;12;-1
p3395-zhang;3  Participants  We recruited;3;-1
p3395-zhang;n = 60;60;-1
p3395-zhang;n = 97;97;-1
p3395-zhang;n = 58;58;-1
p3395-zhang;n =  96;96;-1
p3395-zhang;n = 35;35;-1
p3395-zhang;n =  78;78;-1
p3395-zhang;n = 1;1;-1
p3395-zhang;n = 3;3;-1
p3395-zhang;n = 8;8;-1
p3395-zhang;n = 10;10;-1
p3395-zhang;n = 23;23;-1
p3395-zhang;n = 25;25;-1
p3413-rajanen;total of 15;15;-1
p3413-rajanen;total of 40;40;-1
p3423-watkins;12   women;12;-1
p3423-watkins;20 people;20;-1
p3423-watkins;20 individuals;20;-1
p3423-watkins;total of 100;100;-1
p3433-gruning;total of 39;39;-1
p3443-van-gennip;15 participants;15;-1
p3453-gulotta;12 adults;12;-1
p3463-gao;57 individuals;57;-1
p3463-gao;N = 19;19;-1
p3463-gao;total of 57;57;-1
p347-kay;50 participants;50;-1
p347-kay;22 participants;22;-1
p347-kay;N = 26;26;-1
p347-kay;N = 24;24;-1
p3473-hara;46 participants;46;-1
p3473-hara;16 participants;16;-1
p3473-hara;30 participants;30;-1
p3473-hara;46   participants;46;-1
p3473-hara;40 million foreign-born individuals;40;-1
p3473-hara;N=16;16;-1
p3473-hara;N=30;30;-1
p3473-hara;N=46;46;-1
p3473-hara;total of 23;23;-1
p3473-hara;total of 46;46;-1
p3483-steichen;885 participants;885;-1
p3483-steichen;885   participants;885;-1
p3483-steichen;15 When participants;15;-1
p3483-steichen;1220 participants;1220;-1
p3483-steichen;193   participants;193;-1
p3483-steichen;48 participants;48;-1
p3483-steichen;9 participants;9;-1
p3483-steichen;1 was participants;1;-1
p3483-steichen;24    When splitting participants;24;-1
p3483-steichen;total of 4;4;-1
p3483-steichen;total of 1220;1220;-1
p3483-steichen;total of 76;76;-1
p3493-plimmer;6 family groups were   recruited;6;-1
p3503-edge;12 participants;12;-1
p3513-jones;2 PIM panel participants;2;-1
p3513-jones;2 participants;2;-1
p3513-jones;1 were recruited;1;-1
p3513-jones;2 were recruited;2;-1
p3523-ahmed;9 women;9;-1
p3523-ahmed;14 visually impaired participants;14;-1
p3523-ahmed;14 participants;14;-1
p3523-ahmed;8 million people;8;-1
p3523-ahmed;6 people;6;-1
p3523-ahmed;4 people;4;-1
p3523-ahmed;14 vi-  sually impaired people;14;-1
p3523-ahmed;N=14;14;-1
p3523-ahmed;N=7;7;-1
p3523-ahmed;N=5;5;-1
p3523-ahmed;N=2;2;-1
p3523-ahmed;N=9;9;-1
p3523-ahmed;N=4;4;-1
p3523-ahmed;N=3;3;-1
p3523-ahmed;N=11;11;-1
p3523-ahmed;N=6;6;-1
p3543-flatla;22 unpaid participants;22;-1
p3543-flatla;n=26;26;-1
p3543-flatla;total of 65536;65536;-1
p3553-oskamp;26 participants;26;2928
p3553-oskamp;25 participants;25;6187
p3553-oskamp;6 participants;6;2927
p3553-oskamp;24 participants;24;13354
p3553-oskamp;17   participants;17;14297
p3553-oskamp;total of 9;9;2141
p3563-willett;20 participants;20;-1
p3563-willett;14 unpaid participants;14;-1
p3563-willett;n = 27;27;-1
p3563-willett;n = 30;30;-1
p3563-willett;total of 8,100;8100;-1
p357-cockburn;10 participants;10;-1
p357-cockburn;32 participants;32;-1
p357-cockburn;16 participants;16;-1
p357-cockburn;total of 25;25;-1
p3573-lobo;3 distinct participants;3;-1
p3573-lobo;15 participants;15;-1
p3573-lobo;total of 120;120;-1
p3573-lobo;total of 1071;1071;-1
p3583-fechner;39 participants;39;-1
p3583-fechner;17 participants;17;-1
p3583-fechner;19 participants;19;-1
p3583-fechner;36 participants;36;-1
p3583-fechner;39 participants were recruited;39;-1
p3583-fechner;n = 20;20;-1
p3603-andrist;22 participants;22;-1
p3603-andrist;30 participants;30;-1
p3603-andrist;40 participants;40;-1
p3603-andrist;2 between-participants;2;-1
p3603-andrist;001 and intro-  verted participants;1;-1
p3613-sauppe;total of 17;17;-1
p3623-walther-franks;16 participants;16;904
p3623-walther-franks;15 participants;15;482
p3623-walther-franks;n=0;0;2468
p3643-sridhar;13 participants;13;-1
p3643-sridhar;10 right-handed participants;10;-1
p3643-sridhar;4 within-subjects;4;-1
p3643-sridhar;n = 5;5;-1
p3643-sridhar;total of 48;48;-1
p3643-sridhar; data from  4;4;-1
p3653-haque;7  participants;7;-1
p3653-haque;14 participants;14;-1
p3661-withana;n = 3;3;12783
p3661-withana;n = 23;23;5783
p3661-withana;n = 28;28;5761
p3661-withana;total of 7;7;11292
p367-asthana;N = 1353;1353;-1
p367-asthana;N = 1082;1082;-1
p367-asthana;total of 8,748;8748;-1
p3671-kardan;18 participants;18;8984
p3671-kardan; dataset of 110;110;21456
p3691-sadauskas;14 student   participants;14;-1
p3691-sadauskas;46 participants;46;-1
p3691-sadauskas;97 people;97;-1
p3691-sadauskas;1209 people;1209;-1
p3691-sadauskas;25 people;25;-1
p3691-sadauskas;total of 130;130;-1
p3691-sadauskas;   data imported from the 46;46;-1
p3701-cai;20 participants;20;-1
p3701-cai;21 participants;21;-1
p3701-cai;20  people;20;-1
p3701-cai;21 participants were recruited;21;-1
p3701-cai;n=25;25;-1
p3701-cai;n=1;1;-1
p3701-cai;n=3973;3973;-1
p3701-cai;n=4888;4888;-1
p3701-cai;n=3628;3628;-1
p3701-cai;n=4009;4009;-1
p3701-cai;n=4209;4209;-1
p3701-cai;n=2216;2216;-1
p3701-cai;n=3446;3446;-1
p3701-cai;n=6;6;-1
p3701-cai;n=5;5;-1
p3701-cai;total of 249;249;-1
p3711-yan;n  = 0;0;-1
p3721-johnson;72   participants;72;-1
p3721-johnson;72 participants;72;-1
p3721-johnson;n = 72;72;-1
p3721-johnson;n = 55;55;-1
p3731-das;16 participants;16;-1
p3731-das;n=4;4;-1
p3731-das;n=3;3;-1
p3731-das;n=5;5;-1
p3735-preist;11   subjects;11;-1
p3735-preist;11 subjects;11;-1
p3735-preist;10 subjects;10;-1
p3739-kwak;N = 580,480;580480;-1
p3739-kwak;N = 3,108,172;3108172;-1
p3739-kwak;N  = 1,955,297;1955297;-1
p3749-yerousis;total of 59;59;-1
p3769-engel;4 persons;4;-1
p3769-engel;4 people;4;-1
p3779-brzozowski;12 subjects;12;-1
p3789-vasilescu;500 individuals;500;-1
p3799-mudliar;n=109;109;-1
p3799-mudliar;n =53;53;-1
p3799-mudliar;n = 109;109;-1
p3809-haimson;N = 3;3;-1
p3809-haimson;N = 2;2;-1
p3809-haimson;N = 1;1;-1
p3809-haimson;N =   4;4;-1
p3819-kay;8 images of women;8;-1
p3829-konrad;77 participants;77;22915
p3829-konrad;24 participants;24;21674
p3839-you;4 women;4;8333
p3839-you;3 women;3;2890
p3839-you;20 participants;20;9084
p3839-you;27 participants;27;8368
p3839-you;8 inter-  vention participants;8;3969
p3839-you;27 clinical patients;27;31381
p3839-you;27 alcohol-dependent patients;27;26213
p3839-you;27  alcohol-dependent patients;27;10149
p3839-you;27 patients;27;9140
p3839-you;27 inter-  vened patients;27;2753
p3839-you;5 intervened patients;5;3261
p3839-you; data from 27;27;9151
p3839-you; data from 20;20;7541
p3859-latulipe;36 patient participants;36;-1
p3859-latulipe;31 patient participants;31;-1
p3859-latulipe;74,000 patients;74000;-1
p3859-latulipe;36 patients;36;-1
p3859-latulipe;20 patients;20;-1
p3859-latulipe;16  patients;16;-1
p3859-latulipe;52 individuals;52;-1
p3869-muller;12 participants;12;-1
p387-hazzard;6 participants;6;-1
p3889-dalton;24 participants;24;-1
p3889-dalton;22 participants;22;-1
p3889-dalton;12 participants;12;-1
p3889-dalton;24 participants were recruited;24;-1
p3889-dalton;total of 3;3;-1
p3889-dalton;total of 59;59;-1
p3899-huber; data from 115;115;-1
p39-guerreiro;30 novice   touchscreen participants;30;-1
p39-guerreiro;30 visually impaired participants;30;-1
p39-guerreiro;total of 150;150;-1
p3903-jokela;14 participants;14;-1
p3903-jokela;14 people;14;-1
p3903-jokela;total of 14;14;-1
p3903-jokela;total of 111;111;-1
p3903-jokela;total of 123;123;-1
p3913-radle;5   participants;5;-1
p3913-radle;12 participants;12;-1
p3913-radle;17 participants;17;-1
p3913-radle;13   participants;13;-1
p3913-radle;11 participants;11;-1
p3913-radle;8 participants;8;-1
p3913-radle;N=17;17;-1
p3913-radle;N=12;12;-1
p3913-radle;n=26;26;-1
p3913-radle;n=3;3;-1
p3913-radle;n=2;2;-1
p3913-radle;n=4;4;-1
p3913-radle;n=5;5;-1
p3913-radle;n = 20;20;-1
p3923-chi;12   participants;12;-1
p3923-chi;12 participants;12;-1
p3923-chi;n=28;28;-1
p3923-chi;n=9;9;-1
p3933-grubert;23 participants;23;-1
p3933-grubert;6 participants;6;-1
p3933-grubert;total of 23;23;-1
p3943-caramiaux;43 participants;43;-1
p3943-caramiaux;15 participants;15;-1
p3943-caramiaux;6 participants;6;-1
p3943-caramiaux;9   participants;9;-1
p3943-caramiaux;total of 43;43;-1
p3953-mcmillan;total of 2,502;2502;-1
p3963-wolters;10 older participants;10;-1
p3963-wolters;10 participants;10;-1
p3963-wolters;45 study participants;45;-1
p3963-wolters;45 participants;45;-1
p3963-wolters;total of 174;174;-1
p3963-wolters; data from 35;35;-1
p3967-limerick;4 participants;4;-1
p3971-politis;30 min   and participants;30;-1
p3971-politis;30 min and participants;30;-1
p3971-politis;2 within subjects;2;-1
p3971-politis;total of 82;82;-1
p3981-hanrahan;20 participants;20;-1
p3981-hanrahan;52 participants;52;-1
p3981-hanrahan;14 participants;14;-1
p3985-fleck;285 participants;285;-1
p3985-fleck;26 participants;26;-1
p3989-cecchinato;19 participants;19;-1
p3989-cecchinato;16 participants;16;-1
p3989-cecchinato;11 participants;11;-1
p3989-cecchinato;n =13,877;13877;-1
p3989-cecchinato;n=596;596;-1
p3989-cecchinato;N=9;9;-1
p3989-cecchinato;N=6;6;-1
p3989-cecchinato;total of 17;17;-1
p3999-shami; data from all of   2013;2013;-1
p4009-zhang;415 remaining participants;415;-1
p4009-zhang;74 people;74;-1
p4009-zhang;708  unique people;708;-1
p4009-zhang;800 people;800;-1
p4019-renaud;134 participants;134;3340
p4019-renaud;5 participants;5;2395
p4019-renaud;33 participants;33;1334
p4019-renaud;1601 participants;1601;4678
p4019-renaud;869 child participants;869;11833
p4019-renaud;100 participants;100;12977
p4019-renaud;74 adults;74;4315
p4019-renaud;24 adults;24;1266
p4019-renaud;219 adults;219;4714
p4019-renaud;356 adults;356;11895
p4019-renaud;18 and over were recruited;18;4272
p4019-renaud;33 participants were recruited;33;1334
p4019-renaud;N=2;2;3013
p4019-renaud;total of 33;33;1343
p4019-renaud;total of 1601;1601;4669
p4019-renaud;total of 44;44;7643
p4029-wisniewski;N = 75;75;-1
p4029-wisniewski;total of 75;75;-1
p4039-jang;27K teens and adults;27;-1
p4039-jang;8,596 adults;8596;-1
p4039-jang;26,885 teens and adults;26885;-1
p4039-jang;8,596 teens and   adults;8596;-1
p4039-jang;N=26,885;26885;-1
p4039-jang;total of 100;100;-1
p4039-jang;total of 160;160;-1
p4039-jang;total of   27;27;-1
p4039-jang;total of 26,885;26885;-1
p4047-grevet;8 participants;8;-1
p4047-grevet;71 participants;71;-1
p4047-grevet;112 participants;112;-1
p4047-grevet;33 participants;33;-1
p4047-grevet;31 participants;31;-1
p4061-cheng;110 participants;110;-1
p4061-cheng;110 people;110;-1
p4061-cheng;total of 110;110;-1
p4065-kuznetsov;4 participants;4;-1
p4069-tinati;10,000 people;10000;-1
p4069-tinati;10,000  people;10000;-1
p407-coughlan;6 participants;6;-1
p407-coughlan;total of 145;145;-1
p407-coughlan; database of 70,000;70000;-1
p4079-french;248   participants;248;-1
p4083-ludwig;150 people;150;-1
p4083-ludwig;14,000 people;14000;-1
p4113-palen;40,000 people;40000;-1
p4113-palen;8 million people;8;-1
p4113-palen;14 million people;14;-1
p4123-tang;16 participants;16;-1
p4123-tang;14 participants;14;-1
p4123-tang;n = 10;10;-1
p4123-tang;n = 28;28;-1
p4133-tetteroo;20 participants;20;-1
p4143-smeddinck;29 patients;29;-1
p4143-smeddinck;n  =0;0;-1
p4143-smeddinck;n = 5;5;-1
p4143-smeddinck;n = 6;6;-1
p4143-smeddinck;n = 0;0;-1
p4165-mayer;11 remaining participants;11;-1
p4165-mayer;total of 420;420;-1
p4165-mayer; data of the 11;11;-1
p4169-jakobsen;N = 384;384;-1
p4169-jakobsen;N = 160;160;-1
p417-vashistha;1,500 people;1500;-1
p417-vashistha;73 people;73;-1
p417-vashistha;204  people;204;-1
p417-vashistha;100 people;100;-1
p417-vashistha;11,751 people;11751;-1
p417-vashistha;N=36;36;-1
p417-vashistha;N=21;21;-1
p417-vashistha;N=16;16;-1
p417-vashistha;N=6;6;-1
p417-vashistha;N=4;4;-1
p417-vashistha;N=3;3;-1
p417-vashistha;N=2;2;-1
p417-vashistha;N=25;25;-1
p417-vashistha;N=11;11;-1
p417-vashistha;N=8;8;-1
p417-vashistha;N = 100;100;-1
p417-vashistha;N=15;15;-1
p417-vashistha;N=7;7;-1
p417-vashistha;N=5;5;-1
p417-vashistha;N=10;10;-1
p417-vashistha;N=9;9;-1
p417-vashistha;total of 204;204;-1
p4179-turner;16 participants;16;29104
p4199-nancel;12 participants;12;6965
p4203-brumby;total of 3,600;3600;-1
p4207-jalal;4 women;4;-1
p4207-jalal;2 women;2;-1
p4207-jalal;3 women;3;-1
p4207-jalal;16 participants;16;-1
p4207-jalal;total of 34;34;-1
p4217-chen;31 participants;31;-1
p4227-myers;8 participants;8;-1
p427-kumar;309 women;309;-1
p427-kumar;1,000 women;1000;-1
p427-kumar;3 women;3;-1
p43-cartwright;248 unique participants;248;-1
p43-cartwright;185 unique participants;185;-1
p43-cartwright;175 participants;175;-1
p43-cartwright;n=1;1;-1
p43-cartwright;N=40;40;-1
p43-cartwright;N=120;120;-1
p43-cartwright;n=0;0;-1
p43-cartwright;total of 9174;9174;-1
p437-ahmed;1500 people;1500;-1
p447-therias;total of 26;26;-1
p457-luger;21 participants;21;-1
p457-luger;5 participants;5;-1
p457-luger;30 mins and participants;30;-1
p457-luger;2 suggested supporting older   people;2;-1
p467-ismail;26 participants;26;6555
p467-ismail;30 participants;30;3793
p467-ismail;22 participants;22;2505
p467-ismail;3 participants;3;2444
p467-ismail;8 participants;8;2153
p467-ismail;11 participants;11;2126
p467-ismail;3 we asked participants;3;4096
p467-ismail;N = 26;26;35631
p467-ismail;total of 15;15;11275
p467-ismail;total of 137;137;2571
p467-ismail;30 participants enrolled;30;3793
p47-tubb;8  subjects;8;-1
p47-tubb;n = 1;1;-1
p477-gilbert;10 participants;10;-1
p477-gilbert;10 local participants;10;-1
p477-gilbert;19 remote participants;19;-1
p487-kim; data from 15;15;-1
p497-mcnaney;8   participants;8;-1
p497-mcnaney;5 million people;5;-1
p497-mcnaney; data from 3;3;-1
p501-mcnaney;6 participants;6;-1
p501-mcnaney;3 participants;3;-1
p501-mcnaney;8 participants;8;-1
p501-mcnaney;1 million people;1;-1
p501-mcnaney;8 participants were recruited;8;-1
p501-mcnaney;n=10;10;-1
p521-gromala;n = 49;49;-1
p525-buehler;258 of these designers are individuals;258;-1
p545-mayer;52   approached people;52;-1
p545-mayer;12 people;12;-1
p545-mayer;6 approached   people;6;-1
p545-mayer;15   approached people;15;-1
p545-mayer;N=58;58;-1
p545-mayer;total of 58;58;-1
p555-nguyen;411 pairs of English speaking participants;411;9743
p555-nguyen;4 participants;4;9442
p555-nguyen;1   Did participants;1;25330
p555-nguyen;N = 76;76;32
p555-nguyen;N= 76;76;3342
p555-nguyen;N=76;76;6323
p555-nguyen;n = 0;0;6344
p555-nguyen;n = 1;1;6793
p555-nguyen;n   = 0;0;6890
p555-nguyen;n = 6;6;7553
p555-nguyen;n = 15;15;7565
p555-nguyen;total of 30;30;10363
p565-damian;total of 15;15;-1
p565-damian;total of 30;30;-1
p57-suzuki; data rate of 667;667;-1
p575-odom;31 participants;31;-1
p575-odom;5   participants;5;-1
p575-odom;n=38;38;-1
p575-odom;n=3;3;-1
p575-odom;total of 31;31;-1
p595-tanahashi;19 participants;19;2902
p595-tanahashi;15 participants;15;2998
p595-tanahashi;3 participants;3;3080
p595-tanahashi;total of 31;31;4092
p605-matthews;62 participants;62;-1
p639-oehlberg;n = 2;2;-1
p639-oehlberg;n = 39;39;-1
p639-oehlberg;n = 3;3;-1
p649-fowler;45 individuals;45;-1
p659-vertanen;45 participants;45;-1
p659-vertanen;24 participants;24;-1
p659-vertanen;11 participants;11;-1
p659-vertanen;12  participants;12;-1
p659-vertanen;12 participants;12;-1
p659-vertanen;5 participants;5;-1
p659-vertanen;n =  24;24;-1
p659-vertanen;n = 28;28;-1
p659-vertanen;n = 0;0;-1
p659-vertanen;n = 24;24;-1
p659-vertanen;n = 25;25;-1
p659-vertanen;n = 6;6;-1
p659-vertanen;n = 26;26;-1
p659-vertanen;n = 21;21;-1
p659-vertanen;total of 240;240;-1
p669-leiva;20 participants;20;7551
p669-leiva;12 cases participants;12;3920
p679-reyal;16   participants;16;-1
p679-reyal;16 participants;16;-1
p679-reyal;10 participants;10;-1
p679-reyal;14 participants;14;-1
p679-reyal;n = 25;25;-1
p679-reyal;n = 27;27;-1
p679-reyal;total of 1,008;1008;-1
p689-lee;50 participants;50;-1
p689-lee;52 participants;52;-1
p689-lee;32 participants;32;-1
p689-lee;total of 50;50;-1
p689-lee;total of 11;11;-1
p689-lee;total of 1,277;1277;-1
p699-bianchi;10   participants;10;-1
p709-cramer;20 participants;20;-1
p709-cramer;19   participants;19;-1
p709-cramer;20   participants;20;-1
p709-cramer;n=7;7;-1
p713-brereton;5 people;5;-1
p713-brereton;6 people;6;-1
p717-melvin;1000 people;1000;-1
p717-melvin;15   For people;15;-1
p717-melvin; data transfer of 125;125;-1
p727-hiniker;466   adult participants;466;23499
p727-hiniker;111 participants;111;21488
p727-hiniker;25 participants;25;20765
p727-hiniker;111 adults;111;22678
p727-hiniker;25 adults;25;22539
p727-hiniker;n =   9;9;19598
p727-hiniker;n = 2;2;147
p727-hiniker;n = 3;3;269
p727-hiniker;total of 33;33;22095
p727-hiniker; data from 466;466;34198
p727-hiniker; data from 55;55;29226
p737-fourney;1,892 women;1892;-1
p737-fourney;13,030 individuals;13030;-1
p737-fourney;8,535   individuals;8535;-1
p737-fourney;n=13,030;13030;-1
p737-fourney;n=8,535;8535;-1
p747-flintham;17 participants;17;-1
p747-flintham;8   individuals;8;-1
p747-flintham;total of 412;412;-1
p747-flintham;total   of 486;486;-1
p747-flintham;total of 5;5;-1
p757-curmi;76 of these participants;76;-1
p757-curmi;n=64;64;-1
p757-curmi;n=41;41;-1
p757-curmi;total of 727;727;-1
p757-curmi;total of 60;60;-1
p767-schofield;3 different subjects;3;-1
p767-schofield;300 people;300;-1
p777-hong;n=1,174;1174;-1
p777-hong;n=4;4;-1
p777-hong;n=3;3;-1
p777-hong;n=29;29;-1
p777-hong;n=2;2;-1
p777-hong;n=6;6;-1
p777-hong;n=11;11;-1
p777-hong;n=1;1;-1
p777-hong;N=100;100;-1
p777-hong;n=0;0;-1
p777-hong;n=195;195;-1
p777-hong;n=118;118;-1
p787-almuhimedi;23 participants;23;-1
p787-almuhimedi;22 participants;22;-1
p787-almuhimedi;12  participants;12;-1
p787-almuhimedi;3 positively affected participants;3;-1
p787-almuhimedi;11 participants;11;-1
p787-almuhimedi;n=23;23;-1
p797-warshaw;18 participants;18;-1
p797-warshaw;14 pilot   participants;14;-1
p797-warshaw;5 participants;5;-1
p797-warshaw;13 participants;13;-1
p797-warshaw;N=14;14;-1
p797-warshaw;N=9;9;-1
p797-warshaw;N=16;16;-1
p797-warshaw;N=11;11;-1
p797-warshaw;N=15;15;-1
p797-warshaw;N=17;17;-1
p807-shih;34 participants;34;-1
p807-shih;61 participants;61;-1
p807-shih;5 participants;5;-1
p807-shih;4 participants;4;-1
p807-shih;3 participants;3;-1
p807-shih;4These participants;4;-1
p807-shih;1 billion other people;1;-1
p807-shih;N = 34;34;-1
p807-shih;total of 14;14;-1
p81-claes;n=6;6;-1
p81-claes;n=11;11;-1
p81-claes;n=7;7;-1
p81-claes;n=4;4;-1
p81-claes;n=3;3;-1
p817-wang;124 participants;124;-1
p817-wang;124  participants;124;-1
p817-wang;224 people;224;-1
p817-wang;50 people;50;-1
p817-wang;n = 224;224;-1
p817-wang;total of 52;52;-1
p827-skov;1   While some participants;1;-1
p827-skov;19   ICD patients;19;-1
p827-skov;700 ICD patients;700;-1
p827-skov;14 contacted patients;14;-1
p827-skov;664 ICD patients;664;-1
p827-skov;000 people;0;-1
p827-skov;19   people;19;-1
p837-adib;14 participants;14;-1
p837-adib;14 subjects;14;-1
p837-adib;total of 112;112;-1
p837-adib;total of 448,000;448000;-1
p847-han;2 participants;2;-1
p847-han;12 subjects;12;-1
p847-han;total of 10,398;10398;-1
p85-luusua;55 yea  d only women;55;-1
p85-luusua;48 participants;48;-1
p85-luusua;56 participants;56;-1
p85-luusua;20 participants;20;-1
p85-luusua;21 participants;21;-1
p85-luusua;20 young adults;20;-1
p857-lyu;40 participants;40;-1
p857-lyu;3   was also one of the five participants;3;-1
p857-lyu;39 participants;39;-1
p857-lyu;8 compares two   participants;8;-1
p867-block;345   adults;345;-1
p867-block;N = 343;343;-1
p867-block;total of 76;76;-1
p867-block; data from 629;629;-1
p887-reilly;36 participants;36;-1
p887-reilly;total of 36;36;-1
p887-reilly;total of 34;34;-1
p897-bowser;20 participants;20;-1
p897-bowser;13 participants;13;-1
p897-bowser;7 participants;7;-1
p897-bowser;N = 5;5;-1
p897-bowser;N = 4;4;-1
p897-bowser;N = 2;2;-1
p907-pritchard;6 of   these participants;6;-1
p917-gunaratne;487 participants;487;-1
p917-gunaratne;N=162;162;-1
p917-gunaratne;N=158;158;-1
p917-gunaratne;N=167;167;-1
p917-gunaratne; data, both from 1980;1980;-1
p917-gunaratne;   data from 1980;1980;-1
p929-amma;5 subjects;5;-1
p929-amma;25 subjects;25;-1
p929-amma;N=3;3;-1
p929-amma;N = 1;1;-1
p929-amma;N = 3;3;-1
p929-amma;total of 52;52;-1
p929-amma;total of 168;168;-1
p929-amma; dataset of 10;10;-1
p939-lopes;10 participants;10;-1
p939-lopes;12 participants;12;-1
p939-lopes;5  number of participants;5;-1
p939-lopes;n= 4;4;-1
p939-lopes;n = 6;6;-1
p939-lopes;n = 5;5;-1
p939-lopes;n = 2;2;-1
p939-lopes;n = 3;3;-1
p939-lopes;n = 4;4;-1
p949-heller;20   participants;20;-1
p949-heller;n=5;5;-1
p949-heller;n=4;4;-1
p95-harboe;13 participants;13;-1
p95-harboe;16   participants;16;-1
p95-harboe;15 of   their participants;15;-1
p95-harboe;4 people;4;-1
p95-harboe;20 people;20;-1
p95-harboe;7 people;7;-1
p95-harboe;15 people;15;-1
p95-harboe;30 people;30;-1
p95-harboe;8   people;8;-1
p953-oh;20 participants;20;-1
p953-oh;n=10;10;-1
p953-oh;n=20;20;-1
p957-jones;18 participants;18;-1
p971-samsonov; dataset of 1,219;1219;-1
p975-loepp;33 participants;33;-1
p975-loepp;n = 17;17;-1
p975-loepp;n = 16;16;-1
p985-park;43 participants;43;-1
p995-kleiman;24 participants;24;-1
p995-kleiman;15 participants;15;-1
p995-kleiman;5 participants;5;-1
p995-kleiman;N=24;24;-1
p995-kleiman;total of 64;64;-1
p995-kleiman;total of 24;24;-1
Individual-differences-in-reading-aloud-A-mega-study-item-effects-and-some-models_2014_Cognitive-Psychology;100 participants;100;-1
Individual-differences-in-reading-aloud-A-mega-study-item-effects-and-some-models_2014_Cognitive-Psychology;20 of the participants;20;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 5;5;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 4;4;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 10;10;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 12;12;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 13;13;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 27;27;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 14;14;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 87;87;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 21;21;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 22;22;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 99;99;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 33;33;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;n = 9;9;-1
Insights-into-failed-lexical-retrieval-from-network-science_2014_Cognitive-Psychology;total of 48;48;-1
Memory-indexing-of-sequential-symptom-processing-in-diagnostic-reasoning_2014_Cognitive-Psychology;17 participants;17;-1
Memory-indexing-of-sequential-symptom-processing-in-diagnostic-reasoning_2014_Cognitive-Psychology;11 participants;11;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;30 participants;30;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;1075 individuals;1075;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;4  Picture naming Young adults;4;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;3  Picture naming Young adults;3;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;3  Shadowing Young adults;3;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;total of 1681;1681;-1
Reconciling-phonological-neighborhood-effects-in-speech-production-through-single-trial-analysis_2014_Cognitive-Psychology;total of 2253;2253;-1
Conflict-tasks-and-the-diffusion-framework-Insight-in-model-constraints-based-on-psychological-laws_2014_Cognitive-Psychology;12 participants;12;-1
Conflict-tasks-and-the-diffusion-framework-Insight-in-model-constraints-based-on-psychological-laws_2014_Cognitive-Psychology;12 subjects;12;-1
Conflict-tasks-and-the-diffusion-framework-Insight-in-model-constraints-based-on-psychological-laws_2014_Cognitive-Psychology;n = 0;0;-1
Conflict-tasks-and-the-diffusion-framework-Insight-in-model-constraints-based-on-psychological-laws_2014_Cognitive-Psychology; data from 1;1;-1
Extending-the-Failure-to-Engage-theory-of-task-switch-costs_2014_Cognitive-Psychology;32 participants;32;-1
Extending-the-Failure-to-Engage-theory-of-task-switch-costs_2014_Cognitive-Psychology;n = 21;21;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;18 participants;18;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;45 participants;45;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;210 common cause and chain participants;210;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;105 common ef-  fect participants;105;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;26 participants;26;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;5 ANOVA of  these subjects;5;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;3 provided subjects;3;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;315 subjects;315;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;107  people;107;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;N = 18;18;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;N = 45;45;-1
Independence-and-dependence-in-human-causal-reasoning_2014_Cognitive-Psychology;N = 23;23;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;16 adults;16;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 3;3;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 2;2;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 16;16;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 4;4;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 1;1;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 5;5;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 12;12;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 9;9;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 8;8;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 13;13;-1
Infants-detect-changes-in-everyday-scenes-The-role-of-scene-gist_2014_Cognitive-Psychology;n = 15;15;-1
Long-term-memory-and-the-control-of-attentional-control_2014_Cognitive-Psychology;10 subjects;10;-1
Long-term-memory-and-the-control-of-attentional-control_2014_Cognitive-Psychology;N = 20;20;-1
Long-term-memory-and-the-control-of-attentional-control_2014_Cognitive-Psychology;total of 60;60;-1
Long-term-memory-and-the-control-of-attentional-control_2014_Cognitive-Psychology;total of 40;40;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;13 participants;13;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;10 participants;10;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;53  participants;53;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;N=12;12;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;n=12;12;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;n = 80;80;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology;N=36;36;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology; data of the 11;11;-1
Toward-exact-number-Young-children-use-one-to-one-correspondence-to-measure-set-identity-but-not-numerical-equality_2014_Cognitive-Psychology; data from the 11;11;-1
A-rational-account-of-pedagogical-reasoning-Teaching-by-and-learning-from-examples_2014_Cognitive-Psychology;2 Two participants;2;-1
A-rational-account-of-pedagogical-reasoning-Teaching-by-and-learning-from-examples_2014_Cognitive-Psychology;total of 27;27;-1
A-rational-account-of-pedagogical-reasoning-Teaching-by-and-learning-from-examples_2014_Cognitive-Psychology;total of 196;196;-1
A-rational-account-of-pedagogical-reasoning-Teaching-by-and-learning-from-examples_2014_Cognitive-Psychology;total of 165;165;-1
The-discovery-and-comparison-of-symbolic-magnitudes_2014_Cognitive-Psychology;total of 174,792;174792;-1
The-discovery-and-comparison-of-symbolic-magnitudes_2014_Cognitive-Psychology;total of 52;52;-1
The-discovery-and-comparison-of-symbolic-magnitudes_2014_Cognitive-Psychology;total of 77;77;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;171 participants;171;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;26  At test participants;26;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;5 consisted of high ability participants;5;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;2 consisted of individuals;2;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;3 consisted of individuals;3;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;total of 171;171;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;total of 75;75;-1
Working-memory-and-fluid-intelligence-Capacity-attention-control-and-secondary-memory-retrieval_2014_Cognitive-Psychology;total of 78;78;-1
Costs-and-benefits-of-automatization-in-category-learning-of-ill-defined-rules_2014_Cognitive-Psychology;68 participants;68;-1
Costs-and-benefits-of-automatization-in-category-learning-of-ill-defined-rules_2014_Cognitive-Psychology;N = 31;31;-1
Costs-and-benefits-of-automatization-in-category-learning-of-ill-defined-rules_2014_Cognitive-Psychology;N = 14;14;-1
Costs-and-benefits-of-automatization-in-category-learning-of-ill-defined-rules_2014_Cognitive-Psychology;N = 17;17;-1
Costs-and-benefits-of-automatization-in-category-learning-of-ill-defined-rules_2014_Cognitive-Psychology;N = 28;28;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;30 younger participants;30;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;30 young participants;30;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;30 older participants;30;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;1  Older and young participants;1;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;30 participants;30;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;N = 30;30;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;N = 320;320;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;n = 0;0;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;n = 32;32;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;n = 8;8;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;total of 320;320;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;total of  336;336;-1
Number-skills-are-maintained-in-healthy-ageing_2014_Cognitive-Psychology;total of 288;288;-1
Spatial-demonstratives-and-perceptual-space-Describing-and-remembering-object-location_2014_Cognitive-Psychology;51  participants;51;-1
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;32 participants;32;7996
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;1 presents participants;1;4200
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;19 subjects;19;37151
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;n = 64;64;3032
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;n = 36;36;1357
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;n = 48;48;11561
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;n = 19;19;11757
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;n = 51;51;11877
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;total of 240;240;19095
How-lexical-is-the-lexicon-Evidence-for-integrated-auditory-memory-representations_2014_Cognitive-Psychology;total of 288;288;27927
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;19 participants;19;14789
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;32 participants;32;10519
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;12 participants;12;10386
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;7 indicating  participants;7;44932
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;n = 32;32;11434
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;n = 12;12;11341
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;N = 62;62;27355
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;n = 8;8;27824
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;n = 6;6;27963
Singing-with-yourself-Evidence-for-an-inverse-modeling-account-of-poor-pitch-singing_2014_Cognitive-Psychology;N = 57;57;37949
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;42 participants;42;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;2 signifi-  cantly increased participants;2;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;24 participants;24;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;n = 6;6;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;total of 47;47;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;total of 58;58;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;total of 26;26;-1
The-road-to-understanding-is-paved-with-the-speaker-s-intentions-Cues-to-the-speaker-s-attention-and-intentions-affect-pronoun-comprehension_2014_Cogn;total of 49;49;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 4;4;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 2;2;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 14;14;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 5;5;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 12;12;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 6;6;-1
Developmental-origins-of-recoding-and-decoding-in-memory_2014_Cognitive-Psychology;n = 1;1;-1
Inferring-word-meanings-by-assuming-that-speakers-are-informative_2014_Cognitive-Psychology;201 unique individuals;201;-1
Inferring-word-meanings-by-assuming-that-speakers-are-informative_2014_Cognitive-Psychology;144 children recruited;144;-1
Inferring-word-meanings-by-assuming-that-speakers-are-informative_2014_Cognitive-Psychology;N = 12;12;-1
Inferring-word-meanings-by-assuming-that-speakers-are-informative_2014_Cognitive-Psychology;N = 13;13;-1
Inferring-word-meanings-by-assuming-that-speakers-are-informative_2014_Cognitive-Psychology;N = 24;24;-1
Inferring-word-meanings-by-assuming-that-speakers-are-informative_2014_Cognitive-Psychology;total of 21;21;-1
Literacy-effects-on-language-and-vision-Emergent-effects-from-an-amodal-shared-resource-ASR-computational-model_2014_Cognitive-Psychology;n = 40;40;-1
Literacy-effects-on-language-and-vision-Emergent-effects-from-an-amodal-shared-resource-ASR-computational-model_2014_Cognitive-Psychology;n = 24;24;-1
Literacy-effects-on-language-and-vision-Emergent-effects-from-an-amodal-shared-resource-ASR-computational-model_2014_Cognitive-Psychology;n = 960;960;-1
Literacy-effects-on-language-and-vision-Emergent-effects-from-an-amodal-shared-resource-ASR-computational-model_2014_Cognitive-Psychology;n = 15;15;-1
Literacy-effects-on-language-and-vision-Emergent-effects-from-an-amodal-shared-resource-ASR-computational-model_2014_Cognitive-Psychology;total of 14;14;-1
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;20 women;20;69065
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;25 women;25;54858
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;24 women;24;49914
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;26 women;26;40182
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;29 women;29;28705
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;41 women;41;4390
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;36 women;36;3340
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;70 participants;70;4460
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;70 Mechanical Turk participants;70;3373
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;70  Mechanical Turk participants;70;346
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;48 adults;48;69076
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;5 Because adults;5;35875
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;70 participants recruited;70;4460
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;N = 480;480;93430
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;n = 24;24;68486
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;n = 2;2;68486
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;n = 0;0;26144
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol;N = 70;70;3377
The-inherence-heuristic-across-development-Systematic-differences-between-children-s-and-adults-explanations-for-everyday-facts_2014_Cognitive-Psychol; data from our 120;120;3966
Word-categorization-from-distributional-information-Frames-confer-more-than-the-sum-of-their-Bigram-parts_2014_Cognitive-Psychology;12 subjects;12;-1
Word-categorization-from-distributional-information-Frames-confer-more-than-the-sum-of-their-Bigram-parts_2014_Cognitive-Psychology;total of 12;12;-1
Word-categorization-from-distributional-information-Frames-confer-more-than-the-sum-of-their-Bigram-parts_2014_Cognitive-Psychology;total of  118;118;-1
Word-categorization-from-distributional-information-Frames-confer-more-than-the-sum-of-their-Bigram-parts_2014_Cognitive-Psychology; data from 12;12;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;83  participants;83;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;10 participants;10;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;174 distinct participants;174;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;257 distinct participants;257;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;20 participants;20;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;56 distinct participants;56;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of  2;2;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 900;900;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 9000;9000;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 174;174;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of  2000;2000;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 20,000;20000;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 257;257;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 120;120;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 2400;2400;-1
Corpus-based-estimates-of-word-association-predict-biases-in-judgment-of-word-co-occurrence-likelihood_2014_Cognitive-Psychology;total of 56;56;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;1 participants;1;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;75 participants;75;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;74 participants;74;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;40 of the participants;40;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;40 adults;40;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;40 of the participants were adults;40;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology;n = 75;75;-1
Extending-problem-solving-procedures-through-reflection_2014_Cognitive-Psychology; data from 40;40;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;3 Both groups of  participants;3;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;20 adult participants;20;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;140 participants;140;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;65  both adults;65;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;30 adults;30;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;20 adults;20;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;65 undergraduates recruited;65;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology;N = 30;30;-1
Win-Stay-Lose-Sample-A-simple-sequential-algorithm-for-approximating-Bayesian-inference_2014_Cognitive-Psychology; data from 20;20;-1
Do-as-I-say-not-as-I-do-A-lexical-distributional-account-of-English-locative-verb-class-acquisition_2014_Cognitive-Psychology;total of  40,000;40000;-1
Do-as-I-say-not-as-I-do-A-lexical-distributional-account-of-English-locative-verb-class-acquisition_2014_Cognitive-Psychology;total of 40,000;40000;-1
Priming-sentence-planning_2014_Cognitive-Psychology;1  Eye-tracked participants;1;-1
Priming-sentence-planning_2014_Cognitive-Psychology;23 items had animate patients;23;-1
Priming-sentence-planning_2014_Cognitive-Psychology;20 items had human patients;20;-1
Priming-sentence-planning_2014_Cognitive-Psychology;19 items had human patients;19;-1
Priming-sentence-planning_2014_Cognitive-Psychology;n = 30;30;-1
Priming-sentence-planning_2014_Cognitive-Psychology;n = 103;103;-1
Priming-sentence-planning_2014_Cognitive-Psychology;n = 25;25;-1
13814788%2E2013%2E818132;4,151 unselected subjects;4151;-1
13814788%2E2013%2E818132;1 334 consecutive patients;1334;-1
13814788%2E2013%2E818132;23   patients;23;-1
13814788%2E2013%2E818132;1 793 consecutive patients;1793;-1
13814788%2E2013%2E818132;997 patients;997;-1
13814788%2E2013%2E818132;1334 patients;1334;-1
13814788%2E2013%2E818132;23 patients;23;-1
13814788%2E2013%2E818655;100 patients;100;-1
13814788%2E2013%2E818655;20 individuals;20;-1
13814788%2E2013%2E819849;10 participants;10;113
13814788%2E2013%2E823600;108 000 Norwegian-born   persons;108000;-1
13814788%2E2013%2E823600;4 740 904 persons;4740904;-1
13814788%2E2013%2E823600;95  patients;95;-1
13814788%2E2013%2E823600;100 patients;100;-1
13814788%2E2013%2E823600;2008 and their patients;2008;-1
13814788%2E2013%2E823600;23  Actual number of patients;23;-1
13814788%2E2013%2E825769;55 veiled   women;55;-1
13814788%2E2013%2E825769;22 Danish   women;22;-1
13814788%2E2013%2E825769;33 patients;33;-1
13814788%2E2013%2E825769;49 young   patients;49;-1
13814788%2E2013%2E825769;22 patients;22;-1
13814788%2E2013%2E825769;49 patients;49;-1
13814788%2E2013%2E825769;299 patients;299;-1
13814788%2E2013%2E825769;69 adults;69;-1
13814788%2E2013%2E825769;49 adults;49;-1
13814788%2E2013%2E826642;201 patients;201;-1
13814788%2E2013%2E826642;1c testing of patients;1;-1
13814788%2E2013%2E826642;350 patients;350;-1
13814788%2E2013%2E826642;000 people;0;-1
13814788%2E2013%2E826642;201 individuals;201;-1
13814788%2E2013%2E826642;000 individuals;0;-1
13814788%2E2013%2E826642;n = 282 000;282000;-1
13814788%2E2013%2E826642;n = 30 050;30050;-1
13814788%2E2013%2E826642;n = 251 950;251950;-1
13814788%2E2013%2E826642;n = 10 551;10551;-1
13814788%2E2013%2E826642;n = 241 399;241399;-1
13814788%2E2013%2E826642;n = 10 201;10201;-1
13814788%2E2013%2E826642;n = 350;350;-1
13814788%2E2013%2E826643;2020 students were recruited;2020;-1
13814788%2E2013%2E826643;total of 2020;2020;-1
13814788%2E2013%2E826643;total of 2352;2352;-1
13814788%2E2013%2E827167;1100 persons;1100;-1
13814788%2E2013%2E828201;366 patients;366;-1
13814788%2E2013%2E839651;18 820 patients;18820;-1
13814788%2E2013%2E839652;500 000 patients;500000;-1
13814788%2E2013%2E840825;n = 571;571;-1
13814788%2E2013%2E840825;n = 524;524;-1
13814788%2E2013%2E840825;n = 63;63;-1
13814788%2E2013%2E840825;n = 43;43;-1
13814788%2E2013%2E840825;n = 24;24;-1
13814788%2E2013%2E840825;n = 11;11;-1
13814788%2E2013%2E840825;n = 5;5;-1
13814788%2E2013%2E840825;n = 2;2;-1
13814788%2E2013%2E840825;n = 1;1;-1
13814788%2E2013%2E840825;n = 20;20;-1
13814788%2E2013%2E840825;n = 18;18;-1
13814788%2E2013%2E840825;n = 16;16;-1
13814788%2E2013%2E840825;total of   63;63;-1
13814788%2E2013%2E842970;210 adult patients;210;-1
13814788%2E2013%2E842970;1 000 patients;1000;-1
13814788%2E2013%2E842970; datasets of 177;177;-1
13814788%2E2013%2E845877;56 participants;56;-1
13814788%2E2013%2E845877;196   patients;196;-1
13814788%2E2013%2E845877;210 patients;210;-1
13814788%2E2013%2E845877;209 patients;209;-1
13814788%2E2013%2E845877;56 patients;56;-1
13814788%2E2013%2E845877;n = 226;226;-1
13814788%2E2013%2E845877;n = 17;17;-1
13814788%2E2013%2E845877;n = 4;4;-1
13814788%2E2013%2E845877;n = 13;13;-1
13814788%2E2013%2E845877;n = 210;210;-1
13814788%2E2013%2E845877;n = 105;105;-1
13814788%2E2013%2E845877;n = 0;0;-1
13814788%2E2013%2E845877;n = 1;1;-1
13814788%2E2013%2E845877;n = 104;104;-1
13814788%2E2013%2E847083;2 diabetic patients;2;-1
13814788%2E2013%2E848339;001  Average number of patients;1;-1
13814788%2E2013%2E852535;5 million patients;5;-1
13814788%2E2013%2E852535;1 760 223 permanently registered patients;1760223;-1
13814788%2E2013%2E852535;653 patients;653;-1
13814788%2E2013%2E852535;21 096 patients;21096;-1
13814788%2E2013%2E852535;20 443 patients;20443;-1
13814788%2E2013%2E852535;296 patients;296;-1
13814788%2E2013%2E852535;79 884   atrial fi brillation patients;79884;-1
13814788%2E2013%2E852535;total of 17;17;-1
13814788%2E2013%2E857399;191   In older persons;191;-1
13814788%2E2013%2E857399;10 participants;10;-1
13814788%2E2013%2E857399;4 variable MDRD equation  All participants;4;-1
13814788%2E2013%2E857399;1304   participants;1304;-1
13814788%2E2013%2E857399;567 subjects;567;-1
13814788%2E2013%2E868431;251 consecutive patients;251;-1
13814788%2E2013%2E868431;179 patients;179;-1
13814788%2E2013%2E868431;1500 patients;1500;-1
13814788%2E2013%2E868431;40 patients;40;-1
13814788%2E2013%2E868431;72 non-hypertensive patients;72;-1
13814788%2E2013%2E868431;179 primary   hypertensive patients;179;-1
13814788%2E2013%2E868431;72 normotensive   control patients;72;-1
13814788%2E2013%2E868431;58 patients;58;-1
13814788%2E2013%2E868431;251 chronically ill primary care patients;251;-1
13814788%2E2013%2E868431;559   patients;559;-1
13814788%2E2013%2E868431; data of 179;179;-1
13814788%2E2013%2E872621; data from the 13;13;-1
13814788%2E2013%2E877130;2 diabetic subjects;2;-1
13814788%2E2013%2E877130;total of 44;44;-1
13814788%2E2013%2E877440;41 women;41;-1
13814788%2E2013%2E877440;400 persons;400;-1
13814788%2E2013%2E877440;860   participants;860;-1
13814788%2E2013%2E877440;12 patients;12;-1
13814788%2E2013%2E877440;9 895 patients;9895;-1
13814788%2E2013%2E877440;40 116 diabetic patients;40116;-1
13814788%2E2013%2E877440;2DM patients;2;-1
13814788%2E2013%2E877440;400   patients;400;-1
13814788%2E2013%2E877440;30 patients;30;-1
13814788%2E2013%2E877440;212 patients;212;-1
13814788%2E2013%2E877440;75 patients;75;-1
13814788%2E2013%2E877440;27 patients;27;-1
13814788%2E2013%2E877440;52   patients;52;-1
13814788%2E2013%2E877440;27 patients out of all studied people;27;-1
13814788%2E2013%2E877440;2 diabetes were recruited;2;-1
13814788%2E2013%2E877440;total of 254;254;-1
13814788%2E2013%2E877440;total of 40;40;-1
13814788%2E2013%2E877440; data of all 233;233;-1
13814788%2E2013%2E877440; data from 70;70;-1
13814788%2E2014%2E887674;2 diabetic patients;2;-1
13814788%2E2014%2E887674;2 DM patients;2;-1
13814788%2E2014%2E887674;396 patients;396;-1
13814788%2E2014%2E887674;342 DM   patients;342;-1
13814788%2E2014%2E887674;2 DM   patients;2;-1
13814788%2E2014%2E887674;371 million people;371;-1
13814788%2E2014%2E887674;study population included 342;342;-1
13814788%2E2014%2E887674;study population included 2251;2251;-1
13814788%2E2014%2E899349;31 patients;31;-1
13814788%2E2014%2E899349;total of 65;65;-1
13814788%2E2014%2E899349;study population included 60;60;-1
13814788%2E2014%2E899578;1228 women;1228;-1
13814788%2E2014%2E899578;153 patients;153;-1
13814788%2E2014%2E899578;885 patients;885;-1
13814788%2E2014%2E899578;7 patients;7;-1
13814788%2E2014%2E899578;1079 patients;1079;-1
13814788%2E2014%2E899578;22 patients;22;-1
13814788%2E2014%2E899578;153   patients;153;-1
13814788%2E2014%2E899578;3 patients;3;-1
13814788%2E2014%2E899578;20 patients;20;-1
13814788%2E2014%2E899578;133 other patients;133;-1
13814788%2E2014%2E899578;133 patients;133;-1
13814788%2E2014%2E899578;49 patients;49;-1
13814788%2E2014%2E899578;33 patients;33;-1
13814788%2E2014%2E899578;47 patients;47;-1
13814788%2E2014%2E899578;14 patients;14;-1
13814788%2E2014%2E899578;74 patients;74;-1
13814788%2E2014%2E899578;2 patients;2;-1
13814788%2E2014%2E899578;831 patients;831;-1
13814788%2E2014%2E899578;59 patients;59;-1
13814788%2E2014%2E899578;34   patients;34;-1
13814788%2E2014%2E899578;total of 1079;1079;-1
13814788%2E2014%2E899578;total of 885;885;-1
13814788%2E2014%2E899578;total of 150;150;-1
13814788%2E2014%2E900534;6  Healthy adults;6;-1
13814788%2E2014%2E905826;4DSQ?    METHODS    Design and participants;4;-1
13814788%2E2014%2E905826;4DSQ helps   patients;4;-1
13814788%2E2014%2E905826;2127 patients;2127;-1
13814788%2E2014%2E905826;205 English-speaking patients;205;-1
13814788%2E2014%2E905826;302 patients;302;-1
13814788%2E2014%2E905826;total of 205;205;-1
13814788%2E2014%2E905826;total of 302;302;-1
13814788%2E2014%2E905826; data of 2127;2127;-1
13814788%2E2014%2E905912;414 patients;414;-1
13814788%2E2014%2E905912;10   methadone patients;10;-1
13814788%2E2014%2E938630;56 women;56;-1
13814788%2E2014%2E938630;10 persons;10;-1
13814788%2E2014%2E938630;11 476 registered eligible older persons;11476;-1
13814788%2E2014%2E938630;225 randomly chosen persons;225;-1
13814788%2E2014%2E938630;1916 subjects;1916;-1
13814788%2E2014%2E938630;471 subjects;471;-1
13814788%2E2014%2E938630;914 subjects;914;-1
13814788%2E2014%2E938630;19 423 patients;19423;-1
13814788%2E2014%2E938630;221  index patients;221;-1
13814788%2E2014%2E938630;139 patients;139;-1
13814788%2E2014%2E938630;392   patients;392;-1
13814788%2E2014%2E938630;430 deceased cancer patients;430;-1
13814788%2E2014%2E938630;532 patients;532;-1
13814788%2E2014%2E938630;693 patients;693;-1
13814788%2E2014%2E938630;630 people;630;-1
13814788%2E2014%2E938630;30 community dwelling older   people;30;-1
13814788%2E2014%2E938630;691 individuals;691;-1
13814788%2E2014%2E938630;total of 1916;1916;-1
13814788%2E2014%2E938630;total of 532;532;-1
Doc10;N   =   2;2;-1
Doc10;N = 550,921;550921;-1
Doc11;n = 1;1;-1
Doc11;n = 0;0;-1
Doc2;2014  individuals;2014;-1
Doc3;2014  individuals;2014;-1
Doc4;N = 221;221;-1
Doc4; data from 221;221;-1
Doc7;n = 452;452;-1
Doc7;n = 30;30;-1
Doc8;N   =   2;2;-1
Doc8;N = 8,804;8804;-1
Doc9;N   =   1;1;-1
Doc9;N = 1,754;1754;-1
Doc1;total of 636,484;636484;-1
Doc11;total of 29;29;-1
Doc11;total of 35;35;-1
Doc2;31  wherein participants;31;-1
Doc2;37  participants;37;-1
Doc4;2014  individuals;2014;-1
Doc9;N = 12,915;12915;-1
Doc10;442 women;442;-1
Doc10;48 African   American women;48;-1
Doc10;355 persons;355;-1
Doc10;235 participants;235;-1
Doc10;200 individuals;200;-1
Doc2; data from 495;495;-1
Doc4;n = 11;11;-1
Doc4;n = 5;5;-1
Doc4;n = 153;153;-1
Doc4;N = 23,564;23564;-1
Doc4;total of 664;664;-1
Doc4;total of 68;68;-1
Doc5;total of 60;60;-1
Doc8;143   adults;143;-1
Doc1;N = 772;772;-1
Doc1;n = 577;577;-1
Doc1;n = 84;84;-1
Doc1;n = 111;111;-1
Doc1;n = 2;2;-1
Doc1;n = 3;3;-1
Doc10;n   =   4;4;-1
Doc10;n = 423;423;-1
Doc10;n = 427;427;-1
Doc10;total of   36;36;-1
Doc10;total of 427;427;-1
Doc11;N = 452;452;-1
Doc11;N   =   4;4;-1
Doc11;total of 68;68;-1
Doc11;total of 608;608;-1
Doc3;2014  storylines have positioned women;2014;-1
Doc3;27 women;27;-1
Doc3;2006 Catalyst census of women;2006;-1
Doc3;200 individuals;200;-1
Doc3;N = 112;112;-1
Doc3;N   =   1;1;-1
Doc3;n   =   0;0;-1
Doc3;n   =   1;1;-1
Doc3;n = 112;112;-1
Doc3;total of 112;112;-1
Doc4;N = 114;114;-1
Doc4;N = 473;473;-1
Doc4;N = 440;440;-1
Doc4;N = 129;129;-1
Doc4;total of 129;129;-1
Doc6;total of 804;804;-1
Doc7;N = 206;206;27705
Doc7;n = 0;0;27083
Doc7;N = 287;287;17438
Doc7; data of 115;115;31586
Doc8;N = 267;267;17872
Doc8;N = 58;58;17826
Doc8;N = 216;216;17781
Doc8;N = 685;685;17726
Doc8;N = 223;223;17648
Doc8;N = 420;420;17524
Doc8;N = 344;344;17462
Doc8;N = 187;187;17419
Doc8;N = 1,725;1725;17376
Doc8;N = 1,828;1828;17310
Doc8;N   =   3;3;6979
Doc9;0 = subjects;0;-1
Doc9;1 = subjects;1;-1
Doc9;N = 7,167;7167;-1
Doc9;n = 3,354;3354;-1
Doc9;n = 2,211;2211;-1
Doc9;n = 5,127;5127;-1
Doc9;n = 638;638;-1
Doc9;n = 1,078;1078;-1
Doc9;n = 2,120;2120;-1
Doc9;n = 2,567;2567;-1
Doc9;n = 3,343;3343;-1
Doc9;n = 2,422;2422;-1
Doc9;n = 2,528;2528;-1
Doc9;n = 3,237;3237;-1
Doc9;n = 4,206;4206;-1
Doc9;n = 1,559;1559;-1
Doc9;n = 4,397;4397;-1
Doc9;n =   1,368;1368;-1
Doc9;n = 1,402;1402;-1
Doc9;n = 4,649;4649;-1
Doc9;n = 1,116;1116;-1
Doc9;total of 47;47;-1
Doc1;2014  women;2014;-1
Doc1;129 women;129;-1
Doc1;10  Hours enrolled;10;-1
Doc2;1,000 participants;1000;-1
Doc2;75 participants;75;-1
Doc2;46 participants;46;-1
Doc2;n = 14;14;-1
Doc2;n = 5;5;-1
Doc2;N = 100;100;-1
Doc2;n = 1;1;-1
Doc2;n = 75;75;-1
Doc3;1 participants;1;-1
Doc3;2 participants;2;-1
Doc3;3 participants;3;-1
Doc3;4 participants;4;-1
Doc3;394 adults;394;-1
Doc3;253 adults;253;-1
Doc3;588 adults;588;-1
Doc3;N = 581;581;-1
Doc3;N = 582;582;-1
Doc3;total of 13;13;-1
Doc3;total of 20;20;-1
Doc4;N   =   2;2;42995
Doc4;total of 2,064;2064;42204
Doc4;total of 74;74;2041
Doc4; data from 2001;2001;22444
Doc5;N   =   7;7;3157
Doc5;N   =   2;2;2977
Doc5;N = 223;223;7832
Doc5;total of 733;733;11596
Doc5;total of 286;286;11322
Doc6;193 participants;193;-1
Doc6;152 subordinate participants;152;-1
Doc6;N = 199;199;-1
Doc6;N = 156;156;-1
Doc6;N = 152;152;-1
Doc6;N = 259;259;-1
Doc6;total of 400;400;-1
Doc6;total of 88;88;-1
Doc6;total of 143;143;-1
Doc6;total of 193;193;-1
Doc6;total of 161;161;-1
Doc6;total of 152;152;-1
Doc7;2014  participants;2014;-1
Doc7;N = 82;82;-1
Doc7;N = 225;225;-1
Doc7;total of 125;125;-1
Doc8;N = 235;235;-1
Doc8;total of 235;235;-1
Doc1;168 participants;168;-1
Doc1;117 participants;117;-1
Doc1;90 participants;90;-1
Doc1;86   participants;86;-1
Doc1;104 participants;104;-1
Doc1;N   =   1;1;-1
Doc1;N = 168;168;-1
Doc1;total of 1,179;1179;-1
Doc1;total of 7,205;7205;-1
Doc2;N = 231;231;-1
Doc2;n = 1;1;-1
Doc2;n = 4;4;-1
Doc2;total of 79;79;-1
Doc3;N   =   1;1;-1
Doc3;N = 154;154;-1
Doc3; data from 55;55;-1
Doc4;136   participants;136;-1
Doc4;100 participants;100;-1
Doc4;451 participants;451;-1
Doc4;N = 136;136;-1
Doc4;N = 451;451;-1
Doc5;50 individuals;50;-1
Doc5;N   =   9;9;-1
Doc5;N = 95;95;-1
Doc5; data from 95;95;-1
Doc6;10,317 women;10317;-1
Doc6;2,839 individuals;2839;-1
Doc6;6,875 individuals;6875;-1
Doc6;10,317 individuals;10317;-1
Doc6;14 individuals;14;-1
Doc6;14   individuals;14;-1
Doc6;4 over N   individuals;4;-1
Doc6;2,839 adults;2839;-1
Doc6;n = 0;0;-1
Doc6;n = 6;6;-1
Doc6;n = 9;9;-1
Doc6;n = 12;12;-1
Doc6; data set from 1957;1957;-1
Doc7;N = 108;108;-1
Doc7;N = 54;54;-1
Doc8;   data set of 2,102;2102;-1
Doc9;N = 450;450;-1
Doc1;n = 3;3;-1
Doc10;N = 543;543;-1
Doc10;N   = 543;543;-1
Doc10;n = 390;390;-1
Doc10;n = 153;153;-1
Doc10;N = 217;217;-1
Doc10;68 MBA students enrolled;68;-1
Doc11;23 million people;23;-1
Doc12;165 participants;165;-1
Doc12;161 participants;161;-1
Doc12;12 participants;12;-1
Doc12;149 participants;149;-1
Doc2;5 persons;5;-1
Doc2;216 individuals;216;-1
Doc2;n = 179;179;-1
Doc2;n = 92;92;-1
Doc2;n = 210;210;-1
Doc2;n = 151;151;-1
Doc2;N = 179;179;-1
Doc2; data of 179;179;-1
Doc4;10 participants;10;-1
Doc4;total of 76;76;-1
Doc4;total of 80;80;-1
Doc4;total of 78;78;-1
Doc4;total of 68;68;-1
Doc5;n = 204;204;-1
Doc5;n = 17;17;-1
Doc5;n = 5;5;-1
Doc5;n = 100;100;-1
Doc5;n = 61;61;-1
Doc5;n = 11;11;-1
Doc5;n = 44;44;-1
Doc6;2014  politically skilled individuals;2014;-1
Doc6;N = 175;175;-1
Doc6;N = 155;155;-1
Doc6;total   of 998;998;-1
Doc7;62 women;62;-1
Doc7;24 women;24;-1
Doc7;1 = women;1;-1
Doc7;n = 164;164;-1
Doc7;n = 111;111;-1
Doc7;n   =   2;2;-1
Doc7;n   =   1;1;-1
Doc9;20 people;20;-1
Doc9;5   people;5;-1
Doc9;100 people;100;-1
Doc9;total of 1,000;1000;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;6 We did not elicit participants;6;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;210 participants;210;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;9  Five participants;9;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;210  participants;210;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;17 participants;17;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;23 only very few participants;23;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;35 participants;35;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;19 individuals;19;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 35;35;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 36;36;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 47;47;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 42;42;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 41;41;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 37;37;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 35;35;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 33;33;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Ambiguous-incentives-and-the-persistence-of-effort-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;total of 210;210;-1
Awards-unbundled-Evidence-from-a-natural-field-experiment_2014_Journal-of-Economic-Behavior-Organization;3500 individuals;3500;-1
Awards-unbundled-Evidence-from-a-natural-field-experiment_2014_Journal-of-Economic-Behavior-Organization;314 individuals;314;-1
Awards-unbundled-Evidence-from-a-natural-field-experiment_2014_Journal-of-Economic-Behavior-Organization;60 individuals;60;-1
Deterrence-vs-gamesmanship-Taxpayer-response-to-targeted-audits-and-endogenous-penalties_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Deterrence-vs-gamesmanship-Taxpayer-response-to-targeted-audits-and-endogenous-penalties_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
Gender-differences-in-competition-and-sabotage_2014_Journal-of-Economic-Behavior-Organization;21 participants;21;-1
Gender-differences-in-competition-and-sabotage_2014_Journal-of-Economic-Behavior-Organization;450 German subjects;450;-1
Gender-differences-in-competition-and-sabotage_2014_Journal-of-Economic-Behavior-Organization;14 subjects;14;-1
Gender-differences-in-competition-and-sabotage_2014_Journal-of-Economic-Behavior-Organization;336 students enrolled;336;-1
Imitation-and-efficient-contagion_2014_Journal-of-Economic-Behavior-Organization;1  individuals;1;-1
Imitation-and-efficient-contagion_2014_Journal-of-Economic-Behavior-Organization;n = 4;4;-1
Personal-traits-and-individual-choices-Taking-action-in-economic-and-non-economic-decisions_2014_Journal-of-Economic-Behavior-Organization;75  I  usually do what other people;75;-1
Personal-traits-and-individual-choices-Taking-action-in-economic-and-non-economic-decisions_2014_Journal-of-Economic-Behavior-Organization;N = 1648;1648;-1
Personal-traits-and-individual-choices-Taking-action-in-economic-and-non-economic-decisions_2014_Journal-of-Economic-Behavior-Organization;N = 1518;1518;-1
Personal-traits-and-individual-choices-Taking-action-in-economic-and-non-economic-decisions_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
Pro-social-missions-and-worker-motivation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;16 Both labs recruit participants;16;-1
Pro-social-missions-and-worker-motivation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;70 subjects;70;-1
Pro-social-missions-and-worker-motivation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;270 subjects;270;-1
Pro-social-missions-and-worker-motivation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;14 We use a standard student subjects;14;-1
Pro-social-missions-and-worker-motivation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;total of 270;270;-1
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;20 persons;20;23798
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;9 Type-X persons;9;19872
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;11 Type-X persons;11;14372
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;20 subjects;20;23285
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;16 subjects;16;23171
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;152 subjects;152;22988
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;1 allowed subjects;1;22498
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;1 decisions  In each treatment subjects;1;15635
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;14 Type-Y subjects;14;10798
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;12 instances where Type-X subjects;12;12361
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 12;12;7371
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 8;8;7311
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 14;14;7291
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 26;26;5935
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 22;22;5905
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 20;20;5876
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 340;340;3901
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 432;432;3325
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 288;288;3539
Allocating-a-voluntarily-provided-common-property-resource-An-experimental-examination_2014_Journal-of-Economic-Behavior-Organization;n = 504;504;3775
Do-social-networks-prevent-or-promote-bank-runs-_2014_Journal-of-Economic-Behavior-Organization;48 subjects;48;-1
Do-social-networks-prevent-or-promote-bank-runs-_2014_Journal-of-Economic-Behavior-Organization;total of 48;48;-1
Do-social-networks-prevent-or-promote-bank-runs-_2014_Journal-of-Economic-Behavior-Organization;total of 20;20;-1
Eliciting-subjective-probabilities-with-binary-lotteries_2014_Journal-of-Economic-Behavior-Organization;16 We assign subjects;16;-1
Eliciting-subjective-probabilities-with-binary-lotteries_2014_Journal-of-Economic-Behavior-Organization;68 subjects;68;-1
Eliciting-subjective-probabilities-with-binary-lotteries_2014_Journal-of-Economic-Behavior-Organization;70 subjects;70;-1
Employment-restrictions-and-political-violence-in-the-Israeli-Palestinian-conflict_2014_Journal-of-Economic-Behavior-Organization;200  persons;200;-1
Short-sale-constraints-divergence-of-opinion-and-asset-prices-Evidence-from-the-laboratory_2014_Journal-of-Economic-Behavior-Organization;40 participants;40;-1
Short-sale-constraints-divergence-of-opinion-and-asset-prices-Evidence-from-the-laboratory_2014_Journal-of-Economic-Behavior-Organization;240 different subjects;240;-1
Short-sale-constraints-divergence-of-opinion-and-asset-prices-Evidence-from-the-laboratory_2014_Journal-of-Economic-Behavior-Organization;16 Even if subjects;16;-1
Short-sale-constraints-divergence-of-opinion-and-asset-prices-Evidence-from-the-laboratory_2014_Journal-of-Economic-Behavior-Organization;9 Participants are recruited;9;-1
Short-sale-constraints-divergence-of-opinion-and-asset-prices-Evidence-from-the-laboratory_2014_Journal-of-Economic-Behavior-Organization;total of 240;240;-1
The-role-of-ex-post-transparency-in-information-transmission-An-experiment_2014_Journal-of-Economic-Behavior-Organization;70 participants;70;-1
The-role-of-ex-post-transparency-in-information-transmission-An-experiment_2014_Journal-of-Economic-Behavior-Organization;84 sender participants;84;-1
The-role-of-ex-post-transparency-in-information-transmission-An-experiment_2014_Journal-of-Economic-Behavior-Organization;60 subjects;60;-1
Who-holds-the-purse-strings-within-the-household-The-determinants-of-intra-family-decision-making_2014_Journal-of-Economic-Behavior-Organization;total of 59,389;59389;-1
Who-holds-the-purse-strings-within-the-household-The-determinants-of-intra-family-decision-making_2014_Journal-of-Economic-Behavior-Organization; data from the 2003;2003;-1
A-tale-of-an-unwanted-outcome-Transfers-and-local-endowments-of-trust-and-cooperation_2014_Journal-of-Economic-Behavior-Organization;2 We  index civic individuals;2;-1
Deferred-compensation-vs-efficiency-wages-An-experimental-test-of-effort-provision-and-self-selection_2014_Journal-of-Economic-Behavior-Organization;290 subjects;290;-1
Deferred-compensation-vs-efficiency-wages-An-experimental-test-of-effort-provision-and-self-selection_2014_Journal-of-Economic-Behavior-Organization;3  the demographics of the subjects;3;-1
Deferred-compensation-vs-efficiency-wages-An-experimental-test-of-effort-provision-and-self-selection_2014_Journal-of-Economic-Behavior-Organization;total of 13;13;-1
Deferred-compensation-vs-efficiency-wages-An-experimental-test-of-effort-provision-and-self-selection_2014_Journal-of-Economic-Behavior-Organization;total of 290;290;-1
Guilt-aversion-revisited-An-experimental-test-of-a-new-model_2014_Journal-of-Economic-Behavior-Organization;116  subjects;116;-1
Guilt-aversion-revisited-An-experimental-test-of-a-new-model_2014_Journal-of-Economic-Behavior-Organization;1  Aggregate data of subjects;1;-1
Guilt-aversion-revisited-An-experimental-test-of-a-new-model_2014_Journal-of-Economic-Behavior-Organization;total of 116;116;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;1 participants;1;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;20 participants;20;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;200 participants;200;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;174 participants;174;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;13  Experimental subjects;13;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;32  subjects;32;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;26 subjects;26;-1
Optimal-prizes-in-dynamic-elimination-contests-Theory-and-experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;total of 10;10;-1
Regional-concentration-of-entrepreneurial-activities_2014_Journal-of-Economic-Behavior-Organization;1 High-skilled individuals;1;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;3 persons;3;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;16 individuals;16;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;15  individuals;15;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;12 individuals;12;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;63 individuals;63;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;18  individuals;18;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;18 individuals;18;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;11 We exclude unmatched individuals;11;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;117 individuals;117;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;18 Fifty-four unique individuals;18;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;54 individuals;54;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;27 Such individuals;27;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;30  If these individuals;30;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;n = 2;2;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;n = 25;25;-1
Starting-small-toward-voluntary-formation-of-efficient-large-groups-in-public-goods-provision_2014_Journal-of-Economic-Behavior-Organization;total of 63;63;-1
A-comparison-of-performance-of-Islamic-and-conventional-banks-2004-2009_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;8963
Bank-insured-RoSCA-for-microfinance-Experimental-evidence-in-poor-Egyptian-villages_2014_Journal-of-Economic-Behavior-Organization;50 subjects;50;-1
Bank-insured-RoSCA-for-microfinance-Experimental-evidence-in-poor-Egyptian-villages_2014_Journal-of-Economic-Behavior-Organization;22  More subjects;22;-1
Bank-insured-RoSCA-for-microfinance-Experimental-evidence-in-poor-Egyptian-villages_2014_Journal-of-Economic-Behavior-Organization;7 billion adults;7;-1
Bank-insured-RoSCA-for-microfinance-Experimental-evidence-in-poor-Egyptian-villages_2014_Journal-of-Economic-Behavior-Organization;total of 12;12;-1
Corporate-social-responsibility-and-financial-performance-in-Islamic-banks_2014_Journal-of-Economic-Behavior-Organization;n=1;1;-1
Credit-risk-in-Islamic-joint-venture-bond_2014_Journal-of-Economic-Behavior-Organization;  data consists of 52;52;-1
Credit-risk-in-Islamic-joint-venture-bond_2014_Journal-of-Economic-Behavior-Organization;  data from  52;52;-1
Credit-risk-in-Islamic-joint-venture-bond_2014_Journal-of-Economic-Behavior-Organization; data from 52;52;-1
Endogenous-peer-effects-local-aggregate-or-local-average-_2014_Journal-of-Economic-Behavior-Organization;20,000 individuals;20000;-1
Endogenous-peer-effects-local-aggregate-or-local-average-_2014_Journal-of-Economic-Behavior-Organization;n = 63;63;-1
Endogenous-peer-effects-local-aggregate-or-local-average-_2014_Journal-of-Economic-Behavior-Organization;n = 8607;8607;-1
Expert-advice-for-amateurs_2014_Journal-of-Economic-Behavior-Organization;113 million adults;113;-1
Expert-advice-for-amateurs_2014_Journal-of-Economic-Behavior-Organization;N = 1;1;-1
Expert-advice-for-amateurs_2014_Journal-of-Economic-Behavior-Organization;N = 2;2;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;240 individual participants;240;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;66 participants;66;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;3 individuals;3;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 90;90;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 30;30;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 45;45;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 15;15;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 105;105;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 35;35;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;n = 6;6;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;N = 80;80;-1
Group-decisions-under-ambiguity-Convergence-to-neutrality_2014_Journal-of-Economic-Behavior-Organization;total of 100;100;-1
The-impact-of-immigration-on-the-well-being-of-natives_2014_Journal-of-Economic-Behavior-Organization;8 million individuals;8;-1
The-Political-Coase-Theorem-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;160 participants;160;-1
The-Political-Coase-Theorem-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;16 subjects;16;-1
The-Political-Coase-Theorem-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;4 subjects;4;-1
The-Political-Coase-Theorem-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;total of 160;160;-1
-Unfinished-business-Historic-complementarities-political-competition-and-ethnic-violence-in-Gujarat_2014_Journal-of-Economic-Behavior-Organization;58 people;58;44601
-Unfinished-business-Historic-complementarities-political-competition-and-ethnic-violence-in-Gujarat_2014_Journal-of-Economic-Behavior-Organization;98,000 people;98000;44337
-Unfinished-business-Historic-complementarities-political-competition-and-ethnic-violence-in-Gujarat_2014_Journal-of-Economic-Behavior-Organization;N = 167;167;2013
-Unfinished-business-Historic-complementarities-political-competition-and-ethnic-violence-in-Gujarat_2014_Journal-of-Economic-Behavior-Organization;N = 13;13;1988
-Unfinished-business-Historic-complementarities-political-competition-and-ethnic-violence-in-Gujarat_2014_Journal-of-Economic-Behavior-Organization;N = 180;180;2173
Confucianism-and-preferences-Evidence-from-lab-experiments-in-Taiwan-and-China_2014_Journal-of-Economic-Behavior-Organization;380 subjects;380;-1
Confucianism-and-preferences-Evidence-from-lab-experiments-in-Taiwan-and-China_2014_Journal-of-Economic-Behavior-Organization;9 NTU subjects;9;-1
Confucianism-and-preferences-Evidence-from-lab-experiments-in-Taiwan-and-China_2014_Journal-of-Economic-Behavior-Organization;9 NTU subjects recruited;9;-1
Religion-and-risky-health-behaviors-among-U-S-adolescents-and-adults_2014_Journal-of-Economic-Behavior-Organization;12,000 individuals;12000;-1
Religion-and-risky-health-behaviors-among-U-S-adolescents-and-adults_2014_Journal-of-Economic-Behavior-Organization;5000 individuals;5000;-1
Religion-and-risky-health-behaviors-among-U-S-adolescents-and-adults_2014_Journal-of-Economic-Behavior-Organization;N = 20,745;20745;-1
Religion-and-risky-health-behaviors-among-U-S-adolescents-and-adults_2014_Journal-of-Economic-Behavior-Organization;N = 15,197;15197;-1
Religion-and-risky-health-behaviors-among-U-S-adolescents-and-adults_2014_Journal-of-Economic-Behavior-Organization;N = 15,701;15701;-1
Religion-politician-identity-and-development-outcomes-Evidence-from-India_2014_Journal-of-Economic-Behavior-Organization; data from 1977;1977;-1
Religion-politician-identity-and-development-outcomes-Evidence-from-India_2014_Journal-of-Economic-Behavior-Organization;  data from the 16;16;-1
Religiosity-and-state-welfare_2014_Journal-of-Economic-Behavior-Organization; data from 1990;1990;-1
The-construction-of-morals_2014_Journal-of-Economic-Behavior-Organization;21 If subjects;21;-1
The-construction-of-morals_2014_Journal-of-Economic-Behavior-Organization;1 as obscene may  cause people;1;-1
The-construction-of-morals_2014_Journal-of-Economic-Behavior-Organization;N = 600;600;-1
The-construction-of-morals_2014_Journal-of-Economic-Behavior-Organization;N = 1974;1974;-1
The-construction-of-morals_2014_Journal-of-Economic-Behavior-Organization;n=1;1;-1
The-construction-of-morals_2014_Journal-of-Economic-Behavior-Organization;total of 645;645;-1
The-effect-of-education-on-religion-Evidence-from-compulsory-schooling-laws_2014_Journal-of-Economic-Behavior-Organization;13 These individuals;13;-1
The-effect-of-education-on-religion-Evidence-from-compulsory-schooling-laws_2014_Journal-of-Economic-Behavior-Organization;755,386 individuals;755386;-1
The-effect-of-education-on-religion-Evidence-from-compulsory-schooling-laws_2014_Journal-of-Economic-Behavior-Organization;73,135 individuals;73135;-1
The-effect-of-education-on-religion-Evidence-from-compulsory-schooling-laws_2014_Journal-of-Economic-Behavior-Organization;497,721 individuals;497721;-1
The-effect-of-political-violence-on-religiosity_2014_Journal-of-Economic-Behavior-Organization;7000 individuals;7000;-1
Behavioral-heuristics-and-market-patterns-in-a-Bertrand-Edgeworth-game_2014_Journal-of-Economic-Behavior-Organization;31 more than half of the  participants;31;-1
Behavioral-heuristics-and-market-patterns-in-a-Bertrand-Edgeworth-game_2014_Journal-of-Economic-Behavior-Organization;13 All subjects;13;-1
Behavioral-heuristics-and-market-patterns-in-a-Bertrand-Edgeworth-game_2014_Journal-of-Economic-Behavior-Organization;N = 10;10;-1
Behavioral-heuristics-and-market-patterns-in-a-Bertrand-Edgeworth-game_2014_Journal-of-Economic-Behavior-Organization;N = 6;6;-1
Behavioral-heuristics-and-market-patterns-in-a-Bertrand-Edgeworth-game_2014_Journal-of-Economic-Behavior-Organization;N  = 20;20;-1
Conflict-settlement-and-the-shadow-of-the-future_2014_Journal-of-Economic-Behavior-Organization;24 subjects;24;-1
Conflict-settlement-and-the-shadow-of-the-future_2014_Journal-of-Economic-Behavior-Organization;12 subjects;12;-1
Conflict-settlement-and-the-shadow-of-the-future_2014_Journal-of-Economic-Behavior-Organization;5 if  subjects;5;-1
Conflict-settlement-and-the-shadow-of-the-future_2014_Journal-of-Economic-Behavior-Organization;15 Clearly not all subjects;15;-1
Heterogeneous-expectations-in-asset-pricing-Empirical-evidence-from-the-S-amp-P500_2014_Journal-of-Economic-Behavior-Organization;total of 502;502;-1
Honesty-vs-advocacy_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Linguistic-barriers-in-the-destination-language-acquisition-of-immigrants_2014_Journal-of-Economic-Behavior-Organization;20,000 individuals;20000;-1
Linguistic-barriers-in-the-destination-language-acquisition-of-immigrants_2014_Journal-of-Economic-Behavior-Organization;215 million individuals;215;-1
Linguistic-barriers-in-the-destination-language-acquisition-of-immigrants_2014_Journal-of-Economic-Behavior-Organization; data is taken from the 2006;2006;-1
Patient-mobility-health-care-quality-and-welfare_2014_Journal-of-Economic-Behavior-Organization;1 cannot turn down patients;1;-1
Patient-mobility-health-care-quality-and-welfare_2014_Journal-of-Economic-Behavior-Organization;1 of treating patients;1;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;1999 and allowed individuals;1999;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;n = 9;9;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;n = 1006;1006;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;n = 1060;1060;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;n = 429;429;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;n = 216;216;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization;n = 258;258;-1
Piracy-and-music-sales-The-effects-of-an-anti-piracy-law_2014_Journal-of-Economic-Behavior-Organization; data from 2004;2004;-1
Raising-the-price-of-talk-An-experimental-analysis-of-transparent-leadership_2014_Journal-of-Economic-Behavior-Organization;12 participants;12;-1
Raising-the-price-of-talk-An-experimental-analysis-of-transparent-leadership_2014_Journal-of-Economic-Behavior-Organization;12 subjects;12;-1
Raising-the-price-of-talk-An-experimental-analysis-of-transparent-leadership_2014_Journal-of-Economic-Behavior-Organization;8 subjects;8;-1
Raising-the-price-of-talk-An-experimental-analysis-of-transparent-leadership_2014_Journal-of-Economic-Behavior-Organization;6 All subjects;6;-1
Raising-the-price-of-talk-An-experimental-analysis-of-transparent-leadership_2014_Journal-of-Economic-Behavior-Organization;6 All subjects were  recruited;6;-1
Raising-the-price-of-talk-An-experimental-analysis-of-transparent-leadership_2014_Journal-of-Economic-Behavior-Organization;n = 4;4;-1
The-evolution-of-R-amp-D-networks_2014_Journal-of-Economic-Behavior-Organization;n = 25;25;-1
The-evolution-of-R-amp-D-networks_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;24 subjects;24;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;5 and  subjects;5;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;332 individuals;332;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;n = 4;4;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;n = 20;20;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;n = 80;80;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;n = 9;9;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
The-impact-of-burden-sharing-rules-on-the-voluntary-provision-of-public-goods_2014_Journal-of-Economic-Behavior-Organization;n = 44;44;-1
1-s2.0-S0167268114002017-main;94 subjects;94;-1
1-s2.0-S0167268114002017-main;4168 individuals;4168;-1
1-s2.0-S0167268114002017-main;total of 94;94;-1
1-s2.0-S016726811400211X-main;10 subjects;10;-1
1-s2.0-S016726811400211X-main;1 does not directly enter into subjects;1;-1
1-s2.0-S016726811400211X-main;10 individual human subjects;10;-1
1-s2.0-S016726811400211X-main;60 subjects;60;-1
1-s2.0-S016726811400211X-main;30  subjects;30;-1
1-s2.0-S016726811400211X-main;30 subjects;30;-1
1-s2.0-S016726811400211X-main;2 we also provided subjects;2;-1
1-s2.0-S016726811400211X-main;N = 10;10;-1
1-s2.0-S016726811400211X-main; data  from 3;3;-1
1-s2.0-S0167268114002212-main;N = 1000;1000;-1
1-s2.0-S016726811400225X-main; data from the 19;19;-1
Crowding-in-of-complementary-contributions-to-public-goods-Firm-investment-into-open-source-software_2014_Journal-of-Economic-Behavior-Organization;n = 2;2;-1
Crowding-in-of-complementary-contributions-to-public-goods-Firm-investment-into-open-source-software_2014_Journal-of-Economic-Behavior-Organization;n=2;2;-1
Decomposing-firm-level-sales-variation_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
Decomposing-firm-level-sales-variation_2014_Journal-of-Economic-Behavior-Organization;n =  1;1;-1
Decomposing-firm-level-sales-variation_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Decomposing-firm-level-sales-variation_2014_Journal-of-Economic-Behavior-Organization;total of 119,217;119217;-1
Decomposing-firm-level-sales-variation_2014_Journal-of-Economic-Behavior-Organization; data  from 2001;2001;-1
Does-competition-lead-to-customization-_2014_Journal-of-Economic-Behavior-Organization;total of 2400;2400;-1
Doing-wrong-to-do-right-Social-preferences-and-dishonest-behavior_2014_Journal-of-Economic-Behavior-Organization;12 three-digit numbers and participants;12;6422
Doing-wrong-to-do-right-Social-preferences-and-dishonest-behavior_2014_Journal-of-Economic-Behavior-Organization;7 We  recruited;7;5540
Doing-wrong-to-do-right-Social-preferences-and-dishonest-behavior_2014_Journal-of-Economic-Behavior-Organization;total of 89;89;7888
Interest-group-size-and-legislative-lobbying_2014_Journal-of-Economic-Behavior-Organization;N = 4;4;-1
Interest-group-size-and-legislative-lobbying_2014_Journal-of-Economic-Behavior-Organization;N = 5;5;-1
Long-term-savings-decisions-Financial-reform-peer-effects-and-ethnicity_2014_Journal-of-Economic-Behavior-Organization;N = 64;64;-1
Long-term-savings-decisions-Financial-reform-peer-effects-and-ethnicity_2014_Journal-of-Economic-Behavior-Organization;N = 77;77;-1
Long-term-savings-decisions-Financial-reform-peer-effects-and-ethnicity_2014_Journal-of-Economic-Behavior-Organization;total of 6;6;-1
Long-term-savings-decisions-Financial-reform-peer-effects-and-ethnicity_2014_Journal-of-Economic-Behavior-Organization;total of 150;150;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;107 participants;107;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;n = 40;40;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;n = 28;28;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;n = 18;18;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;n = 21;21;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;N = 40;40;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;N = 28;28;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;N = 18;18;-1
Money-is-no-object-Testing-the-endowment-effect-in-exchange-goods_2014_Journal-of-Economic-Behavior-Organization;N = 21;21;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;11,200 persons;11200;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;25,000 persons;25000;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;6700 individuals;6700;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;4584 young  individuals;4584;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;20,000 individuals;20000;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;10 We exclude individuals;10;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;172,000 individuals;172000;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;300,000 individuals;300000;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;20 Young individuals;20;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization;4400 young individuals;4400;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization; data from the 1992;1992;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization; data from 1987;1987;-1
Occupational-sorting-of-school-graduates-The-role-of-economic-preferences_2014_Journal-of-Economic-Behavior-Organization; data from 1996;1996;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;10 subjects;10;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;136 subjects;136;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;14 Some subjects;14;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;10 patients;10;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;10 distinct patients;10;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;10 subjects were recruited;10;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;total of 10;10;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;total of 171;171;-1
Payment-systems-in-the-healthcare-industry-An-experimental-study-of-physician-incentives_2014_Journal-of-Economic-Behavior-Organization;total of 136;136;-1
Signs-and-counter-signals-of-trustworthiness_2014_Journal-of-Economic-Behavior-Organization;17 We did not tell subjects;17;-1
Signs-and-counter-signals-of-trustworthiness_2014_Journal-of-Economic-Behavior-Organization;26 Only three subjects;26;-1
Signs-and-counter-signals-of-trustworthiness_2014_Journal-of-Economic-Behavior-Organization;158 active subjects;158;-1
Signs-and-counter-signals-of-trustworthiness_2014_Journal-of-Economic-Behavior-Organization;35 passive subjects;35;-1
Signs-and-counter-signals-of-trustworthiness_2014_Journal-of-Economic-Behavior-Organization;total of 158;158;-1
Signs-and-counter-signals-of-trustworthiness_2014_Journal-of-Economic-Behavior-Organization;total of 7;7;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;102 subjects;102;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;34 subjects;34;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;231 217 224  Excludes subjects;231217224;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;40 subjects;40;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;32  For subjects;32;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;576 576 576 576  Excludes subjects;5,76577E+11;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;19 Subjects were recruited;19;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;total of 102;102;-1
Strategic-complexity-and-cooperation-An-experimental-study_2014_Journal-of-Economic-Behavior-Organization;total of 34;34;-1
Taxation-income-redistribution-and-debt-dynamics-in-a-seven-equation-model-of-the-business-cycle_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
The-effect-of-unpleasant-experiences-on-evaluation-and-behavior_2014_Journal-of-Economic-Behavior-Organization;47 subjects;47;-1
The-effect-of-unpleasant-experiences-on-evaluation-and-behavior_2014_Journal-of-Economic-Behavior-Organization;32 subjects;32;-1
The-effects-of-exposure-to-hyperinflation-on-occupational-choice_2014_Journal-of-Economic-Behavior-Organization;9 We  discard individuals;9;-1
The-effects-of-exposure-to-hyperinflation-on-occupational-choice_2014_Journal-of-Economic-Behavior-Organization;238 individuals;238;-1
The-French-unhappiness-puzzle-The-cultural-dimension-of-happiness_2014_Journal-of-Economic-Behavior-Organization;21 425 individuals;21425;-1
The-French-unhappiness-puzzle-The-cultural-dimension-of-happiness_2014_Journal-of-Economic-Behavior-Organization;7 Some individuals;7;-1
The-lure-of-illusory-luck-How-much-are-people-willing-to-pay-for-random-shocks_2014_Journal-of-Economic-Behavior-Organization; data set of 1;1;-1
Trust-issues-Evidence-on-the-intergenerational-trust-transmission-among-children-of-immigrants_2014_Journal-of-Economic-Behavior-Organization;8 includes all individuals;8;-1
Trust-issues-Evidence-on-the-intergenerational-trust-transmission-among-children-of-immigrants_2014_Journal-of-Economic-Behavior-Organization;5 include native born individuals;5;-1
Behavioral-responses-to-Daylight-Savings-Time_2014_Journal-of-Economic-Behavior-Organization;39,219  individuals;39219;5304
Behavioral-responses-to-Daylight-Savings-Time_2014_Journal-of-Economic-Behavior-Organization; data from 2006;2006;15660
Behavioral-responses-to-Daylight-Savings-Time_2014_Journal-of-Economic-Behavior-Organization; data from 2007;2007;15619
California-energy-efficiency-Lessons-for-the-rest-of-the-world-or-not-_2014_Journal-of-Economic-Behavior-Organization;6 persons;6;-1
California-energy-efficiency-Lessons-for-the-rest-of-the-world-or-not-_2014_Journal-of-Economic-Behavior-Organization;36 persons;36;-1
California-energy-efficiency-Lessons-for-the-rest-of-the-world-or-not-_2014_Journal-of-Economic-Behavior-Organization;19 people;19;-1
Conflicts-of-interest-distort-public-evaluations-Evidence-from-NCAA-football-coaches_2014_Journal-of-Economic-Behavior-Organization;80 million people;80;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;24 participants;24;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;231 subjects;231;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;80  subjects;80;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;5 In each of these cases individuals;5;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;N = 120;120;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;N = 111;111;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;n = 120;120;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;n = 111;111;-1
Deception-choice-and-self-selection-The-importance-of-being-earnest_2014_Journal-of-Economic-Behavior-Organization;n = 231;231;-1
Does-the-quality-of-electricity-matter-Evidence-from-rural-India_2014_Journal-of-Economic-Behavior-Organization;288 million people;288;-1
Does-the-quality-of-electricity-matter-Evidence-from-rural-India_2014_Journal-of-Economic-Behavior-Organization;364 million people;364;-1
Does-the-quality-of-electricity-matter-Evidence-from-rural-India_2014_Journal-of-Economic-Behavior-Organization;670 million individuals;670;-1
Does-the-quality-of-electricity-matter-Evidence-from-rural-India_2014_Journal-of-Economic-Behavior-Organization;6 individuals;6;-1
Does-the-quality-of-electricity-matter-Evidence-from-rural-India_2014_Journal-of-Economic-Behavior-Organization;9791  Share  of adults;9791;-1
Dynamic-salience-with-intermittent-billing-Evidence-from-smart-electricity-meters_2014_Journal-of-Economic-Behavior-Organization;total of 2,914,313;2914313;-1
Elements-of-emission-market-design-An-experimental-analysis-of-California-s-market-for-greenhouse-gas-allowances_2014_Journal-of-Economic-Behavior-Org;12 subjects;12;-1
Elements-of-emission-market-design-An-experimental-analysis-of-California-s-market-for-greenhouse-gas-allowances_2014_Journal-of-Economic-Behavior-Org;n = 14;14;-1
Elements-of-emission-market-design-An-experimental-analysis-of-California-s-market-for-greenhouse-gas-allowances_2014_Journal-of-Economic-Behavior-Org;n = 8;8;-1
Elements-of-emission-market-design-An-experimental-analysis-of-California-s-market-for-greenhouse-gas-allowances_2014_Journal-of-Economic-Behavior-Org;n = 12;12;-1
Elements-of-emission-market-design-An-experimental-analysis-of-California-s-market-for-greenhouse-gas-allowances_2014_Journal-of-Economic-Behavior-Org;N = 2000;2000;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 1062;1062;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 787;787;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 294;294;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 768;768;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 233;233;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 556;556;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 1056;1056;-1
Environmental-Justice-Evidence-from-Superfund-cleanup-durations_2014_Journal-of-Economic-Behavior-Organization;N = 786;786;-1
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;1 subjects;1;14457
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;343 subjects;343;10821
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;29  subjects;29;8513
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;2 subjects;2;7775
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;43 subjects;43;10820
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;132 subjects;132;1695
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;30 subjects;30;4375
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;10 people;10;9919
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;11 people;11;9685
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;9 people;9;9655
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;N = 78;78;200
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;N = 30;30;233
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;N = 61;61;338
Everyone-believes-in-redemption-Nudges-and-overoptimism-in-costly-task-completion_2014_Journal-of-Economic-Behavior-Organization;N = 29;29;372
Free-to-choose-Promoting-conservation-by-relaxing-outdoor-watering-restrictions_2014_Journal-of-Economic-Behavior-Organization;n = 135,044;135044;-1
Free-to-choose-Promoting-conservation-by-relaxing-outdoor-watering-restrictions_2014_Journal-of-Economic-Behavior-Organization;n = 74,417;74417;-1
Free-to-choose-Promoting-conservation-by-relaxing-outdoor-watering-restrictions_2014_Journal-of-Economic-Behavior-Organization;n = 132,167;132167;-1
Free-to-choose-Promoting-conservation-by-relaxing-outdoor-watering-restrictions_2014_Journal-of-Economic-Behavior-Organization;n = 57,435;57435;-1
Free-to-choose-Promoting-conservation-by-relaxing-outdoor-watering-restrictions_2014_Journal-of-Economic-Behavior-Organization;n = 50,176;50176;-1
Free-to-choose-Promoting-conservation-by-relaxing-outdoor-watering-restrictions_2014_Journal-of-Economic-Behavior-Organization;total of 14;14;-1
How-different-are-smokers-An-analysis-based-on-personal-finances_2014_Journal-of-Economic-Behavior-Organization;1 represents individuals;1;-1
How-different-are-smokers-An-analysis-based-on-personal-finances_2014_Journal-of-Economic-Behavior-Organization;4 includes individuals;4;-1
How-different-are-smokers-An-analysis-based-on-personal-finances_2014_Journal-of-Economic-Behavior-Organization;n = 567;567;-1
How-different-are-smokers-An-analysis-based-on-personal-finances_2014_Journal-of-Economic-Behavior-Organization;total of 15;15;-1
Learning-tastes-through-social-interaction_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Learning-tastes-through-social-interaction_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;5 Five subjects;5;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;83 individuals;83;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 83;83;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 42;42;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 19;19;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 11;11;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 41;41;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 21;21;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 12;12;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 9;9;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 16;16;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 17;17;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 15;15;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 5;5;-1
Moral-hypocrisy-power-and-social-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 22;22;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;4  Dedication towards patients;4;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;343 individuals;343;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;N = 67;67;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 578;578;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 6;6;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 2;2;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 368;368;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 299;299;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 5;5;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 39;39;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;n = 20;20;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;N = 144;144;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;N = 36;36;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;N = 27;27;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;total of 377;377;-1
Pro-social-preferences-and-self-selection-into-jobs-Evidence-from-South-African-nurses_2014_Journal-of-Economic-Behavior-Organization;total of 343;343;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;205 participants;205;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;6 female participants;6;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;5 male participants;5;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;194 participants;194;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;194  participants;194;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;59 participants;59;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;51 subjects;51;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;97 108  Number of subjects;97108;-1
Roll-a-die-and-tell-a-lie-What-affects-honesty-_2014_Journal-of-Economic-Behavior-Organization;total of 253;253;-1
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;13 One reason why subjects;13;38846
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;562 subjects;562;14492
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;76 subjects;76;13718
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;24 All subjects;24;4436
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;110 subjects;110;3904
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;15 subjects;15;2425
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;737 subjects;737;3769
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;150 and people;150;28900
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;110 subjects were recruited;110;3904
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;737 subjects were recruited;737;3769
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization;n = 5;5;40943
Savings-and-prize-linked-savings-accounts_2014_Journal-of-Economic-Behavior-Organization; data of 15;15;2434
Spatial-and-temporal-heterogeneity-of-marginal-emissions-Implications-for-electric-cars-and-other-electricity-shifting-policies_2014_Journal-of-Econom; data of 2008;2008;-1
Temporal-spillovers-in-land-conservation_2014_Journal-of-Economic-Behavior-Organization; data consist of 1996;1996;-1
The-performance-of-non-experimental-designs-in-the-evaluation-of-environmental-programs-A-design-replication-study-using-a-large-scale-randomized-expe;3000 people;3000;-1
The-performance-of-non-experimental-designs-in-the-evaluation-of-environmental-programs-A-design-replication-study-using-a-large-scale-randomized-expe;1500  people;1500;-1
The-performance-of-non-experimental-designs-in-the-evaluation-of-environmental-programs-A-design-replication-study-using-a-large-scale-randomized-expe;N = 10,044;10044;-1
The-performance-of-non-experimental-designs-in-the-evaluation-of-environmental-programs-A-design-replication-study-using-a-large-scale-randomized-expe;N = 9985;9985;-1
The-performance-of-non-experimental-designs-in-the-evaluation-of-environmental-programs-A-design-replication-study-using-a-large-scale-randomized-expe;N = 61,556;61556;-1
The-performance-of-non-experimental-designs-in-the-evaluation-of-environmental-programs-A-design-replication-study-using-a-large-scale-randomized-expe;N = 30,757;30757;-1
Towards-understanding-the-role-of-price-in-residential-electricity-choices-Evidence-from-a-natural-experiment_2014_Journal-of-Economic-Behavior-Organi;total of 1000;1000;-1
1-s2.0-S0167268114001218-main;83 women;83;-1
1-s2.0-S0167268114001218-main;168 participants;168;-1
1-s2.0-S0167268114001218-main;10 time series where subjects;10;-1
1-s2.0-S0167268114001218-main;168 subjects;168;-1
1-s2.0-S0167268114001218-main;17 All subjects;17;-1
1-s2.0-S0167268114001218-main;19 All subjects;19;-1
1-s2.0-S0167268114001218-main;1530 790 740 790 740  No.  of subjects;1,53079E+15;-1
1-s2.0-S0167268114001218-main;790 790 740 740 790 790 790 740 740 740  No.  of subjects;7,90791E+29;-1
1-s2.0-S0167268114001218-main;total of  21;21;-1
1-s2.0-S0167268114001218-main;total of 120;120;-1
Adaptive-learning-and-survey-data_2014_Journal-of-Economic-Behavior-Organization;150 professional market participants;150;-1
An-empirical-examination-of-heterogeneity-and-switching-in-foreign-exchange-markets_2014_Journal-of-Economic-Behavior-Organization;146 averages over individuals;146;6565
Asset-holdings-caps-and-bubbles-in-experimental-asset-markets_2014_Journal-of-Economic-Behavior-Organization;13 Many of the subjects;13;-1
Asset-holdings-caps-and-bubbles-in-experimental-asset-markets_2014_Journal-of-Economic-Behavior-Organization;total of 36;36;-1
Asset-holdings-caps-and-bubbles-in-experimental-asset-markets_2014_Journal-of-Economic-Behavior-Organization; data from 24;24;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;31 participants;31;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;15,170 Wave I participants;15170;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;12,000  individuals;12000;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;2574 individuals;2574;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;288 individuals;288;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;126,559 individuals;126559;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;N = 12,369;12369;-1
Credit-card-borrowing-and-the-monoamine-oxidase-A-MAOA-gene_2014_Journal-of-Economic-Behavior-Organization;N = 117;117;-1
Debiasing-the-disposition-effect-by-reducing-the-saliency-of-information-about-a-stock-s-purchase-price_2014_Journal-of-Economic-Behavior-Organization;6 All subjects;6;-1
Debiasing-the-disposition-effect-by-reducing-the-saliency-of-information-about-a-stock-s-purchase-price_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Do-positional-goods-inhibit-saving-Evidence-from-a-life-cycle-experiment_2014_Journal-of-Economic-Behavior-Organization;7 subjects;7;-1
Do-positional-goods-inhibit-saving-Evidence-from-a-life-cycle-experiment_2014_Journal-of-Economic-Behavior-Organization;9 subjects;9;-1
Do-positional-goods-inhibit-saving-Evidence-from-a-life-cycle-experiment_2014_Journal-of-Economic-Behavior-Organization;13 These averages include two subjects;13;-1
Do-positional-goods-inhibit-saving-Evidence-from-a-life-cycle-experiment_2014_Journal-of-Economic-Behavior-Organization;14 subjects;14;-1
Do-positional-goods-inhibit-saving-Evidence-from-a-life-cycle-experiment_2014_Journal-of-Economic-Behavior-Organization;total of 60;60;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;24 market participants;24;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;2 subjects;2;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;4 subjects;4;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;20 None of the subjects;20;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;192 subjects;192;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;24 subjects;24;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;68 condition subjects;68;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;n = 6;6;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;n = 12;12;-1
Does-ambiguity-aversion-survive-in-experimental-asset-markets-_2014_Journal-of-Economic-Behavior-Organization;total of 192;192;-1
Empirical-behavioral-finance_2014_Journal-of-Economic-Behavior-Organization;12,000 individuals;12000;-1
Empirical-behavioral-finance_2014_Journal-of-Economic-Behavior-Organization;total of 239;239;-1
Experimental-evidence-on-varying-uncertainty-and-skewness-in-laboratory-double-auction-markets_2014_Journal-of-Economic-Behavior-Organization;10  In state SAMPLING subjects;10;-1
Experimental-evidence-on-varying-uncertainty-and-skewness-in-laboratory-double-auction-markets_2014_Journal-of-Economic-Behavior-Organization;N = 9;9;-1
Experimental-evidence-on-varying-uncertainty-and-skewness-in-laboratory-double-auction-markets_2014_Journal-of-Economic-Behavior-Organization;total of 270;270;-1
Funding-decisions-and-entrepreneurial-team-diversity-A-field-study_2014_Journal-of-Economic-Behavior-Organization;2894  individuals;2894;-1
Funding-decisions-and-entrepreneurial-team-diversity-A-field-study_2014_Journal-of-Economic-Behavior-Organization;2894  individuals  recruited;2894;-1
Funding-decisions-and-entrepreneurial-team-diversity-A-field-study_2014_Journal-of-Economic-Behavior-Organization;180 students recruited;180;-1
Gender-differences-in-optimism-and-asset-allocation_2014_Journal-of-Economic-Behavior-Organization; data of 1200;1200;33850
Gender-differences-in-optimism-and-asset-allocation_2014_Journal-of-Economic-Behavior-Organization; data from 56;56;5664
Investor-sentiment-from-internet-message-postings-and-the-predictability-of-stock-returns_2014_Journal-of-Economic-Behavior-Organization;total of 32,613,045;32613045;-1
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;39  participants;39;22055
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;32 participants;32;22163
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;37 participants;37;22301
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;2 types of within-subjects;2;14098
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;3 between-subjects;3;13389
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;2 between-subjects;2;5137
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;n = 24;24;3013
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;n = 20;20;2974
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;n = 25;25;486
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;229
Keeping-your-gains-close-but-your-money-closer-The-prepayment-effect-in-riskless-choices_2014_Journal-of-Economic-Behavior-Organization;total of 7;7;13442
Path-dependence-in-risky-choice-Affective-and-deliberative-processes-in-brain-and-behavior_2014_Journal-of-Economic-Behavior-Organization;20 subjects;20;-1
Path-dependence-in-risky-choice-Affective-and-deliberative-processes-in-brain-and-behavior_2014_Journal-of-Economic-Behavior-Organization;19 subjects;19;-1
Path-dependence-in-risky-choice-Affective-and-deliberative-processes-in-brain-and-behavior_2014_Journal-of-Economic-Behavior-Organization;n = 115;115;-1
Path-dependence-in-risky-choice-Affective-and-deliberative-processes-in-brain-and-behavior_2014_Journal-of-Economic-Behavior-Organization;n = 25;25;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;138 additional participants;138;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;1 participants;1;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 119;119;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 12;12;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 319;319;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 292;292;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 178;178;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 155;155;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 141;141;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 124;124;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 97;97;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;n = 113;113;-1
Second-order-beliefs-and-the-individual-investor_2014_Journal-of-Economic-Behavior-Organization;total of 19,251;19251;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;20,750 subjects;20750;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;167 subjects;167;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;7 Participants were recruited;7;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 167;167;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;N  = 167;167;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 77;77;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 52;52;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;N = 38;38;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;n = 0;0;-1
Stereotypes-and-false-consensus-How-financial-professionals-predict-risk-preferences_2014_Journal-of-Economic-Behavior-Organization;n     =   1;1;-1
Technical-analysis-and-individual-investors_2014_Journal-of-Economic-Behavior-Organization;n = 63;63;-1
Technical-analysis-and-individual-investors_2014_Journal-of-Economic-Behavior-Organization; data and that of the 972;972;-1
Technical-analysis-and-individual-investors_2014_Journal-of-Economic-Behavior-Organization; data from the 1960;1960;-1
Technical-analysis-and-individual-investors_2014_Journal-of-Economic-Behavior-Organization; data from 49;49;-1
The-dark-side-of-sunshine-Regulatory-oversight-and-status-quo-bias_2014_Journal-of-Economic-Behavior-Organization; data from 2000;2000;-1
The-meerkat-effect-Personality-and-market-returns-affect-investors-portfolio-monitoring-behaviour_2014_Journal-of-Economic-Behavior-Organization;617 UK private individuals;617;11767
The-meerkat-effect-Personality-and-market-returns-affect-investors-portfolio-monitoring-behaviour_2014_Journal-of-Economic-Behavior-Organization;total of 19,251;19251;6726
The-meerkat-effect-Personality-and-market-returns-affect-investors-portfolio-monitoring-behaviour_2014_Journal-of-Economic-Behavior-Organization; data set is from 617;617;11785
The-role-of-surprise-Understanding-overreaction-and-underreaction-to-unanticipated-events-using-in-play-soccer-betting-market_2014_Journal-of-Economic;n = 1;1;-1
The-role-of-surprise-Understanding-overreaction-and-underreaction-to-unanticipated-events-using-in-play-soccer-betting-market_2014_Journal-of-Economic;n = 0;0;-1
The-role-of-surprise-Understanding-overreaction-and-underreaction-to-unanticipated-events-using-in-play-soccer-betting-market_2014_Journal-of-Economic;total of 2687;2687;-1
1-s2.0-S0167268113002333-main;120 subjects;120;-1
1-s2.0-S0167268113002333-main;60 subjects;60;-1
1-s2.0-S0167268113002333-main;20 In Slonim and Roth subjects;20;-1
1-s2.0-S0167268113003016-main;154 participants;154;-1
1-s2.0-S0167268113003016-main;158 subjects;158;-1
1-s2.0-S0167268113003016-main;79 German subjects;79;-1
1-s2.0-S0167268113003016-main;3 subjects;3;-1
1-s2.0-S0167268113003016-main;308 subjects;308;-1
1-s2.0-S0167268113003016-main;154 German subjects;154;-1
1-s2.0-S0167268113003016-main;n = 27;27;-1
1-s2.0-S0167268113003016-main;n = 23;23;-1
1-s2.0-S0167268113003016-main;n = 24;24;-1
1-s2.0-S0167268113003016-main;n = 29;29;-1
1-s2.0-S0167268113003016-main;n = 26;26;-1
1-s2.0-S0167268113003016-main;n = 12;12;-1
1-s2.0-S0167268113003016-main;n = 32;32;-1
1-s2.0-S0167268113003107-main;18 subjects;18;-1
1-s2.0-S0167268113003107-main;1 choices of subjects;1;-1
1-s2.0-S0167268113003107-main;2 of those  subjects;2;-1
1-s2.0-S0167268113003107-main;2 compares choices within subjects;2;-1
1-s2.0-S0167268113003107-main;141 subjects;141;-1
1-s2.0-S0167268113003107-main;N = 141;141;-1
1-s2.0-S0167268114000055-main;10 For self-interested subjects;10;-1
1-s2.0-S0167268114000055-main;192 undergraduate student subjects;192;-1
1-s2.0-S0167268114000055-main;8 subjects;8;-1
1-s2.0-S0167268114000055-main;16 subjects;16;-1
1-s2.0-S0167268114000067-main;288 subjects;288;-1
1-s2.0-S0167268114000067-main;16  people;16;-1
1-s2.0-S0167268114000067-main;total of 288;288;-1
1-s2.0-S0167268114000080-main;100  participants;100;-1
1-s2.0-S0167268114000080-main;n = 4;4;-1
1-s2.0-S0167268114000080-main;n = 6;6;-1
1-s2.0-S0167268114000171-main;94 participants;94;-1
1-s2.0-S0167268114000171-main;78 participants;78;-1
1-s2.0-S0167268114000195-main;27 participants;27;-1
1-s2.0-S0167268114000195-main;9 participants;9;-1
1-s2.0-S0167268114000195-main;6 of the high  cost participants;6;-1
1-s2.0-S0167268114000407-main;20  #  participants;20;-1
1-s2.0-S0167268114000407-main;16 participants;16;-1
1-s2.0-S0167268114000419-main;20 participants;20;-1
1-s2.0-S0167268114000419-main;N = 80;80;-1
1-s2.0-S0167268114000419-main;N = 36;36;-1
1-s2.0-S0167268114000419-main;N = 84;84;-1
1-s2.0-S0167268114000419-main;N = 100;100;-1
1-s2.0-S0167268114000547-main;4 This test has participants;4;-1
1-s2.0-S0167268114000547-main;90 participants;90;-1
1-s2.0-S0167268114000547-main;30 participants;30;-1
1-s2.0-S0167268114000547-main;n=1;1;-1
1-s2.0-S0167268114000547-main;N = 4;4;-1
1-s2.0-S0167268114000547-main;N = 72;72;-1
1-s2.0-S0167268114000699-main;32 participants;32;-1
1-s2.0-S0167268114000699-main;18 This should also stimulate participants;18;-1
1-s2.0-S0167268114000699-main;64 individuals;64;-1
1-s2.0-S0167268114002091-main;400,000 women;400000;-1
1-s2.0-S0167268114002091-main;n =1;1;-1
1-s2.0-S0167268114002091-main;total of 30;30;-1
1-s2.0-S0167268114002091-main;total of 60;60;-1
1-s2.0-S0167268114002121-main;26  women;26;-1
1-s2.0-S0167268114002121-main;20  women;20;-1
1-s2.0-S0167268114002121-main;20  women;20;-1
1-s2.0-S0167268114002121-main;52 women;52;-1
1-s2.0-S0167268114002121-main;28 women;28;-1
1-s2.0-S0167268114002121-main;41 women;41;-1
1-s2.0-S0167268114002121-main;3 women;3;-1
1-s2.0-S0167268114002121-main;25 women;25;-1
1-s2.0-S0167268114002121-main;143 participants;143;-1
1-s2.0-S0167268114002121-main;138 participants;138;-1
1-s2.0-S0167268114002121-main;21 participants;21;-1
1-s2.0-S0167268114002121-main;57 female participants;57;-1
1-s2.0-S0167268114002121-main;69 male participants;69;-1
1-s2.0-S0167268114002121-main;17 male participants;17;-1
1-s2.0-S0167268114002121-main;15 female participants;15;-1
1-s2.0-S0167268114002121-main;22 male participants;22;-1
1-s2.0-S0167268114002121-main;34 male participants;34;-1
1-s2.0-S0167268114002121-main;20 female participants;20;-1
1-s2.0-S0167268114002121-main;35 male participants;35;-1
1-s2.0-S0167268114002121-main;20 female  participants;20;-1
1-s2.0-S0167268114002121-main;78 male participants;78;-1
1-s2.0-S0167268114002121-main;8 male participants;8;-1
1-s2.0-S0167268114002121-main;67 male participants;67;-1
1-s2.0-S0167268114002121-main;2 male participants;2;-1
1-s2.0-S0167268114002121-main;52 female participants;52;-1
1-s2.0-S0167268114002121-main;5 female participants;5;-1
1-s2.0-S0167268114002121-main;65 female participants;65;-1
1-s2.0-S0167268114002121-main;4 female participants;4;-1
1-s2.0-S0167268114002121-main;61 female participants;61;-1
1-s2.0-S0167268114002121-main;62 male participants;62;-1
1-s2.0-S0167268114002121-main;7 female participants;7;-1
1-s2.0-S0167268114002121-main;8 female participants;8;-1
1-s2.0-S0167268114002121-main;9  female participants;9;-1
1-s2.0-S0167268114002121-main;14 female participants;14;-1
1-s2.0-S0167268114002121-main;105 participants;105;-1
1-s2.0-S0167268114002121-main;60 participants;60;-1
1-s2.0-S0167268114002121-main;18 participants;18;-1
1-s2.0-S0167268114002121-main;16 Recruitment of participants;16;-1
1-s2.0-S0167268114002121-main;4 could have anchored participants;4;-1
1-s2.0-S0167268114002121-main;11 participants;11;-1
1-s2.0-S0167268114002121-main;43  participants;43;-1
1-s2.0-S0167268114002121-main;6 participants;6;-1
1-s2.0-S0167268114002121-main;35 participants;35;-1
1-s2.0-S0167268114002121-main;24 participants;24;-1
1-s2.0-S0167268114002121-main;20 participants;20;-1
1-s2.0-S0167268114002121-main;34 participants;34;-1
1-s2.0-S0167268114002121-main;57 participants;57;-1
1-s2.0-S0167268114002121-main;3 participants;3;-1
1-s2.0-S0167268114002121-main;11 Participants were recruited;11;-1
1-s2.0-S0167268114002121-main;n = 0;0;-1
1-s2.0-S0167268114002121-main;N = 29;29;-1
1-s2.0-S0167268114002121-main;N = 10;10;-1
1-s2.0-S0167268114002121-main;total of 143;143;-1
1-s2.0-S0167268114002121-main;total of 86;86;-1
1-s2.0-S0167268114002121-main;total of 46;46;-1
1-s2.0-S0167268114002121-main;total of 5000;5000;-1
1-s2.0-S0167268114002121-main;total of 138;138;-1
1-s2.0-S0167268114002121-main;total of 23;23;-1
1-s2.0-S0167268114002121-main;total of 60;60;-1
1-s2.0-S0167268114002157-main;total of 20;20;-1
1-s2.0-S0167268114002157-main;total of 200;200;-1
1-s2.0-S0167268114002200-main;n = 20;20;-1
1-s2.0-S0167268114002200-main;n = 10;10;-1
1-s2.0-S0167268114002200-main;N = 1;1;-1
1-s2.0-S0167268114002200-main;N = 7;7;-1
1-s2.0-S0167268114002315-main;48 participants;48;-1
1-s2.0-S0167268114002315-main;total of 300;300;-1
1-s2.0-S0167268114002327-main;n=0;0;-1
1-s2.0-S0167268114002327-main;n = 1;1;-1
1-s2.0-S0167268114002339-main;4 We  invited participants;4;-1
1-s2.0-S0167268114002339-main;50 participants;50;-1
1-s2.0-S0167268114002339-main;48 participants;48;-1
1-s2.0-S0167268114002339-main;47 participants;47;-1
1-s2.0-S0167268114002339-main;N = 50;50;-1
1-s2.0-S0167268114002339-main;N = 47;47;-1
1-s2.0-S0167268114002339-main;N = 48;48;-1
1-s2.0-S0167268114002339-main;N=50;50;-1
1-s2.0-S0167268114002339-main;N=47;47;-1
1-s2.0-S0167268114002455-main;N = 10;10;-1
1-s2.0-S0167268114002467-main;32 subjects;32;-1
1-s2.0-S0167268114002467-main; data from 91;91;-1
1-s2.0-S0167268114002479-main;58 subjects;58;-1
1-s2.0-S0167268114002479-main;125 people;125;-1
1-s2.0-S0167268114002479-main;8000 individuals;8000;-1
1-s2.0-S0167268114002479-main;11,661 individuals;11661;-1
1-s2.0-S0167268114002479-main;7047 individuals;7047;-1
1-s2.0-S0167268114002479-main;  data  are from the 1949;1949;-1
1-s2.0-S0167268114002479-main; data are from 1943;1943;-1
1-s2.0-S0167268114002479-main; data from the 1949;1949;-1
1-s2.0-S0167268114002480-main;700 people;700;-1
1-s2.0-S0167268114002480-main;n = 221;221;-1
1-s2.0-S0167268114002480-main;total of 700;700;-1
1-s2.0-S0167268114002492-main;total of 1536;1536;14836
1-s2.0-S0167268114002510-main;3 persons;3;-1
1-s2.0-S0167268114002510-main;30 cases  participants;30;-1
1-s2.0-S0167268114002546-main;3 of the participants;3;-1
1-s2.0-S0167268114002546-main;22 Six participants;22;-1
1-s2.0-S0167268114002546-main;29 female participants;29;-1
1-s2.0-S0167268114002546-main;5 participants;5;-1
1-s2.0-S0167268114002546-main;3 where subjects;3;-1
1-s2.0-S0167268114002546-main;N = 75;75;-1
1-s2.0-S0167268114002546-main;N = 73;73;-1
1-s2.0-S0167268114002546-main;N = 33;33;-1
1-s2.0-S0167268114002546-main;N = 30;30;-1
1-s2.0-S0167268114002546-main;N = 0;0;-1
1-s2.0-S0167268114002546-main;N = 13;13;-1
1-s2.0-S0167268114002546-main;N = 15;15;-1
1-s2.0-S0167268114002546-main;N = 9;9;-1
1-s2.0-S0167268114002546-main;N = 10;10;-1
1-s2.0-S0167268114002546-main;N = 8;8;-1
1-s2.0-S0167268114002546-main;N = 12;12;-1
1-s2.0-S0167268114002546-main;N = 11;11;-1
1-s2.0-S0167268114002546-main;N = 14;14;-1
1-s2.0-S0167268114002546-main;N = 29;29;-1
1-s2.0-S0167268114002546-main;N = 44;44;-1
1-s2.0-S0167268114002546-main;N = 60;60;-1
1-s2.0-S0167268114002546-main;N = 36;36;-1
1-s2.0-S0167268114002650-main;258  subjects;258;-1
1-s2.0-S0167268114002698-main;160 participants;160;-1
1-s2.0-S0167268114002698-main;10 participants;10;-1
1-s2.0-S0167268114002698-main; data from 80;80;-1
1-s2.0-S0167268114002741-main;385 participants;385;-1
1-s2.0-S0167268114002789-main;24 subjects;24;-1
1-s2.0-S0167268114002789-main;96 subjects;96;-1
1-s2.0-S0167268114002789-main;8 subjects;8;-1
1-s2.0-S0167268114002789-main;24 indicates a group of four subjects;24;-1
1-s2.0-S0167268114002789-main;8 individuals;8;-1
1-s2.0-S0167268114002789-main;n = 4;4;-1
1-s2.0-S0167268114002789-main;total of 40;40;-1
1-s2.0-S0167268114002789-main;total of 96;96;-1
1-s2.0-S0167268114002789-main;total of 12;12;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;12 subjects;12;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;3000 subjects;3000;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;24 subjects;24;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;78 subjects;78;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;010  rational individuals;10;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;N = 180;180;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;N = 108;108;-1
Can-higher-rewards-lead-to-less-effort-Incentive-reversal-in-teams_2014_Journal-of-Economic-Behavior-Organization;n = 3;3;-1
Decision-costs-and-price-sensitivity-Field-experimental-evidence-from-India_2014_Journal-of-Economic-Behavior-Organization;382 women;382;-1
Decision-costs-and-price-sensitivity-Field-experimental-evidence-from-India_2014_Journal-of-Economic-Behavior-Organization;3 required some participants;3;-1
Decision-costs-and-price-sensitivity-Field-experimental-evidence-from-India_2014_Journal-of-Economic-Behavior-Organization;22 participants;22;-1
Decision-costs-and-price-sensitivity-Field-experimental-evidence-from-India_2014_Journal-of-Economic-Behavior-Organization;9 poorer people;9;-1
Does-laboratory-trading-mirror-behavior-in-real-world-markets-Fair-bargaining-and-competitive-bidding-on-eBay_2014_Journal-of-Economic-Behavior-Organi;100 participants;100;-1
Does-laboratory-trading-mirror-behavior-in-real-world-markets-Fair-bargaining-and-competitive-bidding-on-eBay_2014_Journal-of-Economic-Behavior-Organi;300 subjects;300;-1
Does-laboratory-trading-mirror-behavior-in-real-world-markets-Fair-bargaining-and-competitive-bidding-on-eBay_2014_Journal-of-Economic-Behavior-Organi;n = 2;2;-1
Hierarchy-coercion-and-exploitation-An-experimental-analysis_2014_Journal-of-Economic-Behavior-Organization;20 participants;20;-1
Hierarchy-coercion-and-exploitation-An-experimental-analysis_2014_Journal-of-Economic-Behavior-Organization;20 senior  subjects;20;-1
Hierarchy-coercion-and-exploitation-An-experimental-analysis_2014_Journal-of-Economic-Behavior-Organization;20 senior subjects;20;-1
Hierarchy-coercion-and-exploitation-An-experimental-analysis_2014_Journal-of-Economic-Behavior-Organization;N = 200;200;-1
Hierarchy-coercion-and-exploitation-An-experimental-analysis_2014_Journal-of-Economic-Behavior-Organization;N = 160;160;-1
Indecisiveness-in-behavioral-welfare-economics_2014_Journal-of-Economic-Behavior-Organization;010  For a society of individuals;10;-1
Misery-Loves-Company-Exogenous-shocks-in-retirement-expectations-and-social-comparison-effects-on-subjective-well-being_2014_Journal-of-Economic-Behav;1950 are women;1950;8798
Misery-Loves-Company-Exogenous-shocks-in-retirement-expectations-and-social-comparison-effects-on-subjective-well-being_2014_Journal-of-Economic-Behav;2 million ABP participants;2;17553
Misery-Loves-Company-Exogenous-shocks-in-retirement-expectations-and-social-comparison-effects-on-subjective-well-being_2014_Journal-of-Economic-Behav;8516 individuals;8516;7304
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;007  We  find inexperienced participants;7;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;6 We provide participants;6;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;30 participants;30;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;10 We did not invite participants;10;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;63 FULL participants;63;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;62 AGGR participants;62;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;70 142  Between-participants;70142;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;60 154  Between-participants;60154;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;14  Between-participants;14;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;10 percent of the subjects;10;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;13 subjects;13;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;N = 16;16;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;N = 4;4;-1
Myopic-loss-aversion-and-market-experience_2014_Journal-of-Economic-Behavior-Organization;total of 16;16;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;80 subjects;80;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;60 subjects;60;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;3 subjects;3;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;0  #  subjects;0;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;1 subjects;1;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;360 360 240 240  No.  of subjects;3,6036E+11;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;120 300  No.  of subjects;120300;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;720 720 600 600  No.  of subjects;7,20721E+11;-1
Myopic-risk-taking-in-tournaments_2014_Journal-of-Economic-Behavior-Organization;total of 300;300;-1
Risk-taking-of-executives-under-different-incentive-contracts-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;96 subjects;96;-1
Risk-taking-of-executives-under-different-incentive-contracts-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;18 subjects;18;-1
Risk-taking-of-executives-under-different-incentive-contracts-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;48 subjects;48;-1
Risk-taking-of-executives-under-different-incentive-contracts-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;48  subjects;48;-1
Risk-taking-of-executives-under-different-incentive-contracts-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;96 subjects were recruited;96;-1
Scale-manipulation-in-dictator-games_2014_Journal-of-Economic-Behavior-Organization;320 subjects;320;-1
Scale-manipulation-in-dictator-games_2014_Journal-of-Economic-Behavior-Organization;2 between-subjects;2;-1
Scale-manipulation-in-dictator-games_2014_Journal-of-Economic-Behavior-Organization;32 subjects;32;-1
Scale-manipulation-in-dictator-games_2014_Journal-of-Economic-Behavior-Organization;20 subjects;20;-1
Scale-manipulation-in-dictator-games_2014_Journal-of-Economic-Behavior-Organization;4 For experienced subjects;4;-1
Social-capital-and-entrepreneurial-activity-A-pseudo-panel-approach_2014_Journal-of-Economic-Behavior-Organization;10 people;10;-1
Social-learning-and-health-insurance-enrollment-Evidence-from-China-s-New-Cooperative-Medical-Scheme_2014_Journal-of-Economic-Behavior-Organization;500  individuals;500;-1
The-costs-of-conflict_2014_Journal-of-Economic-Behavior-Organization;12 participants;12;13178
The-costs-of-conflict_2014_Journal-of-Economic-Behavior-Organization;13  We  randomly pair subjects;13;17832
The-costs-of-conflict_2014_Journal-of-Economic-Behavior-Organization;1 subjects;1;17427
The-costs-of-conflict_2014_Journal-of-Economic-Behavior-Organization;108 subjects;108;13268
The-costs-of-conflict_2014_Journal-of-Economic-Behavior-Organization;n = 4;4;11339
The-costs-of-conflict_2014_Journal-of-Economic-Behavior-Organization;n =  4;4;10556
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;480 subjects;480;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;60 min  and subjects;60;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;192 subjects;192;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;96 subjects;96;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;24 subjects;24;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;12 subjects;12;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;5 subjects;5;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;1 both subjects;1;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;total of 480;480;-1
Worker-characteristics-and-wage-differentials-Evidence-from-a-gift-exchange-experiment_2014_Journal-of-Economic-Behavior-Organization;total of 90;90;-1
-Let-me-dream-on-Anticipatory-emotions-and-preference-for-timing-in-lotteries_2014_Journal-of-Economic-Behavior-Organization;13  Before dismissing subjects;13;-1
-Let-me-dream-on-Anticipatory-emotions-and-preference-for-timing-in-lotteries_2014_Journal-of-Economic-Behavior-Organization;65 student  subjects;65;-1
-Let-me-dream-on-Anticipatory-emotions-and-preference-for-timing-in-lotteries_2014_Journal-of-Economic-Behavior-Organization;total of 65;65;-1
Healthy-habits-The-connection-between-diet-exercise-and-locus-of-control_2014_Journal-of-Economic-Behavior-Organization;3901 women;3901;-1
Healthy-habits-The-connection-between-diet-exercise-and-locus-of-control_2014_Journal-of-Economic-Behavior-Organization;13,969 individuals;13969;-1
Healthy-habits-The-connection-between-diet-exercise-and-locus-of-control_2014_Journal-of-Economic-Behavior-Organization;10,503 individuals;10503;-1
Healthy-habits-The-connection-between-diet-exercise-and-locus-of-control_2014_Journal-of-Economic-Behavior-Organization;3190 individuals;3190;-1
Healthy-habits-The-connection-between-diet-exercise-and-locus-of-control_2014_Journal-of-Economic-Behavior-Organization;total of 13,969;13969;-1
Healthy-habits-The-connection-between-diet-exercise-and-locus-of-control_2014_Journal-of-Economic-Behavior-Organization; data from 2003;2003;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization;170 participants;170;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization;N = 170;170;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization;total of 80;80;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization;total of 10,080;10080;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization;total of 8;8;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization;total of 30;30;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization; data from 8;8;-1
On-the-advantages-and-disadvantages-of-subjective-measures_2014_Journal-of-Economic-Behavior-Organization; data from 16;16;-1
Who-cooperates-in-repeated-games-The-role-of-altruism-inequity-aversion-and-demographics_2014_Journal-of-Economic-Behavior-Organization;30 subjects;30;-1
Who-cooperates-in-repeated-games-The-role-of-altruism-inequity-aversion-and-demographics_2014_Journal-of-Economic-Behavior-Organization;278 subjects;278;-1
Who-cooperates-in-repeated-games-The-role-of-altruism-inequity-aversion-and-demographics_2014_Journal-of-Economic-Behavior-Organization;32 subjects;32;-1
Who-cooperates-in-repeated-games-The-role-of-altruism-inequity-aversion-and-demographics_2014_Journal-of-Economic-Behavior-Organization;10 Even though subjects;10;-1
Who-cooperates-in-repeated-games-The-role-of-altruism-inequity-aversion-and-demographics_2014_Journal-of-Economic-Behavior-Organization;27 Some subjects;27;-1
Who-cooperates-in-repeated-games-The-role-of-altruism-inequity-aversion-and-demographics_2014_Journal-of-Economic-Behavior-Organization;7 These recipients were recruited;7;-1
Why-are-educated-and-risk-loving-persons-more-mobile-across-regions-_2014_Journal-of-Economic-Behavior-Organization;10,393  individuals;10393;-1
Why-are-educated-and-risk-loving-persons-more-mobile-across-regions-_2014_Journal-of-Economic-Behavior-Organization;994 individuals;994;-1
Why-are-educated-and-risk-loving-persons-more-mobile-across-regions-_2014_Journal-of-Economic-Behavior-Organization;89 individuals;89;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;22 subjects;22;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 0;0;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 2;2;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 4;4;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 9;9;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 2 351 339 287 331 250;2,35134E+15;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N  = 4 277 377 254 300 188;4,27738E+15;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N  = 9 380 251 348 326;9,38025E+12;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N = 4 293;4293;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N=2;2;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N=9;9;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;N=4;4;-1
Bounded-rationality-and-group-size-in-Tullock-contests-Experimental-evidence_2014_Journal-of-Economic-Behavior-Organization;total of 9;9;-1
Envy-guilt-and-the-Phillips-curve_2014_Journal-of-Economic-Behavior-Organization;n  = 1;1;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;017  men  and women;17;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;44 women;44;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;10 people;10;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;219 individuals;219;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;2 as individuals;2;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;1000 adults;1000;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 75;75;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 135;135;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 144;144;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 150;150;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 81;81;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 107;107;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 44;44;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N  = 219;219;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 94;94;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;N = 125;125;-1
Gender-differences-in-risk-aversion-Do-single-sex-environments-affect-their-development-_2014_Journal-of-Economic-Behavior-Organization;total of 22;22;-1
How-many-pears-would-a-pear-packer-pack-if-a-pear-packer-could-pack-pears-at-quasi-exogenously-varying-piece-rates-_2014_Journal-of-Economic-Behavior-;N = 3908;3908;-1
How-many-pears-would-a-pear-packer-pack-if-a-pear-packer-could-pack-pears-at-quasi-exogenously-varying-piece-rates-_2014_Journal-of-Economic-Behavior-;N = 2262;2262;-1
How-many-pears-would-a-pear-packer-pack-if-a-pear-packer-could-pack-pears-at-quasi-exogenously-varying-piece-rates-_2014_Journal-of-Economic-Behavior-;total of 38;38;-1
How-many-pears-would-a-pear-packer-pack-if-a-pear-packer-could-pack-pears-at-quasi-exogenously-varying-piece-rates-_2014_Journal-of-Economic-Behavior-;total of 1,346,770;1346770;-1
Individualism-and-the-cultural-roots-of-management-practices_2014_Journal-of-Economic-Behavior-Organization;n = 16;16;-1
Individualism-and-the-cultural-roots-of-management-practices_2014_Journal-of-Economic-Behavior-Organization;n = 2955;2955;-1
Individualism-and-the-cultural-roots-of-management-practices_2014_Journal-of-Economic-Behavior-Organization;n = 5228;5228;-1
Individualism-and-the-cultural-roots-of-management-practices_2014_Journal-of-Economic-Behavior-Organization;total of 5228;5228;-1
Network-analysis-and-calibration-of-the-leveraged-network-based-financial-accelerator-_2014_Journal-of-Economic-Behavior-Organization;n = 1;1;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;4 subjects;4;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;20 subjects;20;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;108 subjects;108;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;4 include only periods where subjects;4;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;108 subjects were recruited;108;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;N = 32;32;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;N = 40;40;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;N = 20;20;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;total of 45;45;-1
Platform-selection-in-the-lab_2014_Journal-of-Economic-Behavior-Organization;total of 108;108;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n = 3;3;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n = 42;42;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n = 43;43;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n  = 1;1;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n = 4;4;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n = 2;2;-1
Self-organization-of-hexagonal-agglomeration-patterns-in-new-economic-geography-models_2014_Journal-of-Economic-Behavior-Organization;n = 7;7;-1
When-parity-promotes-peace-Resolving-conflict-between-asymmetric-agents_2014_Journal-of-Economic-Behavior-Organization;180 participants;180;-1
When-parity-promotes-peace-Resolving-conflict-between-asymmetric-agents_2014_Journal-of-Economic-Behavior-Organization;24 participants;24;-1
When-parity-promotes-peace-Resolving-conflict-between-asymmetric-agents_2014_Journal-of-Economic-Behavior-Organization;15 periods  after participants;15;-1
When-parity-promotes-peace-Resolving-conflict-between-asymmetric-agents_2014_Journal-of-Economic-Behavior-Organization;15 periods after participants;15;-1
When-parity-promotes-peace-Resolving-conflict-between-asymmetric-agents_2014_Journal-of-Economic-Behavior-Organization;28 of those experiments individuals;28;-1
When-parity-promotes-peace-Resolving-conflict-between-asymmetric-agents_2014_Journal-of-Economic-Behavior-Organization;180 participants were recruited;180;-1
Doc1 2;168 participants;168;-1
Doc1 2;117 participants;117;-1
Doc1 2;90 participants;90;-1
Doc1 2;86   participants;86;-1
Doc1 2;104 participants;104;-1
Doc1 2;N   =   1;1;-1
Doc1 2;N = 168;168;-1
Doc1 2;total of 1,179;1179;-1
Doc1 2;total of 7,205;7205;-1
Doc1 3;N = 772;772;-1
Doc1 3;n = 577;577;-1
Doc1 3;n = 84;84;-1
Doc1 3;n = 111;111;-1
Doc1 3;n = 2;2;-1
Doc1 3;n = 3;3;-1
Doc1 4;n = 3;3;-1
Doc1 5;2014  women;2014;-1
Doc1 5;129 women;129;-1
Doc1 5;10  Hours enrolled;10;-1
Doc1 6;total of 636,484;636484;-1
Doc10 2;N = 543;543;-1
Doc10 2;N   = 543;543;-1
Doc10 2;n = 390;390;-1
Doc10 2;n = 153;153;-1
Doc10 2;N = 217;217;-1
Doc10 2;68 MBA students enrolled;68;-1
Doc10 3;N   =   2;2;-1
Doc10 3;N = 550,921;550921;-1
Doc10 5;442 women;442;-1
Doc10 5;48 African   American women;48;-1
Doc10 5;355 persons;355;-1
Doc10 5;235 participants;235;-1
Doc10 5;200 individuals;200;-1
Doc10;n   =   4;4;-1
Doc10;n = 423;423;-1
Doc10;n = 427;427;-1
Doc10;total of   36;36;-1
Doc10;total of 427;427;-1
Doc11 2;23 million people;23;-1
Doc11 3;N = 452;452;-1
Doc11 3;N   =   4;4;-1
Doc11 3;total of 68;68;-1
Doc11 3;total of 608;608;-1
Doc11 4;n = 1;1;-1
Doc11 4;n = 0;0;-1
Doc11;total of 29;29;-1
Doc11;total of 35;35;-1
Doc12;165 participants;165;-1
Doc12;161 participants;161;-1
Doc12;12 participants;12;-1
Doc12;149 participants;149;-1
Doc2 2;5 persons;5;-1
Doc2 2;216 individuals;216;-1
Doc2 2;n = 179;179;-1
Doc2 2;n = 92;92;-1
Doc2 2;n = 210;210;-1
Doc2 2;n = 151;151;-1
Doc2 2;N = 179;179;-1
Doc2 2; data of 179;179;-1
Doc2 3;1,000 participants;1000;-1
Doc2 3;75 participants;75;-1
Doc2 3;46 participants;46;-1
Doc2 3;n = 14;14;-1
Doc2 3;n = 5;5;-1
Doc2 3;N = 100;100;-1
Doc2 3;n = 1;1;-1
Doc2 3;n = 75;75;-1
Doc2 5;N = 231;231;-1
Doc2 5;n = 1;1;-1
Doc2 5;n = 4;4;-1
Doc2 5;total of 79;79;-1
Doc2 6;2014  individuals;2014;-1
Doc2 7; data from 495;495;-1
Doc2;31  wherein participants;31;-1
Doc2;37  participants;37;-1
Doc3 2;N   =   1;1;-1
Doc3 2;N = 154;154;-1
Doc3 2; data from 55;55;-1
Doc3 4;2014  storylines have positioned women;2014;-1
Doc3 4;27 women;27;-1
Doc3 4;2006 Catalyst census of women;2006;-1
Doc3 4;200 individuals;200;-1
Doc3 4;N = 112;112;-1
Doc3 4;N   =   1;1;-1
Doc3 4;n   =   0;0;-1
Doc3 4;n   =   1;1;-1
Doc3 4;n = 112;112;-1
Doc3 4;total of 112;112;-1
Doc3 5;1 participants;1;-1
Doc3 5;2 participants;2;-1
Doc3 5;3 participants;3;-1
Doc3 5;4 participants;4;-1
Doc3 5;394 adults;394;-1
Doc3 5;253 adults;253;-1
Doc3 5;588 adults;588;-1
Doc3 5;N = 581;581;-1
Doc3 5;N = 582;582;-1
Doc3 5;total of 13;13;-1
Doc3 5;total of 20;20;-1
Doc3 7;2014  individuals;2014;-1
Doc4 2;N = 221;221;-1
Doc4 2; data from 221;221;-1
Doc4 3;10 participants;10;-1
Doc4 3;total of 76;76;-1
Doc4 3;total of 80;80;-1
Doc4 3;total of 78;78;-1
Doc4 3;total of 68;68;-1
Doc4 4;N   =   2;2;42995
Doc4 4;total of 2,064;2064;42204
Doc4 4;total of 74;74;2041
Doc4 4; data from 2001;2001;22444
Doc4 5;N = 114;114;-1
Doc4 5;N = 473;473;-1
Doc4 5;N = 440;440;-1
Doc4 5;N = 129;129;-1
Doc4 5;total of 129;129;-1
Doc4 6;136   participants;136;-1
Doc4 6;100 participants;100;-1
Doc4 6;451 participants;451;-1
Doc4 6;N = 136;136;-1
Doc4 6;N = 451;451;-1
Doc4 7;n = 11;11;-1
Doc4 7;n = 5;5;-1
Doc4 7;n = 153;153;-1
Doc4 7;N = 23,564;23564;-1
Doc4 7;total of 664;664;-1
Doc4 7;total of 68;68;-1
Doc4;2014  individuals;2014;-1
Doc5 2;50 individuals;50;-1
Doc5 2;N   =   9;9;-1
Doc5 2;N = 95;95;-1
Doc5 2; data from 95;95;-1
Doc5 4;N   =   7;7;3157
Doc5 4;N   =   2;2;2977
Doc5 4;N = 223;223;7832
Doc5 4;total of 733;733;11596
Doc5 4;total of 286;286;11322
Doc5 5;n = 204;204;-1
Doc5 5;n = 17;17;-1
Doc5 5;n = 5;5;-1
Doc5 5;n = 100;100;-1
Doc5 5;n = 61;61;-1
Doc5 5;n = 11;11;-1
Doc5 5;n = 44;44;-1
Doc5 7;total of 60;60;-1
Doc6 3;10,317 women;10317;-1
Doc6 3;2,839 individuals;2839;-1
Doc6 3;6,875 individuals;6875;-1
Doc6 3;10,317 individuals;10317;-1
Doc6 3;14 individuals;14;-1
Doc6 3;14   individuals;14;-1
Doc6 3;4 over N   individuals;4;-1
Doc6 3;2,839 adults;2839;-1
Doc6 3;n = 0;0;-1
Doc6 3;n = 6;6;-1
Doc6 3;n = 9;9;-1
Doc6 3;n = 12;12;-1
Doc6 3; data set from 1957;1957;-1
Doc6 4;193 participants;193;-1
Doc6 4;152 subordinate participants;152;-1
Doc6 4;N = 199;199;-1
Doc6 4;N = 156;156;-1
Doc6 4;N = 152;152;-1
Doc6 4;N = 259;259;-1
Doc6 4;total of 400;400;-1
Doc6 4;total of 88;88;-1
Doc6 4;total of 143;143;-1
Doc6 4;total of 193;193;-1
Doc6 4;total of 161;161;-1
Doc6 4;total of 152;152;-1
Doc6 5;total of 804;804;-1
Doc6 6;2014  politically skilled individuals;2014;-1
Doc6 6;N = 175;175;-1
Doc6 6;N = 155;155;-1
Doc6 6;total   of 998;998;-1
Doc7 2;N = 206;206;27705
Doc7 2;n = 0;0;27083
Doc7 2;N = 287;287;17438
Doc7 2; data of 115;115;31586
Doc7 3;62 women;62;-1
Doc7 3;24 women;24;-1
Doc7 3;1 = women;1;-1
Doc7 3;n = 164;164;-1
Doc7 3;n = 111;111;-1
Doc7 3;n   =   2;2;-1
Doc7 3;n   =   1;1;-1
Doc7 4;2014  participants;2014;-1
Doc7 4;N = 82;82;-1
Doc7 4;N = 225;225;-1
Doc7 4;total of 125;125;-1
Doc7 6;n = 452;452;-1
Doc7 6;n = 30;30;-1
Doc7;N = 108;108;-1
Doc7;N = 54;54;-1
Doc8 2;N   =   2;2;-1
Doc8 2;N = 8,804;8804;-1
Doc8 3;N = 235;235;-1
Doc8 3;total of 235;235;-1
Doc8 4;   data set of 2,102;2102;-1
Doc8 6;143   adults;143;-1
Doc8;N = 267;267;17872
Doc8;N = 58;58;17826
Doc8;N = 216;216;17781
Doc8;N = 685;685;17726
Doc8;N = 223;223;17648
Doc8;N = 420;420;17524
Doc8;N = 344;344;17462
Doc8;N = 187;187;17419
Doc8;N = 1,725;1725;17376
Doc8;N = 1,828;1828;17310
Doc8;N   =   3;3;6979
Doc9 2;N = 12,915;12915;-1
Doc9 3;N = 450;450;-1
Doc9 4;20 people;20;-1
Doc9 4;5   people;5;-1
Doc9 4;100 people;100;-1
Doc9 4;total of 1,000;1000;-1
Doc9 5;0 = subjects;0;-1
Doc9 5;1 = subjects;1;-1
Doc9 5;N = 7,167;7167;-1
Doc9 5;n = 3,354;3354;-1
Doc9 5;n = 2,211;2211;-1
Doc9 5;n = 5,127;5127;-1
Doc9 5;n = 638;638;-1
Doc9 5;n = 1,078;1078;-1
Doc9 5;n = 2,120;2120;-1
Doc9 5;n = 2,567;2567;-1
Doc9 5;n = 3,343;3343;-1
Doc9 5;n = 2,422;2422;-1
Doc9 5;n = 2,528;2528;-1
Doc9 5;n = 3,237;3237;-1
Doc9 5;n = 4,206;4206;-1
Doc9 5;n = 1,559;1559;-1
Doc9 5;n = 4,397;4397;-1
Doc9 5;n =   1,368;1368;-1
Doc9 5;n = 1,402;1402;-1
Doc9 5;n = 4,649;4649;-1
Doc9 5;n = 1,116;1116;-1
Doc9 5;total of 47;47;-1
Doc9;N   =   1;1;-1
Doc9;N = 1,754;1754;-1
S0140-6736(12)61461-5;37 participants;37;-1
S0140-6736(12)61461-5;200 participants;200;-1
S0140-6736(12)61461-5;5803 participants;5803;-1
S0140-6736(12)61461-5;5285 participants;5285;-1
S0140-6736(12)61461-5;201 participants;201;-1
S0140-6736(12)61461-5;243 participants;243;-1
S0140-6736(12)61461-5;N=2279;2279;-1
S0140-6736(12)61461-5;N=2263;2263;-1
S0140-6736(12)61461-5;N=743;743;-1
S0140-6736(12)61461-5;N=5285;5285;-1
S0140-6736(12)61461-5;200 participants enrolled;200;-1
S0140-6736(12)61461-5;5803 participants enrolled;5803;-1
S0140-6736(12)61461-5; data from 459 000;459000;-1
S0140-6736(13)61603-7;1007 participants;1007;-1
S0140-6736(13)61603-7;13 a substantial number of patients;13;-1
S0140-6736(13)61603-7;7303 patients;7303;-1
S0140-6736(13)61603-7;7067 patients;7067;-1
S0140-6736(13)61603-7;478 patients;478;-1
S0140-6736(13)61603-7;450 patients;450;-1
S0140-6736(13)61603-7;123 patients;123;-1
S0140-6736(13)61603-7;115 patients;115;-1
S0140-6736(13)61603-7;145 patients;145;-1
S0140-6736(13)61603-7;146 patients;146;-1
S0140-6736(13)61603-7;305 patients;305;-1
S0140-6736(13)61603-7;355 patients;355;-1
S0140-6736(13)61603-7;335 patients;335;-1
S0140-6736(13)61603-7;12 510 patients;12510;-1
S0140-6736(13)61603-7;928 patients;928;-1
S0140-6736(13)61603-7;333 patients;333;-1
S0140-6736(13)61603-7;n=450;450;-1
S0140-6736(13)61603-7;n=478;478;-1
S0140-6736(13)61603-7;n=1007;1007;-1
S0140-6736(13)61603-7;n=928;928;-1
S0140-6736(13)61612-8;5001 people;5001;-1
S0140-6736(13)61612-8;8 million individuals;8;-1
S0140-6736(13)61612-8;4278 age-stratifi ed individuals;4278;-1
S0140-6736(13)61612-8;5001 individuals;5001;-1
S0140-6736(13)61612-8;4278 individuals;4278;-1
S0140-6736(13)61612-8;336 individuals;336;-1
S0140-6736(13)61612-8; data from the 2009;2009;-1
S0140-6736(13)61612-8; data from   1998;1998;-1
S0140-6736(13)61645-1;n=227;227;-1
S0140-6736(13)61645-1;n=118;118;-1
S0140-6736(13)61645-1;n=119;119;-1
S0140-6736(13)61645-1;n=220;220;-1
S0140-6736(13)61645-1;514 enrolled;514;-1
S0140-6736(13)61645-1;74 babies not enrolled;74;-1
S0140-6736(13)61645-1;514 babies enrolled;514;-1
S0140-6736(13)61647-5;69 women;69;-1
S0140-6736(13)61647-5;4082 participants;4082;-1
S0140-6736(13)61647-5;68 500 patients;68500;-1
S0140-6736(13)61647-5;n=1791;1791;-1
S0140-6736(13)61647-5;n=2294;2294;-1
S0140-6736(13)61647-5;n=871;871;-1
S0140-6736(13)61647-5;n=1181;1181;-1
S0140-6736(13)61647-5;n=610;610;-1
S0140-6736(13)61647-5;n=1860;1860;-1
S0140-6736(13)61647-5;n=243;243;-1
S0140-6736(13)61647-5;n=739;739;-1
S0140-6736(13)61647-5;n=125;125;-1
S0140-6736(13)61647-5;n=1648;1648;-1
S0140-6736(13)61648-7;26 For women;26;-1
S0140-6736(13)61648-7;218 patients;218;-1
S0140-6736(13)61648-7;60 assessable patients;60;-1
S0140-6736(13)61648-7;70 patients;70;-1
S0140-6736(13)61648-7;196 patients;196;-1
S0140-6736(13)61648-7;22 more patients;22;-1
S0140-6736(13)61648-7;2484 screened patients;2484;-1
S0140-6736(13)61648-7;271 eligible patients;271;-1
S0140-6736(13)61648-7;68 patients;68;-1
S0140-6736(13)61648-7;15 patients;15;-1
S0140-6736(13)61648-7;34  Very large numbers of patients;34;-1
S0140-6736(13)61648-7;n=4;4;-1
S0140-6736(13)61648-7;n=8;8;-1
S0140-6736(13)61648-7;n=13;13;-1
S0140-6736(13)61648-7;n=68;68;-1
S0140-6736(13)61648-7;n=70;70;-1
S0140-6736(13)61648-7;n=80;80;-1
S0140-6736(13)61648-7;total of 60;60;-1
S0140-6736(13)61687-6;32 patients Premenopausal women;32;-1
S0140-6736(13)61687-6;50 patients Premenopausal women;50;-1
S0140-6736(13)61687-6;5191 patients;5191;-1
S0140-6736(13)61687-6;66 patients;66;-1
S0140-6736(13)61687-6;134 patients;134;-1
S0140-6736(13)61687-6;57 patients;57;-1
S0140-6736(13)61687-6;20 patients;20;-1
S0140-6736(13)61687-6;25 patients;25;-1
S0140-6736(13)61687-6;28 patients;28;-1
S0140-6736(13)61687-6;32 patients;32;-1
S0140-6736(13)61687-6;50 patients;50;-1
S0140-6736(13)61687-6;27 patients;27;-1
S0140-6736(13)61687-6;63 patients;63;-1
S0140-6736(13)61687-6;694 patients Female patients;694;-1
S0140-6736(13)61687-6;183 patients;183;-1
S0140-6736(13)61687-6;127 patients Female patients;127;-1
S0140-6736(13)61687-6;54 patients;54;-1
S0140-6736(13)61687-6;1791 patients;1791;-1
S0140-6736(13)61687-6;150 patients;150;-1
S0140-6736(13)61687-6;122 patients;122;-1
S0140-6736(13)61687-6;17 patients;17;-1
S0140-6736(13)61687-6;62 patients;62;-1
S0140-6736(13)61687-6;427 patients;427;-1
S0140-6736(13)61687-6;191 patients;191;-1
S0140-6736(13)61687-6;67 patients;67;-1
S0140-6736(13)61687-6;181 patients;181;-1
S0140-6736(13)61687-6;62 patients Female patients;62;-1
S0140-6736(13)61687-6;23 patients;23;-1
S0140-6736(13)61687-6;498 patients Female patients;498;-1
S0140-6736(13)61687-6;11 patients;11;-1
S0140-6736(13)61687-6;15 patients Female patients;15;-1
S0140-6736(13)61687-6;5381 patients;5381;-1
S0140-6736(13)61687-6;22 patients Female patients;22;-1
S0140-6736(13)61687-6;72 patients Female patients;72;-1
S0140-6736(13)61687-6;64 patients Female patients;64;-1
S0140-6736(13)61687-6;40 patients;40;-1
S0140-6736(13)61687-6;1184 patients;1184;-1
S0140-6736(13)61687-6;408 patients;408;-1
S0140-6736(13)61687-6;776 patients;776;-1
S0140-6736(13)61687-6;3052 patients;3052;-1
S0140-6736(13)61687-6;1517 patients;1517;-1
S0140-6736(13)61687-6;1535 patients;1535;-1
S0140-6736(13)61687-6;386 patients;386;-1
S0140-6736(13)61687-6;90 patients;90;-1
S0140-6736(13)61687-6;282 patients;282;-1
S0140-6736(13)61687-6;111 patients;111;-1
S0140-6736(13)61687-6;80 patients;80;-1
S0140-6736(13)61687-6;4000 patients;4000;-1
S0140-6736(13)61688-8;1007 participants;1007;-1
S0140-6736(13)61688-8;450 dyads of patients;450;-1
S0140-6736(13)61688-8;928 patients;928;-1
S0140-6736(13)61688-8;800 community-based patients;800;-1
S0140-6736(13)61688-8;n=18;18;-1
S0140-6736(13)61719-5;355 patients;355;-1
S0140-6736(13)61719-5;3 In patients;3;-1
S0140-6736(13)61719-5;17 patients;17;-1
S0140-6736(13)61719-5;459 patients;459;-1
S0140-6736(13)61719-5;278 patients;278;-1
S0140-6736(13)61719-5;615 patients;615;-1
S0140-6736(13)61719-5;36 patients;36;-1
S0140-6736(13)61719-5;315 patients;315;-1
S0140-6736(13)61719-5;348 patients;348;-1
S0140-6736(13)61719-5;n=238;238;-1
S0140-6736(13)61719-5;n=117;117;-1
S0140-6736(13)61719-5;n=236;236;-1
S0140-6736(13)61719-5;n=115;115;-1
S0140-6736(13)61719-5; data cutoff , 278;278;-1
S0140-6736(13)61719-5; data cutoff , 222;222;-1
S0140-6736(13)61721-3;68 500 patients;68500;-1
S0140-6736(13)61725-0;308 patients;308;-1
S0140-6736(13)61725-0;608 patients;608;-1
S0140-6736(13)61725-0;400 patients;400;-1
S0140-6736(13)61725-0;536 patients;536;-1
S0140-6736(13)61725-0;721 patients;721;-1
S0140-6736(13)61725-0;152 patients;152;-1
S0140-6736(13)61725-0;9 patients;9;-1
S0140-6736(13)61725-0;119 patients;119;-1
S0140-6736(13)61725-0;270 patients;270;-1
S0140-6736(13)61725-0;40 A higher   proportion of patients;40;-1
S0140-6736(13)61725-0;n=147;147;-1
S0140-6736(13)61725-0;n=161;161;-1
S0140-6736(13)61725-0;n=119;119;-1
S0140-6736(13)61725-0;n=113;113;-1
S0140-6736(13)61725-0;n=145;145;-1
S0140-6736(13)61725-0;n=159;159;-1
S0140-6736(13)61725-0;n=8;8;-1
S0140-6736(13)61746-8;135 participants;135;14288
S0140-6736(13)61746-8;54 patients;54;21710
S0140-6736(13)61746-8;55 patients;55;78
S0140-6736(13)61746-8;242 patients;242;176
S0140-6736(13)61746-8;727 patients;727;4490
S0140-6736(13)61746-8;127 patients;127;5554
S0140-6736(13)61746-8;57 patients;57;12272
S0140-6736(13)61746-8;99   Data are number of patients;99;26326
S0140-6736(13)61746-8;727 adults;727;21920
S0140-6736(13)61746-8;n=80;80;10938
S0140-6736(13)61746-8;n=82;82;11030
S0140-6736(13)61746-8;n=58;58;25741
S0140-6736(13)61746-8;n=65;65;25779
S0140-6736(13)61746-8;n=46;46;25808
S0140-6736(13)61746-8;total of 73;73;21638
S0140-6736(13)61747-X;149 participants;149;-1
S0140-6736(13)61747-X;171 participants;171;-1
S0140-6736(13)61747-X;177 participants;177;-1
S0140-6736(13)61747-X;17 participants;17;-1
S0140-6736(13)61747-X;79 participants;79;-1
S0140-6736(13)61747-X;60 participants;60;-1
S0140-6736(13)61747-X;65 patients;65;-1
S0140-6736(13)61747-X;79 patients;79;-1
S0140-6736(13)61747-X;30 patients;30;-1
S0140-6736(13)61747-X;2 million   people;2;-1
S0140-6736(13)61747-X;668 people;668;-1
S0140-6736(13)61747-X;17 people;17;-1
S0140-6736(13)61747-X;177 adults;177;-1
S0140-6736(13)61747-X;n=79;79;-1
S0140-6736(13)61747-X;n=98;98;-1
S0140-6736(13)61747-X;n=171;171;-1
S0140-6736(13)61747-X;n=149;149;-1
S0140-6736(13)61747-X;n=54;54;-1
S0140-6736(13)61747-X;n=38;38;-1
S0140-6736(13)61747-X;n=12;12;-1
S0140-6736(13)61747-X;n=16;16;-1
S0140-6736(13)61747-X;n=92;92;-1
S0140-6736(13)61747-X;177 participants enrolled;177;-1
S0140-6736(13)61751-1;460 participants;460;-1
S0140-6736(13)61751-1;1636 patients;1636;-1
S0140-6736(13)61751-1;466 patients;466;-1
S0140-6736(13)61751-1;460 patients;460;-1
S0140-6736(13)61751-1;926 patients;926;-1
S0140-6736(13)61751-1;10 We excluded patients;10;-1
S0140-6736(13)61751-1;1032 patients;1032;-1
S0140-6736(13)61751-1;11  patients;11;-1
S0140-6736(13)61751-1;n=71;71;-1
S0140-6736(13)61751-1;n=73;73;-1
S0140-6736(13)61751-1;n=5;5;-1
S0140-6736(13)61751-1;n=6;6;-1
S0140-6736(13)61751-1;n=3;3;-1
S0140-6736(13)61751-1;n=102;102;-1
S0140-6736(13)61751-1;n=105;105;-1
S0140-6736(13)61751-1;n=259;259;-1
S0140-6736(13)61751-1;n=112;112;-1
S0140-6736(13)61751-1;n=348;348;-1
S0140-6736(13)61751-1;n=513;513;-1
S0140-6736(13)61751-1;n=508;508;-1
S0140-6736(13)61751-1;n=331;331;-1
S0140-6736(13)61751-1;n=1;1;-1
S0140-6736(13)61751-1;n=4;4;-1
S0140-6736(13)61751-1;n=2;2;-1
S0140-6736(13)61751-1;1032 patients were enrolled;1032;-1
S0140-6736(13)61754-7;40 patients;40;-1
S0140-6736(13)61754-7;13  All patients;13;-1
S0140-6736(13)61754-7;7 In patients;7;-1
S0140-6736(13)61754-7;12  In patients;12;-1
S0140-6736(13)61754-7;36 patients;36;-1
S0140-6736(13)61754-7;22 patients;22;-1
S0140-6736(13)61754-7;12 patients;12;-1
S0140-6736(13)61754-7;18 patients;18;-1
S0140-6736(13)61754-7;n=40;40;-1
S0140-6736(13)61754-7;n=26;26;-1
S0140-6736(13)61754-7;n=14;14;-1
S0140-6736(13)61754-7;n=15;15;-1
S0140-6736(13)61754-7;n=24;24;-1
S0140-6736(13)61754-7;n=10;10;-1
S0140-6736(13)61755-9;218 patients;218;-1
S0140-6736(13)61808-5;60 000 participants;60000;-1
S0140-6736(13)61836-X;300 000 persons;300000;-1
S0140-6736(13)61836-X;8 million participants;8;-1
S0140-6736(13)61836-X;8 million   participants;8;-1
S0140-6736(13)61836-X;1 million participants;1;-1
S0140-6736(13)61836-X;4 million participants;4;-1
S0140-6736(13)61836-X;0 million participants;0;-1
S0140-6736(13)61836-X;310 000 participants;310000;-1
S0140-6736(13)61836-X;170 000 participants;170000;-1
S0140-6736(13)61836-X;7 million participants;7;-1
S0140-6736(13)61836-X;900 000 adults;900000;-1
S0140-6736(13)61836-X; data from 97;97;-1
S0140-6736(13)61836-X; data from   170 000;170000;-1
S0140-6736(13)61841-3;25 participants;25;-1
S0140-6736(13)61841-3;16 participants;16;-1
S0140-6736(13)61841-3;11 participants;11;-1
S0140-6736(13)61841-3;19 other participants;19;-1
S0140-6736(13)61841-3;5  All participants;5;-1
S0140-6736(13)61841-3;10 000 people;10000;-1
S0140-6736(13)61841-3;25 participants were recruited;25;-1
S0140-6736(13)61841-3;n=25;25;-1
S0140-6736(13)61841-3;n=5;5;-1
S0140-6736(13)61841-3;n=3;3;-1
S0140-6736(13)61841-3;n=23;23;-1
S0140-6736(13)61898-X;11 million people;11;-1
S0140-6736(13)61898-X;8 million people;8;-1
S0140-6736(13)61902-9;154 women;154;-1
S0140-6736(13)61902-9;166 women;166;-1
S0140-6736(13)61902-9;320 women;320;-1
S0140-6736(13)61902-9;410 patients;410;-1
S0140-6736(13)61902-9;26 patients;26;-1
S0140-6736(13)61902-9;4012 patients;4012;-1
S0140-6736(13)61902-9;364 patients;364;-1
S0140-6736(13)61902-9;800 patients;800;-1
S0140-6736(13)61902-9;803 patients;803;-1
S0140-6736(13)61902-9;803 were outpatients;803;-1
S0140-6736(13)61902-9;764 patients;764;-1
S0140-6736(13)61902-9;33 patients;33;-1
S0140-6736(13)61902-9;17 patients;17;-1
S0140-6736(13)61902-9;16 patients;16;-1
S0140-6736(13)61902-9;38 patients;38;-1
S0140-6736(13)61902-9;48 patients;48;-1
S0140-6736(13)61902-9;574 patients;574;-1
S0140-6736(13)61902-9;345 patients;345;-1
S0140-6736(13)61902-9;336 patients;336;-1
S0140-6736(13)61902-9;194 patients;194;-1
S0140-6736(13)61902-9;180 patients;180;-1
S0140-6736(13)61902-9;138 patients;138;-1
S0140-6736(13)61902-9;n=409;409;-1
S0140-6736(13)61902-9;n=394;394;-1
S0140-6736(13)61902-9;n=478;478;-1
S0140-6736(13)61902-9;n=317;317;-1
S0140-6736(13)61902-9;n=210;210;-1
S0140-6736(13)61902-9;n=303;303;-1
S0140-6736(13)61902-9;n=282;282;-1
S0140-6736(13)61902-9;n=132;132;-1
S0140-6736(13)61902-9;n=435;435;-1
S0140-6736(13)61902-9;n=228;228;-1
S0140-6736(13)61902-9;n=307;307;-1
S0140-6736(13)61902-9;n=488;488;-1
S0140-6736(13)61902-9;n=795;795;-1
S0140-6736(13)61902-9;total of   574;574;-1
S0140-6736(13)61902-9;26 patients were enrolled;26;-1
S0140-6736(13)61904-2;12 patients;12;-1
S0140-6736(13)61904-2;130 individuals;130;-1
S0140-6736(13)61905-4;219 participants;219;-1
S0140-6736(13)61905-4;205 participants;205;-1
S0140-6736(13)61905-4;28 991 patients;28991;-1
S0140-6736(13)61905-4;122 patients;122;-1
S0140-6736(13)61905-4;152 patients;152;-1
S0140-6736(13)61905-4;466 patients;466;-1
S0140-6736(13)61905-4;445 patients;445;-1
S0140-6736(13)61905-4;444 patients;444;-1
S0140-6736(13)61905-4;15 patients;15;-1
S0140-6736(13)61905-4;194 patients;194;-1
S0140-6736(13)61905-4;n=219;219;-1
S0140-6736(13)61905-4;n=225;225;-1
S0140-6736(13)61905-4;n=172;172;-1
S0140-6736(13)61905-4;n=170;170;-1
S0140-6736(13)61910-8;170 000 participants;170000;-1
S0140-6736(13)61910-8;80 people;80;-1
S0140-6736(13)61910-8; data from   170 000;170000;-1
S0140-6736(13)61911-X;40 patients;40;-1
S0140-6736(13)61911-X;18 patients;18;-1
S0140-6736(13)61911-X;40   patients;40;-1
S0140-6736(13)61912-1;177 participants;177;-1
S0140-6736(13)61914-5;32 participants;32;-1
S0140-6736(13)61914-5;34  Methods  Study design and participants;34;-1
S0140-6736(13)61914-5;32 eligible participants;32;-1
S0140-6736(13)61914-5;90 056 participants;90056;-1
S0140-6736(13)61914-5;18 686 people;18686;-1
S0140-6736(13)61914-5;15 Several individuals;15;-1
S0140-6736(13)61914-5;n=3;3;-1
S0140-6736(13)61914-5;n=6;6;-1
S0140-6736(13)61914-5;n=24;24;-1
S0140-6736(13)61914-5;n=8;8;-1
S0140-6736(13)61914-5;n=7;7;-1
S0140-6736(13)61914-5;n=5;5;-1
S0140-6736(13)61914-5; data from 90 056;90056;-1
S0140-6736(13)61939-X;15 patients;15;-1
S0140-6736(13)61939-X;11 patients;11;-1
S0140-6736(13)61939-X;3 patients;3;-1
S0140-6736(13)61939-X;17 patients;17;-1
S0140-6736(13)61939-X;12 patients;12;-1
S0140-6736(13)61939-X;5 million people;5;-1
S0140-6736(13)61939-X;n=15;15;-1
S0140-6736(13)61939-X;n=14;14;-1
S0140-6736(13)61939-X;n=3;3;-1
S0140-6736(13)61939-X;n=6;6;-1
S0140-6736(13)61939-X;25 were enrolled;25;-1
S0140-6736(13)61939-X;17 patients were   enrolled;17;-1
S0140-6736(13)61940-6;242 patients;242;-1
S0140-6736(13)61941-8;1000 patients;1000;-1
S0140-6736(13)61941-8;n=517;517;-1
S0140-6736(13)61941-8;n=515;515;-1
S0140-6736(13)61946-7;218 patients;218;-1
S0140-6736(13)61950-9;6 women;6;-1
S0140-6736(13)61950-9;10 801 women;10801;-1
S0140-6736(13)61950-9;2232   participants;2232;-1
S0140-6736(13)61950-9;1721 patients;1721;-1
S0140-6736(13)61950-9;3451 patients;3451;-1
S0140-6736(13)61950-9;1200   additional patients;1200;-1
S0140-6736(13)61950-9;2232 patients;2232;-1
S0140-6736(13)61950-9;1140 patients;1140;-1
S0140-6736(13)61950-9;2020 patients;2020;-1
S0140-6736(13)61950-9;1222 patients;1222;-1
S0140-6736(13)61950-9;2298 patients;2298;-1
S0140-6736(13)61950-9;17 patients;17;-1
S0140-6736(13)61950-9;15 patients;15;-1
S0140-6736(13)61950-9;12 patients;12;-1
S0140-6736(13)61950-9;27 patients;27;-1
S0140-6736(13)61950-9;1153 patients;1153;-1
S0140-6736(13)61950-9;1222 of these patients;1222;-1
S0140-6736(13)61950-9;n=2298;2298;-1
S0140-6736(13)61950-9;n=1153;1153;-1
S0140-6736(13)61950-9;n=3451;3451;-1
S0140-6736(13)61950-9;n=2232;2232;-1
S0140-6736(13)61950-9;n=1222;1222;-1
S0140-6736(13)61950-9;n=3375;3375;-1
S0140-6736(13)61950-9;n=2234;2234;-1
S0140-6736(13)61950-9;n=1141;1141;-1
S0140-6736(13)61950-9;n=1450;1450;-1
S0140-6736(13)61950-9;n=817;817;-1
S0140-6736(13)61950-9;n=782;782;-1
S0140-6736(13)61950-9;n=405;405;-1
S0140-6736(13)61950-9;n=1300;1300;-1
S0140-6736(13)61950-9;n=1143;1143;-1
S0140-6736(13)61951-0;600 participants;600;-1
S0140-6736(13)61951-0;45 participants;45;-1
S0140-6736(13)61951-0;626 patients;626;-1
S0140-6736(13)61951-0;16 patients;16;-1
S0140-6736(13)61951-0;21 patients;21;-1
S0140-6736(13)61951-0;60 patients;60;-1
S0140-6736(13)61951-0;40 patients;40;-1
S0140-6736(13)61951-0;357 patients;357;-1
S0140-6736(13)61951-0;12 patients;12;-1
S0140-6736(13)61951-0;618 patients;618;-1
S0140-6736(13)61951-0;11 patients;11;-1
S0140-6736(13)61951-0;23 patients;23;-1
S0140-6736(13)61951-0;311 patients;311;-1
S0140-6736(13)61951-0;315 patients;315;-1
S0140-6736(13)61951-0;226 patients;226;-1
S0140-6736(13)61951-0;218 patients;218;-1
S0140-6736(13)61951-0;37 patients;37;-1
S0140-6736(13)61951-0;15 patients;15;-1
S0140-6736(13)61951-0;14 patients;14;-1
S0140-6736(13)61951-0;300 patients;300;-1
S0140-6736(13)61951-0;303 patients;303;-1
S0140-6736(13)61951-0;24 patients;24;-1
S0140-6736(13)61951-0;921 patients;921;-1
S0140-6736(13)61951-0;1200 patients;1200;-1
S0140-6736(13)61951-0;n=311;311;-1
S0140-6736(13)61951-0;n=315;315;-1
S0140-6736(13)61951-0;n=603;603;-1
S0140-6736(13)61951-0;626 enrolled;626;-1
S0140-6736(13)61951-0;1 year after we   enrolled;1;-1
S0140-6736(13)61953-4;7 million   participants;7;-1
S0140-6736(13)61953-4;4 million participants;4;-1
S0140-6736(13)61953-4;0 million participants;0;-1
S0140-6736(13)61953-4;1 million participants;1;-1
S0140-6736(13)61953-4;100 000 people;100000;-1
S0140-6736(13)61953-4; databases from 1990;1990;-1
S0140-6736(13)61977-7;253 women;253;-1
S0140-6736(13)61977-7;21 We included women;21;-1
S0140-6736(13)61977-7;445 women;445;-1
S0140-6736(13)61977-7;2093 women;2093;-1
S0140-6736(13)61977-7;222 women;222;-1
S0140-6736(13)61977-7;138 women;138;-1
S0140-6736(13)61977-7;109 women;109;-1
S0140-6736(13)61977-7;33  Articles  women;33;-1
S0140-6736(13)61977-7;447 eligible patients;447;-1
S0140-6736(13)61977-7;n=225;225;-1
S0140-6736(13)61977-7;n=222;222;-1
S0140-6736(13)61977-7;N=225;225;-1
S0140-6736(13)61977-7;N=222;222;-1
S0140-6736(13)61977-7;n=214;214;-1
S0140-6736(13)61977-7;n=210;210;-1
S0140-6736(13)61977-7;n=223;223;-1
S0140-6736(13)61977-7;n=217;217;-1
S0140-6736(13)61977-7;n=196;196;-1
S0140-6736(13)61977-7;n=201;201;-1
S0140-6736(13)61977-7;n=224;224;-1
S0140-6736(13)61977-7;n=218;218;-1
S0140-6736(13)61977-7;n=216;216;-1
S0140-6736(13)61977-7;n=188;188;-1
S0140-6736(13)61977-7;n=189;189;-1
S0140-6736(13)61977-7;n=145;145;-1
S0140-6736(13)61977-7;n=139;139;-1
S0140-6736(13)61977-7;n=168;168;-1
S0140-6736(13)61977-7;n=171;171;-1
S0140-6736(13)61977-7;n=138;138;-1
S0140-6736(13)61977-7;n=187;187;-1
S0140-6736(13)61977-7;n=128;128;-1
S0140-6736(13)61977-7;n=124;124;-1
S0140-6736(13)61977-7;n=123;123;-1
S0140-6736(13)61977-7;n=183;183;-1
S0140-6736(13)61977-7;n=181;181;-1
S0140-6736(13)61977-7;n=126;126;-1
S0140-6736(13)61977-7;n=70;70;-1
S0140-6736(13)61999-6;153 patients;153;-1
S0140-6736(13)61999-6;101 patients;101;-1
S0140-6736(13)61999-6;94 patients;94;-1
S0140-6736(13)62000-0;50 million people;50;-1
S0140-6736(13)62002-4;5191 patients;5191;-1
S0140-6736(13)62002-4;578 patients;578;-1
S0140-6736(13)62002-4; data of 5191;5191;-1
S0140-6736(13)62003-6;56 fewer patients;56;-1
S0140-6736(13)62003-6;n=56;56;-1
S0140-6736(13)62026-7;12,903 institutionalised subjects;12903;-1
S0140-6736(13)62026-7;247 people;247;-1
S0140-6736(13)62026-7;244 people;244;-1
S0140-6736(13)62026-7;58 people;58;-1
S0140-6736(13)62026-7;189 people;189;-1
S0140-6736(13)62026-7;1 Clear identifi cation of people;1;-1
S0140-6736(13)62026-7;7 million individuals;7;-1
S0140-6736(13)62026-7;n=6962;6962;-1
S0140-6736(13)62026-7;n=8543;8543;-1
S0140-6736(13)62026-7;N=247;247;-1
S0140-6736(13)62026-7;N=480 467;480467;-1
S0140-6736(13)62026-7;N=56;56;-1
S0140-6736(13)62026-7;N=482 164;482164;-1
S0140-6736(13)62026-7;n=58;58;-1
S0140-6736(13)62028-0;175 000 women;175000;-1
S0140-6736(13)62037-1;1810 remaining trial participants;1810;2300
S0140-6736(13)62037-1;1811 eligible all-comer patients;1811;21890
S0140-6736(13)62037-1;906 patients;906;21670
S0140-6736(13)62037-1;1810 patients;1810;21269
S0140-6736(13)62037-1;905 patients;905;21139
S0140-6736(13)62037-1;10   all-comer patients;10;15811
S0140-6736(13)62037-1;3954 patients;3954;8087
S0140-6736(13)62037-1;721 patients;721;3483
S0140-6736(13)62037-1;703 patients;703;3425
S0140-6736(13)62037-1;903 patients;903;3289
S0140-6736(13)62037-1;902 patients;902;3110
S0140-6736(13)62037-1;900 patients;900;2946
S0140-6736(13)62037-1;1788 patients;1788;274
S0140-6736(13)62037-1;1811 eligible   all-comer patients;1811;1718
S0140-6736(13)62037-1;1811 patients;1811;2197
S0140-6736(13)62037-1;1062 patients;1062;2719
S0140-6736(13)62037-1;899 patients;899;11129
S0140-6736(13)62037-1;29  Very few patients;29;14816
S0140-6736(13)62037-1;150 patients;150;17005
S0140-6736(13)62037-1;2938 patients;2938;20740
S0140-6736(13)62037-1;n=906;906;5508
S0140-6736(13)62037-1;n=905;905;5455
S0140-6736(13)62037-1;n=1205;1205;2722
S0140-6736(13)62037-1;n=1166;1166;2669
S0140-6736(13)62037-1;n=1810;1810;7121
S0140-6736(13)62037-1;1811 enrolled;1811;7973
S0140-6736(13)62037-1;1413 not enrolled;1413;7034
S0140-6736(13)62037-1; data from 900;900;2957
S0140-6736(13)62038-3;224 patients;224;-1
S0140-6736(13)62038-3;227 patients;227;-1
S0140-6736(13)62038-3;451 patients;451;-1
S0140-6736(13)62038-3;210 patients;210;-1
S0140-6736(13)62038-3;191 patients;191;-1
S0140-6736(13)62038-3;9 Eligible patients;9;-1
S0140-6736(13)62038-3;11 patients;11;-1
S0140-6736(13)62038-3;13 patients;13;-1
S0140-6736(13)62038-3;7 patients;7;-1
S0140-6736(13)62038-3;3 patients;3;-1
S0140-6736(13)62038-3;382 patients;382;-1
S0140-6736(13)62038-3;185 patients;185;-1
S0140-6736(13)62038-3;175 patients;175;-1
S0140-6736(13)62038-3;N=227;227;-1
S0140-6736(13)62038-3;N=224;224;-1
S0140-6736(13)62038-3;n=1;1;-1
S0140-6736(13)62038-3;n=2;2;-1
S0140-6736(13)62038-3;n=7;7;-1
S0140-6736(13)62038-3;n=4;4;-1
S0140-6736(13)62038-3;n=5;5;-1
S0140-6736(13)62039-5;308 patients;308;-1
S0140-6736(13)62061-9;9018 participants;9018;-1
S0140-6736(13)62061-9;42 149 patients;42149;-1
S0140-6736(13)62061-9;32 843 patients;32843;-1
S0140-6736(13)62061-9;9306 patients;9306;-1
S0140-6736(13)62061-9;9306 individuals;9306;-1
S0140-6736(13)62061-9;14 Participants were recruited;14;-1
S0140-6736(13)62061-9;n=343;343;-1
S0140-6736(13)62061-9;n=547;547;-1
S0140-6736(13)62061-9;N=1099;1099;-1
S0140-6736(13)62061-9;N=1068;1068;-1
S0140-6736(13)62061-9;N=1097;1097;-1
S0140-6736(13)62061-9;N=1081;1081;-1
S0140-6736(13)62061-9;N=4345;4345;-1
S0140-6736(13)62061-9;n=93;93;-1
S0140-6736(13)62061-9;n=969;969;-1
S0140-6736(13)62061-9;9306 patients who were enrolled;9306;-1
S0140-6736(13)62062-0;170 participants;170;-1
S0140-6736(13)62062-0;222 patients;222;-1
S0140-6736(13)62062-0;108 patients;108;-1
S0140-6736(13)62062-0;109 patients;109;-1
S0140-6736(13)62062-0;16 We pretreated all   patients;16;-1
S0140-6736(13)62062-0;91 patients;91;-1
S0140-6736(13)62062-0;50 patients;50;-1
S0140-6736(13)62062-0;16 no patients;16;-1
S0140-6736(13)62062-0;3311 patients;3311;-1
S0140-6736(13)62062-0;19 patients;19;-1
S0140-6736(13)62062-0;208 patients;208;-1
S0140-6736(13)62062-0;201 patients;201;-1
S0140-6736(13)62062-0;202 patients;202;-1
S0140-6736(13)62062-0;124 patients;124;-1
S0140-6736(13)62062-0;30  Not all patients;30;-1
S0140-6736(13)62062-0;201 people;201;-1
S0140-6736(13)62062-0;n=27;27;-1
S0140-6736(13)62062-0;n=55;55;-1
S0140-6736(13)62062-0;n=56;56;-1
S0140-6736(13)62062-0;n=110;110;-1
S0140-6736(13)62062-0;n=112;112;-1
S0140-6736(13)62062-0;n=111;111;-1
S0140-6736(13)62062-0;total of 174;174;-1
S0140-6736(13)62069-3;56 patients;56;-1
S0140-6736(13)62069-3;42 patients;42;-1
S0140-6736(13)62069-3;15  High-risk patients;15;-1
S0140-6736(13)62069-3;58 patients;58;-1
S0140-6736(13)62069-3;56 eligible patients;56;-1
S0140-6736(13)62069-3;34 patients;34;-1
S0140-6736(13)62069-3;13 patients;13;-1
S0140-6736(13)62069-3;21 patients;21;-1
S0140-6736(13)62069-3;45 patients;45;-1
S0140-6736(13)62069-3;29 patients;29;-1
S0140-6736(13)62069-3;24 patients;24;-1
S0140-6736(13)62069-3;44 patients;44;-1
S0140-6736(13)62069-3;12 patients;12;-1
S0140-6736(13)62069-3;16 treated ten patients;16;-1
S0140-6736(13)62069-3;15 patients;15;-1
S0140-6736(13)62069-3;368 patients;368;-1
S0140-6736(13)62069-3;13 patients were adults;13;-1
S0140-6736(13)62069-3;74 children and   adults;74;-1
S0140-6736(13)62069-3;n=11;11;-1
S0140-6736(13)62069-3;n=19;19;-1
S0140-6736(13)62069-3;n=3;3;-1
S0140-6736(13)62069-3;n=1;1;-1
S0140-6736(13)62069-3;n=2;2;-1
S0140-6736(13)62069-3;n=21;21;-1
S0140-6736(13)62069-3;n=36;36;-1
S0140-6736(13)62069-3;n=20;20;-1
S0140-6736(13)62069-3;n=35;35;-1
S0140-6736(13)62069-3;58 patients enrolled;58;-1
S0140-6736(13)62069-3;58 patients were enrolled;58;-1
S0140-6736(13)62070-X;119 786 patients;119786;-1
S0140-6736(13)62070-X;30 randomly selected   patients;30;-1
S0140-6736(13)62070-X;20 randomly selected   patients;20;-1
S0140-6736(13)62070-X;739 828  Study population of AMI patients;739828;-1
S0140-6736(13)62070-X;129 patients;129;-1
S0140-6736(13)62070-X;n=119 786;119786;-1
S0140-6736(13)62070-X;n=391 077;391077;-1
S0140-6736(13)62073-5;758 patients;758;-1
S0140-6736(13)62073-5;1502 eligible patients;1502;-1
S0140-6736(13)62073-5;63 culture-positive patients;63;-1
S0140-6736(13)62073-5;153 patients;153;-1
S0140-6736(13)62073-5;170 patients;170;-1
S0140-6736(13)62073-5;550 patients;550;-1
S0140-6736(13)62073-5;345 culture-positive patients;345;-1
S0140-6736(13)62073-5;182 culture-  positive patients;182;-1
S0140-6736(13)62073-5;185 culture-  positive patients;185;-1
S0140-6736(13)62073-5;60 patients;60;-1
S0140-6736(13)62073-5;124 HIV-  infected patients;124;-1
S0140-6736(13)62073-5;181 culture-positive  patients;181;-1
S0140-6736(13)62073-5;185 culture-positive  patients;185;-1
S0140-6736(13)62073-5;1502 patients;1502;-1
S0140-6736(13)62073-5;39  Culture-positive patients;39;-1
S0140-6736(13)62073-5;333 patients;333;-1
S0140-6736(13)62073-5;54 patients;54;-1
S0140-6736(13)62073-5;28 culture-positive patients;28;-1
S0140-6736(13)62073-5;154 patients;154;-1
S0140-6736(13)62073-5;0004  In culture-positive patients;4;-1
S0140-6736(13)62073-5;0001  In culture-negative patients;1;-1
S0140-6736(13)62073-5;12  In patients;12;-1
S0140-6736(13)62073-5;98 patients;98;-1
S0140-6736(13)62073-5;N=758;758;-1
S0140-6736(13)62073-5;N=744;744;-1
S0140-6736(13)62075-9;25 participants;25;-1
S0140-6736(13)62075-9;25 adult   patients;25;-1
S0140-6736(13)62075-9;1 Even   patients;1;-1
S0140-6736(13)62076-0;8 million   participants;8;-1
S0140-6736(13)62076-0;2 million individuals;2;-1
S0140-6736(13)62077-2; data from 56;56;-1
S0140-6736(13)62106-6;200 participants;200;-1
S0140-6736(13)62106-6;100 participants;100;-1
S0140-6736(13)62106-6;314 participants;314;-1
S0140-6736(13)62106-6;199 patients;199;-1
S0140-6736(13)62106-6;16 patients;16;-1
S0140-6736(13)62106-6;153 patients;153;-1
S0140-6736(13)62106-6;10 million people;10;-1
S0140-6736(13)62106-6;314 individuals;314;-1
S0140-6736(13)62106-6;n=90;90;-1
S0140-6736(13)62106-6;n=95;95;-1
S0140-6736(13)62106-6;n=94;94;-1
S0140-6736(13)62106-6;n=104;104;-1
S0140-6736(13)62107-8;30 patients;30;-1
S0140-6736(13)62107-8;28 000 patients;28000;-1
S0140-6736(13)62107-8;14 people;14;-1
S0140-6736(13)62108-X;15 patients;15;-1
S0140-6736(13)62108-X;3090 patients;3090;-1
S0140-6736(13)62108-X;10 million people;10;-1
S0140-6736(13)62108-X;15 children and adults;15;-1
S0140-6736(13)62110-8; data from 56;56;-1
S0140-6736(13)62112-1;45 million people;45;-1
S0140-6736(13)62116-9;13 participants;13;-1
S0140-6736(13)62116-9;15 participants;15;-1
S0140-6736(13)62116-9;1501 participants;1501;-1
S0140-6736(13)62116-9;2008  Male participants;2008;-1
S0140-6736(13)62116-9;50  Male participants Female participants;50;-1
S0140-6736(13)62116-9;733 participants;733;-1
S0140-6736(13)62116-9;1  Male participants Female participants;1;-1
S0140-6736(13)62116-9;1761 individuals;1761;-1
S0140-6736(13)62116-9;n=898;898;-1
S0140-6736(13)62116-9;n=1727;1727;-1
S0140-6736(13)62116-9;n=1697;1697;-1
S0140-6736(13)62116-9;n=1628;1628;-1
S0140-6736(13)62116-9;n=1575;1575;-1
S0140-6736(13)62116-9;n=1530;1530;-1
S0140-6736(13)62116-9;n=1601;1601;-1
S0140-6736(13)62116-9;n=1520;1520;-1
S0140-6736(13)62116-9;n=1501;1501;-1
S0140-6736(13)62116-9;n=821;821;-1
S0140-6736(13)62116-9;n=929;929;-1
S0140-6736(13)62117-0;15 children and adults;15;-1
S0140-6736(13)62118-2;4967 women;4967;-1
S0140-6736(13)62118-2;26 510 individuals;26510;-1
S0140-6736(13)62118-2;n=26 510;26510;-1
S0140-6736(13)62118-2;n=36 784;36784;-1
S0140-6736(13)62118-2;n=47 853;47853;-1
S0140-6736(13)62118-2;n=32 920;32920;-1
S0140-6736(13)62118-2;n=13 447;13447;-1
S0140-6736(13)62118-2;n=183 707;183707;-1
S0140-6736(13)62118-2;n=3189;3189;-1
S0140-6736(13)62118-2;n=11 011;11011;-1
S0140-6736(13)62118-2;n=20 369;20369;-1
S0140-6736(13)62118-2;n=21 104;21104;-1
S0140-6736(13)62118-2;n=18 712;18712;-1
S0140-6736(13)62118-2;n=15 553;15553;-1
S0140-6736(13)62118-2;n=15 274;15274;-1
S0140-6736(13)62118-2;n=4967;4967;-1
S0140-6736(13)62118-2;n=5406;5406;-1
S0140-6736(13)62121-2;100 adult patients;100;-1
S0140-6736(13)62121-2;40 patients;40;-1
S0140-6736(13)62121-2;20 patients;20;-1
S0140-6736(13)62121-2;21 patients;21;-1
S0140-6736(13)62121-2;19 patients;19;-1
S0140-6736(13)62121-2;25 treatment-naive patients;25;-1
S0140-6736(13)62121-2;116 patients;116;-1
S0140-6736(13)62121-2;60   patients;60;-1
S0140-6736(13)62121-2;37 patients;37;-1
S0140-6736(13)62121-2;22 patients;22;-1
S0140-6736(13)62121-2;13 patients;13;-1
S0140-6736(13)62121-2;100 patients;100;-1
S0140-6736(13)62121-2;97 patients;97;-1
S0140-6736(13)62121-2;33 patients;33;-1
S0140-6736(13)62121-2;60 treatment-naive patients;60;-1
S0140-6736(13)62121-2;40 previously treated patients;40;-1
S0140-6736(13)62121-2;1900 patients;1900;-1
S0140-6736(13)62121-2;444040 trial did not include patients;444040;-1
S0140-6736(13)62121-2;1 patients;1;-1
S0140-6736(13)62121-2;n=20;20;-1
S0140-6736(13)62121-2;n=21;21;-1
S0140-6736(13)62121-2;n=19;19;-1
S0140-6736(13)62121-2;100 patients   enrolled;100;-1
S0140-6736(13)62143-1;626 patients;626;-1
S0140-6736(13)62143-1;37 patients;37;-1
S0140-6736(13)62143-1;921 patients;921;-1
S0140-6736(13)62144-3;56 patients;56;-1
S0140-6736(13)62144-3;368 patients;368;-1
S0140-6736(13)62144-3;n=56;56;-1
S0140-6736(13)62151-0;40 participants;40;-1
S0140-6736(13)62151-0;100 participants;100;-1
S0140-6736(13)62151-0;7 And if such participants;7;-1
S0140-6736(13)62151-0;100 patients;100;-1
S0140-6736(13)62151-0;2000 individuals;2000;-1
S0140-6736(13)62151-0;n=60;60;-1
S0140-6736(13)62151-0;n=40;40;-1
S0140-6736(13)62151-0;n=20;20;-1
S0140-6736(13)62151-0;n=19;19;-1
S0140-6736(13)62151-0;n=21;21;-1
S0140-6736(13)62157-1;199 patients;199;-1
S0140-6736(13)62157-1;4 enrolled;4;-1
S0140-6736(13)62158-3;367 251 participants;367251;-1
S0140-6736(13)62158-3;14 cohorts including all participants;14;-1
S0140-6736(13)62158-3;n=0;0;-1
S0140-6736(13)62158-3; data from 22;22;-1
S0140-6736(13)62159-5;2385 patients;2385;-1
S0140-6736(13)62159-5;2381 patients;2381;-1
S0140-6736(13)62159-5;1778 patients;1778;-1
S0140-6736(13)62159-5;2326 patients;2326;-1
S0140-6736(13)62159-5;1913 patients;1913;-1
S0140-6736(13)62159-5;1283 patients;1283;-1
S0140-6736(13)62159-5;2359 patients;2359;-1
S0140-6736(13)62159-5;2198 patients;2198;-1
S0140-6736(13)62159-5;2171 patients;2171;-1
S0140-6736(13)62159-5;2288 patients;2288;-1
S0140-6736(13)62159-5;198 patients;198;-1
S0140-6736(13)62159-5;90 patients;90;-1
S0140-6736(13)62159-5;106 patients;106;-1
S0140-6736(13)62159-5;528 similar patients;528;-1
S0140-6736(13)62159-5;36 and one   trial only recruited;36;-1
S0140-6736(13)62159-5;n=15;15;-1
S0140-6736(13)62159-5;n=14;14;-1
S0140-6736(13)62159-5;n=12;12;-1
S0140-6736(13)62159-5; data   from 15;15;-1
S0140-6736(13)62159-5; data from 15;15;-1
S0140-6736(13)62189-3;2010  Male individuals;2010;-1
S0140-6736(13)62190-X;247 individuals;247;-1
S0140-6736(13)62191-1;451 patients;451;-1
S0140-6736(13)62191-1;13 patients;13;-1
S0140-6736(13)62191-1;227 patients;227;-1
S0140-6736(13)62191-1;224 patients;224;-1
S0140-6736(13)62191-1;2143 patients;2143;-1
S0140-6736(13)62192-3;153 patients;153;-1
S0140-6736(13)62192-3;88 patients;88;-1
S0140-6736(13)62192-3;111 patients;111;-1
S0140-6736(13)62192-3;150 patients;150;-1
S0140-6736(13)62192-3;13 patients;13;-1
S0140-6736(13)62192-3;80 patients;80;-1
S0140-6736(13)62192-3;28 patients;28;-1
S0140-6736(13)62192-3;15 patients;15;-1
S0140-6736(13)62192-3;29  patients;29;-1
S0140-6736(13)62192-3;18 patients;18;-1
S0140-6736(13)62192-3;1 billion   people;1;-1
S0140-6736(13)62192-3;n=150;150;-1
S0140-6736(13)62192-3;n=88;88;-1
S0140-6736(13)62192-3;n=80;80;-1
S0140-6736(13)62192-3;n=85;85;-1
S0140-6736(13)62192-3;n=82;82;-1
S0140-6736(13)62192-3;n=141;141;-1
S0140-6736(13)62192-3;n=144;144;-1
S0140-6736(13)62192-3;n=132;132;-1
S0140-6736(13)62192-3;n=105;105;-1
S0140-6736(13)62192-3;n=10;10;-1
S0140-6736(13)62192-3;n=118;118;-1
S0140-6736(13)62192-3;n=9;9;-1
S0140-6736(13)62192-3;n=92;92;-1
S0140-6736(13)62192-3;n=6;6;-1
S0140-6736(13)62192-3;n=78;78;-1
S0140-6736(13)62192-3;n=98;98;-1
S0140-6736(13)62192-3;n=34;34;-1
S0140-6736(13)62192-3;n=27;27;-1
S0140-6736(13)62192-3;n=65;65;-1
S0140-6736(13)62192-3;n=23;23;-1
S0140-6736(13)62192-3;n=86;86;-1
S0140-6736(13)62192-3;153 patients enrolled;153;-1
S0140-6736(13)62193-5;1   Those patients;1;-1
S0140-6736(13)62218-7;176 464 women;176464;-1
S0140-6736(13)62218-7;1 women;1;-1
S0140-6736(13)62218-7;19 We included all randomised   women;19;-1
S0140-6736(13)62218-7;44,102 women;44102;-1
S0140-6736(13)62218-7;13 Women recruited;13;-1
S0140-6736(13)62218-7;total of 1 214 415;1214415;-1
S0140-6736(13)62218-7;176 464 women were   enrolled;176464;-1
S0140-6736(13)62218-7; data of 44,102;44102;-1
S0140-6736(13)62242-4;140 participants;140;-1
S0140-6736(13)62242-4;134 participants;134;-1
S0140-6736(13)62242-4;91 participants;91;-1
S0140-6736(13)62242-4;70 participants;70;-1
S0140-6736(13)62242-4;13  Initial clinical studies of patients;13;-1
S0140-6736(13)62242-4;408 patients;408;-1
S0140-6736(13)62242-4;54 patients;54;-1
S0140-6736(13)62242-4;70 patients;70;-1
S0140-6736(13)62242-4;49 patients;49;-1
S0140-6736(13)62242-4;52 patients;52;-1
S0140-6736(13)62242-4;130 patients;130;-1
S0140-6736(13)62242-4;n=70;70;-1
S0140-6736(13)62242-4;n=307;307;-1
S0140-6736(13)62243-6;14 women;14;-1
S0140-6736(13)62246-1;20 participants;20;12634
S0140-6736(13)62246-1;30 participants;30;33
S0140-6736(13)62246-1;143 participants;143;879
S0140-6736(13)62246-1;22 participants;22;12696
S0140-6736(13)62246-1;37 participants;37;14075
S0140-6736(13)62246-1;74 individuals;74;17246
S0140-6736(13)62246-1;80 individuals;80;9747
S0140-6736(13)62246-1;n=37;37;17147
S0140-6736(13)62246-1;n=5;5;3120
S0140-6736(13)62246-1;n=34;34;1326
S0140-6736(13)62246-1;n=30;30;1491
S0140-6736(13)62246-1;n=26;26;1656
S0140-6736(13)62246-1;n=25;25;1732
S0140-6736(13)62246-1;n=28;28;5406
S0140-6736(13)62246-1;n=24;24;5431
S0140-6736(13)62246-1;n=23;23;5456
S0140-6736(13)62246-1;n=19;19;5481
S0140-6736(13)62246-1;n=22;22;5506
S0140-6736(13)62246-1;n=18;18;5556
S0140-6736(13)62246-1;n=21;21;5581
S0140-6736(13)62246-1;n=16;16;5631
S0140-6736(13)62246-1;n=17;17;5656
S0140-6736(13)62246-1;n=15;15;6796
S0140-6736(13)62246-1;n=13;13;6845
S0140-6736(13)62246-1;n=27;27;6923
S0140-6736(13)62246-1;n=14;14;7677
S0140-6736(13)62246-1;n=11;11;7727
S0140-6736(13)62246-1;n=20;20;8564
S0140-6736(13)62246-1;total of 18;18;736
S0140-6736(13)62246-1; data   rates of 29;29;10911
S0140-6736(13)62247-3;41 738 women;41738;-1
S0140-6736(13)62247-3;72 500 women;72500;-1
S0140-6736(13)62247-3;782 women;782;-1
S0140-6736(13)62247-3;1000 persons;1000;-1
S0140-6736(13)62247-3;12 000 participants;12000;-1
S0140-6736(13)62247-3;151 811 participants;151811;-1
S0140-6736(13)62247-3;151 000 participants;151000;-1
S0140-6736(13)62247-3;151 000 adults;151000;-1
S0140-6736(13)62247-3;200 000 adults;200000;-1
S0140-6736(13)62247-3;200 000 Russian   adults;200000;-1
S0140-6736(13)62247-3;210 002 adults;210002;-1
S0140-6736(13)62247-3;n=5435;5435;-1
S0140-6736(13)62247-3;n=1066;1066;-1
S0140-6736(13)62247-3;n=321;321;-1
S0140-6736(13)62247-3;n=57 361;57361;-1
S0140-6736(13)62247-3;n=12 278;12278;-1
S0140-6736(13)62247-3; data from 210 002;210002;-1
S0140-6736(13)62292-8;1920 women;1920;-1
S0140-6736(13)62292-8;40 women;40;-1
S0140-6736(13)62292-8;3864 women;3864;-1
S0140-6736(13)62292-8;1000 women;1000;-1
S0140-6736(13)62292-8;4000 women;4000;-1
S0140-6736(13)62292-8;3500 women;3500;-1
S0140-6736(13)62292-8;1803 women;1803;-1
S0140-6736(13)62292-8;326 women;326;-1
S0140-6736(13)62292-8;19 399 women;19399;-1
S0140-6736(13)62292-8;979 women;979;-1
S0140-6736(13)62292-8;357 women;357;-1
S0140-6736(13)62292-8;36 women;36;-1
S0140-6736(13)62292-8;n=1920;1920;-1
S0140-6736(13)62292-8;n=1944;1944;-1
S0140-6736(13)62301-6;39 participants;39;-1
S0140-6736(13)62301-6;31 participants;31;-1
S0140-6736(13)62301-6;76 participants;76;-1
S0140-6736(13)62301-6;21 participants;21;-1
S0140-6736(13)62301-6;19 We excluded participants;19;-1
S0140-6736(13)62301-6;104 participants;104;-1
S0140-6736(13)62301-6;52 participants;52;-1
S0140-6736(13)62301-6;35 waiting list group participants;35;-1
S0140-6736(13)62301-6;n=46;46;-1
S0140-6736(13)62301-6;n=39;39;-1
S0140-6736(13)62301-6;n=20;20;-1
S0140-6736(13)62301-6;n=19;19;-1
S0140-6736(13)62301-6;total of 26;26;-1
S0140-6736(13)62304-1;10 801 women;10801;-1
S0140-6736(13)62304-1;1305 patients;1305;-1
S0140-6736(13)62304-1;2234 patients;2234;-1
S0140-6736(13)62304-1;654 patients;654;-1
S0140-6736(13)62304-1;4004 patients;4004;-1
S0140-6736(13)62304-1;223 patients;223;-1
S0140-6736(13)62304-1;n=2298;2298;-1
S0140-6736(13)62304-1;n=1153;1153;-1
S0140-6736(13)62367-3;119 786 patients;119786;-1
S0140-6736(13)62368-5;457 participants;457;-1
S0140-6736(13)62368-5;300 participants;300;-1
S0140-6736(13)62368-5;20 We could not mask participants;20;-1
S0140-6736(13)62368-5;400 participants;400;-1
S0140-6736(13)62368-5;489 participants;489;-1
S0140-6736(13)62368-5;103 participants;103;-1
S0140-6736(13)62368-5;2954 people;2954;-1
S0140-6736(13)62368-5;3411 people;3411;-1
S0140-6736(13)62368-5;n=230;230;-1
S0140-6736(13)62368-5;n=224;224;-1
S0140-6736(13)62368-5;n=454;454;-1
S0140-6736(13)62370-3;5039 women;5039;-1
S0140-6736(13)62370-3;4505 women;4505;-1
S0140-6736(13)62372-7;626 patients;626;-1
S0140-6736(13)62417-4;46 185 individuals;46185;-1
S0140-6736(13)62417-4; data from 2;2;-1
S0140-6736(13)62420-4;356 programme participants;356;-1
S0140-6736(13)62420-4;34 271 participants;34271;-1
S0140-6736(13)62420-4;11 million adults;11;-1
S0140-6736(13)62420-4;34,271 adults;34271;-1
S0140-6736(13)62420-4;n=374;374;-1
S0140-6736(13)62420-4;n=373;373;-1
S0140-6736(13)62420-4;n=747;747;-1
S0140-6736(13)62420-4;1231 men enrolled;1231;-1
S0140-6736(13)62422-8;200 patients;200;-1
S0140-6736(13)62422-8;11 955 patients;11955;-1
S0140-6736(13)62422-8;13 856 patients;13856;-1
S0140-6736(13)62422-8;11 869 patients;11869;-1
S0140-6736(13)62422-8;11 807 patients;11807;-1
S0140-6736(13)62422-8;12   patients;12;-1
S0140-6736(13)62422-8;1989 patients;1989;-1
S0140-6736(13)62422-8;7328 patients;7328;-1
S0140-6736(13)62422-8;2000 patients;2000;-1
S0140-6736(13)62422-8;n=668;668;-1
S0140-6736(13)62422-8;n=1355;1355;-1
S0140-6736(13)62422-8;n=1554;1554;-1
S0140-6736(13)62422-8;n=2131;2131;-1
S0140-6736(13)62422-8;n=2598;2598;-1
S0140-6736(13)62422-8;n=1856;1856;-1
S0140-6736(13)62422-8;n=907;907;-1
S0140-6736(13)62422-8;n=1495;1495;-1
S0140-6736(13)62422-8;n=2072;2072;-1
S0140-6736(13)62422-8;n=285;285;-1
S0140-6736(13)62422-8;n=334;334;-1
S0140-6736(13)62422-8;n=1523;1523;-1
S0140-6736(13)62422-8;n=2411;2411;-1
S0140-6736(13)62422-8;n=733;733;-1
S0140-6736(13)62422-8;n=217;217;-1
S0140-6736(13)62422-8;n=785;785;-1
S0140-6736(13)62422-8;n=7328;7328;-1
S0140-6736(13)62422-8;n=2493;2493;-1
S0140-6736(13)62422-8;n=781;781;-1
S0140-6736(13)62422-8;n=482;482;-1
S0140-6736(13)62422-8;n=6320;6320;-1
S0140-6736(13)62422-8;n=5487;5487;-1
S0140-6736(13)62422-8;n=8567;8567;-1
S0140-6736(13)62422-8;n=1221;1221;-1
S0140-6736(13)62422-8;n=475;475;-1
S0140-6736(13)62422-8;n=426;426;-1
S0140-6736(13)62422-8;n=4392;4392;-1
S0140-6736(13)62422-8;n=3217;3217;-1
S0140-6736(13)62422-8;n=1986;1986;-1
S0140-6736(13)62422-8;n=630;630;-1
S0140-6736(13)62422-8;n=385;385;-1
S0140-6736(13)62422-8;n=701;701;-1
S0140-6736(13)62422-8;n=364;364;-1
S0140-6736(13)62422-8;n=471;471;-1
S0140-6736(13)62422-8;n=1157;1157;-1
S0140-6736(13)62422-8;13 856 patients enrolled;13856;-1
S0140-6736(13)62422-8; data from 12;12;-1
S0140-6736(13)62550-7;1 million participants;1;-1
S0140-6736(13)62550-7;172 female   patients;172;-1
S0140-6736(13)62550-7;121 individuals;121;-1
S0140-6736(13)62555-6;3864 postmenopausal   women;3864;-1
S0140-6736(13)62555-6;1920 women;1920;-1
S0140-6736(13)62555-6;200 additional women;200;-1
S0140-6736(13)62555-6;329 patients;329;-1
S0140-6736(13)62556-8;45 patients;45;-1
S0140-6736(13)62556-8;35 million people;35;-1
S0140-6736(13)62556-8;600 people;600;-1
S0140-6736(13)62556-8;10 million   people;10;-1
S0140-6736(13)62566-0;15 persons;15;-1
S0140-6736(13)62566-0;7 million people;7;-1
S0140-6736(13)62566-0;6 million people;6;-1
S0140-6736(13)62566-0;200 million additional people;200;-1
S0140-6736(13)62566-0;848 million people;848;-1
S0140-6736(13)62566-0;n=635;635;-1
S0140-6736(13)62566-0;n=815;815;-1
S0140-6736(13)62571-4;3090 patients;3090;-1
S0140-6736(13)62571-4;10 million people;10;-1
S0140-6736(13)62629-X;187 participants;187;-1
S0140-6736(13)62629-X;1021 participants;1021;-1
S0140-6736(13)62629-X;187 eligible patients;187;-1
S0140-6736(13)62629-X;n=187;187;-1
S0140-6736(13)62629-X;n=95;95;-1
S0140-6736(13)62629-X;n=0;0;-1
S0140-6736(13)62629-X;n=246;246;-1
S0140-6736(13)62629-X;n=162;162;-1
S0140-6736(13)62629-X;n=84;84;-1
S0140-6736(13)62641-0;140 patients;140;-1
S0140-6736(13)62641-0;0  Data are number of patients;0;-1
S0140-6736(13)62671-9;39 OIT participants;39;-1
S0140-6736(13)62671-9;46 participants;46;-1
S0140-6736(13)62671-9;119 786 patients;119786;-1
S0140-6736(13)62674-4;459 participants;459;-1
S0140-6736(13)62674-4;1789 white participants;1789;-1
S0140-6736(13)62674-4;339 unrelated white patients;339;-1
S0140-6736(13)62674-4;1789 white patients;1789;-1
S0140-6736(13)62674-4;14 These   patients;14;-1
S0140-6736(13)62674-4;479 individuals;479;-1
S0140-6736(13)62674-4;20 individuals;20;-1
S0140-6736(13)62674-4;479 white individuals;479;-1
S0140-6736(13)62674-4;17 All individuals;17;-1
S0140-6736(13)62674-4;123 000 individuals;123000;-1
S0140-6736(13)62674-4;249 796 individuals;249796;-1
S0140-6736(13)62674-4;n=635;635;-1
S0140-6736(13)62674-4;n=395;395;-1
S0140-6736(13)62674-4;n=241;241;-1
S0140-6736(13)62674-4;n=238;238;-1
S0140-6736(13)62674-4;n=339;339;-1
S0140-6736(13)62674-4;n=1789;1789;-1
S0140-6736(13)62674-4;n=239;239;-1
S0140-6736(13)62674-4;n=220;220;-1
S0140-6736(13)62674-4;n=123 791;123791;-1
S0140-6736(13)62674-4;n=123 847;123847;-1
S0140-6736(13)62675-6;107 patients;107;-1
S0140-6736(13)62675-6;56 patients;56;-1
S0140-6736(13)62675-6;44 patients;44;-1
S0140-6736(13)62675-6;17 patients;17;-1
S0140-6736(13)62675-6;12 patients;12;-1
S0140-6736(13)62675-6;45 patients;45;-1
S0140-6736(13)62675-6;22 patients;22;-1
S0140-6736(13)62675-6;8 patients;8;-1
S0140-6736(13)62675-6;107   of these patients;107;-1
S0140-6736(13)62675-6;91 patients;91;-1
S0140-6736(13)62675-6;39 patients;39;-1
S0140-6736(13)62675-6;52 patients;52;-1
S0140-6736(13)62675-6;21 patients;21;-1
S0140-6736(13)62675-6;68 patients;68;-1
S0140-6736(13)62675-6;29 patients;29;-1
S0140-6736(13)62675-6;19 patients;19;-1
S0140-6736(13)62675-6;79 patients;79;-1
S0140-6736(13)62675-6;11 patients;11;-1
S0140-6736(13)62675-6;63 patients;63;-1
S0140-6736(13)62675-6;100 patients;100;-1
S0140-6736(13)62675-6;2 patients;2;-1
S0140-6736(13)62675-6;4 patients;4;-1
S0140-6736(13)62675-6;35 patients;35;-1
S0140-6736(13)62675-6;12  patients;12;-1
S0140-6736(13)62675-6;100 000 individuals;100000;-1
S0140-6736(13)62675-6;114 adults;114;-1
S0140-6736(13)62675-6;n=107;107;-1
S0140-6736(13)62675-6;n=44;44;-1
S0140-6736(13)62675-6;n=63;63;-1
S0140-6736(13)62675-6;n=56;56;-1
S0140-6736(13)62675-6;n=19;19;-1
S0140-6736(13)62675-6;n=26;26;-1
S0140-6736(13)62675-6;n=68;68;-1
S0140-6736(13)62675-6;n=22;22;-1
S0140-6736(13)62675-6;n=17;17;-1
S0140-6736(13)62675-6;n=39;39;-1
S0140-6736(13)62675-6;n=21;21;-1
S0140-6736(13)62676-8;228 patients;228;-1
S0140-6736(13)62685-9;215 eligible   patients;215;-1
S0140-6736(13)62686-0;215 eligible   patients;215;-1
S0140-6736(13)62690-2;5 million people;5;-1
S0140-6736(13)62691-4;5 million people;5;-1
S0140-6736(13)62692-6;5 million people;5;-1
S0140-6736(13)62692-6;800 million   people;800;-1
S0140-6736(13)62692-6;2 million people;2;-1
S0140-6736(13)62692-6;n=0;0;-1
S0140-6736(13)62693-8;800 million   people;800;-1
S0140-6736(13)62693-8;2 million people;2;-1
S0140-6736(13)62693-8;n=0;0;-1
S0140-6736(13)62698-7;274 women;274;-1
S0140-6736(13)62698-7;1 139 patients;1139;-1
S0140-6736(13)62709-9;13  Methods  Study design and participants;13;7610
S0140-6736(13)62709-9;18  All participants;18;4322
S0140-6736(13)62709-9;240 patients;240;9983
S0140-6736(13)62709-9;260 patients;260;942
S0140-6736(13)62709-9;120 patients;120;1415
S0140-6736(13)62709-9;23 patients;23;4873
S0140-6736(13)62709-9;52 patients;52;18701
S0140-6736(13)62709-9;n=120;120;2669
S0140-6736(13)62709-9;240 patients were enrolled;240;9983
S0140-6736(13)62710-5;1 million participants;1;-1
S0140-6736(13)62710-5;172 female   patients;172;-1
S0140-6736(13)62711-7;39 OIT participants;39;-1
S0140-6736(13)62714-2; data   from 22;22;-1
S0140-6736(13)62715-4;180 million   people;180;-1
S0140-6736(13)62715-4;60 million people;60;-1
S0140-6736(13)62715-4;25 000 children and people;25000;-1
S0140-6736(13)62716-6;180 million   people;180;-1
S0140-6736(13)62716-6;60 million people;60;-1
S0140-6736(13)62716-6;25 000 children and people;25000;-1
S0140-6736(13)62729-4;10 million people;10;-1
S0140-6736(13)62729-4;6 million   individuals;6;-1
S0140-6736(13)62730-0;10 million people;10;-1
S0140-6736(13)62730-0;6 million   individuals;6;-1
S0140-6736(13)62731-2;10 million people;10;-1
S0140-6736(13)62731-2;6 million   individuals;6;-1
S0140-6736(13)62732-4;10 million people;10;-1
S0140-6736(13)62732-4;6 million   individuals;6;-1
S0140-6736(13)62734-8;2926 patients;2926;-1
S0140-6736(13)62734-8;64 patients;64;-1
S0140-6736(13)62735-X;2926 patients;2926;-1
S0140-6736(13)62735-X;64 patients;64;-1
S0140-6736(14)60001-5;10 801 women;10801;-1
S0140-6736(14)60001-5;223 patients;223;-1
S0140-6736(14)60001-5;35 patients;35;-1
S0140-6736(14)60001-5;11 patients;11;-1
S0140-6736(14)60001-5;153 patients;153;-1
S0140-6736(14)60001-5;101 patients;101;-1
S0140-6736(14)60001-5;94 patients;94;-1
S0140-6736(14)60001-5;n=109;109;-1
S0140-6736(14)60001-5;n=114;114;-1
S0140-6736(14)60001-5;n=30;30;-1
S0140-6736(14)60001-5;n=31;31;-1
S0140-6736(14)60001-5;n=17;17;-1
S0140-6736(14)60002-7;8447 patients;8447;-1
S0140-6736(14)60002-7;4584 patients;4584;-1
S0140-6736(14)60002-7;13 patients;13;-1
S0140-6736(14)60003-9;45 852 patients;45852;-1
S0140-6736(14)60012-X;250 million people;250;-1
S0140-6736(14)60014-3;88 000 patients;88000;-1
S0140-6736(14)60016-7;88 000 patients;88000;-1
S0140-6736(14)60016-7; data from 2007;2007;-1
S0140-6736(14)60017-9; data from 2007;2007;-1
S0140-6736(14)60018-0; data from 2007;2007;-1
S0140-6736(14)60021-0;total of 168;168;-1
S0140-6736(14)60022-2;total of 168;168;-1
S0140-6736(14)60032-5;50 000 people;50000;-1
S0140-6736(14)60032-5;24 people;24;-1
S0140-6736(14)60033-7;9 All patients;9;-1
S0140-6736(14)60033-7;15 children and adults;15;-1
S0140-6736(14)60034-9;12 000 women;12000;-1
S0140-6736(14)60038-6;45 patients;45;-1
S0140-6736(14)60038-6;35 million people;35;-1
S0140-6736(14)60038-6;600 people;600;-1
S0140-6736(14)60038-6;10 million   people;10;-1
S0140-6736(14)60038-6;151 000 adults;151000;-1
S0140-6736(14)60040-4;7 million participants;7;-1
S0140-6736(14)60040-4;347 million people;347;-1
S0140-6736(14)60040-4;775 385 individuals;775385;-1
S0140-6736(14)60040-4;738 082 individuals;738082;-1
S0140-6736(14)60040-4; data   from 55;55;-1
S0140-6736(14)60042-8;41 patients;41;-1
S0140-6736(14)60042-8;102 patients;102;-1
S0140-6736(14)60042-8;65 patients;65;-1
S0140-6736(14)60042-8;35 Some patients;35;-1
S0140-6736(14)60042-8;126 patients;126;-1
S0140-6736(14)60042-8;81 patients;81;-1
S0140-6736(14)60042-8;50 patients;50;-1
S0140-6736(14)60042-8;13 patients;13;-1
S0140-6736(14)60042-8;130 people;130;-1
S0140-6736(14)60042-8;89 people;89;-1
S0140-6736(14)60043-X;107 South African patients;107;-1
S0140-6736(14)60043-X;49 patients;49;-1
S0140-6736(14)60043-X;12 patients;12;-1
S0140-6736(14)60043-X;45 patients;45;-1
S0140-6736(14)60043-X;6 Although patients;6;-1
S0140-6736(14)60043-X;100 000 individuals;100000;-1
S0140-6736(14)60043-X;100 000   individuals;100000;-1
S0140-6736(14)60043-X;17 individuals;17;-1
S0140-6736(14)60044-1; data from   26 746;26746;-1
S0140-6736(14)60055-6;5039 women;5039;-1
S0140-6736(14)60055-6;4505 women;4505;-1
S0140-6736(14)60067-2;564 patients;564;-1
S0140-6736(14)60067-2; data from 564;564;-1
S0140-6736(14)60068-4;564 patients;564;-1
S0140-6736(14)60068-4; data from 564;564;-1
S0140-6736(14)60082-9;1 366 862 participants;1366862;-1
S0140-6736(14)60082-9;9 million participants;9;-1
S0140-6736(14)60082-9;1 305 965 participants;1305965;-1
S0140-6736(14)60082-9;7 million people;7;-1
S0140-6736(14)60082-9;1 366 862 individuals;1366862;-1
S0140-6736(14)60082-9;9 million individuals;9;-1
S0140-6736(14)60082-9;N=4;4;-1
S0140-6736(14)60082-9; data from 192;192;-1
S0140-6736(14)60084-2;595 patients;595;-1
S0140-6736(14)60084-2;484 patients;484;-1
S0140-6736(14)60084-2;234 evaluable patients;234;-1
S0140-6736(14)60084-2;242 patients;242;-1
S0140-6736(14)60084-2;61 patients;61;-1
S0140-6736(14)60084-2;10 patients;10;-1
S0140-6736(14)60084-2;0  Data are number of patients;0;-1
S0140-6736(14)60084-2;31 No patients;31;-1
S0140-6736(14)60084-2;n=242;242;-1
S0140-6736(14)60084-2;n=214;214;-1
S0140-6736(14)60084-2;n=206;206;-1
S0140-6736(14)60084-2;n=192;192;-1
S0140-6736(14)60084-2;n=211;211;-1
S0140-6736(14)60084-2;n=200;200;-1
S0140-6736(14)60084-2;n=212;212;-1
S0140-6736(14)60084-2;n=201;201;-1
S0140-6736(14)60084-2;n=202;202;-1
S0140-6736(14)60084-2;n=190;190;-1
S0140-6736(14)60084-2;n=210;210;-1
S0140-6736(14)60084-2;n=199;199;-1
S0140-6736(14)60084-2;n=204;204;-1
S0140-6736(14)60085-4;37 patients;37;-1
S0140-6736(14)60087-8;184 million   people;184;-1
S0140-6736(14)60093-3;19th-century doctors and their patients;19;-1
S0140-6736(14)60095-7;2364 patients;2364;-1
S0140-6736(14)60095-7;16  Intensive care patients;16;-1
S0140-6736(14)60095-7;386 people;386;-1
S0140-6736(14)60095-7;total of 2364;2364;-1
S0140-6736(14)60096-9;2364 patients;2364;-1
S0140-6736(14)60096-9;16  Intensive care patients;16;-1
S0140-6736(14)60096-9;386 people;386;-1
S0140-6736(14)60096-9;total of 2364;2364;-1
S0140-6736(14)60097-0;2364 patients;2364;-1
S0140-6736(14)60097-0;16  Intensive care patients;16;-1
S0140-6736(14)60097-0;386 people;386;-1
S0140-6736(14)60097-0;total of 2364;2364;-1
S0140-6736(14)60098-2;3 HIV-positive women;3;-1
S0140-6736(14)60099-4;3 HIV-positive women;3;-1
S0140-6736(14)60100-8;3 HIV-positive women;3;-1
S0140-6736(14)60100-8;1 eight patients;1;-1
S0140-6736(14)60100-8;9 million   individuals;9;-1
S0140-6736(14)60101-X;1 eight patients;1;-1
S0140-6736(14)60101-X;9 million   individuals;9;-1
S0140-6736(14)60102-1;1 eight patients;1;-1
S0140-6736(14)60102-1;9 million   individuals;9;-1
S0140-6736(14)60104-5;42 412   patients;42412;-1
S0140-6736(14)60109-4;11 799 patients;11799;-1
S0140-6736(14)60109-4;23 838 patients;23838;-1
S0140-6736(14)60109-4;8694 patients;8694;-1
S0140-6736(14)60109-4;9512 patients;9512;-1
S0140-6736(14)60109-4;45 individuals;45;-1
S0140-6736(14)60113-6;9 patients;9;-1
S0140-6736(14)60113-6;120 patients;120;-1
S0140-6736(14)60113-6;240 patients;240;-1
S0140-6736(14)60113-6;52 patients;52;-1
S0140-6736(14)60114-8;211 261 people;211261;-1
S0140-6736(14)60114-8;775 385 individuals;775385;-1
S0140-6736(14)60114-8;n=4;4;-1
S0140-6736(14)60114-8;n=8646;8646;-1
S0140-6736(14)60114-8;n=350;350;-1
S0140-6736(14)60117-3; data   from the 1999;1999;-1
S0140-6736(14)60123-9;446 women;446;-1
S0140-6736(14)60123-9;18 women;18;-1
S0140-6736(14)60123-9;450 women;450;-1
S0140-6736(14)60123-9;139 women;139;-1
S0140-6736(14)60123-9;154 women;154;-1
S0140-6736(14)60123-9;215 women;215;-1
S0140-6736(14)60123-9;231 women;231;-1
S0140-6736(14)60123-9;404 women;404;-1
S0140-6736(14)60123-9;51 women;51;-1
S0140-6736(14)60123-9;43 women;43;-1
S0140-6736(14)60123-9;164 women;164;-1
S0140-6736(14)60123-9;201 women;201;-1
S0140-6736(14)60123-9;649 women;649;-1
S0140-6736(14)60123-9;276 women;276;-1
S0140-6736(14)60123-9;29 women;29;-1
S0140-6736(14)60123-9;n=215;215;-1
S0140-6736(14)60123-9;n=231;231;-1
S0140-6736(14)60123-9;total of 649;649;-1
S0140-6736(14)60126-4; data   from the 1999;1999;-1
S0140-6736(14)60129-X;446 women;446;-1
S0140-6736(14)60129-X;5 For women;5;-1
S0140-6736(14)60130-6;172 patients;172;-1
S0140-6736(14)60130-6;1224 patients;1224;-1
S0140-6736(14)60130-6;607 patients;607;-1
S0140-6736(14)60130-6;1185 patients;1185;-1
S0140-6736(14)60130-6;3   because people;3;-1
S0140-6736(14)60131-8;196 participants;196;-1
S0140-6736(14)60131-8;n=98;98;-1
S0140-6736(14)60131-8; data from   26 746;26746;-1
S0140-6736(14)60132-X;40 participants;40;-1
S0140-6736(14)60132-X;100 participants;100;-1
S0140-6736(14)60132-X;100 patients;100;-1
S0140-6736(14)60132-X;6 million people;6;-1
S0140-6736(14)60132-X;n=60;60;-1
S0140-6736(14)60132-X;n=40;40;-1
S0140-6736(14)60132-X;n=20;20;-1
S0140-6736(14)60132-X;n=19;19;-1
S0140-6736(14)60132-X;n=21;21;-1
S0140-6736(14)60134-3;25 million people;25;-1
S0140-6736(14)60134-3;9 million   people;9;-1
S0140-6736(14)60134-3;100 000 people;100000;-1
S0140-6736(14)60134-3;215 people;215;-1
S0140-6736(14)60134-3;5000 individuals;5000;-1
S0140-6736(14)60139-2;100 000 people;100000;-1
S0140-6736(14)60143-4;69 000 people;69000;-1
S0140-6736(14)60147-1;2 of patients;2;-1
S0140-6736(14)60148-3;2 of patients;2;-1
S0140-6736(14)60149-5;2 of patients;2;-1
S0140-6736(14)60153-7;14 participants;14;-1
S0140-6736(14)60153-7;14 patients;14;-1
S0140-6736(14)60153-7;11 patients;11;-1
S0140-6736(14)60153-7;12 patients;12;-1
S0140-6736(14)60153-7;2 patients;2;-1
S0140-6736(14)60153-7;13 patients;13;-1
S0140-6736(14)60153-7;30 patients;30;-1
S0140-6736(14)60153-7;n=2;2;-1
S0140-6736(14)60153-7;n=12;12;-1
S0140-6736(14)60157-4;1228 women;1228;-1
S0140-6736(14)60157-4;242 women;242;-1
S0140-6736(14)60157-4;24   women;24;-1
S0140-6736(14)60157-4;8 women;8;-1
S0140-6736(14)60157-4;1212 women;1212;-1
S0140-6736(14)60157-4;9364 pregnant women;9364;-1
S0140-6736(14)60157-4;1600 participants;1600;-1
S0140-6736(14)60157-4;1078 participants;1078;-1
S0140-6736(14)60157-4;849 participants;849;-1
S0140-6736(14)60157-4;189 participants;189;-1
S0140-6736(14)60157-4;2653 participants;2653;-1
S0140-6736(14)60157-4;1119 participants;1119;-1
S0140-6736(14)60157-4;6403 participants;6403;-1
S0140-6736(14)60157-4;6 of non-IVF patients;6;-1
S0140-6736(14)60157-4;1228 women were recruited;1228;-1
S0140-6736(14)60157-4;n=615;615;-1
S0140-6736(14)60157-4;n=613;613;-1
S0140-6736(14)60157-4;n=1078;1078;-1
S0140-6736(14)60157-4;n=535;535;-1
S0140-6736(14)60157-4;n=543;543;-1
S0140-6736(14)60157-4;n=242;242;-1
S0140-6736(14)60157-4;n=250;250;-1
S0140-6736(14)60157-4;n=293;293;-1
S0140-6736(14)60157-4;n=24;24;-1
S0140-6736(14)60157-4;n=8;8;-1
S0140-6736(14)60157-4;n=364;364;-1
S0140-6736(14)60157-4;n=1228;1228;-1
S0140-6736(14)60157-4;n=275;275;-1
S0140-6736(14)60157-4;n=274;274;-1
S0140-6736(14)60157-4;n=340;340;-1
S0140-6736(14)60157-4;n=339;339;-1
S0140-6736(14)60158-6;211 261 people;211261;-1
S0140-6736(14)60158-6;775 385 individuals;775385;-1
S0140-6736(14)60158-6; data from 64;64;-1
S0140-6736(14)60159-8;5 million people;5;-1
S0140-6736(14)60162-8;1329 participants;1329;-1
S0140-6736(14)60162-8;1 year after participants;1;-1
S0140-6736(14)60162-8;1369 participants;1369;-1
S0140-6736(14)60162-8;478 participants;478;-1
S0140-6736(14)60162-8;95 participants;95;-1
S0140-6736(14)60162-8;34 participants;34;-1
S0140-6736(14)60162-8;12 and   three participants;12;-1
S0140-6736(14)60162-8;2138 patients;2138;-1
S0140-6736(14)60162-8;662 individuals;662;-1
S0140-6736(14)60162-8;667 individuals;667;-1
S0140-6736(14)60162-8;291 individuals;291;-1
S0140-6736(14)60162-8;2138 individuals;2138;-1
S0140-6736(14)60162-8;25 individuals;25;-1
S0140-6736(14)60162-8;100 individuals;100;-1
S0140-6736(14)60162-8;n=662;662;-1
S0140-6736(14)60162-8;n=667;667;-1
S0140-6736(14)60162-8;n=1329;1329;-1
S0140-6736(14)60162-8;n=602;602;-1
S0140-6736(14)60162-8;n=657;657;-1
S0140-6736(14)60162-8;n=1100;1100;-1
S0140-6736(14)60162-8;1369 participants were enrolled;1369;-1
S0140-6736(14)60166-5;2 million adults;2;-1
S0140-6736(14)60173-2;18th-century   Johnstones are people;18;-1
S0140-6736(14)60176-8;9 000 patients;9000;-1
S0140-6736(14)60176-8;75 000 Norwegian adults;75000;-1
S0140-6736(14)60177-X;9 000 patients;9000;-1
S0140-6736(14)60177-X;75 000 Norwegian adults;75000;-1
S0140-6736(14)60178-1;9 000 patients;9000;-1
S0140-6736(14)60178-1;75 000 Norwegian adults;75000;-1
S0140-6736(14)60179-3;467 individuals;467;-1
S0140-6736(14)60180-X;42 572 participants;42572;-1
S0140-6736(14)60180-X;20 330 patients;20330;-1
S0140-6736(14)60180-X;3680 patients;3680;-1
S0140-6736(14)60180-X;467 individuals;467;-1
S0140-6736(14)60181-1;42 572 participants;42572;-1
S0140-6736(14)60181-1;20 330 patients;20330;-1
S0140-6736(14)60181-1;3680 patients;3680;-1
S0140-6736(14)60182-3;42 572 participants;42572;-1
S0140-6736(14)60182-3;20 330 patients;20330;-1
S0140-6736(14)60182-3;3680 patients;3680;-1
S0140-6736(14)60182-3;6105 individuals;6105;-1
S0140-6736(14)60183-5;6105 individuals;6105;-1
S0140-6736(14)60184-7;6105 individuals;6105;-1
S0140-6736(14)60188-4;420 000 patients;420000;-1
S0140-6736(14)60188-4;3 patients;3;-1
S0140-6736(14)60189-6;4 billion people;4;-1
S0140-6736(14)60192-6;10 801 women;10801;-1
S0140-6736(14)60192-6;8135 women;8135;-1
S0140-6736(14)60192-6;300 000 women;300000;-1
S0140-6736(14)60195-1; data   from the 151;151;-1
S0140-6736(14)60196-3;210 eligible participants;210;-1
S0140-6736(14)60196-3;67 participants;67;-1
S0140-6736(14)60196-3;78 participants;78;-1
S0140-6736(14)60196-3;65 participants;65;-1
S0140-6736(14)60196-3;29 participants;29;-1
S0140-6736(14)60196-3;16 participants;16;-1
S0140-6736(14)60196-3;51 participants;51;-1
S0140-6736(14)60196-3;64 participants;64;-1
S0140-6736(14)60196-3;192 participants;192;-1
S0140-6736(14)60196-3;67 eligible participants;67;-1
S0140-6736(14)60196-3;65 eligible participants;65;-1
S0140-6736(14)60196-3;78 eligible participants;78;-1
S0140-6736(14)60196-3;13 participants;13;-1
S0140-6736(14)60196-3;914 patients;914;-1
S0140-6736(14)60196-3;273 individuals;273;-1
S0140-6736(14)60196-3;272 individuals;272;-1
S0140-6736(14)60196-3;369 individuals;369;-1
S0140-6736(14)60196-3;n=67;67;-1
S0140-6736(14)60196-3;n=78;78;-1
S0140-6736(14)60196-3;n=65;65;-1
S0140-6736(14)60196-3;N=210;210;-1
S0140-6736(14)60196-3;n=210;210;-1
S0140-6736(14)60196-3;n=96;96;-1
S0140-6736(14)60197-5;100 patients;100;10482
S0140-6736(14)60197-5;n=197;197;13272
S0140-6736(14)60197-5;n=194;194;13299
S0140-6736(14)60198-7;874 patients;874;-1
S0140-6736(14)60198-7;171 patients;171;-1
S0140-6736(14)60198-7;n=120 707;120707;-1
S0140-6736(14)60198-7;n=2031;2031;-1
S0140-6736(14)60198-7;n=20 055;20055;-1
S0140-6736(14)60198-7;n=74 326;74326;-1
S0140-6736(14)60198-7;n=26 326;26326;-1
S0140-6736(14)60200-2;1 million participants;1;-1
S0140-6736(14)60200-2;71 683 patients;71683;-1
S0140-6736(14)60200-2;16 billion overweight   people;16;-1
S0140-6736(14)60200-2;12 billion obese individuals;12;-1
S0140-6736(14)60211-7; data from 27;27;-1
S0140-6736(14)60212-9; data from 27;27;-1
S0140-6736(14)60213-0; data from 27;27;-1
S0140-6736(14)60214-2;128 standard ised patients;128;-1
S0140-6736(14)60214-2;n=64;64;-1
S0140-6736(14)60214-2; data from 27;27;-1
S0140-6736(14)60215-4;128 standard ised patients;128;-1
S0140-6736(14)60215-4;n=64;64;-1
S0140-6736(14)60222-1;24 participants;24;-1
S0140-6736(14)60222-1;4  generally recommended once patients;4;-1
S0140-6736(14)60222-1;7 For patients;7;-1
S0140-6736(14)60222-1;425 patients;425;-1
S0140-6736(14)60222-1;28 patients;28;-1
S0140-6736(14)60222-1;24 patients;24;-1
S0140-6736(14)60222-1;60 patients;60;-1
S0140-6736(14)60222-1;30 patients;30;-1
S0140-6736(14)60222-1;98 patients;98;-1
S0140-6736(14)60222-1;n=7;7;-1
S0140-6736(14)60222-1;n=9;9;-1
S0140-6736(14)60222-1;n=8;8;-1
S0140-6736(14)60222-1;n=6;6;-1
S0140-6736(14)60223-3;126 patients;126;-1
S0140-6736(14)60223-3;36 clinically unresponsive patients;36;-1
S0140-6736(14)60223-3;n=24;24;-1
S0140-6736(14)60223-3;n=13;13;-1
S0140-6736(14)60224-5;10 Treatment of patients;10;-1
S0140-6736(14)60224-5;8447 patients;8447;-1
S0140-6736(14)60224-5;4584 patients;4584;-1
S0140-6736(14)60238-5;1185 participants;1185;-1
S0140-6736(14)60238-5;1224 patients;1224;-1
S0140-6736(14)60238-5;375 patients;375;-1
S0140-6736(14)60238-5;6310 patients;6310;-1
S0140-6736(14)60238-5;750 randomised   patients;750;-1
S0140-6736(14)60238-5;1200 patients;1200;-1
S0140-6736(14)60238-5;607 patients;607;-1
S0140-6736(14)60238-5;617 patients;617;-1
S0140-6736(14)60238-5;1185 patients;1185;-1
S0140-6736(14)60238-5;913 patients;913;-1
S0140-6736(14)60238-5;587 patients;587;-1
S0140-6736(14)60238-5;1011 patients;1011;-1
S0140-6736(14)60238-5;838 patients;838;-1
S0140-6736(14)60238-5;989 patients;989;-1
S0140-6736(14)60238-5;3020 patients;3020;-1
S0140-6736(14)60238-5;385 patients;385;-1
S0140-6736(14)60238-5;270 patients;270;-1
S0140-6736(14)60238-5;25 patients;25;-1
S0140-6736(14)60238-5;10 patients;10;-1
S0140-6736(14)60238-5;44 patients;44;-1
S0140-6736(14)60238-5;141 patients;141;-1
S0140-6736(14)60238-5;75 patients;75;-1
S0140-6736(14)60238-5;16 patients;16;-1
S0140-6736(14)60238-5;17 patients;17;-1
S0140-6736(14)60238-5;20 patients;20;-1
S0140-6736(14)60238-5;34 patients;34;-1
S0140-6736(14)60238-5;108 patients;108;-1
S0140-6736(14)60238-5;21 patients;21;-1
S0140-6736(14)60238-5;5 patients;5;-1
S0140-6736(14)60238-5;24 patients;24;-1
S0140-6736(14)60238-5;66 patients;66;-1
S0140-6736(14)60238-5;12 patients;12;-1
S0140-6736(14)60238-5;38 patients;38;-1
S0140-6736(14)60238-5;72 patients;72;-1
S0140-6736(14)60238-5;45 patients;45;-1
S0140-6736(14)60238-5;39 patients;39;-1
S0140-6736(14)60238-5;53 patients;53;-1
S0140-6736(14)60238-5;n=587;587;-1
S0140-6736(14)60238-5;n=598;598;-1
S0140-6736(14)60238-5;n=583;583;-1
S0140-6736(14)60238-5;n=602;602;-1
S0140-6736(14)60238-5;total of   3020;3020;-1
S0140-6736(14)60238-5;1224 patients had been enrolled;1224;-1
S0140-6736(14)60238-5;1224 enrolled;1224;-1
S0140-6736(14)60238-5;1200 patients were enrolled;1200;-1
S0140-6736(14)60240-3;7 million people;7;-1
S0140-6736(14)60241-5;5 million people;5;-1
S0140-6736(14)60242-7;5 million people;5;-1
S0140-6736(14)60268-3;1329 adults;1329;-1
S0140-6736(14)60269-5;249,796 individuals;249796;-1
S0140-6736(14)60270-1;24 people;24;-1
S0140-6736(14)60379-2;41 710 women;41710;-1
S0140-6736(14)60379-2;1 858 984 women;1858984;-1
S0140-6736(14)60379-2;604 women;604;-1
S0140-6736(14)60379-2;403 participants;403;-1
S0140-6736(14)60379-2;82 647 patients;82647;-1
S0140-6736(14)60379-2;19 In patients;19;-1
S0140-6736(14)60379-2;9382 patients;9382;-1
S0140-6736(14)60379-2;73 261 patients;73261;-1
S0140-6736(14)60379-2;82 627 patients;82627;-1
S0140-6736(14)60379-2;8405 inpatients;8405;-1
S0140-6736(14)60379-2;30 We initially   included all people;30;-1
S0140-6736(14)60379-2;n=20 700;20700;-1
S0140-6736(14)60379-2;n=40 937;40937;-1
S0140-6736(14)60379-2;n=41 710;41710;-1
S0140-6736(14)60382-2;18 patients;18;2539
S0140-6736(14)60382-2;10 patients;10;3598
S0140-6736(14)60382-2;50 000 people;50000;15111
S0140-6736(14)60382-2;250 individuals;250;10349
S0140-6736(14)60382-2;n=8;8;5860
S0140-6736(14)60382-2;n=2;2;5838
S0140-6736(14)60382-2;n=10;10;2487
S0140-6736(14)60382-2;n=12;12;5574
S0140-6736(14)60382-2; data from a 6;6;32872
S0140-6736(14)60386-X;134 individuals;134;-1
S0140-6736(14)60389-5;11 million people;11;-1
S0140-6736(14)60390-1;11 million people;11;-1
S0140-6736(14)60397-4;30 patients;30;-1
S0140-6736(14)60398-6;30 patients;30;-1
S0140-6736(14)60399-8;30 patients;30;-1
S0140-6736(14)60399-8;n=6;6;-1
S0140-6736(14)60400-1;1 patients;1;-1
S0140-6736(14)60400-1;n=6;6;-1
S0140-6736(14)60401-3;4   LGBT persons;4;-1
S0140-6736(14)60401-3;1 patients;1;-1
S0140-6736(14)60402-5;4   LGBT persons;4;-1
S0140-6736(14)60403-7;4   LGBT persons;4;-1
S0140-6736(14)60405-0;2332 eligible adult patients;2332;-1
S0140-6736(14)60405-0;1162 patients;1162;-1
S0140-6736(14)60405-0;2332 patients;2332;-1
S0140-6736(14)60405-0;9221 patients;9221;-1
S0140-6736(14)60405-0;1170 patients;1170;-1
S0140-6736(14)60405-0;4 patients;4;-1
S0140-6736(14)60405-0;n=1985;1985;-1
S0140-6736(14)60405-0;n=2236;2236;-1
S0140-6736(14)60405-0;n=1162;1162;-1
S0140-6736(14)60405-0;n=1170;1170;-1
S0140-6736(14)60405-0;2332 enrolled;2332;-1
S0140-6736(14)60411-6;50 000 patients;50000;-1
S0140-6736(14)60412-8;30 people;30;-1
S0140-6736(14)60412-8;2 million people;2;-1
S0140-6736(14)60412-8;56 million people;56;-1
S0140-6736(14)60416-5;453 participants;453;5410
S0140-6736(14)60416-5;900 patients;900;11815
S0140-6736(14)60416-5;447 patients;447;11002
S0140-6736(14)60416-5;445 patients;445;10559
S0140-6736(14)60416-5;449 patients;449;10501
S0140-6736(14)60416-5;3 million patients;3;9614
S0140-6736(14)60416-5;4 We excluded patients;4;6478
S0140-6736(14)60416-5;300 patients;300;329
S0140-6736(14)60416-5;600 patients;600;312
S0140-6736(14)60416-5;14 patients;14;6132
S0140-6736(14)60416-5;34 patients;34;9276
S0140-6736(14)60416-5;437 patients;437;10314
S0140-6736(14)60416-5;447 individuals;447;5241
S0140-6736(14)60416-5;449 individuals;449;6080
S0140-6736(14)60416-5;443 individuals;443;10374
S0140-6736(14)60416-5;n=445;445;809
S0140-6736(14)60416-5;n=449;449;837
S0140-6736(14)60416-5;n=5;5;9405
S0140-6736(14)60416-5;n=3;3;9448
S0140-6736(14)60416-5;n=14;14;9481
S0140-6736(14)60416-5;n=10;10;9517
S0140-6736(14)60416-5;n=2;2;9548
S0140-6736(14)60417-7;535 patients;535;-1
S0140-6736(14)60417-7;90 patients;90;-1
S0140-6736(14)60417-7;9 patients;9;-1
S0140-6736(14)60417-7;526 patients;526;-1
S0140-6736(14)60417-7;78 patients;78;-1
S0140-6736(14)60417-7;76 patients;76;-1
S0140-6736(14)60417-7;43 patients;43;-1
S0140-6736(14)60417-7;150 assessable patients;150;-1
S0140-6736(14)60417-7;525 patients;525;-1
S0140-6736(14)60417-7;0  Fatigue  Proportion of patients;0;-1
S0140-6736(14)60417-7;391 patients;391;-1
S0140-6736(14)60417-7;68 patients;68;-1
S0140-6736(14)60417-7;n=388;388;-1
S0140-6736(14)60417-7;n=138;138;-1
S0140-6736(14)60417-7;n=90;90;-1
S0140-6736(14)60417-7;n=135;135;-1
S0140-6736(14)60417-7;n=199;199;-1
S0140-6736(14)60417-7;n=192;192;-1
S0140-6736(14)60417-7;n=391;391;-1
S0140-6736(14)60417-7;n=196;196;-1
S0140-6736(14)60417-7;535 patients enrolled;535;-1
S0140-6736(14)60417-7;16 Patients were enrolled;16;-1
S0140-6736(14)60418-9;196 patients;196;-1
S0140-6736(14)60418-9;78 patients;78;-1
S0140-6736(14)60418-9;73 patients;73;-1
S0140-6736(14)60418-9;90 patients;90;-1
S0140-6736(14)60418-9;88 patients;88;-1
S0140-6736(14)60418-9;87 patients;87;-1
S0140-6736(14)60418-9;98 patients;98;-1
S0140-6736(14)60418-9;175 randomly assigned patients;175;-1
S0140-6736(14)60418-9;169 patients;169;-1
S0140-6736(14)60418-9;156 patients;156;-1
S0140-6736(14)60418-9;173 patients;173;-1
S0140-6736(14)60418-9;68 surviving patients;68;-1
S0140-6736(14)60418-9;69 patients;69;-1
S0140-6736(14)60418-9;83 patients;83;-1
S0140-6736(14)60418-9;85 patients;85;-1
S0140-6736(14)60418-9;36 patients;36;-1
S0140-6736(14)60418-9;11 patients;11;-1
S0140-6736(14)60418-9;165 patients;165;-1
S0140-6736(14)60418-9;663 patients;663;-1
S0140-6736(14)60418-9;n=15;15;-1
S0140-6736(14)60418-9;n=3;3;-1
S0140-6736(14)60418-9;n=2;2;-1
S0140-6736(14)60418-9;n=1;1;-1
S0140-6736(14)60418-9;n=87;87;-1
S0140-6736(14)60418-9;n=88;88;-1
S0140-6736(14)60418-9;n=76;76;-1
S0140-6736(14)60418-9;n=79;79;-1
S0140-6736(14)60418-9;n=75;75;-1
S0140-6736(14)60418-9;n=74;74;-1
S0140-6736(14)60418-9;n=49;49;-1
S0140-6736(14)60418-9;n=53;53;-1
S0140-6736(14)60418-9;n=71;71;-1
S0140-6736(14)60418-9;n=70;70;-1
S0140-6736(14)60418-9;n=63;63;-1
S0140-6736(14)60418-9;n=55;55;-1
S0140-6736(14)60418-9;n=56;56;-1
S0140-6736(14)60418-9;n=33;33;-1
S0140-6736(14)60418-9;n=36;36;-1
S0140-6736(14)60418-9;n=98;98;-1
S0140-6736(14)60418-9;n=78;78;-1
S0140-6736(14)60418-9;n=73;73;-1
S0140-6736(14)60419-0;101 330 matched patients;101330;-1
S0140-6736(14)60419-0;100 patients;100;-1
S0140-6736(14)60419-0;9  A large proportion of patients;9;-1
S0140-6736(14)60419-0;76 074 patients;76074;-1
S0140-6736(14)60419-0;102 patients;102;-1
S0140-6736(14)60419-0;1217 patients;1217;-1
S0140-6736(14)60419-0;n=1;1;-1
S0140-6736(14)60419-0;total of 341 749;341749;-1
S0140-6736(14)60421-9;417 patients;417;-1
S0140-6736(14)60421-9;420 enrolled and randomised patients;420;-1
S0140-6736(14)60421-9;419 patients;419;-1
S0140-6736(14)60421-9;416 patients;416;-1
S0140-6736(14)60421-9;556 patients;556;-1
S0140-6736(14)60421-9;444 patients;444;-1
S0140-6736(14)60421-9;n=209;209;-1
S0140-6736(14)60421-9;n=210;210;-1
S0140-6736(14)60421-9;n=207;207;-1
S0140-6736(14)60421-9;420 enrolled;420;-1
S0140-6736(14)60421-9;556 patients enrolled;556;-1
S0140-6736(14)60421-9; data cutoff  of Aug 31;31;-1
S0140-6736(14)60422-0;3864 postmenopausal   women;3864;-1
S0140-6736(14)60422-0;1920 women;1920;-1
S0140-6736(14)60422-0;4 Other   patients;4;-1
S0140-6736(14)60422-0;56 million people;56;-1
S0140-6736(14)60422-0;30 million   people;30;-1
S0140-6736(14)60422-0;3 million people;3;-1
S0140-6736(14)60422-0;3 million   people;3;-1
S0140-6736(14)60422-0;450 000 people;450000;-1
S0140-6736(14)60422-0;1 million people;1;-1
S0140-6736(14)60423-2;23 000 participants;23000;-1
S0140-6736(14)60435-9;5 million women;5;-1
S0140-6736(14)60435-9;062  Estimates of   women;62;-1
S0140-6736(14)60435-9;1_molestation-cases-  stranded-women;1;-1
S0140-6736(14)60436-0;5 million women;5;-1
S0140-6736(14)60436-0;062  Estimates of   women;62;-1
S0140-6736(14)60436-0;1_molestation-cases-  stranded-women;1;-1
S0140-6736(14)60436-0;3 As older people;3;-1
S0140-6736(14)60436-0;78 million   people;78;-1
S0140-6736(14)60437-2;3 As older people;3;-1
S0140-6736(14)60437-2;78 million   people;78;-1
S0140-6736(14)60438-4;3 As older people;3;-1
S0140-6736(14)60438-4;78 million   people;78;-1
S0140-6736(14)60442-6;134 individuals;134;-1
S0140-6736(14)60443-8;202 million elderly   people;202;-1
S0140-6736(14)60444-X;202 million elderly   people;202;-1
S0140-6736(14)60447-5;0  Data are number of patients;0;-1
S0140-6736(14)60450-5;8 million   participants;8;-1
S0140-6736(14)60451-7;120 million women;120;-1
S0140-6736(14)60455-4;n=368;368;-1
S0140-6736(14)60455-4;n=364;364;-1
S0140-6736(14)60455-4;n=383;383;-1
S0140-6736(14)60455-4;n=374;374;-1
S0140-6736(14)60455-4;n=84;84;-1
S0140-6736(14)60455-4;n=83;83;-1
S0140-6736(14)60455-4;n=81;81;-1
S0140-6736(14)60455-4;n=757;757;-1
S0140-6736(14)60455-4;n=732;732;-1
S0140-6736(14)60455-4;n=738;738;-1
S0140-6736(14)60455-4;n=751;751;-1
S0140-6736(14)60455-4;n=134;134;-1
S0140-6736(14)60455-4;n=80;80;-1
S0140-6736(14)60455-4;n=108;108;-1
S0140-6736(14)60455-4;n=106;106;-1
S0140-6736(14)60455-4;n=696;696;-1
S0140-6736(14)60455-4;n=701;701;-1
S0140-6736(14)60455-4;n=661;661;-1
S0140-6736(14)60455-4;n=680;680;-1
S0140-6736(14)60455-4;n=658;658;-1
S0140-6736(14)60455-4;n=676;676;-1
S0140-6736(14)60455-4;n=699;699;-1
S0140-6736(14)60455-4;n= 705;705;-1
S0140-6736(14)60455-4;n=748;748;-1
S0140-6736(14)60455-4;n=725;725;-1
S0140-6736(14)60455-4;n=741;741;-1
S0140-6736(14)60455-4;n=687;687;-1
S0140-6736(14)60455-4;n=659;659;-1
S0140-6736(14)60455-4;n=650;650;-1
S0140-6736(14)60455-4;n=686;686;-1
S0140-6736(14)60455-4;n=642;642;-1
S0140-6736(14)60455-4;n=652;652;-1
S0140-6736(14)60455-4;n=667;667;-1
S0140-6736(14)60455-4;n=693;693;-1
S0140-6736(14)60455-4;total of 3550;3550;-1
S0140-6736(14)60455-4;368 infants were enrolled;368;-1
S0140-6736(14)60455-4;374 infants enrolled;374;-1
S0140-6736(14)60455-4;383 infants enrolled;383;-1
S0140-6736(14)60455-4;364 infants enrolled;364;-1
S0140-6736(14)60455-4;368 infants enrolled;368;-1
S0140-6736(14)60457-8;172 participants;172;-1
S0140-6736(14)60457-8;157 participants;157;-1
S0140-6736(14)60457-8;809 participants;809;-1
S0140-6736(14)60457-8;1 This group of people;1;-1
S0140-6736(14)60457-8;9  Participants were recruited;9;-1
S0140-6736(14)60457-8;n=86;86;-1
S0140-6736(14)60457-8;n=50;50;-1
S0140-6736(14)60457-8;n=4;4;-1
S0140-6736(14)60457-8;n=3;3;-1
S0140-6736(14)60457-8;n=1;1;-1
S0140-6736(14)60457-8;n=85;85;-1
S0140-6736(14)60457-8;n=81;81;-1
S0140-6736(14)60457-8;n=76;76;-1
S0140-6736(14)60457-8;n=74;74;-1
S0140-6736(14)60457-8;n=71;71;-1
S0140-6736(14)60460-8;310 000 participants;310000;-1
S0140-6736(14)60460-8;8 million participants;8;-1
S0140-6736(14)60460-8;1000 people;1000;-1
S0140-6736(14)60460-8;671 million obese individuals;671;-1
S0140-6736(14)60460-8;900 000 adults;900000;-1
S0140-6736(14)60460-8;n=1769;1769;-1
S0140-6736(14)60460-8;n=19 244;19244;-1
S0140-6736(14)60460-8; data from   369;369;-1
S0140-6736(14)60461-X;1162 patients;1162;-1
S0140-6736(14)60461-X;1170 patients;1170;-1
S0140-6736(14)60461-X;n=1162;1162;-1
S0140-6736(14)60461-X;n=1170;1170;-1
S0140-6736(14)60463-3;800 000 people;800000;-1
S0140-6736(14)60480-3;2012  Pregnant women;2012;-1
S0140-6736(14)60481-5;2012  Pregnant women;2012;-1
S0140-6736(14)60481-5;3 billion individuals;3;-1
S0140-6736(14)60481-5;1  Individuals recruited;1;-1
S0140-6736(14)60482-7;3 billion individuals;3;-1
S0140-6736(14)60482-7;1  Individuals recruited;1;-1
S0140-6736(14)60485-2;n=666;666;-1
S0140-6736(14)60485-2;n=462;462;-1
S0140-6736(14)60485-2;n=664;664;-1
S0140-6736(14)60485-2;total of 666;666;-1
S0140-6736(14)60485-2; data from 1970;1970;-1
S0140-6736(14)60488-8;8135 women;8135;-1
S0140-6736(14)60488-8;3786 women;3786;-1
S0140-6736(14)60488-8;700 women;700;-1
S0140-6736(14)60488-8;1314 women;1314;-1
S0140-6736(14)60488-8;1772 women;1772;-1
S0140-6736(14)60488-8;400 women;400;-1
S0140-6736(14)60488-8;5424 women;5424;-1
S0140-6736(14)60488-8;3831 women;3831;-1
S0140-6736(14)60488-8;0 women;0;-1
S0140-6736(14)60488-8;3131 women;3131;-1
S0140-6736(14)60488-8;45 women;45;-1
S0140-6736(14)60488-8;1594 women;1594;-1
S0140-6736(14)60488-8;870 women;870;-1
S0140-6736(14)60488-8;5821 women;5821;-1
S0140-6736(14)60488-8;3 women;3;-1
S0140-6736(14)60488-8;813 women;813;-1
S0140-6736(14)60488-8;1133 women;1133;-1
S0140-6736(14)60488-8;318 women;318;-1
S0140-6736(14)60488-8;173 unirradiated women;173;-1
S0140-6736(14)60488-8;365 women;365;-1
S0140-6736(14)60488-8;542 women;542;-1
S0140-6736(14)60488-8;431 women;431;-1
S0140-6736(14)60488-8;2304 women;2304;-1
S0140-6736(14)60488-8;1494 women;1494;-1
S0140-6736(14)60488-8;1029 women;1029;-1
S0140-6736(14)60488-8;2000 women;2000;-1
S0140-6736(14)60488-8;10 801 women;10801;-1
S0140-6736(14)60488-8;100 000 women;100000;-1
S0140-6736(14)60488-8;total of   2304;2304;-1
S0140-6736(14)60490-6;67 participants;67;-1
S0140-6736(14)60492-X;600 people;600;-1
S0140-6736(14)60492-X;2 million people;2;-1
S0140-6736(14)60492-X;260 000 people;260000;-1
S0140-6736(14)60492-X;783 million   people;783;-1
S0140-6736(14)60492-X;100 000 people;100000;-1
S0140-6736(14)60494-3;394 patients;394;-1
S0140-6736(14)60494-3;150 million chronically infected patients;150;-1
S0140-6736(14)60494-3;481 patients;481;-1
S0140-6736(14)60494-3;125 patients;125;-1
S0140-6736(14)60494-3;264 patients;264;-1
S0140-6736(14)60494-3;202 patients;202;-1
S0140-6736(14)60494-3;247 patients;247;-1
S0140-6736(14)60494-3;28 patients;28;-1
S0140-6736(14)60494-3;60 simeprevir-treated   patients;60;-1
S0140-6736(14)60494-3;38 patients;38;-1
S0140-6736(14)60494-3;86 patients;86;-1
S0140-6736(14)60494-3;117 patients;117;-1
S0140-6736(14)60494-3;20 patients;20;-1
S0140-6736(14)60494-3;16 patients;16;-1
S0140-6736(14)60494-3;12 patients;12;-1
S0140-6736(14)60494-3;99 patients;99;-1
S0140-6736(14)60494-3;1 HCV infected patients;1;-1
S0140-6736(14)60494-3;1   patients;1;-1
S0140-6736(14)60494-3;4 million   individuals;4;-1
S0140-6736(14)60494-3;n=264;264;-1
S0140-6736(14)60494-3;n=130;130;-1
S0140-6736(14)60494-3;n=263;263;-1
S0140-6736(14)60494-3;n=259;259;-1
S0140-6736(14)60494-3;n=128;128;-1
S0140-6736(14)60494-3;n=71;71;-1
S0140-6736(14)60501-8;100 outpatients;100;-1
S0140-6736(14)60502-X;16 000 patients;16000;-1
S0140-6736(14)60502-X;3 million people;3;-1
S0140-6736(14)60502-X;3 million   people;3;-1
S0140-6736(14)60503-1;16 000 patients;16000;-1
S0140-6736(14)60503-1;3 million people;3;-1
S0140-6736(14)60503-1;3 million   people;3;-1
S0140-6736(14)60514-6;4   IPV-vaccinated individuals;4;-1
S0140-6736(14)60515-8;4   IPV-vaccinated individuals;4;-1
S0140-6736(14)60524-9;1250 participants;1250;190
S0140-6736(14)60524-9;49 participants;49;13079
S0140-6736(14)60524-9;13 participants;13;13353
S0140-6736(14)60524-9;562 participants;562;18269
S0140-6736(14)60524-9;568 participants;568;18318
S0140-6736(14)60524-9;16 participants;16;25479
S0140-6736(14)60524-9;n=627;627;262
S0140-6736(14)60524-9;n=623;623;292
S0140-6736(14)60524-9;n=9;9;13550
S0140-6736(14)60524-9;n=4;4;13561
S0140-6736(14)60524-9;n=1;1;13592
S0140-6736(14)60524-9;n=2;2;13647
S0140-6736(14)60524-9;n=624;624;16356
S0140-6736(14)60524-9;n=1247;1247;16392
S0140-6736(14)60524-9;n=562;562;16414
S0140-6736(14)60524-9;n=568;568;16434
S0140-6736(14)60524-9;n=1130;1130;16450
S0140-6736(14)60524-9;1250 enrolled;1250;11796
S0140-6736(14)60525-0;11   Allocation of participants;11;-1
S0140-6736(14)60529-8;124 patients;124;-1
S0140-6736(14)60529-8;41 patients;41;-1
S0140-6736(14)60530-4;2 million people;2;-1
S0140-6736(14)60533-X;30 patients;30;-1
S0140-6736(14)60533-X;444 patients;444;-1
S0140-6736(14)60536-5;2   Increasing numbers of people;2;-1
S0140-6736(14)60537-7;580 000 persons;580000;-1
S0140-6736(14)60537-7; data   from 2010;2010;-1
S0140-6736(14)60538-9;257 patients;257;-1
S0140-6736(14)60538-9;125 patients;125;-1
S0140-6736(14)60538-9;474 patients;474;-1
S0140-6736(14)60538-9;391 patients;391;-1
S0140-6736(14)60538-9;134 patients;134;-1
S0140-6736(14)60538-9;255 patients;255;-1
S0140-6736(14)60538-9;77 patients;77;-1
S0140-6736(14)60538-9;80 patients;80;-1
S0140-6736(14)60538-9;100 patients;100;-1
S0140-6736(14)60538-9;179 patients;179;-1
S0140-6736(14)60538-9;17 patients;17;-1
S0140-6736(14)60538-9;15 patients;15;-1
S0140-6736(14)60538-9;27   In patients;27;-1
S0140-6736(14)60538-9;40 patients;40;-1
S0140-6736(14)60538-9;103 patients;103;-1
S0140-6736(14)60538-9;24 patients;24;-1
S0140-6736(14)60538-9;52 patients;52;-1
S0140-6736(14)60538-9;30 patients;30;-1
S0140-6736(14)60538-9;21 patients;21;-1
S0140-6736(14)60538-9;1 HCV infected patients;1;-1
S0140-6736(14)60538-9;1 patients;1;-1
S0140-6736(14)60538-9;150 million individuals;150;-1
S0140-6736(14)60538-9;n=257;257;-1
S0140-6736(14)60538-9;n=134;134;-1
S0140-6736(14)60538-9;n=77;77;-1
S0140-6736(14)60538-9;n=45;45;-1
S0140-6736(14)60538-9;n=122;122;-1
S0140-6736(14)60538-9;n=80;80;-1
S0140-6736(14)60538-9;n=43;43;-1
S0140-6736(14)60538-9;n=123;123;-1
S0140-6736(14)60540-7;1183 patients;1183;-1
S0140-6736(14)60540-7;6433 patients;6433;-1
S0140-6736(14)60540-7;20078 and patients;20078;-1
S0140-6736(14)60540-7;10 000 patients;10000;-1
S0140-6736(14)60540-7;n=0;0;-1
S0140-6736(14)60540-7;total of 45;45;-1
S0140-6736(14)60541-9;52 patients;52;-1
S0140-6736(14)60541-9;30 patients;30;-1
S0140-6736(14)60541-9;48 patients;48;-1
S0140-6736(14)60541-9;20 patients;20;-1
S0140-6736(14)60541-9;17 patients;17;-1
S0140-6736(14)60541-9;11 patients;11;-1
S0140-6736(14)60541-9;63 patients;63;-1
S0140-6736(14)60541-9;n=18;18;-1
S0140-6736(14)60541-9;n=2;2;-1
S0140-6736(14)60541-9;n=24;24;-1
S0140-6736(14)60542-0;4 All patients;4;-1
S0140-6736(14)60542-0;182 patients;182;-1
S0140-6736(14)60544-4;2 million patients;2;-1
S0140-6736(14)60544-4;n=4;4;-1
S0140-6736(14)60544-4;n=1;1;-1
S0140-6736(14)60545-6;249,796 individuals;249796;-1
S0140-6736(14)60547-X;5 million people;5;-1
S0140-6736(14)60548-1;10 000 people;10000;-1
S0140-6736(14)60548-1;5 million people;5;-1
S0140-6736(14)60548-1;36 million people;36;-1
S0140-6736(14)60549-3;10 000 people;10000;-1
S0140-6736(14)60549-3;5 million people;5;-1
S0140-6736(14)60549-3;36 million people;36;-1
S0140-6736(14)60554-7;n=98;98;-1
S0140-6736(14)60577-8;67 participants;67;-1
S0140-6736(14)60577-8;1224 patients;1224;-1
S0140-6736(14)60577-8;607 patients;607;-1
S0140-6736(14)60577-8;1185 patients;1185;-1
S0140-6736(14)60577-8;7102 patients;7102;-1
S0140-6736(14)60577-8;434 patients;434;-1
S0140-6736(14)60580-8;7547 women;7547;-1
S0140-6736(14)60580-8;497 women;497;-1
S0140-6736(14)60580-8;9661 women;9661;-1
S0140-6736(14)60580-8;4677 women;4677;-1
S0140-6736(14)60580-8;3885 women;3885;-1
S0140-6736(14)60580-8;314 623 women;314623;-1
S0140-6736(14)60580-8;22 women;22;-1
S0140-6736(14)60580-8;29 women;29;-1
S0140-6736(14)60580-8;23 women;23;-1
S0140-6736(14)60580-8;842 women;842;-1
S0140-6736(14)60580-8;10 781 women;10781;-1
S0140-6736(14)60580-8;286 137 women;286137;-1
S0140-6736(14)60580-8;229 women;229;-1
S0140-6736(14)60580-8;4906 women;4906;-1
S0140-6736(14)60580-8;2612 women;2612;-1
S0140-6736(14)60580-8;303 842 women;303842;-1
S0140-6736(14)60580-8;17 705 women;17705;-1
S0140-6736(14)60580-8;1957 women;1957;-1
S0140-6736(14)60580-8;274 women;274;-1
S0140-6736(14)60580-8;n=346;346;-1
S0140-6736(14)60580-8;n=497;497;-1
S0140-6736(14)60580-8;n=7547;7547;-1
S0140-6736(14)60580-8;n=9661;9661;-1
S0140-6736(14)60580-8;n=17 705;17705;-1
S0140-6736(14)60580-8;N=94 740;94740;-1
S0140-6736(14)60580-8;n=3900;3900;-1
S0140-6736(14)60580-8;n=3373;3373;-1
S0140-6736(14)60580-8;N=131 835;131835;-1
S0140-6736(14)60580-8;N=16 611;16611;-1
S0140-6736(14)60580-8;N=36 460;36460;-1
S0140-6736(14)60580-8;N=24 196;24196;-1
S0140-6736(14)60580-8;n=3836;3836;-1
S0140-6736(14)60580-8;n=7273;7273;-1
S0140-6736(14)60580-8;n=4677;4677;-1
S0140-6736(14)60580-8; data from   314 623;314623;-1
S0140-6736(14)60583-3;183 patients;183;-1
S0140-6736(14)60584-5;6756 participants;6756;-1
S0140-6736(14)60584-5;3721 participants;3721;-1
S0140-6736(14)60584-5;3035 participants;3035;-1
S0140-6736(14)60584-5;270 participants;270;-1
S0140-6736(14)60584-5;6756 patients;6756;-1
S0140-6736(14)60584-5;787 patients;787;-1
S0140-6736(14)60584-5;3035 patients;3035;-1
S0140-6736(14)60584-5;244 patients;244;-1
S0140-6736(14)60584-5;3 patients;3;-1
S0140-6736(14)60584-5;198 patients;198;-1
S0140-6736(14)60584-5;3391 patients;3391;-1
S0140-6736(14)60584-5;22  All patients;22;-1
S0140-6736(14)60584-5;1729 patients;1729;-1
S0140-6736(14)60584-5;1700 patients;1700;-1
S0140-6736(14)60584-5;3 and patients;3;-1
S0140-6736(14)60584-5;n=0;0;-1
S0140-6736(14)60584-5;n=3391;3391;-1
S0140-6736(14)60584-5;n=3365;3365;-1
S0140-6736(14)60584-5; data from 6756;6756;-1
S0140-6736(14)60584-5; data from IST-3;3;-1
S0140-6736(14)60587-0;2105 adults;2105;-1
S0140-6736(14)60588-2;778 people;778;-1
S0140-6736(14)60588-2;528 people;528;-1
S0140-6736(14)60588-2;23 392 people;23392;-1
S0140-6736(14)60589-4;778 people;778;-1
S0140-6736(14)60589-4;528 people;528;-1
S0140-6736(14)60589-4;23 392 people;23392;-1
S0140-6736(14)60604-8;3909 people;3909;-1
S0140-6736(14)60604-8;1859 people;1859;-1
S0140-6736(14)60604-8;49 731 individuals;49731;-1
S0140-6736(14)60604-8;n=155;155;-1
S0140-6736(14)60604-8;n=38;38;-1
S0140-6736(14)60604-8;n=35;35;-1
S0140-6736(14)60604-8;n=26;26;-1
S0140-6736(14)60604-8;n=3909;3909;-1
S0140-6736(14)60604-8;n=256;256;-1
S0140-6736(14)60604-8;n=788;788;-1
S0140-6736(14)60604-8;n=862;862;-1
S0140-6736(14)60604-8;n=718;718;-1
S0140-6736(14)60604-8;n=658;658;-1
S0140-6736(14)60604-8;n=627;627;-1
S0140-6736(14)60606-1;2 In patients;2;-1
S0140-6736(14)60606-1;1620 patients;1620;-1
S0140-6736(14)60606-1;528 patients;528;-1
S0140-6736(14)60606-1;632 patients;632;-1
S0140-6736(14)60606-1;460 patients;460;-1
S0140-6736(14)60606-1;n=199;199;-1
S0140-6736(14)60606-1;n=192;192;-1
S0140-6736(14)60606-1;n=135;135;-1
S0140-6736(14)60606-1;total of 1620;1620;-1
S0140-6736(14)60609-7;831 million people;831;-1
S0140-6736(14)60611-5;10 251 men and women;10251;-1
S0140-6736(14)60611-5;10 251 adults;10251;-1
S0140-6736(14)60611-5;n=5128;5128;-1
S0140-6736(14)60611-5;n=5123;5123;-1
S0140-6736(14)60612-7;2440 patients;2440;-1
S0140-6736(14)60612-7;1259 eligible patients;1259;-1
S0140-6736(14)60612-7;23 All   patients;23;-1
S0140-6736(14)60612-7;21 We excluded   patients;21;-1
S0140-6736(14)60612-7;43 patients;43;-1
S0140-6736(14)60612-7;51 patients;51;-1
S0140-6736(14)60612-7;1492 patients;1492;-1
S0140-6736(14)60612-7;1181 patients;1181;-1
S0140-6736(14)60612-7;1259 patients;1259;-1
S0140-6736(14)60612-7;181 patients;181;-1
S0140-6736(14)60612-7;20 we randomly allocated patients;20;-1
S0140-6736(14)60612-7;12 536 enrolled patients;12536;-1
S0140-6736(14)60612-7;n=635;635;-1
S0140-6736(14)60612-7;n=624;624;-1
S0140-6736(14)60612-7;n=671;671;-1
S0140-6736(14)60612-7;n=253;253;-1
S0140-6736(14)60612-7;n=201;201;-1
S0140-6736(14)60612-7;n=29;29;-1
S0140-6736(14)60612-7;n=27;27;-1
S0140-6736(14)60612-7;total of   12 536;12536;-1
S0140-6736(14)60612-7;2440 patients enrolled;2440;-1
S0140-6736(14)60612-7;1286 enrolled;1286;-1
S0140-6736(14)60612-7;1259 were enrolled;1259;-1
S0140-6736(14)60612-7;12 536 enrolled;12536;-1
S0140-6736(14)60612-7; databases from Jan 1;1;-1
S0140-6736(14)60614-0;500 participants;500;23
S0140-6736(14)60614-0;3750 participants;3750;136
S0140-6736(14)60614-0;11 000 participants;11000;26171
S0140-6736(14)60614-0;11,000 participants;11000;29616
S0140-6736(14)60614-0;4161 patients;4161;11484
S0140-6736(14)60614-0;1 For patients;1;10348
S0140-6736(14)60614-0;8 patients;8;5703
S0140-6736(14)60614-0;13 250 patients;13250;6439
S0140-6736(14)60614-0;n=277;277;10784
S0140-6736(14)60614-0;n=555;555;10926
S0140-6736(14)60614-0;n=554;554;10988
S0140-6736(14)60614-0;n=52;52;17929
S0140-6736(14)60614-0;n=110;110;17964
S0140-6736(14)60614-0;n=107;107;17995
S0140-6736(14)60614-0;n=105;105;18027
S0140-6736(14)60614-0;total of 11 000;11000;26162
S0140-6736(14)60616-4;8 million   participants;8;-1
S0140-6736(14)60616-4;4 million participants;4;-1
S0140-6736(14)60616-4;7 million   participants;7;-1
S0140-6736(14)60616-4;1 million participants;1;-1
S0140-6736(14)60616-4;8 million participants;8;-1
S0140-6736(14)60616-4;0 million participants;0;-1
S0140-6736(14)60618-8;4161 patients;4161;-1
S0140-6736(14)60629-2;1 billion people;1;-1
S0140-6736(14)60630-9;185 million people;185;-1
S0140-6736(14)60630-9;2 million people;2;-1
S0140-6736(14)60631-0;185 million people;185;-1
S0140-6736(14)60631-0;2 million people;2;-1
S0140-6736(14)60636-X;95 mentally   ill people;95;-1
S0140-6736(14)60637-1;375 older men and women;375;-1
S0140-6736(14)60637-1;300 older women;300;-1
S0140-6736(14)60637-1;95 mentally   ill people;95;-1
S0140-6736(14)60637-1;n=2201;2201;-1
S0140-6736(14)60638-3;375 older men and women;375;-1
S0140-6736(14)60638-3;300 older women;300;-1
S0140-6736(14)60638-3;n=2201;2201;-1
S0140-6736(14)60639-5;375 older men and women;375;-1
S0140-6736(14)60639-5;300 older women;300;-1
S0140-6736(14)60639-5;n=2201;2201;-1
S0140-6736(14)60640-1;375 older men and women;375;-1
S0140-6736(14)60640-1;300 older women;300;-1
S0140-6736(14)60640-1;n=2201;2201;-1
S0140-6736(14)60642-5;19 patients;19;-1
S0140-6736(14)60643-7;19 patients;19;-1
S0140-6736(14)60644-9;19 patients;19;-1
S0140-6736(14)60654-1;24 participants;24;-1
S0140-6736(14)60654-1;44 participants;44;-1
S0140-6736(14)60654-1;2 diabetic patients;2;-1
S0140-6736(14)60656-5;151 000 adults;151000;-1
S0140-6736(14)60657-7;5 million people;5;-1
S0140-6736(14)60661-9;124 patients;124;-1
S0140-6736(14)60661-9;39 patients;39;-1
S0140-6736(14)60661-9;41 patients;41;-1
S0140-6736(14)60661-9;40 patients;40;-1
S0140-6736(14)60661-9;43 patients;43;-1
S0140-6736(14)60661-9;120 patients;120;-1
S0140-6736(14)60661-9;187 patients;187;-1
S0140-6736(14)60661-9;124 randomly   assigned patients;124;-1
S0140-6736(14)60661-9;16 patients;16;-1
S0140-6736(14)60661-9;12 patients;12;-1
S0140-6736(14)60661-9;22 patients;22;-1
S0140-6736(14)60661-9;81 patients;81;-1
S0140-6736(14)60661-9;80 All patients;80;-1
S0140-6736(14)60661-9;11  All patients;11;-1
S0140-6736(14)60661-9;n=41;41;-1
S0140-6736(14)60661-9;n=40;40;-1
S0140-6736(14)60661-9;n=43;43;-1
S0140-6736(14)60661-9;n=34;34;-1
S0140-6736(14)60661-9;n=38;38;-1
S0140-6736(14)60661-9;n=39;39;-1
S0140-6736(14)60661-9;n=390;390;-1
S0140-6736(14)60661-9;n=20;20;-1
S0140-6736(14)60661-9;n=15;15;-1
S0140-6736(14)60661-9;n=18;18;-1
S0140-6736(14)60661-9;n=21;21;-1
S0140-6736(14)60661-9;n=24;24;-1
S0140-6736(14)60661-9;n=210;210;-1
S0140-6736(14)60661-9;n=17;17;-1
S0140-6736(14)60661-9;n=14;14;-1
S0140-6736(14)60661-9;n=26;26;-1
S0140-6736(14)60661-9;n=22;22;-1
S0140-6736(14)60661-9;n=25;25;-1
S0140-6736(14)60661-9;n=16;16;-1
S0140-6736(14)60661-9;n=12;12;-1
S0140-6736(14)60661-9;n=250;250;-1
S0140-6736(14)60661-9;n=8;8;-1
S0140-6736(14)60661-9;n=6;6;-1
S0140-6736(14)60661-9;n=9;9;-1
S0140-6736(14)60661-9;n=33;33;-1
S0140-6736(14)60661-9;n=30;30;-1
S0140-6736(14)60661-9;n=19;19;-1
S0140-6736(14)60661-9;n=5;5;-1
S0140-6736(14)60661-9;n=10;10;-1
S0140-6736(14)60661-9;n=2;2;-1
S0140-6736(14)60661-9;n=13;13;-1
S0140-6736(14)60661-9;n=11;11;-1
S0140-6736(14)60661-9;n=4;4;-1
S0140-6736(14)60661-9;n=7;7;-1
S0140-6736(14)60662-0;10 even why women;10;-1
S0140-6736(14)60662-0;6756 patients;6756;-1
S0140-6736(14)60662-0;10 251 patients;10251;-1
S0140-6736(14)60663-2;417 patients;417;-1
S0140-6736(14)60663-2;30 patients;30;-1
S0140-6736(14)60663-2;55 patients;55;-1
S0140-6736(14)60663-2;0 patients;0;-1
S0140-6736(14)60663-2;19 patients;19;-1
S0140-6736(14)60663-2;15 patients;15;-1
S0140-6736(14)60663-2;444 patients;444;-1
S0140-6736(14)60665-6;748 million people;748;-1
S0140-6736(14)60665-6;5 billion   people;5;-1
S0140-6736(14)60665-6;1 billion people;1;-1
S0140-6736(14)60665-6; data from 90;90;-1
S0140-6736(14)60666-8;500 million people;500;-1
S0140-6736(14)60667-X;500 million people;500;-1
S0140-6736(14)60670-X;1 million patients;1;-1
S0140-6736(14)60676-0;1 000 000 people;1000000;-1
S0140-6736(14)60677-2;1 000 000 people;1000000;-1
S0140-6736(14)60683-8;28 few participants;28;-1
S0140-6736(14)60683-8;1620 patients;1620;-1
S0140-6736(14)60683-8;632 patients;632;-1
S0140-6736(14)60683-8;460 patients;460;-1
S0140-6736(14)60683-8;528 patients;528;-1
S0140-6736(14)60683-8;300 patients;300;-1
S0140-6736(14)60683-8;1500 patients;1500;-1
S0140-6736(14)60683-8;1272 patients;1272;-1
S0140-6736(14)60683-8;16 patients;16;-1
S0140-6736(14)60683-8;333 patients;333;-1
S0140-6736(14)60683-8;203 patients;203;-1
S0140-6736(14)60683-8;5247 patients;5247;-1
S0140-6736(14)60683-8;3525 patients;3525;-1
S0140-6736(14)60683-8;100 000 people;100000;-1
S0140-6736(14)60683-8;1620 people;1620;-1
S0140-6736(14)60683-8;n=1058;1058;-1
S0140-6736(14)60683-8;n=348;348;-1
S0140-6736(14)60683-8;n=214;214;-1
S0140-6736(14)60683-8;n=528;528;-1
S0140-6736(14)60683-8;n=878;878;-1
S0140-6736(14)60683-8;n=459;459;-1
S0140-6736(14)60683-8;N=460;460;-1
S0140-6736(14)60683-8;n=91;91;-1
S0140-6736(14)60685-1;2694 Framingham   participants;2694;-1
S0140-6736(14)60685-1;1000 participants;1000;-1
S0140-6736(14)60685-1;25 million patients;25;-1
S0140-6736(14)60685-1;1 258 006 patients;1258006;-1
S0140-6736(14)60685-1;25 million people;25;-1
S0140-6736(14)60685-1;61 cohorts recruited;61;-1
S0140-6736(14)60685-1;n=10 349;10349;-1
S0140-6736(14)60685-1;n=4139;4139;-1
S0140-6736(14)60685-1;n=11 029;11029;-1
S0140-6736(14)60685-1;n=3661;3661;-1
S0140-6736(14)60685-1;n=10 437;10437;-1
S0140-6736(14)60685-1;n=2355;2355;-1
S0140-6736(14)60685-1;n=8767;8767;-1
S0140-6736(14)60685-1;n=4329;4329;-1
S0140-6736(14)60685-1;n=830;830;-1
S0140-6736(14)60685-1;n=1639;1639;-1
S0140-6736(14)60685-1;n=8414;8414;-1
S0140-6736(14)60685-1;n=2261;2261;-1
S0140-6736(14)60685-1;n=83 098;83098;-1
S0140-6736(14)60685-1;n=3949;3949;-1
S0140-6736(14)60685-1;n=5422;5422;-1
S0140-6736(14)60685-1;n=4486;4486;-1
S0140-6736(14)60685-1;n=861;861;-1
S0140-6736(14)60685-1;n=1245;1245;-1
S0140-6736(14)60685-1;n=954;954;-1
S0140-6736(14)60685-1;n=2094;2094;-1
S0140-6736(14)60685-1;n=937;937;-1
S0140-6736(14)60685-1;n=533;533;-1
S0140-6736(14)60685-1;n=434;434;-1
S0140-6736(14)60685-1;n=2695;2695;-1
S0140-6736(14)60685-1;n=310;310;-1
S0140-6736(14)60685-1;n=5688;5688;-1
S0140-6736(14)60685-1;n=6110;6110;-1
S0140-6736(14)60685-1;n=5316;5316;-1
S0140-6736(14)60685-1;n=1940;1940;-1
S0140-6736(14)60685-1;n=5798;5798;-1
S0140-6736(14)60685-1;n=1261;1261;-1
S0140-6736(14)60685-1;n=4874;4874;-1
S0140-6736(14)60685-1;n=2452;2452;-1
S0140-6736(14)60685-1;n=254;254;-1
S0140-6736(14)60685-1;n=879;879;-1
S0140-6736(14)60685-1;n=4697;4697;-1
S0140-6736(14)60685-1;n=1567;1567;-1
S0140-6736(14)60685-1;n=712;712;-1
S0140-6736(14)60685-1;n=817;817;-1
S0140-6736(14)60685-1;n=1227;1227;-1
S0140-6736(14)60685-1;n=860;860;-1
S0140-6736(14)60685-1;n=3394;3394;-1
S0140-6736(14)60685-1;n=140;140;-1
S0140-6736(14)60685-1;n=1799;1799;-1
S0140-6736(14)60685-1;n=940;940;-1
S0140-6736(14)60685-1;n=43;43;-1
S0140-6736(14)60685-1;n=326;326;-1
S0140-6736(14)60685-1;n=1022;1022;-1
S0140-6736(14)60685-1;n=384;384;-1
S0140-6736(14)60685-1;n=2146;2146;-1
S0140-6736(14)60685-1;n=1717;1717;-1
S0140-6736(14)60685-1;n=276;276;-1
S0140-6736(14)60685-1;n=14 139;14139;-1
S0140-6736(14)60685-1;n=14 329;14329;-1
S0140-6736(14)60686-3;26 684 women;26684;-1
S0140-6736(14)60686-3;638 women;638;-1
S0140-6736(14)60686-3;241 women;241;-1
S0140-6736(14)60686-3;n=76;76;-1
S0140-6736(14)60686-3;n=12;12;-1
S0140-6736(14)60686-3;n=2;2;-1
S0140-6736(14)60686-3;n=90;90;-1
S0140-6736(14)60686-3;n=62;62;-1
S0140-6736(14)60688-7;2579 women;2579;-1
S0140-6736(14)60688-7;2292 women;2292;-1
S0140-6736(14)60688-7;4540 people;4540;-1
S0140-6736(14)60688-7;213 individuals;213;-1
S0140-6736(14)60688-7;8610 adults;8610;-1
S0140-6736(14)60688-7;n=8;8;-1
S0140-6736(14)60688-7;n=19;19;-1
S0140-6736(14)60688-7;n=154;154;-1
S0140-6736(14)60688-7;n=618;618;-1
S0140-6736(14)60688-7;n=772;772;-1
S0140-6736(14)60688-7;n=350;350;-1
S0140-6736(14)60688-7;n=277;277;-1
S0140-6736(14)60688-7;n=112;112;-1
S0140-6736(14)60688-7;n=33;33;-1
S0140-6736(14)60688-7; data from the 2011;2011;-1
S0140-6736(14)60689-9;350 participants;350;-1
S0140-6736(14)60689-9;39 participants;39;-1
S0140-6736(14)60689-9;396 patients;396;-1
S0140-6736(14)60689-9;1594 eligible patients;1594;-1
S0140-6736(14)60689-9;390 patients;390;-1
S0140-6736(14)60689-9;11 patients;11;-1
S0140-6736(14)60689-9;16 patients;16;-1
S0140-6736(14)60689-9;1620 patients;1620;-1
S0140-6736(14)60689-9;n=196;196;-1
S0140-6736(14)60689-9;n=200;200;-1
S0140-6736(14)60689-9;396 were enrolled;396;-1
S0140-6736(14)60693-0;10 Treatment of patients;10;-1
S0140-6736(14)60694-2;41 710 women;41710;-1
S0140-6736(14)60694-2;9 of   the patients;9;-1
S0140-6736(14)60696-6;total   of 21;21;-1
S0140-6736(14)60696-6; data coverage of   97;97;-1
S0140-6736(14)60696-6; data from 180;180;-1
S0140-6736(14)60710-8;1000 individuals;1000;-1
S0140-6736(14)60710-8;899 adults;899;-1
S0140-6736(14)60711-X;1000 individuals;1000;-1
S0140-6736(14)60711-X;899 adults;899;-1
S0140-6736(14)60712-1;1000 individuals;1000;-1
S0140-6736(14)60712-1;899 adults;899;-1
S0140-6736(14)60716-9;151 000 adults;151000;-1
S0140-6736(14)60717-0;151 000 adults;151000;-1
S0140-6736(14)60722-4;3885 women;3885;-1
S0140-6736(14)60722-4;60 000 women;60000;-1
S0140-6736(14)60722-4;1218 infants enrolled;1218;-1
S0140-6736(14)60726-1;29 234 patients;29234;-1
S0140-6736(14)60728-5;6 million people;6;-1
S0140-6736(14)60739-X;100 000 people;100000;-1
S0140-6736(14)60740-6;100 000 people;100000;-1
S0140-6736(14)60743-1;3 million people;3;-1
S0140-6736(14)60744-3;3 million people;3;-1
S0140-6736(14)60746-7;1000 individuals;1000;-1
S0140-6736(14)60747-9;1000 individuals;1000;-1
S0140-6736(14)60751-0;5 million people;5;-1
S0140-6736(14)60756-X;770 people;770;-1
S0140-6736(14)60756-X;470 people;470;-1
S0140-6736(14)60756-X;218 people;218;-1
S0140-6736(14)60756-X;37 people;37;-1
S0140-6736(14)60756-X;10 people;10;-1
S0140-6736(14)60756-X;5 million people;5;-1
S0140-6736(14)60758-3;74 046 individuals;74046;-1
S0140-6736(14)60767-4;580,000 subjects;580000;-1
S0140-6736(14)60767-4;24 million UK adults;24;-1
S0140-6736(14)60767-4; data from 183;183;-1
S0140-6736(14)60768-6;1259 PCI-treated patients;1259;-1
S0140-6736(14)60768-6;20 000 patients;20000;-1
S0140-6736(14)60768-6;n=624;624;-1
S0140-6736(14)60768-6;n=635;635;-1
S0140-6736(14)60772-8;46 000 people;46000;-1
S0140-6736(14)60772-8;670 people;670;-1
S0140-6736(14)60772-8;40 000 people;40000;-1
S0140-6736(14)60773-X;46 000 people;46000;-1
S0140-6736(14)60773-X;670 people;670;-1
S0140-6736(14)60773-X;40 000 people;40000;-1
S0140-6736(14)60781-9;580 000 persons;580000;-1
S0140-6736(14)60781-9;6 Treated   participants;6;-1
S0140-6736(14)60781-9;20 patients;20;-1
S0140-6736(14)60781-9; data   from 2010;2010;-1
S0140-6736(14)60782-0;6 Treated   participants;6;-1
S0140-6736(14)60782-0;20 patients;20;-1
S0140-6736(14)60782-0;18 surgical patients;18;-1
S0140-6736(14)60783-2;18 surgical patients;18;-1
S0140-6736(14)60784-4;18 surgical patients;18;-1
S0140-6736(14)60784-4;109 patients;109;-1
S0140-6736(14)60784-4;1012 treated   patients;1012;-1
S0140-6736(14)60785-6;109 patients;109;-1
S0140-6736(14)60785-6;1012 treated   patients;1012;-1
S0140-6736(14)60786-8;109 patients;109;-1
S0140-6736(14)60786-8;1012 treated   patients;1012;-1
S0140-6736(14)60786-8;748 million people;748;-1
S0140-6736(14)60786-8;1 billion   people;1;-1
S0140-6736(14)60793-5;292 women;292;-1
S0140-6736(14)60793-5;146 women;146;-1
S0140-6736(14)60793-5;3022 women;3022;-1
S0140-6736(14)60793-5;143 women;143;-1
S0140-6736(14)60793-5;141 women;141;-1
S0140-6736(14)60793-5;469 eligible women;469;-1
S0140-6736(14)60793-5;26 women;26;-1
S0140-6736(14)60793-5;289 randomised women;289;-1
S0140-6736(14)60793-5;34 women;34;-1
S0140-6736(14)60793-5;15 participants;15;-1
S0140-6736(14)60793-5;11 participants;11;-1
S0140-6736(14)60793-5;143 patients;143;-1
S0140-6736(14)60793-5;36 centres screened patients;36;-1
S0140-6736(14)60793-5;14 patients;14;-1
S0140-6736(14)60793-5;12 patients;12;-1
S0140-6736(14)60793-5;3 patients;3;-1
S0140-6736(14)60793-5;6 patients;6;-1
S0140-6736(14)60793-5;146 patients;146;-1
S0140-6736(14)60793-5;21 centres recruited;21;-1
S0140-6736(14)60793-5;n=146;146;-1
S0140-6736(14)60793-5;n=143;143;-1
S0140-6736(14)60793-5;n=148;148;-1
S0140-6736(14)60793-5;n=144;144;-1
S0140-6736(14)60793-5;n=141;141;-1
S0140-6736(14)60793-5;n=2;2;-1
S0140-6736(14)60795-9;50 patients;50;-1
S0140-6736(14)60795-9;183 patients;183;-1
S0140-6736(14)60795-9;318 patients;318;-1
S0140-6736(14)60795-9;n=196;196;-1
S0140-6736(14)60795-9;n=175;175;-1
S0140-6736(14)60803-5;326 patients;326;-1
S0140-6736(14)60803-5;219 patients;219;-1
S0140-6736(14)60803-5;32 patients;32;-1
S0140-6736(14)60803-5;600 patients;600;-1
S0140-6736(14)60803-5;320 patients;320;-1
S0140-6736(14)60803-5;326 randomised patients;326;-1
S0140-6736(14)60803-5;353 patients;353;-1
S0140-6736(14)60803-5;25 As patients;25;-1
S0140-6736(14)60803-5;n=126;126;-1
S0140-6736(14)60803-5;n=133;133;-1
S0140-6736(14)60803-5;n=67;67;-1
S0140-6736(14)60803-5;n=3;3;-1
S0140-6736(14)60803-5;n=1;1;-1
S0140-6736(14)60803-5;n=4;4;-1
S0140-6736(14)60803-5;n=6;6;-1
S0140-6736(14)60803-5;n=5;5;-1
S0140-6736(14)60803-5;n=7;7;-1
S0140-6736(14)60803-5;n=2;2;-1
S0140-6736(14)60803-5;n=11;11;-1
S0140-6736(14)60803-5;n=37;37;-1
S0140-6736(14)60803-5;n=89;89;-1
S0140-6736(14)60803-5;n=94;94;-1
S0140-6736(14)60803-5;n=49;49;-1
S0140-6736(14)60803-5;n=45;45;-1
S0140-6736(14)60803-5;n=100;100;-1
S0140-6736(14)60803-5;n=53;53;-1
S0140-6736(14)60803-5;n=47;47;-1
S0140-6736(14)60803-5;10 were enrolled;10;-1
S0140-6736(14)60805-9;550 participants;550;-1
S0140-6736(14)60805-9;25 participants;25;-1
S0140-6736(14)60805-9;1643 participants;1643;-1
S0140-6736(14)60805-9;1594 participants;1594;-1
S0140-6736(14)60805-9;1650 patients;1650;-1
S0140-6736(14)60805-9;4606 patients;4606;-1
S0140-6736(14)60805-9;550 patients;550;-1
S0140-6736(14)60805-9;1652 patients;1652;-1
S0140-6736(14)60805-9;549 patients;549;-1
S0140-6736(14)60805-9;553 patients;553;-1
S0140-6736(14)60805-9;12 patients;12;-1
S0140-6736(14)60805-9;3 patients;3;-1
S0140-6736(14)60805-9;13 patients;13;-1
S0140-6736(14)60805-9;546 patients;546;-1
S0140-6736(14)60805-9;547 patients;547;-1
S0140-6736(14)60805-9;230 patients;230;-1
S0140-6736(14)60805-9;196 patients;196;-1
S0140-6736(14)60805-9;229 patients;229;-1
S0140-6736(14)60805-9;461 recruited;461;-1
S0140-6736(14)60805-9;60 recruited;60;-1
S0140-6736(14)60805-9;29 recruited;29;-1
S0140-6736(14)60805-9;472 recruited;472;-1
S0140-6736(14)60805-9;51 recruited;51;-1
S0140-6736(14)60805-9;23 recruited;23;-1
S0140-6736(14)60805-9;468 recruited;468;-1
S0140-6736(14)60805-9;53 recruited;53;-1
S0140-6736(14)60805-9;26 recruited;26;-1
S0140-6736(14)60805-9;N=550;550;-1
S0140-6736(14)60805-9;N=546;546;-1
S0140-6736(14)60805-9;N=547;547;-1
S0140-6736(14)60805-9;N=545;545;-1
S0140-6736(14)60805-9;N=543;543;-1
S0140-6736(14)60805-9;N=544;544;-1
S0140-6736(14)60805-9;N=548;548;-1
S0140-6736(14)60805-9;N=542;542;-1
S0140-6736(14)60805-9;N=491;491;-1
S0140-6736(14)60805-9;N=478;478;-1
S0140-6736(14)60805-9;N=474;474;-1
S0140-6736(14)60805-9;N=455;455;-1
S0140-6736(14)60805-9;N=456;456;-1
S0140-6736(14)60805-9;N=450;450;-1
S0140-6736(14)60805-9;N=342;342;-1
S0140-6736(14)60805-9;N=343;343;-1
S0140-6736(14)60805-9;N=330;330;-1
S0140-6736(14)60805-9;N=308;308;-1
S0140-6736(14)60805-9;N=313;313;-1
S0140-6736(14)60805-9;N=296;296;-1
S0140-6736(14)60805-9;N=532;532;-1
S0140-6736(14)60805-9;N=528;528;-1
S0140-6736(14)60805-9;N=529;529;-1
S0140-6736(14)60805-9;N=490;490;-1
S0140-6736(14)60805-9;N=473;473;-1
S0140-6736(14)60805-9;N=472;472;-1
S0140-6736(14)60805-9;N=453;453;-1
S0140-6736(14)60805-9;N=454;454;-1
S0140-6736(14)60805-9;N=448;448;-1
S0140-6736(14)60805-9;N=340;340;-1
S0140-6736(14)60805-9;N=328;328;-1
S0140-6736(14)60805-9;N=306;306;-1
S0140-6736(14)60805-9;N=312;312;-1
S0140-6736(14)60805-9;N=449;449;-1
S0140-6736(14)60805-9;N=416;416;-1
S0140-6736(14)60805-9;n=46;46;-1
S0140-6736(14)60805-9;n=309;309;-1
S0140-6736(14)60805-9;n=745;745;-1
S0140-6736(14)60807-2;391 previously   untreated patients;391;-1
S0140-6736(14)60807-2;264 patients;264;-1
S0140-6736(14)60807-2;130 patients;130;-1
S0140-6736(14)60807-2;257 patients;257;-1
S0140-6736(14)60807-2;236 patients;236;-1
S0140-6736(14)60807-2;80 patients;80;-1
S0140-6736(14)60807-2;200 million people;200;-1
S0140-6736(14)60807-2;1 enrolled;1;-1
S0140-6736(14)60807-2;2 enrolled;2;-1
S0140-6736(14)60810-2;25 000 women;25000;-1
S0140-6736(14)60811-4;4540 people;4540;-1
S0140-6736(14)60814-X;100 million patients;100;-1
S0140-6736(14)60815-1;100 million patients;100;-1
S0140-6736(14)60821-7;20 000 patients;20000;-1
S0140-6736(14)60822-9;20 patients;20;-1
S0140-6736(14)60823-0;20 patients;20;-1
S0140-6736(14)60824-2;10 801 women;10801;-1
S0140-6736(14)60824-2;20 patients;20;-1
S0140-6736(14)60824-2;3451 patients;3451;-1
S0140-6736(14)60825-4;10 801 women;10801;-1
S0140-6736(14)60825-4;3451 patients;3451;-1
S0140-6736(14)60826-6;10 801 women;10801;-1
S0140-6736(14)60826-6;3451 patients;3451;-1
S0140-6736(14)60826-6;1665 patients;1665;-1
S0140-6736(14)60826-6;1261 patients;1261;-1
S0140-6736(14)60826-6;n=6;6;-1
S0140-6736(14)60827-8;1665 patients;1665;-1
S0140-6736(14)60827-8;1261 patients;1261;-1
S0140-6736(14)60827-8;n=6;6;-1
S0140-6736(14)60828-X;1665 patients;1665;-1
S0140-6736(14)60828-X;1261 patients;1261;-1
S0140-6736(14)60828-X;26 patients;26;-1
S0140-6736(14)60828-X;1222 patients;1222;-1
S0140-6736(14)60828-X;n=6;6;-1
S0140-6736(14)60828-X;total of 37;37;-1
S0140-6736(14)60829-1;26 patients;26;-1
S0140-6736(14)60829-1;1222 patients;1222;-1
S0140-6736(14)60829-1;2232 patients;2232;-1
S0140-6736(14)60829-1;n=1222;1222;-1
S0140-6736(14)60829-1;total of 37;37;-1
S0140-6736(14)60830-8;2232 patients;2232;-1
S0140-6736(14)60830-8;1222 patients;1222;-1
S0140-6736(14)60830-8;n=1222;1222;-1
S0140-6736(14)60836-9;4161 patients;4161;-1
S0140-6736(14)60836-9;n=805;805;-1
S0140-6736(14)60837-0;172 patients;172;-1
S0140-6736(14)60837-0;3   because people;3;-1
S0140-6736(14)60838-2;4 T cells of persons;4;-1
S0140-6736(14)60841-2;54 participants;54;-1
S0140-6736(14)60841-2;156 participants;156;-1
S0140-6736(14)60841-2;165 participants;165;-1
S0140-6736(14)60841-2;343 participants;343;-1
S0140-6736(14)60841-2;173 participants;173;-1
S0140-6736(14)60841-2;146 participants;146;-1
S0140-6736(14)60841-2;10 participants;10;-1
S0140-6736(14)60841-2;151 participants;151;-1
S0140-6736(14)60841-2;159 participants;159;-1
S0140-6736(14)60841-2;14 participants;14;-1
S0140-6736(14)60841-2;161 participants;161;-1
S0140-6736(14)60841-2;198 participants;198;-1
S0140-6736(14)60841-2;490 participants;490;-1
S0140-6736(14)60841-2;508 patients;508;-1
S0140-6736(14)60841-2;n=165;165;-1
S0140-6736(14)60841-2;n=175;175;-1
S0140-6736(14)60841-2;n=168;168;-1
S0140-6736(14)60841-2;n=343;343;-1
S0140-6736(14)60842-4;2954 participants;2954;-1
S0140-6736(14)60842-4;600 participants;600;-1
S0140-6736(14)60842-4;14 enrolled participants;14;-1
S0140-6736(14)60842-4;2968 participants;2968;-1
S0140-6736(14)60842-4;2968 subjects;2968;-1
S0140-6736(14)60842-4;850 assessable individuals;850;-1
S0140-6736(14)60842-4;2968 individuals;2968;-1
S0140-6736(14)60842-4;N=979;979;-1
S0140-6736(14)60842-4;N=988;988;-1
S0140-6736(14)60842-4;N=987;987;-1
S0140-6736(14)60842-4;N=2968;2968;-1
S0140-6736(14)60842-4;n=977;977;-1
S0140-6736(14)60842-4;n=2966;2966;-1
S0140-6736(14)60842-4;n=973;973;-1
S0140-6736(14)60842-4;n=985;985;-1
S0140-6736(14)60842-4;n=986;986;-1
S0140-6736(14)60842-4;n=2950;2950;-1
S0140-6736(14)60842-4;n=974;974;-1
S0140-6736(14)60842-4;n=987;987;-1
S0140-6736(14)60842-4;n=2953;2953;-1
S0140-6736(14)60842-4;n=826;826;-1
S0140-6736(14)60842-4;n=156;156;-1
S0140-6736(14)60842-4;n=319;319;-1
S0140-6736(14)60842-4;n=263;263;-1
S0140-6736(14)60842-4;n=121;121;-1
S0140-6736(14)60842-4;n=255;255;-1
S0140-6736(14)60842-4;n=501;501;-1
S0140-6736(14)60842-4;n=308;308;-1
S0140-6736(14)60842-4;n=206;206;-1
S0140-6736(14)60842-4;n=13;13;-1
S0140-6736(14)60842-4;N=974;974;-1
S0140-6736(14)60842-4;N=984;984;-1
S0140-6736(14)60842-4;N=981;981;-1
S0140-6736(14)60842-4;n=100;100;-1
S0140-6736(14)60842-4;N=2489;2489;-1
S0140-6736(14)60842-4;N=2576;2576;-1
S0140-6736(14)60842-4;n=185;185;-1
S0140-6736(14)60842-4;n=176;176;-1
S0140-6736(14)60842-4;n=182;182;-1
S0140-6736(14)60842-4;N=3520;3520;-1
S0140-6736(14)60842-4;N=3504;3504;-1
S0140-6736(14)60842-4;2968 subjects enrolled;2968;-1
S0140-6736(14)60842-4;2 inappropriately enrolled;2;-1
S0140-6736(14)60842-4;1 inappropriately enrolled;1;-1
S0140-6736(14)60842-4;11 inappropriately enrolled;11;-1
S0140-6736(14)60842-4;600 participants enrolled;600;-1
S0140-6736(14)60842-4;14 enrolled;14;-1
S0140-6736(14)60842-4;2968 individuals were enrolled;2968;-1
S0140-6736(14)60842-4;2968 participants enrolled;2968;-1
S0140-6736(14)60844-8;0  Male individuals  Female individuals;0;-1
S0140-6736(14)60844-8;6 million   fewer individuals;6;-1
S0140-6736(14)60844-8; data from 46;46;-1
S0140-6736(14)60845-X;1825 patients;1825;-1
S0140-6736(14)60845-X;1253 patients;1253;-1
S0140-6736(14)60845-X;628 patients;628;-1
S0140-6736(14)60845-X;625 patients;625;-1
S0140-6736(14)60845-X;627 patients;627;-1
S0140-6736(14)60845-X;618 patients;618;-1
S0140-6736(14)60845-X;306 patients;306;-1
S0140-6736(14)60845-X;3 and some patients;3;-1
S0140-6736(14)60845-X;10 Treatment of patients;10;-1
S0140-6736(14)60845-X;18 Eligible patients;18;-1
S0140-6736(14)60845-X;1242 patients;1242;-1
S0140-6736(14)60845-X;621 control group patients;621;-1
S0140-6736(14)60845-X;624 ramucirumab group patients;624;-1
S0140-6736(14)60845-X;143 patients;143;-1
S0140-6736(14)60845-X;63 patients;63;-1
S0140-6736(14)60845-X;48 patients;48;-1
S0140-6736(14)60845-X;31 patients;31;-1
S0140-6736(14)60845-X;884 patients;884;-1
S0140-6736(14)60845-X;320 patients;320;-1
S0140-6736(14)60845-X;54 patients;54;-1
S0140-6736(14)60845-X;30 patients;30;-1
S0140-6736(14)60845-X;16 patients;16;-1
S0140-6736(14)60845-X;14 patients;14;-1
S0140-6736(14)60845-X;18 patients;18;-1
S0140-6736(14)60845-X;53 patients;53;-1
S0140-6736(14)60845-X;43 patients;43;-1
S0140-6736(14)60845-X;22 patients;22;-1
S0140-6736(14)60845-X;13 patients;13;-1
S0140-6736(14)60845-X;75 patients;75;-1
S0140-6736(14)60845-X;32 patients;32;-1
S0140-6736(14)60845-X;11 patients;11;-1
S0140-6736(14)60845-X;33 patients;33;-1
S0140-6736(14)60845-X;1825 consented   patients;1825;-1
S0140-6736(14)60845-X;50,000 patients;50000;-1
S0140-6736(14)60845-X;n=628;628;-1
S0140-6736(14)60845-X;n=625;625;-1
S0140-6736(14)60845-X;n=627;627;-1
S0140-6736(14)60845-X;n=618;618;-1
S0140-6736(14)60845-X; data cutoff  611;611;-1
S0140-6736(14)60845-X; data cutoff  613;613;-1
S0140-6736(14)60848-5;50 000 patients;50000;-1
S0140-6736(14)60850-3;292 women;292;-1
S0140-6736(14)60850-3;146 women;146;-1
S0140-6736(14)60851-5;22 000 individuals;22000;-1
S0140-6736(14)60852-7;138 patients;138;-1
S0140-6736(14)60852-7;total of 572;572;-1
S0140-6736(14)60855-2;500 patients;500;-1
S0140-6736(14)60856-4;3 enabling matching of women;3;-1
S0140-6736(14)60856-4;2013 survey of   women;2013;-1
S0140-6736(14)60876-X;224 929 women;224929;-1
S0140-6736(14)60876-X;138 624   women;138624;-1
S0140-6736(14)60876-X;254 women;254;-1
S0140-6736(14)60876-X;553 women;553;-1
S0140-6736(14)60876-X;4 Were   study participants;4;-1
S0140-6736(14)60877-1;224 929 women;224929;-1
S0140-6736(14)60877-1;138 624   women;138624;-1
S0140-6736(14)60877-1;254 women;254;-1
S0140-6736(14)60877-1;553 women;553;-1
S0140-6736(14)60877-1;4 Were   study participants;4;-1
S0140-6736(14)60878-3;224 929 women;224929;-1
S0140-6736(14)60878-3;138 624   women;138624;-1
S0140-6736(14)60878-3;254 women;254;-1
S0140-6736(14)60878-3;553 women;553;-1
S0140-6736(14)60878-3;4 Were   study participants;4;-1
S0140-6736(14)60878-3;74 046 individuals;74046;-1
S0140-6736(14)60879-5;74 046 individuals;74046;-1
S0140-6736(14)60884-9;10 251 patients;10251;-1
S0140-6736(14)60884-9;160 patients;160;-1
S0140-6736(14)60884-9;n=3967;3967;-1
S0140-6736(14)60884-9;n=11 140;11140;-1
S0140-6736(14)60884-9;n=1791;1791;-1
S0140-6736(14)60884-9;n=160;160;-1
S0140-6736(14)60885-0;7 For patients;7;-1
S0140-6736(14)60885-0;1183 patients;1183;-1
S0140-6736(14)60885-0;7000 patients;7000;-1
S0140-6736(14)60885-0;101 330 matched patients;101330;-1
S0140-6736(14)60885-0;90 000 people;90000;-1
S0140-6736(14)60886-2;114 million   adults;114;-1
S0140-6736(14)60892-8;1 million Norwegian women;1;-1
S0140-6736(14)60892-8;25,157 women;25157;-1
S0140-6736(14)60892-8;4808 EPIC-Oxford participants;4808;-1
S0140-6736(14)60892-8;3790 additional annual UK patients;3790;-1
S0140-6736(14)60892-8;3790 extra patients;3790;-1
S0140-6736(14)60892-8;3790 additional patients;3790;-1
S0140-6736(14)60892-8;24 million individuals;24;-1
S0140-6736(14)60892-8;10 038 812 individuals;10038812;-1
S0140-6736(14)60892-8;6 185 050 individuals;6185050;-1
S0140-6736(14)60892-8;5 366 741 individuals;5366741;-1
S0140-6736(14)60892-8;5 366 639 individuals;5366639;-1
S0140-6736(14)60892-8;04 million individuals;4;-1
S0140-6736(14)60892-8;24 million UK adults;24;-1
S0140-6736(14)60892-8; data from 2003;2003;-1
S0140-6736(14)60893-X;10 102 eligible patients;10102;-1
S0140-6736(14)60893-X;7112 patients;7112;-1
S0140-6736(14)60893-X;3483 patients;3483;-1
S0140-6736(14)60893-X;506 patients;506;-1
S0140-6736(14)60893-X;378 patients;378;-1
S0140-6736(14)60893-X;2050 patients;2050;-1
S0140-6736(14)60893-X;12 140 patients;12140;-1
S0140-6736(14)60893-X;10 102 patients;10102;-1
S0140-6736(14)60893-X;7000 patients;7000;-1
S0140-6736(14)60893-X;5000 patients;5000;-1
S0140-6736(14)60893-X;7011 patients;7011;-1
S0140-6736(14)60893-X;6992 patients;6992;-1
S0140-6736(14)60893-X;283 patients;283;-1
S0140-6736(14)60893-X;91 patients;91;-1
S0140-6736(14)60893-X;640 patients;640;-1
S0140-6736(14)60893-X;230 million people;230;-1
S0140-6736(14)60893-X;37 485 individuals;37485;-1
S0140-6736(14)60893-X;n=3495;3495;-1
S0140-6736(14)60893-X;n=3516;3516;-1
S0140-6736(14)60893-X;n=29;29;-1
S0140-6736(14)60893-X;n=28;28;-1
S0140-6736(14)60893-X;n=3483;3483;-1
S0140-6736(14)60893-X;n=3509;3509;-1
S0140-6736(14)60893-X;n=3052;3052;-1
S0140-6736(14)60893-X;n=3069;3069;-1
S0140-6736(14)60893-X;n=421;421;-1
S0140-6736(14)60893-X;n=439;439;-1
S0140-6736(14)60893-X;n=20;20;-1
S0140-6736(14)60893-X;n=579;579;-1
S0140-6736(14)60893-X;7112 patients enrolled;7112;-1
S0140-6736(14)60893-X;8 previously enrolled;8;-1
S0140-6736(14)60893-X;7112 patients   were enrolled;7112;-1
S0140-6736(14)60894-1;900 patients;900;-1
S0140-6736(14)60894-1;445 patients;445;-1
S0140-6736(14)60894-1;449 patients;449;-1
S0140-6736(14)60894-1;29 343 patients;29343;-1
S0140-6736(14)60895-3;118 patients;118;-1
S0140-6736(14)60895-3;133 patients;133;-1
S0140-6736(14)60895-3;33 patients;33;-1
S0140-6736(14)60895-3;251 patients;251;-1
S0140-6736(14)60895-3;1200 adults;1200;-1
S0140-6736(14)60896-5;21167 patients;21167;-1
S0140-6736(14)60896-5;25 million people;25;-1
S0140-6736(14)60896-5;4540 people;4540;-1
S0140-6736(14)60902-8;2 billion people;2;-1
S0140-6736(14)60911-9;18 patients;18;-1
S0140-6736(14)60911-9;28 patients;28;-1
S0140-6736(14)60911-9;45 patients;45;-1
S0140-6736(14)60912-0;18 patients;18;-1
S0140-6736(14)60912-0;28 patients;28;-1
S0140-6736(14)60912-0;45 patients;45;-1
S0140-6736(14)60913-2;18 patients;18;-1
S0140-6736(14)60913-2;28 patients;28;-1
S0140-6736(14)60913-2;45 patients;45;-1
S0140-6736(14)60913-2;3   patients;3;-1
S0140-6736(14)60920-X;5752 women;5752;-1
S0140-6736(14)60920-X;2881 women;2881;-1
S0140-6736(14)60920-X;5777 women;5777;-1
S0140-6736(14)60920-X;5400 women;5400;-1
S0140-6736(14)60920-X;3200 women;3200;-1
S0140-6736(14)60920-X;143 initially   seronegative women;143;-1
S0140-6736(14)60920-X;18  Initially seronegative women;18;-1
S0140-6736(14)60920-X;11 All women;11;-1
S0140-6736(14)60920-X;40 and HPV vaccination of   women;40;-1
S0140-6736(14)60920-X;1 million women;1;-1
S0140-6736(14)60920-X;30 000 trial participants;30000;-1
S0140-6736(14)60920-X;n=2881;2881;-1
S0140-6736(14)60920-X;n=2871;2871;-1
S0140-6736(14)60920-X;n=2264;2264;-1
S0140-6736(14)60920-X;n=2241;2241;-1
S0140-6736(14)60920-X;n=1138;1138;-1
S0140-6736(14)60920-X;n=4505;4505;-1
S0140-6736(14)60920-X;n=4985;4985;-1
S0140-6736(14)60920-X;n=5752;5752;-1
S0140-6736(14)60920-X;n=345;345;-1
S0140-6736(14)60920-X;n=360;360;-1
S0140-6736(14)60920-X;5777 women enrolled;5777;-1
S0140-6736(14)60924-7;47 participants;47;2668
S0140-6736(14)60924-7;1917 patients;1917;18042
S0140-6736(14)60924-7;905 patients;905;17838
S0140-6736(14)60924-7;907 patients;907;17783
S0140-6736(14)60924-7;122 patients;122;17631
S0140-6736(14)60924-7;140 patients;140;17583
S0140-6736(14)60924-7;751 patients;751;3596
S0140-6736(14)60924-7;740 patients;740;3541
S0140-6736(14)60924-7;900 patients;900;2395
S0140-6736(14)60924-7;1800 patients;1800;570
S0140-6736(14)60924-7;1829 patients;1829;1814
S0140-6736(14)60924-7;17 surviving patients;17;2322
S0140-6736(14)60924-7;47 participants remained inpatients;47;2668
S0140-6736(14)60924-7;1595 patients;1595;2778
S0140-6736(14)60924-7;95 patients;95;2780
S0140-6736(14)60924-7;748 patients;748;10190
S0140-6736(14)60924-7;733 patients;733;10232
S0140-6736(14)60924-7;728 patients;728;10312
S0140-6736(14)60924-7;n=905;905;8829
S0140-6736(14)60924-7;n=907;907;8807
S0140-6736(14)60932-6;59 137 pregnant women;59137;-1
S0140-6736(14)60932-6;52 171 women;52171;-1
S0140-6736(14)60932-6;7929 women;7929;-1
S0140-6736(14)60932-6;1027 women;1027;-1
S0140-6736(14)60932-6;n=1595;1595;-1
S0140-6736(14)60932-6;n=3551;3551;-1
S0140-6736(14)60932-6;n=2493;2493;-1
S0140-6736(14)60932-6;n=2358;2358;-1
S0140-6736(14)60932-6;n=3702;3702;-1
S0140-6736(14)60932-6;n=2821;2821;-1
S0140-6736(14)60932-6;n=2939;2939;-1
S0140-6736(14)60932-6;n=1027;1027;-1
S0140-6736(14)60932-6;n=20 486;20486;-1
S0140-6736(14)60932-6;59 137 pregnant women enrolled;59137;-1
S0140-6736(14)60934-X;5   Infected adults;5;-1
S0140-6736(14)60934-X;n=224;224;-1
S0140-6736(14)60934-X;n=222;222;-1
S0140-6736(14)60934-X;n=221;221;-1
S0140-6736(14)60934-X;total of   7;7;-1
S0140-6736(14)60934-X;450 children were enrolled;450;-1
S0140-6736(14)60934-X;450 children enrolled;450;-1
S0140-6736(14)60935-1;508 patients;508;-1
S0140-6736(14)60935-1;8  Indigenous Australian people;8;-1
S0140-6736(14)60937-5;382 million people;382;-1
S0140-6736(14)60938-7;340 people;340;-1
S0140-6736(14)60939-9;340 people;340;-1
S0140-6736(14)60942-9;600 patients;600;-1
S0140-6736(14)60948-X;70 000 people;70000;-1
S0140-6736(14)60949-1;70 000 people;70000;-1
S0140-6736(14)60950-8;70 000 people;70000;-1
S0140-6736(14)60955-7;9 Deaths of women;9;-1
S0140-6736(14)60955-7;20 More women;20;-1
S0140-6736(14)60955-7;6000 people;6000;-1
S0140-6736(14)60955-7;10 million   people;10;-1
S0140-6736(14)60955-7;1000 people;1000;-1
S0140-6736(14)60955-7; data from the 2001;2001;-1
S0140-6736(14)60956-9;14 participants;14;-1
S0140-6736(14)60956-9;14 patients;14;-1
S0140-6736(14)60956-9;15 children and adults;15;-1
S0140-6736(14)60957-0;112 842 Chinese patients;112842;-1
S0140-6736(14)60958-2;173 patients;173;-1
S0140-6736(14)60958-2;81 patients;81;-1
S0140-6736(14)60958-2;135 patients;135;-1
S0140-6736(14)60958-2;48 patients;48;-1
S0140-6736(14)60958-2;60 patients;60;-1
S0140-6736(14)60958-2;100 patients;100;-1
S0140-6736(14)60958-2;178 patients;178;-1
S0140-6736(14)60958-2;80 ipilimumab-refractory patients;80;-1
S0140-6736(14)60958-2;84 patients;84;-1
S0140-6736(14)60958-2;170 patients;170;-1
S0140-6736(14)60958-2;131 patients;131;-1
S0140-6736(14)60958-2;26 patients;26;-1
S0140-6736(14)60958-2;58 patients;58;-1
S0140-6736(14)60958-2;27 patients;27;-1
S0140-6736(14)60958-2;31 patients;31;-1
S0140-6736(14)60958-2;n=89;89;-1
S0140-6736(14)60958-2;n=84;84;-1
S0140-6736(14)60958-2;n=173;173;-1
S0140-6736(14)60958-2;n=81;81;-1
S0140-6736(14)60958-2;n=76;76;-1
S0140-6736(14)60958-2;n=91;91;-1
S0140-6736(14)60958-2;n=87;87;-1
S0140-6736(14)60958-2;n=21;21;-1
S0140-6736(14)60958-2;n=20;20;-1
S0140-6736(14)60958-2;n=24;24;-1
S0140-6736(14)60958-2;n=27;27;-1
S0140-6736(14)60962-4;200 participants;200;-1
S0140-6736(14)60962-4;1620 patients;1620;-1
S0140-6736(14)60962-4;528 patients;528;-1
S0140-6736(14)60962-4;632 patients;632;-1
S0140-6736(14)60962-4;460 patients;460;-1
S0140-6736(14)60962-4;3090 patients;3090;-1
S0140-6736(14)60962-4;total of 1620;1620;-1
S0140-6736(14)60970-3;100 000 women;100000;-1
S0140-6736(14)60970-3;70 000 people;70000;-1
S0140-6736(14)60970-3;8 million people;8;-1
S0140-6736(14)60976-4;269 participants;269;-1
S0140-6736(14)60976-4;599 patients;599;-1
S0140-6736(14)60976-4;299 patients;299;-1
S0140-6736(14)60976-4;300 patients;300;-1
S0140-6736(14)60976-4;296 randomly   assigned patients;296;-1
S0140-6736(14)60976-4;814 patients;814;-1
S0140-6736(14)60976-4;599 eligible patients;599;-1
S0140-6736(14)60976-4;19 patients;19;-1
S0140-6736(14)60976-4;252 patients;252;-1
S0140-6736(14)60976-4;26  Only patients;26;-1
S0140-6736(14)60976-4;812 patients;812;-1
S0140-6736(14)60976-4;19   whereas patients;19;-1
S0140-6736(14)60976-4;n=299;299;-1
S0140-6736(14)60976-4;n=300;300;-1
S0140-6736(14)60977-6;14 participants;14;-1
S0140-6736(14)60977-6;15 children and adults;15;-1
S0140-6736(14)60977-6;n=33;33;-1
S0140-6736(14)60977-6;n=15;15;-1
S0140-6736(14)60978-8;1652 patients;1652;-1
S0140-6736(14)60978-8;1 represent a large group   of patients;1;-1
S0140-6736(14)60978-8;180 million individuals;180;-1
S0140-6736(14)60981-8;314 million people;314;-1
S0140-6736(14)60981-8;8 million people;8;-1
S0140-6736(14)60983-1;140,000   observations in men and women;140000;-1
S0140-6736(14)60983-1;14 patients;14;-1
S0140-6736(14)60988-0;46 participants;46;-1
S0140-6736(14)60989-2;46 participants;46;-1
S0140-6736(14)60989-2;584 participants;584;-1
S0140-6736(14)60989-2;8 million participants;8;-1
S0140-6736(14)60990-9;584 participants;584;-1
S0140-6736(14)60990-9;8 million participants;8;-1
S0140-6736(14)60991-0;584 participants;584;-1
S0140-6736(14)60991-0;8 million participants;8;-1
S0140-6736(14)60991-0;5  An analysis of participants;5;-1
S0140-6736(14)60991-0;220 000 participants;220000;-1
S0140-6736(14)60991-0;5 million   people;5;-1
S0140-6736(14)60991-0;400 000 people;400000;-1
S0140-6736(14)60992-2;5  An analysis of participants;5;-1
S0140-6736(14)60992-2;8 million participants;8;-1
S0140-6736(14)60992-2;220 000 participants;220000;-1
S0140-6736(14)60992-2;7 million   participants;7;-1
S0140-6736(14)60992-2;1 million participants;1;-1
S0140-6736(14)60992-2;5 million   people;5;-1
S0140-6736(14)60992-2;400 000 people;400000;-1
S0140-6736(14)60993-4;7 million   participants;7;-1
S0140-6736(14)60993-4;1 million participants;1;-1
S0140-6736(14)60993-4;60 patients;60;-1
S0140-6736(14)60994-6;60 patients;60;-1
S0140-6736(14)60995-8;60 patients;60;-1
S0140-6736(14)61008-4;7 If most of the patients;7;-1
S0140-6736(14)61008-4;326 patients;326;-1
S0140-6736(14)61008-4;126 patients;126;-1
S0140-6736(14)61008-4;133 patients;133;-1
S0140-6736(14)61008-4;67 patients;67;-1
S0140-6736(14)61008-4;47 patients;47;-1
S0140-6736(14)61008-4;275 patients;275;-1
S0140-6736(14)61008-4;138 patients;138;-1
S0140-6736(14)61008-4;1101 patients;1101;-1
S0140-6736(14)61008-4;335 patients;335;-1
S0140-6736(14)61013-8;300 000 people;300000;-1
S0140-6736(14)61013-8;5 million   people;5;-1
S0140-6736(14)61013-8;50 million people;50;-1
S0140-6736(14)61013-8;100 000 people;100000;-1
S0140-6736(14)61013-8;100 000   people;100000;-1
S0140-6736(14)61014-X;300 000 people;300000;-1
S0140-6736(14)61014-X;5 million   people;5;-1
S0140-6736(14)61014-X;50 million people;50;-1
S0140-6736(14)61014-X;100 000 people;100000;-1
S0140-6736(14)61014-X;100 000   people;100000;-1
S0140-6736(14)61022-9;22 women;22;-1
S0140-6736(14)61022-9;39 women;39;-1
S0140-6736(14)61023-0;22 women;22;-1
S0140-6736(14)61023-0;39 women;39;-1
S0140-6736(14)61023-0;185 million people;185;-1
S0140-6736(14)61024-2;185 million people;185;-1
S0140-6736(14)61025-4;185 million people;185;-1
S0140-6736(14)61030-8;14 patients;14;-1
S0140-6736(14)61034-5;60 patients;60;-1
S0140-6736(14)61034-5;16 patients;16;-1
S0140-6736(14)61034-5;60 exposed patients;60;-1
S0140-6736(14)61034-5;43 patients;43;-1
S0140-6736(14)61034-5;43 exposed patients;43;-1
S0140-6736(14)61034-5;8 perhaps advising patients;8;-1
S0140-6736(14)61034-5;n=18;18;-1
S0140-6736(14)61034-5;n=25;25;-1
S0140-6736(14)61034-5;n=4;4;-1
S0140-6736(14)61034-5;n=13;13;-1
S0140-6736(14)61036-9;168 patients;168;-1
S0140-6736(14)61036-9;54 patients;54;-1
S0140-6736(14)61036-9;31 patients;31;-1
S0140-6736(14)61036-9;30 patients;30;-1
S0140-6736(14)61036-9;167 of patients;167;-1
S0140-6736(14)61036-9;108 patients;108;-1
S0140-6736(14)61036-9;40 treatment-naive patients;40;-1
S0140-6736(14)61036-9;24 patients;24;-1
S0140-6736(14)61036-9;20 patients;20;-1
S0140-6736(14)61036-9;1b patients;1;-1
S0140-6736(14)61036-9;12 even though patients;12;-1
S0140-6736(14)61036-9;100804020  Observed proportion of patients;100804020;-1
S0140-6736(14)61036-9;1 treatment-  experienced patients;1;-1
S0140-6736(14)61036-9;150   million people;150;-1
S0140-6736(14)61036-9;n=80;80;-1
S0140-6736(14)61036-9;n=87;87;-1
S0140-6736(14)61036-9;n=72;72;-1
S0140-6736(14)61036-9;n=82;82;-1
S0140-6736(14)61036-9;n=52;52;-1
S0140-6736(14)61036-9;n=33;33;-1
S0140-6736(14)61036-9;n=26;26;-1
S0140-6736(14)61036-9;n=22;22;-1
S0140-6736(14)61036-9;n=167;167;-1
S0140-6736(14)61036-9;n=24;24;-1
S0140-6736(14)61036-9;n=15;15;-1
S0140-6736(14)61036-9;n=27;27;-1
S0140-6736(14)61036-9;n=14;14;-1
S0140-6736(14)61036-9;n=30;30;-1
S0140-6736(14)61036-9;n=16;16;-1
S0140-6736(14)61036-9;n=54;54;-1
S0140-6736(14)61036-9;n=31;31;-1
S0140-6736(14)61036-9;n=28;28;-1
S0140-6736(14)61036-9;n=1;1;-1
S0140-6736(14)61036-9;168 patients were enrolled;168;-1
S0140-6736(14)61037-0;320 participants;320;-1
S0140-6736(14)61037-0;2 diabetes   enrolled few participants;2;-1
S0140-6736(14)61037-0;590 screened patients;590;-1
S0140-6736(14)61037-0;114 patients;114;-1
S0140-6736(14)61037-0;590 patients;590;-1
S0140-6736(14)61037-0;23 patients;23;-1
S0140-6736(14)61037-0;158 patients;158;-1
S0140-6736(14)61037-0;8 of patients;8;-1
S0140-6736(14)61037-0;21 patients;21;-1
S0140-6736(14)61037-0;2 diabetic patients;2;-1
S0140-6736(14)61037-0;102 patients;102;-1
S0140-6736(14)61037-0;2   diabetic patients;2;-1
S0140-6736(14)61037-0;n=168;168;-1
S0140-6736(14)61037-0;n=163;163;-1
S0140-6736(14)61037-0;2 diabetes   enrolled;2;-1
S0140-6736(14)61038-2;2119 patients;2119;-1
S0140-6736(14)61038-2;1063 patients;1063;-1
S0140-6736(14)61038-2;1056 patients;1056;-1
S0140-6736(14)61038-2;2060 patients;2060;-1
S0140-6736(14)61038-2;2129 patients;2129;-1
S0140-6736(14)61038-2;1066 patients;1066;-1
S0140-6736(14)61038-2;1050 patients;1050;-1
S0140-6736(14)61038-2;4  Articles  patients;4;-1
S0140-6736(14)61038-2;n=0;0;-1
S0140-6736(14)61038-2;n=1063;1063;-1
S0140-6736(14)61038-2;n=1056;1056;-1
S0140-6736(14)61038-2;n=1008;1008;-1
S0140-6736(14)61038-2;n=995;995;-1
S0140-6736(14)61038-2;n=852;852;-1
S0140-6736(14)61038-2;n=845;845;-1
S0140-6736(14)61038-2;n=1594;1594;-1
S0140-6736(14)61038-2;n=1545;1545;-1
S0140-6736(14)61038-2;n=1560;1560;-1
S0140-6736(14)61038-2;n=1523;1523;-1
S0140-6736(14)61038-2;n=1575;1575;-1
S0140-6736(14)61038-2;n=1540;1540;-1
S0140-6736(14)61038-2;n=1517;1517;-1
S0140-6736(14)61038-2;n=1483;1483;-1
S0140-6736(14)61038-2;N=1063;1063;-1
S0140-6736(14)61038-2;N=1056;1056;-1
S0140-6736(14)61039-4;25 participants;25;-1
S0140-6736(14)61039-4;326 patients;326;-1
S0140-6736(14)61039-4;126 patients;126;-1
S0140-6736(14)61039-4;133 patients;133;-1
S0140-6736(14)61039-4;67 patients;67;-1
S0140-6736(14)61039-4;47 patients;47;-1
S0140-6736(14)61039-4;275 patients;275;-1
S0140-6736(14)61039-4;138 patients;138;-1
S0140-6736(14)61039-4;1101 patients;1101;-1
S0140-6736(14)61039-4;335 patients;335;-1
S0140-6736(14)61039-4;54 patients;54;-1
S0140-6736(14)61039-4;25 patients;25;-1
S0140-6736(14)61039-4;12   Four patients;12;-1
S0140-6736(14)61039-4;15   All patients;15;-1
S0140-6736(14)61039-4;n=5;5;-1
S0140-6736(14)61039-4;n=10;10;-1
S0140-6736(14)61040-0;1829 patients;1829;-1
S0140-6736(14)61040-0;905 patients;905;-1
S0140-6736(14)61041-2;1829 patients;1829;-1
S0140-6736(14)61041-2;18 065 patients;18065;-1
S0140-6736(14)61041-2;905 patients;905;-1
S0140-6736(14)61044-8;8 million people;8;-1
S0140-6736(14)61053-9;800 000 people;800000;-1
S0140-6736(14)61053-9;total of 13;13;-1
S0140-6736(14)61058-8;20 990 patients;20990;-1
S0140-6736(14)61058-8;7000 patients;7000;-1
S0140-6736(14)61058-8;20 patients;20;-1
S0140-6736(14)61058-8;3500 patients;3500;-1
S0140-6736(14)61058-8;8000 patients;8000;-1
S0140-6736(14)61058-8;3751 patients;3751;-1
S0140-6736(14)61058-8;500 patients;500;-1
S0140-6736(14)61058-8;550 patients;550;-1
S0140-6736(14)61058-8;7017 patients;7017;-1
S0140-6736(14)61058-8;7525 patients;7525;-1
S0140-6736(14)61058-8;7719 patients;7719;-1
S0140-6736(14)61058-8;6695 patients;6695;-1
S0140-6736(14)61058-8;6032 patients;6032;-1
S0140-6736(14)61058-8;6598 patients;6598;-1
S0140-6736(14)61058-8;5984 patients;5984;-1
S0140-6736(14)61058-8;7012 patients;7012;-1
S0140-6736(14)61058-8;7283 patients;7283;-1
S0140-6736(14)61058-8;502 patients;502;-1
S0140-6736(14)61058-8;551 patients;551;-1
S0140-6736(14)61058-8;520 patients;520;-1
S0140-6736(14)61058-8;22 261 patients;22261;-1
S0140-6736(14)61058-8;16 279 patients;16279;-1
S0140-6736(14)61058-8;4113 patients;4113;-1
S0140-6736(14)61058-8;3837 patients;3837;-1
S0140-6736(14)61058-8;4182 patients;4182;-1
S0140-6736(14)61058-8;5171 patients;5171;-1
S0140-6736(14)61058-8;5468 patients;5468;-1
S0140-6736(14)61058-8;1000 patients;1000;-1
S0140-6736(14)61058-8;n=13;13;-1
S0140-6736(14)61058-8;n=15;15;-1
S0140-6736(14)61058-8;n=14;14;-1
S0140-6736(14)61058-8;n=6695;6695;-1
S0140-6736(14)61058-8;n=5171;5171;-1
S0140-6736(14)61058-8;n  =2;2;-1
S0140-6736(14)61058-8;n  =1;1;-1
S0140-6736(14)61058-8;n=7012;7012;-1
S0140-6736(14)61058-8;n=7283;7283;-1
S0140-6736(14)61058-8;N=5171;5171;-1
S0140-6736(14)61058-8;N=5468;5468;-1
S0140-6736(14)61058-8;N=5572;5572;-1
S0140-6736(14)61059-X;307 treatment-naive patients;307;-1
S0140-6736(14)61059-X;200 patients;200;-1
S0140-6736(14)61059-X;100 treatment-naive patients;100;-1
S0140-6736(14)61059-X;293 patients;293;-1
S0140-6736(14)61059-X;453 patients;453;-1
S0140-6736(14)61059-X;12 status of patients;12;-1
S0140-6736(14)61059-X;596 patients;596;-1
S0140-6736(14)61059-X;27 patients;27;-1
S0140-6736(14)61059-X;75 patients;75;-1
S0140-6736(14)61059-X;521 patients;521;-1
S0140-6736(14)61059-X;78 patients;78;-1
S0140-6736(14)61059-X;39 patients;39;-1
S0140-6736(14)61059-X;13 patients;13;-1
S0140-6736(14)61059-X;150 million people;150;-1
S0140-6736(14)61059-X;n=205;205;-1
S0140-6736(14)61059-X;n=102;102;-1
S0140-6736(14)61059-X;n=235;235;-1
S0140-6736(14)61059-X;n=203;203;-1
S0140-6736(14)61059-X;n=599;599;-1
S0140-6736(14)61059-X;n=634;634;-1
S0140-6736(14)61059-X;n=630;630;-1
S0140-6736(14)61059-X;n=8;8;-1
S0140-6736(14)61059-X;N=203;203;-1
S0140-6736(14)61060-6;18 participants;18;-1
S0140-6736(14)61060-6;10 278 participants;10278;-1
S0140-6736(14)61060-6;10 632 participants;10632;-1
S0140-6736(14)61060-6;575 participants;575;-1
S0140-6736(14)61060-6;100 million people;100;-1
S0140-6736(14)61060-6;96 million people;96;-1
S0140-6736(14)61060-6;n=6851;6851;-1
S0140-6736(14)61060-6;n=3424;3424;-1
S0140-6736(14)61060-6;n=6852;6852;-1
S0140-6736(14)61060-6;n=3426;3426;-1
S0140-6736(14)61060-6;n=5;5;-1
S0140-6736(14)61060-6;n=3;3;-1
S0140-6736(14)61060-6;n=1;1;-1
S0140-6736(14)61060-6;N=6851;6851;-1
S0140-6736(14)61060-6;N=3424;3424;-1
S0140-6736(14)61060-6;N=6848;6848;-1
S0140-6736(14)61060-6;total of 5;5;-1
S0140-6736(14)61061-8;7000 patients;7000;-1
S0140-6736(14)61061-8;101 330 matched patients;101330;-1
S0140-6736(14)61061-8;283 patients;283;-1
S0140-6736(14)61061-8;296 patients;296;-1
S0140-6736(14)61061-8;8 additional people;8;-1
S0140-6736(14)61061-8;4 Infected individuals;4;-1
S0140-6736(14)61062-X;6 million fewer individuals;6;-1
S0140-6736(14)61063-1;100 000 people;100000;-1
S0140-6736(14)61066-7;44 million people;44;-1
S0140-6736(14)61090-4;653 adult patients;653;-1
S0140-6736(14)61090-4;2 664 patients;2664;-1
S0140-6736(14)61090-4;333 patients;333;-1
S0140-6736(14)61090-4;238 patients;238;-1
S0140-6736(14)61092-8;600 million people;600;-1
S0140-6736(14)61092-8;500 million people;500;-1
S0140-6736(14)61095-3;852 participants;852;-1
S0140-6736(14)61095-3;426 participants;426;-1
S0140-6736(14)61095-3;164 participants;164;-1
S0140-6736(14)61095-3;171 participants;171;-1
S0140-6736(14)61095-3;43 participants;43;-1
S0140-6736(14)61095-3;852 patients;852;-1
S0140-6736(14)61095-3;800 patients;800;-1
S0140-6736(14)61095-3;829 patients;829;-1
S0140-6736(14)61095-3;n=426;426;-1
S0140-6736(14)61097-7;599 patients;599;-1
S0140-6736(14)61097-7;11 and patients;11;-1
S0140-6736(14)61098-9;1257 patients;1257;-1
S0140-6736(14)61098-9;331 patients;331;-1
S0140-6736(14)61098-9;2 diabetic patients;2;-1
S0140-6736(14)61100-4;42 million American adults;42;-1
S0140-6736(14)61101-6;42 million American adults;42;-1
S0140-6736(14)61102-8;4   patients;4;-1
S0140-6736(14)61103-X;4   patients;4;-1
S0140-6736(14)61106-5;60 participants;60;-1
S0140-6736(14)61107-7;60 participants;60;-1
S0140-6736(14)61108-9;60 participants;60;-1
S0140-6736(14)61108-9;20 individuals;20;-1
S0140-6736(14)61109-0;2143 patients;2143;-1
S0140-6736(14)61109-0;3 a substantial number of   patients;3;-1
S0140-6736(14)61109-0;114 intention-to-treat   patients;114;-1
S0140-6736(14)61109-0;20 individuals;20;-1
S0140-6736(14)61116-8;600 000 people;600000;-1
S0140-6736(14)61119-3;150 000 people;150000;-1
S0140-6736(14)61123-5;170 000 participants;170000;-1
S0140-6736(14)61123-5;9795 people;9795;-1
S0140-6736(14)61123-5; data from   170 000;170000;-1
S0140-6736(14)61124-7;74 patients;74;-1
S0140-6736(14)61124-7;8 million people;8;-1
S0140-6736(14)61126-0;100 people;100;-1
S0140-6736(14)61126-0;8 million   people;8;-1
S0140-6736(14)61127-2;100 people;100;-1
S0140-6736(14)61127-2;8 million   people;8;-1
S0140-6736(14)61128-4;7 For patients;7;-1
S0140-6736(14)61128-4;1183 patients;1183;-1
S0140-6736(14)61128-4;90 000 people;90000;-1
S0140-6736(14)61130-2;10 million women;10;-1
S0140-6736(14)61130-2;34 million women;34;-1
S0140-6736(14)61130-2;3 billion people;3;-1
S0140-6736(14)61130-2;510 million people;510;-1
S0140-6736(14)61135-1;n=2531;2531;-1
S0140-6736(14)61135-1;n=1 013 363;1013363;-1
S0140-6736(14)61135-1;n=10 202;10202;-1
S0140-6736(14)61135-1;n=5642;5642;-1
S0140-6736(14)61135-1;n=5;5;-1
S0140-6736(14)61135-1;n=1 029 207;1029207;-1
S0140-6736(14)61135-1;n=970 725;970725;-1
S0140-6736(14)61135-1;n=58 482;58482;-1
S0140-6736(14)61135-1; data from 1995;1995;-1
S0140-6736(14)61140-5;173 patients;173;-1
S0140-6736(14)61140-5;7 Although patients;7;-1
S0140-6736(14)61140-5;n=31;31;-1
S0140-6736(14)61154-5;5000 patients;5000;-1
S0140-6736(14)61155-7;5000 patients;5000;-1
S0140-6736(14)61160-0;120 000 individuals;120000;-1
S0140-6736(14)61160-0;100 million individuals;100;-1
S0140-6736(14)61161-2;260 000 people;260000;-1
S0140-6736(14)61161-2;120 000 individuals;120000;-1
S0140-6736(14)61161-2;100 million individuals;100;-1
S0140-6736(14)61162-4;260 000 people;260000;-1
S0140-6736(14)61170-3;206 participants;206;-1
S0140-6736(14)61170-3;143 study participants;143;-1
S0140-6736(14)61170-3;805 patients;805;-1
S0140-6736(14)61170-3;940 patients;940;-1
S0140-6736(14)61170-3;400 assessable   patients;400;-1
S0140-6736(14)61170-3;61 patients;61;-1
S0140-6736(14)61170-3;11 patients;11;-1
S0140-6736(14)61170-3;14 patients;14;-1
S0140-6736(14)61170-3;52  Total number of patients;52;-1
S0140-6736(14)61170-3;15  PDVF patients;15;-1
S0140-6736(14)61170-3;9  No PDVF patients;9;-1
S0140-6736(14)61170-3;401 patients;401;-1
S0140-6736(14)61170-3;250 patients;250;-1
S0140-6736(14)61170-3;n=401;401;-1
S0140-6736(14)61170-3;n=404;404;-1
S0140-6736(14)61170-3;n=378;378;-1
S0140-6736(14)61170-3;n=389;389;-1
S0140-6736(14)61170-3;n=4;4;-1
S0140-6736(14)61170-3;n=3;3;-1
S0140-6736(14)61170-3;n=46;46;-1
S0140-6736(14)61170-3;n=484;484;-1
S0140-6736(14)61170-3;n=77;77;-1
S0140-6736(14)61170-3;n=198;198;-1
S0140-6736(14)61170-3;805 patients enrolled;805;-1
S0140-6736(14)61170-3;805 enrolled;805;-1
S0140-6736(14)61172-7;24 million persons;24;-1
S0140-6736(14)61172-7;580,000 subjects;580000;-1
S0140-6736(14)61172-7;166 000 people;166000;-1
S0140-6736(14)61172-7;24 million individuals;24;-1
S0140-6736(14)61172-7;24 million UK adults;24;-1
S0140-6736(14)61173-9;16 211 patients;16211;-1
S0140-6736(14)61173-9;1218 infants enrolled;1218;-1
S0140-6736(14)61174-0;292 women;292;-1
S0140-6736(14)61174-0;31 patients;31;-1
S0140-6736(14)61174-0;68 patients;68;-1
S0140-6736(14)61174-0;153 patients;153;-1
S0140-6736(14)61174-0;44 patients;44;-1
S0140-6736(14)61174-0;n=426;426;-1
S0140-6736(14)61175-2;3000 patients;3000;-1
S0140-6736(14)61176-4;716 patients;716;-1
S0140-6736(14)61176-4;333 patients;333;-1
S0140-6736(14)61176-4;27 patients;27;-1
S0140-6736(14)61176-4;10 Consenting patients;10;-1
S0140-6736(14)61176-4;620 patients;620;-1
S0140-6736(14)61176-4;720 patients;720;-1
S0140-6736(14)61176-4;664 patients;664;-1
S0140-6736(14)61176-4;238 patients;238;-1
S0140-6736(14)61176-4;29 patients;29;-1
S0140-6736(14)61176-4;35 patients;35;-1
S0140-6736(14)61176-4;143 patients;143;-1
S0140-6736(14)61176-4;131 patients;131;-1
S0140-6736(14)61176-4;190 patients;190;-1
S0140-6736(14)61176-4;15 patients;15;-1
S0140-6736(14)61176-4;280 patients;280;-1
S0140-6736(14)61176-4;63 patients;63;-1
S0140-6736(14)61176-4;18 patients;18;-1
S0140-6736(14)61176-4;10 272 patients;10272;-1
S0140-6736(14)61176-4;2710 patients;2710;-1
S0140-6736(14)61176-4;1570 patients;1570;-1
S0140-6736(14)61176-4;8323 patients;8323;-1
S0140-6736(14)61176-4;30 Both studies enrolled   patients;30;-1
S0140-6736(14)61176-4;710 patients;710;-1
S0140-6736(14)61176-4;n=333;333;-1
S0140-6736(14)61176-4;n=331;331;-1
S0140-6736(14)61176-4;n=908;908;-1
S0140-6736(14)61176-4;n=431;431;-1
S0140-6736(14)61176-4;716 patients enrolled;716;-1
S0140-6736(14)61176-4;716 patients were   enrolled;716;-1
S0140-6736(14)61176-4;30 Both studies enrolled;30;-1
S0140-6736(14)61178-8;7579 people;7579;-1
S0140-6736(14)61181-8;4 T cells of persons;4;-1
S0140-6736(14)61181-8;12 patients;12;-1
S0140-6736(14)61185-5;25 participants;25;17528
S0140-6736(14)61185-5;89 participants;89;9076
S0140-6736(14)61185-5;n=5;5;17421
S0140-6736(14)61185-5;n=10;10;17408
S0140-6736(14)61185-5;n=25;25;9895
S0140-6736(14)61185-5;25 participants were enrolled;25;17528
S0140-6736(14)61185-5;25 enrolled;25;9034
S0140-6736(14)61194-6;8 million people;8;-1
S0140-6736(14)61194-6;200 000 people;200000;-1
S0140-6736(14)61195-8;8 million people;8;-1
S0140-6736(14)61195-8;200 000 people;200000;-1
S0140-6736(14)61201-0;37 male patients;37;-1
S0140-6736(14)61203-4;1 Partners   of these women;1;-1
S0140-6736(14)61204-6;1 Partners   of these women;1;-1
S0140-6736(14)61212-5;1000 patients;1000;-1
S0140-6736(14)61212-5;51 917 patients;51917;-1
S0140-6736(14)61212-5;50 000 patients;50000;-1
S0140-6736(14)61212-5;2 diabetic patients;2;-1
S0140-6736(14)61212-5;14 224 people;14224;-1
S0140-6736(14)61212-5;67 475 individuals;67475;-1
S0140-6736(14)61212-5;14 633 individuals;14633;-1
S0140-6736(14)61212-5;6105 individuals;6105;-1
S0140-6736(14)61212-5;n=691;691;-1
S0140-6736(14)61212-5;n=991;991;-1
S0140-6736(14)61212-5;n=51 917;51917;-1
S0140-6736(14)61212-5;n=25 480;25480;-1
S0140-6736(14)61212-5;n=12 544;12544;-1
S0140-6736(14)61212-5;n=8287;8287;-1
S0140-6736(14)61212-5;n=5606;5606;-1
S0140-6736(14)61212-5;n=52 035;52035;-1
S0140-6736(14)61212-5;n=48 198;48198;-1
S0140-6736(14)61212-5; data from   27;27;-1
S0140-6736(14)61216-2;33 958 patients;33958;-1
S0140-6736(14)61216-2;27 and seven enrolled patients;27;-1
S0140-6736(14)61216-2;2422 patients;2422;-1
S0140-6736(14)61216-2;1406 patients;1406;-1
S0140-6736(14)61216-2;31 748 patients;31748;-1
S0140-6736(14)61216-2;n=4;4;-1
S0140-6736(14)61216-2;n=3;3;-1
S0140-6736(14)61216-2;total of   33 958;33958;-1
S0140-6736(14)61216-2;27 and seven enrolled;27;-1
S0140-6736(14)61216-2; data from 16;16;-1
S0140-6736(14)61225-3;1 represent a large group   of patients;1;-1
S0140-6736(14)61225-3;11 patients;11;-1
S0140-6736(14)61225-3;645 patients;645;-1
S0140-6736(14)61225-3;205 treatment-naive   patients;205;-1
S0140-6736(14)61225-3;235 patients;235;-1
S0140-6736(14)61225-3;75 patients;75;-1
S0140-6736(14)61225-3;167 patients;167;-1
S0140-6736(14)61225-3;28 patients;28;-1
S0140-6736(14)61225-3;80 patients;80;-1
S0140-6736(14)61225-3;20 non-cirrhotic patients;20;-1
S0140-6736(14)61225-3;1 patients;1;-1
S0140-6736(14)61225-3;180 million individuals;180;-1
S0140-6736(14)61226-5;29 patients;29;-1
S0140-6736(14)61226-5;1   positive individuals;1;-1
S0140-6736(14)61226-5;805 antiretroviral-naive adults;805;-1
S0140-6736(14)61226-5;1 infected adults;1;-1
S0140-6736(14)61230-7;4348 participants;4348;-1
S0140-6736(14)61230-7;2881 patients;2881;-1
S0140-6736(14)61230-7;2871 patients;2871;-1
S0140-6736(14)61230-7;24 patients;24;-1
S0140-6736(14)61230-7;n=2881;2881;-1
S0140-6736(14)61230-7;n=2871;2871;-1
S0140-6736(14)61231-9;500 participants;500;-1
S0140-6736(14)61231-9;231 participants;231;-1
S0140-6736(14)61231-9;250 participants;250;-1
S0140-6736(14)61231-9;217 participants;217;-1
S0140-6736(14)61231-9;1428 patients;1428;-1
S0140-6736(14)61231-9;500 patients;500;-1
S0140-6736(14)61231-9;28   and monitor patients;28;-1
S0140-6736(14)61231-9;483 patients;483;-1
S0140-6736(14)61231-9;500 people;500;-1
S0140-6736(14)61231-9;4 million   people;4;-1
S0140-6736(14)61231-9;23  We enrolled adults;23;-1
S0140-6736(14)61231-9;n=253;253;-1
S0140-6736(14)61231-9;n=247;247;-1
S0140-6736(14)61231-9;n=249;249;-1
S0140-6736(14)61231-9;n=244;244;-1
S0140-6736(14)61231-9;n=252;252;-1
S0140-6736(14)61231-9;n=246;246;-1
S0140-6736(14)61231-9;n=251;251;-1
S0140-6736(14)61231-9;n=231;231;-1
S0140-6736(14)61231-9;n=217;217;-1
S0140-6736(14)61231-9;n=218;218;-1
S0140-6736(14)61231-9;n=228;228;-1
S0140-6736(14)61231-9;n=227;227;-1
S0140-6736(14)61231-9;500 participants were enrolled;500;-1
S0140-6736(14)61231-9;23  We enrolled;23;-1
S0140-6736(14)61231-9; data, ranging from 217;217;-1
S0140-6736(14)61231-9; data from 462;462;-1
S0140-6736(14)61234-4;3 For   non-STEMI patients;3;-1
S0140-6736(14)61234-4;150 000 people;150000;-1
S0140-6736(14)61235-6;3 For   non-STEMI patients;3;-1
S0140-6736(14)61236-8;3 For   non-STEMI patients;3;-1
S0140-6736(14)61236-8;2 These missing patients;2;-1
S0140-6736(14)61237-X;2 These missing patients;2;-1
S0140-6736(14)61238-1;9   million women;9;-1
S0140-6736(14)61238-1;2 These missing patients;2;-1
S0140-6736(14)61238-1;25 million people;25;-1
S0140-6736(14)61239-3;9   million women;9;-1
S0140-6736(14)61239-3;25 million people;25;-1
S0140-6736(14)61239-3;3 billion people;3;-1
S0140-6736(14)61239-3;510 million people;510;-1
S0140-6736(14)61240-X;10 million women;10;-1
S0140-6736(14)61240-X;34 million women;34;-1
S0140-6736(14)61256-3;3 million people;3;-1
S0140-6736(14)61256-3;9 million people;9;-1
S0140-6736(14)61271-X;74 patients;74;-1
S0140-6736(14)61272-1;17 final participants;17;-1
S0140-6736(14)61273-3;17 final participants;17;-1
S0140-6736(14)61287-3;4000 pregnant women;4000;-1
S0140-6736(14)61289-7;2 billion people;2;-1
S0140-6736(14)61290-3;25 participants;25;-1
S0140-6736(14)61290-3;n=5;5;-1
S0140-6736(14)61290-3;n=10;10;-1
S0140-6736(14)61291-5;51 917 participants;51917;-1
S0140-6736(14)61291-5;2 664 patients;2664;-1
S0140-6736(14)61291-5;333 patients;333;-1
S0140-6736(14)61291-5;238 patients;238;-1
S0140-6736(14)61291-5;1650 patients;1650;-1
S0140-6736(14)61291-5;1000 patients;1000;-1
S0140-6736(14)61297-6;181 Palestinian women;181;-1
S0140-6736(14)61297-6;1160 women;1160;-1
S0140-6736(14)61297-6;8 million people;8;-1
S0140-6736(14)61301-5;166 women;166;-1
S0140-6736(14)61301-5;60 elderly   people;60;-1
S0140-6736(14)61302-7;166 women;166;-1
S0140-6736(14)61302-7;60 elderly   people;60;-1
S0140-6736(14)61303-9;166 women;166;-1
S0140-6736(14)61303-9;60 elderly   people;60;-1
S0140-6736(14)61304-0;166 women;166;-1
S0140-6736(14)61304-0;60 elderly   people;60;-1
S0140-6736(14)61316-7;100 000 people;100000;-1
S0140-6736(14)61317-9;112 842 Chinese patients;112842;-1
S0140-6736(14)61319-2;100 patients;100;-1
S0140-6736(14)61319-2;5 million people;5;-1
S0140-6736(14)61319-2;1603 people;1603;-1
S0140-6736(14)61320-9;100 patients;100;-1
S0140-6736(14)61320-9;5 million people;5;-1
S0140-6736(14)61320-9;1603 people;1603;-1
S0140-6736(14)61321-0;900 patients;900;-1
S0140-6736(14)61321-0;445 patients;445;-1
S0140-6736(14)61321-0;449 patients;449;-1
S0140-6736(14)61328-3;41 behaviourally   unresponsive patients;41;-1
S0140-6736(14)61329-5;41 behaviourally   unresponsive patients;41;-1
S0140-6736(14)61332-5;170 000 participants;170000;-1
S0140-6736(14)61332-5;4444 patients;4444;-1
S0140-6736(14)61332-5;9795 people;9795;-1
S0140-6736(14)61332-5; data from   170 000;170000;-1
S0140-6736(14)61333-7;34 000 patients;34000;-1
S0140-6736(14)61333-7;n=4;4;-1
S0140-6736(14)61333-7;n=3;3;-1
S0140-6736(14)61333-7;n=9;9;-1
S0140-6736(14)61333-7;n=5;5;-1
S0140-6736(14)61333-7; data from 27;27;-1
S0140-6736(14)61334-9;51 917 participants;51917;-1
S0140-6736(14)61334-9;1000 patients;1000;-1
S0140-6736(14)61334-9; data from 27;27;-1
S0140-6736(14)61335-0;4348 participants;4348;-1
S0140-6736(14)61335-0;1136 participants;1136;-1
S0140-6736(14)61335-0;3356 participants;3356;-1
S0140-6736(14)61335-0;28 three trials compared   patients;28;-1
S0140-6736(14)61335-0;N=4348;4348;-1
S0140-6736(14)61335-0;N=3356;3356;-1
S0140-6736(14)61335-0;N=3941;3941;-1
S0140-6736(14)61342-8;142 participants;142;-1
S0140-6736(14)61342-8;500 patients;500;-1
S0140-6736(14)61342-8;173 patients;173;-1
S0140-6736(14)61342-8;2 Walker and colleagues recruited;2;-1
S0140-6736(14)61345-3;20 000 people;20000;-1
S0140-6736(14)61345-3;11 million people;11;-1
S0140-6736(14)61350-7;8 million patients;8;-1
S0140-6736(14)61350-7;650 million people;650;-1
S0140-6736(14)61351-9;8 million patients;8;-1
S0140-6736(14)61351-9;650 million people;650;-1
S0140-6736(14)61354-4;13 000 people;13000;-1
S0140-6736(14)61367-2;33 patients;33;-1
S0140-6736(14)61367-2;251 patients;251;-1
S0140-6736(14)61367-2;1200 adults;1200;-1
S0140-6736(14)61367-2;1329 adults;1329;-1
S0140-6736(14)61373-8;18 254 patients;18254;-1
S0140-6736(14)61373-8;18 000 patients;18000;-1
S0140-6736(14)61373-8;300 patients;300;-1
S0140-6736(14)61373-8;844 patients;844;-1
S0140-6736(14)61373-8;13 946 individual patients;13946;-1
S0140-6736(14)61373-8;13 084 patients;13084;-1
S0140-6736(14)61373-8;76 patients;76;-1
S0140-6736(14)61373-8;6722 patients;6722;-1
S0140-6736(14)61373-8;27 recruited patients;27;-1
S0140-6736(14)61373-8;27 recruited;27;-1
S0140-6736(14)61373-8;n=13 946;13946;-1
S0140-6736(14)61373-8;n=3066;3066;-1
S0140-6736(14)61373-8;n=2237;2237;-1
S0140-6736(14)61373-8;n=633;633;-1
S0140-6736(14)61373-8;n=13 645;13645;-1
S0140-6736(14)61373-8;n=3002;3002;-1
S0140-6736(14)61373-8;n=0;0;-1
S0140-6736(14)61378-7;6756 patients;6756;-1
S0140-6736(14)61378-7; data from 6756;6756;-1
S0140-6736(14)61379-9;6756 patients;6756;-1
S0140-6736(14)61379-9; data from 6756;6756;-1
S0140-6736(14)61385-4;500 participants;500;-1
S0140-6736(14)61385-4;14 patients;14;-1
S0140-6736(14)61386-6;14 patients;14;-1
S0140-6736(14)61386-6;6912 patients;6912;-1
S0140-6736(14)61386-6;3483 patients;3483;-1
S0140-6736(14)61386-6;3977 patients;3977;-1
S0140-6736(14)61386-6;7012 patients;7012;-1
S0140-6736(14)61386-6;10 187 patients;10187;-1
S0140-6736(14)61386-6;4153 patients;4153;-1
S0140-6736(14)61386-6;276 patients;276;-1
S0140-6736(14)61386-6;2759 patients;2759;-1
S0140-6736(14)61387-8;6912 patients;6912;-1
S0140-6736(14)61387-8;3483 patients;3483;-1
S0140-6736(14)61387-8;3977 patients;3977;-1
S0140-6736(14)61387-8;7012 patients;7012;-1
S0140-6736(14)61387-8;10 187 patients;10187;-1
S0140-6736(14)61387-8;4153 patients;4153;-1
S0140-6736(14)61387-8;276 patients;276;-1
S0140-6736(14)61387-8;2759 patients;2759;-1
S0140-6736(14)61387-8;90 more   patients;90;-1
S0140-6736(14)61387-8;1000 patients;1000;-1
S0140-6736(14)61388-X;90 more   patients;90;-1
S0140-6736(14)61388-X;1000 patients;1000;-1
S0140-6736(14)61388-X;total of 76 621;76621;-1
S0140-6736(14)61389-1;total of 76 621;76621;-1
S0140-6736(14)61395-7;508 patients;508;-1
S0140-6736(14)61395-7;508 randomised   patients;508;-1
S0140-6736(14)61395-7;82 patients;82;-1
S0140-6736(14)61395-7;500 patients;500;-1
S0140-6736(14)61395-7;8  Indigenous Australian people;8;-1
S0140-6736(14)61395-7;20 000 people;20000;-1
S0140-6736(14)61409-4;4348 participants;4348;-1
S0140-6736(14)61409-4;24 patients;24;-1
S0140-6736(14)61409-4;2 diabetes patients;2;-1
S0140-6736(14)61409-4;18 254 patients;18254;-1
S0140-6736(14)61409-4;18 254 patients enrolled;18254;-1
S0140-6736(14)61409-4; data from   18 254;18254;-1
S0140-6736(14)61410-0;20 patients;20;-1
S0140-6736(14)61410-0;20 individuals;20;-1
S0140-6736(14)61410-0;total of 20;20;-1
S0140-6736(14)61410-0;20 patients will be enrolled;20;-1
S0140-6736(14)61412-4;508 randomised   patients;508;-1
S0140-6736(14)61412-4;82 patients;82;-1
S0140-6736(14)61412-4;500 patients;500;-1
S0140-6736(14)61412-4;20 000 people;20000;-1
S0140-6736(14)61413-6;140,000   observations in men and women;140000;-1
S0140-6736(14)61415-X;2129 patients;2129;-1
S0140-6736(14)61415-X;250 000 patients;250000;-1
S0140-6736(14)61415-X;n=6439;6439;-1
S0140-6736(14)61415-X;250 000 patients were enrolled;250000;-1
S0140-6736(14)61416-1;4000 pregnant women;4000;-1
S0140-6736(14)61419-7;4 For   women;4;-1
S0140-6736(14)61419-7;51 million patients;51;-1
S0140-6736(14)61419-7;2 In patients;2;-1
S0140-6736(14)61419-7;1 billion people;1;-1
S0140-6736(14)61419-7;100 million people;100;-1
S0140-6736(14)61419-7;total of 51;51;-1
S0140-6736(14)61421-5;6000 patients;6000;-1
S0140-6736(14)61422-7;6000 patients;6000;-1
S0140-6736(14)61432-X;5388 patients;5388;-1
S0140-6736(14)61433-1;5388 patients;5388;-1
S0140-6736(14)61433-1;100 patients;100;-1
S0140-6736(14)61434-3;100 patients;100;-1
S0140-6736(14)61435-5;100 patients;100;-1
S0140-6736(14)61437-9;39 patients;39;-1
S0140-6736(14)61437-9;100 outpatients;100;-1
S0140-6736(14)61437-9; data from 316;316;-1
S0140-6736(14)61438-0;39 patients;39;-1
S0140-6736(14)61438-0;100 outpatients;100;-1
S0140-6736(14)61438-0; data from 316;316;-1
S0140-6736(14)61475-6;35 000 indigenous Inuit people;35000;-1
S0140-6736(14)61480-X;422 730 patients;422730;-1
S0140-6736(14)61481-1;422 730 patients;422730;-1
S0140-6736(14)61482-3;422 730 patients;422730;-1
S0140-6736(14)61490-2;13 108 women;13108;-1
S0140-6736(14)61490-2;13  We scanned women;13;-1
S0140-6736(14)61490-2;4000 women;4000;-1
S0140-6736(14)61490-2;500 pregnant women;500;-1
S0140-6736(14)61490-2;13 108 pregnant women;13108;-1
S0140-6736(14)61490-2;3976 women;3976;-1
S0140-6736(14)61490-2;4500 women;4500;-1
S0140-6736(14)61490-2;4607 women;4607;-1
S0140-6736(14)61490-2;8501 women;8501;-1
S0140-6736(14)61490-2;10  Methods  Study design and participants;10;-1
S0140-6736(14)61490-2;8501 ineligible patients;8501;-1
S0140-6736(14)61490-2;n=4321;4321;-1
S0140-6736(14)61490-2;4607 women enrolled;4607;-1
S0140-6736(14)61603-2;26 of south Asian women;26;-1
S0140-6736(14)61603-2;125 million women;125;-1
S0140-6736(14)61603-2;80 patients;80;-1
S0140-6736(14)61603-2;89  only a third of patients;89;-1
S0140-6736(14)61603-2;138 If you leave people;138;-1
S0140-6736(14)61603-2;50 000 adults;50000;-1
S0140-6736(14)61625-1;155 million working-age   adults;155;-1
S0140-6736(14)61626-3;155 million working-age   adults;155;-1
S0140-6736(14)61627-5;155 million working-age   adults;155;-1
S0140-6736(14)61652-4;1000 people;1000;-1
S0140-6736(14)61657-3;42 000 younger people;42000;-1
S0140-6736(14)61657-3;670 000 unpaid carers of people;670000;-1
S0140-6736(14)61657-3;816 000 individuals;816000;-1
S0140-6736(14)61658-5;42 000 younger people;42000;-1
S0140-6736(14)61658-5;670 000 unpaid carers of people;670000;-1
S0140-6736(14)61658-5;816 000 individuals;816000;-1
S0140-6736(14)61672-X;342 patients;342;-1
S0140-6736(14)61672-X;1000 patients;1000;-1
S0140-6736(14)61672-X;2   diabetic patients;2;-1
S0140-6736(14)61672-X;3040 randomly assigned patients;3040;-1
S0140-6736(14)61673-1;342 patients;342;-1
S0140-6736(14)61673-1;1000 patients;1000;-1
S0140-6736(14)61673-1;2   diabetic patients;2;-1
S0140-6736(14)61673-1;3040 randomly assigned patients;3040;-1
S0140-6736(14)61673-1;12 900 people;12900;-1
S0140-6736(14)61673-1; data from the 10;10;-1
S0140-6736(14)61674-3;12 900 people;12900;-1
S0140-6736(14)61674-3; data from the 10;10;-1
S0140-6736(14)61693-7;50 patients;50;-1
S0140-6736(14)61694-9;1257 patients;1257;-1
S0140-6736(14)61696-2;8 additional people;8;-1
S0140-6736(14)61696-2;4 Infected individuals;4;-1
S0140-6736(14)61708-6;22 million   people;22;-1
S0140-6736(14)61709-8;22 million   people;22;-1
S0140-6736(14)61717-7;3 Of patients;3;-1
S0140-6736(14)61718-9;3 Of patients;3;-1
S0140-6736(14)61721-9;142 patients;142;-1
S0140-6736(14)61722-0;142 patients;142;-1
S0140-6736(14)61732-3;300 000 people;300000;-1
S0140-6736(14)61732-3;30 000 people;30000;-1
S0140-6736(14)61732-3;1 billion   people;1;-1
S0140-6736(14)61738-4;80 people;80;-1
S0140-6736(14)61738-4;60 people;60;-1
S0140-6736(14)61757-8;2000 people;2000;-1
S0140-6736(14)61761-X;4452 patients;4452;-1
S0140-6736(14)61761-X;3675 patients;3675;-1
S0140-6736(14)61761-X;3564 patients;3564;-1
S0140-6736(14)61761-X;4394 adults;4394;-1
S0140-6736(14)61761-X;n=15;15;-1
S0140-6736(14)61761-X;n=3;3;-1
S0140-6736(14)61761-X;n=12;12;-1
S0140-6736(14)61762-1;4452 patients;4452;-1
S0140-6736(14)61762-1;3675 patients;3675;-1
S0140-6736(14)61762-1;3564 patients;3564;-1
S0140-6736(14)61762-1;4394 adults;4394;-1
S0140-6736(14)61762-1;n=15;15;-1
S0140-6736(14)61762-1;n=3;3;-1
S0140-6736(14)61762-1;n=12;12;-1
S0140-6736(14)61762-1;n=29 234;29234;-1
S0140-6736(14)61763-3;n=29 234;29234;-1
S0140-6736(14)61764-5;n=29 234;29234;-1
S0140-6736(14)61765-7;3302 patients;3302;-1
S0140-6736(14)61765-7;3293 patients;3293;-1
S0140-6736(14)61765-7;97 patients;97;-1
S0140-6736(14)61815-8;50 patients;50;-1
S0140-6736(14)61838-9;6378 participants;6378;-1
S0140-6736(14)61838-9;18  A third of patients;18;-1
S0140-6736(14)61838-9;33 of patients;33;-1
S0140-6736(14)61838-9;100 critical care units admit patients;100;-1
S0140-6736(14)61838-9;3300 patients;3300;-1
S0140-6736(14)61838-9;831 patients;831;-1
S0140-6736(14)61838-9;2 Triage of patients;2;-1
S0140-6736(14)61838-9;3 Referral of patients;3;-1
S0140-6736(14)61838-9;404 patients;404;-1
S0140-6736(14)61838-9;102 of patients;102;-1
S0140-6736(14)61838-9;28 000 patients;28000;-1
S0140-6736(14)61838-9;23 targeting patients;23;-1
S0140-6736(14)61838-9;2533 patients;2533;-1
S0140-6736(14)61838-9;12 368 patients;12368;-1
S0140-6736(14)61838-9;920 patients;920;-1
S0140-6736(14)61838-9;400 patients;400;-1
S0140-6736(14)61838-9;7000 patients;7000;-1
S0140-6736(14)61838-9;59 995 for   patients;59995;-1
S0140-6736(14)61838-9;600 000 people;600000;-1
S0140-6736(14)61838-9;60 000 people;60000;-1
S0140-6736(14)61838-9;5000 people;5000;-1
S0140-6736(14)61838-9;2 million people;2;-1
S0140-6736(14)61838-9;15 278 people;15278;-1
S0140-6736(14)61838-9;98 160 000 people;98160000;-1
S0140-6736(14)61838-9;200 000 people;200000;-1
S0140-6736(14)61838-9;1000 people;1000;-1
S0140-6736(14)61838-9;7000 new people;7000;-1
S0140-6736(14)61838-9;95 000 people;95000;-1
S0140-6736(14)61838-9;12 people;12;-1
S0140-6736(14)61838-9;34 347 people;34347;-1
S0140-6736(14)61838-9;26 million people;26;-1
S0140-6736(14)61838-9;35 million people;35;-1
S0140-6736(14)61838-9;5 million people;5;-1
S0140-6736(14)61838-9;77 Of individuals;77;-1
S0140-6736(14)61838-9;24 million UK adults;24;-1
S0140-6736(14)61839-0;1   placing patients;1;-1
S0140-6736(14)61839-0;9 million people;9;-1
S0140-6736(14)61839-0;36 people;36;-1
S0140-6736(14)61839-0;260 000 people;260000;-1
S0140-6736(14)61853-5;190 000 people;190000;-1
S0140-6736(14)61853-5;4 million people;4;-1
S0140-6736(14)61857-2;410 patients;410;-1
S0140-6736(14)61857-2;856 patients;856;-1
S0140-6736(14)61857-2;1185 patients;1185;-1
S0140-6736(14)61857-2;3 856 patients;3856;-1
S0140-6736(14)61857-2;5   To defi ne a subset of patients;5;-1
S0140-6736(14)61857-2;3 856 patients were recruited;3856;-1
S0140-6736(14)61858-4;410 patients;410;-1
S0140-6736(14)61858-4;856 patients;856;-1
S0140-6736(14)61858-4;1185 patients;1185;-1
S0140-6736(14)61858-4;3 856 patients;3856;-1
S0140-6736(14)61858-4;5   To defi ne a subset of patients;5;-1
S0140-6736(14)61858-4;3 856 patients were recruited;3856;-1
S0140-6736(14)61860-2;2 million people;2;-1
S0140-6736(14)61861-4;2 million people;2;-1
S0140-6736(14)61862-6;234 233 Syrian   patients;234233;-1
S0140-6736(14)61862-6;280 Syrian   patients;280;-1
S0140-6736(14)61862-6;80 trauma   patients;80;-1
S0140-6736(14)61862-6;2 million people;2;-1
S0140-6736(14)61862-6;n=44;44;-1
S0140-6736(14)61863-8;234 233 Syrian   patients;234233;-1
S0140-6736(14)61863-8;280 Syrian   patients;280;-1
S0140-6736(14)61863-8;80 trauma   patients;80;-1
S0140-6736(14)61863-8;n=44;44;-1
S0140-6736(14)61865-1;1000 participants;1000;-1
S0140-6736(14)61888-2;230 HCM   patients;230;-1
S0140-6736(14)61888-2;22 patients;22;-1
S0140-6736(14)61888-2;126 control individuals;126;-1
S0140-6736(14)61896-1;51 million people;51;-1
S0140-6736(14)61896-1;7 million of these   people;7;-1
S0140-6736(14)61896-1;90 000 people;90000;-1
S0140-6736(14)61896-1;1 Some people;1;-1
S0140-6736(14)61899-7;400 participants;400;-1
S0140-6736(14)61914-0;1   placing patients;1;-1
S0140-6736(14)61914-0;9 million people;9;-1
S0140-6736(14)61914-0;36 people;36;-1
S0140-6736(14)61914-0;260 000 people;260000;-1
S0140-6736(14)61916-4;300 patients;300;-1
S0140-6736(14)61916-4; data from 2013;2013;-1
S0140-6736(14)61917-6;300 patients;300;-1
S0140-6736(14)61917-6; data from 2013;2013;-1
S0140-6736(14)61924-3;1 million   people;1;-1
S0140-6736(14)61925-5;1 million   people;1;-1
S0140-6736(14)61927-9;20 000 individuals;20000;-1
S0140-6736(14)61928-0;51 million people;51;-1
S0140-6736(14)61928-0;7 million of these   people;7;-1
S0140-6736(14)61938-3;5 million healthy individuals;5;-1
S0140-6736(14)61948-6;3 Giving patients;3;-1
S0140-6736(14)61970-X;1000 people;1000;-1
S0140-6736(14)61971-1;1000 people;1000;-1
S0140-6736(14)61976-0;20 million   people;20;-1
S0140-6736(14)61976-0;1000 people;1000;-1
S0140-6736(14)61977-2; data from   54;54;-1
S0140-6736(14)61978-4; data from   54;54;-1
S0140-6736(14)61979-6; data from   54;54;-1
S0140-6736(14)61980-2;1 such patients;1;-1
S0140-6736(14)61981-4;1 such patients;1;-1
S0140-6736(14)61982-6;1 such patients;1;-1
S0140-6736(14)61982-6;1503 patients;1503;-1
S0140-6736(14)61983-8;1503 patients;1503;-1
S0140-6736(14)61984-X;1503 patients;1503;-1
S0140-6736(14)62012-2;N=23;23;-1
S0140-6736(14)62012-2;N=24;24;-1
S0140-6736(14)62012-2;N=79;79;-1
S0140-6736(14)62012-2;N=80;80;-1
S0140-6736(14)62017-1;20 million people;20;-1
S0140-6736(14)62018-3;20 million people;20;-1
S0140-6736(14)62022-5;76 women;76;-1
S0140-6736(14)62029-8;441 patients;441;-1
S0140-6736(14)62029-8;445 patients;445;-1
S0140-6736(14)62029-8;265 patients;265;-1
S0140-6736(14)62030-4;441 patients;441;-1
S0140-6736(14)62030-4;445 patients;445;-1
S0140-6736(14)62030-4;265 patients;265;-1
S0140-6736(14)62030-4;3 659 patients;3659;-1
S0140-6736(14)62031-6;3 659 patients;3659;-1
S0140-6736(14)62036-5;12 some participants;12;-1
S0140-6736(14)62037-7;1   positive individuals;1;-1
S0140-6736(14)62037-7;1 infected adults;1;-1
S0140-6736(14)62045-6;5 million people;5;-1
S0140-6736(14)62045-6;6 million   people;6;-1
S0140-6736(14)62046-8;225 million women;225;-1
S0140-6736(14)62046-8;125 million women;125;-1
S0140-6736(14)62046-8;43 million   women;43;-1
S0140-6736(14)62046-8;21 million women;21;-1
S0140-6736(14)62054-7;805 million people;805;-1
S0140-6736(14)62054-7;2 billion   people;2;-1
S0140-6736(14)62055-9;400 million women;400;-1
S0140-6736(14)62056-0;400 million women;400;-1
S0140-6736(14)62063-8;5000 people;5000;-1
S0140-6736(14)62066-3;5 Can we ethically watch   patients;5;-1
S0140-6736(14)62068-7; data   from 11;11;-1
S0140-6736(14)62069-9; data   from 11;11;-1
S0140-6736(14)62070-5; data   from 11;11;-1
S0140-6736(14)62070-5; data from 27;27;-1
S0140-6736(14)62071-7;N=23;23;-1
S0140-6736(14)62071-7;N=24;24;-1
S0140-6736(14)62071-7;N=79;79;-1
S0140-6736(14)62071-7;N=80;80;-1
S0140-6736(14)62071-7; data from 27;27;-1
S0140-6736(14)62124-3;17 people;17;-1
S0140-6736(14)62126-7;1000 people;1000;-1
S0140-6736(14)62218-2;60 000 women;60000;-1
S0140-6736(14)62228-5;1 million people;1;-1
S0140-6736(14)62228-5;372 000 people;372000;-1
S0140-6736(14)62229-7;1 million people;1;-1
S0140-6736(14)62229-7;372 000 people;372000;-1
S0140-6736(14)62237-6;8135 women;8135;-1
S0140-6736(14)62237-6;100 000 women;100000;-1
S0140-6736(14)62237-6;1133 women;1133;-1
S0140-6736(14)62238-8;8135 women;8135;-1
S0140-6736(14)62238-8;100 000 women;100000;-1
S0140-6736(14)62238-8;1133 women;1133;-1
S0140-6736(14)62239-X;8135 women;8135;-1
S0140-6736(14)62239-X;1 patients;1;-1
S0140-6736(14)62240-6;8135 women;8135;-1
S0140-6736(14)62240-6;10 801 women;10801;-1
S0140-6736(14)62240-6;1 patients;1;-1
S0140-6736(14)62241-8;8135 women;8135;-1
S0140-6736(14)62241-8;10 801 women;10801;-1
S0140-6736(14)62242-X;8135 women;8135;-1
S0140-6736(14)62242-X;7000 patients;7000;-1
S0140-6736(14)62242-X;20 patients;20;-1
S0140-6736(14)62250-9;800 000 women;800000;-1
S0140-6736(14)62250-9;101 330 matched patients;101330;-1
S0140-6736(14)62250-9;5000 people;5000;-1
S0140-6736(14)62252-2;7521 participants;7521;-1
S0140-6736(14)62252-2;15 and   participants;15;-1
S0140-6736(14)62252-2;6756 patients;6756;-1
S0140-6736(14)62276-5;77 million people;77;-1
S0140-6736(14)62277-7;77 million people;77;-1
S0140-6736(14)62291-1;8 million people;8;-1
S0140-6736(14)62334-5;n=2;2;-1
S0140-6736(14)62334-5;n=1;1;-1
S0140-6736(14)62335-7;n=2;2;-1
S0140-6736(14)62335-7;n=1;1;-1
S0140-6736(14)62340-0;2 diabetes patients;2;-1
S0140-6736(14)62340-0;18 254 patients;18254;-1
S0140-6736(14)62340-0;3066 patients;3066;-1
S0140-6736(14)62340-0;17 people;17;-1
S0140-6736(14)62340-0;18 254 patients enrolled;18254;-1
S0140-6736(14)62340-0; data from   18 254;18254;-1
S0140-6736(14)62358-8;220 000 people;220000;-1
S0140-6736(14)62358-8;8 million people;8;-1
S0140-6736(14)62358-8;19 000 people;19000;-1
S0140-6736(14)62358-8;170 000 people;170000;-1
S0140-6736(14)62358-8;300 people;300;-1
S0140-6736(14)62362-X;6 million people;6;-1
S0140-6736(14)62364-3;800 000 women;800000;-1
S0140-6736(14)62364-3;5000 people;5000;-1
S0140-6736(14)62365-5;101 330 matched patients;101330;-1
S0140-6736(14)62370-9;800 transgender   patients;800;-1
S0140-6736(14)62371-0;800 transgender   patients;800;-1
S0140-6736(14)62372-2;6 million women;6;-1
S0140-6736(14)62372-2;800 transgender   patients;800;-1
S0140-6736(14)62373-4;6 million women;6;-1
S0140-6736(14)62412-0;300 million people;300;-1
S0140-6736(14)62420-X;3500 participants;3500;-1
S0140-6736(14)62420-X;10 000 people;10000;-1
S0140-6736(14)62424-7;5 mortality and women;5;-1
S0140-6736(14)62425-9;5 mortality and women;5;-1
S1470-2045(13)70397-8;541 patients;541;-1
S1470-2045(13)70397-8;67 patients;67;-1
S1470-2045(13)70402-9;364 Asian patients;364;-1
S1470-2045(13)70402-9;18 patients;18;-1
S1470-2045(13)70510-2;1513 patients;1513;-1
S1470-2045(13)70510-2;274 patients;274;-1
S1470-2045(13)70510-2;829 patients;829;-1
S1470-2045(13)70510-2;410 patients;410;-1
S1470-2045(13)70510-2;1024 patients;1024;-1
S1470-2045(13)70510-2;477 patients;477;-1
S1470-2045(13)70510-2;24 patients;24;-1
S1470-2045(13)70510-2;1322 patients;1322;-1
S1470-2045(13)70510-2;274 excluded patients;274;-1
S1470-2045(13)70510-2;1200 patients;1200;-1
S1470-2045(13)70510-2;1239 patients;1239;-1
S1470-2045(13)70510-2;531 patients;531;-1
S1470-2045(13)70510-2;177 patients;177;-1
S1470-2045(13)70510-2;97 patients;97;-1
S1470-2045(13)70510-2;806 patients;806;-1
S1470-2045(13)70510-2;433 patients;433;-1
S1470-2045(13)70510-2;0  Data are number of patients;0;-1
S1470-2045(13)70510-2;N=829;829;-1
S1470-2045(13)70510-2;N=410;410;-1
S1470-2045(13)70510-2;n=538;538;-1
S1470-2045(13)70510-2;n=291;291;-1
S1470-2045(13)70510-2;n=268;268;-1
S1470-2045(13)70510-2;n=142;142;-1
S1470-2045(13)70510-2;n=487;487;-1
S1470-2045(13)70510-2;n=752;752;-1
S1470-2045(13)70510-2;n=321;321;-1
S1470-2045(13)70510-2;n=475;475;-1
S1470-2045(13)70510-2;n=443;443;-1
S1470-2045(13)70510-2;n=396;396;-1
S1470-2045(13)70510-2;n=843;843;-1
S1470-2045(13)70510-2;n=806;806;-1
S1470-2045(13)70510-2;n=433;433;-1
S1470-2045(13)70510-2;N=806;806;-1
S1470-2045(13)70510-2;n=521;521;-1
S1470-2045(13)70510-2;n=285;285;-1
S1470-2045(13)70510-2;n=537;537;-1
S1470-2045(13)70510-2;n=269;269;-1
S1470-2045(13)70510-2;n=737;737;-1
S1470-2045(13)70510-2;n=67;67;-1
S1470-2045(13)70510-2;n=358;358;-1
S1470-2045(13)70510-2;n=442;442;-1
S1470-2045(13)70510-2;n=310;310;-1
S1470-2045(13)70510-2;n=496;496;-1
S1470-2045(13)70510-2;n=365;365;-1
S1470-2045(13)70510-2;n=131;131;-1
S1470-2045(13)70510-2;n=762;762;-1
S1470-2045(13)70510-2;n=44;44;-1
S1470-2045(13)70510-2;N=538;538;-1
S1470-2045(13)70510-2;N=268;268;-1
S1470-2045(13)70510-2;n=0;0;-1
S1470-2045(13)70510-2;N=291;291;-1
S1470-2045(13)70510-2;N=142;142;-1
S1470-2045(13)70510-2;N=433;433;-1
S1470-2045(13)70510-2;n=277;277;-1
S1470-2045(13)70510-2;n=156;156;-1
S1470-2045(13)70510-2;n=309;309;-1
S1470-2045(13)70510-2;n=124;124;-1
S1470-2045(13)70510-2;n=406;406;-1
S1470-2045(13)70510-2;n=27;27;-1
S1470-2045(13)70510-2;n=207;207;-1
S1470-2045(13)70510-2;n=224;224;-1
S1470-2045(13)70510-2;n=84;84;-1
S1470-2045(13)70510-2;n=402;402;-1
S1470-2045(13)70510-2;n=31;31;-1
S1470-2045(13)70510-2;N=409;409;-1
S1470-2045(13)70510-2;N=1024;1024;-1
S1470-2045(13)70510-2;N=477;477;-1
S1470-2045(13)70510-2;1513 patients were   enrolled;1513;-1
S1470-2045(13)70511-4;281 patients;281;-1
S1470-2045(13)70511-4;258 patients;258;-1
S1470-2045(13)70511-4;129 patients;129;-1
S1470-2045(13)70511-4;116 patients;116;-1
S1470-2045(13)70511-4;12 patients;12;-1
S1470-2045(13)70511-4;14 patients;14;-1
S1470-2045(13)70511-4;76 patients;76;-1
S1470-2045(13)70511-4;88 censored patients;88;-1
S1470-2045(13)70511-4;257 patients;257;-1
S1470-2045(13)70511-4;84 censored patients;84;-1
S1470-2045(13)70511-4;175 patients;175;-1
S1470-2045(13)70511-4;129 eligible patients;129;-1
S1470-2045(13)70511-4;128 patients;128;-1
S1470-2045(13)70511-4;0 129  Data were missing for some patients;129;-1
S1470-2045(13)70511-4;17 patients;17;-1
S1470-2045(13)70511-4;26 patients;26;-1
S1470-2045(13)70511-4;19 Optimum care of   patients;19;-1
S1470-2045(13)70511-4;n=129;129;-1
S1470-2045(13)70511-4;n=281;281;-1
S1470-2045(13)70511-4;281 patients were enrolled;281;-1
S1470-2045(13)70511-4;281 patients enrolled;281;-1
S1470-2045(13)70511-4;258 enrolled;258;-1
S1470-2045(13)70512-6;58 participants;58;-1
S1470-2045(13)70512-6;50 patients;50;-1
S1470-2045(13)70512-6;61 patients;61;-1
S1470-2045(13)70512-6;41 patients;41;-1
S1470-2045(13)70512-6;58 patients;58;-1
S1470-2045(13)70512-6;29 patients;29;-1
S1470-2045(13)70512-6;611 patients;611;-1
S1470-2045(13)70512-6;46 people;46;-1
S1470-2045(13)70512-6;n=15;15;-1
S1470-2045(13)70512-6;n=50;50;-1
S1470-2045(13)70512-6;n=14;14;-1
S1470-2045(13)70512-6;n=26;26;-1
S1470-2045(13)70512-6;n=13;13;-1
S1470-2045(13)70512-6;n=27;27;-1
S1470-2045(13)70512-6;n=20;20;-1
S1470-2045(13)70512-6;n=45;45;-1
S1470-2045(13)70512-6;n=6;6;-1
S1470-2045(13)70512-6;n=10;10;-1
S1470-2045(13)70512-6;n=22;22;-1
S1470-2045(13)70512-6;n=36;36;-1
S1470-2045(13)70512-6;n=58;58;-1
S1470-2045(13)70512-6;61 patients   were enrolled;61;-1
S1470-2045(13)70513-8;29 patients;29;-1
S1470-2045(13)70513-8;31 patients;31;-1
S1470-2045(13)70513-8;56 patients;56;-1
S1470-2045(13)70513-8;50 assessable patients;50;-1
S1470-2045(13)70513-8;21 All patients;21;-1
S1470-2045(13)70513-8;24 patients;24;-1
S1470-2045(13)70513-8;36 patients;36;-1
S1470-2045(13)70513-8;27 patients;27;-1
S1470-2045(13)70513-8;22 patients;22;-1
S1470-2045(13)70513-8;13 patients;13;-1
S1470-2045(13)70513-8;12 patients;12;-1
S1470-2045(13)70513-8;11 patients;11;-1
S1470-2045(13)70513-8;13 of these   patients;13;-1
S1470-2045(13)70513-8;20 patients;20;-1
S1470-2045(13)70513-8;23 patients;23;-1
S1470-2045(13)70513-8;142 patients;142;-1
S1470-2045(13)70513-8;N=31;31;-1
S1470-2045(13)70513-8;n=21;21;-1
S1470-2045(13)70513-8;n=4;4;-1
S1470-2045(13)70513-8;n=19;19;-1
S1470-2045(13)70513-8;n=20;20;-1
S1470-2045(13)70513-8;n=23;23;-1
S1470-2045(13)70513-8;n=22;22;-1
S1470-2045(13)70513-8;n=26;26;-1
S1470-2045(13)70513-8;n=16;16;-1
S1470-2045(13)70513-8;n=18;18;-1
S1470-2045(13)70513-8;n=25;25;-1
S1470-2045(13)70530-8;501 participants;501;-1
S1470-2045(13)70530-8;213 participants;213;-1
S1470-2045(13)70530-8;188 participants;188;-1
S1470-2045(13)70530-8;249 participants;249;-1
S1470-2045(13)70530-8;13  Eligible participants;13;-1
S1470-2045(13)70530-8;947 participants;947;-1
S1470-2045(13)70530-8;18 participants;18;-1
S1470-2045(13)70530-8;229 participants;229;-1
S1470-2045(13)70530-8;211 patients;211;-1
S1470-2045(13)70530-8;14 We excluded   patients;14;-1
S1470-2045(13)70530-8;16 patients;16;-1
S1470-2045(13)70530-8;213 patients;213;-1
S1470-2045(13)70530-8;188 patients;188;-1
S1470-2045(13)70530-8;202 patients;202;-1
S1470-2045(13)70530-8;187 patients;187;-1
S1470-2045(13)70530-8;150 patients;150;-1
S1470-2045(13)70530-8;117 patients;117;-1
S1470-2045(13)70530-8;109 patients;109;-1
S1470-2045(13)70530-8;160 imiquimod   treated patients;160;-1
S1470-2045(13)70530-8;166 surgery patients;166;-1
S1470-2045(13)70530-8;195 patients;195;-1
S1470-2045(13)70530-8;174 patients;174;-1
S1470-2045(13)70530-8;242 patients;242;-1
S1470-2045(13)70530-8;201 patients;201;-1
S1470-2045(13)70530-8;249 patients;249;-1
S1470-2045(13)70530-8;347 patients;347;-1
S1470-2045(13)70530-8;n=254;254;-1
S1470-2045(13)70530-8;n=247;247;-1
S1470-2045(13)70530-8;n=220;220;-1
S1470-2045(13)70530-8;n=249;249;-1
S1470-2045(13)70530-8;n=229;229;-1
S1470-2045(13)70530-8;total of   6;6;-1
S1470-2045(13)70546-1;40 Older English   women;40;-1
S1470-2045(13)70546-1;10 million   patients;10;-1
S1470-2045(13)70546-1;22 million records of patients;22;-1
S1470-2045(13)70546-1;10 million patients;10;-1
S1470-2045(13)70546-1;370 000 cancer patients;370000;-1
S1470-2045(13)70546-1;9 million adults;9;-1
S1470-2045(13)70546-1; data.  Eight of the 29;29;-1
S1470-2045(13)70546-1; data from 107;107;-1
S1470-2045(13)70546-1; data from   107;107;-1
S1470-2045(13)70546-1; data from 99;99;-1
S1470-2045(13)70549-7;35 women;35;-1
S1470-2045(13)70549-7;168 patients;168;-1
S1470-2045(13)70549-7;50 patients;50;-1
S1470-2045(13)70549-7;154 patients;154;-1
S1470-2045(13)70549-7;10 Eligible patients;10;-1
S1470-2045(13)70549-7;320 patients;320;-1
S1470-2045(13)70549-7;164 patients;164;-1
S1470-2045(13)70549-7;84 patients;84;-1
S1470-2045(13)70549-7;65 patients;65;-1
S1470-2045(13)70549-7;16 patients;16;-1
S1470-2045(13)70549-7;80 patients;80;-1
S1470-2045(13)70549-7;56 patients;56;-1
S1470-2045(13)70549-7;242 patients;242;-1
S1470-2045(13)70549-7;40 patients;40;-1
S1470-2045(13)70549-7;133 patients;133;-1
S1470-2045(13)70549-7;69 patients;69;-1
S1470-2045(13)70549-7;355 patients;355;-1
S1470-2045(13)70549-7;12 We also included patients;12;-1
S1470-2045(13)70549-7;n=3;3;-1
S1470-2045(13)70549-7;n=5;5;-1
S1470-2045(13)70549-7;n=84;84;-1
S1470-2045(13)70549-7;n=81;81;-1
S1470-2045(13)70549-7;n=74;74;-1
S1470-2045(13)70549-7;total of 164;164;-1
S1470-2045(13)70549-7;total of 57;57;-1
S1470-2045(13)70551-5;32 patients;32;13992
S1470-2045(13)70551-5;14 patients;14;13693
S1470-2045(13)70551-5;13 patients;13;13665
S1470-2045(13)70551-5;29 patients;29;13553
S1470-2045(13)70551-5;9 In patients;9;9868
S1470-2045(13)70551-5;25 patients;25;1491
S1470-2045(13)70551-5;30 patients;30;1260
S1470-2045(13)70551-5;30 treated patients;30;1366
S1470-2045(13)70551-5;22 All patients;22;1540
S1470-2045(13)70551-5;18 patients;18;6431
S1470-2045(13)70551-5;191 patients;191;11406
S1470-2045(13)70551-5;n=30;30;6303
S1470-2045(13)70551-5;total of   12;12;4921
S1470-2045(13)70551-5;   dataset of 191;191;11392
S1470-2045(13)70554-0;831 women;831;-1
S1470-2045(13)70554-0;100 000 women;100000;-1
S1470-2045(13)70554-0;831 participants;831;-1
S1470-2045(13)70554-0;828 patients;828;-1
S1470-2045(13)70554-0;404 patients;404;-1
S1470-2045(13)70554-0;408 patients;408;-1
S1470-2045(13)70554-0;406 patients;406;-1
S1470-2045(13)70554-0;812 patients;812;-1
S1470-2045(13)70554-0;200 patients;200;-1
S1470-2045(13)70554-0;400 patients;400;-1
S1470-2045(13)70554-0;831 patients;831;-1
S1470-2045(13)70554-0;27 patients;27;-1
S1470-2045(13)70554-0;107 patients;107;-1
S1470-2045(13)70554-0;750 patients;750;-1
S1470-2045(13)70554-0;191 patients;191;-1
S1470-2045(13)70554-0;812 eligible patients;812;-1
S1470-2045(13)70554-0;828 eligible patients;828;-1
S1470-2045(13)70554-0;410 patients;410;-1
S1470-2045(13)70554-0;409 patients;409;-1
S1470-2045(13)70554-0;413 patients;413;-1
S1470-2045(13)70554-0;110 patients;110;-1
S1470-2045(13)70554-0;819 patients;819;-1
S1470-2045(13)70554-0;141 patients;141;-1
S1470-2045(13)70554-0;671 patients;671;-1
S1470-2045(13)70554-0;1414 patients;1414;-1
S1470-2045(13)70554-0;1596 patients;1596;-1
S1470-2045(13)70554-0;314 patients;314;-1
S1470-2045(13)70554-0;276 patients;276;-1
S1470-2045(13)70554-0;6377 patients;6377;-1
S1470-2045(13)70554-0;1327 patients;1327;-1
S1470-2045(13)70554-0;187 patients;187;-1
S1470-2045(13)70554-0;662 patients;662;-1
S1470-2045(13)70554-0;911 patients;911;-1
S1470-2045(13)70554-0;36 663 patients;36663;-1
S1470-2045(13)70554-0;94 such patients;94;-1
S1470-2045(13)70554-0;37 280 patients;37280;-1
S1470-2045(13)70554-0;n=828;828;-1
S1470-2045(13)70554-0;n=413;413;-1
S1470-2045(13)70554-0;n=415;415;-1
S1470-2045(13)70554-0;n=414;414;-1
S1470-2045(13)70554-0;n=404;404;-1
S1470-2045(13)70554-0;n=408;408;-1
S1470-2045(13)70554-0;n=406;406;-1
S1470-2045(13)70554-0;107 patients enrolled;107;-1
S1470-2045(13)70554-0; data from 1414;1414;-1
S1470-2045(13)70566-7;22 million patients;22;-1
S1470-2045(13)70566-7;85 patients;85;-1
S1470-2045(13)70566-7;31 patients;31;-1
S1470-2045(13)70572-2;532 patients;532;-1
S1470-2045(13)70573-4;29 enrolled patients;29;-1
S1470-2045(13)70573-4;3 Although patients;3;-1
S1470-2045(13)70573-4;29 enrolled;29;-1
S1470-2045(13)70580-1;40 pretreated patients;40;-1
S1470-2045(13)70580-1;202 Korean patients;202;-1
S1470-2045(13)70580-1;168 patients;168;-1
S1470-2045(13)70580-1;n=84;84;-1
S1470-2045(13)70581-3;850 patients;850;-1
S1470-2045(13)70581-3;425 patients;425;-1
S1470-2045(13)70581-3;258 patients;258;-1
S1470-2045(13)70581-3;263 patients;263;-1
S1470-2045(13)70581-3;n=0;0;-1
S1470-2045(13)70581-3; data from 36;36;-1
S1470-2045(13)70582-5;213 participants;213;-1
S1470-2045(13)70582-5;281 Japanese patients;281;-1
S1470-2045(13)70584-9;404 patients;404;-1
S1470-2045(13)70584-9;408 patients;408;-1
S1470-2045(13)70584-9;406 patients;406;-1
S1470-2045(13)70584-9;6377 patients;6377;-1
S1470-2045(13)70586-2;655 patients;655;-1
S1470-2045(13)70586-2;206 patients;206;-1
S1470-2045(13)70586-2;199 patients;199;-1
S1470-2045(13)70586-2;322 patients;322;-1
S1470-2045(13)70586-2;35 patients;35;-1
S1470-2045(13)70586-2;60 patients;60;-1
S1470-2045(13)70586-2;1300 patients;1300;-1
S1470-2045(13)70586-2;1773 patients;1773;-1
S1470-2045(13)70586-2;1314 randomised patients;1314;-1
S1470-2045(13)70586-2;658 patients;658;-1
S1470-2045(13)70586-2;555 patients;555;-1
S1470-2045(13)70586-2;1314 patients;1314;-1
S1470-2045(13)70586-2;336 patients;336;-1
S1470-2045(13)70586-2;279 patients;279;-1
S1470-2045(13)70586-2;659 patients;659;-1
S1470-2045(13)70586-2;n=655;655;-1
S1470-2045(13)70586-2;n=659;659;-1
S1470-2045(13)70586-2;n=322;322;-1
S1470-2045(13)70586-2;n=336;336;-1
S1470-2045(13)70586-2;n=206;206;-1
S1470-2045(13)70586-2;n=199;199;-1
S1470-2045(13)70586-2;n=652;652;-1
S1470-2045(13)70586-2; data cutoff 646;646;-1
S1470-2045(13)70586-2; data cutoff 650;650;-1
S1470-2045(13)70588-6;3469 participants;3469;-1
S1470-2045(13)70588-6;13 of these participants;13;-1
S1470-2045(13)70588-6;119 participants;119;-1
S1470-2045(13)70588-6;6 Selection of patients;6;-1
S1470-2045(13)70588-6;3052 individuals;3052;-1
S1470-2045(13)70588-6;3469 individuals;3469;-1
S1470-2045(13)70588-6;1415 individuals;1415;-1
S1470-2045(13)70588-6;n=3469;3469;-1
S1470-2045(13)70588-6;n=0;0;-1
S1470-2045(13)70596-5;49 patients;49;-1
S1470-2045(13)70596-5;37 patients;37;-1
S1470-2045(13)70596-5;12 patients;12;-1
S1470-2045(13)70596-5;11  Proportion of patients;11;-1
S1470-2045(13)70596-5;49 enrolled patients;49;-1
S1470-2045(13)70596-5;39 patients;39;-1
S1470-2045(13)70596-5;0  Data are number of patients;0;-1
S1470-2045(13)70596-5;18 patients;18;-1
S1470-2045(13)70596-5;751,871 in patients;751871;-1
S1470-2045(13)70596-5;11 individuals;11;-1
S1470-2045(13)70596-5;13 individuals;13;-1
S1470-2045(13)70596-5;n=37;37;-1
S1470-2045(13)70596-5;n=12;12;-1
S1470-2045(13)70596-5;n=49;49;-1
S1470-2045(13)70596-5;49 patients were enrolled;49;-1
S1470-2045(13)70596-5;37 patients were enrolled;37;-1
S1470-2045(13)70596-5;37 patients enrolled;37;-1
S1470-2045(13)70596-5;49 patients   were enrolled;49;-1
S1470-2045(13)70596-5;49 enrolled;49;-1
S1470-2045(13)70599-0;1011 patients;1011;-1
S1470-2045(13)70599-0;0 patients;0;-1
S1470-2045(13)70599-0;505 patients;505;-1
S1470-2045(13)70599-0;506 patients;506;-1
S1470-2045(13)70599-0;501 patients;501;-1
S1470-2045(13)70599-0;980 patients;980;-1
S1470-2045(13)70599-0;37 patients;37;-1
S1470-2045(13)70599-0;252 patients;252;-1
S1470-2045(13)70599-0;253 patients;253;-1
S1470-2045(13)70599-0;355 patients;355;-1
S1470-2045(13)70599-0;787 patients;787;-1
S1470-2045(13)70599-0;31 patients;31;-1
S1470-2045(13)70599-0;11 patients;11;-1
S1470-2045(13)70599-0;19 patients;19;-1
S1470-2045(13)70599-0;526 patients;526;-1
S1470-2045(13)70599-0;665 patients;665;-1
S1470-2045(13)70599-0;470 patients;470;-1
S1470-2045(13)70599-0;787 eligible patients;787;-1
S1470-2045(13)70599-0;n=0;0;-1
S1470-2045(13)70599-0;N=252;252;-1
S1470-2045(13)70599-0;N=253;253;-1
S1470-2045(13)70604-1;910 patients;910;-1
S1470-2045(13)70604-1;239 patients;239;-1
S1470-2045(13)70604-1;113 patients;113;-1
S1470-2045(13)70604-1;330 patients;330;-1
S1470-2045(13)70604-1;364 eligible patients;364;-1
S1470-2045(13)70604-1;364 patients;364;-1
S1470-2045(13)70604-1;6 included   patients;6;-1
S1470-2045(13)70604-1;n=242;242;-1
S1470-2045(13)70604-1;n=122;122;-1
S1470-2045(13)70604-1;n=239;239;-1
S1470-2045(13)70604-1;n=113;113;-1
S1470-2045(13)70604-1;n=364;364;-1
S1470-2045(13)70604-1;n=345;345;-1
S1470-2045(13)70604-1; data cutoff 0;0;-1
S1470-2045(13)70605-3; data from 36;36;-1
S1470-2045(13)70606-5;32 465 patients;32465;-1
S1470-2045(13)70606-5;5 and we judged   patients;5;-1
S1470-2045(13)70606-5;16 595 patients;16595;-1
S1470-2045(13)70606-5;1187 patients;1187;-1
S1470-2045(13)70606-5;3533 patients;3533;-1
S1470-2045(13)70606-5;17 845 patients;17845;-1
S1470-2045(13)70606-5;n=839;839;-1
S1470-2045(13)70606-5;N=15 870;15870;-1
S1470-2045(13)70606-5;N=16 595;16595;-1
S1470-2045(13)70606-5; data from 22;22;-1
S1470-2045(13)70612-0;400 000 people;400000;-1
S1470-2045(14)70009-9;502 patients;502;-1
S1470-2045(14)70009-9;127 patients;127;-1
S1470-2045(14)70009-9;280 patients;280;-1
S1470-2045(14)70013-0;3469 participants;3469;-1
S1470-2045(14)70013-0;50 patients;50;-1
S1470-2045(14)70015-4;1310 patients;1310;-1
S1470-2045(14)70015-4;17,845 patients;17845;-1
S1470-2045(14)70016-6;404 patients;404;-1
S1470-2045(14)70016-6;408 patients;408;-1
S1470-2045(14)70016-6;406 patients;406;-1
S1470-2045(14)70021-X;23 recruited patients;23;-1
S1470-2045(14)70021-X;17 patients;17;-1
S1470-2045(14)70021-X;23 patients;23;-1
S1470-2045(14)70021-X;21 patients;21;-1
S1470-2045(14)70021-X;14 patients;14;-1
S1470-2045(14)70021-X;19 patients;19;-1
S1470-2045(14)70021-X;60 adult patients;60;-1
S1470-2045(14)70021-X;22 patients;22;-1
S1470-2045(14)70021-X;20 lymphoma patients;20;-1
S1470-2045(14)70021-X;680 000   people;680000;-1
S1470-2045(14)70021-X;21 In adults;21;-1
S1470-2045(14)70021-X;23 recruited;23;-1
S1470-2045(14)70030-0;284 patients;284;-1
S1470-2045(14)70030-0;280 patients;280;-1
S1470-2045(14)70030-0;4 Nearly all patients;4;-1
S1470-2045(14)70030-0;764 patients;764;-1
S1470-2045(14)70030-0;570 patients;570;-1
S1470-2045(14)70030-0;550 patients;550;-1
S1470-2045(14)70030-0;194 patients;194;-1
S1470-2045(14)70030-0;570 randomly assigned patients;570;-1
S1470-2045(14)70030-0;265 patients;265;-1
S1470-2045(14)70030-0;230 evaluable patients;230;-1
S1470-2045(14)70030-0;241 evaluable patients;241;-1
S1470-2045(14)70030-0;48 patients;48;-1
S1470-2045(14)70030-0;170 patients;170;-1
S1470-2045(14)70030-0;85 patients;85;-1
S1470-2045(14)70030-0;66 patients;66;-1
S1470-2045(14)70030-0;281 patients;281;-1
S1470-2045(14)70030-0;28 patients;28;-1
S1470-2045(14)70030-0;2 trial of patients;2;-1
S1470-2045(14)70030-0;n=284;284;-1
S1470-2045(14)70030-0;n=286;286;-1
S1470-2045(14)70030-0;n=70;70;-1
S1470-2045(14)70030-0;n=280;280;-1
S1470-2045(14)70030-0;n=230;230;-1
S1470-2045(14)70030-0;n=241;241;-1
S1470-2045(14)70030-0;total of 411;411;-1
S1470-2045(14)70030-0;194 not enrolled;194;-1
S1470-2045(14)70036-1;282 patients;282;-1
S1470-2045(14)70036-1;96 patients;96;-1
S1470-2045(14)70036-1;226 patients;226;-1
S1470-2045(14)70036-1;4 Gy  All patients;4;-1
S1470-2045(14)70036-1;94 patients;94;-1
S1470-2045(14)70036-1;12 patients;12;-1
S1470-2045(14)70036-1;134 patients;134;-1
S1470-2045(14)70036-1;n=299;299;-1
S1470-2045(14)70036-1;n=315;315;-1
S1470-2045(14)70037-3;680 000 people;680000;-1
S1470-2045(14)70038-5;212 patients;212;-1
S1470-2045(14)70038-5;3 So a notable proportion   of individuals;3;-1
S1470-2045(14)70040-3;16  Methods   Study design and participants;16;-1
S1470-2045(14)70040-3;391 patients;391;-1
S1470-2045(14)70040-3;421 patients;421;-1
S1470-2045(14)70040-3;422 patients;422;-1
S1470-2045(14)70040-3;18 All patients;18;-1
S1470-2045(14)70040-3;800 patients;800;-1
S1470-2045(14)70040-3;1 shows characteristics of the patients;1;-1
S1470-2045(14)70040-3;831 patients;831;-1
S1470-2045(14)70040-3;12 patients;12;-1
S1470-2045(14)70040-3;838 enrolled patients;838;-1
S1470-2045(14)70040-3;833 patients;833;-1
S1470-2045(14)70040-3;843 patients;843;-1
S1470-2045(14)70040-3;117 patients;117;-1
S1470-2045(14)70040-3;221 patients;221;-1
S1470-2045(14)70040-3;170 patients;170;-1
S1470-2045(14)70040-3;91 patients;91;-1
S1470-2045(14)70040-3;224 435  N=number of patients;224435;-1
S1470-2045(14)70040-3;N=421;421;-1
S1470-2045(14)70040-3;N=422;422;-1
S1470-2045(14)70040-3;N=126;126;-1
S1470-2045(14)70040-3;838 enrolled;838;-1
S1470-2045(14)70059-2;675 patients;675;-1
S1470-2045(14)70059-2;57 patients;57;-1
S1470-2045(14)70059-2;600K mutations enrolled;600;-1
S1470-2045(14)70060-9;367 patients;367;-1
S1470-2045(14)70060-9;13 patients;13;-1
S1470-2045(14)70060-9;217 patients;217;-1
S1470-2045(14)70060-9;101 patients;101;-1
S1470-2045(14)70060-9;38 patients;38;-1
S1470-2045(14)70060-9;11 patients;11;-1
S1470-2045(14)70060-9;59 patients;59;-1
S1470-2045(14)70060-9;18 patients;18;-1
S1470-2045(14)70060-9;392 patients;392;-1
S1470-2045(14)70060-9;25 patients;25;-1
S1470-2045(14)70060-9;2 stage patients;2;-1
S1470-2045(14)70060-9;240 patients;240;-1
S1470-2045(14)70060-9;23 selected   patients;23;-1
S1470-2045(14)70060-9;22 patients;22;-1
S1470-2045(14)70060-9;n=217;217;-1
S1470-2045(14)70060-9;n=101;101;-1
S1470-2045(14)70060-9;n=38;38;-1
S1470-2045(14)70060-9;n=11;11;-1
S1470-2045(14)70060-9;n=367;367;-1
S1470-2045(14)70060-9;n=104;104;-1
S1470-2045(14)70060-9;n=24;24;-1
S1470-2045(14)70060-9;n=369;369;-1
S1470-2045(14)70060-9;n=23;23;-1
S1470-2045(14)70060-9;n=40;40;-1
S1470-2045(14)70060-9;n=41;41;-1
S1470-2045(14)70060-9; data derived from   367;367;-1
S1470-2045(14)70062-2;15 participants;15;-1
S1470-2045(14)70066-X;3226 patients;3226;-1
S1470-2045(14)70066-X;675 patients;675;-1
S1470-2045(14)70078-6;384 patients;384;-1
S1470-2045(14)70081-6;843 participants;843;-1
S1470-2045(14)70081-6;N=1006;1006;-1
S1470-2045(14)70081-6;N=473;473;-1
S1470-2045(14)70090-7;3  Not all patients;3;-1
S1470-2045(14)70090-7;4519 additional   patients;4519;-1
S1470-2045(14)70091-9;1944 patients and   these patients;1944;-1
S1470-2045(14)70091-9;455 patients;455;-1
S1470-2045(14)70092-0;5   and because patients;5;-1
S1470-2045(14)70092-0;3  Not all patients;3;-1
S1470-2045(14)70105-6;2 wild-type patients;2;-1
S1470-2045(14)70105-6;117 patients;117;-1
S1470-2045(14)70105-6;2   wild-type patients;2;-1
S1470-2045(14)70105-6;364 patients;364;-1
S1470-2045(14)70105-6;621 patients;621;-1
S1470-2045(14)70105-6;272 patients;272;-1
S1470-2045(14)70105-6;22 patients;22;-1
S1470-2045(14)70105-6;52 patients;52;-1
S1470-2045(14)70105-6;268 patients;268;-1
S1470-2045(14)70105-6;349 patients;349;-1
S1470-2045(14)70105-6;235 patients;235;-1
S1470-2045(14)70105-6;14 patients;14;-1
S1470-2045(14)70105-6;128 patients;128;-1
S1470-2045(14)70105-6;129 patients;129;-1
S1470-2045(14)70105-6;73 patients;73;-1
S1470-2045(14)70105-6;119 patients;119;-1
S1470-2045(14)70105-6;222 patients;222;-1
S1470-2045(14)70105-6;98 patients;98;-1
S1470-2045(14)70105-6;24 patients;24;-1
S1470-2045(14)70105-6;110 patients;110;-1
S1470-2045(14)70105-6;112 patients;112;-1
S1470-2045(14)70105-6;n=128;128;-1
S1470-2045(14)70105-6;n=129;129;-1
S1470-2045(14)70105-6;n=134;134;-1
S1470-2045(14)70105-6;n=104;104;-1
S1470-2045(14)70105-6;n=137;137;-1
S1470-2045(14)70105-6;n=105;105;-1
S1470-2045(14)70106-8;401 patients;401;-1
S1470-2045(14)70106-8;64 patients;64;-1
S1470-2045(14)70106-8;77 patients;77;-1
S1470-2045(14)70106-8;92 patients;92;-1
S1470-2045(14)70106-8;119 patients;119;-1
S1470-2045(14)70106-8;282 patients;282;-1
S1470-2045(14)70106-8;158 patients;158;-1
S1470-2045(14)70106-8;226 patients;226;-1
S1470-2045(14)70106-8;78 KRAS wild-type patients;78;-1
S1470-2045(14)70106-8;24 patients;24;-1
S1470-2045(14)70106-8;169 patients;169;-1
S1470-2045(14)70106-8;13 patients;13;-1
S1470-2045(14)70106-8;78 patients;78;-1
S1470-2045(14)70106-8;42 patients;42;-1
S1470-2045(14)70106-8;107 patients;107;-1
S1470-2045(14)70106-8;n=78;78;-1
S1470-2045(14)70106-8;n=91;91;-1
S1470-2045(14)70106-8;n=112;112;-1
S1470-2045(14)70106-8;n=114;114;-1
S1470-2045(14)70106-8;n=169;169;-1
S1470-2045(14)70106-8;n=29;29;-1
S1470-2045(14)70106-8;n=17;17;-1
S1470-2045(14)70106-8;n=1630;1630;-1
S1470-2045(14)70106-8;n=978;978;-1
S1470-2045(14)70106-8;226 of whom were enrolled;226;-1
S1470-2045(14)70106-8;226 patients were enrolled;226;-1
S1470-2045(14)70106-8;119 patients were enrolled;119;-1
S1470-2045(14)70106-8; data from CR06;6;-1
S1470-2045(14)70108-1;436 patients;436;-1
S1470-2045(14)70110-X;3394 participants;3394;-1
S1470-2045(14)70110-X;1343 patients;1343;-1
S1470-2045(14)70110-X;1343 enrolled patients;1343;-1
S1470-2045(14)70110-X;671 patients;671;-1
S1470-2045(14)70110-X;672 patients;672;-1
S1470-2045(14)70110-X;1320 patients;1320;-1
S1470-2045(14)70110-X;660 patients;660;-1
S1470-2045(14)70110-X;368 patients;368;-1
S1470-2045(14)70110-X;38 patients;38;-1
S1470-2045(14)70110-X;652 patients;652;-1
S1470-2045(14)70110-X;645 assessed patients;645;-1
S1470-2045(14)70110-X;354 patients;354;-1
S1470-2045(14)70110-X;n=671;671;-1
S1470-2045(14)70110-X;n=672;672;-1
S1470-2045(14)70110-X;N=1343;1343;-1
S1470-2045(14)70110-X;1343 enrolled;1343;-1
S1470-2045(14)70121-4;541 patients;541;-1
S1470-2045(14)70121-4;67 patients;67;-1
S1470-2045(14)70126-3;5   and because patients;5;-1
S1470-2045(14)70127-5;4519 additional   patients;4519;-1
S1470-2045(14)70129-9;47 participants;47;-1
S1470-2045(14)70129-9;60 participants;60;-1
S1470-2045(14)70129-9;62 patients;62;-1
S1470-2045(14)70129-9;67 patients;67;-1
S1470-2045(14)70129-9;63 patients;63;-1
S1470-2045(14)70129-9;26 patients;26;-1
S1470-2045(14)70129-9;16 patients;16;-1
S1470-2045(14)70129-9;61 patients;61;-1
S1470-2045(14)70129-9;24 patients;24;-1
S1470-2045(14)70129-9;n=24;24;-1
S1470-2045(14)70129-9;n=23;23;-1
S1470-2045(14)70129-9;n=13;13;-1
S1470-2045(14)70129-9;n=12;12;-1
S1470-2045(14)70129-9;n=67;67;-1
S1470-2045(14)70129-9;n=41;41;-1
S1470-2045(14)70129-9;n=26;26;-1
S1470-2045(14)70129-9;67 men were enrolled;67;-1
S1470-2045(14)70131-7;148 participants;148;-1
S1470-2045(14)70131-7;160 patients;160;-1
S1470-2045(14)70131-7;73 patients;73;-1
S1470-2045(14)70131-7;27 patients;27;-1
S1470-2045(14)70131-7;26 patients;26;-1
S1470-2045(14)70131-7;170 patients;170;-1
S1470-2045(14)70131-7;12 patients;12;-1
S1470-2045(14)70131-7;148 patients;148;-1
S1470-2045(14)70131-7;130 patients;130;-1
S1470-2045(14)70131-7;119 patients;119;-1
S1470-2045(14)70131-7;n=80;80;-1
S1470-2045(14)70131-7;n=73;73;-1
S1470-2045(14)70131-7;n=75;75;-1
S1470-2045(14)70131-7;n=59;59;-1
S1470-2045(14)70131-7;n=89;89;-1
S1470-2045(14)70131-7;   data from 148;148;-1
S1470-2045(14)70136-6;569 women;569;-1
S1470-2045(14)70136-6;639 patients;639;-1
S1470-2045(14)70137-8;1 Median survival of patients;1;-1
S1470-2045(14)70137-8;4   For patients;4;-1
S1470-2045(14)70138-X;569 women;569;-1
S1470-2045(14)70138-X;569 patients;569;-1
S1470-2045(14)70138-X;280 patients;280;-1
S1470-2045(14)70138-X;282 patients;282;-1
S1470-2045(14)70138-X;572 patients;572;-1
S1470-2045(14)70138-X;284 patients;284;-1
S1470-2045(14)70138-X;285 patients;285;-1
S1470-2045(14)70138-X;48 patients;48;-1
S1470-2045(14)70138-X;189 patients;189;-1
S1470-2045(14)70138-X;29 patients;29;-1
S1470-2045(14)70138-X;24 patients;24;-1
S1470-2045(14)70138-X;n=284;284;-1
S1470-2045(14)70138-X;n=285;285;-1
S1470-2045(14)70138-X;n=0;0;-1
S1470-2045(14)70138-X;n=280;280;-1
S1470-2045(14)70138-X;n=282;282;-1
S1470-2045(14)70138-X;569 women were enrolled;569;-1
S1470-2045(14)70140-8;275 million people;275;-1
S1470-2045(14)70140-8;20 million people;20;-1
S1470-2045(14)70154-8;1210 patients;1210;13971
S1470-2045(14)70154-8;552 operated patients;552;13804
S1470-2045(14)70154-8;339 patients;339;13447
S1470-2045(14)70154-8;82 patients;82;13355
S1470-2045(14)70154-8;2 patients;2;13354
S1470-2045(14)70154-8;563 patients;563;2781
S1470-2045(14)70154-8;647 patients;647;2908
S1470-2045(14)70154-8;563 of the   patients;563;5355
S1470-2045(14)70154-8;313 patients;313;5809
S1470-2045(14)70154-8;11 patients;11;8561
S1470-2045(14)70154-8;95 patients;95;8792
S1470-2045(14)70154-8;552 patients;552;9483
S1470-2045(14)70154-8;438 patients;438;9653
S1470-2045(14)70154-8;257 patients;257;9703
S1470-2045(14)70154-8;54 patients;54;10158
S1470-2045(14)70154-8;28 patients;28;10232
S1470-2045(14)70154-8;23 patients;23;10446
S1470-2045(14)70154-8;34 patients;34;10474
S1470-2045(14)70154-8;15 patients;15;12737
S1470-2045(14)70154-8;114 patients;114;12911
S1470-2045(14)70154-8;1023 patients;1023;13470
S1470-2045(14)70154-8;83 patients;83;14356
S1470-2045(14)70154-8;187 of these patients;187;16049
S1470-2045(14)70154-8;460 patients;460;16101
S1470-2045(14)70154-8;385 patients;385;16203
S1470-2045(14)70154-8;30 centres contributed   patients;30;21190
S1470-2045(14)70154-8;n=563;563;7265
S1470-2045(14)70177-9;652 patients;652;-1
S1470-2045(14)70197-4;90 patients;90;-1
S1470-2045(14)70197-4;89 patients;89;-1
S1470-2045(14)70197-4;20 patients;20;-1
S1470-2045(14)70197-4;221 patients;221;-1
S1470-2045(14)70197-4;225 patients;225;-1
S1470-2045(14)70197-4;376 patients;376;-1
S1470-2045(14)70197-4;22 centres enrolled;22;-1
S1470-2045(14)70198-6;1071 patients;1071;-1
S1470-2045(14)70199-8;680,000 people;680000;-1
S1470-2045(14)70200-1;2012 patients;2012;-1
S1470-2045(14)70200-1;1 In patients;1;-1
S1470-2045(14)70200-1;34 252 patients;34252;-1
S1470-2045(14)70200-1;19 This cohort includes all patients;19;-1
S1470-2045(14)70200-1;86 patients;86;-1
S1470-2045(14)70200-1;100 patients;100;-1
S1470-2045(14)70200-1;896 patients;896;-1
S1470-2045(14)70200-1;817 patients;817;-1
S1470-2045(14)70200-1;127,805 unselected patients;127805;-1
S1470-2045(14)70200-1;n=3672;3672;-1
S1470-2045(14)70200-1;n=2012;2012;-1
S1470-2045(14)70200-1; data from a   1;1;-1
S1470-2045(14)70205-0;340 patients;340;-1
S1470-2045(14)70205-0;1408 patients;1408;-1
S1470-2045(14)70205-0;1044 patients;1044;-1
S1470-2045(14)70205-0;135 patients;135;-1
S1470-2045(14)70205-0;n=170;170;-1
S1470-2045(14)70214-1;90 patients;90;-1
S1470-2045(14)70214-1;89 patients;89;-1
S1470-2045(14)70214-1;20 patients;20;-1
S1470-2045(14)70214-1;221 patients;221;-1
S1470-2045(14)70214-1;225 patients;225;-1
S1470-2045(14)70214-1;376 patients;376;-1
S1470-2045(14)70214-1;690 patients;690;-1
S1470-2045(14)70214-1;201 patients;201;-1
S1470-2045(14)70214-1;n=104;104;-1
S1470-2045(14)70214-1;n=39;39;-1
S1470-2045(14)70214-1;n=0;0;-1
S1470-2045(14)70214-1;22 centres enrolled;22;-1
S1470-2045(14)70215-3;1482 patients;1482;-1
S1470-2045(14)70217-7;1 of   patients;1;-1
S1470-2045(14)70217-7;614 patients;614;-1
S1470-2045(14)70217-7;307 patients;307;-1
S1470-2045(14)70227-X;2096 patients;2096;-1
S1470-2045(14)70227-X;2559 patients;2559;-1
S1470-2045(14)70227-X;785 patients;785;-1
S1470-2045(14)70227-X;15  In patients;15;-1
S1470-2045(14)70227-X;2 wild-type   patients;2;-1
S1470-2045(14)70227-X;450 patients;450;-1
S1470-2045(14)70227-X;1407 patients;1407;-1
S1470-2045(14)70227-X;18   patients;18;-1
S1470-2045(14)70227-X;805 patients;805;-1
S1470-2045(14)70227-X;2 subgroup of patients;2;-1
S1470-2045(14)70227-X;n=984;984;-1
S1470-2045(14)70227-X;n=742;742;-1
S1470-2045(14)70227-X;n=791;791;-1
S1470-2045(14)70227-X;n=811;811;-1
S1470-2045(14)70227-X;n=368;368;-1
S1470-2045(14)70227-X;n=374;374;-1
S1470-2045(14)70227-X;N=785;785;-1
S1470-2045(14)70227-X;N=805;805;-1
S1470-2045(14)70227-X;N=364;364;-1
S1470-2045(14)70227-X;N=374;374;-1
S1470-2045(14)70227-X;n=2096;2096;-1
S1470-2045(14)70227-X;n=957;957;-1
S1470-2045(14)70227-X;N=791;791;-1
S1470-2045(14)70227-X;N=811;811;-1
S1470-2045(14)70227-X;N=492;492;-1
S1470-2045(14)70227-X;N=368;368;-1
S1470-2045(14)70227-X;N=79;79;-1
S1470-2045(14)70227-X;N=67;67;-1
S1470-2045(14)70227-X;2   mutated tumours enrolled;2;-1
S1470-2045(14)70227-X;2559 patients   were enrolled;2559;-1
S1470-2045(14)70237-2;2012 unselected older   women;2012;-1
S1470-2045(14)70237-2;49 patients;49;-1
S1470-2045(14)70237-2;45 patients;45;-1
S1470-2045(14)70237-2;32 patients;32;-1
S1470-2045(14)70237-2;16 patients;16;-1
S1470-2045(14)70238-4;3184 patients;3184;-1
S1470-2045(14)70238-4;76 patients;76;-1
S1470-2045(14)70238-4;74 patients;74;-1
S1470-2045(14)70240-2;24 patients;24;-1
S1470-2045(14)70240-2;1 patients;1;-1
S1470-2045(14)70240-2;124 patients;124;-1
S1470-2045(14)70240-2;38 patients;38;-1
S1470-2045(14)70240-2;35 patients;35;-1
S1470-2045(14)70240-2;201 patients;201;-1
S1470-2045(14)70240-2;134 patients;134;-1
S1470-2045(14)70240-2;32 patients;32;-1
S1470-2045(14)70240-2;169 patients;169;-1
S1470-2045(14)70240-2;21 patients;21;-1
S1470-2045(14)70240-2;31 evaluable patients;31;-1
S1470-2045(14)70240-2;17 inhibitior-naive patients;17;-1
S1470-2045(14)70240-2;17 inhibitor-naive patients;17;-1
S1470-2045(14)70240-2;11   Data are number of patients;11;-1
S1470-2045(14)70240-2;140 patients;140;-1
S1470-2045(14)70240-2;800 patients;800;-1
S1470-2045(14)70240-2;n=38;38;-1
S1470-2045(14)70240-2;n=37;37;-1
S1470-2045(14)70240-2;n=35;35;-1
S1470-2045(14)70240-2;n=24;24;-1
S1470-2045(14)70240-2;n=3;3;-1
S1470-2045(14)70240-2;n=7;7;-1
S1470-2045(14)70240-2;n=124;124;-1
S1470-2045(14)70240-2;n=15;15;-1
S1470-2045(14)70240-2;n=16;16;-1
S1470-2045(14)70240-2;n=32;32;-1
S1470-2045(14)70240-2;n=55;55;-1
S1470-2045(14)70240-2;n=111;111;-1
S1470-2045(14)70240-2;1 were enrolled;1;-1
S1470-2045(14)70240-2;24 patients were enrolled;24;-1
S1470-2045(14)70240-2;136 enrolled;136;-1
S1470-2045(14)70240-2;24 were enrolled;24;-1
S1470-2045(14)70240-2;24 patients   enrolled;24;-1
S1470-2045(14)70242-6;280 patients;280;-1
S1470-2045(14)70242-6;282 patients;282;-1
S1470-2045(14)70243-8;75,000 women;75000;-1
S1470-2045(14)70243-8;533 MRD high-risk patients;533;-1
S1470-2045(14)70243-8;2 Continuing therapy  Female patients;2;-1
S1470-2045(14)70243-8;112  Male patients;112;-1
S1470-2045(14)70243-8;164  Clinical intermediate-risk patients;164;-1
S1470-2045(14)70243-8;117  Male patients;117;-1
S1470-2045(14)70243-8;3207 patients;3207;-1
S1470-2045(14)70243-8;52 patients;52;-1
S1470-2045(14)70243-8;450 randomised patients;450;-1
S1470-2045(14)70243-8;3126 eligible patients;3126;-1
S1470-2045(14)70243-8;808 eligible MRD high-risk patients;808;-1
S1470-2045(14)70243-8;267 patients;267;-1
S1470-2045(14)70243-8;3184 patients;3184;-1
S1470-2045(14)70243-8;n=266;266;-1
S1470-2045(14)70243-8;n=267;267;-1
S1470-2045(14)70243-8;n=3126;3126;-1
S1470-2045(14)70243-8;n=808;808;-1
S1470-2045(14)70243-8;n=275;275;-1
S1470-2045(14)70243-8;n=533;533;-1
S1470-2045(14)70243-8;total of 12 000;12000;-1
S1470-2045(14)70245-1;3 study recruited patients;3;-1
S1470-2045(14)70245-1;297 patients;297;-1
S1470-2045(14)70245-1;174 patients;174;-1
S1470-2045(14)70245-1;293 patients;293;-1
S1470-2045(14)70245-1;83 patients;83;-1
S1470-2045(14)70245-1;84 patients;84;-1
S1470-2045(14)70245-1;297 eligible patients;297;-1
S1470-2045(14)70245-1;3 patients;3;-1
S1470-2045(14)70245-1;174 eligible and willing patients;174;-1
S1470-2045(14)70245-1;89 patients;89;-1
S1470-2045(14)70245-1;12 patients;12;-1
S1470-2045(14)70245-1;166 patients;166;-1
S1470-2045(14)70245-1;70 patients;70;-1
S1470-2045(14)70245-1;123 patients;123;-1
S1470-2045(14)70245-1;110 patients;110;-1
S1470-2045(14)70245-1;26 patients;26;-1
S1470-2045(14)70245-1;85 patients;85;-1
S1470-2045(14)70245-1;17 patients;17;-1
S1470-2045(14)70245-1;22 patients;22;-1
S1470-2045(14)70245-1;2 patients;2;-1
S1470-2045(14)70245-1;7 patients;7;-1
S1470-2045(14)70245-1;30 patients;30;-1
S1470-2045(14)70245-1;57 patients;57;-1
S1470-2045(14)70245-1;25 patients;25;-1
S1470-2045(14)70245-1;68 patients;68;-1
S1470-2045(14)70245-1;16 patients;16;-1
S1470-2045(14)70245-1;279 patients;279;-1
S1470-2045(14)70245-1;6 patients;6;-1
S1470-2045(14)70245-1;460 patients;460;-1
S1470-2045(14)70245-1;297 registered   patients;297;-1
S1470-2045(14)70245-1;297 registered patients;297;-1
S1470-2045(14)70245-1;297   patients;297;-1
S1470-2045(14)70245-1;174 randomly assigned patients;174;-1
S1470-2045(14)70245-1;29 patients;29;-1
S1470-2045(14)70245-1;32 patients;32;-1
S1470-2045(14)70245-1;167 patients;167;-1
S1470-2045(14)70245-1;174 overall because not all patients;174;-1
S1470-2045(14)70245-1;266 patients;266;-1
S1470-2045(14)70245-1;200 patients;200;-1
S1470-2045(14)70245-1;3 study recruited;3;-1
S1470-2045(14)70245-1;n=89;89;-1
S1470-2045(14)70245-1;n=85;85;-1
S1470-2045(14)70245-1;n=297;297;-1
S1470-2045(14)70245-1;n=174;174;-1
S1470-2045(14)70245-1;n=22;22;-1
S1470-2045(14)70245-1;n=54;54;-1
S1470-2045(14)70245-1;n=84;84;-1
S1470-2045(14)70245-1;n=6;6;-1
S1470-2045(14)70245-1;n=112;112;-1
S1470-2045(14)70245-1;n=47;47;-1
S1470-2045(14)70245-1;n=75;75;-1
S1470-2045(14)70245-1;n=13;13;-1
S1470-2045(14)70245-1;n=293;293;-1
S1470-2045(14)70245-1;n=110;110;-1
S1470-2045(14)70245-1;n=167;167;-1
S1470-2045(14)70245-1;n=83;83;-1
S1470-2045(14)70245-1; data cutoff , 125;125;-1
S1470-2045(14)70272-4;2559 patients;2559;-1
S1470-2045(14)70272-4;1602 patients;1602;-1
S1470-2045(14)70273-6;3 if more patients;3;-1
S1470-2045(14)70280-3;3184 patients;3184;-1
S1470-2045(14)70281-5;3325 participants;3325;-1
S1470-2045(14)70281-5;3324 participants;3324;-1
S1470-2045(14)70281-5;3325 patients;3325;-1
S1470-2045(14)70281-5;142 patients;142;-1
S1470-2045(14)70281-5;5 and   older patients;5;-1
S1470-2045(14)70281-5;295 patients;295;-1
S1470-2045(14)70281-5;14 patients;14;-1
S1470-2045(14)70281-5;6 included patients;6;-1
S1470-2045(14)70281-5;2728 patients;2728;-1
S1470-2045(14)70281-5;785 patients;785;-1
S1470-2045(14)70281-5;1110 patients;1110;-1
S1470-2045(14)70281-5;1488 patients;1488;-1
S1470-2045(14)70281-5;197 patients;197;-1
S1470-2045(14)70281-5;23  In identifying patients;23;-1
S1470-2045(14)70281-5;788 patients;788;-1
S1470-2045(14)70281-5;5876 younger adult patients;5876;-1
S1470-2045(14)70281-5;1312 patients;1312;-1
S1470-2045(14)70281-5;n=133;133;-1
S1470-2045(14)70281-5;n=565;565;-1
S1470-2045(14)70281-5;n=196;196;-1
S1470-2045(14)70281-5;n=205;205;-1
S1470-2045(14)70281-5;n=72;72;-1
S1470-2045(14)70281-5;n=283;283;-1
S1470-2045(14)70281-5;n=67;67;-1
S1470-2045(14)70281-5;n=173;173;-1
S1470-2045(14)70281-5;n=33;33;-1
S1470-2045(14)70281-5;n=576;576;-1
S1470-2045(14)70281-5;n=264;264;-1
S1470-2045(14)70281-5;n=242;242;-1
S1470-2045(14)70281-5;n=0;0;-1
S1470-2045(14)70281-5;n=224;224;-1
S1470-2045(14)70281-5;n=14;14;-1
S1470-2045(14)70281-5;n=9;9;-1
S1470-2045(14)70281-5;n=179;179;-1
S1470-2045(14)70281-5;n=57;57;-1
S1470-2045(14)70281-5;n=186;186;-1
S1470-2045(14)70281-5;total of 5;5;-1
S1470-2045(14)70281-5;3325 patients who were enrolled;3325;-1
S1470-2045(14)70282-7;1480 patients;1480;-1
S1470-2045(14)70282-7;9 EUROCARE Survival of cancer patients;9;-1
S1470-2045(14)70282-7; data from 1992;1992;-1
S1470-2045(14)70282-7;   data from 1992;1992;-1
S1470-2045(14)70293-1;2 resection patients;2;-1
S1470-2045(14)70293-1;9 and   east Asian patients;9;-1
S1470-2045(14)70294-3;256 women;256;-1
S1470-2045(14)70294-3;47 697 patients;47697;-1
S1470-2045(14)70295-5;263 000   patients;263000;-1
S1470-2045(14)70331-6;39 patients;39;-1
S1470-2045(14)70331-6;63 patients;63;-1
S1470-2045(14)70331-6;66 patients;66;-1
S1470-2045(14)70331-6;n=66;66;-1
S1470-2045(14)70331-6;n=63;63;-1
S1470-2045(14)70334-1;14 as are women;14;-1
S1470-2045(14)70334-1;410 female patients;410;-1
S1470-2045(14)70334-1;410 patients;410;-1
S1470-2045(14)70334-1;13 patients;13;-1
S1470-2045(14)70334-1;20 patients;20;-1
S1470-2045(14)70334-1;20 assessable patients;20;-1
S1470-2045(14)70334-1;14 assessable patients;14;-1
S1470-2045(14)70334-1;376 patients;376;-1
S1470-2045(14)70334-1;42 patients;42;-1
S1470-2045(14)70334-1;34 patients;34;-1
S1470-2045(14)70334-1;14 patients;14;-1
S1470-2045(14)70334-1;20 assessable   patients;20;-1
S1470-2045(14)70334-1;410 female cancer patients;410;-1
S1470-2045(14)70334-1;18 individuals;18;-1
S1470-2045(14)70334-1;n=98;98;-1
S1470-2045(14)70334-1;n=14;14;-1
S1470-2045(14)70334-1;n=6;6;-1
S1470-2045(14)70334-1;n=141;141;-1
S1470-2045(14)70334-1;n=20;20;-1
S1470-2045(14)70335-3;40 patients;40;-1
S1470-2045(14)70335-3;15 patients;15;-1
S1470-2045(14)70335-3;85 patients;85;-1
S1470-2045(14)70335-3;34 patients;34;-1
S1470-2045(14)70335-3;15  In patients;15;-1
S1470-2045(14)70335-3;34 evaluable patients;34;-1
S1470-2045(14)70335-3;31 patients;31;-1
S1470-2045(14)70335-3;39 patients;39;-1
S1470-2045(14)70335-3;20 patients;20;-1
S1470-2045(14)70335-3;38 patients;38;-1
S1470-2045(14)70335-3;24 patients;24;-1
S1470-2045(14)70335-3;174 patients;174;-1
S1470-2045(14)70335-3;116 patients;116;-1
S1470-2045(14)70335-3;1482 patients;1482;-1
S1470-2045(14)70335-3;n=40;40;-1
S1470-2045(14)70335-3;n=33;33;-1
S1470-2045(14)70335-3;n=39;39;-1
S1470-2045(14)70335-3;n=36;36;-1
S1470-2045(14)70335-3;n=10;10;-1
S1470-2045(14)70335-3;n=13;13;-1
S1470-2045(14)70335-3;n=15;15;-1
S1470-2045(14)70335-3;n=7;7;-1
S1470-2045(14)70335-3;n=11;11;-1
S1470-2045(14)70335-3;n=2;2;-1
S1470-2045(14)70335-3;n=35;35;-1
S1470-2045(14)70335-3;n=5;5;-1
S1470-2045(14)70335-3;n=37;37;-1
S1470-2045(14)70335-3;n=4;4;-1
S1470-2045(14)70335-3;n=30;30;-1
S1470-2045(14)70335-3;n=32;32;-1
S1470-2045(14)70335-3;40 patients were   enrolled;40;-1
S1470-2045(14)70336-5;174 patients;174;-1
S1470-2045(14)70336-5;83 patients;83;-1
S1470-2045(14)70336-5;98 patients;98;-1
S1470-2045(14)70336-5;58 patients;58;-1
S1470-2045(14)70336-5;16 did not consist of human patients;16;-1
S1470-2045(14)70336-5;28 patients;28;-1
S1470-2045(14)70336-5;18 patients;18;-1
S1470-2045(14)70336-5;13 patients;13;-1
S1470-2045(14)70336-5;2 Few   patients;2;-1
S1470-2045(14)70336-5;n=174;174;-1
S1470-2045(14)70336-5;n=126;126;-1
S1470-2045(14)70336-5;n=40;40;-1
S1470-2045(14)70336-5;n=18;18;-1
S1470-2045(14)70336-5;n=98;98;-1
S1470-2045(14)70336-5;n=58;58;-1
S1470-2045(14)70336-5;n=22;22;-1
S1470-2045(14)70336-5;n=15;15;-1
S1470-2045(14)70336-5;n=7;7;-1
S1470-2045(14)70337-7;3 a far higher proportion of   patients;3;-1
S1470-2045(14)70337-7;10 000 people;10000;-1
S1470-2045(14)70360-2;295 patients;295;-1
S1470-2045(14)70360-2;1137 patients;1137;-1
S1470-2045(14)70361-4;247 pilot study participants;247;-1
S1470-2045(14)70361-4;429 recruited participants;429;-1
S1470-2045(14)70361-4;130 recruited participants;130;-1
S1470-2045(14)70361-4;46 recruited participants;46;-1
S1470-2045(14)70361-4;279 recruited participants;279;-1
S1470-2045(14)70361-4;1643 participants;1643;-1
S1470-2045(14)70361-4;2664 participants;2664;-1
S1470-2045(14)70361-4;82 429 participants;82429;-1
S1470-2045(14)70361-4;46 patients;46;-1
S1470-2045(14)70361-4;24 patients;24;-1
S1470-2045(14)70361-4;4 and PIVOT   treatment trial patients;4;-1
S1470-2045(14)70361-4;32  a UK cohort of patients;32;-1
S1470-2045(14)70361-4;429 recruited;429;-1
S1470-2045(14)70361-4;18 015 not recruited;18015;-1
S1470-2045(14)70361-4;82 429 were recruited;82429;-1
S1470-2045(14)70361-4;2417 men recruited;2417;-1
S1470-2045(14)70361-4;130 recruited;130;-1
S1470-2045(14)70361-4;46 recruited;46;-1
S1470-2045(14)70361-4;279 recruited;279;-1
S1470-2045(14)70361-4;2417 recruited;2417;-1
S1470-2045(14)70361-4;247 recruited;247;-1
S1470-2045(14)70361-4;n=79 208;79208;-1
S1470-2045(14)70361-4;n=2896;2896;-1
S1470-2045(14)70361-4;n=82 429;82429;-1
S1470-2045(14)70361-4;n=8566;8566;-1
S1470-2045(14)70361-4;n=7414;7414;-1
S1470-2045(14)70361-4;n=545;545;-1
S1470-2045(14)70361-4;n=553;553;-1
S1470-2045(14)70361-4;n=1643;1643;-1
S1470-2045(14)70361-4;n=997;997;-1
S1470-2045(14)70362-6;47 patients;47;-1
S1470-2045(14)70362-6;44 patients;44;-1
S1470-2045(14)70362-6;21 patients;21;-1
S1470-2045(14)70362-6;46 patients;46;-1
S1470-2045(14)70362-6;85 patients;85;-1
S1470-2045(14)70362-6;0  Data are number of patients;0;-1
S1470-2045(14)70362-6;26 patients;26;-1
S1470-2045(14)70362-6;44 assessable patients;44;-1
S1470-2045(14)70362-6;n=47;47;-1
S1470-2045(14)70362-6;n=21;21;-1
S1470-2045(14)70362-6;n=7;7;-1
S1470-2045(14)70362-6;n=13;13;-1
S1470-2045(14)70362-6;n=42;42;-1
S1470-2045(14)70362-6;n=9;9;-1
S1470-2045(14)70362-6;47 patients were enrolled;47;-1
S1470-2045(14)70362-6; data cut-  off , 24;24;-1
S1470-2045(14)70377-8;321 patients;321;-1
S1470-2045(14)70377-8;149 patients;149;-1
S1470-2045(14)70377-8;146 patients;146;-1
S1470-2045(14)70377-8;322 patients;322;-1
S1470-2045(14)70377-8;320 patients;320;-1
S1470-2045(14)70377-8;26 patients;26;-1
S1470-2045(14)70377-8;295 patients;295;-1
S1470-2045(14)70377-8;161 patients;161;-1
S1470-2045(14)70377-8;160 patients;160;-1
S1470-2045(14)70377-8;0  Data are number of patients;0;-1
S1470-2045(14)70377-8;1,864 patients;1864;-1
S1470-2045(14)70377-8;n=161;161;-1
S1470-2045(14)70377-8;n=160;160;-1
S1470-2045(14)70377-8;n=149;149;-1
S1470-2045(14)70377-8;n=146;146;-1
S1470-2045(14)70377-8;n=102;102;-1
S1470-2045(14)70377-8;n=96;96;-1
S1470-2045(14)70377-8;n=58;58;-1
S1470-2045(14)70377-8;n=65;65;-1
S1470-2045(14)70377-8; data cutoff , 21;21;-1
S1470-2045(14)70378-X;141 assessable patients;141;-1
S1470-2045(14)70378-X;455 patients;455;-1
S1470-2045(14)70379-1;24  Methods  Study design and participants;24;-1
S1470-2045(14)70379-1;3471 patients;3471;-1
S1470-2045(14)70379-1;926 patients;926;-1
S1470-2045(14)70379-1;52 patients;52;-1
S1470-2045(14)70379-1;411 patients;411;-1
S1470-2045(14)70379-1;2134 patients;2134;-1
S1470-2045(14)70379-1;382 ineligble patients;382;-1
S1470-2045(14)70379-1;545 eligible patients;545;-1
S1470-2045(14)70379-1;504 patients;504;-1
S1470-2045(14)70379-1;252 patients;252;-1
S1470-2045(14)70379-1;382 patients;382;-1
S1470-2045(14)70379-1;545 patients;545;-1
S1470-2045(14)70379-1;272 patients;272;-1
S1470-2045(14)70379-1;152 patients;152;-1
S1470-2045(14)70379-1;3500 patients;3500;-1
S1470-2045(14)70379-1;n=272;272;-1
S1470-2045(14)70379-1;n=273;273;-1
S1470-2045(14)70379-1;n=545;545;-1
S1470-2045(14)70379-1;n=136;136;-1
S1470-2045(14)70379-1;n=409;409;-1
S1470-2045(14)70379-1;n=291;291;-1
S1470-2045(14)70379-1;n=254;254;-1
S1470-2045(14)70379-1;n=419;419;-1
S1470-2045(14)70379-1;n=90;90;-1
S1470-2045(14)70379-1;n=65;65;-1
S1470-2045(14)70379-1;n=368;368;-1
S1470-2045(14)70379-1;n=112;112;-1
S1470-2045(14)70379-1;n=86;86;-1
S1470-2045(14)70379-1;n=453;453;-1
S1470-2045(14)70379-1;n=307;307;-1
S1470-2045(14)70379-1;n=237;237;-1
S1470-2045(14)70379-1;n=106;106;-1
S1470-2045(14)70379-1;n=432;432;-1
S1470-2045(14)70379-1;n=216;216;-1
S1470-2045(14)70379-1;n=329;329;-1
S1470-2045(14)70379-1;n=269;269;-1
S1470-2045(14)70379-1;n=274;274;-1
S1470-2045(14)70379-1;n=111;111;-1
S1470-2045(14)70379-1;n=220;220;-1
S1470-2045(14)70379-1;n=213;213;-1
S1470-2045(14)70379-1;n=157;157;-1
S1470-2045(14)70379-1;n=153;153;-1
S1470-2045(14)70379-1;n=263;263;-1
S1470-2045(14)70379-1;n=258;258;-1
S1470-2045(14)70379-1;total of 60;60;-1
S1470-2045(14)70381-X;154 patients;154;-1
S1470-2045(14)70381-X;75 patients;75;-1
S1470-2045(14)70381-X;2 In this subgroup of patients;2;-1
S1470-2045(14)70381-X;12 patients;12;-1
S1470-2045(14)70381-X;150 patients;150;-1
S1470-2045(14)70381-X;152 patients;152;-1
S1470-2045(14)70381-X;77 patients;77;-1
S1470-2045(14)70381-X;77   patients;77;-1
S1470-2045(14)70381-X;11 patients;11;-1
S1470-2045(14)70381-X;n=75;75;-1
S1470-2045(14)70381-X;n=77;77;-1
S1470-2045(14)70381-X;154 patients were enrolled;154;-1
S1470-2045(14)70381-X;154 patients   were enrolled;154;-1
S1470-2045(14)70381-X; data from   152;152;-1
S1470-2045(14)70387-0;15 822 participants;15822;-1
S1470-2045(14)70387-0;7155 participants;7155;-1
S1470-2045(14)70387-0;7155 screened participants;7155;-1
S1470-2045(14)70387-0;7915 participants;7915;-1
S1470-2045(14)70387-0;7438 Dutch participants;7438;-1
S1470-2045(14)70387-0;7907 participants;7907;-1
S1470-2045(14)70387-0;477 Belgian participants;477;-1
S1470-2045(14)70387-0;283 participants;283;-1
S1470-2045(14)70387-0;477 participants;477;-1
S1470-2045(14)70387-0;7438 participants;7438;-1
S1470-2045(14)70387-0;187 participants;187;-1
S1470-2045(14)70387-0;19 participants;19;-1
S1470-2045(14)70387-0;34 participants;34;-1
S1470-2045(14)70387-0;15 participants;15;-1
S1470-2045(14)70387-0;34 patients;34;-1
S1470-2045(14)70387-0;15 822 individuals;15822;-1
S1470-2045(14)70387-0;n=15 822;15822;-1
S1470-2045(14)70387-0;n=7155;7155;-1
S1470-2045(14)70387-0;n=8667;8667;-1
S1470-2045(14)70387-0;n=61;61;-1
S1470-2045(14)70387-0;n=25;25;-1
S1470-2045(14)70387-0;n=110;110;-1
S1470-2045(14)70387-0;n=42;42;-1
S1470-2045(14)70387-0;n=1;1;-1
S1470-2045(14)70387-0;n=54;54;-1
S1470-2045(14)70387-0;n=79;79;-1
S1470-2045(14)70387-0;n=145;145;-1
S1470-2045(14)70387-0;n=94;94;-1
S1470-2045(14)70387-0;n=3;3;-1
S1470-2045(14)70387-0;n=7915;7915;-1
S1470-2045(14)70387-0;n=7907;7907;-1
S1470-2045(14)70387-0;n=5;5;-1
S1470-2045(14)70387-0;n=7;7;-1
S1470-2045(14)70387-0;n=12;12;-1
S1470-2045(14)70387-0;n=19;19;-1
S1470-2045(14)70387-0;n=34;34;-1
S1470-2045(14)70387-0;n=6934;6934;-1
S1470-2045(14)70387-0;n=187;187;-1
S1470-2045(14)70387-0;n=66;66;-1
S1470-2045(14)70387-0;n=56;56;-1
S1470-2045(14)70387-0;n=74;74;-1
S1470-2045(14)70387-0;n=4;4;-1
S1470-2045(14)70387-0;n=196;196;-1
S1470-2045(14)70387-0;n=16;16;-1
S1470-2045(14)70387-0;n=35;35;-1
S1470-2045(14)70387-0;n=231;231;-1
S1470-2045(14)70387-0;total of 196;196;-1
S1470-2045(14)70387-0;total of 35;35;-1
S1470-2045(14)70387-0;15 822 participants were enrolled;15822;-1
S1470-2045(14)70387-0;15 822 participants enrolled;15822;-1
S1470-2045(14)70388-2;n=40;40;-1
S1470-2045(14)70389-4;7438 participants were   women;7438;-1
S1470-2045(14)70389-4;7155 participants;7155;-1
S1470-2045(14)70389-4;14  Methods  Study design and participants;14;-1
S1470-2045(14)70389-4;15 822 participants;15822;-1
S1470-2045(14)70389-4;7907 participants;7907;-1
S1470-2045(14)70389-4;477 participants;477;-1
S1470-2045(14)70389-4;283 participants;283;-1
S1470-2045(14)70389-4;7438 participants;7438;-1
S1470-2045(14)70389-4;283 Dutch participants;283;-1
S1470-2045(14)70389-4;27 Dutch participants;27;-1
S1470-2045(14)70389-4;239 Dutch   participants;239;-1
S1470-2045(14)70389-4;935 Belgian participants;935;-1
S1470-2045(14)70389-4;14 887 Dutch participants;14887;-1
S1470-2045(14)70389-4;7449 participants;7449;-1
S1470-2045(14)70389-4;0001  All participants;1;-1
S1470-2045(14)70389-4;n=3;3;-1
S1470-2045(14)70389-4;n=16;16;-1
S1470-2045(14)70389-4;n=5;5;-1
S1470-2045(14)70389-4;n=61;61;-1
S1470-2045(14)70389-4;n=25;25;-1
S1470-2045(14)70389-4;n=110;110;-1
S1470-2045(14)70389-4;n=42;42;-1
S1470-2045(14)70389-4;n=1;1;-1
S1470-2045(14)70389-4;n=7135;7135;-1
S1470-2045(14)70389-4;n=66;66;-1
S1470-2045(14)70389-4;total of 15 822;15822;-1
S1470-2045(14)70389-4;15 822 participants were enrolled;15822;-1
S1470-2045(14)70389-4;15 822 participants enrolled;15822;-1
S1470-2045(14)70390-0;1071 patients;1071;-1
S1470-2045(14)70390-0;44 patients;44;-1
S1470-2045(14)70390-0;64 patients;64;-1
S1470-2045(14)70390-0;21 patients;21;-1
S1470-2045(14)70390-0;8 In ALK inhibitor-naive   patients;8;-1
S1470-2045(14)70390-0;12 patients;12;-1
S1470-2045(14)70390-0;10   patients;10;-1
S1470-2045(14)70390-0;141 assessable patients;141;-1
S1470-2045(14)70390-0;n=17;17;-1
S1470-2045(14)70391-2;46 women;46;-1
S1470-2045(14)70391-2;47 women;47;-1
S1470-2045(14)70391-2;43 women;43;-1
S1470-2045(14)70391-2;22 women;22;-1
S1470-2045(14)70391-2;24 women;24;-1
S1470-2045(14)70391-2;2 trial is no longer accruing patients;2;-1
S1470-2045(14)70391-2;12 patients;12;-1
S1470-2045(14)70391-2;90 patients;90;-1
S1470-2045(14)70391-2;46 patients;46;-1
S1470-2045(14)70391-2;44 patients;44;-1
S1470-2045(14)70391-2;19 patients;19;-1
S1470-2045(14)70391-2;90 enrolled patients;90;-1
S1470-2045(14)70391-2;n=46;46;-1
S1470-2045(14)70391-2;n=44;44;-1
S1470-2045(14)70391-2;90 patients were   enrolled;90;-1
S1470-2045(14)70391-2;90 enrolled;90;-1
S1470-2045(14)70396-1;127 patients;127;-1
S1470-2045(14)70396-1;20 patients;20;-1
S1470-2045(14)70399-7;40 patients;40;-1
S1470-2045(14)70402-4;1139 patients;1139;-1
S1470-2045(14)70402-4;419 patients;419;-1
S1470-2045(14)70402-4;416 patients;416;-1
S1470-2045(14)70402-4;411 patients;411;-1
S1470-2045(14)70402-4;1220 randomised patients;1220;-1
S1470-2045(14)70402-4;1139 eligible patients;1139;-1
S1470-2045(14)70402-4;571 patients;571;-1
S1470-2045(14)70402-4;305 patients;305;-1
S1470-2045(14)70402-4;568 patients;568;-1
S1470-2045(14)70402-4;831 patients;831;-1
S1470-2045(14)70402-4;835 patients;835;-1
S1470-2045(14)70402-4;13 randomised only   patients;13;-1
S1470-2045(14)70402-4;138 patients;138;-1
S1470-2045(14)70402-4;81 patients;81;-1
S1470-2045(14)70402-4;n=571;571;-1
S1470-2045(14)70402-4;n=568;568;-1
S1470-2045(14)70402-4;n=0;0;-1
S1470-2045(14)70402-4;n=308;308;-1
S1470-2045(14)70402-4;n=297;297;-1
S1470-2045(14)70402-4;n=314;314;-1
S1470-2045(14)70402-4;n=220;220;-1
S1470-2045(14)70402-4;n=1139;1139;-1
S1470-2045(14)70402-4;n=831;831;-1
S1470-2045(14)70402-4;n=770;770;-1
S1470-2045(14)70402-4;n=369;369;-1
S1470-2045(14)70402-4;n=910;910;-1
S1470-2045(14)70402-4;n=229;229;-1
S1470-2045(14)70402-4;n=906;906;-1
S1470-2045(14)70402-4;n=233;233;-1
S1470-2045(14)70402-4;n=320;320;-1
S1470-2045(14)70402-4;n=576;576;-1
S1470-2045(14)70402-4;n=243;243;-1
S1470-2045(14)70402-4;n=263;263;-1
S1470-2045(14)70402-4;n=683;683;-1
S1470-2045(14)70402-4;n=148;148;-1
S1470-2045(14)70402-4;n=660;660;-1
S1470-2045(14)70402-4;n=171;171;-1
S1470-2045(14)70402-4;n=247;247;-1
S1470-2045(14)70402-4;n=470;470;-1
S1470-2045(14)70402-4;n=114;114;-1
S1470-2045(14)70402-4;total of 831;831;-1
S1470-2045(14)70418-8;31 000 screening participants;31000;-1
S1470-2045(14)70420-6;665 patients;665;-1
S1470-2045(14)70420-6;663 patients;663;-1
S1470-2045(14)70420-6;794 screened patients;794;-1
S1470-2045(14)70420-6;794 patients;794;-1
S1470-2045(14)70420-6;327 patients;327;-1
S1470-2045(14)70420-6;329 patients;329;-1
S1470-2045(14)70420-6;656 patients;656;-1
S1470-2045(14)70420-6;5  Any patients;5;-1
S1470-2045(14)70420-6;17 patients;17;-1
S1470-2045(14)70420-6;n=330;330;-1
S1470-2045(14)70420-6;n=335;335;-1
S1470-2045(14)70420-6;N=330;330;-1
S1470-2045(14)70420-6;N=335;335;-1
S1470-2045(14)70420-6;n=398;398;-1
S1470-2045(14)70420-6;n=44;44;-1
S1470-2045(14)70420-6;n=223;223;-1
S1470-2045(14)70420-6;n=327;327;-1
S1470-2045(14)70420-6;n=329;329;-1
S1470-2045(14)70421-8;44 patients;44;-1
S1470-2045(14)70439-5;494 patients;494;-1
S1470-2045(14)70439-5;245 patients;245;-1
S1470-2045(14)70439-5;238 patients;238;-1
S1470-2045(14)70439-5;6   In patients;6;-1
S1470-2045(14)70439-5;76 patients;76;-1
S1470-2045(14)70439-5;488 patients;488;-1
S1470-2045(14)70439-5;247 patients;247;-1
S1470-2045(14)70439-5;50 patients;50;-1
S1470-2045(14)70439-5;102 patients;102;-1
S1470-2045(14)70439-5;98 patients;98;-1
S1470-2045(14)70439-5;483 patients;483;-1
S1470-2045(14)70439-5;494 patients   recruited;494;-1
S1470-2045(14)70439-5;n=247;247;-1
S1470-2045(14)70439-5;n=494;494;-1
S1470-2045(14)70439-5;n=238;238;-1
S1470-2045(14)70439-5;n=245;245;-1
S1470-2045(14)70439-5;n=483;483;-1
S1470-2045(14)70439-5; data cut-off , 102;102;-1
S1470-2045(14)70440-1;3 trial of patients;3;-1
S1470-2045(14)70440-1;768 patients;768;-1
S1470-2045(14)70440-1;381 patients;381;-1
S1470-2045(14)70440-1;377 patients;377;-1
S1470-2045(14)70440-1;1062 patients;1062;-1
S1470-2045(14)70440-1;n=387;387;-1
S1470-2045(14)70440-1;n=381;381;-1
S1470-2045(14)70440-1;n=768;768;-1
S1470-2045(14)70440-1;n=499;499;-1
S1470-2045(14)70440-1;n=232;232;-1
S1470-2045(14)70440-1;n=37;37;-1
S1470-2045(14)70440-1;n=407;407;-1
S1470-2045(14)70440-1;n=361;361;-1
S1470-2045(14)70440-1;n=445;445;-1
S1470-2045(14)70440-1;n=323;323;-1
S1470-2045(14)70440-1;n=308;308;-1
S1470-2045(14)70440-1;n=359;359;-1
S1470-2045(14)70440-1;n=249;249;-1
S1470-2045(14)70440-1;n=514;514;-1
S1470-2045(14)70440-1;n=352;352;-1
S1470-2045(14)70440-1;n=416;416;-1
S1470-2045(14)70440-1;n=432;432;-1
S1470-2045(14)70440-1;n=336;336;-1
S1470-2045(14)70440-1;n=329;329;-1
S1470-2045(14)70440-1;n=439;439;-1
S1470-2045(14)70440-1;n=283;283;-1
S1470-2045(14)70440-1;n=485;485;-1
S1470-2045(14)70440-1;n=570;570;-1
S1470-2045(14)70440-1;n=198;198;-1
S1470-2045(14)70440-1;n=122;122;-1
S1470-2045(14)70440-1;n=378;378;-1
S1470-2045(14)70440-1;n=195;195;-1
S1470-2045(14)70440-1;n=73;73;-1
S1470-2045(14)70440-1;n=275;275;-1
S1470-2045(14)70440-1;n=482;482;-1
S1470-2045(14)70440-1;n=167;167;-1
S1470-2045(14)70440-1;n=377;377;-1
S1470-2045(14)70440-1;n=2;2;-1
S1470-2045(14)70440-1;n=7;7;-1
S1470-2045(14)70440-1;n=1;1;-1
S1470-2045(14)70440-1;n=4;4;-1
S1470-2045(14)70440-1;768 patients were enrolled;768;-1
S1470-2045(14)70440-1;294 not enrolled;294;-1
S1470-2045(14)70440-1;2 was enrolled;2;-1
S1470-2045(14)70440-1;   data cutoff , 286;286;-1
S1470-2045(14)70441-3;100 000 persons;100000;-1
S1470-2045(14)70441-3;4 In individual   patients;4;-1
S1470-2045(14)70441-3;127 patients;127;-1
S1470-2045(14)70443-7;768 patients;768;-1
S1470-2045(14)70443-7;758 patients;758;-1
S1470-2045(14)70444-9;284 patients;284;-1
S1470-2045(14)70444-9;91 patients;91;-1
S1470-2045(14)70444-9;92 patients;92;-1
S1470-2045(14)70444-9;230 patients;230;-1
S1470-2045(14)70444-9;331 patients;331;-1
S1470-2045(14)70444-9;360 patients;360;-1
S1470-2045(14)70444-9;287 patients;287;-1
S1470-2045(14)70444-9;94 patients;94;-1
S1470-2045(14)70444-9;0  Data are number of patients;0;-1
S1470-2045(14)70444-9;3 trials of patients;3;-1
S1470-2045(14)70444-9;3 trial of patients;3;-1
S1470-2045(14)70444-9;n=99;99;-1
S1470-2045(14)70444-9;n=185;185;-1
S1470-2045(14)70444-9;n=92;92;-1
S1470-2045(14)70444-9;n=91;91;-1
S1470-2045(14)70444-9;n=94;94;-1
S1470-2045(14)70444-9;n=284;284;-1
S1470-2045(14)70444-9;287 enrolled;287;-1
S1470-2045(14)70444-9;287 patients were enrolled;287;-1
S1470-2045(14)70453-X;20 patients;20;-1
S1470-2045(14)70455-3;110 patients;110;21104
S1470-2045(14)70455-3;103 evaluable patients;103;20927
S1470-2045(14)70455-3;28 patients;28;20776
S1470-2045(14)70455-3;46 evaluable patients;46;20747
S1470-2045(14)70455-3;27 evaluable patients;27;20612
S1470-2045(14)70455-3;30 evaluable patients;30;20485
S1470-2045(14)70455-3;30 patients;30;12515
S1470-2045(14)70455-3;50 patients;50;12315
S1470-2045(14)70455-3;32 All patients;32;9441
S1470-2045(14)70455-3;33 Seven patients;33;9287
S1470-2045(14)70455-3;103 patients;103;5515
S1470-2045(14)70455-3;45 patients;45;4417
S1470-2045(14)70455-3;18 patients;18;2803
S1470-2045(14)70455-3;13 patients;13;2017
S1470-2045(14)70455-3;27 patients;27;1825
S1470-2045(14)70455-3;n=50;50;21065
S1470-2045(14)70455-3;n=30;30;21034
S1470-2045(14)70455-3;n=5;5;21065
S1470-2045(14)70455-3;n=1;1;9145
S1470-2045(14)70455-3;n=2;2;5803
S1470-2045(14)70455-3;110 patients enrolled;110;9792
S1470-2045(14)70456-5;100 000 women;100000;-1
S1470-2045(14)70456-5;15 women;15;-1
S1470-2045(14)70456-5;67 women;67;-1
S1470-2045(14)70456-5;180 participants;180;-1
S1470-2045(14)70456-5;87 participants;87;-1
S1470-2045(14)70456-5;174 participants;174;-1
S1470-2045(14)70456-5;89 patients;89;-1
S1470-2045(14)70456-5;84 patients;84;-1
S1470-2045(14)70456-5;0  Data are number of patients;0;-1
S1470-2045(14)70456-5;180 patients;180;-1
S1470-2045(14)70456-5;91 patients;91;-1
S1470-2045(14)70456-5;87 patients;87;-1
S1470-2045(14)70456-5;72 patients;72;-1
S1470-2045(14)70456-5;69 patients;69;-1
S1470-2045(14)70456-5;91   patients;91;-1
S1470-2045(14)70456-5;87   patients;87;-1
S1470-2045(14)70456-5;23 patients;23;-1
S1470-2045(14)70456-5;83 patients;83;-1
S1470-2045(14)70456-5;62 patients;62;-1
S1470-2045(14)70456-5;32 patients;32;-1
S1470-2045(14)70456-5;33 patients;33;-1
S1470-2045(14)70456-5;3322 published patients;3322;-1
S1470-2045(14)70456-5;89 individuals;89;-1
S1470-2045(14)70456-5;n=89;89;-1
S1470-2045(14)70456-5;n=91;91;-1
S1470-2045(14)70456-5;n=84;84;-1
S1470-2045(14)70456-5;n=72;72;-1
S1470-2045(14)70456-5;n=69;69;-1
S1470-2045(14)70456-5;total of   174;174;-1
S1470-2045(14)70456-5;180 participants were enrolled;180;-1
S1470-2045(14)70456-5;182 enrolled;182;-1
S1470-2045(14)70458-9;total of   5;5;-1
S1470-2045(14)70459-0;100 000 persons;100000;-1
S1470-2045(14)70459-0;4 In individual   patients;4;-1
S1470-2045(14)70460-7;4823 patients;4823;-1
S1470-2045(14)70460-7;2402 patients;2402;-1
S1470-2045(14)70460-7;1425 patients;1425;-1
S1470-2045(14)70460-7;672 patients;672;-1
S1470-2045(14)70460-7;744 patients;744;-1
S1470-2045(14)70460-7;17 patients;17;-1
S1470-2045(14)70460-7;4806 patients;4806;-1
S1470-2045(14)70460-7;132 patients;132;-1
S1470-2045(14)70460-7;41 patients;41;-1
S1470-2045(14)70460-7;12 patients;12;-1
S1470-2045(14)70460-7;3131 patients;3131;-1
S1470-2045(14)70460-7;1265 patients;1265;-1
S1470-2045(14)70460-7;655 patients;655;-1
S1470-2045(14)70460-7;586 patients;586;-1
S1470-2045(14)70460-7;26 When those patients;26;-1
S1470-2045(14)70460-7;72 patients;72;-1
S1470-2045(14)70460-7;34  Articles  patients;34;-1
S1470-2045(14)70460-7;n=744;744;-1
S1470-2045(14)70460-7;n=681;681;-1
S1470-2045(14)70460-7;4823 patients were enrolled;4823;-1
S1470-2045(14)70460-7;4823 patients   were enrolled;4823;-1
S1470-2045(14)70460-7; data cutoff  of Oct 31;31;-1
S1470-2045(14)70461-9;89 patients;89;-1
S1470-2045(14)70461-9;121 patients;121;-1
S1470-2045(14)70461-9;0  Proportion of patients;0;-1
S1470-2045(14)70461-9;20 and defi ned patients;20;-1
S1470-2045(14)70461-9;80 patients;80;-1
S1470-2045(14)70461-9;89 enrolled patients;89;-1
S1470-2045(14)70461-9;45 patients;45;-1
S1470-2045(14)70461-9;31 patients;31;-1
S1470-2045(14)70461-9;16 patients;16;-1
S1470-2045(14)70461-9;23 patients;23;-1
S1470-2045(14)70461-9;1 study all patients;1;-1
S1470-2045(14)70461-9;155 patients;155;-1
S1470-2045(14)70461-9;n=25;25;-1
S1470-2045(14)70461-9;n=20;20;-1
S1470-2045(14)70461-9;n=89;89;-1
S1470-2045(14)70461-9;n=45;45;-1
S1470-2045(14)70461-9;n=8;8;-1
S1470-2045(14)70461-9;n=14;14;-1
S1470-2045(14)70461-9;n=22;22;-1
S1470-2045(14)70461-9;89 patients   were enrolled;89;-1
S1470-2045(14)70461-9;89 enrolled;89;-1
S1470-2045(14)70461-9; data cutoff , 61;61;-1
S1470-2045(14)70461-9; data   cutoff , 24;24;-1
S1470-2045(14)70461-9; data of 10;10;-1
S1470-2045(14)70463-2;2314 patients;2314;-1
S1470-2045(14)70463-2;791 patients;791;-1
S1470-2045(14)70464-4;214 participants;214;-1
S1470-2045(14)70464-4;35 study   participants;35;-1
S1470-2045(14)70473-5;16  Methods  Study design  and participants;16;-1
S1470-2045(14)70473-5;1035 participants;1035;-1
S1470-2045(14)70473-5;1035 patients;1035;-1
S1470-2045(14)70473-5;103 patients;103;-1
S1470-2045(14)70473-5;141 patients;141;-1
S1470-2045(14)70473-5;16 Eligible patients;16;-1
S1470-2045(14)70473-5;512 patients;512;-1
S1470-2045(14)70473-5;973 patients;973;-1
S1470-2045(14)70473-5;62 patients;62;-1
S1470-2045(14)70473-5;520 patients;520;-1
S1470-2045(14)70473-5;515 patients;515;-1
S1470-2045(14)70473-5;52 patients;52;-1
S1470-2045(14)70473-5;3838 patients;3838;-1
S1470-2045(14)70473-5;15 patients;15;-1
S1470-2045(14)70473-5;n=188;188;-1
S1470-2045(14)70473-5;n=118;118;-1
S1470-2045(14)70473-5;n=520;520;-1
S1470-2045(14)70473-5;n=515;515;-1
S1470-2045(14)70473-5;n=203;203;-1
S1470-2045(14)70473-5;n=139;139;-1
S1470-2045(14)70473-5;1035 patients   were enrolled;1035;-1
S1470-2045(14)70474-7;921 randomly assigned   patients;921;-1
S1470-2045(14)70474-7;518 patients;518;-1
S1470-2045(14)70474-7;383 patients;383;-1
S1470-2045(14)70474-7;347 patients;347;-1
S1470-2045(14)70474-7;171 patients;171;-1
S1470-2045(14)70474-7;253 patients;253;-1
S1470-2045(14)70474-7;130 patients;130;-1
S1470-2045(14)70474-7;3 trial studied patients;3;-1
S1470-2045(14)70474-7;18 patients;18;-1
S1470-2045(14)70474-7;599 patients;599;-1
S1470-2045(14)70474-7;302 patients;302;-1
S1470-2045(14)70474-7;921 patients;921;-1
S1470-2045(14)70474-7;900 patients;900;-1
S1470-2045(14)70474-7;347 vs no patients;347;-1
S1470-2045(14)70474-7;352 patients;352;-1
S1470-2045(14)70474-7;600 patients;600;-1
S1470-2045(14)70474-7;600   patients;600;-1
S1470-2045(14)70474-7;n=352;352;-1
S1470-2045(14)70474-7;n=174;174;-1
S1470-2045(14)70474-7;n=262;262;-1
S1470-2045(14)70474-7;n=133;133;-1
S1470-2045(14)70474-7;n=307;307;-1
S1470-2045(14)70474-7;n=151;151;-1
S1470-2045(14)70474-7;n=236;236;-1
S1470-2045(14)70474-7;n=120;120;-1
S1470-2045(14)70474-7;n=290;290;-1
S1470-2045(14)70474-7;n=139;139;-1
S1470-2045(14)70474-7;n=   236;236;-1
S1470-2045(14)70474-7;n=119;119;-1
S1470-2045(14)70474-7;n=347;347;-1
S1470-2045(14)70474-7;n=171;171;-1
S1470-2045(14)70474-7;n=253;253;-1
S1470-2045(14)70474-7;n=130;130;-1
S1470-2045(14)70474-7;921 patients enrolled;921;-1
S1470-2045(14)70475-9;152 women;152;-1
S1470-2045(14)70475-9;40 women;40;-1
S1470-2045(14)70475-9;29 women;29;-1
S1470-2045(14)70475-9;30 women;30;-1
S1470-2045(14)70475-9;98   women;98;-1
S1470-2045(14)70475-9;152 patients;152;-1
S1470-2045(14)70475-9;142 patients;142;-1
S1470-2045(14)70475-9;15 patients;15;-1
S1470-2045(14)70475-9;67 patients;67;-1
S1470-2045(14)70475-9;47 patients;47;-1
S1470-2045(14)70475-9;25 patients;25;-1
S1470-2045(14)70475-9;52 patients;52;-1
S1470-2045(14)70475-9;26 patients;26;-1
S1470-2045(14)70475-9;48 patients;48;-1
S1470-2045(14)70475-9;135 patients;135;-1
S1470-2045(14)70475-9;176 patients;176;-1
S1470-2045(14)70475-9;24 patients;24;-1
S1470-2045(14)70475-9;12 patients;12;-1
S1470-2045(14)70475-9;73 patients;73;-1
S1470-2045(14)70475-9;69 patients;69;-1
S1470-2045(14)70475-9;60 patients;60;-1
S1470-2045(14)70475-9;1206 patients;1206;-1
S1470-2045(14)70475-9;2447 patients;2447;-1
S1470-2045(14)70475-9;2 positive breast cancer   patients;2;-1
S1470-2045(14)70475-9;152 patients were recruited;152;-1
S1470-2045(14)70475-9;n=48;48;-1
S1470-2045(14)70475-9;n=25;25;-1
S1470-2045(14)70475-9;n=139;139;-1
S1470-2045(14)70475-9;n=69;69;-1
S1470-2045(14)70475-9;n=67;67;-1
S1470-2045(14)70475-9;n=47;47;-1
S1470-2045(14)70475-9;152 patients enrolled;152;-1
S1470-2045(14)70475-9; data from 2447;2447;-1
S1470-2045(14)70486-3;8734 patients;8734;-1
S1470-2045(14)70486-3;8734 total patients;8734;-1
S1470-2045(14)70486-3;1982 patients;1982;-1
S1470-2045(14)70486-3;2867 patients;2867;-1
S1470-2045(14)70486-3;1881 patients;1881;-1
S1470-2045(14)70486-3;2004 patients;2004;-1
S1470-2045(14)70486-3;982 patients;982;-1
S1470-2045(14)70486-3;942 patients;942;-1
S1470-2045(14)70486-3;1000 patients;1000;-1
S1470-2045(14)70486-3;5819 patients;5819;-1
S1470-2045(14)70486-3;1942 patients;1942;-1
S1470-2045(14)70486-3;952   patients;952;-1
S1470-2045(14)70486-3;3829 patients;3829;-1
S1470-2045(14)70486-3;1927 patients;1927;-1
S1470-2045(14)70486-3;757 patients;757;-1
S1470-2045(14)70486-3;659 patients;659;-1
S1470-2045(14)70486-3;1222 patients;1222;-1
S1470-2045(14)70486-3;n=1921;1921;-1
S1470-2045(14)70486-3;n=2898;2898;-1
S1470-2045(14)70486-3;n=3877;3877;-1
S1470-2045(14)70486-3;n=1942;1942;-1
S1470-2045(14)70486-3;n=1000;1000;-1
S1470-2045(14)70486-3;n=942;942;-1
S1470-2045(14)70486-3;N=744;744;-1
S1470-2045(14)70486-3;N=757;757;-1
S1470-2045(14)70486-3;N=1222;1222;-1
S1470-2045(14)70486-3;N=659;659;-1
S1470-2045(14)70486-3;n=322;322;-1
S1470-2045(14)70486-3;n=584;584;-1
S1470-2045(14)70486-3;n=3829;3829;-1
S1470-2045(14)70486-3;n=1927;1927;-1
S1470-2045(14)70486-3;N=8734;8734;-1
S1470-2045(14)70486-3;n=744;744;-1
S1470-2045(14)70486-3;n=499;499;-1
S1470-2045(14)70486-3;n=964;964;-1
S1470-2045(14)70486-3;n=659;659;-1
S1470-2045(14)70486-3;n=380;380;-1
S1470-2045(14)70486-3;n=279;279;-1
S1470-2045(14)70486-3;total of 5819;5819;-1
S1470-2045(14)70486-3;total of 1942;1942;-1
S1470-2045(14)70486-3;total of 757;757;-1
S1470-2045(14)70487-5;89 patients;89;-1
S1470-2045(14)70487-5;45 patients;45;-1
S1470-2045(14)70488-7;110 patients;110;-1
S1470-2045(14)70488-7;18 patients;18;-1
S1470-2045(14)70489-9;47 women;47;-1
S1470-2045(14)70489-9;28 women;28;-1
S1470-2045(14)70489-9;52 women;52;-1
S1470-2045(14)70489-9;117 randomly assigned patients;117;-1
S1470-2045(14)70489-9;105 patients;105;-1
S1470-2045(14)70489-9;104 patients;104;-1
S1470-2045(14)70489-9;76 patients;76;-1
S1470-2045(14)70489-9;29 patients;29;-1
S1470-2045(14)70489-9;78 patients;78;-1
S1470-2045(14)70489-9;18 patients;18;-1
S1470-2045(14)70489-9;117 patients;117;-1
S1470-2045(14)70489-9;111 patients;111;-1
S1470-2045(14)70489-9;41 patients;41;-1
S1470-2045(14)70489-9;34 patients;34;-1
S1470-2045(14)70489-9;110 patients;110;-1
S1470-2045(14)70489-9;79 patients;79;-1
S1470-2045(14)70489-9;12 patients;12;-1
S1470-2045(14)70489-9;1 million people;1;-1
S1470-2045(14)70489-9;N=111;111;-1
S1470-2045(14)70489-9;n=4;4;-1
S1470-2045(14)70489-9;n=106;106;-1
S1470-2045(14)70489-9;n=105;105;-1
S1470-2045(14)70489-9;n=104;104;-1
S1470-2045(14)70489-9;n=76;76;-1
S1470-2045(14)70489-9;n=29;29;-1
S1470-2045(14)70489-9;n=75;75;-1
S1470-2045(14)70489-9;n=19;19;-1
S1470-2045(14)70489-9;total of 25;25;-1
S1470-2045(14)70489-9;117 patients were enrolled;117;-1
S1470-2045(14)70490-5;263 patients;263;-1
S1470-2045(14)70490-5;16 A subgroup of   patients;16;-1
S1470-2045(14)70490-5;196 patients;196;-1
S1470-2045(14)70490-5;240 patients;240;-1
S1470-2045(14)70490-5;254 patients;254;-1
S1470-2045(14)70490-5;253 patients;253;-1
S1470-2045(14)70490-5;97 patients;97;-1
S1470-2045(14)70490-5;94 patients;94;-1
S1470-2045(14)70490-5;91 patients;91;-1
S1470-2045(14)70490-5;105 patients;105;-1
S1470-2045(14)70490-5;103 remaining patients;103;-1
S1470-2045(14)70490-5;103 patients;103;-1
S1470-2045(14)70490-5;12 patients;12;-1
S1470-2045(14)70490-5;93 patients;93;-1
S1470-2045(14)70490-5;98 patients;98;-1
S1470-2045(14)70490-5;51 patients;51;-1
S1470-2045(14)70490-5;64 patients;64;-1
S1470-2045(14)70490-5;72 patients;72;-1
S1470-2045(14)70490-5;11 we selected patients;11;-1
S1470-2045(14)70490-5;0  Unfav-BEP=patients;0;-1
S1470-2045(14)70490-5;n=98;98;-1
S1470-2045(14)70490-5;n=105;105;-1
S1470-2045(14)70490-5;n=51;51;-1
S1470-2045(14)70490-5;total of 240;240;-1
S1470-2045(14)70490-5;263 patients were enrolled;263;-1
S1470-2045(14)70490-5;263 patients   were enrolled;263;-1
S1470-2045(14)70491-7;89 patients;89;-1
S1470-2045(14)70491-7;91 patients;91;-1
S1470-2045(14)70491-7;84 patients;84;-1
S1470-2045(14)70491-7;15 patients;15;-1
S1470-2045(14)70491-7;3322 published patients;3322;-1
S1470-2045(14)71017-4;48 eligible patients;48;12715
S1470-2045(14)71017-4;48 patients;48;969
S1470-2045(14)71017-4;48 eligible   patients;48;521
S1470-2045(14)71017-4;45 assessable patients;45;3845
S1470-2045(14)71017-4;47 surviving patients;47;4010
S1470-2045(14)71017-4;40 surviving patients;40;4097
S1470-2045(14)71017-4;11 patients;11;5008
S1470-2045(14)71017-4;48 treated patients;48;7314
S1470-2045(14)71017-4;15 patients;15;7619
S1470-2045(14)71017-4;44 patients;44;7780
S1470-2045(14)71017-4;30 patients;30;7830
S1470-2045(14)71017-4;40 patients;40;7870
S1470-2045(14)71017-4;39 patients;39;7979
S1470-2045(14)71017-4;53 untreated patients;53;18947
S1470-2045(14)71017-4;n=48;48;871
S1470-2045(14)71017-4;n=27;27;2294
S1470-2045(14)71017-4;n=26;26;2337
S1470-2045(14)71018-6;1 patients;1;-1
S1470-2045(14)71018-6;1 specifi cally excluded those patients;1;-1
S1470-2045(14)71018-6;110 patients;110;-1
S1470-2045(14)71018-6;18 patients;18;-1
S1470-2045(14)71019-8;335   Japanese lung cancer patients;335;-1
S1470-2045(14)71020-4;142 patients;142;-1
S1470-2045(14)71020-4;73 patients;73;-1
S1470-2045(14)71020-4;48 patients;48;-1
S1470-2045(14)71021-6;3  Low-risk patients;3;-1
S1470-2045(14)71021-6;126 patients;126;-1
S1470-2045(14)71021-6;1 patients;1;-1
S1470-2045(14)71021-6;3 patients;3;-1
S1470-2045(14)71021-6;2 patients;2;-1
S1470-2045(14)71021-6;250 patients;250;-1
S1470-2045(14)71021-6;108 MSKCC patients;108;-1
S1470-2045(14)71021-6;110 Cambridge   patients;110;-1
S1470-2045(14)71021-6;108 MSKCC   patients;108;-1
S1470-2045(14)71021-6;39 patients;39;-1
S1470-2045(14)71021-6;1000 patients;1000;-1
S1470-2045(14)71021-6;144 patients;144;-1
S1470-2045(14)71021-6;n=210;210;-1
S1470-2045(14)71021-6;n=271;271;-1
S1470-2045(14)71021-6;n=336;336;-1
S1470-2045(14)71027-7;335   Japanese lung cancer patients;335;-1
S1470-2045(14)71034-4;142 patients;142;-1
S1470-2045(14)71034-4;73 patients;73;-1
S1470-2045(14)71035-6;260 women;260;-1
S1470-2045(14)71035-6;77 women;77;-1
S1470-2045(14)71035-6;73 women;73;-1
S1470-2045(14)71035-6;1008 women;1008;-1
S1470-2045(14)71035-6;310 women;310;-1
S1470-2045(14)71035-6;342 women;342;-1
S1470-2045(14)71035-6;149 women;149;-1
S1470-2045(14)71035-6;46 women;46;-1
S1470-2045(14)71035-6;60 women;60;-1
S1470-2045(14)71035-6;12 Eligible women;12;-1
S1470-2045(14)71035-6;237 women;237;-1
S1470-2045(14)71035-6;257 women;257;-1
S1470-2045(14)71035-6;85 women;85;-1
S1470-2045(14)71035-6;68 women;68;-1
S1470-2045(14)71035-6;3864 women;3864;-1
S1470-2045(14)71035-6;500 women;500;-1
S1470-2045(14)71035-6;1410 postmenopausal women;1410;-1
S1470-2045(14)71035-6;358 women;358;-1
S1470-2045(14)71035-6;55 women;55;-1
S1470-2045(14)71035-6;13 of these women;13;-1
S1470-2045(14)71035-6;1410 women;1410;-1
S1470-2045(14)71035-6;866 women;866;-1
S1470-2045(14)71035-6;65 women;65;-1
S1470-2045(14)71035-6;20 women;20;-1
S1470-2045(14)71035-6;23 women;23;-1
S1470-2045(14)71035-6;109 women;109;-1
S1470-2045(14)71035-6;44 women;44;-1
S1470-2045(14)71035-6;51 women;51;-1
S1470-2045(14)71035-6;14 women;14;-1
S1470-2045(14)71035-6;711 women;711;-1
S1470-2045(14)71035-6;3864 women recruited;3864;-1
S1470-2045(14)71035-6;n=257;257;-1
S1470-2045(14)71035-6;n=237;237;-1
S1470-2045(14)71035-6;n=85;85;-1
S1470-2045(14)71035-6;n=68;68;-1
S1470-2045(14)71035-6;n=73;73;-1
S1470-2045(14)71035-6;n=77;77;-1
S1470-2045(14)71035-6;n=60;60;-1
S1470-2045(14)71035-6;n=46;46;-1
S1470-2045(14)71035-6;n=147;147;-1
S1470-2045(14)71035-6;n=142;142;-1
S1470-2045(14)71035-6;n=70;70;-1
S1470-2045(14)71035-6;n=58;58;-1
S1470-2045(14)71035-6;n=69;69;-1
S1470-2045(14)71035-6;n=67;67;-1
S1470-2045(14)71035-6;n=43;43;-1
S1470-2045(14)71035-6;n=31;31;-1
S1470-2045(14)71094-0;100 000 people;100000;-1
S1470-2045(14)71101-5;28 women;28;-1
S1470-2045(14)71101-5;105 patients;105;-1
S1470-2045(14)71101-5;76 patients;76;-1
S1470-2045(14)71101-5;1 million people;1;-1
S1470-2045(14)71103-9;1 only six patients;1;-1
S1470-2045(14)71105-2;48 patients;48;-1
S1470-2045(14)71105-2;1008 patients;1008;-1
S1470-2045(14)71113-1;1008 patients;1008;-1
S1470-2045(14)71113-1;212 patients;212;-1
S1470-2045(14)71113-1;333 patients;333;-1
S1470-2045(14)71113-1;2317 conservatively treated   patients;2317;-1
S1470-2045(14)71113-1;1 ratio of patients;1;-1
S1470-2045(14)71113-1;49 patients;49;-1
S1470-2045(14)71113-1;48 patients;48;-1
S1470-2045(14)71113-1;256 patients;256;-1
S1470-2045(14)71113-1;545 patients;545;-1
S1470-2045(14)71113-1;960 patients;960;-1
S1470-2045(14)71113-1;1000 patients;1000;-1
S1470-2045(14)71113-1;n=545;545;-1
S1470-2045(14)71113-1;n=212;212;-1
S1470-2045(14)71113-1;n=333;333;-1
S1470-2045(14)71113-1;n=232;232;-1
S1470-2045(14)71113-1;n=183;183;-1
S1470-2045(14)71113-1;n=75;75;-1
S1470-2045(14)71113-1;n=157;157;-1
S1470-2045(14)71113-1;n=49;49;-1
S1470-2045(14)71113-1;n=134;134;-1
S1470-2045(14)71113-1;n=9;9;-1
S1470-2045(14)71113-1;n=39;39;-1
S1470-2045(14)71113-1;n=48;48;-1
S1470-2045(14)71113-1;n=463;463;-1
S1470-2045(14)71113-1;n=  4;4;-1
S1470-2045(14)71113-1;n  =2;2;-1
S1470-2045(14)71113-1;n=  12;12;-1
S1470-2045(14)71113-1;n=  9;9;-1
S1470-2045(14)71113-1;n=  3;3;-1
S1470-2045(14)71113-1;n  =1;1;-1
S1470-2045(14)71113-1;n=  20;20;-1
S1470-2045(14)71113-1;n=  2;2;-1
S1470-2045(14)71113-1;n=  5;5;-1
S1470-2045(14)71113-1;n=  1;1;-1
S1470-2045(14)71113-1;n  =5;5;-1
S1470-2045(14)71113-1;n  =4;4;-1
S1470-2045(14)71113-1;n=  10;10;-1
S1470-2045(14)71113-1;n=  7;7;-1
S1470-2045(14)71113-1;n=  29;29;-1
S1470-2045(14)71113-1;n  =3;3;-1
S1470-2045(14)71113-1;n=  13;13;-1
S1470-2045(14)71113-1;n  =9;9;-1
S1470-2045(14)71113-1;n=  8;8;-1
S1470-2045(14)71113-1;n=  15;15;-1
S1470-2045(14)71113-1;n  =6;6;-1
S1470-2045(14)71113-1;n=960;960;-1
S1470-2045(14)71113-1;n=44;44;-1
S1470-2045(14)71113-1;n=37;37;-1
S1470-2045(14)71113-1;n=68;68;-1
S1470-2045(14)71113-1;n=230;230;-1
S1470-2045(14)71114-3;2 Studies of patients;2;-1
S1470-2045(14)71114-3;10 000 patients;10000;-1
S1470-2045(14)71122-2;205 women;205;-1
S1470-2045(14)71122-2;196 women;196;-1
S1470-2045(14)71122-2;130 men had accepted patients;130;-1
S1470-2045(14)71122-2;20 statements probing what individuals;20;-1
S1470-2045(14)71124-6;1008 patients;1008;-1
S1470-2045(14)71125-8;65 patients;65;-1
S1470-2045(14)71125-8;11 patients;11;-1
S1470-2045(14)71125-8;64 response-evaluable patients;64;-1
S1470-2045(14)71125-8;25 patients;25;-1
S1470-2045(14)71125-8;40 patients;40;-1
S1470-2045(14)71125-8;22 patients;22;-1
S1470-2045(14)71125-8;13 patients;13;-1
S1470-2045(14)71125-8;64 patients;64;-1
S1470-2045(14)71125-8;24 evaluable patients;24;-1
S1470-2045(14)71125-8;14 patients;14;-1
S1470-2045(14)71125-8;50 patients;50;-1
S1470-2045(14)71125-8;20 patients;20;-1
S1470-2045(14)71125-8;52 response-evaluable patients;52;-1
S1470-2045(14)71125-8;100  Individual patients;100;-1
S1470-2045(14)71125-8;n=15;15;-1
S1470-2045(14)71125-8;n=50;50;-1
S1470-2045(14)71125-8;n=65;65;-1
S1470-2045(14)71125-8;n=53;53;-1
S1470-2045(14)71125-8;n=25;25;-1
S1470-2045(14)71125-8;n=42;42;-1
S1470-2045(14)71125-8;n=49;49;-1
S1470-2045(14)71125-8;n=52;52;-1
S1470-2045(14)71125-8;n=64;64;-1
S1470-2045(14)71125-8;n=9;9;-1
S1470-2045(14)71125-8;n=21;21;-1
S1470-2045(14)71125-8;n=29;29;-1
S1470-2045(14)71125-8;65 patients were enrolled;65;-1
S1470-2045(14)71125-8;15 were enrolled;15;-1
S1470-2045(14)71125-8;50 were enrolled;50;-1
S1473-3099(13)70254-8;13 140 people;13140;-1
S1473-3099(13)70254-8;21 We excluded individuals;21;-1
S1473-3099(13)70254-8;50 copies per mL  All individuals;50;-1
S1473-3099(13)70254-8;5264 individuals;5264;-1
S1473-3099(13)70258-5;371 participants;371;-1
S1473-3099(13)70258-5;13 participants;13;-1
S1473-3099(13)70258-5;144 participants;144;-1
S1473-3099(13)70258-5;29 participants;29;-1
S1473-3099(13)70258-5;872 participants;872;-1
S1473-3099(13)70258-5;72 participants;72;-1
S1473-3099(13)70258-5;52 participants;52;-1
S1473-3099(13)70258-5;27 participants;27;-1
S1473-3099(13)70258-5;101 participants;101;-1
S1473-3099(13)70258-5;954 participants;954;-1
S1473-3099(13)70258-5;17 participants;17;-1
S1473-3099(13)70258-5;200 000 patients;200000;-1
S1473-3099(13)70258-5;185 individuals;185;-1
S1473-3099(13)70258-5;n=185;185;-1
S1473-3099(13)70258-5;n=186;186;-1
S1473-3099(13)70258-5;n=0;0;-1
S1473-3099(13)70268-8;468 participants;468;-1
S1473-3099(13)70268-8;22   Eligible participants;22;-1
S1473-3099(13)70268-8;120 participants;120;-1
S1473-3099(13)70268-8;460 participants;460;-1
S1473-3099(13)70268-8;99 participants;99;-1
S1473-3099(13)70268-8;50 participants;50;-1
S1473-3099(13)70268-8;1215 patients;1215;-1
S1473-3099(13)70268-8;n=117;117;-1
S1473-3099(13)70268-8;n=115;115;-1
S1473-3099(13)70268-8;n=113;113;-1
S1473-3099(13)70268-8;n=116;116;-1
S1473-3099(13)70284-6;27 patients;27;-1
S1473-3099(13)70284-6;9000 patients;9000;-1
S1473-3099(13)70288-3;6PD-defi cient patients;6;-1
S1473-3099(13)70294-9;6749 participants;6749;-1
S1473-3099(13)70294-9;11 950 patients;11950;-1
S1473-3099(13)70294-9;101 patients;101;-1
S1473-3099(13)70294-9;153 patients;153;-1
S1473-3099(13)70294-9;13 498 to allow for other patients;13498;-1
S1473-3099(13)70294-9;17 412 patients;17412;-1
S1473-3099(13)70294-9;12 829 adult patients;12829;-1
S1473-3099(13)70294-9;12 099 patients;12099;-1
S1473-3099(13)70294-9;11 patients;11;-1
S1473-3099(13)70294-9;29 patients;29;-1
S1473-3099(13)70294-9;87 people;87;-1
S1473-3099(13)70294-9;12 677 individuals;12677;-1
S1473-3099(13)70294-9;12 829 adults;12829;-1
S1473-3099(13)70294-9;12 829 adult patients were recruited;12829;-1
S1473-3099(13)70294-9;n=11 950;11950;-1
S1473-3099(13)70294-9;n=11 722;11722;-1
S1473-3099(13)70294-9;n=1107;1107;-1
S1473-3099(13)70294-9;n=1781;1781;-1
S1473-3099(13)70295-0;709 patients;709;-1
S1473-3099(13)70295-0;1334 patients;1334;-1
S1473-3099(13)70295-0;960 patients;960;-1
S1473-3099(13)70295-0;14 390 patients;14390;-1
S1473-3099(13)70295-0;8519 patients;8519;-1
S1473-3099(13)70295-0;8976 patients;8976;-1
S1473-3099(13)70295-0;8184 patients;8184;-1
S1473-3099(13)70295-0;500 patients;500;-1
S1473-3099(13)70295-0;n=2043;2043;-1
S1473-3099(13)70295-0;n=2072;2072;-1
S1473-3099(13)70295-0;n=2348;2348;-1
S1473-3099(13)70295-0;n=2513;2513;-1
S1473-3099(13)70295-0;n=3215;3215;-1
S1473-3099(13)70295-0;n=1962;1962;-1
S1473-3099(13)70295-0;n=1688;1688;-1
S1473-3099(13)70295-0;n=3345;3345;-1
S1473-3099(13)70295-0;n=1926;1926;-1
S1473-3099(13)70295-0;n=1681;1681;-1
S1473-3099(13)70295-0;n=3710;3710;-1
S1473-3099(13)70295-0;n=2280;2280;-1
S1473-3099(13)70295-0;n=2029;2029;-1
S1473-3099(13)70295-0;n=4120;4120;-1
S1473-3099(13)70295-0;n=2351;2351;-1
S1473-3099(13)70295-0;n=2007;2007;-1
S1473-3099(13)70295-0;n=979;979;-1
S1473-3099(13)70295-0;n=1020;1020;-1
S1473-3099(13)70295-0;n=983;983;-1
S1473-3099(13)70295-0;n=906;906;-1
S1473-3099(13)70297-4;2036 participants;2036;-1
S1473-3099(13)70297-4;821 participants;821;-1
S1473-3099(13)70297-4;1015 participants;1015;-1
S1473-3099(13)70297-4;1019 participants;1019;-1
S1473-3099(13)70297-4;25 participants;25;-1
S1473-3099(13)70297-4;849 participants;849;-1
S1473-3099(13)70297-4;842 participants;842;-1
S1473-3099(13)70297-4;1800 participants;1800;-1
S1473-3099(13)70297-4;2034 participants;2034;-1
S1473-3099(13)70297-4;1644 participants;1644;-1
S1473-3099(13)70297-4;417 LT-  vaccinated participants;417;-1
S1473-3099(13)70297-4;59 participants;59;-1
S1473-3099(13)70297-4;304 participants;304;-1
S1473-3099(13)70297-4;2036 participants were recruited;2036;-1
S1473-3099(13)70297-4;n=821;821;-1
S1473-3099(13)70297-4;n=823;823;-1
S1473-3099(13)70297-4;n=140;140;-1
S1473-3099(13)70297-4;n=125;125;-1
S1473-3099(13)70297-4;n=809;809;-1
S1473-3099(13)70297-4;n=814;814;-1
S1473-3099(13)70297-4;n=788;788;-1
S1473-3099(13)70297-4;n=804;804;-1
S1473-3099(13)70297-4;n=5;5;-1
S1473-3099(13)70297-4;n=268;268;-1
S1473-3099(13)70297-4;n=272;272;-1
S1473-3099(13)70297-4;n=259;259;-1
S1473-3099(13)70297-4;n=264;264;-1
S1473-3099(13)70297-4;n=279;279;-1
S1473-3099(13)70297-4;n=286;286;-1
S1473-3099(13)70297-4;n=321;321;-1
S1473-3099(13)70297-4;n=50 227;50227;-1
S1473-3099(13)70297-4;n=799;799;-1
S1473-3099(13)70297-4;n=1528;1528;-1
S1473-3099(13)70304-9;56 patients;56;-1
S1473-3099(13)70304-9;n=14;14;-1
S1473-3099(13)70304-9;n=4;4;-1
S1473-3099(13)70304-9;total of 940;940;-1
S1473-3099(13)70305-0;9000 patients;9000;-1
S1473-3099(13)70305-0;n=1966;1966;-1
S1473-3099(13)70305-0;n=346;346;-1
S1473-3099(13)70305-0;n=508;508;-1
S1473-3099(13)70319-0;400 patients;400;-1
S1473-3099(13)70323-2;100 million people;100;-1
S1473-3099(13)70323-2;438 individuals;438;-1
S1473-3099(13)70323-2;120 and   two other individuals;120;-1
S1473-3099(13)70323-2;n=16;16;-1
S1473-3099(13)70323-2;n=4;4;-1
S1473-3099(13)70323-2;n=2;2;-1
S1473-3099(13)70323-2;n=1;1;-1
S1473-3099(13)70323-2;n=12;12;-1
S1473-3099(13)70323-2;n=5;5;-1
S1473-3099(13)70323-2;n=9;9;-1
S1473-3099(13)70323-2;n=14;14;-1
S1473-3099(13)70323-2;n=6;6;-1
S1473-3099(13)70323-2;n=3;3;-1
S1473-3099(13)70323-2; data from A76;76;-1
S1473-3099(13)70325-6;1075 patients;1075;-1
S1473-3099(13)70329-3;77 people;77;-1
S1473-3099(13)70329-3;57 individuals;57;-1
S1473-3099(13)70332-3;100 000 people;100000;-1
S1473-3099(13)70332-3;4 million people;4;-1
S1473-3099(13)70338-4;15 876 participants;15876;-1
S1473-3099(13)70338-4;15 368 participants;15368;-1
S1473-3099(13)70338-4;15878 participants;15878;-1
S1473-3099(13)70338-4;7675 participants;7675;-1
S1473-3099(13)70338-4;8442 participants;8442;-1
S1473-3099(13)70338-4;14 865 participants;14865;-1
S1473-3099(13)70338-4;7559 participants;7559;-1
S1473-3099(13)70338-4;7674 participants;7674;-1
S1473-3099(13)70338-4;45 974 participants;45974;-1
S1473-3099(13)70338-4;20 327 participants;20327;-1
S1473-3099(13)70338-4;10 200 participants;10200;-1
S1473-3099(13)70338-4;47 366 individuals;47366;-1
S1473-3099(13)70338-4;n=651;651;-1
S1473-3099(13)70338-4;n=11;11;-1
S1473-3099(13)70338-4;n=20 327;20327;-1
S1473-3099(13)70338-4;n=10 200;10200;-1
S1473-3099(13)70338-4;47 000 children were enrolled;47000;-1
S1473-3099(13)70338-4;47 366 children enrolled;47366;-1
S1473-3099(13)70342-6;82486 patients;82486;-1
S1473-3099(13)70342-6;n=425;425;-1
S1473-3099(13)70342-6;n=25;25;-1
S1473-3099(13)70342-6;n=7 200 092;7200092;-1
S1473-3099(13)70342-6;n=2457;2457;-1
S1473-3099(13)70342-6;n=267 942;267942;-1
S1473-3099(13)70342-6;n=6 932 150;6932150;-1
S1473-3099(13)70343-8;345 participants;345;-1
S1473-3099(13)70343-8;136 participants;136;-1
S1473-3099(13)70343-8;20 participants;20;-1
S1473-3099(13)70343-8;100 participants;100;-1
S1473-3099(13)70343-8;4x treated   participants;4;-1
S1473-3099(13)70343-8;137 participants;137;-1
S1473-3099(13)70343-8;135 of   these participants;135;-1
S1473-3099(13)70343-8;135 participants;135;-1
S1473-3099(13)70343-8;4x participants Placebo participants;4;-1
S1473-3099(13)70343-8;43 placebo participants;43;-1
S1473-3099(13)70343-8;39 placebo participants;39;-1
S1473-3099(13)70343-8;32 placebo participants;32;-1
S1473-3099(13)70343-8;25 placebo participants;25;-1
S1473-3099(13)70343-8;18 placebo participants;18;-1
S1473-3099(13)70343-8;4x group two participants;4;-1
S1473-3099(13)70343-8;30 participants;30;-1
S1473-3099(13)70343-8;4x participants;4;-1
S1473-3099(13)70343-8;63 participants;63;-1
S1473-3099(13)70343-8;4x and placebo participants;4;-1
S1473-3099(13)70343-8;12  Articles  participants;12;-1
S1473-3099(13)70343-8;174 patients;174;-1
S1473-3099(13)70343-8;22 patients;22;-1
S1473-3099(13)70343-8;1 infected patients;1;-1
S1473-3099(13)70343-8;174 individuals;174;-1
S1473-3099(13)70343-8;1 infected individuals;1;-1
S1473-3099(13)70343-8;n=7;7;-1
S1473-3099(13)70343-8;n=15;15;-1
S1473-3099(13)70343-8;n=16;16;-1
S1473-3099(13)70343-8;n=32;32;-1
S1473-3099(13)70343-8;20 participants   enrolled;20;-1
S1473-3099(13)70343-8;100 participants were enrolled;100;-1
S1473-3099(13)70343-8;137 enrolled;137;-1
S1473-3099(13)70346-3;21 000 participants;21000;-1
S1473-3099(13)70355-4;821   participants;821;-1
S1473-3099(13)70355-4;17 participants;17;-1
S1473-3099(13)70356-6;17 participants;17;-1
S1473-3099(13)70356-6;13 000 adult patients;13000;-1
S1473-3099(13)70357-8;133 patients;133;-1
S1473-3099(13)70359-1;21 000 participants;21000;-1
S1473-3099(13)70359-1;133 patients;133;-1
S1473-3099(13)70362-1;21 000 participants;21000;-1
S1473-3099(13)70362-1;400 patients;400;-1
S1473-3099(13)70368-2;100 000 people;100000;-1
S1473-3099(13)70368-2;total of 17;17;-1
S1473-3099(13)70692-3;40 participants;40;-1
S1473-3099(13)70692-3;1 infected participants;1;-1
S1473-3099(13)70692-3;14 participants;14;-1
S1473-3099(13)70692-3;51 participants;51;-1
S1473-3099(13)70692-3;34 patients;34;-1
S1473-3099(13)70692-3;38 patients;38;-1
S1473-3099(13)70692-3;12 patients;12;-1
S1473-3099(13)70692-3;61 patients;61;-1
S1473-3099(13)70692-3;13 patients;13;-1
S1473-3099(13)70692-3;1763 people;1763;-1
S1473-3099(13)70692-3;77 people;77;-1
S1473-3099(13)70692-3;26 people;26;-1
S1473-3099(13)70692-3;40 people;40;-1
S1473-3099(13)70692-3;20 people;20;-1
S1473-3099(13)70692-3;57 individuals;57;-1
S1473-3099(13)70692-3;8 and excludes two individuals;8;-1
S1473-3099(13)70692-3;15 individuals;15;-1
S1473-3099(13)70692-3;n=886;886;-1
S1473-3099(13)70692-3;n=875;875;-1
S1473-3099(13)70692-3;n=162;162;-1
S1473-3099(13)70692-3;n=120;120;-1
S1473-3099(13)70692-3;n=54;54;-1
S1473-3099(13)70692-3;n=35;35;-1
S1473-3099(13)70692-3;n=21;21;-1
S1473-3099(13)70692-3;n=921;921;-1
S1473-3099(13)70692-3;2 enrolled;2;-1
S1473-3099(13)70692-3;15 individuals enrolled;15;-1
S1473-3099(13)70693-5;n=114;114;-1
S1473-3099(13)70693-5;n=26;26;-1
S1473-3099(13)70694-7;13 000 adult patients;13000;-1
S1473-3099(13)70695-9;11 921 individuals;11921;-1
S1473-3099(14)70002-7;700   treatment-naive patients;700;-1
S1473-3099(14)70002-7;708   treatment-naive patients;708;-1
S1473-3099(14)70020-9;801 participants;801;-1
S1473-3099(14)70020-9;1 uninfected   participants;1;-1
S1473-3099(14)70020-9;695 participants;695;-1
S1473-3099(14)70020-9;1 infected   participants;1;-1
S1473-3099(14)70020-9;3000 participants;3000;-1
S1473-3099(14)70020-9;100 participants;100;-1
S1473-3099(14)70020-9;458 of these participants;458;-1
S1473-3099(14)70020-9;463 participants;463;-1
S1473-3099(14)70020-9;22 Male   participants;22;-1
S1473-3099(14)70020-9;1 vaccine trials should inform participants;1;-1
S1473-3099(14)70020-9;1428 individuals;1428;-1
S1473-3099(14)70020-9;1 uninfected adults;1;-1
S1473-3099(14)70020-9;1 study of healthy adults;1;-1
S1473-3099(14)70020-9;n=0;0;-1
S1473-3099(14)70020-9;627 not enrolled;627;-1
S1473-3099(14)70020-9;3000 participants were enrolled;3000;-1
S1473-3099(14)70020-9;463 participants enrolled;463;-1
S1473-3099(14)70022-2;204 patients;204;-1
S1473-3099(14)70022-2;12 patients;12;-1
S1473-3099(14)70022-2;40 individuals;40;-1
S1473-3099(14)70022-2;204 individuals;204;-1
S1473-3099(14)70022-2;21  individuals;21;-1
S1473-3099(14)70022-2;n=40;40;-1
S1473-3099(14)70022-2;n=149;149;-1
S1473-3099(14)70022-2;n=186;186;-1
S1473-3099(14)70022-2;n=185;185;-1
S1473-3099(14)70022-2;n=116;116;-1
S1473-3099(14)70022-2;n=173;173;-1
S1473-3099(14)70022-2;total of 22;22;-1
S1473-3099(14)70022-2;total of 13;13;-1
S1473-3099(14)70025-8;2499 MSM and transgender women;2499;-1
S1473-3099(14)70025-8;12 uninfected participants;12;-1
S1473-3099(14)70025-8;32 participants;32;-1
S1473-3099(14)70025-8;1248 participants;1248;-1
S1473-3099(14)70025-8;1248 patients;1248;-1
S1473-3099(14)70025-8;n=1248;1248;-1
S1473-3099(14)70025-8;n=83;83;-1
S1473-3099(14)70025-8;n=1165;1165;-1
S1473-3099(14)70026-X;700   treatment-naive patients;700;-1
S1473-3099(14)70026-X;708   treatment-naive patients;708;-1
S1473-3099(14)70026-X;6 patients;6;-1
S1473-3099(14)70026-X;n=29;29;-1
S1473-3099(14)70026-X;n=50;50;-1
S1473-3099(14)70027-1;79 people;79;-1
S1473-3099(14)70027-1;85 people;85;-1
S1473-3099(14)70027-1;50 people;50;-1
S1473-3099(14)70027-1;46 people;46;-1
S1473-3099(14)70027-1;100 000 people;100000;-1
S1473-3099(14)70027-1; dataset from 1963;1963;-1
S1473-3099(14)70027-1; data from 2000;2000;-1
S1473-3099(14)70028-3;2 billion people;2;-1
S1473-3099(14)70030-1;204 patients;204;-1
S1473-3099(14)70031-3;108 patients;108;-1
S1473-3099(14)70031-3;22 patients;22;-1
S1473-3099(14)70031-3;77 patients;77;-1
S1473-3099(14)70067-2;1371 participants;1371;-1
S1473-3099(14)70067-2;691 female participants;691;-1
S1473-3099(14)70067-2;200 million people;200;-1
S1473-3099(14)70067-2;74 individuals;74;-1
S1473-3099(14)70067-2;394 individuals;394;-1
S1473-3099(14)70067-2;51 serum samples of individuals;51;-1
S1473-3099(14)70067-2;94 infected individuals;94;-1
S1473-3099(14)70067-2;26 individuals;26;-1
S1473-3099(14)70067-2;26 infected individuals;26;-1
S1473-3099(14)70067-2;68 infected individuals;68;-1
S1473-3099(14)70067-2;n=158;158;-1
S1473-3099(14)70067-2;n=144;144;-1
S1473-3099(14)70067-2;n=5;5;-1
S1473-3099(14)70067-2;n=20;20;-1
S1473-3099(14)70067-2;n=159;159;-1
S1473-3099(14)70067-2;total of 171;171;-1
S1473-3099(14)70067-2;1371 residents enrolled;1371;-1
S1473-3099(14)70067-2;1371 participants were enrolled;1371;-1
S1473-3099(14)70067-2;1371 enrolled;1371;-1
S1473-3099(14)70067-2; database of   3464;3464;-1
S1473-3099(14)70068-4;15 patients;15;-1
S1473-3099(14)70068-4;11 patients;11;-1
S1473-3099(14)70068-4;64 patients;64;-1
S1473-3099(14)70068-4;total of   64;64;-1
S1473-3099(14)70070-2;2 million people;2;-1
S1473-3099(14)70072-6;649 patients;649;-1
S1473-3099(14)70072-6;50 million people;50;-1
S1473-3099(14)70072-6;n=2014;2014;-1
S1473-3099(14)70702-9;204 patients;204;-1
S1473-3099(14)70703-0;2 103 patients;2103;-1
S1473-3099(14)70703-0; data   from the 12;12;-1
S1473-3099(14)70705-4;2 103 patients;2103;-1
S1473-3099(14)70705-4;108 patients;108;-1
S1473-3099(14)70705-4;22 patients;22;-1
S1473-3099(14)70706-6;2 A study of patients;2;-1
S1473-3099(14)70711-X;133 patients;133;-1
S1473-3099(14)70711-X;39 patients;39;-1
S1473-3099(14)70711-X;40 patients;40;-1
S1473-3099(14)70711-X;32 patients;32;-1
S1473-3099(14)70711-X;49 patients;49;-1
S1473-3099(14)70711-X;50 patients;50;-1
S1473-3099(14)70711-X;179 patients;179;-1
S1473-3099(14)70711-X;153 patients;153;-1
S1473-3099(14)70711-X;75 patients;75;-1
S1473-3099(14)70711-X;46 patients;46;-1
S1473-3099(14)70711-X;38 patients;38;-1
S1473-3099(14)70711-X;33 patients;33;-1
S1473-3099(14)70711-X;34 patients;34;-1
S1473-3099(14)70711-X;806 patients;806;-1
S1473-3099(14)70711-X;15 two patients;15;-1
S1473-3099(14)70711-X;16 eight patients;16;-1
S1473-3099(14)70711-X;155 individuals;155;-1
S1473-3099(14)70711-X;1 infected individuals;1;-1
S1473-3099(14)70711-X;N=51;51;-1
S1473-3099(14)70711-X;N=153;153;-1
S1473-3099(14)70712-1;499 people;499;-1
S1473-3099(14)70712-1;254 individuals;254;-1
S1473-3099(14)70712-1;225 individuals;225;-1
S1473-3099(14)70712-1;13 For   adults;13;-1
S1473-3099(14)70712-1;38 adults;38;-1
S1473-3099(14)70712-1;264 neonates   enrolled;264;-1
S1473-3099(14)70712-1;284 new villagers enrolled;284;-1
S1473-3099(14)70712-1;776 villagers enrolled;776;-1
S1473-3099(14)70717-0;650 participants;650;-1
S1473-3099(14)70717-0;24 participants;24;-1
S1473-3099(14)70717-0;16 For participants;16;-1
S1473-3099(14)70717-0;624 participants;624;-1
S1473-3099(14)70717-0;257 participants;257;-1
S1473-3099(14)70717-0;89 participants;89;-1
S1473-3099(14)70717-0;113 participants;113;-1
S1473-3099(14)70717-0;096  All treated participants;96;-1
S1473-3099(14)70717-0;13 participants;13;-1
S1473-3099(14)70717-0;70 participants;70;-1
S1473-3099(14)70717-0;300 mg and   ten participants;300;-1
S1473-3099(14)70717-0;259 participants;259;-1
S1473-3099(14)70717-0;212 participants;212;-1
S1473-3099(14)70717-0;212 patients;212;-1
S1473-3099(14)70717-0;201 patients;201;-1
S1473-3099(14)70717-0;211 patients;211;-1
S1473-3099(14)70717-0;13  We recruited patients;13;-1
S1473-3099(14)70717-0;59 patients;59;-1
S1473-3099(14)70717-0;73 patients;73;-1
S1473-3099(14)70717-0;63 patients;63;-1
S1473-3099(14)70717-0;0  Data are number of patients;0;-1
S1473-3099(14)70717-0;650 people;650;-1
S1473-3099(14)70717-0;13  We recruited;13;-1
S1473-3099(14)70717-0;n=212;212;-1
S1473-3099(14)70717-0;n=201;201;-1
S1473-3099(14)70717-0;n=211;211;-1
S1473-3099(14)70717-0;n=16;16;-1
S1473-3099(14)70717-0;n=89;89;-1
S1473-3099(14)70717-0;n=79;79;-1
S1473-3099(14)70717-0;n=41;41;-1
S1473-3099(14)70717-0;n=39;39;-1
S1473-3099(14)70717-0;total of   545;545;-1
S1473-3099(14)70717-0;212 patients enrolled;212;-1
S1473-3099(14)70717-0;624 enrolled;624;-1
S1473-3099(14)70717-0;624 participants enrolled;624;-1
S1473-3099(14)70717-0;257 participants enrolled;257;-1
S1473-3099(14)70717-0;624 participants   enrolled;624;-1
S1473-3099(14)70719-4;8000 people;8000;-1
S1473-3099(14)70719-4;284 000 people;284000;-1
S1473-3099(14)70719-4;775 individuals;775;-1
S1473-3099(14)70728-5;702 participants;702;-1
S1473-3099(14)70729-7;15 patients;15;-1
S1473-3099(14)70729-7;11 patients;11;-1
S1473-3099(14)70729-7;64 patients;64;-1
S1473-3099(14)70729-7;total of   64;64;-1
S1473-3099(14)70730-3;69 patients;69;-1
S1473-3099(14)70730-3;600 patients;600;-1
S1473-3099(14)70730-3;12 patients;12;-1
S1473-3099(14)70730-3;25 patients;25;-1
S1473-3099(14)70730-3;32 patients;32;-1
S1473-3099(14)70730-3;14 patients;14;-1
S1473-3099(14)70730-3;100  All patients;100;-1
S1473-3099(14)70730-3;17 To   identify patients;17;-1
S1473-3099(14)70730-3;1 non responder patients;1;-1
S1473-3099(14)70730-3;n=24;24;-1
S1473-3099(14)70730-3;n=26;26;-1
S1473-3099(14)70730-3;n=11;11;-1
S1473-3099(14)70730-3;n=21;21;-1
S1473-3099(14)70730-3;n=13;13;-1
S1473-3099(14)70730-3;n=5;5;-1
S1473-3099(14)70730-3;n=50;50;-1
S1473-3099(14)70731-5;702 participants;702;-1
S1473-3099(14)70731-5;15 patients;15;-1
S1473-3099(14)70731-5;11 patients;11;-1
S1473-3099(14)70731-5;64 patients;64;-1
S1473-3099(14)70731-5;total of   64;64;-1
S1473-3099(14)70733-9;1538 patients were women;1538;-1
S1473-3099(14)70733-9;13 588 patients;13588;-1
S1473-3099(14)70733-9;767 patients;767;-1
S1473-3099(14)70733-9;331 patients;331;-1
S1473-3099(14)70733-9;834 patients;834;-1
S1473-3099(14)70733-9;3 million patients;3;-1
S1473-3099(14)70733-9;900 patients;900;-1
S1473-3099(14)70733-9;1675 patients;1675;-1
S1473-3099(14)70733-9;1538 patients;1538;-1
S1473-3099(14)70733-9;69 patients;69;-1
S1473-3099(14)70733-9;841 patients;841;-1
S1473-3099(14)70733-9;18 included patients;18;-1
S1473-3099(14)70733-9;100 patients;100;-1
S1473-3099(14)70733-9;51 patients;51;-1
S1473-3099(14)70733-9;n=767;767;-1
S1473-3099(14)70733-9;n=771;771;-1
S1473-3099(14)70733-9;n=834;834;-1
S1473-3099(14)70733-9;n=841;841;-1
S1473-3099(14)70733-9;13 588 patients and enrolled;13588;-1
S1473-3099(14)70733-9;1675 enrolled;1675;-1
S1473-3099(14)70735-2;1 million people;1;-1
S1473-3099(14)70736-4;22 participants;22;3850
S1473-3099(14)70736-4;217 patients;217;16206
S1473-3099(14)70736-4;198 patients;198;16105
S1473-3099(14)70736-4;189 patients;189;15983
S1473-3099(14)70736-4;543 patients;543;8857
S1473-3099(14)70736-4;410 patients;410;979
S1473-3099(14)70736-4;416 patients;416;2188
S1473-3099(14)70736-4;214 patients;214;3458
S1473-3099(14)70736-4;22 patients;22;4273
S1473-3099(14)70736-4;23   patients;23;10030
S1473-3099(14)70736-4;007  Total number of patients;7;11032
S1473-3099(14)70736-4;n=10;10;15540
S1473-3099(14)70736-4;n=1;1;15540
S1473-3099(14)70736-4;n=214;214;4749
S1473-3099(14)70736-4;n=202;202;4726
S1473-3099(14)70736-4;n=416;416;5326
S1473-3099(14)70736-4;n=180;180;5454
S1473-3099(14)70736-4;n=373;373;5637
S1473-3099(14)70736-4;n=11;11;7174
S1473-3099(14)70737-6;22  Methods  Study design and participants;22;-1
S1473-3099(14)70737-6;666 patients;666;-1
S1473-3099(14)70737-6;331 patients;331;-1
S1473-3099(14)70737-6;327 patients;327;-1
S1473-3099(14)70737-6;329 patients;329;-1
S1473-3099(14)70737-6;17 patients;17;-1
S1473-3099(14)70737-6;12 patients;12;-1
S1473-3099(14)70737-6;293 patients;293;-1
S1473-3099(14)70737-6;314 patients;314;-1
S1473-3099(14)70737-6;305 patients;305;-1
S1473-3099(14)70737-6;299 patients;299;-1
S1473-3099(14)70737-6;200 patients;200;-1
S1473-3099(14)70737-6;698 individuals;698;-1
S1473-3099(14)70737-6;n=332;332;-1
S1473-3099(14)70737-6;n=334;334;-1
S1473-3099(14)70737-6;n=5;5;-1
S1473-3099(14)70737-6;n=331;331;-1
S1473-3099(14)70737-6;n=327;327;-1
S1473-3099(14)70737-6;n=1;1;-1
S1473-3099(14)70737-6;n=2;2;-1
S1473-3099(14)70737-6;n=197;197;-1
S1473-3099(14)70737-6;n=202;202;-1
S1473-3099(14)70737-6;2 enrolled;2;-1
S1473-3099(14)70739-X;155 patients;155;-1
S1473-3099(14)70739-X;51 patients;51;-1
S1473-3099(14)70739-X;51   patients;51;-1
S1473-3099(14)70739-X;2 million people;2;-1
S1473-3099(14)70740-6;702 participants;702;-1
S1473-3099(14)70741-8;54 participants;54;16405
S1473-3099(14)70741-8;31 Eligible participants;31;7765
S1473-3099(14)70741-8;301 participants;301;3937
S1473-3099(14)70741-8;50 participants;50;1052
S1473-3099(14)70741-8;224 participants;224;795
S1473-3099(14)70741-8;n=61;61;16466
S1473-3099(14)70741-8;n=60;60;16453
S1473-3099(14)70741-8;5  We enrolled;5;8741
S1473-3099(14)70743-1;1   RNA-suppressed participants;1;-1
S1473-3099(14)70743-1;10 patients;10;-1
S1473-3099(14)70743-1;476 patients;476;-1
S1473-3099(14)70743-1;433 patients;433;-1
S1473-3099(14)70743-1;290 of patients;290;-1
S1473-3099(14)70743-1;434 patients;434;-1
S1473-3099(14)70743-1;1 infected individuals;1;-1
S1473-3099(14)70743-1;1  In adults;1;-1
S1473-3099(14)70747-9;76 participants;76;-1
S1473-3099(14)70747-9;40 participants;40;-1
S1473-3099(14)70747-9;39 participants;39;-1
S1473-3099(14)70753-4;426 treatment-naive patients;426;-1
S1473-3099(14)70753-4;189 patients;189;-1
S1473-3099(14)70753-4;1 infected individuals;1;-1
S1473-3099(14)70767-4;187 336 patients;187336;-1
S1473-3099(14)70767-4;N=175;175;-1
S1473-3099(14)70767-4;N=457;457;-1
S1473-3099(14)70767-4;N=187 336;187336;-1
S1473-3099(14)70767-4;n=78;78;-1
S1473-3099(14)70767-4;n=20;20;-1
S1473-3099(14)70767-4;n=94;94;-1
S1473-3099(14)70767-4;n=113;113;-1
S1473-3099(14)70767-4;n=35;35;-1
S1473-3099(14)70767-4;n=16;16;-1
S1473-3099(14)70767-4;n=23;23;-1
S1473-3099(14)70767-4;n=26;26;-1
S1473-3099(14)70767-4;n=79;79;-1
S1473-3099(14)70767-4;n=70;70;-1
S1473-3099(14)70767-4;n=61;61;-1
S1473-3099(14)70767-4;n=114;114;-1
S1473-3099(14)70767-4;n=175;175;-1
S1473-3099(14)70767-4;n=13;13;-1
S1473-3099(14)70767-4;n=1;1;-1
S1473-3099(14)70767-4;n=8;8;-1
S1473-3099(14)70767-4;n=9;9;-1
S1473-3099(14)70767-4;n=5;5;-1
S1473-3099(14)70767-4;n=4;4;-1
S1473-3099(14)70767-4; databases from Jan 1;1;-1
S1473-3099(14)70767-4; data from 48;48;-1
S1473-3099(14)70768-6;1538 African patients;1538;-1
S1473-3099(14)70768-6;331 patients;331;-1
S1473-3099(14)70768-6;35 million people;35;-1
S1473-3099(14)70770-4;24 patients;24;-1
S1473-3099(14)70770-4;4 billion people;4;-1
S1473-3099(14)70770-4;390 million individuals;390;-1
S1473-3099(14)70773-X;6PD-deficient individuals;6;-1
S1473-3099(14)70775-3;6PD-deficient individuals;6;-1
S1473-3099(14)70777-7;2 A study of patients;2;-1
S1473-3099(14)70777-7;6PD-deficient individuals;6;-1
S1473-3099(14)70778-9;1   RNA-suppressed participants;1;-1
S1473-3099(14)70778-9;1  In adults;1;-1
S1473-3099(14)70779-0;67 women;67;-1
S1473-3099(14)70779-0;48 were women;48;-1
S1473-3099(14)70779-0;124 patients;124;-1
S1473-3099(14)70779-0;39 patients;39;-1
S1473-3099(14)70779-0;41 patients;41;-1
S1473-3099(14)70779-0;38 patients;38;-1
S1473-3099(14)70779-0;5 Antiparasitic   treatment of patients;5;-1
S1473-3099(14)70779-0;167 consenting patients;167;-1
S1473-3099(14)70779-0;167 patients;167;-1
S1473-3099(14)70779-0;43 patients;43;-1
S1473-3099(14)70779-0;63 patients;63;-1
S1473-3099(14)70779-0;118 patients;118;-1
S1473-3099(14)70779-0;18 patients;18;-1
S1473-3099(14)70779-0;58 patients;58;-1
S1473-3099(14)70779-0;18 714 patients;18714;-1
S1473-3099(14)70779-0;31 273 patients;31273;-1
S1473-3099(14)70779-0;6960 patients;6960;-1
S1473-3099(14)70779-0;7200 patients;7200;-1
S1473-3099(14)70779-0;11 762 patients;11762;-1
S1473-3099(14)70779-0;24 073 patients;24073;-1
S1473-3099(14)70779-0;203 patients;203;-1
S1473-3099(14)70779-0;80 individuals;80;-1
S1473-3099(14)70779-0;n=240;240;-1
S1473-3099(14)70779-0;n=41;41;-1
S1473-3099(14)70779-0;n=43;43;-1
S1473-3099(14)70779-0;n=40;40;-1
S1473-3099(14)70779-0;n=39;39;-1
S1473-3099(14)70779-0;n=38;38;-1
S1473-3099(14)70779-0;n=14;14;-1
S1473-3099(14)70779-0;n=2;2;-1
S1473-3099(14)70780-7;1000 people;1000;-1
S1473-3099(14)70782-0;433 participants;433;-1
S1473-3099(14)70782-0;139 participants;139;-1
S1473-3099(14)70782-0;290 participants;290;-1
S1473-3099(14)70782-0;632 participants;632;-1
S1473-3099(14)70782-0;420 participants;420;-1
S1473-3099(14)70782-0;267 participants;267;-1
S1473-3099(14)70782-0;1 RNA-suppressed participants;1;-1
S1473-3099(14)70782-0;12 Virologically suppressed   patients;12;-1
S1473-3099(14)70782-0;469 patients;469;-1
S1473-3099(14)70782-0;707 virologically suppressed patients;707;-1
S1473-3099(14)70782-0;273 virologically suppressed   patients;273;-1
S1473-3099(14)70782-0;1 infected   patients;1;-1
S1473-3099(14)70782-0;632 individuals;632;-1
S1473-3099(14)70782-0;n=293;293;-1
S1473-3099(14)70782-0;n=140;140;-1
S1473-3099(14)70782-0;n=290;290;-1
S1473-3099(14)70782-0;n=139;139;-1
S1473-3099(14)70782-0;n=1;1;-1
S1473-3099(14)70783-2;298 other people;298;-1
S1473-3099(14)70783-2;300 people;300;-1
S1473-3099(14)70794-7;26 individuals;26;-1
S1473-3099(14)70796-0;439 participants;439;-1
S1473-3099(14)70796-0;290 participants;290;-1
S1473-3099(14)70796-0;143 participants;143;-1
S1473-3099(14)70796-0;291 participants;291;-1
S1473-3099(14)70796-0;420 participants;420;-1
S1473-3099(14)70796-0;571 participants;571;-1
S1473-3099(14)70796-0;434 participants;434;-1
S1473-3099(14)70796-0;96 participants;96;-1
S1473-3099(14)70796-0;269 participants;269;-1
S1473-3099(14)70796-0;3 studies of treatment-  naive patients;3;-1
S1473-3099(14)70796-0;1 infected   patients;1;-1
S1473-3099(14)70796-0;n=291;291;-1
S1473-3099(14)70796-0;n=143;143;-1
S1473-3099(14)70796-0;n=290;290;-1
S1473-3099(14)70796-0;n=57;57;-1
S1473-3099(14)70796-0;n=16;16;-1
S1473-3099(14)70796-0;n=23;23;-1
S1473-3099(14)70796-0;n=2;2;-1
S1473-3099(14)70796-0;n=15;15;-1
S1473-3099(14)70798-4;332 patients;332;-1
S1473-3099(14)70798-4;4 billion people;4;-1
S1473-3099(14)70798-4;390 million individuals;390;-1
S1473-3099(14)70804-7;study population included 259 944;259944;-1
S1473-3099(14)70804-7; data from 22;22;-1
S1473-3099(14)70804-7;data from   18;18;-1
S1473-3099(14)70805-9;100 000 people;100000;-1
S1473-3099(14)70805-9;100 000   people;100000;-1
S1473-3099(14)70805-9;6  In adults;6;-1
S1473-3099(14)70806-0;14 410 participants;14410;-1
S1473-3099(14)70806-0;n=748;748;-1
S1473-3099(14)70806-0;n=216;216;-1
S1473-3099(14)70806-0;n=192;192;-1
S1473-3099(14)70806-0;n=1999;1999;-1
S1473-3099(14)70806-0;n=319;319;-1
S1473-3099(14)70806-0;n=275;275;-1
S1473-3099(14)70806-0;n=517;517;-1
S1473-3099(14)70806-0;n=175;175;-1
S1473-3099(14)70806-0;n=127;127;-1
S1473-3099(14)70806-0; data from 1960;1960;-1
S1473-3099(14)70807-2;26 individuals;26;-1
S1473-3099(14)70808-4;n=34;34;-1
S1473-3099(14)70811-4;40 participants;40;-1
S1473-3099(14)70811-4;39 participants;39;-1
S1473-3099(14)70811-4;79 participants;79;-1
S1473-3099(14)70811-4;67 participants;67;-1
S1473-3099(14)70811-4;76 participants;76;-1
S1473-3099(14)70811-4;40 vaccine participants;40;-1
S1473-3099(14)70811-4;8 placebo participants;8;-1
S1473-3099(14)70811-4;36 vaccine participants;36;-1
S1473-3099(14)70811-4;7 placebo participants;7;-1
S1473-3099(14)70811-4;3 vaccine participants;3;-1
S1473-3099(14)70811-4;2 placebo participants;2;-1
S1473-3099(14)70811-4;21 participants;21;-1
S1473-3099(14)70811-4;18 participants;18;-1
S1473-3099(14)70811-4;11 participants;11;-1
S1473-3099(14)70811-4;96 patients;96;-1
S1473-3099(14)70811-4;112 patients;112;-1
S1473-3099(14)70811-4;173 patients;173;-1
S1473-3099(14)70811-4;n=24;24;-1
S1473-3099(14)70811-4;n=25;25;-1
S1473-3099(14)70811-4;n=23;23;-1
S1473-3099(14)70811-4;n=19;19;-1
S1473-3099(14)70811-4;n=5;5;-1
S1473-3099(14)70811-4;n=21;21;-1
S1473-3099(14)70811-4;n=3;3;-1
S1473-3099(14)70811-4;n=4;4;-1
S1473-3099(14)70811-4;n=18;18;-1
S1473-3099(14)70811-4;n=79;79;-1
S1473-3099(14)70811-4;n=17;17;-1
S1473-3099(14)70822-9;n=126;126;-1
S1473-3099(14)70822-9;n=237;237;-1
S1473-3099(14)70822-9;n=100;100;-1
S1473-3099(14)70823-0;85 patients;85;-1
S1473-3099(14)70829-1;332 patients;332;-1
S1473-3099(14)70830-8;269 patients;269;-1
S1473-3099(14)70830-8;170 million people;170;-1
S1473-3099(14)70835-7;170 million people;170;-1
S1473-3099(14)70836-9;269 patients;269;-1
S1473-3099(14)70837-0;240 patients;240;-1
S1473-3099(14)70837-0;15 patients;15;-1
S1473-3099(14)70837-0;60 000 people;60000;-1
S1473-3099(14)70838-2;240 patients;240;-1
S1473-3099(14)70839-4;15 patients;15;-1
S1473-3099(14)70839-4;85 patients;85;-1
S1473-3099(14)70839-4;60 000 people;60000;-1
S1473-3099(14)70841-2;202 women;202;-1
S1473-3099(14)70841-2;404 women;404;-1
S1473-3099(14)70841-2;15 included women;15;-1
S1473-3099(14)70841-2;14 These   women;14;-1
S1473-3099(14)70841-2;268 unvaccinated women;268;-1
S1473-3099(14)70841-2;1340 women;1340;-1
S1473-3099(14)70841-2;4  Articles  Of women;4;-1
S1473-3099(14)70841-2;1058 women;1058;-1
S1473-3099(14)70841-2;518 fully   vaccinated women;518;-1
S1473-3099(14)70841-2;518 women;518;-1
S1473-3099(14)70841-2;25 year-  old women;25;-1
S1473-3099(14)70841-2;1058 participants;1058;-1
S1473-3099(14)70841-2;202 women were recruited;202;-1
S1473-3099(14)70841-2;1058 were recruited;1058;-1
S1473-3099(14)70841-2;4  Articles  Of women recruited;4;-1
S1473-3099(14)70841-2;n=202;202;-1
S1473-3099(14)70841-2;n=1058;1058;-1
S1473-3099(14)70841-2;n=149;149;-1
S1473-3099(14)70841-2;n=391;391;-1
S1473-3099(14)70841-2;n=518;518;-1
S1473-3099(14)70841-2;n=515;515;-1
S1473-3099(14)70841-2;n=7;7;-1
S1473-3099(14)70841-2;n=161;161;-1
S1473-3099(14)70841-2;n=20;20;-1
S1473-3099(14)70841-2;n=37;37;-1
S1473-3099(14)70841-2;n=804;804;-1
S1473-3099(14)70841-2;n=29;29;-1
S1473-3099(14)70841-2;n= 391;391;-1
S1473-3099(14)70841-2;404 women   enrolled;404;-1
S1473-3099(14)70842-4;15 patients;15;-1
S1473-3099(14)70842-4;60 000 people;60000;-1
S1473-3099(14)70843-6;76 participants;76;-1
S1473-3099(14)70843-6;40 participants;40;-1
S1473-3099(14)70843-6;39 participants;39;-1
S1473-3099(14)70845-X;24 enrolled participants;24;-1
S1473-3099(14)70845-X;22 participants;22;-1
S1473-3099(14)70845-X;24 participants;24;-1
S1473-3099(14)70845-X;20 participants;20;-1
S1473-3099(14)70845-X;12 participants;12;-1
S1473-3099(14)70845-X;38 people;38;-1
S1473-3099(14)70845-X;24 adults;24;-1
S1473-3099(14)70845-X;n=12;12;-1
S1473-3099(14)70845-X;24 enrolled;24;-1
S1473-3099(14)70845-X;24 participants enrolled;24;-1
S1473-3099(14)70845-X; data   from 1;1;-1
S1473-3099(14)70847-3;2 and   hetero sexual men and women;2;-1
S1473-3099(14)70847-3;27 Transgender women;27;-1
S1473-3099(14)70847-3;14   All participants;14;-1
S1473-3099(14)70847-3;2499 participants;2499;-1
S1473-3099(14)70847-3;279 participants;279;-1
S1473-3099(14)70847-3;68 participants;68;-1
S1473-3099(14)70847-3;814 eligible iPrEx participants;814;-1
S1473-3099(14)70847-3;30 participants;30;-1
S1473-3099(14)70847-3;1603 participants;1603;-1
S1473-3099(14)70847-3;1573 asymptomatic seronegative participants;1573;-1
S1473-3099(14)70847-3;63   participants;63;-1
S1473-3099(14)70847-3;92 participants;92;-1
S1473-3099(14)70847-3;1573 eligible HIV-negative   participants;1573;-1
S1473-3099(14)70847-3;365 participants;365;-1
S1473-3099(14)70847-3;1603   seronegative patients;1603;-1
S1473-3099(14)70847-3;1603 HIV-negative people;1603;-1
S1473-3099(14)70847-3;30 people;30;-1
S1473-3099(14)70847-3;446 people;446;-1
S1473-3099(14)70847-3;1603 people;1603;-1
S1473-3099(14)70847-3;41 people;41;-1
S1473-3099(14)70847-3;60 people;60;-1
S1473-3099(14)70847-3;n=305;305;-1
S1473-3099(14)70847-3;n=851;851;-1
S1473-3099(14)70847-3;n=33;33;-1
S1473-3099(14)70847-3;n=1;1;-1
S1473-3099(14)70847-3;n=2;2;-1
S1473-3099(14)70847-3;total   of 72;72;-1
S1473-3099(14)70847-3;279 originally enrolled;279;-1
S1473-3099(14)70847-3;2009 and enrolled;2009;-1
S1473-3099(14)70847-3;1603 who   enrolled;1603;-1
S1473-3099(14)70849-7;706 patients;706;-1
S1473-3099(14)70852-7;657 patients;657;-1
S1473-3099(14)70852-7;123 patients;123;-1
S1473-3099(14)70852-7;37 no TBM patients;37;-1
S1473-3099(14)70852-7;17 no patients;17;-1
S1473-3099(14)70852-7;5 patients;5;-1
S1473-3099(14)70852-7;15 did not follow up   patients;15;-1
S1473-3099(14)70852-7;3 patients;3;-1
S1473-3099(14)70852-7;2 patients;2;-1
S1473-3099(14)70852-7;63 patients;63;-1
S1473-3099(14)70852-7;184 patients;184;-1
S1473-3099(14)70852-7;74 treated patients;74;-1
S1473-3099(14)70853-9;34 million people;34;-1
S1473-3099(14)70853-9;2 billion people;2;-1
S1473-3099(14)70853-9;100 000 people;100000;-1
S1473-3099(14)70855-2;21 694 patients;21694;-1
S1473-3099(14)70855-2;54 patients;54;-1
S1473-3099(14)70855-2;197 studies enrolled patients;197;-1
S1473-3099(14)70855-2;198 clinical trials enrolling patients;198;-1
S1473-3099(14)70855-2;15 455 patients;15455;-1
S1473-3099(14)70855-2;1132 patients;1132;-1
S1473-3099(14)70855-2;1092 patients;1092;-1
S1473-3099(14)70855-2;377 patients;377;-1
S1473-3099(14)70855-2;222 patients;222;-1
S1473-3099(14)70855-2;583 patients;583;-1
S1473-3099(14)70855-2;1595 patients;1595;-1
S1473-3099(14)70855-2;48  Origin of patients;48;-1
S1473-3099(14)70855-2;14 studies included patients;14;-1
S1473-3099(14)70855-2;18 patients;18;-1
S1473-3099(14)70855-2;24 patients;24;-1
S1473-3099(14)70855-2;197 studies enrolled;197;-1
S1473-3099(14)70857-6;2 million people;2;-1
S1473-3099(14)70857-6;50 million   people;50;-1
S1473-3099(14)70857-6;2000 people;2000;-1
S1473-3099(14)70870-9;3   In healthy people;3;-1
S1473-3099(14)70870-9;147 people;147;-1
S1473-3099(14)70870-9;100 000 people;100000;-1
S1473-3099(14)70870-9;1 million people;1;-1
S1473-3099(14)70870-9;n=0;0;-1
S1473-3099(14)70873-4;11 and only benefi ts treated individuals;11;-1
S1473-3099(14)70876-X;583 patients;583;-1
S1473-3099(14)70876-X;185 patients;185;-1
S1473-3099(14)70876-X;397 patients;397;-1
S1473-3099(14)70876-X;139 patients;139;-1
S1473-3099(14)70876-X;245 patients;245;-1
S1473-3099(14)70876-X;582 patients;582;-1
S1473-3099(14)70876-X;n=582;582;-1
S1473-3099(14)70876-X;n=185;185;-1
S1473-3099(14)70876-X;n=397;397;-1
S1473-3099(14)70879-5;700 000   people;700000;-1
S1473-3099(14)70879-5;118 individuals;118;-1
S1473-3099(14)70881-3;1511 patients;1511;-1
S1473-3099(14)70881-3;500 patients;500;-1
S1473-3099(14)70881-3;700 000   people;700000;-1
S1473-3099(14)70881-3;118 individuals;118;-1
S1473-3099(14)70881-3;n=1177;1177;-1
S1473-3099(14)70881-3;n=24;24;-1
S1473-3099(14)70881-3;n=723;723;-1
S1473-3099(14)70882-5;1511 patients;1511;-1
S1473-3099(14)70882-5;500 patients;500;-1
S1473-3099(14)70882-5;n=1177;1177;-1
S1473-3099(14)70882-5;n=24;24;-1
S1473-3099(14)70882-5;n=723;723;-1
S1473-3099(14)70883-7;165 patients;165;-1
S1473-3099(14)70883-7;153 patients;153;-1
S1473-3099(14)70883-7;40 patients;40;-1
S1473-3099(14)70883-7;157 patients;157;-1
S1473-3099(14)70883-7;113 patients;113;-1
S1473-3099(14)70883-7;117 people;117;-1
S1473-3099(14)70883-7;165 people;165;-1
S1473-3099(14)70883-7;131 people;131;-1
S1473-3099(14)70883-7;10 000 people;10000;-1
S1473-3099(14)70883-7;n=165;165;-1
S1473-3099(14)70883-7;N=99;99;-1
S1473-3099(14)70883-7;N=18;18;-1
S1473-3099(14)70884-9;27 MFI   All patients;27;-1
S1473-3099(14)70884-9;1 infected   individuals;1;-1
S1473-3099(14)70884-9;n=63;63;-1
S1473-3099(14)70884-9;n=113;113;-1
S1473-3099(14)70884-9;n=18;18;-1
S1473-3099(14)70884-9;n=8;8;-1
S1473-3099(14)70884-9;n=12;12;-1
S1473-3099(14)70884-9;n=3;3;-1
S1473-3099(14)70884-9;n=1;1;-1
S1473-3099(14)70884-9;n=23;23;-1
S1473-3099(14)70884-9;n=50;50;-1
S1473-3099(14)70884-9;n=290;290;-1
S1473-3099(14)70894-1;11 000 patients;11000;-1
S1473-3099(14)70897-7;521 patients;521;-1
S1473-3099(14)70897-7;165 patients;165;-1
S1473-3099(14)70897-7;10 000 people;10000;-1
S1473-3099(14)70900-4;2 It reduces   both patients;2;-1
S1473-3099(14)70900-4;5932 patients;5932;-1
S1473-3099(14)70901-6;157 patients;157;-1
S1473-3099(14)70901-6;100 000 people;100000;-1
S1473-3099(14)70901-6;56 567 800 people;56567800;-1
S1473-3099(14)70903-X;2 billion people;2;-1
S1473-3099(14)70903-X;100 000 people;100000;-1
S1473-3099(14)70904-1;582 patients;582;-1
S1473-3099(14)70904-1;521 patients;521;-1
S1473-3099(14)70904-1;165 patients;165;-1
S1473-3099(14)70919-3;160 women;160;-1
S1473-3099(14)70919-3;14 We included all   patients;14;-1
S1473-3099(14)70919-3;n=1075;1075;-1
S1473-3099(14)70919-3;n=474;474;-1
S1473-3099(14)70919-3; data from 1987;1987;-1
S1473-3099(14)70920-X;20 patients;20;65
S1473-3099(14)70920-X;19 patients;19;8532
S1473-3099(14)70920-X;13 patients;13;8565
S1473-3099(14)70920-X;22 patients;22;8598
S1473-3099(14)70920-X;44 patients;44;10458
S1473-3099(14)70920-X;18 patients;18;13723
S1473-3099(14)70920-X;70 individuals;70;10027
S1473-3099(14)70920-X;n=20;20;6901
S1473-3099(14)70920-X;n=24;24;6928
S1473-3099(14)70921-1;10 000 people;10000;-1
S1473-3099(14)70926-0;2 It reduces   both patients;2;-1
S1473-3099(14)70926-0;5932 patients;5932;-1
S1473-3099(14)70926-0;157 patients;157;-1
S1473-3099(14)70926-0;100 000 people;100000;-1
S1473-3099(14)70926-0;56 567 800 people;56567800;-1
S1473-3099(14)70927-2;21 elderly   people;21;-1
S1473-3099(14)70927-2;n=13;13;-1
S1473-3099(14)70927-2; data from 21;21;-1
S1473-3099(14)70937-5;77 pregnant   and breastfeeding women;77;-1
S1473-3099(14)70937-5;3  All participants;3;-1
S1473-3099(14)70937-5;1 RNA PCR and   participants;1;-1
S1473-3099(14)70937-5;15 Masked follow-up   of participants;15;-1
S1473-3099(14)70937-5;1 uninfected individuals;1;-1
S1473-3099(14)70937-5;30 individuals;30;-1
S1473-3099(14)70937-5;100 individuals;100;-1
S1473-3099(14)70937-5;4747 individuals;4747;-1
S1473-3099(14)70937-5;4427 individuals;4427;-1
S1473-3099(14)70937-5;1 infected partners of individuals;1;-1
S1473-3099(14)70937-5;12 individuals;12;-1
S1473-3099(14)70937-5;51 individuals;51;-1
S1473-3099(14)70937-5;64 individuals;64;-1
S1473-3099(14)70937-5;52 individuals;52;-1
S1473-3099(14)70937-5;n=1584;1584;-1
S1473-3099(14)70937-5;n=631;631;-1
S1473-3099(14)70937-5;n=2215;2215;-1
S1473-3099(14)70937-5;n=1579;1579;-1
S1473-3099(14)70937-5;n=633;633;-1
S1473-3099(14)70937-5;n=2212;2212;-1
S1473-3099(14)70937-5;n=0;0;-1
S1473-3099(14)70937-5;4747 couples were enrolled;4747;-1
S1473-3099(14)70938-7;9 of pregnant women;9;-1
S1473-3099(14)70938-7;44 patients;44;-1
S1473-3099(14)70938-7;24 control patients;24;-1
S1473-3099(14)70938-7;9 patients;9;-1
S1473-3099(14)70939-9;44 patients;44;-1
S1473-3099(14)70939-9;24 control patients;24;-1
S1473-3099(14)70939-9;9 patients;9;-1
S1473-3099(14)70940-5;538 patients;538;-1
S1473-3099(14)70940-5;n=540;540;-1
S1473-3099(14)70940-5;n=1434;1434;-1
S1473-3099(14)70940-5;n=370;370;-1
S1473-3099(14)70940-5;n=1024;1024;-1
S1473-3099(14)70940-5;n=1069;1069;-1
S1473-3099(14)70940-5;n=230;230;-1
S1473-3099(14)70940-5;n=76;76;-1
S1473-3099(14)70940-5;n=64;64;-1
S1473-3099(14)70940-5;n=42;42;-1
S1473-3099(14)70940-5;n=38;38;-1
S1473-3099(14)70940-5;n=28;28;-1
S1473-3099(14)70940-5;n=45;45;-1
S1473-3099(14)70940-5;n=15;15;-1
S1473-3099(14)70946-6;2054 participants;2054;-1
S1473-3099(14)70946-6;166 participants;166;-1
S1473-3099(14)70946-6;23 991 participants;23991;-1
S1473-3099(14)70946-6;33 861 patients;33861;-1
S1473-3099(14)70946-6;25 303 patients;25303;-1
S1473-3099(14)70946-6;714 patients;714;-1
S1473-3099(14)70946-6;45 patients;45;-1
S1473-3099(14)70946-6;9 million   people;9;-1
S1473-3099(14)70946-6;400 million people;400;-1
S1473-3099(14)70946-6;70 694 people;70694;-1
S1473-3099(14)70946-6;700 000 people;700000;-1
S1473-3099(14)70946-6;2,041 HBsAg- and HIV-positive   individuals;2041;-1
S1473-3099(14)70946-6;n=33 861;33861;-1
S1473-3099(14)70946-6;n=1114;1114;-1
S1473-3099(14)70946-6;n=6149;6149;-1
S1473-3099(14)70946-6;n=2958;2958;-1
S1473-3099(14)70946-6;n=23 640;23640;-1
S1473-3099(14)70946-6;n=33 695;33695;-1
S1473-3099(14)70946-6;n=35 855;35855;-1
S1473-3099(14)70946-6;n=978;978;-1
S1473-3099(14)70952-1;6812 inpatients;6812;-1
S1473-3099(14)70952-1;1200 randomly selected   patients;1200;-1
S1473-3099(14)70952-1;9  In a cohort of inpatients;9;-1
S1473-3099(14)70952-1;6812 patients;6812;-1
S1473-3099(14)70952-1;4119 patients;4119;-1
S1473-3099(14)70952-1;730 patients;730;-1
S1473-3099(14)70952-1;59 patients;59;-1
S1473-3099(14)70952-1;50 of those patients;50;-1
S1473-3099(14)70952-1;84  Baseline is patients;84;-1
S1473-3099(14)70952-1;n=13;13;-1
S1473-3099(14)70952-1;n=730;730;-1
S1473-3099(14)70952-1;n=282;282;-1
S1473-3099(14)70952-1;n=90;90;-1
S1473-3099(14)70952-1;n=98;98;-1
S1473-3099(14)70952-1;n=272;272;-1
S1473-3099(14)70952-1;n=105;105;-1
S1473-3099(14)70952-1;n=115;115;-1
S1473-3099(14)70952-1;n=91;91;-1
S1473-3099(14)70952-1;n=82;82;-1
S1473-3099(14)70952-1;n=65;65;-1
S1473-3099(14)70952-1;n=88;88;-1
S1473-3099(14)70952-1;n=485;485;-1
S1473-3099(14)70952-1;n=157;157;-1
S1473-3099(14)70954-5;352 people;352;-1
S1473-3099(14)70959-4;34 million people;34;-1
S1473-3099(14)70960-0;N=36;36;-1
S1473-3099(14)70960-0;N=40;40;-1
S1473-3099(14)70960-0;N=44;44;-1
S1473-3099(14)70960-0;N=49;49;-1
S1473-3099(14)70960-0;N=13;13;-1
S1473-3099(14)70963-6;80 individuals;80;-1
S1473-3099(14)70963-6;11 individuals;11;-1
S1473-3099(14)70963-6;39 eligible individuals;39;-1
S1473-3099(14)70963-6;650 individuals;650;-1
S1473-3099(14)70963-6;39 of the individuals;39;-1
S1473-3099(14)70963-6;n=9;9;-1
S1473-3099(14)70963-6;n=10;10;-1
S1473-3099(14)70963-6;n=5;5;-1
S1473-3099(14)70963-6;n=7;7;-1
S1473-3099(14)70963-6;n=6;6;-1
S1473-3099(14)70963-6;n=1;1;-1
S1473-3099(14)70963-6;n=2;2;-1
S1473-3099(14)70963-6;27 volunteers   were enrolled;27;-1
S1473-3099(14)70966-1;232 million people;232;-1
S1473-3099(14)70966-1;100 000 people;100000;-1
S1473-3099(14)70966-1;100 000 individuals;100000;-1
S1473-3099(14)70966-1;452 971 individuals;452971;-1
S1473-3099(14)70966-1;569 210 individuals;569210;-1
S1473-3099(14)70966-1;100 000   individuals;100000;-1
S1473-3099(14)70966-1;183 individuals;183;-1
S1473-3099(14)70966-1;3 154 873 individuals;3154873;-1
S1473-3099(14)70966-1;20 587 individuals;20587;-1
S1473-3099(14)70966-1;3500 individuals;3500;-1
S1473-3099(14)70966-1;N=70125393;70125393;-1
S1473-3099(14)70966-1;total of   14;14;-1
S1473-3099(14)70977-6;352 people;352;-1
S1473-3099(14)70984-3;400 participants;400;-1
S1473-3099(14)70985-5;5 of adult inpatients;5;-1
S1473-3099(14)70989-2;400 participants;400;-1
S1473-3099(14)70989-2;5 of adult inpatients;5;-1
S1473-3099(14)70991-0;40 000 inpatients;40000;-1
S1473-3099(14)70991-0;2  Data are number of patients;2;-1
S1473-3099(14)70991-0;119 patients;119;-1
S1473-3099(14)70991-0;34 patients;34;-1
S1473-3099(14)70991-0;74 inpatients;74;-1
S1473-3099(14)70991-0;148 undiagnosed patients;148;-1
S1473-3099(14)70991-0;493 patients;493;-1
S1473-3099(14)70991-0;237 patients;237;-1
S1473-3099(14)70991-0;n=641;641;-1
S1473-3099(14)70991-0;n=969;969;-1
S1473-3099(14)70991-0;n=7297;7297;-1
S1473-3099(14)70991-0;n=4582;4582;-1
S1473-3099(14)70991-0;n=458;458;-1
S1473-3099(14)70991-0;n=396;396;-1
S1473-3099(14)70991-0;n=44;44;-1
S1473-3099(14)70991-0; data   from 2008;2008;-1
S1473-3099(14)70995-8;1700 patients;1700;-1
S1473-3099(14)70995-8;10 000 people;10000;-1
S1473-3099(14)70995-8;75 000 people;75000;-1
S1473-3099(14)70995-8;23 people;23;-1
S1473-3099(14)70995-8;total of 170 996;170996;-1
S1473-3099(14)70995-8;total of 27 378;27378;-1
S1473-3099(14)71005-9;400 participants;400;-1
S1473-3099(14)71020-5;13 540 people;13540;-1
S1473-3099(14)71020-5;300 000 people;300000;-1
S1473-3099(14)71020-5;100 000   people;100000;-1
S1474-4422(13)70237-0;18 families had individuals;18;-1
S1474-4422(13)70263-1;8382 participants;8382;-1
S1474-4422(13)70263-1;230 patients;230;-1
S1474-4422(13)70263-1;5 In patients;5;-1
S1474-4422(13)70263-1;111 patients;111;-1
S1474-4422(13)70263-1;1691 patients;1691;-1
S1474-4422(13)70263-1;142 patients;142;-1
S1474-4422(13)70263-1;374 patients;374;-1
S1474-4422(13)70263-1;50 patients;50;-1
S1474-4422(13)70263-1;703 patients;703;-1
S1474-4422(13)70263-1;102 patients;102;-1
S1474-4422(13)70263-1;419 patients;419;-1
S1474-4422(13)70263-1;93 patients;93;-1
S1474-4422(13)70263-1;5720 patients;5720;-1
S1474-4422(13)70263-1;57 patients;57;-1
S1474-4422(13)70263-1;8382 patients;8382;-1
S1474-4422(13)70263-1;220 patients;220;-1
S1474-4422(13)70263-1;n=17;17;-1
S1474-4422(13)70263-1;n=40;40;-1
S1474-4422(13)70263-1;n=220;220;-1
S1474-4422(13)70263-1;n=8162;8162;-1
S1474-4422(13)70263-1;n=7776;7776;-1
S1474-4422(13)70263-1; data from 8382;8382;-1
S1474-4422(13)70265-5;11 individuals;11;20836
S1474-4422(13)70265-5;18 families had individuals;18;20720
S1474-4422(13)70265-5;18 individuals;18;20423
S1474-4422(13)70265-5;6118 individuals;6118;3435
S1474-4422(13)70265-5;11 aff ected individuals;11;2396
S1474-4422(13)70265-5;17 enrolled;17;20967
S1474-4422(13)70272-2;1691 patients;1691;-1
S1474-4422(13)70272-2;93 patients;93;-1
S1474-4422(13)70275-8;35 million people;35;-1
S1474-4422(13)70277-1;100 control participants;100;-1
S1474-4422(13)70277-1;250 patients;250;-1
S1474-4422(13)70277-1;27 patients;27;-1
S1474-4422(13)70277-1;24 patients;24;-1
S1474-4422(13)70282-5;100 control participants;100;-1
S1474-4422(13)70282-5;45 patients;45;-1
S1474-4422(13)70282-5;23 patients;23;-1
S1474-4422(13)70282-5;250 patients;250;-1
S1474-4422(13)70282-5;35 patients;35;-1
S1474-4422(13)70282-5;20 patients;20;-1
S1474-4422(13)70282-5;2 Only patients;2;-1
S1474-4422(13)70282-5;100 consecutive patients;100;-1
S1474-4422(13)70282-5;74 patients;74;-1
S1474-4422(13)70282-5;100 control patients;100;-1
S1474-4422(13)70282-5;11 patients;11;-1
S1474-4422(13)70282-5;459 patients;459;-1
S1474-4422(13)70282-5;8 patients;8;-1
S1474-4422(13)70282-5;4 patients;4;-1
S1474-4422(13)70282-5;571 patients;571;-1
S1474-4422(13)70282-5;49 patients;49;-1
S1474-4422(13)70282-5;648 patients;648;-1
S1474-4422(13)70282-5;14 patients;14;-1
S1474-4422(13)70282-5;577 patients;577;-1
S1474-4422(13)70285-0;38 patients;38;-1
S1474-4422(13)70285-0;77 eligible individuals;77;-1
S1474-4422(13)70290-4;n=96;96;-1
S1474-4422(13)70290-4;n=16;16;-1
S1474-4422(13)70290-4;n=47;47;-1
S1474-4422(13)70290-4;n=10;10;-1
S1474-4422(13)70290-4;n=23;23;-1
S1474-4422(13)70291-6;71 patients;71;-1
S1474-4422(13)70293-X;20 participants;20;-1
S1474-4422(13)70293-X;31 participants;31;-1
S1474-4422(13)70293-X;71 participants;71;-1
S1474-4422(13)70293-X;35 patients;35;-1
S1474-4422(13)70293-X;31 patients;31;-1
S1474-4422(13)70293-X;37 patients;37;-1
S1474-4422(13)70293-X;34 patients;34;-1
S1474-4422(13)70293-X;36 patients;36;-1
S1474-4422(13)70293-X;33 patients;33;-1
S1474-4422(13)70293-X;71 patients;71;-1
S1474-4422(13)70293-X;n=37;37;-1
S1474-4422(13)70293-X;n=34;34;-1
S1474-4422(13)70293-X;n=35;35;-1
S1474-4422(13)70293-X;n=31;31;-1
S1474-4422(13)70293-X;n=71;71;-1
S1474-4422(13)70293-X;34 patients were enrolled;34;-1
S1474-4422(13)70299-0;140 patients;140;-1
S1474-4422(13)70299-0;416 patients;416;-1
S1474-4422(13)70299-0;416 control patients;416;-1
S1474-4422(13)70299-0;12 patients;12;-1
S1474-4422(13)70299-0;15 patients;15;-1
S1474-4422(13)70299-0;13 In some   patients;13;-1
S1474-4422(13)70299-0;1134   patients;1134;-1
S1474-4422(13)70299-0;1134 patients;1134;-1
S1474-4422(13)70299-0;41 seronegative patients;41;-1
S1474-4422(13)70299-0;238 patients;238;-1
S1474-4422(13)70299-0;35 patients;35;-1
S1474-4422(13)70299-0;143 patients;143;-1
S1474-4422(13)70299-0;19 patients;19;-1
S1474-4422(13)70299-0;18 patients;18;-1
S1474-4422(13)70299-0;20 patients;20;-1
S1474-4422(13)70299-0;75 otherwise healthy   individuals;75;-1
S1474-4422(13)70301-6;100 participants;100;-1
S1474-4422(13)70301-6;49 participants;49;-1
S1474-4422(13)70301-6;50 participants;50;-1
S1474-4422(13)70301-6;38 participants;38;-1
S1474-4422(13)70301-6;46 participants;46;-1
S1474-4422(13)70301-6;30 participants;30;-1
S1474-4422(13)70301-6;15 participants;15;-1
S1474-4422(13)70301-6;79 participants;79;-1
S1474-4422(13)70301-6;82 participants;82;-1
S1474-4422(13)70301-6;90 participants;90;-1
S1474-4422(13)70301-6;99 participants;99;-1
S1474-4422(13)70301-6;40 participants;40;-1
S1474-4422(13)70301-6;64 participants;64;-1
S1474-4422(13)70301-6;176 participants;176;-1
S1474-4422(13)70301-6;33 patients;33;-1
S1474-4422(13)70301-6;67 patients;67;-1
S1474-4422(13)70301-6;400 patients;400;-1
S1474-4422(13)70301-6;n=15;15;-1
S1474-4422(13)70301-6;n=50;50;-1
S1474-4422(13)70301-6;n=43;43;-1
S1474-4422(13)70301-6;n=60;60;-1
S1474-4422(13)70301-6;n=174;174;-1
S1474-4422(13)70301-6;n=760;760;-1
S1474-4422(13)70301-6;n=9;9;-1
S1474-4422(13)70301-6;n=33;33;-1
S1474-4422(13)70303-X;30 participants;30;-1
S1474-4422(13)70303-X;617 patients;617;-1
S1474-4422(13)70303-X;100 patients;100;-1
S1474-4422(13)70305-3;80 participants;80;-1
S1474-4422(13)70305-3;44 participants;44;-1
S1474-4422(13)70305-3;25 participants;25;-1
S1474-4422(13)70305-3;30 participants;30;-1
S1474-4422(13)70305-3;34 participants;34;-1
S1474-4422(13)70305-3;73 participants;73;-1
S1474-4422(13)70305-3;38 patients;38;-1
S1474-4422(13)70305-3;600 patients;600;-1
S1474-4422(13)70305-3;100 patients;100;-1
S1474-4422(13)70305-3;240 patients;240;-1
S1474-4422(13)70305-3;20 patients;20;-1
S1474-4422(13)70305-3;27 patients;27;-1
S1474-4422(13)70305-3;275 patients;275;-1
S1474-4422(13)70305-3;63   patients;63;-1
S1474-4422(13)70305-3;13 patients;13;-1
S1474-4422(13)70305-3;15 patients;15;-1
S1474-4422(13)70305-3;2 million people;2;-1
S1474-4422(13)70305-3;143 individuals;143;-1
S1474-4422(13)70305-3;n=38;38;-1
S1474-4422(13)70305-3;n=35;35;-1
S1474-4422(13)70307-7;103 participants;103;-1
S1474-4422(13)70307-7;560 participants;560;-1
S1474-4422(13)70307-7;300 subjects;300;-1
S1474-4422(13)70307-7;121 patients;121;-1
S1474-4422(13)70307-7;13 A small number of patients;13;-1
S1474-4422(13)70307-7;30 patients;30;-1
S1474-4422(13)70307-7;80 patients;80;-1
S1474-4422(13)70307-7;20 patients;20;-1
S1474-4422(13)70307-7;663 patients;663;-1
S1474-4422(13)70307-7;97 Italian and French   patients;97;-1
S1474-4422(13)70307-7;97 patients;97;-1
S1474-4422(13)70307-7;74 patients;74;-1
S1474-4422(13)70307-7;39 patients;39;-1
S1474-4422(13)70307-7;11 patients;11;-1
S1474-4422(13)70307-7;54 patients;54;-1
S1474-4422(13)70307-7;28 patients;28;-1
S1474-4422(13)70307-7;51 patients;51;-1
S1474-4422(13)70307-7;121 individuals;121;-1
S1474-4422(13)70307-7;114 individuals;114;-1
S1474-4422(13)70307-7;66 individuals;66;-1
S1474-4422(13)70307-7;30 patients recruited;30;-1
S1474-4422(13)70307-7;n=2;2;-1
S1474-4422(13)70307-7;n=1;1;-1
S1474-4422(13)70307-7;n=4;4;-1
S1474-4422(13)70307-7;n=62;62;-1
S1474-4422(13)70307-7;n=59;59;-1
S1474-4422(13)70307-7;n=10;10;-1
S1474-4422(13)70308-9;1169 patients;1169;-1
S1474-4422(13)70308-9;370 patients;370;-1
S1474-4422(13)70308-9;385 patients;385;-1
S1474-4422(13)70308-9;409 patients;409;-1
S1474-4422(13)70308-9;371 patients;371;-1
S1474-4422(13)70308-9;2 patients;2;-1
S1474-4422(13)70308-9;14 female patients;14;-1
S1474-4422(13)70308-9;404 patients;404;-1
S1474-4422(13)70308-9;367 patients;367;-1
S1474-4422(13)70308-9;382 patients;382;-1
S1474-4422(13)70308-9;14 mg group and no   patients;14;-1
S1474-4422(13)70308-9;0001  Proportion of patients;1;-1
S1474-4422(13)70308-9;3 study enrolled adults;3;-1
S1474-4422(13)70308-9;n=389;389;-1
S1474-4422(13)70308-9;n=408;408;-1
S1474-4422(13)70308-9;n=372;372;-1
S1474-4422(13)70308-9;n=388;388;-1
S1474-4422(13)70308-9;n=407;407;-1
S1474-4422(13)70308-9;n=370;370;-1
S1474-4422(13)70308-9;n=385;385;-1
S1474-4422(13)70308-9;n=409;409;-1
S1474-4422(13)70308-9;n=371;371;-1
S1474-4422(13)70308-9;n=384;384;-1
S1474-4422(13)70308-9;3 study enrolled;3;-1
S1474-4422(13)70309-0;458 individuals;458;-1
S1474-4422(13)70309-0;261 individuals;261;-1
S1474-4422(13)70309-0;72 individuals;72;-1
S1474-4422(13)70309-0;59 individuals;59;-1
S1474-4422(13)70309-0;total of 114;114;-1
S1474-4422(13)70311-9;4 621 patients;4621;-1
S1474-4422(13)70311-9;n=522;522;-1
S1474-4422(13)70311-9;n=259;259;-1
S1474-4422(14)70001-8;300 subjects;300;-1
S1474-4422(14)70001-8;663 screened patients;663;-1
S1474-4422(14)70001-8;38 patients;38;-1
S1474-4422(14)70001-8;77 eligible individuals;77;-1
S1474-4422(14)70005-5;903 participants;903;-1
S1474-4422(14)70005-5;616 patients;616;-1
S1474-4422(14)70005-5;32 patients;32;-1
S1474-4422(14)70005-5;30 patients;30;-1
S1474-4422(14)70005-5;18 patients;18;-1
S1474-4422(14)70005-5;600 patients;600;-1
S1474-4422(14)70005-5;617 patients;617;-1
S1474-4422(14)70005-5;204 patients;204;-1
S1474-4422(14)70005-5;206 patients;206;-1
S1474-4422(14)70005-5;25 patients;25;-1
S1474-4422(14)70005-5;3 studies excluded such patients;3;-1
S1474-4422(14)70005-5;24 patients;24;-1
S1474-4422(14)70005-5;34 patients;34;-1
S1474-4422(14)70005-5;n=204;204;-1
S1474-4422(14)70005-5;n=206;206;-1
S1474-4422(14)70005-5;N=616;616;-1
S1474-4422(14)70005-5;n=3;3;-1
S1474-4422(14)70005-5;n=1;1;-1
S1474-4422(14)70005-5;n=2;2;-1
S1474-4422(14)70005-5;n=193;193;-1
S1474-4422(14)70005-5;n=190;190;-1
S1474-4422(14)70005-5;n=154;154;-1
S1474-4422(14)70005-5;n=155;155;-1
S1474-4422(14)70005-5;n=292;292;-1
S1474-4422(14)70005-5;n=176;176;-1
S1474-4422(14)70005-5;n=243;243;-1
S1474-4422(14)70005-5;n=238;238;-1
S1474-4422(14)70005-5;n=175;175;-1
S1474-4422(14)70005-5;n=171;171;-1
S1474-4422(14)70005-5;617 patients were enrolled;617;-1
S1474-4422(14)70013-4;140 patients;140;-1
S1474-4422(14)70013-4;416 patients;416;-1
S1474-4422(14)70013-4;20 patients;20;-1
S1474-4422(14)70018-3;7  Methods  Study design and participants;7;-1
S1474-4422(14)70018-3;2839 participants;2839;-1
S1474-4422(14)70018-3;1381 participants;1381;-1
S1474-4422(14)70018-3;2839 adult patients;2839;-1
S1474-4422(14)70018-3;400 consecutive patients;400;-1
S1474-4422(14)70018-3;2839 patients;2839;-1
S1474-4422(14)70018-3;959 patients;959;-1
S1474-4422(14)70018-3;36 of patients;36;-1
S1474-4422(14)70018-3;1000 patients;1000;-1
S1474-4422(14)70018-3;117 patients;117;-1
S1474-4422(14)70018-3;1 million   people;1;-1
S1474-4422(14)70018-3;2839 adults;2839;-1
S1474-4422(14)70018-3;n=2645;2645;-1
S1474-4422(14)70018-3;n=2347;2347;-1
S1474-4422(14)70018-3;2 enrolled;2;-1
S1474-4422(14)70018-3;1000 patients enrolled;1000;-1
S1474-4422(14)70019-5;420 patients;420;-1
S1474-4422(14)70021-3;35 patients;35;-1
S1474-4422(14)70021-3;23 patients;23;-1
S1474-4422(14)70021-3;458 individuals;458;-1
S1474-4422(14)70021-3;188 individuals;188;-1
S1474-4422(14)70021-3;129 individuals;129;-1
S1474-4422(14)70021-3;205 individuals;205;-1
S1474-4422(14)70021-3;210 individuals;210;-1
S1474-4422(14)70021-3;8 We did not   actively call individuals;8;-1
S1474-4422(14)70021-3;138 individuals;138;-1
S1474-4422(14)70021-3;72 individuals;72;-1
S1474-4422(14)70021-3;200 individuals;200;-1
S1474-4422(14)70021-3;61 individuals;61;-1
S1474-4422(14)70021-3;44 individuals;44;-1
S1474-4422(14)70021-3;98 individuals;98;-1
S1474-4422(14)70021-3;59 individuals;59;-1
S1474-4422(14)70021-3;116 000 individuals;116000;-1
S1474-4422(14)70021-3;n=458;458;-1
S1474-4422(14)70021-3;n=37;37;-1
S1474-4422(14)70021-3;n=55;55;-1
S1474-4422(14)70021-3;n=22;22;-1
S1474-4422(14)70022-5;30 participants;30;-1
S1474-4422(14)70022-5;100 patients;100;-1
S1474-4422(14)70022-5;285 patients;285;-1
S1474-4422(14)70022-5;100 eligible patients;100;-1
S1474-4422(14)70022-5;140 patients;140;-1
S1474-4422(14)70022-5;416 patients;416;-1
S1474-4422(14)70027-4;13 women;13;11897
S1474-4422(14)70027-4;14 women;14;11827
S1474-4422(14)70027-4;55 eligible participants;55;11962
S1474-4422(14)70027-4;19 participants;19;3713
S1474-4422(14)70027-4;11 participants;11;11014
S1474-4422(14)70027-4;15 participants;15;11088
S1474-4422(14)70027-4;13  Procedures  All subjects;13;6283
S1474-4422(14)70027-4;600 patients;600;9585
S1474-4422(14)70027-4;8000 asymptomatic at-risk individuals;8000;9549
S1474-4422(14)70027-4;60 individuals;60;567
S1474-4422(14)70027-4;21 individuals;21;2802
S1474-4422(14)70027-4;n=17;17;11690
S1474-4422(14)70027-4;n=3;3;11634
S1474-4422(14)70027-4;n=4;4;11620
S1474-4422(14)70027-4;n=13;13;2978
S1474-4422(14)70027-4;n=10;10;3020
S1474-4422(14)70027-4;n=8;8;3096
S1474-4422(14)70027-4;n=11;11;7791
S1474-4422(14)70027-4;n=19;19;7858
S1474-4422(14)70027-4;n=21;21;15420
S1474-4422(14)70027-4;n=6;6;15453
S1474-4422(14)70027-4;n=2;2;15420
S1474-4422(14)70027-4;40 enrolled;40;4442
S1474-4422(14)70028-6;255 patients;255;-1
S1474-4422(14)70028-6;9 In patients;9;-1
S1474-4422(14)70028-6;73 patients;73;-1
S1474-4422(14)70028-6;324 patients;324;-1
S1474-4422(14)70028-6;52 patients;52;-1
S1474-4422(14)70028-6;254 patients;254;-1
S1474-4422(14)70028-6;184 patients;184;-1
S1474-4422(14)70028-6;n=165;165;-1
S1474-4422(14)70028-6;n=63;63;-1
S1474-4422(14)70028-6;n=64;64;-1
S1474-4422(14)70028-6;n=65;65;-1
S1474-4422(14)70028-6;n=25;25;-1
S1474-4422(14)70028-6;n=34;34;-1
S1474-4422(14)70028-6;n=35;35;-1
S1474-4422(14)70028-6;n=33;33;-1
S1474-4422(14)70031-6;653 consecutive eligible patients;653;-1
S1474-4422(14)70031-6;33  All patients;33;-1
S1474-4422(14)70031-6;14 patients;14;-1
S1474-4422(14)70031-6;653 patients;653;-1
S1474-4422(14)70031-6;523 patients;523;-1
S1474-4422(14)70031-6;113 patients;113;-1
S1474-4422(14)70031-6;229 patients;229;-1
S1474-4422(14)70031-6;65 patients;65;-1
S1474-4422(14)70031-6;111 patients;111;-1
S1474-4422(14)70031-6;248 patients;248;-1
S1474-4422(14)70031-6;N=523;523;-1
S1474-4422(14)70031-6;N=113;113;-1
S1474-4422(14)70031-6;n=734;734;-1
S1474-4422(14)70032-8;800 patients;800;-1
S1474-4422(14)70039-0;567 patients;567;-1
S1474-4422(14)70039-0;11 patients;11;-1
S1474-4422(14)70039-0;621 patients;621;-1
S1474-4422(14)70039-0;18 patients;18;-1
S1474-4422(14)70039-0;517 patients;517;-1
S1474-4422(14)70039-0;115 patients;115;-1
S1474-4422(14)70039-0;114 patients;114;-1
S1474-4422(14)70039-0;12 patients;12;-1
S1474-4422(14)70039-0;n=3;3;-1
S1474-4422(14)70039-0;n=86;86;-1
S1474-4422(14)70039-0;n=87;87;-1
S1474-4422(14)70039-0;n=84;84;-1
S1474-4422(14)70039-0;n=88;88;-1
S1474-4422(14)70039-0;n=79;79;-1
S1474-4422(14)70039-0;n=65;65;-1
S1474-4422(14)70039-0;n=64;64;-1
S1474-4422(14)70039-0;n=68;68;-1
S1474-4422(14)70039-0;n=129;129;-1
S1474-4422(14)70039-0;n=163;163;-1
S1474-4422(14)70039-0;n=132;132;-1
S1474-4422(14)70042-0;11 Both trials have included patients;11;-1
S1474-4422(14)70042-0;458 individuals;458;-1
S1474-4422(14)70042-0;261 individuals;261;-1
S1474-4422(14)70043-2;6 In patients;6;-1
S1474-4422(14)70043-2;72 individuals;72;-1
S1474-4422(14)70043-2;59 individuals;59;-1
S1474-4422(14)70043-2;4   For individuals;4;-1
S1474-4422(14)70043-2;total of 114;114;-1
S1474-4422(14)70044-4;21 participants;21;-1
S1474-4422(14)70044-4;19 participants;19;-1
S1474-4422(14)70044-4;263 patients;263;-1
S1474-4422(14)70044-4;40 individuals;40;-1
S1474-4422(14)70049-3;1083 patients;1083;-1
S1474-4422(14)70049-3;0 patients;0;-1
S1474-4422(14)70049-3;358 patients;358;-1
S1474-4422(14)70049-3;355 patients;355;-1
S1474-4422(14)70049-3;113 switched   patients;113;-1
S1474-4422(14)70049-3;1555 patients;1555;-1
S1474-4422(14)70049-3;1080 randomised patients;1080;-1
S1474-4422(14)70049-3;360 patients;360;-1
S1474-4422(14)70049-3;370 patients;370;-1
S1474-4422(14)70049-3;25 mg group and no patients;25;-1
S1474-4422(14)70049-3;27 patients;27;-1
S1474-4422(14)70049-3;369 patients;369;-1
S1474-4422(14)70049-3;354 patients;354;-1
S1474-4422(14)70049-3;350 patients;350;-1
S1474-4422(14)70049-3;7 A high proportion of patients;7;-1
S1474-4422(14)70049-3;N=370;370;-1
S1474-4422(14)70049-3;N=358;358;-1
S1474-4422(14)70049-3;N=355;355;-1
S1474-4422(14)70049-3;n=366;366;-1
S1474-4422(14)70049-3;n=353;353;-1
S1474-4422(14)70049-3;n=350;350;-1
S1474-4422(14)70049-3;n=360;360;-1
S1474-4422(14)70049-3;n=351;351;-1
S1474-4422(14)70049-3;n=346;346;-1
S1474-4422(14)70049-3;n=330;330;-1
S1474-4422(14)70049-3;n=315;315;-1
S1474-4422(14)70049-3;n=326;326;-1
S1474-4422(14)70050-X;3 patients;3;-1
S1474-4422(14)70050-X;n=63;63;-1
S1474-4422(14)70050-X;n=64;64;-1
S1474-4422(14)70050-X;n=65;65;-1
S1474-4422(14)70051-1;298 patients;298;-1
S1474-4422(14)70051-1;4 Some patients;4;-1
S1474-4422(14)70051-1;7 and patients;7;-1
S1474-4422(14)70051-1;30  Two patients;30;-1
S1474-4422(14)70053-5;522 patients;522;-1
S1474-4422(14)70053-5;521 patients;521;-1
S1474-4422(14)70053-5;27 patients;27;-1
S1474-4422(14)70053-5;69 patients;69;-1
S1474-4422(14)70053-5;517 patients;517;-1
S1474-4422(14)70053-5;500 patients;500;-1
S1474-4422(14)70053-5;250 patients;250;-1
S1474-4422(14)70053-5;100 suvorexant-treated patients;100;-1
S1474-4422(14)70053-5;1076 patients;1076;-1
S1474-4422(14)70053-5;484 patients;484;-1
S1474-4422(14)70053-5;397 patients;397;-1
S1474-4422(14)70053-5;196 patients;196;-1
S1474-4422(14)70053-5;N=521;521;-1
S1474-4422(14)70053-5;N=258;258;-1
S1474-4422(14)70053-5;n=26;26;-1
S1474-4422(14)70053-5;n=12;12;-1
S1474-4422(14)70053-5;n=464;464;-1
S1474-4422(14)70053-5;n=228;228;-1
S1474-4422(14)70053-5;N=517;517;-1
S1474-4422(14)70053-5;N=254;254;-1
S1474-4422(14)70053-5;N=492;492;-1
S1474-4422(14)70053-5;N=245;245;-1
S1474-4422(14)70053-5;N=298;298;-1
S1474-4422(14)70053-5;N=147;147;-1
S1474-4422(14)70054-7;421 patients;421;17368
S1474-4422(14)70054-7;50 patients;50;12008
S1474-4422(14)70054-7;420 patients;420;1395
S1474-4422(14)70054-7;1129 patients;1129;1158
S1474-4422(14)70054-7;211 patients;211;1852
S1474-4422(14)70054-7;411 patients;411;4860
S1474-4422(14)70054-7;15 patients;15;4910
S1474-4422(14)70054-7;11 patients;11;1853
S1474-4422(14)70054-7;200 patients;200;6258
S1474-4422(14)70054-7;24 patients;24;17672
S1474-4422(14)70054-7;n=211;211;5883
S1474-4422(14)70054-7;n=200;200;5865
S1474-4422(14)70054-7;n=51;51;1657
S1474-4422(14)70054-7;n=58;58;1650
S1474-4422(14)70054-7;n=111;111;10495
S1474-4422(14)70054-7;n=95;95;10513
S1474-4422(14)70054-7;n=100;100;10532
S1474-4422(14)70054-7;n=105;105;10550
S1474-4422(14)70054-7;n=411;411;10810
S1474-4422(14)70054-7;n=421;421;11018
S1474-4422(14)70054-7;n=398;398;11125
S1474-4422(14)70054-7;n=152;152;11266
S1474-4422(14)70054-7;n=259;259;11327
S1474-4422(14)70054-7;n=205;205;11404
S1474-4422(14)70054-7;n=206;206;11469
S1474-4422(14)70054-7;n=136;136;11707
S1474-4422(14)70054-7;n=138;138;11776
S1474-4422(14)70054-7;n=135;135;11845
S1474-4422(14)70055-9;191 patients;191;-1
S1474-4422(14)70055-9;124 patients;124;-1
S1474-4422(14)70055-9;43 patients;43;-1
S1474-4422(14)70055-9;192 patients;192;-1
S1474-4422(14)70055-9;1658 patients;1658;-1
S1474-4422(14)70055-9;622 patients;622;-1
S1474-4422(14)70055-9;374 patients;374;-1
S1474-4422(14)70055-9;244 patients;244;-1
S1474-4422(14)70055-9;3 patients;3;-1
S1474-4422(14)70055-9;67 patients;67;-1
S1474-4422(14)70055-9;10 patients;10;-1
S1474-4422(14)70055-9;4 patients;4;-1
S1474-4422(14)70055-9;121 patients;121;-1
S1474-4422(14)70055-9;57 patients;57;-1
S1474-4422(14)70055-9;122 patients;122;-1
S1474-4422(14)70055-9;63 patients;63;-1
S1474-4422(14)70055-9;61 patients;61;-1
S1474-4422(14)70055-9;2 patients;2;-1
S1474-4422(14)70055-9;191 eligible patients;191;-1
S1474-4422(14)70055-9;n=124;124;-1
S1474-4422(14)70055-9;n=67;67;-1
S1474-4422(14)70055-9;n=4;4;-1
S1474-4422(14)70055-9;n=10;10;-1
S1474-4422(14)70055-9;n=83;83;-1
S1474-4422(14)70056-0;4 621 patients;4621;-1
S1474-4422(14)70056-0;total of 24;24;-1
S1474-4422(14)70065-1;3526 patients;3526;-1
S1474-4422(14)70065-1;2154 patients;2154;-1
S1474-4422(14)70065-1;1372 patients;1372;-1
S1474-4422(14)70065-1;515 patients;515;-1
S1474-4422(14)70065-1;2621   patients;2621;-1
S1474-4422(14)70065-1;3500 patients;3500;-1
S1474-4422(14)70065-1;100 000 individuals;100000;-1
S1474-4422(14)70065-1;19 all individuals;19;-1
S1474-4422(14)70065-1;74 046 individuals;74046;-1
S1474-4422(14)70066-3;240 patients;240;-1
S1474-4422(14)70066-3;656 patients;656;-1
S1474-4422(14)70066-3;182 patients;182;-1
S1474-4422(14)70066-3;426 patients;426;-1
S1474-4422(14)70066-3;35 patients;35;-1
S1474-4422(14)70066-3;12 patients;12;-1
S1474-4422(14)70066-3;58 patients;58;-1
S1474-4422(14)70066-3;434 patients;434;-1
S1474-4422(14)70066-3;222 patients;222;-1
S1474-4422(14)70066-3;83 patients;83;-1
S1474-4422(14)70066-3;118 patients;118;-1
S1474-4422(14)70066-3;623 patients;623;-1
S1474-4422(14)70066-3;n=54;54;-1
S1474-4422(14)70066-3;n=83;83;-1
S1474-4422(14)70066-3;n=182;182;-1
S1474-4422(14)70066-3;n=58;58;-1
S1474-4422(14)70066-3;656 patients enrolled;656;-1
S1474-4422(14)70067-5;191 patients;191;-1
S1474-4422(14)70068-7;500 participants;500;-1
S1474-4422(14)70068-7;18 participants;18;-1
S1474-4422(14)70068-7;1512 participants;1512;-1
S1474-4422(14)70068-7;1936 patients;1936;-1
S1474-4422(14)70068-7;0114  Proportion of patients;114;-1
S1474-4422(14)70068-7;1512 patients;1512;-1
S1474-4422(14)70068-7;500 patients;500;-1
S1474-4422(14)70068-7;1000 patients;1000;-1
S1474-4422(14)70068-7;n=500;500;-1
S1474-4422(14)70068-7;n=512;512;-1
S1474-4422(14)70068-7;n=2;2;-1
S1474-4422(14)70068-7;n=4;4;-1
S1474-4422(14)70068-7;1936 patients and enrolled;1936;-1
S1474-4422(14)70068-7;1516 enrolled;1516;-1
S1474-4422(14)70070-5;3526 patients;3526;-1
S1474-4422(14)70074-2;191 patients;191;-1
S1474-4422(14)70074-2;182 patients;182;-1
S1474-4422(14)70074-2;73 patients;73;-1
S1474-4422(14)70074-2;345 patients;345;-1
S1474-4422(14)70074-2; data from 182;182;-1
S1474-4422(14)70084-5;803 patients;803;-1
S1474-4422(14)70084-5;271 patients;271;-1
S1474-4422(14)70084-5;600 000 patients;600000;-1
S1474-4422(14)70084-5;7000 patients;7000;-1
S1474-4422(14)70084-5;3500 patients;3500;-1
S1474-4422(14)70084-5;3640 patients;3640;-1
S1474-4422(14)70084-5;800 randomised   patients;800;-1
S1474-4422(14)70084-5;391 patients;391;-1
S1474-4422(14)70084-5;412 patients;412;-1
S1474-4422(14)70084-5;289 patients;289;-1
S1474-4422(14)70084-5;803   patients;803;-1
S1474-4422(14)70084-5;44 patients;44;-1
S1474-4422(14)70084-5;18 patients;18;-1
S1474-4422(14)70084-5;64 patients;64;-1
S1474-4422(14)70084-5;62 patients;62;-1
S1474-4422(14)70084-5;16 patients;16;-1
S1474-4422(14)70084-5;28 patients;28;-1
S1474-4422(14)70084-5;340 patients;340;-1
S1474-4422(14)70084-5;32 patients;32;-1
S1474-4422(14)70084-5;2143 patients;2143;-1
S1474-4422(14)70084-5;1 was recruited;1;-1
S1474-4422(14)70084-5;n=391;391;-1
S1474-4422(14)70084-5;n=412;412;-1
S1474-4422(14)70084-5;n=70;70;-1
S1474-4422(14)70084-5;n=74;74;-1
S1474-4422(14)70084-5;n=496;496;-1
S1474-4422(14)70086-9;182 patients;182;-1
S1474-4422(14)70086-9;73 patients;73;-1
S1474-4422(14)70086-9;345 patients;345;-1
S1474-4422(14)70086-9;2 patients;2;-1
S1474-4422(14)70086-9;35 patients;35;-1
S1474-4422(14)70086-9;n=78;78;-1
S1474-4422(14)70086-9;n=26;26;-1
S1474-4422(14)70086-9;n=34;34;-1
S1474-4422(14)70086-9;n=30;30;-1
S1474-4422(14)70086-9; data from 182;182;-1
S1474-4422(14)70088-2;313 participants;313;-1
S1474-4422(14)70088-2;10 All   participants;10;-1
S1474-4422(14)70088-2;17 participants;17;-1
S1474-4422(14)70088-2;23 participants;23;-1
S1474-4422(14)70088-2;21 participants;21;-1
S1474-4422(14)70088-2;8 and   therefore patients;8;-1
S1474-4422(14)70088-2;360 patients;360;-1
S1474-4422(14)70088-2;100 000 individuals;100000;-1
S1474-4422(14)70088-2;144 individuals;144;-1
S1474-4422(14)70088-2;360 individuals;360;-1
S1474-4422(14)70088-2;n=157;157;-1
S1474-4422(14)70088-2;n=156;156;-1
S1474-4422(14)70088-2;n=151;151;-1
S1474-4422(14)70088-2;n=153;153;-1
S1474-4422(14)70088-2;n=304;304;-1
S1474-4422(14)70088-2;n=21;21;-1
S1474-4422(14)70088-2;n=12;12;-1
S1474-4422(14)70088-2;n=118;118;-1
S1474-4422(14)70088-2;n=123;123;-1
S1474-4422(14)70088-2;n=241;241;-1
S1474-4422(14)70088-2;n=106;106;-1
S1474-4422(14)70088-2;n=111;111;-1
S1474-4422(14)70088-2;n=217;217;-1
S1474-4422(14)70088-2;n=108;108;-1
S1474-4422(14)70088-2;n=219;219;-1
S1474-4422(14)70088-2;n=10;10;-1
S1474-4422(14)70088-2;n=22;22;-1
S1474-4422(14)70088-2;n=11;11;-1
S1474-4422(14)70088-2;n=23;23;-1
S1474-4422(14)70088-2;n=13;13;-1
S1474-4422(14)70088-2;n=6;6;-1
S1474-4422(14)70088-2;n=19;19;-1
S1474-4422(14)70088-2;n=7;7;-1
S1474-4422(14)70088-2;n=5;5;-1
S1474-4422(14)70088-2;n=20;20;-1
S1474-4422(14)70088-2;n=37;37;-1
S1474-4422(14)70088-2;n=312;312;-1
S1474-4422(14)70088-2;21 participants enrolled;21;-1
S1474-4422(14)70091-2;8382 patients;8382;-1
S1474-4422(14)70091-2;60 000 patients;60000;-1
S1474-4422(14)70091-2;1691 patients;1691;-1
S1474-4422(14)70091-2;6513 patients;6513;-1
S1474-4422(14)70095-X;90,056 participants;90056;-1
S1474-4422(14)70095-X;100 patients;100;-1
S1474-4422(14)70095-X;200 patients;200;-1
S1474-4422(14)70095-X;100 000 people;100000;-1
S1474-4422(14)70095-X; data from   90,056;90056;-1
S1474-4422(14)70096-1;5 In patients;5;-1
S1474-4422(14)70096-1;3 In other patients;3;-1
S1474-4422(14)70100-0;2 lesions and proportion of patients;2;-1
S1474-4422(14)70100-0;8 of healthy people;8;-1
S1474-4422(14)70112-7;90,056 participants;90056;-1
S1474-4422(14)70112-7;7 Trial participants;7;-1
S1474-4422(14)70112-7;200 patients;200;-1
S1474-4422(14)70112-7;313 patients;313;-1
S1474-4422(14)70112-7;3526 patients;3526;-1
S1474-4422(14)70112-7;100 000 people;100000;-1
S1474-4422(14)70112-7; data from   90,056;90056;-1
S1474-4422(14)70122-X;10 women;10;-1
S1474-4422(14)70122-X;6 women;6;-1
S1474-4422(14)70122-X;92 women;92;-1
S1474-4422(14)70122-X;9  Methods  Study design and participants;9;-1
S1474-4422(14)70122-X;n=10;10;-1
S1474-4422(14)70122-X;n=6;6;-1
S1474-4422(14)70122-X;n=607;607;-1
S1474-4422(14)70122-X;n=8;8;-1
S1474-4422(14)70122-X;n=58;58;-1
S1474-4422(14)70122-X;n=252;252;-1
S1474-4422(14)70122-X;n=255;255;-1
S1474-4422(14)70122-X;n=355;355;-1
S1474-4422(14)70122-X;n=69;69;-1
S1474-4422(14)70122-X;N=49;49;-1
S1474-4422(14)70122-X;N=9;9;-1
S1474-4422(14)70122-X;total of 25;25;-1
S1474-4422(14)70122-X; data from 64;64;-1
S1474-4422(14)70126-7;98 patients;98;-1
S1474-4422(14)70126-7;104 patients;104;-1
S1474-4422(14)70126-7;48 patients;48;-1
S1474-4422(14)70126-7;28 patients;28;-1
S1474-4422(14)70128-0;217 of patients   were women;217;-1
S1474-4422(14)70128-0;218 patients;218;-1
S1474-4422(14)70128-0;482 patients;482;-1
S1474-4422(14)70128-0;13 patients;13;-1
S1474-4422(14)70128-0;190 patients;190;-1
S1474-4422(14)70128-0;160 patients;160;-1
S1474-4422(14)70128-0;107 patients;107;-1
S1474-4422(14)70128-0;110 patients;110;-1
S1474-4422(14)70128-0;217 of patients;217;-1
S1474-4422(14)70128-0;217 patients;217;-1
S1474-4422(14)70128-0;98 patients;98;-1
S1474-4422(14)70128-0;20 patients;20;-1
S1474-4422(14)70128-0;n=108;108;-1
S1474-4422(14)70128-0;n=110;110;-1
S1474-4422(14)70128-0;n=107;107;-1
S1474-4422(14)70136-X; data from 23;23;-1
S1474-4422(14)70139-5;119 men enrolled;119;-1
S1474-4422(14)70141-3;12 women;12;-1
S1474-4422(14)70141-3;57 clinic-based   patients;57;-1
S1474-4422(14)70141-3;25 patients;25;-1
S1474-4422(14)70141-3;50 of the clinic-based patients;50;-1
S1474-4422(14)70141-3;15 patients;15;-1
S1474-4422(14)70141-3;12 patients;12;-1
S1474-4422(14)70141-3;57 patients;57;-1
S1474-4422(14)70141-3;176 patients;176;-1
S1474-4422(14)70141-3;53 patients;53;-1
S1474-4422(14)70141-3;22 patients;22;-1
S1474-4422(14)70141-3;286 multiple sclerosis patients;286;-1
S1474-4422(14)70141-3;50 clinic-based patients;50;-1
S1474-4422(14)70141-3;286 patients;286;-1
S1474-4422(14)70141-3;11 patients;11;-1
S1474-4422(14)70141-3;397 patients;397;-1
S1474-4422(14)70141-3;50 patients;50;-1
S1474-4422(14)70141-3;5000 patients;5000;-1
S1474-4422(14)70141-3;77 patients;77;-1
S1474-4422(14)70141-3;177 patients;177;-1
S1474-4422(14)70141-3;32 That patients;32;-1
S1474-4422(14)70141-3;15 individuals;15;-1
S1474-4422(14)70141-3;208 control individuals;208;-1
S1474-4422(14)70141-3;n=90;90;-1
S1474-4422(14)70141-3;n=9;9;-1
S1474-4422(14)70141-3;n=50;50;-1
S1474-4422(14)70141-3;n=8;8;-1
S1474-4422(14)70141-3;n=99;99;-1
S1474-4422(14)70141-3;n=77;77;-1
S1474-4422(14)70141-3;n=32;32;-1
S1474-4422(14)70141-3;n=53;53;-1
S1474-4422(14)70141-3;n=176;176;-1
S1474-4422(14)70141-3;n=57;57;-1
S1474-4422(14)70141-3;n=286;286;-1
S1474-4422(14)70141-3;n=208;208;-1
S1474-4422(14)70142-5;21  All patients;21;-1
S1474-4422(14)70142-5;16 patients;16;-1
S1474-4422(14)70142-5;21 patients;21;-1
S1474-4422(14)70143-7;62 patients;62;-1
S1474-4422(14)70143-7;32 patients;32;-1
S1474-4422(14)70143-7;30 patients;30;-1
S1474-4422(14)70143-7;404 patients;404;-1
S1474-4422(14)70143-7;85 patients;85;-1
S1474-4422(14)70143-7;51 patients;51;-1
S1474-4422(14)70143-7;10 patients;10;-1
S1474-4422(14)70143-7;390   per million people;390;-1
S1474-4422(14)70143-7;n=32;32;-1
S1474-4422(14)70143-7;n=30;30;-1
S1474-4422(14)70143-7;n=62;62;-1
S1474-4422(14)70143-7;total of 51;51;-1
S1474-4422(14)70143-7;62 patients enrolled;62;-1
S1474-4422(14)70146-2;1 Although patients;1;-1
S1474-4422(14)70148-6;420 randomised patients;420;-1
S1474-4422(14)70148-6;84 patients;84;-1
S1474-4422(14)70148-6;601 patients;601;-1
S1474-4422(14)70148-6;80 patients;80;-1
S1474-4422(14)70148-6;70 patients;70;-1
S1474-4422(14)70148-6;420 patients;420;-1
S1474-4422(14)70148-6;73 patients;73;-1
S1474-4422(14)70148-6;0 patients vs fi ve patients;0;-1
S1474-4422(14)70148-6;0 patients;0;-1
S1474-4422(14)70148-6;n=84;84;-1
S1474-4422(14)70148-6;n=85;85;-1
S1474-4422(14)70148-6;n=82;82;-1
S1474-4422(14)70148-6;n=420;420;-1
S1474-4422(14)70148-6;n=336;336;-1
S1474-4422(14)70149-8;397 patients;397;-1
S1474-4422(14)70149-8;329 patients;329;-1
S1474-4422(14)70149-8;19 patients;19;-1
S1474-4422(14)70149-8;268 patients;268;-1
S1474-4422(14)70149-8;268 people;268;-1
S1474-4422(14)70151-6;65 patients;65;-1
S1474-4422(14)70151-6;2 patients;2;-1
S1474-4422(14)70153-X;420 patients;420;-1
S1474-4422(14)70153-X;65 patients;65;-1
S1474-4422(14)70154-1;397 patients;397;-1
S1474-4422(14)70154-1;329 patients;329;-1
S1474-4422(14)70154-1;19 patients;19;-1
S1474-4422(14)70158-9;186 patients;186;-1
S1474-4422(14)70168-1;656 patients;656;-1
S1474-4422(14)70171-1;40 789 participants;40789;-1
S1474-4422(14)70171-1;3445 patients;3445;-1
S1474-4422(14)70171-1;1018 patients;1018;-1
S1474-4422(14)70171-1;1493 patients;1493;-1
S1474-4422(14)70171-1;10 064 people;10064;-1
S1474-4422(14)70171-1;12 cohorts of individuals;12;-1
S1474-4422(14)70171-1;34 853 individuals;34853;-1
S1474-4422(14)70171-1;21 596 individuals;21596;-1
S1474-4422(14)70171-1;28 916 individuals;28916;-1
S1474-4422(14)70171-1;n=8696;8696;-1
S1474-4422(14)70171-1;n=2606;2606;-1
S1474-4422(14)70171-1;n=5310;5310;-1
S1474-4422(14)70171-1;n=26 157;26157;-1
S1474-4422(14)70171-1;total of 34 853;34853;-1
S1474-4422(14)70171-1; data from 12;12;-1
S1474-4422(14)70171-1; data taken from the 1000;1000;-1
S1474-4422(14)70177-2;100 000   people;100000;-1
S1474-4422(14)70178-4;183 cases per million people;183;-1
S1474-4422(14)70178-4;total   of 6;6;-1
S1474-4422(14)70179-6;66 patients;66;-1
S1474-4422(14)70179-6;21 patients;21;-1
S1474-4422(14)70179-6;23 patients;23;-1
S1474-4422(14)70179-6;22 patients;22;-1
S1474-4422(14)70179-6;514 patients;514;-1
S1474-4422(14)70179-6;278 patients;278;-1
S1474-4422(14)70179-6;500 patients;500;-1
S1474-4422(14)70179-6;150 000 people;150000;-1
S1474-4422(14)70179-6;total   of 514;514;-1
S1474-4422(14)70191-7;780 participants;780;-1
S1474-4422(14)70191-7;846 screened participants;846;-1
S1474-4422(14)70191-7;618 patients;618;-1
S1474-4422(14)70191-7;214 patients;214;-1
S1474-4422(14)70191-7;216 patients;216;-1
S1474-4422(14)70191-7;846 patients;846;-1
S1474-4422(14)70191-7;260 patients;260;-1
S1474-4422(14)70191-7;199 patients;199;-1
S1474-4422(14)70191-7;614 patients;614;-1
S1474-4422(14)70191-7;197 patients;197;-1
S1474-4422(14)70191-7;14 mg group and two patients;14;-1
S1474-4422(14)70191-7;23 Few patients;23;-1
S1474-4422(14)70191-7;n=216;216;-1
S1474-4422(14)70191-7;n=205;205;-1
S1474-4422(14)70191-7;n=197;197;-1
S1474-4422(14)70191-7;n=214;214;-1
S1474-4422(14)70191-7;n=203;203;-1
S1474-4422(14)70191-7;n=249;249;-1
S1474-4422(14)70191-7;n=207;207;-1
S1474-4422(14)70191-7;n=191;191;-1
S1474-4422(14)70191-7;total of 454;454;-1
S1474-4422(14)70191-7;618 patients were enrolled;618;-1
S1474-4422(14)70194-2;985 eligible participants;985;-1
S1474-4422(14)70194-2;133 participants;133;-1
S1474-4422(14)70194-2;75 individuals;75;-1
S1474-4422(14)70194-2;985 individuals;985;-1
S1474-4422(14)70194-2;n=985;985;-1
S1474-4422(14)70194-2;n=503;503;-1
S1474-4422(14)70194-2;n=213;213;-1
S1474-4422(14)70194-2;n=130;130;-1
S1474-4422(14)70194-2;n=139;139;-1
S1474-4422(14)70195-4;53 patients;53;-1
S1474-4422(14)70195-4;14 patients;14;-1
S1474-4422(14)70195-4;15 patients;15;-1
S1474-4422(14)70195-4;16 patients;16;-1
S1474-4422(14)70195-4;12 patients;12;-1
S1474-4422(14)70195-4;0  Data are number of patients;0;-1
S1474-4422(14)70195-4;8  Whereas patients;8;-1
S1474-4422(14)70195-4;35 patients;35;-1
S1474-4422(14)70195-4;18 patients;18;-1
S1474-4422(14)70195-4;12 individuals;12;-1
S1474-4422(14)70195-4;n=18;18;-1
S1474-4422(14)70195-4;n=17;17;-1
S1474-4422(14)70195-4;n=15;15;-1
S1474-4422(14)70195-4;n=16;16;-1
S1474-4422(14)70195-4;n=186;186;-1
S1474-4422(14)70196-6;79 patients;79;-1
S1474-4422(14)70196-6;88 patients;88;-1
S1474-4422(14)70196-6;30 of   these patients;30;-1
S1474-4422(14)70196-6;303 patients;303;-1
S1474-4422(14)70197-8;79 patients;79;-1
S1474-4422(14)70197-8;88 patients;88;-1
S1474-4422(14)70197-8;30 of   these patients;30;-1
S1474-4422(14)70197-8;303 patients;303;-1
S1474-4422(14)70198-X;278 patients;278;-1
S1474-4422(14)70198-X;132 patients;132;-1
S1474-4422(14)70198-X;25 patients;25;-1
S1474-4422(14)70198-X;16 patients;16;-1
S1474-4422(14)70198-X;135 patients;135;-1
S1474-4422(14)70198-X;145 patients;145;-1
S1474-4422(14)70198-X;133 patients;133;-1
S1474-4422(14)70198-X;13 patients;13;-1
S1474-4422(14)70198-X;27 patients;27;-1
S1474-4422(14)70198-X;0  Data are number of patients;0;-1
S1474-4422(14)70198-X;742457 versus patients;742457;-1
S1474-4422(14)70198-X;n=133;133;-1
S1474-4422(14)70198-X;n=145;145;-1
S1474-4422(14)70198-X;n=38;38;-1
S1474-4422(14)70199-1;7 068 334 patients;7068334;-1
S1474-4422(14)70199-1;2 372 223 patients;2372223;-1
S1474-4422(14)70200-5;7 068 334 patients;7068334;-1
S1474-4422(14)70200-5;2 372 223 patients;2372223;-1
S1474-4422(14)70202-9;205 patients;205;-1
S1474-4422(14)70202-9;216 patients;216;-1
S1474-4422(14)70202-9;197 patients;197;-1
S1474-4422(14)70204-2;1 Although patients;1;-1
S1474-4422(14)70205-4;79 patients;79;-1
S1474-4422(14)70205-4;88 patients;88;-1
S1474-4422(14)70205-4;30 of   these patients;30;-1
S1474-4422(14)70205-4;303 patients;303;-1
S1474-4422(14)70209-1;174 patients;174;-1
S1474-4422(14)70209-1;81 patients;81;-1
S1474-4422(14)70209-1;1 Few patients;1;-1
S1474-4422(14)70209-1;160 randomly assigned patients;160;-1
S1474-4422(14)70209-1;360   patients;360;-1
S1474-4422(14)70209-1;163 patients;163;-1
S1474-4422(14)70209-1;143 patients;143;-1
S1474-4422(14)70209-1;81   patients;81;-1
S1474-4422(14)70209-1;n=81;81;-1
S1474-4422(14)70209-1;n=82;82;-1
S1474-4422(14)70209-1;n=80;80;-1
S1474-4422(14)70209-1;n=76;76;-1
S1474-4422(14)70209-1;n=78;78;-1
S1474-4422(14)70209-1;n=73;73;-1
S1474-4422(14)70219-4;17 All participants;17;-1
S1474-4422(14)70219-4;34 million   people;34;-1
S1474-4422(14)70222-4;66 participants;66;-1
S1474-4422(14)70222-4;448 new participants;448;-1
S1474-4422(14)70222-4;340 participants;340;-1
S1474-4422(14)70222-4;41 participants;41;-1
S1474-4422(14)70222-4;0 participants;0;-1
S1474-4422(14)70222-4;600 participants;600;-1
S1474-4422(14)70222-4;500 participants;500;-1
S1474-4422(14)70222-4;22 participants;22;-1
S1474-4422(14)70222-4;513 participants;513;-1
S1474-4422(14)70222-4;184 participants;184;-1
S1474-4422(14)70222-4;102 participants;102;-1
S1474-4422(14)70222-4;15 participants;15;-1
S1474-4422(14)70222-4;296 participants;296;-1
S1474-4422(14)70222-4;3 participants;3;-1
S1474-4422(14)70222-4;200 participants;200;-1
S1474-4422(14)70222-4;732 patients;732;-1
S1474-4422(14)70222-4;173 patients;173;-1
S1474-4422(14)70222-4;337 patients;337;-1
S1474-4422(14)70222-4;333 patients;333;-1
S1474-4422(14)70222-4;732 people;732;-1
S1474-4422(14)70222-4;n=53;53;-1
S1474-4422(14)70222-4;n=45;45;-1
S1474-4422(14)70222-4;n=340;340;-1
S1474-4422(14)70222-4;n=173;173;-1
S1474-4422(14)70222-4;3 enrolled;3;-1
S1474-4422(14)70224-8;3 participants;3;-1
S1474-4422(14)70224-8;3020   participants;3020;-1
S1474-4422(14)70224-8;104 participants;104;-1
S1474-4422(14)70224-8;2916 participants;2916;-1
S1474-4422(14)70224-8;1586 participants;1586;-1
S1474-4422(14)70224-8;1304 participants;1304;-1
S1474-4422(14)70224-8;9954 participants;9954;-1
S1474-4422(14)70224-8;3020 participants;3020;-1
S1474-4422(14)70224-8;180 patients;180;-1
S1474-4422(14)70224-8;721 patients;721;-1
S1474-4422(14)70224-8;692 patients;692;-1
S1474-4422(14)70224-8;713 patients;713;-1
S1474-4422(14)70224-8;700 patients;700;-1
S1474-4422(14)70224-8;2668 patients;2668;-1
S1474-4422(14)70224-8;376 patients;376;-1
S1474-4422(14)70224-8;275 patients;275;-1
S1474-4422(14)70224-8;20 332 patients;20332;-1
S1474-4422(14)70224-8;6105 individuals;6105;-1
S1474-4422(14)70224-8;n=2472;2472;-1
S1474-4422(14)70224-8;n=1968;1968;-1
S1474-4422(14)70224-8;n=1521;1521;-1
S1474-4422(14)70224-8;n=1135;1135;-1
S1474-4422(14)70224-8;n=803;803;-1
S1474-4422(14)70224-8;n=1468;1468;-1
S1474-4422(14)70224-8;n=1448;1448;-1
S1474-4422(14)70224-8;n=1452;1452;-1
S1474-4422(14)70224-8;n=1464;1464;-1
S1474-4422(14)70224-8;n=0;0;-1
S1474-4422(14)70224-8;n=752;752;-1
S1474-4422(14)70224-8;n=1689;1689;-1
S1474-4422(14)70224-8;n=475;475;-1
S1474-4422(14)70224-8;n=1632;1632;-1
S1474-4422(14)70224-8;n=120;120;-1
S1474-4422(14)70224-8;n=109;109;-1
S1474-4422(14)70224-8;n=693;693;-1
S1474-4422(14)70224-8;n=362;362;-1
S1474-4422(14)70224-8;n=1457;1457;-1
S1474-4422(14)70224-8;n=1459;1459;-1
S1474-4422(14)70224-8;n=1586;1586;-1
S1474-4422(14)70224-8;n=1303;1303;-1
S1474-4422(14)70224-8;n=2611;2611;-1
S1474-4422(14)70224-8;n=300;300;-1
S1474-4422(14)70224-8;n=1710;1710;-1
S1474-4422(14)70224-8;n=1126;1126;-1
S1474-4422(14)70224-8;n=1437;1437;-1
S1474-4422(14)70224-8;n=804;804;-1
S1474-4422(14)70224-8;n=625;625;-1
S1474-4422(14)70224-8;n=6105;6105;-1
S1474-4422(14)70224-8;3 participants were enrolled;3;-1
S1474-4422(14)70225-X;656 patients;656;-1
S1474-4422(14)70228-5;218 patients;218;-1
S1474-4422(14)70228-5;163 patients;163;-1
S1474-4422(14)70228-5;7 885 patients;7885;-1
S1474-4422(14)70228-5;100 000   people;100000;-1
S1474-4422(14)70228-5;n=81;81;-1
S1474-4422(14)70228-5;n=82;82;-1
S1474-4422(14)70229-7;656 patients;656;-1
S1474-4422(14)70232-7;278 patients;278;-1
S1474-4422(14)70232-7;500 patients;500;-1
S1474-4422(14)70232-7;930 patients;930;-1
S1474-4422(14)70232-7;684 patients;684;-1
S1474-4422(14)70232-7;342 patients;342;-1
S1474-4422(14)70232-7;218 patients;218;-1
S1474-4422(14)70232-7;163 patients;163;-1
S1474-4422(14)70232-7;n=81;81;-1
S1474-4422(14)70232-7;n=82;82;-1
S1474-4422(14)70238-8;14  Control participants;14;-1
S1474-4422(14)70238-8;206 control participants;206;-1
S1474-4422(14)70238-8;1078 gene-  expanded participants;1078;-1
S1474-4422(14)70238-8;260 control participants;260;-1
S1474-4422(14)70238-8;225 participants;225;-1
S1474-4422(14)70238-8;1078 individuals;1078;-1
S1474-4422(14)70238-8;n=853;853;-1
S1474-4422(14)70238-8;n=225;225;-1
S1474-4422(14)70238-8;n=1078;1078;-1
S1474-4422(14)70253-4;293 people;293;-1
S1474-4422(14)70253-4;290 individuals;290;-1
S1474-4422(14)70253-4;211 individuals;211;-1
S1474-4422(14)70253-4;total of   293;293;-1
S1474-4422(14)70258-3;2876 patients;2876;-1
S1474-4422(14)70258-3;110 000 patients;110000;-1
S1474-4422(14)70258-3;2800 patients;2800;-1
S1474-4422(14)70258-3;1438 patients;1438;-1
S1474-4422(14)70258-3;2799 patients;2799;-1
S1474-4422(14)70258-3;151 patients;151;-1
S1474-4422(14)70258-3;26 patients;26;-1
S1474-4422(14)70258-3;n=1438;1438;-1
S1474-4422(14)70258-3;n=2799;2799;-1
S1474-4422(14)70260-1;1 participants;1;-1
S1474-4422(14)70260-1;1078 individuals;1078;-1
S1474-4422(14)70263-7;1 participants;1;-1
S1474-4422(14)70263-7;1078 individuals;1078;-1
S1474-4422(14)70272-8;44 million people;44;-1
S2213-2600(13)70200-5;886 patients;886;-1
S2213-2600(13)70200-5;14 In patients;14;-1
S2213-2600(13)70200-5;1 week run-in period patients;1;-1
S2213-2600(13)70200-5;150 patients;150;-1
S2213-2600(13)70200-5;35 patients;35;-1
S2213-2600(13)70200-5;148 144 149 142  Number of patients;1,48144E+11;-1
S2213-2600(13)70200-5;148 144 149 141  Number of patients;1,48144E+11;-1
S2213-2600(13)70200-5;130 135 136 127  Number of patients;1,30135E+11;-1
S2213-2600(13)70200-5;n=19;19;-1
S2213-2600(13)70200-5;n=20;20;-1
S2213-2600(13)70200-5;n=11;11;-1
S2213-2600(13)70200-5;n=13;13;-1
S2213-2600(13)70200-5;n=153;153;-1
S2213-2600(13)70200-5;n=149;149;-1
S2213-2600(13)70200-5;n=151;151;-1
S2213-2600(13)70200-5;n=46;46;-1
S2213-2600(13)70200-5;n=17;17;-1
S2213-2600(13)70200-5;602 were enrolled;602;-1
S2213-2600(13)70232-7;873 123 recorded COPD deaths   in women;873123;-1
S2213-2600(13)70232-7;298 participants;298;-1
S2213-2600(13)70232-7;328 million people;328;-1
S2213-2600(13)70232-7;3 billion   individuals;3;-1
S2213-2600(13)70232-7;N=5993;5993;-1
S2213-2600(13)70234-0;30 patients;30;-1
S2213-2600(13)70234-0;5 All patients;5;-1
S2213-2600(13)70234-0;30 individuals;30;-1
S2213-2600(13)70234-0;21 individuals;21;-1
S2213-2600(13)70234-0;16 individuals;16;-1
S2213-2600(13)70234-0;n=30;30;-1
S2213-2600(13)70234-0;n=217;217;-1
S2213-2600(13)70245-5;259 participants;259;-1
S2213-2600(13)70245-5;129 participants;129;-1
S2213-2600(13)70245-5;23 and all trial   participants;23;-1
S2213-2600(13)70245-5;288 participants;288;-1
S2213-2600(13)70245-5;216 participants;216;-1
S2213-2600(13)70245-5;137 participants;137;-1
S2213-2600(13)70245-5;139 participants;139;-1
S2213-2600(13)70245-5;61 participants;61;-1
S2213-2600(13)70245-5;276 participants;276;-1
S2213-2600(13)70245-5;192 participants;192;-1
S2213-2600(13)70245-5;276 patients;276;-1
S2213-2600(13)70245-5;137 patients;137;-1
S2213-2600(13)70245-5;339 patients;339;-1
S2213-2600(13)70245-5;297 eligible patients;297;-1
S2213-2600(13)70245-5;259 patients;259;-1
S2213-2600(13)70245-5;13  In patients;13;-1
S2213-2600(13)70245-5;10 In adults;10;-1
S2213-2600(13)70245-5;n=137;137;-1
S2213-2600(13)70245-5;n=139;139;-1
S2213-2600(13)70245-5;n=6;6;-1
S2213-2600(13)70245-5;n=2;2;-1
S2213-2600(13)70245-5;n=3;3;-1
S2213-2600(13)70245-5;n=5;5;-1
S2213-2600(13)70245-5;n=1;1;-1
S2213-2600(13)70245-5;n=4;4;-1
S2213-2600(13)70245-5;n=99;99;-1
S2213-2600(13)70245-5;n=93;93;-1
S2213-2600(13)70245-5;n=84;84;-1
S2213-2600(13)70245-5;n=85;85;-1
S2213-2600(13)70245-5;n=133;133;-1
S2213-2600(13)70245-5;n=136;136;-1
S2213-2600(13)70245-5;n=120;120;-1
S2213-2600(13)70245-5;n=125;125;-1
S2213-2600(13)70245-5;n=117;117;-1
S2213-2600(13)70245-5;n=122;122;-1
S2213-2600(13)70245-5;n=22;22;-1
S2213-2600(13)70245-5;n=39;39;-1
S2213-2600(13)70248-0;16Gly   participants;16;11015
S2213-2600(13)70248-0;9000 participants;9000;20366
S2213-2600(13)70248-0;7376 patients;7376;15800
S2213-2600(13)70248-0;5125 patients;5125;14675
S2213-2600(13)70248-0;16Gly patients;16;8554
S2213-2600(13)70248-0;16Arg patients;16;8871
S2213-2600(13)70248-0;2357 patients;2357;10791
S2213-2600(13)70248-0;2768 patients;2768;11220
S2213-2600(13)70248-0;2866 patients;2866;17800
S2213-2600(13)70248-0;3444 patients;3444;24422
S2213-2600(13)70248-0;n=960;960;4093
S2213-2600(13)70248-0;n=946;946;4071
S2213-2600(13)70248-0;n=1170;1170;4049
S2213-2600(13)70248-0;n=1200;1200;4026
S2213-2600(13)70248-0;n=434;434;4003
S2213-2600(13)70248-0;n=415;415;3981
S2213-2600(13)70248-0;n=528;528;3959
S2213-2600(13)70248-0;n=514;514;3937
S2213-2600(13)70248-0;n=1173;1173;3915
S2213-2600(13)70248-0;n=1218;1218;3892
S2213-2600(13)70248-0;n=863;863;3869
S2213-2600(13)70248-0;n=829;829;3847
S2213-2600(13)70259-5;150 patients;150;-1
S2213-2600(13)70259-5;59 patients;59;-1
S2213-2600(13)70259-5;37 patients;37;-1
S2213-2600(13)70259-5;1  patients;1;-1
S2213-2600(13)70259-5;200 000 critically ill patients;200000;-1
S2213-2600(13)70259-5;150 eligible patients;150;-1
S2213-2600(13)70259-5;41 patients;41;-1
S2213-2600(13)70259-5;18 patients;18;-1
S2213-2600(13)70259-5;36 treated patients;36;-1
S2213-2600(13)70259-5;22 patients;22;-1
S2213-2600(13)70259-5;37 treated patients;37;-1
S2213-2600(13)70259-5;23 patients;23;-1
S2213-2600(13)70259-5;14 patients;14;-1
S2213-2600(13)70259-5;19 control patients;19;-1
S2213-2600(13)70259-5;59 control   patients;59;-1
S2213-2600(13)70259-5;51 control patients;51;-1
S2213-2600(13)70259-5;1201 treated patients;1201;-1
S2213-2600(13)70259-5;26 individuals;26;-1
S2213-2600(13)70259-5;59 patients who were recruited;59;-1
S2213-2600(13)70259-5;113 not recruited;113;-1
S2213-2600(13)70259-5;37 recruited;37;-1
S2213-2600(13)70259-5;n=4;4;-1
S2213-2600(13)70259-5;n=37;37;-1
S2213-2600(13)70259-5;n=26;26;-1
S2213-2600(13)70259-5;n=23;23;-1
S2213-2600(13)70259-5;n=22;22;-1
S2213-2600(13)70259-5;37 were enrolled;37;-1
S2213-2600(13)70260-1;5125 COPD patients;5125;-1
S2213-2600(13)70263-7;5125 COPD patients;5125;-1
S2213-2600(13)70276-5;251 patients;251;-1
S2213-2600(13)70276-5;503 patients;503;-1
S2213-2600(13)70276-5;660 consecutive outpatients;660;-1
S2213-2600(13)70276-5;59 patients;59;-1
S2213-2600(13)70276-5;201 patients;201;-1
S2213-2600(13)70276-5;89 patients;89;-1
S2213-2600(13)70276-5;19 In   unselected patients;19;-1
S2213-2600(13)70276-5;n=252;252;-1
S2213-2600(13)70276-5;n=45;45;-1
S2213-2600(13)70276-5;n=157;157;-1
S2213-2600(13)70276-5;n=57;57;-1
S2213-2600(13)70276-5;n=251;251;-1
S2213-2600(13)70276-5;n=89;89;-1
S2213-2600(13)70276-5;n=503;503;-1
S2213-2600(13)70276-5;n=2;2;-1
S2213-2600(13)70276-5;total of 503;503;-1
S2213-2600(13)70277-7;19 recruited;19;-1
S2213-2600(13)70277-7;n=16 147;16147;-1
S2213-2600(13)70277-7;n=6270;6270;-1
S2213-2600(13)70277-7;n=11 080;11080;-1
S2213-2600(13)70277-7;n=7895;7895;-1
S2213-2600(13)70277-7;N=4579;4579;-1
S2213-2600(13)70277-7;N=8366;8366;-1
S2213-2600(13)70277-7;N=1587;1587;-1
S2213-2600(13)70277-7;N=3423;3423;-1
S2213-2600(13)70285-6;22 patients;22;-1
S2213-2600(13)70285-6;26 patients;26;-1
S2213-2600(13)70285-6;59 patients;59;-1
S2213-2600(13)70285-6;98  Comment  treated patients;98;-1
S2213-2600(13)70285-6;30 patients;30;-1
S2213-2600(13)70286-8;100 participants;100;-1
S2213-2600(13)70286-8;1297 patients;1297;-1
S2213-2600(13)70286-8;482 patients;482;-1
S2213-2600(13)70286-8;495 patients;495;-1
S2213-2600(13)70286-8;286 patients;286;-1
S2213-2600(13)70286-8;1250 patients;1250;-1
S2213-2600(13)70286-8;1006 patients;1006;-1
S2213-2600(13)70286-8;33 patients;33;-1
S2213-2600(13)70286-8;36 patients;36;-1
S2213-2600(13)70286-8;221 patients;221;-1
S2213-2600(13)70286-8;218 patients;218;-1
S2213-2600(13)70286-8;44 patients;44;-1
S2213-2600(13)70286-8;523 patients;523;-1
S2213-2600(13)70286-8;120 Chinese patients;120;-1
S2213-2600(13)70286-8;13 286 patients;13286;-1
S2213-2600(13)70286-8;120 patients;120;-1
S2213-2600(13)70286-8;n=504;504;-1
S2213-2600(13)70286-8;n=502;502;-1
S2213-2600(13)70286-8;n=495;495;-1
S2213-2600(13)70289-3;355 participants;355;-1
S2213-2600(13)70289-3;1022 participants;1022;-1
S2213-2600(13)70289-3;73 Puerto Rican participants;73;-1
S2213-2600(13)70289-3;772 control participants;772;-1
S2213-2600(13)70289-3;176 participants;176;-1
S2213-2600(13)70289-3;8018 participants;8018;-1
S2213-2600(13)70289-3;62 748 participants;62748;-1
S2213-2600(13)70289-3;46 800 participants;46800;-1
S2213-2600(13)70289-3;46 800 patients;46800;-1
S2213-2600(13)70289-3;73 Puerto Rican patients;73;-1
S2213-2600(13)70289-3;1165 patients;1165;-1
S2213-2600(13)70289-3;659 non-Hispanic white patients;659;-1
S2213-2600(13)70289-3;34 patients;34;-1
S2213-2600(13)70289-3;553 patients;553;-1
S2213-2600(13)70289-3;176 white patients;176;-1
S2213-2600(13)70289-3;1626 patients;1626;-1
S2213-2600(13)70289-3;659 non-  Hispanic white patients;659;-1
S2213-2600(13)70289-3;952 non-Hispanic white patients;952;-1
S2213-2600(13)70289-3;191 non-Hispanic white patients;191;-1
S2213-2600(13)70289-3;213 African American patients;213;-1
S2213-2600(13)70289-3;316 African American patients;316;-1
S2213-2600(13)70289-3;1209 patients;1209;-1
S2213-2600(13)70289-3;587 LABA-treated patients;587;-1
S2213-2600(13)70289-3;418 non-LABA-treated patients;418;-1
S2213-2600(13)70289-3;164Ile   Non-Hispanic white patients;164;-1
S2213-2600(13)70289-3;81 patients;81;-1
S2213-2600(13)70289-3;155 patients;155;-1
S2213-2600(13)70289-3;46 African American patients;46;-1
S2213-2600(13)70289-3;164Ile patients;164;-1
S2213-2600(13)70289-3;13 non-Hispanic white patients;13;-1
S2213-2600(13)70289-3;13 non-Hispanic white   patients;13;-1
S2213-2600(13)70289-3;251 patients;251;-1
S2213-2600(13)70289-3;37 In African   American patients;37;-1
S2213-2600(13)70289-3;150 non-Hispanic white people;150;-1
S2213-2600(13)70289-3;1300 people;1300;-1
S2213-2600(13)70289-3;16 were recruited;16;-1
S2213-2600(13)70289-3;16 recruited;16;-1
S2213-2600(13)70289-3;n=73;73;-1
S2213-2600(13)70289-3;n=707;707;-1
S2213-2600(13)70289-3;n=260;260;-1
S2213-2600(13)70289-3;n=176;176;-1
S2213-2600(13)70289-3;n=1143;1143;-1
S2213-2600(13)70289-3;n=315;315;-1
S2213-2600(13)70289-3;n=95;95;-1
S2213-2600(13)70289-3;n=410;410;-1
S2213-2600(13)70289-3;n=236;236;-1
S2213-2600(13)70289-3;n=1626;1626;-1
S2213-2600(13)70289-3;n=75;75;-1
S2213-2600(13)70289-3;n=1134;1134;-1
S2213-2600(13)70289-3;n=18;18;-1
S2213-2600(13)70289-3;n=553;553;-1
S2213-2600(13)70289-3;n=6;6;-1
S2213-2600(13)70289-3;n=181;181;-1
S2213-2600(13)70289-3;n=179;179;-1
S2213-2600(13)70289-3;n=119;119;-1
S2213-2600(13)70289-3;n=5;5;-1
S2213-2600(13)70289-3;n=13;13;-1
S2213-2600(13)70289-3;n=384;384;-1
S2213-2600(13)70289-3;n=218;218;-1
S2213-2600(13)70289-3;n=10;10;-1
S2213-2600(13)70289-3;n=446;446;-1
S2213-2600(13)70289-3;n=430;430;-1
S2213-2600(13)70289-3;n=1300;1300;-1
S2213-2600(13)70291-1;total of 1;1;-1
S2213-2600(13)70294-7;1000 patients;1000;-1
S2213-2600(13)70294-7;482 patients;482;-1
S2213-2600(13)70294-7;482 individuals;482;-1
S2213-2600(13)70295-9;30 patients;30;-1
S2213-2600(13)70295-9;1 uninfected people;1;-1
S2213-2600(13)70295-9;1   infected individuals;1;-1
S2213-2600(14)70001-3;200 patients;200;9518
S2213-2600(14)70001-3;565 patients;565;3812
S2213-2600(14)70001-3;500 patients;500;3105
S2213-2600(14)70001-3;675 patients;675;632
S2213-2600(14)70001-3;46 patients;46;3326
S2213-2600(14)70001-3;14 patients;14;8066
S2213-2600(14)70001-3;110 non-COPD patients;110;14410
S2213-2600(14)70001-3;200 patients recruited;200;9518
S2213-2600(14)70001-3;3 recruited;3;9972
S2213-2600(14)70001-3;n=565;565;1597
S2213-2600(14)70001-3;n=147;147;7002
S2213-2600(14)70001-3;n=84;84;9367
S2213-2600(14)70001-3;n=164;164;12047
S2213-2600(14)70001-3;n=64;64;12190
S2213-2600(14)70001-3;n=51;51;12521
S2213-2600(14)70002-5;2859 ICGN participants;2859;-1
S2213-2600(14)70002-5;1000 non-Hispanic   white participants;1000;-1
S2213-2600(14)70002-5;3500 participants;3500;-1
S2213-2600(14)70002-5;1000 non-Hispanic white participants;1000;-1
S2213-2600(14)70002-5;15 patients;15;-1
S2213-2600(14)70002-5;56 and   people;56;-1
S2213-2600(14)70002-5;6633 individuals;6633;-1
S2213-2600(14)70002-5;5704 control individuals;5704;-1
S2213-2600(14)70002-5;3497 individuals;3497;-1
S2213-2600(14)70002-5;18 individuals;18;-1
S2213-2600(14)70002-5;2859 individuals;2859;-1
S2213-2600(14)70002-5;977 European individuals;977;-1
S2213-2600(14)70002-5;876 control individuals;876;-1
S2213-2600(14)70002-5;n=2812;2812;-1
S2213-2600(14)70002-5;n=2534;2534;-1
S2213-2600(14)70002-5;n=821;821;-1
S2213-2600(14)70002-5;n=1749;1749;-1
S2213-2600(14)70002-5;n=1764;1764;-1
S2213-2600(14)70002-5;n=178;178;-1
S2213-2600(14)70002-5;n=373;373;-1
S2213-2600(14)70002-5;n=435;435;-1
S2213-2600(14)70002-5;n=863;863;-1
S2213-2600(14)70002-5;n=808;808;-1
S2213-2600(14)70002-5;n=999;999;-1
S2213-2600(14)70002-5;n=383;383;-1
S2213-2600(14)70002-5;n=1390;1390;-1
S2213-2600(14)70002-5;n=352;352;-1
S2213-2600(14)70002-5; data from 2859;2859;-1
S2213-2600(14)70008-6;38 859 patients;38859;-1
S2213-2600(14)70008-6;842 patients;842;-1
S2213-2600(14)70008-6;6897 patients;6897;-1
S2213-2600(14)70008-6;25 All patients;25;-1
S2213-2600(14)70008-6;1 122 787 patients;1122787;-1
S2213-2600(14)70008-6;22 821 patients;22821;-1
S2213-2600(14)70008-6;2 million   people;2;-1
S2213-2600(14)70008-6;18 Identifi cation of people;18;-1
S2213-2600(14)70008-6;46 Because   people;46;-1
S2213-2600(14)70008-6;n=38 859;38859;-1
S2213-2600(14)70008-6;n=22 821;22821;-1
S2213-2600(14)70008-6;n=22 286;22286;-1
S2213-2600(14)70008-6;n=9351;9351;-1
S2213-2600(14)70008-6;n=1167;1167;-1
S2213-2600(14)70008-6;total of   1 122 787;1122787;-1
S2213-2600(14)70008-6; data from Jan 1;1;-1
S2213-2600(14)70009-8;10  Unlike adults;10;-1
S2213-2600(14)70011-6;1087 participants;1087;-1
S2213-2600(14)70011-6;1087 consecutive participants;1087;-1
S2213-2600(14)70011-6;120 participants;120;-1
S2213-2600(14)70011-6;1087 consecutively screened patients;1087;-1
S2213-2600(14)70011-6;111 patients;111;-1
S2213-2600(14)70011-6;84 patients;84;-1
S2213-2600(14)70011-6;120 patients;120;-1
S2213-2600(14)70011-6;1087 patients;1087;-1
S2213-2600(14)70011-6;494 patients;494;-1
S2213-2600(14)70011-6;315 patients;315;-1
S2213-2600(14)70011-6;9 patients;9;-1
S2213-2600(14)70011-6;11 patients;11;-1
S2213-2600(14)70011-6;98 patients;98;-1
S2213-2600(14)70011-6;976 patients;976;-1
S2213-2600(14)70011-6;135 patients;135;-1
S2213-2600(14)70011-6;21 patients;21;-1
S2213-2600(14)70011-6;102 patients;102;-1
S2213-2600(14)70011-6;n=111;111;-1
S2213-2600(14)70011-6;n=84;84;-1
S2213-2600(14)70011-6;n=120;120;-1
S2213-2600(14)70011-6;n=388;388;-1
S2213-2600(14)70011-6;n=102;102;-1
S2213-2600(14)70011-6;n=171;171;-1
S2213-2600(14)70013-X;60 participants;60;13119
S2213-2600(14)70013-X;1908 participants;1908;7324
S2213-2600(14)70013-X;120 patients;120;13919
S2213-2600(14)70013-X;60 patients;60;13304
S2213-2600(14)70013-X;19 patients;19;13179
S2213-2600(14)70013-X;104 patients;104;321
S2213-2600(14)70013-X;89 patients;89;2405
S2213-2600(14)70013-X;25 patients;25;6640
S2213-2600(14)70013-X;113 patients;113;12261
S2213-2600(14)70013-X;64 patients;64;23652
S2213-2600(14)70013-X;n=60;60;13860
S2213-2600(14)70013-X;n=56;56;3108
S2213-2600(14)70013-X;n=57;57;3125
S2213-2600(14)70013-X;n=88;88;5435
S2213-2600(14)70013-X;n=23;23;5467
S2213-2600(14)70013-X;n=26;26;5879
S2213-2600(14)70013-X;n=58;58;6070
S2213-2600(14)70013-X;n=73;73;6570
S2213-2600(14)70013-X;n=120;120;14421
S2213-2600(14)70014-1;2 Although patients;2;-1
S2213-2600(14)70019-0;33 participants;33;4999
S2213-2600(14)70019-0;92 patients;92;15412
S2213-2600(14)70019-0;2 patients;2;15411
S2213-2600(14)70019-0;433 patients;433;7106
S2213-2600(14)70019-0;47 patients;47;6440
S2213-2600(14)70019-0;45 patients;45;6504
S2213-2600(14)70019-0;26   Inclusion of patients;26;15992
S2213-2600(14)70019-0;36 patients;36;19931
S2213-2600(14)70019-0;46 individuals;46;4571
S2213-2600(14)70019-0;n=47;47;15373
S2213-2600(14)70019-0;n=45;45;15345
S2213-2600(14)70019-0;N=84;84;2251
S2213-2600(14)70019-0;N=129;129;2256
S2213-2600(14)70019-0;n=41;41;6624
S2213-2600(14)70019-0;n=36;36;6642
S2213-2600(14)70019-0;n=3;3;6642
S2213-2600(14)70019-0;n=2;2;8931
S2213-2600(14)70019-0;n=0;0;9015
S2213-2600(14)70019-0;n=4;4;15373
S2213-2600(14)70019-0;n=12;12;9195
S2213-2600(14)70025-6;9  Should we genotype individuals;9;-1
S2213-2600(14)70025-6;6633 individuals;6633;-1
S2213-2600(14)70025-6;5704 control individuals;5704;-1
S2213-2600(14)70025-6;3500 individuals;3500;-1
S2213-2600(14)70026-8;6633 individuals;6633;-1
S2213-2600(14)70026-8;5704 control individuals;5704;-1
S2213-2600(14)70026-8;3500 individuals;3500;-1
S2213-2600(14)70027-X;384 patients;384;-1
S2213-2600(14)70027-X;390 patients;390;-1
S2213-2600(14)70027-X;12 patients;12;-1
S2213-2600(14)70027-X;269 patients;269;-1
S2213-2600(14)70027-X;247 patients;247;-1
S2213-2600(14)70027-X;380 patients;380;-1
S2213-2600(14)70027-X;380 evaluable patients;380;-1
S2213-2600(14)70027-X;261 evaluable patients;261;-1
S2213-2600(14)70027-X;46 patients;46;-1
S2213-2600(14)70027-X;13 UK-born patients;13;-1
S2213-2600(14)70027-X;254 patients;254;-1
S2213-2600(14)70027-X;125 patients;125;-1
S2213-2600(14)70027-X;255 patients;255;-1
S2213-2600(14)70027-X;62 patients;62;-1
S2213-2600(14)70027-X;25 By genomically linking patients;25;-1
S2213-2600(14)70027-X;n=43 000;43000;-1
S2213-2600(14)70027-X;n=62 000;62000;-1
S2213-2600(14)70027-X;n=47 000;47000;-1
S2213-2600(14)70029-3;38 859 patients;38859;-1
S2213-2600(14)70029-3;500 patients;500;-1
S2213-2600(14)70029-3;4 although patients;4;-1
S2213-2600(14)70029-3;315 patients;315;-1
S2213-2600(14)70029-3;84 patients;84;-1
S2213-2600(14)70029-3;102 patients;102;-1
S2213-2600(14)70029-3; data of   38 859;38859;-1
S2213-2600(14)70030-X;135 participants;135;-1
S2213-2600(14)70030-X;315 patients;315;-1
S2213-2600(14)70030-X;84 patients;84;-1
S2213-2600(14)70030-X;102 patients;102;-1
S2213-2600(14)70032-3;100 000 people;100000;-1
S2213-2600(14)70032-3;   data from 2005;2005;-1
S2213-2600(14)70034-7;327 participants;327;-1
S2213-2600(14)70034-7;1742 participants;1742;-1
S2213-2600(14)70034-7;567 participants;567;-1
S2213-2600(14)70034-7;1730 participants;1730;-1
S2213-2600(14)70034-7;8172 registered patients;8172;-1
S2213-2600(14)70034-7;1371 registered patients;1371;-1
S2213-2600(14)70034-7;379 PCR-confirmable registered patients;379;-1
S2213-2600(14)70034-7;24 medically attended patients;24;-1
S2213-2600(14)70034-7;96 patients;96;-1
S2213-2600(14)70034-7;93 people;93;-1
S2213-2600(14)70034-7;459 people;459;-1
S2213-2600(14)70034-7;n=102;102;-1
S2213-2600(14)70034-7;n=35;35;-1
S2213-2600(14)70034-7;n=10;10;-1
S2213-2600(14)70034-7;n=385;385;-1
S2213-2600(14)70034-7;n=189;189;-1
S2213-2600(14)70034-7;n=147;147;-1
S2213-2600(14)70034-7;n=195;195;-1
S2213-2600(14)70034-7;n=70;70;-1
S2213-2600(14)70036-0;120   patients;120;-1
S2213-2600(14)70039-6;8 If excluded   patients;8;-1
S2213-2600(14)70041-4;28  Pregnant women;28;-1
S2213-2600(14)70041-4;07  Pregnant women;7;-1
S2213-2600(14)70041-4;59  Pregnant women;59;-1
S2213-2600(14)70041-4;36  Pregnant women;36;-1
S2213-2600(14)70041-4;29 234 patients;29234;-1
S2213-2600(14)70041-4;78 studies of patients;78;-1
S2213-2600(14)70041-4;168 117 potentially eligible patients;168117;-1
S2213-2600(14)70041-4;24 416 patients;24416;-1
S2213-2600(14)70041-4;143 701 patients;143701;-1
S2213-2600(14)70041-4;106 138 outpatients;106138;-1
S2213-2600(14)70041-4;34 970 inpatients;34970;-1
S2213-2600(14)70041-4;5736 patients;5736;-1
S2213-2600(14)70041-4;168 117 patients;168117;-1
S2213-2600(14)70041-4;106 138 were outpatients;106138;-1
S2213-2600(14)70041-4;0215  Critical care patients;215;-1
S2213-2600(14)70041-4;0026  Critical care patients;26;-1
S2213-2600(14)70041-4;0118  Critical care patients;118;-1
S2213-2600(14)70041-4;51  Critical care patients;51;-1
S2213-2600(14)70041-4;4233 patients;4233;-1
S2213-2600(14)70041-4;n=29 226;29226;-1
S2213-2600(14)70041-4;n=29 034;29034;-1
S2213-2600(14)70041-4;n=22 527;22527;-1
S2213-2600(14)70041-4;n=19 066;19066;-1
S2213-2600(14)70041-4;n=29 234;29234;-1
S2213-2600(14)70041-4;n=28 672;28672;-1
S2213-2600(14)70041-4;n=20 518;20518;-1
S2213-2600(14)70041-4;n=17 081;17081;-1
S2213-2600(14)70041-4;n=17 853;17853;-1
S2213-2600(14)70041-4;n=18 419;18419;-1
S2213-2600(14)70041-4;n=19 860;19860;-1
S2213-2600(14)70041-4;n=12 264;12264;-1
S2213-2600(14)70041-4;n=9803;9803;-1
S2213-2600(14)70041-4;n=13 598;13598;-1
S2213-2600(14)70041-4;n=24 764;24764;-1
S2213-2600(14)70041-4;n=25 268;25268;-1
S2213-2600(14)70041-4;n=4382;4382;-1
S2213-2600(14)70041-4;n=23 769;23769;-1
S2213-2600(14)70041-4;n=13 254;13254;-1
S2213-2600(14)70041-4;n=12 284;12284;-1
S2213-2600(14)70041-4;n=20 362;20362;-1
S2213-2600(14)70041-4;n=9982;9982;-1
S2213-2600(14)70041-4;n=22 366;22366;-1
S2213-2600(14)70041-4;n=16 551;16551;-1
S2213-2600(14)70041-4;n=24 435;24435;-1
S2213-2600(14)70041-4;n=25 001;25001;-1
S2213-2600(14)70041-4;n=19 816;19816;-1
S2213-2600(14)70041-4;n=9218;9218;-1
S2213-2600(14)70041-4;n=2166;2166;-1
S2213-2600(14)70041-4;n=5103;5103;-1
S2213-2600(14)70041-4;n=1725;1725;-1
S2213-2600(14)70041-4;n=12 992;12992;-1
S2213-2600(14)70041-4;n=9270;9270;-1
S2213-2600(14)70041-4;n=3899;3899;-1
S2213-2600(14)70041-4;n=917;917;-1
S2213-2600(14)70041-4;n=3385;3385;-1
S2213-2600(14)70041-4;n=683;683;-1
S2213-2600(14)70041-4;n=16 425;16425;-1
S2213-2600(14)70041-4;n=13 200;13200;-1
S2213-2600(14)70041-4;n=10 607;10607;-1
S2213-2600(14)70041-4;n=5696;5696;-1
S2213-2600(14)70041-4;n=1303;1303;-1
S2213-2600(14)70041-4;n=1608;1608;-1
S2213-2600(14)70041-4;n=572;572;-1
S2213-2600(14)70041-4;n=17 670;17670;-1
S2213-2600(14)70041-4;n=14 409;14409;-1
S2213-2600(14)70041-4;n=12 269;12269;-1
S2213-2600(14)70041-4;n=5282;5282;-1
S2213-2600(14)70041-4;n=1302;1302;-1
S2213-2600(14)70041-4;n=2977;2977;-1
S2213-2600(14)70041-4;n=644;644;-1
S2213-2600(14)70041-4; data from the 2009;2009;-1
S2213-2600(14)70042-6;5 million patients;5;-1
S2213-2600(14)70042-6;19 million patients;19;-1
S2213-2600(14)70042-6;10 069 critically ill patients;10069;-1
S2213-2600(14)70043-8;734  patients;734;-1
S2213-2600(14)70043-8;7 million people;7;-1
S2213-2600(14)70050-5;82 patients;82;-1
S2213-2600(14)70050-5;30 patients;30;-1
S2213-2600(14)70050-5;750 patients;750;-1
S2213-2600(14)70050-5;24 patients;24;-1
S2213-2600(14)70050-5;29 patients;29;-1
S2213-2600(14)70050-5;26 patients;26;-1
S2213-2600(14)70050-5;0  Two patients;0;-1
S2213-2600(14)70050-5;26   studied patients;26;-1
S2213-2600(14)70050-5;501 patients;501;-1
S2213-2600(14)70050-5;30 individuals;30;-1
S2213-2600(14)70050-5;60 individuals;60;-1
S2213-2600(14)70050-5;24 individuals;24;-1
S2213-2600(14)70050-5;n=1;1;-1
S2213-2600(14)70050-5;n=30;30;-1
S2213-2600(14)70050-5;n=24;24;-1
S2213-2600(14)70050-5;n=29;29;-1
S2213-2600(14)70051-7;800 subjects;800;-1
S2213-2600(14)70051-7;821 patients;821;-1
S2213-2600(14)70051-7;448 patients;448;-1
S2213-2600(14)70051-7;382 patients;382;-1
S2213-2600(14)70051-7;406 patients;406;-1
S2213-2600(14)70051-7;347 patients;347;-1
S2213-2600(14)70051-7;255 patients;255;-1
S2213-2600(14)70051-7;428 patients;428;-1
S2213-2600(14)70051-7;2 For these patients;2;-1
S2213-2600(14)70051-7;21 We   regarded patients;21;-1
S2213-2600(14)70051-7;21 We regarded patients;21;-1
S2213-2600(14)70051-7;285 patients;285;-1
S2213-2600(14)70051-7;826 patients;826;-1
S2213-2600(14)70051-7;569 surviving   patients;569;-1
S2213-2600(14)70051-7;59 patients;59;-1
S2213-2600(14)70051-7;5210 patients;5210;-1
S2213-2600(14)70051-7;84 patients;84;-1
S2213-2600(14)70051-7;137 patients;137;-1
S2213-2600(14)70051-7;115 patients;115;-1
S2213-2600(14)70051-7;217 patients;217;-1
S2213-2600(14)70051-7;117 patients;117;-1
S2213-2600(14)70051-7;25 patients;25;-1
S2213-2600(14)70051-7;149 patients;149;-1
S2213-2600(14)70051-7;116 patients;116;-1
S2213-2600(14)70051-7;19 patients;19;-1
S2213-2600(14)70051-7;467 patients;467;-1
S2213-2600(14)70051-7;404 patients;404;-1
S2213-2600(14)70051-7;346 patients;346;-1
S2213-2600(14)70051-7;251 patients;251;-1
S2213-2600(14)70051-7;231 patients;231;-1
S2213-2600(14)70051-7;34 patients;34;-1
S2213-2600(14)70051-7;217 individuals;217;-1
S2213-2600(14)70051-7;422 individuals;422;-1
S2213-2600(14)70051-7;5 million individuals;5;-1
S2213-2600(14)70051-7;11 We also excluded   individuals;11;-1
S2213-2600(14)70051-7;383 individuals;383;-1
S2213-2600(14)70051-7;200 individuals;200;-1
S2213-2600(14)70051-7;25 of individuals;25;-1
S2213-2600(14)70051-7;374 of individuals;374;-1
S2213-2600(14)70051-7;372 individuals;372;-1
S2213-2600(14)70051-7;n=821;821;-1
S2213-2600(14)70051-7;n=467;467;-1
S2213-2600(14)70051-7;n=448;448;-1
S2213-2600(14)70051-7;n=382;382;-1
S2213-2600(14)70051-7;n=110;110;-1
S2213-2600(14)70051-7;n=156;156;-1
S2213-2600(14)70051-7;n=142;142;-1
S2213-2600(14)70051-7;n=112;112;-1
S2213-2600(14)70051-7;n=164;164;-1
S2213-2600(14)70051-7;n=152;152;-1
S2213-2600(14)70051-7;n=161;161;-1
S2213-2600(14)70051-7;n=149;149;-1
S2213-2600(14)70051-7;n=100;100;-1
S2213-2600(14)70051-7;n=148;148;-1
S2213-2600(14)70051-7;n=126;126;-1
S2213-2600(14)70051-7;n=147;147;-1
S2213-2600(14)70051-7;n=125;125;-1
S2213-2600(14)70051-7;n=113;113;-1
S2213-2600(14)70051-7;n=141;141;-1
S2213-2600(14)70051-7;n=93;93;-1
S2213-2600(14)70051-7;821 patients enrolled;821;-1
S2213-2600(14)70051-7;46 previously enrolled;46;-1
S2213-2600(14)70051-7;826 enrolled;826;-1
S2213-2600(14)70052-9;2 Although patients;2;-1
S2213-2600(14)70053-0;5 and a proportion of infected individuals;5;-1
S2213-2600(14)70053-0;6   A large number of well individuals;6;-1
S2213-2600(14)70053-0;n=30;30;-1
S2213-2600(14)70054-2;2 Although patients;2;-1
S2213-2600(14)70060-8;n=325;325;-1
S2213-2600(14)70060-8;n=316;316;-1
S2213-2600(14)70060-8;n=1219;1219;-1
S2213-2600(14)70060-8;n=24;24;-1
S2213-2600(14)70060-8;total of   316;316;-1
S2213-2600(14)70060-8;325 cases enrolled;325;-1
S2213-2600(14)70061-X;10 069 patients;10069;-1
S2213-2600(14)70061-X;5445 patients;5445;-1
S2213-2600(14)70061-X;2973 patients;2973;-1
S2213-2600(14)70061-X;546 patients;546;-1
S2213-2600(14)70061-X;24 patients;24;-1
S2213-2600(14)70061-X;10 000 patients;10000;-1
S2213-2600(14)70061-X;n=10 069;10069;-1
S2213-2600(14)70061-X;n=1209;1209;-1
S2213-2600(14)70061-X;n=2504;2504;-1
S2213-2600(14)70061-X;n=6356;6356;-1
S2213-2600(14)70061-X;n=730;730;-1
S2213-2600(14)70061-X;n=62;62;-1
S2213-2600(14)70061-X;n=237;237;-1
S2213-2600(14)70061-X;n=431;431;-1
S2213-2600(14)70061-X;data missing from 70;70;-1
S2213-2600(14)70065-7;1141 participants;1141;-1
S2213-2600(14)70065-7;1191 participants;1191;-1
S2213-2600(14)70065-7;212 patients;212;-1
S2213-2600(14)70065-7;217 patients;217;-1
S2213-2600(14)70065-7;94 assessable patients;94;-1
S2213-2600(14)70065-7;146 assessable patients;146;-1
S2213-2600(14)70065-7;208 patients;208;-1
S2213-2600(14)70065-7;1141 patients;1141;-1
S2213-2600(14)70065-7;20 patients;20;-1
S2213-2600(14)70065-7;1191 patients;1191;-1
S2213-2600(14)70065-7;1141 participants were recruited;1141;-1
S2213-2600(14)70065-7;20 patients recruited;20;-1
S2213-2600(14)70065-7;n=208;208;-1
S2213-2600(14)70065-7;n=209;209;-1
S2213-2600(14)70065-7;n=214;214;-1
S2213-2600(14)70065-7;n=212;212;-1
S2213-2600(14)70065-7;n=215;215;-1
S2213-2600(14)70065-7;n=222;222;-1
S2213-2600(14)70065-7;n=217;217;-1
S2213-2600(14)70065-7;n=206;206;-1
S2213-2600(14)70065-7;n=211;211;-1
S2213-2600(14)70065-7;n=221;221;-1
S2213-2600(14)70065-7;n=216;216;-1
S2213-2600(14)70065-7;n=203;203;-1
S2213-2600(14)70065-7;n=205;205;-1
S2213-2600(14)70065-7;n=219;219;-1
S2213-2600(14)70065-7;n=202;202;-1
S2213-2600(14)70065-7;n=210;210;-1
S2213-2600(14)70065-7;n=213;213;-1
S2213-2600(14)70065-7;n=207;207;-1
S2213-2600(14)70065-7;n=201;201;-1
S2213-2600(14)70065-7;n=204;204;-1
S2213-2600(14)70065-7;1141 participants enrolled;1141;-1
S2213-2600(14)70065-7;1191 participants enrolled;1191;-1
S2213-2600(14)70065-7;1141 patients enrolled;1141;-1
S2213-2600(14)70065-7;1191 patients   were enrolled;1191;-1
S2213-2600(14)70069-4;71 available patients;71;-1
S2213-2600(14)70069-4;55 patients;55;-1
S2213-2600(14)70069-4;16 patients;16;-1
S2213-2600(14)70069-4;35 patients;35;-1
S2213-2600(14)70069-4;18 patients;18;-1
S2213-2600(14)70069-4;22 patients;22;-1
S2213-2600(14)70069-4;20 patients;20;-1
S2213-2600(14)70069-4;36 individuals;36;-1
S2213-2600(14)70069-4;n=55;55;-1
S2213-2600(14)70069-4;total of 200;200;-1
S2213-2600(14)70070-0;n=30;30;-1
S2213-2600(14)70071-2;448 participants;448;-1
S2213-2600(14)70071-2;382 participants;382;-1
S2213-2600(14)70071-2;821 critically ill patients;821;-1
S2213-2600(14)70071-2;6 In patients;6;-1
S2213-2600(14)70071-2;5 million patients;5;-1
S2213-2600(14)70071-2;19 million patients;19;-1
S2213-2600(14)70071-2;10 069 critically ill patients;10069;-1
S2213-2600(14)70075-X;50 patients;50;-1
S2213-2600(14)70076-1;734  patients;734;-1
S2213-2600(14)70087-6;4 and patients;4;-1
S2213-2600(14)70087-6;433 patients;433;-1
S2213-2600(14)70088-8;55 patients;55;-1
S2213-2600(14)70088-8;55 individuals;55;-1
S2213-2600(14)70090-6;1 These patients;1;-1
S2213-2600(14)70096-7;800 participants;800;-1
S2213-2600(14)70096-7;n=800;800;-1
S2213-2600(14)70096-7;n=236;236;-1
S2213-2600(14)70096-7;n=564;564;-1
S2213-2600(14)70097-9;46 participants;46;-1
S2213-2600(14)70097-9;1022 patients;1022;-1
S2213-2600(14)70097-9;18 Some   patients;18;-1
S2213-2600(14)70097-9;194 patients;194;-1
S2213-2600(14)70097-9;41 additional patients;41;-1
S2213-2600(14)70097-9;861 patients;861;-1
S2213-2600(14)70097-9;41 patients;41;-1
S2213-2600(14)70097-9;549 patients;549;-1
S2213-2600(14)70097-9;202 patients;202;-1
S2213-2600(14)70097-9;74 patients;74;-1
S2213-2600(14)70097-9;71 patients;71;-1
S2213-2600(14)70097-9;2299 patients;2299;-1
S2213-2600(14)70097-9;717 patients;717;-1
S2213-2600(14)70097-9;n=429;429;-1
S2213-2600(14)70097-9;n=473;473;-1
S2213-2600(14)70097-9;n=549;549;-1
S2213-2600(14)70097-9;n=318;318;-1
S2213-2600(14)70097-9;n=155;155;-1
S2213-2600(14)70097-9;n=404;404;-1
S2213-2600(14)70097-9;n=145;145;-1
S2213-2600(14)70097-9;n=202;202;-1
S2213-2600(14)70097-9;n=71;71;-1
S2213-2600(14)70097-9;n=74;74;-1
S2213-2600(14)70097-9;194 patients were   enrolled;194;-1
S2213-2600(14)70097-9;18 Patients were enrolled;18;-1
S2213-2600(14)70097-9;861 patients enrolled;861;-1
S2213-2600(14)70097-9;41 patients enrolled;41;-1
S2213-2600(14)70097-9;549 patients enrolled;549;-1
S2213-2600(14)70098-0;50 patients;50;-1
S2213-2600(14)70099-2;1 These patients;1;-1
S2213-2600(14)70100-6;3 study enrolled patients;3;13653
S2213-2600(14)70100-6;238 patients;238;12776
S2213-2600(14)70100-6;118 patients;118;11647
S2213-2600(14)70100-6;120 patients;120;11585
S2213-2600(14)70100-6;77 patients;77;9995
S2213-2600(14)70100-6;3 trial recruited patients;3;7367
S2213-2600(14)70100-6;232 patients;232;2200
S2213-2600(14)70100-6;118   patients;118;3861
S2213-2600(14)70100-6;114 patients;114;8305
S2213-2600(14)70100-6;111 patients;111;8344
S2213-2600(14)70100-6;100 patients;100;9234
S2213-2600(14)70100-6;103 patients;103;9287
S2213-2600(14)70100-6;116 patients;116;12160
S2213-2600(14)70100-6;0  Data are number of patients;0;24359
S2213-2600(14)70100-6;3 trial recruited;3;7367
S2213-2600(14)70100-6;n=120;120;2042
S2213-2600(14)70100-6;n=118;118;2063
S2213-2600(14)70100-6;n=116;116;7522
S2213-2600(14)70100-6;n=72;72;19055
S2213-2600(14)70100-6;n=74;74;19071
S2213-2600(14)70100-6;n=44;44;19088
S2213-2600(14)70100-6;n=42;42;19104
S2213-2600(14)70100-6;3 study enrolled;3;13653
S2213-2600(14)70101-8;100 000 people for   women;100000;-1
S2213-2600(14)70101-8;23 315 patients;23315;-1
S2213-2600(14)70101-8;15 259 patients;15259;-1
S2213-2600(14)70101-8;12 066 patients;12066;-1
S2213-2600(14)70101-8;3195 patients;3195;-1
S2213-2600(14)70101-8;100 000 people;100000;-1
S2213-2600(14)70101-8;3 716 485 people;3716485;-1
S2213-2600(14)70101-8;n=12 066;12066;-1
S2213-2600(14)70101-8;n=5197;5197;-1
S2213-2600(14)70101-8;n=3195;3195;-1
S2213-2600(14)70101-8; data from 1997;1997;-1
S2213-2600(14)70101-8; data   from 1;1;-1
S2213-2600(14)70101-8; data from 2001;2001;-1
S2213-2600(14)70108-0;508del homozygous   patients;508;-1
S2213-2600(14)70108-0;508del homozygous patients;508;-1
S2213-2600(14)70108-0;232 patients;232;-1
S2213-2600(14)70108-0;508del homozygous   individuals;508;-1
S2213-2600(14)70108-0;55 individuals;55;-1
S2213-2600(14)70115-8;34 970   patients;34970;-1
S2213-2600(14)70115-8;2000 patients;2000;-1
S2213-2600(14)70115-8;4 patients;4;-1
S2213-2600(14)70116-X;1022 patients;1022;-1
S2213-2600(14)70116-X;N=1022;1022;-1
S2213-2600(14)70117-1;100 000 people;100000;-1
S2213-2600(14)70124-9;370 patients;370;-1
S2213-2600(14)70124-9;149 patients;149;-1
S2213-2600(14)70124-9;221 patients;221;-1
S2213-2600(14)70124-9;139 patients;139;-1
S2213-2600(14)70124-9;54 patients;54;-1
S2213-2600(14)70124-9;38 patients;38;-1
S2213-2600(14)70124-9;149 Dallas patients;149;-1
S2213-2600(14)70124-9;n=139;139;-1
S2213-2600(14)70124-9;n=54;54;-1
S2213-2600(14)70124-9;n=221;221;-1
S2213-2600(14)70124-9;n=149;149;-1
S2213-2600(14)70124-9;n=148;148;-1
S2213-2600(14)70124-9;n=147;147;-1
S2213-2600(14)70124-9;n=137;137;-1
S2213-2600(14)70124-9;n=211;211;-1
S2213-2600(14)70124-9;n=122;122;-1
S2213-2600(14)70124-9;n=187;187;-1
S2213-2600(14)70124-9;n=136;136;-1
S2213-2600(14)70124-9;n=123;123;-1
S2213-2600(14)70124-9;n=49;49;-1
S2213-2600(14)70124-9;n=195;195;-1
S2213-2600(14)70124-9;n=46;46;-1
S2213-2600(14)70124-9;n=106;106;-1
S2213-2600(14)70124-9;n=126;126;-1
S2213-2600(14)70124-9;n=17;17;-1
S2213-2600(14)70124-9;n=30;30;-1
S2213-2600(14)70124-9;n=10;10;-1
S2213-2600(14)70124-9;n=22;22;-1
S2213-2600(14)70124-9;n=16;16;-1
S2213-2600(14)70124-9;n=135;135;-1
S2213-2600(14)70124-9;n=143;143;-1
S2213-2600(14)70124-9;n=124;124;-1
S2213-2600(14)70124-9;n=50;50;-1
S2213-2600(14)70124-9;n=307;307;-1
S2213-2600(14)70124-9;n=317;317;-1
S2213-2600(14)70124-9;370 patients were enrolled;370;-1
S2213-2600(14)70126-2;34 970   patients;34970;-1
S2213-2600(14)70126-2;2000 patients;2000;-1
S2213-2600(14)70126-2;4 patients;4;-1
S2213-2600(14)70126-2; datasets from   37;37;-1
S2213-2600(14)70127-4; datasets from   37;37;-1
S2213-2600(14)70132-8;64 participants;64;17763
S2213-2600(14)70132-8;97 participants;97;17114
S2213-2600(14)70132-8;1 Mean age of all participants;1;1352
S2213-2600(14)70132-8;508del   CFTR homozygous patients;508;18620
S2213-2600(14)70132-8;508del CFTR homozygous patients;508;17706
S2213-2600(14)70132-8;508del CFTR heterozygous   patients;508;16156
S2213-2600(14)70132-8;508del CFTR   homozygous patients;508;11514
S2213-2600(14)70132-8;508del CFTR heterozygous patients;508;11097
S2213-2600(14)70132-8;20 patients;20;6929
S2213-2600(14)70132-8;2 assessed patients;2;6642
S2213-2600(14)70132-8;28 pooled placebo patients;28;1675
S2213-2600(14)70132-8;62 patients;62;1587
S2213-2600(14)70132-8;64 patients;64;4393
S2213-2600(14)70132-8;111 patients;111;7696
S2213-2600(14)70132-8;15 patients;15;7727
S2213-2600(14)70132-8;109 patients;109;9492
S2213-2600(14)70132-8;27 patients;27;9606
S2213-2600(14)70132-8;21 patients;21;9821
S2213-2600(14)70132-8;97 patients;97;21718
S2213-2600(14)70132-8;508del CFTR patients;508;27980
S2213-2600(14)70132-8;508del CFTR hetero-  zygous patients;508;29494
S2213-2600(14)70132-8;508del CFTR hetero zygous patients;508;30043
S2213-2600(14)70132-8;n=20;20;5451
S2213-2600(14)70132-8;n=21;21;5445
S2213-2600(14)70132-8;n=23;23;5433
S2213-2600(14)70132-8;n=17;17;5415
S2213-2600(14)70132-8;n=6;6;5403
S2213-2600(14)70132-8;n=11;11;5398
S2213-2600(14)70132-8;n=4;4;5392
S2213-2600(14)70132-8;n=27;27;2290
S2213-2600(14)70132-8;n=18;18;25079
S2213-2600(14)70135-3;320 patients;320;-1
S2213-2600(14)70135-3;158 patients;158;-1
S2213-2600(14)70135-3;139 patients;139;-1
S2213-2600(14)70135-3;788 patients;788;-1
S2213-2600(14)70135-3;151 patients;151;-1
S2213-2600(14)70135-3;160 patients;160;-1
S2213-2600(14)70135-3;352 patients;352;-1
S2213-2600(14)70135-3;n=160;160;-1
S2213-2600(14)70135-3;n=158;158;-1
S2213-2600(14)70135-3;n=157;157;-1
S2213-2600(14)70135-3;n=150;150;-1
S2213-2600(14)70135-3;n=144;144;-1
S2213-2600(14)70135-3;total of 320;320;-1
S2213-2600(14)70136-5;508del homozygous   patients;508;-1
S2213-2600(14)70136-5;508del homozygous patients;508;-1
S2213-2600(14)70136-5;508del homozygous individuals;508;-1
S2213-2600(14)70136-5;508del   homozygous individuals;508;-1
S2213-2600(14)70136-5;508del homozygous   individuals;508;-1
S2213-2600(14)70137-7;27 541 patients;27541;-1
S2213-2600(14)70137-7; datasets from   37;37;-1
S2213-2600(14)70137-7; data from 27 541;27541;-1
S2213-2600(14)70139-0;45 974 participants;45974;-1
S2213-2600(14)70139-0;15 878 participants;15878;-1
S2213-2600(14)70139-0;15 368 participants;15368;-1
S2213-2600(14)70139-0;8442 participants;8442;-1
S2213-2600(14)70139-0;7675 participants;7675;-1
S2213-2600(14)70139-0;15 876 participants;15876;-1
S2213-2600(14)70139-0;14 865 participants;14865;-1
S2213-2600(14)70139-0;7559 participants;7559;-1
S2213-2600(14)70139-0;7674 participants;7674;-1
S2213-2600(14)70139-0;N=651;651;-1
S2213-2600(14)70139-0;N=264;264;-1
S2213-2600(14)70139-0;N=55;55;-1
S2213-2600(14)70139-0;N=32;32;-1
S2213-2600(14)70139-0;N=87;87;-1
S2213-2600(14)70139-0;N=46;46;-1
S2213-2600(14)70139-0;N=44;44;-1
S2213-2600(14)70139-0;47 366 children were enrolled;47366;-1
S2213-2600(14)70139-0;47 366 children enrolled;47366;-1
S2213-2600(14)70143-2;n=16;16;-1
S2213-2600(14)70143-2;n=174;174;-1
S2213-2600(14)70143-2;n=67;67;-1
S2213-2600(14)70144-4;168 participants;168;499
S2213-2600(14)70144-4;336 patients;336;24466
S2213-2600(14)70144-4;165 patients;165;24371
S2213-2600(14)70144-4;653 patients;653;14540
S2213-2600(14)70144-4;121 patients;121;9036
S2213-2600(14)70144-4;326 patients;326;8713
S2213-2600(14)70144-4;220 patients;220;8508
S2213-2600(14)70144-4;271 patients;271;3787
S2213-2600(14)70144-4;247 patients;247;3904
S2213-2600(14)70144-4;163 patients;163;4161
S2213-2600(14)70144-4;125 patients;125;5086
S2213-2600(14)70144-4;132 patients;132;5138
S2213-2600(14)70144-4;38 patients;38;5688
S2213-2600(14)70144-4;31 patients;31;5739
S2213-2600(14)70144-4;29 involving patients;29;12872
S2213-2600(14)70144-4;499 brain-injured patients;499;26266
S2213-2600(14)70144-4;10008 adults;10008;25883
S2213-2600(14)70144-4;n=165;165;11740
S2213-2600(14)70144-4;n=163;163;11716
S2213-2600(14)70144-4;n=125;125;11692
S2213-2600(14)70144-4;n=132;132;11668
S2213-2600(14)70144-4;n=38;38;11644
S2213-2600(14)70144-4;n=31;31;11621
S2213-2600(14)70144-4;N=38;38;3517
S2213-2600(14)70144-4;N=31;31;3494
S2213-2600(14)70144-4;n=138;138;6488
S2213-2600(14)70144-4;n=190;190;6536
S2213-2600(14)70144-4;n=0;0;6554
S2213-2600(14)70144-4;14 not enrolled;14;14420
S2213-2600(14)70144-4;33 enrolled;33;14383
S2213-2600(14)70144-4;336 enrolled;336;14342
S2213-2600(14)70144-4;336 were enrolled;336;440
S2213-2600(14)70146-8;1066 patients;1066;-1
S2213-2600(14)70146-8;100 000 people;100000;-1
S2213-2600(14)70152-3;545 394 women;545394;-1
S2213-2600(14)70152-3;4 In susceptible people;4;-1
S2213-2600(14)70152-3;n=7733;7733;-1
S2213-2600(14)70152-3;n=13 619;13619;-1
S2213-2600(14)70152-3;n=43 722;43722;-1
S2213-2600(14)70153-5;195 patients;195;-1
S2213-2600(14)70153-5;102 patients;102;-1
S2213-2600(14)70153-5;93 patients;93;-1
S2213-2600(14)70153-5;3  In patients;3;-1
S2213-2600(14)70153-5;15  Methods  Study design and patients;15;-1
S2213-2600(14)70153-5;150 patients;150;-1
S2213-2600(14)70153-5;352 patients;352;-1
S2213-2600(14)70153-5;12 patients;12;-1
S2213-2600(14)70153-5;11 patients;11;-1
S2213-2600(14)70153-5;85 patients;85;-1
S2213-2600(14)70153-5;70 patients;70;-1
S2213-2600(14)70153-5;48 patients;48;-1
S2213-2600(14)70153-5;111 patients;111;-1
S2213-2600(14)70153-5;52 patients;52;-1
S2213-2600(14)70153-5;80 patients;80;-1
S2213-2600(14)70153-5;13 included patients;13;-1
S2213-2600(14)70153-5;13 patients;13;-1
S2213-2600(14)70153-5;252 patients;252;-1
S2213-2600(14)70153-5;16 Patients were recruited;16;-1
S2213-2600(14)70153-5;n=102;102;-1
S2213-2600(14)70153-5;n=93;93;-1
S2213-2600(14)70153-5;n=144;144;-1
S2213-2600(14)70157-2;1050 randomised women;1050;-1
S2213-2600(14)70157-2;1050 participants;1050;-1
S2213-2600(14)70157-2;1036 participants;1036;-1
S2213-2600(14)70157-2;13 Within those participants;13;-1
S2213-2600(14)70157-2;26 participants;26;-1
S2213-2600(14)70157-2;990 participants;990;-1
S2213-2600(14)70157-2;n=521;521;-1
S2213-2600(14)70157-2;n=529;529;-1
S2213-2600(14)70157-2;n=448;448;-1
S2213-2600(14)70157-2;n=452;452;-1
S2213-2600(14)70157-2;n= 445;445;-1
S2213-2600(14)70157-2;n=446;446;-1
S2213-2600(14)70157-2;n=606;606;-1
S2213-2600(14)70157-2;n=294;294;-1
S2213-2600(14)70157-2;n=150;150;-1
S2213-2600(14)70157-2;n=602;602;-1
S2213-2600(14)70157-2;n=289;289;-1
S2213-2600(14)70157-2;n=119;119;-1
S2213-2600(14)70157-2;n=12;12;-1
S2213-2600(14)70157-2;n=14;14;-1
S2213-2600(14)70157-2;n=18;18;-1
S2213-2600(14)70157-2;n=118;118;-1
S2213-2600(14)70157-2;n=1010;1010;-1
S2213-2600(14)70157-2;n=2;2;-1
S2213-2600(14)70157-2;n=1;1;-1
S2213-2600(14)70157-2;n=4;4;-1
S2213-2600(14)70157-2;n=6;6;-1
S2213-2600(14)70158-4;1 Index-case patients;1;-1
S2213-2600(14)70158-4;226 people;226;-1
S2213-2600(14)70158-4;179 people;179;-1
S2213-2600(14)70159-6;201 patients;201;-1
S2213-2600(14)70163-8;3 participants;3;-1
S2213-2600(14)70163-8;3 In patients;3;-1
S2213-2600(14)70163-8;3 patients;3;-1
S2213-2600(14)70163-8;3   patients;3;-1
S2213-2600(14)70165-1;348 patients;348;24537
S2213-2600(14)70165-1;404 patients;404;24422
S2213-2600(14)70165-1;266 patients;266;12718
S2213-2600(14)70165-1;218 treated patients;218;7729
S2213-2600(14)70165-1;274 patients;274;7469
S2213-2600(14)70165-1;242 treated patients;242;7367
S2213-2600(14)70165-1;134 patients;134;4989
S2213-2600(14)70165-1;132 patients;132;4920
S2213-2600(14)70165-1;136 patients;136;4768
S2213-2600(14)70165-1;138 patients;138;4695
S2213-2600(14)70165-1;2 patients;2;4918
S2213-2600(14)70165-1;131 patients;131;2525
S2213-2600(14)70165-1;4 points placebo-treated patients;4;2199
S2213-2600(14)70165-1;97  All patients;97;4454
S2213-2600(14)70165-1;135 patients;135;5383
S2213-2600(14)70165-1;137 patients;137;5422
S2213-2600(14)70165-1;134 AZLI-  treated patients;134;5677
S2213-2600(14)70165-1;132 placebo-treated   patients;132;5721
S2213-2600(14)70165-1;27 patients;27;5841
S2213-2600(14)70165-1;137 placebo-treated patients;137;6274
S2213-2600(14)70165-1;29 patients;29;7059
S2213-2600(14)70165-1;5 of stable patients;5;10926
S2213-2600(14)70165-1;1 enables selection of patients;1;16694
S2213-2600(14)70165-1;n=134;134;10762
S2213-2600(14)70165-1;n=132;132;10744
S2213-2600(14)70165-1;n=266;266;10728
S2213-2600(14)70165-1;n=136;136;10713
S2213-2600(14)70165-1;n=138;138;10695
S2213-2600(14)70165-1;n=274;274;10679
S2213-2600(14)70165-1;n=102;102;8898
S2213-2600(14)70165-1;n=90;90;8907
S2213-2600(14)70165-1;n=97;97;8914
S2213-2600(14)70165-1;n=99;99;8921
S2213-2600(14)70165-1;n=94;94;8929
S2213-2600(14)70165-1;n=70;70;8937
S2213-2600(14)70165-1;n=78;78;8945
S2213-2600(14)70165-1;n=76;76;8953
S2213-2600(14)70165-1;n=91;91;8961
S2213-2600(14)70165-1;n=104;104;8975
S2213-2600(14)70165-1;n=101;101;8984
S2213-2600(14)70165-1;n=100;100;8993
S2213-2600(14)70165-1;n=85;85;9018
S2213-2600(14)70165-1;n=95;95;9026
S2213-2600(14)70165-1;n=80;80;9050
S2213-2600(14)70165-1;n=135;135;13172
S2213-2600(14)70165-1;n=137;137;13190
S2213-2600(14)70165-1;n=118;118;16459
S2213-2600(14)70165-1;n=126;126;16487
S2213-2600(14)70165-1;n=129;129;16530
S2213-2600(14)70165-1;n=130;130;16560
S2213-2600(14)70166-3;6 patients;6;-1
S2213-2600(14)70166-3;n=262;262;-1
S2213-2600(14)70166-3;n=183;183;-1
S2213-2600(14)70166-3;n=368;368;-1
S2213-2600(14)70166-3;n=342;342;-1
S2213-2600(14)70166-3;n=385;385;-1
S2213-2600(14)70166-3;n=331;331;-1
S2213-2600(14)70166-3;n=294;294;-1
S2213-2600(14)70166-3;n=773;773;-1
S2213-2600(14)70166-3;n=1279;1279;-1
S2213-2600(14)70166-3;n=1274;1274;-1
S2213-2600(14)70166-3;n=1615;1615;-1
S2213-2600(14)70170-5;6 patients;6;-1
S2213-2600(14)70172-9;278 patients;278;-1
S2213-2600(14)70172-9;140 patients;140;-1
S2213-2600(14)70172-9;138 patients;138;-1
S2213-2600(14)70172-9;116 patients;116;-1
S2213-2600(14)70172-9;122 patients;122;-1
S2213-2600(14)70172-9;5 270 patients;5270;-1
S2213-2600(14)70172-9;1614 patients;1614;-1
S2213-2600(14)70172-9;1073 ineligible patients;1073;-1
S2213-2600(14)70172-9;48 patients;48;-1
S2213-2600(14)70172-9;117 patients;117;-1
S2213-2600(14)70172-9;102 patients;102;-1
S2213-2600(14)70172-9;12 patients;12;-1
S2213-2600(14)70172-9;13 patients;13;-1
S2213-2600(14)70172-9;1073 patients;1073;-1
S2213-2600(14)70172-9;n=113;113;-1
S2213-2600(14)70172-9;n=118;118;-1
S2213-2600(14)70172-9;N=138;138;-1
S2213-2600(14)70172-9;N=140;140;-1
S2213-2600(14)70172-9;total of 24;24;-1
S2213-2600(14)70173-0;6 million people;6;-1
S2213-2600(14)70173-0;2 million people;2;-1
S2213-2600(14)70178-X;3 billion people;3;-1
S2213-2600(14)70181-X;266 patients;266;-1
S2213-2600(14)70181-X;274 patients;274;-1
S2213-2600(14)70181-X;5 not benefi t patients;5;-1
S2213-2600(14)70181-X;3 In patients;3;-1
S2213-2600(14)70181-X;3 patients;3;-1
S2213-2600(14)70182-1;266 patients;266;-1
S2213-2600(14)70182-1;274 patients;274;-1
S2213-2600(14)70182-1;5 not benefi t patients;5;-1
S2213-2600(14)70182-1;1050 pregnant smokers   recruited;1050;-1
S2213-2600(14)70183-3;3 billion people;3;-1
S2213-2600(14)70183-3;600 000 people;600000;-1
S2213-2600(14)70183-3;2   and more people;2;-1
S2213-2600(14)70183-3; data from 13;13;-1
S2213-2600(14)70184-5;3 billion people;3;-1
S2213-2600(14)70185-7;9986 patients were women;9986;2577
S2213-2600(14)70185-7;4661 women;4661;3638
S2213-2600(14)70185-7;10 364 patients;10364;7801
S2213-2600(14)70185-7;9986 patients;9986;7631
S2213-2600(14)70185-7;4439 patients;4439;2876
S2213-2600(14)70185-7;1238 patients;1238;4639
S2213-2600(14)70185-7;2493 patients;2493;26420
S2213-2600(14)70185-7;143 individuals;143;2252
S2213-2600(14)70185-7;9986 individuals;9986;2758
S2213-2600(14)70185-7;n=9986;9986;2446
S2213-2600(14)70185-7;n=453;453;5307
S2213-2600(14)70185-7;n=9533;9533;5371
S2213-2600(14)70185-7;n=198;198;5440
S2213-2600(14)70185-7;n=4241;4241;5504
S2213-2600(14)70185-7;n=255;255;5573
S2213-2600(14)70185-7;n=5292;5292;5637
S2213-2600(14)70185-7;10 364 patients enrolled;10364;7801
S2213-2600(14)70186-9;13 Thus individuals;13;12120
S2213-2600(14)70186-9;n=669;669;16734
S2213-2600(14)70186-9;n=677;677;16715
S2213-2600(14)70186-9;n=0;0;16057
S2213-2600(14)70186-9;n=26;26;6961
S2213-2600(14)70186-9;n=652;652;7905
S2213-2600(14)70186-9;n=656;656;7932
S2213-2600(14)70187-0;90 participants;90;-1
S2213-2600(14)70187-0;95 participants;95;-1
S2213-2600(14)70187-0;101 patients;101;-1
S2213-2600(14)70187-0;82 patients;82;-1
S2213-2600(14)70187-0;50 patients;50;-1
S2213-2600(14)70187-0;14 vs nine patients;14;-1
S2213-2600(14)70187-0;421 patients;421;-1
S2213-2600(14)70187-0;80 patients;80;-1
S2213-2600(14)70187-0;15 patients;15;-1
S2213-2600(14)70187-0;19 patients;19;-1
S2213-2600(14)70187-0;14 patients;14;-1
S2213-2600(14)70187-0;12 In people;12;-1
S2213-2600(14)70187-0;n=50;50;-1
S2213-2600(14)70187-0;n=51;51;-1
S2213-2600(14)70187-0;n=40;40;-1
S2213-2600(14)70187-0;n=42;42;-1
S2213-2600(14)70187-0;n=21;21;-1
S2213-2600(14)70187-0;n=20;20;-1
S2213-2600(14)70187-0;n=34;34;-1
S2213-2600(14)70187-0;n=7;7;-1
S2213-2600(14)70187-0;n=37;37;-1
S2213-2600(14)70187-0;n=17;17;-1
S2213-2600(14)70187-0;n=25;25;-1
S2213-2600(14)70187-0;n=12;12;-1
S2213-2600(14)70191-2;192 patients;192;-1
S2213-2600(14)70194-8;100 patients;100;-1
S2213-2600(14)70195-X;4613 participants;4613;-1
S2213-2600(14)70195-X;2142 participants;2142;-1
S2213-2600(14)70195-X;2471 participants;2471;-1
S2213-2600(14)70195-X;1054 participants;1054;-1
S2213-2600(14)70195-X;1238 participants;1238;-1
S2213-2600(14)70195-X;7785 participants;7785;-1
S2213-2600(14)70195-X;28 and a third   of participants;28;-1
S2213-2600(14)70195-X;938 participants;938;-1
S2213-2600(14)70195-X;818 participants;818;-1
S2213-2600(14)70195-X;1216 participants;1216;-1
S2213-2600(14)70195-X;1088 participants;1088;-1
S2213-2600(14)70195-X;1233 participants;1233;-1
S2213-2600(14)70195-X;1069 participants;1069;-1
S2213-2600(14)70195-X;1223 participants;1223;-1
S2213-2600(14)70195-X;319 participants;319;-1
S2213-2600(14)70195-X;359 participants;359;-1
S2213-2600(14)70195-X;204 participants;204;-1
S2213-2600(14)70195-X;12 423 participants;12423;-1
S2213-2600(14)70195-X;4922   participants;4922;-1
S2213-2600(14)70195-X;4370   participants;4370;-1
S2213-2600(14)70195-X;n=2321;2321;-1
S2213-2600(14)70195-X;n=2292;2292;-1
S2213-2600(14)70195-X;N=2142;2142;-1
S2213-2600(14)70195-X;N=2471;2471;-1
S2213-2600(14)70195-X;N=4613;4613;-1
S2213-2600(14)70195-X;n=1088;1088;-1
S2213-2600(14)70195-X;n=1054;1054;-1
S2213-2600(14)70195-X;n=1233;1233;-1
S2213-2600(14)70195-X;n=1238;1238;-1
S2213-2600(14)70195-X;n=1;1;-1
S2213-2600(14)70195-X;n=3;3;-1
S2213-2600(14)70195-X;n=2;2;-1
S2213-2600(14)70195-X;n=4;4;-1
S2213-2600(14)70195-X;n=237;237;-1
S2213-2600(14)70195-X;n=1687;1687;-1
S2213-2600(14)70195-X;n=260;260;-1
S2213-2600(14)70195-X;n=68;68;-1
S2213-2600(14)70195-X;n=54;54;-1
S2213-2600(14)70195-X;n=378;378;-1
S2213-2600(14)70197-3;2   and more people;2;-1
S2213-2600(14)70197-3; data from 13;13;-1
S2213-2600(14)70199-7;201 patients;201;-1
S2213-2600(14)70199-7;93 patients;93;-1
S2213-2600(14)70199-7;102 patients;102;-1
S2213-2600(14)70200-0;201 patients;201;-1
S2213-2600(14)70201-2;385 participants;385;-1
S2213-2600(14)70201-2;280 eosinophilic participants;280;-1
S2213-2600(14)70201-2;242 non-  eosinophilic participants;242;-1
S2213-2600(14)70201-2;324 participants;324;-1
S2213-2600(14)70201-2;290 participants;290;-1
S2213-2600(14)70201-2;12 participants;12;-1
S2213-2600(14)70201-2;324 patients;324;-1
S2213-2600(14)70201-2;282 patients;282;-1
S2213-2600(14)70201-2;609 patients;609;-1
S2213-2600(14)70201-2;964 patients;964;-1
S2213-2600(14)70201-2;355 patients;355;-1
S2213-2600(14)70201-2;281 patients;281;-1
S2213-2600(14)70201-2;324 eosinophilic individuals;324;-1
S2213-2600(14)70201-2;285 non-eosinophilic   individuals;285;-1
S2213-2600(14)70201-2;n=80;80;-1
S2213-2600(14)70201-2;n=81;81;-1
S2213-2600(14)70201-2;n=82;82;-1
S2213-2600(14)70201-2;n=142;142;-1
S2213-2600(14)70201-2;n=143;143;-1
S2213-2600(14)70201-2;n=70;70;-1
S2213-2600(14)70201-2;n=97;97;-1
S2213-2600(14)70201-2;n=83;83;-1
S2213-2600(14)70201-2;n=140;140;-1
S2213-2600(14)70201-2;n=65;65;-1
S2213-2600(14)70201-2;n=139;139;-1
S2213-2600(14)70201-2;n=16;16;-1
S2213-2600(14)70201-2;n=11;11;-1
S2213-2600(14)70201-2;n=124;124;-1
S2213-2600(14)70201-2;n=221;221;-1
S2213-2600(14)70201-2;n=223;223;-1
S2213-2600(14)70201-2;n=385;385;-1
S2213-2600(14)70204-8;216 patients;216;-1
S2213-2600(14)70204-8;105 patients;105;-1
S2213-2600(14)70213-9;117 participants;117;-1
S2213-2600(14)70213-9;86 randomly assigned patients;86;-1
S2213-2600(14)70213-9;1 Adult patients;1;-1
S2213-2600(14)70213-9;24 patients;24;-1
S2213-2600(14)70213-9;n=44;44;-1
S2213-2600(14)70213-9;n=42;42;-1
S2213-2600(14)70214-0;4613 participants;4613;-1
S2213-2600(14)70214-0;2292 participants;2292;-1
S2213-2600(14)70214-0;1054   participants;1054;-1
S2213-2600(14)70214-0;1238 participants;1238;-1
S2213-2600(14)70215-2;93 patients;93;-1
S2213-2600(14)70215-2;102 patients;102;-1
S2213-2600(14)70218-8;78 participants;78;-1
S2213-2600(14)70218-8;83 participants;83;-1
S2213-2600(14)70218-8;26 participants;26;-1
S2213-2600(14)70218-8;17 participants;17;-1
S2213-2600(14)70218-8;4 participants;4;-1
S2213-2600(14)70218-8;192 patients;192;-1
S2213-2600(14)70218-8;551Asp-CFTR patients;551;-1
S2213-2600(14)70218-8;144 adults;144;-1
S2213-2600(14)70218-8;N=67;67;-1
S2213-2600(14)70218-8;N=77;77;-1
S2213-2600(14)70218-8;N=22;22;-1
S2213-2600(14)70218-8;N=26;26;-1
S2213-2600(14)70218-8;n=18;18;-1
S2213-2600(14)70218-8;n=17;17;-1
S2213-2600(14)70218-8;N=89;89;-1
S2213-2600(14)70218-8;N=103;103;-1
S2213-2600(14)70218-8;total of 144;144;-1
S2213-2600(14)70218-8;48 children enrolled;48;-1
S2213-2600(14)70218-8;192 patients enrolled;192;-1
S2213-2600(14)70223-1;4613 participants;4613;-1
S2213-2600(14)70223-1;2292 participants;2292;-1
S2213-2600(14)70223-1;1054   participants;1054;-1
S2213-2600(14)70223-1;1238 participants;1238;-1
S2213-2600(14)70223-1;216 patients;216;-1
S2213-2600(14)70223-1;105 patients;105;-1
S2213-2600(14)70224-3;n=138;138;-1
S2213-2600(14)70224-3;n=140;140;-1
S2213-2600(14)70225-5;324 patients;324;-1
S2213-2600(14)70225-5;101 patients;101;-1
S2213-2600(14)70226-7;105 consenting patients;105;27018
S2213-2600(14)70226-7;20 patients;20;13991
S2213-2600(14)70226-7;34 patients;34;13463
S2213-2600(14)70226-7;110 patients;110;13252
S2213-2600(14)70226-7;216 eligible patients;216;9383
S2213-2600(14)70226-7;13 patients;13;6184
S2213-2600(14)70226-7;105 patients;105;4770
S2213-2600(14)70226-7;42 patients;42;1818
S2213-2600(14)70226-7;42 control patients;42;1693
S2213-2600(14)70226-7;30 patients;30;11969
S2213-2600(14)70226-7;75 million people;75;25562
S2213-2600(14)70226-7;65 million people;65;25479
S2213-2600(14)70226-7;47 individuals;47;12110
S2213-2600(14)70226-7;n=105;105;9077
S2213-2600(14)70226-7;n=53;53;9028
S2213-2600(14)70226-7;n=52;52;9004
S2213-2600(14)70226-7;n=42;42;1554
S2213-2600(14)70226-7;n=40;40;1530
S2213-2600(14)70226-7;n=21;21;5601
S2213-2600(14)70226-7;n=84;84;5696
S2213-2600(14)70226-7;30 patients enrolled;30;11969
S2213-2600(14)70227-9;10 In patients;10;-1
S2213-2600(14)70228-0;3365 patients;3365;-1
S2213-2600(14)70228-0;4 non-surgical patients;4;-1
S2213-2600(14)70228-0;n=3;3;-1
S2213-2600(14)70228-0;n=2;2;-1
S2213-2600(14)70228-0;n=6;6;-1
S2213-2600(14)70228-0;n=1;1;-1
S2213-2600(14)70228-0;n=3365;3365;-1
S2213-2600(14)70228-0;n=3150;3150;-1
S2213-2600(14)70228-0;n=123;123;-1
S2213-2600(14)70228-0;n=0;0;-1
S2213-2600(14)70228-0; data from 12;12;-1
S2213-2600(14)70229-2;86 patients;86;-1
S2213-2600(14)70236-X;86 patients;86;-1
S2213-2600(14)70240-1;n=138;138;-1
S2213-2600(14)70240-1;n=140;140;-1
S2213-2600(14)70256-5;1007  In patients;1007;-1
S2213-2600(14)70256-5;3365 patients;3365;-1
S2213-2600(14)70258-9;1600 patients;1600;-1
S2213-2600(14)70258-9;200 000 people;200000;-1
S2213-2600(14)70258-9;37 000 people;37000;-1
S2213-8587(13)70021-4;788 patients;788;-1
S2213-8587(13)70021-4;784 patients;784;-1
S2213-8587(13)70021-4;6 All patients;6;-1
S2213-8587(13)70021-4;1099 patients;1099;-1
S2213-8587(13)70021-4;295 patients;295;-1
S2213-8587(13)70021-4;590 patients;590;-1
S2213-8587(13)70021-4;738 patients;738;-1
S2213-8587(13)70021-4;369 patients;369;-1
S2213-8587(13)70021-4;2 diabetic patients;2;-1
S2213-8587(13)70021-4;2 diabetic   patients;2;-1
S2213-8587(13)70021-4;78,945 patients;78945;-1
S2213-8587(13)70021-4;n=361;361;-1
S2213-8587(13)70021-4;n=350;350;-1
S2213-8587(13)70021-4;n=360;360;-1
S2213-8587(13)70021-4;n=335;335;-1
S2213-8587(13)70021-4;n=317;317;-1
S2213-8587(13)70021-4;n=130;130;-1
S2213-8587(13)70021-4;n=122;122;-1
S2213-8587(13)70021-4;n=108;108;-1
S2213-8587(13)70021-4;n=124;124;-1
S2213-8587(13)70021-4;n=125;125;-1
S2213-8587(13)70021-4;n=116;116;-1
S2213-8587(13)70021-4;n=100;100;-1
S2213-8587(13)70021-4;n=89;89;-1
S2213-8587(13)70021-4;n=103;103;-1
S2213-8587(13)70021-4;n=93;93;-1
S2213-8587(13)70021-4;n=148;148;-1
S2213-8587(13)70021-4;n=139;139;-1
S2213-8587(13)70021-4;n=134;134;-1
S2213-8587(13)70021-4;n=123;123;-1
S2213-8587(13)70021-4;n=212;212;-1
S2213-8587(13)70021-4;n=196;196;-1
S2213-8587(13)70021-4;n=216;216;-1
S2213-8587(13)70021-4;n=194;194;-1
S2213-8587(13)70021-4;n=371;371;-1
S2213-8587(13)70021-4;n=366;366;-1
S2213-8587(13)70021-4;total of 590;590;-1
S2213-8587(13)70021-4;total of   738;738;-1
S2213-8587(13)70070-6;2300 patients;2300;-1
S2213-8587(13)70070-6;690 patients;690;-1
S2213-8587(13)70070-6;436 patients;436;-1
S2213-8587(13)70070-6;438 patients;438;-1
S2213-8587(13)70070-6;129 patients;129;-1
S2213-8587(13)70070-6;252 patients;252;-1
S2213-8587(13)70070-6;226 patients;226;-1
S2213-8587(13)70070-6;n=690;690;-1
S2213-8587(13)70070-6;n=276;276;-1
S2213-8587(13)70070-6;n=113;113;-1
S2213-8587(13)70090-1;401 patients;401;-1
S2213-8587(13)70090-1;7 For   patients;7;-1
S2213-8587(13)70090-1;203 patients;203;-1
S2213-8587(13)70090-1;1008 patients;1008;-1
S2213-8587(13)70090-1;201 patients;201;-1
S2213-8587(13)70090-1;371 million people;371;-1
S2213-8587(13)70090-1;n=201;201;-1
S2213-8587(13)70090-1;n=200;200;-1
S2213-8587(13)70090-1;n=401;401;-1
S2213-8587(13)70090-1;n=397;397;-1
S2213-8587(13)70103-7;27 779 participants;27779;-1
S2213-8587(13)70103-7;455 569 participants;455569;-1
S2213-8587(13)70103-7;366 million people;366;-1
S2213-8587(13)70103-7;27 779 individuals;27779;-1
S2213-8587(13)70103-7;n=18 497;18497;-1
S2213-8587(13)70107-4;788 Chinese   patients;788;-1
S2213-8587(13)70108-6;690 patients;690;-1
S2213-8587(13)70108-6;788 Chinese   patients;788;-1
S2213-8587(13)70108-6;n=389;389;-1
S2213-8587(13)70116-5;27 779 individuals;27779;-1
S2213-8587(13)70120-7;7 and people;7;-1
S2213-8587(13)70122-0;2   Illness perceptions of patients;2;-1
S2213-8587(13)70122-0;5 In patients;5;-1
S2213-8587(13)70122-0;2057 family members of people;2057;-1
S2213-8587(13)70144-X;703 participants;703;-1
S2213-8587(13)70144-X;1 diabetic subjects;1;-1
S2213-8587(13)70144-X;1 diabetes   mellitus patients;1;-1
S2213-8587(13)70144-X;1 diabetic patients;1;-1
S2213-8587(13)70144-X;599 adults;599;-1
S2213-8587(13)70144-X;32  adults;32;-1
S2213-8587(13)70144-X;32 and one recruited;32;-1
S2213-8587(13)70147-5;282 429 patients;282429;-1
S2213-8587(13)70147-5;2 diabetes patients;2;-1
S2213-8587(13)70147-5;309 477 individuals;309477;-1
S2213-8587(13)70147-5;282 429 individuals;282429;-1
S2213-8587(13)70147-5;n=1003;1003;-1
S2213-8587(13)70147-5;n=4012;4012;-1
S2213-8587(13)70147-5; dataset of 282 429;282429;-1
S2213-8587(13)70149-9;51 participants;51;-1
S2213-8587(13)70149-9;322 patients;322;-1
S2213-8587(13)70149-9;55 patients;55;-1
S2213-8587(13)70149-9;54 patients;54;-1
S2213-8587(13)70149-9;52 patients;52;-1
S2213-8587(13)70149-9;51 patients;51;-1
S2213-8587(13)70149-9;4 In patients;4;-1
S2213-8587(13)70149-9;384 patients;384;-1
S2213-8587(13)70149-9;306 patients;306;-1
S2213-8587(13)70149-9;2DM patients;2;-1
S2213-8587(13)70149-9;472 could provide clinicians and patients;472;-1
S2213-8587(13)70149-9;0  Data are number of patients;0;-1
S2213-8587(13)70149-9;n=55;55;-1
S2213-8587(13)70149-9;n=54;54;-1
S2213-8587(13)70149-9;n=52;52;-1
S2213-8587(13)70149-9;n=51;51;-1
S2213-8587(13)70149-9;total of   306;306;-1
S2213-8587(13)70149-9;384 patients enrolled;384;-1
S2213-8587(13)70152-9;16  All participants;16;-1
S2213-8587(13)70152-9;180 participants;180;-1
S2213-8587(13)70152-9;115 participants;115;-1
S2213-8587(13)70152-9;3000 potential participants;3000;-1
S2213-8587(13)70152-9;12 participants;12;-1
S2213-8587(13)70152-9;101 participants;101;-1
S2213-8587(13)70152-9;64 participants;64;-1
S2213-8587(13)70152-9;60 participants;60;-1
S2213-8587(13)70152-9;11 participants;11;-1
S2213-8587(13)70152-9;18 participants;18;-1
S2213-8587(13)70152-9;13 110 participants;13110;-1
S2213-8587(13)70152-9;173 participants;173;-1
S2213-8587(13)70152-9;170 000 participants;170000;-1
S2213-8587(13)70152-9;356 patients;356;-1
S2213-8587(13)70152-9;64 patients;64;-1
S2213-8587(13)70152-9;60 patients;60;-1
S2213-8587(13)70152-9;390 patients;390;-1
S2213-8587(13)70152-9;11 385 patients;11385;-1
S2213-8587(13)70152-9;12 000 people;12000;-1
S2213-8587(13)70152-9;n=86;86;-1
S2213-8587(13)70152-9;n=87;87;-1
S2213-8587(13)70152-9;n=60;60;-1
S2213-8587(13)70152-9;n=161;161;-1
S2213-8587(13)70152-9;n=19;19;-1
S2213-8587(13)70152-9;n=10;10;-1
S2213-8587(13)70152-9;n=6;6;-1
S2213-8587(13)70152-9;n=140;140;-1
S2213-8587(13)70152-9;n=5;5;-1
S2213-8587(13)70152-9;n=8;8;-1
S2213-8587(13)70152-9;173 were enrolled;173;-1
S2213-8587(13)70152-9; data   from 170 000;170000;-1
S2213-8587(13)70155-4;7 For lactating women;7;23246
S2213-8587(13)70155-4;64 study participants;64;13696
S2213-8587(13)70155-4;n=26;26;8643
S2213-8587(13)70155-4;n=10;10;14068
S2213-8587(13)70155-4;n=8;8;14173
S2213-8587(13)70156-6;12 participants;12;-1
S2213-8587(13)70156-6;12 South Asian participants;12;-1
S2213-8587(13)70156-6;12 Caucasian   participants;12;-1
S2213-8587(13)70156-6;23 assessable participants;23;-1
S2213-8587(13)70156-6;2 diabetic patients;2;-1
S2213-8587(13)70156-6;n=12;12;-1
S2213-8587(13)70157-8;12 000 patients;12000;-1
S2213-8587(13)70164-5;20 000 participants;20000;-1
S2213-8587(13)70170-0;11 women;11;-1
S2213-8587(13)70170-0;26 participants;26;-1
S2213-8587(13)70170-0;40 evaluable participants;40;-1
S2213-8587(13)70170-0;2 participants;2;-1
S2213-8587(13)70170-0;21 participants;21;-1
S2213-8587(13)70170-0;2   diabetic subjects;2;-1
S2213-8587(13)70170-0;41 patients;41;-1
S2213-8587(13)70170-0;35 patients;35;-1
S2213-8587(13)70170-0;12 patients;12;-1
S2213-8587(13)70170-0;229 patients;229;-1
S2213-8587(13)70170-0;74 patients;74;-1
S2213-8587(13)70170-0;n=35;35;-1
S2213-8587(13)70170-0;n=34;34;-1
S2213-8587(13)70170-0;N=40;40;-1
S2213-8587(13)70170-0;N=39;39;-1
S2213-8587(13)70170-0;N=35;35;-1
S2213-8587(13)70171-2;173 patients;173;-1
S2213-8587(13)70171-2;40 patients;40;-1
S2213-8587(13)70171-2;118 patients;118;-1
S2213-8587(13)70171-2;500 patients;500;-1
S2213-8587(13)70171-2;950 patients;950;-1
S2213-8587(13)70171-2;10 of   patients;10;-1
S2213-8587(13)70171-2;12 000 patients;12000;-1
S2213-8587(13)70171-2;n=29;29;-1
S2213-8587(13)70186-4;50 000 patients;50000;-1
S2213-8587(13)70186-4;4 million   individuals;4;-1
S2213-8587(13)70186-4;total of 1003;1003;-1
S2213-8587(13)70186-4; data from 65 870;65870;-1
S2213-8587(13)70187-6;382 million people;382;-1
S2213-8587(13)70187-6;114 million people;114;-1
S2213-8587(13)70190-6;2 diabetic patients;2;-1
S2213-8587(13)70190-6;1 In patients;1;-1
S2213-8587(13)70192-X;5653 participants;5653;-1
S2213-8587(13)70192-X;502 were non-white participants;502;-1
S2213-8587(13)70192-X;10 308 participants;10308;-1
S2213-8587(13)70192-X;5653 people;5653;-1
S2213-8587(13)70192-X;5183 people;5183;-1
S2213-8587(13)70192-X;31 of adults;31;-1
S2213-8587(13)70192-X;10 308 participants recruited;10308;-1
S2213-8587(13)70192-X;n=8637;8637;-1
S2213-8587(13)70192-X;n=5183;5183;-1
S2213-8587(13)70192-X;n=7870;7870;-1
S2213-8587(13)70192-X;n=6967;6967;-1
S2213-8587(13)70192-X;n=5653;5653;-1
S2213-8587(13)70192-X;n=6761;6761;-1
S2213-8587(13)70192-X;n=502;502;-1
S2213-8587(13)70192-X;n=4703;4703;-1
S2213-8587(13)70192-X;n=648;648;-1
S2213-8587(13)70192-X;n=115;115;-1
S2213-8587(13)70192-X;n=187;187;-1
S2213-8587(13)70192-X;n =0;0;-1
S2213-8587(13)70192-X;n=0;0;-1
S2213-8587(13)70199-2;15 000 participants;15000;-1
S2213-8587(13)70199-2;14 348 participants;14348;-1
S2213-8587(13)70199-2;10 946 participants;10946;-1
S2213-8587(13)70199-2;9445 participants;9445;-1
S2213-8587(13)70199-2;12 081 participants;12081;-1
S2213-8587(13)70199-2;10 000 people;10000;-1
S2213-8587(13)70199-2;11 348 adults;11348;-1
S2213-8587(13)70199-2;958 adults;958;-1
S2213-8587(13)70199-2;N=12 081;12081;-1
S2213-8587(13)70199-2;N=10 946;10946;-1
S2213-8587(13)70199-2;N=12 306;12306;-1
S2213-8587(13)70200-6;5037 of these participants;5037;-1
S2213-8587(13)70200-6;31 040 participants;31040;-1
S2213-8587(13)70200-6;25 580 participants;25580;-1
S2213-8587(13)70200-6;80 404 participants;80404;-1
S2213-8587(13)70200-6;5460 participants;5460;-1
S2213-8587(13)70200-6;9765 participants;9765;-1
S2213-8587(13)70200-6;6254 participants;6254;-1
S2213-8587(13)70200-6;84 526 participants;84526;-1
S2213-8587(13)70200-6;249,796 individuals;249796;-1
S2213-8587(13)70200-6;11 and was recruited;11;-1
S2213-8587(13)70200-6;n=12 489;12489;-1
S2213-8587(13)70200-6;n=13 091;13091;-1
S2213-8587(13)70200-6;n=5460;5460;-1
S2213-8587(13)70202-X;690 patients;690;-1
S2213-8587(13)70202-X;136 patients;136;-1
S2213-8587(13)70202-X;N=690;690;-1
S2213-8587(13)70202-X;N=136;136;-1
S2213-8587(13)70204-3;85 participants;85;-1
S2213-8587(13)70204-3;86 participants;86;-1
S2213-8587(13)70204-3;171 participants;171;-1
S2213-8587(13)70204-3;84 participants;84;-1
S2213-8587(13)70204-3;83 participants;83;-1
S2213-8587(13)70204-3;140 south Asian participants;140;-1
S2213-8587(13)70204-3;2 diabetes of people;2;-1
S2213-8587(13)70204-3;1319 people;1319;-1
S2213-8587(13)70204-3;150 people;150;-1
S2213-8587(13)70204-3;2089 people;2089;-1
S2213-8587(13)70204-3;2 included people;2;-1
S2213-8587(13)70204-3;1319 individuals;1319;-1
S2213-8587(13)70204-3;171 individuals;171;-1
S2213-8587(13)70204-3;N=84;84;-1
S2213-8587(13)70204-3;N=83;83;-1
S2213-8587(13)70204-3;N=81;81;-1
S2213-8587(13)70204-3;N=82;82;-1
S2213-8587(13)70208-0;83 patients;83;-1
S2213-8587(13)70208-0;156 patients;156;-1
S2213-8587(13)70208-0;1317 patients;1317;-1
S2213-8587(13)70208-0;74 patients;74;-1
S2213-8587(13)70208-0;85 patients;85;-1
S2213-8587(13)70208-0;167 patients;167;-1
S2213-8587(13)70208-0;30 patients;30;-1
S2213-8587(13)70208-0;682 patients;682;-1
S2213-8587(13)70208-0;375 patients;375;-1
S2213-8587(13)70208-0;51 of the treated patients;51;-1
S2213-8587(13)70208-0;18 patients;18;-1
S2213-8587(13)70208-0;23 patients;23;-1
S2213-8587(13)70208-0;15 patients;15;-1
S2213-8587(13)70208-0;2 diabetic patients;2;-1
S2213-8587(13)70208-0;2642 patients;2642;-1
S2213-8587(13)70208-0;3 million people;3;-1
S2213-8587(13)70208-0;n=290;290;-1
S2213-8587(13)70208-0;n=374;374;-1
S2213-8587(13)70208-0;n=95;95;-1
S2213-8587(13)70208-0;n=98;98;-1
S2213-8587(13)70208-0;n=97;97;-1
S2213-8587(13)70208-0;n=89;89;-1
S2213-8587(13)70208-0;n=94;94;-1
S2213-8587(13)70208-0;n=91;91;-1
S2213-8587(13)70208-0;n=63;63;-1
S2213-8587(13)70208-0;n=74;74;-1
S2213-8587(13)70208-0;n=187;187;-1
S2213-8587(13)70208-0;n=178;178;-1
S2213-8587(13)70208-0;n=175;175;-1
S2213-8587(13)70208-0;n=132;132;-1
S2213-8587(13)70208-0;n=133;133;-1
S2213-8587(13)70208-0;n=37;37;-1
S2213-8587(13)70208-0;total of 682;682;-1
S2213-8587(13)70210-9;540 participants;540;-1
S2213-8587(13)70210-9;171 participants;171;-1
S2213-8587(13)70210-9;6   although participants;6;-1
S2213-8587(13)70210-9;171 participants were enrolled;171;-1
S2213-8587(13)70211-0;198 outpatients;198;-1
S2213-8587(13)70211-0;114 patients;114;-1
S2213-8587(13)70211-0;198 non-surgical patients;198;-1
S2213-8587(13)70211-0;23 patients;23;-1
S2213-8587(13)70211-0;103 patients;103;-1
S2213-8587(13)70211-0;61 patients;61;-1
S2213-8587(13)70211-0;224 patients;224;-1
S2213-8587(13)70211-0;81 patients;81;-1
S2213-8587(13)70211-0;27 patients;27;-1
S2213-8587(13)70211-0;125 patients;125;-1
S2213-8587(13)70211-0;118 patients;118;-1
S2213-8587(13)70211-0;3 million people;3;-1
S2213-8587(13)70211-0;114 individuals;114;-1
S2213-8587(13)70211-0;23 individuals;23;-1
S2213-8587(13)70211-0;n=129;129;-1
S2213-8587(13)70211-0;n=59;59;-1
S2213-8587(13)70211-0;n=10;10;-1
S2213-8587(13)70211-0;n=114;114;-1
S2213-8587(13)70211-0;n=61;61;-1
S2213-8587(13)70211-0;n=23;23;-1
S2213-8587(13)70211-0;n=14;14;-1
S2213-8587(13)70211-0;n=1;1;-1
S2213-8587(13)70212-2;50 000 participants;50000;-1
S2213-8587(13)70212-2;130 000 participants;130000;-1
S2213-8587(13)70212-2;200 000 participants;200000;-1
S2213-8587(13)70212-2;350 000 participants;350000;-1
S2213-8587(13)70212-2;48 647 patients;48647;-1
S2213-8587(13)70212-2;46 431 patients;46431;-1
S2213-8587(13)70212-2;48 167 patients;48167;-1
S2213-8587(13)70212-2;76 497 patients;76497;-1
S2213-8587(13)70212-2;27 834 patients;27834;-1
S2213-8587(13)70212-2;3853 patients;3853;-1
S2213-8587(13)70212-2;46 237 patients;46237;-1
S2213-8587(13)70212-2;33 In community-dwelling   individuals;33;-1
S2213-8587(13)70212-2;N=48 687;48687;-1
S2213-8587(13)70212-2;N=46 431;46431;-1
S2213-8587(13)70212-2;N=48 167;48167;-1
S2213-8587(13)70212-2;N=76 497;76497;-1
S2213-8587(13)70212-2;N=27 834;27834;-1
S2213-8587(13)70212-2;N=50 090;50090;-1
S2213-8587(13)70212-2;N=81 173;81173;-1
S2213-8587(13)70212-2; data from 44;44;-1
S2213-8587(13)70213-4;2 diabetic patients;2;-1
S2213-8587(13)70214-6;841 adult participants;841;11276
S2213-8587(13)70214-6;402 participants;402;10168
S2213-8587(13)70214-6;25 participants;25;12339
S2213-8587(13)70214-6;422 patients;422;10467
S2213-8587(13)70214-6;404 patients;404;10371
S2213-8587(13)70214-6;400 patients;400;4133
S2213-8587(13)70214-6;728 patients;728;622
S2213-8587(13)70214-6;320 patients;320;60
S2213-8587(13)70214-6;9  For patients;9;2034
S2213-8587(13)70214-6;18 patients;18;3580
S2213-8587(13)70214-6;58 patients;58;3724
S2213-8587(13)70214-6;346 patients;346;3881
S2213-8587(13)70214-6;2 patients;2;10465
S2213-8587(13)70214-6;402 patients;402;4001
S2213-8587(13)70214-6;419 patients;419;4119
S2213-8587(13)70214-6;11 patients;11;4164
S2213-8587(13)70214-6;408 patients;408;4302
S2213-8587(13)70214-6;68 patients;68;4334
S2213-8587(13)70214-6;340 patients;340;4491
S2213-8587(13)70214-6;5 patients;5;4532
S2213-8587(13)70214-6;403 patients;403;4611
S2213-8587(13)70214-6;841 patients;841;4719
S2213-8587(13)70214-6;12 patients;12;11884
S2213-8587(13)70214-6;1   Patients were recruited;1;5749
S2213-8587(13)70214-6;n=643;643;5664
S2213-8587(13)70214-6;n=33;33;5636
S2213-8587(13)70214-6;n=67;67;5612
S2213-8587(13)70214-6;n=25;25;5579
S2213-8587(13)70214-6;n=35;35;5548
S2213-8587(13)70214-6;n=10;10;5524
S2213-8587(13)70214-6;n=16;16;5498
S2213-8587(13)70214-6;n=12;12;5471
S2213-8587(13)70214-6;n=404;404;8626
S2213-8587(13)70214-6;n=408;408;8649
S2213-8587(13)70214-6;n=402;402;9347
S2213-8587(13)70214-6;n=403;403;9370
S2213-8587(13)70214-6;2 diabetes were enrolled;2;5342
S2213-8587(13)70215-8;7 For these   patients;7;-1
S2213-8587(13)70215-8;9 Some patients;9;-1
S2213-8587(13)70215-8;444 patients;444;-1
S2213-8587(13)70220-1;70,528 patients;70528;-1
S2213-8587(13)70220-1;100 000 Danish adults;100000;-1
S2213-8587(14)70002-6;400 million patients;400;-1
S2213-8587(14)70002-6;534   patients;534;-1
S2213-8587(14)70002-6;2 diabetes patients;2;-1
S2213-8587(14)70002-6;1 diabetes patients;1;-1
S2213-8587(14)70002-6;1  In healthy people;1;-1
S2213-8587(14)70006-3;2 studies of patients;2;-1
S2213-8587(14)70006-3;236 patients;236;-1
S2213-8587(14)70006-3;69 patients;69;-1
S2213-8587(14)70006-3;17 All patients;17;-1
S2213-8587(14)70006-3;43 patients;43;-1
S2213-8587(14)70006-3;26 patients;26;-1
S2213-8587(14)70006-3;564 patients;564;-1
S2213-8587(14)70006-3;21 patients;21;-1
S2213-8587(14)70006-3;17 patients;17;-1
S2213-8587(14)70006-3;22 patients;22;-1
S2213-8587(14)70006-3;23 patients;23;-1
S2213-8587(14)70006-3;47 eprotirome-treated patients;47;-1
S2213-8587(14)70006-3;22 placebo-  treated patients;22;-1
S2213-8587(14)70006-3;156 patients;156;-1
S2213-8587(14)70006-3;109 patients;109;-1
S2213-8587(14)70006-3;175 patients;175;-1
S2213-8587(14)70006-3;7000 people;7000;-1
S2213-8587(14)70006-3;100 000 people;100000;-1
S2213-8587(14)70006-3;564 individuals;564;-1
S2213-8587(14)70006-3;n=1;1;-1
S2213-8587(14)70006-3;N=23;23;-1
S2213-8587(14)70006-3;N=24;24;-1
S2213-8587(14)70006-3;N=22;22;-1
S2213-8587(14)70006-3;n=2;2;-1
S2213-8587(14)70006-3;n=4;4;-1
S2213-8587(14)70009-9;4776 patients;4776;-1
S2213-8587(14)70009-9;60 patients;60;-1
S2213-8587(14)70013-0;1022 women;1022;-1
S2213-8587(14)70013-0;2005 adults;2005;-1
S2213-8587(14)70013-0;2005 UK adults;2005;-1
S2213-8587(14)70019-1;25 participants;25;-1
S2213-8587(14)70020-8;2 000 000 people;2000000;-1
S2213-8587(14)70020-8;4 billion individuals;4;-1
S2213-8587(14)70021-X;60 patients;60;-1
S2213-8587(14)70025-7;1044 patients;1044;-1
S2213-8587(14)70026-9;24 patients;24;-1
S2213-8587(14)70026-9;169 patients;169;-1
S2213-8587(14)70026-9;236 patients;236;-1
S2213-8587(14)70026-9;69 patients;69;-1
S2213-8587(14)70026-9;456 patients;456;-1
S2213-8587(14)70026-9;n=80;80;-1
S2213-8587(14)70026-9;n=79;79;-1
S2213-8587(14)70026-9;n=77;77;-1
S2213-8587(14)70026-9;n=2;2;-1
S2213-8587(14)70027-0;1524 outpatients;1524;-1
S2213-8587(14)70027-0;46 239 adults;46239;-1
S2213-8587(14)70027-0;4 million adults;4;-1
S2213-8587(14)70028-2;1 In patients;1;-1
S2213-8587(14)70028-2;n=35;35;-1
S2213-8587(14)70028-2;n=39;39;-1
S2213-8587(14)70029-4;223 participants;223;-1
S2213-8587(14)70029-4;456 patients;456;-1
S2213-8587(14)70029-4;233 patients;233;-1
S2213-8587(14)70029-4;36 patients;36;-1
S2213-8587(14)70029-4;4 patients;4;-1
S2213-8587(14)70029-4;4 Eligible patients;4;-1
S2213-8587(14)70029-4;205 patients;205;-1
S2213-8587(14)70029-4;287 patients;287;-1
S2213-8587(14)70029-4;659 patients;659;-1
S2213-8587(14)70029-4;223 patients;223;-1
S2213-8587(14)70029-4;24 antibody-positive patients;24;-1
S2213-8587(14)70029-4;2 diabetic   patients;2;-1
S2213-8587(14)70029-4;2 diabetic patients;2;-1
S2213-8587(14)70029-4;n=233;233;-1
S2213-8587(14)70029-4;n=223;223;-1
S2213-8587(14)70029-4;n=140;140;-1
S2213-8587(14)70029-4;n=147;147;-1
S2213-8587(14)70029-4;n=228;228;-1
S2213-8587(14)70029-4;n=220;220;-1
S2213-8587(14)70029-4;n=216;216;-1
S2213-8587(14)70029-4;n=209;209;-1
S2213-8587(14)70029-4;n=230;230;-1
S2213-8587(14)70029-4;n=222;222;-1
S2213-8587(14)70029-4;n=116;116;-1
S2213-8587(14)70029-4;n=117;117;-1
S2213-8587(14)70029-4;n=96;96;-1
S2213-8587(14)70029-4;n=127;127;-1
S2213-8587(14)70029-4;n=1;1;-1
S2213-8587(14)70029-4;n=4;4;-1
S2213-8587(14)70029-4;n=163;163;-1
S2213-8587(14)70029-4;n=70;70;-1
S2213-8587(14)70029-4;n=156;156;-1
S2213-8587(14)70029-4;n=67;67;-1
S2213-8587(14)70029-4;n=213;213;-1
S2213-8587(14)70029-4;n=202;202;-1
S2213-8587(14)70029-4;n=188;188;-1
S2213-8587(14)70029-4;n=164;164;-1
S2213-8587(14)70029-4;n=139;139;-1
S2213-8587(14)70029-4;n=161;161;-1
S2213-8587(14)70029-4;n=49;49;-1
S2213-8587(14)70029-4;n=15;15;-1
S2213-8587(14)70030-0;89 eligible patients;89;-1
S2213-8587(14)70030-0;45 patients;45;-1
S2213-8587(14)70030-0;89 patients;89;-1
S2213-8587(14)70030-0;255 unselected   outpatients;255;-1
S2213-8587(14)70030-0;43 patients;43;-1
S2213-8587(14)70030-0;39 patients;39;-1
S2213-8587(14)70030-0;45   patients;45;-1
S2213-8587(14)70030-0;2 diabetic patients;2;-1
S2213-8587(14)70030-0;2   diabetic patients;2;-1
S2213-8587(14)70030-0;13 and healthy individuals;13;-1
S2213-8587(14)70030-0;n=45;45;-1
S2213-8587(14)70030-0;n=160;160;-1
S2213-8587(14)70030-0;48 enrolled;48;-1
S2213-8587(14)70035-X;444 patients;444;-1
S2213-8587(14)70035-X;3 For these patients;3;-1
S2213-8587(14)70035-X;400 patients;400;-1
S2213-8587(14)70035-X;50 new patients;50;-1
S2213-8587(14)70035-X;1 diabetes patients;1;-1
S2213-8587(14)70035-X;1   diabetic patients;1;-1
S2213-8587(14)70036-1;7 All participants;7;-1
S2213-8587(14)70036-1;2 diabetic subjects;2;-1
S2213-8587(14)70036-1;456 patients;456;-1
S2213-8587(14)70036-1;233 patients;233;-1
S2213-8587(14)70036-1;223 patients;223;-1
S2213-8587(14)70036-1;12 patients;12;-1
S2213-8587(14)70036-1;22 patients;22;-1
S2213-8587(14)70036-1;116 patients;116;-1
S2213-8587(14)70036-1;47 patients;47;-1
S2213-8587(14)70036-1;27 patients;27;-1
S2213-8587(14)70036-1;2 diabetic patients;2;-1
S2213-8587(14)70040-3;1 participants;1;-1
S2213-8587(14)70040-3;7 million participants;7;-1
S2213-8587(14)70040-3;1 million participants;1;-1
S2213-8587(14)70040-3;4 million participants;4;-1
S2213-8587(14)70040-3;0 million participants;0;-1
S2213-8587(14)70040-3;1273 participants;1273;-1
S2213-8587(14)70040-3;11 of hospital treat ment of patients;11;-1
S2213-8587(14)70040-3;775 385 individuals;775385;-1
S2213-8587(14)70043-9;300 older women;300;-1
S2213-8587(14)70047-6;300 older women;300;-1
S2213-8587(14)70048-8;22 critically ill patients;22;-1
S2213-8587(14)70049-X;22 critically ill patients;22;-1
S2213-8587(14)70050-6;18 705   participants;18705;-1
S2213-8587(14)70050-6;10 000 patients;10000;-1
S2213-8587(14)70050-6;4134 patients;4134;-1
S2213-8587(14)70050-6;3499 patients;3499;-1
S2213-8587(14)70050-6;6992 patients;6992;-1
S2213-8587(14)70050-6;2085 patients;2085;-1
S2213-8587(14)70050-6;1465 patients;1465;-1
S2213-8587(14)70050-6;1942 because   some patients;1942;-1
S2213-8587(14)70050-6;4450 patients;4450;-1
S2213-8587(14)70050-6;5600 patients;5600;-1
S2213-8587(14)70050-6;5386 individuals;5386;-1
S2213-8587(14)70050-6;5386 independent individuals;5386;-1
S2213-8587(14)70050-6;2085 individuals;2085;-1
S2213-8587(14)70050-6;8000 individuals;8000;-1
S2213-8587(14)70050-6;n=1465;1465;-1
S2213-8587(14)70050-6;n=620;620;-1
S2213-8587(14)70050-6; data from 2085;2085;-1
S2213-8587(14)70052-X;113 800 participants;113800;-1
S2213-8587(14)70052-X;40 162 participants;40162;-1
S2213-8587(14)70052-X;370 patients;370;-1
S2213-8587(14)70052-X;280 patients;280;-1
S2213-8587(14)70053-1;1044 patients;1044;-1
S2213-8587(14)70054-3;113 800 participants;113800;-1
S2213-8587(14)70054-3;40 162 participants;40162;-1
S2213-8587(14)70054-3;370 patients;370;-1
S2213-8587(14)70054-3;280 patients;280;-1
S2213-8587(14)70056-7;3   Studies of people;3;-1
S2213-8587(14)70057-9;576 participants;576;-1
S2213-8587(14)70057-9;174 participants;174;-1
S2213-8587(14)70057-9;148 participants;148;-1
S2213-8587(14)70057-9;155 participants;155;-1
S2213-8587(14)70057-9;136 participants;136;-1
S2213-8587(14)70057-9;577 study participants;577;-1
S2213-8587(14)70057-9;20 participants;20;-1
S2213-8587(14)70057-9;542 participants;542;-1
S2213-8587(14)70057-9;563 participants;563;-1
S2213-8587(14)70057-9;78 participants;78;-1
S2213-8587(14)70057-9;35 participants;35;-1
S2213-8587(14)70057-9;577 patients;577;-1
S2213-8587(14)70057-9;577 people;577;-1
S2213-8587(14)70057-9;439 people;439;-1
S2213-8587(14)70057-9;138 people;138;-1
S2213-8587(14)70057-9;10,532 people;10532;-1
S2213-8587(14)70057-9;577 adults;577;-1
S2213-8587(14)70057-9;92 million adults;92;-1
S2213-8587(14)70057-9;n=430;430;-1
S2213-8587(14)70057-9;n=138;138;-1
S2213-8587(14)70057-9;n=59;59;-1
S2213-8587(14)70057-9;n=200;200;-1
S2213-8587(14)70057-9;n=79;79;-1
S2213-8587(14)70057-9;n=230;230;-1
S2213-8587(14)70057-9;total of   439;439;-1
S2213-8587(14)70057-9;577 patients enrolled;577;-1
S2213-8587(14)70062-2;3392 ORIGIN participants;3392;-1
S2213-8587(14)70062-2;2000 participants;2000;-1
S2213-8587(14)70062-2;3714 participants;3714;-1
S2213-8587(14)70062-2;12 537 people;12537;-1
S2213-8587(14)70062-2;11 685 people;11685;-1
S2213-8587(14)70062-2;12 484 people;12484;-1
S2213-8587(14)70062-2;2833 people;2833;-1
S2213-8587(14)70062-2;3392 individuals;3392;-1
S2213-8587(14)70062-2;n=0;0;-1
S2213-8587(14)70062-2;n=11 685;11685;-1
S2213-8587(14)70062-2;n=5811;5811;-1
S2213-8587(14)70062-2;n=5874;5874;-1
S2213-8587(14)70062-2;n=5855;5855;-1
S2213-8587(14)70062-2;n=5830;5830;-1
S2213-8587(14)70062-2;n=3392;3392;-1
S2213-8587(14)70062-2;n=1683;1683;-1
S2213-8587(14)70062-2;n=1709;1709;-1
S2213-8587(14)70062-2;n=1699;1699;-1
S2213-8587(14)70062-2;n=1693;1693;-1
S2213-8587(14)70062-2;n=6264;6264;-1
S2213-8587(14)70062-2;n=6273;6273;-1
S2213-8587(14)70062-2;n=6281;6281;-1
S2213-8587(14)70062-2;n=6255;6255;-1
S2213-8587(14)70064-6;438 patients;438;-1
S2213-8587(14)70064-6;9 of patients;9;-1
S2213-8587(14)70066-X;23 participants;23;-1
S2213-8587(14)70066-X;25 participants;25;-1
S2213-8587(14)70066-X;12 079 participants;12079;-1
S2213-8587(14)70066-X;14 normal and dysglycaemia participants;14;-1
S2213-8587(14)70066-X;51 patients;51;-1
S2213-8587(14)70066-X;17  For all patients;17;-1
S2213-8587(14)70066-X;12 patients;12;-1
S2213-8587(14)70066-X;2 diabetes mellitus   patients;2;-1
S2213-8587(14)70066-X;2 diabetic patients;2;-1
S2213-8587(14)70066-X;23 people;23;-1
S2213-8587(14)70066-X;n=25;25;-1
S2213-8587(14)70066-X;n=26;26;-1
S2213-8587(14)70066-X;n=23;23;-1
S2213-8587(14)70067-1;2 diabetic patients;2;-1
S2213-8587(14)70067-1;366 million people;366;-1
S2213-8587(14)70068-3;68 500 patients;68500;-1
S2213-8587(14)70068-3;n=29 535;29535;-1
S2213-8587(14)70068-3;n=22 291;22291;-1
S2213-8587(14)70068-3;n=9919;9919;-1
S2213-8587(14)70068-3;N=29 535;29535;-1
S2213-8587(14)70068-3;N=22 291;22291;-1
S2213-8587(14)70068-3;N=9919;9919;-1
S2213-8587(14)70068-3; data from 20;20;-1
S2213-8587(14)70071-3;3   Studies of people;3;-1
S2213-8587(14)70073-7;370 participants;370;-1
S2213-8587(14)70073-7;159 patients;159;-1
S2213-8587(14)70073-7;18 patients;18;-1
S2213-8587(14)70073-7;141 patients;141;-1
S2213-8587(14)70073-7;6112 patients;6112;-1
S2213-8587(14)70073-7;3861 patients;3861;-1
S2213-8587(14)70073-7;27 patients;27;-1
S2213-8587(14)70073-7;114 patients;114;-1
S2213-8587(14)70073-7;15 patients;15;-1
S2213-8587(14)70073-7;28 patients;28;-1
S2213-8587(14)70073-7;159 randomly assigned patients;159;-1
S2213-8587(14)70073-7;159 randomised patients;159;-1
S2213-8587(14)70073-7;119 patients;119;-1
S2213-8587(14)70073-7;135 patients;135;-1
S2213-8587(14)70073-7;64 patients;64;-1
S2213-8587(14)70073-7;33 patients;33;-1
S2213-8587(14)70073-7;1 diabetic patients;1;-1
S2213-8587(14)70073-7;1076 adult patients;1076;-1
S2213-8587(14)70073-7;159 patients were recruited;159;-1
S2213-8587(14)70073-7;n=159;159;-1
S2213-8587(14)70073-7;n=114;114;-1
S2213-8587(14)70073-7;n=41;41;-1
S2213-8587(14)70073-7;n=32;32;-1
S2213-8587(14)70074-9;2 diabetic subjects;2;-1
S2213-8587(14)70074-9;2 diabetic patients;2;-1
S2213-8587(14)70074-9;438 patients;438;-1
S2213-8587(14)70074-9;9 of patients;9;-1
S2213-8587(14)70082-8;2 diabetic patients;2;-1
S2213-8587(14)70084-1;30 000 participants;30000;-1
S2213-8587(14)70084-1;n=0;0;-1
S2213-8587(14)70088-9;620 patients;620;7426
S2213-8587(14)70088-9;271 patients;271;7233
S2213-8587(14)70088-9;1240 patients;1240;1019
S2213-8587(14)70088-9;4444 patients;4444;24910
S2213-8587(14)70088-9;n=306;306;7348
S2213-8587(14)70088-9;n=314;314;7317
S2213-8587(14)70088-9;n=272;272;2889
S2213-8587(14)70088-9;n=129;129;2853
S2213-8587(14)70088-9;n=119;119;2821
S2213-8587(14)70088-9;n=100;100;2787
S2213-8587(14)70088-9;n=30;30;7348
S2213-8587(14)70088-9;n=10;10;2787
S2213-8587(14)70088-9;n=271;271;5430
S2213-8587(14)70088-9;n=285;285;5456
S2213-8587(14)70100-7;100 people;100;-1
S2213-8587(14)70102-0;100 000 for women;100000;-1
S2213-8587(14)70102-0;100 000 women;100000;-1
S2213-8587(14)70102-0;310 000 participants;310000;-1
S2213-8587(14)70102-0;7 million   participants;7;-1
S2213-8587(14)70102-0;1 million participants;1;-1
S2213-8587(14)70102-0;4 million participants;4;-1
S2213-8587(14)70102-0;0 million participants;0;-1
S2213-8587(14)70102-0;8 million participants;8;-1
S2213-8587(14)70102-0;560 352 participants;560352;-1
S2213-8587(14)70102-0;90 056 participants;90056;-1
S2213-8587(14)70102-0;900 000 adults;900000;-1
S2213-8587(14)70102-0; data were from the 2000;2000;-1
S2213-8587(14)70102-0; data, were from the 2000;2000;-1
S2213-8587(14)70102-0; data from 61;61;-1
S2213-8587(14)70102-0; data   from 90 056;90056;-1
S2213-8587(14)70103-2;300 000 persons;300000;-1
S2213-8587(14)70103-2;2856 participants;2856;-1
S2213-8587(14)70103-2;17 participants;17;-1
S2213-8587(14)70103-2;1152 patients;1152;-1
S2213-8587(14)70103-2;1270 patients;1270;-1
S2213-8587(14)70103-2;1 billion people;1;-1
S2213-8587(14)70103-2;300 million people;300;-1
S2213-8587(14)70103-2;13 people;13;-1
S2213-8587(14)70103-2;1082 people;1082;-1
S2213-8587(14)70103-2;900 000 adults;900000;-1
S2213-8587(14)70103-2;5362 original births recruited;5362;-1
S2213-8587(14)70103-2;n=191;191;-1
S2213-8587(14)70103-2;n=425;425;-1
S2213-8587(14)70103-2;n=553;553;-1
S2213-8587(14)70103-2;n=292;292;-1
S2213-8587(14)70103-2;n=285;285;-1
S2213-8587(14)70103-2;n=100;100;-1
S2213-8587(14)70103-2;n=183;183;-1
S2213-8587(14)70103-2;n=145;145;-1
S2213-8587(14)70103-2;n=211;211;-1
S2213-8587(14)70103-2;n=158;158;-1
S2213-8587(14)70104-4;30 000 participants;30000;-1
S2213-8587(14)70104-4;11 685 individuals;11685;-1
S2213-8587(14)70104-4;n=0;0;-1
S2213-8587(14)70105-6;370 patients;370;-1
S2213-8587(14)70105-6;159 eligible patients;159;-1
S2213-8587(14)70105-6;6000 patients;6000;-1
S2213-8587(14)70105-6;1 diabetic patients;1;-1
S2213-8587(14)70106-8;1 participants;1;-1
S2213-8587(14)70106-8;11 of hospital treat ment of patients;11;-1
S2213-8587(14)70108-1;7 million participants;7;-1
S2213-8587(14)70108-1;1 million participants;1;-1
S2213-8587(14)70108-1;4 million participants;4;-1
S2213-8587(14)70108-1;0 million participants;0;-1
S2213-8587(14)70108-1;1273 participants;1273;-1
S2213-8587(14)70108-1;366 million people;366;-1
S2213-8587(14)70108-1;775 385 individuals;775385;-1
S2213-8587(14)70111-1;1 and   patients;1;-1
S2213-8587(14)70111-1;40 000 people;40000;-1
S2213-8587(14)70111-1;n=26;26;-1
S2213-8587(14)70112-3;2 diabetic   patients;2;-1
S2213-8587(14)70113-5;2218 women;2218;-1
S2213-8587(14)70113-5;1320 women;1320;-1
S2213-8587(14)70113-5;1166 women;1166;-1
S2213-8587(14)70113-5;3627 women;3627;-1
S2213-8587(14)70113-5;0 women;0;-1
S2213-8587(14)70113-5;2977 women;2977;-1
S2213-8587(14)70113-5;7703 women;7703;-1
S2213-8587(14)70113-5;285 women;285;-1
S2213-8587(14)70113-5;2203 women;2203;-1
S2213-8587(14)70113-5;1769 women;1769;-1
S2213-8587(14)70113-5;1684 women;1684;-1
S2213-8587(14)70113-5;447 women;447;-1
S2213-8587(14)70113-5;1307 women;1307;-1
S2213-8587(14)70113-5;1334 women;1334;-1
S2213-8587(14)70113-5;384 women;384;-1
S2213-8587(14)70113-5;569 women;569;-1
S2213-8587(14)70113-5;459 women;459;-1
S2213-8587(14)70113-5;4985 women;4985;-1
S2213-8587(14)70113-5;1349 women;1349;-1
S2213-8587(14)70113-5;991 women;991;-1
S2213-8587(14)70113-5;3601 women;3601;-1
S2213-8587(14)70113-5;994 women;994;-1
S2213-8587(14)70113-5;1370 women;1370;-1
S2213-8587(14)70113-5;2755 women;2755;-1
S2213-8587(14)70113-5;670 women;670;-1
S2213-8587(14)70113-5;497 women;497;-1
S2213-8587(14)70113-5;728 women;728;-1
S2213-8587(14)70113-5;421 women;421;-1
S2213-8587(14)70113-5;2691 women;2691;-1
S2213-8587(14)70113-5;18 000 participants;18000;-1
S2213-8587(14)70113-5;101 patients;101;-1
S2213-8587(14)70113-5;108 173 individuals;108173;-1
S2213-8587(14)70113-5;6 and those investigating individuals;6;-1
S2213-8587(14)70113-5;146 581 individuals;146581;-1
S2213-8587(14)70113-5;n=49 363;49363;-1
S2213-8587(14)70113-5;n=146 581;146581;-1
S2213-8587(14)70113-5;n=142 255;142255;-1
S2213-8587(14)70113-5;n=36 282;36282;-1
S2213-8587(14)70113-5;n=99 582;99582;-1
S2213-8587(14)70113-5;n=8591;8591;-1
S2213-8587(14)70113-5;n=29 136;29136;-1
S2213-8587(14)70113-5;n=34 433;34433;-1
S2213-8587(14)70113-5;n=51 122;51122;-1
S2213-8587(14)70113-5;n=7152;7152;-1
S2213-8587(14)70113-5;n=1684;1684;-1
S2213-8587(14)70113-5;n=1998;1998;-1
S2213-8587(14)70113-5;n=8199;8199;-1
S2213-8587(14)70113-5;n=5654;5654;-1
S2213-8587(14)70113-5;n=868;868;-1
S2213-8587(14)70113-5;n=1554;1554;-1
S2213-8587(14)70113-5;n=2906;2906;-1
S2213-8587(14)70113-5;n=1210;1210;-1
S2213-8587(14)70113-5;n=3287;3287;-1
S2213-8587(14)70113-5;n=2911;2911;-1
S2213-8587(14)70113-5;n=4488;4488;-1
S2213-8587(14)70113-5;n=995;995;-1
S2213-8587(14)70113-5;n=9467;9467;-1
S2213-8587(14)70113-5;n=2392;2392;-1
S2213-8587(14)70113-5;n=1129;1129;-1
S2213-8587(14)70113-5;n=2443;2443;-1
S2213-8587(14)70113-5;n=58 337;58337;-1
S2213-8587(14)70113-5;n=49 346;49346;-1
S2213-8587(14)70113-5;n=901;901;-1
S2213-8587(14)70113-5;n=941;941;-1
S2213-8587(14)70113-5;n=1842;1842;-1
S2213-8587(14)70113-5;n=1776;1776;-1
S2213-8587(14)70113-5;n=907;907;-1
S2213-8587(14)70113-5;n=5054;5054;-1
S2213-8587(14)70113-5;n=1465;1465;-1
S2213-8587(14)70113-5;n=1728;1728;-1
S2213-8587(14)70113-5;n=13 235;13235;-1
S2213-8587(14)70113-5;n=1717;1717;-1
S2213-8587(14)70113-5;n=2771;2771;-1
S2213-8587(14)70113-5;n=2674;2674;-1
S2213-8587(14)70113-5;n=718;718;-1
S2213-8587(14)70113-5;n=3649;3649;-1
S2213-8587(14)70113-5;n=498;498;-1
S2213-8587(14)70113-5;n=782;782;-1
S2213-8587(14)70113-5;n=5146;5146;-1
S2213-8587(14)70113-5;n=41 245;41245;-1
S2213-8587(14)70113-5;n=5460;5460;-1
S2213-8587(14)70113-5;n=1289;1289;-1
S2213-8587(14)70113-5;n=69 395;69395;-1
S2213-8587(14)70113-5;n=108 173;108173;-1
S2213-8587(14)70113-5;n=6877;6877;-1
S2213-8587(14)70113-5; data from   35;35;-1
S2213-8587(14)70114-7;25 participants;25;14543
S2213-8587(14)70114-7;24 participants;24;289
S2213-8587(14)70114-7;25 eligible participants;25;730
S2213-8587(14)70114-7;24 patients;24;14303
S2213-8587(14)70114-7;28 patients;28;1459
S2213-8587(14)70114-7;n=24;24;1889
S2213-8587(14)70114-7;N=112;112;12573
S2213-8587(14)70114-7;27 enrolled;27;1438
S2213-8587(14)70119-6;8 Why all treated   participants;8;-1
S2213-8587(14)70119-6;2 In healthy people;2;-1
S2213-8587(14)70119-6;146 581 individuals;146581;-1
S2213-8587(14)70121-4;4607 women;4607;-1
S2213-8587(14)70121-4;59 137 women;59137;-1
S2213-8587(14)70121-4;15 Eligible women;15;-1
S2213-8587(14)70121-4;20 486 women;20486;-1
S2213-8587(14)70121-4;4500 women;4500;-1
S2213-8587(14)70121-4;8501 women;8501;-1
S2213-8587(14)70121-4;13 108 women;13108;-1
S2213-8587(14)70121-4;500 pregnant women;500;-1
S2213-8587(14)70121-4;13 108 pregnant women;13108;-1
S2213-8587(14)70121-4;36 women;36;-1
S2213-8587(14)70121-4;4422 women;4422;-1
S2213-8587(14)70121-4;31 685 ineligible women;31685;-1
S2213-8587(14)70121-4;60 000 pregnant   women;60000;-1
S2213-8587(14)70121-4;15 Eligible women were   recruited;15;-1
S2213-8587(14)70121-4;4607 were recruited;4607;-1
S2213-8587(14)70121-4;n=8406;8406;-1
S2213-8587(14)70121-4;n  =  41;41;-1
S2213-8587(14)70121-4;n  =1;1;-1
S2213-8587(14)70121-4;n  =  60;60;-1
S2213-8587(14)70121-4;n  =3;3;-1
S2213-8587(14)70121-4;n  =   62;62;-1
S2213-8587(14)70121-4;n  =2;2;-1
S2213-8587(14)70121-4;n  =  50;50;-1
S2213-8587(14)70121-4;n  =  61;61;-1
S2213-8587(14)70121-4;n  =  59;59;-1
S2213-8587(14)70121-4;n  =  64;64;-1
S2213-8587(14)70121-4;n  =  31;31;-1
S2213-8587(14)70121-4;N  =  43;43;-1
S2213-8587(14)70121-4;N  =  20;20;-1
S2213-8587(14)70121-4;n  =4;4;-1
S2213-8587(14)70121-4;n  =6;6;-1
S2213-8587(14)70121-4;n  =5;5;-1
S2213-8587(14)70121-4;N  =4;4;-1
S2213-8587(14)70121-4;N  =2;2;-1
S2213-8587(14)70121-4;N=4265;4265;-1
S2213-8587(14)70121-4;N=4237;4237;-1
S2213-8587(14)70121-4;N=20 166;20166;-1
S2213-8587(14)70121-4;N=4217;4217;-1
S2213-8587(14)70121-4;15 879 were   enrolled;15879;-1
S2213-8587(14)70121-4;4607 women enrolled;4607;-1
S2213-8587(14)70121-4;59 137 women enrolled;59137;-1
S2213-8587(14)70121-4;15 consented and were enrolled;15;-1
S2213-8587(14)70121-4;4607 enrolled;4607;-1
S2213-8587(14)70125-1;68 500 patients;68500;-1
S2213-8587(14)70125-1;100 people;100;-1
S2213-8587(14)70125-1;25 people;25;-1
S2213-8587(14)70125-1;57 000 people;57000;-1
S2213-8587(14)70125-1;7000 older adults;7000;-1
S2213-8587(14)70127-5;68 500 patients;68500;-1
S2213-8587(14)70127-5;100 people;100;-1
S2213-8587(14)70127-5;25 people;25;-1
S2213-8587(14)70127-5;57 000 people;57000;-1
S2213-8587(14)70130-5;2 diabetic   patients;2;-1
S2213-8587(14)70130-5;7000 older adults;7000;-1
S2213-8587(14)70131-7;7000 older adults;7000;-1
S2213-8587(14)70137-8;27 of women;27;-1
S2213-8587(14)70137-8;41 029 patients;41029;-1
S2213-8587(14)70137-8;7481 patients;7481;-1
S2213-8587(14)70137-8;2114 Chinese patients;2114;-1
S2213-8587(14)70137-8;8054 patients;8054;-1
S2213-8587(14)70137-8;9505 patients;9505;-1
S2213-8587(14)70137-8;27 In Asian patients;27;-1
S2213-8587(14)70137-8;382 million people;382;-1
S2213-8587(14)70137-8;26 million people;26;-1
S2213-8587(14)70137-8;96 individuals;96;-1
S2213-8587(14)70137-8;858,507   individuals;858507;-1
S2213-8587(14)70137-8;n=33 548;33548;-1
S2213-8587(14)70137-8;n=748;748;-1
S2213-8587(14)70137-8;n=106;106;-1
S2213-8587(14)70137-8;n=2650;2650;-1
S2213-8587(14)70137-8;n=1195;1195;-1
S2213-8587(14)70137-8;n=41 029;41029;-1
S2213-8587(14)70137-8;n=107;107;-1
S2213-8587(14)70137-8;n=275;275;-1
S2213-8587(14)70137-8;n=385;385;-1
S2213-8587(14)70137-8;n=705;705;-1
S2213-8587(14)70137-8;n=1751;1751;-1
S2213-8587(14)70137-8;n=7712;7712;-1
S2213-8587(14)70137-8;n=9107;9107;-1
S2213-8587(14)70137-8;n=5646;5646;-1
S2213-8587(14)70137-8;n=15 341;15341;-1
S2213-8587(14)70146-9;340 234 European participants;340234;-1
S2213-8587(14)70146-9;2 diabetes and subcohort participants;2;-1
S2213-8587(14)70146-9;27 779 participants;27779;-1
S2213-8587(14)70146-9;15 919 subcohort   participants;15919;-1
S2213-8587(14)70146-9;16 835 participants;16835;-1
S2213-8587(14)70146-9;340 234 EPIC participants;340234;-1
S2213-8587(14)70146-9;27 296 participants;27296;-1
S2213-8587(14)70146-9;2 diabetes and subcohort   participants;2;-1
S2213-8587(14)70146-9;12 403 people;12403;-1
S2213-8587(14)70146-9;340 234 people;340234;-1
S2213-8587(14)70146-9;16 835 people;16835;-1
S2213-8587(14)70146-9;15 919 people;15919;-1
S2213-8587(14)70146-9;755 people;755;-1
S2213-8587(14)70146-9;15 809 people;15809;-1
S2213-8587(14)70146-9;2348 people;2348;-1
S2213-8587(14)70146-9;723 people;723;-1
S2213-8587(14)70146-9;16 154 individuals;16154;-1
S2213-8587(14)70146-9;110 individuals;110;-1
S2213-8587(14)70146-9;755 individuals;755;-1
S2213-8587(14)70146-9;27 296 adults;27296;-1
S2213-8587(14)70146-9;n=15 919;15919;-1
S2213-8587(14)70146-9;n=15 164;15164;-1
S2213-8587(14)70146-9;n=12 132;12132;-1
S2213-8587(14)70146-9;n=1524;1524;-1
S2213-8587(14)70146-9;n=10 919;10919;-1
S2213-8587(14)70146-9;n=3476;3476;-1
S2213-8587(14)70146-9;n=6002;6002;-1
S2213-8587(14)70146-9;n=9917;9917;-1
S2213-8587(14)70146-9;n=7052;7052;-1
S2213-8587(14)70146-9;n=6255;6255;-1
S2213-8587(14)70146-9;n=2502;2502;-1
S2213-8587(14)70146-9;n=1048;1048;-1
S2213-8587(14)70146-9; data from a 7;7;-1
S2213-8587(14)70147-0;309 patients;309;-1
S2213-8587(14)70147-0;2 diabetes versus older individuals;2;-1
S2213-8587(14)70147-0;41 029 adults;41029;-1
S2213-8587(14)70153-6;200 obese individuals;200;-1
S2213-8587(14)70154-8;14 593 pregnant women;14593;-1
S2213-8587(14)70154-8;17 186 pregnant women;17186;-1
S2213-8587(14)70154-8;6,587 patients;6587;-1
S2213-8587(14)70154-8;20 patients;20;-1
S2213-8587(14)70155-X;1441 participants;1441;-1
S2213-8587(14)70155-X;726 participants;726;-1
S2213-8587(14)70155-X;715 participants;715;-1
S2213-8587(14)70155-X;1415 participants;1415;-1
S2213-8587(14)70155-X;1220 participants;1220;-1
S2213-8587(14)70155-X;N=1441;1441;-1
S2213-8587(14)70155-X;N=1415;1415;-1
S2213-8587(14)70155-X;N=1220;1220;-1
S2213-8587(14)70155-X;n=711;711;-1
S2213-8587(14)70155-X;n=730;730;-1
S2213-8587(14)70155-X;n=698;698;-1
S2213-8587(14)70155-X;n=717;717;-1
S2213-8587(14)70155-X;n=622;622;-1
S2213-8587(14)70155-X;n=598;598;-1
S2213-8587(14)70155-X;N=711;711;-1
S2213-8587(14)70155-X;N=730;730;-1
S2213-8587(14)70155-X;1 diabetes   were enrolled;1;-1
S2213-8587(14)70156-1;5145 participants;5145;-1
S2213-8587(14)70156-1;n=2575;2575;-1
S2213-8587(14)70156-1;n=2570;2570;-1
S2213-8587(14)70156-1;n=0;0;-1
S2213-8587(14)70156-1;total of 296;296;-1
S2213-8587(14)70157-3;4607 pregnant women;4607;-1
S2213-8587(14)70161-5;7 million   participants;7;-1
S2213-8587(14)70161-5;30 million children and young   people;30;-1
S2213-8587(14)70161-5;100 000 individuals;100000;-1
S2213-8587(14)70161-5;598 216 adults;598216;-1
S2213-8587(14)70161-5;75 000 new adults;75000;-1
S2213-8587(14)70161-5;2011 all adults;2011;-1
S2213-8587(14)70161-5;1000 adults;1000;-1
S2213-8587(14)70161-5; data from 2001;2001;-1
S2213-8587(14)70166-4;340 234 people;340234;-1
S2213-8587(14)70169-X;1288 subjects;1288;-1
S2213-8587(14)70169-X;198 patients;198;-1
S2213-8587(14)70169-X;358 patients;358;-1
S2213-8587(14)70169-X;176 patients;176;-1
S2213-8587(14)70169-X;182 patients;182;-1
S2213-8587(14)70169-X;62 patients;62;-1
S2213-8587(14)70169-X;354 patients;354;-1
S2213-8587(14)70169-X;27 patients;27;-1
S2213-8587(14)70169-X;12 patients;12;-1
S2213-8587(14)70169-X;125 patients;125;-1
S2213-8587(14)70169-X;110 acromegalic patients;110;-1
S2213-8587(14)70169-X;n=65;65;-1
S2213-8587(14)70169-X;n=68;68;-1
S2213-8587(14)70169-X;n=1;1;-1
S2213-8587(14)70169-X;n=63;63;-1
S2213-8587(14)70169-X;n=62;62;-1
S2213-8587(14)70169-X;n=66;66;-1
S2213-8587(14)70169-X;198 patients were enrolled;198;-1
S2213-8587(14)70169-X;15 Patients   enrolled;15;-1
S2213-8587(14)70172-X;7 million participants;7;-1
S2213-8587(14)70172-X;198 patients;198;-1
S2213-8587(14)70172-X;347 million people;347;-1
S2213-8587(14)70172-X;1000 US   adults;1000;-1
S2213-8587(14)70173-1;66 women;66;-1
S2213-8587(14)70173-1;2866 patients;2866;-1
S2213-8587(14)70173-1;19 246 patients;19246;-1
S2213-8587(14)70173-1;2978 patients;2978;-1
S2213-8587(14)70173-1;2985 patients;2985;-1
S2213-8587(14)70173-1;213 974 people;213974;-1
S2213-8587(14)70173-1;162 people;162;-1
S2213-8587(14)70173-1;5963 people;5963;-1
S2213-8587(14)70173-1;15 679 individuals;15679;-1
S2213-8587(14)70173-1;47 037 individuals;47037;-1
S2213-8587(14)70173-1;9560 individuals;9560;-1
S2213-8587(14)70173-1;186 295 individuals;186295;-1
S2213-8587(14)70173-1;18   individuals;18;-1
S2213-8587(14)70173-1;166 individuals;166;-1
S2213-8587(14)70173-1;n=15 679;15679;-1
S2213-8587(14)70173-1;n=47 037;47037;-1
S2213-8587(14)70173-1;n=272 994;272994;-1
S2213-8587(14)70173-1;n=90 998;90998;-1
S2213-8587(14)70173-1;n=30;30;-1
S2213-8587(14)70173-1;n=133;133;-1
S2213-8587(14)70174-3;825 participants;825;-1
S2213-8587(14)70174-3;825 patients;825;-1
S2213-8587(14)70174-3;3004 patients;3004;-1
S2213-8587(14)70174-3;833   patients;833;-1
S2213-8587(14)70174-3;412 patients;412;-1
S2213-8587(14)70174-3;16 patients;16;-1
S2213-8587(14)70174-3;15 patients;15;-1
S2213-8587(14)70174-3;1   diabetic patients;1;-1
S2213-8587(14)70174-3;1663 adults;1663;-1
S2213-8587(14)70174-3;n=833;833;-1
S2213-8587(14)70174-3;n=413;413;-1
S2213-8587(14)70174-3;n=414;414;-1
S2213-8587(14)70174-3;n=825;825;-1
S2213-8587(14)70174-3;n=412;412;-1
S2213-8587(14)70175-5;7 million participants;7;-1
S2213-8587(14)70175-5;198 patients;198;-1
S2213-8587(14)70177-9;2978 patients;2978;-1
S2213-8587(14)70177-9;60 000 patients;60000;-1
S2213-8587(14)70177-9;5963 people;5963;-1
S2213-8587(14)70185-8;2978 patients;2978;-1
S2213-8587(14)70185-8;60 000 patients;60000;-1
S2213-8587(14)70187-1;   data from 0;0;-1
S2213-8587(14)70189-5;500 million people;500;-1
S2213-8587(14)70189-5;100 million adults;100;-1
S2213-8587(14)70194-9;170 patients;170;-1
S2213-8587(14)70194-9;166 patients;166;-1
S2213-8587(14)70194-9;158 patients;158;-1
S2213-8587(14)70194-9;146 patients;146;-1
S2213-8587(14)70194-9;169 patients;169;-1
S2213-8587(14)70194-9;340 patients;340;-1
S2213-8587(14)70194-9;550 patients;550;-1
S2213-8587(14)70194-9;214 patients;214;-1
S2213-8587(14)70194-9;336 patients;336;-1
S2213-8587(14)70194-9;332 patients;332;-1
S2213-8587(14)70194-9;13 patients;13;-1
S2213-8587(14)70194-9;314 patients;314;-1
S2213-8587(14)70194-9;304 patients;304;-1
S2213-8587(14)70194-9;289 patients;289;-1
S2213-8587(14)70194-9;163 patients;163;-1
S2213-8587(14)70194-9;15 patients;15;-1
S2213-8587(14)70194-9;550 patients were recruited;550;-1
S2213-8587(14)70194-9;n=162;162;-1
S2213-8587(14)70194-9;n=152;152;-1
S2213-8587(14)70194-9;n=137;137;-1
S2213-8587(14)70194-9;n=122;122;-1
S2213-8587(14)70194-9;n=159;159;-1
S2213-8587(14)70194-9;n=151;151;-1
S2213-8587(14)70194-9;n=158;158;-1
S2213-8587(14)70194-9;n=143;143;-1
S2213-8587(14)70194-9;n=127;127;-1
S2213-8587(14)70194-9;n=169;169;-1
S2213-8587(14)70194-9;n=163;163;-1
S2213-8587(14)70200-1;153 women;153;-1
S2213-8587(14)70200-1;204 participants;204;-1
S2213-8587(14)70200-1;200 participants;200;-1
S2213-8587(14)70200-1;40 sequential participants;40;-1
S2213-8587(14)70200-1;13 200 participants;13200;-1
S2213-8587(14)70200-1;525 potential participants;525;-1
S2213-8587(14)70200-1;66 participants;66;-1
S2213-8587(14)70200-1;3 participants;3;-1
S2213-8587(14)70200-1;47 participants;47;-1
S2213-8587(14)70200-1;76 participants;76;-1
S2213-8587(14)70200-1;51 participants;51;-1
S2213-8587(14)70200-1;61 participants;61;-1
S2213-8587(14)70200-1;43 participants;43;-1
S2213-8587(14)70200-1;34 participants;34;-1
S2213-8587(14)70200-1;36 participants;36;-1
S2213-8587(14)70200-1;75 participants;75;-1
S2213-8587(14)70200-1;57 participants;57;-1
S2213-8587(14)70200-1;40 patients;40;-1
S2213-8587(14)70200-1;17 patients;17;-1
S2213-8587(14)70200-1;n=103;103;-1
S2213-8587(14)70200-1;n=97;97;-1
S2213-8587(14)70200-1;n=43;43;-1
S2213-8587(14)70200-1;n=61;61;-1
S2213-8587(14)70200-1;n=200;200;-1
S2213-8587(14)70200-1;n=127;127;-1
S2213-8587(14)70200-1;n=76;76;-1
S2213-8587(14)70200-1;n=51;51;-1
S2213-8587(14)70200-1;n=45;45;-1
S2213-8587(14)70200-1;n=15;15;-1
S2213-8587(14)70200-1;n=18;18;-1
S2213-8587(14)70200-1;n=20;20;-1
S2213-8587(14)70200-1;n=16;16;-1
S2213-8587(14)70200-1;n=19;19;-1
S2213-8587(14)70200-1;n=11;11;-1
S2213-8587(14)70200-1;n=9;9;-1
S2213-8587(14)70200-1;n=55;55;-1
S2213-8587(14)70200-1;n=34;34;-1
S2213-8587(14)70200-1;n=24;24;-1
S2213-8587(14)70203-7;   data from 0;0;-1
S2213-8587(14)70214-1;796 participants;796;-1
S2213-8587(14)70214-1;1658 participants;1658;-1
S2213-8587(14)70214-1;300 participants;300;-1
S2213-8587(14)70214-1;2167 patients;2167;-1
S2213-8587(14)70214-1;1658 patients;1658;-1
S2213-8587(14)70214-1;103 502 obese patients;103502;-1
S2213-8587(14)70214-1;4793 obese   patients;4793;-1
S2213-8587(14)70214-1;401 patients;401;-1
S2213-8587(14)70214-1;2167 obese patients;2167;-1
S2213-8587(14)70214-1;14 people;14;-1
S2213-8587(14)70214-1;878 people;878;-1
S2213-8587(14)70214-1;0001  Data are number of people;1;-1
S2213-8587(14)70214-1;5 million   individuals;5;-1
S2213-8587(14)70214-1;103 502 obese individuals;103502;-1
S2213-8587(14)70214-1;1324 individuals;1324;-1
S2213-8587(14)70214-1;n=1053;1053;-1
S2213-8587(14)70214-1;n=2167;2167;-1
S2213-8587(14)70216-5;309 patients;309;-1
S2213-8587(14)70216-5;825 patients;825;-1
S2213-8587(14)70216-5;200 obese individuals;200;-1
S2213-8587(14)70218-9;14 593 pregnant women;14593;-1
S2213-8587(14)70218-9;17 186 pregnant women;17186;-1
S2213-8587(14)70218-9;5 In a study   of patients;5;-1
S2213-8587(14)70218-9;6,587 patients;6587;-1
S2213-8587(14)70218-9;2167 obese adults;2167;-1
S2214-109X(13)70048-2;100 000 HIV-infected individuals;100000;-1
S2214-109X(13)70081-0;4 also identifi es individuals;4;-1
S2214-109X(13)70086-X;9 High-level panel of eminent persons;9;-1
S2214-109X(13)70114-1;3 Cohorts of patients;3;-1
S2214-109X(13)70118-9;300 participants;300;-1
S2214-109X(13)70118-9;298 participants;298;-1
S2214-109X(13)70118-9;36 participants;36;-1
S2214-109X(13)70118-9;299 participants;299;-1
S2214-109X(13)70118-9;300 patients;300;-1
S2214-109X(13)70118-9;296 patients;296;-1
S2214-109X(13)70118-9;594 patients;594;-1
S2214-109X(13)70118-9;324 patients;324;-1
S2214-109X(13)70118-9;300 enrolled patients;300;-1
S2214-109X(13)70118-9;400 000 individuals;400000;-1
S2214-109X(13)70118-9;n=175;175;-1
S2214-109X(13)70118-9;n=125;125;-1
S2214-109X(13)70118-9;n=300;300;-1
S2214-109X(13)70118-9;300 enrolled;300;-1
S2214-109X(13)70118-9;24 not enrolled;24;-1
S2214-109X(13)70144-X;300 individuals;300;-1
S2214-109X(13)70145-1;129 664 participants;129664;-1
S2214-109X(13)70145-1;41 We   included only participants;41;-1
S2214-109X(13)70145-1;129 664 individuals;129664;-1
S2214-109X(13)70145-1;1000 elderly individuals;1000;-1
S2214-109X(13)70149-9;126 263 patients;126263;-1
S2214-109X(13)70149-9;15 270 patients;15270;-1
S2214-109X(13)70149-9;3500 patients;3500;-1
S2214-109X(13)70149-9;201 822 patients;201822;-1
S2214-109X(13)70149-9;100 000 adult patients;100000;-1
S2214-109X(13)70149-9;18 000 records for patients;18000;-1
S2214-109X(13)70149-9;16 635 patients;16635;-1
S2214-109X(13)70149-9;1144 patients;1144;-1
S2214-109X(13)70149-9;924 patients;924;-1
S2214-109X(13)70149-9;295 patients;295;-1
S2214-109X(13)70149-9;14 272 patients;14272;-1
S2214-109X(13)70149-9;12 606 patients;12606;-1
S2214-109X(13)70149-9;102 713 patients;102713;-1
S2214-109X(13)70149-9;10  For patients;10;-1
S2214-109X(13)70149-9;5911 patients;5911;-1
S2214-109X(13)70149-9;8384 patients;8384;-1
S2214-109X(13)70149-9;975 patients;975;-1
S2214-109X(13)70149-9;37 patients;37;-1
S2214-109X(13)70149-9;3 patients;3;-1
S2214-109X(13)70149-9;6 patients;6;-1
S2214-109X(13)70149-9;7 patients;7;-1
S2214-109X(13)70149-9;126 263 adult patients;126263;-1
S2214-109X(13)70149-9;100 000   previously ART-naive adult patients;100000;-1
S2214-109X(13)70149-9;102 713 individuals;102713;-1
S2214-109X(13)70149-9;142 898 adults;142898;-1
S2214-109X(13)70149-9;126 263 adult patients enrolled;126263;-1
S2214-109X(13)70150-5;N=95 101;95101;-1
S2214-109X(13)70150-5;n=123;123;-1
S2214-109X(13)70150-5;N=106 557;106557;-1
S2214-109X(13)70150-5;n=135;135;-1
S2214-109X(13)70150-5;N=104 851;104851;-1
S2214-109X(13)70150-5;n=141;141;-1
S2214-109X(13)70150-5;N=122 919;122919;-1
S2214-109X(13)70150-5;n=156;156;-1
S2214-109X(13)70150-5;N=187 013;187013;-1
S2214-109X(13)70150-5;n=167;167;-1
S2214-109X(13)70150-5;N=104 872;104872;-1
S2214-109X(13)70150-5;n=137;137;-1
S2214-109X(13)70150-5;N=41 378;41378;-1
S2214-109X(13)70150-5;n=121;121;-1
S2214-109X(13)70150-5;N=157 266;157266;-1
S2214-109X(13)70150-5;n=140;140;-1
S2214-109X(13)70150-5;N=65 761;65761;-1
S2214-109X(13)70150-5;N=268 030;268030;-1
S2214-109X(13)70150-5;n=158;158;-1
S2214-109X(13)70150-5;N=95 066;95066;-1
S2214-109X(13)70150-5;n=134;134;-1
S2214-109X(13)70150-5;N=422 642;422642;-1
S2214-109X(13)70150-5;n=159;159;-1
S2214-109X(13)70150-5;N=106 199;106199;-1
S2214-109X(13)70150-5;n=126;126;-1
S2214-109X(13)70150-5;N=684 584;684584;-1
S2214-109X(13)70150-5;n=155;155;-1
S2214-109X(13)70150-5;N=142 986;142986;-1
S2214-109X(13)70152-9;7 million   people;7;-1
S2214-109X(13)70153-0;n=15;15;-1
S2214-109X(13)70155-4;1 billion people;1;-1
S2214-109X(13)70155-4;1 billion   people;1;-1
S2214-109X(13)70160-8;2 of long intervention Reach women;2;11463
S2214-109X(13)70160-8;2000 people;2000;25589
S2214-109X(13)70160-8;1857 people;1857;1198
S2214-109X(13)70160-8;N=173;173;3072
S2214-109X(13)70160-8;N=175;175;3097
S2214-109X(13)70160-8; data from the 6;6;6172
S2214-109X(13)70163-3;4 million people;4;-1
S2214-109X(13)70163-3;191 million people;191;-1
S2214-109X(13)70163-3;196 million people;196;-1
S2214-109X(13)70165-7;6 and workshop   participants;6;-1
S2214-109X(13)70168-2;n=1310;1310;-1
S2214-109X(13)70168-2;n=904;904;-1
S2214-109X(13)70169-4;6   Young people;6;-1
S2214-109X(13)70172-4;395  All HIV-positive adults;395;-1
S2214-109X(13)70173-6;9 Reasons include women;9;-1
S2214-109X(13)70173-6;700 people;700;-1
S2214-109X(13)70173-6;5 Adolescents and adults;5;-1
S2214-109X(13)70175-X;126 000 patients;126000;-1
S2214-109X(13)70175-X;123 000 patients;123000;-1
S2214-109X(13)70176-1;14 million people;14;-1
S2214-109X(13)70176-1;6 individuals;6;-1
S2214-109X(13)70177-3;249 women;249;-1
S2214-109X(13)70178-5;30 million   people;30;-1
S2214-109X(13)70179-7;16 million women;16;-1
S2214-109X(13)70179-7;n=185;185;-1
S2214-109X(13)70179-7;n=65;65;-1
S2214-109X(13)70179-7;n=25;25;-1
S2214-109X(13)70179-7;n=54;54;-1
S2214-109X(13)70179-7; data for each of the 144;144;-1
S2214-109X(13)70179-7; data from 144;144;-1
S2214-109X(13)70181-5;140 patients;140;-1
S2214-109X(13)70181-5;200 000. That deaths in patients;200000;-1
S2214-109X(13)70181-5;15 000 patients;15000;-1
S2214-109X(14)70002-6;1 If participants;1;2939
S2214-109X(14)70002-6;2 If participants;2;2575
S2214-109X(14)70002-6;900 million people;900;9828
S2214-109X(14)70002-6;8 million people;8;9478
S2214-109X(14)70002-6;22 million people;22;9029
S2214-109X(14)70002-6;64 307 people;64307;912
S2214-109X(14)70002-6;4000 people;4000;4275
S2214-109X(14)70002-6;65 million people;65;13114
S2214-109X(14)70002-6;n=21;21;11819
S2214-109X(14)70002-6;n=6;6;3211
S2214-109X(14)70002-6;n=10;10;6261
S2214-109X(14)70006-3;800 women;800;-1
S2214-109X(14)70007-5;52 per thousand   women;52;-1
S2214-109X(14)70007-5;100 000 pregnancies   currently in women;100000;-1
S2214-109X(14)70007-5;264 695 Danish women;264695;-1
S2214-109X(14)70007-5; data from   144;144;-1
S2214-109X(14)70008-7; data from 22;22;-1
S2214-109X(14)70014-2;26 million people;26;-1
S2214-109X(14)70014-2;44 145 studied individuals;44145;-1
S2214-109X(14)70015-4;6 million   people;6;-1
S2214-109X(14)70018-X;75 000 people;75000;-1
S2214-109X(14)70018-X;87 000 people;87000;-1
S2214-109X(14)70018-X;14 505 individuals;14505;-1
S2214-109X(14)70018-X;7657 adults;7657;-1
S2214-109X(14)70018-X; data from   7657;7657;-1
S2214-109X(14)70019-1;90 participants;90;-1
S2214-109X(14)70019-1;90 case participants;90;-1
S2214-109X(14)70019-1;17 participants;17;-1
S2214-109X(14)70019-1;73 participants;73;-1
S2214-109X(14)70019-1;35 case participants;35;-1
S2214-109X(14)70019-1;216 patients;216;-1
S2214-109X(14)70019-1;73   patients;73;-1
S2214-109X(14)70019-1;3117 people;3117;-1
S2214-109X(14)70019-1;90 people;90;-1
S2214-109X(14)70019-1;216 people;216;-1
S2214-109X(14)70019-1;17 people;17;-1
S2214-109X(14)70019-1;1000 people;1000;-1
S2214-109X(14)70019-1;n=42;42;-1
S2214-109X(14)70019-1;n=19;19;-1
S2214-109X(14)70019-1;n=12;12;-1
S2214-109X(14)70019-1;90 people were enrolled;90;-1
S2214-109X(14)70020-8;3885 women;3885;-1
S2214-109X(14)70020-8;1003 women;1003;-1
S2214-109X(14)70020-8;536 women;536;-1
S2214-109X(14)70020-8;118 women;118;-1
S2214-109X(14)70020-8;total of   3885;3885;-1
S2214-109X(14)70022-1;400 patients;400;-1
S2214-109X(14)70022-1;5 Other   patients;5;-1
S2214-109X(14)70022-1;152 adults;152;-1
S2214-109X(14)70023-3;1899 patients;1899;-1
S2214-109X(14)70023-3;1 diabetic patients;1;-1
S2214-109X(14)70023-3;260 000 people;260000;-1
S2214-109X(14)70023-3;18 712 adults;18712;-1
S2214-109X(14)70023-3; data from 18 712;18712;-1
S2214-109X(14)70024-5; data from 22;22;-1
S2214-109X(14)70024-5; data from 54;54;-1
S2214-109X(14)70025-7;n=328;328;-1
S2214-109X(14)70025-7;n=520;520;-1
S2214-109X(14)70025-7; data from 121;121;-1
S2214-109X(14)70025-7; data from 63;63;-1
S2214-109X(14)70025-7; data   from 121;121;-1
S2214-109X(14)70028-2; data   from 40;40;-1
S2214-109X(14)70032-4;500 assessment participants;500;1246
S2214-109X(14)70032-4;900 assessment participants;900;1172
S2214-109X(14)70032-4;1430 assessment participants;1430;1090
S2214-109X(14)70032-4;60 000 potentially eligible participants;60000;4451
S2214-109X(14)70032-4;7366 participants;7366;8113
S2214-109X(14)70032-4;315 participants;315;8296
S2214-109X(14)70032-4;292 participants;292;8471
S2214-109X(14)70032-4;23 participants;23;8542
S2214-109X(14)70032-4;39 012 HIV-negative participants;39012;9407
S2214-109X(14)70032-4;7361 HIV-positive   participants;7361;9444
S2214-109X(14)70032-4;46 378 study participants;46378;9921
S2214-109X(14)70032-4;864 651 participants;864651;30957
S2214-109X(14)70032-4;2882 individuals;2882;4356
S2214-109X(14)70032-4;n=14 567;14567;17599
S2214-109X(14)70032-4;n=56 683;56683;17563
S2214-109X(14)70032-4;N=7;7;4852
S2214-109X(14)70032-4;N=4;4;4875
S2214-109X(14)70032-4;N=5;5;4898
S2214-109X(14)70032-4;n=3787;3787;11672
S2214-109X(14)70032-4;n=3832;3832;11689
S2214-109X(14)70032-4;n=5923;5923;11707
S2214-109X(14)70032-4;n=5957;5957;11724
S2214-109X(14)70032-4;n=4684;4684;11742
S2214-109X(14)70032-4;n=4357;4357;11759
S2214-109X(14)70032-4;n=5913;5913;11777
S2214-109X(14)70032-4;n=5929;5929;11794
S2214-109X(14)70032-4;n=6846;6846;11812
S2214-109X(14)70032-4;n=6769;6769;11829
S2214-109X(14)70032-4;n=23 366;23366;11847
S2214-109X(14)70032-4;n=23 012;23012;11866
S2214-109X(14)70032-4;50 communities were enrolled;50;2684
S2214-109X(14)70032-4; data from   39 012;39012;9394
S2214-109X(14)70033-6;4 million participants;4;-1
S2214-109X(14)70033-6;1095 adults;1095;-1
S2214-109X(14)70033-6;N=4;4;-1
S2214-109X(14)70033-6;N=8;8;-1
S2214-109X(14)70033-6;N=12;12;-1
S2214-109X(14)70033-6;N=24;24;-1
S2214-109X(14)70033-6;N=176;176;-1
S2214-109X(14)70033-6;N=92;92;-1
S2214-109X(14)70033-6;N=67;67;-1
S2214-109X(14)70033-6;N=34;34;-1
S2214-109X(14)70033-6;N=68;68;-1
S2214-109X(14)70033-6;N=150;150;-1
S2214-109X(14)70033-6;N=83;83;-1
S2214-109X(14)70037-3; database of 33;33;-1
S2214-109X(14)70038-5;20 million people;20;-1
S2214-109X(14)70038-5;7 million   people;7;-1
S2214-109X(14)70038-5;16 million people;16;-1
S2214-109X(14)70188-3;5 million individuals;5;-1
S2214-109X(14)70188-3;40 000 individuals;40000;-1
S2214-109X(14)70188-3;4020 individuals;4020;-1
S2214-109X(14)70188-3;82 individuals;82;-1
S2214-109X(14)70188-3;n=2;2;-1
S2214-109X(14)70188-3; data from a   2012;2012;-1
S2214-109X(14)70194-9;20 million people;20;-1
S2214-109X(14)70195-0;15 of HIV-positive adults;15;-1
S2214-109X(14)70195-0;n=535;535;-1
S2214-109X(14)70195-0;n=89;89;-1
S2214-109X(14)70195-0;n=250;250;-1
S2214-109X(14)70195-0;n=196;196;-1
S2214-109X(14)70195-0;n=106;106;-1
S2214-109X(14)70195-0;n=429;429;-1
S2214-109X(14)70195-0;1053 children enrolled;1053;-1
S2214-109X(14)70195-0;16 All children enrolled;16;-1
S2214-109X(14)70196-2;549 women;549;-1
S2214-109X(14)70196-2;21  Methods  Study design and participants;21;-1
S2214-109X(14)70196-2;1271 participants;1271;-1
S2214-109X(14)70196-2;747 baseline rural participants;747;-1
S2214-109X(14)70196-2;1022 people;1022;-1
S2214-109X(14)70196-2;1022 adults;1022;-1
S2214-109X(14)70196-2;1554 invited adults;1554;-1
S2214-109X(14)70196-2;1554 adults;1554;-1
S2214-109X(14)70196-2;1038 recruited;1038;-1
S2214-109X(14)70196-2;n=1022;1022;-1
S2214-109X(14)70196-2;n=860;860;-1
S2214-109X(14)70196-2;n=162;162;-1
S2214-109X(14)70196-2;n=851;851;-1
S2214-109X(14)70196-2;n=171;171;-1
S2214-109X(14)70196-2;1271 participants enrolled;1271;-1
S2214-109X(14)70197-4;4 These individuals;4;-1
S2214-109X(14)70197-4;73 individuals;73;-1
S2214-109X(14)70197-4;n=42;42;-1
S2214-109X(14)70197-4;n=12;12;-1
S2214-109X(14)70200-1; data from 121;121;-1
S2214-109X(14)70201-3;681 patients;681;18525
S2214-109X(14)70201-3;1632 patients;1632;18467
S2214-109X(14)70201-3;100 patients;100;2608
S2214-109X(14)70201-3;729 patients;729;5120
S2214-109X(14)70201-3;1879 patients;1879;5395
S2214-109X(14)70201-3;2021 patients;2021;5674
S2214-109X(14)70201-3;681 febrile patients;681;13585
S2214-109X(14)70201-3;1669 patients;1669;23925
S2214-109X(14)70201-3;53  Febrile patients;53;26798
S2214-109X(14)70201-3;n=9;9;7209
S2214-109X(14)70201-3;n=18;18;7230
S2214-109X(14)70201-3;n=19;19;7257
S2214-109X(14)70201-3;n=681;681;11126
S2214-109X(14)70201-3;n=1632;1632;11149
S2214-109X(14)70201-3;n=1669;1669;11178
S2214-109X(14)70201-3;n=39;39;26421
S2214-109X(14)70201-3;n=95;95;26445
S2214-109X(14)70201-3;n=103;103;26474
S2214-109X(14)70203-7;50 participants;50;-1
S2214-109X(14)70203-7;131 participants;131;-1
S2214-109X(14)70203-7;363 participants;363;-1
S2214-109X(14)70203-7;135 patients;135;-1
S2214-109X(14)70203-7;64 patients;64;-1
S2214-109X(14)70203-7;106 patients;106;-1
S2214-109X(14)70203-7;14 patients;14;-1
S2214-109X(14)70203-7; database.   of 33;33;-1
S2214-109X(14)70207-4;n=250;250;-1
S2214-109X(14)70207-4;n=196;196;-1
S2214-109X(14)70211-6;n=157;157;-1
S2214-109X(14)70211-6;n=192;192;-1
S2214-109X(14)70218-9;212 participants;212;-1
S2214-109X(14)70218-9;93 enrolled participants;93;-1
S2214-109X(14)70218-9;93 enrolled;93;-1
S2214-109X(14)70223-2;14 patients;14;-1
S2214-109X(14)70223-2;3 In some patients;3;-1
S2214-109X(14)70223-2;2598 patients;2598;-1
S2214-109X(14)70223-2;300 patients;300;-1
S2214-109X(14)70223-2;1511 patients;1511;-1
S2214-109X(14)70223-2;186 male patients;186;-1
S2214-109X(14)70223-2;187 female patients;187;-1
S2214-109X(14)70223-2;750 individuals;750;-1
S2214-109X(14)70223-2;n=427;427;-1
S2214-109X(14)70223-2;n=158;158;-1
S2214-109X(14)70224-4;2031 participants;2031;-1
S2214-109X(14)70224-4;260 000 people;260000;-1
S2214-109X(14)70224-4;500 individuals;500;-1
S2214-109X(14)70224-4;n=2031;2031;-1
S2214-109X(14)70224-4;n=2;2;-1
S2214-109X(14)70224-4;n=3;3;-1
S2214-109X(14)70224-4;n=506;506;-1
S2214-109X(14)70224-4;n=511;511;-1
S2214-109X(14)70224-4;n=504;504;-1
S2214-109X(14)70224-4;n=510;510;-1
S2214-109X(14)70224-4;total of 872;872;-1
S2214-109X(14)70224-4;500 individuals were enrolled;500;-1
S2214-109X(14)70224-4;2031 participants were enrolled;2031;-1
S2214-109X(14)70225-6;6 million people;6;-1
S2214-109X(14)70227-X; datasets from 115;115;-1
S2214-109X(14)70227-X; datapoints from 79;79;-1
S2214-109X(14)70227-X; datapoints from 32;32;-1
S2214-109X(14)70227-X; datapoints from 11;11;-1
S2214-109X(14)70227-X; datapoints from 115;115;-1
S2214-109X(14)70227-X; data from 79;79;-1
S2214-109X(14)70231-1;703 participants;703;-1
S2214-109X(14)70231-1;504 participants;504;-1
S2214-109X(14)70231-1;707 eligible participants;707;-1
S2214-109X(14)70231-1;182 participants;182;-1
S2214-109X(14)70231-1;579 people;579;-1
S2214-109X(14)70231-1;703 individuals;703;-1
S2214-109X(14)70231-1;504 participants were recruited;504;-1
S2214-109X(14)70231-1;199 were recruited;199;-1
S2214-109X(14)70231-1;n=282;282;-1
S2214-109X(14)70231-1;n=45;45;-1
S2214-109X(14)70231-1;n=41;41;-1
S2214-109X(14)70231-1;n=31;31;-1
S2214-109X(14)70231-1;n=28;28;-1
S2214-109X(14)70231-1;n=38;38;-1
S2214-109X(14)70231-1;n=55;55;-1
S2214-109X(14)70231-1;n=30;30;-1
S2214-109X(14)70231-1;n=12;12;-1
S2214-109X(14)70231-1;n=2;2;-1
S2214-109X(14)70231-1;707 children were enrolled;707;-1
S2214-109X(14)70231-1;507 enrolled;507;-1
S2214-109X(14)70231-1;200 enrolled;200;-1
S2214-109X(14)70231-1;208 enrolled;208;-1
S2214-109X(14)70234-7;1006 patients;1006;-1
S2214-109X(14)70234-7;100 000 per   year in people;100000;-1
S2214-109X(14)70234-7;100 000 per   year in individuals;100000;-1
S2214-109X(14)70237-2;n=34;34;-1
S2214-109X(14)70237-2;n=46;46;-1
S2214-109X(14)70237-2;n=133;133;-1
S2214-109X(14)70237-2;n=1;1;-1
S2214-109X(14)70237-2;n=3;3;-1
S2214-109X(14)70237-2;n=42;42;-1
S2214-109X(14)70237-2;n=20;20;-1
S2214-109X(14)70237-2;n=5;5;-1
S2214-109X(14)70237-2;n=10;10;-1
S2214-109X(14)70237-2;n=22;22;-1
S2214-109X(14)70237-2;n=23;23;-1
S2214-109X(14)70237-2;n=27;27;-1
S2214-109X(14)70237-2;n=6;6;-1
S2214-109X(14)70237-2;n=8;8;-1
S2214-109X(14)70237-2;n=12;12;-1
S2214-109X(14)70237-2; data from 179;179;-1
S2214-109X(14)70238-4;100 000 people;100000;-1
S2214-109X(14)70241-4;3   and older people;3;-1
S2214-109X(14)70241-4;2 adults;2;-1
S2214-109X(14)70244-X;2 million   women;2;-1
S2214-109X(14)70244-X;2 patients;2;-1
S2214-109X(14)70244-X;11 million people;11;-1
S2214-109X(14)70248-7;50 million individuals;50;-1
S2214-109X(14)70251-7;2 million women;2;-1
S2214-109X(14)70254-2;105 adults;105;-1
S2214-109X(14)70256-6;4 million pregnant women;4;-1
S2214-109X(14)70256-6;4 million women;4;-1
S2214-109X(14)70256-6;total of 27;27;-1
S2214-109X(14)70260-8;118 women;118;-1
S2214-109X(14)70260-8;536 women;536;-1
S2214-109X(14)70260-8;204 women;204;-1
S2214-109X(14)70260-8;139 women;139;-1
S2214-109X(14)70260-8;682 women;682;-1
S2214-109X(14)70260-8;575 women;575;-1
S2214-109X(14)70260-8;886 women;886;-1
S2214-109X(14)70264-5;40 million women;40;-1
S2214-109X(14)70274-8;100 women;100;-1
S2214-109X(14)70274-8;n=878;878;-1
S2214-109X(14)70274-8;n=879;879;-1
S2214-109X(14)70274-8;n=0;0;-1
S2214-109X(14)70274-8;n=12 119;12119;-1
S2214-109X(14)70274-8;n=7642;7642;-1
S2214-109X(14)70274-8;n=4589;4589;-1
S2214-109X(14)70274-8;n=5640;5640;-1
S2214-109X(14)70274-8;n=3663;3663;-1
S2214-109X(14)70274-8;n=2279;2279;-1
S2214-109X(14)70274-8; data from 1999;1999;-1
S2214-109X(14)70274-8; data from all 182;182;-1
S2214-109X(14)70274-8; data from the 100;100;-1
S2214-109X(14)70274-8; data from BHP,10;10;-1
S2214-109X(14)70275-X;30 000 individuals;30000;-1
S2214-109X(14)70275-X;total of 79;79;-1
S2214-109X(14)70276-1;100 000 people;100000;-1
S2214-109X(14)70276-1;100 000   people;100000;-1
S2214-109X(14)70276-1;5000 individuals;5000;-1
S2214-109X(14)70276-1; data from the 2003;2003;-1
S2214-109X(14)70276-1; data from 2003;2003;-1
S2214-109X(14)70276-1; data from 2011;2011;-1
S2214-109X(14)70276-1; data from 2008;2008;-1
S2214-109X(14)70277-3;2 million people;2;-1
S2214-109X(14)70277-3;500 000 people;500000;-1
S2214-109X(14)70277-3;25  Coverage of ART of eligible individuals;25;-1
S2214-109X(14)70278-5;2218 people;2218;-1
S2214-109X(14)70281-5;4471 participants;4471;-1
S2214-109X(14)70281-5;20 811 individuals;20811;-1
S2214-109X(14)70281-5;1315 individuals;1315;-1
S2214-109X(14)70281-5;1349 individuals;1349;-1
S2214-109X(14)70281-5;643 individuals;643;-1
S2214-109X(14)70281-5;n=456;456;-1
S2214-109X(14)70281-5;n=1081;1081;-1
S2214-109X(14)70281-5;n=3418;3418;-1
S2214-109X(14)70283-9;58 922 pregnant women;58922;-1
S2214-109X(14)70283-9;30 pregnant women;30;-1
S2214-109X(14)70283-9;496 women;496;-1
S2214-109X(14)70283-9;1,020 patients;1020;-1
S2214-109X(14)70283-9;3 billion   individuals;3;-1
S2214-109X(14)70283-9; data from   54;54;-1
S2214-109X(14)70290-6;7 Consenting   women;7;-1
S2214-109X(14)70290-6;49 women;49;-1
S2214-109X(14)70290-6;5236 people;5236;-1
S2214-109X(14)70290-6;3 289 000 people;3289000;-1
S2214-109X(14)70290-6;7 people;7;-1
S2214-109X(14)70290-6;19 025 people;19025;-1
S2214-109X(14)70290-6;278 individuals;278;-1
S2214-109X(14)70290-6;n=2187;2187;-1
S2214-109X(14)70290-6;n=99;99;-1
S2214-109X(14)70290-6;n=98;98;-1
S2214-109X(14)70290-6;n=298;298;-1
S2214-109X(14)70290-6;n=249;249;-1
S2214-109X(14)70290-6;n=100;100;-1
S2214-109X(14)70290-6;n=1343;1343;-1
S2214-109X(14)70290-6;n=2170;2170;-1
S2214-109X(14)70290-6;n=97;97;-1
S2214-109X(14)70290-6;n=295;295;-1
S2214-109X(14)70290-6;n=1333;1333;-1
S2214-109X(14)70290-6;n=242;242;-1
S2214-109X(14)70290-6;n=246;246;-1
S2214-109X(14)70290-6;n=718;718;-1
S2214-109X(14)70290-6;n=86;86;-1
S2214-109X(14)70290-6;n=155;155;-1
S2214-109X(14)70290-6;n=235;235;-1
S2214-109X(14)70290-6;n=612;612;-1
S2214-109X(14)70290-6;n=253;253;-1
S2214-109X(14)70290-6;n=234;234;-1
S2214-109X(14)70290-6;n=125;125;-1
S2214-109X(14)70290-6;n=187;187;-1
S2214-109X(14)70290-6;n=3225;3225;-1
S2214-109X(14)70290-6;n=5230;5230;-1
S2214-109X(14)70290-6;n=147;147;-1
S2214-109X(14)70290-6;n=92;92;-1
S2214-109X(14)70290-6;n=39;39;-1
S2214-109X(14)70291-8;1 tests   all patients;1;-1
S2214-109X(14)70291-8;1000 individuals;1000;-1
S2214-109X(14)70292-X;185 million people;185;-1
S2214-109X(14)70294-3;513  Comment  women;513;-1
S2214-109X(14)70294-3;1 billion people;1;-1
S2214-109X(14)70294-3; data from 192;192;-1
S2214-109X(14)70295-5;154 425 individuals;154425;-1
S2214-109X(14)70296-7;total of 182 088;182088;-1
S2214-109X(14)70300-6;11  Mean nets-to-people;11;-1
S2214-109X(14)70300-6;10  Proportion of people;10;-1
S2214-109X(14)70300-6;n=1;1;-1
S2214-109X(14)70300-6; data from 29;29;-1
S2214-109X(14)70301-8;529 patients;529;-1
S2214-109X(14)70301-8;7415 cases of patients;7415;-1
S2214-109X(14)70301-8;14 we counted people;14;-1
S2214-109X(14)70301-8;100 000 people;100000;-1
S2214-109X(14)70301-8;100 000 individuals;100000;-1
S2214-109X(14)70301-8;n=25;25;-1
S2214-109X(14)70305-5;581  Comment  HIV-uninfected people;581;-1
S2214-109X(14)70307-9;162 participants;162;-1
S2214-109X(14)70307-9;19  Methods  Study design and participants;19;-1
S2214-109X(14)70307-9;20 Masking   of participants;20;-1
S2214-109X(14)70307-9;5 billion people;5;-1
S2214-109X(14)70307-9;24 969 individuals;24969;-1
S2214-109X(14)70307-9;25 982 individuals;25982;-1
S2214-109X(14)70307-9;10 269 individuals;10269;-1
S2214-109X(14)70307-9;10 014 individuals;10014;-1
S2214-109X(14)70307-9;1462 individuals;1462;-1
S2214-109X(14)70307-9;1490 individuals;1490;-1
S2214-109X(14)70307-9;350 individuals;350;-1
S2214-109X(14)70307-9;33 400 children and adults;33400;-1
S2214-109X(14)70307-9;n=1961;1961;-1
S2214-109X(14)70307-9;n=650;650;-1
S2214-109X(14)70307-9;n=637;637;-1
S2214-109X(14)70307-9; data from   112;112;-1
S2214-109X(14)70309-2;n=50 396;50396;-1
S2214-109X(14)70309-2;n=122 757;122757;-1
S2214-109X(14)70309-2;n=392 300;392300;-1
S2214-109X(14)70309-2; data from 206;206;-1
S2214-109X(14)70309-2; data from 1986;1986;-1
S2214-109X(14)70310-9;1,900 patients;1900;-1
S2214-109X(14)70310-9;1000 people;1000;-1
S2214-109X(14)70310-9;100 000 people;100000;-1
S2214-109X(14)70310-9;500 individuals;500;-1
S2214-109X(14)70310-9;23 studies individuals;23;-1
S2214-109X(14)70314-6;1200 women;1200;-1
S2214-109X(14)70314-6;1985 women;1985;-1
S2214-109X(14)70314-6;14 women;14;-1
S2214-109X(14)70314-6;n=422;422;-1
S2214-109X(14)70314-6;n=419;419;-1
S2214-109X(14)70314-6;n=69;69;-1
S2214-109X(14)70314-6;n=290;290;-1
S2214-109X(14)70315-8;1643 women;1643;-1
S2214-109X(14)70315-8;2773 women;2773;-1
S2214-109X(14)70315-8;0001  All women;1;-1
S2214-109X(14)70315-8;0001  HIV-infected women;1;-1
S2214-109X(14)70315-8;0001  HIV-uninfected women;1;-1
S2214-109X(14)70315-8;115 women;115;-1
S2214-109X(14)70315-8;103 women;103;-1
S2214-109X(14)70315-8;25 All   participants;25;-1
S2214-109X(14)70315-8;25 All participants;25;-1
S2214-109X(14)70315-8;21 individuals;21;-1
S2214-109X(14)70315-8;n=2946;2946;-1
S2214-109X(14)70315-8;n=1770;1770;-1
S2214-109X(14)70315-8;n=1575;1575;-1
S2214-109X(14)70315-8;n=1371;1371;-1
S2214-109X(14)70315-8;n=574;574;-1
S2214-109X(14)70315-8;n=1196;1196;-1
S2214-109X(14)70315-8;n=4682;4682;-1
S2214-109X(14)70315-8;n=1759;1759;-1
S2214-109X(14)70315-8;n=2923;2923;-1
S2214-109X(14)70315-8;n=4696;4696;-1
S2214-109X(14)70315-8;n=2935;2935;-1
S2214-109X(14)70315-8;n=1761;1761;-1
S2214-109X(14)70315-8;n=0;0;-1
S2214-109X(14)70315-8;n=4389;4389;-1
S2214-109X(14)70315-8;n=1645;1645;-1
S2214-109X(14)70315-8;n=2744;2744;-1
S2214-109X(14)70315-8;n=4416;4416;-1
S2214-109X(14)70315-8;n=2773;2773;-1
S2214-109X(14)70315-8;n=1643;1643;-1
S2214-109X(14)70316-X;1 million people;1;-1
S2214-109X(14)70318-3;400 000 people;400000;-1
S2214-109X(14)70319-5;n=70;70;-1
S2214-109X(14)70321-3;18 PhD fellows were recruited;18;-1
S2214-109X(14)70325-0;36 million people;36;-1
S2214-109X(14)70329-8;n=87;87;-1
S2214-109X(14)70329-8;n=98;98;-1
S2214-109X(14)70329-8;n=46;46;-1
S2214-109X(14)70329-8;n=45;45;-1
S2214-109X(14)70329-8;n=88;88;-1
S2214-109X(14)70329-8;n=48;48;-1
S2214-109X(14)70329-8;18 were enrolled;18;-1
S2214-109X(14)70330-4;67 500 cases in pregnant women;67500;-1
S2214-109X(14)70330-4;4 For pregnant women;4;-1
S2214-109X(14)70330-4;1000   pregnant women;1000;-1
S2214-109X(14)70330-4;1000 pregnant women;1000;-1
S2214-109X(14)70330-4;200 000 pregnant   women;200000;-1
S2214-109X(14)70331-6;1000 people;1000;-1
S2214-109X(14)70331-6;100 000 people;100000;-1
S2214-109X(14)70338-9;3 million women;3;-1
S2214-109X(14)70339-0;103 patients;103;-1
S2214-109X(14)70355-9;125 million girls and women;125;-1
S2214-109X(15)70024-0;1400 individuals;1400;-1
S2215-0366(14)00073-X;260 participants;260;-1
S2215-0366(14)00073-X;6  Eligible participants;6;-1
S2215-0366(14)00073-X;173 participants;173;-1
S2215-0366(14)00073-X;84 patients;84;-1
S2215-0366(14)00073-X;n=200;200;-1
S2215-0366(14)00073-X;n=260;260;-1
S2215-0366(14)00073-X;n=183;183;-1
S2215-0366(14)00073-X;n=87;87;-1
S2215-0366(14)00073-X;n=172;172;-1
S2215-0366(14)00073-X;n=173;173;-1
S2215-0366(14)00073-X;n=86;86;-1
S2215-0366(14)00073-X;n=171;171;-1
S2215-0366(14)00073-X;n=84;84;-1
S2215-0366(14)00073-X;n=165;165;-1
S2215-0366(14)00073-X;n=242;242;-1
S2215-0366(14)00073-X;n=232;232;-1
S2215-0366(14)00073-X;n=67;67;-1
S2215-0366(14)00073-X;n=64;64;-1
S2215-0366(14)00073-X;n=138;138;-1
S2215-0366(14)00073-X;n=132;132;-1
S2215-0366(14)00073-X;n=209;209;-1
S2215-0366(14)00073-X;n=192;192;-1
S2215-0366(14)00073-X;n=61;61;-1
S2215-0366(14)00073-X;n=55;55;-1
S2215-0366(14)00073-X;n=121;121;-1
S2215-0366(14)00073-X;n=113;113;-1
S2215-0366(14)00073-X;n=189;189;-1
S2215-0366(14)00073-X;n=53;53;-1
S2215-0366(14)00073-X;n=49;49;-1
S2215-0366(14)00073-X;n=114;114;-1
S2215-0366(14)00073-X;n=95;95;-1
S2215-0366(14)00073-X;n=174;174;-1
S2215-0366(14)00073-X;n=168;168;-1
S2215-0366(14)00073-X;n=47;47;-1
S2215-0366(14)00073-X;n=176;176;-1
S2215-0366(14)00073-X;n=163;163;-1
S2215-0366(14)00073-X;n=161;161;-1
S2215-0366(14)00073-X;n=157;157;-1
S2215-0366(14)00073-X;n=147;147;-1
S2215-0366(14)00073-X;n=145;145;-1
S2215-0366(14)00073-X;n=141;141;-1
S2215-0366(14)00073-X;n=140;140;-1
S2215-0366(14)00073-X;n=134;134;-1
S2215-0366(14)00073-X;n=131;131;-1
S2215-0366(14)00073-X;n=129;129;-1
S2215-0366(14)00073-X;n=127;127;-1
S2215-0366(14)00073-X;n=208;208;-1
S2215-0366(14)00073-X;n=199;199;-1
S2215-0366(14)00073-X;n=247;247;-1
S2215-0366(14)00073-X;n=206;206;-1
S2215-0366(14)00073-X;n=197;197;-1
S2215-0366(14)00073-X;n=213;213;-1
S2215-0366(14)00073-X;n=204;204;-1
S2215-0366(14)00073-X;n=190;190;-1
S2215-0366(14)00073-X;n=184;184;-1
S2215-0366(14)00073-X;n=179;179;-1
S2215-0366(14)00073-X;260 enrolled;260;-1
S2215-0366(14)00079-0;8692 patients;8692;-1
S2215-0366(14)00079-0;918 patients;918;-1
S2215-0366(14)00079-0;10 million   patients;10;-1
S2215-0366(14)00079-0;17 All patients;17;-1
S2215-0366(14)00079-0;1 685 430 334 250  Number of patients;1,68543E+12;-1
S2215-0366(14)00079-0;26 Eligible patients;26;-1
S2215-0366(14)00079-0;8692 registered patients;8692;-1
S2215-0366(14)00079-0;918   registered patients;918;-1
S2215-0366(14)00079-0;5256 patients;5256;-1
S2215-0366(14)00079-0;771 patients;771;-1
S2215-0366(14)00079-0;2034 patients;2034;-1
S2215-0366(14)00079-0;9610 patients;9610;-1
S2215-0366(14)00079-0;n=4645;4645;-1
S2215-0366(14)00079-0;n=611;611;-1
S2215-0366(14)00079-0;n=1119;1119;-1
S2215-0366(14)00079-0;n=325;325;-1
S2215-0366(14)00079-0;n=659;659;-1
S2215-0366(14)00079-0;n=112;112;-1
S2215-0366(14)00079-0; data, from 2009;2009;-1
S2215-0366(14)70223-8;2058 women;2058;-1
S2215-0366(14)70223-8;9676 women;9676;-1
S2215-0366(14)70223-8;24 297 patients;24297;-1
S2215-0366(14)70223-8;1 we have included both outpatients;1;-1
S2215-0366(14)70223-8;24 297 people;24297;-1
S2215-0366(14)70223-8;24 827 people;24827;-1
S2215-0366(14)70223-8;n=485 940;485940;-1
S2215-0366(14)70223-8;n=26 357;26357;-1
S2215-0366(14)70223-8;n=7 238 800;7238800;-1
S2215-0366(14)70223-8;n=14 621;14621;-1
S2215-0366(14)70223-8;n=9676;9676;-1
S2215-0366(14)70223-8;n=24 297;24297;-1
S2215-0366(14)70223-8;n=8003;8003;-1
S2215-0366(14)70223-8;n=280;280;-1
S2215-0366(14)70223-8;n=590;590;-1
S2215-0366(14)70223-8;n=0;0;-1
S2215-0366(14)70223-8; datapoints from 1979;1979;-1
S2215-0366(14)70235-4;n=911;911;-1
S2215-0366(14)70235-4;n=1822;1822;-1
S2215-0366(14)70235-4;n=946;946;-1
S2215-0366(14)70235-4;n=1707;1707;-1
S2215-0366(14)70235-4;n=937;937;-1
S2215-0366(14)70235-4;n=2013;2013;-1
S2215-0366(14)70243-3;1 represents individuals;1;-1
S2215-0366(14)70243-3;2 represents individuals;2;-1
S2215-0366(14)70243-3;1=individuals;1;-1
S2215-0366(14)70243-3;2=individuals;2;-1
S2215-0366(14)70243-3;n=1897;1897;-1
S2215-0366(14)70243-3;n=1729;1729;-1
S2215-0366(14)70243-3;n=1703;1703;-1
S2215-0366(14)70243-3;n=1751;1751;-1
S2215-0366(14)70243-3;n=1745;1745;-1
S2215-0366(14)70243-3;n=1741;1741;-1
S2215-0366(14)70243-3;n=1717;1717;-1
S2215-0366(14)70243-3;n=1727;1727;-1
S2215-0366(14)70243-3; data from the 2003;2003;-1
S2215-0366(14)70244-5;1448 eligible participants;1448;-1
S2215-0366(14)70244-5;n=497;497;-1
S2215-0366(14)70244-5;n=509;509;-1
S2215-0366(14)70244-5;n=442;442;-1
S2215-0366(14)70244-5;n=268;268;-1
S2215-0366(14)70244-5;N=489;489;-1
S2215-0366(14)70244-5;N=472;472;-1
S2215-0366(14)70244-5;N=401;401;-1
S2215-0366(14)70244-5;n=489;489;-1
S2215-0366(14)70244-5;n=449;449;-1
S2215-0366(14)70244-5;n=472;472;-1
S2215-0366(14)70244-5;n=436;436;-1
S2215-0366(14)70244-5;n=401;401;-1
S2215-0366(14)70244-5;n=372;372;-1
S2215-0366(14)70244-5;45 schools were enrolled;45;-1
S2215-0366(14)70244-5;45 schools enrolled;45;-1
S2215-0366(14)70244-5;45 schools were   enrolled;45;-1
S2215-0366(14)70246-9;26 million people;26;-1
S2215-0366(14)70247-0;197 participants;197;-1
S2215-0366(14)70247-0;85 participants;85;-1
S2215-0366(14)70247-0;676 participants;676;-1
S2215-0366(14)70247-0;98 participants;98;-1
S2215-0366(14)70247-0;197   participants;197;-1
S2215-0366(14)70247-0;136 participants;136;-1
S2215-0366(14)70247-0;86 participants;86;-1
S2215-0366(14)70247-0;676 patients;676;-1
S2215-0366(14)70247-0;100 individuals;100;-1
S2215-0366(14)70247-0;n=98;98;-1
S2215-0366(14)70247-0;n=99;99;-1
S2215-0366(14)70247-0;n=119;119;-1
S2215-0366(14)70247-0;n=34;34;-1
S2215-0366(14)70247-0;n=42;42;-1
S2215-0366(14)70247-0;n=11;11;-1
S2215-0366(14)70247-0;n=5;5;-1
S2215-0366(14)70247-0;n=9;9;-1
S2215-0366(14)70247-0;n=14;14;-1
S2215-0366(14)70247-0;n=26;26;-1
S2215-0366(14)70247-0;n=197;197;-1
S2215-0366(14)70247-0;n=178;178;-1
S2215-0366(14)70247-0;n=191;191;-1
S2215-0366(14)70247-0;n=95;95;-1
S2215-0366(14)70247-0;n=96;96;-1
S2215-0366(14)70247-0;n=195;195;-1
S2215-0366(14)70247-0;n=97;97;-1
S2215-0366(14)70247-0;n=194;194;-1
S2215-0366(14)70247-0;n=196;196;-1
S2215-0366(14)70247-0;n=193;193;-1
S2215-0366(14)70247-0;n= 197;197;-1
S2215-0366(14)70247-0;n=87;87;-1
S2215-0366(14)70247-0;n=85;85;-1
S2215-0366(14)70247-0;n=75;75;-1
S2215-0366(14)70247-0;n=81;81;-1
S2215-0366(14)70247-0;n=86;86;-1
S2215-0366(14)70247-0;n=76;76;-1
S2215-0366(14)70247-0;n=82;82;-1
S2215-0366(14)70247-0;n=84;84;-1
S2215-0366(14)70247-0;n=89;89;-1
S2215-0366(14)70247-0;n=83;83;-1
S2215-0366(14)70247-0;n=77;77;-1
S2215-0366(14)70247-0;n=88;88;-1
S2215-0366(14)70247-0;n=78;78;-1
S2215-0366(14)70247-0;n=80;80;-1
S2215-0366(14)70247-0;n=79;79;-1
S2215-0366(14)70247-0;n= 86;86;-1
S2215-0366(14)70247-0;n=74;74;-1
S2215-0366(14)70247-0;n=73;73;-1
S2215-0366(14)70248-2;118 women;118;-1
S2215-0366(14)70248-2;26 adult   psychiatric patients;26;-1
S2215-0366(14)70248-2;1200 patients;1200;-1
S2215-0366(14)70248-2;102 young people;102;-1
S2215-0366(14)70248-2;374 adults;374;-1
S2215-0366(14)70248-2;42 adults;42;-1
S2215-0366(14)70248-2;n=78;78;-1
S2215-0366(14)70248-2;n=38;38;-1
S2215-0366(14)70248-2;n=116;116;-1
S2215-0366(14)70248-2;n=256;256;-1
S2215-0366(14)70248-2;n=118;118;-1
S2215-0366(14)70248-2;n=374;374;-1
S2215-0366(14)70305-0;45 unmedicated participants;45;-1
S2215-0366(14)70305-0;15 of these   patients;15;-1
S2215-0366(14)70305-0;45 unmedicated people;45;-1
S2215-0366(14)70305-0;10 In people;10;-1
S2215-0366(14)70305-0;n=5;5;-1
S2215-0366(14)70305-0;n=1;1;-1
S2215-0366(14)70305-0;n= 22;22;-1
S2215-0366(14)70305-0;n=23;23;-1
S2215-0366(14)70305-0;n=15;15;-1
S2215-0366(14)70313-X;21 151 patients;21151;-1
S2215-0366(14)70313-X;1538 patients;1538;-1
S2215-0366(14)70313-X;26 570 patients;26570;-1
S2215-0366(14)70313-X;5510 patients;5510;-1
S2215-0366(14)70313-X;21 151 screened patients;21151;-1
S2215-0366(14)70313-X;1599 patients;1599;-1
S2215-0366(14)70313-X;26 Of the patients;26;-1
S2215-0366(14)70313-X;10 071 patients;10071;-1
S2215-0366(14)70313-X;33   some patients;33;-1
S2215-0366(14)70313-X;3 million people;3;-1
S2215-0366(14)70313-X;4 million people;4;-1
S2215-0366(14)70313-X;N=21 151;21151;-1
S2215-0366(14)70313-X;N=4316;4316;-1
S2215-0366(14)70313-X;N=3010;3010;-1
S2215-0366(14)70313-X;N=8461;8461;-1
S2215-0366(14)70313-X;N=3355;3355;-1
S2215-0366(14)70313-X;N=2009;2009;-1
S2215-0366(14)70313-X;n  =4;4;-1
S2215-0366(14)70313-X;n  =8;8;-1
S2215-0366(14)70313-X;n  =2;2;-1
S2215-0366(14)70313-X;n  =3;3;-1
S2215-0366(14)70313-X;n=701;701;-1
S2215-0366(14)70313-X;n=1130;1130;-1
S2215-0366(14)70313-X;n=408;408;-1
S2215-0366(14)70329-3;13 164 participants;13164;-1
S2215-0366(14)70329-3;14 229 participants;14229;-1
S2215-0366(14)70329-3;839 participants;839;-1
S2215-0366(14)70329-3;156 participants;156;-1
S2215-0366(14)70329-3;23   and participants;23;-1
S2215-0366(14)70329-3;30 people;30;-1
S2215-0366(14)70329-3;125 people;125;-1
S2215-0366(14)70329-3;n=29;29;-1
S2215-0366(14)70329-3;n=20;20;-1
S2215-0366(14)70329-3;n=2;2;-1
S2215-0366(14)70329-3;n=1;1;-1
S2215-0366(14)70329-3;n=64;64;-1
S2215-0366(14)70329-3;n=28;28;-1
S2215-0366(14)70329-3;n=7;7;-1
S2215-0366(14)70329-3;n=148;148;-1
S2215-0366(14)70329-3;n=4043;4043;-1
S2215-0366(14)70329-3;n=999;999;-1
S2215-0366(14)70329-3;n=3312;3312;-1
S2215-0366(14)70351-7;100 trials and thousands   of patients;100;-1
S2215-0366(14)70361-X;1866 women;1866;-1
S2215-0366(14)70361-X;1012 women;1012;-1
S2215-0366(14)70361-X;n=1190;1190;-1
S2215-0366(14)70361-X;n=645;645;-1
S2215-0366(14)70361-X;n=164;164;-1
S2215-0366(14)70361-X;n=481;481;-1
S2215-0366(14)70375-X;3273 women;3273;-1
S2215-0366(14)70375-X;3273 women were   enrolled;3273;-1
S2352-3018(14)70001-3;5112 HIV-diagnosed men and   women;5112;-1
S2352-3018(14)70001-3;3258 patients;3258;-1
S2352-3018(14)70001-3;1138 individuals;1138;-1
S2352-3018(14)70001-3;5112 individuals;5112;-1
S2352-3018(14)70001-3;2248 individuals;2248;-1
S2352-3018(14)70001-3;68 individuals;68;-1
S2352-3018(14)70001-3;n=68;68;-1
S2352-3018(14)70001-3;n=503;503;-1
S2352-3018(14)70001-3;n=540;540;-1
S2352-3018(14)70001-3;N=1138;1138;-1
S2352-3018(14)70001-3;N=353;353;-1
S2352-3018(14)70001-3;n=388;388;-1
S2352-3018(14)70001-3;N=1527;1527;-1
S2352-3018(14)70007-4;6 Drug use might make people;6;-1
S2352-3018(14)70018-9;3258 of participants;3258;-1
S2352-3018(14)70018-9;8503 participants;8503;-1
S2352-3018(14)70018-9;3258 participants;3258;-1
S2352-3018(14)70018-9;3258 people;3258;-1
S2352-3018(14)70018-9;8503 people;8503;-1
S2352-3018(14)70018-9;n=170;170;-1
S2352-3018(14)70018-9;n=3151;3151;-1
S2352-3018(14)70018-9;n=7424;7424;-1
S2352-3018(14)70018-9; data from 2009;2009;-1
Doc10;total of 17;17;-1
Doc12;252 participants;252;12267
Doc12;6 subjects;6;12290
Doc12; data from  236;236;18193
Doc13;N = 8;8;-1
Doc13;N = 8401151 411;8401151411;-1
Doc13;n = 51101;51101;-1
Doc13;n = 101151;101151;-1
Doc13;n= 5;5;-1
Doc13;n= 5011001;5011001;-1
Doc13;n= 4;4;-1
Doc13;n =  3141;3141;-1
Doc13;total of 900;900;-1
Doc13;total  of 11,700;11700;-1
Doc16;n = 20;20;-1
Doc16;n = 21;21;-1
Doc16;N = 71;71;-1
Doc16;n = 10;10;-1
Doc16;n= 20;20;-1
Doc16;n = 48;48;-1
Doc16;N = 639;639;-1
Doc16;total of 306;306;-1
Doc16;total of 639;639;-1
Doc2;total of 97,226;97226;3434
Doc8;57 participants;57;-1
Doc8;28 participants;28;-1
Doc8;112 participants;112;-1
Doc8;N = 6;6;-1
Doc8;N = 22;22;-1
Doc8;N = 52;52;-1
Doc8;N = 82;82;-1
Doc8;N = 99;99;-1
Doc8;N = 117;117;-1
Doc9;15 To avoid subjects;15;-1
Doc9;101 subjects;101;-1
Doc9;0 subjectsa subjects;0;-1
Doc9;6 subjects;6;-1
Doc9;19 subjects;19;-1
Doc9;8 subjects;8;-1
Doc9;7 subjects;7;-1
Doc9;5 subjects;5;-1
Doc9;2 subjects;2;-1
Doc9;24 subjects;24;-1
Doc9;16 subjects;16;-1
Doc9;40 subjects;40;-1
Doc9;48 subjects;48;-1
Doc9;64 subjects;64;-1
Doc9;47 subjects;47;-1
Doc9;97 subjects;97;-1
Doc9;90 subjectsb subjects;90;-1
Doc9;11 subjects;11;-1
Doc9;90 subjects;90;-1
Doc9;total of 47;47;-1
Doc1; data from 445;445;-1
Doc10;n= 2;2;-1
Doc10;total of 120;120;-1
Doc10;total of 3,671;3671;-1
Doc10;total of 134;134;-1
Doc10;total of 949;949;-1
Doc12;266 subjects;266;-1
Doc12; data from C0;0;-1
Doc2;1,000 people;1000;-1
Doc2;10,000 people;10000;-1
Doc2;5 people;5;-1
Doc2;506 English-  speaking adults;506;-1
Doc2;N = 23,422;23422;-1
Doc2;N = 328,351;328351;-1
Doc2;N = 84,982;84982;-1
Doc2;N = 167,241;167241;-1
Doc2;N = 475;475;-1
Doc2;N = 477;477;-1
Doc2;N = 483;483;-1
Doc2;N = 373;373;-1
Doc2;N = 410;410;-1
Doc2;N = 455;455;-1
Doc2;N = 370;370;-1
Doc3;n = 41270;41270;-1
Doc3;n = 507;507;-1
Doc3;n = 803;803;-1
Doc3;total of  18;18;-1
Doc3; data for each of the 445;445;-1
Doc3; data from 445;445;-1
Doc3; data from 451;451;-1
Doc4;n = 2;2;-1
Doc5;16  Ninety-six participants;16;-1
Doc5;928 subjects;928;-1
Doc5;N = 104;104;-1
Doc5;n = 64;64;-1
Doc5;n = 40;40;-1
Doc5;N = 136;136;-1
Doc5;n = 44;44;-1
Doc5;n = 52;52;-1
Doc5;N = 140;140;-1
Doc5;n = 60;60;-1
Doc5;n = 24;24;-1
Doc5;n = 56;56;-1
Doc5;N = 92;92;-1
Doc5;n = 48;48;-1
Doc5;N = 80;80;-1
Doc5;N = 96;96;-1
Doc5;n = 32;32;-1
Doc5;N = 84;84;-1
Doc5;N = 116;116;-1
Doc5;n = 80;80;-1
Doc6;total of 3,601;3601;-1
Doc6;total of 20;20;-1
Doc7;61 female salespeople;61;-1
Doc7;10 salespeople;10;-1
Doc7;3 salespeople;3;-1
Doc7;6 compensating salespeople;6;-1
Doc7;600 and two low-ability salespeople;600;-1
Doc7;26 salespeople;26;-1
Doc9;2005  classes linking subjects;2005;-1
Doc9;10 subjects;10;-1
Doc9;7 subjects;7;-1
Doc9;16 subjects;16;-1
Doc9;5 subjects;5;-1
Doc9;36 subjects;36;-1
Doc9;53 subjects;53;-1
Doc10;3,181 unique  individuals;3181;-1
Doc10;20 individuals;20;-1
Doc10;n = 607;607;-1
Doc10;n = 303;303;-1
Doc10;total of 40;40;-1
Doc14;n = 291;291;-1
Doc14;total of 651;651;-1
Doc3;n=110001;110001;-1
Doc3;n = 8;8;-1
Doc3;n= 11;11;-1
Doc3;n=1;1;-1
Doc3;n=161;161;-1
Doc5;n = 5;5;-1
Doc6;n = 5;5;-1
Doc6;n= 1;1;-1
Doc9;N = 54;54;-1
Doc9;n = 30;30;-1
Doc9;n = 0013;13;-1
Doc11;20  Unframed men  Unframed women;20;-1
Doc11;33 women;33;-1
Doc11;66 subjects;66;-1
Doc11; data from 19;19;-1
Doc14;n = 0017;17;-1
Doc14; data from 2005;2005;-1
Doc17; data from 1964;1964;-1
Doc2;500 people;500;-1
Doc2;total of 344;344;-1
Doc3;226 participants;226;-1
Doc3;4  We provided participants;4;-1
Doc3;82 novels and required participants;82;-1
Doc3;215 participants;215;-1
Doc3;5 Two participants;5;-1
Doc3;1 averages exclude participants;1;-1
Doc3;212 participants;212;-1
Doc3;211 participants;211;-1
Doc3;137 participants;137;-1
Doc3;3 We first sorted individuals;3;-1
Doc3;233 undergraduates were recruited;233;-1
Doc3;n = 75;75;-1
Doc3;n= 75;75;-1
Doc3;n= 76;76;-1
Doc3;n = 0;0;-1
Doc3;N = 226;226;-1
Doc3;N = 76;76;-1
Doc3;N = 75;75;-1
Doc3;N = 215;215;-1
Doc3;N = 89;89;-1
Doc3;N = 72;72;-1
Doc3;N = 66;66;-1
Doc3;N = 71;71;-1
Doc3;N = 70;70;-1
Doc3;N = 65;65;-1
Doc3;N = 695;695;-1
Doc4;n= 1;1;-1
Doc4;n = 114;114;-1
Doc4;n= 4;4;-1
Doc4;n = 1;1;-1
Doc4;n = 4;4;-1
Doc6;N = 1,944;1944;-1
Doc6; data from 2006;2006;-1
Doc8;n = 111777;111777;12447
Doc8;n = 111175;111175;12144
Doc8;n = 91431;91431;11820
Doc8;n =  71196;71196;11622
Doc8;n= 355;355;11537
Doc8;n = 45;45;10342
Doc8;n= 202;202;9671
Doc10;n = 8;8;-1
Doc10;n = 4;4;-1
Doc10;n = 2;2;-1
Doc10;n = 0;0;-1
Doc10;n = 1;1;-1
Doc10;n = 1121;1121;-1
Doc10;N = 50;50;-1
Doc10;n= 2;2;-1
Doc10;N = 2;2;-1
Doc10;N = 10;10;-1
Doc10;n =  1;1;-1
Doc10;n =  4;4;-1
Doc11;2304  Unemployed persons;2304;-1
Doc11;15404  Unemployed persons;15404;-1
Doc11;31 and unemployed persons;31;-1
Doc11;4002465  Unemployed persons;4002465;-1
Doc11;4001315  Unemployed persons;4001315;-1
Doc12;n = 1;1;-1
Doc12;N = 2;2;-1
Doc3;total of 105;105;-1
Doc4;2014 INFORMS  participants;2014;-1
Doc4;585 participants;585;-1
Doc4;1 leads  people;1;-1
Doc4;15 individuals;15;-1
Doc4;51  some individuals;51;-1
Doc4;N = 21806;21806;-1
Doc4;total of 585;585;-1
Doc7;n = 2;2;-1
Doc7;N = 12,842;12842;-1
Doc7;N = 4,631;4631;-1
Doc8;n = 1;1;-1
Doc8;n=1;1;-1
Doc8;n= 05;5;-1
Doc8;n = 0;0;-1
Doc8;n = 8;8;-1
Doc8;n= 011121;11121;-1
Doc8;n = 4;4;-1
Doc8;n = 0001;1;-1
Doc8;n = 05;5;-1
Doc9;N = 10;10;-1
Doc9;N  =  1;1;-1
Doc9;n = 8;8;-1
Doc10;N = 14;14;-1
Doc10;n = 0;0;-1
Doc13;N = 61002;61002;-1
Doc14;35 subjects;35;13328
Doc14;1 subjects;1;10031
Doc14;70 subjects;70;1809
Doc14;22 subjects;22;3129
Doc14;33 subjects;33;3233
Doc14;46 subjects;46;10836
Doc14;50 subjects;50;16810
Doc3;total of  900;900;-1
Doc3;total of 969,033;969033;-1
Doc3;total of 25;25;-1
Doc3;total of 56;56;-1
Doc4;23 people;23;17946
Doc4; data starting from 2002;2002;43380
Doc6;n = 3801982;3801982;-1
Doc6;n = 131536;131536;-1
Doc6;total of 13,536;13536;-1
Doc8;N = 104;104;-1
Doc8;N = 101;101;-1
Doc8;N = 108;108;-1
Doc8;total of  11;11;-1
Doc9;75 women;75;25803
Doc9;15 participants;15;28662
Doc9;14 We generate participants;14;17841
Doc9;21 different scenarios where participants;21;12962
Doc9;104 participants;104;4723
Doc9;1,000 people;1000;4392
Doc9;10 people;10;4964
Doc9;N = 17;17;3297
Doc9;N = 10;10;3339
Doc9;N = 12;12;3422
Doc9;total of 21;21;24786
Doc11;total of 500;500;-1
Doc11;total of 6,000;6000;-1
Doc11;total of 3,500;3500;-1
Doc11;total of 74;74;-1
Doc12;n = 215;215;-1
Doc12;n = 441;441;-1
Doc12;n= 215;215;-1
Doc12;n = 1;1;-1
Doc12;n = 5110120;5110120;-1
Doc13;n= 011121;11121;-1
Doc13;total of 143;143;-1
Doc14;n = 00256;256;-1
Doc14;n = 00536;536;-1
Doc14;n = 00214;214;-1
Doc14; data consist of 11;11;-1
Doc15;2009 Suruga recruited;2009;-1
Doc15;n = 8;8;-1
Doc15;n = 1;1;-1
Doc15;n = 0;0;-1
Doc15;n = 2;2;-1
Doc15;n = 3;3;-1
Doc15;n = 4;4;-1
Doc15;n = 15;15;-1
Doc15;n  =  40;40;-1
Doc15;n=1;1;-1
Doc15;total of 40,000;40000;-1
Doc15;total of 2,000;2000;-1
Doc3; data from 7,730;7730;-1
Doc4;n=1;1;34573
Doc5;2,179 individuals;2179;-1
Doc5;10,000 individuals;10000;-1
Doc5;1,000 individuals out of all individuals;1000;-1
Doc5;1,000 individuals;1000;-1
Doc5;1,000 selected individuals;1000;-1
Doc5;1,000  individuals;1000;-1
Doc5;n= 0;0;-1
Doc6;n = 31709;31709;-1
Doc6;N = 1081257;1081257;-1
Doc6;n = 11457;11457;-1
Doc6;N = 421887;421887;-1
Doc6;n = 286;286;-1
Doc6;N = 81342;81342;-1
Doc6;n = 0;0;-1
Doc6;n = 005;5;-1
Doc6;n = 009;9;-1
Doc7;130 subjects;130;-1
Doc7;total of 210;210;-1
Doc7;total of 83;83;-1
Doc7;total  of 79;79;-1
Doc8;5 Website participants;5;-1
Doc8;N = 11692;11692;-1
Doc8;N = 118;118;-1
Doc8;N = 298;298;-1
Doc8;N = 92;92;-1
Doc8;N = 11184;11184;-1
Doc8;N = 392;392;-1
Doc8;N = 31;31;-1
Doc8;N = 11116;11116;-1
Doc8;N = 153;153;-1
Doc9;1,000 individuals;1000;-1
Doc9;total of 39;39;-1
Doc10;N = 81121;81121;-1
Doc10;total of  2,500;2500;-1
Doc10;total of 64;64;-1
Doc11;N = 0;0;-1
Doc11;N = 009;9;-1
Doc11;N = 4;4;-1
Doc11;N = 01;1;-1
Doc11;N  = 41;41;-1
Doc11;N =01;1;-1
Doc11;N  =2;2;-1
Doc12; data set of 100;100;-1
Doc13;11 across rounds  and participants;11;-1
Doc13;93 subjects;93;-1
Doc13;87 subjects;87;-1
Doc13;20 subjects;20;-1
Doc15;n = 0;0;-1
Doc15;n = 01;1;-1
Doc15;n =  41;41;-1
Doc15;N =  1;1;-1
Doc15;N = 41;41;-1
Doc3;120 subjects;120;-1
Doc3;5 106 subjects;5106;-1
Doc3;118 subjects;118;-1
Doc3;110 subjects;110;-1
Doc3;112 subjects;112;-1
Doc3;534 subjects;534;-1
Doc3;312 subjects;312;-1
Doc3;n = 222;222;-1
Doc3;n = 117;117;-1
Doc3;n = 165;165;-1
Doc3;n = 60;60;-1
Doc3;n = 53;53;-1
Doc3;n = 59;59;-1
Doc3;n = 55;55;-1
Doc3;n = 68;68;-1
Doc3;n = 47;47;-1
Doc3;n = 51;51;-1
Doc3;n = 29;29;-1
Doc3;n = 35;35;-1
Doc3;n = 115;115;-1
Doc3;n = 219;219;-1
Doc3;total of 534;534;-1
Doc3;total of 312;312;-1
Doc4;18 participants;18;-1
Doc4;36 subjects;36;-1
Doc4;38 subjects;38;-1
Doc4;N = 1;1;-1
Doc4;N = 0;0;-1
Doc4;total of 146;146;-1
Doc4;total of 36;36;-1
Doc4;total of 38;38;-1
Doc4;total of 16;16;-1
Doc5;1 What people;1;-1
Doc5;n = 3;3;-1
Doc6;N = 48;48;-1
Doc6;N = 49;49;-1
Doc6;N = 30;30;-1
Doc9;total of 98;98;66960
Doc10;N = 2;2;-1
Doc10;N = 8;8;-1
Doc10;N = 4;4;-1
Doc10;N = 0;0;-1
Doc11;n=1;1;-1
Doc12;n = 30;30;-1
Doc12;n = 9;9;-1
Doc12;n = 0;0;-1
Doc12;n = 1;1;-1
Doc14;N = 236;236;-1
Doc14;N = 520;520;-1
Doc14;N = 40;40;-1
Doc14;N = 2,800;2800;-1
Doc14;N = 7,120;7120;-1
Doc14;N = 21800;21800;-1
Doc14;N = 85;85;-1
Doc14;N = 321;321;-1
Doc15;n= 7;7;-1
Doc15;n = 8;8;-1
Doc15;n = 7;7;-1
Doc16;310 subjects;310;-1
Doc16;269 of these  subjects;269;-1
Doc16;41 subjects;41;-1
Doc16;total of 310;310;-1
Doc2; data from the 2005;2005;-1
Doc3;27 participants;27;-1
Doc3;1099  individuals;1099;-1
Doc3;N = 737;737;-1
Doc3;n = 123;123;-1
Doc3;n = 51152;51152;-1
Doc3;n= 15;15;-1
Doc3;n= 11559;11559;-1
Doc3;n = 33;33;-1
Doc3;n =  640;640;-1
Doc3;n = 49;49;-1
Doc3;n = 11458;11458;-1
Doc3;n = 8;8;-1
Doc3;n = 346;346;-1
Doc4;100 subjects;100;-1
Doc4;98,278 subjects;98278;-1
Doc4;79,680 subjects;79680;-1
Doc4;128,690 individual-wave subjects;128690;-1
Doc4;3,493 subjects;3493;-1
Doc4;1,283 informed-  of-reward subjects;1283;-1
Doc4;1 million people;1;-1
Doc4;92,722 individuals;92722;-1
Doc4;35,968 individuals;35968;-1
Doc4;328 individuals;328;-1
Doc4;9 extra noncontacted individuals;9;-1
Doc4;100 individuals;100;-1
Doc4;100 contacted individuals;100;-1
Doc4;N = 3,516;3516;-1
Doc4;N = 89,206;89206;-1
Doc4;N = 79,317;79317;-1
Doc4;N = 92,722;92722;-1
Doc4;N = 2,939;2939;-1
Doc4;N = 12;12;-1
Doc4;N = 108;108;-1
Doc5;11 Using subjects;11;36645
Doc5;40 independent pairs of subjects;40;8115
Doc5;1 If people;1;56240
Doc7;300 individuals;300;-1
Doc7;n = 007;7;-1
Doc8;total  of 32;32;-1
Doc11;n = 741262;741262;-1
Doc11;n = 441550;441550;-1
Doc11;n = 601657;601657;-1
Doc11;n = 81087;81087;-1
Doc11;n = 241502;241502;-1
Doc11;  data set of 212,058;212058;-1
Doc11;  database of 697,456;697456;-1
Doc12;N = 8;8;-1
Doc12;N = 3;3;-1
Doc12;n= 256;256;-1
Doc12;n= 10;10;-1
Doc13;147 subjects;147;-1
Doc13;n = 19;19;-1
Doc13;total of 276;276;-1
Doc2;total of 40;40;-1
Doc3;N = 43;43;1721
Doc4;40 participants;40;-1
Doc4;29  participants;29;-1
Doc4;30 participants;30;-1
Doc4;344 subjects;344;-1
Doc4;N = 42;42;-1
Doc4;N = 40;40;-1
Doc4;N = 29;29;-1
Doc4;total of 344;344;-1
Doc6;N  =  1;1;-1
Doc6;N  =  4;4;-1
Doc6;N = 12;12;-1
Doc6;N  = 4;4;-1
Doc6;n= 5;5;-1
Doc6;n= 1;1;-1
Doc6;n= 2;2;-1
Doc6;N = 4;4;-1
Doc7;n= 25;25;-1
Doc7;n= 2;2;-1
Doc8;total of 43;43;984
Doc10;6 For four subjects;6;-1
Doc10;N = 00;0;-1
Doc10;N =00;0;-1
Doc10;N = 20;20;-1
Doc10;N = 0;0;-1
Doc10;total of 50;50;-1
Doc11;3 Their patients;3;-1
Doc11;n= 0;0;-1
Doc11;N = 87;87;-1
Doc11; data from 35;35;-1
Doc12;52 participants;52;-1
Doc12;53 participants;53;-1
Doc12;49 participants;49;-1
Doc12;1 examines people;1;-1
Doc12;2014 INFORMS  help people;2014;-1
Doc12;n = 1;1;-1
Doc12;N = 0;0;-1
Doc13;N = 811;811;-1
Doc13;N = 8112139;8112139;-1
Doc13;n= 15;15;-1
Doc13;n= 30;30;-1
Doc13;total of 12;12;-1
Doc14;N  =  44;44;-1
Doc14;total of 9,734;9734;-1
Doc3;N = 81121;81121;-1
Doc5;79  aAll participants;79;-1
Doc5;2455  participants;2455;-1
Doc5;12 pairs of participants;12;-1
Doc5;N = 1;1;-1
Doc6;2014 INFORMS  patients;2014;-1
Doc7; data  only from 1986;1986;-1
Doc8; database of 13;13;6549
Doc10;N = 11810;11810;1933
Doc10;N = 11469;11469;1451
Doc10;  database from 2002;2002;22694
Doc10; data from 1967;1967;30832
Doc10; data from 1997;1997;31011
Doc10; data from 1962;1962;32646
Doc11;n = 15;15;-1
Doc13;n = 7;7;-1
Doc13;n = 25;25;-1
Doc13;n = 55;55;-1
Doc13;n = 12;12;-1
Doc13;N =  112,857;112857;-1
Doc13;N = 576,640;576640;-1
Doc14;39 individuals;39;-1
Doc14;30 ran-  domly chosen individuals;30;-1
Doc14;16 individuals;16;-1
Doc14;N = 90;90;-1
Doc14;total of 158;158;-1
Doc14;total  of 39;39;-1
Doc14;total of 16;16;-1
Doc14;45 students enrolled;45;-1
Doc14;2014 INFORMS  currently enrolled;2014;-1
Doc15;12 million people;12;-1
Doc15;total of 85,168;85168;-1
Doc2;2,486 individuals;2486;-1
Doc3;N = 585;585;-1
Doc3;n = 45;45;-1
Doc3;total of 466,830;466830;-1
Doc4;5 evolves as people;5;-1
Doc4;490 individuals;490;-1
Doc4;490 selected individuals;490;-1
Doc4;3 is not because  individuals;3;-1
Doc4;5 captures individuals;5;-1
Doc4;7 is common  across individuals;7;-1
Doc4;27 is heterogeneous across  individuals;27;-1
Doc4;160  individuals;160;-1
Doc5;n = 41;41;-1
Doc5;n =  61;61;-1
Doc5;n =  41;41;-1
Doc7;10 To allow subjects;10;-1
Doc7;36 subjects;36;-1
Doc7;32 subjects;32;-1
Doc7;17 When subjects;17;-1
Doc7;16 Three subjects;16;-1
Doc7;9,681  Number of subjects;9681;-1
Doc7;12,120  Number of subjects;12120;-1
Doc7;3,957  Number of subjects;3957;-1
Doc7;77 subjects;77;-1
Doc7;total of 104;104;-1
Doc7;total of 36;36;-1
Doc10;total of 17;17;-1
Doc12;252 participants;252;12267
Doc12;6 subjects;6;12290
Doc12; data from  236;236;18193
Doc13;N = 8;8;-1
Doc13;N = 8401151 411;8401151411;-1
Doc13;n = 51101;51101;-1
Doc13;n = 101151;101151;-1
Doc13;n= 5;5;-1
Doc13;n= 5011001;5011001;-1
Doc13;n= 4;4;-1
Doc13;n =  3141;3141;-1
Doc13;total of 900;900;-1
Doc13;total  of 11,700;11700;-1
Doc16;n = 20;20;-1
Doc16;n = 21;21;-1
Doc16;N = 71;71;-1
Doc16;n = 10;10;-1
Doc16;n= 20;20;-1
Doc16;n = 48;48;-1
Doc16;N = 639;639;-1
Doc16;total of 306;306;-1
Doc16;total of 639;639;-1
Doc2;total of 97,226;97226;3434
Doc8;57 participants;57;-1
Doc8;28 participants;28;-1
Doc8;112 participants;112;-1
Doc8;N = 6;6;-1
Doc8;N = 22;22;-1
Doc8;N = 52;52;-1
Doc8;N = 82;82;-1
Doc8;N = 99;99;-1
Doc8;N = 117;117;-1
Doc9;15 To avoid subjects;15;-1
Doc9;101 subjects;101;-1
Doc9;0 subjectsa subjects;0;-1
Doc9;6 subjects;6;-1
Doc9;19 subjects;19;-1
Doc9;8 subjects;8;-1
Doc9;7 subjects;7;-1
Doc9;5 subjects;5;-1
Doc9;2 subjects;2;-1
Doc9;24 subjects;24;-1
Doc9;16 subjects;16;-1
Doc9;40 subjects;40;-1
Doc9;48 subjects;48;-1
Doc9;64 subjects;64;-1
Doc9;47 subjects;47;-1
Doc9;97 subjects;97;-1
Doc9;90 subjectsb subjects;90;-1
Doc9;11 subjects;11;-1
Doc9;90 subjects;90;-1
Doc9;total of 47;47;-1
Doc1; data from 445;445;-1
Doc10;n= 2;2;-1
Doc10;total of 120;120;-1
Doc10;total of 3,671;3671;-1
Doc10;total of 134;134;-1
Doc10;total of 949;949;-1
Doc12;266 subjects;266;-1
Doc12; data from C0;0;-1
Doc2;1,000 people;1000;-1
Doc2;10,000 people;10000;-1
Doc2;5 people;5;-1
Doc2;506 English-  speaking adults;506;-1
Doc2;N = 23,422;23422;-1
Doc2;N = 328,351;328351;-1
Doc2;N = 84,982;84982;-1
Doc2;N = 167,241;167241;-1
Doc2;N = 475;475;-1
Doc2;N = 477;477;-1
Doc2;N = 483;483;-1
Doc2;N = 373;373;-1
Doc2;N = 410;410;-1
Doc2;N = 455;455;-1
Doc2;N = 370;370;-1
Doc3;n = 41270;41270;-1
Doc3;n = 507;507;-1
Doc3;n = 803;803;-1
Doc3;total of  18;18;-1
Doc3; data for each of the 445;445;-1
Doc3; data from 445;445;-1
Doc3; data from 451;451;-1
Doc4;n = 2;2;-1
Doc5;16  Ninety-six participants;16;-1
Doc5;928 subjects;928;-1
Doc5;N = 104;104;-1
Doc5;n = 64;64;-1
Doc5;n = 40;40;-1
Doc5;N = 136;136;-1
Doc5;n = 44;44;-1
Doc5;n = 52;52;-1
Doc5;N = 140;140;-1
Doc5;n = 60;60;-1
Doc5;n = 24;24;-1
Doc5;n = 56;56;-1
Doc5;N = 92;92;-1
Doc5;n = 48;48;-1
Doc5;N = 80;80;-1
Doc5;N = 96;96;-1
Doc5;n = 32;32;-1
Doc5;N = 84;84;-1
Doc5;N = 116;116;-1
Doc5;n = 80;80;-1
Doc6;total of 3,601;3601;-1
Doc6;total of 20;20;-1
Doc7;61 female salespeople;61;-1
Doc7;10 salespeople;10;-1
Doc7;3 salespeople;3;-1
Doc7;6 compensating salespeople;6;-1
Doc7;600 and two low-ability salespeople;600;-1
Doc7;26 salespeople;26;-1
Doc9;2005  classes linking subjects;2005;-1
Doc9;10 subjects;10;-1
Doc9;7 subjects;7;-1
Doc9;16 subjects;16;-1
Doc9;5 subjects;5;-1
Doc9;36 subjects;36;-1
Doc9;53 subjects;53;-1
Doc10;3,181 unique  individuals;3181;-1
Doc10;20 individuals;20;-1
Doc10;n = 607;607;-1
Doc10;n = 303;303;-1
Doc10;total of 40;40;-1
Doc14;n = 291;291;-1
Doc14;total of 651;651;-1
Doc3;n=110001;110001;-1
Doc3;n = 8;8;-1
Doc3;n= 11;11;-1
Doc3;n=1;1;-1
Doc3;n=161;161;-1
Doc5;n = 5;5;-1
Doc6;n = 5;5;-1
Doc6;n= 1;1;-1
Doc9;N = 54;54;-1
Doc9;n = 30;30;-1
Doc9;n = 0013;13;-1
Doc11;20  Unframed men  Unframed women;20;-1
Doc11;33 women;33;-1
Doc11;66 subjects;66;-1
Doc11; data from 19;19;-1
Doc14;n = 0017;17;-1
Doc14; data from 2005;2005;-1
Doc17; data from 1964;1964;-1
Doc2;500 people;500;-1
Doc2;total of 344;344;-1
Doc3;226 participants;226;-1
Doc3;4  We provided participants;4;-1
Doc3;82 novels and required participants;82;-1
Doc3;215 participants;215;-1
Doc3;5 Two participants;5;-1
Doc3;1 averages exclude participants;1;-1
Doc3;212 participants;212;-1
Doc3;211 participants;211;-1
Doc3;137 participants;137;-1
Doc3;3 We first sorted individuals;3;-1
Doc3;233 undergraduates were recruited;233;-1
Doc3;n = 75;75;-1
Doc3;n= 75;75;-1
Doc3;n= 76;76;-1
Doc3;n = 0;0;-1
Doc3;N = 226;226;-1
Doc3;N = 76;76;-1
Doc3;N = 75;75;-1
Doc3;N = 215;215;-1
Doc3;N = 89;89;-1
Doc3;N = 72;72;-1
Doc3;N = 66;66;-1
Doc3;N = 71;71;-1
Doc3;N = 70;70;-1
Doc3;N = 65;65;-1
Doc3;N = 695;695;-1
Doc4;n= 1;1;-1
Doc4;n = 114;114;-1
Doc4;n= 4;4;-1
Doc4;n = 1;1;-1
Doc4;n = 4;4;-1
Doc6;N = 1,944;1944;-1
Doc6; data from 2006;2006;-1
Doc8;n = 111777;111777;12447
Doc8;n = 111175;111175;12144
Doc8;n = 91431;91431;11820
Doc8;n =  71196;71196;11622
Doc8;n= 355;355;11537
Doc8;n = 45;45;10342
Doc8;n= 202;202;9671
Doc10;n = 8;8;-1
Doc10;n = 4;4;-1
Doc10;n = 2;2;-1
Doc10;n = 0;0;-1
Doc10;n = 1;1;-1
Doc10;n = 1121;1121;-1
Doc10;N = 50;50;-1
Doc10;n= 2;2;-1
Doc10;N = 2;2;-1
Doc10;N = 10;10;-1
Doc10;n =  1;1;-1
Doc10;n =  4;4;-1
Doc11;2304  Unemployed persons;2304;-1
Doc11;15404  Unemployed persons;15404;-1
Doc11;31 and unemployed persons;31;-1
Doc11;4002465  Unemployed persons;4002465;-1
Doc11;4001315  Unemployed persons;4001315;-1
Doc12;n = 1;1;-1
Doc12;N = 2;2;-1
Doc3;total of 105;105;-1
Doc4;2014 INFORMS  participants;2014;-1
Doc4;585 participants;585;-1
Doc4;1 leads  people;1;-1
Doc4;15 individuals;15;-1
Doc4;51  some individuals;51;-1
Doc4;N = 21806;21806;-1
Doc4;total of 585;585;-1
Doc7;n = 2;2;-1
Doc7;N = 12,842;12842;-1
Doc7;N = 4,631;4631;-1
Doc8;n = 1;1;-1
Doc8;n=1;1;-1
Doc8;n= 05;5;-1
Doc8;n = 0;0;-1
Doc8;n = 8;8;-1
Doc8;n= 011121;11121;-1
Doc8;n = 4;4;-1
Doc8;n = 0001;1;-1
Doc8;n = 05;5;-1
Doc9;N = 10;10;-1
Doc9;N  =  1;1;-1
Doc9;n = 8;8;-1
Doc10;N = 14;14;-1
Doc10;n = 0;0;-1
Doc13;N = 61002;61002;-1
Doc14;35 subjects;35;13328
Doc14;1 subjects;1;10031
Doc14;70 subjects;70;1809
Doc14;22 subjects;22;3129
Doc14;33 subjects;33;3233
Doc14;46 subjects;46;10836
Doc14;50 subjects;50;16810
Doc3;total of  900;900;-1
Doc3;total of 969,033;969033;-1
Doc3;total of 25;25;-1
Doc3;total of 56;56;-1
Doc4;23 people;23;17946
Doc4; data starting from 2002;2002;43380
Doc6;n = 3801982;3801982;-1
Doc6;n = 131536;131536;-1
Doc6;total of 13,536;13536;-1
Doc8;N = 104;104;-1
Doc8;N = 101;101;-1
Doc8;N = 108;108;-1
Doc8;total of  11;11;-1
Doc9;75 women;75;25803
Doc9;15 participants;15;28662
Doc9;14 We generate participants;14;17841
Doc9;21 different scenarios where participants;21;12962
Doc9;104 participants;104;4723
Doc9;1,000 people;1000;4392
Doc9;10 people;10;4964
Doc9;N = 17;17;3297
Doc9;N = 10;10;3339
Doc9;N = 12;12;3422
Doc9;total of 21;21;24786
Doc11;total of 500;500;-1
Doc11;total of 6,000;6000;-1
Doc11;total of 3,500;3500;-1
Doc11;total of 74;74;-1
Doc12;n = 215;215;-1
Doc12;n = 441;441;-1
Doc12;n= 215;215;-1
Doc12;n = 1;1;-1
Doc12;n = 5110120;5110120;-1
Doc13;n= 011121;11121;-1
Doc13;total of 143;143;-1
Doc14;n = 00256;256;-1
Doc14;n = 00536;536;-1
Doc14;n = 00214;214;-1
Doc14; data consist of 11;11;-1
Doc15;2009 Suruga recruited;2009;-1
Doc15;n = 8;8;-1
Doc15;n = 1;1;-1
Doc15;n = 0;0;-1
Doc15;n = 2;2;-1
Doc15;n = 3;3;-1
Doc15;n = 4;4;-1
Doc15;n = 15;15;-1
Doc15;n  =  40;40;-1
Doc15;n=1;1;-1
Doc15;total of 40,000;40000;-1
Doc15;total of 2,000;2000;-1
Doc3; data from 7,730;7730;-1
Doc4;n=1;1;34573
Doc5;2,179 individuals;2179;-1
Doc5;10,000 individuals;10000;-1
Doc5;1,000 individuals out of all individuals;1000;-1
Doc5;1,000 individuals;1000;-1
Doc5;1,000 selected individuals;1000;-1
Doc5;1,000  individuals;1000;-1
Doc5;n= 0;0;-1
Doc6;n = 31709;31709;-1
Doc6;N = 1081257;1081257;-1
Doc6;n = 11457;11457;-1
Doc6;N = 421887;421887;-1
Doc6;n = 286;286;-1
Doc6;N = 81342;81342;-1
Doc6;n = 0;0;-1
Doc6;n = 005;5;-1
Doc6;n = 009;9;-1
Doc7;130 subjects;130;-1
Doc7;total of 210;210;-1
Doc7;total of 83;83;-1
Doc7;total  of 79;79;-1
Doc8;5 Website participants;5;-1
Doc8;N = 11692;11692;-1
Doc8;N = 118;118;-1
Doc8;N = 298;298;-1
Doc8;N = 92;92;-1
Doc8;N = 11184;11184;-1
Doc8;N = 392;392;-1
Doc8;N = 31;31;-1
Doc8;N = 11116;11116;-1
Doc8;N = 153;153;-1
Doc9;1,000 individuals;1000;-1
Doc9;total of 39;39;-1
Doc10;N = 81121;81121;-1
Doc10;total of  2,500;2500;-1
Doc10;total of 64;64;-1
Doc11;N = 0;0;-1
Doc11;N = 009;9;-1
Doc11;N = 4;4;-1
Doc11;N = 01;1;-1
Doc11;N  = 41;41;-1
Doc11;N =01;1;-1
Doc11;N  =2;2;-1
Doc12; data set of 100;100;-1
Doc13;11 across rounds  and participants;11;-1
Doc13;93 subjects;93;-1
Doc13;87 subjects;87;-1
Doc13;20 subjects;20;-1
Doc15;n = 0;0;-1
Doc15;n = 01;1;-1
Doc15;n =  41;41;-1
Doc15;N =  1;1;-1
Doc15;N = 41;41;-1
Doc3;120 subjects;120;-1
Doc3;5 106 subjects;5106;-1
Doc3;118 subjects;118;-1
Doc3;110 subjects;110;-1
Doc3;112 subjects;112;-1
Doc3;534 subjects;534;-1
Doc3;312 subjects;312;-1
Doc3;n = 222;222;-1
Doc3;n = 117;117;-1
Doc3;n = 165;165;-1
Doc3;n = 60;60;-1
Doc3;n = 53;53;-1
Doc3;n = 59;59;-1
Doc3;n = 55;55;-1
Doc3;n = 68;68;-1
Doc3;n = 47;47;-1
Doc3;n = 51;51;-1
Doc3;n = 29;29;-1
Doc3;n = 35;35;-1
Doc3;n = 115;115;-1
Doc3;n = 219;219;-1
Doc3;total of 534;534;-1
Doc3;total of 312;312;-1
Doc4;18 participants;18;-1
Doc4;36 subjects;36;-1
Doc4;38 subjects;38;-1
Doc4;N = 1;1;-1
Doc4;N = 0;0;-1
Doc4;total of 146;146;-1
Doc4;total of 36;36;-1
Doc4;total of 38;38;-1
Doc4;total of 16;16;-1
Doc5;1 What people;1;-1
Doc5;n = 3;3;-1
Doc6;N = 48;48;-1
Doc6;N = 49;49;-1
Doc6;N = 30;30;-1
Doc9;total of 98;98;66960
Doc10;N = 2;2;-1
Doc10;N = 8;8;-1
Doc10;N = 4;4;-1
Doc10;N = 0;0;-1
Doc11;n=1;1;-1
Doc12;n = 30;30;-1
Doc12;n = 9;9;-1
Doc12;n = 0;0;-1
Doc12;n = 1;1;-1
Doc14;N = 236;236;-1
Doc14;N = 520;520;-1
Doc14;N = 40;40;-1
Doc14;N = 2,800;2800;-1
Doc14;N = 7,120;7120;-1
Doc14;N = 21800;21800;-1
Doc14;N = 85;85;-1
Doc14;N = 321;321;-1
Doc15;n= 7;7;-1
Doc15;n = 8;8;-1
Doc15;n = 7;7;-1
Doc16;310 subjects;310;-1
Doc16;269 of these  subjects;269;-1
Doc16;41 subjects;41;-1
Doc16;total of 310;310;-1
Doc2; data from the 2005;2005;-1
Doc3;27 participants;27;-1
Doc3;1099  individuals;1099;-1
Doc3;N = 737;737;-1
Doc3;n = 123;123;-1
Doc3;n = 51152;51152;-1
Doc3;n= 15;15;-1
Doc3;n= 11559;11559;-1
Doc3;n = 33;33;-1
Doc3;n =  640;640;-1
Doc3;n = 49;49;-1
Doc3;n = 11458;11458;-1
Doc3;n = 8;8;-1
Doc3;n = 346;346;-1
Doc4;100 subjects;100;-1
Doc4;98,278 subjects;98278;-1
Doc4;79,680 subjects;79680;-1
Doc4;128,690 individual-wave subjects;128690;-1
Doc4;3,493 subjects;3493;-1
Doc4;1,283 informed-  of-reward subjects;1283;-1
Doc4;1 million people;1;-1
Doc4;92,722 individuals;92722;-1
Doc4;35,968 individuals;35968;-1
Doc4;328 individuals;328;-1
Doc4;9 extra noncontacted individuals;9;-1
Doc4;100 individuals;100;-1
Doc4;100 contacted individuals;100;-1
Doc4;N = 3,516;3516;-1
Doc4;N = 89,206;89206;-1
Doc4;N = 79,317;79317;-1
Doc4;N = 92,722;92722;-1
Doc4;N = 2,939;2939;-1
Doc4;N = 12;12;-1
Doc4;N = 108;108;-1
Doc5;11 Using subjects;11;36645
Doc5;40 independent pairs of subjects;40;8115
Doc5;1 If people;1;56240
Doc7;300 individuals;300;-1
Doc7;n = 007;7;-1
Doc8;total  of 32;32;-1
Doc11;n = 741262;741262;-1
Doc11;n = 441550;441550;-1
Doc11;n = 601657;601657;-1
Doc11;n = 81087;81087;-1
Doc11;n = 241502;241502;-1
Doc11;  data set of 212,058;212058;-1
Doc11;  database of 697,456;697456;-1
Doc12;N = 8;8;-1
Doc12;N = 3;3;-1
Doc12;n= 256;256;-1
Doc12;n= 10;10;-1
Doc13;147 subjects;147;-1
Doc13;n = 19;19;-1
Doc13;total of 276;276;-1
Doc2;total of 40;40;-1
Doc3;N = 43;43;1721
Doc4;40 participants;40;-1
Doc4;29  participants;29;-1
Doc4;30 participants;30;-1
Doc4;344 subjects;344;-1
Doc4;N = 42;42;-1
Doc4;N = 40;40;-1
Doc4;N = 29;29;-1
Doc4;total of 344;344;-1
Doc6;N  =  1;1;-1
Doc6;N  =  4;4;-1
Doc6;N = 12;12;-1
Doc6;N  = 4;4;-1
Doc6;n= 5;5;-1
Doc6;n= 1;1;-1
Doc6;n= 2;2;-1
Doc6;N = 4;4;-1
Doc7;n= 25;25;-1
Doc7;n= 2;2;-1
Doc8;total of 43;43;984
Doc10;6 For four subjects;6;-1
Doc10;N = 00;0;-1
Doc10;N =00;0;-1
Doc10;N = 20;20;-1
Doc10;N = 0;0;-1
Doc10;total of 50;50;-1
Doc11;3 Their patients;3;-1
Doc11;n= 0;0;-1
Doc11;N = 87;87;-1
Doc11; data from 35;35;-1
Doc12;52 participants;52;-1
Doc12;53 participants;53;-1
Doc12;49 participants;49;-1
Doc12;1 examines people;1;-1
Doc12;2014 INFORMS  help people;2014;-1
Doc12;n = 1;1;-1
Doc12;N = 0;0;-1
Doc13;N = 811;811;-1
Doc13;N = 8112139;8112139;-1
Doc13;n= 15;15;-1
Doc13;n= 30;30;-1
Doc13;total of 12;12;-1
Doc14;N  =  44;44;-1
Doc14;total of 9,734;9734;-1
Doc3;N = 81121;81121;-1
Doc5;79  aAll participants;79;-1
Doc5;2455  participants;2455;-1
Doc5;12 pairs of participants;12;-1
Doc5;N = 1;1;-1
Doc6;2014 INFORMS  patients;2014;-1
Doc7; data  only from 1986;1986;-1
Doc8; database of 13;13;6549
Doc10;N = 11810;11810;1933
Doc10;N = 11469;11469;1451
Doc10;  database from 2002;2002;22694
Doc10; data from 1967;1967;30832
Doc10; data from 1997;1997;31011
Doc10; data from 1962;1962;32646
Doc11;n = 15;15;-1
Doc13;n = 7;7;-1
Doc13;n = 25;25;-1
Doc13;n = 55;55;-1
Doc13;n = 12;12;-1
Doc13;N =  112,857;112857;-1
Doc13;N = 576,640;576640;-1
Doc14;39 individuals;39;-1
Doc14;30 ran-  domly chosen individuals;30;-1
Doc14;16 individuals;16;-1
Doc14;N = 90;90;-1
Doc14;total of 158;158;-1
Doc14;total  of 39;39;-1
Doc14;total of 16;16;-1
Doc14;45 students enrolled;45;-1
Doc14;2014 INFORMS  currently enrolled;2014;-1
Doc15;12 million people;12;-1
Doc15;total of 85,168;85168;-1
Doc2;2,486 individuals;2486;-1
Doc3;N = 585;585;-1
Doc3;n = 45;45;-1
Doc3;total of 466,830;466830;-1
Doc4;5 evolves as people;5;-1
Doc4;490 individuals;490;-1
Doc4;490 selected individuals;490;-1
Doc4;3 is not because  individuals;3;-1
Doc4;5 captures individuals;5;-1
Doc4;7 is common  across individuals;7;-1
Doc4;27 is heterogeneous across  individuals;27;-1
Doc4;160  individuals;160;-1
Doc5;n = 41;41;-1
Doc5;n =  61;61;-1
Doc5;n =  41;41;-1
Doc7;10 To allow subjects;10;-1
Doc7;36 subjects;36;-1
Doc7;32 subjects;32;-1
Doc7;17 When subjects;17;-1
Doc7;16 Three subjects;16;-1
Doc7;9,681  Number of subjects;9681;-1
Doc7;12,120  Number of subjects;12120;-1
Doc7;3,957  Number of subjects;3957;-1
Doc7;77 subjects;77;-1
Doc7;total of 104;104;-1
Doc7;total of 36;36;-1
-1025566349_In%20Brief_070414;190  Young women;190;-1
-1025566349_In%20Brief_070414;34 000   participants;34000;-1
-1025566349_In%20Brief_070414;1123 patients;1123;-1
-1025566349_In%20Brief_070414;1351 American adults;1351;-1
-1025566349_In%20Brief_070414;total of 76;76;-1
-1055270345_lee11166_fm;3281 vaccinated patients;3281;-1
-1055270345_lee11166_fm;2342 patients;2342;-1
-1055270345_lee11166_fm;11166  Of the patients;11166;-1
-1055270345_lee11166_fm;374 patients;374;-1
-1055270345_lee11166_fm;510  patients;510;-1
-1055270345_lee11166_fm;184 adult  patients;184;-1
-1055270345_lee11166_fm;3281 patients;3281;-1
-1055270345_lee11166_fm;2134  individuals;2134;-1
-1055270345_lee11166_fm;n = 302;302;-1
-1055270345_lee11166_fm;n = 1000;1000;-1
-1055270345_lee11166_fm;n = 1053;1053;-1
-1055270345_lee11166_fm;n = 2228;2228;-1
-1055270345_lee11166_fm;n = 53;53;-1
-1055270345_lee11166_fm;n = 698;698;-1
-1055270345_lee11166_fm;n = 2;2;-1
-1055270345_lee11166_fm;n = 643;643;-1
-1055270345_lee11166_fm;n = 210;210;-1
-1055270345_lee11166_fm;n = 7;7;-1
-1055270345_lee11166_fm;n = 85;85;-1
-1055270345_lee11166_fm;n = 582;582;-1
-1055270345_lee11166_fm;n = 1644;1644;-1
-1055270345_lee11166_fm;n = 211;211;-1
-1055270345_lee11166_fm;n = 4;4;-1
-1055270345_lee11166_fm;n = 1429;1429;-1
-1055270345_lee11166_fm;n = 300;300;-1
-1055270345_lee11166_fm;n = 37;37;-1
-1055270345_lee11166_fm;n = 245;245;-1
-1055270345_lee11166_fm;n = 2226;2226;-1
-1055270345_lee11166_fm;total of 3281;3281;-1
-1158774783_eve11311;1135 potential participants;1135;2074
-1158774783_eve11311;1135   potential participants;1135;337
-1158774783_eve11311;n = 259;259;3591
-1158774783_eve11311;n = 250;250;3741
-1158774783_eve11311;n = 108;108;8375
-1158774783_eve11311;n   = 1;1;8533
-1158774783_eve11311;n   = 2;2;8579
-1158774783_eve11311;n = 143;143;8819
-1158774783_eve11311;n   = 3;3;8965
-1158774783_eve11311;n = 114;114;15778
-1158774783_eve11311;n = 145;145;15788
-1161045212_rox10435_fm;1172  patients;1172;-1
-1161045212_rox10435_fm;3369  patients;3369;-1
-1161045212_rox10435_fm;187 patients;187;-1
-1161045212_rox10435_fm;10435  patients;10435;-1
-1161045212_rox10435_fm;172 LiN  patients;172;-1
-1161045212_rox10435_fm;187 people;187;-1
-1177879570_zel00055;9370   patients;9370;-1
-1177879570_zel00055;291,413 patients;291413;-1
-1177879570_zel00055;n = 14;14;-1
-1177879570_zel00055;n = 23;23;-1
-1210642009_letters_070714;1150 people;1150;-1
-1271554441_duk10132_fm;214 826 adult  patients;214826;-1
-1271554441_duk10132_fm;74 181 patients;74181;-1
-1271554441_duk10132_fm;17 772 deaths among  ICU patients;17772;-1
-1271554441_duk10132_fm;10 000 patients;10000;-1
-1271554441_duk10132_fm;108 171 people;108171;-1
-1271554441_duk10132_fm;90 399 older people;90399;-1
-1300193214_lok00172;78   patients;78;-1
-1300193214_lok00172;n = 7;7;-1
-1300193214_lok00172;total of 99;99;-1
-1300193214_lok00172;total of 10;10;-1
-1300193214_lok00172;total of 198;198;-1
-1300193214_lok00172;total of 245;245;-1
-1300193214_lok00172;9 Patients were then enrolled;9;-1
-1301683083_bra00175;3055 survey participants;3055;-1
-1356870359_lar10145_fm;147 patients;147;-1
-1356870359_lar10145_fm;n = 27;27;-1
-1356870359_lar10145_fm;n = 25;25;-1
-1356870359_lar10145_fm;n = 13;13;-1
-1356870359_lar10145_fm;n = 147;147;-1
-1356870359_lar10145_fm;n = 21;21;-1
-1356870359_lar10145_fm;n = 14;14;-1
-1356870359_lar10145_fm;n = 7;7;-1
-1356870359_lar10145_fm;n = 5;5;-1
-1356870359_lar10145_fm;n = 4;4;-1
-1356870359_lar10145_fm;n = 3;3;-1
-1356870359_lar10145_fm;n = 149;149;-1
-139627022_wan10630;2010 of all   patients;2010;-1
-139627022_wan10630;1175 patients;1175;-1
-139627022_wan10630;62 splenectomy patients;62;-1
-139627022_wan10630;536   patients;536;-1
-139627022_wan10630;65 patients;65;-1
-139627022_wan10630;1304 people;1304;-1
-139627022_wan10630;1304 people   enrolled;1304;-1
-1431314118_gun10832;557 patients;557;-1
-1431314118_gun10832;45 people;45;-1
-1431314118_gun10832;n = 625 147;625147;-1
-1431314118_gun10832;n = 5845;5845;-1
-1431314118_gun10832;n = 619 302;619302;-1
-1431314118_gun10832;n = 1296;1296;-1
-1431314118_gun10832;n = 4549;4549;-1
-1431314118_gun10832;n = 83;83;-1
-1431314118_gun10832;n = 1213;1213;-1
-1431314118_gun10832;n = 3;3;-1
-1431314118_gun10832;n = 80;80;-1
-1431314118_gun10832;total of   557;557;-1
-1432617247_In%20Brief_070414;190  Young women;190;-1
-1432617247_In%20Brief_070414;34 000   participants;34000;-1
-1432617247_In%20Brief_070414;1123 patients;1123;-1
-1432617247_In%20Brief_070414;1351 American adults;1351;-1
-1432617247_In%20Brief_070414;total of 76;76;-1
-1465437492_bre10982_fm;53   patients;53;-1
-1465437492_bre10982_fm;24   patients;24;-1
-1465437492_bre10982_fm;10982  Twenty-five patients;10982;-1
-1465437492_bre10982_fm;14 patients;14;-1
-1465437492_bre10982_fm;53 patients;53;-1
-1465437492_bre10982_fm;24 patients;24;-1
-1465437492_bre10982_fm; database from   1;1;-1
-1482415402_neh10856;14 For patients;14;-1
-1482415402_neh10856;25 and excludes patients;25;-1
-1482415402_neh10856;10   people;10;-1
-1482415402_neh10856;200 people;200;-1
-1482415402_neh10856;1000   people;1000;-1
-1482415402_neh10856;3000 people;3000;-1
-1482415402_neh10856;2 million   people;2;-1
-1482415402_neh10856;7000 people;7000;-1
-1482415402_neh10856;8 million people;8;-1
-1482415402_neh10856;10 people;10;-1
-1482415402_neh10856;200   people;200;-1
-1482415402_neh10856;1000 people;1000;-1
-1508119728_mac00293;284 participants;284;-1
-1508119728_mac00293;482 participants;482;-1
-1508119728_mac00293;95 participants;95;-1
-1508119728_mac00293;121 participants;121;-1
-1508119728_mac00293;68 participants;68;-1
-1508119728_mac00293;8 In individuals;8;-1
-1508119728_mac00293;n = 51;51;-1
-1508119728_mac00293;n = 37;37;-1
-1508119728_mac00293;n = 14;14;-1
-1508119728_mac00293;n = 28;28;-1
-1508119728_mac00293;n = 22;22;-1
-1508119728_mac00293;n = 3;3;-1
-1508119728_mac00293;n = 20;20;-1
-1508119728_mac00293;n = 17;17;-1
-1508119728_mac00293;n = 61;61;-1
-1508119728_mac00293;n = 44;44;-1
-1508119728_mac00293;n = 1;1;-1
-1508119728_mac00293;n = 16;16;-1
-1508119728_mac00293;n = 45;45;-1
-1508119728_mac00293;n = 141;141;-1
-1508119728_mac00293;n = 109;109;-1
-1508119728_mac00293;n = 127;127;-1
-1508119728_mac00293;n = 70;70;-1
-1508119728_mac00293;n = 49;49;-1
-1508119728_mac00293;n = 21;21;-1
-1508119728_mac00293;n = 82;82;-1
-1508119728_mac00293;n = 39;39;-1
-1508119728_mac00293;n = 2;2;-1
-1508119728_mac00293;n = 0;0;-1
-1508119728_mac00293;n = 4;4;-1
-1508119728_mac00293;n = 12;12;-1
-1508119728_mac00293;n = 48;48;-1
-1508119728_mac00293;n = 150;150;-1
-1508119728_mac00293;n = 98;98;-1
-1508119728_mac00293;n = 306;306;-1
-1508119728_mac00293;total of 482;482;-1
-1508119728_mac00293;total of 284;284;-1
-1529399894_anu00132;1192 women;1192;-1
-1529399894_anu00132;6 We further cat-  egorised women;6;-1
-1529399894_anu00132;283 women;283;-1
-1529399894_anu00132;149 of these women;149;-1
-1529399894_anu00132;461 patients;461;-1
-1533032914_wan11318_0;300 000 patients;300000;-1
-1550627073_sul00106;1775 patients;1775;-1
-1550627073_sul00106;1414 patients;1414;-1
-1550627073_sul00106;5195 patients;5195;-1
-1550627073_sul00106;235 patients;235;-1
-1550627073_sul00106;10 vaccinated patients;10;-1
-1550627073_sul00106;n = 74;74;-1
-1550627073_sul00106;n = 8;8;-1
-1550627073_sul00106;n = 32;32;-1
-1550627073_sul00106;n = 3;3;-1
-1550627073_sul00106;n = 16;16;-1
-1550627073_sul00106;n = 7;7;-1
-1550627073_sul00106;n = 5;5;-1
-1550627073_sul00106;total of 275;275;-1
-1557058816_gri00255;17 remaining patients;17;-1
-1557058816_gri00255;13 patients;13;-1
-1557058816_gri00255;218 000   people;218000;-1
-1579122586_swe00528;3   Colonisation disrupted people;3;-1
-1599655896_jor10710_fm;129 patients;129;-1
-1599655896_jor10710_fm;41 patients;41;-1
-1599655896_jor10710_fm;6890 people;6890;-1
-1599655896_jor10710_fm;n = 98;98;-1
-1599655896_jor10710_fm;n = 91;91;-1
-1599655896_jor10710_fm;n = 42;42;-1
-1599655896_jor10710_fm;n = 39;39;-1
-1599655896_jor10710_fm; data from 6;6;-1
-1646426740_don10798;n = 313;313;-1
-1646426740_don10798;n = 153;153;-1
-1646426740_don10798;n = 220;220;-1
-1646426740_don10798;n = 122;122;-1
-1646426740_don10798;total of  242;242;-1
-1679490168_letters_050514_1;1260 participants;1260;-1
-1679490168_letters_050514_1;n = 9922;9922;-1
-1679490168_letters_050514_1;n = 1 321 950;1321950;-1
-1679490169_letters_050514_0;1260 participants;1260;-1
-1679490169_letters_050514_0;n = 9922;9922;-1
-1679490169_letters_050514_0;n = 1 321 950;1321950;-1
-1707868329_luk00046;41   women;41;622
-1707868329_luk00046;65 participants;65;11429
-1707868329_luk00046;68 participants;68;519
-1707868329_luk00046;49,364 obese participants;49364;14670
-1707868329_luk00046;47   patients;47;3390
-1707868329_luk00046;2  Proportions of patients;2;4323
-1707868329_luk00046;total of 288;288;5770
-1721844373_woo00097;n = 852;852;-1
-1721844373_woo00097;n = 200;200;-1
-1721844373_woo00097;n = 1;1;-1
-1721844373_woo00097;n = 5;5;-1
-1721844373_woo00097;n =1;1;-1
-1721844373_woo00097;n =2;2;-1
-1721844373_woo00097;981 children enrolled;981;-1
-1769199717_azi11203;total of 246 665;246665;-1
-1769199717_azi11203;total of 8750;8750;-1
-1777246346_letters_070714;1150 people;1150;-1
-1786115086_mit00235;398 patients;398;-1
-1786115086_mit00235;3147 patients;3147;-1
-1786115086_mit00235;191 patients;191;-1
-1786115086_mit00235;1200 ma-  jor trauma patients;1200;-1
-1786115086_mit00235;n = 201;201;-1
-1786115086_mit00235;n = 197;197;-1
-1790618653_cam00278;60 potential participants;60;-1
-1790618653_cam00278;22 participants;22;-1
-1790618653_cam00278;60 people;60;-1
-1790618653_cam00278; data from 2003;2003;-1
-1833412570_hil00152;n = 9345;9345;-1
-1833412570_hil00152;n = 9145;9145;-1
-1833412570_hil00152;n = 9243;9243;-1
-1833412570_hil00152;n = 9126;9126;-1
-1833412570_hil00152;n = 8989;8989;-1
-1833412570_hil00152;n = 8963;8963;-1
-1833412570_hil00152;n = 8988;8988;-1
-1833412570_hil00152;n = 8877;8877;-1
-1833412570_hil00152;n = 8903;8903;-1
-1833412570_hil00152;n = 8593;8593;-1
-1833412570_hil00152;n = 8759;8759;-1
-1833412570_hil00152;n = 8775;8775;-1
-1833412570_hil00152;n = 7977;7977;-1
-1833412570_hil00152;n = 8112;8112;-1
-1833412570_hil00152;n = 8126;8126;-1
-1833412570_hil00152;n = 7912;7912;-1
-1833412570_hil00152;n = 8044;8044;-1
-1833412570_hil00152;n = 8059;8059;-1
-1854235824_letters_160614;1600   Indigenous adults;1600;-1
-1864416493_ilt11175;19  NSTEACS  All patients;19;-1
-1955182519_lan00183;16 Some patients;16;-1
-2000952932_par10466_fm;7 patients;7;-1
-2000952932_par10466_fm;22  patients;22;-1
-2000952932_par10466_fm;1495 patients;1495;-1
-2000952932_par10466_fm;764 patients;764;-1
-2000952932_par10466_fm;83 patients;83;-1
-2000952932_par10466_fm;123 patients;123;-1
-2000952932_par10466_fm;22 patients;22;-1
-2000952932_par10466_fm;764 adults;764;-1
-2000952932_par10466_fm;n = 764;764;-1
-2000952932_par10466_fm;n = 83;83;-1
-2000952932_par10466_fm;n = 56;56;-1
-2000952932_par10466_fm;n = 708;708;-1
-2000952932_par10466_fm;n = 123;123;-1
-2000952932_par10466_fm;total of 141;141;-1
-2078740981_ale10448;104 patients;104;-1
-2078740981_ale10448;12 patients;12;-1
-2078740981_ale10448;17,600 melanoma   patients;17600;-1
-2078740981_ale10448;n = 11;11;-1
-2078740981_ale10448;n = 8;8;-1
-2078740981_ale10448;n = 79;79;-1
-2078740981_ale10448;n = 104;104;-1
-2085358991_letters_190514_4;1861 participants;1861;-1
-2085358991_letters_190514_4;143 participants;143;-1
-2085358991_letters_190514_4;66 patients;66;-1
-2085358991_letters_190514_4;31   people;31;-1
-2085358991_letters_190514_4;n = 1718;1718;-1
-2085358991_letters_190514_4;n = 143;143;-1
-2088628685_cur00365;3040 patients;3040;-1
-2088628685_cur00365;24 patients;24;-1
-2088628685_cur00365;29 patients;29;-1
-2088628685_cur00365;255 patients;255;-1
-2088628685_cur00365;3211 resected patients;3211;-1
-2088628685_cur00365;n = 3040;3040;-1
-2091949702_wal00267;3   Young Aboriginal people;3;-1
-209727656_smi11182_fm;908 patients;908;-1
-209727656_smi11182_fm;1621 patients;1621;-1
-209727656_smi11182_fm;9618 people;9618;-1
-209727656_smi11182_fm;1000 people;1000;-1
-209727656_smi11182_fm;n = 908;908;-1
-209727656_smi11182_fm;n = 1621;1621;-1
-209727656_smi11182_fm;n = 467;467;-1
-209727656_smi11182_fm;n = 441;441;-1
-209727656_smi11182_fm;n = 737;737;-1
-209727656_smi11182_fm;n = 884;884;-1
-209727656_smi11182_fm;total of 42;42;-1
-209727656_smi11182_fm;total of 84;84;-1
-2111729946_mul00035;478 patients;478;-1
-2111729946_mul00035;1000 patients;1000;-1
-2111729946_mul00035;132 individuals;132;-1
-2129240116_letters_070714;1150 people;1150;-1
-218666342_bai00256;103 participants;103;-1
-218666342_bai00256;100 Indigenous   people;100;-1
-218666342_bai00256;   data from 24;24;-1
-258807855_che00647;17 445 patients;17445;-1
-258807855_che00647;n = 2392;2392;-1
-258807855_che00647;n = 2405;2405;-1
-271090756_yeu10729_fm;1 In  women;1;-1
-271090756_yeu10729_fm;6 In  men and women;6;-1
-271090756_yeu10729_fm;3027 women;3027;-1
-271090756_yeu10729_fm;2813 women;2813;-1
-271090756_yeu10729_fm;1,844 women;1844;-1
-271090756_yeu10729_fm;657 control women;657;-1
-271090756_yeu10729_fm;4284 participants;4284;-1
-271090756_yeu10729_fm;13 participants;13;-1
-271090756_yeu10729_fm;1 Study participants;1;-1
-271090756_yeu10729_fm;100 patients;100;-1
-271090756_yeu10729_fm;4284 patients;4284;-1
-271090756_yeu10729_fm;500 people;500;-1
-271090756_yeu10729_fm;n = 6147;6147;-1
-271090756_yeu10729_fm;n = 4233;4233;-1
-271090756_yeu10729_fm;n = 1914;1914;-1
-271090756_yeu10729_fm;N = 4284;4284;-1
-271090756_yeu10729_fm;n = 1130;1130;-1
-271090756_yeu10729_fm;n = 2814;2814;-1
-271090756_yeu10729_fm;n = 3409;3409;-1
-271090756_yeu10729_fm;n = 528;528;-1
-271090756_yeu10729_fm;n = 1061;1061;-1
-271090756_yeu10729_fm;n = 2807;2807;-1
-271090756_yeu10729_fm;n = 3336;3336;-1
-271090756_yeu10729_fm;n = 525;525;-1
-271090756_yeu10729_fm;n = 1129;1129;-1
-271090756_yeu10729_fm;n = 2761;2761;-1
-271090756_yeu10729_fm;n = 3357;3357;-1
-271090756_yeu10729_fm;n = 526;526;-1
-271090756_yeu10729_fm;n = 1091;1091;-1
-271090756_yeu10729_fm;n = 2530;2530;-1
-271090756_yeu10729_fm;n = 3124;3124;-1
-271090756_yeu10729_fm;n = 490;490;-1
-271090756_yeu10729_fm;n = 910;910;-1
-271090756_yeu10729_fm;n = 2477;2477;-1
-271090756_yeu10729_fm;n = 2939;2939;-1
-271090756_yeu10729_fm;n = 443;443;-1
-271090756_yeu10729_fm;n = 1175;1175;-1
-271090756_yeu10729_fm;n = 2867;2867;-1
-271090756_yeu10729_fm;n = 3499;3499;-1
-271090756_yeu10729_fm;n = 535;535;-1
-271090756_yeu10729_fm;total of 134;134;-1
-271090756_yeu10729_fm;total of 4284;4284;-1
-271090756_yeu10729_fm;total of 699;699;-1
-271090756_yeu10729_fm;100 patients were enrolled;100;-1
-272297064_cha10998;4 dying patients;4;-1
-272297064_cha10998;35 general medical   patients;35;-1
-336460953_ham00039;170,000 participants;170000;-1
-336460953_ham00039;169 138 subjects;169138;-1
-336460953_ham00039;39 612 patients;39612;-1
-336460953_ham00039;129 526 patients;129526;-1
-336460953_ham00039; data from 170,000;170000;-1
-336475897_hof00002;36 More vulnerable patients;36;-1
-336475897_hof00002;38  Engaging patients;38;-1
-336475897_hof00002;1000   people;1000;-1
-336475897_hof00002;8000 people;8000;-1
-396117547_kel01281;12 Protection   of older adults;12;-1
-470083229_kev00099;1000 women;1000;-1
-470083229_kev00099;319 patients;319;-1
-470083229_kev00099;n = 319;319;-1
-579073487_letters_061014;24 018 Victorian women;24018;-1
-579073487_letters_061014;1235 of   these women;1235;-1
-579073487_letters_061014;83 000   women;83000;-1
-579073487_letters_061014;22 171 patients;22171;-1
-579073487_letters_061014;5   recruited;5;-1
-579073487_letters_061014; data from   53;53;-1
-595697734_oat10213_fm;total of 101;101;-1
-665540510_letters_070714;1150 people;1150;-1
-703170766_nor10776_fm;n = 3377;3377;-1
-703170766_nor10776_fm;n = 1143;1143;-1
-729537059_gro01089;5 Of those patients;5;-1
-729537059_gro01089;total of 70 000;70000;-1
-734809453_letters_070714;1150 people;1150;-1
-842680965_tho00637;99s-  children-and-young-people;99;-1
-842680965_tho00637;n = 557;557;-1
-842680965_tho00637;n = 311;311;-1
-842680965_tho00637;n = 107;107;-1
-842680965_tho00637;n = 116;116;-1
-842680965_tho00637;n = 23;23;-1
-842680965_tho00637;n = 42;42;-1
-842680965_tho00637;n = 7;7;-1
-842680965_tho00637;n = 19;19;-1
-842680965_tho00637;n = 48;48;-1
-864110813_har00121;329 women;329;-1
-864110813_har00121;572 women;572;-1
-864110813_har00121;865 Aboriginal patients;865;-1
-864110813_har00121;13 For   patients;13;-1
-864110813_har00121;17 180 patients;17180;-1
-864110813_har00121;865 patients;865;-1
-864110813_har00121;2959 people;2959;-1
-864110813_har00121;995   individuals;995;-1
-864110813_har00121;total of 2959;2959;-1
-864110813_har00121;total of   865;865;-1
-864110813_har00121;total of 17 180;17180;-1
-864110813_har00121;total of 983;983;-1
-864110813_har00121;total of 572;572;-1
-901039838_che00019;001  IHCA patients;1;-1
1030948670_oco10875;2011   Indigenous women;2011;-1
1030948670_oco10875;168 729 new patients;168729;-1
1030948670_oco10875;179 276 patients;179276;-1
1030948670_oco10875;437 patients;437;-1
1030948670_oco10875;168 729   patients;168729;-1
1030948670_oco10875;1  Proportion of fi rst-time patients;1;-1
1030948670_oco10875;5   Indigenous people;5;-1
1030948670_oco10875;3   Indigenous people;3;-1
1030948670_oco10875;25   Indigenous people;25;-1
1030948670_oco10875;n = 3158;3158;-1
1030948670_oco10875;n = 3945;3945;-1
1030948670_oco10875;n = 479;479;-1
1030948670_oco10875;n = 5219;5219;-1
1030948670_oco10875;n = 427;427;-1
1030948670_oco10875;n = 7043;7043;-1
1030948670_oco10875;n = 168 729;168729;-1
1030948670_oco10875;total of 179 276;179276;-1
1030948670_oco10875; data from 1;1;-1
1083442215_bud00021;1 For women;1;-1
1083442215_bud00021;222   Victorian women;222;-1
1083442215_bud00021;1272 young vaccinated   women;1272;-1
1100348282_hod11142;1655 women;1655;-1
1100348282_hod11142;9229 women;9229;-1
1100348282_hod11142;17 763 women;17763;-1
1100348282_hod11142;10 548 women;10548;-1
1100348282_hod11142;n = 4245;4245;-1
1100348282_hod11142;n = 167 746;167746;-1
1100348282_hod11142;n = 130 026;130026;-1
1110500771_sli11153_fm;total of 12 683;12683;-1
1110500771_sli11153_fm; data from 2008;2008;-1
113231889_sin11138;n   =   14;14;-1
113231889_sin11138;n   =   2;2;-1
113231889_sin11138;n   =   8;8;-1
113231889_sin11138;n   =   13;13;-1
113231889_sin11138;n   =   3;3;-1
113231889_sin11138;n   =   9;9;-1
113231889_sin11138;n   =   14;14;-1
113231889_sin11138;n   =   21;21;-1
113231889_sin11138;n   =   8;8;-1
113231889_sin11138;n   =   13;13;-1
113231889_sin11138;n   =   3;3;-1
113231889_sin11138;n   =   9;9;-1
1153202036_letters_070714;1150 people;1150;-1
1186873296_dem00277;100 women;100;-1
1186873296_dem00277;23 316 women;23316;-1
1186873296_dem00277;13 Of these women;13;-1
1186873296_dem00277;23 316 women enrolled;23316;-1
1186873296_dem00277; data from 23 316;23316;-1
1213867765_vre10170;2  Target population  All women;2;-1
1213867765_vre10170;9  Young women;9;-1
1213867765_vre10170;20  Case study  All women;20;-1
1290705610_wri11329;total of 101;101;-1
1327386593_thr11170;250 798 to non-Indigenous   women;250798;-1
1327386593_thr11170;13 582 to Indigenous   women;13582;-1
1327386593_thr11170;241 270 to non-Indige-  nous women;241270;-1
1327386593_thr11170;n = 13 582;13582;-1
1327386593_thr11170;n = 241 270;241270;-1
1339961860_letters_201014;n = 6987;6987;-1
1339961860_letters_201014;n = 5926;5926;-1
1339961860_letters_201014;n = 1271;1271;-1
1342721971_fra00261;20 people;20;-1
1342721971_fra00261;17 Previously unvaccinated individuals;17;-1
1342721971_fra00261;total of   20;20;-1
1379127139_lai11288;426,344 pregnant women;426344;-1
1382045777_Letters_210414_4;4  When women;4;-1
1391993969_how00567;10 patients;10;-1
1410541284_letters_050514;1260 participants;1260;-1
1410541284_letters_050514;n = 9922;9922;-1
1410541284_letters_050514;n = 1 321 950;1321950;-1
1427606295_letters_160614;1600   Indigenous adults;1600;-1
1430491667_bac00104;2308 adult inpatients;2308;-1
1430491667_bac00104;2308 inpatients;2308;-1
1430491667_bac00104;388 patients;388;-1
1430491667_bac00104;583 patients;583;-1
1430491667_bac00104;323 patients;323;-1
1430491667_bac00104;1354 patients;1354;-1
1430491667_bac00104;474 patients;474;-1
1430491667_bac00104;404 patients;404;-1
1430491667_bac00104;82 patients;82;-1
1430491667_bac00104;388   patients;388;-1
1430491667_bac00104;270 patients;270;-1
1430491667_bac00104;158 patients;158;-1
1430491667_bac00104;51 patients;51;-1
1430491667_bac00104;227 patients;227;-1
1430491667_bac00104;20 patients;20;-1
1430491667_bac00104;189 patients;189;-1
1430491667_bac00104;495 patients;495;-1
1430491667_bac00104;424 patients;424;-1
1430491667_bac00104;437 patients;437;-1
1430491667_bac00104;449   patients;449;-1
1430491667_bac00104;451 patients;451;-1
1430491667_bac00104;483 patients;483;-1
1430491667_bac00104;290 patients;290;-1
1430491667_bac00104;278 patients;278;-1
1430491667_bac00104;346 patients;346;-1
1430491667_bac00104;527   patients;527;-1
1430491667_bac00104;500 patients;500;-1
1430491667_bac00104;490 patients;490;-1
1430491667_bac00104;473 patients;473;-1
1430491667_bac00104;401   patients;401;-1
1430491667_bac00104;276 patients;276;-1
1430491667_bac00104;8   inpatients;8;-1
1430491667_bac00104;2000 patients;2000;-1
1430491667_bac00104;5963 people;5963;-1
1430491667_bac00104;n = 583;583;-1
1430491667_bac00104;n = 334;334;-1
152475858_kel10503;221 participants;221;-1
152475858_kel10503;100 participants;100;-1
152475858_kel10503;755 survey   participants;755;-1
152475858_kel10503;755 people;755;-1
152475858_kel10503;total of 755;755;-1
1538581763_san11680_fm;2011 were  of patients;2011;-1
1538581763_san11680_fm;001  Medical patients;1;-1
1538581763_san11680_fm;1115  patients;1115;-1
1538581763_san11680_fm;89  patients;89;-1
1538581763_san11680_fm;n = 58 158;58158;-1
1538581763_san11680_fm;n = 47 124;47124;-1
1538581763_san11680_fm;n = 11 034;11034;-1
1551848994_cor00279;21 Refugees and people;21;-1
1611818143_ber10701;938 participants;938;-1
1611818143_ber10701;1860 participants;1860;-1
1611818143_ber10701;n = 1860;1860;-1
1611818143_ber10701;n = 938;938;-1
1611818143_ber10701;n = 2325;2325;-1
1611818143_ber10701;n = 1165;1165;-1
1611818143_ber10701;total of 2103;2103;-1
1693460956_letters_160614;1600   Indigenous adults;1600;-1
1808834913_tid10645_fm;34 172  admissions of patients;34172;-1
1808834913_tid10645_fm;4549 patients;4549;-1
1808834913_tid10645_fm;5630 patients;5630;-1
1808834913_tid10645_fm;64  million people;64;-1
1808834913_tid10645_fm;600 000 people;600000;-1
1808834913_tid10645_fm;15 000  people;15000;-1
1839356913_yip00117;12 360 consecutive patients;12360;-1
1839356913_yip00117;12 360 con-  secutive patients;12360;-1
1839356913_yip00117;8 patients;8;-1
1839356913_yip00117;436   patients;436;-1
1839356913_yip00117;n = 1897;1897;-1
1839356913_yip00117;n = 944;944;-1
1839356913_yip00117;N = 12 360;12360;-1
1839356913_yip00117;n = 8090;8090;-1
1839356913_yip00117;n = 4270;4270;-1
1866045522_tho11316_0;14 184 patients;14184;-1
1866045522_tho11316_0;234 800 people;234800;-1
1866045522_tho11316_0;2 Indigenous people;2;-1
1866045522_tho11316_0;6 Indigenous people;6;-1
1866045522_tho11316_0;n = 1421;1421;-1
1866045522_tho11316_0;n = 1892;1892;-1
1866045522_tho11316_0;n = 772;772;-1
1866045522_tho11316_0;n = 119;119;-1
1866045522_tho11316_0;n = 63;63;-1
1866045522_tho11316_0;n = 18;18;-1
1866045522_tho11316_0;n = 278;278;-1
1866045522_tho11316_0;n = 393;393;-1
1866045522_tho11316_0;n = 50;50;-1
1866045522_tho11316_0;n = 1024;1024;-1
1866045522_tho11316_0;n = 1436;1436;-1
1866045522_tho11316_0;n = 704;704;-1
1866045522_tho11316_0;total of 14 184;14184;-1
1965344665_pan00005;4000 people;4000;-1
2028815767_hil01260;11 These are patients;11;-1
2046520653_ree11062;1394 participants;1394;-1
2046520653_ree11062;415 participants;415;-1
2046520653_ree11062;1271 participants;1271;-1
2046520653_ree11062;50 000 people;50000;-1
2046520653_ree11062;2247 individuals;2247;-1
2080776570_whi00153;141 participants;141;-1
2080776570_whi00153;15 participants;15;-1
2080776570_whi00153;129 study   participants;129;-1
2080776570_whi00153;n = 129;129;-1
2080776570_whi00153;total of 17;17;-1
2080776570_whi00153;141 participants enrolled;141;-1
2089688301_letters_160614;1600   Indigenous adults;1600;-1
2105200761_gar10049_fm;  data from all 4;4;-1
2106763799_jan10365;35 000 people;35000;-1
2106763799_jan10365;total of 164;164;-1
2106763799_jan10365; data drawn from the 2006;2006;-1
2106855885_wil10103_fm;n = 2626;2626;-1
2106855885_wil10103_fm;n = 1072;1072;-1
2106855885_wil10103_fm;n = 3698;3698;-1
2106855885_wil10103_fm;n = 2187;2187;-1
2106855885_wil10103_fm;n = 439;439;-1
2106855885_wil10103_fm;891 enrolled;891;-1
2106855885_wil10103_fm;2187 domestic students  enrolled;2187;-1
2106855885_wil10103_fm;2047 medical students enrolled;2047;-1
223101424_lim10108_fm;31 682 tests in   women;31682;-1
223101424_lim10108_fm;31 682 chlamydia tests among women;31682;-1
223101424_lim10108_fm;498 women;498;-1
223101424_lim10108_fm;10 teenage young women;10;-1
228620924_fra11342_fm;727 contacts of patients;727;-1
228620924_fra11342_fm;13  MDR-TB patients;13;-1
228620924_fra11342_fm;21 All nine patients;21;-1
228620924_fra11342_fm;9,153 patients;9153;-1
228620924_fra11342_fm;n = 1352;1352;-1
228620924_fra11342_fm;n = 16;16;-1
228620924_fra11342_fm;n = 48;48;-1
228620924_fra11342_fm;total of 196;196;-1
313355755_lin00823;5000 patients;5000;-1
313355755_lin00823;400 000 people;400000;-1
336825184_ege00344;2766 patients;2766;-1
365698437_letters_070714;1150 people;1150;-1
365698438_letters_070714;1150 people;1150;-1
367610152_mat10920;100 000 patients;100000;-1
426915362_ste00197;143 207 women;143207;-1
426915362_ste00197;55 777 participants;55777;-1
426915362_ste00197;196 464   participants;196464;-1
426915362_ste00197;196 464 included participants;196464;-1
426915362_ste00197;196 464 people;196464;-1
426915362_ste00197;100 000 individuals;100000;-1
426915362_ste00197;267 113 individuals;267113;-1
426915362_ste00197;196 464 people from NSW recruited;196464;-1
426915362_ste00197;n = 103 977;103977;-1
426915362_ste00197;n = 92 487;92487;-1
426915362_ste00197;n = 196 464;196464;-1
426915362_ste00197;n = 454;454;-1
426915362_ste00197;n = 240;240;-1
426915362_ste00197;n = 349;349;-1
426915362_ste00197;total of 196 464;196464;-1
426915362_ste00197;total of 267 113;267113;-1
426915362_ste00197;total of 1096;1096;-1
471056765_slu00186;19 019 patients;19019;-1
471056765_slu00186;403 patients;403;-1
471056765_slu00186;100   patients;100;-1
471056765_slu00186;total of 19 019;19019;-1
485906966_you11070_fm; data from 1;1;-1
506025967_gut00015;90   patients;90;-1
509168010_letters_070714;1150 people;1150;-1
533680753_cro00141_fm;11 Pregnant women;11;-1
533680753_cro00141_fm;400  patients;400;-1
533680753_cro00141_fm;11 patients;11;-1
533680753_cro00141_fm;33  patients;33;-1
533680753_cro00141_fm;400 patients;400;-1
533680753_cro00141_fm;115 patients;115;-1
533680753_cro00141_fm;356 patients;356;-1
533680753_cro00141_fm;345 patients;345;-1
533680753_cro00141_fm;293 patients;293;-1
533680753_cro00141_fm;284 patients;284;-1
533680753_cro00141_fm;24 patients were inpatients;24;-1
533680753_cro00141_fm;800 million  people;800;-1
533680753_cro00141_fm;48 adults;48;-1
558094007_whi00217;n = 2858;2858;-1
594900104_obr11331_fm;30 patients;30;-1
613824930_letters_070714;1150 people;1150;-1
635489911_letters_160614;1600   Indigenous adults;1600;-1
646786837_par11117;12 patients;12;-1
646786837_par11117;7 patients;7;-1
646786837_par11117;2005  All patients;2005;-1
646786837_par11117;230 000 people;230000;-1
67318213_gol00011;9477 women;9477;-1
67318213_gol00011;6348 women;6348;-1
67318213_gol00011;7162 women;7162;-1
67318213_gol00011;2532   women;2532;-1
67318213_gol00011;1742 women;1742;-1
67318213_gol00011;986 women;986;-1
67318213_gol00011;10 women;10;-1
686107548_har10614;n = 18 983;18983;-1
686107548_har10614;n = 5518;5518;-1
686107548_har10614;n = 5407;5407;-1
686107548_har10614;n = 8058;8058;-1
686107548_har10614;n = 254;254;-1
686107548_har10614;n = 7417;7417;-1
700526680_wor10599;2072 male patients;2072;-1
700526680_wor10599;1132 female   patients;1132;-1
700526680_wor10599;n = 350;350;-1
700526680_wor10599;total of   3205;3205;-1
809576383_letters_070714;1150 people;1150;-1
851128385_pla11082_fm;n = 258;258;-1
851128385_pla11082_fm;n = 759;759;-1
851128385_pla11082_fm;n = 1017;1017;-1
851128385_pla11082_fm;total of 67;67;-1
854030297_mar00173;6 people;6;-1
85574414_wil10999;100 000 women;100000;-1
85574414_wil10999;1000 women;1000;-1
85574414_wil10999;8 Of Australian women;8;-1
869047080_blo10594_fm;n = 304;304;-1
869047080_blo10594_fm;n = 847;847;-1
869047080_blo10594_fm;n = 135;135;-1
881840289_letters_201014;n = 6987;6987;-1
881840289_letters_201014;n = 5926;5926;-1
881840289_letters_201014;n = 1271;1271;-1
940122425_mag10941;n = 6725;6725;-1
940122425_mag10941;n = 6728;6728;-1
940122425_mag10941;n = 6720;6720;-1
940122425_mag10941;n = 21 690;21690;-1
95779058_pag00032;30 000 patients;30000;-1
95779058_pag00032;23 million people;23;-1
95779058_pag00032;300 000 people;300000;-1
NEJMc1308504;99   patients;99;-1
NEJMc1308504;54   patients;54;-1
NEJMc1309449;63 patients;63;-1
NEJMc1309480;213 patients;213;-1
NEJMc1309480;total of 87;87;-1
NEJMc1309730;6503 persons;6503;-1
NEJMc1309730;250 patients;250;-1
NEJMc1309730;30 patients;30;-1
NEJMc1309730;18 of these patients;18;-1
NEJMc1309730;2 patients;2;-1
NEJMc1309730;total of 30;30;-1
NEJMc1309730;total of 16;16;-1
NEJMc1310150;69 Chinese women;69;-1
NEJMc1310150;41 patients;41;-1
NEJMc1310150;192 Chinese patients;192;-1
NEJMc1310849;99 patients;99;-1
NEJMc1310849;54 patients;54;-1
NEJMc1311039;3414 patients;3414;-1
NEJMc1311039;25,673 patients;25673;-1
NEJMc1311039;N = 1718;1718;-1
NEJMc1311039;N = 1696;1696;-1
NEJMc1311092;13 adults;13;-1
NEJMc1311092;13 preterm adults;13;-1
NEJMc1311763;299 Korean persons;299;-1
NEJMc1311763;365 unaffected Korean persons;365;-1
NEJMc1311763;788 persons;788;-1
NEJMc1311763;1900 persons;1900;-1
NEJMc1311763;600 unaffected persons;600;-1
NEJMc1311763;2 patients;2;-1
NEJMc1313112;1016 patients;1016;-1
NEJMc1313112;11 patients;11;-1
NEJMc1313112; data from 11;11;-1
NEJMc1313113;3 involving patients;3;-1
NEJMc1313113;756 patients;756;-1
NEJMc1313214;20 patients;20;-1
NEJMc1313506;1016 patients;1016;-1
NEJMc1313506;11 patients;11;-1
NEJMc1313506;59 patients;59;-1
NEJMc1313506;316 patients;316;-1
NEJMc1313506;196   patients;196;-1
NEJMc1313506;2 and all patients;2;-1
NEJMc1313506;77 patients;77;-1
NEJMc1313506; data from 11;11;-1
NEJMc1313601;132 medical in-  patients;132;-1
NEJMc1313601;1 patients;1;-1
NEJMc1313601;total of 45;45;-1
NEJMc1313655;76 patients;76;-1
NEJMc1313655;7 patients;7;-1
NEJMc1313655;total of 263;263;-1
NEJMc1313769;77 patients;77;-1
NEJMc1313883;2 patients;2;-1
NEJMc1313883;10 patients;10;-1
NEJMc1313883;13 patients;13;-1
NEJMc1313883;25 patients;25;-1
NEJMc1313886;1 patients;1;-1
NEJMc1313886;2 In   ICU patients;2;-1
NEJMc1313942;3 Although some patients;3;-1
NEJMc1314100;36 patients;36;-1
NEJMc1314411;11,000 patients;11000;-1
NEJMc1314511;36 patients;36;-1
NEJMc1314511;76 patients;76;-1
NEJMc1314511;7 patients;7;-1
NEJMc1314511;total of 263;263;-1
NEJMc1314560;1 recruited women;1;-1
NEJMc1314560;1 recruited;1;-1
NEJMc1314757;150 patients;150;-1
NEJMc1314757;354 patients;354;-1
NEJMc1314757;800 patients;800;-1
NEJMc1314761;1   an increased proportion of patients;1;-1
NEJMc1314761;30 large trials involving patients;30;-1
NEJMc1314999;100   patients;100;-1
NEJMc1315232;192 Chinese patients;192;-1
NEJMc1315288;1680 patients;1680;-1
NEJMc1315288;258 patients;258;-1
NEJMc1315351;40 such patients;40;-1
NEJMc1315502;2216 patients;2216;-1
NEJMc1315502;13 patients;13;-1
NEJMc1315502;162 patients;162;-1
NEJMc1315507;680,000 persons;680000;-1
NEJMc1315507;7 million people;7;-1
NEJMc1315653;680,000 persons;680000;-1
NEJMc1315653;7 million people;7;-1
NEJMc1315678;7244   patients;7244;-1
NEJMc1315678;2216 patients;2216;-1
NEJMc1315678;4950 patients;4950;-1
NEJMc1315908;6503 persons;6503;-1
NEJMc1315908;2685 Euro-  pean persons;2685;-1
NEJMc1315908;1,000 participants;1000;-1
NEJMc1315908;250 patients;250;-1
NEJMc1315908;30 patients;30;-1
NEJMc1315908;18 of these patients;18;-1
NEJMc1315908;2 patients;2;-1
NEJMc1315908;2000 patients;2000;-1
NEJMc1315908;total of 30;30;-1
NEJMc1315908;total of 16;16;-1
NEJMc1316140;2 and   women;2;-1
NEJMc1316140;70,000 women;70000;-1
NEJMc1316140;30 patients;30;-1
NEJMc1316254;2 On-  cologists may not refer patients;2;-1
NEJMc1316332;2 and   women;2;-1
NEJMc1316332;70,000 women;70000;-1
NEJMc1316382;35 patients;35;-1
NEJMc1316382;3 patients;3;-1
NEJMc1316382;4 new patients;4;-1
NEJMc1316382;7 patients;7;-1
NEJMc1316382;22 patients;22;-1
NEJMc1316382;13 patients;13;-1
NEJMc1316382;9 patients;9;-1
NEJMc1316382;4 patients;4;-1
NEJMc1316382;total of 11;11;-1
NEJMc1400186;108 patients;108;-1
NEJMc1400186;3 In such   patients;3;-1
NEJMc1400242;30 patients;30;-1
NEJMc1400242; data from the 1962;1962;-1
NEJMc1400243;2 On-  cologists may not refer patients;2;-1
NEJMc1400243;108 patients;108;-1
NEJMc1400243;3 In such   patients;3;-1
NEJMc1400292;1 two of us described three patients;1;-1
NEJMc1400292;3 patients;3;-1
NEJMc1400292;20 patients;20;-1
NEJMc1400292;853   patients;853;-1
NEJMc1400499;2 patients;2;-1
NEJMc1400499;23 geno-  typed patients;23;-1
NEJMc1400731;650 patients;650;-1
NEJMc1400731;557 patients;557;-1
NEJMc1400731;151 patients;151;-1
NEJMc1400731;152 patients;152;-1
NEJMc1400731;322 patients;322;-1
NEJMc1400731;328 patients;328;-1
NEJMc1400731;67 patients;67;-1
NEJMc1400731;52 patients;52;-1
NEJMc1400731;23 patients;23;-1
NEJMc1400731;554 patients;554;-1
NEJMc1400731;548   patients;548;-1
NEJMc1400731;548 patients;548;-1
NEJMc1400731;306 patients;306;-1
NEJMc1400731;299 patients;299;-1
NEJMc1400731;total   of 334;334;-1
NEJMc1400872;650 patients;650;-1
NEJMc1400872;557 patients;557;-1
NEJMc1400872;151 patients;151;-1
NEJMc1400872;152 patients;152;-1
NEJMc1400872;322 patients;322;-1
NEJMc1400872;328 patients;328;-1
NEJMc1400872;total   of 334;334;-1
NEJMc1400883;19,540 patients;19540;-1
NEJMc1400883;5 patients;5;-1
NEJMc1400883;6 patients;6;-1
NEJMc1400883;17 patients;17;-1
NEJMc1400883;N=5;5;-1
NEJMc1400883;N=6;6;-1
NEJMc1400883;N=17;17;-1
NEJMc1400883;total   of 61,482;61482;-1
NEJMc1400883;total of 19;19;-1
NEJMc1400974;3 Although some patients;3;-1
NEJMc1401128;205 patients;205;-1
NEJMc1401250;275 participants;275;-1
NEJMc1401250;939 participants;939;-1
NEJMc1401250;4 Because patients;4;-1
NEJMc1401250;138 patients;138;-1
NEJMc1401250;939 patients;939;-1
NEJMc1401343;3438 patients;3438;-1
NEJMc1401343;total of 3438;3438;-1
NEJMc1401768;220 patients;220;-1
NEJMc1401768;88 patients;88;-1
NEJMc1401768;69 patients;69;-1
NEJMc1401768;837 patients;837;-1
NEJMc1401768;6910 patients;6910;-1
NEJMc1401768;989 patients;989;-1
NEJMc1401768;total of 163;163;-1
NEJMc1401815;10 patients;10;-1
NEJMc1401815;N = 222;222;-1
NEJMc1401817;2  In women;2;-1
NEJMc1401817;109 patients;109;-1
NEJMc1401817;394   study patients;394;-1
NEJMc1401817;N = 63;63;-1
NEJMc1401817;N = 109;109;-1
NEJMc1401817;N = 73;73;-1
NEJMc1401817;N = 154;154;-1
NEJMc1401831;144,165 persons;144165;-1
NEJMc1401831;1 million persons;1;-1
NEJMc1401831;269,179 patients;269179;-1
NEJMc1401831;260,048 of these patients;260048;-1
NEJMc1401831;2 patients;2;-1
NEJMc1401831;N = 162,385;162385;-1
NEJMc1401831;N = 97,663;97663;-1
NEJMc1401876;0  Total participants;0;-1
NEJMc1401876;138 patients;138;-1
NEJMc1401876;939 patients;939;-1
NEJMc1401876; data from the 1970;1970;-1
NEJMc1402234;213 patients;213;-1
NEJMc1402234;total of 87;87;-1
NEJMc1402278;989 patients;989;-1
NEJMc1402278;516   patients;516;-1
NEJMc1402396;9 persons;9;-1
NEJMc1402396;13 persons;13;-1
NEJMc1402396;5 persons;5;-1
NEJMc1402396;11 persons;11;-1
NEJMc1402396;44 case patients;44;-1
NEJMc1402401;5   of patients;5;-1
NEJMc1402401;1   In patients;1;-1
NEJMc1402402;67 patients;67;-1
NEJMc1402402;67 patients enrolled;67;-1
NEJMc1402425;837 patients;837;-1
NEJMc1402425;6910 patients;6910;-1
NEJMc1402425;989 patients;989;-1
NEJMc1402425;total of 163;163;-1
NEJMc1402521;4300 persons;4300;-1
NEJMc1402521;2203 persons;2203;-1
NEJMc1402521;113 persons;113;-1
NEJMc1402521;49 persons;49;-1
NEJMc1402521;701 patients;701;-1
NEJMc1402521;334 patients;334;-1
NEJMc1402521;150 patients;150;-1
NEJMc1402521;N = 239;239;-1
NEJMc1402521;N = 245;245;-1
NEJMc1402687;3 These   patients;3;-1
NEJMc1402687;17   patients;17;-1
NEJMc1402687;80 reliably identifies patients;80;-1
NEJMc1402692;2915 women;2915;-1
NEJMc1402692;3694 women;3694;-1
NEJMc1402787;9 persons;9;-1
NEJMc1402787;13 persons;13;-1
NEJMc1402787;5 persons;5;-1
NEJMc1402787;11 persons;11;-1
NEJMc1402787;44 case patients;44;-1
NEJMc1402787;1 two of us described three patients;1;-1
NEJMc1402787;3 patients;3;-1
NEJMc1402787;20 patients;20;-1
NEJMc1402787;853   patients;853;-1
NEJMc1402822;2  In women;2;-1
NEJMc1402822;2915 women;2915;-1
NEJMc1402822;3694 women;3694;-1
NEJMc1402987;3 clinical trial involving patients;3;-1
NEJMc1402987;180 patients;180;-1
NEJMc1402987;178   patients;178;-1
NEJMc1402987;182 patients;182;-1
NEJMc1402989;700 patients;700;-1
NEJMc1403007;77 patients;77;-1
NEJMc1403007;50 patients;50;-1
NEJMc1403007;N=70;70;-1
NEJMc1403007;N=7;7;-1
NEJMc1403007;N=22;22;-1
NEJMc1403007;N=24;24;-1
NEJMc1403007;50 volunteers enrolled;50;-1
NEJMc1403303;5 Anything less exposes patients;5;-1
NEJMc1403303;3 clinical trial involving patients;3;-1
NEJMc1403768;2 Other patients;2;-1
NEJMc1403799;5342 women;5342;-1
NEJMc1403799;172 patients;172;-1
NEJMc1403799;   data from 2008;2008;-1
NEJMc1403841;10 patients;10;-1
NEJMc1403862;700 patients;700;-1
NEJMc1403862;5557 black patients;5557;-1
NEJMc1404326;200,000 or more  No data  Number of patients;200000;-1
NEJMc1404381;2 Other patients;2;-1
NEJMc1404583;200,000 patients;200000;-1
NEJMc1404583; data from   101;101;-1
NEJMc1404585;1 involving critically ill patients;1;-1
NEJMc1404715;70 kDa autoantibody   positive patients;70;-1
NEJMc1404715;N = 60;60;-1
NEJMc1404715;N = 58;58;-1
NEJMc1404716;4 six of seven   patients;4;-1
NEJMc1404716;2700 patients;2700;-1
NEJMc1404855; data from   101;101;-1
NEJMc1404896;1989 participants;1989;-1
NEJMc1404896;4 six of seven   patients;4;-1
NEJMc1404896;2700 patients;2700;-1
NEJMc1404896;33 severely malnourished   patients;33;-1
NEJMc1404896;46 patients;46;-1
NEJMc1405042;total of 112;112;-1
NEJMc1405198;1121 patients;1121;-1
NEJMc1405198;42 patients;42;-1
NEJMc1405198;10 patients;10;-1
NEJMc1405198;3 additional patients;3;-1
NEJMc1405198;N = 42;42;-1
NEJMc1405198;N = 10;10;-1
NEJMc1405198;N = 32;32;-1
NEJMc1405213;70 kDa autoantibody   positive patients;70;-1
NEJMc1405213;118 patients;118;-1
NEJMc1405213;58 patients;58;-1
NEJMc1405213;37 patients;37;-1
NEJMc1405213;N = 60;60;-1
NEJMc1405213;N = 58;58;-1
NEJMc1405213;total of 4;4;-1
NEJMc1405215;10,000 persons;10000;-1
NEJMc1405215;792 persons;792;-1
NEJMc1405215;296 persons;296;-1
NEJMc1405215;2235   participants;2235;-1
NEJMc1405337;142 patients;142;-1
NEJMc1405337;4   Early access can benefit patients;4;-1
NEJMc1405337;total of 30;30;-1
NEJMc1405486;2275 preg-  nant women;2275;-1
NEJMc1405486;5010 women;5010;-1
NEJMc1405486;5010   pregnant women;5010;-1
NEJMc1405486;759 pregnant women;759;-1
NEJMc1405486;736 patients;736;-1
NEJMc1405664;N=6195;6195;-1
NEJMc1405664;N=1771;1771;-1
NEJMc1405664;N=59;59;-1
NEJMc1405664;8025 Were enrolled;8025;-1
NEJMc1405675;1121 patients;1121;-1
NEJMc1405676;4   Early access can benefit patients;4;-1
NEJMc1405680;5 million persons;5;-1
NEJMc1405680;1 million persons;1;-1
NEJMc1405680;32,225 diabetic   and nondiabetic patients;32225;-1
NEJMc1405680;8 million more adults;8;-1
NEJMc1405680;8 million additional adults;8;-1
NEJMc1405805;4 T cells of persons;4;-1
NEJMc1405805;4 adults;4;-1
NEJMc1405805;3 adults;3;-1
NEJMc1406009;10,000 persons;10000;-1
NEJMc1406009;2 diabetic   patients;2;-1
NEJMc1406028;190 female patients;190;-1
NEJMc1406028;12 Dutch breast-cancer patients;12;-1
NEJMc1406028;675 fe-  male patients;675;-1
NEJMc1406028;1 patients;1;-1
NEJMc1406028;total of 675;675;-1
NEJMc1406276;123 patients;123;-1
NEJMc1406283;303 patients;303;-1
NEJMc1406283;344 patients;344;-1
NEJMc1406283;335 patients;335;-1
NEJMc1406283;162 patients;162;-1
NEJMc1406283;164 patients;164;-1
NEJMc1406586;3310 young adults;3310;-1
NEJMc1406586;6840 young   adults;6840;-1
NEJMc1406586;2245 adults;2245;-1
NEJMc1406586;4799 adults;4799;-1
NEJMc1406745;1341 patients;1341;-1
NEJMc1406756;2275 preg-  nant women;2275;-1
NEJMc1406756;5010 women;5010;-1
NEJMc1406756;131 patients;131;-1
NEJMc1407264;80,000 women;80000;-1
NEJMc1407264;192 participants;192;-1
NEJMc1407264;173 participants;173;-1
NEJMc1407264;30 patients;30;-1
NEJMc1407391;80,000 women;80000;-1
NEJMc1407393;18 patients;18;-1
NEJMc1407393;11 patients;11;-1
NEJMc1407393;2 diabetic patients;2;-1
NEJMc1407470;220 patients;220;-1
NEJMc1407470;109 patients;109;-1
NEJMc1407658;5342 women;5342;-1
NEJMc1407658;172 patients;172;-1
NEJMc1407658;   data from 2008;2008;-1
NEJMc1407683;total of 3;3;-1
NEJMc1407775;290   patients;290;-1
NEJMc1407775;18 patients;18;-1
NEJMc1407775;5 patients;5;-1
NEJMc1407776;7800   Geisinger MyCode Project participants;7800;-1
NEJMc1407776;178   patients;178;-1
NEJMc1407776;82 patients;82;-1
NEJMc1407776;96 patients;96;-1
NEJMc1407776;484 patients;484;-1
NEJMc1407776;154 patients;154;-1
NEJMc1407902;57,030 eligible patients;57030;-1
NEJMc1407902;N = 1157;1157;-1
NEJMc1407902;N = 14,751;14751;-1
NEJMc1407902;N = 27,491;27491;-1
NEJMc1407902;N = 43,399;43399;-1
NEJMc1407908;6 patients;6;-1
NEJMc1407908;N = 6015;6015;-1
NEJMc1407908;N = 6076;6076;-1
NEJMc1407908;N = 6022;6022;-1
NEJMc1407914;35 patients;35;-1
NEJMc1407921;4 adults;4;-1
NEJMc1407921;3 adults;3;-1
NEJMc1407925;651 patients;651;-1
NEJMc1407925;127 patients;127;-1
NEJMc1407925;13 patients;13;-1
NEJMc1407925;2000 European patients;2000;-1
NEJMc1407925;606 patients;606;-1
NEJMc1407925;581 patients;581;-1
NEJMc1407925;1995 patients;1995;-1
NEJMc1407925;402 patients;402;-1
NEJMc1407925;186 patients;186;-1
NEJMc1407925;total of 10;10;-1
NEJMc1407925;total of 2;2;-1
NEJMc1407925;total of 17;17;-1
NEJMc1407928;1359 patients;1359;-1
NEJMc1408235;7800   Geisinger MyCode Project participants;7800;-1
NEJMc1408237;4 patients;4;-1
NEJMc1408237;1359 patients;1359;-1
NEJMc1408237;N = 2080;2080;-1
NEJMc1408237;N = 3633;3633;-1
NEJMc1408396;795 patients;795;-1
NEJMc1408396;1000 patients;1000;-1
NEJMc1408559;605 participants;605;-1
NEJMc1408559;total   of 1183;1183;-1
NEJMc1408607;24 participants;24;-1
NEJMc1408861;3018 patients;3018;-1
NEJMc1408861;32 patients;32;-1
NEJMc1408866;378 patients;378;-1
NEJMc1408866;70 patients;70;-1
NEJMc1408866;45 patients;45;-1
NEJMc1408866;5000 patients;5000;-1
NEJMc1408866;186 patients;186;-1
NEJMc1408914;total of 56;56;-1
NEJMc1408914;total of 24;24;-1
NEJMc1409052;24 participants;24;-1
NEJMc1409052;1 infected patients;1;-1
NEJMc1409052;71 patients;71;-1
NEJMc1409052;65 patients;65;-1
NEJMc1409203;total of 56;56;-1
NEJMc1409203;total of 24;24;-1
NEJMc1409204;total of 3;3;-1
NEJMc1409206;18F-FDG PET-CT evaluated patients;18;-1
NEJMc1409366;567 women;567;-1
NEJMc1409366;1996   patients;1996;-1
NEJMc1409495;378 patients;378;-1
NEJMc1409495;70 patients;70;-1
NEJMc1409495;45 patients;45;-1
NEJMc1409550;6 patients;6;-1
NEJMc1409550;N = 6015;6015;-1
NEJMc1409550;N = 6076;6076;-1
NEJMc1409550;N = 6022;6022;-1
NEJMc1409657;3018 patients;3018;-1
NEJMc1409847;567 women;567;-1
NEJMc1409960;18F-FDG PET-CT evaluated patients;18;-1
NEJMc1409960;36 critically ill adult patients;36;-1
NEJMc1410041;1277 patients;1277;-1
NEJMc1410041;total of 2;2;-1
NEJMc1410239;251 patients;251;-1
NEJMc1410501;251 patients;251;-1
NEJMc1410501;9699   patients;9699;-1
NEJMc1410504;36 critically ill adult patients;36;-1
NEJMc1410504;132 patients;132;-1
NEJMc1410670;12 additional patients;12;-1
NEJMc1410673;2 negative Chinese women;2;-1
NEJMc1410673;100 Asian   patients;100;-1
NEJMc1410673;78 patients;78;-1
NEJMc1410673;100 Asian   patients enrolled;100;-1
NEJMc1410732;12 additional patients;12;-1
NEJMc1410735;170,000 participants;170000;-1
NEJMc1410735;3 in-  cluded patients;3;-1
NEJMc1410735;57,030 eligible patients;57030;-1
NEJMc1410735; data from 170,000;170000;-1
NEJMc1410799;132 patients;132;-1
NEJMc1410951;88 patients;88;-1
NEJMc1411240;170,000 participants;170000;-1
NEJMc1411240;3 in-  cluded patients;3;-1
NEJMc1411240; data from 170,000;170000;-1
NEJMc1411443;1277 patients;1277;-1
NEJMc1411784;3CA of healthy persons;3;-1
NEJMc1411785;3CA of healthy persons;3;-1
NEJMc1412035;20 consecutive patients;20;-1
NEJMc1412035;20 patients;20;-1
NEJMc1412035;2 patients;2;-1
NEJMc1412035;3   patients;3;-1
NEJMc1412035;7 patients;7;-1
NEJMc1412035;20   patients;20;-1
NEJMc1412035;N = 20;20;-1
NEJMc1412050;3 vaccination of pregnant   women;3;-1
NEJMc1412050;3 vaccination of   pregnant women;3;-1
NEJMc1412113;2275 persons;2275;-1
NEJMc1412113;270,000 persons;270000;-1
NEJMc1412113;131 participants;131;-1
NEJMc1412113;1439 French patients;1439;-1
NEJMc1412113;101,945 people;101945;-1
NEJMc1412113;370,000 people;370000;-1
NEJMc1412123;92 ado-  lescents and young adults;92;-1
NEJMc1412123;45 adults;45;-1
NEJMc1412123;67 older   adults;67;-1
NEJMc1412427;N=91;91;-1
NEJMc1412427;N=189;189;-1
NEJMc1412594;45 patients;45;-1
NEJMc1412594;38 patients;38;-1
NEJMc1412654;1  If these patients;1;-1
NEJMc1412729;906 patients;906;-1
NEJMc1412729;952 patients;952;-1
NEJMc1412729;30 patients;30;-1
NEJMc1412729;19 patients;19;-1
NEJMcibr1315544;1200 patients;1200;-1
NEJMcibr1315544;45 patients;45;-1
NEJMcibr1402199;38 In patients;38;-1
NEJMcibr1403629;4 T cells of persons;4;-1
NEJMcibr1403629;12 patients;12;-1
NEJMcibr1408663;3 million   people;3;-1
NEJMclde1314766;1000 persons;1000;-1
NEJMclde1314766;500 patients;500;-1
NEJMclde1314766;50 people;50;-1
NEJMclde1314766; data   from 27;27;-1
NEJMclde1401118;total of 88;88;-1
NEJMcp1001120;32 In a study involving patients;32;-1
NEJMcp1103640;5  Black women;5;-1
NEJMcp1204188;19  For symptomatic patients;19;-1
NEJMcp1214825;100,000 persons;100000;-1
NEJMcp1214825;638 participants;638;-1
NEJMcp1214825;77 subjects;77;-1
NEJMcp1214825;764 patients;764;-1
NEJMcp1214825;998 patients;998;-1
NEJMcp1214825;112 patients;112;-1
NEJMcp1214825;total of 998;998;-1
NEJMcp1214825;total of 638;638;-1
NEJMcp1302681;7  In sensitized persons;7;-1
NEJMcp1302681;324 subjects;324;-1
NEJMcp1302681;7 For patients;7;-1
NEJMcp1302681;103 patients;103;-1
NEJMcp1307215;total of 12;12;-1
NEJMcp1309481;3 Even though patients;3;-1
NEJMcp1309481;99 patients;99;-1
NEJMcp1309481;15 patients;15;-1
NEJMcp1309481;60 patients;60;-1
NEJMcp1309481;50 patients;50;-1
NEJMcp1313051;30  Some persons;30;-1
NEJMcp1313051;46 patients;46;-1
NEJMcp1313051;41 patients;41;-1
NEJMcp1314291;100,000 persons;100000;-1
NEJMcp1314291;24 Asplenic   persons;24;-1
NEJMcp1314291;4   In patients;4;-1
NEJMcp1314325;7 In some patients;7;-1
NEJMcp1314325;180 patients;180;-1
NEJMcp1314325;140 patients;140;-1
NEJMcp1314325;39   Anxious patients;39;-1
NEJMcp1314325;43 In patients;43;-1
NEJMcp1314325;50 people;50;-1
NEJMcp1401430;15,000   patients;15000;-1
NEJMcp1401430;47  patients;47;-1
NEJMcp1401430;20,536 people;20536;-1
NEJMcp1401430;3 million individuals;3;-1
NEJMcp1402176;75 subjects;75;-1
NEJMcp1402176;42  For patients;42;-1
NEJMcp1402176;118 patients;118;-1
NEJMcp1402180;350 participants;350;-1
NEJMcp1403062;1000 persons;1000;-1
NEJMcp1403062;1272 participants;1272;-1
NEJMcp1403062;566 patients;566;-1
NEJMcp1403062;total of 1272;1272;-1
NEJMcp1404070;12 In a small number of patients;12;-1
NEJMcp1404070;9 these patients;9;-1
NEJMcp1404070;10 involv-  ing patients;10;-1
NEJMcp1404070;21 In patients;21;-1
NEJMcp1404070;300 patients;300;-1
NEJMcp1404071;50,000 persons;50000;-1
NEJMcp1404071;1000   persons;1000;-1
NEJMcp1404071;1000 persons;1000;-1
NEJMcp1404071;50,000 persons enrolled;50000;-1
NEJMcpc1214220;34   A minority of patients;34;-1
NEJMcpc1214220;443 patients;443;-1
NEJMcpc1214220;66 patients;66;-1
NEJMcpc1214220;231 patients;231;-1
NEJMcpc1214220;49 patients;49;-1
NEJMcpc1214220; data from   242;242;-1
NEJMcpc1305989;1 Some patients;1;-1
NEJMcpc1305989;17 consecutive out-  patients;17;-1
NEJMcpc1305989;147 patients;147;-1
NEJMcpc1305990;186 patients;186;-1
NEJMcpc1305992;593 patients;593;-1
NEJMcpc1310000;300 patients;300;-1
NEJMcpc1310000;113 patients;113;-1
NEJMcpc1310004;108 patients;108;-1
NEJMcpc1310004;80 patients;80;-1
NEJMcpc1310004;287 patients;287;-1
NEJMcpc1310004;total of 6;6;-1
NEJMcpc1310005;10 patients;10;-1
NEJMcpc1310005;5 patients;5;-1
NEJMcpc1310005;49 patients;49;-1
NEJMcpc1310008;5000 new   patients;5000;-1
NEJMcpc1310008;87 trauma patients;87;-1
NEJMcpc1310008;390   damage control laparotomy patients;390;-1
NEJMcpc1310008;20 people;20;-1
NEJMcpc1310008; data   from 2001;2001;-1
NEJMcpc1400833;100,000 patients;100000;-1
NEJMcpc1400834;177 consecutive patients;177;-1
NEJMcpc1400835;1 million patients;1;-1
NEJMcpc1400835;183 patients;183;-1
NEJMcpc1400838;1570 patients;1570;-1
NEJMcpc1400838;111 patients;111;-1
NEJMcpc1400838;11   patients;11;-1
NEJMcpc1400838;301 pediatric patients;301;-1
NEJMcpc1400838;111   patients;111;-1
NEJMcpc1400838;10 patients;10;-1
NEJMcpc1400838;3 patients;3;-1
NEJMcpc1400838;50 patients;50;-1
NEJMcpc1400838;250 patients;250;-1
NEJMcpc1400838;101 patients;101;-1
NEJMcpc1400839;9 HIV-   infected women;9;-1
NEJMcpc1400842;22 Although some patients;22;-1
NEJMcpc1400842;total of 2;2;-1
NEJMcpc1403307;47 con-  secutive patients;47;-1
NEJMcpc1403308;324 consecutive patients;324;-1
NEJMcpc1403308;128 patients;128;-1
NEJMcpc1405218;33 patients;33;-1
NEJMcpc1405218;9 patients;9;-1
NEJMcpc1406191;4  and patients;4;-1
NEJMcpc1406191;21 In patients;21;-1
NEJMcpc1406191;111 patients;111;-1
NEJMcpc1407131;121 patients;121;-1
NEJMcpc1410938;248   patients;248;-1
NEJMcps1212211;18 patients;18;-1
NEJMcps1212310;1 million persons;1;-1
NEJMcps1213196;1 million   patients;1;-1
NEJMcps1300859;14 adults;14;-1
NEJMcps1301321;2 Although men and women;2;-1
NEJMcps1313772;total of 1691;1691;-1
NEJMct1208450;126 patients;126;-1
NEJMct1208450;112 patients;112;-1
NEJMct1215532;1   RNA-suppressed participants;1;-1
NEJMct1215532;6321 patients;6321;-1
NEJMct1215532;202 patients;202;-1
NEJMct1215532;7000 patients;7000;-1
NEJMct1215532;1 patients;1;-1
NEJMct1215532;5295 people;5295;-1
NEJMct1215532;1 posi-  tive individuals;1;-1
NEJMe1312403;700 million people;700;-1
NEJMe1313155;719   patients;719;-1
NEJMe1313690;290 patients;290;-1
NEJMe1313690;2313 patients;2313;-1
NEJMe1313770;2300   cardiac surgical patients;2300;-1
NEJMe1315721;93 patients;93;-1
NEJMe1316036;total of 70;70;-1
NEJMe1316173;4 Treatment of patients;4;-1
NEJMe1316173;114 patients;114;-1
NEJMe1400092;689   participants;689;-1
NEJMe1400092;34 participants;34;-1
NEJMe1400092;154 participants;154;-1
NEJMe1400593;4 T cells of persons;4;-1
NEJMe1400599;59 persons;59;-1
NEJMe1400599;57 patients;57;-1
NEJMe1400599;46 patients;46;-1
NEJMe1400599;32 patients;32;-1
NEJMe1400599;7 patients;7;-1
NEJMe1400599;85 patients;85;-1
NEJMe1401025;200,000 patients;200000;-1
NEJMe1401025;1006 patients;1006;-1
NEJMe1401025;506 patients;506;-1
NEJMe1401025;499 patients;499;-1
NEJMe1401025;500   patients;500;-1
NEJMe1401231;3445   patients;3445;-1
NEJMe1401440;59 persons;59;-1
NEJMe1401440;57 patients;57;-1
NEJMe1401440;46 patients;46;-1
NEJMe1401440;32 patients;32;-1
NEJMe1401440;7 patients;7;-1
NEJMe1401440;85 patients;85;-1
NEJMe1401440;18 addi-  tional patients;18;-1
NEJMe1401440;20 patients;20;-1
NEJMe1401440;56 patients;56;-1
NEJMe1401508;539 patients;539;-1
NEJMe1401508;1952 patients;1952;-1
NEJMe1401508;2 patients;2;-1
NEJMe1402066;2  High-target group  All patients;2;-1
NEJMe1402388;32 patients;32;-1
NEJMe1402388;40 patients;40;-1
NEJMe1402388;20 patients;20;-1
NEJMe1402388;25 patients;25;-1
NEJMe1402388;200,000 patients;200000;-1
NEJMe1402388;1006 patients;1006;-1
NEJMe1402976;10,010 patients;10010;-1
NEJMe1402976;4382 patients;4382;-1
NEJMe1403689;8 million people;8;-1
NEJMe1404737;2 In some patients;2;-1
NEJMe1405746;49,000 women;49000;-1
NEJMe1405746;5 In postmenopausal   women;5;-1
NEJMe1405766;6 Further studies in-  volving patients;6;-1
NEJMe1406410;3414 patients;3414;-1
NEJMe1406410;25,673 adults;25673;-1
NEJMe1406870;8 In patients;8;-1
NEJMe1407026;11 patients;11;-1
NEJMe1407026;5 patients;5;-1
NEJMe1407026;10 patients;10;-1
NEJMe1407442;2   In patients;2;-1
NEJMe1407477;1725 children and   young adults;1725;-1
NEJMe1407695;3317 participants;3317;-1
NEJMe1407695;1 bil-  lion adults;1;-1
NEJMe1407695;100,000 adults;100000;-1
NEJMe1408614;13 involving patients;13;-1
NEJMe1408976;998 critically   ill patients;998;-1
NEJMe1408976;838 critically ill patients;838;-1
NEJMe1408976;6264 patients;6264;-1
NEJMe1408976;1341 patients;1341;-1
NEJMe1408976;1600 patients;1600;-1
NEJMe1409219;3426 patients;3426;-1
NEJMe1409219;2488 of these patients;2488;-1
NEJMe1409356;1400 patients;1400;-1
NEJMe1409369;6505 patients;6505;-1
NEJMe1409369;12,049 patients;12049;-1
NEJMe1409369;12,000 patients;12000;-1
NEJMe1409449;1 more patients;1;-1
NEJMe1409898;1725 children and   young adults;1725;-1
NEJMe1410394;115 patients;115;-1
NEJMe1411319;50 patients;50;-1
NEJMe1411378;998 critically   ill patients;998;-1
NEJMe1411378;838 critically ill patients;838;-1
NEJMe1411471;2800 people;2800;-1
NEJMe1411903;96 patients;96;-1
NEJMe1412264;1 studied hospitalizations of patients;1;-1
NEJMe1412586;1 enrolled patients;1;-1
NEJMe1412586;2 enrolled patients;2;-1
NEJMe1412586;1 studied hospitalizations of patients;1;-1
NEJMe1412586;1 enrolled;1;-1
NEJMe1412586;2 enrolled;2;-1
NEJMe1412744;3  Two patients;3;-1
NEJMe1412950;28 patients;28;-1
NEJMe1412950;233 adults;233;-1
NEJMe1412950; data from 233;233;-1
NEJMe1413139;50 patients;50;-1
NEJMe1413297;9961 patients;9961;-1
NEJMhle1311198;467 patients;467;-1
NEJMhle1311198;total of 28;28;-1
NEJMhle1311493;100,000   patients;100000;-1
NEJMhle1311493;104 patients;104;-1
NEJMhle1311493;total of 22;22;-1
NEJMhpr1405667;25 million people;25;-1
NEJMhpr1405667;4 million people;4;-1
NEJMhpr1405667;5 million people;5;-1
NEJMhpr1405667;500,000   people;500000;-1
NEJMhpr1405667;5 million uninsured   people;5;-1
NEJMhpr1405667;6 million   people;6;-1
NEJMhpr1405667;46 million   people;46;-1
NEJMhpr1405667;8 million adults;8;-1
NEJMhpr1405667;1701_Collins   _covering_young_adults;1701;-1
NEJMhpr1405667;total   of 38;38;-1
NEJMicm1310017;total of 24;24;-1
NEJMicm1313055;total of 21;21;-1
NEJMms1310675;100,000 U.S. patients;100000;-1
NEJMms1310675;2 A survey of patients;2;-1
NEJMms1314569;4 These groups are patients;4;-1
NEJMms1406844;66 patients;66;-1
NEJMms1409003;5 So women;5;-1
NEJMoa1114576;779 patients;779;3739
NEJMoa1114576;16 patients;16;3307
NEJMoa1114576;15 patients;15;3058
NEJMoa1114576;31 patients;31;3018
NEJMoa1114576;148 patients;148;2884
NEJMoa1114576;68 patients;68;2744
NEJMoa1114576;3 patients;3;2230
NEJMoa1114576;109 patients;109;1157
NEJMoa1114576;93 patients;93;990
NEJMoa1114576;54 patients;54;1731
NEJMoa1114576;18 patients;18;3064
NEJMoa1114576;86 patients;86;4793
NEJMoa1114576;79 patients;79;3738
NEJMoa1114576;161 patients;161;11965
NEJMoa1114576;N = 462;462;2038
NEJMoa1114576;N = 317;317;2092
NEJMoa1206605;19 patients;19;-1
NEJMoa1206605;15 patients;15;-1
NEJMoa1206605;4 patients;4;-1
NEJMoa1206605;11 patients;11;-1
NEJMoa1206605;13   patients;13;-1
NEJMoa1206605;17 patients;17;-1
NEJMoa1206605;total of 19;19;-1
NEJMoa1206605;total of 21;21;-1
NEJMoa1211161;268 patients;268;7831
NEJMoa1211161;107 patients;107;7611
NEJMoa1211161;14 We screened   patients;14;4054
NEJMoa1211161;64 patients;64;3257
NEJMoa1211161;25 patients;25;3006
NEJMoa1211161;14 patients;14;15912
NEJMoa1211161;15 patients;15;15970
NEJMoa1211161;21 patients;21;16082
NEJMoa1211161;4 patients;4;3256
NEJMoa1211161;5 patients;5;3005
NEJMoa1211161;12 patients;12;17255
NEJMoa1211161;2 patients;2;17256
NEJMoa1211161;N = 51;51;1682
NEJMoa1211161;N = 217;217;1642
NEJMoa1211161;N=60;60;7030
NEJMoa1211161;N=208;208;7053
NEJMoa1211161;N=71;71;7224
NEJMoa1211161;N=197;197;7247
NEJMoa1211161;N=53;53;7444
NEJMoa1211161;N=137;137;7469
NEJMoa1211161;N=37;37;7501
NEJMoa1211161;N=23;23;7533
NEJMoa1211161;N=110;110;7572
NEJMoa1211161;N=80;80;7610
NEJMoa1211161;N=170;170;7677
NEJMoa1211161;N = 268;268;11032
NEJMoa1211161;N = 330;330;11061
NEJMoa1212444;1761 patients;1761;-1
NEJMoa1212444;294 patients;294;-1
NEJMoa1212444;100 patients;100;-1
NEJMoa1212444;24 patients;24;-1
NEJMoa1212444;94 patients;94;-1
NEJMoa1212444;17 We excluded patients;17;-1
NEJMoa1212444;1647 patients;1647;-1
NEJMoa1212444;114 patients;114;-1
NEJMoa1212444;14 patients;14;-1
NEJMoa1212444;19 For patients;19;-1
NEJMoa1212444;100   patients;100;-1
NEJMoa1212444;394 study patients;394;-1
NEJMoa1212444;394 patients;394;-1
NEJMoa1212444;418 patients;418;-1
NEJMoa1212444;1761 patients recruited;1761;-1
NEJMoa1212444;N = 294;294;-1
NEJMoa1212444;N = 100;100;-1
NEJMoa1212444;N = 394;394;-1
NEJMoa1214289;N = 6397;6397;-1
NEJMoa1214289;N = 7561;7561;-1
NEJMoa1214289;N = 13,958;13958;-1
NEJMoa1214289;N = 6263;6263;-1
NEJMoa1214289;N = 4646;4646;-1
NEJMoa1214289;total   of 12;12;-1
NEJMoa1214289;total of 166;166;-1
NEJMoa1214289;total of 4646;4646;-1
NEJMoa1214482;1005 patients;1005;-1
NEJMoa1214482;439 patients;439;-1
NEJMoa1214482;186 patients;186;-1
NEJMoa1214482;32 patients;32;-1
NEJMoa1214482;133 severely ill patients;133;-1
NEJMoa1214482;105 patients;105;-1
NEJMoa1214482;625 patients;625;-1
NEJMoa1214482;103 patients;103;-1
NEJMoa1214482;120 patients;120;-1
NEJMoa1214482;2 patients;2;-1
NEJMoa1214482;N = 507;507;-1
NEJMoa1214482;N = 498;498;-1
NEJMoa1214482;total of 70;70;-1
NEJMoa1214482;total of 1010;1010;-1
NEJMoa1214482;total of 160;160;-1
NEJMoa1214482;total of 227;227;-1
NEJMoa1214482;total of 105;105;-1
NEJMoa1214482;507 children enrolled;507;-1
NEJMoa1214901;758 participants;758;-1
NEJMoa1214901;376 participants;376;-1
NEJMoa1214901;72 participants;72;-1
NEJMoa1214901;2 participants;2;-1
NEJMoa1214901;1012 participants;1012;-1
NEJMoa1214901;758   participants;758;-1
NEJMoa1214901;754   participants;754;-1
NEJMoa1214901;38 participants;38;-1
NEJMoa1214901;22 participants;22;-1
NEJMoa1214901;1145 participants;1145;-1
NEJMoa1214901;5 participants;5;-1
NEJMoa1214901;3 participants;3;-1
NEJMoa1214901;22   participants;22;-1
NEJMoa1214901;14 participants;14;-1
NEJMoa1214901;77 participants;77;-1
NEJMoa1214901;39 participants;39;-1
NEJMoa1214901;57 participants;57;-1
NEJMoa1214901;38   participants;38;-1
NEJMoa1214901;55 participants;55;-1
NEJMoa1214901;10 participants;10;-1
NEJMoa1214901;24 involving ART-treated adults;24;-1
NEJMoa1214901;8 and adults;8;-1
NEJMoa1214901;N = 376;376;-1
NEJMoa1214901;N = 382;382;-1
NEJMoa1214901;total of 758;758;-1
NEJMoa1214901;total of   2;2;-1
NEJMoa1214901;total of 1012;1012;-1
NEJMoa1214901;total of 384;384;-1
NEJMoa1214901;total of 38;38;-1
NEJMoa1214901;total of 96;96;-1
NEJMoa1214901;total of 2;2;-1
NEJMoa1214901;total of 21;21;-1
NEJMoa1214901;total of 72;72;-1
NEJMoa1214901;total of 252;252;-1
NEJMoa1214901;total of 5;5;-1
NEJMoa1215246;59 patients;59;6353
NEJMoa1215246;10 patients;10;5463
NEJMoa1215246;4 patients;4;5188
NEJMoa1215246;3 patients;3;4331
NEJMoa1215246;4 and patients;4;4274
NEJMoa1215246;22 patients;22;2535
NEJMoa1215246;34 patients;34;832
NEJMoa1215246;20 patients;20;925
NEJMoa1215246;5 patients;5;989
NEJMoa1215246;2 patients;2;2534
NEJMoa1215246;17 patients;17;1671
NEJMoa1215246;36 patients;36;1902
NEJMoa1215246;4 other patients;4;2678
NEJMoa1215246;32 patients;32;3540
NEJMoa1215246;57 patients;57;3611
NEJMoa1215246;56 patients;56;4254
NEJMoa1215246;39 patients;39;4722
NEJMoa1215246;18 patients;18;5002
NEJMoa1215246;12 patients;12;5119
NEJMoa1215246;6 patients;6;1903
NEJMoa1215246;15 patients;15;7850
NEJMoa1215246;24 patients;24;8210
NEJMoa1215246;N = 46;46;19645
NEJMoa1215246;N = 13;13;19710
NEJMoa1300662;7 participants;7;-1
NEJMoa1300662;11 participants;11;-1
NEJMoa1300662;12 patients;12;-1
NEJMoa1300662;6 patients;6;-1
NEJMoa1300662;12   patients;12;-1
NEJMoa1300662;2 patients;2;-1
NEJMoa1300662;total of   30;30;-1
NEJMoa1300955;20,000 participants;20000;-1
NEJMoa1300955;25,000 participants;25000;-1
NEJMoa1300955;25,673 participants;25673;-1
NEJMoa1300955;1696 participants;1696;-1
NEJMoa1300955;1758 participants;1758;-1
NEJMoa1300955;2203 participants;2203;-1
NEJMoa1300955;2159 participants;2159;-1
NEJMoa1300955;798 participants;798;-1
NEJMoa1300955;8299 participants;8299;-1
NEJMoa1300955;17,374 participants;17374;-1
NEJMoa1300955;1000  participants;1000;-1
NEJMoa1300955;10,000 participants;10000;-1
NEJMoa1300955;1000 participants;1000;-1
NEJMoa1300955;674 participants;674;-1
NEJMoa1300955;59 participants;59;-1
NEJMoa1300955;174 participants;174;-1
NEJMoa1300955;170,000 participants;170000;-1
NEJMoa1300955;1000 patients;1000;-1
NEJMoa1300955;37 patients;37;-1
NEJMoa1300955;139 patients;139;-1
NEJMoa1300955;51,698 people;51698;-1
NEJMoa1300955;25,673 adults;25673;-1
NEJMoa1300955;N = 12,838;12838;-1
NEJMoa1300955;N = 12,835;12835;-1
NEJMoa1300955;N = 25,673;25673;-1
NEJMoa1300955;N=12,838;12838;-1
NEJMoa1300955;N=12,835;12835;-1
NEJMoa1300955;total of 2;2;-1
NEJMoa1300955;total of 25,673;25673;-1
NEJMoa1300955; data from   170,000;170000;-1
NEJMoa1301150;4 In immunocompromised   persons;4;-1
NEJMoa1301150;261 persons;261;-1
NEJMoa1301150;147 participants;147;-1
NEJMoa1301150;4 participants;4;-1
NEJMoa1301150;3 participants;3;-1
NEJMoa1301150;2 participants;2;-1
NEJMoa1301150;155 participants;155;-1
NEJMoa1301150;18 participants;18;-1
NEJMoa1301150;N = 30;30;-1
NEJMoa1301150;N = 33;33;-1
NEJMoa1301150;N = 32;32;-1
NEJMoa1301150;N = 29;29;-1
NEJMoa1301150;N = 31;31;-1
NEJMoa1301150;N = 155;155;-1
NEJMoa1301150;total of 147;147;-1
NEJMoa1301150;total of 4180;4180;-1
NEJMoa1301630;N = 76;76;-1
NEJMoa1301630;N = 77;77;-1
NEJMoa1301630;N = 230;230;-1
NEJMoa1301630;N   =   7;7;-1
NEJMoa1301630;total of 1133;1133;-1
NEJMoa1301630;total of 230;230;-1
NEJMoa1301630;total of 16;16;-1
NEJMoa1301824;300 morbidly obese white patients;300;-1
NEJMoa1301956;95 participants;95;-1
NEJMoa1301956;1 billion people;1;-1
NEJMoa1301956;N = 119;119;-1
NEJMoa1301956;N = 121;121;-1
NEJMoa1301956;N = 120;120;-1
NEJMoa1301956;N = 480;480;-1
NEJMoa1301956;total of 380;380;-1
NEJMoa1301956;total of 4;4;-1
NEJMoa1301956;total of 18;18;-1
NEJMoa1301956;total of 84;84;-1
NEJMoa1301956;total of 443;443;-1
NEJMoa1301956;total of 349;349;-1
NEJMoa1302097;1006 patients;1006;-1
NEJMoa1302097;6 patients;6;-1
NEJMoa1302097;32 patients;32;-1
NEJMoa1302097;12 patients;12;-1
NEJMoa1302097;10 patients;10;-1
NEJMoa1302097;16 patients;16;-1
NEJMoa1302097;9 These patients;9;-1
NEJMoa1302097;1000 patients;1000;-1
NEJMoa1302097;1005 patients;1005;-1
NEJMoa1302097;5 patients;5;-1
NEJMoa1302097;9 patients;9;-1
NEJMoa1302097;303 patients;303;-1
NEJMoa1302097;13 patients;13;-1
NEJMoa1302097;28   patients;28;-1
NEJMoa1302097;8 patients;8;-1
NEJMoa1302097;25 patients;25;-1
NEJMoa1302097;18 patients;18;-1
NEJMoa1302097;3 patients;3;-1
NEJMoa1302097;14 patients;14;-1
NEJMoa1302097;15 patients;15;-1
NEJMoa1302097;58 patients;58;-1
NEJMoa1302097;10 of these patients;10;-1
NEJMoa1302097;59 patients;59;-1
NEJMoa1302097;15,520 patients;15520;-1
NEJMoa1302097;N = 506;506;-1
NEJMoa1302097;N = 499;499;-1
NEJMoa1302097;N=506;506;-1
NEJMoa1302097;N=499;499;-1
NEJMoa1302097;total of 6;6;-1
NEJMoa1302097;total of 12;12;-1
NEJMoa1302097;total   of 1006;1006;-1
NEJMoa1302097;1006 patients were enrolled;1006;-1
NEJMoa1302564;1369 patients;1369;-1
NEJMoa1302564;694 patients;694;-1
NEJMoa1302564;675 patients;675;-1
NEJMoa1302564;135 patients;135;-1
NEJMoa1302564;799 patients;799;-1
NEJMoa1302564;570 patients;570;-1
NEJMoa1302564;18 Were not recruited;18;-1
NEJMoa1302564;513 Were not recruited;513;-1
NEJMoa1302564;N = 694;694;-1
NEJMoa1302564;N = 675;675;-1
NEJMoa1302564;total of 1369;1369;-1
NEJMoa1302564;total of 19,924;19924;-1
NEJMoa1302564;total of 60;60;-1
NEJMoa1302564;total of 135;135;-1
NEJMoa1302564;total of 11;11;-1
NEJMoa1303224;5600 participants;5600;532
NEJMoa1303224;12,000 eligible participants;12000;1881
NEJMoa1303224;5481 participants;5481;1995
NEJMoa1303224;12,000 participants;12000;2978
NEJMoa1303224;514 participants;514;3337
NEJMoa1303224;1 of the participants;1;6462
NEJMoa1303224;1000   participants;1000;9160
NEJMoa1303224;41 participants;41;10456
NEJMoa1303224;2 patients;2;7241
NEJMoa1303224;N = 6000;6000;4703
NEJMoa1303224;N = 549;549;4762
NEJMoa1303224;N = 550;550;4791
NEJMoa1303224;total of 12,000;12000;11433
NEJMoa1303224;total of 14,445;14445;1797
NEJMoa1303224;total of   514;514;3326
NEJMoa1303224;total of 594;594;3879
NEJMoa1303224;total of 202;202;4224
NEJMoa1303224;total of   68;68;10325
NEJMoa1303646;719 participants;719;-1
NEJMoa1303646;8  In patients;8;-1
NEJMoa1303646;750 patients;750;-1
NEJMoa1303646;731 patients;731;-1
NEJMoa1303646;235 patients;235;-1
NEJMoa1303646;225 patients;225;-1
NEJMoa1303646;176 patients;176;-1
NEJMoa1303646;167 patients;167;-1
NEJMoa1303646;178 patients;178;-1
NEJMoa1303646;37 patients;37;-1
NEJMoa1303646;179 patients;179;-1
NEJMoa1303646;138 patients;138;-1
NEJMoa1303646;N = 182;182;-1
NEJMoa1303646;N = 178;178;-1
NEJMoa1303646;N = 180;180;-1
NEJMoa1303646;N = 179;179;-1
NEJMoa1303646;N = 59;59;-1
NEJMoa1303646;N = 61;61;-1
NEJMoa1303646;total of 719;719;-1
NEJMoa1303646;total of 731;731;-1
NEJMoa1303657;157 patients;157;-1
NEJMoa1303657;189 patients;189;-1
NEJMoa1303657;14 patients;14;-1
NEJMoa1303657;44 patients;44;-1
NEJMoa1303657;8 patients;8;-1
NEJMoa1303657;64 randomly selected patients;64;-1
NEJMoa1303657;9 patients;9;-1
NEJMoa1303657;35 patients;35;-1
NEJMoa1303657;55 patients;55;-1
NEJMoa1303657;5 patients;5;-1
NEJMoa1303657;19 patients;19;-1
NEJMoa1303657;17 patients;17;-1
NEJMoa1303657;N   =   2;2;-1
NEJMoa1303657;N   =   1;1;-1
NEJMoa1303657;N   =   3;3;-1
NEJMoa1303657;total of 1599;1599;-1
NEJMoa1303944;N = 882;882;-1
NEJMoa1303944;total of 102;102;-1
NEJMoa1303944;total of 444;444;-1
NEJMoa1303944;9 Newborns were enrolled;9;-1
NEJMoa1304127;6970 persons;6970;-1
NEJMoa1304127;1 million persons;1;-1
NEJMoa1304127;38 million participants;38;-1
NEJMoa1304127;4 million   participants;4;-1
NEJMoa1304127;1 million adults;1;-1
NEJMoa1304127;1 million   adults;1;-1
NEJMoa1304127;total of 1;1;-1
NEJMoa1304127; data from   24;24;-1
NEJMoa1304127; data from 66;66;-1
NEJMoa1304501;20 women;20;-1
NEJMoa1304501;8970 participants;8970;-1
NEJMoa1304501;2457 participants;2457;-1
NEJMoa1304501;59 HPFS participants;59;-1
NEJMoa1304501;123 HPFS participants;123;-1
NEJMoa1304501;11,427 participants;11427;-1
NEJMoa1304501;2457 HPFS participants;2457;-1
NEJMoa1304501;179,081 for all participants;179081;-1
NEJMoa1304501;2 diabetic patients;2;-1
NEJMoa1304501;11,427 adults;11427;-1
NEJMoa1304501;46 million white adults;46;-1
NEJMoa1304501;total of 3083;3083;-1
NEJMoa1304501;total of 227;227;-1
NEJMoa1304501;total of 20;20;-1
NEJMoa1304501;total   of 20;20;-1
NEJMoa1304617;139 persons;139;-1
NEJMoa1304617;131 persons;131;-1
NEJMoa1304617;137 persons;137;-1
NEJMoa1304617;47 persons;47;-1
NEJMoa1304617;47   persons;47;-1
NEJMoa1304617;30 persons;30;-1
NEJMoa1304617;2 patients;2;-1
NEJMoa1304617;2675 close contacts of case patients;2675;-1
NEJMoa1304617;9 case patients;9;-1
NEJMoa1304617;104 patients;104;-1
NEJMoa1304617;108 patients;108;-1
NEJMoa1304617;79 case patients;79;-1
NEJMoa1304617;9 Nine of the patients;9;-1
NEJMoa1304617;139 patients;139;-1
NEJMoa1304617;103 patients;103;-1
NEJMoa1304617;2 critically ill   patients;2;-1
NEJMoa1304617;107 patients;107;-1
NEJMoa1304617;8 patients;8;-1
NEJMoa1304617;23 patients;23;-1
NEJMoa1304617;79 patients;79;-1
NEJMoa1304617;32 patients;32;-1
NEJMoa1304617;107 case patients;107;-1
NEJMoa1304617;45 patients;45;-1
NEJMoa1304617;139 case patients;139;-1
NEJMoa1304617;137 patients;137;-1
NEJMoa1304617;109 of the patients;109;-1
NEJMoa1304617;83 patients;83;-1
NEJMoa1304617;47 patients;47;-1
NEJMoa1304617;1953 close contacts of the patients;1953;-1
NEJMoa1304617;87 patients;87;-1
NEJMoa1304617;9 case   patients;9;-1
NEJMoa1304617;1   case patients;1;-1
NEJMoa1304617;48 case patients;48;-1
NEJMoa1304617;9   patients;9;-1
NEJMoa1304617;N = 139;139;-1
NEJMoa1304617;total of 137;137;-1
NEJMoa1304617;total of 47;47;-1
NEJMoa1304617;total of 139;139;-1
NEJMoa1304617;total of   47;47;-1
NEJMoa1304617;total of 79;79;-1
NEJMoa1304617;total of 87;87;-1
NEJMoa1304617; data from H7;7;-1
NEJMoa1304839;1000 participants;1000;11936
NEJMoa1304839;1300 participants;1300;11726
NEJMoa1304839;141 participants;141;10864
NEJMoa1304839;3 trials involv-  ing patients;3;19664
NEJMoa1304839;2   clinical studies involving patients;2;16510
NEJMoa1304839;1121   patients;1121;3817
NEJMoa1304839;1331 patients;1331;3608
NEJMoa1304839;1090 patients;1090;3273
NEJMoa1304839;1114 patients;1114;3129
NEJMoa1304839;141 patients;141;270
NEJMoa1304839;75 patients;75;3685
NEJMoa1304839;12 patients;12;3804
NEJMoa1304839;432 patients;432;5690
NEJMoa1304839;493 patients;493;6161
NEJMoa1304839;47 patients;47;7213
NEJMoa1304839;352 patients;352;8612
NEJMoa1304839;169 patients;169;8733
NEJMoa1304839;337 patients;337;12154
NEJMoa1304839;329 patients;329;12235
NEJMoa1304839;20 patients;20;13232
NEJMoa1304839;448 patients;448;15490
NEJMoa1304839;524 patients;524;15655
NEJMoa1304839;7 patients;7;7214
NEJMoa1304839;N = 1090;1090;1849
NEJMoa1304839;N = 1114;1114;1826
NEJMoa1304839;N = 432;432;1805
NEJMoa1304839;N = 658;658;1768
NEJMoa1304839;N = 493;493;1748
NEJMoa1304839;N = 314;314;1711
NEJMoa1304839;N = 307;307;1674
NEJMoa1304839;total of   1090;1090;18993
NEJMoa1304839;total of 6;6;4005
NEJMoa1304839;total   of 5;5;16395
NEJMoa1304839; data from the 2;2;196
NEJMoa1304839; data from 448;448;15479
NEJMoa1304839; data from 524;524;15644
NEJMoa1304923;5000 participants;5000;-1
NEJMoa1304923;9165 participants;9165;-1
NEJMoa1304923;119 participants;119;-1
NEJMoa1304923;150 participants;150;-1
NEJMoa1304923;158 participants;158;-1
NEJMoa1304923;1291 participants;1291;-1
NEJMoa1304923;11 participants;11;-1
NEJMoa1304923;1291 children recruited;1291;-1
NEJMoa1304923;N = 5044;5044;-1
NEJMoa1304923;N = 5033;5033;-1
NEJMoa1304923;total of 10,077;10077;-1
NEJMoa1304923;total of 5041;5041;-1
NEJMoa1304923;total of   9165;9165;-1
NEJMoa1304923;total of 119;119;-1
NEJMoa1304923;total   of 1950;1950;-1
NEJMoa1304923;total of 150;150;-1
NEJMoa1304923;10,077 children were   enrolled;10077;-1
NEJMoa1305224;419 postmenopausal women;419;-1
NEJMoa1305224;419 postmenopausal   women;419;-1
NEJMoa1305224;419 participants;419;-1
NEJMoa1305224;367 of the participants;367;-1
NEJMoa1305224;52 participants;52;-1
NEJMoa1305224;50 participants;50;-1
NEJMoa1305224;36 participants;36;-1
NEJMoa1305224;N=55;55;-1
NEJMoa1305224;N=51;51;-1
NEJMoa1305224;N=52;52;-1
NEJMoa1305224;N=53;53;-1
NEJMoa1305224;N=54;54;-1
NEJMoa1305224;N=22;22;-1
NEJMoa1305224;N=30;30;-1
NEJMoa1305224;N = 52;52;-1
NEJMoa1305224;N = 51;51;-1
NEJMoa1305224;N = 55;55;-1
NEJMoa1305224;N = 261;261;-1
NEJMoa1305224;N = 50;50;-1
NEJMoa1305224;N = 49;49;-1
NEJMoa1305224;N = 53;53;-1
NEJMoa1305224;N = 48;48;-1
NEJMoa1305224;N = 54;54;-1
NEJMoa1305224;N = 255;255;-1
NEJMoa1305224;total of 367;367;-1
NEJMoa1305224;total of 419;419;-1
NEJMoa1305224;419 participants were enrolled;419;-1
NEJMoa1305727;1818 patients;1818;-1
NEJMoa1305727;895 patients;895;-1
NEJMoa1305727;888 patients;888;-1
NEJMoa1305727;700 patients;700;-1
NEJMoa1305727;1800 patients;1800;-1
NEJMoa1305727;841 patients;841;-1
NEJMoa1305727;910 patients;910;-1
NEJMoa1305727;579 patients;579;-1
NEJMoa1305727;8 patients;8;-1
NEJMoa1305727;2 patients;2;-1
NEJMoa1305727;903 patients;903;-1
NEJMoa1305727;888   patients;888;-1
NEJMoa1305727;1121 patients;1121;-1
NEJMoa1305727;582 patients;582;-1
NEJMoa1305727;N = 903;903;-1
NEJMoa1305727;N = 907;907;-1
NEJMoa1305727;total   of 1818;1818;-1
NEJMoa1305727;total   of 8;8;-1
NEJMoa1305727; data from the 1121;1121;-1
NEJMoa1306187;544 persons;544;-1
NEJMoa1306187;146 participants;146;-1
NEJMoa1306187;181 participants;181;-1
NEJMoa1306187;10 participants;10;-1
NEJMoa1306187;136 participants;136;-1
NEJMoa1306187;90 participants;90;-1
NEJMoa1306187;181 patients;181;-1
NEJMoa1306187;N = 61;61;-1
NEJMoa1306187;N = 58;58;-1
NEJMoa1306187;N = 62;62;-1
NEJMoa1306187;total of 10;10;-1
NEJMoa1306187;total of 544;544;-1
NEJMoa1306187;total of 136;136;-1
NEJMoa1306218;44 previously untreated   patients;44;-1
NEJMoa1306218;44 patients;44;-1
NEJMoa1306218;123 additional patients;123;-1
NEJMoa1306218;82 previously untreated patients;82;-1
NEJMoa1306218;41 patients;41;-1
NEJMoa1306218;211 patients;211;-1
NEJMoa1306218;126 previously untreated patients;126;-1
NEJMoa1306218;26 patients;26;-1
NEJMoa1306218;18 patients;18;-1
NEJMoa1306218;82 untreated patients;82;-1
NEJMoa1306218;40 patients;40;-1
NEJMoa1306218;14 patients;14;-1
NEJMoa1306218;20 patients;20;-1
NEJMoa1306218;126 untreated patients;126;-1
NEJMoa1306218;167 patients;167;-1
NEJMoa1306218;85 patients;85;-1
NEJMoa1306218;82   patients;82;-1
NEJMoa1306218;3 patients;3;-1
NEJMoa1306218;132 patients;132;-1
NEJMoa1306218;35 patients;35;-1
NEJMoa1306218;61 patients;61;-1
NEJMoa1306218;150 patients;150;-1
NEJMoa1306218;175 patients;175;-1
NEJMoa1306218;10 patients;10;-1
NEJMoa1306218;90 patients;90;-1
NEJMoa1306218;121 patients;121;-1
NEJMoa1306218;126 patients;126;-1
NEJMoa1306218;6 patients;6;-1
NEJMoa1306218;123 untreated patients;123;-1
NEJMoa1306218;23 patients;23;-1
NEJMoa1306218;193 patients;193;-1
NEJMoa1306218;27 patients;27;-1
NEJMoa1306218;5 patients;5;-1
NEJMoa1306218;1b patients;1;-1
NEJMoa1306218;170 mil-lion people;170;-1
NEJMoa1306218;N   =   1;1;-1
NEJMoa1306218;N   =   4;4;-1
NEJMoa1306218;N   =   2;2;-1
NEJMoa1306218;N = 16;16;-1
NEJMoa1306218;N = 14;14;-1
NEJMoa1306218;N = 44;44;-1
NEJMoa1306218;N = 15;15;-1
NEJMoa1306218;N = 41;41;-1
NEJMoa1306218;N = 126;126;-1
NEJMoa1306218;N = 21;21;-1
NEJMoa1306218;N = 20;20;-1
NEJMoa1306218;N = 31;31;-1
NEJMoa1306218;N = 28;28;-1
NEJMoa1306218;N = 29;29;-1
NEJMoa1306218;total of 92;92;-1
NEJMoa1306218;total of 211;211;-1
NEJMoa1306218;total of 44;44;-1
NEJMoa1306227;571 patients;571;-1
NEJMoa1306227;11 Because   patients;11;-1
NEJMoa1306227;1013 patients;1013;-1
NEJMoa1306227;438 previously untreated patients;438;-1
NEJMoa1306227;166 patients;166;-1
NEJMoa1306227;79 patients;79;-1
NEJMoa1306227;80 patients;80;-1
NEJMoa1306227;41 patients;41;-1
NEJMoa1306227;0  SAFETY  A total of eight patients;0;-1
NEJMoa1306227;11 patients;11;-1
NEJMoa1306227;5 patients;5;-1
NEJMoa1306227;7 patients;7;-1
NEJMoa1306227;4 patients;4;-1
NEJMoa1306227;24 patients;24;-1
NEJMoa1306227;25 pre-  viously untreated patients;25;-1
NEJMoa1306227;10 patients;10;-1
NEJMoa1306227;1B patients;1;-1
NEJMoa1306227;1 patients;1;-1
NEJMoa1306227;N = 438;438;-1
NEJMoa1306227;N = 133;133;-1
NEJMoa1306227;N=80;80;-1
NEJMoa1306227;N=41;41;-1
NEJMoa1306227;N=79;79;-1
NEJMoa1306227;N=45;45;-1
NEJMoa1306227;N=43;43;-1
NEJMoa1306227;N   =   8;8;-1
NEJMoa1306227;N   =   4;4;-1
NEJMoa1306227;N   =   7;7;-1
NEJMoa1306227;total of 1013;1013;-1
NEJMoa1306227;total of 571;571;-1
NEJMoa1306227;total of 11;11;-1
NEJMoa1306227;total of 5;5;-1
NEJMoa1306766;318 participants;318;-1
NEJMoa1306766;301   participants;301;-1
NEJMoa1306766;301 participants;301;-1
NEJMoa1306766;37 participants;37;-1
NEJMoa1306766;318 patients;318;-1
NEJMoa1306766;31 Eligible patients;31;-1
NEJMoa1306766;36  Since patients;36;-1
NEJMoa1306766;36  Since patients were recruited;36;-1
NEJMoa1306766;N = 97;97;-1
NEJMoa1306766;N = 90;90;-1
NEJMoa1306766;N = 94;94;-1
NEJMoa1306766;N = 93;93;-1
NEJMoa1306766;N = 95;95;-1
NEJMoa1306766;total of 301;301;-1
NEJMoa1306766;846 Were enrolled;846;-1
NEJMoa1306801;11,282 patients;11282;-1
NEJMoa1306801;648,000 patients;648000;-1
NEJMoa1306801;100 patients;100;-1
NEJMoa1306801;11,290 patients;11290;-1
NEJMoa1306801;4504 patients;4504;-1
NEJMoa1306801;494 patients;494;-1
NEJMoa1306801;452 patients;452;-1
NEJMoa1306801;436 patients;436;-1
NEJMoa1306801;109 patients;109;-1
NEJMoa1306801;27 patients;27;-1
NEJMoa1306801;25 in-  patients;25;-1
NEJMoa1306801;N = 11,282;11282;-1
NEJMoa1306801;N = 10,830;10830;-1
NEJMoa1306801;N = 452;452;-1
NEJMoa1306801;N = 504;504;-1
NEJMoa1306801;N = 110;110;-1
NEJMoa1306801;N = 86;86;-1
NEJMoa1306801;N = 65;65;-1
NEJMoa1306801;N = 50;50;-1
NEJMoa1306801;total of 183;183;-1
NEJMoa1306801;total of 504;504;-1
NEJMoa1306801;total of 481;481;-1
NEJMoa1306801;total of 43;43;-1
NEJMoa1306801;total of 44;44;-1
NEJMoa1306801;total of 42;42;-1
NEJMoa1307095;110,970 persons;110970;-1
NEJMoa1307095;150 persons;150;-1
NEJMoa1307095;3734 persons;3734;-1
NEJMoa1307095;6823 persons;6823;-1
NEJMoa1307095;13 persons;13;-1
NEJMoa1307095;3734 participants;3734;-1
NEJMoa1307095;41,671 participants;41671;-1
NEJMoa1307095;3238 fasting participants;3238;-1
NEJMoa1307095;2082 participants;2082;-1
NEJMoa1307095;34,432 participants;34432;-1
NEJMoa1307095;7239 participants;7239;-1
NEJMoa1307095;110,970 study participants;110970;-1
NEJMoa1307095;110,970 participants;110970;-1
NEJMoa1307095;3061 participants;3061;-1
NEJMoa1307095;27 participants;27;-1
NEJMoa1307095;3237 participants;3237;-1
NEJMoa1307095;34,002 patients;34002;-1
NEJMoa1307095;794 patients;794;-1
NEJMoa1307095;N = 34,432;34432;-1
NEJMoa1307095;N = 7239;7239;-1
NEJMoa1307095;N = 41,671;41671;-1
NEJMoa1307095;N=2913;2913;-1
NEJMoa1307095;N=2722;2722;-1
NEJMoa1307095;N=2485;2485;-1
NEJMoa1307095;N=1390;1390;-1
NEJMoa1307095;total of 3061;3061;-1
NEJMoa1307095;total of   1;1;-1
NEJMoa1307361;11   In all five patients;11;-1
NEJMoa1307361;12   These patients;12;-1
NEJMoa1307361;94 patients;94;-1
NEJMoa1307361;46 patients;46;-1
NEJMoa1307362;3 affected persons;3;-1
NEJMoa1307362;4 persons;4;-1
NEJMoa1307362;19 persons;19;-1
NEJMoa1307362;19 Georgian Jewish participants;19;-1
NEJMoa1307362;19 patients;19;-1
NEJMoa1307362;16 patients;16;-1
NEJMoa1307362;14 unrelated Turkish   patients;14;-1
NEJMoa1307362;15 patients;15;-1
NEJMoa1307362;3 patients;3;-1
NEJMoa1307362;4 patients;4;-1
NEJMoa1307362;13 patients;13;-1
NEJMoa1307362;2 of the patients;2;-1
NEJMoa1307362;20 patients;20;-1
NEJMoa1307362;2 patients;2;-1
NEJMoa1307362;115 patients;115;-1
NEJMoa1307362;200 Turkish adults;200;-1
NEJMoa1307362;total of 4;4;-1
NEJMoa1307362;total of 20;20;-1
NEJMoa1307581;16 Affected   persons;16;-1
NEJMoa1307581;N=5;5;-1
NEJMoa1307581;N  =1;1;-1
NEJMoa1307581;N  =9;9;-1
NEJMoa1308027;75,725 participants;75725;-1
NEJMoa1308027;10,797 participants;10797;-1
NEJMoa1308027;10,333 consecu-  tive participants;10333;-1
NEJMoa1308027;65,392 consecutive participants;65392;-1
NEJMoa1308027;7980 participants;7980;-1
NEJMoa1308027;7557 of these   participants;7557;-1
NEJMoa1308027;10,333 participants;10333;-1
NEJMoa1308027;41 participants;41;-1
NEJMoa1308027;250 participants;250;-1
NEJMoa1308027;251,000 participants;251000;-1
NEJMoa1308027;54,500 individuals;54500;-1
NEJMoa1308027;8 Participants were recruited;8;-1
NEJMoa1308027;N = 19,924;19924;-1
NEJMoa1308027;N = 35,122;35122;-1
NEJMoa1308027;N = 12,699;12699;-1
NEJMoa1308027;N = 4419;4419;-1
NEJMoa1308027;N = 3561;3561;-1
NEJMoa1308027;N=75,465;75465;-1
NEJMoa1308027;N=260;260;-1
NEJMoa1308027;N=75,692;75692;-1
NEJMoa1308027;N=33;33;-1
NEJMoa1308027;N=75,516;75516;-1
NEJMoa1308027;N=209;209;-1
NEJMoa1308027;N=75,707;75707;-1
NEJMoa1308027;N=18;18;-1
NEJMoa1308027;total of 75,725;75725;-1
NEJMoa1308027;total of 13;13;-1
NEJMoa1308027;total of 41;41;-1
NEJMoa1308027; data from 75,725;75725;-1
NEJMoa1308130;18 patients;18;-1
NEJMoa1308345;458 patients;458;-1
NEJMoa1308345;463 patients;463;-1
NEJMoa1308345;921 patients;921;-1
NEJMoa1308345;911 patients;911;-1
NEJMoa1308345;10 patients;10;-1
NEJMoa1308345;43 patients;43;-1
NEJMoa1308345;354 patients;354;-1
NEJMoa1308345;387 patients;387;-1
NEJMoa1308345;284 patients;284;-1
NEJMoa1308345;27 patients;27;-1
NEJMoa1308345;7 patients;7;-1
NEJMoa1308345;339 patients;339;-1
NEJMoa1308345;333 patients;333;-1
NEJMoa1308345;20 patients;20;-1
NEJMoa1308345;12 patients;12;-1
NEJMoa1308345;122 patients;122;-1
NEJMoa1308345;61 patients;61;-1
NEJMoa1308345;8 patients;8;-1
NEJMoa1308345;6 patients;6;-1
NEJMoa1308345;N = 458;458;-1
NEJMoa1308345;N = 463;463;-1
NEJMoa1308345;N = 461;461;-1
NEJMoa1308345;N = 450;450;-1
NEJMoa1308345;total of 458;458;-1
NEJMoa1308345;total   of 921;921;-1
NEJMoa1308345;total   of 911;911;-1
NEJMoa1308345;total of 741;741;-1
NEJMoa1308345;total of 284;284;-1
NEJMoa1308345;total of 21;21;-1
NEJMoa1308345;921 patients were enrolled;921;-1
NEJMoa1308573;978 patients;978;-1
NEJMoa1308573;612 eligible patients;612;-1
NEJMoa1308573;320 patients;320;-1
NEJMoa1308573;621 patients;621;-1
NEJMoa1308573;20 patients;20;-1
NEJMoa1308573;312 patients;312;-1
NEJMoa1308573;309 patients;309;-1
NEJMoa1308573;57 patients;57;-1
NEJMoa1308573;268 patients;268;-1
NEJMoa1308573;274 patients;274;-1
NEJMoa1308573;88 patients;88;-1
NEJMoa1308573;45 patients;45;-1
NEJMoa1308573;317 patients;317;-1
NEJMoa1308573;155 patients;155;-1
NEJMoa1308573;178 patients;178;-1
NEJMoa1308573;39 patients;39;-1
NEJMoa1308573;512 patients;512;-1
NEJMoa1308573;500 patients;500;-1
NEJMoa1308573;303 patients;303;-1
NEJMoa1308573;75 patients;75;-1
NEJMoa1308573;4  number of patients;4;-1
NEJMoa1308573;416 patients;416;-1
NEJMoa1308573;N = 303;303;-1
NEJMoa1308573;N = 300;300;-1
NEJMoa1308573;N = 260;260;-1
NEJMoa1308573;N = 233;233;-1
NEJMoa1308573;total of 978;978;-1
NEJMoa1308573;total of 12;12;-1
NEJMoa1308573;total of 637;637;-1
NEJMoa1308659;29 This design filtered   out persons;29;1589
NEJMoa1308659;126 participants;126;14607
NEJMoa1308659;23 participants;23;13983
NEJMoa1308659;25  Qualified participants;25;7669
NEJMoa1308659;46 consecutive   participants;46;3749
NEJMoa1308659;108 participants;108;377
NEJMoa1308659;40 participants;40;422
NEJMoa1308659;46 consecutive participants;46;4023
NEJMoa1308659;32   Screening potential participants;32;9352
NEJMoa1308659;929 participants;929;10383
NEJMoa1308659;598 participants;598;10480
NEJMoa1308659;56 of these participants;56;10639
NEJMoa1308659;222 participants;222;10753
NEJMoa1308659;30 These patients;30;7760
NEJMoa1308659;N = 126;126;6435
NEJMoa1308659;N=23;23;18925
NEJMoa1308659;total of 124;124;1697
NEJMoa1308659;total of 33;33;5469
NEJMoa1308659;total of 18;18;5852
NEJMoa1308659;total of 126;126;10804
NEJMoa1308659;929 Patients were enrolled;929;9429
NEJMoa1308659;929 participants enrolled;929;10383
NEJMoa1308663;4 million   people;4;-1
NEJMoa1308851;1 and those of the af-  fected women;1;-1
NEJMoa1308851;394 people;394;-1
NEJMoa1308893;11 patients;11;-1
NEJMoa1308893;15   patients;15;-1
NEJMoa1308893;4 ad-  ditional patients;4;-1
NEJMoa1308893;2 patients;2;-1
NEJMoa1308893;69 patients;69;-1
NEJMoa1309086;223,842 patients;223842;-1
NEJMoa1309086;331,164 Total colonoscopies in patients;331164;-1
NEJMoa1309086;223,842   patients;223842;-1
NEJMoa1309086;41,882 Were performed in patients;41882;-1
NEJMoa1309086;3 million people;3;-1
NEJMoa1309086;N = 314,872;314872;-1
NEJMoa1309086;N = 712;712;-1
NEJMoa1309220;10 participants;10;-1
NEJMoa1309220;02  Average of all subjects;2;-1
NEJMoa1309220;N = 159;159;-1
NEJMoa1309220;N = 160;160;-1
NEJMoa1309220;N = 121;121;-1
NEJMoa1309220;N = 127;127;-1
NEJMoa1309220;N = 150;150;-1
NEJMoa1309220;N = 154;154;-1
NEJMoa1309220;N = 109;109;-1
NEJMoa1309220;N = 116;116;-1
NEJMoa1309220;total of 319;319;-1
NEJMoa1309533;22 con-  secutive patients;22;-1
NEJMoa1309533;44 patients;44;-1
NEJMoa1309533;33 patients;33;-1
NEJMoa1309533;11 patients;11;-1
NEJMoa1309533;167 screened patients;167;-1
NEJMoa1309533;2 patients;2;-1
NEJMoa1309533;98 patients;98;-1
NEJMoa1309533;31 patients;31;-1
NEJMoa1309533;9 patients;9;-1
NEJMoa1309533;5 patients;5;-1
NEJMoa1309533;20 patients;20;-1
NEJMoa1309533;15 patients;15;-1
NEJMoa1309533;4 patients;4;-1
NEJMoa1309533;7 patients;7;-1
NEJMoa1309533;N = 33;33;-1
NEJMoa1309533;N = 31;31;-1
NEJMoa1309533;N = 34;34;-1
NEJMoa1309533;N = 98;98;-1
NEJMoa1309533;total of 131;131;-1
NEJMoa1309635;357 con-  secutive patients;357;-1
NEJMoa1309748;452 women;452;-1
NEJMoa1309748;452 patients;452;-1
NEJMoa1309748;450 patients;450;-1
NEJMoa1309748;173 patients;173;-1
NEJMoa1309748;6 patients;6;-1
NEJMoa1309748;219 patients;219;-1
NEJMoa1309748;7 patients;7;-1
NEJMoa1309748;220 patients;220;-1
NEJMoa1309748;15 patients;15;-1
NEJMoa1309748;21 patients;21;-1
NEJMoa1309748;17 patients;17;-1
NEJMoa1309748;9 patients;9;-1
NEJMoa1309748;11 patients;11;-1
NEJMoa1309748;N  =  22;22;-1
NEJMoa1309748;N  =  11;11;-1
NEJMoa1309748;N = 219;219;-1
NEJMoa1309748;N = 220;220;-1
NEJMoa1309748;total of   452;452;-1
NEJMoa1309748;total of 15;15;-1
NEJMoa1309748;452 women were enrolled;452;-1
NEJMoa1309748;425 Patients were enrolled;425;-1
NEJMoa1309753;7738 participants;7738;-1
NEJMoa1309753;N   =   6;6;-1
NEJMoa1309753;N   =   5;5;-1
NEJMoa1309753;N   =   1;1;-1
NEJMoa1309753;total of 45;45;-1
NEJMoa1309753;total of 31;31;-1
NEJMoa1310214;124 pregnant women;124;-1
NEJMoa1310214;123 women;123;-1
NEJMoa1310214;61 women;61;-1
NEJMoa1310214;62 women;62;-1
NEJMoa1310214;4 Identification of pregnant women;4;-1
NEJMoa1310214;60   women;60;-1
NEJMoa1310214;338 pregnant women;338;-1
NEJMoa1310214;157 eli-  gible women;157;-1
NEJMoa1310214;124 women;124;-1
NEJMoa1310214;338 Pregnant women;338;-1
NEJMoa1310214;181 women;181;-1
NEJMoa1310214;89 women;89;-1
NEJMoa1310214;45 women;45;-1
NEJMoa1310214;13 women;13;-1
NEJMoa1310214;14 women;14;-1
NEJMoa1310214;27 women;27;-1
NEJMoa1310214;59   women;59;-1
NEJMoa1310214;16 women;16;-1
NEJMoa1310214;10 women;10;-1
NEJMoa1310214;4 women;4;-1
NEJMoa1310214;53 women;53;-1
NEJMoa1310214;51 women;51;-1
NEJMoa1310214;104 women;104;-1
NEJMoa1310214;N = 61;61;-1
NEJMoa1310214;N = 62;62;-1
NEJMoa1310214;N = 10;10;-1
NEJMoa1310214;N = 38;38;-1
NEJMoa1310214;N = 17;17;-1
NEJMoa1310214;N = 30;30;-1
NEJMoa1310214;total of 124;124;-1
NEJMoa1310214;total of 123;123;-1
NEJMoa1310214;total of 271;271;-1
NEJMoa1310214;total of 18;18;-1
NEJMoa1310214;total of 20;20;-1
NEJMoa1310214;124 women enrolled;124;-1
NEJMoa1310246;652 participants;652;-1
NEJMoa1310246;700 participants;700;-1
NEJMoa1310246;11 patients;11;-1
NEJMoa1310246;4 patients;4;-1
NEJMoa1310246;04 and two patients;4;-1
NEJMoa1310246;N = 214;214;-1
NEJMoa1310246;N = 213;213;-1
NEJMoa1310246;N = 232;232;-1
NEJMoa1310246;N=214;214;-1
NEJMoa1310246;N=213;213;-1
NEJMoa1310246;N=232;232;-1
NEJMoa1310246;N=117;117;-1
NEJMoa1310246;N=115;115;-1
NEJMoa1310246;N=118;118;-1
NEJMoa1310246;N=124;124;-1
NEJMoa1310246;N=125;125;-1
NEJMoa1310246;N=121;121;-1
NEJMoa1310246;N = 211;211;-1
NEJMoa1310246;N = 212;212;-1
NEJMoa1310246;N = 231;231;-1
NEJMoa1310246;N = 228;228;-1
NEJMoa1310246;N = 226;226;-1
NEJMoa1310246;N = 230;230;-1
NEJMoa1310246; data from the 4;4;-1
NEJMoa1310359;2000 persons;2000;-1
NEJMoa1310359;44 subjects;44;-1
NEJMoa1310359;10 patients;10;-1
NEJMoa1310359;171 patients;171;-1
NEJMoa1310359;35 patients;35;-1
NEJMoa1310359;40 patients;40;-1
NEJMoa1310359;82 patients;82;-1
NEJMoa1310359;139 patients;139;-1
NEJMoa1310359;42 patients;42;-1
NEJMoa1310359;181   patients;181;-1
NEJMoa1310359;26 of these patients;26;-1
NEJMoa1310359;14 patients;14;-1
NEJMoa1310359;19 patients;19;-1
NEJMoa1310359;6 patients;6;-1
NEJMoa1310359;5 patients;5;-1
NEJMoa1310359;59 patients;59;-1
NEJMoa1310359;20 patients;20;-1
NEJMoa1310359;N   =   2;2;-1
NEJMoa1310359;N   =   4;4;-1
NEJMoa1310359;N   =   5;5;-1
NEJMoa1310422;475 patients;475;-1
NEJMoa1310422;479 patients;479;-1
NEJMoa1310422;120 patients;120;-1
NEJMoa1310422;250 patients;250;-1
NEJMoa1310422;960 patients;960;-1
NEJMoa1310422;204 patients;204;-1
NEJMoa1310422;500 patients;500;-1
NEJMoa1310422;N = 475;475;-1
NEJMoa1310422;N = 479;479;-1
NEJMoa1310422;N = 244;244;-1
NEJMoa1310422;N = 242;242;-1
NEJMoa1310422;N = 473;473;-1
NEJMoa1310422;N = 481;481;-1
NEJMoa1310460;2001 patients;2001;12505
NEJMoa1310460;900 patients;900;1276
NEJMoa1310460;1200 patients;1200;890
NEJMoa1310460;1270 patients;1270;1793
NEJMoa1310460;290 patients;290;1948
NEJMoa1310460;232 patients;232;2060
NEJMoa1310460;500 patients;500;4671
NEJMoa1310460;117 patients;117;5000
NEJMoa1310460;770 patients;770;5317
NEJMoa1310460;643 patients;643;5615
NEJMoa1310460;765 patients;765;5810
NEJMoa1310460;173 patients;173;5927
NEJMoa1310460;116 patients;116;6162
NEJMoa1310460;1134 patients;1134;30429
NEJMoa1310460;2,313 patients;2313;31649
NEJMoa1310460;N=31;31;13474
NEJMoa1310460;N=87;87;13525
NEJMoa1310460;N=12;12;13583
NEJMoa1310460;N=44;44;13634
NEJMoa1310460;N=122;122;13655
NEJMoa1310460;N=57;57;13679
NEJMoa1310476;6   Study participants;6;-1
NEJMoa1310476;958 patients;958;-1
NEJMoa1310476;956 patients;956;-1
NEJMoa1310476;770 patients;770;-1
NEJMoa1310476;186 patients;186;-1
NEJMoa1310476;5 patients;5;-1
NEJMoa1310476;373 patients;373;-1
NEJMoa1310476;397 patients;397;-1
NEJMoa1310476;13 patients;13;-1
NEJMoa1310476;26 patients;26;-1
NEJMoa1310476;130 patients;130;-1
NEJMoa1310476;371 patients;371;-1
NEJMoa1310476;395 patients;395;-1
NEJMoa1310476;369 patients;369;-1
NEJMoa1310476;393 patients;393;-1
NEJMoa1310476;184 patients;184;-1
NEJMoa1310476;106 patients;106;-1
NEJMoa1310476;105 patients;105;-1
NEJMoa1310476;2 patients;2;-1
NEJMoa1310476;6 patients;6;-1
NEJMoa1310476;11 patients;11;-1
NEJMoa1310476;3 study involving   patients;3;-1
NEJMoa1310476;N = 373;373;-1
NEJMoa1310476;N = 397;397;-1
NEJMoa1310476;N = 186;186;-1
NEJMoa1310476;N   =   3;3;-1
NEJMoa1310476;N   =   1;1;-1
NEJMoa1310476;total of 31;31;-1
NEJMoa1310476; data   from 346;346;-1
NEJMoa1310476; data from 369;369;-1
NEJMoa1310476; data from 166;166;-1
NEJMoa1310480;659 patients;659;-1
NEJMoa1310480;1086 patients;1086;-1
NEJMoa1310480;556 patients;556;-1
NEJMoa1310480;1312 patients;1312;-1
NEJMoa1310480;1303   patients;1303;-1
NEJMoa1310480;652 patients;652;-1
NEJMoa1310480;288 patients;288;-1
NEJMoa1310480;23 patients;23;-1
NEJMoa1310480;9 patients;9;-1
NEJMoa1310480;4 patients;4;-1
NEJMoa1310480;N   =   2;2;-1
NEJMoa1310480;N   =   3;3;-1
NEJMoa1310480;N   =   6;6;-1
NEJMoa1310480;N = 652;652;-1
NEJMoa1310480;N = 651;651;-1
NEJMoa1310480;total of 608;608;-1
NEJMoa1310753;947 participants;947;-1
NEJMoa1310753;1080 participants;1080;-1
NEJMoa1310753;16 participants;16;-1
NEJMoa1310753;5322 Potential participants;5322;-1
NEJMoa1310753;931 trial participants;931;-1
NEJMoa1310753;19 patients;19;-1
NEJMoa1310753;5322 patients;5322;-1
NEJMoa1310753;467 patients;467;-1
NEJMoa1310753;480 patients;480;-1
NEJMoa1310753;472 patients;472;-1
NEJMoa1310753;459 patients;459;-1
NEJMoa1310753;11 patients;11;-1
NEJMoa1310753;N = 459;459;-1
NEJMoa1310753;N = 472;472;-1
NEJMoa1310753;total of 5322;5322;-1
NEJMoa1310753;total of 12;12;-1
NEJMoa1310753;4375 Were not enrolled;4375;-1
NEJMoa1310799;10,000 persons;10000;-1
NEJMoa1310799;57,000 adults;57000;-1
NEJMoa1311037;1914 women;1914;-1
NEJMoa1311037;1741 pregnant women;1741;-1
NEJMoa1311037;2052 women;2052;-1
NEJMoa1311037;39 patients;39;-1
NEJMoa1311037;18 patients;18;-1
NEJMoa1311037;1909 patients;1909;-1
NEJMoa1311037;1905 patients;1905;-1
NEJMoa1311037;57 patients;57;-1
NEJMoa1311037;10 patients;10;-1
NEJMoa1311037;6 patients;6;-1
NEJMoa1311037;3 patients;3;-1
NEJMoa1311037;1914 patients;1914;-1
NEJMoa1311037;9 patients;9;-1
NEJMoa1311037;899 patients;899;-1
NEJMoa1311037;1015 patients;1015;-1
NEJMoa1311037;17 patients;17;-1
NEJMoa1311037;27 patients;27;-1
NEJMoa1311037;13 patients;13;-1
NEJMoa1311037;1912 patients;1912;-1
NEJMoa1311037;1909 unaffected patients;1909;-1
NEJMoa1311037;1906 patients;1906;-1
NEJMoa1311037;1905 unaffected   patients;1905;-1
NEJMoa1311037;1952 patients;1952;-1
NEJMoa1311037;1947 unaffected patients;1947;-1
NEJMoa1311037;1950 unaffected patients;1950;-1
NEJMoa1311037;N = 1909;1909;-1
NEJMoa1311037;N = 1905;1905;-1
NEJMoa1311037;N = 1365;1365;-1
NEJMoa1311037;N = 1361;1361;-1
NEJMoa1311037;N = 899;899;-1
NEJMoa1311037;total of 12;12;-1
NEJMoa1311037;total of 2052;2052;-1
NEJMoa1311084;100 persons;100;-1
NEJMoa1311084;120 Han Chinese   persons;120;-1
NEJMoa1311084;90 persons;90;-1
NEJMoa1311084;120 Han Chinese persons;120;-1
NEJMoa1311084;90   persons;90;-1
NEJMoa1311084;120 Han   Chinese persons;120;-1
NEJMoa1311084;345 Japanese patients;345;-1
NEJMoa1311084;11 patients;11;-1
NEJMoa1311084;29 patients;29;-1
NEJMoa1311084;2 patients;2;-1
NEJMoa1311084;12 patients;12;-1
NEJMoa1311084;11 Japanese patients;11;-1
NEJMoa1311084;7 patients;7;-1
NEJMoa1311084;27 patients;27;-1
NEJMoa1311084;9 other Japanese patients;9;-1
NEJMoa1311084;345 Japa nese patients;345;-1
NEJMoa1311084;total of 97,942;97942;-1
NEJMoa1311107;59 patients;59;-1
NEJMoa1311107;71 patients;71;-1
NEJMoa1311107;130 patients;130;-1
NEJMoa1311107;114 patients;114;-1
NEJMoa1311107;80 patients;80;-1
NEJMoa1311107;18   Approximately one third of patients;18;-1
NEJMoa1311107;8 patients;8;-1
NEJMoa1311107;81 patients;81;-1
NEJMoa1311107;32 patients;32;-1
NEJMoa1311107;12 patients;12;-1
NEJMoa1311107;11 patients;11;-1
NEJMoa1311107;78 patients;78;-1
NEJMoa1311107;122 patients;122;-1
NEJMoa1311107;50 patients;50;-1
NEJMoa1311107;34 patients;34;-1
NEJMoa1311107;66 patients;66;-1
NEJMoa1311107;43 patients;43;-1
NEJMoa1311107;18   patients;18;-1
NEJMoa1311107;64 patients;64;-1
NEJMoa1311107;19 patients;19;-1
NEJMoa1311107;7 patients;7;-1
NEJMoa1311107;321 patients;321;-1
NEJMoa1311107;N = 130;130;-1
NEJMoa1311107;N = 10;10;-1
NEJMoa1311107;N = 14;14;-1
NEJMoa1311107;N = 5;5;-1
NEJMoa1311107;N = 81;81;-1
NEJMoa1311107;total of 59;59;-1
NEJMoa1311107;total of 130;130;-1
NEJMoa1311107;total of 83;83;-1
NEJMoa1311107;total   of 66;66;-1
NEJMoa1311107;total of   114;114;-1
NEJMoa1311107;total of 19;19;-1
NEJMoa1311107;59 patients were enrolled;59;-1
NEJMoa1311107;3 was enrolled;3;-1
NEJMoa1311194;55 persons;55;-1
NEJMoa1311194;48 persons;48;-1
NEJMoa1311194;180 persons;180;-1
NEJMoa1311194;220 persons;220;-1
NEJMoa1311194;248 persons;248;-1
NEJMoa1311194;10,000 persons;10000;-1
NEJMoa1311194;9989 participants;9989;-1
NEJMoa1311194;12,000 participants;12000;-1
NEJMoa1311194;12,776 participants;12776;-1
NEJMoa1311194;9989 of these participants;9989;-1
NEJMoa1311194;65 participants;65;-1
NEJMoa1311194;757 participants;757;-1
NEJMoa1311194;65   participants;65;-1
NEJMoa1311194;60   participants;60;-1
NEJMoa1311194;39 participants;39;-1
NEJMoa1311194;9167 participants;9167;-1
NEJMoa1311194;4457 participants;4457;-1
NEJMoa1311194;10,000 participants;10000;-1
NEJMoa1311194;2840 participants;2840;-1
NEJMoa1311194;3271 participants;3271;-1
NEJMoa1311194;N = 9989;9989;-1
NEJMoa1311194;N=29;29;-1
NEJMoa1311194;N=21;21;-1
NEJMoa1311194;N=10;10;-1
NEJMoa1311194;N=4;4;-1
NEJMoa1311194;N=60;60;-1
NEJMoa1311194;N=39;39;-1
NEJMoa1311194;N=99;99;-1
NEJMoa1311194;N  =1;1;-1
NEJMoa1311194;N  =5;5;-1
NEJMoa1311194;N  =7;7;-1
NEJMoa1311194;N  =3;3;-1
NEJMoa1311194;N  =4;4;-1
NEJMoa1311194;N = 1611;1611;-1
NEJMoa1311194;N = 8389;8389;-1
NEJMoa1311194;N = 696;696;-1
NEJMoa1311194;N = 9304;9304;-1
NEJMoa1311194;total of 12,776;12776;-1
NEJMoa1311194;total of 65;65;-1
NEJMoa1311194;total of 757;757;-1
NEJMoa1311194;total of 69;69;-1
NEJMoa1311194;12,776 participants were enrolled;12776;-1
NEJMoa1311274;426 patients;426;-1
NEJMoa1311274;433 patients;433;-1
NEJMoa1311274;418 patients;418;-1
NEJMoa1311274;255 patients;255;-1
NEJMoa1311274;400 patients;400;-1
NEJMoa1311274;1277 patients;1277;-1
NEJMoa1311274;232 patients;232;-1
NEJMoa1311274;381   patients;381;-1
NEJMoa1311274;379 patients;379;-1
NEJMoa1311274;194 patients;194;-1
NEJMoa1311274;43 patients;43;-1
NEJMoa1311274;22 patients;22;-1
NEJMoa1311274;10 patients;10;-1
NEJMoa1311274;9 patients;9;-1
NEJMoa1311274;2 patients;2;-1
NEJMoa1311274;3 patients;3;-1
NEJMoa1311274;48 patients;48;-1
NEJMoa1311274;6 patients;6;-1
NEJMoa1311274;1268 patients;1268;-1
NEJMoa1311274;1247 patients;1247;-1
NEJMoa1311274;1238 patients;1238;-1
NEJMoa1311274;1277 adults;1277;-1
NEJMoa1311274;N = 426;426;-1
NEJMoa1311274;N = 433;433;-1
NEJMoa1311274;N = 418;418;-1
NEJMoa1311274;N = 1277;1277;-1
NEJMoa1311274;N   =   4;4;-1
NEJMoa1311274;total of 6;6;-1
NEJMoa1311274;total of 48;48;-1
NEJMoa1311367;112 patients;112;-1
NEJMoa1311367;11 patients;11;-1
NEJMoa1311367;82   patients;82;-1
NEJMoa1311367;40 patients;40;-1
NEJMoa1311367;42 patients;42;-1
NEJMoa1311367;30 additional patients;30;-1
NEJMoa1311367;9 patients;9;-1
NEJMoa1311367;21 patients;21;-1
NEJMoa1311367;49 patients;49;-1
NEJMoa1311367;63 patients;63;-1
NEJMoa1311367;47 patients;47;-1
NEJMoa1311367;62 patients;62;-1
NEJMoa1311367;75 and no patients;75;-1
NEJMoa1311367;N = 49;49;-1
NEJMoa1311367;N = 63;63;-1
NEJMoa1311367;N=49;49;-1
NEJMoa1311367;N=63;63;-1
NEJMoa1311367;N=62;62;-1
NEJMoa1311367;N=47;47;-1
NEJMoa1311367;total of   112;112;-1
NEJMoa1311367;total of 30;30;-1
NEJMoa1311367; data from 11;11;-1
NEJMoa1311485;1,687,930 women;1687930;-1
NEJMoa1311485;1015 women;1015;-1
NEJMoa1311485;N = 1015;1015;-1
NEJMoa1311485;N = 1,686,915;1686915;-1
NEJMoa1311593;23 patients;23;-1
NEJMoa1311593;7 patients;7;-1
NEJMoa1311593;N = 347;347;-1
NEJMoa1311593;N = 348;348;-1
NEJMoa1311593;N   =   3;3;-1
NEJMoa1311593;total of 347;347;-1
NEJMoa1311593;total of 294;294;-1
NEJMoa1311593;total of 447;447;-1
NEJMoa1311593;total of 63;63;-1
NEJMoa1311593;695 men enrolled;695;-1
NEJMoa1311738;total of 7;7;-1
NEJMoa1311738; data from 18;18;-1
NEJMoa1311889;101,945 persons;101945;-1
NEJMoa1311889;156,424   persons;156424;-1
NEJMoa1311889;3317 participants;3317;-1
NEJMoa1311889;23 Selection of the participants;23;-1
NEJMoa1311889;101,945 participants;101945;-1
NEJMoa1311889;448 participants;448;-1
NEJMoa1311889;1976 participants;1976;-1
NEJMoa1311889;21,220 participants;21220;-1
NEJMoa1311889;57,988 participants and excluded participants;57988;-1
NEJMoa1311889;305 participants;305;-1
NEJMoa1311889;397 participants;397;-1
NEJMoa1311889;58 participants;58;-1
NEJMoa1311889;101,887   participants;101887;-1
NEJMoa1311889;397   participants;397;-1
NEJMoa1311889;101,887 participants;101887;-1
NEJMoa1311889;57,954 participants and excluded participants;57954;-1
NEJMoa1311889;101,945 people;101945;-1
NEJMoa1311889;N   =   1;1;-1
NEJMoa1311889;N   =   2;2;-1
NEJMoa1311889;N   =   4;4;-1
NEJMoa1311889;N = 10,810;10810;-1
NEJMoa1311889;N = 21,131;21131;-1
NEJMoa1311889;N = 46,663;46663;-1
NEJMoa1311889;N = 12,324;12324;-1
NEJMoa1311889;N = 11,017;11017;-1
NEJMoa1311889;N = 14,262;14262;-1
NEJMoa1311889;N = 31,466;31466;-1
NEJMoa1311889;N = 30,956;30956;-1
NEJMoa1311889;N = 17,171;17171;-1
NEJMoa1311889;N = 8032;8032;-1
NEJMoa1311889; data from   61;61;-1
NEJMoa1311890;156,424 persons;156424;-1
NEJMoa1311890;156,424   persons;156424;-1
NEJMoa1311890;388,796 persons;388796;-1
NEJMoa1311890;156,424 of the eligible persons;156424;-1
NEJMoa1311890;152,606 participants;152606;-1
NEJMoa1311890;1163   participants;1163;-1
NEJMoa1311890;4646 participants;4646;-1
NEJMoa1311890;150,000 adults;150000;-1
NEJMoa1311890;N   =   7;7;-1
NEJMoa1311890;N   =   8;8;-1
NEJMoa1311890;N   =   4;4;-1
NEJMoa1311890;N   =   6;6;-1
NEJMoa1311890;N   =   1;1;-1
NEJMoa1311890;total of 200,905;200905;-1
NEJMoa1311989;218 persons;218;-1
NEJMoa1311989;482 persons;482;-1
NEJMoa1311989;235 persons;235;-1
NEJMoa1311989;112 persons;112;-1
NEJMoa1311989;412 persons;412;-1
NEJMoa1311989;102,216 participants;102216;-1
NEJMoa1311989;448 participants;448;-1
NEJMoa1311989;8637 participants;8637;-1
NEJMoa1311989;43,042 participants;43042;-1
NEJMoa1311989;1083 people;1083;-1
NEJMoa1311989;102,216 adults;102216;-1
NEJMoa1311989;157,543 adults;157543;-1
NEJMoa1311989;102,216   adults;102216;-1
NEJMoa1311989;N = 102,216;102216;-1
NEJMoa1311989;N = 157,543;157543;-1
NEJMoa1311989; data from 61;61;-1
NEJMoa1312173;776 patients;776;-1
NEJMoa1312173;388 patients;388;-1
NEJMoa1312173;600 patients;600;-1
NEJMoa1312173;64 patients;64;-1
NEJMoa1312173;40 patients;40;-1
NEJMoa1312173;14 patients;14;-1
NEJMoa1312173;26 patients;26;-1
NEJMoa1312173;11 patients;11;-1
NEJMoa1312173;N = 388;388;-1
NEJMoa1312173;258 Were enrolled;258;-1
NEJMoa1312547;53,452   persons;53452;-1
NEJMoa1312547;53,302 participants;53302;-1
NEJMoa1312547;49,338 participants;49338;-1
NEJMoa1312547;11,696   participants;11696;-1
NEJMoa1312547;53,302   participants;53302;-1
NEJMoa1312547;18,840 participants;18840;-1
NEJMoa1312547;37 All participants;37;-1
NEJMoa1312547;150 NLST participants;150;-1
NEJMoa1312547;47 of these participants;47;-1
NEJMoa1312547;53,452 patients;53452;-1
NEJMoa1312547;3964 patients;3964;-1
NEJMoa1312547;total of 53,452;53452;-1
NEJMoa1312547;53,452   persons were enrolled;53452;-1
NEJMoa1312547;   data from 5133;5133;-1
NEJMoa1312625;2 We   studied six patients;2;-1
NEJMoa1312625;4 patients;4;-1
NEJMoa1312625;11 patients;11;-1
NEJMoa1312625;5 patients;5;-1
NEJMoa1312625;3 patients;3;-1
NEJMoa1312680;40 case patients;40;-1
NEJMoa1312680;90 case patients;90;-1
NEJMoa1312680;239 patients;239;-1
NEJMoa1312680;40 patients;40;-1
NEJMoa1312680;36 case patients;36;-1
NEJMoa1312680;43 case patients;43;-1
NEJMoa1312680;48 patients;48;-1
NEJMoa1312680;172 controls were recruited;172;-1
NEJMoa1312680;N = 160;160;-1
NEJMoa1312680;N = 40;40;-1
NEJMoa1312680;total of   239;239;-1
NEJMoa1312680;160 controls were enrolled;160;-1
NEJMoa1312808;251 patients;251;-1
NEJMoa1312808;8 million patients;8;-1
NEJMoa1312808;447 of these patients;447;-1
NEJMoa1312808;11 patients;11;-1
NEJMoa1312808;4000 patients;4000;-1
NEJMoa1312808;N = 126;126;-1
NEJMoa1312808;N = 125;125;-1
NEJMoa1312828;949,504 pregnant women;949504;-1
NEJMoa1312828;64,389 women;64389;-1
NEJMoa1312828;46,144 women;46144;-1
NEJMoa1312828;14,040 women;14040;-1
NEJMoa1312828;38   Medicaid-eligible pregnant women;38;-1
NEJMoa1312828;N = 46,144;46144;-1
NEJMoa1312828;N = 885,115;885115;-1
NEJMoa1312828;N = 36,778;36778;-1
NEJMoa1312828;N = 180,564;180564;-1
NEJMoa1312828;total of 64,389;64389;-1
NEJMoa1312828;total of 200;200;-1
NEJMoa1312889;1040 patients;1040;-1
NEJMoa1312889;1012 patients;1012;-1
NEJMoa1312889;25 patients;25;-1
NEJMoa1312889;20 patients;20;-1
NEJMoa1312889;32 patients;32;-1
NEJMoa1312889;169 patients;169;-1
NEJMoa1312889;97 patients;97;-1
NEJMoa1312889;N = 506;506;-1
NEJMoa1312889;N = 519;519;-1
NEJMoa1312889;N = 521;521;-1
NEJMoa1312889;N = 325;325;-1
NEJMoa1312889;N = 322;322;-1
NEJMoa1312889;N = 1027;1027;-1
NEJMoa1312889;N = 1025;1025;-1
NEJMoa1312889;total of 1012;1012;-1
NEJMoa1312889;total of 169;169;-1
NEJMoa1312889;1012 patients were enrolled;1012;-1
NEJMoa1312889;1040 patients were enrolled;1040;-1
NEJMoa1312890;10 patients;10;-1
NEJMoa1312890;27 untreated patients;27;-1
NEJMoa1312890;5   In patients;5;-1
NEJMoa1312890;74 patients;74;-1
NEJMoa1312890;37 patients;37;-1
NEJMoa1312890;4 patients;4;-1
NEJMoa1312890;12 patients;12;-1
NEJMoa1312890;26 patients;26;-1
NEJMoa1312890;56 of these patients;56;-1
NEJMoa1312890;27 patients;27;-1
NEJMoa1312890;N = 10;10;-1
NEJMoa1312890;N = 12;12;-1
NEJMoa1312890;N = 45;45;-1
NEJMoa1312890;N = 25;25;-1
NEJMoa1312890;N = 20;20;-1
NEJMoa1312890;N = 74;74;-1
NEJMoa1312890;N = 37;37;-1
NEJMoa1312890;N = 27;27;-1
NEJMoa1312890;total   of 1359;1359;-1
NEJMoa1313122;47 were   women;47;-1
NEJMoa1313122;78 patients;78;-1
NEJMoa1313122;2 patients;2;-1
NEJMoa1313122;5 patients;5;-1
NEJMoa1313122;4 patients;4;-1
NEJMoa1313122;10 randomly selected patients;10;-1
NEJMoa1313122;26 patients;26;-1
NEJMoa1313122;79 patients;79;-1
NEJMoa1313122;51   of the patients;51;-1
NEJMoa1313122;7 patients;7;-1
NEJMoa1313122;16 patients;16;-1
NEJMoa1313122;17 patients;17;-1
NEJMoa1313122;N = 26;26;-1
NEJMoa1313122;total of 79;79;-1
NEJMoa1313122;total of 51;51;-1
NEJMoa1313122;total of 7;7;-1
NEJMoa1313265;400 randomly as-  signed participants;400;-1
NEJMoa1313265;400 patients;400;-1
NEJMoa1313265;2224   patients;2224;-1
NEJMoa1313265;200 patients;200;-1
NEJMoa1313265;282 patients;282;-1
NEJMoa1313265;N = 200;200;-1
NEJMoa1313265;total of 2224;2224;-1
NEJMoa1313265;total of 282;282;-1
NEJMoa1313385;837 patients;837;-1
NEJMoa1313385;66 patients;66;-1
NEJMoa1313385;11 patients;11;-1
NEJMoa1313385;40 patients;40;-1
NEJMoa1313385;280 patients;280;-1
NEJMoa1313385;287 patients;287;-1
NEJMoa1313385;19 patients;19;-1
NEJMoa1313385;2 patients;2;-1
NEJMoa1313385;38 patients;38;-1
NEJMoa1313385;66   patients;66;-1
NEJMoa1313385;148 patients;148;-1
NEJMoa1313385;total of 72;72;-1
NEJMoa1313385;total of 895;895;-1
NEJMoa1313385;total of 11;11;-1
NEJMoa1313385;total of 21;21;-1
NEJMoa1313385; data from 837;837;-1
NEJMoa1313517;750 women;750;-1
NEJMoa1313517;750 infertile women;750;-1
NEJMoa1313517;158 women;158;-1
NEJMoa1313517;300 patients;300;-1
NEJMoa1313517;750 patients;750;-1
NEJMoa1313517;320 patients;320;-1
NEJMoa1313517;N = 376;376;-1
NEJMoa1313517;N = 374;374;-1
NEJMoa1313517;N=750;750;-1
NEJMoa1313517;N=250;250;-1
NEJMoa1313517;N=249;249;-1
NEJMoa1313517;N=251;251;-1
NEJMoa1313517;total of 750;750;-1
NEJMoa1313517;total   of 158;158;-1
NEJMoa1313688;300 patients;300;-1
NEJMoa1313688;152 patients;152;-1
NEJMoa1313688;148 patients;148;-1
NEJMoa1313688;220 patients;220;-1
NEJMoa1313688;80   patients;80;-1
NEJMoa1313688;136 patients;136;-1
NEJMoa1313688;164 patients;164;-1
NEJMoa1313688;150 patients;150;-1
NEJMoa1313688;539 patients;539;-1
NEJMoa1313688;208 patients;208;-1
NEJMoa1313688;202 patients;202;-1
NEJMoa1313688;52 patients;52;-1
NEJMoa1313688;4 patients;4;-1
NEJMoa1313688;56 patients;56;-1
NEJMoa1313688;51 patients;51;-1
NEJMoa1313688;3 patients;3;-1
NEJMoa1313688;54 patients;54;-1
NEJMoa1313688;152   patients;152;-1
NEJMoa1313688;154 patients;154;-1
NEJMoa1313688;300   patients;300;-1
NEJMoa1313688;14 patients;14;-1
NEJMoa1313688;31 patients;31;-1
NEJMoa1313688;80 patients;80;-1
NEJMoa1313688;37 patients;37;-1
NEJMoa1313688;12 patients;12;-1
NEJMoa1313688;25 patients;25;-1
NEJMoa1313688;20 patients;20;-1
NEJMoa1313688;5 patients;5;-1
NEJMoa1313688;17 patients;17;-1
NEJMoa1313688;79 patients;79;-1
NEJMoa1313688;221 patients;221;-1
NEJMoa1313688;140   patients;140;-1
NEJMoa1313688;133   patients;133;-1
NEJMoa1313688;908 patients;908;-1
NEJMoa1313688;6336 patients;6336;-1
NEJMoa1313688;N = 152;152;-1
NEJMoa1313688;N = 148;148;-1
NEJMoa1313688;N  =3;3;-1
NEJMoa1313688;N  =2;2;-1
NEJMoa1313688;N  =8;8;-1
NEJMoa1313688;N  =1;1;-1
NEJMoa1313688;N=300;300;-1
NEJMoa1313688;N=152;152;-1
NEJMoa1313688;N=148;148;-1
NEJMoa1313731;551 participants;551;-1
NEJMoa1313731;630 participants;630;-1
NEJMoa1313731;18  All randomly assigned participants;18;-1
NEJMoa1313731;3445 participants;3445;-1
NEJMoa1313731;1151 participants;1151;-1
NEJMoa1313731;311 participants;311;-1
NEJMoa1313731;65 participants;65;-1
NEJMoa1313731;590 participants;590;-1
NEJMoa1313731;671 participants;671;-1
NEJMoa1313731;3445 patients;3445;-1
NEJMoa1313731;1722 patients;1722;-1
NEJMoa1313731;1723 patients;1723;-1
NEJMoa1313731;206 patients;206;-1
NEJMoa1313731;245 patients;245;-1
NEJMoa1313731;4 Such patients;4;-1
NEJMoa1313731;3515 patients;3515;-1
NEJMoa1313731;981 patients;981;-1
NEJMoa1313731;113 patients;113;-1
NEJMoa1313731;229 patients;229;-1
NEJMoa1313731;239 patients;239;-1
NEJMoa1313731;203 patients;203;-1
NEJMoa1313731;197 patients;197;-1
NEJMoa1313731;160 patients;160;-1
NEJMoa1313731;176 patients;176;-1
NEJMoa1313731;3 patients;3;-1
NEJMoa1313731;5 patients;5;-1
NEJMoa1313731;242 patients;242;-1
NEJMoa1313731;280 patients;280;-1
NEJMoa1313731;78   patients;78;-1
NEJMoa1313731;71 patients;71;-1
NEJMoa1313731;N = 1722;1722;-1
NEJMoa1313731;N = 1723;1723;-1
NEJMoa1313731;total   of 22;22;-1
NEJMoa1313731;total   of 3445;3445;-1
NEJMoa1313731;total of 2464;2464;-1
NEJMoa1313731;total of 311;311;-1
NEJMoa1313731;total of 671;671;-1
NEJMoa1313731;981 patients enrolled;981;-1
NEJMoa1313865;160 patients;160;-1
NEJMoa1313865;75 patients;75;-1
NEJMoa1313865;282 patients;282;-1
NEJMoa1313865;79 patients;79;-1
NEJMoa1313865;132 patients;132;-1
NEJMoa1313865;60 patients;60;-1
NEJMoa1313865;66   patients;66;-1
NEJMoa1313865;66 patients;66;-1
NEJMoa1313865;28 patients;28;-1
NEJMoa1313865;9 patients;9;-1
NEJMoa1313865;7 patients;7;-1
NEJMoa1313865;3 patients;3;-1
NEJMoa1313865;4 patients;4;-1
NEJMoa1313865;8 patients;8;-1
NEJMoa1313865;25 patients;25;-1
NEJMoa1313865;37 patients;37;-1
NEJMoa1313865;39 patients;39;-1
NEJMoa1313865;46 patients;46;-1
NEJMoa1313865;15 patients;15;-1
NEJMoa1313865;12 patients;12;-1
NEJMoa1313865;18 patients;18;-1
NEJMoa1313865;26 patients;26;-1
NEJMoa1313865;38 patients;38;-1
NEJMoa1313865;2 patients;2;-1
NEJMoa1313865;16 patients;16;-1
NEJMoa1313865;5 patients;5;-1
NEJMoa1313865;81 patients;81;-1
NEJMoa1313865;6 patients;6;-1
NEJMoa1313865;9153 patients;9153;-1
NEJMoa1313865;233   patients;233;-1
NEJMoa1313865;9,153 patients;9153;-1
NEJMoa1313865;N = 66;66;-1
NEJMoa1313865;N = 132;132;-1
NEJMoa1313865;N = 79;79;-1
NEJMoa1313865;N = 81;81;-1
NEJMoa1313865;N=66;66;-1
NEJMoa1313865;total of 28;28;-1
NEJMoa1313977;1 diabetes were enrolled;1;-1
NEJMoa1313984;781 patients;781;-1
NEJMoa1313984;21 Previously untreated patients;21;-1
NEJMoa1313984;189 centers enrolled patients;189;-1
NEJMoa1313984;118 patients;118;-1
NEJMoa1313984;15 patients;15;-1
NEJMoa1313984;N = 238;238;-1
NEJMoa1313984;N = 118;118;-1
NEJMoa1313984;N = 233;233;-1
NEJMoa1313984;N = 333;333;-1
NEJMoa1313984;N = 330;330;-1
NEJMoa1313984;N = 241;241;-1
NEJMoa1313984;N = 116;116;-1
NEJMoa1313984;N = 225;225;-1
NEJMoa1313984;N = 336;336;-1
NEJMoa1313984;N = 321;321;-1
NEJMoa1313984;N=238;238;-1
NEJMoa1313984;N=118;118;-1
NEJMoa1313984;N=233;233;-1
NEJMoa1313984;N=333;333;-1
NEJMoa1313984;N=329;329;-1
NEJMoa1313984;total of 781;781;-1
NEJMoa1313984;189 centers enrolled;189;-1
NEJMoa1313984;781 patients were enrolled;781;-1
NEJMoa1314210;827 participants;827;-1
NEJMoa1314210;827 patients;827;-1
NEJMoa1314210;514 patients;514;-1
NEJMoa1314210;17 patients;17;-1
NEJMoa1314210;4 patients;4;-1
NEJMoa1314210;42 patients;42;-1
NEJMoa1314210;158 patients;158;-1
NEJMoa1314210;219 patients;219;-1
NEJMoa1314210;436 patients;436;-1
NEJMoa1314210;38 patients;38;-1
NEJMoa1314210;25 patients;25;-1
NEJMoa1314210;8 patients;8;-1
NEJMoa1314210;6 of these patients;6;-1
NEJMoa1314210;N = 188;188;-1
NEJMoa1314210;N = 193;193;-1
NEJMoa1314210;N = 212;212;-1
NEJMoa1314210;N = 593;593;-1
NEJMoa1314210;total of 827;827;-1
NEJMoa1314210;total of 97;97;-1
NEJMoa1314210;total of 593;593;-1
NEJMoa1314210;total of 45;45;-1
NEJMoa1314210;827 patients were enrolled;827;-1
NEJMoa1314258;738 patients;738;-1
NEJMoa1314258;1306 patients;1306;-1
NEJMoa1314258;700 patients;700;-1
NEJMoa1314258;737 patients;737;-1
NEJMoa1314258;1305 patients;1305;-1
NEJMoa1314258;7 patients;7;-1
NEJMoa1314258;22 patients;22;-1
NEJMoa1314258;4 patients;4;-1
NEJMoa1314258;9 patients;9;-1
NEJMoa1314258;980   secukinumab-treated patients;980;-1
NEJMoa1314258;19 patients;19;-1
NEJMoa1314258;7 of these patients;7;-1
NEJMoa1314258;2 patients;2;-1
NEJMoa1314258;702 patients;702;-1
NEJMoa1314258;N = 245;245;-1
NEJMoa1314258;N = 248;248;-1
NEJMoa1314258;N = 327;327;-1
NEJMoa1314258;N = 326;326;-1
NEJMoa1314258;N=323;323;-1
NEJMoa1314258;N=327;327;-1
NEJMoa1314258;N=245;245;-1
NEJMoa1314258;N=244;244;-1
NEJMoa1314258;N=243;243;-1
NEJMoa1314258;N=246;246;-1
NEJMoa1314258;N=324;324;-1
NEJMoa1314258;N   =   3;3;-1
NEJMoa1314258;N   =   4;4;-1
NEJMoa1314258;total of 700;700;-1
NEJMoa1314258;total of 737;737;-1
NEJMoa1314258;total   of 1305;1305;-1
NEJMoa1314432;158 persons;158;-1
NEJMoa1314432;30 persons;30;-1
NEJMoa1314432;27 persons;27;-1
NEJMoa1314432;50 persons;50;-1
NEJMoa1314474;52 patients;52;-1
NEJMoa1314474;20 patients;20;-1
NEJMoa1314474;32 patients;32;-1
NEJMoa1314474;9 patients;9;-1
NEJMoa1314474;11 patients;11;-1
NEJMoa1314474;12 of the patients;12;-1
NEJMoa1314474;20 adults;20;-1
NEJMoa1314474;N   =   2;2;-1
NEJMoa1314474;N   =   3;3;-1
NEJMoa1314474;total of 52;52;-1
NEJMoa1314583;125 patients;125;-1
NEJMoa1314583;72 patients;72;-1
NEJMoa1314583;125   patients;125;-1
NEJMoa1314583;1 studies in-  volving patients;1;-1
NEJMoa1314583;100 patients;100;-1
NEJMoa1314583;75,000 per cubic millimeter. Of the patients;75000;-1
NEJMoa1314583;73 patients;73;-1
NEJMoa1314583;111 patients;111;-1
NEJMoa1314583;81 patients;81;-1
NEJMoa1314583;60 patients;60;-1
NEJMoa1314583;50 patients;50;-1
NEJMoa1314583;36 patients;36;-1
NEJMoa1314583;124   patients;124;-1
NEJMoa1314583;108 patients;108;-1
NEJMoa1314583;99 patients;99;-1
NEJMoa1314583;112 patients;112;-1
NEJMoa1314583;7 patients;7;-1
NEJMoa1314583;63 patients;63;-1
NEJMoa1314583;28 patients;28;-1
NEJMoa1314583;68 patients;68;-1
NEJMoa1314583;40 patients;40;-1
NEJMoa1314583;122 patients;122;-1
NEJMoa1314583;110 patients;110;-1
NEJMoa1314583;25 patients;25;-1
NEJMoa1314583;5 patients;5;-1
NEJMoa1314583;4 patients;4;-1
NEJMoa1314583;3 patients;3;-1
NEJMoa1314583;2 patients;2;-1
NEJMoa1314583;42 patients;42;-1
NEJMoa1314583;13 patients;13;-1
NEJMoa1314583;9 patients;9;-1
NEJMoa1314583;20 patients;20;-1
NEJMoa1314583;8 patients;8;-1
NEJMoa1314583;16 patients;16;-1
NEJMoa1314583;31 comprising patients;31;-1
NEJMoa1314583;20,000 people;20000;-1
NEJMoa1314583;N = 125;125;-1
NEJMoa1314583;N=125;125;-1
NEJMoa1314583;N=72;72;-1
NEJMoa1314583;N=28;28;-1
NEJMoa1314583;N=15;15;-1
NEJMoa1314583;N=10;10;-1
NEJMoa1314583;N=71;71;-1
NEJMoa1314583;total   of 99;99;-1
NEJMoa1314583;total of 7;7;-1
NEJMoa1314583;total of 28;28;-1
NEJMoa1314583; data cutoff, 108;108;-1
NEJMoa1314768;6 patients;6;-1
NEJMoa1314768;8 patients;8;-1
NEJMoa1314768;10 patients;10;-1
NEJMoa1314768;14 patients;14;-1
NEJMoa1314768;13 patients;13;-1
NEJMoa1314768;109 patients;109;-1
NEJMoa1314768;54 patients;54;-1
NEJMoa1314768;50 patients;50;-1
NEJMoa1314768;18 patients;18;-1
NEJMoa1314768;80 patients;80;-1
NEJMoa1314768;127 patients;127;-1
NEJMoa1314768;7 patients;7;-1
NEJMoa1314768;5 patients;5;-1
NEJMoa1314768;127 dupilumab-  treated patients;127;-1
NEJMoa1314768;3 patients;3;-1
NEJMoa1314768;471 patients;471;-1
NEJMoa1314768;N = 16;16;-1
NEJMoa1314768;N = 51;51;-1
NEJMoa1314768;N = 54;54;-1
NEJMoa1314768;N = 55;55;-1
NEJMoa1314768;N = 10;10;-1
NEJMoa1314768;N = 21;21;-1
NEJMoa1314768;total of 109;109;-1
NEJMoa1314768;total of 10;10;-1
NEJMoa1314768;total of 5;5;-1
NEJMoa1314768;total of 17;17;-1
NEJMoa1314981;1952 patients;1952;-1
NEJMoa1314981;50 patients;50;-1
NEJMoa1314981;60   patients;60;-1
NEJMoa1314981;14 patients;14;-1
NEJMoa1314981;18,865 patients;18865;-1
NEJMoa1314981;1241 patients;1241;-1
NEJMoa1314981;125 patients;125;-1
NEJMoa1314981;48 patients;48;-1
NEJMoa1314981;47 patients;47;-1
NEJMoa1314981;39 patients;39;-1
NEJMoa1314981;2 patients;2;-1
NEJMoa1314981;3 patients;3;-1
NEJMoa1314981;1241 adults;1241;-1
NEJMoa1314981;total of   18,865;18865;-1
NEJMoa1314981;total of 12;12;-1
NEJMoa1315200;8 women;8;-1
NEJMoa1315200;11 women;11;-1
NEJMoa1315200;1 case per   million persons;1;-1
NEJMoa1315200;31 persons;31;-1
NEJMoa1315200;31 patients;31;-1
NEJMoa1315200;43 patients;43;-1
NEJMoa1315200;31   patients;31;-1
NEJMoa1315200;12   patients;12;-1
NEJMoa1315200;15 patients;15;-1
NEJMoa1315200;4 of the patients;4;-1
NEJMoa1315200;14 patients;14;-1
NEJMoa1315200;43 control patients;43;-1
NEJMoa1315200;30 patients;30;-1
NEJMoa1315200;25 patients;25;-1
NEJMoa1315200;5 patients;5;-1
NEJMoa1315200;17 For four of the patients;17;-1
NEJMoa1315200;N  =3;3;-1
NEJMoa1315200;N  =1;1;-1
NEJMoa1315200;N  =2;2;-1
NEJMoa1315226;220 patients;220;-1
NEJMoa1315226;2 For these   patients;2;-1
NEJMoa1315226;110 patients;110;-1
NEJMoa1315226;3 patients;3;-1
NEJMoa1315226;2 patients;2;-1
NEJMoa1315226;63 patients;63;-1
NEJMoa1315226;12 patients;12;-1
NEJMoa1315226;53 patients;53;-1
NEJMoa1315226;4 patients;4;-1
NEJMoa1315226;176 patients;176;-1
NEJMoa1315226;88 patients;88;-1
NEJMoa1315226;169 patients;169;-1
NEJMoa1315226;44 patients;44;-1
NEJMoa1315226;37 patients;37;-1
NEJMoa1315226;9 patients;9;-1
NEJMoa1315226;11 patients;11;-1
NEJMoa1315226;N = 110;110;-1
NEJMoa1315226;N = 107;107;-1
NEJMoa1315226;total of 8;8;-1
NEJMoa1315226;total of 78;78;-1
NEJMoa1315226;total of 110;110;-1
NEJMoa1315226;total of 63;63;-1
NEJMoa1315226;total of 169;169;-1
NEJMoa1315231;168 patients;168;-1
NEJMoa1315231;156 patients;156;-1
NEJMoa1315231;45 patients;45;-1
NEJMoa1315231;199 patients;199;-1
NEJMoa1315231;22 patients;22;-1
NEJMoa1315231;21 patients;21;-1
NEJMoa1315231;55 patients;55;-1
NEJMoa1315231;53 patients;53;-1
NEJMoa1315231;40 patients;40;-1
NEJMoa1315231;31 patients;31;-1
NEJMoa1315231;10 patients;10;-1
NEJMoa1315231;24 Two   patients;24;-1
NEJMoa1315231;N = 55;55;-1
NEJMoa1315231;N = 57;57;-1
NEJMoa1315231;N = 56;56;-1
NEJMoa1315231;N = 113;113;-1
NEJMoa1315231;N = 112;112;-1
NEJMoa1315496;52   women;52;-1
NEJMoa1315496;3 women;3;-1
NEJMoa1315496;49 women;49;-1
NEJMoa1315496;31     non-Amish persons;31;-1
NEJMoa1315496;2738 Amish participants;2738;-1
NEJMoa1315496;2 study participants;2;-1
NEJMoa1315496;24   Old Order Amish study participants;24;-1
NEJMoa1315496;2738 study participants;2738;-1
NEJMoa1315496;7 study participants;7;-1
NEJMoa1315496;total of 7;7;-1
NEJMoa1315496;2738 study participants enrolled;2738;-1
NEJMoa1315665;100 participants;100;-1
NEJMoa1315665;36 participants;36;-1
NEJMoa1315665;3773 participants;3773;-1
NEJMoa1315665;2135 participants;2135;-1
NEJMoa1315665;599 participants;599;-1
NEJMoa1315665;552 participants;552;-1
NEJMoa1315665;3773 NHANES   participants;3773;-1
NEJMoa1315665;2 million adults;2;-1
NEJMoa1315665;4 million adults;4;-1
NEJMoa1315665;8 million adults;8;-1
NEJMoa1315665;6 million   adults;6;-1
NEJMoa1315665;0 million additional   adults;0;-1
NEJMoa1315665;1 million   adults;1;-1
NEJMoa1315665;4 million   adults;4;-1
NEJMoa1315665;5 million adults;5;-1
NEJMoa1315665;N = 3773;3773;-1
NEJMoa1315665;N = 1583;1583;-1
NEJMoa1315665;N = 2135;2135;-1
NEJMoa1315665;N = 599;599;-1
NEJMoa1315665;N = 115;115;-1
NEJMoa1315665;N = 43;43;-1
NEJMoa1315665;N = 56;56;-1
NEJMoa1315665;N = 14;14;-1
NEJMoa1315665; data from 3773;3773;-1
NEJMoa1315665; data from 2005;2005;-1
NEJMoa1315722;631 patients;631;-1
NEJMoa1315722;600 patients;600;-1
NEJMoa1315722;450 patients;450;-1
NEJMoa1315722;855 patients;855;-1
NEJMoa1315722;473 patients;473;-1
NEJMoa1315722;464 patients;464;-1
NEJMoa1315722;322 patients;322;-1
NEJMoa1315722;31 patients;31;-1
NEJMoa1315722;363 patients;363;-1
NEJMoa1315722;463 patients;463;-1
NEJMoa1315722;3 patients;3;-1
NEJMoa1315722;10 patients;10;-1
NEJMoa1315722;13 patients;13;-1
NEJMoa1315722;469 patients;469;-1
NEJMoa1315722;4 patients;4;-1
NEJMoa1315722;1 patients;1;-1
NEJMoa1315722;184 million people;184;-1
NEJMoa1315722;350,000   people;350000;-1
NEJMoa1315722;N=473;473;-1
NEJMoa1315722;N=158;158;-1
NEJMoa1315722;N = 473;473;-1
NEJMoa1315722;N = 158;158;-1
NEJMoa1315722;total of 631;631;-1
NEJMoa1315722;total of 855;855;-1
NEJMoa1315722;total of 7;7;-1
NEJMoa1315722;total of 2;2;-1
NEJMoa1315727;31,989 participants;31989;-1
NEJMoa1315727;228 participants;228;-1
NEJMoa1315727;301 participants;301;-1
NEJMoa1315727;30,000 participants;30000;-1
NEJMoa1315727;14,500 participants;14500;-1
NEJMoa1315727;3745 participants;3745;-1
NEJMoa1315727;3827 participants;3827;-1
NEJMoa1315727;529 participants;529;-1
NEJMoa1315727;1323   participants;1323;-1
NEJMoa1315727;1442 participants;1442;-1
NEJMoa1315727;99 participants;99;-1
NEJMoa1315727;103 participants;103;-1
NEJMoa1315727;N = 15,990;15990;-1
NEJMoa1315727;N = 15,993;15993;-1
NEJMoa1315727;N   =   1;1;-1
NEJMoa1315727;N   =   2;2;-1
NEJMoa1315727;N   =   5;5;-1
NEJMoa1315727;N  =5;5;-1
NEJMoa1315727;total of 31,989;31989;-1
NEJMoa1315727;total of 14,500;14500;-1
NEJMoa1315727;total of 99;99;-1
NEJMoa1315727;31,989 participants were enrolled;31989;-1
NEJMoa1315727;14,500 participants were enrolled;14500;-1
NEJMoa1315727;7645 reenrolled;7645;-1
NEJMoa1315788;N = 145;145;-1
NEJMoa1315788;N = 135;135;-1
NEJMoa1315788;N = 280;280;-1
NEJMoa1315788;N = 45;45;-1
NEJMoa1315788;N = 163;163;-1
NEJMoa1315788;N = 162;162;-1
NEJMoa1315788;N = 98;98;-1
NEJMoa1315788;N = 86;86;-1
NEJMoa1315788;total of 75;75;-1
NEJMoa1315788;total of 45;45;-1
NEJMoa1315788;total of 86;86;-1
NEJMoa1315815;7 status of the participants;7;-1
NEJMoa1315815;62 participants;62;-1
NEJMoa1315815;31 enzalutamide-treated patients;31;-1
NEJMoa1315815;31 abiraterone-treated patients;31;-1
NEJMoa1315815;30 patients;30;-1
NEJMoa1315815;30   patients;30;-1
NEJMoa1315815;62 patients;62;-1
NEJMoa1315815;31 patients;31;-1
NEJMoa1315815;20 patients;20;-1
NEJMoa1315815;11 patients;11;-1
NEJMoa1315815;4 patients;4;-1
NEJMoa1315815;27 patients;27;-1
NEJMoa1315815;6 abiraterone-treated patients;6;-1
NEJMoa1315815;12 enzalutamide-treated patients;12;-1
NEJMoa1315815;31   abiraterone-treated patients;31;-1
NEJMoa1315815;10 patients;10;-1
NEJMoa1315815;5 patients;5;-1
NEJMoa1315815;6 patients;6;-1
NEJMoa1315815;16 patients;16;-1
NEJMoa1315815;7  In all patients;7;-1
NEJMoa1315815;14   Studies involving patients;14;-1
NEJMoa1315815;total of 31;31;-1
NEJMoa1315815;total of 35;35;-1
NEJMoa1315815;total of 39;39;-1
NEJMoa1315815;total of 55;55;-1
NEJMoa1315815;total of 50;50;-1
NEJMoa1315815;30 patients had been enrolled;30;-1
NEJMoa1315817;1836 patients;1836;-1
NEJMoa1315817;1356 patients;1356;-1
NEJMoa1315817;697 patients;697;-1
NEJMoa1315817;138 patients;138;-1
NEJMoa1315817;41 patients;41;-1
NEJMoa1315817;63 patients;63;-1
NEJMoa1315817;2 patients;2;-1
NEJMoa1315817;140 patients;140;-1
NEJMoa1315817;77 patients;77;-1
NEJMoa1315817;20 patients;20;-1
NEJMoa1315817;57   patients;57;-1
NEJMoa1315817;43 patients;43;-1
NEJMoa1315817;694 patients;694;-1
NEJMoa1315817;33 patients;33;-1
NEJMoa1315817;9 patients;9;-1
NEJMoa1315817;791 patients;791;-1
NEJMoa1315817;794 patients;794;-1
NEJMoa1315817;16 patients;16;-1
NEJMoa1315817;6 patients;6;-1
NEJMoa1315817;3 patients;3;-1
NEJMoa1315817;5 patients;5;-1
NEJMoa1315817;N = 848;848;-1
NEJMoa1315817;N = 844;844;-1
NEJMoa1315817;total of 1836;1836;-1
NEJMoa1315817;total of   1836;1836;-1
NEJMoa1315817;total of 1356;1356;-1
NEJMoa1315817;total of 2;2;-1
NEJMoa1315817;total of 16;16;-1
NEJMoa1315817;1836 patients were enrolled;1836;-1
NEJMoa1315817;138 patients enrolled;138;-1
NEJMoa1315860;10 patients;10;-1
NEJMoa1315860;5076 patients;5076;-1
NEJMoa1315860;14 patients;14;-1
NEJMoa1315860;12 In patients;12;-1
NEJMoa1315860;3202 patients;3202;-1
NEJMoa1315860;206 patients;206;-1
NEJMoa1315860;21 patients;21;-1
NEJMoa1315860;2 patients;2;-1
NEJMoa1315860;10 adults;10;-1
NEJMoa1315860;N = 10;10;-1
NEJMoa1315860;N = 11;11;-1
NEJMoa1315860;N=11;11;-1
NEJMoa1315860;N=10;10;-1
NEJMoa1315860;N = 21;21;-1
NEJMoa1315860;N = 9;9;-1
NEJMoa1315860;total of 21;21;-1
NEJMoa1315860;21 patients were   enrolled;21;-1
NEJMoa1315870;40,826 patients;40826;-1
NEJMoa1315870;1273 patients;1273;-1
NEJMoa1315870;22 patients;22;-1
NEJMoa1315870;457 patients;457;-1
NEJMoa1315870;20,423 patients;20423;-1
NEJMoa1315870;442 patients;442;-1
NEJMoa1315870;220 patients;220;-1
NEJMoa1315870;383 patients;383;-1
NEJMoa1315870;total of 398;398;-1
NEJMoa1315870;total of 20,423;20423;-1
NEJMoa1315870;total of 1273;1273;-1
NEJMoa1315878;79,036 participants;79036;-1
NEJMoa1315878;15,828 patients;15828;-1
NEJMoa1315878;7924 patients;7924;-1
NEJMoa1315878;7904 patients;7904;-1
NEJMoa1315878;7924   patients;7924;-1
NEJMoa1315878;737   patients;737;-1
NEJMoa1315878;814 patients;814;-1
NEJMoa1315878;2650 patients;2650;-1
NEJMoa1315878;7322 patients;7322;-1
NEJMoa1315878;7498 patients;7498;-1
NEJMoa1315878;N = 7904;7904;-1
NEJMoa1315878;N = 7924;7924;-1
NEJMoa1315878;N = 7890;7890;-1
NEJMoa1315878;N = 7912;7912;-1
NEJMoa1315878;total of 7924;7924;-1
NEJMoa1316133;306 patients;306;-1
NEJMoa1316133;28 patients;28;-1
NEJMoa1316133;3 patients;3;-1
NEJMoa1316133;55 patients;55;-1
NEJMoa1316133;165 patients;165;-1
NEJMoa1316133;300   patients;300;-1
NEJMoa1316133;306   enrolled patients;306;-1
NEJMoa1316133;198 patients;198;-1
NEJMoa1316133;63 patients;63;-1
NEJMoa1316133;131 patients;131;-1
NEJMoa1316133;305 patients;305;-1
NEJMoa1316133;157 patients;157;-1
NEJMoa1316133;302 patients;302;-1
NEJMoa1316133;193 patients;193;-1
NEJMoa1316133;132 patients;132;-1
NEJMoa1316133;61 patients;61;-1
NEJMoa1316133;N   =   6;6;-1
NEJMoa1316133;N   =   5;5;-1
NEJMoa1316133;N   =   4;4;-1
NEJMoa1316133;N   =   3;3;-1
NEJMoa1316133;N = 63;63;-1
NEJMoa1316133;N = 65;65;-1
NEJMoa1316133;N = 53;53;-1
NEJMoa1316133;N = 46;46;-1
NEJMoa1316133;N = 32;32;-1
NEJMoa1316133;total of 198;198;-1
NEJMoa1316133;total of 131;131;-1
NEJMoa1316133;total of 79;79;-1
NEJMoa1316133;306 patients enrolled;306;-1
NEJMoa1316133;306   enrolled;306;-1
NEJMoa1316145;91 patients;91;-1
NEJMoa1316145;419 patients;419;-1
NEJMoa1316145;73 patients;73;-1
NEJMoa1316145;3 trials involving patients;3;-1
NEJMoa1316145;320 patients;320;-1
NEJMoa1316145;80 patients;80;-1
NEJMoa1316145;475 patients;475;-1
NEJMoa1316145;68 patients;68;-1
NEJMoa1316145;250 patients;250;-1
NEJMoa1316145;213 patients;213;-1
NEJMoa1316145;334 patients;334;-1
NEJMoa1316145;6 patients;6;-1
NEJMoa1316145;47 patients;47;-1
NEJMoa1316145;1 patients;1;-1
NEJMoa1316145;N = 85;85;-1
NEJMoa1316145;N = 73;73;-1
NEJMoa1316145;N = 11;11;-1
NEJMoa1316145;N = 250;250;-1
NEJMoa1316145;N = 84;84;-1
NEJMoa1316145;total of 475;475;-1
NEJMoa1316145;419 patients who were enrolled;419;-1
NEJMoa1316158;101 patients;101;-1
NEJMoa1316158;103 patients;103;-1
NEJMoa1316158;85 patients;85;-1
NEJMoa1316158;200 patients;200;-1
NEJMoa1316158;100 patients;100;-1
NEJMoa1316158;204 patients;204;-1
NEJMoa1316158;53 patients;53;-1
NEJMoa1316158;26 patients;26;-1
NEJMoa1316158;30 patients;30;-1
NEJMoa1316158;120 mg and patients;120;-1
NEJMoa1316158;5 patients;5;-1
NEJMoa1316158;2 patients;2;-1
NEJMoa1316158;10 patients;10;-1
NEJMoa1316158;4 patients;4;-1
NEJMoa1316158;3 patients;3;-1
NEJMoa1316158;57 patients;57;-1
NEJMoa1316158;95 patients;95;-1
NEJMoa1316158;98 patients;98;-1
NEJMoa1316158;64 patients;64;-1
NEJMoa1316158;1 tumors and few patients;1;-1
NEJMoa1316158;100,000 people;100000;-1
NEJMoa1316158;N = 101;101;-1
NEJMoa1316158;N = 103;103;-1
NEJMoa1316158;total of 204;204;-1
NEJMoa1316158;total of 57;57;-1
NEJMoa1316222;901 patients;901;-1
NEJMoa1316222;1104 patients;1104;-1
NEJMoa1316222;2120 patients;2120;-1
NEJMoa1316222;302 patients;302;-1
NEJMoa1316222;33 patients;33;-1
NEJMoa1316222;13 patients;13;-1
NEJMoa1316222;3 patients;3;-1
NEJMoa1316222;34 patients;34;-1
NEJMoa1316222;15 patients;15;-1
NEJMoa1316222;7 patients;7;-1
NEJMoa1316222;24 patients;24;-1
NEJMoa1316222;9 patients;9;-1
NEJMoa1316222;5 patients;5;-1
NEJMoa1316222;16  More patients;16;-1
NEJMoa1316222;1300   patients;1300;-1
NEJMoa1316222;N   =   3;3;-1
NEJMoa1316222;N   =   7;7;-1
NEJMoa1316222;N   =   1;1;-1
NEJMoa1316222;N   =   2;2;-1
NEJMoa1316222;N   =   6;6;-1
NEJMoa1316222;N   =   5;5;-1
NEJMoa1316222;N = 302;302;-1
NEJMoa1316222;N = 599;599;-1
NEJMoa1316366;440 patients;440;-1
NEJMoa1316366;100 patients;100;-1
NEJMoa1316366;551 patients;551;-1
NEJMoa1316366;109 patients;109;-1
NEJMoa1316366;11 patients;11;-1
NEJMoa1316366;427 patients;427;-1
NEJMoa1316366;439 patients;439;-1
NEJMoa1316366;228 patients;228;-1
NEJMoa1316366;163 patients;163;-1
NEJMoa1316366;7 patients;7;-1
NEJMoa1316366;4 patients;4;-1
NEJMoa1316366;1 patients;1;-1
NEJMoa1316366;170 million people;170;-1
NEJMoa1316366;N = 109;109;-1
NEJMoa1316366;N = 111;111;-1
NEJMoa1316366;total of 20;20;-1
NEJMoa1316366;total of   10;10;-1
NEJMoa1400029;9 Few patients;9;-1
NEJMoa1400029;15 We evaluated patients;15;-1
NEJMoa1400029;32 In patients;32;-1
NEJMoa1400284;3 Nearly all patients;3;-1
NEJMoa1400284;25  Because patients;25;-1
NEJMoa1400376;391 patients;391;-1
NEJMoa1400376;57 patients;57;-1
NEJMoa1400376;5 patients;5;-1
NEJMoa1400376;15 patients;15;-1
NEJMoa1400376;17 patients;17;-1
NEJMoa1400376;4  number of patients;4;-1
NEJMoa1400376;10 patients;10;-1
NEJMoa1400376;N = 195;195;-1
NEJMoa1400376;N = 196;196;-1
NEJMoa1400376;N=195;195;-1
NEJMoa1400376;N=196;196;-1
NEJMoa1400376;N = 191;191;-1
NEJMoa1400382;311 women;311;-1
NEJMoa1400382;58,209 women;58209;-1
NEJMoa1400382;101,986 women;101986;-1
NEJMoa1400382;75 Nordic patients;75;-1
NEJMoa1400382;total of 63;63;-1
NEJMoa1400382; data from 154;154;-1
NEJMoa1400382; data from 52;52;-1
NEJMoa1400506;1404 teenage girls and women;1404;-1
NEJMoa1400506;1404 teenage   participants;1404;-1
NEJMoa1400506;2 participants;2;-1
NEJMoa1400506;16 Participants were   recruited;16;-1
NEJMoa1400506;N = 1404;1404;-1
NEJMoa1400506;N = 484;484;-1
NEJMoa1400506;N = 920;920;-1
NEJMoa1400506;1404 adolescents   who enrolled;1404;-1
NEJMoa1400590;795 patients;795;12311
NEJMoa1400590;790   patients;790;2040
NEJMoa1400590;995 patients;995;316
NEJMoa1400590;747 patients;747;524
NEJMoa1400590;323 patients;323;615
NEJMoa1400590;5 patients;5;12309
NEJMoa1400590;3,519 patients;3519;23994
NEJMoa1400590;663 patients;663;25026
NEJMoa1400590;N = 394;394;2822
NEJMoa1400590;N = 401;401;2849
NEJMoa1400590;N = 390;390;2872
NEJMoa1400590;N = 357;357;2899
NEJMoa1400590;total of 795;795;12320
NEJMoa1400590;total of 355;355;2253
NEJMoa1400590;total of 995;995;307
NEJMoa1400590;871 Were enrolled;871;2154
NEJMoa1400697;707 participants;707;11150
NEJMoa1400697;125 patients;125;2464
NEJMoa1400697;5 patients;5;2466
NEJMoa1400697;N = 297;297;864
NEJMoa1400697;N = 256;256;843
NEJMoa1400697;N = 117;117;13625
NEJMoa1400697;N = 93;93;13662
NEJMoa1400697;N = 436;436;13694
NEJMoa1400697;total of 26;26;5278
NEJMoa1400697; data from all 553;553;3366
NEJMoa1400781;798 participants;798;-1
NEJMoa1400781;6592 participants;6592;-1
NEJMoa1400781;13 participants;13;-1
NEJMoa1400781;5 participants;5;-1
NEJMoa1400781;3 participants;3;-1
NEJMoa1400781;779 patients;779;-1
NEJMoa1400781;19  For patients;19;-1
NEJMoa1400781;21  Me thods  Patients  We recruited;21;-1
NEJMoa1400781;N = 210;210;-1
NEJMoa1400781;N = 286;286;-1
NEJMoa1400781;N = 289;289;-1
NEJMoa1400781;total of 13;13;-1
NEJMoa1400962;390,652 patients;390652;-1
NEJMoa1401105;10,010 patients;10010;-1
NEJMoa1401105;5628 patients;5628;-1
NEJMoa1401105;4382 patients;4382;-1
NEJMoa1401105;4998 patients;4998;-1
NEJMoa1401105;5012 patients;5012;-1
NEJMoa1401105;230 patients;230;-1
NEJMoa1401105;188 patients;188;-1
NEJMoa1401105;110,000 patients;110000;-1
NEJMoa1401105;5012   patients;5012;-1
NEJMoa1401105;309 patients;309;-1
NEJMoa1401105;315 patients;315;-1
NEJMoa1401105;16 patients;16;-1
NEJMoa1401105;19 patients;19;-1
NEJMoa1401105;1000 patients;1000;-1
NEJMoa1401105;13,356 patients;13356;-1
NEJMoa1401105;31  For patients;31;-1
NEJMoa1401105;N = 4998;4998;-1
NEJMoa1401105;N = 5012;5012;-1
NEJMoa1401105;total of 10,010;10010;-1
NEJMoa1401105;10,010 patients were enrolled;10010;-1
NEJMoa1401106;10,010 patients;10010;-1
NEJMoa1401106;329 patients;329;-1
NEJMoa1401106;295 patients;295;-1
NEJMoa1401106;2385 patients;2385;-1
NEJMoa1401106;1854 patients;1854;-1
NEJMoa1401106;16 patients;16;-1
NEJMoa1401106;5 patients;5;-1
NEJMoa1401106;5009 patients;5009;-1
NEJMoa1401106;600 patients;600;-1
NEJMoa1401106;403 patients;403;-1
NEJMoa1401106;12 trials in-  volving patients;12;-1
NEJMoa1401106;605 patients;605;-1
NEJMoa1401106;300 patients;300;-1
NEJMoa1401106;8351 patients;8351;-1
NEJMoa1401106;9841 patients;9841;-1
NEJMoa1401106;N = 5009;5009;-1
NEJMoa1401106;N = 5001;5001;-1
NEJMoa1401106;N = 10,010;10010;-1
NEJMoa1401106;N = 624;624;-1
NEJMoa1401106;total of 10,010;10010;-1
NEJMoa1401106;total of 81;81;-1
NEJMoa1401106;total of 88;88;-1
NEJMoa1401106;23 countries were   enrolled;23;-1
NEJMoa1401177;34   For selected patients;34;-1
NEJMoa1401177;30 patients;30;-1
NEJMoa1401177;90 patients;90;-1
NEJMoa1401177;121 patients;121;-1
NEJMoa1401177;N = 240;240;-1
NEJMoa1401177;N = 32;32;-1
NEJMoa1401177;N = 138;138;-1
NEJMoa1401177;N = 8;8;-1
NEJMoa1401177;N = 62;62;-1
NEJMoa1401177;total of 23;23;-1
NEJMoa1401177; data   from 240;240;-1
NEJMoa1401184;54 participants;54;-1
NEJMoa1401184;100   participants;100;-1
NEJMoa1401184;372 screened participants;372;-1
NEJMoa1401184;87 participants;87;-1
NEJMoa1401184;53 participants;53;-1
NEJMoa1401184;39 participants;39;-1
NEJMoa1401184;5 participants;5;-1
NEJMoa1401184;4 participants;4;-1
NEJMoa1401184;27 participants;27;-1
NEJMoa1401184;3 participants;3;-1
NEJMoa1401184;13 participants;13;-1
NEJMoa1401184;11 participants;11;-1
NEJMoa1401184;61 participants;61;-1
NEJMoa1401184;2 participants;2;-1
NEJMoa1401184;2 of   these participants;2;-1
NEJMoa1401184;12 and elderly   patients;12;-1
NEJMoa1401184;N = 39;39;-1
NEJMoa1401184;N = 17;17;-1
NEJMoa1401184;N = 14;14;-1
NEJMoa1401184;N = 87;87;-1
NEJMoa1401184;N = 53;53;-1
NEJMoa1401184;N = 27;27;-1
NEJMoa1401184;N = 13;13;-1
NEJMoa1401184;N = 10;10;-1
NEJMoa1401184;N = 11;11;-1
NEJMoa1401184;N = 30;30;-1
NEJMoa1401184;total of 5;5;-1
NEJMoa1401184;total of 3;3;-1
NEJMoa1401184;total of 69;69;-1
NEJMoa1401268;N=589;589;-1
NEJMoa1401268;N=475;475;-1
NEJMoa1401268;N=15;15;-1
NEJMoa1401268;N=99;99;-1
NEJMoa1401268;N=107,016;107016;-1
NEJMoa1401268;N=106,988;106988;-1
NEJMoa1401268;N=28;28;-1
NEJMoa1401268;total of 8,187,737;8187737;-1
NEJMoa1401268;total of 475;475;-1
NEJMoa1401268; data set of 10,196,620;10196620;-1
NEJMoa1401329;150 obese patients;150;-1
NEJMoa1401329;150 obese   patients;150;-1
NEJMoa1401329;150 patients;150;-1
NEJMoa1401329;9 patients;9;-1
NEJMoa1401329;8 patients;8;-1
NEJMoa1401329;4 patients;4;-1
NEJMoa1401329;137 patients;137;-1
NEJMoa1401329;49 patients;49;-1
NEJMoa1401329;13 patients;13;-1
NEJMoa1401329;10 patients;10;-1
NEJMoa1401329;43 patients;43;-1
NEJMoa1401329;N = 40;40;-1
NEJMoa1401329;N = 48;48;-1
NEJMoa1401329;N = 49;49;-1
NEJMoa1401329;N = 43;43;-1
NEJMoa1401329;N = 50;50;-1
NEJMoa1401329;total of 91;91;-1
NEJMoa1401329;total of 9;9;-1
NEJMoa1401426;1691 surviving patients;1691;-1
NEJMoa1401426;854 patients;854;-1
NEJMoa1401426;1820   patients;1820;-1
NEJMoa1401426;1820 patients;1820;-1
NEJMoa1401426;1818 patients;1818;-1
NEJMoa1401426;2010 and   included all surviving patients;2010;-1
NEJMoa1401426;1818   patients;1818;-1
NEJMoa1401426;16 patients;16;-1
NEJMoa1401426;8 patients;8;-1
NEJMoa1401426;N = 327;327;-1
NEJMoa1401426;N = 527;527;-1
NEJMoa1401426;total of 854;854;-1
NEJMoa1401426;total of 40;40;-1
NEJMoa1401426;1820 patients who were enrolled;1820;-1
NEJMoa1401426;1818 Patients were enrolled;1818;-1
NEJMoa1401426;758 Were not enrolled;758;-1
NEJMoa1401480;2116 pregnant women;2116;10670
NEJMoa1401480;194 pregnant women;194;10613
NEJMoa1401480;2116 black African pregnant women;2116;2702
NEJMoa1401480;183 HIV-infected   women;183;3911
NEJMoa1401480;796 women;796;7285
NEJMoa1401480;789 women;789;7317
NEJMoa1401480;180 participants;180;414
NEJMoa1401480;376 participants;376;4040
NEJMoa1401480;N   =   1;1;28750
NEJMoa1401480;N   =   8;8;28905
NEJMoa1401480;N   =   9;9;30651
NEJMoa1401520;1000 patients;1000;-1
NEJMoa1401520;60 enrolled patients;60;-1
NEJMoa1401520;344 enrolled   patients;344;-1
NEJMoa1401520;225 patients;225;-1
NEJMoa1401520;81 patients;81;-1
NEJMoa1401520;105 patients;105;-1
NEJMoa1401520;250 patients;250;-1
NEJMoa1401520;745 patients;745;-1
NEJMoa1401520;7 patients;7;-1
NEJMoa1401520;171 patients;171;-1
NEJMoa1401520;339 patients;339;-1
NEJMoa1401520;109 patients;109;-1
NEJMoa1401520;13 patients;13;-1
NEJMoa1401520;12 patients;12;-1
NEJMoa1401520;508 patients;508;-1
NEJMoa1401520;237 patients;237;-1
NEJMoa1401520;16 patients;16;-1
NEJMoa1401520;650 patients;650;-1
NEJMoa1401520;60 patients;60;-1
NEJMoa1401520;N = 379;379;-1
NEJMoa1401520;N = 366;366;-1
NEJMoa1401520;N = 54;54;-1
NEJMoa1401520;N = 55;55;-1
NEJMoa1401520;total of 339;339;-1
NEJMoa1401520;60 enrolled;60;-1
NEJMoa1401520;344 enrolled;344;-1
NEJMoa1401520;225 patients were enrolled;225;-1
NEJMoa1401520;250 patients enrolled;250;-1
NEJMoa1401520;508 patients had been enrolled;508;-1
NEJMoa1401520;237 patients   enrolled;237;-1
NEJMoa1401561;394 patients;394;-1
NEJMoa1401561;297 patients;297;-1
NEJMoa1401561;86 patients;86;-1
NEJMoa1401561;65 patients;65;-1
NEJMoa1401561;146 patients;146;-1
NEJMoa1401561;2b study involving patients;2;-1
NEJMoa1401561;400 patients;400;-1
NEJMoa1401561;12 and all patients;12;-1
NEJMoa1401561;562 patients;562;-1
NEJMoa1401561;286 patients;286;-1
NEJMoa1401561;173 patients;173;-1
NEJMoa1401561;123 patients;123;-1
NEJMoa1401561;293 patients;293;-1
NEJMoa1401561;5 patients;5;-1
NEJMoa1401561;2 patients;2;-1
NEJMoa1401561;4 patients;4;-1
NEJMoa1401561;3 patients;3;-1
NEJMoa1401561;78 patients;78;-1
NEJMoa1401561;50 patients;50;-1
NEJMoa1401561;36 patients;36;-1
NEJMoa1401561;87 patients;87;-1
NEJMoa1401561;59 patients;59;-1
NEJMoa1401561;3 trial involving   patients;3;-1
NEJMoa1401561;18 In patients;18;-1
NEJMoa1401561;N = 297;297;-1
NEJMoa1401561;N = 97;97;-1
NEJMoa1401561;total of 394;394;-1
NEJMoa1401561;total of 562;562;-1
NEJMoa1401561;total of 286;286;-1
NEJMoa1401561;total of 166;166;-1
NEJMoa1401602;1341 patients;1341;-1
NEJMoa1401602;1950 patients;1950;-1
NEJMoa1401602;650 patients;650;-1
NEJMoa1401602;1300 patients;1300;-1
NEJMoa1401602;1350 patients;1350;-1
NEJMoa1401602;1351 patients;1351;-1
NEJMoa1401602;404 patients;404;-1
NEJMoa1401602;435 patients;435;-1
NEJMoa1401602;439 patients;439;-1
NEJMoa1401602;10 patients;10;-1
NEJMoa1401602;4 patients;4;-1
NEJMoa1401602;252 patients;252;-1
NEJMoa1401602;264 patients;264;-1
NEJMoa1401602;346 patients;346;-1
NEJMoa1401602;18 patients;18;-1
NEJMoa1401602;16 patients;16;-1
NEJMoa1401602;411 patients;411;-1
NEJMoa1401602;92 patients;92;-1
NEJMoa1401602;885 patients;885;-1
NEJMoa1401602;N = 439;439;-1
NEJMoa1401602;N = 446;446;-1
NEJMoa1401602;N = 456;456;-1
NEJMoa1401602;total of 1350;1350;-1
NEJMoa1401602;total of 92;92;-1
NEJMoa1401602;1300 patients had been enrolled;1300;-1
NEJMoa1401731;100,000 persons;100000;-1
NEJMoa1401731;204 participants;204;-1
NEJMoa1401731;196 participants;196;-1
NEJMoa1401731;9 participants;9;-1
NEJMoa1401731;90 participants;90;-1
NEJMoa1401731;6 participants;6;-1
NEJMoa1401731;97 participants;97;-1
NEJMoa1401731;99   participants;99;-1
NEJMoa1401731;11 participants;11;-1
NEJMoa1401731;1 of these participants;1;-1
NEJMoa1401731;2 participants;2;-1
NEJMoa1401731;31 participants;31;-1
NEJMoa1401731;N = 97;97;-1
NEJMoa1401731;N = 99;99;-1
NEJMoa1401731;total of 196;196;-1
NEJMoa1401731;total of 3236;3236;-1
NEJMoa1401731;total of 31;31;-1
NEJMoa1401731;total of 9;9;-1
NEJMoa1401739;131 patients;131;-1
NEJMoa1401739;105 patients;105;-1
NEJMoa1401739;130 patients;130;-1
NEJMoa1401739;264 patients;264;-1
NEJMoa1401739;133 patients;133;-1
NEJMoa1401739;6 patients;6;-1
NEJMoa1401739;3 patients;3;-1
NEJMoa1401739;N = 133;133;-1
NEJMoa1401739;N = 131;131;-1
NEJMoa1401739;N = 81;81;-1
NEJMoa1401739;N = 78;78;-1
NEJMoa1401739;N = 52;52;-1
NEJMoa1401739;N = 53;53;-1
NEJMoa1401739;total of 139;139;-1
NEJMoa1401739;total of 34;34;-1
NEJMoa1401739;131 patients were enrolled;131;-1
NEJMoa1401811;N = 302;302;-1
NEJMoa1401811;N = 305;305;-1
NEJMoa1401811;N = 607;607;-1
NEJMoa1401811;total of   484;484;-1
NEJMoa1401811;total of 25;25;-1
NEJMoa1401811;total of 98;98;-1
NEJMoa1401811;total of 21;21;-1
NEJMoa1401811;total of 37;37;-1
NEJMoa1401811;20 We enrolled;20;-1
NEJMoa1401914;2 mil-  lion persons;2;-1
NEJMoa1401914;100,000 people;100000;-1
NEJMoa1401914;total of 35,192;35192;-1
NEJMoa1402338;2 study involving patients;2;-1
NEJMoa1402338;419 patients;419;-1
NEJMoa1402338;305 patients;305;-1
NEJMoa1402338;25 patients;25;-1
NEJMoa1402338;436 screened   patients;436;-1
NEJMoa1402338;629 patients;629;-1
NEJMoa1402338;95 patients;95;-1
NEJMoa1402338;100 patients;100;-1
NEJMoa1402338;205   patients;205;-1
NEJMoa1402338;18 patients;18;-1
NEJMoa1402338;3 patients;3;-1
NEJMoa1402338;16 patients;16;-1
NEJMoa1402338;18   patients;18;-1
NEJMoa1402338;210 patients;210;-1
NEJMoa1402338;209 patients;209;-1
NEJMoa1402338;6 patients;6;-1
NEJMoa1402338;2 of   these patients;2;-1
NEJMoa1402338;N=100;100;-1
NEJMoa1402338;N=205;205;-1
NEJMoa1402338;N=210;210;-1
NEJMoa1402338;N=209;209;-1
NEJMoa1402338;N = 100;100;-1
NEJMoa1402338;N = 205;205;-1
NEJMoa1402338;N = 210;210;-1
NEJMoa1402338;N = 209;209;-1
NEJMoa1402338;total of 629;629;-1
NEJMoa1402338;total of 18;18;-1
NEJMoa1402338;1a study were enrolled;1;-1
NEJMoa1402338;1a study   were enrolled;1;-1
NEJMoa1402338;1b study were   enrolled;1;-1
NEJMoa1402355;647 previously untreated   patients;647;-1
NEJMoa1402355;200 patients;200;-1
NEJMoa1402355;831 patients;831;-1
NEJMoa1402355;215 patients;215;-1
NEJMoa1402355;647 patients;647;-1
NEJMoa1402355;23 patients;23;-1
NEJMoa1402355;11 patients;11;-1
NEJMoa1402355;15 patients;15;-1
NEJMoa1402355;10 patients;10;-1
NEJMoa1402355;2 patients;2;-1
NEJMoa1402355;3 patients;3;-1
NEJMoa1402355;25 patients;25;-1
NEJMoa1402355;3 million people;3;-1
NEJMoa1402355;N = 215;215;-1
NEJMoa1402355;N = 216;216;-1
NEJMoa1402355;total of 10;10;-1
NEJMoa1402355;total of   2;2;-1
NEJMoa1402355;total of 11;11;-1
NEJMoa1402355;total of 3;3;-1
NEJMoa1402454;865 patients;865;-1
NEJMoa1402454;200 patients;200;-1
NEJMoa1402454;665 patients;665;-1
NEJMoa1402454;1015 patients;1015;-1
NEJMoa1402454;5 patients;5;-1
NEJMoa1402454;4 patients;4;-1
NEJMoa1402454;214 patients;214;-1
NEJMoa1402454;2 patients;2;-1
NEJMoa1402454;861   patients;861;-1
NEJMoa1402454;1b included four patients;1;-1
NEJMoa1402454;861 patients;861;-1
NEJMoa1402454;3 patients;3;-1
NEJMoa1402454;10 of   these patients;10;-1
NEJMoa1402454;33 patients;33;-1
NEJMoa1402454;18 patients;18;-1
NEJMoa1402454;11,241 patients;11241;-1
NEJMoa1402454;N = 214;214;-1
NEJMoa1402454;N = 217;217;-1
NEJMoa1402454;total of 5;5;-1
NEJMoa1402454;total of 19;19;-1
NEJMoa1402454;total of 1;1;-1
NEJMoa1402454;total of 2;2;-1
NEJMoa1402551;1623 patients;1623;-1
NEJMoa1402551;535 patients;535;-1
NEJMoa1402551;541 patients;541;-1
NEJMoa1402551;547 patients;547;-1
NEJMoa1402551;1590 patients;1590;-1
NEJMoa1402551;535   patients;535;-1
NEJMoa1402551;173 patients;173;-1
NEJMoa1402551;16 Six patients;16;-1
NEJMoa1402551;17 patients;17;-1
NEJMoa1402551;15 patients;15;-1
NEJMoa1402551;25 and more   patients;25;-1
NEJMoa1402551;26   We enrolled patients;26;-1
NEJMoa1402551;21 patients;21;-1
NEJMoa1402551;1175 patients;1175;-1
NEJMoa1402551;N = 535;535;-1
NEJMoa1402551;N = 541;541;-1
NEJMoa1402551;N = 547;547;-1
NEJMoa1402551;N=535;535;-1
NEJMoa1402551;N=541;541;-1
NEJMoa1402551;N=547;547;-1
NEJMoa1402551;N=402;402;-1
NEJMoa1402551;N=397;397;-1
NEJMoa1402551;N=341;341;-1
NEJMoa1402551;N = 532;532;-1
NEJMoa1402551;N = 540;540;-1
NEJMoa1402551;total of 1623;1623;-1
NEJMoa1402551;total of 39;39;-1
NEJMoa1402551;26   We enrolled;26;-1
NEJMoa1402551; data cutoff of May 24;24;-1
NEJMoa1402551;   data from 6;6;-1
NEJMoa1402582;555 patients;555;-1
NEJMoa1402582;275 patients;275;-1
NEJMoa1402582;779 patients;779;-1
NEJMoa1402582;522 patients;522;-1
NEJMoa1402582;261 patients;261;-1
NEJMoa1402582;55 patients;55;-1
NEJMoa1402582;39 patients;39;-1
NEJMoa1402582;237 patients;237;-1
NEJMoa1402582;46 patients;46;-1
NEJMoa1402582;88 patients;88;-1
NEJMoa1402582;63 patients;63;-1
NEJMoa1402582;27 patients;27;-1
NEJMoa1402582;99 patients;99;-1
NEJMoa1402582;81 patients;81;-1
NEJMoa1402582;100 patients;100;-1
NEJMoa1402582;20 patients;20;-1
NEJMoa1402582;3 patients;3;-1
NEJMoa1402582;7 patients;7;-1
NEJMoa1402582;1247 patients;1247;-1
NEJMoa1402582;15 patients;15;-1
NEJMoa1402582;4 patients;4;-1
NEJMoa1402582;5 patients;5;-1
NEJMoa1402582;69 patients;69;-1
NEJMoa1402582;52 patients;52;-1
NEJMoa1402582;56 patients;56;-1
NEJMoa1402582;40 patients;40;-1
NEJMoa1402582;30 patients;30;-1
NEJMoa1402582;N = 278;278;-1
NEJMoa1402582;N = 277;277;-1
NEJMoa1402582;N=278;278;-1
NEJMoa1402582;N=277;277;-1
NEJMoa1402582;total of   555;555;-1
NEJMoa1402582;total of 522;522;-1
NEJMoa1402582;555 patients were enrolled;555;-1
NEJMoa1402584;1066 patients;1066;14415
NEJMoa1402584;432 patients;432;11876
NEJMoa1402584;194 patients;194;95
NEJMoa1402584;291 patients;291;55
NEJMoa1402584;515 patients;515;434
NEJMoa1402584;551 patients;551;465
NEJMoa1402584;513 patients;513;565
NEJMoa1402584;78 patients;78;699
NEJMoa1402584;36 patients;36;749
NEJMoa1402584;65 patients;65;1086
NEJMoa1402584;548 patients;548;1198
NEJMoa1402584;44 patients;44;1383
NEJMoa1402584;62 patients;62;1723
NEJMoa1402584;218 patients;218;4509
NEJMoa1402584;298 patients;298;4649
NEJMoa1402584;202 patients;202;4693
NEJMoa1402584;326 patients;326;4784
NEJMoa1402584;217 patients;217;4825
NEJMoa1402584;14 patients;14;18625
NEJMoa1402584;15 patients;15;435
NEJMoa1402584;17 patients;17;4826
NEJMoa1402584;2 patients;2;11874
NEJMoa1402584;5 patients;5;436
NEJMoa1402584;N = 309;309;2627
NEJMoa1402584;N = 204;204;2649
NEJMoa1402584;N = 329;329;2675
NEJMoa1402584;N = 219;219;2697
NEJMoa1402584;N  =3;3;5797
NEJMoa1402584;N  =2;2;5827
NEJMoa1402584;N   =   3;3;10656
NEJMoa1402584;N   =   2;2;10694
NEJMoa1402584;total of 1066;1066;14424
NEJMoa1402584;total   of 1066;1066;382
NEJMoa1402584;total of 513;513;556
NEJMoa1402584;total of 78;78;690
NEJMoa1402584;total of 548;548;1189
NEJMoa1402584;total of 15;15;19388
NEJMoa1402584;total of 17;17;19652
NEJMoa1402670;535 patients;535;-1
NEJMoa1402670;316 patients;316;-1
NEJMoa1402670;158 patients;158;-1
NEJMoa1402670;530 patients;530;-1
NEJMoa1402670;1441 patients;1441;-1
NEJMoa1402670;31   patients;31;-1
NEJMoa1402670;4,121 patients;4121;-1
NEJMoa1402670;N = 364;364;-1
NEJMoa1402670;N = 171;171;-1
NEJMoa1402670;N=364;364;-1
NEJMoa1402670;N=171;171;-1
NEJMoa1402670;N=353;353;-1
NEJMoa1402670;N=360;360;-1
NEJMoa1402670;N=167;167;-1
NEJMoa1402670;N=329;329;-1
NEJMoa1402670;N=162;162;-1
NEJMoa1402670;total of 535;535;-1
NEJMoa1402670;total of 530;530;-1
NEJMoa1402670;total of 1441;1441;-1
NEJMoa1402685;466 participants;466;-1
NEJMoa1402685;548 participants;548;-1
NEJMoa1402685;1156 screened participants;1156;-1
NEJMoa1402685;423 participants;423;-1
NEJMoa1402685;1156 participants;1156;-1
NEJMoa1402685;N = 273;273;-1
NEJMoa1402685;N = 285;285;-1
NEJMoa1402685;N = 284;284;-1
NEJMoa1402685;N = 274;274;-1
NEJMoa1402686;485 participants;485;-1
NEJMoa1402686;435 participants;435;-1
NEJMoa1402686;486 patients;486;-1
NEJMoa1402686;1156 patients;1156;-1
NEJMoa1402686;244 patients;244;-1
NEJMoa1402686;208 patients;208;-1
NEJMoa1402686;25 involving patients;25;-1
NEJMoa1402686;N   = 244;244;-1
NEJMoa1402686;N = 242;242;-1
NEJMoa1402686;N = 244;244;-1
NEJMoa1402869;380 patients;380;-1
NEJMoa1402869;208 patients;208;-1
NEJMoa1402869;172 patients;172;-1
NEJMoa1402869;3   studies involving patients;3;-1
NEJMoa1402869;24 and   patients;24;-1
NEJMoa1402869;26 Previously treated patients;26;-1
NEJMoa1402869;671 patients;671;-1
NEJMoa1402869;42 patients;42;-1
NEJMoa1402869;50 patients;50;-1
NEJMoa1402869;203 patients;203;-1
NEJMoa1402869;12 patients;12;-1
NEJMoa1402869;17   patients;17;-1
NEJMoa1402869;2 patients;2;-1
NEJMoa1402869;15 patients;15;-1
NEJMoa1402869;19 patients;19;-1
NEJMoa1402869;34 patients;34;-1
NEJMoa1402869;25 For patients;25;-1
NEJMoa1402869;184 million people;184;-1
NEJMoa1402869;N = 208;208;-1
NEJMoa1402869;N = 172;172;-1
NEJMoa1402869;N = 380;380;-1
NEJMoa1402869;total of 191;191;-1
NEJMoa1402869;total of 165;165;-1
NEJMoa1402869;total of 15;15;-1
NEJMoa1402869;381 were   enrolled;381;-1
NEJMoa1402888;273 patients;273;-1
NEJMoa1402888;251 patients;251;-1
NEJMoa1402888;400 patients;400;-1
NEJMoa1402888;240 patients;240;-1
NEJMoa1402888;402 patients;402;-1
NEJMoa1402888;237 patients;237;-1
NEJMoa1402888;45 patients;45;-1
NEJMoa1402888;24 patients;24;-1
NEJMoa1402888;156 patients;156;-1
NEJMoa1402888;399 patients;399;-1
NEJMoa1402888;N = 399;399;-1
NEJMoa1402888;N = 141;141;-1
NEJMoa1402888;N = 132;132;-1
NEJMoa1402888;N = 116;116;-1
NEJMoa1402888;N = 115;115;-1
NEJMoa1402888;total of 402;402;-1
NEJMoa1402888;402 Patients were enrolled;402;-1
NEJMoa1402888;402 patients were enrolled;402;-1
NEJMoa1402895;31 patients;31;-1
NEJMoa1402895;15 patients;15;-1
NEJMoa1402895;28   patients;28;-1
NEJMoa1402895;N = 15;15;-1
NEJMoa1402895;N = 16;16;-1
NEJMoa1402895;total of 28;28;-1
NEJMoa1403086;885 participants;885;-1
NEJMoa1403086;878 participants;878;-1
NEJMoa1403086;877 participants;877;-1
NEJMoa1403086;28 A small number of   participants;28;-1
NEJMoa1403086;36 participants;36;-1
NEJMoa1403086;27 Before patients;27;-1
NEJMoa1403086;911 patients;911;-1
NEJMoa1403086;1002 patients;1002;-1
NEJMoa1403086;1126 patients;1126;-1
NEJMoa1403086;430 patients;430;-1
NEJMoa1403086;447 patients;447;-1
NEJMoa1403086;155 patients;155;-1
NEJMoa1403086;12 mo  All patients;12;-1
NEJMoa1403086;30 patients;30;-1
NEJMoa1403086;17 patients;17;-1
NEJMoa1403086;4444 patients;4444;-1
NEJMoa1403086;5963 people;5963;-1
NEJMoa1403086;N = 433;433;-1
NEJMoa1403086;N = 452;452;-1
NEJMoa1403086;N = 430;430;-1
NEJMoa1403086;N = 447;447;-1
NEJMoa1403086;total of 885;885;-1
NEJMoa1403086;total of 44;44;-1
NEJMoa1403086;total of 1982;1982;-1
NEJMoa1403086;total of 296;296;-1
NEJMoa1403086;total of 36;36;-1
NEJMoa1403088;1725 patients;1725;-1
NEJMoa1403088;154 patients;154;-1
NEJMoa1403088;2013 patients;2013;-1
NEJMoa1403088;136 patients;136;-1
NEJMoa1403088;7 patients;7;-1
NEJMoa1403088;160 patients;160;-1
NEJMoa1403088;264 patients;264;-1
NEJMoa1403088;45 patients;45;-1
NEJMoa1403088;61 patients;61;-1
NEJMoa1403088;17 patients;17;-1
NEJMoa1403088;30 patients;30;-1
NEJMoa1403088;124   patients;124;-1
NEJMoa1403088;11 patients;11;-1
NEJMoa1403088;4 patients;4;-1
NEJMoa1403088;31   patients;31;-1
NEJMoa1403088;8 patients;8;-1
NEJMoa1403088;34 patients;34;-1
NEJMoa1403088;22 of these   patients;22;-1
NEJMoa1403088;10 patients;10;-1
NEJMoa1403088;12 patients;12;-1
NEJMoa1403088;168 young adults;168;-1
NEJMoa1403088;500 adolescents and young   adults;500;-1
NEJMoa1403088;total of 154;154;-1
NEJMoa1403088;total of 123;123;-1
NEJMoa1403108;508 patients;508;-1
NEJMoa1403108;450 patients;450;-1
NEJMoa1403108;508   patients;508;-1
NEJMoa1403108;256 patients;256;-1
NEJMoa1403108;407 patients;407;-1
NEJMoa1403108;406 patients;406;-1
NEJMoa1403108;23 patients;23;-1
NEJMoa1403108;12 patients;12;-1
NEJMoa1403108;139 patients;139;-1
NEJMoa1403108;142 patients;142;-1
NEJMoa1403108;114 patients;114;-1
NEJMoa1403108;130 patients;130;-1
NEJMoa1403108;252 patients;252;-1
NEJMoa1403108;173   patients;173;-1
NEJMoa1403108;166 patients;166;-1
NEJMoa1403108;3825 patients;3825;-1
NEJMoa1403108;N = 256;256;-1
NEJMoa1403108;N = 252;252;-1
NEJMoa1403108;N = 254;254;-1
NEJMoa1403108;N = 250;250;-1
NEJMoa1403108;total of 508;508;-1
NEJMoa1403108;total of 139;139;-1
NEJMoa1403108;total of 142;142;-1
NEJMoa1403141;19 patients;19;-1
NEJMoa1403141;11 Enrollment of   patients;11;-1
NEJMoa1403141;13 patients;13;-1
NEJMoa1403141;30 patients;30;-1
NEJMoa1403141;338 patients;338;-1
NEJMoa1403141;N = 8;8;-1
NEJMoa1403141;N = 11;11;-1
NEJMoa1403141;N = 7;7;-1
NEJMoa1403141;N = 12;12;-1
NEJMoa1403141;total of 16;16;-1
NEJMoa1403285;540 patients;540;11256
NEJMoa1403285;259 patients;259;11237
NEJMoa1403285;524 patients;524;874
NEJMoa1403285;5926 patients;5926;1006
NEJMoa1403285;8 patients;8;1104
NEJMoa1403285;5 patients;5;1292
NEJMoa1403285;2 patients;2;1565
NEJMoa1403285;258 patients;258;13353
NEJMoa1403285;N = 259;259;4630
NEJMoa1403285;N = 280;280;4650
NEJMoa1403285;total of 540;540;428
NEJMoa1403285;total of 8;8;1095
NEJMoa1403285;total of 5;5;428
NEJMoa1403285;103 Were enrolled;103;3880
NEJMoa1403290;576 patients;576;-1
NEJMoa1403290;180 patients;180;-1
NEJMoa1403290;802 patients;802;-1
NEJMoa1403290;19 patients;19;-1
NEJMoa1403290;N = 191;191;-1
NEJMoa1403290;N = 194;194;-1
NEJMoa1403290;total of 449;449;-1
NEJMoa1403291;135 patients;135;-1
NEJMoa1403291;20 patients;20;-1
NEJMoa1403291;120 patients;120;-1
NEJMoa1403291;185 patients;185;-1
NEJMoa1403291;6 patients;6;-1
NEJMoa1403291;12   These patients;12;-1
NEJMoa1403291;N = 66;66;-1
NEJMoa1403291;N = 69;69;-1
NEJMoa1403291;N=66;66;-1
NEJMoa1403291;N=69;69;-1
NEJMoa1403352;126 unrelated   patients;126;-1
NEJMoa1404037;2359 premenopausal women;2359;-1
NEJMoa1404037;4690 women;4690;-1
NEJMoa1404037;1803   premenopausal women;1803;-1
NEJMoa1404037;1996 women;1996;-1
NEJMoa1404037;4690 patients;4690;-1
NEJMoa1404037;325 patients;325;-1
NEJMoa1404037;194 patients;194;-1
NEJMoa1404037;7 patients;7;-1
NEJMoa1404037;383 patients;383;-1
NEJMoa1404037;3 patients;3;-1
NEJMoa1404037;186 patients;186;-1
NEJMoa1404037;N = 4690;4690;-1
NEJMoa1404037;N = 1053;1053;-1
NEJMoa1404037;N = 943;943;-1
NEJMoa1404037;N = 1607;1607;-1
NEJMoa1404037;N = 1087;1087;-1
NEJMoa1404037;N   =   2;2;-1
NEJMoa1404037;total of 42;42;-1
NEJMoa1404037;total of 60;60;-1
NEJMoa1404037;total of 1803;1803;-1
NEJMoa1404037;total of 73;73;-1
NEJMoa1404037; data from 4690;4690;-1
NEJMoa1404172;475 participants;475;-1
NEJMoa1404172;483 participants;483;-1
NEJMoa1404172;69 participants;69;-1
NEJMoa1404172;N = 475;475;-1
NEJMoa1404172;N = 469;469;-1
NEJMoa1404172;total of 963;963;-1
NEJMoa1404172;total of 25;25;-1
NEJMoa1404172;total of 19;19;-1
NEJMoa1404172;total of 99;99;-1
NEJMoa1404172;total of 141;141;-1
NEJMoa1404172;total of 59;59;-1
NEJMoa1404172;total of 101;101;-1
NEJMoa1404172;total of 75;75;-1
NEJMoa1404231;115 enrolled patients;115;11608
NEJMoa1404231;58 patients;58;11427
NEJMoa1404231;57 patients;57;11400
NEJMoa1404231;17 patients;17;11341
NEJMoa1404231;2 patients;2;10810
NEJMoa1404231;3 patients;3;8405
NEJMoa1404231;118 patients;118;370
NEJMoa1404231;115 patients;115;822
NEJMoa1404231;17   patients;17;1704
NEJMoa1404231;4 patients;4;1917
NEJMoa1404231;20 patients;20;3071
NEJMoa1404231;8 patients;8;11426
NEJMoa1404231;11 patients;11;4293
NEJMoa1404231;25 patients;25;18384
NEJMoa1404231;445 patients;445;28513
NEJMoa1404231;N = 58;58;8152
NEJMoa1404231;N = 57;57;8180
NEJMoa1404231;N = 115;115;8198
NEJMoa1404231;total   of 118;118;381
NEJMoa1404231;total of   118;118;629
NEJMoa1404231;total of 6;6;1346
NEJMoa1404231;total of 25;25;18375
NEJMoa1404231;115 enrolled;115;11608
NEJMoa1404231;118 patients were enrolled;118;640
NEJMoa1404231;118 Patients were enrolled;118;6655
NEJMoa1404380;1600 enrolled patients;1600;10148
NEJMoa1404380;1600 patients;1600;844
NEJMoa1404380;9 patients;9;2327
NEJMoa1404380;793 patients;793;2441
NEJMoa1404380;798 patients;798;2458
NEJMoa1404380;2 patients;2;2561
NEJMoa1404380;1588 patients;1588;2644
NEJMoa1404380;555 patients;555;2992
NEJMoa1404380;365 patients;365;3133
NEJMoa1404380;714   patients;714;4832
NEJMoa1404380;494 patients;494;5062
NEJMoa1404380;5 patients;5;2994
NEJMoa1404380;3 patients;3;2443
NEJMoa1404380;792 patients;792;8887
NEJMoa1404380;796 patients;796;8939
NEJMoa1404380;56 patients;56;19831
NEJMoa1404380;42 patients;42;19874
NEJMoa1404380;18 Were previously recruited;18;7075
NEJMoa1404380;N = 793;793;10081
NEJMoa1404380;N = 798;798;10104
NEJMoa1404380;N   =   7;7;12789
NEJMoa1404380;1600 enrolled;1600;10148
NEJMoa1404393;208 patients;208;-1
NEJMoa1404393;101 patients;101;-1
NEJMoa1404393;72 patients;72;-1
NEJMoa1404393;348 patients;348;-1
NEJMoa1404393;25 patients;25;-1
NEJMoa1404393;867 patients;867;-1
NEJMoa1404393;102 patients;102;-1
NEJMoa1404393;3 patients;3;-1
NEJMoa1404393;2 patients;2;-1
NEJMoa1404393;104 patients;104;-1
NEJMoa1404393;30 patients;30;-1
NEJMoa1404393;32 patients;32;-1
NEJMoa1404393;46 In nine patients;46;-1
NEJMoa1404393;167 patients;167;-1
NEJMoa1404393;N = 101;101;-1
NEJMoa1404393;N = 104;104;-1
NEJMoa1404393;total of 208;208;-1
NEJMoa1404393;total of   867;867;-1
NEJMoa1404393;total of 101;101;-1
NEJMoa1404393;total of 5;5;-1
NEJMoa1404393;total of 18;18;-1
NEJMoa1404393;208 patients were enrolled;208;-1
NEJMoa1404401;2000 persons;2000;-1
NEJMoa1404401;238 persons;238;-1
NEJMoa1404401;10 persons;10;-1
NEJMoa1404401;14 patients;14;-1
NEJMoa1404401;4 patients;4;-1
NEJMoa1404401;50 patients;50;-1
NEJMoa1404401;68 patients;68;-1
NEJMoa1404401;3 patients;3;-1
NEJMoa1404401;10 patients;10;-1
NEJMoa1404401;10 different patients;10;-1
NEJMoa1404401;30,000 people;30000;-1
NEJMoa1404446;2759 patients;2759;-1
NEJMoa1404446;2500 patients;2500;-1
NEJMoa1404446;3638 patients;3638;-1
NEJMoa1404446;2776 patients;2776;-1
NEJMoa1404446;17 of those   patients;17;-1
NEJMoa1404446;908 patients;908;-1
NEJMoa1404446;113 patients;113;-1
NEJMoa1404446;11 patients;11;-1
NEJMoa1404446;6 patients;6;-1
NEJMoa1404446;316 patients;316;-1
NEJMoa1404446;17 patients;17;-1
NEJMoa1404446;3 patients;3;-1
NEJMoa1404446;579 patients;579;-1
NEJMoa1404446;569 patients;569;-1
NEJMoa1404446;615 patients;615;-1
NEJMoa1404446;623 patients;623;-1
NEJMoa1404446;633 patients;633;-1
NEJMoa1404446;680 patients;680;-1
NEJMoa1404446;650 patients;650;-1
NEJMoa1404446;709 patients;709;-1
NEJMoa1404446;777 patients;777;-1
NEJMoa1404446;766 patients;766;-1
NEJMoa1404446;680,000 people;680000;-1
NEJMoa1404446;N = 908;908;-1
NEJMoa1404446;N = 893;893;-1
NEJMoa1404446;N = 958;958;-1
NEJMoa1404446;total of 2759;2759;-1
NEJMoa1404446;total of 2776;2776;-1
NEJMoa1404446;total of 113;113;-1
NEJMoa1404446;total of 466;466;-1
NEJMoa1404505;20 patients;20;-1
NEJMoa1404505;5 patients;5;-1
NEJMoa1404505;14 patients;14;-1
NEJMoa1404505;total of 111;111;-1
NEJMoa1404588;20 patients;20;-1
NEJMoa1404588;8 patients;8;-1
NEJMoa1404588;7 patients;7;-1
NEJMoa1404588;19 Our patients;19;-1
NEJMoa1404588;1 patients;1;-1
NEJMoa1404588;4 patients;4;-1
NEJMoa1404588;total of   2;2;-1
NEJMoa1404588;total of 125;125;-1
NEJMoa1404588;20 patients enrolled;20;-1
NEJMoa1404588;8 patients enrolled;8;-1
NEJMoa1404731;608 participants;608;11238
NEJMoa1404731;604   participants;604;1807
NEJMoa1404731;36 participants;36;1588
NEJMoa1404731;303 participants;303;846
NEJMoa1404731;543 participants;543;5662
NEJMoa1404731;5 participants;5;5830
NEJMoa1404731;3 participants;3;848
NEJMoa1404731;535 participants;535;6230
NEJMoa1404731;268 participants;268;6295
NEJMoa1404731;5000 people;5000;9989
NEJMoa1404731;N = 303;303;6914
NEJMoa1404731;N = 305;305;6935
NEJMoa1404731;total of 21;21;11278
NEJMoa1404731;total of 535;535;6221
NEJMoa1404731;total of 543;543;24256
NEJMoa1404731;21 clinical centers enrolled;21;11269
NEJMoa1405095;1717 patients;1717;-1
NEJMoa1405095;626 patients;626;-1
NEJMoa1405095;532 patients;532;-1
NEJMoa1405095;1680   patients;1680;-1
NEJMoa1405095;1715 patients;1715;-1
NEJMoa1405095;832 patients;832;-1
NEJMoa1405095;801 patients;801;-1
NEJMoa1405095;872 patients;872;-1
NEJMoa1405095;845 patients;845;-1
NEJMoa1405095;278 patients;278;-1
NEJMoa1405095;309 patients;309;-1
NEJMoa1405095;3  number of patients;3;-1
NEJMoa1405095;N = 872;872;-1
NEJMoa1405095;N = 845;845;-1
NEJMoa1405095;N = 871;871;-1
NEJMoa1405095;N = 844;844;-1
NEJMoa1405095;total of 626;626;-1
NEJMoa1405095;total of 1717;1717;-1
NEJMoa1405095;1717 patients were enrolled;1717;-1
NEJMoa1405386;25,000 initially healthy American women;25000;-1
NEJMoa1405386;650 persons;650;-1
NEJMoa1405386;22,092 participants;22092;-1
NEJMoa1405386;91,002 participants;91002;-1
NEJMoa1405386;2836 participants;2836;-1
NEJMoa1405386;1951 participants;1951;-1
NEJMoa1405386;34 participants;34;-1
NEJMoa1405386;650 participants;650;-1
NEJMoa1405386;22,590 participants;22590;-1
NEJMoa1405386;13,626 participants;13626;-1
NEJMoa1405386;43,628 study   participants;43628;-1
NEJMoa1405386;11 participants;11;-1
NEJMoa1405386;113,094 study participants;113094;-1
NEJMoa1405386;170,000 participants;170000;-1
NEJMoa1405386;7364 patients;7364;-1
NEJMoa1405386;22,590 patients;22590;-1
NEJMoa1405386;29,954 patients;29954;-1
NEJMoa1405386;28,223 patients;28223;-1
NEJMoa1405386;total of 91,002;91002;-1
NEJMoa1405386;total of 34;34;-1
NEJMoa1405386; data from 170,000;170000;-1
NEJMoa1405584;224 patients;224;-1
NEJMoa1405584;111 patients;111;-1
NEJMoa1405584;113 patients;113;-1
NEJMoa1405584;30,000 patients;30000;-1
NEJMoa1405584;2 patients;2;-1
NEJMoa1405584;110 patients;110;-1
NEJMoa1405584;220 patients;220;-1
NEJMoa1405584;16   Because patients;16;-1
NEJMoa1405584;102 patients;102;-1
NEJMoa1405584;110 adults;110;-1
NEJMoa1405584;N = 111;111;-1
NEJMoa1405584;N = 113;113;-1
NEJMoa1405584;N = 108;108;-1
NEJMoa1405584;N = 112;112;-1
NEJMoa1405584;total of 224;224;-1
NEJMoa1405584;total   of 111;111;-1
NEJMoa1405584;total of 201;201;-1
NEJMoa1405584;16   Because patients enrolled;16;-1
NEJMoa1405707;7244 patients;7244;13683
NEJMoa1405707;3621 patients;3621;13243
NEJMoa1405707;1071 patients;1071;11036
NEJMoa1405707;11,956 patients;11956;4058
NEJMoa1405707;15 additional patients;15;1833
NEJMoa1405707;3623   patients;3623;5299
NEJMoa1405707;1498 patients;1498;16509
NEJMoa1405707;10,700 patients;10700;17401
NEJMoa1405707;N = 3623;3623;2276
NEJMoa1405707;N = 3621;3621;2233
NEJMoa1405707;N = 3543;3543;2211
NEJMoa1405707;N = 1169;1169;2166
NEJMoa1405707;total of 15;15;1824
NEJMoa1405707;total of 66;66;11146
NEJMoa1405707;7244 were enrolled;7244;4011
NEJMoa1405707;   data from 1498;1498;16496
NEJMoa1405858;3024 participants;3024;-1
NEJMoa1405858;26 index patients;26;-1
NEJMoa1405858;17 of the patients;17;-1
NEJMoa1405858;total of 59;59;-1
NEJMoa1405858;total of 6;6;-1
NEJMoa1405858;total of 44;44;-1
NEJMoa1406037;423 previously untreated patients;423;-1
NEJMoa1406037;947 patients;947;-1
NEJMoa1406037;423 of these patients;423;-1
NEJMoa1406037;423 patients;423;-1
NEJMoa1406037;211 patients;211;-1
NEJMoa1406037;212 patients;212;-1
NEJMoa1406037;245 patients;245;-1
NEJMoa1406037;6 patients;6;-1
NEJMoa1406037;18 patients;18;-1
NEJMoa1406037;40 patients;40;-1
NEJMoa1406037;55 patients;55;-1
NEJMoa1406037;77 patients;77;-1
NEJMoa1406037;71 patients;71;-1
NEJMoa1406037;133 patients;133;-1
NEJMoa1406037;140 patients;140;-1
NEJMoa1406037;22 patients;22;-1
NEJMoa1406037;210 patients;210;-1
NEJMoa1406037;3  number of patients;3;-1
NEJMoa1406037;209 patients;209;-1
NEJMoa1406037;52 patients;52;-1
NEJMoa1406037;28 patients;28;-1
NEJMoa1406037;103 patients;103;-1
NEJMoa1406037;67 patients;67;-1
NEJMoa1406037;27 patients;27;-1
NEJMoa1406037;5 patients;5;-1
NEJMoa1406037;3 patients;3;-1
NEJMoa1406037;107 patients;107;-1
NEJMoa1406037;30 patients;30;-1
NEJMoa1406037;79 patients;79;-1
NEJMoa1406037;N = 211;211;-1
NEJMoa1406037;N = 212;212;-1
NEJMoa1406037;N = 423;423;-1
NEJMoa1406037;N=211;211;-1
NEJMoa1406037;N=212;212;-1
NEJMoa1406037;N=77;77;-1
NEJMoa1406037;N=71;71;-1
NEJMoa1406037;N = 210;210;-1
NEJMoa1406037;N = 179;179;-1
NEJMoa1406037;N = 180;180;-1
NEJMoa1406037;N = 31;31;-1
NEJMoa1406037;N = 30;30;-1
NEJMoa1406037;N = 209;209;-1
NEJMoa1406430;19,102 patients;19102;-1
NEJMoa1406430;12,049 patients;12049;-1
NEJMoa1406430;16,850   patients;16850;-1
NEJMoa1406430;1972 patients;1972;-1
NEJMoa1406430;1384 patients;1384;-1
NEJMoa1406430;272 patients;272;-1
NEJMoa1406430;1446 patients;1446;-1
NEJMoa1406430;3588 patients;3588;-1
NEJMoa1406430;1 In patients;1;-1
NEJMoa1406430;N = 9550;9550;-1
NEJMoa1406430;N = 9552;9552;-1
NEJMoa1406430;N = 9539;9539;-1
NEJMoa1406430;N = 9544;9544;-1
NEJMoa1406430;total of 19,102;19102;-1
NEJMoa1406430;total of 73;73;-1
NEJMoa1406498;64 patients;64;-1
NEJMoa1406498;11 patients;11;-1
NEJMoa1406498;14 patients;14;-1
NEJMoa1406498;39 patients;39;-1
NEJMoa1406498;25 ipilimumab-treated patients;25;-1
NEJMoa1406498;25 patients;25;-1
NEJMoa1406498;N = 11;11;-1
NEJMoa1406498;N = 14;14;-1
NEJMoa1406498;N = 25;25;-1
NEJMoa1406498;N=8;8;-1
NEJMoa1406498;N=17;17;-1
NEJMoa1406498;N=23;23;-1
NEJMoa1406498;N=16;16;-1
NEJMoa1406498;N=15;15;-1
NEJMoa1406498;N=10;10;-1
NEJMoa1406617;1005 patients;1005;-1
NEJMoa1406617;502 patients;502;-1
NEJMoa1406617;500 patients;500;-1
NEJMoa1406617;15 patients;15;-1
NEJMoa1406617;5 additional patients;5;-1
NEJMoa1406617;14 patients;14;-1
NEJMoa1406617;1000   patients;1000;-1
NEJMoa1406617;5 patients;5;-1
NEJMoa1406617;4 patients;4;-1
NEJMoa1406617;2 patients;2;-1
NEJMoa1406617;998 patients;998;-1
NEJMoa1406617;488 patients;488;-1
NEJMoa1406617;176 patients;176;-1
NEJMoa1406617;216 patients;216;-1
NEJMoa1406617;77 patients;77;-1
NEJMoa1406617;51 patients;51;-1
NEJMoa1406617;28   An important exception is patients;28;-1
NEJMoa1406617;21 patients;21;-1
NEJMoa1406617;53  All patients;53;-1
NEJMoa1406617;N = 502;502;-1
NEJMoa1406617;N         = 496;496;-1
NEJMoa1406617;total of 15;15;-1
NEJMoa1406617;total of 5;5;-1
NEJMoa1406617;total of 29;29;-1
NEJMoa1406617;total of 1545;1545;-1
NEJMoa1406617;total of 176;176;-1
NEJMoa1406617;total of 7;7;-1
NEJMoa1406617;total of 21;21;-1
NEJMoa1406617;total   of 1;1;-1
NEJMoa1406617; data from 998;998;-1
NEJMoa1406766;50 patients;50;-1
NEJMoa1406766;25 patients;25;-1
NEJMoa1406766;30 patients;30;-1
NEJMoa1406766;27 of these patients;27;-1
NEJMoa1406766;3 patients;3;-1
NEJMoa1406766;14 patients;14;-1
NEJMoa1406766;20   patients;20;-1
NEJMoa1406766;49 patients;49;-1
NEJMoa1406766;50 study patients;50;-1
NEJMoa1406766;33 patients;33;-1
NEJMoa1406766;9 patients;9;-1
NEJMoa1406766;36 patients;36;-1
NEJMoa1406766;4 patients;4;-1
NEJMoa1406766;1 cohort of patients;1;-1
NEJMoa1406766;27 patients;27;-1
NEJMoa1406766;143 patients;143;-1
NEJMoa1406766;3  All   Grades  number of patients;3;-1
NEJMoa1406766;50 study   patients;50;-1
NEJMoa1406766;N = 50;50;-1
NEJMoa1406766;total of   30;30;-1
NEJMoa1406766; data cutoff, 23;23;-1
NEJMoa1407024;1862 patients;1862;-1
NEJMoa1407024;1875 patients;1875;-1
NEJMoa1407024;909 patients;909;-1
NEJMoa1407024;953 patients;953;-1
NEJMoa1407024;37 patients;37;-1
NEJMoa1407024;906   patients;906;-1
NEJMoa1407024;30 patients;30;-1
NEJMoa1407024;82 patients;82;-1
NEJMoa1407024;51 patients;51;-1
NEJMoa1407024;18 patients;18;-1
NEJMoa1407024;N = 909;909;-1
NEJMoa1407024;N = 953;953;-1
NEJMoa1407024;N = 906;906;-1
NEJMoa1407024;N = 952;952;-1
NEJMoa1407024;total of 12;12;-1
NEJMoa1407024;total of 1875;1875;-1
NEJMoa1407024;total of 30;30;-1
NEJMoa1407024;1875 Patients were enrolled;1875;-1
NEJMoa1407024;1875 patients were enrolled;1875;-1
NEJMoa1407154;2485 patients;2485;-1
NEJMoa1407154;2456 patients;2456;-1
NEJMoa1407154;2234 patients;2234;-1
NEJMoa1407154;17 patients;17;-1
NEJMoa1407154;44 patients;44;-1
NEJMoa1407154;N = 1243;1243;-1
NEJMoa1407154;N = 1242;1242;-1
NEJMoa1407154;N = 2485;2485;-1
NEJMoa1407154;total of 2485;2485;-1
NEJMoa1407154;total of 82;82;-1
NEJMoa1407154;3426 Patients were enrolled;3426;-1
NEJMoa1407222;25 were participants;25;-1
NEJMoa1407222;30 were participants;30;-1
NEJMoa1407222;27 patients;27;-1
NEJMoa1407222;2 patients;2;-1
NEJMoa1407222;30 patients;30;-1
NEJMoa1407222;25 patients;25;-1
NEJMoa1407222;5 older patients;5;-1
NEJMoa1407222;22 patients;22;-1
NEJMoa1407222;3 patients;3;-1
NEJMoa1407222;15 patients;15;-1
NEJMoa1407222;4 patients;4;-1
NEJMoa1407222;18 patients;18;-1
NEJMoa1407222;019  Five patients;19;-1
NEJMoa1407222;8 patients;8;-1
NEJMoa1407222;19 patients;19;-1
NEJMoa1407222;16 adult patients;16;-1
NEJMoa1407222;3 This study included patients;3;-1
NEJMoa1407222;18   patients;18;-1
NEJMoa1407222;30 children and adults;30;-1
NEJMoa1407222;N = 25;25;-1
NEJMoa1407222;N = 5;5;-1
NEJMoa1407222;N = 30;30;-1
NEJMoa1407222;total of 30;30;-1
NEJMoa1407222;total of 25;25;-1
NEJMoa1407309;6 patients;6;-1
NEJMoa1407309;2 patients;2;-1
NEJMoa1407309;4 additional patients;4;-1
NEJMoa1407309;10 patients;10;-1
NEJMoa1407309;10 study patients;10;-1
NEJMoa1407309;total of 10;10;-1
NEJMoa1407309;total of 128;128;-1
NEJMoa1407380;1371 participants;1371;-1
NEJMoa1407380;1223 participants;1223;-1
NEJMoa1407380;1400 patients;1400;-1
NEJMoa1407380;1250 patients;1250;-1
NEJMoa1407380;44 patients;44;-1
NEJMoa1407380;240 patients;240;-1
NEJMoa1407380;940 patients;940;-1
NEJMoa1407380;1400 adults;1400;-1
NEJMoa1407380;N = 706;706;-1
NEJMoa1407380;N = 694;694;-1
NEJMoa1407380;N = 625;625;-1
NEJMoa1407380;N   =   7;7;-1
NEJMoa1407380;N   =   6;6;-1
NEJMoa1407380;total of 1400;1400;-1
NEJMoa1407380;total of 1250;1250;-1
NEJMoa1407380;total of 44;44;-1
NEJMoa1407380;1400 patients were enrolled;1400;-1
NEJMoa1407380;1250 patients were enrolled;1250;-1
NEJMoa1407380;1400 patients enrolled;1400;-1
NEJMoa1407426;1931 patients;1931;-1
NEJMoa1407426;127 patients;127;-1
NEJMoa1407426;633 patients;633;-1
NEJMoa1407426;2763 patients;2763;-1
NEJMoa1407426;436 patients;436;-1
NEJMoa1407426;467 patients;467;-1
NEJMoa1407426;419 patients;419;-1
NEJMoa1407426;436   patients;436;-1
NEJMoa1407426;46 patients;46;-1
NEJMoa1407426;12 patients;12;-1
NEJMoa1407426;24 patients;24;-1
NEJMoa1407426;27 patients;27;-1
NEJMoa1407426;148 patients;148;-1
NEJMoa1407426;17 patients;17;-1
NEJMoa1407426;122 patients;122;-1
NEJMoa1407426;111 patients;111;-1
NEJMoa1407426;173   patients;173;-1
NEJMoa1407426;50 patients;50;-1
NEJMoa1407426;600 patients;600;-1
NEJMoa1407426;N = 510;510;-1
NEJMoa1407426;N = 514;514;-1
NEJMoa1407426;N = 524;524;-1
NEJMoa1407426;N = 1548;1548;-1
NEJMoa1407426;N = 555;555;-1
NEJMoa1407426;N = 568;568;-1
NEJMoa1407426;N = 551;551;-1
NEJMoa1407426;N = 1674;1674;-1
NEJMoa1407426;N = 639;639;-1
NEJMoa1407426;N = 655;655;-1
NEJMoa1407426;N = 636;636;-1
NEJMoa1407426;N = 1930;1930;-1
NEJMoa1407426;total of 2763;2763;-1
NEJMoa1407426; data from 24;24;-1
NEJMoa1407764;204 participants;204;-1
NEJMoa1407764;134 participants;134;-1
NEJMoa1407764;1 month we also asked participants;1;-1
NEJMoa1407764;134   participants;134;-1
NEJMoa1407764;107 participants;107;-1
NEJMoa1407764;88 participants;88;-1
NEJMoa1407764;348 participants;348;-1
NEJMoa1407764;1 month participants;1;-1
NEJMoa1407764;1410 participants;1410;-1
NEJMoa1407764;171 participants;171;-1
NEJMoa1407764;1310 people;1310;-1
NEJMoa1407764;3001 people;3001;-1
NEJMoa1407764;N = 655;655;-1
NEJMoa1407764;N=655;655;-1
NEJMoa1407764;N =655;655;-1
NEJMoa1407778;96 patients;96;-1
NEJMoa1407778;9 patients;9;-1
NEJMoa1407778;4 patients;4;-1
NEJMoa1407963;10,261 participants;10261;-1
NEJMoa1407963;11,140 patients;11140;-1
NEJMoa1407963;8494 patients;8494;-1
NEJMoa1407963;10,082 patients;10082;-1
NEJMoa1407963;7279 patients;7279;-1
NEJMoa1407963;879 patients;879;-1
NEJMoa1407963;1000 patients;1000;-1
NEJMoa1407963;1386   patients;1386;-1
NEJMoa1407963;1166 patients;1166;-1
NEJMoa1407963;1031 patients;1031;-1
NEJMoa1407963;1147 patients;1147;-1
NEJMoa1407963;1234   patients;1234;-1
NEJMoa1407963;1019 patients;1019;-1
NEJMoa1407963;N   =   5;5;-1
NEJMoa1407963;N   =   4;4;-1
NEJMoa1407963;total of   10;10;-1
NEJMoa1408028;43 patients;43;-1
NEJMoa1408028;13 patients;13;-1
NEJMoa1408028;248 patients;248;-1
NEJMoa1408028;9 and two patients;9;-1
NEJMoa1408028;3 patients;3;-1
NEJMoa1408028;12 patients;12;-1
NEJMoa1408028;4 patients;4;-1
NEJMoa1408028;43   patients;43;-1
NEJMoa1408028;2 patients;2;-1
NEJMoa1408028;11 patients;11;-1
NEJMoa1408028;8 patients;8;-1
NEJMoa1408028;15 additional patients;15;-1
NEJMoa1408028;N = 14;14;-1
NEJMoa1408028;N = 29;29;-1
NEJMoa1408214;33,915 patients;33915;-1
NEJMoa1408214;33,915   patients;33915;-1
NEJMoa1408214;2701   patients;2701;-1
NEJMoa1408214;912 patients;912;-1
NEJMoa1408214;132 patients;132;-1
NEJMoa1408214;84 patients;84;-1
NEJMoa1408214;82 patients;82;-1
NEJMoa1408214;613 patients;613;-1
NEJMoa1408214;70 patients;70;-1
NEJMoa1408214;176 patients;176;-1
NEJMoa1408214;2455   patients;2455;-1
NEJMoa1408214;28  Unlike patients;28;-1
NEJMoa1408214;23,000 patients;23000;-1
NEJMoa1408214;1 diabetic patients;1;-1
NEJMoa1408214;20,985 patients;20985;-1
NEJMoa1408214;7,454 patients;7454;-1
NEJMoa1408214;1 diabetic   patients;1;-1
NEJMoa1408214;N   =   1;1;-1
NEJMoa1408214;N   =   3;3;-1
NEJMoa1408214;N   =   6;6;-1
NEJMoa1408214;N   =   7;7;-1
NEJMoa1408214;N   =   8;8;-1
NEJMoa1408214;N   =   5;5;-1
NEJMoa1408214;N   =   4;4;-1
NEJMoa1408440;343 patients;343;-1
NEJMoa1408440;3 trial involving   patients;3;-1
NEJMoa1408440;340 patients;340;-1
NEJMoa1408440;171   patients;171;-1
NEJMoa1408440;91 patients;91;-1
NEJMoa1408440;25 patients;25;-1
NEJMoa1408440;26   patients;26;-1
NEJMoa1408440;171 patients;171;-1
NEJMoa1408440;172 patients;172;-1
NEJMoa1408440;89 patients;89;-1
NEJMoa1408440;21 patients;21;-1
NEJMoa1408440;79   patients;79;-1
NEJMoa1408440;62 patients;62;-1
NEJMoa1408440;24 patients;24;-1
NEJMoa1408440;4 patients;4;-1
NEJMoa1408440;4  number of patients;4;-1
NEJMoa1408440;N = 172;172;-1
NEJMoa1408440;N = 171;171;-1
NEJMoa1408440;N = 169;169;-1
NEJMoa1408440;total of   343;343;-1
NEJMoa1408440;total of 21;21;-1
NEJMoa1408440; data cutoff, 79;79;-1
NEJMoa1408758;1220 patients;1220;-1
NEJMoa1408758;816 patients;816;-1
NEJMoa1408758;447 patients;447;-1
NEJMoa1408758;441 patients;441;-1
NEJMoa1408758;332 registry patients;332;-1
NEJMoa1408758;888 patients;888;-1
NEJMoa1408758;36 patients;36;-1
NEJMoa1408758;86 patients;86;-1
NEJMoa1408758;15 patients;15;-1
NEJMoa1408758;18 patients;18;-1
NEJMoa1408758;72 patients;72;-1
NEJMoa1408758;90 patients;90;-1
NEJMoa1408758;28 patients;28;-1
NEJMoa1408758;44 patients;44;-1
NEJMoa1408758;179 patients;179;-1
NEJMoa1408758;166 registry patients;166;-1
NEJMoa1408758;151 patients;151;-1
NEJMoa1408758;232 patients;232;-1
NEJMoa1408758;110 patients;110;-1
NEJMoa1408758;204 patients;204;-1
NEJMoa1408758;N = 447;447;-1
NEJMoa1408758;N = 441;441;-1
NEJMoa1408758;n=0;0;-1
NEJMoa1408758;total of   888;888;-1
NEJMoa1408758;1220 patients who were enrolled;1220;-1
NEJMoa1408868;495 patients;495;-1
NEJMoa1408868;63 patients;63;-1
NEJMoa1408868;1049 patients;1049;-1
NEJMoa1408868;495   patients;495;-1
NEJMoa1408868;247 patients;247;-1
NEJMoa1408868;0  All patients;0;-1
NEJMoa1408868;111 167  Percent of patients;111167;-1
NEJMoa1408868;493 patients;493;-1
NEJMoa1408868;4  number of patients;4;-1
NEJMoa1408868;85 patients;85;-1
NEJMoa1408868;N = 248;248;-1
NEJMoa1408868;N = 247;247;-1
NEJMoa1408868;N=247;247;-1
NEJMoa1408868;N=248;248;-1
NEJMoa1408868;N = 239;239;-1
NEJMoa1408868;N = 254;254;-1
NEJMoa1408868;total of 1049;1049;-1
NEJMoa1408868;total of 493;493;-1
NEJMoa1408868;total of 85;85;-1
NEJMoa1408921;34 study participants;34;-1
NEJMoa1408921;34 patients;34;-1
NEJMoa1408921;29 patients;29;-1
NEJMoa1408921;34   patients;34;-1
NEJMoa1408921;5 patients;5;-1
NEJMoa1408921;19 patients;19;-1
NEJMoa1408921;9 patients;9;-1
NEJMoa1408921;5 of these patients;5;-1
NEJMoa1408921;8 patients;8;-1
NEJMoa1408921;170 million people;170;-1
NEJMoa1408921;N = 34;34;-1
NEJMoa1409065;2971 persons;2971;-1
NEJMoa1409065;2924 participants;2924;-1
NEJMoa1409065;2416 participants;2416;-1
NEJMoa1409065;132 participants;132;-1
NEJMoa1409065;2924 adults;2924;-1
NEJMoa1409065;N = 2924;2924;-1
NEJMoa1409065;N = 731;731;-1
NEJMoa1409065;N = 2416;2416;-1
NEJMoa1409065;N = 602;602;-1
NEJMoa1409065;N = 605;605;-1
NEJMoa1409065;N = 607;607;-1
NEJMoa1409065;total of 2971;2971;-1
NEJMoa1409065;total of 57;57;-1
NEJMoa1409065;total of 132;132;-1
NEJMoa1409077;8442 patients;8442;-1
NEJMoa1409077;914 patients;914;-1
NEJMoa1409077;1117 patients;1117;-1
NEJMoa1409077;711 patients;711;-1
NEJMoa1409077;835   patients;835;-1
NEJMoa1409077;8 patients;8;-1
NEJMoa1409077;8000 patients;8000;-1
NEJMoa1409077;2410 patients;2410;-1
NEJMoa1409077;20 patients;20;-1
NEJMoa1409077;45 patients;45;-1
NEJMoa1409077;10,521 patients;10521;-1
NEJMoa1409077;43 patients;43;-1
NEJMoa1409077;4187 patients;4187;-1
NEJMoa1409077;746 patients;746;-1
NEJMoa1409077;833 patients;833;-1
NEJMoa1409077;9 patients;9;-1
NEJMoa1409077;2670 patients;2670;-1
NEJMoa1409077;2638 patients;2638;-1
NEJMoa1409077;696 Better  All patients;696;-1
NEJMoa1409077;658 patients;658;-1
NEJMoa1409077;835 patients;835;-1
NEJMoa1409077;84   patients;84;-1
NEJMoa1409077;83 patients;83;-1
NEJMoa1409077;94 patients;94;-1
NEJMoa1409077;108 patients;108;-1
NEJMoa1409077;19 patients;19;-1
NEJMoa1409077;10 patients;10;-1
NEJMoa1409077;12,440   patients;12440;-1
NEJMoa1409077;N = 4187;4187;-1
NEJMoa1409077;N = 4212;4212;-1
NEJMoa1409077;total of 711;711;-1
NEJMoa1409077;total of 10,521;10521;-1
NEJMoa1409077;total of 2670;2670;-1
NEJMoa1409077;total of 558;558;-1
NEJMoa1409077;total of   94;94;-1
NEJMoa1409312;9961 patients;9961;-1
NEJMoa1409312;5009 patients;5009;-1
NEJMoa1409312;9800   patients;9800;-1
NEJMoa1409312;9960   patients;9960;-1
NEJMoa1409312;25,682 patients;25682;-1
NEJMoa1409312;N = 5020;5020;-1
NEJMoa1409312;N = 4941;4941;-1
NEJMoa1409312;N = 4710;4710;-1
NEJMoa1409312;N = 4649;4649;-1
NEJMoa1409312;total of 9961;9961;-1
NEJMoa1409312;total of 6594;6594;-1
NEJMoa1409312;11 countries   were enrolled;11;-1
NEJMoa1409354;2 All study   participants;2;-1
NEJMoa1409354;44 patients;44;-1
NEJMoa1409354;110 patients;110;-1
NEJMoa1409354;74 patients;74;-1
NEJMoa1409354;76 patients;76;-1
NEJMoa1409354;154 patients;154;-1
NEJMoa1409354;65 patients;65;-1
NEJMoa1409354;4 patients;4;-1
NEJMoa1409354;152 patients;152;-1
NEJMoa1409354;365 patients;365;-1
NEJMoa1409354;10 additional patients;10;-1
NEJMoa1409354;12 Three of these patients;12;-1
NEJMoa1409354;7A-seropositive patients;7;-1
NEJMoa1409354;7A-pos-  itive patients;7;-1
NEJMoa1409354;15 patients;15;-1
NEJMoa1409354;total of 7;7;-1
NEJMoa1409838;103 patients;103;-1
NEJMoa1409838;total of 13,042;13042;-1
NEJMoa1409860;2400 patients;2400;-1
NEJMoa1409860;1188 patients;1188;-1
NEJMoa1409860;1195 patients;1195;-1
NEJMoa1409860;44 patients;44;-1
NEJMoa1409860;74 patients;74;-1
NEJMoa1409860;100 patients;100;-1
NEJMoa1409860;194 patients;194;-1
NEJMoa1409860;1184 patients;1184;-1
NEJMoa1409860;1200 patients;1200;-1
NEJMoa1409860;11,108 patients;11108;-1
NEJMoa1409860;12   patients;12;-1
NEJMoa1409860;2388 patients;2388;-1
NEJMoa1409860;37 patients;37;-1
NEJMoa1409860;81 patients;81;-1
NEJMoa1409860;18 patients;18;-1
NEJMoa1409860;58 patients;58;-1
NEJMoa1409860;4 patients;4;-1
NEJMoa1409860;5 patients;5;-1
NEJMoa1409860;29 patients;29;-1
NEJMoa1409860;1552 patients;1552;-1
NEJMoa1409860;24 patients;24;-1
NEJMoa1409860;262 patients;262;-1
NEJMoa1409860;253 patients;253;-1
NEJMoa1409860;6 patients;6;-1
NEJMoa1409860;4 and patients;4;-1
NEJMoa1409860;31 sites involving patients;31;-1
NEJMoa1409860;N = 1191;1191;-1
NEJMoa1409860;N = 1197;1197;-1
NEJMoa1409860;total of 25;25;-1
NEJMoa1409860;total of 48;48;-1
NEJMoa1409860;84 Were previously enrolled;84;-1
NEJMoa1409860;2400 were enrolled;2400;-1
NEJMoa1410490;301 patients;301;-1
NEJMoa1410490;300 patients;300;-1
NEJMoa1410490;725 patients;725;-1
NEJMoa1410490;102 patients;102;-1
NEJMoa1410490;73 patients;73;-1
NEJMoa1410490;103 patients;103;-1
NEJMoa1410490;N = 151;151;-1
NEJMoa1410490;N = 150;150;-1
NEJMoa1410490;total of 725;725;-1
NEJMoa1411099;69   patients;69;-1
NEJMoa1411099;3 patients;3;-1
NEJMoa1411099;28 patients;28;-1
NEJMoa1411099;69 patients;69;-1
NEJMoa1411099;21 male   patients;21;-1
NEJMoa1411099;28 female patients;28;-1
NEJMoa1411099;28 paired contacts of patients;28;-1
NEJMoa1411099;49 patients;49;-1
NEJMoa1411099;29 patients;29;-1
NEJMoa1411099;2 patients;2;-1
NEJMoa1411099;30 patients;30;-1
NEJMoa1411099;11 patients;11;-1
NEJMoa1411099;1121 contacts of the patients;1121;-1
NEJMoa1411099;N = 60;60;-1
NEJMoa1411099;N = 28;28;-1
NEJMoa1411099;N = 38;38;-1
NEJMoa1411099;total of 69;69;-1
NEJMoa1411099;total of   5;5;-1
NEJMoa1411099;total of 1121;1121;-1
NEJMoa1411099;total of   830;830;-1
NEJMoa1411100;995 patients;995;-1
NEJMoa1411100;1737   patients;1737;-1
NEJMoa1411100;30   patients;30;-1
NEJMoa1411100;103 patients;103;-1
NEJMoa1411100;20 million people;20;-1
NEJMoa1411100;1 million people;1;-1
NEJMoa1411100;total of 4507;4507;-1
NEJMoa1411100;total of 718;718;-1
NEJMoa1411100;total of 318;318;-1
NEJMoa1411100;total of 67;67;-1
NEJMoa1411100;total of 70;70;-1
NEJMoa1411680;106 patients;106;-1
NEJMoa1411680;78 patients;78;-1
NEJMoa1411680;213 patients;213;-1
NEJMoa1411680;59   patients;59;-1
NEJMoa1411680;87 patients;87;-1
NEJMoa1411680;19 patients;19;-1
NEJMoa1411680;65 patients;65;-1
NEJMoa1411680;43 patients;43;-1
NEJMoa1411680;20 patients;20;-1
NEJMoa1411680;5 patients;5;-1
NEJMoa1411680;44 patients;44;-1
NEJMoa1411680;106   patients;106;-1
NEJMoa1411680;N=23;23;-1
NEJMoa1411680;N=47;47;-1
NEJMoa1411680;N=16;16;-1
NEJMoa1411680;N=15;15;-1
NEJMoa1411680;N=30;30;-1
NEJMoa1411680;N=18;18;-1
NEJMoa1411680;N=36;36;-1
NEJMoa1411680;N=8;8;-1
NEJMoa1411680;N=25;25;-1
NEJMoa1411680;N=6;6;-1
NEJMoa1411680;N=29;29;-1
NEJMoa1411680;N=39;39;-1
NEJMoa1411680;N=17;17;-1
NEJMoa1411680;total of 213;213;-1
NEJMoa1411680;total of 27;27;-1
NEJMp1310132;20,000 of their patients;20000;-1
NEJMp1311068;20,000 of their patients;20000;-1
NEJMp1311941;1 million people;1;-1
NEJMp1311941;6 million people;6;-1
NEJMp1311941;7 million people;7;-1
NEJMp1311941;1143   adults;1143;-1
NEJMp1313325;2 In   one study assessing women;2;-1
NEJMp1313325;200 women;200;-1
NEJMp1313325;1  Preventing women;1;-1
NEJMp1313325;150   incarcerated women;150;-1
NEJMp1313325;62,000 women;62000;-1
NEJMp1313771;8 million people;8;-1
NEJMp1313771;700 million people;700;-1
NEJMp1313866;300 persons;300;-1
NEJMp1313866;702 participants;702;-1
NEJMp1313866;20 patients;20;-1
NEJMp1313866;   data from a 12;12;-1
NEJMp1314078;8 mil-lion diabetic patients;8;-1
NEJMp1314078;16,492   patients;16492;-1
NEJMp1314078;5380 patients;5380;-1
NEJMp1314078;   data from a 2013;2013;-1
NEJMp1314078; data from 14,611;14611;-1
NEJMp1314385;47 patients;47;-1
NEJMp1314385;79 patients;79;-1
NEJMp1314385;233 patients;233;-1
NEJMp1314385;81 patients;81;-1
NEJMp1314385;79 bedaquiline-  treated patients;79;-1
NEJMp1314385;4 other patients;4;-1
NEJMp1314385;8 patients;8;-1
NEJMp1314626;3   While people;3;-1
NEJMp1314868;8 million people;8;-1
NEJMp1314965;25 Choos-  ing Wisely participants;25;-1
NEJMp1315214;700 million people;700;-1
NEJMp1315416;total of 35;35;-1
NEJMp1315416;total of 25;25;-1
NEJMp1315559;1 Al-  though patients;1;-1
NEJMp1315559;n=1;1;-1
NEJMp1315568;12,000 patients;12000;-1
NEJMp1315568;4  These patients;4;-1
NEJMp1315607;12,000 patients;12000;-1
NEJMp1315956;total of 10;10;-1
NEJMp1315956;   data from a 12;12;-1
NEJMp1315960;300 new patients;300;-1
NEJMp1315960;25 million people;25;-1
NEJMp1315960;5000 people;5000;-1
NEJMp1315960;250,000 people;250000;-1
NEJMp1315960;total of 2686;2686;-1
NEJMp1316042; data   from 1974;1974;-1
NEJMp1400034;2 For se-  verely ill patients;2;-1
NEJMp1400062;20 patients;20;-1
NEJMp1400062;100 patients;100;-1
NEJMp1400062;3 One group   of patients;3;-1
NEJMp1400062;142 patients;142;-1
NEJMp1400062;50 patients;50;-1
NEJMp1400104;250 patients;250;-1
NEJMp1400104;32,000 patients;32000;-1
NEJMp1400160;150 million people;150;-1
NEJMp1400160;10 million   people;10;-1
NEJMp1400601;8 mil-lion diabetic patients;8;-1
NEJMp1400613;1143   adults;1143;-1
NEJMp1400613;540 adults;540;-1
NEJMp1400613;total of 84,000;84000;-1
NEJMp1400707;6 million   people;6;-1
NEJMp1400707;19 million people;19;-1
NEJMp1400707;2 million people;2;-1
NEJMp1400788;43 patients;43;-1
NEJMp1400788;25,000   people;25000;-1
NEJMp1400986;170   million people;170;-1
NEJMp1401127;43 million   adults;43;-1
NEJMp1401335;n=1;1;-1
NEJMp1401658;6,000 of   patients;6000;-1
NEJMp1401658;9,000   benefit cap for patients;9000;-1
NEJMp1401658;50,000 drug.  Although many patients;50000;-1
NEJMp1401820;1 million people;1;-1
NEJMp1401820;23 people;23;-1
NEJMp1401833;170   million people;170;-1
NEJMp1401875;600,000 women;600000;-1
NEJMp1401875;1003 women;1003;-1
NEJMp1401875;723 women;723;-1
NEJMp1401875;1000   women;1000;-1
NEJMp1401875;1000 women;1000;-1
NEJMp1401875;670 women;670;-1
NEJMp1402080;1184 menopausal   women;1184;-1
NEJMp1402080;total of 1184;1184;-1
NEJMp1402837;97,774 participants;97774;-1
NEJMp1402837;4 billion people;4;-1
NEJMp1403496;2 Pregnant   women;2;-1
NEJMp1403496;5   Some pregnant women;5;-1
NEJMp1404194;37 million people;37;-1
NEJMp1404194;8 million people;8;-1
NEJMp1404194;3 million   have enrolled;3;-1
NEJMp1404298;8 million people;8;-1
NEJMp1404298;3 million   have enrolled;3;-1
NEJMp1404358; data breach of 2009;2009;-1
NEJMp1404860;2 When children be-  come patients;2;-1
NEJMp1405158;N = 207;207;-1
NEJMp1405158;N = 851;851;-1
NEJMp1405158;N = 444;444;-1
NEJMp1405709;4   Might patients;4;-1
NEJMp1406707;1 Unin-  sured people;1;-1
NEJMp1406868;9 million are enrolled;9;-1
NEJMp1407698;total of 576,535;576535;-1
NEJMp1407698;total   of 484;484;-1
NEJMp1407883;1118   patients;1118;-1
NEJMp1408376;5 Some patients;5;-1
NEJMp1408457;4000 people;4000;-1
NEJMp1408460;1 and   patients;1;-1
NEJMp1408480;4 million young adults;4;-1
NEJMp1408480;5 million older adults;5;-1
NEJMp1408509;total of 576,535;576535;-1
NEJMp1408647;1 and   patients;1;-1
NEJMp1408647;N=158;158;-1
NEJMp1408647;N=1227;1227;-1
NEJMp1408647;N=3762;3762;-1
NEJMp1408647;N=1294;1294;-1
NEJMp1408647;N=11,423;11423;-1
NEJMp1408696;18 other   people;18;-1
NEJMp1408779;2 Pregnant   women;2;-1
NEJMp1408779;100,000 people;100000;-1
NEJMp1409353;5 Some patients;5;-1
NEJMp1409360;9 million people;9;-1
NEJMp1409360;9 million   newly insured adults;9;-1
NEJMp1409494;84 patients;84;-1
NEJMp1409494;103   patients;103;-1
NEJMp1409600;322,000 low-income adults;322000;-1
NEJMp1409600;N = 327,912;327912;-1
NEJMp1409600;N = 605,376;605376;-1
NEJMp1409817;103   patients;103;-1
NEJMp1409841;40,000 people;40000;-1
NEJMp1409858;100,000 people;100000;-1
NEJMp1409859;100,000 people;100000;-1
NEJMp1409859;5 million people;5;-1
NEJMp1409903;1000 people;1000;-1
NEJMp1410179;250 contacts of infect-  ed persons;250;-1
NEJMp1410179;8 new patients;8;-1
NEJMp1410179;64 patients;64;-1
NEJMp1410179;2 patients;2;-1
NEJMp1410179;470,000 people;470000;-1
NEJMp1410288;900 people;900;-1
NEJMp1410301;5 million people;5;-1
NEJMp1410509;413,000 people;413000;-1
NEJMp1410540;70 people;70;-1
NEJMp1410540;275,000 people;275000;-1
NEJMp1410540;4 million young adults;4;-1
NEJMp1410540;N=57;57;-1
NEJMp1410540;N=109;109;-1
NEJMp1410540;total   of 318;318;-1
NEJMp1410790;200   qualifying patients;200;-1
NEJMp1411685;900 patients;900;-1
NEJMp1411794;total of 36;36;-1
NEJMp1411794;total of 4;4;-1
NEJMp1411794;   data from 1;1;-1
NEJMp1413084;4   When patients;4;-1
NEJMp1413084;50 patients;50;-1
NEJMp1413425;20,000 women;20000;-1
NEJMra1011035;23 and persons;23;-1
NEJMra1011035;69 In   healthy young persons;69;-1
NEJMra1011035;2 diabetic patients;2;-1
NEJMra1110897;100 million people;100;-1
NEJMra1111610;8 All people;8;-1
NEJMra1111610;1 billion people;1;-1
NEJMra1204664;22 For patients;22;-1
NEJMra1204664;5 patients;5;-1
NEJMra1207059;88 patients;88;-1
NEJMra1207059;416 consecutive patients;416;-1
NEJMra1207059;642 patients;642;-1
NEJMra1207059;416 patients;416;-1
NEJMra1207059;32 patients;32;-1
NEJMra1207059;300 patients;300;-1
NEJMra1208626;8  In such patients;8;-1
NEJMra1208626;20,000 trauma patients;20000;-1
NEJMra1208705;36 patients;36;-1
NEJMra1208705;103   patients;103;-1
NEJMra1208705;614 critically ill patients;614;-1
NEJMra1208708;182 patients;182;-1
NEJMra1208708;17 patients;17;-1
NEJMra1208708;163 severely   head-injured patients;163;-1
NEJMra1208802;500 million persons;500;-1
NEJMra1208802;100 million   persons;100;-1
NEJMra1208802;total of 73;73;-1
NEJMra1208802; data as of the 31;31;-1
NEJMra1212788;9004 persons;9004;-1
NEJMra1212788;500 participants;500;-1
NEJMra1212788;101 patients;101;-1
NEJMra1212788;915 patients;915;-1
NEJMra1212788;527 patients;527;-1
NEJMra1212788;146 patients;146;-1
NEJMra1212788;126 patients;126;-1
NEJMra1212788;126 adults;126;-1
NEJMra1212788;48 adults;48;-1
NEJMra1212788;56 adults;56;-1
NEJMra1212788;212 adults;212;-1
NEJMra1212788;31 adults;31;-1
NEJMra1213566;83 women;83;-1
NEJMra1213566;47 of these   pregnant women;47;-1
NEJMra1213566;220 consecutive pregnant women;220;-1
NEJMra1213566;12  HSV Infection  Pregnant women;12;-1
NEJMra1213566;18 Pregnant women;18;-1
NEJMra1213566;43 pregnant women;43;-1
NEJMra1213566;28   of these women;28;-1
NEJMra1213566;144 women;144;-1
NEJMra1213566;1373 women;1373;-1
NEJMra1213566;45 Hispanic   women;45;-1
NEJMra1213566;13 After patients;13;-1
NEJMra1213956;20 For patients;20;-1
NEJMra1213956;68 patients;68;-1
NEJMra1213956;70 pe-  diatric patients;70;-1
NEJMra1214243;16 For patients;16;-1
NEJMra1216008;23 In patients;23;-1
NEJMra1216008;52 Most of   the infected patients;52;-1
NEJMra1216008;57 patients;57;-1
NEJMra1301069;19   In patients;19;-1
NEJMra1301069;100,000 people;100000;-1
NEJMra1301069;100,000   people;100000;-1
NEJMra1301635;115 patients;115;-1
NEJMra1301635;97 patients;97;-1
NEJMra1301635;22 In immunocompromised patients;22;-1
NEJMra1301635;71 patients;71;-1
NEJMra1301635;59 patients;59;-1
NEJMra1301635;28   In patients;28;-1
NEJMra1301635;973 patients;973;-1
NEJMra1301758;7000 participants;7000;-1
NEJMra1301758;1 million people;1;-1
NEJMra1302901;95 patients;95;-1
NEJMra1303917;21 In   these patients;21;-1
NEJMra1303917;33 patients;33;-1
NEJMra1303917;total of 152;152;-1
NEJMra1304623;234 patients;234;-1
NEJMra1304623;130 patients;130;-1
NEJMra1304623;1118 patients;1118;-1
NEJMra1304623;329 patients;329;-1
NEJMra1304623;4640 critically ill patients;4640;-1
NEJMra1304623;305 patients;305;-1
NEJMra1304623;686 patients;686;-1
NEJMra1304623;798 patients;798;-1
NEJMra1304623;517 patients;517;-1
NEJMra1304623;14 For these patients;14;-1
NEJMra1304623;50 patients;50;-1
NEJMra1304623;485 patients;485;-1
NEJMra1304623;500 patients;500;-1
NEJMra1304623;1223 patients;1223;-1
NEJMra1304623;411 patients;411;-1
NEJMra1304623;272 patients;272;-1
NEJMra1304623;100 patients;100;-1
NEJMra1304623;N  =  10;10;-1
NEJMra1304623;N  =  13;13;-1
NEJMra1304623;N  =  46;46;-1
NEJMra1304623;N  =  30;30;-1
NEJMra1304623;N  =  49;49;-1
NEJMra1304623;N  =  50;50;-1
NEJMra1304623;N  =  68;68;-1
NEJMra1304623;N  =  23;23;-1
NEJMra1304623;N  =  15;15;-1
NEJMra1304623;N  =  65;65;-1
NEJMra1304623;total of 234;234;-1
NEJMra1304623;total of 798;798;-1
NEJMra1304623;total of 485;485;-1
NEJMra1304623;total of   411;411;-1
NEJMra1308383;11 and women;11;-1
NEJMra1308383;1960s few women;1960;-1
NEJMra1308383;57 In motivated persons;57;-1
NEJMra1308383;1 billion people;1;-1
NEJMra1308383;3 billion people;3;-1
NEJMra1308383;39 and help prevent young   people;39;-1
NEJMra1308383;3 billion individuals;3;-1
NEJMra1309483;11 In patients;11;-1
NEJMra1309483;60  In patients;60;-1
NEJMra1312353;37 patients;37;-1
NEJMra1312353;22 patients;22;-1
NEJMra1312353;total of   37;37;-1
NEJMra1312543;1,000 participants;1000;-1
NEJMra1312885;34,892 subjects;34892;-1
NEJMra1312885;62  For patients;62;-1
NEJMra1312885;70 Such patients;70;-1
NEJMra1313875;37  In some patients;37;-1
NEJMra1313875;61 In patients;61;-1
NEJMra1313875;2344 patients;2344;-1
NEJMra1313875;total of 65,000;65000;-1
NEJMra1314094;3 million patients;3;-1
NEJMra1314376;10 In adults;10;-1
NEJMra1314376; data from   1987;1987;-1
NEJMra1314704;5 In patients;5;-1
NEJMra1314704;19 Untreated patients;19;-1
NEJMra1314704;45 For   patients;45;-1
NEJMra1314704;38 case patients;38;-1
NEJMra1314704;540 patients;540;-1
NEJMra1314704;147 patients;147;-1
NEJMra1314704;210 patients;210;-1
NEJMra1314704;136 patients;136;-1
NEJMra1314704;349 patients;349;-1
NEJMra1401108;15 patients;15;-1
NEJMra1401108;8 patients;8;-1
NEJMra1401108;7 patients;7;-1
NEJMra1401108;70 patients;70;-1
NEJMra1402309;7 million people;7;-1
NEJMra1402309;1 million people;1;-1
NEJMra1404198;269 patients;269;-1
NEJMra1404198;100,000 people;100000;-1
NEJMra1404198;46,000 people;46000;-1
NEJMra1404198;40,000 people;40000;-1
NEJMra1404415;100,000 persons;100000;-1
NEJMra1404415;total of 53,600;53600;-1
NEJMra1407298;24 In patients;24;-1
NEJMra1407298;28  In patients;28;-1
NEJMra1407550;1822 patients;1822;-1
NEJMra1407550;19 In other patients;19;-1
NEJMra1407550;1034 patients;1034;-1
NEJMra1407550;745 patients;745;-1
NEJMra1407550;36 In low-risk   patients;36;-1
NEJMra1407550;38 For patients;38;-1
NEJMra1407550;184 patients;184;-1
NEJMra1407550;216 patients;216;-1
NEJMra1407550;1500 patients;1500;-1
NEJMra1407550;216 patients were   enrolled;216;-1
NEJMsa1204142;43   women;43;-1
NEJMsa1204142;109 participants;109;-1
NEJMsa1204142;22 participants;22;-1
NEJMsa1204142;87 participants;87;-1
NEJMsa1204142;109 adults;109;-1
NEJMsa1204142;total of 22;22;-1
NEJMsa1300991;61,523 patients;61523;-1
NEJMsa1300991;20 For   patients;20;-1
NEJMsa1300991;612 patients;612;-1
NEJMsa1300991;total of 4372;4372;-1
NEJMsa1308261;20 Some patients;20;-1
NEJMsa1308261;13 million people;13;-1
NEJMsa1308261;N = 109,341;109341;-1
NEJMsa1308261;N = 106,370;106370;-1
NEJMsa1308261;total of 101;101;-1
NEJMsa1311707;110 adults;110;-1
NEJMsa1313308;20  Medicare patients;20;-1
NEJMsa1404026;18 mil-  lion persons;18;-1
NEJMsa1404026;total of 18;18;-1
NEJMsa1405003; data from the 2010;2010;-1
NEJMsa1405003; data from   2005;2005;-1
NEJMsa1405556;5752   unique patients;5752;-1
NEJMsa1405556;13 patients;13;-1
NEJMsa1405556;2281 patients;2281;-1
NEJMsa1405556;11 patients;11;-1
NEJMsa1405556;N = 5516;5516;-1
NEJMsa1405556;N = 5224;5224;-1
NEJMsa1405556;total of 432;432;-1
NEJMsa1405556;total of   207;207;-1
NEJMsa1405556;total of 875;875;-1
NEJMsa1406552;N = 21,463;21463;-1
NEJMsa1406552;N = 186,846;186846;-1
NEJMsa1406552;total of 82;82;-1
NEJMsa1406552; data from 2010;2010;-1
NEJMsa1407273;94,171 persons;94171;-1
NEJMsa1407273;N = 94,171;94171;-1
NEJMsa1407273;N = 2,307,553;2307553;-1
NEJMsa1407273;N = 112,039;112039;-1
NEJMsa1407273;N = 653,039;653039;-1
NEJMsa1407273;N = 105,848;105848;-1
NEJMsa1407273;N = 1,065,508;1065508;-1
NEJMsa1407273;   data from 30;30;-1
NEJMsb1402963;7 For   care of pediatric patients;7;-1
NEJMsb1405487;20,000 people;20000;-1
NEJMsr1405012;24 Since a study involving   patients;24;-1
NEJMsr1405012;10 million people;10;-1
NEJMsr1405012;100,000   people;100000;-1
NEJMsr1405012;40   million people;40;-1
NEJMsr1405012;8 million people;8;-1
NEJMsr1406753;7500 adults;7500;-1
NEJMsr1406753;17 Our sample excluded   adults;17;-1
NEJMsr1406753;420,449 adults;420449;-1
NEJMsr1406753;198 million adults;198;-1
NEJMsr1406753;3 million adults;3;-1
NEJMsr1406753;2 million adults;2;-1
NEJMsr1406753;N = 420,449;420449;-1
NEJMsr1406753;total of 63;63;-1
NEJMsr1412118;   data from 27;27;-1
NEJMvcm1211809;1000   persons;1000;-1
NEJMvcm1211809;100 patients;100;-1
NEJMx130049;63 patients;63;-1
NEJMx130059;99 patients;99;-1
NEJMx130059;54 patients;54;-1
NEJMx130060;99 patients;99;-1
NEJMx130060;54 patients;54;-1
NEJMx140003;63 patients;63;-1
NEJMx140004;99   patients;99;-1
NEJMx140004;54   patients;54;-1
NEJMx140006;99   patients;99;-1
NEJMx140006;54   patients;54;-1
NEJMx140007;99   patients;99;-1
NEJMx140007;54   patients;54;-1
NEJMx140012;466 patients;466;-1
NEJMx140012;456 patients;456;-1
NEJMx140023;67 patients;67;-1
NEJMx140023;52 patients;52;-1
NEJMx140023;23 patients;23;-1
NEJMx140023;554 patients;554;-1
NEJMx140023;548   patients;548;-1
NEJMx140023;548 patients;548;-1
NEJMx140023;306 patients;306;-1
NEJMx140023;299 patients;299;-1
NEJMx140039;118 patients;118;-1
NEJMx140039;58 patients;58;-1
NEJMx140039;37 patients;37;-1
NEJMx140039;total of 4;4;-1
NEJMx140040;118 patients;118;-1
NEJMx140040;58 patients;58;-1
NEJMx140040;37 patients;37;-1
NEJMx140040;total of 4;4;-1
NEJMx140041;1 patients;1;-1
NEJMx140042;1 patients;1;-1
NEJMx140043;1 patients;1;-1
NEJMx140059;N = 20;20;-1
